Citrus Sinensis ID: 017503

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370
Protein Sequence
MSCRCFGGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR
Secondary Structure (PSIPRED)
cEEEEEcccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHccccccccEEEEEcccccEEEEEEEcccccHHHHccccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccEEEccccccHHHHccccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccEEEcccccccccccccccccccccccccEEEEEEccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHccccccccccccccccccccccccccHHHHHHHHccccHHccccccccccEEEcEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccEccccccHHHEEEEHHHEEEEccccHHHHcccHccEEEEEEEEccccccHHHHHccccccHHHHHHHHEEEEEEEccccccccccccccHHHHHHHHHHHHccccHHHccccHccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccccEEcccccccccccccccccccccccccccEEEcccc
Coil and Loop (DISEMBL)
mscrcfggsrfhskksaereapqgvdgellrnvnhfsytelrsatddfhlsnkigrggfgtvykgtltngrriavkplsaeskQGVREFITEIMTlsnvrhpnlVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVphivhrdikasnilldqefnpkigdfglaklfpdnithittriagttgylapeyvlggqltmkadvYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHqeekplelvdpelgeyppneIIRYMKVAFFCTqaaasrrpQMNQVIKMLTKNIrlneeeltapglfqdsesssvgtsdkkssdstlqmssvpvtitqvtpr
Flexible Loop (DISEMBL)
mscrcfggsrfhskksaereapqgvdgellRNVNHFSYTELrsatddfhlsnkigrGGFGTVykgtltngrriavkplsaeskqgVREFITEIMtlsnvrhpnLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAasrrpqmnQVIKMLTKNIRLNEEELtapglfqdsesssvgtsdkkssdstlqmssvpvtitqvtpr
Low Complexity Region (SEG)
MSCRCFGGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQdsesssvgtsdkkssdstLQMSSVPVTITQVTPR
Disordered region (IsUnstruct)
****************************LLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS****MNQVIKMLTKNIR***********************************************
Disordered Region (DISOPRED)
MSCRCFGGS***********************VNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR***EELTAPGL****************************TITQVTPR
Disordered Region (DISEMBL)
***********************GVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQ*********************SSVPVTITQVTPR
Disordered Region (DISPRO)
MSCRCFGGSRFH*******************NVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQD*********************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSCRCFGGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	370	2.2.26 [Sep-21-2011]
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.897	0.321	0.464	7e-89
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.891	0.319	0.473	5e-88
C0LGG8	1038	Probable LRR receptor-lik	no	no	0.829	0.295	0.512	6e-87
C0LGN2	1020	Probable leucine-rich rep	no	no	0.840	0.304	0.506	2e-86
C0LGG9	1035	Probable LRR receptor-lik	no	no	0.829	0.296	0.506	5e-86
C0LGE0	1014	Probable LRR receptor-lik	no	no	0.786	0.286	0.529	4e-84
C0LGG7	953	Probable LRR receptor-lik	no	no	0.770	0.299	0.534	1e-83
Q9ASQ6	1019	Probable LRR receptor-lik	no	no	0.854	0.310	0.489	3e-82
Q8S9L6	679	Cysteine-rich receptor-li	no	no	0.881	0.480	0.464	2e-77
Q8GWJ7	645	Cysteine-rich receptor-li	no	no	0.959	0.550	0.426	4e-77

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  327 bits (839), Expect = 7e-89,   Method: Compositional matrix adjust.
 Identities = 158/340 (46%), Positives = 231/340 (67%), Gaps = 8/340 (2%)

Query: 36   FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMT 95
            F+Y+EL+SAT DF  SNK+G GGFG VYKG L +GR +AVK LS  S+QG  +F+ EI+ 
Sbjct: 681  FTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVA 740

Query: 96   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
            +S V+H NLV+L GCC +G  R+LVYEY+ N SLD+ L G  +  + L+W  R +IC+G+
Sbjct: 741  ISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFG--EKTLHLDWSTRYEICLGV 798

Query: 156  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
            A+GL +LHEE    IVHRD+KASNILLD +  PK+ DFGLAKL+ D  THI+TR+AGT G
Sbjct: 799  ARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIG 858

Query: 216  YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 275
            YLAPEY + G LT K DVY+FGV+ LE++SGR +         ++LLEWAW LH++ + +
Sbjct: 859  YLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKGREV 918

Query: 276  ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL- 334
            EL+D +L E+   E  R + +A  CTQ + + RP M++V+ ML+ ++ +++   + PG  
Sbjct: 919  ELIDHQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVT-SKPGYL 977

Query: 335  ----FQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR 370
                F D+ +SS+     +++ ++   +S     ++++PR
Sbjct: 978  TDWRFDDTTASSISGFPLRNTQASESFTSFVAPRSEISPR 1017

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  325 bits (832), Expect = 5e-88,   Method: Compositional matrix adjust.
 Identities = 161/340 (47%), Positives = 228/340 (67%), Gaps = 10/340 (2%)

Query: 36   FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMT 95
            F+Y+EL+SAT DF  SNK+G GGFG VYKG L +GR +AVK LS  S+QG  +F+ EI+ 
Sbjct: 682  FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVA 741

Query: 96   LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
            +S+V H NLV+L GCC +G  R+LVYEY+ N SLD+ L G     + L+W  R +IC+G+
Sbjct: 742  ISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFG--DKTLHLDWSTRYEICLGV 799

Query: 156  AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
            A+GL +LHEE    IVHRD+KASNILLD    P+I DFGLAKL+ D  THI+TR+AGT G
Sbjct: 800  ARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIG 859

Query: 216  YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 275
            YLAPEY + G LT K DVY+FGV+ LE++SGR +      +  K+LLEWAW LH++ + +
Sbjct: 860  YLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDI 919

Query: 276  ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL- 334
            EL+D +L ++   E  R + +A  CTQ + + RP M++V+ ML+ ++ + +   + PG  
Sbjct: 920  ELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVT-SKPGYV 978

Query: 335  ----FQDSESSSVGTSDKKSSDSTLQMSSVPVTITQVTPR 370
                F D+  SS+  S  +  D+T    S+    ++++PR
Sbjct: 979  SDWRFDDTTGSSL--SGFQIKDTTGYSMSLVAPGSEISPR 1016

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1

 Score =  321 bits (822), Expect = 6e-87,   Method: Compositional matrix adjust.
 Identities = 160/312 (51%), Positives = 214/312 (68%), Gaps = 5/312 (1%)

Query: 14  KKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI 73
           K+  E E  +G+D +       F+  +++ AT++F   NKIG GGFG VYKG L +G  I
Sbjct: 639 KEVDENEELRGLDLQ----TGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTI 694

Query: 74  AVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL 133
           AVK LS++SKQG REF+TEI  +S ++HPNLV+L GCC++G   +LVYEY+ENNSL R L
Sbjct: 695 AVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARAL 754

Query: 134 LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF 193
            G  K  + L+W  R+ IC+GIAKGLA+LHEE    IVHRDIKA+N+LLD   N KI DF
Sbjct: 755 FGTEKQRLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDF 814

Query: 194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM 253
           GLAKL  D  THI+TRIAGT GY+APEY + G LT KADVYSFGV+ LEI+SG+++    
Sbjct: 815 GLAKLNDDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYR 874

Query: 254 WGQMNKFLLEWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMN 312
             +   +LL+WA+ L ++   LELVDP+LG  +   E +R + +A  CT  + + RP M+
Sbjct: 875 PKEEFVYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMS 934

Query: 313 QVIKMLTKNIRL 324
            V+ ML   I++
Sbjct: 935 SVVSMLEGKIKV 946

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1

 Score =  319 bits (818), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 158/312 (50%), Positives = 214/312 (68%), Gaps = 1/312 (0%)

Query: 33  VNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITE 92
           ++ FS  +++ ATD+F  +NKIG GGFG V+KG +T+G  IAVK LSA+SKQG REF+ E
Sbjct: 657 ISSFSLRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNE 716

Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 152
           I  +S ++HP+LV+L GCCV+G + +LVYEY+ENNSL R L G  +  I LNW  R  IC
Sbjct: 717 IAMISALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKIC 776

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 212
           VGIA+GLA+LHEE    IVHRDIKA+N+LLD+E NPKI DFGLAKL  +  THI+TR+AG
Sbjct: 777 VGIARGLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRVAG 836

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE 272
           T GY+APEY + G LT KADVYSFGV+ LEI+ G+++  +       +LL+W   L ++ 
Sbjct: 837 TYGYMAPEYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLREQN 896

Query: 273 KPLELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTA 331
             LE+VDP LG +Y   E +  +++   CT  A   RP M+ V+ ML  +  +N E+L  
Sbjct: 897 TLLEVVDPRLGTDYNKQEALMMIQIGMLCTSPAPGDRPSMSTVVSMLEGHSTVNVEKLLE 956

Query: 332 PGLFQDSESSSV 343
             +  + +  SV
Sbjct: 957 ASVNNEKDEESV 968

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2

 Score =  318 bits (814), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 158/312 (50%), Positives = 214/312 (68%), Gaps = 5/312 (1%)

Query: 14  KKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI 73
           K+  E E  +G+D +       F+  +++ AT++F   NKIG GGFG VYKG L +G  I
Sbjct: 637 KEVDENEELRGLDLQ----TGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTI 692

Query: 74  AVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL 133
           AVK LS++SKQG REF+TEI  +S ++HPNLV+L GCC++G   +LVYEY+ENNSL R L
Sbjct: 693 AVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARAL 752

Query: 134 LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF 193
            G  K  + L+W  R+ +C+GIAKGLA+LHEE    IVHRDIKA+N+LLD   N KI DF
Sbjct: 753 FGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDF 812

Query: 194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM 253
           GLAKL  +  THI+TRIAGT GY+APEY + G LT KADVYSFGV+ LEI+SG+++    
Sbjct: 813 GLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYR 872

Query: 254 WGQMNKFLLEWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMN 312
             +   +LL+WA+ L ++   LELVDP+LG  +   E +R + +A  CT  + + RP M+
Sbjct: 873 PKEEFIYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMS 932

Query: 313 QVIKMLTKNIRL 324
            V+ ML   I++
Sbjct: 933 SVVSMLQGKIKV 944

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1

 Score =  311 bits (798), Expect = 4e-84,   Method: Compositional matrix adjust.
 Identities = 155/293 (52%), Positives = 208/293 (70%), Gaps = 2/293 (0%)

Query: 36  FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMT 95
           F+  ++++ATD+F ++ KIG GGFG+VYKG L+ G+ IAVK LSA+S+QG REF+ EI  
Sbjct: 666 FTLRQIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGM 725

Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN-IKLNWEKRSDICVG 154
           +S ++HPNLV+L GCCV+G + ILVYEY+ENN L R L G  +++ +KL+W  R  I +G
Sbjct: 726 ISALQHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLG 785

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
           IAKGL FLHEE    IVHRDIKASN+LLD++ N KI DFGLAKL  D  THI+TRIAGT 
Sbjct: 786 IAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTI 845

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           GY+APEY + G LT KADVYSFGV+ LEI+SG+++      +   +LL+WA+ L +    
Sbjct: 846 GYMAPEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQERGSL 905

Query: 275 LELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 326
           LELVDP L  +Y   E +  + VA  CT A+ + RP M+QV+ ++     + E
Sbjct: 906 LELVDPTLASDYSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEGKTAMQE 958

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2

 Score =  310 bits (793), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 154/288 (53%), Positives = 204/288 (70%), Gaps = 3/288 (1%)

Query: 33  VNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITE 92
           +  FS  +++ AT++F  +N+IG GGFG VYKG L +G  IAVK LS  SKQG REF+ E
Sbjct: 609 IASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNE 668

Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 152
           I  +S + HPNLV+L GCCV+G + +LVYE+VENNSL R L G  +  ++L+W  R  IC
Sbjct: 669 IGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKIC 728

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 212
           +G+A+GLA+LHEE    IVHRDIKA+N+LLD++ NPKI DFGLAKL  ++ THI+TRIAG
Sbjct: 729 IGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAG 788

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF-LLEWAWQLHQE 271
           T GY+APEY + G LT KADVYSFG++ LEI+ GR S K    + N F L++W   L ++
Sbjct: 789 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGR-SNKIERSKNNTFYLIDWVEVLREK 847

Query: 272 EKPLELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
              LELVDP LG EY   E +  +++A  CT +    RP M++V+KML
Sbjct: 848 NNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKML 895

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3

 Score =  305 bits (781), Expect = 3e-82,   Method: Compositional matrix adjust.
 Identities = 157/321 (48%), Positives = 219/321 (68%), Gaps = 5/321 (1%)

Query: 36  FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMT 95
           FS+ +L++AT++F  +NK+G GGFG+V+KG L++G  IAVK LS++S QG REF+ EI  
Sbjct: 661 FSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGM 720

Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +S + HPNLV+L GCCV+  + +LVYEY+ENNSL   L G  + ++KL+W  R  ICVGI
Sbjct: 721 ISGLNHPNLVKLYGCCVERDQLLLVYEYMENNSLALALFG--QNSLKLDWAARQKICVGI 778

Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           A+GL FLH+     +VHRDIK +N+LLD + N KI DFGLA+L     THI+T++AGT G
Sbjct: 779 ARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAGTIG 838

Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 275
           Y+APEY L GQLT KADVYSFGV+ +EI+SG+++ K      +  L+ WA  L Q    L
Sbjct: 839 YMAPEYALWGQLTEKADVYSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQTGDIL 898

Query: 276 ELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL 334
           E+VD  L GE+  +E +R +KVA  CT ++ S RP M++ +KML   I +  + ++ PG+
Sbjct: 899 EIVDRMLEGEFNRSEAVRMIKVALVCTNSSPSLRPTMSEAVKMLEGEIEIT-QVMSDPGI 957

Query: 335 F-QDSESSSVGTSDKKSSDST 354
           +  D   S +   D  SS ST
Sbjct: 958 YGHDWSISKLRDIDTHSSSST 978

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1

 Score =  289 bits (740), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 158/340 (46%), Positives = 216/340 (63%), Gaps = 14/340 (4%)

Query: 38  YTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLS 97
           +  L++ATD+F   N++GRGGFG+VYKG    G+ IAVK LS  S QG  EF  EI+ L+
Sbjct: 347 FETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEFKNEILLLA 406

Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++H NLV LIG C+QG  R+LVYE+++N SLD+ +    K  + L+W  R  +  GIA+
Sbjct: 407 KLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQL-LDWVVRYKMIGGIAR 465

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD--NITH-ITTRIAGTT 214
           GL +LHE+    I+HRD+KASNILLDQE NPKI DFGLAKLF     +TH  T+RIAGT 
Sbjct: 466 GLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTY 525

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFLLEWAWQLHQEE 272
           GY+APEY + GQ ++K DV+SFGVLV+EII+G+  N+G +   +  + LL W W+  +E+
Sbjct: 526 GYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRSWRED 585

Query: 273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAP 332
             L ++DP L     NEI+R + +   C Q +A+ RP M  V  M      LN    T P
Sbjct: 586 TILSVIDPSLTAGSRNEILRCIHIGLLCVQESAATRPTMATVSLM------LNSYSFTLP 639

Query: 333 GLFQDSE--SSSVGTSDKKSSDSTLQMSSVPVTITQVTPR 370
              + +    S V  S+  SS   LQMSS  VT+++ +PR
Sbjct: 640 TPLRPAFVLESVVIPSNVSSSTEGLQMSSNDVTVSEFSPR 679

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2

 Score =  288 bits (737), Expect = 4e-77,   Method: Compositional matrix adjust.
 Identities = 156/366 (42%), Positives = 226/366 (61%), Gaps = 11/366 (3%)

Query: 10  RFHSKKSAEREAPQGVDGELLRNVN--HFSYTELRSATDDFHLSNKIGRGGFGTVYKGTL 67
           R  +K++   + P   DG  +       F +  + +AT+ F   NK+G+GGFG VYKGTL
Sbjct: 286 RAKNKRTLNEKEPVAEDGNDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTL 345

Query: 68  TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 127
           ++G ++AVK LS  S QG +EF  E++ ++ ++H NLV+L+G C++G  +ILVYE+V N 
Sbjct: 346 SSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNK 405

Query: 128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 187
           SLD  L  +T   +KL+W +R  I  GIA+G+ +LH++    I+HRD+KA NILLD + N
Sbjct: 406 SLDHFLFDST-MKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMN 464

Query: 188 PKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PKI DFG+A++F  D    +T R+ GT GY++PEY + GQ +MK+DVYSFGVLVLEIISG
Sbjct: 465 PKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISG 524

Query: 247 -RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE-YPPNEIIRYMKVAFFCTQAA 304
            +NS      +    L+ + W+L     P ELVDP  G+ Y  +EI R + +A  C Q  
Sbjct: 525 MKNSSLYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQED 584

Query: 305 ASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSVPVTI 364
           A  RP M+ +++MLT ++ +   E   PG F  S+    G     S DS+   S    +I
Sbjct: 585 AEDRPTMSSIVQMLTTSL-IALAEPRPPGFFFRSKQEQAG----PSIDSSTHCSVDEASI 639

Query: 365 TQVTPR 370
           T+VTPR
Sbjct: 640 TRVTPR 645

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	370
356521337	367	PREDICTED: probable LRR receptor-like se	0.989	0.997	0.698	1e-150
359496587	364	PREDICTED: probable LRR receptor-like se	0.983	1.0	0.713	1e-150
297742896	441	unnamed protein product [Vitis vinifera]	0.983	0.825	0.713	1e-150
356548747	367	PREDICTED: probable LRR receptor-like se	0.986	0.994	0.696	1e-149
255555999	367	Serine/threonine-protein kinase PBS1, pu	0.983	0.991	0.699	1e-148
358346657	392	hypothetical protein MTR_084s0004 [Medic	0.991	0.936	0.688	1e-146
224078940	306	predicted protein [Populus trichocarpa]	0.827	1.0	0.777	1e-143
224125454	310	predicted protein [Populus trichocarpa]	0.832	0.993	0.75	1e-141
449457713	383	PREDICTED: probable leucine-rich repeat	0.997	0.963	0.634	1e-138
357446519	370	Cysteine-rich receptor-like protein kina	0.983	0.983	0.638	1e-136

>gi|356521337|ref|XP_003529313.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53430-like [Glycine max]

 Score =  538 bits (1386), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 259/371 (69%), Positives = 308/371 (83%), Gaps = 5/371 (1%)

Query: 1   MSCRCFGGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFG 60
           MSC CFG S    K++   + P  +DG  L NV +FS  +LR ATD+++ S K+GRGGFG
Sbjct: 1   MSCGCFGASTLKKKRNPS-DTPNEIDGFPLDNVKNFSDKDLRLATDNYNPSKKLGRGGFG 59

Query: 61  TVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 120
            VY+GTL NGR++AVK LSA SKQGVREF+TEI T+SNV+HPNLVEL+GCCVQ   RILV
Sbjct: 60  IVYQGTLKNGRQVAVKTLSAGSKQGVREFLTEIKTISNVKHPNLVELVGCCVQEPNRILV 119

Query: 121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 180
           YE+VENNSLDR LLG+  +NI+L+W KRS IC+G A+GLAFLHEE VPHIVHRDIKASNI
Sbjct: 120 YEFVENNSLDRALLGSRGSNIRLDWRKRSAICMGTARGLAFLHEEHVPHIVHRDIKASNI 179

Query: 181 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 240
           LLD++FNPKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY +GGQLTMKADVYSFGVL+
Sbjct: 180 LLDRDFNPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYAMGGQLTMKADVYSFGVLI 239

Query: 241 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 300
           LEIISG++S +  WG  NKFLLEWAWQL++E K LELVDP++ E+P  E+IRYMKVAFFC
Sbjct: 240 LEIISGKSSARTNWGGSNKFLLEWAWQLYEEGKLLELVDPDMVEFPEKEVIRYMKVAFFC 299

Query: 301 TQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDST-LQMSS 359
           TQAAASRRP M+QV+ ML+KN+RLNE++LTAPGLFQDS +SS     K S +ST  Q SS
Sbjct: 300 TQAAASRRPMMSQVVDMLSKNMRLNEKQLTAPGLFQDSGASS---QKKSSFESTGYQFSS 356

Query: 360 VPVTITQVTPR 370
            P +ITQ+ PR
Sbjct: 357 NPSSITQLAPR 367

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496587|ref|XP_003635271.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Vitis vinifera]

 Score =  536 bits (1382), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 264/370 (71%), Positives = 301/370 (81%), Gaps = 6/370 (1%)

Query: 1   MSCRCFGGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFG 60
           MSC CFG S   SK    R A Q +DG LL      S+ EL+ ATD+FH S+KIGRGGFG
Sbjct: 1   MSCSCFGVSTADSKGKGNR-ASQKIDGNLLEKTKQISFNELKKATDNFHPSSKIGRGGFG 59

Query: 61  TVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 120
           TVYKGTL NGR +AVK LS  SKQG+REF+TEI T+SNVRHPNLVELIGCCV G  +ILV
Sbjct: 60  TVYKGTLKNGREVAVKMLSTSSKQGLREFLTEINTISNVRHPNLVELIGCCVHGNNKILV 119

Query: 121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 180
           YEYVENNS+D+VLLG     I L+W KRS IC+G A+GLAFLHEELVPHIVHRDIKASNI
Sbjct: 120 YEYVENNSIDQVLLGH---KIILDWGKRSAICMGTARGLAFLHEELVPHIVHRDIKASNI 176

Query: 181 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 240
           LL+++F+PKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY LGGQLTMKADVYSFGVLV
Sbjct: 177 LLEKDFSPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYALGGQLTMKADVYSFGVLV 236

Query: 241 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 300
           LEIISG+ S +A +G   KFLLEWAWQLH E + LELVDPEL E+P  E++RY KVAFFC
Sbjct: 237 LEIISGKTSSQANFGGSQKFLLEWAWQLHIEGRFLELVDPELVEFPEEEVMRYAKVAFFC 296

Query: 301 TQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSV 360
           TQAAASRRP M+QV+ ML++NIRLNE+ELTAPG FQ S+  S   S   S  ++ QMSSV
Sbjct: 297 TQAAASRRPLMSQVVDMLSRNIRLNEKELTAPGYFQTSDDCSRKPSSTDS--ASYQMSSV 354

Query: 361 PVTITQVTPR 370
           PVTIT+VTPR
Sbjct: 355 PVTITEVTPR 364

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297742896|emb|CBI35687.3| unnamed protein product [Vitis vinifera]

 Score =  536 bits (1382), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 264/370 (71%), Positives = 301/370 (81%), Gaps = 6/370 (1%)

Query: 1   MSCRCFGGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFG 60
           MSC CFG S   SK    R A Q +DG LL      S+ EL+ ATD+FH S+KIGRGGFG
Sbjct: 78  MSCSCFGVSTADSKGKGNR-ASQKIDGNLLEKTKQISFNELKKATDNFHPSSKIGRGGFG 136

Query: 61  TVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 120
           TVYKGTL NGR +AVK LS  SKQG+REF+TEI T+SNVRHPNLVELIGCCV G  +ILV
Sbjct: 137 TVYKGTLKNGREVAVKMLSTSSKQGLREFLTEINTISNVRHPNLVELIGCCVHGNNKILV 196

Query: 121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 180
           YEYVENNS+D+VLLG     I L+W KRS IC+G A+GLAFLHEELVPHIVHRDIKASNI
Sbjct: 197 YEYVENNSIDQVLLGH---KIILDWGKRSAICMGTARGLAFLHEELVPHIVHRDIKASNI 253

Query: 181 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 240
           LL+++F+PKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY LGGQLTMKADVYSFGVLV
Sbjct: 254 LLEKDFSPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYALGGQLTMKADVYSFGVLV 313

Query: 241 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 300
           LEIISG+ S +A +G   KFLLEWAWQLH E + LELVDPEL E+P  E++RY KVAFFC
Sbjct: 314 LEIISGKTSSQANFGGSQKFLLEWAWQLHIEGRFLELVDPELVEFPEEEVMRYAKVAFFC 373

Query: 301 TQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSV 360
           TQAAASRRP M+QV+ ML++NIRLNE+ELTAPG FQ S+  S   S   S  ++ QMSSV
Sbjct: 374 TQAAASRRPLMSQVVDMLSRNIRLNEKELTAPGYFQTSDDCSRKPSSTDS--ASYQMSSV 431

Query: 361 PVTITQVTPR 370
           PVTIT+VTPR
Sbjct: 432 PVTITEVTPR 441

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356548747|ref|XP_003542761.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Glycine max]

 Score =  533 bits (1374), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 259/372 (69%), Positives = 308/372 (82%), Gaps = 7/372 (1%)

Query: 1   MSCRCFGGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFG 60
           MSC CFG S    K++  R  P  +DG  L NV +FS  +LR ATD+++ S K+GRGGFG
Sbjct: 1   MSCGCFGASTLKRKRNPSR-TPNEIDGFPLDNVKNFSDKDLRLATDNYNPSKKLGRGGFG 59

Query: 61  TVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 120
           TVY+GTL NG+++AVK LSA SKQGVREF+TEI T+SNV+HPNLVEL+GCCVQ   RILV
Sbjct: 60  TVYQGTLKNGQQVAVKTLSAGSKQGVREFLTEIKTISNVKHPNLVELVGCCVQEPNRILV 119

Query: 121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 180
           YEYVENNSLDR LLG   +NI+L+W KRS IC+G A+GLAFLHEELVPHIVHRDIKASNI
Sbjct: 120 YEYVENNSLDRALLGPRSSNIRLDWRKRSAICMGTARGLAFLHEELVPHIVHRDIKASNI 179

Query: 181 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 240
           LLD++F PKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY +GGQLTMKADVYSFGVL+
Sbjct: 180 LLDRDFKPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYAMGGQLTMKADVYSFGVLI 239

Query: 241 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 300
           LEIISG++S +  WG  NKFLLEWAW L++E K LELVDP++ E+P  E+IRYMKVAFFC
Sbjct: 240 LEIISGKSSARTNWGGSNKFLLEWAWNLYEEGKLLELVDPDMVEFPEEEVIRYMKVAFFC 299

Query: 301 TQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSS--DSTLQMS 358
           TQAAASRRP M+QV+ ML+KN+RLNE++LTAPGLFQDS +S    S KKSS   ++ Q S
Sbjct: 300 TQAAASRRPMMSQVVDMLSKNMRLNEKQLTAPGLFQDSGAS----SQKKSSFESTSYQFS 355

Query: 359 SVPVTITQVTPR 370
           S   +ITQ++PR
Sbjct: 356 SNSSSITQLSPR 367

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555999|ref|XP_002519034.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223541697|gb|EEF43245.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  530 bits (1364), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 261/373 (69%), Positives = 302/373 (80%), Gaps = 9/373 (2%)

Query: 1   MSCRCFGGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFG 60
           M C CFG     SK SA R      D ELLR++NHFSY +LRSAT++FHL+NKIGRGGFG
Sbjct: 1   MRCSCFG-----SKGSAARPNLD-ADEELLRDINHFSYNQLRSATNNFHLTNKIGRGGFG 54

Query: 61  TVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 120
            VYKGTL +GR+IAVK LSA+SKQG+REF+ EI TLS VRHPNLVELIGCCV G  RILV
Sbjct: 55  IVYKGTLKDGRQIAVKTLSAQSKQGMREFLNEINTLSRVRHPNLVELIGCCVLGANRILV 114

Query: 121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 180
           YEYVENNSL+R LLG+   N  L+W KRS IC GIAKGLAFLHEELVPHIVHRDIKASN+
Sbjct: 115 YEYVENNSLERALLGSQNTNTTLDWGKRSAICFGIAKGLAFLHEELVPHIVHRDIKASNV 174

Query: 181 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 240
           LLD+E+NPKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY +GG LTMKADVYSFG+L+
Sbjct: 175 LLDKEYNPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYAMGGPLTMKADVYSFGILI 234

Query: 241 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 300
           LEIISGR+S K   G M K LLEWAW+L++  K LELVDP+LGE+P  E+IR+MKVA FC
Sbjct: 235 LEIISGRSSSKPSCGGMEKLLLEWAWELYEGGKLLELVDPQLGEFPEEEVIRHMKVALFC 294

Query: 301 TQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTS--DKKSSDST-LQM 357
           TQ   SRRP M+QV++ML+KNIRLNE+ L+APG F+D    S G S   K S+DST L  
Sbjct: 295 TQEVGSRRPLMSQVVEMLSKNIRLNEKLLSAPGFFRDLSGLSGGPSVTKKSSTDSTGLHT 354

Query: 358 SSVPVTITQVTPR 370
           SS+P TIT++ PR
Sbjct: 355 SSIPGTITELAPR 367

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358346657|ref|XP_003637382.1| hypothetical protein MTR_084s0004 [Medicago truncatula] gi|355503317|gb|AES84520.1| hypothetical protein MTR_084s0004 [Medicago truncatula]

 Score =  523 bits (1346), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 259/376 (68%), Positives = 301/376 (80%), Gaps = 9/376 (2%)

Query: 1   MSCRCFGGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFG 60
           MSC CFG S    K+S     P  +DG  L N+ HFS  +LR ATDD+H S KIGRGGFG
Sbjct: 20  MSCGCFGASTLKKKRSPP-HTPNEIDGYPLENIMHFSEKDLRLATDDYHPSKKIGRGGFG 78

Query: 61  TVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 120
           TVY+GTL NGR++A+K LSA SKQGVREF+TEI T+S+V+HPNLVEL+GCC Q   R LV
Sbjct: 79  TVYQGTLKNGRQVAIKSLSAASKQGVREFLTEIKTISHVKHPNLVELVGCCAQEPNRTLV 138

Query: 121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 180
           YEYVENNSLDR LLG    NIKL+W KRS+IC G A+GLAFLHEE VPHIVHRDIKASNI
Sbjct: 139 YEYVENNSLDRALLGNRSTNIKLDWGKRSNICTGTARGLAFLHEEAVPHIVHRDIKASNI 198

Query: 181 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 240
           LLD+ FNPKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY +GGQLTMKADVYSFGVL+
Sbjct: 199 LLDRHFNPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYAMGGQLTMKADVYSFGVLI 258

Query: 241 LEIISGRNSGKAMWGQMNKFLLEW------AWQLHQEEKPLELVDPELGEYPPNEIIRYM 294
           LE+ISG++S +  WG  NKFLLEW      AWQLH+EE+ LELVDP++ E+P  E+IRYM
Sbjct: 259 LEVISGQSSARTNWGGSNKFLLEWVRFQLPAWQLHEEERLLELVDPDMVEFPKEEVIRYM 318

Query: 295 KVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDST 354
           KVAFFCTQAAASRRP M+QV+ ML+K IRLNE+++TAPG FQ S  SS+  S  +S+   
Sbjct: 319 KVAFFCTQAAASRRPSMSQVVDMLSKKIRLNEKQITAPGFFQTSGESSLKKSSFESTSH- 377

Query: 355 LQMSSVPVTITQVTPR 370
            Q SS PV+ TQVTPR
Sbjct: 378 -QFSSAPVSFTQVTPR 392

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224078940|ref|XP_002305688.1| predicted protein [Populus trichocarpa] gi|222848652|gb|EEE86199.1| predicted protein [Populus trichocarpa]

 Score =  513 bits (1321), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 238/306 (77%), Positives = 272/306 (88%)

Query: 32  NVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFIT 91
           +VNH SY ELRSATD+FH SNKIGRGGFG VYKGTL +G ++AVK LSA+SKQGVREF+ 
Sbjct: 1   DVNHISYNELRSATDNFHSSNKIGRGGFGDVYKGTLRSGIQVAVKTLSAQSKQGVREFLN 60

Query: 92  EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
           EI T+SNVRHPNLVELIGCCVQG  RILVYEY+ENNSLDR LLG+   NI+L+W +RS I
Sbjct: 61  EIKTISNVRHPNLVELIGCCVQGANRILVYEYLENNSLDRALLGSRSTNIRLDWGRRSAI 120

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
           C+GIA+GLAFLHEELVPHIVHRDIKASNILLD++ NPKIGDFGLAKLFP+NITHI+TRIA
Sbjct: 121 CLGIARGLAFLHEELVPHIVHRDIKASNILLDKDLNPKIGDFGLAKLFPENITHISTRIA 180

Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 271
           GTTGYLAPEY LGGQLTMKADVYSFGVL+LEIISGRNS K  WG M K LLEWAWQLH+E
Sbjct: 181 GTTGYLAPEYALGGQLTMKADVYSFGVLILEIISGRNSTKPSWGGMEKLLLEWAWQLHEE 240

Query: 272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTA 331
            +PLELVDPE+GE+P  E+IRY+KVAFFCTQ+AA+RRP  +QV+ ML+K IRLN++ LTA
Sbjct: 241 GRPLELVDPEMGEFPEEEVIRYIKVAFFCTQSAANRRPLTSQVVDMLSKQIRLNDKLLTA 300

Query: 332 PGLFQD 337
           PG F+D
Sbjct: 301 PGFFRD 306

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224125454|ref|XP_002329809.1| predicted protein [Populus trichocarpa] gi|222870871|gb|EEF08002.1| predicted protein [Populus trichocarpa]

 Score =  506 bits (1303), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 231/308 (75%), Positives = 272/308 (88%)

Query: 29  LLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVRE 88
           L++++NH SY ELRSATD+FH SNKIGRGGFGTVYKGTL +G ++AVK LSA+S QGV+E
Sbjct: 3   LIQDINHLSYKELRSATDNFHTSNKIGRGGFGTVYKGTLKSGTQVAVKTLSAQSNQGVQE 62

Query: 89  FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 148
           F+ EI T+S V+HPNLVELIGCC QG+ RILVYEYVENNSLDR LLG+   +IKL+W +R
Sbjct: 63  FLNEIKTISKVKHPNLVELIGCCAQGSNRILVYEYVENNSLDRALLGSRSTDIKLDWGRR 122

Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
           S IC+GIA+GL FLH+E+VPHIVHRDIKASNILLD++FNPKIGDFGLAKLFPDNITHI+T
Sbjct: 123 SAICLGIARGLDFLHKEVVPHIVHRDIKASNILLDKDFNPKIGDFGLAKLFPDNITHIST 182

Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 268
           RIAGTTGYLAPEY LGGQLTMKADVYSFGVL+LEI+SGR+S K  WG   K LLEWAWQL
Sbjct: 183 RIAGTTGYLAPEYALGGQLTMKADVYSFGVLILEIVSGRSSAKPSWGGTQKLLLEWAWQL 242

Query: 269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 328
           H+E K LELVDPE+GE+P  E+IRY+KVAFFCTQ+AA+RRP M QV+ ML++ I+LN++E
Sbjct: 243 HEEGKHLELVDPEMGEFPEEEVIRYIKVAFFCTQSAANRRPIMTQVVDMLSRQIQLNDKE 302

Query: 329 LTAPGLFQ 336
           LTAPG FQ
Sbjct: 303 LTAPGFFQ 310

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449457713|ref|XP_004146592.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Cucumis sativus] gi|449488434|ref|XP_004158036.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Cucumis sativus]

 Score =  496 bits (1278), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 236/372 (63%), Positives = 294/372 (79%), Gaps = 3/372 (0%)

Query: 1   MSCRCFGGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFG 60
           MSC CFG S    ++ + R A + +D +LL NV   S+ ELRSA+DDFH +N+IGRGGFG
Sbjct: 13  MSCICFGSSTLEKERISTR-ADKELDIDLLENVKQISFNELRSASDDFHSNNRIGRGGFG 71

Query: 61  TVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 120
           TVYKGTL NG ++A+K LS ESKQG REF+TEI T+SN+RHPNLVELIGCC Q   RILV
Sbjct: 72  TVYKGTLRNGVQVAIKKLSIESKQGAREFLTEIKTISNIRHPNLVELIGCCSQKASRILV 131

Query: 121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 180
           YEY+ENNSLD  LL   K ++ L+W KRS IC+G A+GL FLHEE VPHIVHRDIKASNI
Sbjct: 132 YEYLENNSLDHALLDPKKISVHLDWRKRSSICIGTARGLQFLHEEAVPHIVHRDIKASNI 191

Query: 181 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 240
           LLD++FNPKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY LGGQLT+KADVYSFGVL+
Sbjct: 192 LLDKDFNPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYALGGQLTLKADVYSFGVLI 251

Query: 241 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 300
           LE++SG+ S      +++  LL   W+L++E K L++VDP LG+YP  E++RYMKVA FC
Sbjct: 252 LELVSGKRSSTVFGVEISILLLGRVWELYEEGKLLDIVDPRLGDYPQEEVLRYMKVALFC 311

Query: 301 TQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSD--STLQMS 358
           TQAAA+RRP M+QVI MLTKN +LNE+ LTAPG +    +S + +  KK+S+  S+ +MS
Sbjct: 312 TQAAANRRPVMSQVIDMLTKNNKLNEKLLTAPGFYGGLGTSDIPSVSKKTSNASSSNEMS 371

Query: 359 SVPVTITQVTPR 370
              ++IT++TPR
Sbjct: 372 FAGISITKITPR 383

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357446519|ref|XP_003593537.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355482585|gb|AES63788.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  489 bits (1259), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 240/376 (63%), Positives = 288/376 (76%), Gaps = 12/376 (3%)

Query: 1   MSCRCFGGSRFHSKKSAEREAPQGVDGEL----LRNVNHFSYTELRSATDDFHLSNKIGR 56
           M C CFG SR   K   ER+    + GE+    L N+ HFS  EL  ATD++HL NKIGR
Sbjct: 1   MRCGCFGASRTRKK---ERKPSDYISGEIEGYPLDNIRHFSDKELSLATDNYHLGNKIGR 57

Query: 57  GGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR 116
           GGFGTVY+GTL +GR+IAVKPLS  SKQGVREF+TEI TLSNV+H NLVEL+G C+QG  
Sbjct: 58  GGFGTVYQGTLKDGRKIAVKPLSVGSKQGVREFLTEIKTLSNVKHSNLVELVGFCIQGPN 117

Query: 117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 176
           R +VYEYVEN +L   LLG    ++K+ W +RS IC+G AKGLA+LHEEL  HIVHRDIK
Sbjct: 118 RTVVYEYVENGNLHTALLGKKSLSVKMKWRERSTICIGTAKGLAYLHEELTQHIVHRDIK 177

Query: 177 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 236
           ASN+LLD++FNPKIGDFG+AKLFPD+ITHI+TRIAGTTGYLAPEY LGGQLT KADVYSF
Sbjct: 178 ASNVLLDKDFNPKIGDFGMAKLFPDDITHISTRIAGTTGYLAPEYALGGQLTKKADVYSF 237

Query: 237 GVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 296
           GVL+LEIISG++S +  W   +K LLEWAWQLH+EEK L LVDPE+ E+P  E+I+Y+KV
Sbjct: 238 GVLILEIISGKSSSRTNWDGSHKSLLEWAWQLHEEEKWLALVDPEMEEFPEKEVIKYIKV 297

Query: 297 AFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTL- 355
           A FCTQAAA RRP M QV+ ML+K I+LN+++LTAPGLF         TS KKS+  +L 
Sbjct: 298 ALFCTQAAARRRPLMTQVVDMLSKEIQLNDKQLTAPGLFNYDAGE---TSQKKSNPESLV 354

Query: 356 -QMSSVPVTITQVTPR 370
              SS   +IT+VT R
Sbjct: 355 YHTSSTQPSITEVTAR 370

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	370
TAIR|locus:2095334	393	AT3G09010 [Arabidopsis thalian	0.902	0.849	0.596	1e-107
TAIR|locus:2017923	390	AT1G16670 [Arabidopsis thalian	0.851	0.807	0.542	3e-92
TAIR|locus:2205260	1047	AT1G56120 [Arabidopsis thalian	0.845	0.298	0.504	2.1e-84
TAIR|locus:2205250	1032	AT1G56130 [Arabidopsis thalian	0.797	0.285	0.506	4.7e-80
TAIR|locus:2203718	1035	AT1G53440 [Arabidopsis thalian	0.829	0.296	0.506	6.8e-79
TAIR|locus:2009630	953	AT1G53420 [Arabidopsis thalian	0.791	0.307	0.527	1e-77
TAIR|locus:2019367	1078	AT1G29740 [Arabidopsis thalian	0.802	0.275	0.506	1.5e-74
TAIR|locus:2019317	969	AT1G29730 [Arabidopsis thalian	0.805	0.307	0.493	1.1e-73
TAIR|locus:2141201	679	CRK29 "cysteine-rich RLK (RECE	0.883	0.481	0.448	7e-70
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.959	0.550	0.412	3e-69

TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)]

 Score = 1065 (380.0 bits), Expect = 1.0e-107, P = 1.0e-107
 Identities = 201/337 (59%), Positives = 253/337 (75%)

Query:     1 MSCRCFGGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFG 60
             M   CFG         ++R   +  +     NV  FSY  LRSATD FH +N+IG GG+G
Sbjct:     1 MRYNCFG--LLDMCNGSDRLGQREAEEICTNNVRVFSYNSLRSATDSFHPTNRIGGGGYG 58

Query:    61 TVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 120
              V+KG L +G ++AVK LSAESKQG REF+TEI  +SN+ HPNLV+LIGCC++G  RILV
Sbjct:    59 VVFKGVLRDGTQVAVKSLSAESKQGTREFLTEINLISNIHHPNLVKLIGCCIEGNNRILV 118

Query:   121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 180
             YEY+ENNSL  VLLG+    + L+W KR+ ICVG A GLAFLHEE+ PH+VHRDIKASNI
Sbjct:   119 YEYLENNSLASVLLGSRSRYVPLDWSKRAAICVGTASGLAFLHEEVEPHVVHRDIKASNI 178

Query:   181 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 240
             LLD  F+PKIGDFGLAKLFPDN+TH++TR+AGT GYLAPEY L GQLT KADVYSFG+LV
Sbjct:   179 LLDSNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADVYSFGILV 238

Query:   241 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 300
             LE+ISG +S +A +G     L+EW W+L +E + LE VDPEL ++P +E+ R++KVA FC
Sbjct:   239 LEVISGNSSTRAAFGDEYMVLVEWVWKLREERRLLECVDPELTKFPADEVTRFIKVALFC 298

Query:   301 TQAAASRRPQMNQVIKMLT-KNIRLNEEELTAPGLFQ 336
             TQAAA +RP M QV++ML  K + LNE+ LT PG+++
Sbjct:   299 TQAAAQKRPNMKQVMEMLRRKELNLNEDALTEPGVYR 335

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)]

 Score = 919 (328.6 bits), Expect = 3.0e-92, P = 3.0e-92
 Identities = 174/321 (54%), Positives = 239/321 (74%)

Query:    19 REAPQGVDGEL--LRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVK 76
             REA + VDGE+  + NV  + Y E+R ATDDF   NKIG GGFG+VYKG L +G+  A+K
Sbjct:    11 REATE-VDGEIAAIDNVKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDGKLAAIK 69

Query:    77 PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL-- 134
              LSAES+QGV+EF+TEI  +S ++H NLV+L GCCV+G  RILVY ++ENNSLD+ LL  
Sbjct:    70 VLSAESRQGVKEFLTEINVISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLAG 129

Query:   135 GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG 194
             G T++ I+ +W  R++ICVG+AKGLAFLHEE+ PHI+HRDIKASNILLD+  +PKI DFG
Sbjct:   130 GYTRSGIQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDFG 189

Query:   195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW 254
             LA+L P N+TH++TR+AGT GYLAPEY + GQLT KAD+YSFGVL++EI+SGR++     
Sbjct:   190 LARLMPPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRSNKNTRL 249

Query:   255 GQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQ 313
                 ++LLE AW+L++  + ++LVD  L G +   E  RY+K+   CTQ +   RP M+ 
Sbjct:   250 PTEYQYLLERAWELYERNELVDLVDSGLNGVFDAEEACRYLKIGLLCTQDSPKLRPSMST 309

Query:   314 VIKMLTKNIRLNEEELTAPGL 334
             V+++LT    ++ ++++ PGL
Sbjct:   310 VVRLLTGEKDIDYKKISRPGL 330

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)]

 Score = 845 (302.5 bits), Expect = 2.1e-84, P = 2.1e-84
 Identities = 161/319 (50%), Positives = 223/319 (69%)

Query:    18 EREAPQGVDGELLR-NVNH--FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIA 74
             +R  P   D E+L  +V    F+Y+EL++AT DF LSNK+G GGFG VYKG L +GR +A
Sbjct:   677 KRRKPYTDDEEILSMDVKPYTFTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVA 736

Query:    75 VKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL 134
             VK LS  S+QG  +F+ EI+ +S+V H NLV+L GCC +G  R+LVYEY+ N SLD+ L 
Sbjct:   737 VKQLSIGSRQGKGQFVAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALF 796

Query:   135 GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG 194
             G    ++ L+W  R +IC+G+A+GL +LHEE    I+HRD+KASNILLD E  PK+ DFG
Sbjct:   797 G--DKSLHLDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFG 854

Query:   195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW 254
             LAKL+ D  THI+TR+AGT GYLAPEY + G LT K DVY+FGV+ LE++SGR +     
Sbjct:   855 LAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENL 914

Query:   255 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV 314
              +  K+LLEWAW LH++ + +EL+D EL EY   E+ R + +A  CTQ++ + RP M++V
Sbjct:   915 EEGKKYLLEWAWNLHEKNRDVELIDDELSEYNMEEVKRMIGIALLCTQSSYALRPPMSRV 974

Query:   315 IKMLTKNIRLNEEELTAPG 333
             + ML+ +  +N+   + PG
Sbjct:   975 VAMLSGDAEVNDAT-SKPG 992

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)]

 Score = 804 (288.1 bits), Expect = 4.7e-80, P = 4.7e-80
 Identities = 151/298 (50%), Positives = 209/298 (70%)

Query:    36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMT 95
             F+Y+EL+SAT DF  SNK+G GGFG VYKG L +GR +AVK LS  S+QG  +F+ EI+ 
Sbjct:   682 FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVA 741

Query:    96 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
             +S+V H NLV+L GCC +G  R+LVYEY+ N SLD+ L G     + L+W  R +IC+G+
Sbjct:   742 ISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFG--DKTLHLDWSTRYEICLGV 799

Query:   156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
             A+GL +LHEE    IVHRD+KASNILLD    P+I DFGLAKL+ D  THI+TR+AGT G
Sbjct:   800 ARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIG 859

Query:   216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 275
             YLAPEY + G LT K DVY+FGV+ LE++SGR +      +  K+LLEWAW LH++ + +
Sbjct:   860 YLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDI 919

Query:   276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
             EL+D +L ++   E  R + +A  CTQ + + RP M++V+ ML+ ++ + +   + PG
Sbjct:   920 ELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVT-SKPG 976

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)]

 Score = 793 (284.2 bits), Expect = 6.8e-79, P = 6.8e-79
 Identities = 158/312 (50%), Positives = 214/312 (68%)

Query:    14 KKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI 73
             K+  E E  +G+D +       F+  +++ AT++F   NKIG GGFG VYKG L +G  I
Sbjct:   637 KEVDENEELRGLDLQ----TGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTI 692

Query:    74 AVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL 133
             AVK LS++SKQG REF+TEI  +S ++HPNLV+L GCC++G   +LVYEY+ENNSL R L
Sbjct:   693 AVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARAL 752

Query:   134 LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF 193
              G  K  + L+W  R+ +C+GIAKGLA+LHEE    IVHRDIKA+N+LLD   N KI DF
Sbjct:   753 FGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDF 812

Query:   194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM 253
             GLAKL  +  THI+TRIAGT GY+APEY + G LT KADVYSFGV+ LEI+SG+++    
Sbjct:   813 GLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYR 872

Query:   254 WGQMNKFLLEWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMN 312
               +   +LL+WA+ L ++   LELVDP+LG  +   E +R + +A  CT  + + RP M+
Sbjct:   873 PKEEFIYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMS 932

Query:   313 QVIKMLTKNIRL 324
              V+ ML   I++
Sbjct:   933 SVVSMLQGKIKV 944

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)]

 Score = 782 (280.3 bits), Expect = 1.0e-77, P = 1.0e-77
 Identities = 156/296 (52%), Positives = 207/296 (69%)

Query:    36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMT 95
             FS  +++ AT++F  +N+IG GGFG VYKG L +G  IAVK LS  SKQG REF+ EI  
Sbjct:   612 FSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGM 671

Query:    96 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
             +S + HPNLV+L GCCV+G + +LVYE+VENNSL R L G  +  ++L+W  R  IC+G+
Sbjct:   672 ISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGV 731

Query:   156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
             A+GLA+LHEE    IVHRDIKA+N+LLD++ NPKI DFGLAKL  ++ THI+TRIAGT G
Sbjct:   732 ARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFG 791

Query:   216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF-LLEWAWQLHQEEKP 274
             Y+APEY + G LT KADVYSFG++ LEI+ GR S K    + N F L++W   L ++   
Sbjct:   792 YMAPEYAMRGHLTDKADVYSFGIVALEIVHGR-SNKIERSKNNTFYLIDWVEVLREKNNL 850

Query:   275 LELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 329
             LELVDP LG EY   E +  +++A  CT +    RP M++V+KML     +  E+L
Sbjct:   851 LELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEKL 906

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)]

 Score = 754 (270.5 bits), Expect = 1.5e-74, P = 1.5e-74
 Identities = 153/302 (50%), Positives = 212/302 (70%)

Query:    36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMT 95
             FS  +L+ ATDDF+  NKIG GGFG+VYKG L NG  IAVK LS++S QG +EFI EI  
Sbjct:   665 FSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGI 724

Query:    96 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
             ++ ++HPNLV+L GCCV+ T+ +LVYEY+ENN L   L G  ++ +KL+W  R  IC+GI
Sbjct:   725 IACLQHPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFG--RSGLKLDWRTRHKICLGI 782

Query:   156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
             A+GLAFLHE+    I+HRDIK +NILLD++ N KI DFGLA+L  D+ +HITTR+AGT G
Sbjct:   783 ARGLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTIG 842

Query:   216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR-NSGKAMWGQMNKFLLEWAWQLHQEEKP 274
             Y+APEY + G LT KADVYSFGV+ +EI+SG+ N+      +    LL+WA+ L ++   
Sbjct:   843 YMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANYTPDNECCVGLLDWAFVLQKKGAF 902

Query:   275 LELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
              E++DP+L G +   E  R +KV+  C+  + + RP M++V+KML     + EE ++ PG
Sbjct:   903 DEILDPKLEGVFDVMEAERMIKVSLLCSSKSPTLRPTMSEVVKMLEGETEI-EEIISDPG 961

Query:   334 LF 335
              +
Sbjct:   962 AY 963

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)]

 Score = 744 (267.0 bits), Expect = 1.1e-73, P = 1.1e-73
 Identities = 149/302 (49%), Positives = 210/302 (69%)

Query:    36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMT 95
             FS  +L+ AT+DF   NKIG GGFG+VYKG L +G  IAVK LS++S QG +EF+ EI  
Sbjct:   628 FSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQGNKEFVNEIGM 687

Query:    96 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
             ++ ++HPNLV+L GCCV+  + +LVYEY+ENN L   L  A ++ +KL W  R  IC+GI
Sbjct:   688 IACLQHPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALF-AGRSCLKLEWGTRHKICLGI 746

Query:   156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
             A+GLAFLHE+    I+HRDIK +N+LLD++ N KI DFGLA+L  DN +HITTR+AGT G
Sbjct:   747 ARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQSHITTRVAGTIG 806

Query:   216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK-AMWGQMNKFLLEWAWQLHQEEKP 274
             Y+APEY + G LT KADVYSFGV+ +EI+SG+++ K     +    LL+WA+ L ++   
Sbjct:   807 YMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTPDDECCVGLLDWAFVLQKKGDI 866

Query:   275 LELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
              E++DP L G +   E  R +KV+  C   +++ RP M+QV+KML     + E+ ++ PG
Sbjct:   867 AEILDPRLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQVVKMLEGETEI-EQIISDPG 925

Query:   334 LF 335
             ++
Sbjct:   926 VY 927

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 708 (254.3 bits), Expect = 7.0e-70, P = 7.0e-70
 Identities = 154/343 (44%), Positives = 211/343 (61%)

Query:    35 HFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIM 94
             HF    L++ATD+F   N++GRGGFG+VYKG    G+ IAVK LS  S QG  EF  EI+
Sbjct:   346 HFE--TLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEFKNEIL 403

Query:    95 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
              L+ ++H NLV LIG C+QG  R+LVYE+++N SLD+ +    K  + L+W  R  +  G
Sbjct:   404 LLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQL-LDWVVRYKMIGG 462

Query:   155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN--ITH-ITTRIA 211
             IA+GL +LHE+    I+HRD+KASNILLDQE NPKI DFGLAKLF     +TH  T+RIA
Sbjct:   463 IARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIA 522

Query:   212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFLLEWAWQLH 269
             GT GY+APEY + GQ ++K DV+SFGVLV+EII+G+  N+G +   +  + LL W W+  
Sbjct:   523 GTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRSW 582

Query:   270 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 329
             +E+  L ++DP L     NEI+R + +   C Q +A+ RP M       T ++ LN    
Sbjct:   583 REDTILSVIDPSLTAGSRNEILRCIHIGLLCVQESAATRPTM------ATVSLMLNSYSF 636

Query:   330 TAPGLFQXXXXXXXXX--XXXXXXXXXLQMSSVPVTITQVTPR 370
             T P   +                    LQMSS  VT+++ +PR
Sbjct:   637 TLPTPLRPAFVLESVVIPSNVSSSTEGLQMSSNDVTVSEFSPR 679

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 702 (252.2 bits), Expect = 3.0e-69, P = 3.0e-69
 Identities = 151/366 (41%), Positives = 220/366 (60%)

Query:    10 RFHSKKSAEREAPQGVDGELLRNVN--HFSYTELRSATDDFHLSNKIGRGGFGTVYKGTL 67
             R  +K++   + P   DG  +       F +  + +AT+ F   NK+G+GGFG VYKGTL
Sbjct:   286 RAKNKRTLNEKEPVAEDGNDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTL 345

Query:    68 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 127
             ++G ++AVK LS  S QG +EF  E++ ++ ++H NLV+L+G C++G  +ILVYE+V N 
Sbjct:   346 SSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNK 405

Query:   128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 187
             SLD  L  +T   +KL+W +R  I  GIA+G+ +LH++    I+HRD+KA NILLD + N
Sbjct:   406 SLDHFLFDSTM-KMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMN 464

Query:   188 PKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             PKI DFG+A++F  D    +T R+ GT GY++PEY + GQ +MK+DVYSFGVLVLEIISG
Sbjct:   465 PKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISG 524

Query:   247 -RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE-YPPNEIIRYMKVAFFCTQAA 304
              +NS      +    L+ + W+L     P ELVDP  G+ Y  +EI R + +A  C Q  
Sbjct:   525 MKNSSLYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQED 584

Query:   305 ASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQXXXXXXXXXXXXXXXXXXLQMSSVPVTI 364
             A  RP M+ +++MLT ++ +   E   PG F                   +  +S    I
Sbjct:   585 AEDRPTMSSIVQMLTTSL-IALAEPRPPGFFFRSKQEQAGPSIDSSTHCSVDEAS----I 639

Query:   365 TQVTPR 370
             T+VTPR
Sbjct:   640 TRVTPR 645

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.IV.2390.1 hypothetical protein (306 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	370
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-51
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-51
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-46
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-43
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-39
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-34
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-34
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-31
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-31
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-31
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-29
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-29
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-28
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-27
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-27
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-26
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-26
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-26
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-25
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-24
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-24
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-24
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-24
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-23
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-23
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-23
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-22
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-22
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-22
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-21
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-21
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-21
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-21
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-21
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-21
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-21
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-20
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-20
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-20
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-19
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-19
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-19
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-19
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-19
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-18
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-18
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-18
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-18
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-18
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-18
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-15
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-14
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-13
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-10
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  174 bits (443), Expect = 2e-52
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 11/202 (5%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLV 105
           + +  K+G G FG VY       G+ +A+K +  +  +  RE  + EI  L  ++HPN+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            L        +  LV EY E   L  +L    K   +L+ ++       I   L +LH +
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHSK 116

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
               IVHRD+K  NILLD++ + K+ DFGLA+   D    +TT + GT  Y+APE +LG 
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFV-GTPEYMAPEVLLGK 171

Query: 226 QLTMKADVYSFGVLVLEIISGR 247
                 D++S GV++ E+++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  172 bits (439), Expect = 3e-52
 Identities = 75/225 (33%), Positives = 114/225 (50%), Gaps = 23/225 (10%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCC 111
           +G GGFGTVY       G+++A+K +  E    + E  + EI  L  + HPN+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
                  LV EY E  SL  +L    +   KL+ ++   I + I +GL +LH      I+
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 172 HRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTM 229
           HRD+K  NILLD      K+ DFGL+KL   +   +   I GT  Y+APE +LG G  + 
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 230 KADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           K+D++S GV++ E+   ++            L+    Q   E++P
Sbjct: 174 KSDIWSLGVILYELPELKD------------LIRKMLQKDPEKRP 206

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  172 bits (438), Expect = 1e-51
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 34/279 (12%)

Query: 50  LSNKIGRGGFGTVYKGTLT-----NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPN 103
           L  K+G G FG VYKG L          +AVK L  + S+Q + EF+ E   +  + HPN
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L+G C +     +V EY+E   L   L        KL+        + IA+G+ +L 
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLE 119

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG---YLAPE 220
            +   + +HRD+ A N L+ +    KI DFGL++   D       R  G      ++APE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD---DDYYRKRGGKLPIRWMAPE 173

Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLELVD 279
            +  G+ T K+DV+SFGVL+ EI +    G+  +  M N+ +LE+    ++  +P     
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTL---GEQPYPGMSNEEVLEYLKNGYRLPQP----- 225

Query: 280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
                  P E+   M     C       RP  ++++++L
Sbjct: 226 ----PNCPPELYDLMLQ---CWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  170 bits (434), Expect = 4e-51
 Identities = 82/280 (29%), Positives = 137/280 (48%), Gaps = 35/280 (12%)

Query: 50  LSNKIGRGGFGTVYKGTLTNG-----RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPN 103
           L  K+G G FG VYKGTL          +AVK L  + S+Q + EF+ E   +  + HPN
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L+G C +    ++V EY+    L   L        +L+        + IA+G+ +L 
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTR---IAGTTGYLAP 219
            +   + +HRD+ A N L+ +    KI DFGL++ L+ D+   +      I     ++AP
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAP 173

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLELV 278
           E +  G+ T K+DV+SFGVL+ EI +    G+  +  M N  +LE+  + ++  KP    
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTL---GEEPYPGMSNAEVLEYLKKGYRLPKP---- 226

Query: 279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
                   P E+ + M     C       RP  ++++++L
Sbjct: 227 -----PNCPPELYKLMLQ---CWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  170 bits (432), Expect = 9e-51
 Identities = 75/204 (36%), Positives = 105/204 (51%), Gaps = 12/204 (5%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNL 104
           + L  K+G G FGTVYK      G+ +AVK     +E  +  +    EI  L  + HPN+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           V LI          LV EY E   L   L         L+ ++   I + I +GL +LH 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHS 116

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
                I+HRD+K  NILLD+    KI DFGLAK    + + +TT   GT  Y+APE +LG
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLG 172

Query: 225 GQL-TMKADVYSFGVLVLEIISGR 247
           G     K DV+S GV++ E+++G+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  168 bits (427), Expect = 6e-50
 Identities = 84/284 (29%), Positives = 134/284 (47%), Gaps = 38/284 (13%)

Query: 52  NKIGRGGFGTVYKGTLTNG----RRIAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVE 106
            K+G G FG VYKG L         +AVK L    S++  ++F+ E   +  + HPN+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK-----LNWEKRSDICVGIAKGLAF 161
           L+G C +     LV EY+E   L   L  +           L+ +      + IAKG+ +
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG-----Y 216
           L  +     VHRD+ A N L+ ++   KI DFGL++   D+  +       T G     +
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173

Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPL 275
           +APE +  G  T K+DV+SFGVL+ EI +    G   +  + N+ +LE+  + ++  KP 
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTL---GATPYPGLSNEEVLEYLRKGYRLPKP- 229

Query: 276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                   EY P+E+   M     C Q     RP  +++++ L 
Sbjct: 230 --------EYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  163 bits (416), Expect = 2e-48
 Identities = 86/283 (30%), Positives = 130/283 (45%), Gaps = 37/283 (13%)

Query: 48  FHLSNKIGRGGFGTVYKGTLT-----NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRH 101
             L  K+G G FG VYKGTL         ++AVK L    S++   EF+ E   +  + H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN+V L+G C QG    +V EY+    L   L    K   KL  +    + + IAKG+ +
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL---- 217
           L  +   + VHRD+ A N L+ +    KI DFGL++     I           G L    
Sbjct: 118 LESK---NFVHRDLAARNCLVTENLVVKISDFGLSRD----IYEDDYYRKRGGGKLPIKW 170

Query: 218 -APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF-LLEWAWQLHQEEKPL 275
            APE +  G+ T K+DV+SFGVL+ EI +    G+  +  M+   +LE     ++  +P 
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTL---GEQPYPGMSNEEVLELLEDGYRLPRP- 226

Query: 276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
                   E  P+E+   M     C       RP  +++++ L
Sbjct: 227 --------ENCPDELYELMLQ---CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  158 bits (403), Expect = 2e-46
 Identities = 73/210 (34%), Positives = 107/210 (50%), Gaps = 19/210 (9%)

Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPN 103
           ++     +GRG FG+VY       G  +AVK   LS +S++ +     EI  LS+++HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 104 LVELIGCCVQ-GTRRILVY-EYVENNSLDRVLLGATKANIKLNWEKRSDICV---GIAKG 158
           +V   G         + ++ EYV   SL  +L    K   KL  E    I      I +G
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKLP-E--PVIRKYTRQILEG 113

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYL 217
           LA+LH      IVHRDIK +NIL+D +   K+ DFG AK   D  T   T  + GT  ++
Sbjct: 114 LAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           APE + G +    AD++S G  V+E+ +G+
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  150 bits (382), Expect = 2e-43
 Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 9/203 (4%)

Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
            F +  KIG+GGFG VYK      G+ +A+K +  ESK+   + I EI  L   +HPN+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +  G  ++     +V E+    SL  +L      N  L   + + +C  + KGL +LH  
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
               I+HRDIKA+NILL  +   K+ DFGL+     + T     + GT  ++APE + G 
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGK 172

Query: 226 QLTMKADVYSFGVLVLEIISGRN 248
               KAD++S G+  +E+  G+ 
Sbjct: 173 PYDYKADIWSLGITAIELAEGKP 195

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  140 bits (354), Expect = 2e-39
 Identities = 66/204 (32%), Positives = 111/204 (54%), Gaps = 11/204 (5%)

Query: 47  DFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
           ++ L + IGRG FG VYKG  L  G  +A+K +S E   ++ ++  + EI  L N++HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+ IG         ++ EY EN SL +++    K          +     + +GLA+LH
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLH 116

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    ++HRDIKA+NIL  ++   K+ DFG+A    D  +     + GT  ++APE + 
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV-SKDDASVVGTPYWMAPEVIE 172

Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
               +  +D++S G  V+E+++G 
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  130 bits (329), Expect = 1e-35
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 7/199 (3%)

Query: 52  NKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELI 108
            +IG+G FG VY     ++G+   +K   LS  S++   + + E+  L  + HPN+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
               +  +  +V EY +   L + +    K       E+  D  V +   L +LH     
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 228
            I+HRDIK  NI L      K+GDFG++K+    +    T + GT  YL+PE        
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181

Query: 229 MKADVYSFGVLVLEIISGR 247
            K+D++S G ++ E+ + +
Sbjct: 182 YKSDIWSLGCVLYELCTLK 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  131 bits (328), Expect = 1e-34
 Identities = 81/334 (24%), Positives = 137/334 (41%), Gaps = 24/334 (7%)

Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHP- 102
            + +  K+G G FG VY       + +A+K L+ +     + V  F+ EI  L+++ HP 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L           LV EYV+  SL+  LL        L+  +   I   I   L +L
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 163 HEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITH-----ITTRIAGTTGY 216
           H +    I+HRDIK  NILLD++    K+ DFGLAKL PD  +      + +   GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 217 LAPEYVLGGQL---TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF-LLEWAWQLHQEE 272
           +APE +LG  L   +  +D++S G+ + E+++G    +           L+   +L    
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234

Query: 273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAP 332
                + P   E         +K            R   +  +          +E   + 
Sbjct: 235 LASP-LSPSNPELISKAASDLLKK---LLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290

Query: 333 GLFQDSESSSVGTSDKKSSDSTLQMSSVPVTITQ 366
            L  D  +    +           ++S+ ++ + 
Sbjct: 291 LLKPDDSAPLRLSLPPSLEALISSLNSLAISGSD 324

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  127 bits (320), Expect = 2e-34
 Identities = 60/199 (30%), Positives = 108/199 (54%), Gaps = 6/199 (3%)

Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           +F L  K+G G FG V++G   N  R+A+K L ++     ++F  E+  L  +RH +L+ 
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           L   C  G    ++ E +E  SL   L       + +      D+   +A+G+A+L E+ 
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV--ASLIDMACQVAEGMAYLEEQ- 123

Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
             + +HRD+ A NIL+ ++   K+ DFGLA+L  +++ ++++       + APE    G 
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGT 180

Query: 227 LTMKADVYSFGVLVLEIIS 245
            + K+DV+SFG+L+ E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  127 bits (320), Expect = 3e-34
 Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 17/206 (8%)

Query: 48  FHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQG---VREFITEIMTLSNVRHPNL 104
             L  K+G G FG V+ GT     ++AVK L    K G      F+ E   +  +RH  L
Sbjct: 8   LKLERKLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKL 63

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           V+L   C +     +V EY+   SL   L       ++L   +  D+   IA+G+A+L  
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLES 121

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIAGTTGYLAPEYV 222
               + +HRD+ A NIL+ +    KI DFGLA+L  D+        +      + APE  
Sbjct: 122 R---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAA 176

Query: 223 LGGQLTMKADVYSFGVLVLEIIS-GR 247
             G+ T+K+DV+SFG+L+ EI++ GR
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  124 bits (312), Expect = 2e-33
 Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 12/203 (5%)

Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           +  L   IG+G FG V  G    G+++AVK L  +S    + F+ E   ++ +RHPNLV+
Sbjct: 7   ELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQ 64

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           L+G  +QG    +V EY+   SL   L   ++    +   ++    + + +G+ +L E+ 
Sbjct: 65  LLGVVLQGNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK- 121

Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
             + VHRD+ A N+L+ ++   K+ DFGLAK    +    + ++     + APE +   +
Sbjct: 122 --NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKK 175

Query: 227 LTMKADVYSFGVLVLEIIS-GRN 248
            + K+DV+SFG+L+ EI S GR 
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRV 198

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  120 bits (304), Expect = 6e-32
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 11/205 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFI-TEIMTLSNVRHPN 103
            D      +G+G  G VYK      G+  A+K +  +  +  R+ +  E+ TL +   P 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 104 LVELIGC-CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           +V+  G    +G   I V EY++  SL  +L    K   K+     + I   I KGL +L
Sbjct: 61  VVKCYGAFYKEGEISI-VLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYL 115

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H +   HI+HRDIK SN+L++ +   KI DFG++K+  + +    T + GT  Y++PE +
Sbjct: 116 HTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERI 172

Query: 223 LGGQLTMKADVYSFGVLVLEIISGR 247
            G   +  AD++S G+ +LE   G+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  119 bits (302), Expect = 9e-32
 Identities = 66/203 (32%), Positives = 98/203 (48%), Gaps = 22/203 (10%)

Query: 54  IGRGGFGTVY----KGTLTNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVE 106
           +G+G FG V     K T   G+  A+K L  +    ++ V   +TE   LS + HP +V+
Sbjct: 1   LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 107 LIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHE 164
           L     Q   ++ LV EY     L   L        + + E+R+      I   L +LH 
Sbjct: 58  LH-YAFQTEEKLYLVLEYAPGGELFSHL----SKEGRFS-EERARFYAAEIVLALEYLHS 111

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
                I++RD+K  NILLD + + K+ DFGLAK      +   T   GT  YLAPE +LG
Sbjct: 112 L---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLG 167

Query: 225 GQLTMKADVYSFGVLVLEIISGR 247
                  D +S GVL+ E+++G+
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  120 bits (303), Expect = 1e-31
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 16/206 (7%)

Query: 50  LSNKIGRGGFGTVYKGTLTN-----GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPN 103
              ++G G FG V            G ++AVK L+    +Q   +F  EI  L  + H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           +V+  G C +   R   L+ EY+ + SL R  L   +  I  N ++       I KG+ +
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSL-RDYLQRHRDQI--NLKRLLLFSSQICKGMDY 124

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAP 219
           L  +     +HRD+ A NIL++ E   KI DFGLAK+ P++  +   +  G +   + AP
Sbjct: 125 LGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E +   + +  +DV+SFGV + E+ +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  120 bits (303), Expect = 1e-31
 Identities = 60/203 (29%), Positives = 109/203 (53%), Gaps = 25/203 (12%)

Query: 53  KIGRGGFGTVYKGTLTN-GRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           KIG G  G VYK T    G+ +A+K   L  ++K+ +   I EI+ + + +HPN+V+   
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYD 82

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
             + G    +V EY++  SL  ++   T+  +++N  + + +C  + +GL +LH +   +
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEYLHSQ---N 136

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR------IAGTTGYLAPEYVL 223
           ++HRDIK+ NILL ++ + K+ DFG A         +T        + GT  ++APE + 
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFA-------AQLTKEKSKRNSVVGTPYWMAPEVIK 189

Query: 224 GGQLTMKADVYSFGVLVLEIISG 246
                 K D++S G++ +E+  G
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 5e-31
 Identities = 62/199 (31%), Positives = 105/199 (52%), Gaps = 7/199 (3%)

Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           L  K+G G FG V++G   N   +AVK L   +    ++F+ E   +  +RHP L++L  
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
            C       +V E ++  SL   L G     +KL   +  D+   +A G+A+L  +   +
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQ---N 123

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
            +HRD+ A N+L+ +    K+ DFGLA++  ++I            + APE  L  + ++
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI 183

Query: 230 KADVYSFGVLVLEIIS-GR 247
           K+DV+SFG+L+ EI++ GR
Sbjct: 184 KSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  117 bits (296), Expect = 6e-31
 Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 46/279 (16%)

Query: 49  HLSNKIGRGGFGTVYKG-TLTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLV 105
              NKIG G FG VY    L  G  +AVK   +     + ++E   E+  L  ++HPNLV
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-----IAKGLA 160
           +  G  V   +  +  EY    +L+ +L      +         +  +      + +GLA
Sbjct: 63  KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILD---------EHVIRVYTLQLLEGLA 113

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG---YL 217
           +LH      IVHRDIK +NI LD     K+GDFG A    +N T +   +    G   Y+
Sbjct: 114 YLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170

Query: 218 APEYVLGGQLTMK---ADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA--WQLHQEE 272
           APE + GG+       AD++S G +VLE+ +G+      W +++    E+   + +    
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP----WSELDN---EFQIMFHVGAGH 223

Query: 273 KPLELVDPELGEYPPNEIIRYMKVAFF--CTQAAASRRP 309
           KP           P +  +      F   C ++   +RP
Sbjct: 224 KP---------PIPDSLQLSPEGKDFLDRCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  117 bits (295), Expect = 8e-31
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 10/203 (4%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL 104
           + F +  K+G G +G+VYK      G+ +A+K +    ++ ++E I EI  L     P +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYI 60

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           V+  G   + T   +V EY    S+   ++  T  N  L  E+ + I     KGL +LH 
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHS 117

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
                 +HRDIKA NILL++E   K+ DFG++    D +    T I GT  ++APE +  
Sbjct: 118 N---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQE 173

Query: 225 GQLTMKADVYSFGVLVLEIISGR 247
                KAD++S G+  +E+  G+
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  119 bits (301), Expect = 2e-29
 Identities = 83/276 (30%), Positives = 137/276 (49%), Gaps = 22/276 (7%)

Query: 52  NKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           N I RG  G  YKG ++ NG +  VK    E         +EI  +  ++HPN+V+LIG 
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVK----EINDVNSIPSSEIADMGKLQHPNIVKLIGL 751

Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI 170
           C       L++EY+E  +L  VL         L+WE+R  I +GIAK L FLH    P +
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAV 804

Query: 171 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 230
           V  ++    I++D +  P +      +L    +    T+   ++ Y+APE      +T K
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEK 858

Query: 231 ADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP--- 287
           +D+Y FG++++E+++G++   A +G ++  ++EWA   + +      +DP +        
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917

Query: 288 NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           NEI+  M +A  CT    + RP  N V+K L    R
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  114 bits (287), Expect = 2e-29
 Identities = 69/234 (29%), Positives = 112/234 (47%), Gaps = 30/234 (12%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR------IAVKPLSAESKQGVRE-FITEIMTLSN 98
           D   L  ++G G FG V+ G   +         +AVK L   +    R+ F  E   L+N
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL----------LGATKANIKLNWEKR 148
            +H N+V+  G C +G   I+V+EY+E+  L++ L                  +L   + 
Sbjct: 65  FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124

Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
             I V IA G+ +L  +   H VHRD+   N L+  +   KIGDFG+++   D  T    
Sbjct: 125 LQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYY 178

Query: 209 RIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
           R+ G T     ++ PE ++  + T ++DV+SFGV++ EI +    GK  W  ++
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT---YGKQPWYGLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  113 bits (285), Expect = 2e-29
 Identities = 76/208 (36%), Positives = 110/208 (52%), Gaps = 18/208 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVRE---FITEIMTLSNVRHP 102
           +   L  K+G G FG V+ G      ++A+K L    KQG      F+ E   +  ++HP
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHP 61

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
            LV L     Q    I + EY+EN SL   L   T   IKL   K  D+   IA+G+AF+
Sbjct: 62  RLVRLYAVVTQEPIYI-ITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFI 118

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPE 220
             +   + +HRD++A+NIL+ +    KI DFGLA+L  DN    T R        + APE
Sbjct: 119 ERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPE 173

Query: 221 YVLGGQLTMKADVYSFGVLVLEIIS-GR 247
            +  G  T+K+DV+SFG+L+ EI++ GR
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  111 bits (279), Expect = 2e-28
 Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 24/212 (11%)

Query: 54  IGRGGFGTVYKG-TLTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           +G G FG+VY+G  L +G   AVK           ++ V++   EI  LS ++HPN+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +G   +     +  E V   SL ++L   G+    +   + ++      I  GL +LH+ 
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHDR 121

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG- 224
              + VHRDIK +NIL+D     K+ DFG+AK   +          G+  ++APE +   
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQ 176

Query: 225 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 256
           G   + AD++S G  VLE+     +GK  W Q
Sbjct: 177 GGYGLAADIWSLGCTVLEMA----TGKPPWSQ 204

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  111 bits (281), Expect = 2e-28
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 21/207 (10%)

Query: 52  NKIGRGGFGTVYKG-TLTNGRRIAVKPLSAES-KQG-VREFITEIMTLSNVRHPNLVELI 108
            +IG G +G VYK      G  +A+K +  E+ K+G     I EI  L  +RHPN+V L 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 109 GCCVQGTRR--ILVYEYVEN--NSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
                  +    +V+EY+++    L D   +  T++ IK            + +GL +LH
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC-------YMKQLLEGLQYLH 117

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYV 222
                 I+HRDIK SNIL++ +   K+ DFGLA+ +   N    T R+  T  Y  PE +
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELL 173

Query: 223 LGG-QLTMKADVYSFGVLVLEIISGRN 248
           LG  +   + D++S G ++ E+  G+ 
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 2e-28
 Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 26/205 (12%)

Query: 54  IGRGGFGTVYKGTLT-NGRRI----AVKPL-SAESKQGVREFITEIMTLSNVRHPNLVEL 107
           +G G FGTVYKG     G ++    A+K L    S +  +E + E   +++V HP++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVL---LGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           +G C+  ++  L+ + +    L   +        +   LNW      CV IAKG+++L E
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLEE 127

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP--DNITHITTRIAGTT--GYLAPE 220
           +    +VHRD+ A N+L+    + KI DFGLAKL    +   H      G     ++A E
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE---GGKVPIKWMALE 181

Query: 221 YVLGGQLTMKADVYSFGVLVLEIIS 245
            +L    T K+DV+S+GV V E+++
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  109 bits (274), Expect = 1e-27
 Identities = 73/212 (34%), Positives = 111/212 (52%), Gaps = 26/212 (12%)

Query: 54  IGRGGFGTVYKGTLTN-------GRRIAVKPL-SAESKQGVREFITEIMTLSNVRHPNLV 105
           +G G FG VY+GT T+         R+AVK L    + Q  +EF+ E   +SN  HPN+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK---LNWEKRSDICVGIAKGLAFL 162
           +L+G C+    + ++ E +E   L   L  A         L  ++  DIC+ +AKG  +L
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 163 HEELVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFPDNITHITTRIAGT---- 213
            +    H +HRD+ A N L+ ++        KIGDFGLA+   D       R  G     
Sbjct: 123 EQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGLLP 176

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
             ++APE +L G+ T ++DV+SFGVL+ EI++
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 2e-27
 Identities = 67/202 (33%), Positives = 107/202 (52%), Gaps = 20/202 (9%)

Query: 54  IGRGGFGTVYKGTLT-NGRR---IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELI 108
           IG G FG V +G L   G++   +A+K L A S    R +F+TE   +    HPN++ L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    +++ EY+EN SLD+ L    + + K    +   +  GIA G+ +L E    
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYLSEM--- 125

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-----IAGTTGYLAPEYVL 223
           + VHRD+ A NIL++     K+ DFGL++   D+    TT+     I  T    APE + 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIA 181

Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + T  +DV+SFG+++ E++S
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  107 bits (269), Expect = 5e-27
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 18/208 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYK------GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV 99
           DD     ++G G  G V K      G +   + I ++   A  KQ +RE   +I  L   
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILREL--DI--LHKC 56

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
             P +V   G         +  EY++  SLD++L         +       I V + KGL
Sbjct: 57  NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR---IPERILGKIAVAVLKGL 113

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
            +LHE+    I+HRD+K SNIL++     K+ DFG++    ++   +     GT+ Y+AP
Sbjct: 114 TYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMAP 168

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G   ++K+D++S G+ ++E+ +GR
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 7e-27
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 8/196 (4%)

Query: 53  KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCC 111
           KIG+G FG VYKG L     +AVK   +     ++  F+ E   L    HPN+V+LIG C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           VQ     +V E V   SL   L    K  + +   K   + +  A G+ +L  +   + +
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRK-KKNRLTVK--KLLQMSLDAAAGMEYLESK---NCI 115

Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-TGYLAPEYVLGGQLTMK 230
           HRD+ A N L+ +    KI DFG+++     I  ++  +      + APE +  G+ T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175

Query: 231 ADVYSFGVLVLEIISG 246
           +DV+S+G+L+ E  S 
Sbjct: 176 SDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 7e-27
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)

Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVKPLSAE-SKQGV-REFITEIMTLSNVRHPNLVELIG 109
           K+G G +G VYK      G  +A+K +  +  ++G+    + EI  L  ++HPN+V+L+ 
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
                 +  LV+EY + + L +  L      +  N  K   I   + +GLA+ H      
Sbjct: 66  VIHTERKLYLVFEYCDMD-L-KKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCHSH---R 118

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-T 228
           I+HRD+K  NIL++++   K+ DFGLA+ F   +   T  +  T  Y APE +LG +  +
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYS 177

Query: 229 MKADVYSFGVLVLEIISGR 247
              D++S G +  E+I+G+
Sbjct: 178 TAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 7e-27
 Identities = 66/202 (32%), Positives = 108/202 (53%), Gaps = 21/202 (10%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQG-VREFITEIMTLSNVRH---PNLVELI 108
           IGRG +G VY+G  +  GR +A+K ++ ++    V +   E+  LS +R    PN+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK---GLAFLHEE 165
           G  ++G R  ++ EY E  S+ R L+ A     K        I V I +    L ++H+ 
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKY-------ISVIIREVLVALKYIHKV 120

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
               ++HRDIKA+NIL+    N K+ DFG+A L   N +  +T   GT  ++APE +  G
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEG 176

Query: 226 QL-TMKADVYSFGVLVLEIISG 246
           +    KAD++S G+ + E+ +G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 1e-26
 Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 13/204 (6%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPN 103
           + F L   IG+G FG VYK       + +A+K +  E ++  + +   EI  LS  R P 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 104 LVELIGCCVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           + +  G  ++G++  ++ EY    S LD +  G      KL+    + I   +  GL +L
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYL 114

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           HEE     +HRDIKA+NILL +E + K+ DFG++      ++   T   GT  ++APE +
Sbjct: 115 HEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVI 170

Query: 223 LGGQLTMKADVYSFGVLVLEIISG 246
                  KAD++S G+  +E+  G
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 2e-26
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 21/204 (10%)

Query: 52  NKIGRGGFGTVYKGT--LTNGRRI--AVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVE 106
            ++G G FG+V KG   + +G+ +  AVK L  E    G +EF+ E   ++ + HP +V 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLG---ATKANIKLNWEKRSDICVGIAKGLAFLH 163
           LIG C +G   +LV E      L + L        +++K     +      +A G+A+L 
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-LAHQ------VAMGMAYLE 112

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEY 221
            +   H VHRD+ A N+LL      KI DFG+++       +     AG     + APE 
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169

Query: 222 VLGGQLTMKADVYSFGVLVLEIIS 245
           +  G+ + K+DV+S+GV + E  S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  105 bits (264), Expect = 2e-26
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 28/250 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
            +  L  +IG G FG V+ G     R++A+K +  E      +FI E   +  + HP LV
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLV 62

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L G C + +   LV+E++E+  L    L A +   K + E    +C+ + +G+A+L   
Sbjct: 63  QLYGVCTERSPICLVFEFMEHGCLSD-YLRAQRG--KFSQETLLGMCLDVCEGMAYLESS 119

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
            V   +HRD+ A N L+ +    K+ DFG+ +   D+    +T       + +PE     
Sbjct: 120 NV---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176

Query: 226 QLTMKADVYSFGVLVLEIIS-GR---------------NSGKAMW-----GQMNKFLLEW 264
           + + K+DV+SFGVL+ E+ S G+               N+G  ++      Q    L++ 
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236

Query: 265 AWQLHQEEKP 274
            W+   E++P
Sbjct: 237 CWKERPEDRP 246

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 2e-26
 Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 11/201 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL 104
           +D+ L  +IG G +G VYK   +  G  +A+K +  E          EI  L   RHPN+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           V   G  ++  +  +V EY    SL  +          L+  + + +C    KGLA+LHE
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLSELQIAYVCRETLKGLAYLHE 119

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV-- 222
                 +HRDIK +NILL ++ + K+ DFG++      I    + I GT  ++APE    
Sbjct: 120 T---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAV 175

Query: 223 -LGGQLTMKADVYSFGVLVLE 242
              G    K D+++ G+  +E
Sbjct: 176 ERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 7e-26
 Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 57/300 (19%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLS-AESKQGVREFITEIMTLSN 98
           +   L  ++G+G FG VY+G            R+A+K ++   S +   EF+ E   +  
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL------------LGATKANIKLNWE 146
               ++V L+G    G   ++V E +    L   L            LG       +   
Sbjct: 66  FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM- 124

Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
                   IA G+A+L  +     VHRD+ A N ++ ++   KIGDFG+ +   D     
Sbjct: 125 -----AAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR---DIYETD 173

Query: 207 TTRIAGT----TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 262
             R  G       ++APE +  G  T K+DV+SFGV++ E+ +               L 
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LA 218

Query: 263 EWAWQLHQEEKPLELVDP----ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           E  +Q    E+ L+ V      +L E  P++++  M++   C Q     RP   +++  L
Sbjct: 219 EQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRM---CWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  103 bits (258), Expect = 2e-25
 Identities = 72/212 (33%), Positives = 110/212 (51%), Gaps = 26/212 (12%)

Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPL-----SAESKQGVREFIT----EIMTLSNVRHPN 103
           IG G FG+VY G   ++G  +AVK +     SA SK   R  +     EI  L  ++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAF 161
           +V+ +G  +      +  EYV   S+  +L   GA +  +  N+ ++      I KGL +
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLNY 121

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-----GTTGY 216
           LH      I+HRDIK +NIL+D +   KI DFG++K    N     T  A     G+  +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           +APE V     T KAD++S G LV+E+++G++
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  103 bits (258), Expect = 3e-25
 Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 41/231 (17%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLS-----AESKQGVREFIT---EIMTL 96
           DDF     IG G F TV         +  A+K L       E K    +++    E++T 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV---KYVKIEKEVLTR 57

Query: 97  SNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
            N  HP +++L     Q    +  V EY  N  L    L   +    L+ +        I
Sbjct: 58  LN-GHPGIIKLY-YTFQDEENLYFVLEYAPNGEL----LQYIRKYGSLDEKCTRFYAAEI 111

Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA---- 211
              L +LH +    I+HRD+K  NILLD++ + KI DFG AK+   N +  + +      
Sbjct: 112 LLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 212 ---------------GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
                          GT  Y++PE +        +D+++ G ++ ++++G+
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  102 bits (255), Expect = 4e-25
 Identities = 69/206 (33%), Positives = 103/206 (50%), Gaps = 13/206 (6%)

Query: 47  DFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKP--LSAESKQGVREFITEIMTLSNVRHPN 103
           DF + NKIG+G FG V+K     + R  A+K   LS  +++   E I E   L+ +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN--WEKRSDICVGIAKGLAF 161
           ++      +   +  +V EY EN  L ++L       +  +  W       + I  GLA 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR----FFIQILLGLAH 116

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH +    I+HRDIK+ N+ LD   N KIGD G+AKL  DN T+    I GT  YL+PE 
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-TNFANTIVGTPYYLSPEL 172

Query: 222 VLGGQLTMKADVYSFGVLVLEIISGR 247
                   K+DV++ GV++ E  +G+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 6e-25
 Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 19/202 (9%)

Query: 54  IGRGGFGTVYKG-TLTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           +G+G FG VY    +  GR +AVK     P S E+K+ V     EI  L N++H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            GC        +  EY+   S+   L   GA    +   + ++      I +G+ +LH  
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ------ILEGVEYLHSN 123

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIAGTTGYLAPEYVL 223
               IVHRDIK +NIL D   N K+GDFG +K      +  T    + GT  +++PE + 
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
           G     KADV+S G  V+E+++
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  102 bits (256), Expect = 7e-25
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 31/211 (14%)

Query: 52  NKIGRGGFGTVYKGTLTN-GRRIAVKPLS----AESKQGV-REFITEIMTLSNVRHPNLV 105
            K+G G +  VYK      GR +A+K +      E+K G+    + EI  L  ++HPN++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 106 ELIGCCVQGTRRILVYEY--------VENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            L+      +   LV+E+        +++ S+  VL   T A+IK ++           +
Sbjct: 66  GLLDVFGHKSNINLVFEFMETDLEKVIKDKSI--VL---TPADIK-SYMLM------TLR 113

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 217
           GL +LH      I+HRD+K +N+L+  +   K+ DFGLA+ F      +T ++  T  Y 
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYR 169

Query: 218 APEYVLGG-QLTMKADVYSFGVLVLEIISGR 247
           APE + G     +  D++S G +  E++   
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (252), Expect = 1e-24
 Identities = 68/211 (32%), Positives = 98/211 (46%), Gaps = 16/211 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPN 103
           DD+ L   IG G    VY    L N  ++A+K +  E  Q  V E   E+  +S   HPN
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV---GIAKGLA 160
           +V+     V G    LV  Y+   SL  ++    K++        + I      + KGL 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIM----KSSYPRGGLDEAIIATVLKEVLKGLE 116

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTR--IAGTTGYL 217
           +LH      I HRDIKA NILL ++ + KI DFG+ A L          R    GT  ++
Sbjct: 117 YLHSN--GQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173

Query: 218 APEYVLGGQ-LTMKADVYSFGVLVLEIISGR 247
           APE +        KAD++SFG+  +E+ +G 
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  100 bits (250), Expect = 2e-24
 Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 8/203 (3%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L   +      F+ E   +  +RH  LV
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G     ++L   +  D+   IA G+A++   
Sbjct: 65  QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVERM 121

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 122 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178

Query: 226 QLTMKADVYSFGVLVLEIIS-GR 247
           + T+K+DV+SFG+L+ E+ + GR
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  100 bits (249), Expect = 2e-24
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 10/202 (4%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G G FG V+ G   N  ++AVK L   +   V+ F+ E   +  ++H  LV
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            L     +     ++ EY+   SL   L   +    K+   K  D    IA+G+A++  +
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSLLDFL--KSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVL 223
              + +HRD++A+N+L+ +    KI DFGLA++  DN    T R        + APE + 
Sbjct: 123 ---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAIN 177

Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
            G  T+K+DV+SFG+L+ EI++
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  101 bits (252), Expect = 3e-24
 Identities = 70/199 (35%), Positives = 98/199 (49%), Gaps = 21/199 (10%)

Query: 53  KIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGV---REFITEIMTLSNVRHPNLVELI 108
           +IG G FG VY          +A+K +S   KQ     ++ I E+  L  +RHPN +E  
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           GC ++     LV EY   ++ D  +L   K    L   + + IC G  +GLA+LH     
Sbjct: 82  GCYLREHTAWLVMEYCLGSASD--ILEVHKK--PLQEVEIAAICHGALQGLAYLHSH--- 134

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLG--- 224
             +HRDIKA NILL +    K+ DFG A L  P N         GT  ++APE +L    
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN------SFVGTPYWMAPEVILAMDE 188

Query: 225 GQLTMKADVYSFGVLVLEI 243
           GQ   K DV+S G+  +E+
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.4 bits (248), Expect = 6e-24
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 20/205 (9%)

Query: 52  NKIGRGGFGTVYKGTLTNGRRI-AVKPLSAES-----KQGVREFITEIMTLSNVRHPNLV 105
           +++G G  G+V K  L N   I A+K ++ +      KQ +RE   EI    + + P +V
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILREL--EIN--KSCKSPYIV 62

Query: 106 ELIGCCV---QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           +  G  +     +  I + EY E  SLD +     K   ++  +    I   + KGL++L
Sbjct: 63  KYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      I+HRDIK SNILL ++   K+ DFG++      +  +     GT+ Y+APE +
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL---VNSLAGTFTGTSFYMAPERI 175

Query: 223 LGGQLTMKADVYSFGVLVLEIISGR 247
            G   ++ +DV+S G+ +LE+   R
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 99.7 bits (249), Expect = 7e-24
 Identities = 70/218 (32%), Positives = 114/218 (52%), Gaps = 23/218 (10%)

Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE-SKQGVR-EFITEIMTL 96
             RS T+ F   N+IG G +G VY+    T+G  +A+K +  +  + G+    + EI  L
Sbjct: 2   RCRSVTE-FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLL 60

Query: 97  SNVRHPNLVELIGCCVQGTRR---ILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSD 150
            N+RHPN+VEL    V G       LV EY E    + LD +    +++ +K        
Sbjct: 61  LNLRHPNIVELKEV-VVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC------- 112

Query: 151 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 210
           + + + +GL +LHE     I+HRD+K SN+LL  +   KI DFGLA+ +      +T ++
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169

Query: 211 AGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 247
             T  Y APE +LG      A D+++ G ++ E+++ +
Sbjct: 170 V-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 99.1 bits (247), Expect = 7e-24
 Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 29/222 (13%)

Query: 47  DFHLSNKIGRGGFGTVYKGTLT--NGRR----IAVKPLSAESKQGVR-EFITEIMTLSNV 99
                 ++G G FG VYKG LT  N R     +A+K L   ++  V+ EF  E   +S++
Sbjct: 6   AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL------------GATKANIKLNWEK 147
           +HPN+V L+G C +     +++EY+ +  L   L+            G       L+   
Sbjct: 66  QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125

Query: 148 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 207
              I + IA G+ +L      H VHRD+ A N L+ +    KI DFGL++   D  +   
Sbjct: 126 FLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADY 179

Query: 208 TRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
            R+   +     ++ PE +L G+ T ++D++SFGV++ EI S
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 98.7 bits (246), Expect = 8e-24
 Identities = 64/204 (31%), Positives = 111/204 (54%), Gaps = 9/204 (4%)

Query: 47  DFHLSNKIGRGGFGTVYK-GTLTNGRRIAVKP--LSAESKQGVREFITEIMTLSNVRHPN 103
           DF +  K+G+G +G+VYK   L++ +  A+K   L + S++   + + EI  L++V HPN
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           ++      + G +  +V EY     L + +    K    +  ++   I + + +GL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K++NILL      KIGD G++K+   N+    T+I GT  Y+APE   
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--TQI-GTPHYMAPEVWK 174

Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   + K+D++S G L+ E+ +  
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 8e-24
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 26/206 (12%)

Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFIT--EIMTLSNVRHPNLVELIG 109
           KIG G +G VYK      G  +A+K +    +          EI  L  + HPN+++L+ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 110 CCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
                    LV+E+++ +    +     G  ++ IK            + +GLAF H   
Sbjct: 66  VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIK-------SYLYQLLQGLAFCHSH- 117

Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITH-ITTRIAGTTGYLAPEYV 222
              I+HRD+K  N+L++ E   K+ DFGLA+ F       TH + TR      Y APE +
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPELL 170

Query: 223 LG-GQLTMKADVYSFGVLVLEIISGR 247
           LG    +   D++S G +  E++S R
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 98.3 bits (245), Expect = 1e-23
 Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 7/193 (3%)

Query: 54  IGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ 113
           +G G FG V+ G       +A+K +  E      +FI E   +  + HPNLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR 173
                +V EY+ N  L    L   K   KL  E   D+C  + + + +L        +HR
Sbjct: 71  QRPIFIVTEYMANGCL-LNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHR 124

Query: 174 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADV 233
           D+ A N L+ ++   K+ DFGLA+   D+    +        +  PE     + + K+DV
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184

Query: 234 YSFGVLVLEIISG 246
           +SFGVL+ E+ S 
Sbjct: 185 WSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 98.3 bits (245), Expect = 1e-23
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 16/207 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN--GRRI--AVKPLSAESKQGVRE-FITEIMTLSNVR 100
           +D  L   IG G FG VY+G   +    +I  AVK     +   VRE F+ E   +    
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI--CVGIAKG 158
           HP++V+LIG   +    I V E      L R  L   K ++ L     S I     ++  
Sbjct: 66  HPHIVKLIGVITENPVWI-VMELAPLGEL-RSYLQVNKYSLDL----ASLILYSYQLSTA 119

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
           LA+L  +     VHRDI A N+L+      K+GDFGL++   D   +  ++      ++A
Sbjct: 120 LAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176

Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIIS 245
           PE +   + T  +DV+ FGV + EI+ 
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 98.4 bits (245), Expect = 1e-23
 Identities = 85/289 (29%), Positives = 130/289 (44%), Gaps = 46/289 (15%)

Query: 54  IGRGGFGTV--YKGTLTN---GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVEL 107
           +G G FG V  Y     N   G  +AVK L  E  Q     +  EI  L  + H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 108 IGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV---GIAKGLAFL 162
            GCC +   +   L+ EYV   SL   L    K  + L     + + +    I +G+A+L
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNL-----AQLLLFAQQICEGMAYL 123

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPE 220
           H +   H +HRD+ A N+LLD +   KIGDFGLAK  P+   +   R  G +   + A E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGRNSGKA-----------MWGQMNKFLLEWAWQLH 269
            +   + +  +DV+SFGV + E+++  +S ++             GQM    L     + 
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL-----IE 235

Query: 270 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
             E+ + L  P   +  P E+   MK    C +  A  RP    +I +L
Sbjct: 236 LLERGMRLPCP---KNCPQEVYILMKN---CWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 97.8 bits (243), Expect = 2e-23
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 16/218 (7%)

Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
             +   L  K+G G FG V+ GT     ++AVK L   +      F+ E   +  +RH  
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62

Query: 104 LVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           LV+L    V     I +V EY+   SL   L       +KL      D+   +A G+A++
Sbjct: 63  LVQLYA--VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYI 118

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPE 220
                 + +HRD++++NIL+      KI DFGLA+L  DN    T R        + APE
Sbjct: 119 ERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN--EYTARQGAKFPIKWTAPE 173

Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
             L G+ T+K+DV+SFG+L+ E+++    G+  +  MN
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT---KGRVPYPGMN 208

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 97.5 bits (243), Expect = 3e-23
 Identities = 72/221 (32%), Positives = 98/221 (44%), Gaps = 27/221 (12%)

Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRR-------IAVKPL-SAESKQGVREFITEIMT 95
             D   L   +G G FG VY+G L  GR        +AVK L  + S+Q   +F+ E + 
Sbjct: 4   PRDSITLLRALGHGAFGEVYEG-LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62

Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL-LGATKAN--IKLNWEKRSDIC 152
           +S   H N+V LIG   +   R ++ E +    L   L     +      L  +      
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITT 208
             +AKG  +L E    H +HRDI A N LL  +  P    KI DFG+A+   D       
Sbjct: 123 RDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR---DIYRASYY 175

Query: 209 RIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           R  G       ++ PE  L G  T K DV+SFGVL+ EI S
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 97.5 bits (243), Expect = 4e-23
 Identities = 79/302 (26%), Positives = 130/302 (43%), Gaps = 54/302 (17%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTL------TNGRRIAVKPLSAE-SKQGVREFITEIMTLSN 98
           D   L   +G G FG V K              +AVK L  + +++ + + ++E+  +  
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA-----TKANIKLNWEKRSDI- 151
           + +H N++ L+G C Q     +V EY  + +L R  L A       A+          + 
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNL-RDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 152 -------CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 204
                     +A+G+ FL  +     +HRD+ A N+L+ ++   KI DFGLA+    +I 
Sbjct: 131 QKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIH 183

Query: 205 HITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQ 256
           HI      T G L     APE +     T ++DV+SFGVL+ EI +   S   G  +  +
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-E 242

Query: 257 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
           + K L E     ++ EKP              E+   M+    C     S+RP   Q+++
Sbjct: 243 LFKLLKEG----YRMEKPQ---------NCTQELYHLMRD---CWHEVPSQRPTFKQLVE 286

Query: 317 ML 318
            L
Sbjct: 287 DL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 97.4 bits (242), Expect = 4e-23
 Identities = 80/295 (27%), Positives = 135/295 (45%), Gaps = 44/295 (14%)

Query: 47  DFHLSNKIGRGGFGTV-----YKGTLTNGRR-IAVKPLSAESKQGVREFITEIMTLSNVR 100
           D  L  ++G G FG V     Y  + T  +  +AVK L   +    ++F  E   L+N++
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 65

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG------------ATKANIKLNWEKR 148
           H ++V+  G C  G   I+V+EY+++  L++ L                +A  +L   + 
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
             I   IA G+ +L  +   H VHRD+   N L+      KIGDFG+++   D  +    
Sbjct: 126 LHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYY 179

Query: 209 RIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLLE 263
           R+ G T     ++ PE ++  + T ++DV+SFGV++ EI +    GK  W Q+ N  ++E
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---YGKQPWFQLSNTEVIE 236

Query: 264 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
              Q    E+P            P E+   M     C Q    +R  + ++ K+L
Sbjct: 237 CITQGRVLERP---------RVCPKEVYDIM---LGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 96.7 bits (241), Expect = 4e-23
 Identities = 76/284 (26%), Positives = 119/284 (41%), Gaps = 44/284 (15%)

Query: 53  KIGRGGFGTVYKGTLTN--GRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPNLVEL 107
           K+G G FG V +G  +   G+ I  AVK L ++     + +F+ E   + ++ H NL+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVL----LGATKANIKLNWEKRSDICVGIAKGLAFLH 163
            G  V     ++V E     SL   L    LG    +   ++       V IA G+ +L 
Sbjct: 62  YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMRYLE 114

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR------IAGTTGYL 217
            +     +HRD+ A NILL  +   KIGDFGL +  P N  H           A    + 
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA----WC 167

Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE- 276
           APE +     +  +DV+ FGV + E+ +        +G+     L  +  L + +K  E 
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFT--------YGEEPWAGLSGSQILKKIDKEGER 219

Query: 277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           L  P   E  P +I   M     C     + RP    + + L +
Sbjct: 220 LERP---EACPQDIYNVMLQ---CWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 4e-23
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 20/220 (9%)

Query: 41  LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVK--PLSAESKQGVREFITEIMTLS 97
           L   T  F L   IG G +G VYK      G+ +A+K   +  + ++ ++E    +   S
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60

Query: 98  NVRHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
           N  HPN+    G  ++           LV E     S+  ++ G  K   +L  E  + I
Sbjct: 61  N--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
                +GLA+LHE     ++HRDIK  NILL +    K+ DFG++      +    T I 
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI- 174

Query: 212 GTTGYLAPEYVLGGQ-----LTMKADVYSFGVLVLEIISG 246
           GT  ++APE +   +        ++DV+S G+  +E+  G
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 97.0 bits (242), Expect = 5e-23
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 19/209 (9%)

Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQG--VREFITEIMTLSNVRHPN 103
            + +  +IG G  G V+K      G  +A+K ++    +G    + + EI  L   +HP 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGA----TKANIKLNWEKRSDICVGIAKGL 159
           +V+L+     G+  +LV EY+ +  L  VL        +A +K            + KG+
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS-------YMRMLLKGV 112

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           A++H      I+HRD+K +N+L+  +   KI DFGLA+LF +    + +    T  Y AP
Sbjct: 113 AYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169

Query: 220 EYVLGGQ-LTMKADVYSFGVLVLEIISGR 247
           E + G +      D+++ G +  E+++G 
Sbjct: 170 ELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 96.8 bits (241), Expect = 5e-23
 Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 23/205 (11%)

Query: 54  IGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G+G FG+V    Y     N G  +AVK L   + + +R+F  EI  L +++H N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 109 GCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEK----RSDICVGIAKGLAFL 162
           G C    RR   LV EY+   SL   L    K   +L+  K     S IC    KG+ +L
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQIC----KGMEYL 124

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPE 220
             +     VHRD+   NIL++ E   KIGDFGL K+ P +  +   R  G +   + APE
Sbjct: 125 GSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181

Query: 221 YVLGGQLTMKADVYSFGVLVLEIIS 245
            +   + ++ +DV+SFGV++ E+ +
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 97.1 bits (241), Expect = 6e-23
 Identities = 81/287 (28%), Positives = 130/287 (45%), Gaps = 45/287 (15%)

Query: 50  LSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
           L  ++G G FG V+     N         +AVK L   S    ++F  E   L+N++H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 104 LVELIGCCVQGTRRILVYEYVENNSL---------DRVLLGATKANIKLNWEKRSDICVG 154
           +V+  G CV+G   I+V+EY+++  L         D VL+       +L   +   I   
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
           IA G+ +L  +   H VHRD+   N L+ +    KIGDFG+++   D  +    R+ G T
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTDYYRVGGHT 182

Query: 215 ----GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQLH 269
                ++ PE ++  + T ++DV+S GV++ EI +    GK  W Q+ N  ++E   Q  
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT---YGKQPWYQLSNNEVIECITQGR 239

Query: 270 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
             ++P            P E+   M     C Q    R P M   IK
Sbjct: 240 VLQRPRTC---------PKEVYDLM---LGCWQ----REPHMRLNIK 270

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 7e-23
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 23/205 (11%)

Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKP-LSAESKQGVREFIT-EIMTLSNVRHPNLVELIG 109
            +G G +G V K      G  +A+K    +E  + V++    E+  L  +RH N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANI------KLNWEKRSDICVGIAKGLAFLH 163
              +  R  LV+EYVE   L+  LL A+   +         W+        + + +A+ H
Sbjct: 68  AFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQ--------LLQAIAYCH 117

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
                +I+HRDIK  NIL+ +    K+ DFG A+          T    T  Y APE ++
Sbjct: 118 SH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174

Query: 224 GGQLTMKA-DVYSFGVLVLEIISGR 247
           G     K  DV++ G ++ E++ G 
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 7e-23
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 21/213 (9%)

Query: 45  TDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
            D + +  ++G G FG VYK      G   A K +  ES++ + +F+ EI  LS  +HPN
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLL----GATKANIKLNWEKRSDICVGIAKGL 159
           +V L        +  ++ E+ +  +LD ++L    G T+  I+        +C  + + L
Sbjct: 64  IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------VCRQMLEAL 116

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
            FLH   V   +HRD+KA NILL  + + K+ DFG++      +    T I GT  ++AP
Sbjct: 117 NFLHSHKV---IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAP 172

Query: 220 EYVL-----GGQLTMKADVYSFGVLVLEIISGR 247
           E V            KAD++S G+ ++E+    
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 21/204 (10%)

Query: 52  NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIG 109
           N+IG G  GTVYK      GR  A+K +    +  VR  I  EI  L +V HPN+V+   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR-SDICVGIAKGLAFLHEELVP 168
                    ++ E+++  SL+            +  E+  +D+   I  G+A+LH     
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE---------GTHIADEQFLADVARQILSGIAYLHRR--- 187

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV-----L 223
           HIVHRDIK SN+L++   N KI DFG++++    +    + + GT  Y++PE +      
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNH 246

Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G       D++S GV +LE   GR
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 21/210 (10%)

Query: 42  RSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFI-TEIMTLSNV 99
           RS  D+F    KIG G  G V   T  + GR++AVK +    KQ  RE +  E++ + + 
Sbjct: 18  RSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDY 73

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +HPN+VE+    + G    +V E++E  +L  ++      + ++N E+ + +C+ + K L
Sbjct: 74  QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKAL 128

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR---IAGTTGY 216
           +FLH + V   +HRDIK+ +ILL  +   K+ DFG    F   ++    R   + GT  +
Sbjct: 129 SFLHAQGV---IHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYW 181

Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           +APE +       + D++S G++V+E++ G
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 80/289 (27%), Positives = 128/289 (44%), Gaps = 41/289 (14%)

Query: 47  DFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           D  L  ++G G FG V+     N         +AVK L   S+   ++F  E   L+ ++
Sbjct: 6   DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ 65

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL-----------GATKANIKLNWEKRS 149
           H ++V   G C +G   ++V+EY+ +  L+R L            G   A  +L   +  
Sbjct: 66  HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125

Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITT 208
            I   IA G+ +L      H VHRD+   N L+ Q    KIGDFG+++ ++  +   +  
Sbjct: 126 AIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182

Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQ 267
           R      ++ PE +L  + T ++D++SFGV++ EI +    GK  W Q+ N   +E   Q
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT---YGKQPWYQLSNTEAIECITQ 239

Query: 268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
             + E+P            P E+   M       Q    R PQ   VIK
Sbjct: 240 GRELERPRTC---------PPEVYAIM-------QGCWQREPQQRMVIK 272

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.4 bits (234), Expect = 3e-22
 Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 11/219 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     ++A+K L   +      F+ E   +  +RH  LV
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLV 64

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            L    V      +V E++   SL   L       +KL   +  D+   IA G+A++   
Sbjct: 65  PLYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIERM 121

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD++A+NIL+      KI DFGLA+L  DN             + APE  L G
Sbjct: 122 ---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178

Query: 226 QLTMKADVYSFGVLVLEIISGRNSGKAMW-GQMNKFLLE 263
           + T+K+DV+SFG+L+ E+++    G+  + G +N+ +LE
Sbjct: 179 RFTIKSDVWSFGILLTELVT---KGRVPYPGMVNREVLE 214

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 94.1 bits (234), Expect = 3e-22
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 13/201 (6%)

Query: 47  DFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           D  + +K+G G +G VY+G        +AVK L  E    V EF+ E   +  ++HPNLV
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 65

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L+G C +     ++ E++   +L   L    +   ++N      +   I+  + +L ++
Sbjct: 66  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVNAVVLLYMATQISSAMEYLEKK 123

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT---GYLAPEYV 222
              + +HRD+ A N L+ +    K+ DFGL++L   +     T  AG      + APE +
Sbjct: 124 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESL 177

Query: 223 LGGQLTMKADVYSFGVLVLEI 243
              + ++K+DV++FGVL+ EI
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 94.5 bits (235), Expect = 4e-22
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 27/222 (12%)

Query: 54  IGRGGFGTVYKG-TLTNGRRIAVK-----PLSAES-----KQGVREFITEIMTLSNVRHP 102
           IG+G +G VY    +T G  +AVK        A       K  V+   +EI TL ++ H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+ +G         +  EYV   S+   L    +   +   +        + +GLA+L
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIAGTTGYLAPE 220
           H +    I+HRD+KA N+L+D +   KI DFG++K   D+I        + G+  ++APE
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVFWMAPE 180

Query: 221 YVLGGQ--LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF 260
            +       + K D++S G +VLE+ +GR      W      
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP----WSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 93.7 bits (233), Expect = 5e-22
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 9/198 (4%)

Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV 112
           +G+G +G VY    L+   RIA+K +     + V+    EI   S ++H N+V+ +G   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 113 QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH 172
           +     +  E V   SL   LL +    +K N +        I +GL +LH+     IVH
Sbjct: 76  ENGFFKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131

Query: 173 RDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ--LTM 229
           RDIK  N+L++      KI DFG +K     I   T    GT  Y+APE +  G      
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGPRGYGA 190

Query: 230 KADVYSFGVLVLEIISGR 247
            AD++S G  ++E+ +G+
Sbjct: 191 PADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 5e-22
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 11/199 (5%)

Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAES-KQGV-REFITEIMTLSNVRHPNLVELIG 109
           KIG G +G VYK      G  +A+K +  E+  +GV    I EI  L  + HPN+V L+ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
                 +  LV+E+++   LD      +     L+          + +G+A+ H      
Sbjct: 66  VVHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---R 119

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLT 228
           ++HRD+K  N+L+D+E   K+ DFGLA+ F   +   T  +  T  Y APE +LG  Q +
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYS 178

Query: 229 MKADVYSFGVLVLEIISGR 247
              D++S G +  E+++ R
Sbjct: 179 TPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 94.2 bits (234), Expect = 7e-22
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 12/196 (6%)

Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           KIG+G  GTVY    +  G+ +A+K ++ + +      I EI+ +   +HPN+V  +   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           + G    +V EY+   SL  V+         ++  + + +C    + L FLH      ++
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 137

Query: 172 HRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 230
           HRDIK+ NILL  + + K+ DFG  A++ P+     T  + GT  ++APE V       K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195

Query: 231 ADVYSFGVLVLEIISG 246
            D++S G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 93.8 bits (234), Expect = 7e-22
 Identities = 70/220 (31%), Positives = 96/220 (43%), Gaps = 45/220 (20%)

Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLS----AESKQGVREFITEIMTLS 97
           DDF     +G G FG V    +KG+   G+  A+K LS     + KQ V   + E   L 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQ-VEHVLNEKRILQ 56

Query: 98  NVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL-------DRVLLGATK---ANIKLNWE 146
           ++RHP LV L G   Q    + LV EYV    L        R      +   A + L   
Sbjct: 57  SIRHPFLVNLYGS-FQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL--- 112

Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
                       L +LH      IV+RD+K  N+LLD +   KI DFG AK         
Sbjct: 113 -----------ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154

Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           T  + GT  YLAPE +L        D ++ G+L+ E+++G
Sbjct: 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 93.7 bits (233), Expect = 7e-22
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 11/204 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYK-GTLTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPN 103
           +D    + +G G  G+V K   +  G  +A K +   +K  VR+ I  E+  +   R P 
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G  +      +  E+++  SLDR+     K    +  E    I V + +GL +L+
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSLDRIY----KKGGPIPVEILGKIAVAVVEGLTYLY 120

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
                 I+HRDIK SNIL++     K+ DFG++    + I  I     GT+ Y++PE + 
Sbjct: 121 NVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQ 175

Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           GG+ T+K+DV+S G+ ++E+  G+
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 93.2 bits (231), Expect = 8e-22
 Identities = 71/232 (30%), Positives = 115/232 (49%), Gaps = 9/232 (3%)

Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           L  K+G G FG V+  T     ++AVK +   S   V  F+ E   +  ++H  LV+L  
Sbjct: 10  LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA 68

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
              +    I+  E++   SL    L + + + K    K  D    IA+G+AF+ +    +
Sbjct: 69  VVTKEPIYIIT-EFMAKGSLLD-FLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQR---N 122

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
            +HRD++A+NIL+      KI DFGLA++  DN             + APE +  G  T+
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182

Query: 230 KADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK-PLELVD 279
           K+DV+SFG+L++EI++ GR     M        LE  +++ + E  P EL +
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 93.1 bits (232), Expect = 9e-22
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 26/208 (12%)

Query: 54  IGRGGFGTVY--KGTLTNGRRIAVKPLSAESKQG---VREFITEIMTLSNVRHPNLVELI 108
           I +G +G V+  K   T G   A+K +          V + +TE   LS  + P +V+L 
Sbjct: 1   ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 109 GCCVQGTRRI-LVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
               QG + + LV EY+    L  +L  +G+      L+ +        I   L +LH  
Sbjct: 60  -YSFQGKKNLYLVMEYLPGGDLASLLENVGS------LDEDVARIYIAEIVLALEYLHSN 112

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-------LFPDNITHITTRIAGTTGYLA 218
               I+HRD+K  NIL+D   + K+ DFGL+K       +  ++      RI GT  Y+A
Sbjct: 113 ---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +LG   +   D +S G ++ E + G
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 94.0 bits (233), Expect = 1e-21
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 21/199 (10%)

Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQG---VREFITEIMTLSNVRHPNLVELI 108
           +IG G FG VY    + N   +A+K +S   KQ     ++ I E+  L  +RHPN ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           GC ++     LV EY   ++ D  LL   K    L   + + +  G  +GLA+LH     
Sbjct: 82  GCYLREHTAWLVMEYCLGSASD--LLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH--- 134

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLG--- 224
           +++HRD+KA NILL +    K+GDFG A +  P N         GT  ++APE +L    
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMDE 188

Query: 225 GQLTMKADVYSFGVLVLEI 243
           GQ   K DV+S G+  +E+
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 93.2 bits (232), Expect = 1e-21
 Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 12/206 (5%)

Query: 47  DFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHPN 103
           D+    KIG G +G VYKG     G+ +A+K +  ES+ +GV    I EI  L  ++HPN
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLD-RVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           +V L    +Q +R  L++E++   S+D +  L +      ++ E        I +G+ F 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L+D +   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 118 HSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVL 173

Query: 223 LGGQL-TMKADVYSFGVLVLEIISGR 247
           LG    +   D++S G +  E+ + +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 93.1 bits (231), Expect = 1e-21
 Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 20/202 (9%)

Query: 54  IGRGGFGTVYKGT-LTNGRRI----AVKPLSAES-KQGVREFITEIMTLSNVRHPNLVEL 107
           +G G FGTV+KG  +  G  I    A+K +   S +Q  +E    ++ + ++ H  +V L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 108 IGCCVQGTRRILVYEYVENNSL---DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           +G C  G    LV +     SL    R    +      LNW      CV IAKG+ +L E
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLEE 127

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGYLAPEYVL 223
                +VHR++ A NILL  +   +I DFG+A L +PD+  +  +       ++A E +L
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
            G+ T ++DV+S+GV V E++S
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 21/208 (10%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS-AESKQGV-----REFITEIMTLSNVR 100
           +    +IG G +GTVYK   L  GR +A+K +    S++G+     RE I  +  L +  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE-IALLKQLESFE 59

Query: 101 HPNLVELIGCC--VQGTRRI---LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           HPN+V L+  C   +  R +   LV+E+V+ + L   L    K  +    E   D+   +
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPP--ETIKDLMRQL 116

Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
            +G+ FLH      IVHRD+K  NIL+  +   KI DFGLA+++   +    T +  T  
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLW 171

Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEI 243
           Y APE +L        D++S G +  E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 76/276 (27%), Positives = 135/276 (48%), Gaps = 27/276 (9%)

Query: 54  IGRGGFGTVYKGTL-TNGRR---IAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G FG V  G L   G+R   +A+K L A  +++  R+F++E   +    HPN++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMKYLSDM--- 125

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + APE +   +
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 186 FTSASDVWSYGIVMWEVMS--YGERPYWEMSNQDVIKAIEEGYRLPAPMDC--------- 234

Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
           P  + + M     C Q   + RP+  Q++ +L K I
Sbjct: 235 PAALHQLM---LDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.9 bits (228), Expect = 2e-21
 Identities = 69/271 (25%), Positives = 132/271 (48%), Gaps = 27/271 (9%)

Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           L   IG G FG V +G  T G+++AVK +  +     + F+ E   ++ + H NLV L+G
Sbjct: 10  LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLG 66

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
             +     I V E +   +L   L   T+    ++  +     + +A+G+ +L  +    
Sbjct: 67  VILHNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---K 120

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
           +VHRD+ A NIL+ ++   K+ DFGLA++    +    +++     + APE +   + + 
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD--NSKLP--VKWTAPEALKHKKFSS 176

Query: 230 KADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE 289
           K+DV+S+GVL+ E+ S    G+A + +M+  L E    + +  +    ++P  G      
Sbjct: 177 KSDVWSYGVLLWEVFS---YGRAPYPKMS--LKEVKECVEKGYR----MEPPEGCPADVY 227

Query: 290 IIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           ++  M     C +    +RP  +++ + L K
Sbjct: 228 VL--MTS---CWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.6 bits (227), Expect = 2e-21
 Identities = 73/268 (27%), Positives = 125/268 (46%), Gaps = 23/268 (8%)

Query: 54  IGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCV 112
           +G+G FG V+KGTL +   +AVK    +  Q ++ +F++E   L    HPN+V+LIG C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 113 QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH 172
           Q     +V E V        L    K   +L  ++     +  A G+A+L  +   + +H
Sbjct: 63  QRQPIYIVMELVPGGDFLSFL---RKKKDELKTKQLVKFALDAAAGMAYLESK---NCIH 116

Query: 173 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKAD 232
           RD+ A N L+ +    KI DFG+++   D I   +        + APE +  G+ + ++D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 233 VYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 291
           V+S+G+L+ E  S G      M  Q  +          Q EK   +  P   +  P+++ 
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAR---------EQVEKGYRMSCP---QKCPDDVY 224

Query: 292 RYMKVAFFCTQAAASRRPQMNQVIKMLT 319
           + M+    C       RP+ +++ K L 
Sbjct: 225 KVMQR---CWDYKPENRPKFSELQKELA 249

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 73/237 (30%), Positives = 108/237 (45%), Gaps = 49/237 (20%)

Query: 43  SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAES-KQGVREFIT---EIMTLS 97
           S   D+ +  K+G G FG VYK   +  GR +A+K +   + K G    IT   EI  L 
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFP--ITALREIKILK 62

Query: 98  NVRHPNLVELIGCCV------QGTRRI--LVYEY--------VENNSLDRVLLGATKANI 141
            ++HPN+V LI   V      +  R    +V  Y        +EN     V L  T++ I
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKL--TESQI 117

Query: 142 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 201
           K          + + +G+ +LHE    HI+HRDIKA+NIL+D +   KI DFGLA+ +  
Sbjct: 118 KC-------YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167

Query: 202 NITHITTRIAGTTG----------YLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 247
              +      G T           Y  PE +LG  + T   D++  G +  E+ + R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 91.5 bits (227), Expect = 3e-21
 Identities = 75/283 (26%), Positives = 138/283 (48%), Gaps = 39/283 (13%)

Query: 54  IGRGGFGTVYKGTLTN-GRR---IAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G FG V +G L   G+R   +A+K L +  +++  R+F++E   +    HPN++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV-----GIAKGLAFLH 163
           G   +    +++ E++EN +LD  L        + N  + + I +     GIA G+ +L 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL--------RQNDGQFTVIQLVGMLRGIAAGMKYLS 123

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTG--YLAP 219
           E    + VHRD+ A NIL++     K+ DFGL++   D+ +    T+ + G     + AP
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD 279
           E +   + T  +DV+S+G+++ E++S     +  W   N+ ++    Q ++   P++   
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS--YGERPYWDMSNQDVINAIEQDYRLPPPMDC-- 236

Query: 280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
                  P  + + M     C Q   + RP+  Q++  L K I
Sbjct: 237 -------PTALHQLM---LDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.6 bits (227), Expect = 3e-21
 Identities = 71/212 (33%), Positives = 104/212 (49%), Gaps = 23/212 (10%)

Query: 47  DFHLSNKIGRGGFGTVYKG-TLTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNVR 100
           ++ L   +GRG FG VY       GR +AVK     P S E+ + V     EI  L N+R
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 101 HPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIA 156
           H  +V+  GC      + L    EY+   S+   L   GA   N+   + ++      I 
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ------IL 116

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG- 215
           +G+++LH  +   IVHRDIK +NIL D   N K+GDFG +K     I    T I   TG 
Sbjct: 117 QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGT 172

Query: 216 --YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
             +++PE + G     KADV+S    V+E+++
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 91.7 bits (227), Expect = 5e-21
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 12/196 (6%)

Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           KIG+G  GTV+    +  G+ +A+K ++ + +      I EI+ +  +++PN+V  +   
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           + G    +V EY+   SL  V+        ++     + +C    + L FLH      ++
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVVTETCMDEAQI-----AAVCRECLQALEFLHAN---QVI 137

Query: 172 HRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 230
           HRDIK+ N+LL  + + K+ DFG  A++ P+     T  + GT  ++APE V       K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195

Query: 231 ADVYSFGVLVLEIISG 246
            D++S G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 90.5 bits (225), Expect = 8e-21
 Identities = 64/209 (30%), Positives = 91/209 (43%), Gaps = 23/209 (11%)

Query: 48  FHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPN 103
           F L   IG+G FG V         +  A+K ++ +    K  VR  + E   L  + HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGA----TKANIKLNWEKRSDICVGIAKGL 159
           LV L           LV + +    L R  L      ++  +K            I   L
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKF-------WICEIVLAL 113

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
            +LH +    I+HRDIK  NILLD++ +  I DF +A     +   +TT  +GT GY+AP
Sbjct: 114 EYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAP 168

Query: 220 EYVLGGQLTMKA-DVYSFGVLVLEIISGR 247
           E VL  Q    A D +S GV   E + G+
Sbjct: 169 E-VLCRQGYSVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 91.2 bits (226), Expect = 9e-21
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 30/207 (14%)

Query: 54  IGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVRHPNLVEL 107
           +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V +P++  L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 108 IGCCVQGTRRIL--------VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +G C+  T +++        + +YV  +  D +      +   LNW      CV IAKG+
Sbjct: 75  LGICLTSTVQLITQLMPFGCLLDYVREHK-DNI-----GSQYLLNW------CVQIAKGM 122

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLA 218
            +L E     +VHRD+ A N+L+    + KI DFGLAKL   D   +          ++A
Sbjct: 123 NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIIS 245
            E +L    T ++DV+S+GV V E+++
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 91.2 bits (226), Expect = 9e-21
 Identities = 68/199 (34%), Positives = 100/199 (50%), Gaps = 19/199 (9%)

Query: 52  NKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQ---GVREFITEIMTLSNVRHPNLVEL 107
           ++IG G FG VY  T       +AVK +S   KQ     ++ I E+  L  ++HPN +E 
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
            GC ++     LV EY   ++ D  LL   K    L   + + I  G  +GLA+LH    
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASD--LLEVHKK--PLQEVEIAAITHGALQGLAYLHSH-- 140

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--- 224
            +++HRDIKA NILL +    K+ DFG A     + +       GT  ++APE +L    
Sbjct: 141 -NMIHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILAMDE 194

Query: 225 GQLTMKADVYSFGVLVLEI 243
           GQ   K DV+S G+  +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 90.4 bits (224), Expect = 9e-21
 Identities = 71/274 (25%), Positives = 134/274 (48%), Gaps = 27/274 (9%)

Query: 54  IGRGGFGTVYKGTL-TNGRR---IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELI 108
           IG G FG V++G L   GR+   +A+K L     +  R +F++E   +    H N++ L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    +++ EY+EN +LD+ L      + + +  +   +  GIA G+ +L +    
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMKYLSDM--- 126

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN--ITHITTRIAGTTGYLAPEYVLGGQ 226
           + VHRD+ A NIL++     K+ DFGL+++  D+   T+ T+       + APE +   +
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+SFG+++ E++S     +  W   N  +++      +   P++          
Sbjct: 187 FTSASDVWSFGIVMWEVMS--FGERPYWDMSNHEVMKAINDGFRLPAPMDC--------- 235

Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           P+ + + M     C Q   +RRP+   ++ +L K
Sbjct: 236 PSAVYQLM---LQCWQQDRARRPRFVDIVNLLDK 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 90.9 bits (225), Expect = 1e-20
 Identities = 55/206 (26%), Positives = 107/206 (51%), Gaps = 13/206 (6%)

Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           R+  D+F    KIG G  G V   T+ ++G+ +AVK +    +Q       E++ + + +
Sbjct: 19  RTYLDNF---IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ 75

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           H N+VE+    + G    +V E++E  +L  ++      + ++N E+ + +C+ + K L+
Sbjct: 76  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALS 130

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            LH +    ++HRDIK+ +ILL  +   K+ DFG        +      + GT  ++APE
Sbjct: 131 VLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPE 186

Query: 221 YVLGGQLTMKADVYSFGVLVLEIISG 246
            +       + D++S G++V+E++ G
Sbjct: 187 LISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 19/203 (9%)

Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGV-REFITEIMTLSNVRHPNLVELIGC 110
           K+G G + TVYKG   T G  +A+K +  ++++G     I EI  +  ++H N+V L   
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 111 CVQGTRRILVYEYVENNSLDRVL-----LGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
                + +LV+EY++ + L + +      GA   N   ++  +      + KG+AF HE 
Sbjct: 67  IHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQ------LLKGIAFCHEN 119

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
               ++HRD+K  N+L+++    K+ DFGLA+ F   +   +  +  T  Y AP+ +LG 
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGS 175

Query: 226 QL-TMKADVYSFGVLVLEIISGR 247
           +  +   D++S G ++ E+I+GR
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 16/212 (7%)

Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS------AESKQGVREFITEIMTLSNV 99
           D+ +   IG+G FGTV K    ++G+ +  K +        E +Q     ++E+  L  +
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQ----LVSEVNILREL 56

Query: 100 RHPNLVELIGCCV--QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           +HPN+V      +        +V EY E   L +++    K    +  E    I   +  
Sbjct: 57  KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116

Query: 158 GLAFLHEELVPH--IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
            L   H    P   ++HRD+K +NI LD   N K+GDFGLAK+   + +   T   GT  
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPY 175

Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           Y++PE +       K+D++S G L+ E+ +  
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 90.1 bits (223), Expect = 1e-20
 Identities = 77/271 (28%), Positives = 123/271 (45%), Gaps = 32/271 (11%)

Query: 52  NKIGRGGFGTVYKGTLTNGRRI-AVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELIG 109
            +IG+G FG VYKG     + + A+K +   E++  + +   EI  LS    P +    G
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 110 CCVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
             ++GT+  ++ EY+   S LD +  G       L     + I   I KGL +LH E   
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKPGP------LEETYIATILREILKGLDYLHSE--- 120

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 228
             +HRDIKA+N+LL ++ + K+ DFG+A    D      T + GT  ++APE +      
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD 179

Query: 229 MKADVYSFGVLVLEIISG-----------------RNSGKAMWGQMNKFLLEWAWQLHQE 271
            KAD++S G+  +E+  G                 +NS   + GQ +K   E+      +
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239

Query: 272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 302
           +        EL ++    I RY K   F T+
Sbjct: 240 DPRFRPTAKELLKH--KFITRYTKKTSFLTE 268

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 90.3 bits (224), Expect = 1e-20
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 11/204 (5%)

Query: 48  FHLSNKIGRGGFGTVYKG-TLTNGRRIAVKP--LSAESKQGVREFITEIMTLSNVRHPNL 104
           F    KIG G +G VYK      G  +A+K   L  E++      I EI  L  + HPN+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           V+L+       +  LV+E++ +  L + +  +  + I L   K       + +GLAF H 
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHS 118

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
             V   +HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +LG
Sbjct: 119 HRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLG 174

Query: 225 GQLTMKA-DVYSFGVLVLEIISGR 247
            +    A D++S G +  E+++ R
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 88.7 bits (220), Expect = 3e-20
 Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 19/203 (9%)

Query: 54  IGRGGFGTVYKGTL--TNGRRI--AVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG+G FG VY GTL  ++G++I  AVK L+     + V +F+ E + + +  HPN++ L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLAFLHEE 165
           G C+      ++V  Y+++  L   +   T      N   +  I  G  +AKG+ +L  +
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK 117

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYLAPEYV 222
                VHRD+ A N +LD+ F  K+ DFGLA+   D      H  T       ++A E +
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
              + T K+DV+SFGVL+ E+++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 88.9 bits (220), Expect = 4e-20
 Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 34/224 (15%)

Query: 50  LSNKIGRGGFGTVY-------------KGTLTNGR--RIAVKPLSAESKQGVR-EFITEI 93
           L  K+G G FG V+                  +G+   +AVK L A+  +  R +F+ EI
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 94  MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI-C 152
             +S +++PN++ L+G CV      ++ EY+EN  L++ L   ++  I+  +   ++I  
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL---SQREIESTFTHANNIPS 125

Query: 153 VG----------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPD 201
           V           IA G+ +L      + VHRD+   N L+   +  KI DFG+++ L+  
Sbjct: 126 VSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182

Query: 202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           +   I  R      ++A E +L G+ T  +DV++FGV + E+ +
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 88.3 bits (219), Expect = 4e-20
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKP------LSAESKQGVREFITEIMTLS 97
             +F +  KIG+G F  VYK   L +GR +A+K       + A+++Q   + + EI  L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57

Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS-DICVGIA 156
            + HPN+++ +   ++     +V E  +   L R ++   K   +L  E+      V + 
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
             L  +H +    I+HRDIK +N+ +      K+GD GL + F    T   + + GT  Y
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172

Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEI 243
           ++PE +       K+D++S G L+ E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 88.2 bits (218), Expect = 5e-20
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 23/207 (11%)

Query: 54  IGRGGFGTVYKG-TLTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           +G+G FG VY    +  GR +A K     P S E+ + V     EI  L N++H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 108 IGCCVQGTRRILV--YEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLH 163
            GC      + L    EY+   S+   L   GA   ++   + ++      I +G+++LH
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGMSYLH 123

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG---YLAPE 220
             +   IVHRDIK +NIL D   N K+GDFG +K     I    T I   TG   +++PE
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSPE 179

Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGR 247
            + G     KADV+S G  V+E+++ +
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 89.0 bits (220), Expect = 6e-20
 Identities = 69/199 (34%), Positives = 101/199 (50%), Gaps = 21/199 (10%)

Query: 53  KIGRGGFGTVY--KGTLTNGRRIAVKPLSAESKQGV---REFITEIMTLSNVRHPNLVEL 107
           +IG G FG VY  +   TN   +A+K +S   KQ     ++ I E+  L  ++HPN +E 
Sbjct: 32  EIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
            GC ++     LV EY   ++ D  LL   K    L   + + I  G  +GLA+LH    
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASD--LLEVHKK--PLQEVEIAAITHGALQGLAYLHSH-- 144

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--- 224
            +++HRDIKA NILL +    K+ DFG A     +I        GT  ++APE +L    
Sbjct: 145 -NMIHRDIKAGNILLTEPGQVKLADFGSA-----SIASPANSFVGTPYWMAPEVILAMDE 198

Query: 225 GQLTMKADVYSFGVLVLEI 243
           GQ   K DV+S G+  +E+
Sbjct: 199 GQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 88.2 bits (218), Expect = 8e-20
 Identities = 57/196 (29%), Positives = 101/196 (51%), Gaps = 12/196 (6%)

Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           KIG+G  GTVY    +  G+ +A+K ++ + +      I EI+ +   ++PN+V  +   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           + G    +V EY+   SL  V+         ++  + + +C    + L FLH      ++
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSN---QVI 137

Query: 172 HRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 230
           HRDIK+ NILL  + + K+ DFG  A++ P+     T  + GT  ++APE V       K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195

Query: 231 ADVYSFGVLVLEIISG 246
            D++S G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 87.4 bits (216), Expect = 8e-20
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 21/213 (9%)

Query: 47  DFHLSNKIGRGGFGTVYKG-TLTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNVR 100
           ++ L   +G+G FG VY       GR +AVK     P S E+ + V     EI  L N+ 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 101 HPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIA 156
           H  +V+  GC      R L    E++   S+   L   GA   N+   + ++      I 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ------IL 116

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIAGTT 214
           +G+++LH  +   IVHRDIK +NIL D   N K+GDFG +K         T    + GT 
Sbjct: 117 EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
            +++PE + G     KAD++S G  V+E+++ +
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 51/195 (26%), Positives = 100/195 (51%), Gaps = 10/195 (5%)

Query: 53  KIGRGGFGTV-YKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           KIG G  G V       +GR++AVK +    +Q       E++ + + +H N+VE+    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           + G    ++ E+++  +L  ++     +  +LN E+ + +C  + + L +LH + V   +
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQGV---I 139

Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKA 231
           HRDIK+ +ILL  +   K+ DFG       ++      + GT  ++APE +       + 
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 232 DVYSFGVLVLEIISG 246
           D++S G++V+E++ G
Sbjct: 199 DIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 86.8 bits (215), Expect = 1e-19
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 22/207 (10%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLS------AESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G F + Y+   +  G  +AVK ++      +E ++ V     EI  ++ + HP+++ 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           ++G   + +   L  E++   S+  +L   GA K  + +N+         + +GL++LHE
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY------TEQLLRGLSYLHE 121

Query: 165 ELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPE 220
                I+HRD+K +N+L+D      +I DFG A       T       ++ GT  ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGR 247
            + G Q     DV+S G +++E+ + +
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 87.5 bits (216), Expect = 2e-19
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 12/196 (6%)

Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           KIG+G  GTVY    +  G+ +A++ ++ + +      I EI+ +   ++PN+V  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           + G    +V EY+   SL  V+         ++  + + +C    + L FLH      ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138

Query: 172 HRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 230
           HRDIK+ NILL  + + K+ DFG  A++ P+      + + GT  ++APE V       K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196

Query: 231 ADVYSFGVLVLEIISG 246
            D++S G++ +E+I G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 86.9 bits (215), Expect = 2e-19
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 31/224 (13%)

Query: 50  LSNKIGRGGFGTVYKGTLTN--GR----RIAVKPLSAESKQG-VREFITEIMTLSNVRHP 102
           L   +G G FG V K T     GR     +AVK L   +    +R+ ++E   L  V HP
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVL------------LGATKANIKLNWEKRSD 150
           ++++L G C Q    +L+ EY +  SL   L                + +  L+      
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123

Query: 151 ICVG--------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPD 201
           + +G        I++G+ +L E     +VHRD+ A N+L+ +    KI DFGL++ ++ +
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           +     ++      ++A E +     T ++DV+SFGVL+ EI++
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 86.4 bits (214), Expect = 2e-19
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 36/230 (15%)

Query: 35  HFSYTELRSATDDFHLSNKIGRGGFGTVY----KGTLTNGRR--IAVKPLSAESKQGVR- 87
            F  + L+  T        +GRG FG V+    KG    G    + VK L     + ++ 
Sbjct: 1   AFPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS 53

Query: 88  EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----- 142
           EF  E+     + H N+V L+G C +     ++ EY +   L + L  ATK+  +     
Sbjct: 54  EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPP 112

Query: 143 -LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK---- 197
            L+ +++  +C  IA G+  L        VHRD+ A N L+  +   K+    L+K    
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169

Query: 198 --LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              +      I  R      +LAPE V     + K+DV+SFGVL+ E+ +
Sbjct: 170 SEYYKLRNALIPLR------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 53  KIGRGGFGTVYKGTLTN-GRRIAVKP-LSAESKQGVREF-ITEIMTLSNVRHPNLVELIG 109
            +G G +G V K      G+ +A+K  L +E  + V++  + EI  L  +RH NLV LI 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
              +  R  LV+E+V++  LD +     K    L+  +       I +G+ F H     +
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHSH---N 120

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
           I+HRDIK  NIL+ Q    K+ DFG A+        + T    T  Y APE ++G     
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 230 KA-DVYSFGVLVLEIISG 246
           +A D+++ G LV E+++G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 51/195 (26%), Positives = 101/195 (51%), Gaps = 10/195 (5%)

Query: 53  KIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           KIG G  G V   T  + G+++AVK +    +Q       E++ + +  H N+V++    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           + G    +V E++E  +L  ++      + ++N E+ + +C+ + + L++LH +    ++
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVI 140

Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKA 231
           HRDIK+ +ILL  +   K+ DFG        +      + GT  ++APE +       + 
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 232 DVYSFGVLVLEIISG 246
           D++S G++V+E+I G
Sbjct: 200 DIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 69/231 (29%), Positives = 120/231 (51%), Gaps = 34/231 (14%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVRE-F-IT---EIMTLSNV 99
           D++   N+I  G +G VY+      G  +A+K L  E +   +E F IT   EI  L  +
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE---KEGFPITSLREINILLKL 61

Query: 100 RHPNLVEL--IGCCVQGTR--RI-LVYEYVENN---SLDRVLLGATKANIKLNWEKRSDI 151
           +HPN+V +  +   V G+   +I +V EYVE++    ++ +     ++ +K        +
Sbjct: 62  QHPNIVTVKEV---VVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC-------L 111

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
            + +  G+A LH+     I+HRD+K SN+LL+     KI DFGLA+ +   +    T++ 
Sbjct: 112 MLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLV 167

Query: 212 GTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRN--SGKAMWGQMNK 259
            T  Y APE +LG +  +   D++S G +  E+++ +    GK+   Q+NK
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK 218

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 27/206 (13%)

Query: 54  IGRGGFGTV----YKGTLTNGRRIAVKPLSAE---SKQGVREFITE--IMTLSNVRHPNL 104
           +G+G FG V     KGT       AVK L  +       V   +TE  ++ L+  +HP L
Sbjct: 3   LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58

Query: 105 VELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
            +L   C Q   R+  V EYV  N  D  L+   + + + +  +       I  GL FLH
Sbjct: 59  TQLH-SCFQTKDRLFFVMEYV--NGGD--LMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTR-IAGTTGYLAPEY 221
           E     I++RD+K  N+LLD E + KI DFG+ K   + I   +TT    GT  Y+APE 
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEI 167

Query: 222 VLGGQLTMKADVYSFGVLVLEIISGR 247
           +         D ++ GVL+ E+++G+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.7 bits (212), Expect = 4e-19
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 26/211 (12%)

Query: 52  NKIGRGGFGTVYKGTLTNGRRIAVKP--------LSAESKQGVREFITEIMTLSNVRHPN 103
             +G+G +GTVY G    G+ IAVK         L+AE +    +   E+  L +++H N
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKE--YEKLQEEVDLLKSLKHVN 63

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAF 161
           +V+ +G C+      +  E+V   S+  +L   G     +   + K+      I  G+A+
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ------ILDGVAY 117

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK---LFPDNITH--ITTRIAGTTGY 216
           LH   V   VHRDIK +N++L      K+ DFG A+       + TH  +   + GT  +
Sbjct: 118 LHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           +APE +       K+D++S G  V E+ +G+
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 18/213 (8%)

Query: 48  FHLSNKIGRGGFGTVYKGTLTNGRR---IAVKPLSAESKQGV---REFITEIMTLSNVRH 101
           + +   IGRG +G VYK    NG+     A+K    + +Q     +    EI  L  ++H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 102 PNLVELIGCCVQ-GTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            N+V L+   ++   + + L+++Y E++    +        + +       +   I  G+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITT--RIAGT 213
            +LH      ++HRD+K +NIL+  E       KIGD GLA+LF   +  +     +  T
Sbjct: 122 HYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178

Query: 214 TGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIIS 245
             Y APE +LG +   KA D+++ G +  E+++
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 85.5 bits (212), Expect = 6e-19
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 29/219 (13%)

Query: 53  KIGRGGFGTVY------------KGTLTNGRR-----IAVKPLSAESKQGVR-EFITEIM 94
           K+G G FG V+            K    N        +AVK L  ++    R +F+ E+ 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 95  TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS----- 149
            LS +  PN+  L+G C       ++ EY+EN  L++ L         L    +S     
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 150 --DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHI 206
              +   IA G+ +L E L  + VHRD+   N L+ + +  KI DFG+++ L+  +   +
Sbjct: 132 LLYMATQIASGMRYL-ESL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
             R      ++A E VL G+ T K+DV++FGV + EI++
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 85.5 bits (211), Expect = 8e-19
 Identities = 57/203 (28%), Positives = 105/203 (51%), Gaps = 25/203 (12%)

Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           ++G G FG VYK      G   A K +  +S++ + +++ EI  L+   HP +V+L+G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 112 VQGTRRILVYEYVENNSLDRVLL----GATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
               +  ++ E+    ++D ++L    G T+  I++       IC  + + L +LH    
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------ICRQMLEALQYLHSM-- 129

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLAPEYVLGG 225
             I+HRD+KA N+LL  + + K+ DFG++     N+  +  R    GT  ++APE V+  
Sbjct: 130 -KIIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 226 QLT-----MKADVYSFGVLVLEI 243
            +       KAD++S G+ ++E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 84.7 bits (209), Expect = 9e-19
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 11/204 (5%)

Query: 52  NKIGRGGFGTVYKGTLTNGRRI-AVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELIG 109
            +IG+G FG V+KG     +++ A+K +   E++  + +   EI  LS    P + +  G
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
             ++GT+  ++ EY+   S   +L        ++     + +   I KGL +LH E    
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEILKGLDYLHSE---K 121

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
            +HRDIKA+N+LL ++ + K+ DFG+A    D      T + GT  ++APE +       
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 180

Query: 230 KADVYSFGVLVLEIISGRNSGKAM 253
           KAD++S G+  +E+  G      M
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 84.9 bits (210), Expect = 9e-19
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 29/218 (13%)

Query: 54  IGRGGFGTVYKGT---LTNGRR---IAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVE 106
           IG+G FG V++     L        +AVK L  E S     +F  E   ++   HPN+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVL----------LGATKANIKLNWEKRSDIC---- 152
           L+G C  G    L++EY+    L+  L          L  + ++ +        +     
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 153 ----VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHIT 207
                 +A G+A+L E      VHRD+   N L+ +    KI DFGL+  ++  +    +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 208 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              A    ++ PE +   + T ++DV+++GV++ EI S
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 78/286 (27%), Positives = 130/286 (45%), Gaps = 46/286 (16%)

Query: 54  IGRGGFGTVYKGT-LTNGRRI----AVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVEL 107
           +G G FGTVYKG  + +G  +    A+K L    S +  +E + E   ++ V  P +  L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 108 IGCCVQGTRRIL--------VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +G C+  T +++        + +YV  N  DR+      +   LNW      CV IAKG+
Sbjct: 75  LGICLTSTVQLVTQLMPYGCLLDYVRENK-DRI-----GSQDLLNW------CVQIAKGM 122

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 218
           ++L E     +VHRD+ A N+L+    + KI DFGLA+L   D   +          ++A
Sbjct: 123 SYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179

Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
            E +L  + T ++DV+S+GV V E+++ G      +  +    LLE   +L Q       
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ------- 232

Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
                   PP   I    +   C    +  RP+  +++   ++  R
Sbjct: 233 --------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 14/203 (6%)

Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           +  L   IG+G FG V  G    G ++AVK +  ++    + F+ E   ++ +RH NLV+
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQ 63

Query: 107 LIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           L+G  V+    + +V EY+   SL   L   ++    L  +      + + + + +L   
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD+ A N+L+ ++   K+ DFGL K    + T  T ++     + APE +   
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREK 174

Query: 226 QLTMKADVYSFGVLVLEIIS-GR 247
           + + K+DV+SFG+L+ EI S GR
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 18/204 (8%)

Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPN 103
           D      +G G  GTVYK   L   R +AVK  PL   + +  ++ ++E+  L     P 
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPY 60

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           ++   G      R  +  E+++  SLD           K+       I V + KGL +L 
Sbjct: 61  IIGFYGAFFVENRISICTEFMDGGSLD--------VYRKIPEHVLGRIAVAVVKGLTYLW 112

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
                 I+HRD+K SN+L++     K+ DFG++      +  I     GT  Y+APE + 
Sbjct: 113 SL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERIS 166

Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G Q  + +DV+S G+  +E+  GR
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 65/208 (31%), Positives = 110/208 (52%), Gaps = 32/208 (15%)

Query: 54  IGRGGFGTVYKGT-LTNGRRI----AVKPLSAES--KQGVREFITEIMTLSNVRHPNLVE 106
           +G G FGTVYKG  +  G  +    A+K L+  +  K  V EF+ E + ++++ HP+LV 
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV-EFMDEALIMASMDHPHLVR 73

Query: 107 LIGCCVQGTRRIL--------VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           L+G C+  T +++        + +YV  +  D +      + + LNW      CV IAKG
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHK-DNI-----GSQLLLNW------CVQIAKG 121

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYL 217
           + +L E     +VHRD+ A N+L+    + KI DFGLA+L   D   +          ++
Sbjct: 122 MMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178

Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIIS 245
           A E +   + T ++DV+S+GV + E+++
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 22/209 (10%)

Query: 53  KIGRGGFGTVYK-GTLTNGRRIAVKP-LSAESKQGVREF-ITEIMTLSNVRHPNLVELIG 109
           KIG G +G V+K      G+ +A+K  + +E    +++  + EI  L  ++HPNLV LI 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 110 CCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
              +  +  LV+EY ++   N L++   G  +  IK        I     + + F H+  
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCHKH- 119

Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG- 225
             + +HRD+K  NIL+ ++   K+ DFG A++        T  +A T  Y APE ++G  
Sbjct: 120 --NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPELLVGDT 176

Query: 226 QLTMKADVYSFGVLVLEIISGRNSGKAMW 254
           Q     DV++ G +  E++    +G+ +W
Sbjct: 177 QYGPPVDVWAIGCVFAELL----TGQPLW 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.4 bits (208), Expect = 1e-18
 Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 15/198 (7%)

Query: 53  KIGRGGFGTVYKGTLTNGRRI-AVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           KIG+G FG V+KG     +++ A+K +   E++  + +   EI  LS    P + +  G 
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 111 CVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
            ++ T+  ++ EY+   S LD +  G       L+  + + I   I KGL +LH E    
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHSE---K 121

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLGGQLT 228
            +HRDIKA+N+LL +    K+ DFG+A    D  T I      GT  ++APE +      
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 229 MKADVYSFGVLVLEIISG 246
            KAD++S G+  +E+  G
Sbjct: 180 SKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 57/224 (25%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVK--------PLSAESKQGVREFITEIMTLSNVRHPNL 104
           IG G +G V        GR++A+K         + A  K+ +RE    I  L ++RH N+
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA--KRILRE----IKLLRHLRHENI 61

Query: 105 VELIGCCVQGTRRIL-------------VYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
           + L          IL             V E +E + L +V+    K+   L  +     
Sbjct: 62  IGL--------LDILRPPSPEDFNDVYIVTELMETD-LHKVI----KSPQPLTDDHIQYF 108

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF------PDNIT- 204
              I +GL +LH     +++HRD+K SNIL++   + KI DFGLA+           +T 
Sbjct: 109 LYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165

Query: 205 HITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 247
           ++ TR      Y APE +L      KA D++S G +  E+++ +
Sbjct: 166 YVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT---LTNGR---RIAVKPLSAESKQGVRE-FITEIMTLSN 98
           ++      +G G FG V + T   L+      ++AVK L   +    RE  ++E+  +S+
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           +  H N+V L+G C  G   +++ EY     L   L    K    L  E        +AK
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL--RRKRESFLTLEDLLSFSYQVAK 152

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-GTT-- 214
           G+AFL  +   + +HRD+ A N+LL      KI DFGLA+    +I + +  +  G    
Sbjct: 153 GMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR----DIMNDSNYVVKGNARL 205

Query: 215 --GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQE 271
              ++APE +     T ++DV+S+G+L+ EI S G N    M   ++    +   + ++ 
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM--PVDSKFYKLIKEGYRM 263

Query: 272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
            +P         E+ P EI   MK    C  A   +RP   Q+++++ K +
Sbjct: 264 AQP---------EHAPAEIYDIMKT---CWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 37/227 (16%)

Query: 53  KIGRGGFGTVYKGTLTN---------------GRR--IAVKPLSAESKQGVR-EFITEIM 94
           K+G G FG V+   + N               GR   +AVK L  ++ +  R +F+ E+ 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 95  TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL---------------LGATKA 139
            LS ++ PN++ L+G CV      ++ EY+EN  L++ L               +     
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-L 198
              +++     + + IA G+ +L      + VHRD+   N L+ +    KI DFG+++ L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           +  +   I  R      ++A E +L G+ T  +DV++FGV + EI+ 
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 21/247 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYK------GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV 99
           DD  +  ++GRG +G V K      GT+   +RI     S E K+ + +     +++ +V
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD---ISMRSV 57

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
             P  V   G   +     +  E V + SLD+         + +  +    I V I K L
Sbjct: 58  DCPYTVTFYGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
            +LH +L   ++HRD+K SN+L+++    K+ DFG++    D++    T  AG   Y+AP
Sbjct: 117 EYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAP 172

Query: 220 EYVLG----GQLTMKADVYSFGVLVLEIISGR---NSGKAMWGQMNKFLLEWAWQLHQEE 272
           E +          +K+DV+S G+ ++E+ +GR   +S K  + Q+ + + E + QL  E+
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232

Query: 273 KPLELVD 279
              E  D
Sbjct: 233 FSPEFQD 239

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 83.8 bits (207), Expect = 2e-18
 Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 14/210 (6%)

Query: 53  KIGRGGFGTVYKGTLTNGRR---IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELI 108
           ++G G FG V KG     ++   +A+K L  E+++ VR E + E   +  + +P +V +I
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G C +    +LV E      L++  L   K  I +      ++   ++ G+ +L  +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNK-FLSGKKDEITV--SNVVELMHQVSMGMKYLEGK--- 114

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGGQ 226
           + VHRD+ A N+LL  +   KI DFGL+K    + ++   R AG     + APE +   +
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 227 LTMKADVYSFGVLVLEIIS-GRNSGKAMWG 255
            + ++DV+S+G+ + E  S G+   K M G
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 83.4 bits (206), Expect = 2e-18
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 7/199 (3%)

Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           D     ++G G FG V  G       +A+K +  E      EFI E   +  + H  LV+
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQ 63

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           L G C +     +V EY+ N  L   L    K   +    +  ++C  + +G+A+L  + 
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK- 119

Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
               +HRD+ A N L+D +   K+ DFGL++   D+    +        +  PE +L  +
Sbjct: 120 --QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177

Query: 227 LTMKADVYSFGVLVLEIIS 245
            + K+DV++FGVL+ E+ S
Sbjct: 178 FSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 18/213 (8%)

Query: 48  FHLSNKIGRGGFGTVYKGTL----TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRH 101
             L   +G G FG+V +G L     +  ++AVK +  +  +   + EF++E   + +  H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 102 PNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKAN--IKLNWEKRSDICV 153
           PN+++LIG C + +        +++  ++++  L   LL +       KL  +      V
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
            IA G+ +L      + +HRD+ A N +L ++    + DFGL+K       +   RIA  
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177

Query: 214 -TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              ++A E +     T K+DV++FGV + EI +
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.4 bits (206), Expect = 4e-18
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 18/207 (8%)

Query: 54  IGRGGFGTVY------KGTLTNGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVE 106
           +G G FG V       +G  T G ++AVK L  ES    + +   EI  L N+ H N+V+
Sbjct: 12  LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 107 LIGCCVQ-GTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
             G C + G   I L+ E++ + SL   L    +   K+N +++    V I KG+ +L  
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLAPEYV 222
                 VHRD+ A N+L++ E   KIGDFGL K    +  + T +  +     + APE +
Sbjct: 128 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 223 LGGQLTMKADVYSFGVLVLEIISGRNS 249
           +  +  + +DV+SFGV + E+++  +S
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDS 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 68/214 (31%), Positives = 92/214 (42%), Gaps = 32/214 (14%)

Query: 48  FHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAE---SKQGVREFITE---IMTLS 97
           F     +GRG FG V    YK T   G   A+K L      ++  V   + E     T +
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57

Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI---CVG 154
           + RHP LV L  C         V EY     L          +  +  E R+     CV 
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDL------MMHIHTDVFSEPRAVFYAACVV 111

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAG 212
           +  GL +LHE     IV+RD+K  N+LLD E   KI DFGL K   + +     T+   G
Sbjct: 112 L--GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCG 163

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           T  +LAPE +     T   D +  GVL+ E++ G
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 82.6 bits (204), Expect = 6e-18
 Identities = 49/182 (26%), Positives = 92/182 (50%), Gaps = 12/182 (6%)

Query: 73  IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 131
           +AVK L  ++ +  R +F+ EI  +S ++ PN++ L+  C+      ++ EY+EN  L++
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 132 VLLGATKANIKLNWEKR----SDIC---VGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 184
            L            +      S +      IA G+ +L      + VHRD+   N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165

Query: 185 EFNPKIGDFGLAK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 243
            +  KI DFG+++ L+  +   I  R      +++ E +L G+ T  +DV++FGV + EI
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Query: 244 IS 245
           ++
Sbjct: 226 LT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 83.2 bits (205), Expect = 6e-18
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 11/204 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF   +++G G  G V K        I A K +  E K  +R + I E+  L     P 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL    K   ++  E    + + + +GLA+L 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLR 120

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  Y++PE + 
Sbjct: 121 EK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 175

Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   ++++D++S G+ ++E+  GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 82.2 bits (203), Expect = 7e-18
 Identities = 70/289 (24%), Positives = 129/289 (44%), Gaps = 42/289 (14%)

Query: 52  NKIGRGGFGTVYKG---TLTNGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVEL 107
           ++IG G FG V  G      +  R+ VK L A +       F+ E+     + HPN+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---------ICVGIAKG 158
           +G C++    +LV E+          LG  K  ++ N    +          +   +A G
Sbjct: 61  LGQCIESIPYLLVLEFCP--------LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYL 217
           L +LH+      +H D+   N  L  + + KIGD+GLA + +P++        A    +L
Sbjct: 113 LLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169

Query: 218 APEYV-------LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 270
           APE V       L    T K++++S GV + E+ +   + +      ++ +L+   +   
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT--AADQPYPDLSDEQVLKQVVR--- 224

Query: 271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
            E+ ++L  P+L +   ++  R+ +V  FC       RP   +V ++LT
Sbjct: 225 -EQDIKLPKPQL-DLKYSD--RWYEVMQFC-WLDPETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 82.0 bits (202), Expect = 9e-18
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 17/208 (8%)

Query: 50  LSNKIGRGGFGTVYKGTLTNGR---RIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNL 104
           L   +G G FG+V +G L       ++AVK +     ++  + +F++E + +    HPN+
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 105 VELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKAN--IKLNWEKRSDICVGIA 156
           + LIG C+Q          +++  ++++  L   LL +   +    L  +        IA
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-TG 215
            G+ +L  +     +HRD+ A N +L++  N  + DFGL+K   +   +   RIA     
Sbjct: 123 SGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEI 243
           ++A E +     T K+DV+SFGV + EI
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 21/203 (10%)

Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQG------VREFITEIMTLSNVRHPNLV 105
           +IG G +GTVYK     +G  +A+K +  ++ +       VRE +  +  L    HPN+V
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPNIV 65

Query: 106 ELIGCCV-----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
            L+  C      + T+  LV+E+V+ + L   L       +    E   D+     +GL 
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPA--ETIKDLMRQFLRGLD 122

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           FLH      IVHRD+K  NIL+      K+ DFGLA+++   +    T +  T  Y APE
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPE 177

Query: 221 YVLGGQLTMKADVYSFGVLVLEI 243
            +L        D++S G +  E+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 11/204 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF   +++G G  G V+K +   +G  +A K +  E K  +R + I E+  L     P 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL  A +   ++       + + + KGL +L 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLR 120

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  Y++PE + 
Sbjct: 121 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 175

Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   ++++D++S G+ ++E+  GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 68/216 (31%), Positives = 111/216 (51%), Gaps = 30/216 (13%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPL-----SAESKQGVREFITEIMTLSNVR- 100
           + +  K+G+G +G V+K         +A+K +     +A   Q  R F  EIM L  +  
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTF-REIMFLQELGD 65

Query: 101 HPNLVELIGCCV---QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           HPN+V+L+   V   +  + I LV+EY+E + L  V+    +ANI  +  KR  I   + 
Sbjct: 66  HPNIVKLLN--VIKAENDKDIYLVFEYMETD-LHAVI----RANILEDVHKRY-IMYQLL 117

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF----PDNITHITTRIAG 212
           K L ++H     +++HRD+K SNILL+ +   K+ DFGLA+       +    + T    
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 213 TTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 247
           T  Y APE +LG     K  D++S G ++ E++ G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 80.7 bits (199), Expect = 2e-17
 Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 7/193 (3%)

Query: 53  KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV 112
           ++G G FG V+ G      ++A+K ++ E      +FI E   +  + HP LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 113 QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH 172
           Q     +V E++EN  L   L    +   KL+ +    +C  + +G+ +L        +H
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIH 123

Query: 173 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKAD 232
           RD+ A N L+      K+ DFG+ +   D+    ++       +  PE     + + K+D
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 233 VYSFGVLVLEIIS 245
           V+SFGVL+ E+ +
Sbjct: 184 VWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 80.4 bits (198), Expect = 2e-17
 Identities = 75/273 (27%), Positives = 123/273 (45%), Gaps = 31/273 (11%)

Query: 53  KIGRGGFGTVYKGTL-TNGRRIAVKP----LSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           +IGRG FG V+ G L  +   +AVK     L  + K    +F+ E   L    HPN+V L
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRL 58

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
           IG C Q     +V E V+       L        +L  ++   +    A G+ +L  +  
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLESK-- 113

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-TGYLAPEYVLGGQ 226
            H +HRD+ A N L+ ++   KI DFG+++   D +   T  +      + APE +  G+
Sbjct: 114 -HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 227 LTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY 285
            + ++DV+SFG+L+ E  S G      +  Q  +  +         E+ + L  PEL   
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI---------EQGVRLPCPELC-- 221

Query: 286 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
            P+ + R M+    C +    +RP  + V + L
Sbjct: 222 -PDAVYRLMER---CWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 11/204 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF    ++G G  G V K     +G  +A K +  E K  +R + I E+  L     P 
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL  A +  I  N   +  I V   +GL +L 
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPENILGKISIAV--LRGLTYLR 116

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  Y++PE + 
Sbjct: 117 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 171

Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   T+++D++S G+ ++E+  GR
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 27/205 (13%)

Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLS--AESKQGVREFI-TEIMTLSNVRHPNLVELIG 109
           +G GGFG V    + +  R  A+K +      + G +E I +E   L    HP +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 110 CCVQGTRRI-LVYEYVENNSL-----DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
              +  + I ++ EY     L     DR L     A               +     +LH
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF---------YIACVVLAFEYLH 110

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGYLAPEYV 222
                 I++RD+K  N+LLD     K+ DFG AK L     T       GT  Y+APE +
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEII 164

Query: 223 LGGQLTMKADVYSFGVLVLEIISGR 247
           L        D +S G+L+ E+++GR
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 31/208 (14%)

Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIG 109
           +G+GGFG V    +   G+  A K L  +    ++G +  + E   L  V    +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-- 58

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW---------EKRSDICVG-IAKGL 159
                      Y +   + L  V+      ++K +          E R+      I  GL
Sbjct: 59  ----------AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL 108

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
             LH+     IV+RD+K  N+LLD   N +I D GLA              AGT GY+AP
Sbjct: 109 EHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAP 163

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G       D ++ G  + E+I+GR
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 79.4 bits (196), Expect = 5e-17
 Identities = 62/269 (23%), Positives = 122/269 (45%), Gaps = 26/269 (9%)

Query: 54  IGRGGFG--TVYKGTLTNGRRIAVKP--LSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           +G+G FG  T+Y+ T  +   +  K   L+  S++  R+ + EI+ LS ++HPN++    
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
             +     ++  EY    +L   ++   K  +    E        I   ++++H+     
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIV-RQKGQL-FEEEMVLWYLFQIVSAVSYIHKA---G 121

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
           I+HRDIK  NI L +    K+GDFG++K+     +   T + GT  Y++PE   G +   
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNF 180

Query: 230 KADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE 289
           K+D+++ G ++ E+++ + +  A         L    ++ Q         P +  Y  +E
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDA------TNPLNLVVKIVQGNY-----TPVVSVY-SSE 228

Query: 290 IIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           +I  +       Q    +RP  ++V+   
Sbjct: 229 LISLVHS---LLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 27/215 (12%)

Query: 53  KIGRGGFGTVYKGTL-----TNGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVE 106
           ++G   FG +YKG L      + + +A+K L    + Q   EF  E   ++ + HPN+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLL---------------GATKANIKLNWEKRSDI 151
           L+G   Q     +++EY+    L   L+               G  K++  L+      I
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS--LDHGDFLHI 129

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRI 210
            + IA G+ +L        VH+D+ A NIL+ ++ + KI D GL++ ++  +   +  + 
Sbjct: 130 AIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186

Query: 211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                ++ PE ++ G+ +  +D++SFGV++ EI S
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 80.1 bits (197), Expect = 6e-17
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)

Query: 53  KIGRGGFGTVYKG-TLTNGRR-IAVKPLSAESKQ------GVREFITEIMTLSNVRHPNL 104
           +IG G +G V+K   L NG R +A+K +  ++ +       +RE +  +  L    HPN+
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNV 66

Query: 105 VELIGCCV-----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           V L   C      + T+  LV+E+V+ + L   L    +  +    E   D+   + +GL
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPT--ETIKDMMFQLLRGL 123

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
            FLH      +VHRD+K  NIL+      K+ DFGLA+++  +     T +  T  Y AP
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAP 178

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E +L        D++S G +  E+   +
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 79.1 bits (195), Expect = 7e-17
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 17/199 (8%)

Query: 54  IGRGGFGTVYKGTLTNG------RRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           +GRG FG V+             ++I V+ ++ + +   +    E   L  + HPN++E 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
               ++    ++V EY    +L   +    + N  L+ +      V I   L  +H +L 
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121

Query: 168 PHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
             I+HRD+K  NILLD+     KIGDFG++K+        T  + GT  Y++PE   G  
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKP 177

Query: 227 LTMKADVYSFGVLVLEIIS 245
              K+D+++ G ++ E+ S
Sbjct: 178 YNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 46/218 (21%)

Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSA-----ESKQGVREFITEIMTLSNVRHPNLVEL 107
           IGRG FGTV K      G  +AVK + +     E K+ + +    +M  S+   P +V+ 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV-VMRSSDC--PYIVKF 68

Query: 108 IGCCV-QGTRRI--------------LVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 152
            G    +G   I               VYE V  + +   +LG               I 
Sbjct: 69  YGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGK--------------IA 113

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 212
           V   K L +L EEL   I+HRD+K SNILLD+  N K+ DFG++    D+I    TR AG
Sbjct: 114 VATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRDAG 169

Query: 213 TTGYLAPEYVLGGQLT---MKADVYSFGVLVLEIISGR 247
              Y+APE +         +++DV+S G+ + E+ +G+
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)

Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           ++G G FG VYK      G   A K +  +S++ + +++ EI  L++  HPN+V+L+   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
                  ++ E+    ++D V+L   +    L   +   +C    + L +LHE     I+
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLHEN---KII 125

Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLAPEYVL-----G 224
           HRD+KA NIL   + + K+ DFG++     N   I  R    GT  ++APE V+      
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 225 GQLTMKADVYSFGVLVLEI 243
                KADV+S G+ ++E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 29/216 (13%)

Query: 53  KIGRGGFGTVYKGTL------TNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLV 105
           ++G   FG VYKG L         + +A+K L  +++  +RE F  E M  S ++HPN+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLL--------GATKAN--IKLNWEKRS--DICV 153
            L+G   +     +++ Y  ++ L   L+        G+T  +  +K   E      I  
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
            IA G+ FL      H+VH+D+   N+L+  + N KI D G   LF +       ++ G 
Sbjct: 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLG---LFREVYAADYYKLMGN 185

Query: 214 T----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           +     +++PE ++ G+ ++ +D++S+GV++ E+ S
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 14/204 (6%)

Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKP------LSAESKQGVREFITEIMTLSNV 99
           +F +  KIGRG F  VY+ T L + + +A+K       + A+++Q   + + EI  L  +
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            HPN+++ +   ++     +V E  +   L +++    K    +         V +   +
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
             +H      ++HRDIK +N+ +      K+GD GL + F    T   + + GT  Y++P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSP 175

Query: 220 EYVLGGQLTMKADVYSFGVLVLEI 243
           E +       K+D++S G L+ E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)

Query: 54  IGRGGFGTVYKGTLTNGRR--IAVKPLS----------AESKQGVREFITEIMTL-SNVR 100
           +G G FG VYK    N  +  +A+K ++           E  + + + ++E+  +   +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V      ++  R  +V + +E   L        +   +   E+  +I V +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           +LH+E    IVHRD+  +NI+L ++    I DFGLAK          T + GT  Y  PE
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYSCPE 183

Query: 221 YVLGGQLTMKADVYSFGVLVLEI 243
            V       KADV++FG ++ ++
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 78.3 bits (194), Expect = 2e-16
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 24/205 (11%)

Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQ-----GVREFITEIMTLSNVRHPNLVE 106
           ++G G FG+VY       G  +A+K +  +         +RE +  +  L+   HPN+V+
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLRE-VKSLRKLNE--HPNIVK 62

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           L     +      V+EY+E N      L   +     +      I   I +GLA +H+  
Sbjct: 63  LKEVFRENDELYFVFEYMEGNLYQ---LMKDRKGKPFSESVIRSIIYQILQGLAHIHKH- 118

Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVL 223
                HRD+K  N+L+      KI DFGLA+     P    +++TR      Y APE +L
Sbjct: 119 --GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEILL 171

Query: 224 GGQL-TMKADVYSFGVLVLEIISGR 247
                +   D+++ G ++ E+ + R
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 16/211 (7%)

Query: 53  KIGRGGFGTVYKG---TLTNGRRIAVKPLSAESKQGV--REFITEIMTLSNVRHPNLVEL 107
           ++G G FGTV KG      + + +AVK L  ++       E + E   +  + +P +V +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
           IG C +    +LV E  E   L++ L    + N  +  +  +++   ++ G+ +L E   
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET-- 114

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGG 225
            + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G     + APE +   
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 226 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWG 255
           + + K+DV+SFGVL+ E  S G+   K M G
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 43/223 (19%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPL-----SAESKQGVREFITEIMTLSNV 99
           +D     +IG G  G VYK      G  +AVK +       E+K+ + +   +++  S+ 
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL--DVVLKSH- 71

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------- 150
             P +V+  G  +  +   +  E +    LD++L             KR           
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELMST-CLDKLL-------------KRIQGPIPEDILG 117

Query: 151 -ICVGIAKGLAFLHEELVPH-IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
            + V I K L +L E+   H ++HRD+K SNILLD   N K+ DFG++    D+     T
Sbjct: 118 KMTVAIVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--T 172

Query: 209 RIAGTTGYLAPEYV----LGGQLTMKADVYSFGVLVLEIISGR 247
           R AG   Y+APE +       +  ++ADV+S G+ ++E+ +G+
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 80.7 bits (199), Expect = 2e-16
 Identities = 54/191 (28%), Positives = 94/191 (49%), Gaps = 20/191 (10%)

Query: 70  GRRIAVKPLSAESKQGVRE---FITEIMTLSNVRHPNLVELIGCCVQGTRRIL-VYEYVE 125
           G  +A+K L  ++ +   +   F  E    + + HPN+V L+         +  V+EYV 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 126 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL--- 182
             +L R +L A  A   L   +   + + +   LA  H +    IVHRD+K  NI++   
Sbjct: 63  GRTL-REVLAADGA---LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQT 115

Query: 183 DQEFNPKIGDFGLAKLFPD----NITHIT--TRIAGTTGYLAPEYVLGGQLTMKADVYSF 236
               + K+ DFG+  L P     ++  +T  T + GT  Y APE + G  +T  +D+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 237 GVLVLEIISGR 247
           G++ LE ++G+
Sbjct: 176 GLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 76/312 (24%), Positives = 137/312 (43%), Gaps = 48/312 (15%)

Query: 44  ATDDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIM 94
             D   L   +G G FG V         K       ++AVK L ++ +++ + + I+E+ 
Sbjct: 16  PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75

Query: 95  TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----------- 142
            +  + +H N++ L+G C Q     ++ EY    +L   L       ++           
Sbjct: 76  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135

Query: 143 -LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 201
            L+++        +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR---- 188

Query: 202 NITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 256
           +I HI      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G 
Sbjct: 189 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGV 246

Query: 257 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
             + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++
Sbjct: 247 PVEELFKLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVE 294

Query: 317 MLTKNIRLNEEE 328
            L + + L   +
Sbjct: 295 DLDRILALTSNQ 306

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT--LTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRH 101
           D +    KIG G +G VYK    +TN   IA+K +  E + +GV    I EI  L  ++H
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
            N+V L        R  LV+EY++   LD      +  +   N          I +G+A+
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      ++HRD+K  N+L+D+  N  K+ DFGLA+ F   +   T  +  T  Y APE
Sbjct: 118 CHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPE 173

Query: 221 YVLGG-QLTMKADVYSFGVLVLEIISGR 247
            +LG    +   D++S G +  E+++ +
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 76.5 bits (188), Expect = 6e-16
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 30/210 (14%)

Query: 48  FHLSNKIGRGGFGTVY--KGTLTNG----RRIAVKPLSAESKQGVREFITEIMTLSNVRH 101
           + +  KIG G FG +Y  K    +     + I +  +  + K+  ++   E++ L+ ++H
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKH 58

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDR-------VLLGATKANIKLNWEKRSDICVG 154
           PN+V       +  R  +V EY +   L +       VL    +    L+W       V 
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI---LSW------FVQ 109

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGT 213
           I+ GL  +H+     I+HRDIK+ NI L +     K+GDFG+A+   D+   +     GT
Sbjct: 110 ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELAYTCVGT 165

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEI 243
             YL+PE         K D++S G ++ E+
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 76.5 bits (188), Expect = 6e-16
 Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 29/276 (10%)

Query: 54  IGRGGFGTVYKGTLT-NGRR---IAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG + +G L    +R   +A+  L A  S +  R F+ E +TL    H N+V L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +G   ++V EY+ N +LD  L    K   +L   +   +  G+A G+ +L E    
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSEM--- 126

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL--APEYVLGGQ 226
             VH+ + A  +L++ +   KI  F   +L  D    I T ++G +  L  APE +    
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            +  +DV+SFG+++ E++S     +  W    + +++        E    L  P      
Sbjct: 185 FSSASDVWSFGIVMWEVMS--YGERPYWDMSGQDVIKAV------EDGFRLPAP---RNC 233

Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
           PN + + M     C Q     RP+ +Q+  +L+K +
Sbjct: 234 PNLLHQLM---LDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 14/204 (6%)

Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKP------LSAESKQGVREFITEIMTLSNV 99
           +F +  KIGRG F  VY+ T L +G  +A+K       + A+++    + I EI  L  +
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            HPN+++     ++     +V E  +   L R++    K    +  +      V +   L
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
             +H      ++HRDIK +N+ +      K+GD GL + F    T   + + GT  Y++P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSP 175

Query: 220 EYVLGGQLTMKADVYSFGVLVLEI 243
           E +       K+D++S G L+ E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 27/196 (13%)

Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAES-KQGVREFIT---EIMTLSNVR 100
             +    KIG+G FG V+K       + +A+K +  E+ K+G    IT   EI  L  ++
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP--ITALREIKILQLLK 69

Query: 101 HPNLVELIGCC---VQGTRR-----ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 152
           H N+V LI  C        R      LV+E+ E++ L  +L   +  N+K    +   + 
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLL---SNKNVKFTLSEIKKVM 125

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP----DNITHITT 208
             +  GL ++H      I+HRD+KA+NIL+ ++   K+ DFGLA+ F           T 
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182

Query: 209 RIAGTTGYLAPEYVLG 224
           R+  T  Y  PE +LG
Sbjct: 183 RVV-TLWYRPPELLLG 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 76.4 bits (188), Expect = 9e-16
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 24/215 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           D+  + +++G+G +G+VYK      G  +A+K +  E  +    + I E+  L     P 
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+  G         +  EY++  SLD++  G            R  I   + KGL FL 
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR-ITYAVVKGLKFLK 119

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGL-----AKLFPDNITHITTRIAGTTGYLA 218
           EE   +I+HRD+K +N+L++     K+ DFG+     A L   NI        G   Y+A
Sbjct: 120 EEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI--------GCQSYMA 169

Query: 219 PEYVLGGQL------TMKADVYSFGVLVLEIISGR 247
           PE +  G        T+++DV+S G+ +LE+  GR
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 80/315 (25%), Positives = 135/315 (42%), Gaps = 58/315 (18%)

Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI---- 151
             + +H N++ L+G C Q     ++ EY    +L   L    +A      E   DI    
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYSYDIARVP 130

Query: 152 -----------CV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 199
                      C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+  
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-- 185

Query: 200 PDNITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW 254
             ++ +I      T G     ++APE +     T ++DV+SFGVL+ EI +    G    
Sbjct: 186 --DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYP 241

Query: 255 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV 314
           G   + L +   + H+ +KP             NE+   M+    C  A  S RP   Q+
Sbjct: 242 GIPVEELFKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAIPSHRPTFKQL 289

Query: 315 IKMLTKNIRL--NEE 327
           ++ L + + L  NEE
Sbjct: 290 VEDLDRILTLTTNEE 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 76/307 (24%), Positives = 137/307 (44%), Gaps = 43/307 (14%)

Query: 44  ATDDFHLSNKIGRGGFGTVYKGT---LTNGR---RIAVKPLSAESKQGVR-EFITEIMTL 96
           + +   L  ++G+G FG VY+G    +  G    R+AVK ++  +    R EF+ E   +
Sbjct: 4   SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63

Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------WEKRS 149
                 ++V L+G   +G   ++V E + +  L +  L + +   + N        ++  
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTLQEMI 122

Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 209
            +   IA G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    +I      
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYY 175

Query: 210 IAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW 264
             G  G     ++APE +  G  T  +D++SFGV++ EI S               L E 
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQ 220

Query: 265 AWQLHQEEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
            +Q    E+ L+ V D    + P N   R   +   C Q     RP   +++ +L  ++ 
Sbjct: 221 PYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280

Query: 324 LNEEELT 330
            +  E++
Sbjct: 281 PSFPEVS 287

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 83/302 (27%), Positives = 132/302 (43%), Gaps = 39/302 (12%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTL-TNGRRI--AVKPLSA-ESKQGVREFITEIMTLSNV-R 100
           +D    + IG G FG V K  +  +G R+  A+K +    SK   R+F  E+  L  +  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLG------ATKANIKLNWEKR 148
           HPN++ L+G C       L  EY  + +L       RVL        A      L+ ++ 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
                 +A+G+ +L ++     +HRD+ A NIL+ + +  KI DFGL++     +     
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 183

Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 268
           R+     ++A E +     T  +DV+S+GVL+ EI+S    G    G     L E   Q 
Sbjct: 184 RLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGTPYCGMTCAELYEKLPQG 239

Query: 269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 328
           ++ EKPL   D         E+   M+    C +     RP   Q++  L    R+ EE 
Sbjct: 240 YRLEKPLNCDD---------EVYDLMRQ---CWREKPYERPSFAQILVSLN---RMLEER 284

Query: 329 LT 330
            T
Sbjct: 285 KT 286

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 23/220 (10%)

Query: 53  KIGRGGFG-TVYKGTLTNGRRIAVKPL--SAESKQGVREFITEIMTLSNVRHPNLV---- 105
           KIG G FG  +   +  +G++  +K +  S  S +   E   E+  LSN++HPN+V    
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 106 --ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
             E  G         +V +Y E   L + +    +  +    ++  D  V I   L  +H
Sbjct: 67  SFEENGNLY------IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVH 118

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           +     I+HRDIK+ NI L ++   K+GDFG+A++    +    T I GT  YL+PE   
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICE 174

Query: 224 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE 263
                 K+D+++ G ++ E+ + +++ +A  G M   +L+
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFEA--GNMKNLVLK 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 21/209 (10%)

Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           D +    K+G G + TVYKG +  NG+ +A+K +  + ++G     I E   L  ++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 104 LVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           +V L           LV+EYV  +    +D+   G    N+KL           + +GL+
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-------FLFQLLRGLS 117

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRIAGTTGYLA 218
           ++H+    +I+HRD+K  N+L+      K+ DFGL  AK  P   +H  +    T  Y  
Sbjct: 118 YIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP---SHTYSNEVVTLWYRP 171

Query: 219 PEYVLGG-QLTMKADVYSFGVLVLEIISG 246
           P+ +LG  + +   D++  G + +E+I G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 12/198 (6%)

Query: 53  KIGRGGFGTVYKGTLTNGRRI-AVKPLSAESK-QGVREF-ITEIMTLSNVRHPNLVELIG 109
           KIG G +GTV+K        I A+K +  +   +GV    + EI  L  ++H N+V L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
                 +  LV+EY + + L +        N  ++ E        + KGLAF H     +
Sbjct: 67  VLHSDKKLTLVFEYCDQD-LKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-T 228
           ++HRD+K  N+L+++    K+ DFGLA+ F   +   +  +  T  Y  P+ + G +L +
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 178

Query: 229 MKADVYSFGVLVLEIISG 246
              D++S G +  E+ + 
Sbjct: 179 TSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 41/291 (14%)

Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITEIMTL 96
           A +   +S ++G+G FG VY+G            R+A+K ++  +    R EF+ E   +
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWEKRSD 150
                 ++V L+G   QG   +++ E +    L    R L    + N      + +K   
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 151 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 210
           +   IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I       
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 176

Query: 211 AGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA 265
            G  G     +++PE +  G  T  +DV+SFGV++ EI +               L E  
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQP 221

Query: 266 WQLHQEEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 315
           +Q    E+ L  V +  L + P N      ++   C Q     RP   ++I
Sbjct: 222 YQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 33/213 (15%)

Query: 47  DFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAES----KQGVREFITEIMTLSN 98
           DF +   +G G FG V    +KGT   G   A+K L        KQ V+    E   L  
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQ-VQHVAQEKSILME 74

Query: 99  VRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI----CV 153
           + HP +V ++ C  Q   R+  + E+V    L   L  A +          +D+      
Sbjct: 75  LSHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFP--------NDVAKFYHA 125

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
            +     +LH +    I++RD+K  N+LLD + + K+ DFG AK  PD     T  + GT
Sbjct: 126 ELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGT 178

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             YLAPE +         D ++ GVL+ E I+G
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 4e-15
 Identities = 60/202 (29%), Positives = 87/202 (43%), Gaps = 25/202 (12%)

Query: 54  IGRGGFGTVY--KGTLTNGRRIAVKPL---SAESKQGVREFITEIMTLSNVRH-PNLVEL 107
           I +G FG+VY  K   T G   A+K L      +K  V     E   +      P + +L
Sbjct: 4   ISKGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK---GLAFLHE 164
                      LV EY+  N  D   L  T   +  +W         IA+   G+  LH+
Sbjct: 63  YYSFQSKDYLYLVMEYL--NGGDCASLIKTLGGLPEDW-----AKQYIAEVVLGVEDLHQ 115

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
                I+HRDIK  N+L+DQ  + K+ DFGL++           +  GT  YLAPE +LG
Sbjct: 116 R---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILG 167

Query: 225 GQLTMKADVYSFGVLVLEIISG 246
                 +D +S G ++ E + G
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 73.2 bits (179), Expect = 9e-15
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 12/206 (5%)

Query: 42  RSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           R+  +DF L  +IG G +G VYK   +  G   A+K +  E  +       EI+ + + +
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           H N+V   G  ++  +  +  E+    SL  +          L+  + + +     +GL 
Sbjct: 65  HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY----HVTGPLSESQIAYVSRETLQGLY 120

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           +LH +     +HRDIK +NILL    + K+ DFG++      I    + I GT  ++APE
Sbjct: 121 YLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPE 176

Query: 221 YVL---GGQLTMKADVYSFGVLVLEI 243
                  G      D+++ G+  +E+
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 73.9 bits (181), Expect = 9e-15
 Identities = 62/202 (30%), Positives = 91/202 (45%), Gaps = 17/202 (8%)

Query: 54  IGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-----RHPNLVELI 108
           IGRG +  V    L    RI    +  +      E I  + T  +V      HP LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
            C    +R   V EYV    L    +   +   KL  E        I+  L +LHE    
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNYLHER--- 115

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
            I++RD+K  N+LLD E + K+ D+G+ K  L P + T   +   GT  Y+APE + G  
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGED 172

Query: 227 LTMKADVYSFGVLVLEIISGRN 248
                D ++ GVL+ E+++GR+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 19/203 (9%)

Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELI 108
           +G+G FG V+   L    +  A+K L  +       V   + E   LS    HP L  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 109 GCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
            C  Q    +  V EY+    L    +   ++  K +  + +     I  GL FLH +  
Sbjct: 63  -CTFQTKENLFFVMEYLNGGDL----MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK-- 115

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIAGTTGYLAPEYVLGG 225
             IV+RD+K  NILLD + + KI DFG+ K   +N+     T    GT  Y+APE +LG 
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLGQ 171

Query: 226 QLTMKADVYSFGVLVLEIISGRN 248
           +     D +SFGVL+ E++ G++
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 25/218 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKG--TLTNGRRIAVKPLSAES-KQGVR-EFITEIMTLSNVRH 101
           D F +  +IG G +G VYK     T G  +A+K +  ++ K+G     I EI  L  + H
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDT-GELVALKKVRLDNEKEGFPITAIREIKILRQLNH 65

Query: 102 PNLVELIGCCVQGTRRI----------LVYEYVENNSLDRVLLGATKAN-IKLNWEKRSD 150
            N+V L          +          LV+EY+     D  L+G  ++  +  + +    
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKS 120

Query: 151 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 210
               + +GL + H++   + +HRDIK SNILL+ +   K+ DFGLA+L+    +   T  
Sbjct: 121 FMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177

Query: 211 AGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 247
             T  Y  PE +LG +    A DV+S G ++ E+ + +
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 31/208 (14%)

Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G V     T  GR++A+K LS   +S    +    E+  L ++ H N++ L+  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 111 CVQGTRRILVYEYVENNSLDRV-----LLGATKANI----KLNWEKRSDICVGIAKGLAF 161
               +                V     L+GA   NI    KL+ +    +   I +GL +
Sbjct: 83  FTPAS---------SLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKY 133

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPE 220
           +H      I+HRD+K SNI ++++   KI DFGLA+   D +T ++ TR      Y APE
Sbjct: 134 IHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 185

Query: 221 YVLG-GQLTMKADVYSFGVLVLEIISGR 247
            +L         D++S G ++ E+++G+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 65/200 (32%), Positives = 97/200 (48%), Gaps = 17/200 (8%)

Query: 54  IGRGGFGTVYKGTL-TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVR-HPNLVELI 108
           +G+G FG V    L  +GR  AVK L  +       V   +TE   LS  R HP L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 109 GCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
            CC Q   R+  V E+V  N  D  L+   + + + +  +       I   L FLH++  
Sbjct: 63  -CCFQTPDRLFFVMEFV--NGGD--LMFHIQKSRRFDEARARFYAAEITSALMFLHDK-- 115

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGYLAPEYVLGGQ 226
             I++RD+K  N+LLD E + K+ DFG+ K    +  T  T+   GT  Y+APE +    
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEML 172

Query: 227 LTMKADVYSFGVLVLEIISG 246
                D ++ GVL+ E++ G
Sbjct: 173 YGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 65/203 (32%), Positives = 95/203 (46%), Gaps = 19/203 (9%)

Query: 54  IGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQGVREFITEIMTLSNV-----RHPNLVEL 107
           IGRG +  V    L   RRI A+K +  E      E I  + T  +V      HP LV L
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVND-DEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
             C    +R   V E+V    L    +   +   KL  E        I+  L FLHE   
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDL----MFHMQRQRKLPEEHARFYSAEISLALNFLHER-- 115

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLAPEYVLGG 225
             I++RD+K  N+LLD E + K+ D+G+ K  + P + T   +   GT  Y+APE + G 
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGE 171

Query: 226 QLTMKADVYSFGVLVLEIISGRN 248
                 D ++ GVL+ E+++GR+
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 31/217 (14%)

Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS------AESKQGVREFITEIMTLSNV 99
           D      IG G FG V+  T   +G+R+A+K +          K+  RE    +  L   
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRE----LKMLCFF 56

Query: 100 RHPNLVELIGCC----VQGTRRILVYEYVENNSLDRVLLGA---TKANIKLNWEKRSDIC 152
           +H N++  +       +     I V   +  + L ++++     +  ++K+         
Sbjct: 57  KHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-------FL 109

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIA 211
             I +GL +LH      I+HRDIK  N+L++     KI DFGLA++  PD   H+T  + 
Sbjct: 110 YQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166

Query: 212 GTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGR 247
            T  Y APE ++G +  T   D++S G +  E++  R
Sbjct: 167 -TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 71/289 (24%), Positives = 132/289 (45%), Gaps = 45/289 (15%)

Query: 53  KIGRGGFGTVYKGTL---TNGRRIAVKPL--SAESKQGVREFITEIMTLSNVRHPNLVEL 107
           +IG G FG V    +   T   R+ VK L  +A SK+   EF+ +      ++HPN+++ 
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQC 60

Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--------ICVGIAKGL 159
           +G CV+    +LV+EY E        LG  K+ +      R +        +   IA G+
Sbjct: 61  LGQCVEAIPYLLVFEYCE--------LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRIAGTTGYL 217
             +H+    + +H D+   N  L  +   K+GD+G+  ++   D I     +      +L
Sbjct: 113 THMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR-WL 168

Query: 218 APEYV-------LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 270
           APE V       +  + T  ++V++ GV + E+    N+ +      ++ +L    +   
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFE--NAAQPYSHLSDREVLNHVIK--- 223

Query: 271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
            ++ ++L  P+L E P +E  R+ +V  FC   +  +R    +V ++LT
Sbjct: 224 -DQQVKLFKPQL-ELPYSE--RWYEVLQFC-WLSPEKRATAEEVHRLLT 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 22/230 (9%)

Query: 31  RNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREF 89
           R+++    + LR     F L   +G G +G VYKG  +  G+  A+K +     +   E 
Sbjct: 1   RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEI 59

Query: 90  ITEIMTLSNV-RHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKAN-I 141
             EI  L     H N+    G  ++ +      +  LV E+    S+   L+  TK N +
Sbjct: 60  KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNAL 118

Query: 142 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 201
           K +W   + IC  I +GLA LH      ++HRDIK  N+LL +    K+ DFG++     
Sbjct: 119 KEDW--IAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173

Query: 202 NITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISG 246
            +    T I GT  ++APE +            ++D++S G+  +E+  G
Sbjct: 174 TVGRRNTFI-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 29/211 (13%)

Query: 47  DFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV 99
           DF +  ++G+GG+G V+    K T   G  +A+K +          VR  +TE   L+  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDT---GEIVALKRMKKSLLFKLNEVRHVLTERDILTTT 58

Query: 100 RHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKR---SDICVGI 155
           +   LV+L+    Q    + L  EYV      R LL      +      R   +++   +
Sbjct: 59  KSEWLVKLL-YAFQDDEYLYLAMEYVPGGDF-RTLLNNL--GVLSEDHARFYMAEMFEAV 114

Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
                 LHE      +HRD+K  N L+D   + K+ DFGL+K     I      + G+  
Sbjct: 115 DA----LHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPD 163

Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           Y+APE + G       D +S G ++ E + G
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 29/214 (13%)

Query: 47  DFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV 99
           DF+    +G+G FG V     KGT       A+K L  +       V   + E   L+  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57

Query: 100 RHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIA 156
             P  +  +  C Q   R+  V EYV    L   +  +G  K    + +         IA
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAE------IA 111

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTR-IAGT 213
            GL FLH +    I++RD+K  N++LD E + KI DFG+ K  +F       TTR   GT
Sbjct: 112 IGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFCGT 164

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
             Y+APE +         D ++FGVL+ E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 69/296 (23%), Positives = 125/296 (42%), Gaps = 49/296 (16%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNG-----RRIAVKPLSAESKQ-GVREFITEIMTLSNV 99
           D   LS+ +  G FG ++ G L +        + VK +   + +  V   + E   L  +
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 100 RHPNLVELIGCCVQGTRRILV-YEYVENNSLDRVL----LGATKANIKLNWEKRSDICVG 154
            H N++ ++  C++      V Y Y+   +L   L    LG       L+ ++   + + 
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGT 213
           IA G+++LH+     ++H+DI A N ++D+E   KI D  L++ LFP +   +       
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 273
             ++A E ++  + +  +DV+SFGVL+ E+++         GQ                 
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT--------LGQT---------------- 218

Query: 274 PLELVDP-ELGEY---------PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
           P   +DP E+  Y         P N       V   C       RP  +Q+++ LT
Sbjct: 219 PYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 17/202 (8%)

Query: 54  IGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-----RHPNLVELI 108
           IGRG +  V    L    +I    +  +      E I  + T  +V      +P LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
            C    +R  LV EYV    L    +   +   KL  E        I   L FLHE    
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDL----MFHMQRQRKLPEEHARFYAAEICIALNFLHER--- 115

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
            I++RD+K  N+LLD + + K+ D+G+ K  L P + T   +   GT  Y+APE + G +
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRGEE 172

Query: 227 LTMKADVYSFGVLVLEIISGRN 248
                D ++ GVL+ E+++GR+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 67/223 (30%), Positives = 100/223 (44%), Gaps = 27/223 (12%)

Query: 41  LRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNV 99
           L   TD + +   IG+G +G VYK T   +G   AVK L       + +   EI    N+
Sbjct: 17  LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-----ISDVDEEIEAEYNI 71

Query: 100 -----RHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 149
                 HPN+V+  G   +     G +  LV E     S+  ++ G      +L+    S
Sbjct: 72  LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131

Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITT 208
            I  G   GL  LH      I+HRD+K +NILL  E   K+ DFG+ A+L    +   T+
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188

Query: 209 RIAGTTGYLAPEYVLGGQ-----LTMKADVYSFGVLVLEIISG 246
              GT  ++APE +   Q        + DV+S G+  +E+  G
Sbjct: 189 --VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 23/204 (11%)

Query: 54  IGRGGFGTVYKGTLTNGRRI-AVKPLSAES---KQGVREFITE--IMTLSNVRHPNLVEL 107
           +G+G FG V    L     + A+K L  +       V   +TE  I+ L+  +HP L  L
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA-AKHPFLTAL 61

Query: 108 IGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEE 165
             CC Q   R+  V EYV    L   +  + K +     E RS      +   L FLH  
Sbjct: 62  H-CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSRFYAAEVTLALMFLHRH 115

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVL 223
            V   ++RD+K  NILLD E + K+ DFG+ K   + I +   TT   GT  Y+APE + 
Sbjct: 116 GV---IYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQ 169

Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
             +     D ++ GVL+ E+++G+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.0 bits (174), Expect = 8e-14
 Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 8/96 (8%)

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAG 212
           I  GL FLH++    I++RD+K  N+LLD++ + KI DFG+ K    N+      +   G
Sbjct: 105 IICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCG 158

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           T  Y+APE + G +     D +SFGVL+ E++ G++
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 53/235 (22%)

Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLS---AESKQGVREFITEIMTLSNVRHPNLVELI 108
            IG+GG G VY        RR+A+K +    +E+    + F+ E    +++ HP +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 109 GCCVQGTRRILVY---EYVENNSLDRVLLGATKANIKLNWEKRS---------------D 150
             C  G     VY    Y+E  +L  +L        K  W+K S                
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLL--------KSVWQKESLSKELAEKTSVGAFLS 117

Query: 151 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK---------LFPD 201
           I   I   + ++H +    ++HRD+K  NILL       I D+G A          L  D
Sbjct: 118 IFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 202 ----NITH----ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 248
               NI +    I  +I GT  Y+APE +LG   +   D+Y+ GV++ ++++   
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229

Length = 932

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 39/228 (17%)

Query: 50  LSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSA--------ESKQGVRE----FIT--EIM 94
               +G G +G V K   T  G+ +A+K +          + +Q V      F T  E+ 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 95  TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
            ++ ++H N++ L+   V+G    LV + + ++ L +V+       I+L   +   I + 
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTESQVKCILLQ 127

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--------------P 200
           I  GL  LH+    + +HRD+  +NI ++ +   KI DFGLA+ +               
Sbjct: 128 ILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 247
                +T+++  T  Y APE ++G +    A D++S G +  E+++G+
Sbjct: 185 QRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 9e-14
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 33/214 (15%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR-IAVKPLSAESKQGVREFI---------TEIMT 95
           DD      +G G FG V+           A+K ++      + E I          E   
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMA------IPEVIRLKQEQHVHNEKRV 54

Query: 96  LSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
           L  V HP ++ L     +  +R L  + EYV    L   L  + + +        S+I  
Sbjct: 55  LKEVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC 112

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
            +     +LH +    IV+RD+K  NILLD+E + K+ DFG AK   D     T  + GT
Sbjct: 113 ALE----YLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGT 161

Query: 214 TGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISG 246
             YLAPE V+  +   KA D ++ G+L+ E++ G
Sbjct: 162 PEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)

Query: 42  RSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           R+   D+ L  ++G G +G VYK   L  G   AVK +  E          EI  +   +
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK 64

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVL-LGATKANIKLNWEKRSDICVGIAKGL 159
           H N+V   G  +   +  +  EY    SL  +  +    + +++ +     +C    +GL
Sbjct: 65  HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-----VCRETLQGL 119

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           A+LH +     +HRDIK +NILL    + K+ DFG+A      I    + I GT  ++AP
Sbjct: 120 AYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAP 175

Query: 220 EYVL---GGQLTMKADVYSFGVLVLEI 243
           E       G      D+++ G+  +E+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 24/214 (11%)

Query: 43  SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVR 100
           +AT   +L  K+G G + TVYKG +  NG+ +A+K +S ++++GV    I E   L  ++
Sbjct: 3   AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL----GATKANIKLNWEKRSDICVGIA 156
           H N+V L            V+EY+  + L + ++    G    N++L           + 
Sbjct: 62  HANIVLLHDIIHTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRL-------FMFQLL 113

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA--KLFPDNITHITTRIAGTT 214
           +GLA++H +   HI+HRD+K  N+L+      K+ DFGLA  K  P   T+ +  +  T 
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSSEVV--TL 167

Query: 215 GYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 247
            Y  P+ +LG    +   D++  G + +E++ G+
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 38/96 (39%), Positives = 59/96 (61%), Gaps = 8/96 (8%)

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 212
           I  GL FLH +    I++RD+K  N++LD++ + KI DFG+ K  +F DN     +   G
Sbjct: 105 IVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCG 158

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           T  Y+APE + G + T   D +SFGVL+ E++ G++
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 21/203 (10%)

Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGC 110
           K+G G + TVYKG +   G+ +A+K +  E ++G     I E   L +++H N+V L   
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 111 CVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                   LV+EY++ +    +D    G +  N++L           + +GLA+ H+   
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRL-------FLFQLLRGLAYCHQR-- 122

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
             ++HRD+K  N+L+ +    K+ DFGL  AK  P   +   +    T  Y  P+ +LG 
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKTYSNEVVTLWYRPPDVLLGS 178

Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
            + +   D++  G +  E+ +GR
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 8/198 (4%)

Query: 54  IGRGGFGTVYKGTL-TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIG 109
           +G+GGFG V    +   G+  A K L+ +    ++G    + E   L+ V    +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
                T   LV   +    L   +    + N      +       I  GL  LH+     
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
           I++RD+K  N+LLD + N +I D GLA    D  +  T   AGT G++APE + G +   
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYDF 176

Query: 230 KADVYSFGVLVLEIISGR 247
             D ++ GV + E+I+ R
Sbjct: 177 SVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 77/292 (26%), Positives = 122/292 (41%), Gaps = 36/292 (12%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT---NGRRIAVKPLSA-ESKQGVREFITEIMTLSNV-R 100
           +D    + IG G FG V +  +         A+K L    S+   R+F  E+  L  +  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 101 HPNLVELIGCCVQGTRRILVYEYVE-NNSLDRV----LLGATKANIK-------LNWEKR 148
           HPN++ L+G C       +  EY    N LD +    +L    A  K       L  ++ 
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
                 +A G+ +L E+     +HRD+ A N+L+ +    KI DFGL++     +     
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178

Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 268
           R+     ++A E +     T K+DV+SFGVL+ EI+S    G    G     L E   Q 
Sbjct: 179 RLP--VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS--LGGTPYCGMTCAELYEKLPQG 234

Query: 269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           ++ EKP    D         E+   M+    C +     RP   Q+   L++
Sbjct: 235 YRMEKPRNCDD---------EVYELMRQ---CWRDRPYERPPFAQISVQLSR 274

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 67/210 (31%), Positives = 91/210 (43%), Gaps = 36/210 (17%)

Query: 54  IGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVE 106
           +G+G FG V     K T   GR  A+K L  E   +K  V   +TE   L N RHP L  
Sbjct: 3   LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 107 LIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRSDIC-VGIAKGL 159
           L        R   V EY     L      +RV             E+R+      I   L
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-----------EERARFYGAEIVSAL 108

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGTTGYL 217
            +LH      +V+RDIK  N++LD++ + KI DFGL K   + I+   T     GT  YL
Sbjct: 109 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYL 162

Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           APE +         D +  GV++ E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 37/212 (17%)

Query: 54  IGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV 112
           +G+GGFG V    +   G+  A K L    K+ +++   E M L+      ++E +    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGESMALN---EKQILEKVN--- 58

Query: 113 QGTRRI--LVYEYVENNSLDRVLLGATKANIKLNW---------EKRS-----DICVGIA 156
             +R +  L Y Y   ++L  VL      ++K +          E R+     +IC G  
Sbjct: 59  --SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG-- 114

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
             L  LH+E    IV+RD+K  NILLD   + +I D GLA   P+  T I  R+ GT GY
Sbjct: 115 --LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGY 167

Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           +APE V   + T   D ++ G L+ E+I+G++
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 64/210 (30%), Positives = 89/210 (42%), Gaps = 36/210 (17%)

Query: 54  IGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVE 106
           +G+G FG V     K T   G+  A+K L  E   +K  V   +TE   L N RHP L  
Sbjct: 3   LGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59

Query: 107 LIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRSDIC-VGIAKGL 159
           L        R   V EY     L      +RV             E R+      I   L
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS-----------EDRARFYGAEIVSAL 108

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYL 217
            +LH      +V+RD+K  N++LD++ + KI DFGL K   + I+         GT  YL
Sbjct: 109 GYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYL 162

Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           APE +         D +  GV++ E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.0 bits (168), Expect = 3e-13
 Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 22/220 (10%)

Query: 41  LRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPL--SAESKQGVREFITEIMTLS 97
           LR     F L   +G G +G VYKG  +  G+  A+K +  + + ++ +++ I  +   S
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60

Query: 98  NVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
           +  H N+    G  ++        +  LV E+    S+   L+  TK N  L  E  + I
Sbjct: 61  H--HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGN-TLKEEWIAYI 116

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
           C  I +GL+ LH+     ++HRDIK  N+LL +    K+ DFG++      +    T I 
Sbjct: 117 CREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI- 172

Query: 212 GTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISG 246
           GT  ++APE +            K+D++S G+  +E+  G
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 52/213 (24%), Positives = 104/213 (48%), Gaps = 18/213 (8%)

Query: 48  FHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRH 101
           F L   +G+G FG+V +  L     + +++AVK L A+  S   + EF+ E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 102 PNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI--CV 153
           PN+++LIG  ++   +      +++  ++++  L   LL +           ++ +   +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAG 212
            IA G+ +L  +   + +HRD+ A N +L++     + DFGL+ K++  +          
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              +LA E +     T  +DV++FGV + EI++
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 25/217 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAES-KQGV-----REFITEIMTLSN 98
           D +    KIG G +G VYK      G+ +A+K    E  ++G+     RE I+ +  LS 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE-ISLLQMLSE 59

Query: 99  VRHPNLVELIGCCVQGTRR-------ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
             +  +V L+   V+            LV+EY++++    +          L  +     
Sbjct: 60  SIY--IVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRI 210
              + KG+A  H+     ++HRD+K  N+L+D++    KI D GL + F   +   T  I
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172

Query: 211 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 246
             T  Y APE +LG    +   D++S G +  E+   
Sbjct: 173 V-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 11/198 (5%)

Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIG 109
           +G+GGFG V    + N G+  A K L  +    K G +  + E   L  V  P +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
                T   LV   +    L   +    +  +++   +       I  G+  LH      
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME--RVIHYSAQITCGILHLHSM---D 115

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
           IV+RD+K  N+LLD + N ++ D GLA    D  T   T+ AGT GY+APE +     + 
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSY 173

Query: 230 KADVYSFGVLVLEIISGR 247
             D ++ G  + E+++GR
Sbjct: 174 PVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 62/200 (31%), Positives = 90/200 (45%), Gaps = 16/200 (8%)

Query: 54  IGRGGFGTV-YKGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIG 109
           +G+G FG V       +G+  A+K L  E   +K  V   +TE   L N RHP L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
                 R   V EYV    L       ++  +  + ++       I   L +LH      
Sbjct: 63  SFQTKDRLCFVMEYVNGGEL---FFHLSRERV-FSEDRTRFYGAEIVSALDYLHSG---K 115

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGTTGYLAPEYVLGGQL 227
           IV+RD+K  N++LD++ + KI DFGL K   + IT   T     GT  YLAPE +     
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 228 TMKADVYSFGVLVLEIISGR 247
               D +  GV++ E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 81/337 (24%), Positives = 145/337 (43%), Gaps = 59/337 (17%)

Query: 50  LSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTLSNV- 99
           L   +G G FG V         K        +AVK L  + + + + + ++E+  +  + 
Sbjct: 16  LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-------------NIKLNWE 146
           +H N++ L+G C Q     ++ EY    +L R  L A +                +L ++
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNL-REYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
                   +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    ++ +I
Sbjct: 135 DLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNI 187

Query: 207 TTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 261
                 T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--LGGSPYPGIPVEEL 245

Query: 262 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 321
            +   + H+ +KP             +E+   M+    C  A  S+RP   Q+++ L + 
Sbjct: 246 FKLLKEGHRMDKPANCT---------HELYMIMRE---CWHAVPSQRPTFKQLVEDLDRV 293

Query: 322 IRLNEE----ELTAPGLFQDSESSSVGTSDKKSSDST 354
           + +       +L+ P      E  S G  D  SS S+
Sbjct: 294 LTVTSTDEYLDLSVP-----FEQYSPGCPDSPSSCSS 325

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 21/204 (10%)

Query: 52  NKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIG 109
           +K+G G + TV+KG +      +A+K +  E ++G     I E+  L N++H N+V L  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 110 CCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
                    LV+EY++++    LD      +  N+K+           + +GL++ H+  
Sbjct: 71  IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI-------FMFQLLRGLSYCHKR- 122

Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRIAGTTGYLAPEYVLG 224
              I+HRD+K  N+L++++   K+ DFGL  AK  P   T   +    T  Y  P+ +LG
Sbjct: 123 --KILHRDLKPQNLLINEKGELKLADFGLARAKSVP---TKTYSNEVVTLWYRPPDVLLG 177

Query: 225 G-QLTMKADVYSFGVLVLEIISGR 247
             + +   D++  G ++ E+ +GR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 19/204 (9%)

Query: 50  LSNKIGRGGFGTVY---------KGTLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNV 99
           L  ++G+G FGTVY         +  L   + I V  L+  E+ Q       E   LS +
Sbjct: 4   LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKL 59

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            HP +V+     ++     ++ EY E   LD  L         L+  +  +  + +  G+
Sbjct: 60  DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
            ++H+     I+HRD+KA NI L      KIGDFG+++L   +    TT   GT  Y++P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYMSP 174

Query: 220 EYVLGGQLTMKADVYSFGVLVLEI 243
           E +       K+D++S G ++ E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 66/208 (31%), Positives = 91/208 (43%), Gaps = 31/208 (14%)

Query: 54  IGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVE 106
           +G+G FG V     K T   GR  A+K L  E   +K  V   +TE   L N RHP L  
Sbjct: 3   LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 107 LIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           L        R   V EY     L      +RV           + ++       I   L 
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVF----------SEDRARFYGAEIVSALD 109

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGYLAP 219
           +LH E   ++V+RD+K  N++LD++ + KI DFGL K    D  T  T    GT  YLAP
Sbjct: 110 YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 165

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E +         D +  GV++ E++ GR
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 22/207 (10%)

Query: 54  IGRGGFGTV--YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIG 109
           IG+G +G V     T T G ++A+K ++   E        + EI  L  +RHP++VE+  
Sbjct: 8   IGKGSYGVVCSAIDTHT-GEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 110 CCVQGTRR-----ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
             +  +RR      +V+E +E++ L +V+    KAN  L  E        + + L ++H 
Sbjct: 67  IMLPPSRREFKDIYVVFELMESD-LHQVI----KANDDLTPEHHQFFLYQLLRALKYIH- 120

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHIT-TRIAGTTGYLAPEYV 222
               ++ HRD+K  NIL + +   KI DFGLA++ F D  T I  T    T  Y APE  
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178

Query: 223 --LGGQLTMKADVYSFGVLVLEIISGR 247
                + T   D++S G +  E+++G+
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)

Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 85  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 138

Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 139 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 192

Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 23/205 (11%)

Query: 52  NKIGRGGFGTVYKG--TLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELI 108
            K+G G + TV+KG   LT    +A+K +  E ++G     I E+  L +++H N+V L 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 109 GCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
                     LV+EY++ +    +D      +  N+K+           I +GLA+ H  
Sbjct: 71  DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKI-------FLYQILRGLAYCHRR 123

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRIAGTTGYLAPEYVL 223
               ++HRD+K  N+L+++    K+ DFGL  AK  P   T   +    T  Y  P+ +L
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP---TKTYSNEVVTLWYRPPDVLL 177

Query: 224 G-GQLTMKADVYSFGVLVLEIISGR 247
           G  + + + D++  G +  E+ SGR
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 16/204 (7%)

Query: 53  KIGRGGFGTVYKGTLTNG---RRIAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVELI 108
           +IG G FG V  G + +G    ++ VK L  + S Q   +F+ E     +++H NL++ +
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKA-NIKLNWEKRSDICVGIAKGLAFLHEELV 167
           G C + T  +LV E+     L   L    KA  +  +      +   IA GL  LH+   
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT-RIAGTTGYLAPEYV--LG 224
            + +H D+   N LL  +   KIGD+GL+        ++T  ++     ++APE V  + 
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 225 GQL-----TMKADVYSFGVLVLEI 243
           G L     T +++V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 19/208 (9%)

Query: 53  KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCC 111
           K+GRG +G VYK    +G+      L      G+      EI  L  ++HPN++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 112 VQGTRR--ILVYEYVENNSLDRVLLG-ATKANIKLNWEKRS---DICVGIAKGLAFLHEE 165
           +  + R   L+++Y E++    +    A+KAN K     RS    +   I  G+ +LH  
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 166 LVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFPDNITHIT--TRIAGTTGYLA 218
            V   +HRD+K +NIL+  E  P     KI D G A+LF   +  +     +  T  Y A
Sbjct: 128 WV---LHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 219 PEYVLGGQLTMKA-DVYSFGVLVLEIIS 245
           PE +LG +   KA D+++ G +  E+++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 28/206 (13%)

Query: 52  NKIGRGGFGTV--YKGTLTNGRRIAVKPL------SAESKQGVREFITEIMTLSNVRHPN 103
             +G G FG V   +  LT G+ +A+K +         +K+  RE    +  L ++RH N
Sbjct: 16  QPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRE----LKLLKHLRHEN 70

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           ++ L    +     I     +    L R+L         L  +        I +GL ++H
Sbjct: 71  IISLSDIFISPLEDIYFVTELLGTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVH 125

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYV 222
              V   VHRD+K SNIL+++  + KI DFGLA++    +T +++TR      Y APE +
Sbjct: 126 SAGV---VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIM 177

Query: 223 LGGQ-LTMKADVYSFGVLVLEIISGR 247
           L  Q   ++ D++S G +  E++ G+
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR--RIAVKPLSAES---KQGVREFITEIMTLSNVR 100
           +DF+    +G G FG V   T  N     +A+K         ++ V    +E   L+ + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HP  V L G     +   LV E+V        + G     ++ N    +D+    A  + 
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFV--------IGGEFFTFLRRNKRFPNDVGCFYAAQIV 141

Query: 161 FLHEELVP-HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
            + E L   +IV+RD+K  N+LLD++   K+ DFG AK+    +   T  + GT  Y+AP
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV----VDTRTYTLCGTPEYIAP 197

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISG 246
           E +L       AD ++ G+ + EI+ G
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 29/208 (13%)

Query: 54  IGRGGFGTV--YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIG 109
           IGRG +G V   K + TN  ++A+K ++   +++   +  + EI  L ++ H N++ +  
Sbjct: 13  IGRGAYGIVCSAKNSETN-EKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71

Query: 110 CCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC----VGIAKGLA 160
                 R       +VYE ++ + L ++        I+ +     D C      + +GL 
Sbjct: 72  IMPPPHREAFNDVYIVYELMDTD-LHQI--------IRSSQTLSDDHCQYFLYQLLRGLK 122

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           ++H     +++HRD+K SN+LL+   + KI DFGLA+   +    +T  +  T  Y APE
Sbjct: 123 YIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPE 178

Query: 221 YVLG-GQLTMKADVYSFGVLVLEIISGR 247
            +L   + T   DV+S G +  E++ GR
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL-GR 205

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 37/217 (17%)

Query: 48  FHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           F     +G+GGFG V    +   G+  A K L    K+ +++   E M L+  +   ++E
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKQ---ILE 55

Query: 107 LIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNW---------EKR-----SD 150
            +      +R +  L Y Y   ++L  VL      ++K +          E+R     ++
Sbjct: 56  KV-----NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE 110

Query: 151 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 210
           I      GL  LH E    IV+RD+K  NILLD   + +I D GLA   P+  T I  R+
Sbjct: 111 ITC----GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV 162

Query: 211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
            GT GY+APE V   + T   D +  G L+ E+I G+
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 37/198 (18%)

Query: 66  TLTNGRR----IAVKPLSAES---KQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRR 117
           TLT G      +A KP   +    K G +   + E M L NV HP+++ +    V G   
Sbjct: 73  TLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132

Query: 118 ILV--------YEYVENNSLDRVLLGATKANIKLNWEKRSDICV--GIAKGLAFLHEELV 167
            +V        Y Y+   S            I         + +   I +GL +LH +  
Sbjct: 133 CMVLPHYSSDLYTYLTKRS--------RPLPI------DQALIIEKQILEGLRYLHAQ-- 176

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K  NI ++      IGD G A+ FP         +AGT    APE +   + 
Sbjct: 177 -RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG-LAGTVETNAPEVLARDKY 233

Query: 228 TMKADVYSFGVLVLEIIS 245
             KAD++S G+++ E+++
Sbjct: 234 NSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 75/312 (24%), Positives = 133/312 (42%), Gaps = 52/312 (16%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR--------IAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V +       +        +AVK L    + + + + I+E M L
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE-MEL 70

Query: 97  SNV--RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------------ANI 141
             +  +H N++ L+G C Q     ++ EY    +L R  L A +                
Sbjct: 71  MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL-REFLRARRPPGPDYTFDITKVPEE 129

Query: 142 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 201
           +L+++        +A+G+ +L        +HRD+ A N+L+ ++   KI DFGLA+    
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR---- 182

Query: 202 NITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 256
            +  I      + G     ++APE +     T ++DV+SFG+L+ EI +    G    G 
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT--LGGSPYPGI 240

Query: 257 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
             + L +   + H+ +KP             +E+   M+    C  A  ++RP   Q+++
Sbjct: 241 PVEELFKLLREGHRMDKPSNC---------THELYMLMRE---CWHAVPTQRPTFKQLVE 288

Query: 317 MLTKNIRLNEEE 328
            L K +    EE
Sbjct: 289 ALDKVLAAVSEE 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 35/220 (15%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGV-REFITEIMTLSNVRHPN 103
             +   + IG G +G V   T    G ++A+K +S    Q   +  + EI  L   +H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 104 LVELIGCCVQGTRRI-------LVYEYVENNSLDRVLLGATKANIKLNWEKRSD--ICV- 153
           ++ ++   +             +V E +E + L +++            +  S+  I   
Sbjct: 65  IIGILD--IIRPPSFESFNDVYIVQELMETD-LYKLIKT----------QHLSNDHIQYF 111

Query: 154 --GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITT 208
              I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++      H   +T 
Sbjct: 112 LYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168

Query: 209 RIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +A T  Y APE +L  +   KA D++S G ++ E++S R
Sbjct: 169 YVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 21/210 (10%)

Query: 47  DFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV 99
           DF+    +G+G FG V     KGT       A+K L  +       V   + E   L+  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALQ 57

Query: 100 RHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
             P  +  +  C Q   R+  V EYV    L    +   +   K    +       I+ G
Sbjct: 58  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL----MYHIQQVGKFKEPQAVFYAAEISVG 113

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYL 217
           L FLH      I++RD+K  N++LD E + KI DFG+ K     +  +TTR   GT  Y+
Sbjct: 114 LFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYI 168

Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           APE +         D +++GVL+ E+++G+
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 31/212 (14%)

Query: 54  IGRGGFGTVYKGTL-------TNGRRIAVKPLSAESKQGVR---EFITEIMTLSNVRHPN 103
           +G+G F  +YKG L         G    V  +        R    F      +S + H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           LV+L G CV+    I+V EYV+   LD V L   K N+ L+W  + D+   +A  L +L 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLD-VFLHREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 164 EELVPHIVHRDIKASNILL-----DQEFNP--KIGDFGLAKLFPDNITHITTRIAGTTGY 216
           ++    +VH ++   NIL+     ++ + P  K+ D G+  +   +      RI     +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP-ITVLSREERVERIP----W 170

Query: 217 LAPEYVLGGQ--LTMKADVYSFGVLVLEIISG 246
           +APE +  GQ  LT+ AD +SFG  +LEI S 
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 20/208 (9%)

Query: 54  IGRGGFGTVYKGTL----TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVEL 107
           +G+G +G V   +L    T+G++  +K L+    S++  +    E   LS ++HPN+V  
Sbjct: 8   VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 108 IGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKR-SDICVGIAKGLAFLHE 164
                +G   +L  V  + E   L   L    +   KL  E +  +  V IA  L +LHE
Sbjct: 65  RESW-EGEDGLLYIVMGFCEGGDLYHKL---KEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
           +   HI+HRD+K  N+ L +    K+GD G+A++  +N   + + + GT  Y++PE    
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSN 176

Query: 225 GQLTMKADVYSFGVLVLEIISGRNSGKA 252
                K+DV++ G  V E+ + +++  A
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNA 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 52  NKIGRGGFGTVYKG--TLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELI 108
           +K+G G + TVYKG   LT+   +A+K +  E ++G     I E+  L +++H N+V L 
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 109 GCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
                     LV+EY++ +    LD         N+KL           + +GL + H  
Sbjct: 71  DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL-------FLFQLLRGLNYCHRR 123

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRIAGTTGYLAPEYVL 223
               ++HRD+K  N+L+++    K+ DFGL  AK  P   T   +    T  Y  P+ +L
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYSNEVVTLWYRPPDILL 177

Query: 224 GG-QLTMKADVYSFGVLVLEIISGR 247
           G    + + D++  G +  E+ +GR
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 45/175 (25%), Positives = 89/175 (50%), Gaps = 27/175 (15%)

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG-T 213
           +A+G+ FL  +   + +HRD+ A N+LL      KI DFGLA+   ++  ++    A   
Sbjct: 221 VAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM---NKF--LLEWAWQL 268
             ++APE +     T+++DV+S+G+L+ EI S    GK+ +  +   +KF  +++  +Q+
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---LGKSPYPGILVNSKFYKMVKRGYQM 334

Query: 269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
            +             ++ P EI   MK+   C     + RP  +Q+ +++ + + 
Sbjct: 335 SRP------------DFAPPEIYSIMKM---CWNLEPTERPTFSQISQLIQRQLG 374

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)

Query: 53  KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCC 111
           K+GRG +G VYK    +G+      L      G+      EI  L  ++HPN++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 112 V-QGTRRI-LVYEYVENNSLDRVLLG-ATKAN---IKLNWEKRSDICVGIAKGLAFLHEE 165
           +    R++ L+++Y E++    +    A+KAN   ++L       +   I  G+ +LH  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 166 LVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFPDNITHIT--TRIAGTTGYLA 218
            V   +HRD+K +NIL+  E  P     KI D G A+LF   +  +     +  T  Y A
Sbjct: 128 WV---LHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 219 PEYVLGGQLTMKA-DVYSFGVLVLEIIS 245
           PE +LG +   KA D+++ G +  E+++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 65.2 bits (159), Expect = 8e-12
 Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 32/215 (14%)

Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV 112
           +G G  G V+    ++  +R+AVK +     Q V+  + EI  +  + H N+V++     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 113 QGTRRI--------------LVYEYVENNSLDRVLLGATKAN--IKLNWEKRSDICVGIA 156
                +              +V EY+E + L  VL     +    +L           + 
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEHARL-------FMYQLL 124

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITH--ITTRIAGT 213
           +GL ++H     +++HRD+K +N+ ++ E    KIGDFGLA++   + +H    +    T
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 214 TGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR 247
             Y +P  +L     T   D+++ G +  E+++G+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 34/77 (44%), Positives = 48/77 (62%), Gaps = 1/77 (1%)

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
           I++RD+K  NILLD+E + K+ DFGL+K   D+         GT  Y+APE V     T 
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVNRRGHTQ 177

Query: 230 KADVYSFGVLVLEIISG 246
            AD +SFGVL+ E+++G
Sbjct: 178 SADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 10/205 (4%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLS-AESKQGVREF-ITEIMTLSNVRHP 102
           + F +   +G G +G V K      + I A+K    +E  + V+E  + E+  L  ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+VEL     +  +  LV+EYVE N L+   L     N     + RS I   + K + + 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYI-YQLIKAIHWC 116

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H+     IVHRDIK  N+L+      K+ DFG A+   +      T    T  Y +PE +
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173

Query: 223 LGGQLTMKADVYSFGVLVLEIISGR 247
           LG       D++S G ++ E+  G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 62/208 (29%), Positives = 89/208 (42%), Gaps = 33/208 (15%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMT-----LSNVRHPNLVEL 107
           IG+G FG V       +G+  AVK L  ++    +E    IM      L NV+HP LV L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVGL 61

Query: 108 IGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRSDICVG-IAKGLA 160
                   +   V +YV    L      +R              E R+      IA  L 
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFP-----------EPRARFYAAEIASALG 110

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLA 218
           +LH     +I++RD+K  NILLD + +  + DFGL K   + I H   T+   GT  YLA
Sbjct: 111 YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLA 164

Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +         D +  G ++ E++ G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 37/212 (17%)

Query: 54  IGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV 112
           +G+GGFG V    +   G+  A K L    K+ +++   E M L+  R   ++E +    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKR---ILEKVN--- 58

Query: 113 QGTRRI--LVYEYVENNSLDRVLLGATKANIKLNW---------EKRS-----DICVGIA 156
             +R +  L Y Y   ++L  VL      ++K +          E+R+     ++C G+ 
Sbjct: 59  --SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLE 116

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
                L  E    IV+RD+K  NILLD   + +I D GLA   P+  T +  R+ GT GY
Sbjct: 117 D----LQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGY 167

Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           +APE +   + T   D +  G L+ E+I G++
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 76/286 (26%), Positives = 117/286 (40%), Gaps = 52/286 (18%)

Query: 54  IGRGGFGTVYKGTLTNGRR------------IAVKPLSAESKQGVREFITEIMTLSNVRH 101
           +G+G F  ++KG     RR            + +K L    +     F      +S + H
Sbjct: 3   LGQGTFTKIFKGI----RREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH 58

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
            +LV   G CV G   I+V EYV+  SLD   L   K  I ++W+      + +AK LA+
Sbjct: 59  KHLVLNYGVCVCGDESIMVQEYVKFGSLD-TYLKKNKNLINISWK------LEVAKQLAW 111

Query: 162 -LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-------HITTRIAGT 213
            LH      + H ++ A N+LL +E + K G+    KL    I+        +  RI   
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-- 169

Query: 214 TGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE 272
             ++ PE +   Q L++ AD +SFG  + EI SG        G      L+   +L   E
Sbjct: 170 --WVPPECIENPQNLSLAADKWSFGTTLWEIFSG--------GDKPLSALDSQKKLQFYE 219

Query: 273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
              +L  P+  E   N I +       C       RP    +I+ L
Sbjct: 220 DRHQLPAPKWTEL-ANLINQ-------CMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 29/214 (13%)

Query: 47  DFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITE--IMTLS 97
           DF+    +G+G FG V     KGT       A+K L  +       V   + E  ++ LS
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57

Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGI 155
             + P L +L  C     R   V EYV    L   +  +G  K    + +         I
Sbjct: 58  G-KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAE------I 110

Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTR-IAGT 213
           A GL FLH +    I++RD+K  N++LD E + KI DFG+ K   +N+   +TT+   GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGT 164

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
             Y+APE +         D ++FGVL+ E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 68/203 (33%), Positives = 96/203 (47%), Gaps = 20/203 (9%)

Query: 54  IGRGGFGTVYKGTLTNGRRI-AVKPLSAE---SKQGVREFITE---IMTLSNVRHPNLVE 106
           IG+G FG VY+    + RRI A+K LS +   +K+ V   I E   ++       P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEE 165
           L       +   LV +Y+    L   L    + +     E R+   +  +   L  LH+ 
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS-----EDRAKFYIAELVLALEHLHKY 115

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGYLAPEYVLG 224
               IV+RD+K  NILLD   +  + DFGL+K    DN T  T    GTT YLAPE +L 
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLD 170

Query: 225 GQ-LTMKADVYSFGVLVLEIISG 246
            +  T   D +S GVLV E+  G
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 61/201 (30%), Positives = 83/201 (41%), Gaps = 18/201 (8%)

Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PNLVELI 108
           L  K+G    G +Y   +     I  K  +AE  +      TE   L  VR  P LV L 
Sbjct: 18  LVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR------TERQVLEAVRRCPFLVTLH 71

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELV 167
                 T+  L+ +YV    L   L            E    + +  I   L  LH+   
Sbjct: 72  YAFQTDTKLHLILDYVNGGELFTHLYQREHFT-----ESEVRVYIAEIVLALDHLHQL-- 124

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I++RDIK  NILLD E +  + DFGL+K F            GT  Y+APE + GG  
Sbjct: 125 -GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183

Query: 228 --TMKADVYSFGVLVLEIISG 246
                 D +S GVL  E+++G
Sbjct: 184 GHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 25/218 (11%)

Query: 45  TDDFHLSNKIGRGGFGTVYK-GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV---- 99
           +D + +   IG+G +G V+K     NG + AVK L       + +   EI    N+    
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-----IHDIDEEIEAEYNILKAL 71

Query: 100 -RHPNLVELIGC-----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
             HPN+V+  G         G +  LV E     S+  ++ G  K   ++     + I  
Sbjct: 72  SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
               GL  LH       +HRD+K +NILL  E   K+ DFG++           T + GT
Sbjct: 132 EALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GT 187

Query: 214 TGYLAPEYV-----LGGQLTMKADVYSFGVLVLEIISG 246
             ++APE +     L      + DV+S G+  +E+  G
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 22/215 (10%)

Query: 47  DFHLSNKIGRGGFG-TVYKGTLTNGRRIAVK----PLSAESKQGVREFITEIMTLSNVRH 101
            +++   +G G FG  +    + + ++ A+K    P S+ + +  R+   E + L+ ++H
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKH 57

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATK---ANIKLNWEKRSDICVGIAK 157
           PN+V             +V EY +   L  ++ L   K    +  L W     +C+G+  
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW--FVQMCLGVQH 115

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 217
               +HE+ V   +HRDIK+ NI L Q    K+GDFG A+L      +  T + GT  Y+
Sbjct: 116 ----IHEKRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167

Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
            PE         K+D++S G ++ E+ + ++  +A
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.6 bits (154), Expect = 2e-11
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)

Query: 54  IGRGGFGTVYKGTLT-NGRRI--AVKPLSA-ESKQGVREFITEIMTLSNV-RHPNLVELI 108
           IG G FG V K  +  +G R+  A+K +    SK   R+F  E+  L  +  HPN++ L+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 109 GCCVQGTRRILVYEYVENNSL------------DRVLLGATKANIKLNWEKRSDICVGIA 156
           G C       L  EY  + +L            D     A      L+ ++       +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
           +G+ +L ++     +HRD+ A NIL+ + +  KI DFGL++     +     R+     +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 177

Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           +A E +     T  +DV+S+GVL+ EI+S
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 14/198 (7%)

Query: 54  IGRGGFGTVYKGTLTNGRRI----AVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           IG+G FG V +    + +RI     ++     S+  V   + E   L+ V  P +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVP 168
                 +  LV  ++    L   L    + +       R+      +   L  LH+    
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFD-----LSRARFYTAELLCALENLHKF--- 112

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 228
           ++++RD+K  NILLD + +  + DFGL KL   +    T    GT  YLAPE +LG   T
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELLLGHGYT 171

Query: 229 MKADVYSFGVLVLEIISG 246
              D ++ GVL+ E+++G
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 39/217 (17%)

Query: 54  IGRGGFGTVYKGTL-TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIG 109
           +G+GGFG V    +   G+  A K L  +    ++G    + E   L  V    +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-- 65

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW---------EKR-----SDICVGI 155
                      Y Y   ++L  VL      ++K +          E+R     ++I  G 
Sbjct: 66  ----------AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG- 114

Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
              L  LH E   + V+RD+K  NILLD   + +I D GLA   P+    I  R+ GT G
Sbjct: 115 ---LEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRV-GTVG 166

Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
           Y+APE +   + T+  D +  G L+ E+I G++  + 
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 66/244 (27%), Positives = 96/244 (39%), Gaps = 61/244 (25%)

Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE----SKQGVREFITEIMTLS 97
           DDF +   IGRG FG V+    K T   G+  A+K L         Q +     E   L+
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDT---GQVYAMKVLRKSDMIKRNQ-IAHVRAERDILA 56

Query: 98  NVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-- 154
           +   P +V+L     Q    + LV EY+    L             +N   R D+     
Sbjct: 57  DADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPEET 102

Query: 155 ----IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK------------- 197
               IA+ +  L        +HRDIK  NIL+D + + K+ DFGL K             
Sbjct: 103 ARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162

Query: 198 -----LFPDNITHITTR----------IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 242
                LF DN+                  GT  Y+APE + G    ++ D +S GV++ E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Query: 243 IISG 246
           ++ G
Sbjct: 223 MLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 35/210 (16%)

Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLS------AESKQGVREFITEIMTLSNVRHPNLVE 106
           IG G  G V        G+ +A+K LS        +K+  RE +  +M L N  H N++ 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV--LMKLVN--HKNIIG 79

Query: 107 LIGCCV-QGTRR-----ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           L+     Q +        LV E ++ N L +V+       + L+ E+ S +   +  G+ 
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVI------QMDLDHERMSYLLYQMLCGIK 132

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTTGYL 217
            LH      I+HRD+K SNI++  +   KI DFGLA+    +     ++ TR      Y 
Sbjct: 133 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YR 184

Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           APE +LG       D++S G ++ E+I G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 3/96 (3%)

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEYVLGGQL 227
           H++HRDIK++NILL      K+GDFG +K++   ++    R   GT  Y+APE       
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222

Query: 228 TMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
           + KAD++S GVL+ E+++ +    G+ M   M+K L
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258

Length = 496

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 27/219 (12%)

Query: 42  RSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           RS    + L N IG G FG VY+   +    ++A+K +  + +   RE    ++ + N+ 
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE----LLIMKNLN 117

Query: 101 HPNLVEL-----IGCCVQGTRRI---LVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 152
           H N++ L       C  +  + I   +V E++   ++ + +    + N  L         
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYS 176

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITT 208
             + + LA++H +    I HRD+K  N+L+D   +  K+ DFG AK       ++++I +
Sbjct: 177 YQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233

Query: 209 RIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 246
           R      Y APE +LG    T   D++S G ++ E+I G
Sbjct: 234 RF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 26/215 (12%)

Query: 47  DFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLS-------AESKQGVREFITEIMT 95
           +F L   +G G +G V+         +G+  A+K L        A++ +  R   TE   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTR---TERQV 57

Query: 96  LSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
           L ++R  P LV L       T+  L+ +Y+    L   L    +       E+   I  G
Sbjct: 58  LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSG 112

Query: 155 -IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
            I   L  LH+     I++RDIK  NILLD   +  + DFGL+K F ++         GT
Sbjct: 113 EIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169

Query: 214 TGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISG 246
             Y+AP+ V GG        D +S GVL+ E+++G
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 62.4 bits (151), Expect = 8e-11
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)

Query: 54  IGRGGFGTVYKGTLTNGR-RIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  R ++AVK LS   +S    R    E+  L +++H N++ L+  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
               T      E      L   L+GA   NI    KL+ E    +   + +GL ++H   
Sbjct: 83  FTPATS----IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS-- 136

Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   +I DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 137 -AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNW 190

Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E++ G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 40/238 (16%)

Query: 48  FHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVR- 100
           + L  ++G+G +G V       T +    +A+K ++     K   +  + E+  L + R 
Sbjct: 2   YELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG------ 154
           H N+  L              + V   + + + L        L+   RS   +       
Sbjct: 61  HKNITCLYD-----------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQS 109

Query: 155 ----IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT----HI 206
               I  GL ++H   V   +HRD+K  N+L++ +   KI DFGLA+ F +N       +
Sbjct: 110 FIYQILCGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166

Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
           T  +A T  Y APE +L  Q   KA DV+S G ++ E++  +    GK    Q+N+ L
Sbjct: 167 TEYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL 223

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 23/172 (13%)

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG-T 213
           +AKG++FL  +   + +HRD+ A NILL      KI DFGLA+   ++  ++    A   
Sbjct: 223 VAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLLEWAWQLHQ 270
             ++APE +     T ++DV+S+G+L+ EI S  +S   G  +  +  K + E    L  
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339

Query: 271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
           E  P E+ D          I++       C  A   +RP   Q+++++ + +
Sbjct: 340 ECAPSEMYD----------IMKS------CWDADPLKRPTFKQIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 37/228 (16%)

Query: 54  IGRGGFGTVYKGTLTNGRRI-AVKPLSAES---KQGVREFITEI-MTLSNVRHPNLVELI 108
           IG+G FG V         +  AVK L  ++   K+  +  ++E  + L NV+HP LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 109 GCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRSDICVG-IAKGLAF 161
                  +   V +Y+    L      +R  L           E R+      IA  L +
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFL-----------EPRARFYAAEIASALGY 111

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAP 219
           LH     +IV+RD+K  NILLD + +  + DFGL K   +NI H   T+   GT  YLAP
Sbjct: 112 LHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAP 165

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISG------RNSGKAMWGQMNKFL 261
           E +         D +  G ++ E++ G      RN+ +     +NK L
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 213

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)

Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           IG G  G V     T  G  +AVK LS   +++   +    E++ L  V H N++ L+  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 111 CV-QGTRR-----ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
              Q +        LV E ++ N L +V+      +++L+ E+ S +   +  G+  LH 
Sbjct: 89  FTPQKSLEEFQDVYLVMELMDAN-LCQVI------HMELDHERMSYLLYQMLCGIKHLHS 141

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
                I+HRD+K SNI++  +   KI DFGLA+    N   + T    T  Y APE +LG
Sbjct: 142 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYRAPEVILG 196

Query: 225 GQLTMKADVYSFGVLVLEIISG 246
                  D++S G ++ E++ G
Sbjct: 197 MGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 39/227 (17%)

Query: 53  KIGRGGFGTVYKGTLT-NGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
            IG G +G V     T +G+++A+K  P + +     +  + E+  L + +H N++ +  
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAI-- 69

Query: 110 CCVQGTRRIL------------VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
                 R IL            V + +E++ L  ++      +  L  E        + +
Sbjct: 70  ------RDILRPPGADFKDVYVVMDLMESD-LHHIIHS----DQPLTEEHIRYFLYQLLR 118

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPDNITHITTRIAGTT 214
           GL ++H     +++HRD+K SN+L++++   +IGDFG+A+     P    +  T    T 
Sbjct: 119 GLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 215 GYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQM 257
            Y APE +L   + T   D++S G +  E++ GR     GK    Q+
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQL 221

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 65/211 (30%), Positives = 92/211 (43%), Gaps = 19/211 (9%)

Query: 47  DFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLS----AESKQGVREFITEIMTLSN 98
           +F L   +G G +G V+          G+  A+K L      +  + V    TE   L +
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 99  VRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IA 156
           VR  P LV L        +  L+ +YV    +   L    + N     E       G I 
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFS---EDEVRFYSGEII 115

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
             L  LH+     IV+RDIK  NILLD E +  + DFGL+K F       T    GT  Y
Sbjct: 116 LALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 217 LAPEYVLGGQLTMKA-DVYSFGVLVLEIISG 246
           +APE + G     KA D +S G+L+ E+++G
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 45/215 (20%)

Query: 54  IGRGGFGTV-YKGTLTNGRRIAVK----PLSAE--SKQGVREFITEIMTLSNVRHPNLVE 106
           +G G +GTV        G ++A+K    P  +E  +K+  RE    +  L +++H N++ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRE----LRLLKHMKHENVIG 78

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVL------------LGATKANIKLNWEKRSDICVG 154
           L+              +  + SLDR              LG    + KL+ ++   +   
Sbjct: 79  LLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ 126

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGT 213
           + KGL ++H      I+HRD+K  N+ ++++   KI DFGLA+     +T ++ TR    
Sbjct: 127 MLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR---- 179

Query: 214 TGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 247
             Y APE +L     T   D++S G ++ E+++G+
Sbjct: 180 -WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 64/274 (23%), Positives = 106/274 (38%), Gaps = 83/274 (30%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTL------TNGRRIAVKPLSAESKQGV-----REFITEIM 94
           D   L   +G G FG V + +       ++   +AVK L    K+G      +  ++E+ 
Sbjct: 7   DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKML----KEGATASEHKALMSELK 62

Query: 95  TLSNV-RHPNLVELIGCCVQGT-----------------------------------RRI 118
            L ++  H N+V L+G C +                                     +R 
Sbjct: 63  ILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRG 122

Query: 119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSD----------------------ICVG-- 154
                VE + +DR +     + +   ++  +                       IC    
Sbjct: 123 RFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQ 182

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 211
           +A+G+ FL        +HRD+ A NILL +    KI DFGLA+     PD +   + R+ 
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
               ++APE +     T ++DV+SFGVL+ EI S
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 8/94 (8%)

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 211
           +A+G+ FL        +HRD+ A NILL +    KI DFGLA+     PD +     R+ 
Sbjct: 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
               ++APE +     T ++DV+SFGVL+ EI S
Sbjct: 239 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 8/94 (8%)

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 211
           +AKG+ FL        +HRD+ A NILL +    KI DFGLA+     PD +     R+ 
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
               ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 245 --LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 33/183 (18%)

Query: 78  LSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT 137
           + A  + G     TE   L  + HP++++L G           + Y   N    ++L   
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKG----------TFTY---NKFTCLILPRY 165

Query: 138 KANIK--LNWEKRSDICVGIA------KGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 189
           K ++   L  ++   IC  +A      + + +LHE     I+HRDIKA NI ++   +  
Sbjct: 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVC 222

Query: 190 IGDFGLAKLFPDNITHITTRI---AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           +GDFG A  FP +I     +    AGT    APE +         D++S G+++ E+ + 
Sbjct: 223 LGDFG-AACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Query: 247 RNS 249
            +S
Sbjct: 280 HDS 282

Length = 391

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 22/204 (10%)

Query: 54  IGRGGFGTVYKGTLT----NGRRIAVKPLS----AESKQGVREFITEIMTLSNVRHPNLV 105
           +G+GG+G V++         G+  A+K L       +++       E   L  V+HP +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHE 164
           +LI     G +  L+ EY+    L    +   +  I +  E  +   +  I+  L  LH+
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGEL---FMHLEREGIFM--EDTACFYLSEISLALEHLHQ 118

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLAPEYV 222
           +    I++RD+K  NILLD + + K+ DFGL K  +    +TH      GT  Y+APE +
Sbjct: 119 Q---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEIL 172

Query: 223 LGGQLTMKADVYSFGVLVLEIISG 246
           +        D +S G L+ ++++G
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 58.8 bits (143), Expect = 7e-10
 Identities = 62/205 (30%), Positives = 89/205 (43%), Gaps = 26/205 (12%)

Query: 52  NKIGRGGFGTVYKG-TLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVR-HPNLVEL 107
            KIG G F  V K  +   G+  A+K +    +S + V     EI  L  +  HPN++ L
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63

Query: 108 IGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIKLNWEKRS-DICVGIAKGLAFLHE 164
           I         R  LV+E ++ N     L    K   +   EKR       + K L  +H 
Sbjct: 64  IEVLFDRKTGRLALVFELMDMN-----LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEY 221
                I HRDIK  NIL+  +   K+ DFG  +     P    +I+TR      Y APE 
Sbjct: 119 N---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYRAPEC 169

Query: 222 VL-GGQLTMKADVYSFGVLVLEIIS 245
           +L  G    K D+++ G +  EI+S
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 31/190 (16%)

Query: 69  NGR--RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 126
           NGR  R+ +K L    +     F      +S V H +L  + G CV+G+  I+V E+VE+
Sbjct: 41  NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100

Query: 127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---- 182
             LD V L   K  + + W  +  +   +A  L++L ++   ++VH ++ A NILL    
Sbjct: 101 GPLD-VCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154

Query: 183 ----DQEF----NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADV 233
                  F    +P +    L++           RI     ++APE V GG  L+  AD 
Sbjct: 155 LAEGTSPFIKLSDPGVSFTALSR------EERVERIP----WIAPECVPGGNSLSTAADK 204

Query: 234 YSFGVLVLEI 243
           +SFG  +LEI
Sbjct: 205 WSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 12/96 (12%)

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-GT 213
           +A+G+ FL  +   + VHRD+ A N+LL Q    KI DFGLA+    +I H +  ++ G+
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGS 298

Query: 214 T----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           T     ++APE +     T  +DV+S+G+L+ EI S
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 28/221 (12%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V        G ++A+K LS   +S+   +    E+  L +++H N++ L+  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 111 CVQGTRR------ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
                         LV  Y++ + L +++         L+ +K   +   +  GL ++H 
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTD-LQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS 135

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVL 223
                I+HRD+K  N+ ++++   KI DFGLA+     +T ++ TR      Y APE +L
Sbjct: 136 A---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187

Query: 224 GG-QLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
                    D++S G ++ E+++G+    GK    Q+ + L
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 15/197 (7%)

Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q +       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS--- 137

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGY 195

Query: 228 TMKADVYSFGVLVLEII 244
               D++S G ++ E++
Sbjct: 196 KENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 24/220 (10%)

Query: 39  TELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAES--KQGVREFITE--- 92
           T+LR   +DF +   IGRG FG V      + +++ A+K LS     K+    F  E   
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
           IM  +N     +V+L     Q  + + +V EY+    L  ++   +  +I   W +    
Sbjct: 96  IMAHAN--SEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTA 149

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRI 210
            V +A  L  +H       +HRD+K  N+LLD+  + K+ DFG   K+  + +    T +
Sbjct: 150 EVVLA--LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204

Query: 211 AGTTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISG 246
            GT  Y++PE +      G    + D +S GV + E++ G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)

Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIG 109
           IGRGGFG VY     + G+  A+K L  +    KQG    + E + LS V   +    I 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIV 60

Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI--------CVGIAKGLAF 161
           C        + Y +   + L  +L      ++  +  +               I  GL  
Sbjct: 61  C--------MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEH 112

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           +H   V   V+RD+K +NILLD+  + +I D GLA  F     H +    GT GY+APE 
Sbjct: 113 MHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166

Query: 222 VLGGQ-LTMKADVYSFGVLVLEIISGRN 248
           +  G      AD +S G ++ +++ G +
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHS 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 28/77 (36%), Positives = 50/77 (64%), Gaps = 1/77 (1%)

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLT 228
           ++HRD+K++NI L      K+GDFG +K + D+++  + +   GT  YLAPE     + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 229 MKADVYSFGVLVLEIIS 245
            KAD++S GV++ E+++
Sbjct: 250 KKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 57/248 (22%), Positives = 94/248 (37%), Gaps = 63/248 (25%)

Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAES---KQGVREFITEIMTLSN 98
             F     +G+G  G V+    KGT   G+  A+K L  +    +  V+  +TE   L+ 
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILAT 57

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD--ICVGIA 156
           + HP L  L       T   LV +Y     L R+L            +++    +   +A
Sbjct: 58  LDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL------------QRQPGKCLSEEVA 105

Query: 157 K--------GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD------- 201
           +         L +LH      IV+RD+K  NILL +  +  + DF L+K           
Sbjct: 106 RFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162

Query: 202 ---------NITHITTRIA------------GTTGYLAPEYVLGGQLTMKADVYSFGVLV 240
                    ++  I +               GT  Y+APE + G       D ++ G+L+
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222

Query: 241 LEIISGRN 248
            E++ G  
Sbjct: 223 YEMLYGTT 230

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 33/208 (15%)

Query: 54  IGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMT-----LSNVRHPNLVEL 107
           IG+G FG V      ++G   AVK L  ++    +E    IM      L N++HP LV L
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVGL 61

Query: 108 IGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRSDICVG-IAKGLA 160
                   +   V +YV    L      +R  L           E R+      +A  + 
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL-----------EPRARFYAAEVASAIG 110

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLA 218
           +LH     +I++RD+K  NILLD + +  + DFGL K  + P+     T+   GT  YLA
Sbjct: 111 YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---TTSTFCGTPEYLA 164

Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +         D +  G ++ E++ G
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 55.7 bits (134), Expect = 8e-09
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 7/90 (7%)

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 217
           GL  +H   V   V+RD+K +NILLD+  + +I D GLA  F     H +    GT GY+
Sbjct: 109 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162

Query: 218 APEYVLGG-QLTMKADVYSFGVLVLEIISG 246
           APE +  G      AD +S G ++ +++ G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 19/224 (8%)

Query: 34  NHFSYTELRSAT----DDFHLSNKIGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQ 84
           N+F   E+  +T      +     IG G  G V   Y   L   R +A+K LS   +++ 
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQT 65

Query: 85  GVREFITEIMTLSNVRHPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKL 143
             +    E++ +  V H N++ L+     Q +       Y+    +D  L    +  ++L
Sbjct: 66  HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MEL 123

Query: 144 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
           + E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGT 178

Query: 204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           + + T    T  Y APE +LG       D++S G ++ E+I G 
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 63/201 (31%), Positives = 89/201 (44%), Gaps = 19/201 (9%)

Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMT-----LSNVRHPNLVEL 107
           IG+G FG V       +G+  AVK L  +     +E    IM      L NV+HP LV L
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVGL 61

Query: 108 IGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEE 165
                Q T ++  V ++V    L   L        +   E R+      IA  L +LH  
Sbjct: 62  -HYSFQTTEKLYFVLDFVNGGELFFHL-----QRERSFPEPRARFYAAEIASALGYLHS- 114

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              +IV+RD+K  NILLD + +  + DFGL K      +  TT   GT  YLAPE +   
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 226 QLTMKADVYSFGVLVLEIISG 246
                 D +  G ++ E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 24/218 (11%)

Query: 41  LRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAES--KQGVREFITE---IM 94
           L+   +D+ +   IGRG FG V      + +++ A+K LS     K+    F  E   IM
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 95  TLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
             +N   P +V+L  C  Q  + + +V EY+    L  ++   +  ++   W K     V
Sbjct: 98  AFAN--SPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEV 151

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAG 212
            +A  L  +H      ++HRD+K  N+LLD+  + K+ DFG   K+    +    T + G
Sbjct: 152 VLA--LDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-G 205

Query: 213 TTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISG 246
           T  Y++PE +      G    + D +S GV + E++ G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 12/96 (12%)

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-GT 213
           +A G+ FL  +   + VHRD+ A N+L+ +    KI DFGLA+    +I   +  I+ G+
Sbjct: 248 VANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLAR----DIMRDSNYISKGS 300

Query: 214 T----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           T     ++APE +     T  +DV+SFG+L+ EI +
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 51.6 bits (124), Expect = 4e-08
 Identities = 34/149 (22%), Positives = 60/149 (40%), Gaps = 14/149 (9%)

Query: 53  KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV-ELIGCC 111
            +  G    VY     +   + +K   +  K   RE    I+ L   R    V +++   
Sbjct: 5   LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62

Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
                  L+ E++E  +LD           +++ E++ DI   +A+ LA LH+  +  + 
Sbjct: 63  ESDGWSYLLMEWIEGETLD-----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLFP 200
           H D+   NIL+D      I D+  A   P
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.9 bits (127), Expect = 7e-08
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)

Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAES---KQGVREFITEIMTLSN 98
           +DF     I  G +G VY    K T     R A+K ++ ++   +  +++   E   L+ 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQ---RFAMKKINKQNLILRNQIQQVFVERDILTF 57

Query: 99  VRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVG 154
             +P +V +  C  + T+R L  V EYVE      +L  +GA   ++   +   + +   
Sbjct: 58  AENPFVVSMF-CSFE-TKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL--- 112

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT------HIT- 207
               L +LH      IVHRD+K  N+L+    + K+ DFGL+K+   ++T      HI  
Sbjct: 113 ---ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 208 -TR------IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            TR      + GT  Y+APE +L        D ++ G+++ E + G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 60/223 (26%), Positives = 90/223 (40%), Gaps = 38/223 (17%)

Query: 46  DDFHLSNKIGRGGFGTVY------KGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV 99
            DF + + +GRG FG V        G +   + +    L A+      E   +I+++SN 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
             P + +L           LV EY     L  +L             +  D      + +
Sbjct: 60  -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL------------NRYEDQ---FDEDM 103

Query: 160 A-FLHEELVPHI--------VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 210
           A F   ELV  I        VHRDIK  N+L+D+  + K+ DFG A     N    +   
Sbjct: 104 AQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP 163

Query: 211 AGTTGYLAPEYVL------GGQLTMKADVYSFGVLVLEIISGR 247
            GT  Y+APE +        G   ++ D +S GV+  E+I GR
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 22/218 (10%)

Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAES--KQGVREFITE---I 93
           +LR   +D+ +   IGRG FG V      + R++ A+K LS     K+    F  E   I
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 94  MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
           M  +N   P +V+L           +V EY+    L  ++   +  ++   W +     V
Sbjct: 97  MAFAN--SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEV 151

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAG 212
            +A  L  +H       +HRD+K  N+LLD+  + K+ DFG   K+  + +    T + G
Sbjct: 152 VLA--LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 205

Query: 213 TTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISG 246
           T  Y++PE +      G    + D +S GV + E++ G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 21/213 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQGVREFITEIMTLSNVRHPNL 104
           DDF +   IGRG FG V    + +  RI A+K L+        E +    T +  R    
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNK------WEMLKRAET-ACFREERN 53

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVL---LGATKANIKLNWEKR--SDIC-VGIAKG 158
           V + G C   T   L Y + + N L  V+   +G     +   +E R   D+    IA+ 
Sbjct: 54  VLVNGDCQWIT--TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEM 111

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
           +  +H     H VHRDIK  N+LLD   + ++ DFG       + T  ++   GT  Y++
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYIS 171

Query: 219 PEYVLG-----GQLTMKADVYSFGVLVLEIISG 246
           PE +       G+   + D +S GV + E++ G
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 34/240 (14%)

Query: 38  YTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVRE-----FITE 92
           Y +  S  +++ +  KIG G FG V+   + + R        A S +G++E      + E
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIE 62

Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSD 150
           +  +  ++H N+V  I   +    + L  + E+ +   L R +    K   K+      D
Sbjct: 63  VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122

Query: 151 ICVGIAKGLAFLHE-ELVPH---IVHRDIKASNILLD-----------QEFN------PK 189
           I   +   LA+ H  +  P+   ++HRD+K  NI L            Q  N       K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182

Query: 190 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM--KADVYSFGVLVLEIISGR 247
           IGDFGL+K     I  +     GT  Y +PE +L    +   K+D+++ G ++ E+ SG+
Sbjct: 183 IGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 41/196 (20%), Positives = 82/196 (41%), Gaps = 22/196 (11%)

Query: 62  VYKGTLTNGRRIAVKPL---SAESKQGVREFITEIMTLSNVRHPNLVELIG----CCVQG 114
           +YKG   N + + ++         K  +     EI  L  +   N++++ G         
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-VPHIVHR 173
            R  L+ EY     L  VL         L+++ + D+ +   KGL  L++    P+   +
Sbjct: 95  PRLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY---K 147

Query: 174 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--GQLTMKA 231
           ++ + + L+ + +  KI   GL K+           +     Y + + +     + T+K 
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKD 203

Query: 232 DVYSFGVLVLEIISGR 247
           D+YS GV++ EI +G+
Sbjct: 204 DIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 15/159 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPL-SAE--SKQGVREFITEIMTLSNVRH 101
           ++F +   I RG FG VY G    N +  AVK +  A+  +K  V +   E   L+  + 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGL 159
           P +V L           LV EY+    +  +L   G     + + +         +A  L
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE------VALAL 117

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 198
            +LH      I+HRD+K  N+L+  E + K+ DFGL+K+
Sbjct: 118 DYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 39/222 (17%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +DF +   IGRG FG V           AV  L    K    + + +   L         
Sbjct: 1   EDFEILKVIGRGAFGEV-----------AVVKLKNADKVFAMKILNKWEMLKRAETACFR 49

Query: 106 ELIGCCVQGTRR---ILVYEYVENNSLDRVL---LGATKANIKLNWEKRSDICVGIAKGL 159
           E     V G  +    L Y + + N+L  V+   +G     +   +E R      + + +
Sbjct: 50  EERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR------LPEDM 103

Query: 160 A--FLHEELVP-------HIVHRDIKASNILLDQEFNPKIGDFG-LAKLFPDNITHITTR 209
           A  +L E ++        H VHRDIK  NIL+D   + ++ DFG   KL  D     +  
Sbjct: 104 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163

Query: 210 IAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISG 246
           + GT  Y++PE +       G+   + D +S GV + E++ G
Sbjct: 164 V-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 45/218 (20%), Positives = 83/218 (38%), Gaps = 40/218 (18%)

Query: 53  KIGR----GGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVE 106
            IG+         + K        +AVK ++ +  SK+ ++    EI+T   ++HPN++ 
Sbjct: 5   LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLL------GATKANIKLNWEKRSDICVGIAKGLA 160
            +   +  +   +V   +   S    LL      G  +  I         I   +   L 
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSC-EDLLKTHFPEGLPELAIAF-------ILKDVLNALD 115

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDF---------GLAKLFPDNITHITTRIA 211
           ++H +     +HR +KAS+ILL  +    +            G  +    +         
Sbjct: 116 YIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD---FPKSSV 169

Query: 212 GTTGYLAPEYVLGGQL---TMKADVYSFGVLVLEIISG 246
               +L+PE VL   L     K+D+YS G+   E+ +G
Sbjct: 170 KNLPWLSPE-VLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 25/162 (15%)

Query: 91  TEIMTLSNVRHPNLVELIG--------CCVQGTRRILVYEYVENNSLDRVLLGATKANIK 142
            EI  L  + H  ++ LI         C V    +  ++ YV+ +               
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG-------------P 181

Query: 143 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPD 201
           L  E+   I   + + LA+LH      I+HRD+K  NI LD+  N  +GDFG A KL   
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 243
             T      +GT    +PE +       K D++S G+++ E+
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 9/85 (10%)

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFG-LAKLFPDNITHITTRIA-GTTGYLAPEYVLG-- 224
             VHRDIK  N+LLD+  + ++ DFG   +L  D    + + +A GT  Y++PE +    
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAME 179

Query: 225 ---GQLTMKADVYSFGVLVLEIISG 246
              G+   + D +S GV + E++ G
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 60/245 (24%), Positives = 100/245 (40%), Gaps = 49/245 (20%)

Query: 120 VYEYVENNSL---DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 176
           +Y ++ + +    DR LL  T+A +K            +   + ++H++    ++HRDIK
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTRAIMK-----------QLLCAVEYIHDKK---LIHRDIK 294

Query: 177 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 236
             NI L+ +    +GDFG A  F            GT    +PE + G       D++S 
Sbjct: 295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354

Query: 237 GVLVLEIIS------GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI 290
           G+++L+++S      G   GK   G+          QL +    L + D E  + PP ++
Sbjct: 355 GLILLDMLSHDFCPIGDGGGKP--GK----------QLLKIIDSLSVCDEEFPD-PPCKL 401

Query: 291 IRYMKVAFFCTQAAASRRPQMNQ----------VIKMLTKNIRL--NEEELTAPGLFQDS 338
             Y+  A     A  S  P +            ++KMLT +  L     EL A  LF   
Sbjct: 402 FDYIDSAEI-DHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460

Query: 339 ESSSV 343
           E   +
Sbjct: 461 EEEEI 465

Length = 501

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 42/216 (19%)

Query: 54  IGRGGFGTVYKGTL-----------TNGRRIAV--KPLSAESKQGVREFITEIMTLSNVR 100
           +GRG    +Y G L           +  + I V  K L    +     F      +  V 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           H ++V L G CV+    I+V E+VE   LD  L    K+++ L    +  +   +A  L+
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDV-LTTPWKFKVAKQLASALS 119

Query: 161 FLHEELVPHIVHRDIKASNILL-----DQEFNP--KIGDFGLAKLFPDNITHIT-----T 208
           +L ++    +VH ++   NILL     D E  P  K+ D G+       IT ++      
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP------ITVLSRQECVE 170

Query: 209 RIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEI 243
           RI     ++APE V   + L++ AD +SFG  + EI
Sbjct: 171 RIP----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 27/74 (36%), Positives = 40/74 (54%), Gaps = 1/74 (1%)

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVLGGQLT 228
           I+HRDIK  N+L++   +  +GDFG A     +  T     IAGT    APE + G   T
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340

Query: 229 MKADVYSFGVLVLE 242
              D++S G+++ E
Sbjct: 341 PSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 55/216 (25%), Positives = 83/216 (38%), Gaps = 37/216 (17%)

Query: 54  IGRGGFGTVY----KGTLTNGRRIAVKPLSAESKQGVREF-----------ITEIMTLSN 98
           IG GGFG VY            +   K  + E++  V E            I     + N
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79

Query: 99  VRHPNLVELIGC-----CVQGTRRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDIC 152
           + H  + +  GC     C    R IL+ + VEN   + + +    K  IK       +I 
Sbjct: 80  IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK-------NIM 132

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA- 211
             +   L ++HE     I H DIK  NI++D      I D+G+A  F  +  HI      
Sbjct: 133 KDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189

Query: 212 -----GTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 242
                GT  Y   +   G  +T + D+ S G  +L+
Sbjct: 190 KDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 31/113 (27%), Positives = 44/113 (38%), Gaps = 37/113 (32%)

Query: 171 VHRDIKASNILLDQEFNPKIGDFGLAKLF----------------PDNITHITT------ 208
           +HRDIK  N+LLD + + K+ DFGL                    P N     +      
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 209 ---------RIA------GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
                    R A      GT  Y+APE  L      + D +S GV++ E++ G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 30/119 (25%), Positives = 47/119 (39%), Gaps = 42/119 (35%)

Query: 171 VHRDIKASNILLDQEFNPKIGDFGLAKLF----------------------PDNITHITT 208
           +HRDIK  NIL+D++ + K+ DFGL   F                       +  + I  
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 209 R--------------------IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
                                + GT  Y+APE +L    T   D +S GV++ E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 13/147 (8%)

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           +PN ++L          +L+ +Y+++  L  +L    K   KL+  +   I   + + L 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEALN 123

Query: 161 FLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
            LH+    +I+H DIK  N+L D+ +    + D+GL K     I    +   GT  Y +P
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSP 175

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISG 246
           E + G    +  D ++ GVL  E+++G
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 14/24 (58%), Positives = 16/24 (66%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN 69
           DDF L  K+G G FG VYK +L N
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVN 155

Length = 566

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 28/86 (32%), Positives = 44/86 (51%), Gaps = 8/86 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTL------TNGRRIAVKPLSAESKQGVRE-FITEIMTLSN 98
           D+      +G G FG V + T        N  R+AVK L A +    RE  ++E+  LS+
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 99  V-RHPNLVELIGCCVQGTRRILVYEY 123
           + +H N+V L+G C  G   +++ EY
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEY 123

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 30/110 (27%), Positives = 44/110 (40%), Gaps = 34/110 (30%)

Query: 171 VHRDIKASNILLDQEFNPKIGDFGLA--------KLFPDNITH----------------- 205
           +HRDIK  N+LLD + + K+ DFGL           F  N+TH                 
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 206 ---------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
                    +     GT  Y+APE  +        D +S GV++ E++ G
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 32/123 (26%), Positives = 48/123 (39%), Gaps = 46/123 (37%)

Query: 171 VHRDIKASNILLDQEFNPKIGDFGLAKLFP------------------------------ 200
           +HRDIK  NIL+D++ + K+ DFGL   F                               
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 201 ----DNITHITTRIA------------GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
               D +  +  R A            GT  Y+APE +L    T   D +S GV++ E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 245 SGR 247
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 24/111 (21%)

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNP-------------KIGDFGLA 196
            G+A  L + H EL  H++H D+K  NIL+   D   +P             +I D G  
Sbjct: 240 TGVA--LDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC 295

Query: 197 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
                +  H  T I  T  Y +PE VLG       D++S G ++ E+ +G+
Sbjct: 296 C----DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 28/110 (25%), Positives = 43/110 (39%), Gaps = 34/110 (30%)

Query: 171 VHRDIKASNILLDQEFNPKIGDFGL----------------------------------A 196
           +HRDIK  N+LLD + + K+ DFGL                                  A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 197 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           + +  N   +     GT  Y+APE  +        D +S GV++ E++ G
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 30/123 (24%), Positives = 49/123 (39%), Gaps = 46/123 (37%)

Query: 171 VHRDIKASNILLDQEFNPKIGDFGLAKLFP-------------------------DNITH 205
           +HRDIK  NIL+D + + K+ DFGL   F                          D++++
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 206 ---------------------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
                                +   + GT  Y+APE +L    T   D +S GV++ E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 245 SGR 247
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	370
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
smart00090	237	RIO RIO-like kinase.	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
KOG1243	690	consensus Protein kinase [General function predict	99.51
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.47
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.44
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.38
KOG3087	229	consensus Serine/threonine protein kinase [General	99.34
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.33
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.15
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.14
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.08
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.07
COG4248	637	Uncharacterized protein with protein kinase and he	99.07
PRK09902	216	hypothetical protein; Provisional	98.97
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.97
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.84
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.8
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.76
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.74
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.71
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.62
PF01636	239	APH: Phosphotransferase enzyme family This family	98.57
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.43
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.37
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.31
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.28
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.26
PLN02876	822	acyl-CoA dehydrogenase	98.22
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.2
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.13
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.12
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.1
PRK05231	319	homoserine kinase; Provisional	98.08
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.03
PRK10593	297	hypothetical protein; Provisional	98.03
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.89
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.87
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.86
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.72
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.71
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.64
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.59
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.57
KOG2270	520	consensus Serine/threonine protein kinase involved	97.47
PLN02236	344	choline kinase	97.44
PLN02756	418	S-methyl-5-thioribose kinase	97.3
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.28
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.11
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	97.06
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.94
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.9
PRK11768	325	serine/threonine protein kinase; Provisional	96.85
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.83
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.73
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.73
COG2334	331	Putative homoserine kinase type II (protein kinase	96.53
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.46
PRK12396	409	5-methylribose kinase; Reviewed	96.28
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.28
PRK06148	1013	hypothetical protein; Provisional	96.24
PTZ00384	383	choline kinase; Provisional	96.13
PTZ00296	442	choline kinase; Provisional	95.64
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.29

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-54  Score=395.86  Aligned_cols=289  Identities=51%  Similarity=0.842  Sum_probs=253.5

Q ss_pred             cccccCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEE
Q 017503           32 NVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC  111 (370)
Q Consensus        32 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  111 (370)
                      ..+.|++++++.|+++|.-...||+|+||.||+|...++..||||.+.........+|.+|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            67889999999999999999999999999999999998899999987765443145699999999999999999999999


Q ss_pred             EeCC-eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEE
Q 017503          112 VQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI  190 (370)
Q Consensus       112 ~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL  190 (370)
                      .+.+ ..+||+||+.+|+|+++++.....  .++|..+++|+.++|.||+|||+...+.|+||||||+|||||++.++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9998 599999999999999999653333  7899999999999999999999998778999999999999999999999


Q ss_pred             eeecCccccCC-CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH
Q 017503          191 GDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       191 ~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      +|||++...+. ........ .||.+|+|||++..+..+.++||||||++|.||+||+.+.+.........+..|++...
T Consensus       219 sDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             cCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999976554 22211111 79999999999999999999999999999999999998877655444555889998889


Q ss_pred             hcCCCcccccCCCC--CCCh-HHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          270 QEEKPLELVDPELG--EYPP-NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       270 ~~~~~~~~~~~~~~--~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      .+....+++|+.+.  .... .++.++..++.+|++.+|.+||+|.+|++.|+.+..
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            88899999999984  4444 688889999999999999999999999999966554

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-50  Score=350.00  Aligned_cols=252  Identities=26%  Similarity=0.432  Sum_probs=209.1

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-eeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-RRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e  122 (370)
                      .+.+..+.||+|..|+||+++++ +++.+|+|.+... +....+++.+|+++++..+|||||.++|.|.... ...++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            35667889999999999999987 6778999999655 4556678999999999999999999999999988 4999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||++|+|+.++.    ....+++....+++.+++.||.|||+ .   +||||||||+||||+..|.+||||||.+..+.+
T Consensus       159 YMDgGSLd~~~k----~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  159 YMDGGSLDDILK----RVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             hcCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            999999999983    34679999999999999999999996 6   999999999999999999999999999987654


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .   ......||..|||||.+.+..|+.++||||||++++|+.+|+.|+....... ....+...         .+.+..
T Consensus       232 S---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~Ll~---------~Iv~~p  298 (364)
T KOG0581|consen  232 S---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFELLC---------AIVDEP  298 (364)
T ss_pred             h---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHHHHH---------HHhcCC
Confidence            3   4456789999999999999999999999999999999999999987651111 11111111         112222


Q ss_pred             CCCCChH-HHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          282 LGEYPPN-EIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       282 ~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .+..|.. +..++..++..||++||.+||++.+++..
T Consensus       299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            2233333 55668999999999999999999999763

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=357.82  Aligned_cols=261  Identities=31%  Similarity=0.460  Sum_probs=213.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-eeEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQGT-RRILVY  121 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~  121 (370)
                      ..+..+.+.||.|+||+||+|.+.....||+|++.....  ...+.|.+|+.+|.+++|||||+++|++.+.. ..++||
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            344555667999999999999998544499999886532  22568999999999999999999999999988 789999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEeecCCCCceEeCCCC-CeEEeeecCcccc
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH-IVHRDIKASNILLDQEF-NPKIGDFGLAKLF  199 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~-iiH~dlkp~Nill~~~~-~~kL~Dfg~~~~~  199 (370)
                      ||+++|+|.+++...  .+..+++..+++|+.+|+.||.|||+.   + ||||||||+|||++.++ ++||+|||+++..
T Consensus       120 Ey~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             EeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            999999999999543  467899999999999999999999999   7 99999999999999997 9999999999876


Q ss_pred             CCCCcceeecccCCCCCCCccccc--CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVL--GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      .... ...+...||+.|||||++.  ...++.++||||||+++|||+||..||.....      .+.+..+......   
T Consensus       195 ~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~R---  264 (362)
T KOG0192|consen  195 VISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLR---  264 (362)
T ss_pred             cccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCC---
Confidence            5432 2233367999999999999  56999999999999999999999999886644      1112222222221   


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                           ...+..+...+..++.+||+.||.+||++.+|+..|+.+....
T Consensus       265 -----p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  265 -----PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             -----CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence                 1222335555778888899999999999999999999887633

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=343.09  Aligned_cols=250  Identities=28%  Similarity=0.479  Sum_probs=203.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ..++|.+.+.||+|.|++||+|+++ ++..||||.+...  .....+.+..|+.+|+.++|||||.+++++...+..|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            3578999999999999999999986 5789999998876  667778889999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC------CCeEEeeec
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE------FNPKIGDFG  194 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~------~~~kL~Dfg  194 (370)
                      ||||+||+|.+|+    .....+++..+..++.||+.||++||++   +||||||||+||||+..      -.+||+|||
T Consensus        88 MEyC~gGDLs~yi----~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   88 MEYCNGGDLSDYI----RRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEeCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            9999999999999    3445799999999999999999999999   99999999999999764      458999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      +++.+...  ......+|++-|||||++..+.|+.|+|+||+|++||+|++|+.||+.....   ++..+..+   ..  
T Consensus       161 fAR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~---eL~~~~~k---~~--  230 (429)
T KOG0595|consen  161 FARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK---ELLLYIKK---GN--  230 (429)
T ss_pred             hhhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHHhc---cc--
Confidence            99988643  3445678999999999999999999999999999999999999998754321   11111110   00  


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHH
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  315 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  315 (370)
                       ++    ....+......+++++...++.+|++|.++.+-.
T Consensus       231 -~~----~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  231 -EI----VPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             -cc----cCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence             01    1111122222345666667778888887766543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-48  Score=356.59  Aligned_cols=248  Identities=25%  Similarity=0.392  Sum_probs=211.1

Q ss_pred             cCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .+|...+.||+|||+.+|.+++ ..|..||+|++...   .....+.+.+||++.+.|+|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999998 78999999998763   3455678889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      |+|..++|..++    +....+++.++..+++||+.||.|||+.   +|+|||||-.|++++++.++||+|||||.....
T Consensus        98 ELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999999998    4566899999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      +. ....+.+||+.|.|||++.....+..+||||+|||+|-||.|++||+...-   +.....+.          .-+- 
T Consensus       171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v---kety~~Ik----------~~~Y-  235 (592)
T KOG0575|consen  171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV---KETYNKIK----------LNEY-  235 (592)
T ss_pred             cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH---HHHHHHHH----------hcCc-
Confidence            43 224457899999999999999999999999999999999999999975421   11111111          0011 


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                        ..|.....+..+||..+|+.+|.+|||+.+|+..
T Consensus       236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              1223444557889999999999999999999863

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-50  Score=336.40  Aligned_cols=258  Identities=23%  Similarity=0.408  Sum_probs=212.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeee-EEEeCCe-eEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIG-CCVQGTR-RIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~-~~l  119 (370)
                      ..+|++.++||.|.||.||++.. .+|..+|.|.+...  +.+..+....|+.+|++|+|||||++++ .+.+... ++|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            45799999999999999999996 47899999988754  5566778899999999999999999999 4555544 899


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP-HIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~-~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      |||+|+.|+|.+.+....+.+..++++.+|+++.|++.||..+|.+.+. -|+||||||.||+|+.+|.+||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999988888888999999999999999999999995432 389999999999999999999999999998


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      +.... .......||+.||+||.+....|+.++||||+||++|||+.-++||...      .+.....+         +.
T Consensus       178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~K---------I~  241 (375)
T KOG0591|consen  178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKK---------IE  241 (375)
T ss_pred             hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHH---------HH
Confidence            87643 3345578999999999999999999999999999999999999998654      12221111         11


Q ss_pred             cCCCCCCC-hHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          279 DPELGEYP-PNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       279 ~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      +...+..| ......+..+|..|+..||+.||+.-.++..+
T Consensus       242 qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  242 QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            22233344 45556688899999999999999854444433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-48  Score=343.59  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=206.6

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-------hhcHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-------KQGVREFITEIMTLSNVRHPNLVELIGCCVQ  113 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  113 (370)
                      +...+.|.+.+.||+|+||.|-+|..+ +++.||||+++...       ........+|+++|++|+|||||++.+++..
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            334577889999999999999999975 79999999987541       1123346789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC---CCeEE
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKI  190 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kL  190 (370)
                      .+..|+||||++||.|.+.+.    .+..+.+..-..+++|++.|+.|||++   ||+||||||+|||+..+   ..+||
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             CCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEe
Confidence            999999999999999999884    344566666778999999999999999   99999999999999766   67999


Q ss_pred             eeecCccccCCCCcceeecccCCCCCCCcccccCCCc---CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 017503          191 GDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL---TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       191 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      +|||++....  ....+.+.+||+.|.|||++.+..+   ..+.|+||+||+||-+|+|.+||........  +.+.+  
T Consensus       321 tDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~eQI--  394 (475)
T KOG0615|consen  321 TDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKEQI--  394 (475)
T ss_pred             cccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHHHH--
Confidence            9999999775  3455677899999999999987643   3578999999999999999999986655331  11111  


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                        .....  .+.   +........+..++|.+||..||++|||+.|++..-
T Consensus       395 --~~G~y--~f~---p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  395 --LKGRY--AFG---PLQWDRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             --hcCcc--ccc---ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence              11111  000   122345566788999999999999999999997654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=350.07  Aligned_cols=259  Identities=29%  Similarity=0.441  Sum_probs=212.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .+.+++++.||+|.||.||.|.++....||+|.++... -....|.+|+.+|++|+|+|||+++++|..+..++|||||+
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            44566789999999999999999988899999887653 23467889999999999999999999999988999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ..|+|.+++..  ..+..++..+.+.++.|||+|++||+++   ++|||||...||||+++..+||+|||+++...++..
T Consensus       284 ~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  284 PKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             ccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            99999999953  3566789999999999999999999999   999999999999999999999999999996666555


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .......-...|.|||.+..+.++.++|||||||+||||+| |+.|+.....   ..++..    ...+-.        -
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---~ev~~~----le~GyR--------l  423 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---EEVLEL----LERGYR--------L  423 (468)
T ss_pred             eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---HHHHHH----HhccCc--------C
Confidence            55444455678999999999999999999999999999999 5666554422   222221    111111        1


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      ..|..++..+.+++..||+.+|++||||..+...|++....
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            23344555566666779999999999999999999887653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=329.46  Aligned_cols=243  Identities=28%  Similarity=0.385  Sum_probs=202.0

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..++|++.++||+|+||+||.++.+ .++-||+|+++..   ..........|..+|.+++||.||+++..|.+...+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3689999999999999999999976 5788999988765   33456778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      |+||+.||.|...+    +....+++..+.-++.+|+.||.|||++   +|+||||||+||||+.+|+++|+|||++...
T Consensus       103 Vld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  103 VLDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            99999999999998    5667899999999999999999999999   9999999999999999999999999999855


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      .... ..+...+||+.|||||++....|+.++|+||||+++|||++|.+||.....   ....+   .... .+      
T Consensus       176 ~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---~~~~~---~I~~-~k------  241 (357)
T KOG0598|consen  176 LKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---KKMYD---KILK-GK------  241 (357)
T ss_pred             ccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---HHHHH---HHhc-Cc------
Confidence            4332 223447899999999999999999999999999999999999999865421   11111   1111 11      


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCC
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRP  309 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  309 (370)
                        +...+.-...+..+++.+.+..+|++|.
T Consensus       242 --~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 --LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             --CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence              1111222333477888889999999995

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.9e-45  Score=313.30  Aligned_cols=263  Identities=24%  Similarity=0.343  Sum_probs=205.1

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      +.|+...++|+|+||.||+.+++ +|+-||||.+....  +...+-.++|+++|++++|+|+|.++.+|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            56888999999999999999987 58999999987653  3444457899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      ||+..-|+.+-    .....++.+.+..+++|++.|+.|+|++   ++|||||||+||||+.+|.+||||||+++.+...
T Consensus        82 ~~dhTvL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDHTVLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecchHHHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            99986666654    4455688999999999999999999999   9999999999999999999999999999987642


Q ss_pred             CcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHH--------HHHHHhcCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW--------AWQLHQEEK  273 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~  273 (370)
                       +...+...-|.+|.|||.+.+ -+|+...|||++||++.||++|.+-|....+-++-.....        ..+.+....
T Consensus       155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence             223344567899999998877 6899999999999999999999986654433222221111        112222222


Q ss_pred             Ccccc------cCC-CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 PLELV------DPE-LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 ~~~~~------~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .+..+      ++. +..-.+....-+++++..|++.||.+|++-++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            11111      111 11122334445789999999999999999888863

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=319.31  Aligned_cols=264  Identities=23%  Similarity=0.347  Sum_probs=212.1

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChh-cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ....++|++...||.|..+.||+|+.. .+..||||++.-+... ....+.+|+..|+.++||||++++-+|..+..+|+
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            345789999999999999999999964 6799999999876432 35889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||+|+.+|++.+++......+  +++..+..|++++++||.|||.+   |.||||||+.||||+.+|.|||+|||.+..+
T Consensus       102 VmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             eehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeee
Confidence            999999999999996554444  89999999999999999999999   9999999999999999999999999998766


Q ss_pred             CCCCcce--e-ecccCCCCCCCcccccC--CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          200 PDNITHI--T-TRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       200 ~~~~~~~--~-~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      .+.....  . ....||++|||||++..  ..|+.|+||||||++..||.+|+.||..+.+      .+.....+++..+
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn~pp  250 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQNDPP  250 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCCCC
Confidence            4432211  1 44579999999998644  4689999999999999999999999976543      2222233333332


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .-.....-.+........+.+++..||+.||.+|||+.++++
T Consensus       251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111000001122233446788888899999999999999984

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=322.72  Aligned_cols=258  Identities=28%  Similarity=0.437  Sum_probs=205.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC-CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC--eeEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT--RRILVY  121 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~  121 (370)
                      ..+|...+.||+|.||.||++.+.+ |...|+|.+...+....+.+.+|+.+|.+++|||||+++|......  ..++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            5668889999999999999999864 8899999887664433677889999999999999999999754444  688999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-CCCeEEeeecCccccC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFP  200 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kL~Dfg~~~~~~  200 (370)
                      ||+.+|+|.+++..   .+..+++..+..++.||++||+|||++   +|+|+||||+|||++. ++.+||+|||++....
T Consensus        96 Ey~~~GsL~~~~~~---~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKR---YGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            99999999999942   222799999999999999999999999   9999999999999999 7999999999998765


Q ss_pred             C--CCcceeecccCCCCCCCcccccCCC-cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          201 D--NITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       201 ~--~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      .  ..........||+.|||||++.++. ...++|||||||++.||+||++||......     ..+........     
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~-----~~~~~~ig~~~-----  239 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE-----AEALLLIGRED-----  239 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch-----HHHHHHHhccC-----
Confidence            3  2222344577999999999998643 346999999999999999999998764111     11111111111     


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                         ..+..+........+++.+|+..+|.+|||+.++++..-..
T Consensus       240 ---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  240 ---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence               11233444555688889999999999999999998865443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.3e-45  Score=350.08  Aligned_cols=262  Identities=27%  Similarity=0.482  Sum_probs=217.2

Q ss_pred             cCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcChh-cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .+.+..+.||+|.||+||+|+..      +.+.||||.++..... ...+|++|++.+..|+|||||+++|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            44556789999999999999853      3567999999887554 7789999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccccc------CCc----cCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCe
Q 017503          119 LVYEYVENNSLDRVLLGATK------ANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP  188 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~------~~~----~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~  188 (370)
                      +|+||+..|+|.+|+.....      .+.    .|+..+.+.|+.|||.|+.||-++   .++||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence            99999999999999953321      222    388999999999999999999999   99999999999999999999


Q ss_pred             EEeeecCccccCC-CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 017503          189 KIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAW  266 (370)
Q Consensus       189 kL~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  266 (370)
                      ||+|||+++.... +..+......-..+|||||.+..++++.++|||||||+|||+++ |+.|+....   ++++++.+ 
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS---n~EVIe~i-  718 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS---NQEVIECI-  718 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc---hHHHHHHH-
Confidence            9999999985433 33333323445679999999999999999999999999999998 677765543   33333322 


Q ss_pred             HHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                         ++        ..+.+.|.+++.++..|+..||+.+|++||+++||-..|+......
T Consensus       719 ---~~--------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  719 ---RA--------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             ---Hc--------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence               22        2234567778888999999999999999999999999999887644

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-45  Score=331.52  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=208.1

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCe
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTR  116 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  116 (370)
                      +....+|.+.+.||.|.|++|++|+.+ .++.||||++...-   ..-...+..|-.+|.+| +||.|++++..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            556789999999999999999999965 68999999886541   12233456788889999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      +|+|+||+++|.|-++|    .+...+++..+..++.+|+.||+|||++   |||||||||+||||+.+++++|+|||.+
T Consensus       149 LYFvLe~A~nGdll~~i----~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLI----KKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHH----HHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            99999999999999999    4556899999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc----------ee--ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHH
Q 017503          197 KLFPDNITH----------IT--TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW  264 (370)
Q Consensus       197 ~~~~~~~~~----------~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~  264 (370)
                      ..+......          ..  ...+||..|.+||++..+..+..+|||+|||+||+|+.|.+||...-    ..+ . 
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N----eyl-i-  295 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN----EYL-I-  295 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc----HHH-H-
Confidence            987542111          11  34789999999999999999999999999999999999999987542    111 0 


Q ss_pred             HHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          265 AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                       .+.+.     . ++   -.+++..+..+.+|+.+.|..||.+|+|.++|-+.
T Consensus       296 -FqkI~-----~-l~---y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  296 -FQKIQ-----A-LD---YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -HHHHH-----H-hc---ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence             11110     0 11   12334444568889999999999999999988653

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.5e-44  Score=330.49  Aligned_cols=263  Identities=25%  Similarity=0.404  Sum_probs=205.2

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeC-
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQG-  114 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-  114 (370)
                      ..++|++.+.||+|+||.||+|.+.      .+..||+|++.... ......+.+|+.+++.+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            4578999999999999999999742      34679999887543 23346788999999999 899999999988764 


Q ss_pred             CeeEEEEEecCCCCHHHHhccccc--------------------------------------------------------
Q 017503          115 TRRILVYEYVENNSLDRVLLGATK--------------------------------------------------------  138 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~--------------------------------------------------------  138 (370)
                      ...++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            457899999999999999854221                                                        


Q ss_pred             --CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc-eeecccCCCC
Q 017503          139 --ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTG  215 (370)
Q Consensus       139 --~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~  215 (370)
                        ....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++......... ......++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence              023478889999999999999999999   9999999999999999999999999999865332211 1122345678


Q ss_pred             CCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHH
Q 017503          216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM  294 (370)
Q Consensus       216 y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  294 (370)
                      |+|||++.+..++.++|||||||++|||++ |..||......  ..+.    ........        ...+......+.
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~----~~~~~~~~--------~~~~~~~~~~l~  307 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFC----QRLKDGTR--------MRAPENATPEIY  307 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHH----HHHhcCCC--------CCCCCCCCHHHH
Confidence            999999999999999999999999999997 99998653221  1111    11111111        111223344588


Q ss_pred             HHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          295 KVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       295 ~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      +++.+||+.+|.+|||+.+|++.|+.++.
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-44  Score=326.45  Aligned_cols=262  Identities=25%  Similarity=0.351  Sum_probs=206.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--CeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l  119 (370)
                      .+.|+.+++||+|.||.||+|++. +|..||+|.+..+.  .....-..+||.+|++|+||||+++.+...+.  ..+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            456889999999999999999964 68899999887764  44455677899999999999999999998876  68999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      |+|||+. +|.-++.   ..+..+++.++..++.||+.||+|+|.+   +|+|||||.+|||||.+|.+||+||||++++
T Consensus       196 VFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            9999987 6766662   4567899999999999999999999999   9999999999999999999999999999988


Q ss_pred             CCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc-------
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE-------  271 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------  271 (370)
                      ........+..+.|++|.|||.+.+. .|+.+.|+||.||||.||++|++.+.....-++-   ..+.+..-.       
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl---~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL---HKIFKLCGSPTEDYWP  345 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH---HHHHHHhCCCChhccc
Confidence            77666656667789999999988775 7999999999999999999999877654332221   111111110       


Q ss_pred             ---CCCcccccCC------CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          272 ---EKPLELVDPE------LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       272 ---~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                         -.....+.+.      +.+.........++|+..+|..||.+|.|+.+++.
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence               0000111111      11111122334678888899999999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-44  Score=328.29  Aligned_cols=251  Identities=25%  Similarity=0.432  Sum_probs=211.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ...|....+||+|+.|.||.++.. +++.||||++........+.+.+|+.+|+..+|+|||++++.+...+.+|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            346888899999999999999964 6888999998776555567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++|+|.+.+.     ...+++.++..|+++++.||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+....
T Consensus       352 m~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  352 MEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             cCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            99999999983     33489999999999999999999999   99999999999999999999999999999776554


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      . ......||+.|||||++....|+.+.||||||+|++||+.|.+||-...      .+...+....+..+..       
T Consensus       424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~------PlrAlyLIa~ng~P~l-------  489 (550)
T KOG0578|consen  424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN------PLRALYLIATNGTPKL-------  489 (550)
T ss_pred             C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC------hHHHHHHHhhcCCCCc-------
Confidence            3 3445679999999999999999999999999999999999999986422      1222333333333221       


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..+......+.+++.+||+.|+.+||++.|+|+.
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            2233444558889999999999999999999874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=325.68  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=206.8

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc----Ch-hcHHHHHHHHHHHHhcC-CCCcceeeeEEEeC
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE----SK-QGVREFITEIMTLSNVR-HPNLVELIGCCVQG  114 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~  114 (370)
                      ....++|.+.+.||+|+||+|+.|.+. ++..||+|++...    .. .....+.+|+.+++.++ ||||++++.++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            345689999999999999999999865 6899999977654    12 23456678999999998 99999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC-CCeEEeee
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDF  193 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kL~Df  193 (370)
                      ...++||||+.+|.|.+++.    ...++.+..+..+++|++.|++|+|+.   +|+||||||+|||++.+ +++||+||
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             CeEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecc
Confidence            99999999999999999993    356788999999999999999999999   99999999999999999 99999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCC-cC-ccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LT-MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      |++.... .........+|++.|+|||++.+.. |+ .++||||+|++||-|++|..||+...   ...+..   . ...
T Consensus       166 G~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---~~~l~~---k-i~~  237 (370)
T KOG0583|consen  166 GLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---VPNLYR---K-IRK  237 (370)
T ss_pred             ccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---HHHHHH---H-Hhc
Confidence            9999874 2223455678999999999999877 75 89999999999999999999998721   111111   1 111


Q ss_pred             CCCcccccCCCCCCChHH-HHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          272 EKPLELVDPELGEYPPNE-IIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..         -.++... ..++..++.+|+..+|.+|+++.+|+.
T Consensus       238 ~~---------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  238 GE---------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             CC---------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            10         0111222 556889999999999999999999983

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=299.30  Aligned_cols=269  Identities=22%  Similarity=0.279  Sum_probs=218.7

Q ss_pred             HHHHhccCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC---
Q 017503           40 ELRSATDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT---  115 (370)
Q Consensus        40 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---  115 (370)
                      ++..+.++|++.+.||+|||+.||.++. .++..||+|.+.....+..+..++|++..++++|||+++++++...+.   
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            3445678999999999999999999994 468899999999888777889999999999999999999998876433   


Q ss_pred             --eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          116 --RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       116 --~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                        ..|++++|...|+|.+.+.....++..+++.+++.|+.++++||++||+..+ +++||||||.||++.+++.++|.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEec
Confidence              4899999999999999997777777789999999999999999999999833 4999999999999999999999999


Q ss_pred             cCccccCCCCcce--------eecccCCCCCCCccccc---CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHH
Q 017503          194 GLAKLFPDNITHI--------TTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL  262 (370)
Q Consensus       194 g~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~  262 (370)
                      |.+....-.....        -....+|..|.|||.+.   +...++++|||||||+||.|+.|..||+..+.+.+.   
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS---  250 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS---  250 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe---
Confidence            9998654321111        11235789999999885   456789999999999999999999999765442221   


Q ss_pred             HHHHHHHhcCCCcccccCCC-CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          263 EWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                                ....+.+..+ ..........+.+++.+|++.||.+||++.+++..+..++
T Consensus       251 ----------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  251 ----------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                      1122223222 1112225666889999999999999999999999887754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-44  Score=303.86  Aligned_cols=237  Identities=27%  Similarity=0.338  Sum_probs=203.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||.|+||.|.+++.+ +|..||+|++....   -.+.++..+|..+|+.+.||.++++++.+.+.+.+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            568999999999999999999976 68889999987663   35567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||++||-|..++    +...++++..+.-++.||+.||+|||+.   +|++|||||+|||+|.+|.+||+|||++....
T Consensus       123 meyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  123 MEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            9999999999999    5666899999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ..    +...+||+.|+|||.+....+..++|.|+|||++|||+.|.+||.....   ....    +.+-+        .
T Consensus       196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY----~KI~~--------~  256 (355)
T KOG0616|consen  196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIY----EKILE--------G  256 (355)
T ss_pred             Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHH----HHHHh--------C
Confidence            43    5668899999999999999999999999999999999999999875432   1111    11111        1


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCC
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRR  308 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~R  308 (370)
                      . -.+|+-....+.+|+...++.|-.+|
T Consensus       257 ~-v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  257 K-VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             c-ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            1 13344445558888888999999888

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.2e-43  Score=294.08  Aligned_cols=262  Identities=27%  Similarity=0.405  Sum_probs=206.9

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++|...+.||+|.||.||+|++. +|+.||||.++..+.  .......+|+..|+.++|+||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            57889999999999999999974 799999998876532  234467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |++. +|+..+.   .....++..++..++.+++.||+|+|.+   .|+||||||.|+|++.+|.+||+|||+++.+...
T Consensus        82 fm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9976 8999983   4566789999999999999999999999   9999999999999999999999999999988765


Q ss_pred             CcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc-----
Q 017503          203 ITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE-----  276 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  276 (370)
                      ....... .-|.+|.|||.+.+ ..|+...||||.||++.||+-|.+-|... .+.++  +..+...+.-.....     
T Consensus       155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-sDidQ--L~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-SDIDQ--LSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-chHHH--HHHHHHHcCCCCcccCcccc
Confidence            4443333 56899999998766 57999999999999999999987643322 22222  111221111111100     


Q ss_pred             ----------cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          277 ----------LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       277 ----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                                ...+.+....+.+.....+++.+|+..||.+|+++.+.++.=
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~  282 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP  282 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence                      011122234455666679999999999999999999997753

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=322.27  Aligned_cols=264  Identities=22%  Similarity=0.293  Sum_probs=206.4

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcH-HHHHHHHHHHHhcC-CCCcceeeeEEEeCC-eeE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGV-REFITEIMTLSNVR-HPNLVELIGCCVQGT-RRI  118 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~  118 (370)
                      ..-++|.++++||.|.||.||+|+.+ .+..||||..+..-.... ..=++|+..|++|+ ||||+++.+++.+.+ .++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            34689999999999999999999965 688899998776532221 12357999999998 999999999999988 999


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +|||||+. +|.+++.+   .+..+++..+..|+.||+.||+|+|.+   |++|||+||+|||+..+..+||+|||+++.
T Consensus        87 fVfE~Md~-NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeHHhhhh-hHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence            99999966 89999853   367899999999999999999999999   999999999999999999999999999997


Q ss_pred             cCCCCcceeecccCCCCCCCcccc-cCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC-----
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYV-LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE-----  272 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  272 (370)
                      .....+  .+..+.|.+|+|||++ +.+.|+.+.|||++||+++|+.+-++-|.....-++-   ..+-+++...     
T Consensus       160 v~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi---~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  160 VRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI---YKICEVLGTPDKDSW  234 (538)
T ss_pred             cccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH---HHHHHHhCCCccccc
Confidence            655433  3445689999999976 5678999999999999999999987755433221111   1111111100     


Q ss_pred             ------------CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          273 ------------KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       273 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                                  ..-......+..+.+....+.++++.+|+.+||.+|||+.+.++.-
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence                        0001111122344456778899999999999999999999998743

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-43  Score=323.95  Aligned_cols=246  Identities=27%  Similarity=0.443  Sum_probs=211.5

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++|.+.+.||+|.||.||+|+-+ +.+.||+|.+...  .++..+.+.+|+++++.++||||+.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57999999999999999999965 5788999988754  45567889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.| +|..++    .+...++++.+..++.+++.||.|||++   +|+|||+||.|||+..++.+|+||||+++.+..+
T Consensus        82 ~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   82 YAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            9987 999998    5677899999999999999999999999   9999999999999999999999999999987653


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                       +..-+...||+.|||||...+++|+..+|+||+||++|||++|++||...      .+.+.+.....        |+  
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~--------d~--  216 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILK--------DP--  216 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhc--------CC--
Confidence             34455678999999999999999999999999999999999999998532      12222222111        11  


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...+......+..++...+..||.+|.+..+++.
T Consensus       217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1334466667889999999999999999999875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.3e-42  Score=315.88  Aligned_cols=264  Identities=25%  Similarity=0.416  Sum_probs=202.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC-----------------CCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcce
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN-----------------GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVE  106 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~  106 (370)
                      .++|++.+.||+|+||.||++.+.+                 +..||+|.+.... ......+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4689999999999999999997532                 3369999887653 334567889999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCCHHHHhccccc---------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 017503          107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATK---------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV  171 (370)
Q Consensus       107 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ii  171 (370)
                      +++++.+.+..++||||+.+++|.+++.....               ....+++..++.++.|++.||.|||+.   +++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            99999999999999999999999998843211               123478889999999999999999999   999


Q ss_pred             eecCCCCceEeCCCCCeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhC--CC
Q 017503          172 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG--RN  248 (370)
Q Consensus       172 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg--~~  248 (370)
                      ||||||+||+++.++.+||+|||++........ .......++..|+|||++..+.++.++||||||+++|+|+++  ..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986543222 112223457789999999888999999999999999999975  45


Q ss_pred             CCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          249 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ||.....   ..................     ....++.++..+.+++.+||+.+|.+|||+.+|.+.|+
T Consensus       241 p~~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTD---EQVIENAGEFFRDQGRQV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCH---HHHHHHHHHHhhhccccc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            5543321   112222222211111100     01112234456889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.9e-42  Score=311.82  Aligned_cols=263  Identities=19%  Similarity=0.306  Sum_probs=206.8

Q ss_pred             cccccccCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChh---cHHHHHHHHHHHHhcCCCCcce
Q 017503           30 LRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQ---GVREFITEIMTLSNVRHPNLVE  106 (370)
Q Consensus        30 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~  106 (370)
                      +.+++.++.+++.     ..-...+|+|+++.||+|.. +|+.||+|.+......   ..+.+.+|+.+|++++||||++
T Consensus         9 ~~~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~   82 (283)
T PHA02988          9 INDIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK   82 (283)
T ss_pred             cCcceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEE
Confidence            4455666666662     22236799999999999998 5889999998765332   2567789999999999999999


Q ss_pred             eeeEEEe----CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe
Q 017503          107 LIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL  182 (370)
Q Consensus       107 ~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill  182 (370)
                      +++++.+    ....++||||+++|+|.+++.    ....+++...+.++.+++.||.|||+..  +++||||||+||++
T Consensus        83 ~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill  156 (283)
T PHA02988         83 IYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLV  156 (283)
T ss_pred             EeeeEEecccCCCceEEEEEeCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEE
Confidence            9999877    456789999999999999984    3456889999999999999999999732  77899999999999


Q ss_pred             CCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccC--CCcCccccchhhhHHHHHHHhCCCCCCcccccchhh
Q 017503          183 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF  260 (370)
Q Consensus       183 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~  260 (370)
                      +.++.+||+|||++.......    ....++..|+|||.+.+  ..++.++|||||||++|||++|..||.....   ..
T Consensus       157 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~  229 (283)
T PHA02988        157 TENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KE  229 (283)
T ss_pred             CCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HH
Confidence            999999999999988654321    23457889999999876  6899999999999999999999999875421   11


Q ss_pred             HHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          261 LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      +..   ........     +   ..+......+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       230 ~~~---~i~~~~~~-----~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        230 IYD---LIINKNNS-----L---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHH---HHHhcCCC-----C---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            111   11111111     1   112234556889999999999999999999999998764

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-42  Score=311.81  Aligned_cols=256  Identities=25%  Similarity=0.378  Sum_probs=204.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC----CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.+.... ......+.+|+..+++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            467899999999999999999863    35689999887653 3334578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+.+++|.+++..   ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++++|||.....
T Consensus        84 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999999843   234689999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |..||.....   .....    .......    
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~----~~~~~~~----  226 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIK----AVEDGFR----  226 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHH----HHHCCCC----
Confidence            3222111122334578999999999999999999999999999875 9988864422   11111    1111111    


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                          ...+...+..+.+++..||+.+|.+||++.+|++.|.+.
T Consensus       227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                112233445688899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-42  Score=320.84  Aligned_cols=246  Identities=24%  Similarity=0.314  Sum_probs=200.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            478999999999999999999986 58899999886542   23345688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+.+++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus        97 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            99999999999883    345688999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ...    ....|++.|+|||++.+..++.++|||||||++|+|++|..||.....   ....    ........      
T Consensus       170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~----~~i~~~~~------  232 (329)
T PTZ00263        170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIY----EKILAGRL------  232 (329)
T ss_pred             CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHH----HHHhcCCc------
Confidence            322    234689999999999999999999999999999999999999864321   1111    11111110      


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCC-----HHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIKM  317 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  317 (370)
                         ..+......+.+++.+||+.||.+||+     +.+++..
T Consensus       233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               111112335788999999999999997     6777644

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=325.37  Aligned_cols=269  Identities=26%  Similarity=0.469  Sum_probs=215.8

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ  113 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  113 (370)
                      .+..++....+++.+...||+|.||+||+|+|.  ..||||+++.+  ..+..+.|++|+..+++-+|.||+-++|+|..
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            445777777888999999999999999999996  46999998876  45678899999999999999999999999998


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      ... .||+.+|+|.+|..+++.   ...++.....+.|++||+.|+.|||.+   +|||||||..||++.++++|||+||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             Cce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence            877 899999999999999964   335688999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCC-cceeecccCCCCCCCcccccC---CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH
Q 017503          194 GLAKLFPDNI-THITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       194 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      |++.....-. ........|...|||||+++.   .+|+..+||||||+++|||+||..||. ....++.     ++.+-
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqI-----ifmVG  606 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQI-----IFMVG  606 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhhe-----EEEec
Confidence            9997532211 111223457789999999864   479999999999999999999999987 2111110     11111


Q ss_pred             hcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          270 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      +     -...+.+.....++..++.+|+..||..++++||.+.+|+..|+.+++.
T Consensus       607 r-----G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  607 R-----GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             c-----cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            1     0111222233345556677788889999999999999999999888773

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=333.78  Aligned_cols=261  Identities=21%  Similarity=0.289  Sum_probs=214.2

Q ss_pred             HhccCCcccceeeecCCeEEEEEEECCC-CEEEEEECcCcChhcHHHHHHHHHHHHhcC-CCCcceeeeE-EEe------
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLTNG-RRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGC-CVQ------  113 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~------  113 (370)
                      ....+++|.+.|.+|||+.||.|....+ ..||+|++...++...+.+.+|+.+|++|. |+|||.++|. ...      
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3466789999999999999999998765 999999988888888999999999999995 9999999993 321      


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      ....+|.||||.+|.|-+++....  ...|++.++++|++++++|+.+||...+ +|||||||-+||||+.+++.|||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEcCCCCEEeCcc
Confidence            235678999999999999995433  3349999999999999999999999843 6999999999999999999999999


Q ss_pred             cCccccCCCCcce--------eecccCCCCCCCcccc---cCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHH
Q 017503          194 GLAKLFPDNITHI--------TTRIAGTTGYLAPEYV---LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL  262 (370)
Q Consensus       194 g~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~  262 (370)
                      |.+...-......        .-....|+.|+|||++   .+.+.++|+|||+|||+||-|+....||+..         
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s---------  261 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES---------  261 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC---------
Confidence            9997432221110        1113468899999976   5678999999999999999999999998643         


Q ss_pred             HHHHHHHhcCCCcccccCCCC-CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          263 EWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                                -...+++.... .-.+.....+..||..||+.+|.+||++.+|++.+.+++...
T Consensus       262 ----------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  262 ----------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ----------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                      12344444431 222577888999999999999999999999999999887644

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.5e-42  Score=312.95  Aligned_cols=264  Identities=22%  Similarity=0.299  Sum_probs=201.9

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++|++.+.||+|+||.||+++++ +++.||+|++...  .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999986 5788999988654  23334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |++++++..+.    .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            99998777654    2334688999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHH--------HHHH-hcCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA--------WQLH-QEEK  273 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~-~~~~  273 (370)
                      .........++..|+|||++.+..++.++|||||||++|+|++|++||...............        .... ....
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            322233456889999999999889999999999999999999999998654221110000000        0000 0000


Q ss_pred             CcccccCCC-------CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 PLELVDPEL-------GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 ~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ......+..       ..........+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000       0011123345889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-44  Score=317.30  Aligned_cols=248  Identities=27%  Similarity=0.433  Sum_probs=210.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ...|+....||+|.||.||+|.+. .++.||+|++.-+ .......+.+|+.+|.+++++||.++|+.+..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            456888899999999999999975 6888999999876 45567889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      ||.||++.+.+    ..+..+.+..+.-++++++.|+.|||..   +.+|||||+.|||+..+|.+||+|||.+-.+...
T Consensus        92 y~~gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   92 YCGGGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HhcCcchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence            99999999998    4555568888888999999999999999   9999999999999999999999999999877655


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC-
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE-  281 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  281 (370)
                      .... ....||+.|||||++....|+.++||||||++.+||.+|.+|+....+-                ....++... 
T Consensus       165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~  227 (467)
T KOG0201|consen  165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSA  227 (467)
T ss_pred             hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCC
Confidence            4433 5678999999999999889999999999999999999999998765441                111222211 


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .+.+.......+.+++..||..+|+.||++.++++
T Consensus       228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            12223345555888889999999999999999975

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.8e-42  Score=309.46  Aligned_cols=251  Identities=24%  Similarity=0.314  Sum_probs=199.8

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .|++.+.||+|+||.||++.+. +++.||+|.+....   ......+.+|+.++++++|+|++++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3788899999999999999974 68999999876442   2223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+|+|..++..  .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999999887742  2234588999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      .  ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........   ........         .
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~~---------~  221 (285)
T cd05631         156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKED---------Q  221 (285)
T ss_pred             C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhcc---------c
Confidence            2  12334689999999999999999999999999999999999999875433211111   11111100         0


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCC-----HHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  316 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  316 (370)
                      ...+......+.+++.+||+.+|.+||+     +.++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            1122233445788999999999999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-42  Score=323.67  Aligned_cols=249  Identities=26%  Similarity=0.359  Sum_probs=208.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .+-|++.+.||.|+-|.|-.|++. +|+..|||++...   .......+.+|+.+|+-++|||++++|+++.+...+|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            466899999999999999999974 7999999998765   223345677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      .||+++|-|.+++    ...+++++.++.+++.||+.|+.|+|..   +|+||||||+|+||+..+++||+|||+|..-.
T Consensus        91 lEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   91 LEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             EEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc
Confidence            9999999999998    4566899999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      .  ...-.+.+|++.|.+||++.+.+| +.++||||+||+||.||||+.||++.  +... ++.   ++.. +       
T Consensus       164 ~--gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--Nir~-LLl---KV~~-G-------  227 (786)
T KOG0588|consen  164 P--GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--NIRV-LLL---KVQR-G-------  227 (786)
T ss_pred             C--CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--cHHH-HHH---HHHc-C-------
Confidence            3  234556789999999999999988 48999999999999999999999822  2222 211   1111 1       


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                        .-+.|.....+..+|+.+|+..||.+|.|+++|++..
T Consensus       228 --~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  228 --VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             --cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence              1122344445588999999999999999999998754

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=318.04  Aligned_cols=253  Identities=22%  Similarity=0.293  Sum_probs=203.2

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|+.++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999986 58899999887542   234456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999983    344688999999999999999999999   999999999999999999999999999975543


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                          ......|++.|+|||++.+..++.++|||||||++|+|++|..||.......   ......   .....  ...+.
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~---~~~~~--~~~~~  221 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWENLK---YWKET--LQRPV  221 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHHHH---hcccc--ccCCC
Confidence                2234568999999999999999999999999999999999999986532211   111111   00000  00111


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...........+.+++.+||..+|.+||++.++++.
T Consensus       222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            111011234457889999999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-42  Score=324.38  Aligned_cols=284  Identities=23%  Similarity=0.413  Sum_probs=214.9

Q ss_pred             CCCCCCccccccccccC-HHHHHHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCc-ChhcHHHHHHH
Q 017503           21 APQGVDGELLRNVNHFS-YTELRSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAE-SKQGVREFITE   92 (370)
Q Consensus        21 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e   92 (370)
                      +.+|....++.... .. .+.+....++|++.+.||+|+||.||+|.+.      ++..||+|.+... .......+.+|
T Consensus        13 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E   91 (374)
T cd05106          13 AAEGNNYTFIDPTQ-LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSE   91 (374)
T ss_pred             hccCCcceeeCCcc-ccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHH
Confidence            44555555544443 33 2334445678999999999999999998852      2357999998754 23345668899


Q ss_pred             HHHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhccccc---------------------------------
Q 017503           93 IMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---------------------------------  138 (370)
Q Consensus        93 ~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------------------  138 (370)
                      +++++.+ +|+||+++++++......++||||+.+|+|.+++.....                                 
T Consensus        92 ~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (374)
T cd05106          92 LKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDS  171 (374)
T ss_pred             HHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccc
Confidence            9999999 899999999999999999999999999999998843210                                 


Q ss_pred             ---------------------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC
Q 017503          139 ---------------------------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE  185 (370)
Q Consensus       139 ---------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~  185 (370)
                                                       ....+++..++.++.|++.||.|||+.   +++||||||+|||++++
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~  248 (374)
T cd05106         172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDG  248 (374)
T ss_pred             cccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCC
Confidence                                             112478889999999999999999999   99999999999999999


Q ss_pred             CCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHH
Q 017503          186 FNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE  263 (370)
Q Consensus       186 ~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~  263 (370)
                      +.++|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||.......  ... 
T Consensus       249 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~-  325 (374)
T cd05106         249 RVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFY-  325 (374)
T ss_pred             CeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHH-
Confidence            99999999999765433221 1112234567999999998999999999999999999997 999986543211  111 


Q ss_pred             HHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          264 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                         .......     .+....   .....+.+++.+||+.+|.+||++.+|++.|++++
T Consensus       326 ---~~~~~~~-----~~~~~~---~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         326 ---KMVKRGY-----QMSRPD---FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ---HHHHccc-----CccCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence               1111111     111111   12345888999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=316.07  Aligned_cols=245  Identities=25%  Similarity=0.291  Sum_probs=200.3

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++....   ......+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999976 68899999886432   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999983    345688999999999999999999999   999999999999999999999999999886543


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .    .....|++.|+|||++.+..++.++|||||||++|+|++|..||.....   .....   ... ....       
T Consensus       154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~---~i~-~~~~-------  215 (291)
T cd05612         154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGIYE---KIL-AGKL-------  215 (291)
T ss_pred             C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHH-hCCc-------
Confidence            2    2234688999999999998899999999999999999999999865321   11111   111 1110       


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCC-----HHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIKM  317 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  317 (370)
                        .++......+.+++.+||+.||.+||+     +.++++.
T Consensus       216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              112222345788999999999999995     8877654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=323.09  Aligned_cols=241  Identities=29%  Similarity=0.467  Sum_probs=201.4

Q ss_pred             cccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCC
Q 017503           49 HLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS  128 (370)
Q Consensus        49 ~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  128 (370)
                      .-++-||.|+.|.||+|+.+ ++.||||.++.-..       .+|.-|++|+||||+.+.|+|.....++||||||..|.
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            33566999999999999997 68899997753322       37888999999999999999999999999999999999


Q ss_pred             HHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceee
Q 017503          129 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT  208 (370)
Q Consensus       129 L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  208 (370)
                      |...+    +.+..+.......|..+||.|+.|||.+   .|||||||.-||||..+..+||+|||.++...+..+.  -
T Consensus       199 L~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk--M  269 (904)
T KOG4721|consen  199 LYEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK--M  269 (904)
T ss_pred             HHHHH----hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhh--h
Confidence            99999    5677889999999999999999999999   9999999999999999999999999999877665333  2


Q ss_pred             cccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChH
Q 017503          209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN  288 (370)
Q Consensus       209 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (370)
                      .+.||..|||||++.+.+.++|.|||||||+|||||||..||.+....      ..+|-+-.     +.+.   ...|..
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss------AIIwGVGs-----NsL~---LpvPst  335 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS------AIIWGVGS-----NSLH---LPVPST  335 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh------eeEEeccC-----Cccc---ccCccc
Confidence            367999999999999999999999999999999999999998654221      11111111     1111   234556


Q ss_pred             HHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          289 EIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       289 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                      ++..+.-|++.||+..|..||+|.+|+..|.-
T Consensus       336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             CchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            66668888888999999999999999998863

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-43  Score=308.03  Aligned_cols=250  Identities=23%  Similarity=0.390  Sum_probs=212.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ..+|++.+.||+|.||+|-++.. ..|+.||||.+..+   +.+..-++.+|+++|..|+||||+.++.+|+..+..+||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45899999999999999999985 68999999988765   556667889999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||..+|.|.+|+    .....|++.++..+++||..|+.|+|.+   +++|||||.+|||+|+|+++||+|||++..+.
T Consensus       132 MEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  132 MEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence            9999999999999    4566899999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ..  ..-+..+|++-|.+||.+++.+| ++..|-||||++||-|+.|..||+...-   ..++..    +..+...   .
T Consensus       205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQ----Is~GaYr---E  272 (668)
T KOG0611|consen  205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQ----ISRGAYR---E  272 (668)
T ss_pred             cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHH----hhccccc---C
Confidence            54  33456789999999999999988 4899999999999999999999976532   222221    1111111   1


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                             +..+....-||+|||..+|++|-|+.+|...-.-
T Consensus       273 -------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  273 -------PETPSDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             -------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence                   1222336779999999999999999999875543

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.9e-42  Score=306.44  Aligned_cols=252  Identities=24%  Similarity=0.423  Sum_probs=201.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.+.||+|+||.||++.++++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            35789999999999999999999888889999876443 23457888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            999999988422   23588999999999999999999999   999999999999999999999999999876543322


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....   .....   ... .....  ..    
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~---~i~-~~~~~--~~----  222 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVE---MIS-RGFRL--YR----  222 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH---HHH-CCCCC--CC----
Confidence            22222334568999999988889999999999999999999 8888754321   11111   111 11110  01    


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                        +......+.+++.+||+.+|.+||++.++++.|
T Consensus       223 --~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         223 --PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              111234578999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-41  Score=314.86  Aligned_cols=262  Identities=24%  Similarity=0.354  Sum_probs=204.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||.||++++. ++..||+|.+... .......+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            578999999999999999999986 5788999988765 33445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|.+++.    ....+++..+..++.|++.||.|||+..  +++||||||+||+++.++.++|+|||++......
T Consensus        84 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999999983    3446889999999999999999999851  5999999999999999999999999998755332


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHh---cCCC-----
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ---EEKP-----  274 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~-----  274 (370)
                      .   .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.......   +.........   ....     
T Consensus       158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCc
Confidence            1   233468899999999999899999999999999999999999986443211   1110000000   0000     


Q ss_pred             --------------------------cccccCCCCCC-ChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          275 --------------------------LELVDPELGEY-PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       275 --------------------------~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                                                ..+........ .......+.+++.+||+.||++|||+.+|++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                      00000000000 112345688999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4e-42  Score=313.70  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=202.6

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..++|++++.||+|+||.||+++.+ +|..+|+|+++..   ......+++.|-.+|...++|.||+++..|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            5789999999999999999999976 6889999999876   34567788889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||++||++..++    .....|++..+..++.+++.||..||+.   |||||||||+|+|||..|++||+||||+..+
T Consensus       219 iMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence            99999999999998    5666899999999999999999999999   9999999999999999999999999999532


Q ss_pred             CC-----------------------CCcc----e-------------------eecccCCCCCCCcccccCCCcCccccc
Q 017503          200 PD-----------------------NITH----I-------------------TTRIAGTTGYLAPEYVLGGQLTMKADV  233 (370)
Q Consensus       200 ~~-----------------------~~~~----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di  233 (370)
                      ..                       ....    .                   .....|||.|+|||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            11                       0000    0                   012469999999999999999999999


Q ss_pred             hhhhHHHHHHHhCCCCCCcccccch-hhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCC--
Q 017503          234 YSFGVLVLEIISGRNSGKAMWGQMN-KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ--  310 (370)
Q Consensus       234 ~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt--  310 (370)
                      ||||||+||||.|.+||....+... ..+..|...       ...  |.-    .....+..+||.+|+. ||.+|..  
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-------l~f--P~~----~~~s~eA~DLI~rll~-d~~~RLG~~  437 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-------LKF--PEE----VDLSDEAKDLITRLLC-DPENRLGSK  437 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-------ccC--CCc----CcccHHHHHHHHHHhc-CHHHhcCcc
Confidence            9999999999999999976544221 112222111       100  100    1111557888999888 9999965  


Q ss_pred             -HHHHH
Q 017503          311 -MNQVI  315 (370)
Q Consensus       311 -~~evl  315 (370)
                       ++||-
T Consensus       438 G~~EIK  443 (550)
T KOG0605|consen  438 GAEEIK  443 (550)
T ss_pred             cHHHHh
Confidence             55554

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-43  Score=319.72  Aligned_cols=252  Identities=24%  Similarity=0.383  Sum_probs=213.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe-eEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR-RILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv  120 (370)
                      -++|.+++.+|+|+||.++.++++ ++..|++|.+...  .....+...+|+.+++++.|||||.+.+.|++++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            468999999999999999999876 5778999988655  23334577889999999999999999999998888 9999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |+||+||++.+.+..  .++..++++.++.|+.|++.|+.|||++   +|+|||||+.||+++.++.|+|+|||+++.+.
T Consensus        83 m~Y~eGg~l~~~i~~--~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKE--QKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EeecCCCCHHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            999999999999954  3367799999999999999999999998   99999999999999999999999999999887


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ... .......||+.|++||.+.+.+|..++|||||||++|||++-+++|......      ..+.+         +...
T Consensus       158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~k---------i~~~  221 (426)
T KOG0589|consen  158 PED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILK---------INRG  221 (426)
T ss_pred             Cch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHH---------Hhhc
Confidence            654 2345578999999999999999999999999999999999999998765321      11111         1111


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .....+.....++..++..|++.+|..||++.+++..
T Consensus       222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            2334556666778889999999999999999999886

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-42  Score=319.67  Aligned_cols=265  Identities=30%  Similarity=0.445  Sum_probs=209.6

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEECC--C---CEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEE
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLTN--G---RRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCV  112 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~--~---~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  112 (370)
                      ++-..++..+.++||+|+||.||+|+.+.  +   ..||+|.....   ......++.+|+++|++++|||||++||++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            44445677778999999999999999652  2   23899988753   4667788999999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEee
Q 017503          113 QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD  192 (370)
Q Consensus       113 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~D  192 (370)
                      ....+++|||+|.||+|.+++.+   ....++..+++.++.+.|.||+|||++   +++||||..+|+|++.++.+||+|
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence            99999999999999999999942   233699999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhc
Q 017503          193 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       193 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      ||+++.-..-. .......-...|+|||.+..+.++.++|||||||++||+++ |..|+......   .+.   ..+..+
T Consensus       306 FGLs~~~~~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~---~kI~~~  378 (474)
T KOG0194|consen  306 FGLSRAGSQYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVK---AKIVKN  378 (474)
T ss_pred             cccccCCccee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHH---HHHHhc
Confidence            99987543111 11111124578999999999999999999999999999999 67776544321   111   111122


Q ss_pred             CCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCc
Q 017503          272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  326 (370)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  326 (370)
                      ....        ..+...+..+..++.+||..+|++||+|.++.+.|+.+.....
T Consensus       379 ~~r~--------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  379 GYRM--------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CccC--------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            2111        1222444456666678999999999999999999999887554

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.4e-42  Score=308.53  Aligned_cols=257  Identities=27%  Similarity=0.459  Sum_probs=211.0

Q ss_pred             HhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ....+|++.+.||.|++|.||+|.+.++..+++|.+..........+..|+.+++.++|+||+++++++.+....++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            44678999999999999999999998889999999887766556788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|.+++...  .+..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          83 LMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             ecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            99999999998532  345689999999999999999999999   9999999999999999999999999999866443


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      ... .....++..|+|||.+....++.++||||||+++|+|++ |+.||.....   .......    .....       
T Consensus       158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~-------  222 (261)
T cd05148         158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQI----TAGYR-------  222 (261)
T ss_pred             ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHH----HhCCc-------
Confidence            222 123345678999999988899999999999999999998 7888854321   1111111    11110       


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                       ...+......+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 -MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence             11123334558899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.5e-42  Score=320.65  Aligned_cols=260  Identities=26%  Similarity=0.432  Sum_probs=203.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEE------CCCCEEEEEECcCcC-hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL------TNGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTR  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  116 (370)
                      .++|++.+.||+|+||.||+|.+      ..+..||+|+++... ......+.+|+.+++.+ +||||+++++++.+...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45899999999999999999974      235679999886542 33445788899999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhccccc----------------------------------------------------------
Q 017503          117 RILVYEYVENNSLDRVLLGATK----------------------------------------------------------  138 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~----------------------------------------------------------  138 (370)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999998853211                                                          


Q ss_pred             -------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc
Q 017503          139 -------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH  205 (370)
Q Consensus       139 -------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  205 (370)
                                   ....+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         122578899999999999999999999   9999999999999999999999999999865433221


Q ss_pred             -eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          206 -ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       206 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                       ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......  ....    .........     .  
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~----~~~~~~~~~-----~--  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFY----KMIKEGYRM-----L--  337 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHH----HHHHhCccC-----C--
Confidence             1112234567999999999999999999999999999998 78887543221  1111    111111110     0  


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                       .+.....++.+++.+||+.+|.+||++.+|++.|++.
T Consensus       338 -~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 -SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence             1111234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.7e-42  Score=317.05  Aligned_cols=241  Identities=26%  Similarity=0.308  Sum_probs=195.2

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      +.||+|+||.||++..+ +++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999975 6889999988754   2233456778999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCccee
Q 017503          128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT  207 (370)
Q Consensus       128 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  207 (370)
                      +|.+++.    .+..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++....... ...
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~  152 (323)
T cd05571          81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM  152 (323)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence            9998883    345689999999999999999999999   99999999999999999999999999987532211 122


Q ss_pred             ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCCh
Q 017503          208 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP  287 (370)
Q Consensus       208 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (370)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ......    .....         ..++.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~----~~~~~---------~~~p~  216 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL----ILMEE---------IRFPR  216 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHH----HHcCC---------CCCCC
Confidence            335689999999999999999999999999999999999999864321   111111    11111         01222


Q ss_pred             HHHHHHHHHHHHchhhccCCCC-----CHHHHHH
Q 017503          288 NEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  316 (370)
Q Consensus       288 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  316 (370)
                      .....+.+++.+||+.||.+||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            3344588899999999999999     7998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.9e-42  Score=306.11  Aligned_cols=255  Identities=28%  Similarity=0.451  Sum_probs=206.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.++||+|++|.||+|...++..||+|.+..... ....+.+|+.+++.++|+||+++++++.+....+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            468999999999999999999988888999998765432 3567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      .+++|.+++...  ....+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            999999998432  344678899999999999999999999   999999999999999999999999999987654322


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .......++..|+|||.+....++.++||||||+++|+|++ |..||.....   ......    .......    +.. 
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~----~~~~~~~----~~~-  226 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSA----LQRGYRM----PRM-  226 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHH----HHcCCCC----CCC-
Confidence            22222345678999999988889999999999999999998 8888754321   111111    1111110    111 


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                         ......+.+++.+||..+|++||++.++++.|+.
T Consensus       227 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         227 ---ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               1233458889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.5e-41  Score=320.38  Aligned_cols=290  Identities=23%  Similarity=0.333  Sum_probs=220.3

Q ss_pred             ccccCCCCCCccccccccccCHHHHHHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcC-hhcHHHH
Q 017503           17 AEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAES-KQGVREF   89 (370)
Q Consensus        17 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~   89 (370)
                      .|.-.++|.+..++.....=--..+....++|++.++||+|+||.||+|.+.      .+..||||.+.... ....+.+
T Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~   87 (400)
T cd05105           8 IESISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQAL   87 (400)
T ss_pred             EeeeCCCCceeeeeccccCCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHH
Confidence            4555677777665544332222344455789999999999999999999863      13469999987543 3334678


Q ss_pred             HHHHHHHHhcC-CCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhccccc------------------------------
Q 017503           90 ITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------------------------------  138 (370)
Q Consensus        90 ~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------  138 (370)
                      .+|+.+++++. ||||+++++++.+....++||||+++|+|.+++.....                              
T Consensus        88 ~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (400)
T cd05105          88 MSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYV  167 (400)
T ss_pred             HHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchh
Confidence            89999999995 99999999999999999999999999999998854211                              


Q ss_pred             --------------------------------------------------------------CCccCCHHHHHHHHHHHH
Q 017503          139 --------------------------------------------------------------ANIKLNWEKRSDICVGIA  156 (370)
Q Consensus       139 --------------------------------------------------------------~~~~l~~~~~~~i~~qi~  156 (370)
                                                                                    ....+++..++.++.|++
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~  247 (400)
T cd05105         168 ILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVA  247 (400)
T ss_pred             hhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHH
Confidence                                                                          113478888999999999


Q ss_pred             HHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchh
Q 017503          157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYS  235 (370)
Q Consensus       157 ~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  235 (370)
                      .||.|||+.   +++|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||
T Consensus       248 ~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS  324 (400)
T cd05105         248 RGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS  324 (400)
T ss_pred             HHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHH
Confidence            999999999   9999999999999999999999999999865432221 122234667899999999999999999999


Q ss_pred             hhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHH
Q 017503          236 FGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV  314 (370)
Q Consensus       236 lG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev  314 (370)
                      |||++|+|++ |..||.......  ..    .........        ...+......+.+++.+||+.+|++||++.+|
T Consensus       325 lGvil~ellt~g~~P~~~~~~~~--~~----~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l  390 (400)
T cd05105         325 YGILLWEIFSLGGTPYPGMIVDS--TF----YNKIKSGYR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL  390 (400)
T ss_pred             HHHHHHHHHHCCCCCCcccchhH--HH----HHHHhcCCC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHH
Confidence            9999999997 888876432211  11    111111111        01122334568899999999999999999999


Q ss_pred             HHHHHhhhc
Q 017503          315 IKMLTKNIR  323 (370)
Q Consensus       315 l~~L~~~~~  323 (370)
                      .+.|+++.+
T Consensus       391 ~~~l~~l~~  399 (400)
T cd05105         391 SDIVESLLP  399 (400)
T ss_pred             HHHHHHHcC
Confidence            999988654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.2e-42  Score=329.80  Aligned_cols=253  Identities=20%  Similarity=0.302  Sum_probs=205.3

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-C-CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-N-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..|.+.+.||+|++|.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            34999999999999999999864 3 678899987666555556778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++..+....
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999988854444455789999999999999999999999   99999999999999999999999999998765432


Q ss_pred             c-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          204 T-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       204 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..+..   ......         .
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~---~~~~~~---------~  288 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQ---QVLYGK---------Y  288 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCC---------C
Confidence            2 123345689999999999999999999999999999999999999864321   11111   111111         0


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...+......+.+++.+||+.+|.+||++.+++.
T Consensus       289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1112223345888999999999999999999864

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.8e-42  Score=308.64  Aligned_cols=258  Identities=28%  Similarity=0.505  Sum_probs=206.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC------CCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|++.+.||+|+||.||+|....      ...|++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            3578999999999999999998642      2579999887543 33455688999999999999999999999998999


Q ss_pred             EEEEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC
Q 017503          118 ILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE  185 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~  185 (370)
                      +++|||+++++|.+++.....            ....+++..++.++.|++.||.|||+.   +++|+||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence            999999999999999854321            114578899999999999999999999   99999999999999999


Q ss_pred             CCeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHH
Q 017503          186 FNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE  263 (370)
Q Consensus       186 ~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~  263 (370)
                      +.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......   .+. 
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~-  236 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVI-  236 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH-
Confidence            9999999999875533221 12223346788999999988899999999999999999998 98887654321   111 


Q ss_pred             HHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          264 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                         .......        ....+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       237 ---~~i~~~~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 ---EMIRSRQ--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHHcCC--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence               1111111        112233445668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.4e-41  Score=311.92  Aligned_cols=252  Identities=25%  Similarity=0.311  Sum_probs=198.2

Q ss_pred             CCcccceeeecCCeEEEEEEEC----CCCEEEEEECcCc----ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCee
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAE----SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  117 (370)
                      +|++.+.||+|+||.||+++..    ++..||+|++...    .......+..|+.+++.+ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5889999999999999999863    5788999988643    223345677899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+.+++|.+++.    ....+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999883    345689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ..............||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........  .......      
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~--~~~~~~~------  225 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE--VSRRILK------  225 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH--HHHHHhc------
Confidence            6543333333345689999999998765 478999999999999999999999864322211111  1111111      


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  317 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  317 (370)
                       .++.+   +......+.+++.+||+.||++||     ++.++++.
T Consensus       226 -~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 -CDPPF---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             -CCCCC---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence             11111   222334478899999999999999     67777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-41  Score=317.90  Aligned_cols=259  Identities=20%  Similarity=0.226  Sum_probs=196.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++.+.||+|+||.||++.+. .++.||+|....      ..+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            367999999999999999999975 688899996532      3456899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +. ++|..++.    ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus       165 ~~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        165 YK-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             CC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            96 57877773    344688999999999999999999999   99999999999999999999999999997543322


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccc----hhhHHHHHHHHHhc---CCC--
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM----NKFLLEWAWQLHQE---EKP--  274 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~---~~~--  274 (370)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|..|+.......    ..............   +..  
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            222334578999999999999999999999999999999999998764322110    00000000000000   000  


Q ss_pred             --------------cccccCCCCC---CChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          275 --------------LELVDPELGE---YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       275 --------------~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                                    .....+....   ........+.+++.+||+.||.+|||+.|+++.
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                          0000000000   011234568899999999999999999999863

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=303.02  Aligned_cols=256  Identities=27%  Similarity=0.460  Sum_probs=206.4

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..++|++.+.||+|++|.||+|.+.+++.||+|.+.... .....+.+|+.++++++|||++++++++...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            357799999999999999999998778889999886543 2346788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+++|.+++...  .+..+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          83 MKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             ccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999998432  234689999999999999999999999   99999999999999999999999999998765332


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      .........+..|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ..+..    .......        
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~----~~~~~~~--------  222 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQ----QVDQGYR--------  222 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHHcCCC--------
Confidence            221222223457999999998899999999999999999999 8888764321   11111    1111110        


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                      ...+......+.+++.+||+.+|.+||++.++++.|++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            01122334568889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.8e-42  Score=304.28  Aligned_cols=253  Identities=25%  Similarity=0.432  Sum_probs=202.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.+.||+|++|.||.|.+.++..+|+|.+..... ....+.+|+.++++++||||+++++++.+....++||||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            357899999999999999999987777899998875432 3467889999999999999999999999988999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      .+++|.+++...   ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            999999998432   23689999999999999999999999   999999999999999999999999999876544322


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .....   ... .....        
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~---~~~-~~~~~--------  220 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVE---KVS-QGLRL--------  220 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHH---HHh-cCCCC--------
Confidence            22222335678999999988889999999999999999998 8888754321   11111   111 11110        


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ..+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            111122356889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=339.80  Aligned_cols=263  Identities=29%  Similarity=0.458  Sum_probs=211.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC--CC----CEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT--NG----RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~--~~----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .+..++...||+|.||.||.|...  ++    ..||+|.+... +.+...+|.+|..+|++++||||++++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            455677889999999999999864  23    34899988765 556678999999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccc---cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          118 ILVYEYVENNSLDRVLLGAT---KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~---~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      +|++|||++|+|..|+...+   .+...++..+.+.++.+||.|+.||+++   ++|||||..+|+||+....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999996442   1255689999999999999999999999   99999999999999999999999999


Q ss_pred             Ccccc-CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          195 LAKLF-PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       195 ~~~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      +++.+ ..+.........-...|||||.+..+.++.++|||||||+|||++| |..||.....   ..+..   .+....
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n---~~v~~---~~~~gg  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---FEVLL---DVLEGG  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch---HHHHH---HHHhCC
Confidence            99943 3332222222233468999999999999999999999999999999 5667654322   11111   111111


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                               ..+.|..++..+.+++..||+.+|++||++..|++.+..+....
T Consensus       922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                     22445666667778888899999999999999999888877643

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3e-41  Score=311.00  Aligned_cols=241  Identities=28%  Similarity=0.332  Sum_probs=194.0

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      +.||+|+||.||+++.. +|..||+|++...   .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999975 6889999988654   2233456778999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCccee
Q 017503          128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT  207 (370)
Q Consensus       128 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  207 (370)
                      +|..++.    .+..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~  152 (323)
T cd05595          81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM  152 (323)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence            9988873    344689999999999999999999999   99999999999999999999999999987532221 112


Q ss_pred             ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCCh
Q 017503          208 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP  287 (370)
Q Consensus       208 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (370)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|..||......   ....   .......          ..+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~---~~~~~~~----------~~p~  216 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LILMEEI----------RFPR  216 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHH---HHhcCCC----------CCCC
Confidence            3356899999999999999999999999999999999999998643211   1111   1111110          1122


Q ss_pred             HHHHHHHHHHHHchhhccCCCC-----CHHHHHH
Q 017503          288 NEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  316 (370)
Q Consensus       288 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  316 (370)
                      .....+.+++.+||+.+|.+||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            2334578899999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-41  Score=302.58  Aligned_cols=256  Identities=29%  Similarity=0.446  Sum_probs=205.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC----CCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|++.+.||+|+||.||+|.++.    ...||+|.+... .......+.+|+.++++++||||+++++++......++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            4679999999999999999999752    457999988754 33345678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      +|||+.+++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            9999999999999843   233689999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          200 PDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       200 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....   .......    .......  
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~~~----~~~~~~~--  227 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKA----VEDGYRL--  227 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHHHH----HHcCCCC--
Confidence            522211 1222334578999999998999999999999999999998 888875432   1111111    1111110  


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                            ..+......+.+++.+||+.+|.+||++.+|++.|.++
T Consensus       228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  11123344588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.6e-42  Score=316.67  Aligned_cols=246  Identities=25%  Similarity=0.308  Sum_probs=199.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC--CCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN--GRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~--~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|++.+.||+|+||.||+|.+++  +..||+|.+...   .......+.+|+.+++.++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            5689999999999999999998643  367999987543   22334567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+.+|+|.+++.    .+..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus       109 v~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        109 VLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999983    345689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ...    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ....    ........     
T Consensus       182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~----~~i~~~~~-----  245 (340)
T PTZ00426        182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIY----QKILEGII-----  245 (340)
T ss_pred             CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HHHH----HHHhcCCC-----
Confidence            432    2335689999999999988899999999999999999999999864321   1111    11111110     


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  317 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  317 (370)
                          ..+......+.+++.+||+.+|.+|+     +++++++.
T Consensus       246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                11122233477899999999999995     88888764

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-41  Score=306.74  Aligned_cols=257  Identities=26%  Similarity=0.467  Sum_probs=205.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC------CCEEEEEECcCcChh-cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|.+.+.||+|+||.||+|.+.+      +..||+|.+...... ....+.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4678999999999999999998643      478999988765433 456888999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccc----------cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          118 ILVYEYVENNSLDRVLLGAT----------KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                      ++||||+++++|.+++....          .....+++..+..++.|++.||.|||++   +++||||+|+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            99999999999999985432          2234578999999999999999999999   9999999999999999999


Q ss_pred             eEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHH
Q 017503          188 PKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWA  265 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~  265 (370)
                      ++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.....   .......
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~  237 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECI  237 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH
Confidence            99999999875432211 11222345678999999999999999999999999999998 9998754322   1111111


Q ss_pred             HHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          266 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                          ....        ....+......+.+++.+||+.+|.+||++.||++.|.
T Consensus       238 ----~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 ----TQGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ----HcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                1111        11112233455889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=306.22  Aligned_cols=260  Identities=25%  Similarity=0.371  Sum_probs=203.2

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--------------hhcHHHHHHHHHHHHhcCCCCcc
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--------------KQGVREFITEIMTLSNVRHPNLV  105 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~iv  105 (370)
                      =.+..++|++.+.||+|.||+|-+|++. +++.||||++....              ....+...+|+.+|++++|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            3445688999999999999999999975 68999999886431              11245788999999999999999


Q ss_pred             eeeeEEEe--CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC
Q 017503          106 ELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD  183 (370)
Q Consensus       106 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~  183 (370)
                      +++.+..+  .+.+|||+|||..|.+...    ......+++.+++.++++++.||+|||.+   +||||||||+|+||+
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS  244 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence            99999876  4678999999998876532    23333489999999999999999999999   999999999999999


Q ss_pred             CCCCeEEeeecCccccCCCCcc----eeecccCCCCCCCcccccCCC----cCccccchhhhHHHHHHHhCCCCCCcccc
Q 017503          184 QEFNPKIGDFGLAKLFPDNITH----ITTRIAGTTGYLAPEYVLGGQ----LTMKADVYSFGVLVLEIISGRNSGKAMWG  255 (370)
Q Consensus       184 ~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~elltg~~p~~~~~~  255 (370)
                      ++|++||+|||.+...+.....    ......||+.|+|||...++.    -+.+.||||+||+||.|+.|+.||.....
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            9999999999999877433111    123367999999999887632    35788999999999999999999854321


Q ss_pred             cchhhHHHHHHHHHhcCCCcccccCCC-CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          256 QMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                            ..    .+.     .+++..+ -...++....+.+||.++|++||++|.++.+|........
T Consensus       325 ------~~----l~~-----KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  325 ------LE----LFD-----KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             ------HH----HHH-----HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence                  11    111     1111111 1122345566889999999999999999999987665443

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-42  Score=299.75  Aligned_cols=269  Identities=24%  Similarity=0.352  Sum_probs=206.9

Q ss_pred             HHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECc--CcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--
Q 017503           39 TELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLS--AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--  113 (370)
Q Consensus        39 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--  113 (370)
                      .+...+...|...+.||.|+||.|+.+.++ +|..||||.+.  .++....++..+|+.+|+.++|+||+.+++.+..  
T Consensus        15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS   94 (359)
T ss_pred             eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence            344556777888899999999999999975 68999999887  4466667888899999999999999999998864  


Q ss_pred             ---CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEE
Q 017503          114 ---GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI  190 (370)
Q Consensus       114 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL  190 (370)
                         -...|+|+|+++ .+|.+.+    +.+..++...+..+++|++.||+|+|+.   +++||||||+|++++.+..+||
T Consensus        95 ~~~f~DvYiV~elMe-tDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI  166 (359)
T KOG0660|consen   95 RDKFNDVYLVFELME-TDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKI  166 (359)
T ss_pred             ccccceeEEehhHHh-hHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEe
Confidence               456799999994 4899988    5666699999999999999999999999   9999999999999999999999


Q ss_pred             eeecCccccCCC-CcceeecccCCCCCCCccccc-CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhH-------
Q 017503          191 GDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL-------  261 (370)
Q Consensus       191 ~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~-------  261 (370)
                      ||||+++..... .....+...-|.+|.|||.+. ...|+.+.||||.||++.||++|++-|.....-.+-.+       
T Consensus       167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt  246 (359)
T KOG0660|consen  167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT  246 (359)
T ss_pred             ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence            999999987543 112235566789999999764 46899999999999999999999986544322111111       


Q ss_pred             -----HHH-----HHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          262 -----LEW-----AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       262 -----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                           ...     +...........  ...+....++.....++|+.+||..||.+|+|++|.+..
T Consensus       247 P~~e~l~~i~s~~ar~yi~slp~~p--~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  247 PSEEDLQKIRSEKARPYIKSLPQIP--KQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CCHHHHHHhccHHHHHHHHhCCCCC--CCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                 000     111111111000  000112223444557899999999999999999999874

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.6e-41  Score=306.46  Aligned_cols=262  Identities=24%  Similarity=0.437  Sum_probs=208.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|+.++++++|||++++++++......+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            457899999999999999999852      24568999887665555677889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccc---------cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeE
Q 017503          119 LVYEYVENNSLDRVLLGAT---------KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK  189 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  189 (370)
                      +||||+.+++|.+++....         .....+++..++.++.|++.||+|||+.   +++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            9999999999999985332         1223589999999999999999999999   999999999999999999999


Q ss_pred             EeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 017503          190 IGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       190 L~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      |+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |.+||.....   .....    
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~----  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIE----  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----
Confidence            999999985543221 11122334678999999998899999999999999999998 8888754322   11111    


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      ........        ..+......+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus       234 ~i~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         234 CITQGRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHcCCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            11111111        11112234588999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-42  Score=307.87  Aligned_cols=250  Identities=32%  Similarity=0.540  Sum_probs=193.8

Q ss_pred             cccceeeecCCeEEEEEEEC-----CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           49 HLSNKIGRGGFGTVYKGTLT-----NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        49 ~~~~~lg~G~~g~v~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++.+.||.|.||.||+|.++     .+..|+||.++.. .......+.+|++.+++++||||++++|++......++|||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            35689999999999999976     3567999999664 33447889999999999999999999999998888999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+|+|.+++...  ....+++..++.|+.|++.||.|||+.   +++|++|+++||+++.++.+||+|||+.......
T Consensus        82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            99999999999533  245789999999999999999999999   9999999999999999999999999999876322


Q ss_pred             C-cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          203 I-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       203 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      . ............|+|||.+....++.++||||||+++|||++ |..|+.....   ..+..    ...+....     
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~----~~~~~~~~-----  224 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIE----KLKQGQRL-----  224 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHH----HHHTTEET-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc----cccccccc-----
Confidence            1 122233446678999999999999999999999999999999 6778655421   11111    11221111     


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                         ..+......+.+++..||..+|++||++.+|++.|
T Consensus       225 ---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 ---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               11223344578899999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.4e-41  Score=306.66  Aligned_cols=262  Identities=26%  Similarity=0.363  Sum_probs=196.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh-hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            578999999999999999999986 688999998875432 223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+ +|.+++.   .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        84 ~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVHT-DLCQYMD---KHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCCc-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            9964 6766663   2334688999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC-------
Q 017503          203 ITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP-------  274 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  274 (370)
                      . .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+ ............       
T Consensus       157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-QDQL-ERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHH-HHHHHHhCCCChhhccchh
Confidence            1 11223457899999998865 45789999999999999999999998754321 1111 111111100000       


Q ss_pred             -cccccCC-CCCCCh----------HHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          275 -LELVDPE-LGEYPP----------NEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       275 -~~~~~~~-~~~~~~----------~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       .....+. .....+          .....+.+++.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             0000000 000000          11234678999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.1e-41  Score=306.02  Aligned_cols=261  Identities=21%  Similarity=0.316  Sum_probs=197.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||.|+||.||+|+.+ ++..||+|.+.... ......+.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            467999999999999999999975 68899999886542 2234567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+ +|.+++.   ..+..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        84 ~~~~-~l~~~l~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          84 YLDS-DLKQYLD---NCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CCCc-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            9985 8888773   2334578899999999999999999999   9999999999999999999999999998754332


Q ss_pred             CcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC--------
Q 017503          203 ITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK--------  273 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  273 (370)
                      ... .....+++.|+|||++.+ ..++.++||||+||++|+|++|++||.......   .............        
T Consensus       157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         157 TKT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE---ELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             Ccc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHHhhccc
Confidence            211 223457889999998865 568999999999999999999999986543211   1111111110000        


Q ss_pred             C----cccccCCC-----CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 P----LELVDPEL-----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 ~----~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .    .....+..     ....+....++.+++.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0    00000000     0001122345789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-41  Score=328.84  Aligned_cols=262  Identities=23%  Similarity=0.345  Sum_probs=208.3

Q ss_pred             HHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 017503           38 YTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG  114 (370)
Q Consensus        38 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  114 (370)
                      .++.....++|++.+.||+|+||+||+++.. +++.||||.+...  .......+.+|+..+..++|+|++++...+...
T Consensus        24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            3445555789999999999999999999864 6899999988654  334456678899999999999999988776533


Q ss_pred             C--------eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC
Q 017503          115 T--------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF  186 (370)
Q Consensus       115 ~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~  186 (370)
                      .        ..++||||+.+|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNG  180 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCC
Confidence            2        36799999999999999865555556789999999999999999999999   999999999999999999


Q ss_pred             CeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHH
Q 017503          187 NPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA  265 (370)
Q Consensus       187 ~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~  265 (370)
                      .+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..+   .
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---~~~---~  254 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEV---M  254 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHH---H
Confidence            999999999986543221 222345689999999999999999999999999999999999999864321   111   1


Q ss_pred             HHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          266 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..... .        .....++.....+.+++.+||+.+|.+||++.+++..
T Consensus       255 ~~~~~-~--------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 HKTLA-G--------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHhc-C--------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11111 1        1111233344568899999999999999999999763

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.3e-41  Score=310.12  Aligned_cols=244  Identities=27%  Similarity=0.365  Sum_probs=192.8

Q ss_pred             CcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHH---HhcCCCCcceeeeEEEeCCeeEEE
Q 017503           48 FHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTL---SNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      |++.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|++++   +.++||||+++++++......++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678999999999999999975 68899999986432   22344566666655   456899999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+.+++|..++.     ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            99999999998873     24689999999999999999999999   99999999999999999999999999987432


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||.....   .....   ..... ..      
T Consensus       153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~---~i~~~-~~------  218 (324)
T cd05589         153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFD---SIVND-EV------  218 (324)
T ss_pred             CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHhC-CC------
Confidence            211 112335689999999999999999999999999999999999999864321   11111   11111 10      


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  316 (370)
                         ..+......+.+++.+||+.||.+||     ++.++++
T Consensus       219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence               11222334578899999999999999     5666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.5e-41  Score=306.12  Aligned_cols=261  Identities=25%  Similarity=0.424  Sum_probs=209.5

Q ss_pred             cCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ++|.+.+.||+|+||.||+|...      ++..+++|.+..........+.+|+.++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            56888999999999999999743      345689998877666556778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          120 VYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                      ||||+++++|.+++.....            ....+++..++.++.|++.||+|||++   +++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            9999999999999854321            223589999999999999999999999   9999999999999999999


Q ss_pred             eEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHH
Q 017503          188 PKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWA  265 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~  265 (370)
                      ++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ...   
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~---  235 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVI---  235 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---
Confidence            99999999975543221 11223345778999999998999999999999999999999 99887543221   111   


Q ss_pred             HHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          266 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                       ........        ...+...+..+.+++.+||+.+|.+||++.+|++.|..+...
T Consensus       236 -~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 -ECITQGRV--------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -HHHhCCCC--------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence             11111111        111222345588999999999999999999999999998663

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.1e-41  Score=304.35  Aligned_cols=268  Identities=28%  Similarity=0.398  Sum_probs=202.4

Q ss_pred             cCC-cccceeeecCCeEEEEEEE-----CCCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--Ce
Q 017503           46 DDF-HLSNKIGRGGFGTVYKGTL-----TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TR  116 (370)
Q Consensus        46 ~~y-~~~~~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~  116 (370)
                      ++| ++.+.||+|+||+||.+..     .++..||+|.+.... ......+.+|+++++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            455 8999999999999988653     357789999887653 23456778899999999999999999988753  46


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .+++|||+.+++|.+++..     ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.++|+|||++
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~  154 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA  154 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence            7899999999999999832     3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc--eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          197 KLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       197 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      .........  ......++..|+|||.+.+..++.++||||||+++|+|++|..|+........... ............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~  233 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMTVVRL  233 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-cccccccchhhh
Confidence            866543221  11122345679999999888999999999999999999999998765432211100 000000000000


Q ss_pred             cccccCC-CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          275 LELVDPE-LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       275 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      ....+.. ....+...+..+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0001111 01123344556889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=310.50  Aligned_cols=239  Identities=25%  Similarity=0.309  Sum_probs=191.6

Q ss_pred             eeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCH
Q 017503           54 IGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL  129 (370)
Q Consensus        54 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  129 (370)
                      ||+|+||.||++++. ++..||+|.+...   .......+..|+.++++++||||+++++++.+....++||||+.+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999976 5788999988643   233455678899999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeec
Q 017503          130 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR  209 (370)
Q Consensus       130 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~  209 (370)
                      .+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....... .....
T Consensus        81 ~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~  152 (312)
T cd05585          81 FHHLQ----REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT  152 (312)
T ss_pred             HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence            99883    344689999999999999999999999   99999999999999999999999999987543222 12233


Q ss_pred             ccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHH
Q 017503          210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE  289 (370)
Q Consensus       210 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (370)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ...   ....... .         ..++...
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---~~~---~~~~~~~-~---------~~~~~~~  216 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---NEM---YRKILQE-P---------LRFPDGF  216 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---HHH---HHHHHcC-C---------CCCCCcC
Confidence            5689999999999999999999999999999999999999864321   111   1111111 0         1122233


Q ss_pred             HHHHHHHHHHchhhccCCCCC---HHHHHH
Q 017503          290 IIRYMKVAFFCTQAAASRRPQ---MNQVIK  316 (370)
Q Consensus       290 ~~~l~~li~~cl~~~p~~RPt---~~evl~  316 (370)
                      ...+.+++.+||+.||.+||+   +.+++.
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            345788999999999999986   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-40  Score=298.71  Aligned_cols=260  Identities=21%  Similarity=0.385  Sum_probs=208.9

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|.+...   .......+.+|+.+++.++|||++++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            68999999999999999999975 6889999976542   3344456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988854444455688999999999999999999999   999999999999999999999999999886654


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......    ...........      .+.
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~------~~~  227 (267)
T cd08228         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQKIEQCD------YPP  227 (267)
T ss_pred             hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHHHhcCC------CCC
Confidence            3221 122457889999999988889999999999999999999999975432211    11111111100      010


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                        .........+.+++.+||..+|.+||++.+|++.|+.+
T Consensus       228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             --CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence              11123345688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.3e-41  Score=311.75  Aligned_cols=252  Identities=24%  Similarity=0.283  Sum_probs=200.4

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++....   ......+.+|+.+++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999975 68899999887542   234456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            99999999999843   234689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeecccCCCCCCCccccc------CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          202 NITHITTRIAGTTGYLAPEYVL------GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      ..........||+.|+|||++.      ...++.++|||||||++|+|++|..||......      .............
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~  228 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFL  228 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCcc
Confidence            4333333456899999999886      456789999999999999999999998643221      1111111111100


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..  +.    .+.....+.+++.+|+. +|.+||++.+++.
T Consensus       229 ~~--~~----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 KF--PE----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CC--CC----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            00  11    11233447788888997 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.8e-41  Score=311.74  Aligned_cols=242  Identities=27%  Similarity=0.335  Sum_probs=195.2

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      +.||+|+||.||++... ++..||+|++...   .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999975 6889999988754   2234456788999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCccee
Q 017503          128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT  207 (370)
Q Consensus       128 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  207 (370)
                      +|..++.    ....+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~  152 (328)
T cd05593          81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM  152 (328)
T ss_pred             CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence            9988883    345689999999999999999999999   99999999999999999999999999987532221 112


Q ss_pred             ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCCh
Q 017503          208 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP  287 (370)
Q Consensus       208 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (370)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   .....   .....       +.   ..+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~---~~~~~-------~~---~~p~  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE---LILME-------DI---KFPR  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHH---HhccC-------Cc---cCCC
Confidence            335689999999999998999999999999999999999999864321   11111   11100       01   1122


Q ss_pred             HHHHHHHHHHHHchhhccCCCC-----CHHHHHHH
Q 017503          288 NEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  317 (370)
Q Consensus       288 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  317 (370)
                      .....+.+++.+||+.+|.+||     ++.++++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            2334578899999999999997     89998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.6e-41  Score=301.48  Aligned_cols=256  Identities=25%  Similarity=0.427  Sum_probs=205.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..+|++.+.||+|++|.||+|.++ .+..|++|.+..+. .....+.+|+++++.++|+|++++++++......+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            356888999999999999999975 57889999887543 3356788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++...  ....+++..++.++.|++.||+|||+.   +++||||+|+||++++++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          84 MTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             CCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            9999999998432  234588999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      .........+..|+|||.+.+..++.++||||||+++|+|++ |..|+.....   ...    .........     +  
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~----~~~~~~~~~-----~--  224 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQV----YELLEKGYR-----M--  224 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHHCCCC-----C--
Confidence            222222234567999999998999999999999999999998 8888754321   111    111111111     1  


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                       ..+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence             11223345588899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-41  Score=313.81  Aligned_cols=252  Identities=24%  Similarity=0.288  Sum_probs=202.4

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999976 68899999986542   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLI----RKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            9999999999984    235789999999999999999999999   999999999999999999999999999986544


Q ss_pred             CC----------------------------cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcc
Q 017503          202 NI----------------------------THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  253 (370)
Q Consensus       202 ~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~  253 (370)
                      ..                            ........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                            11123346899999999999999999999999999999999999998654


Q ss_pred             cccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCC-HHHHHHH
Q 017503          254 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-MNQVIKM  317 (370)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~  317 (370)
                      ....   .   ..........  ..-+....    ....+.+++.+|+. +|.+||+ +.++++.
T Consensus       234 ~~~~---~---~~~i~~~~~~--~~~p~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         234 TLQE---T---YNKIINWKES--LRFPPDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CHHH---H---HHHHhccCCc--ccCCCCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            3211   1   1111110000  00011111    23457888899997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.4e-40  Score=311.73  Aligned_cols=252  Identities=21%  Similarity=0.269  Sum_probs=195.7

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .|++++.||+|+||+||+|++. +++.||+|++...   .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            6889999999999999999975 5789999998654   23345678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+|+|.+++.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            999999999983    344688999999999999999999999   9999999999999999999999999997543110


Q ss_pred             Cc----------------------------------------------ceeecccCCCCCCCcccccCCCcCccccchhh
Q 017503          203 IT----------------------------------------------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSF  236 (370)
Q Consensus       203 ~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  236 (370)
                      ..                                              .......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                              00123468999999999998899999999999


Q ss_pred             hHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHH--chhhccCCCCCHHHH
Q 017503          237 GVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF--CTQAAASRRPQMNQV  314 (370)
Q Consensus       237 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RPt~~ev  314 (370)
                      ||++|||++|..||........      .............  +......    .++.+++.+  |+..++..||++.++
T Consensus       235 G~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~--~~~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTET------QLKVINWENTLHI--PPQVKLS----PEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHH------HHHHHccccccCC--CCCCCCC----HHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999999875432111      0111110111110  1111122    346667766  556677779999999


Q ss_pred             HHH
Q 017503          315 IKM  317 (370)
Q Consensus       315 l~~  317 (370)
                      +..
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.1e-41  Score=312.04  Aligned_cols=260  Identities=24%  Similarity=0.357  Sum_probs=194.8

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----CeeE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TRRI  118 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~  118 (370)
                      +|++.+.||+|+||.||+|.++ ++..||+|.+...  .......+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5899999999999999999975 6889999987643  223345678899999999999999999988643     2479


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+. ++|.+++.    .+..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999996 58888873    445689999999999999999999999   999999999999999999999999999975


Q ss_pred             cCCCCc--ceeecccCCCCCCCcccccC--CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH------
Q 017503          199 FPDNIT--HITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL------  268 (370)
Q Consensus       199 ~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------  268 (370)
                      ......  .......++..|+|||++.+  ..++.++|||||||++|+|++|++||........   .......      
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~  229 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ---LDLITDLLGTPSP  229 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence            432211  11233568999999998866  6789999999999999999999999864322110   0000000      


Q ss_pred             -----HhcCCCccc---ccC----CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          269 -----HQEEKPLEL---VDP----ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       269 -----~~~~~~~~~---~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                           .........   +..    ......+.....+.+++.+||+.+|.+|||+.++++.
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                 000000000   000    0000111223457889999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-40  Score=313.08  Aligned_cols=252  Identities=21%  Similarity=0.246  Sum_probs=195.2

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .+|++.+.||+|+||.||+++.. +++.||+|++....   ......+.+|++++++++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999975 58899999886432   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++|+|.+++.    ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.++|+|||++..+..
T Consensus        81 E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999983    344678899999999999999999999   999999999999999999999999999753210


Q ss_pred             CC------------------------------------------cceeecccCCCCCCCcccccCCCcCccccchhhhHH
Q 017503          202 NI------------------------------------------THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL  239 (370)
Q Consensus       202 ~~------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  239 (370)
                      ..                                          ........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                          000112468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCC---CHHHHHH
Q 017503          240 VLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP---QMNQVIK  316 (370)
Q Consensus       240 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~evl~  316 (370)
                      +|+|++|+.||........      ..........  ...+.....    ...+.+++.+|+ .+|.+|+   ++.+++.
T Consensus       234 lyell~G~~Pf~~~~~~~~------~~~i~~~~~~--~~~~~~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         234 LYEMLVGQPPFLADTPAET------QLKVINWETT--LHIPSQAKL----SREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eeehhhCCCCCCCCCHHHH------HHHHhccCcc--ccCCCCCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            9999999999865432111      0111110000  001111122    233566777766 5999999   8898876


Q ss_pred             H
Q 017503          317 M  317 (370)
Q Consensus       317 ~  317 (370)
                      .
T Consensus       301 h  301 (376)
T cd05598         301 H  301 (376)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.4e-41  Score=304.92  Aligned_cols=259  Identities=25%  Similarity=0.419  Sum_probs=202.5

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT  115 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  115 (370)
                      .+.++|++.+.||+|++|.||+|.+.      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35688999999999999999999853      24679999876432 233456888999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhcccccC------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeE
Q 017503          116 RRILVYEYVENNSLDRVLLGATKA------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK  189 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  189 (370)
                      ..++||||+.+++|.+++......      ...+++..++.++.|++.||.|||+.   +++|+||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence            999999999999999998532211      22467888999999999999999999   999999999999999999999


Q ss_pred             EeeecCccccCCCCcce-eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 017503          190 IGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       190 L~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      |+|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .....    
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~----  232 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLR----  232 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----
Confidence            99999987554322111 112335678999999998899999999999999999999 6777754321   11111    


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ......        ....+......+.+++.+||+.+|.+|||+.++++.|+
T Consensus       233 ~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         233 FVMEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHcCC--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            111111        11112233456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.7e-41  Score=313.51  Aligned_cols=249  Identities=27%  Similarity=0.390  Sum_probs=195.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|+++++.++|+||+++++++.+....++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            456788899999999999999975 68899999886543 3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|....        ...+..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus       153 ~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        153 FMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             cCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            99999986432        346777889999999999999999   9999999999999999999999999999865432


Q ss_pred             CcceeecccCCCCCCCcccccC-----CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          203 ITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      .. ......|+..|+|||++..     ...+.++|||||||++|+|++|+.||..........+   .......      
T Consensus       222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~------  291 (353)
T PLN00034        222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MCAICMS------  291 (353)
T ss_pred             cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHHHhcc------
Confidence            21 1223468999999998743     2345689999999999999999999873322111111   1111000      


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         .....+......+.+++.+||+.+|.+||++.|+++.
T Consensus       292 ---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 ---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0111223344568899999999999999999999874

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-40  Score=306.57  Aligned_cols=200  Identities=28%  Similarity=0.465  Sum_probs=174.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|++++++++|+||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            578999999999999999999986 5788999987654 33344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+++|.+++.    ....+++..+..++.|++.||.|||+..  +++|+||||+||+++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            999999999983    3345888999999999999999999741  6999999999999999999999999998755332


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcc
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  253 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~  253 (370)
                      .   .....++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             c---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            1   22345889999999999888999999999999999999999998654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3e-40  Score=295.84  Aligned_cols=260  Identities=22%  Similarity=0.398  Sum_probs=210.5

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|++|.||+|... +++.||+|.+...   +......+.+|++++++++|+|++++++++.+....++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999986 7899999987532   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|..++......+..+++..++.++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998865445556689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......    ...... ....        .
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~-~~~~--------~  224 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKK-IEKC--------D  224 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH----HHHHhh-hhcC--------C
Confidence            3211 223457888999999988889999999999999999999999975432211    111111 1110        0


Q ss_pred             CCCCCh-HHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          282 LGEYPP-NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       282 ~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      ....+. .....+.+++.+||..+|.+||++.+|++.|+.+.
T Consensus       225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            111122 34456888999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.4e-41  Score=299.73  Aligned_cols=256  Identities=29%  Similarity=0.459  Sum_probs=204.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.++||+|++|.||+|.+.+...||+|.+..... ....+.+|+.+++.++|+||+++++++. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            467999999999999999999987777899998875432 3356888999999999999999999875 45678999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      .+++|.+++...  .+..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            999999998432  234578999999999999999999999   999999999999999999999999999986654332


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .......++..|+|||...+..++.++||||||+++|+|++ |..||......   ....    .......        .
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~----~~~~~~~--------~  222 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERGYR--------M  222 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHH----HHhcCCC--------C
Confidence            22223345678999999988899999999999999999999 77787543221   1111    1111100        1


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      ..+...+..+.+++.+||+.+|.+||++.++++.|+...
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            112334456889999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=312.68  Aligned_cols=252  Identities=24%  Similarity=0.289  Sum_probs=198.1

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||++++. +++.||||++...   .......+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999976 5889999998653   2334456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+|+|.+++.    .+..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++..+..
T Consensus        81 E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            9999999999983    344689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCcc-------------------------------------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHH
Q 017503          202 NITH-------------------------------------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII  244 (370)
Q Consensus       202 ~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  244 (370)
                      ....                                     ......||+.|+|||++....++.++|||||||++|+|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     011235899999999999999999999999999999999


Q ss_pred             hCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCC---HHHHHHH
Q 017503          245 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ---MNQVIKM  317 (370)
Q Consensus       245 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~~  317 (370)
                      +|..||......   ..   .............  +...    .....+.+++.+|+. +|.+|++   +.+++..
T Consensus       234 ~G~~Pf~~~~~~---~~---~~~i~~~~~~~~~--~~~~----~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         234 VGYPPFCSDNPQ---ET---YRKIINWKETLQF--PDEV----PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCCCCCHH---HH---HHHHHcCCCccCC--CCCC----CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999998644221   11   1111111111000  1101    122346778888886 9999998   8888763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-40  Score=307.48  Aligned_cols=243  Identities=25%  Similarity=0.320  Sum_probs=193.7

Q ss_pred             cceeeecCCeEEEEEEEC----CCCEEEEEECcCc----ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           51 SNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAE----SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .+.||+|+||.||+++..    .++.||+|++...    .......+.+|+.+++.++||||+++++++......++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999853    5788999988643    12233456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          81 YLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            999999999883    344678888999999999999999999   9999999999999999999999999998743322


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      . .......|++.|+|||++.+..++.++|||||||++|+|++|+.||......      ......... .         
T Consensus       154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~-~---------  216 (323)
T cd05584         154 G-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKG-K---------  216 (323)
T ss_pred             C-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcC-C---------
Confidence            1 1223356899999999999888999999999999999999999998643211      111111111 1         


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  317 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  317 (370)
                      ...++.....+.+++.+||+.+|.+||     ++.+++..
T Consensus       217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            011222334578999999999999999     78888663

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.2e-41  Score=306.78  Aligned_cols=240  Identities=25%  Similarity=0.362  Sum_probs=188.9

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHh-cCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSN-VRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||+|++. ++..||+|.+....   ......+..|..++.. .+||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 57889999887531   2233445566677765 4899999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++.    ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++....... ..
T Consensus        81 g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            99998883    344689999999999999999999999   99999999999999999999999999997543322 22


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ..+..   . .....      +   ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~---~-i~~~~------~---~~~  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFD---S-ILNDR------P---HFP  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHH---H-HHcCC------C---CCC
Confidence            2345689999999999998999999999999999999999999864321   11111   1 11111      1   112


Q ss_pred             hHHHHHHHHHHHHchhhccCCCCCHH-HHH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRPQMN-QVI  315 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl  315 (370)
                      ......+.+++.+||+.+|.+||++. +++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            22334577889999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.1e-41  Score=307.68  Aligned_cols=259  Identities=27%  Similarity=0.428  Sum_probs=203.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCC----EEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGR----RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      ..+|++.+.||+|+||.||+|.+. ++.    .||+|.+... .......+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            357999999999999999999864 233    4899988754 334456788999999999999999999999865 567


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      ++++|+.+|+|.+++..   ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        85 ~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            99999999999999843   234588999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcce-eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          199 FPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       199 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||......   .+    .........  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~--  229 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI----SSILEKGER--  229 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHhCCCC--
Confidence            65432221 122234568999999999999999999999999999998 88887643211   11    111111111  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                            ...++.+...+.+++.+||..+|.+||++.+++..|..+.+..
T Consensus       230 ------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         230 ------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                  0112223345788999999999999999999999998887543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.3e-41  Score=298.94  Aligned_cols=255  Identities=28%  Similarity=0.462  Sum_probs=203.6

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..++|++.+.||+|++|.||+|...++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            3568999999999999999999988888899998875433 2356889999999999999999999875 4567899999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            9999999998432  234588999999999999999999999   99999999999999999999999999998664432


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ......    ......        
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~--------  221 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQ----VERGYR--------  221 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCCC--------
Confidence            222222334567999999988899999999999999999999 8888854321   111111    111111        


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                      ...+......+.+++.+||..+|.+|||+.++.+.|++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11122334568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.8e-41  Score=303.23  Aligned_cols=260  Identities=24%  Similarity=0.368  Sum_probs=193.4

Q ss_pred             cCCcccceeeecCCeEEEEEEEC--CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhc---CCCCcceeeeEEE-----e
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT--NGRRIAVKPLSAES--KQGVREFITEIMTLSNV---RHPNLVELIGCCV-----Q  113 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~  113 (370)
                      ++|++.+.||+|+||.||+|++.  ++..||+|.+....  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47999999999999999999873  46789999876432  22234556677777665   6999999999985     2


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      ....++||||+. ++|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456889999997 5888887432  233588999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC-
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE-  272 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  272 (370)
                      |++......  .......+++.|+|||.+.+..++.++|||||||++|+|++|.+||.......   ....+....... 
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~  229 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG  229 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence            999865433  22234568899999999988899999999999999999999999987543211   111111111000 


Q ss_pred             ---CCc------ccccCC----CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          273 ---KPL------ELVDPE----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       273 ---~~~------~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                         ...      ......    +....+.....+.+++.+||+.+|++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence               000      000000    00111223345779999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-40  Score=312.61  Aligned_cols=255  Identities=20%  Similarity=0.230  Sum_probs=200.5

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      ...++|++.+.||+|+||.||+++.+ ++..||+|.+...   .......+.+|+.+++.++||||+++++++.+....+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34678999999999999999999975 5888999988643   2233345778999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+++|+|.+++.     +..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       120 lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         120 MVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            9999999999999883     23578888999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCC----CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGG----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      .............||+.|+|||++.+.    .++.++|||||||++|+|++|..||......   ..   ..........
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~---~~~i~~~~~~  265 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GT---YSKIMDHKNS  265 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HH---HHHHHcCCCc
Confidence            543322222345689999999988653    4789999999999999999999998643211   11   1111111111


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCC--CCCHHHHHHH
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASR--RPQMNQVIKM  317 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  317 (370)
                      ..     ... .......+.+++.+||+.+|.+  ||++.+++..
T Consensus       266 ~~-----~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 LT-----FPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CC-----CCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            00     000 1123345788999999999988  9999999765

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-41  Score=298.96  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=200.6

Q ss_pred             cCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecC
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE  125 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  125 (370)
                      .+|++.+.||+|++|.||++.++++..+|+|.+..... ....+.+|+.++++++|+||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            46889999999999999999988777899998764322 23567789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc
Q 017503          126 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH  205 (370)
Q Consensus       126 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  205 (370)
                      +++|.+++..   ....+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++.........
T Consensus        83 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          83 NGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            9999999842   223689999999999999999999999   9999999999999999999999999998765432221


Q ss_pred             eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       206 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ....   . ......     .   .
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~-~~~~~~-----~---~  221 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVE---S-VSAGYR-----L---Y  221 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHH---H-HHcCCc-----C---C
Confidence            1122223457999999998899999999999999999999 78887643221   1111   1 111110     0   1


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      .+......+.+++.+||..+|++|||+.++++.|
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            1122344688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.7e-40  Score=297.74  Aligned_cols=255  Identities=23%  Similarity=0.384  Sum_probs=201.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++.+.||+|+||.||+|+.. ++..||+|++..........+.+|+.++++++||||+++++++......++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            468999999999999999999974 6788999988766544556788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            99999999883    334688999999999999999999999   99999999999999999999999999998654322


Q ss_pred             cceeecccCCCCCCCccccc---CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          204 THITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      . ......++..|+|||.+.   ...++.++||||||+++|+|++|..||.........      .. ....   ....+
T Consensus       161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------~~-~~~~---~~~~~  229 (267)
T cd06646         161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FL-MSKS---NFQPP  229 (267)
T ss_pred             c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------ee-eecC---CCCCC
Confidence            1 112245788999999874   345788999999999999999999987533211100      00 0000   00011


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      .. .........+.+++.+||..+|.+||++.+|++.|
T Consensus       230 ~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            11 11122335688999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2e-40  Score=306.33  Aligned_cols=248  Identities=26%  Similarity=0.350  Sum_probs=194.3

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||++++. ++..||+|++...   .......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999975 6888999998753   223345677899999888 799999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~  152 (329)
T cd05588          81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT  152 (329)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence            99988873    345789999999999999999999999   99999999999999999999999999987422111 12


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccc--hhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM--NKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                      .....||..|+|||++.+..++.++|||||||++|+|++|+.||.......  ......+..........         .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~  223 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------R  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------C
Confidence            233568999999999999999999999999999999999999986322111  11111222222221111         1


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCC------HHHHHH
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQ------MNQVIK  316 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt------~~evl~  316 (370)
                      .+......+.+++.+||+.+|.+||+      +.++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            12223345788999999999999997      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.8e-40  Score=299.72  Aligned_cols=247  Identities=25%  Similarity=0.343  Sum_probs=195.3

Q ss_pred             eeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCH
Q 017503           54 IGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL  129 (370)
Q Consensus        54 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  129 (370)
                      ||+|+||+||++.++ +++.||+|.+....   ......+..|+.+++.++|+||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999975 68899999886432   22335667899999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeec
Q 017503          130 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR  209 (370)
Q Consensus       130 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~  209 (370)
                      ..++......+..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......... ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence            988754444556789999999999999999999999   9999999999999999999999999999765433221 223


Q ss_pred             ccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHH
Q 017503          210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE  289 (370)
Q Consensus       210 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (370)
                      ..|++.|+|||.+.+..++.++||||||+++|+|++|+.||..........  . ......        .. ....+...
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~-~~~~~~--------~~-~~~~~~~~  224 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E-LKQRIL--------ND-SVTYPDKF  224 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--H-HHHhhc--------cc-CCCCcccC
Confidence            468899999999999999999999999999999999999986432211110  0 000000        00 01122334


Q ss_pred             HHHHHHHHHHchhhccCCCC-----CHHHHHH
Q 017503          290 IIRYMKVAFFCTQAAASRRP-----QMNQVIK  316 (370)
Q Consensus       290 ~~~l~~li~~cl~~~p~~RP-----t~~evl~  316 (370)
                      ...+.+++.+||+.+|.+||     ++.++++
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            45588899999999999999     6676765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.6e-41  Score=303.72  Aligned_cols=263  Identities=27%  Similarity=0.427  Sum_probs=207.7

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEECC------CCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ  113 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  113 (370)
                      ....++|++.+.||+|+||.||++.+..      ...+|+|.+... .......+.+|+.+++++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3445789999999999999999998642      357899988754 333456688899999999 89999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccc------------cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceE
Q 017503          114 GTRRILVYEYVENNSLDRVLLGAT------------KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL  181 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nil  181 (370)
                      ....+++|||+.+++|..++....            .....+++..++.++.|++.||.|||+.   +++||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence            999999999999999999985421            2345689999999999999999999999   9999999999999


Q ss_pred             eCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchh
Q 017503          182 LDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNK  259 (370)
Q Consensus       182 l~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~  259 (370)
                      ++.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......   
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---  241 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---  241 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---
Confidence            999999999999999865432211 1122234567999999988899999999999999999997 88887543211   


Q ss_pred             hHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          260 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      ...    ........        ...+......+.+++.+||..+|.+|||+.++++.|..++
T Consensus       242 ~~~----~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 ELF----KLLKEGYR--------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHH----HHHHcCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            111    11111111        1122233456889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-40  Score=299.95  Aligned_cols=252  Identities=26%  Similarity=0.320  Sum_probs=200.3

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .|++.+.||+|+||.||++.+. +++.||+|.+....   ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4888999999999999999975 68899999886532   2223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+++|.+++..  .....+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999988742  2234689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      ..  .....|+..|+|||++.+..++.++||||+|+++|+|++|..||........   ..........         ..
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~---------~~  221 (285)
T cd05605         156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKE---------DQ  221 (285)
T ss_pred             Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhh---------cc
Confidence            21  1234688999999999988999999999999999999999999875432111   1111111111         11


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  317 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  317 (370)
                      ...+......+.+++.+||+.||.+||     ++.+++..
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            112233445578899999999999999     78887653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.3e-41  Score=310.29  Aligned_cols=242  Identities=27%  Similarity=0.320  Sum_probs=193.8

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      +.||+|+||.||++... ++..||+|++...   .......+..|+++++.++||||+++++++......++||||+.++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999975 6889999988754   2233456678999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       128 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      +|..++.    ....+++..+..++.||+.||.|||+ .   +++||||||+|||++.++.+||+|||++....... ..
T Consensus        81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~  152 (325)
T cd05594          81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT  152 (325)
T ss_pred             cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence            9998883    34468999999999999999999997 7   99999999999999999999999999987533221 11


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||.....   .....    ......      .   ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~----~i~~~~------~---~~p  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE----LILMEE------I---RFP  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHH----HHhcCC------C---CCC
Confidence            2234689999999999999999999999999999999999999864321   11111    111110      0   112


Q ss_pred             hHHHHHHHHHHHHchhhccCCCC-----CHHHHHHH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  317 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  317 (370)
                      ......+.+++.+||+.||.+|+     ++.++++.
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            22334578899999999999996     89998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.8e-40  Score=305.25  Aligned_cols=243  Identities=27%  Similarity=0.359  Sum_probs=190.6

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||+++++ +++.||+|++...   .......+..|+.++.++ +||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999975 5788999988753   233345677888888876 899999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~  152 (329)
T cd05618          81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT  152 (329)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence            99988873    345689999999999999999999999   99999999999999999999999999987532211 11


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccc--hhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM--NKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                      .....||..|+|||++.+..++.++|||||||++|+|++|..||.......  ......+.........         ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---------~~  223 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------IR  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------CC
Confidence            233568999999999999999999999999999999999999985322111  1111111222111111         11


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCH
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQM  311 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~  311 (370)
                      .+......+.+++.+||+.||.+||++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            223334457889999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4e-40  Score=308.32  Aligned_cols=201  Identities=25%  Similarity=0.341  Sum_probs=174.3

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||+||++..+ +++.||+|++....   ......+..|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            57999999999999999999975 58899999886532   233456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            9999999999983    345689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCc----------------------------------ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCC
Q 017503          202 NIT----------------------------------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR  247 (370)
Q Consensus       202 ~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~  247 (370)
                      ...                                  .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                  0012346899999999999999999999999999999999999


Q ss_pred             CCCCcc
Q 017503          248 NSGKAM  253 (370)
Q Consensus       248 ~p~~~~  253 (370)
                      .||...
T Consensus       234 ~Pf~~~  239 (363)
T cd05628         234 PPFCSE  239 (363)
T ss_pred             CCCCCC
Confidence            998643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.7e-40  Score=313.08  Aligned_cols=291  Identities=22%  Similarity=0.353  Sum_probs=221.8

Q ss_pred             ccccccCCCCCCccccccccccCHHHHHHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcC-hhcHH
Q 017503           15 KSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAES-KQGVR   87 (370)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~   87 (370)
                      |.++....+|.+..+.....--.-.++....++|.+.+.||+|+||.||+|++.      .+..||+|++.... .....
T Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~   85 (401)
T cd05107           6 KVIESVSSDGHEYIYVDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQ   85 (401)
T ss_pred             EEeeeeccCCceEEEECCCCCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHH
Confidence            456667777777777644432222235555678999999999999999999864      24579999997653 23345


Q ss_pred             HHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhccccc----------------------------
Q 017503           88 EFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----------------------------  138 (370)
Q Consensus        88 ~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------------  138 (370)
                      .+.+|+.+|.++. ||||+++++++......++||||+.+|+|.+++.....                            
T Consensus        86 ~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (401)
T cd05107          86 ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRK  165 (401)
T ss_pred             HHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccc
Confidence            6889999999997 99999999999999999999999999999999854321                            


Q ss_pred             ------------------------------------------------------------------CCccCCHHHHHHHH
Q 017503          139 ------------------------------------------------------------------ANIKLNWEKRSDIC  152 (370)
Q Consensus       139 ------------------------------------------------------------------~~~~l~~~~~~~i~  152 (370)
                                                                                        ....+++..++.++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  245 (401)
T cd05107         166 SHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFS  245 (401)
T ss_pred             cchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHH
Confidence                                                                              11246778889999


Q ss_pred             HHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccc
Q 017503          153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKA  231 (370)
Q Consensus       153 ~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~  231 (370)
                      .|++.||.|||+.   +++||||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++
T Consensus       246 ~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  322 (401)
T cd05107         246 YQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS  322 (401)
T ss_pred             HHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHh
Confidence            9999999999999   999999999999999999999999999986533221 111223467789999999988899999


Q ss_pred             cchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCC
Q 017503          232 DVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ  310 (370)
Q Consensus       232 Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  310 (370)
                      ||||||+++|||++ |..||......  ...    ..........        ..+......+.+++.+||+.+|.+||+
T Consensus       323 DvwslGvil~e~l~~g~~P~~~~~~~--~~~----~~~~~~~~~~--------~~p~~~~~~l~~li~~cl~~~P~~RPs  388 (401)
T cd05107         323 DVWSFGILLWEIFTLGGTPYPELPMN--EQF----YNAIKRGYRM--------AKPAHASDEIYEIMQKCWEEKFEIRPD  388 (401)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCCCCch--HHH----HHHHHcCCCC--------CCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence            99999999999998 78887543211  111    1111111110        112233456888999999999999999


Q ss_pred             HHHHHHHHHhhh
Q 017503          311 MNQVIKMLTKNI  322 (370)
Q Consensus       311 ~~evl~~L~~~~  322 (370)
                      +.+|+..|+.++
T Consensus       389 ~~ell~~L~~~~  400 (401)
T cd05107         389 FSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHHHHHHHh
Confidence            999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.9e-40  Score=311.65  Aligned_cols=259  Identities=23%  Similarity=0.319  Sum_probs=198.0

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----eeE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----RRI  118 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~  118 (370)
                      +|++.+.||+|+||.||++.+. +++.||+|.+...  +......+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5889999999999999999974 6899999988643  2334567889999999999999999999998776     789


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+.+ +|..++    .....+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        81 lv~e~~~~-~l~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQS-DLHKII----VSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeecccc-CHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            99999974 777776    3445789999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH---------
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL---------  268 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---------  268 (370)
                      .............++..|+|||.+.+. .++.++|||||||++|+|++|+.||........   ...+...         
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~  229 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ---LDLITDLLGTPSLEAM  229 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCHHHH
Confidence            544333333334578899999988764 478999999999999999999999865432111   0100000         


Q ss_pred             ----------H-hcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          269 ----------H-QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       269 ----------~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                                . ......... ..+..........+.+++.+||+.||.+|||+.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSL-PVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCch-HHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                      0 000000000 00001112224557899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.1e-40  Score=304.40  Aligned_cols=255  Identities=23%  Similarity=0.240  Sum_probs=196.7

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++...   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999976 5788999988642   2233445778899999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+|+|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999842   234688999999999999999999999   999999999999999999999999999976654


Q ss_pred             CCcceeecccCCCCCCCcccccC-----CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          202 NITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ..........|++.|+|||++.+     +.++.++||||||+++|+|++|+.||......      ............. 
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~-  227 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERF-  227 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcc-
Confidence            33322333568999999998865     56789999999999999999999998643211      1111111111111 


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCC--CCCHHHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASR--RPQMNQVIKM  317 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  317 (370)
                          .+.....+....+.+++.+|+..++.+  |+++.++++.
T Consensus       228 ----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 ----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                011111223345778888888765544  4678888654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-40  Score=297.54  Aligned_cols=255  Identities=30%  Similarity=0.478  Sum_probs=204.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..++|++.++||+|+||.||+|..+++..||+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            4578999999999999999999988889999998875433 3467888999999999999999998864 4568999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+++|.+++..  ..+..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          82 MENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999998843  2344688999999999999999999999   99999999999999999999999999998665322


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      ........++..|+|||.+....++.++||||||+++|+|++ |+.||.....   ......    .......       
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~~~~~~~-------  222 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQN----LERGYRM-------  222 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHH----HHcCCCC-------
Confidence            222222345678999999998899999999999999999999 9999864321   111111    1111110       


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                       ..+......+.+++.+||..+|++||++.+++..|+.
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 -PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence             1112233458899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-40  Score=301.90  Aligned_cols=262  Identities=26%  Similarity=0.415  Sum_probs=203.2

Q ss_pred             cCCcccceeeecCCeEEEEEEE-----CCCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--Cee
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTL-----TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRR  117 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~  117 (370)
                      .-|++.+.||+|+||.||.+..     .++..||+|.+.... ......+.+|+.+++.++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578999999999999999974     257889999987553 34456788999999999999999999998875  568


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            899999999999999842   233589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcc--eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccch--------hhHHHHHHH
Q 017503          198 LFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN--------KFLLEWAWQ  267 (370)
Q Consensus       198 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~  267 (370)
                      ........  ......++..|+|||.+.+..++.++||||||+++|+|+++..|+........        .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            66433221  11234466789999999888899999999999999999998766433221100        000111111


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      .......        ...+......+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       238 ~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGKR--------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCcc--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111111        111223445688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.2e-40  Score=296.90  Aligned_cols=260  Identities=22%  Similarity=0.395  Sum_probs=208.6

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||.|++|.||++... ++..|++|.+...   +......+.+|+.+++.++|+||+++++++.+....+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57899999999999999999964 7889999977543   2334457888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+++|.+++.........+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998864444456789999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......    ........      ....+.
T Consensus       159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~------~~~~~~  227 (267)
T cd08229         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKIE------QCDYPP  227 (267)
T ss_pred             CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhhhhh------cCCCCC
Confidence            3221 223457889999999988889999999999999999999999975432111    11111110      000011


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      .  ........+.+++.+||+.+|.+|||+.+|++.+.+.
T Consensus       228 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         228 L--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             C--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            1  1123445688999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.5e-40  Score=309.92  Aligned_cols=257  Identities=21%  Similarity=0.267  Sum_probs=198.5

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR  116 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  116 (370)
                      +....++|++.+.||+|+||.||++++. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+...
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3344678999999999999999999986 5788999987542   22234457789999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .++||||+++|+|.+++.     ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       118 ~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence            999999999999999983     23578899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccCC----CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLGG----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      ...............||+.|+|||++...    .++.++|||||||++|+|++|..||......      ..........
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~  263 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHK  263 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC
Confidence            87643322223345689999999998654    3789999999999999999999998643211      1111111111


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCC--CCCHHHHHHH
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR--RPQMNQVIKM  317 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  317 (370)
                      .....  +.    .......+.+++.+|+..++.+  ||++.++++.
T Consensus       264 ~~~~~--p~----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 NSLNF--PE----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cccCC--CC----cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            11110  00    0112334677788888755544  8899999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.7e-40  Score=307.44  Aligned_cols=263  Identities=26%  Similarity=0.436  Sum_probs=204.7

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEe-C
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQ-G  114 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~  114 (370)
                      ..++|++.+.||+|+||.||+|...      .++.||+|++.... ......+..|+.++.++ +|+||+++++++.. .
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3468999999999999999999742      24689999887542 23345678899999999 89999999998865 4


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccC-------------------------------------------------------
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKA-------------------------------------------------------  139 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~-------------------------------------------------------  139 (370)
                      ...+++|||+.+++|.+++......                                                       
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            5678999999999999988532210                                                       


Q ss_pred             --CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce-eecccCCCCC
Q 017503          140 --NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGY  216 (370)
Q Consensus       140 --~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~y  216 (370)
                        ...+++..+..++.|++.||.|||+.   +|+||||||.||+++.++.++|+|||++..+....... .....++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              12678999999999999999999999   99999999999999999999999999998654322111 2223456789


Q ss_pred             CCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHH
Q 017503          217 LAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK  295 (370)
Q Consensus       217 ~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  295 (370)
                      +|||++.+..++.++|||||||++|+|++ |..||.......  .+    ..........        ..+......+.+
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~----~~~~~~~~~~--------~~~~~~~~~~~~  307 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EF----CRRLKEGTRM--------RAPEYATPEIYS  307 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HH----HHHHhccCCC--------CCCccCCHHHHH
Confidence            99999999999999999999999999998 988886432211  11    1111111111        111223345889


Q ss_pred             HHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          296 VAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       296 li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      ++.+||+.+|.+||++.+|++.|.+++.
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.1e-41  Score=302.38  Aligned_cols=258  Identities=24%  Similarity=0.420  Sum_probs=203.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC------CCEEEEEECcCcCh-hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      ..+|++.+.||.|+||.||+|.+.+      +..||+|.+..... .....+.+|+.++..++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            3568889999999999999998642      46799999876543 2345678899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccc------------cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC
Q 017503          118 ILVYEYVENNSLDRVLLGAT------------KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE  185 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~  185 (370)
                      ++++||+.+++|.+++....            .....+++..++.++.|++.||.|||+.   +++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence            99999999999999984211            1123578889999999999999999999   99999999999999999


Q ss_pred             CCeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHH
Q 017503          186 FNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE  263 (370)
Q Consensus       186 ~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~  263 (370)
                      +.+||+|||++........ .......+++.|+|||.+.++.++.++||||||+++|||++ |..||.....   .... 
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~-  236 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVI-  236 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH-
Confidence            9999999999886543221 11223345678999999988889999999999999999998 7777754322   1111 


Q ss_pred             HHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          264 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                         .......        ....+...+..+.+++..||+.+|.+||++++|+..|+.
T Consensus       237 ---~~i~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 ---EMIRNRQ--------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ---HHHHcCC--------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence               1111111        112233445558899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.2e-40  Score=294.97  Aligned_cols=251  Identities=25%  Similarity=0.421  Sum_probs=199.3

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ++|++.+.||+|++|.||+|.+. +++.||+|.+... .......+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            47889999999999999999974 6888999987654 334456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|..+.        .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~  149 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI  149 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence            9999997653        467888999999999999999999   99999999999999999999999999997654321


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                         .....++..|+|||++.+..++.++||||||+++|+|++|+.||........................     +.+.
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~  221 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-----PVLP  221 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-----CCCC
Confidence               22346888999999999989999999999999999999999998654322211111111111111111     1110


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                        .......+.+++.+||+.+|.+||++.++++.
T Consensus       222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              11123357889999999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.6e-40  Score=295.45  Aligned_cols=254  Identities=28%  Similarity=0.444  Sum_probs=202.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++...||+|++|.||++.+..+..+|+|.+.... .....+.+|+++++.++|+|++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            46799999999999999999998877789999876543 23456788999999999999999998875 45678999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      .+++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            999999998432  234578999999999999999999999   999999999999999999999999999986644322


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .......++..|+|||...+..++.++||||||+++|+|++ |..||.....   .....    .......        .
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~----~~~~~~~--------~  222 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLE----QVERGYR--------M  222 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHcCCC--------C
Confidence            22222345678999999988899999999999999999999 8888764322   11111    1111110        0


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                      ..+...+..+.+++.+||..+|.+||++.+|++.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1122344568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=310.76  Aligned_cols=252  Identities=22%  Similarity=0.282  Sum_probs=195.7

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||++..+ +++.||||++...   .......+.+|++++++++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999875 6889999987643   2233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||++..+..
T Consensus        81 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999983    345688999999999999999999999   999999999999999999999999999863321


Q ss_pred             CCc-------------c---------------------------------eeecccCCCCCCCcccccCCCcCccccchh
Q 017503          202 NIT-------------H---------------------------------ITTRIAGTTGYLAPEYVLGGQLTMKADVYS  235 (370)
Q Consensus       202 ~~~-------------~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  235 (370)
                      ...             .                                 ......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            000             0                                 001245899999999999999999999999


Q ss_pred             hhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCC---CCHH
Q 017503          236 FGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR---PQMN  312 (370)
Q Consensus       236 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~  312 (370)
                      |||++|||++|..||......   ....   ...........  +..    ......+.+++.+|+. +|.+|   +++.
T Consensus       234 lGvil~elltG~~Pf~~~~~~---~~~~---~i~~~~~~~~~--p~~----~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSH---ETYR---KIINWRETLYF--PDD----IHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHH---HHHH---HHHccCCccCC--CCC----CCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            999999999999998653321   1111   11110111110  110    1123447788888997 66665   6999


Q ss_pred             HHHHH
Q 017503          313 QVIKM  317 (370)
Q Consensus       313 evl~~  317 (370)
                      +++..
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98775

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2e-40  Score=299.80  Aligned_cols=257  Identities=25%  Similarity=0.452  Sum_probs=202.6

Q ss_pred             cCCcccceeeecCCeEEEEEEE-----CCCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTL-----TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ++|++.+.||+|+||.||+|.+     ..+..|++|.+... .......+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5788999999999999999985     24578999988754 33444678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhccccc-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC
Q 017503          120 VYEYVENNSLDRVLLGATK-------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF  186 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~  186 (370)
                      +|||+.+++|.+++.....             ....+++..++.++.|++.||.|||++   +++|+||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999999843211             123578899999999999999999999   999999999999999999


Q ss_pred             CeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHH
Q 017503          187 NPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEW  264 (370)
Q Consensus       187 ~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~  264 (370)
                      .++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ....  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~--  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVI--  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH--
Confidence            999999999976533221 11222335667999999988889999999999999999998 8888754321   1111  


Q ss_pred             HHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          265 AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                        .........        ..+......+.+++.+||+.+|.+||++.+|++.|..
T Consensus       237 --~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 --EMVRKRQLL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHcCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              111111111        1122233458889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.4e-40  Score=306.74  Aligned_cols=241  Identities=27%  Similarity=0.323  Sum_probs=192.5

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCC-CCcceeeeEEEeCCeeEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~  121 (370)
                      +|++.+.||+|+||.||+|..+ +++.||+|++...   .......+..|++++..+.| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5889999999999999999976 5778999988653   22344567789999999866 56888899999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999998883    344688999999999999999999999   999999999999999999999999999874322


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ......    .....        
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~----i~~~~--------  217 (324)
T cd05587         154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQS----IMEHN--------  217 (324)
T ss_pred             CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH----HHcCC--------
Confidence            11 122345689999999999999999999999999999999999999864321   111111    11111        


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQM  311 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  311 (370)
                       ...+......+.+++.+||+.+|.+|++.
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             11122233457889999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=314.76  Aligned_cols=246  Identities=27%  Similarity=0.367  Sum_probs=202.2

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCC
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGT  115 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  115 (370)
                      -+...++|.+.++||+|.||+|+++..+ +++.||||+++...   .+..+..+.|.+++... +||.+++++.+|...+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3455789999999999999999999976 57889999998763   45567778888888877 5999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      ++|+||||+.||++..+     .....+++..+.-++..|+.||+|||++   +|||||||-+|||||.+|++||+|||+
T Consensus       443 ~l~fvmey~~Ggdm~~~-----~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHH-----IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             eEEEEEEecCCCcEEEE-----EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence            99999999999995433     3446799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          196 AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      ++.--. ....+.+.+||+.|+|||++.+..|+.+.|.|+|||+|||||.|..||.....   ..+.+   ....+    
T Consensus       515 cKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---ee~Fd---sI~~d----  583 (694)
T KOG0694|consen  515 CKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---EEVFD---SIVND----  583 (694)
T ss_pred             ccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHH---HHhcC----
Confidence            985321 22345678999999999999999999999999999999999999999864322   11111   11111    


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  311 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  311 (370)
                         +   ..+|.....+...+++++|..+|++|..+
T Consensus       584 ---~---~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 ---E---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---C---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence               1   12344455567788888999999999765

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-41  Score=279.35  Aligned_cols=250  Identities=26%  Similarity=0.366  Sum_probs=207.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||.|-||.||.|+.+ ++.-||+|++-...   ......+.+|+++-..|+||||+++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            678999999999999999999975 56778999876542   23455678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      +||..+|.|...+..  .....+++...+.++.|+|.||.|+|..   +||||||||+|+|++.++.+|++|||.+..-+
T Consensus       101 lEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            999999999988842  2445688899999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      .   ......+||..|.+||+..+...+...|+|++|++.||++.|.+||....   .......+..       ..+   
T Consensus       176 ~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k-------~~~---  239 (281)
T KOG0580|consen  176 S---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRK-------VDL---  239 (281)
T ss_pred             C---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHH-------ccc---
Confidence            2   33455789999999999999999999999999999999999999997553   1222221111       111   


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                         .+|........++|.+|+..+|.+|.+..++++.-
T Consensus       240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             ---cCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence               12234444578999999999999999999997653

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.1e-40  Score=285.01  Aligned_cols=259  Identities=27%  Similarity=0.378  Sum_probs=196.9

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChh-c-HHHHHHHHHHHHhcCCCCcceeeeEEEe--CCeeEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQ-G-VREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILV  120 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~-~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv  120 (370)
                      ++|+....|++|.||.||+|+++ +++.||+|.++.+... . --...+||.+|.+++|||||.+-.+.+.  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            57899999999999999999986 6888999999876322 1 1235689999999999999999888764  4578999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      ||||+. +|..++..   -..++...++..++.|++.|++|||.+   .|+||||||+|+|++..|.+||+|||+++.+.
T Consensus       156 Me~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999987 88888843   335789999999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ... ...+....|.+|.|||.+.+. .|+.+.|+||+||++.||+++++-|.....- ++  ++.+....  +.+.+.+-
T Consensus       229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQ--l~~If~ll--GtPte~iw  302 (419)
T KOG0663|consen  229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQ--LDKIFKLL--GTPSEAIW  302 (419)
T ss_pred             CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HH--HHHHHHHh--CCCccccC
Confidence            653 334456679999999988775 6999999999999999999998765433211 11  11111111  11111111


Q ss_pred             CCC-----------CCCCh---------H-HHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          280 PEL-----------GEYPP---------N-EIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       280 ~~~-----------~~~~~---------~-~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      |.+           ...+.         . ....-.+|+..++..||++|.|+.+.++.
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            110           01111         0 12345677777999999999999988653

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2e-40  Score=294.72  Aligned_cols=247  Identities=27%  Similarity=0.394  Sum_probs=195.7

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCH
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL  129 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  129 (370)
                      +.||+|+||.||+|.+. +++.||+|.+... .......+.+|++++++++||||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999975 6888999987654 334456788999999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCccee-e
Q 017503          130 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-T  208 (370)
Q Consensus       130 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~-~  208 (370)
                      .+++.   ..+..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........... .
T Consensus        81 ~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLR---TEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            99984   2334588999999999999999999999   999999999999999999999999999875443211111 1


Q ss_pred             cccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCCh
Q 017503          209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP  287 (370)
Q Consensus       209 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (370)
                      ....+..|+|||.+.++.++.++||||||+++|+|++ |..||.......   ..    ........        ...+.
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~----~~~~~~~~--------~~~~~  219 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TR----EAIEQGVR--------LPCPE  219 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HH----HHHHcCCC--------CCCcc
Confidence            1123456999999999999999999999999999998 888875432211   11    11111111        11122


Q ss_pred             HHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          288 NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       288 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      .....+.+++.+||+.+|.+||++.+|++.|+
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            33456888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-40  Score=292.78  Aligned_cols=251  Identities=27%  Similarity=0.397  Sum_probs=201.5

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-----hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      +.|++.+.||+|++|.||.+... ++..|++|.+....     ......+.+|++++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999975 68899999875432     2234567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      |+||+.+++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        82 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999999999883    334688999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCccee--ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          200 PDNITHIT--TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       200 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ........  ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......      ..........    
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~----  224 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA------AIFKIATQPT----  224 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH------HHHHHhccCC----
Confidence            43221111  23457789999999999889999999999999999999999986542211      0111111111    


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                          ....+......+.+++.+||..+|.+|||+.++++.
T Consensus       225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         225 ----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                112223344457889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-40  Score=305.11  Aligned_cols=263  Identities=26%  Similarity=0.426  Sum_probs=206.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC--------CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT--------NGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQG  114 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  114 (370)
                      .++|.+.+.||+|+||.||++++.        +...+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            478999999999999999999853        23569999887542 33456688899999999 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe
Q 017503          115 TRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL  182 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill  182 (370)
                      ...++||||+.+++|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            999999999999999999954322            123588999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhh
Q 017503          183 DQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKF  260 (370)
Q Consensus       183 ~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~  260 (370)
                      +.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.....   ..
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~  250 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE  250 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HH
Confidence            99999999999998755432111 1111224468999999998889999999999999999998 7778753211   11


Q ss_pred             HHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          261 LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      +.    ........        ...+......+.+++.+||+.+|.+||++.+|++.|.+++...
T Consensus       251 ~~----~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         251 LF----KLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HH----HHHHcCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            11    11111111        1122233456888999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=296.26  Aligned_cols=256  Identities=30%  Similarity=0.490  Sum_probs=206.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..++|++.+.||+|++|.||+|..++++.|++|.+..... ....+.+|+.++++++|+|++++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            4678999999999999999999988888899998875433 346788899999999999999999999988899999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++...  .+..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999998432  234689999999999999999999999   99999999999999999999999999988665432


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      .........+..|+|||.+.+..++.++||||||+++|+|++ |+.||....   ........    .....     .  
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~----~~~~~-----~--  223 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQV----ERGYR-----M--  223 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HcCCC-----C--
Confidence            222222234568999999998889999999999999999998 888875332   11111111    11100     0  


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                       ..+...+..+.+++.+||..+|.+||+++++++.|+.
T Consensus       224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             1112224458889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5e-40  Score=309.84  Aligned_cols=250  Identities=20%  Similarity=0.242  Sum_probs=192.4

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++++++|+||+++++++.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            6899999999999999999975 57889999886542   2345578889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+|+|.+++.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999999883    234678899999999999999999999   9999999999999999999999999997532100


Q ss_pred             C----------------------------------------------cceeecccCCCCCCCcccccCCCcCccccchhh
Q 017503          203 I----------------------------------------------THITTRIAGTTGYLAPEYVLGGQLTMKADVYSF  236 (370)
Q Consensus       203 ~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  236 (370)
                      .                                              ........||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              000112468999999999999999999999999


Q ss_pred             hHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCC---HHH
Q 017503          237 GVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ---MNQ  313 (370)
Q Consensus       237 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~e  313 (370)
                      ||++|||++|+.||.......      ...........  ...+......    ..+.+++.+|+ .+|.+|++   +.+
T Consensus       235 Gvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~--~~~p~~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLE------TQMKVINWQTS--LHIPPQAKLS----PEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHH------HHHHHHccCCC--cCCCCcccCC----HHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            999999999999986542211      01111110111  0011111222    33556666655 49999987   777


Q ss_pred             HHH
Q 017503          314 VIK  316 (370)
Q Consensus       314 vl~  316 (370)
                      ++.
T Consensus       302 i~~  304 (382)
T cd05625         302 IKA  304 (382)
T ss_pred             Hhc
Confidence            764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.4e-40  Score=304.05  Aligned_cols=237  Identities=26%  Similarity=0.334  Sum_probs=186.7

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHH-HHHhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIM-TLSNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||+||+|.++ +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999985 68899999886432   222334445544 45778999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++.    .+..+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||++....... ..
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (323)
T cd05575          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT  152 (323)
T ss_pred             CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence            99998883    345688999999999999999999999   99999999999999999999999999987532211 12


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||.....   .....   .... .. .        ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~---~i~~-~~-~--------~~~  216 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEMYD---NILN-KP-L--------RLK  216 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HHHHH---HHHc-CC-C--------CCC
Confidence            2335689999999999999999999999999999999999999864321   11111   1111 11 0        111


Q ss_pred             hHHHHHHHHHHHHchhhccCCCCCHH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRPQMN  312 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RPt~~  312 (370)
                      +.....+.+++.+||+.+|.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            22244578899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=299.38  Aligned_cols=257  Identities=24%  Similarity=0.411  Sum_probs=204.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC------CCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|++.+.||+|+||.||+|..+.      +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4689999999999999999998642      3679999886553 33445788899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhccccc------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEe
Q 017503          118 ILVYEYVENNSLDRVLLGATK------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG  191 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~  191 (370)
                      ++||||+.+++|.+++.....      ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            999999999999999854322      123478899999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHH
Q 017503          192 DFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       192 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      |||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .....    ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~----~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLK----FV  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHH----HH
Confidence            9999876543221 12223346778999999988889999999999999999998 8888753321   11111    11


Q ss_pred             hcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          270 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      .....        ...+......+.+++.+||+.+|.+|||+.+++..|+
T Consensus       235 ~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 IDGGH--------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             hcCCC--------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11111        1112223456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.4e-40  Score=303.10  Aligned_cols=243  Identities=27%  Similarity=0.348  Sum_probs=192.0

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||++... +++.||+|++...   .......+.+|+.++.++ +||||+++++++......++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999975 5788999998754   223345677899999888 699999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++.    ....+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  152 (327)
T cd05617          81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT  152 (327)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence            99998873    344689999999999999999999999   99999999999999999999999999987432211 12


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||........................         ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~p  223 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI---------RIP  223 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---------CCC
Confidence            23456899999999999999999999999999999999999999643322221112222222211110         112


Q ss_pred             hHHHHHHHHHHHHchhhccCCCCCH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRPQM  311 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RPt~  311 (370)
                      ......+.+++.+||+.||.+||++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            2233457889999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.3e-40  Score=308.55  Aligned_cols=261  Identities=21%  Similarity=0.262  Sum_probs=201.4

Q ss_pred             HHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 017503           38 YTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ  113 (370)
Q Consensus        38 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  113 (370)
                      ...+....++|++.+.||+|+||.||+++++ +++.||+|++...   .......+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4445556789999999999999999999986 5788999987542   22234457789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      ....++||||+++++|.+++.     ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999999983     23478888999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCC----CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGG----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      |++...............||+.|+|||++...    .++.++|||||||++|+|++|..||.....      ........
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~  260 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIM  260 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence            99987654322223345689999999998653    378999999999999999999999864321      11111111


Q ss_pred             hcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCC--CCCHHHHHHHH
Q 017503          270 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR--RPQMNQVIKML  318 (370)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~L  318 (370)
                      ........  +    ........+.+++..|+..++.+  ||++.++++..
T Consensus       261 ~~~~~~~~--~----~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         261 NHKNSLTF--P----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             cCCCcccC--C----CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            11111111  0    11123345778888899744433  78999988754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-39  Score=297.09  Aligned_cols=265  Identities=23%  Similarity=0.414  Sum_probs=202.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-----------------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcce
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-----------------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVE  106 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-----------------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~  106 (370)
                      .++|++.+.||+|+||.||++.+.                 ++..||+|.+... .......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            367999999999999999998643                 2346899988755 3344567889999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCCHHHHhcccccC-------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCc
Q 017503          107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN  179 (370)
Q Consensus       107 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~N  179 (370)
                      +++++......++||||+.+++|.+++......       ...+++..++.++.|++.||+|||+.   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            999999999999999999999999998543221       23477889999999999999999999   99999999999


Q ss_pred             eEeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh--CCCCCCccccc
Q 017503          180 ILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS--GRNSGKAMWGQ  256 (370)
Q Consensus       180 ill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt--g~~p~~~~~~~  256 (370)
                      |+++.++.++|+|||++..+...... ......++..|++||....+.++.++|||||||++|||++  |..||..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-  239 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence            99999999999999998765432211 1122234578999999888899999999999999999998  5667654322 


Q ss_pred             chhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          257 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                        ................ ....+    .+..+...+.+++.+||+.+|.+||++.+|++.|++
T Consensus       240 --~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         240 --EQVIENTGEFFRDQGR-QVYLP----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             --HHHHHHHHHHHhhccc-cccCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence              1111111111111110 00011    122233568889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.1e-40  Score=296.99  Aligned_cols=259  Identities=28%  Similarity=0.433  Sum_probs=204.2

Q ss_pred             CCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ......+.+|+.+++.++||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            5888999999999999999863      23568999877553 3345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhccccc--------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCc
Q 017503          120 VYEYVENNSLDRVLLGATK--------------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN  179 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~N  179 (370)
                      ++||+.+++|.+++.....                    ....+++..++.++.|++.||.|||+.   +++||||+|+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999998854221                    123578999999999999999999999   99999999999


Q ss_pred             eEeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccc
Q 017503          180 ILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQM  257 (370)
Q Consensus       180 ill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~  257 (370)
                      |++++++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....  
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            99999999999999999765332211 1122345678999999988889999999999999999998 8888754321  


Q ss_pred             hhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          258 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                       ..+    +........     .   ..+......+.+++.+||+.+|.+||++.++++.|++++.
T Consensus       236 -~~~----~~~~~~~~~-----~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 -ERL----FNLLKTGYR-----M---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -HHH----HHHHhCCCC-----C---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence             111    111111110     0   1122233458889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.1e-40  Score=301.79  Aligned_cols=265  Identities=25%  Similarity=0.428  Sum_probs=208.9

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC--------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT--------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCV  112 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  112 (370)
                      ...++|++.+.||+|+||.||+++..        ++..||+|..... .......+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            44788999999999999999999741        2457999988654 234456788999999999 8999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCce
Q 017503          113 QGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI  180 (370)
Q Consensus       113 ~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Ni  180 (370)
                      .....++||||+.+++|.+++.....            ....+++..++.++.|++.||.|||++   +++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            99999999999999999999864322            123578899999999999999999999   999999999999


Q ss_pred             EeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccch
Q 017503          181 LLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMN  258 (370)
Q Consensus       181 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~  258 (370)
                      +++.++.++|+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.....   
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---  245 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---  245 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence            9999999999999999866443221 1222345678999999988889999999999999999998 6777643211   


Q ss_pred             hhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      ..+    ..........        ..+......+.+++.+||+.+|.+||++.+|++.|.++....
T Consensus       246 ~~~----~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         246 EEL----FKLLKEGHRM--------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             HHH----HHHHHcCCcC--------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence            111    1111111111        112234456888999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.5e-40  Score=304.72  Aligned_cols=237  Identities=24%  Similarity=0.307  Sum_probs=186.5

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHH-HHHhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIM-TLSNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||+|++. ++..||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999985 57889999886432   222334455544 57788999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++.    ....+++..+..++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (321)
T cd05603          81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET  152 (321)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence            99988873    345688899999999999999999999   99999999999999999999999999987532221 12


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||.....   .....   .... ..         ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~---~i~~-~~---------~~~~  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYD---NILH-KP---------LQLP  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHH---HHhc-CC---------CCCC
Confidence            2335689999999999988999999999999999999999999864321   11111   1111 10         1122


Q ss_pred             hHHHHHHHHHHHHchhhccCCCCCHH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRPQMN  312 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RPt~~  312 (370)
                      +.....+.+++.+||+.+|.+||+..
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            33345688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-39  Score=299.50  Aligned_cols=255  Identities=22%  Similarity=0.229  Sum_probs=195.4

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .......+.+|+.+++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            57999999999999999999975 5889999988642   2233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+++|.+++..   ....+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999999842   244688999999999999999999999   999999999999999999999999999876544


Q ss_pred             CCcceeecccCCCCCCCcccccC-----CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          202 NITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ..........||+.|+|||++..     ..++.++|||||||++|+|++|+.||.....      ...............
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~  228 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQ  228 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCccc
Confidence            33222233468999999998863     4578899999999999999999999864321      111111111111111


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhh--ccCCCCCHHHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQA--AASRRPQMNQVIKM  317 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~--~p~~RPt~~evl~~  317 (370)
                           +..........+.+++.+|+..  ++..||++.++++.
T Consensus       229 -----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 -----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                 1111112334467777776654  33447899998875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-40  Score=295.80  Aligned_cols=256  Identities=23%  Similarity=0.436  Sum_probs=201.0

Q ss_pred             CcccceeeecCCeEEEEEEECC----CCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe-----
Q 017503           48 FHLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR-----  116 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----  116 (370)
                      |++.+.||+|+||.||.|....    +..||+|.+...  .......+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6788999999999999998642    367999988754  23345678899999999999999999998876554     


Q ss_pred             -eEEEEEecCCCCHHHHhcccc--cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          117 -RILVYEYVENNSLDRVLLGAT--KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       117 -~~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                       .+++|||+.+++|..++....  .....+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             789999999999998884432  2234689999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcce-eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhc
Q 017503          194 GLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       194 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      |++.......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||.....   ..+....    ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~----~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL----RH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----Hc
Confidence            9998654332211 112234568999999988899999999999999999999 8888754321   1121111    11


Q ss_pred             CCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      ...        ...+......+.+++.+||+.+|.+||++.++++.|+++
T Consensus       231 ~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNR--------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC--------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111        112233445688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.5e-40  Score=295.78  Aligned_cols=256  Identities=28%  Similarity=0.437  Sum_probs=203.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-C---CCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-N---GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|++.+.||+|+||.||+|.+. +   +..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            467899999999999999999864 2   3368999887542 3345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++++|.+++..   ....+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          83 VTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            9999999999999843   234689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceee--cccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          200 PDNITHITT--RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       200 ~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      .........  ...++..|++||.+.+..++.++|+||||+++|++++ |..||......   ....    .......  
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~----~~~~~~~--  227 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIK----AIEEGYR--  227 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHH----HHhCCCc--
Confidence            543222211  1223467999999998899999999999999999886 99887543221   1111    1111111  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                         .   ..+...+..+.+++.+||+.+|.+||++.++++.|.++
T Consensus       228 ---~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 ---L---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---C---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence               0   11122334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.4e-40  Score=299.47  Aligned_cols=263  Identities=25%  Similarity=0.408  Sum_probs=202.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-----CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--CCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-----NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~  117 (370)
                      ..+|++.+.||+|+||.||++...     ++..||+|.+..........+.+|++++++++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            457899999999999999999742     578899999887766666788999999999999999999998754  3467


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+.+++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence            899999999999999842   234589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCccee--ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchh---------hHHHHHH
Q 017503          198 LFPDNITHIT--TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK---------FLLEWAW  266 (370)
Q Consensus       198 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~---------~~~~~~~  266 (370)
                      ..........  ....++..|+|||.+.+..++.++||||||+++|||++|..++.........         .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            7654322111  1122345699999999889999999999999999999987664332111000         0000000


Q ss_pred             HHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      ......        .....+......+.+++.+||..+|.+|||+.+|++.|+.+
T Consensus       237 ~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNN--------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcC--------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            111110        01111223345688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.7e-40  Score=291.87  Aligned_cols=247  Identities=28%  Similarity=0.396  Sum_probs=197.3

Q ss_pred             ceeeecCCeEEEEEEECCCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCHH
Q 017503           52 NKIGRGGFGTVYKGTLTNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD  130 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  130 (370)
                      ++||+|+||.||+|...++..||+|.+.... ......+.+|+++++.++||||+++++++......++||||+.+++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4689999999999998888999999887653 233446888999999999999999999999999999999999999999


Q ss_pred             HHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecc
Q 017503          131 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI  210 (370)
Q Consensus       131 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  210 (370)
                      +++..   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            98842   234578999999999999999999999   999999999999999999999999999875443322222222


Q ss_pred             cCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHH
Q 017503          211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE  289 (370)
Q Consensus       211 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (370)
                      .++..|+|||++....++.++||||||+++|+|++ |..||......   ...    ........        ...+...
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~----~~~~~~~~--------~~~~~~~  219 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAR----EQVEKGYR--------MSCPQKC  219 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHH----HHHHcCCC--------CCCCCCC
Confidence            34567999999998899999999999999999998 88887543211   111    11111111        1112233


Q ss_pred             HHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          290 IIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       290 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ...+.+++.+||..+|.+||++.++++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            456889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.2e-40  Score=295.00  Aligned_cols=258  Identities=28%  Similarity=0.414  Sum_probs=200.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCC----EEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGR----RIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .++|++.+.||+|+||.||+|.+. ++.    .+++|.+.... ......+..|+..+++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            357888999999999999999974 343    47888876442 2334567788889999999999999998764 4567


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +++||+.+|+|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        85 ~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            89999999999999842   334689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          199 FPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       199 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ....... ......++..|+|||.+.++.++.++||||||+++|||++ |..||.......   ..    ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~~  231 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VP----DLLEKGERLA  231 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCcCC
Confidence            5433221 1223446678999999998999999999999999999998 988876543211   11    1111111110


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                           .   +..+...+.+++.+||..+|.+|||+.++++.|..+.+.
T Consensus       232 -----~---~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         232 -----Q---PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             -----C---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                 0   111233467788999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.6e-40  Score=305.72  Aligned_cols=236  Identities=28%  Similarity=0.360  Sum_probs=189.0

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||+|+++ +++.||+|++...   .......+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 5788999988643   223345667788888876 799999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....... ..
T Consensus        81 g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~  152 (320)
T cd05590          81 GDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT  152 (320)
T ss_pred             chHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence            99998883    345689999999999999999999999   99999999999999999999999999987532221 12


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.....   .....    .......         ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~----~i~~~~~---------~~~  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLFE----AILNDEV---------VYP  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHH----HHhcCCC---------CCC
Confidence            2335689999999999999999999999999999999999999864321   11111    1111110         111


Q ss_pred             hHHHHHHHHHHHHchhhccCCCCCH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRPQM  311 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RPt~  311 (370)
                      ......+.+++.+||+.||.+||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            2233457889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.3e-40  Score=295.18  Aligned_cols=256  Identities=24%  Similarity=0.430  Sum_probs=198.4

Q ss_pred             CcccceeeecCCeEEEEEEECCC-C--EEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC------Ce
Q 017503           48 FHLSNKIGRGGFGTVYKGTLTNG-R--RIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TR  116 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~~~-~--~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~  116 (370)
                      |.+.+.||+|+||.||+|.+... .  .||+|.+...  .......+.+|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            45778999999999999997643 2  5899987654  344456788899999999999999999987532      24


Q ss_pred             eEEEEEecCCCCHHHHhcccc--cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          117 RILVYEYVENNSLDRVLLGAT--KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      .+++|||+.+++|.+++....  .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998874322  2234589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcce-eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          195 LAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       195 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      ++.......... .....++..|++||.+.+..++.++||||||+++|+|++ |..||.....   ....    ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~----~~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIY----DYLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHcC
Confidence            998764332111 122235678999999999999999999999999999999 7888754321   1111    111211


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      ...        ..++.....+.+++.+||+.+|.+|||+.+|++.|+++
T Consensus       231 ~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 NRL--------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111        11223344588999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.6e-40  Score=298.75  Aligned_cols=257  Identities=26%  Similarity=0.425  Sum_probs=203.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      ..+|++.+.||+|+||.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++.+....+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            457888999999999999999742      35678999887766666678899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccccc-----------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          119 LVYEYVENNSLDRVLLGATK-----------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                      ++|||+.+++|.+++.....           ....+++..++.++.|++.||+|||+.   +++||||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence            99999999999999854321           113578999999999999999999999   9999999999999999999


Q ss_pred             eEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHH
Q 017503          188 PKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWA  265 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~  265 (370)
                      ++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......   ....  
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~--  235 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIE--  235 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHH--
Confidence            999999998755432211 1122234678999999999999999999999999999998 88887543221   1111  


Q ss_pred             HHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          266 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                       . .......        ..+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       236 -~-~~~~~~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 -C-ITQGREL--------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -H-HHcCccC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             1 1111111        111222345789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.9e-40  Score=298.27  Aligned_cols=262  Identities=23%  Similarity=0.381  Sum_probs=207.8

Q ss_pred             hccCCcccceeeecCCeEEEEEEECC-----CCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe-CCe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTN-----GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ-GTR  116 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~  116 (370)
                      ..++|++.+.||+|+||.||+|.+.+     +..|++|.+... .......+.+|+.+++.++|+|++++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            46789999999999999999999865     678999988754 33445678899999999999999999998776 567


Q ss_pred             eEEEEEecCCCCHHHHhcccccC----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEee
Q 017503          117 RILVYEYVENNSLDRVLLGATKA----NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD  192 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~D  192 (370)
                      .+++++|+.+++|.+++......    +..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            88999999999999998543322    25689999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHh
Q 017503          193 FGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQ  270 (370)
Q Consensus       193 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  270 (370)
                      ||+++.+...... ......++..|+|||++.+..++.++||||||+++|++++ |+.||.....   ..+.    ....
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMA----AYLK  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHH----HHHH
Confidence            9999865433221 1222345678999999988899999999999999999999 9998864321   1111    1111


Q ss_pred             cCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      .....        ..+...+..+.+++.+||..+|++|||+.+++..|..+..
T Consensus       234 ~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 DGYRL--------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             cCCCC--------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            11110        0112233457899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.3e-40  Score=292.39  Aligned_cols=250  Identities=29%  Similarity=0.420  Sum_probs=203.6

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||+|++|.||++.++ ++..|++|.+...  .......+.+|+.+++.++|||++++++++.+....++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            5888999999999999999975 6888999987643  344566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+++|.+++...  .+..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999999998532  235688999999999999999999999   99999999999999999999999999988665432


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      . ......++..|+|||++.+..++.++|+||||+++|+|++|+.||.....   .....   ... ..        ...
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~---~~~-~~--------~~~  219 (256)
T cd08529         156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALIL---KII-RG--------VFP  219 (256)
T ss_pred             c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHH-cC--------CCC
Confidence            2 12334578899999999999999999999999999999999999864431   11111   111 11        111


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..+......+.+++.+||+.+|.+||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1222334558899999999999999999999763

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-40  Score=297.73  Aligned_cols=263  Identities=25%  Similarity=0.409  Sum_probs=200.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC---------------CCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN---------------GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELI  108 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~---------------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~  108 (370)
                      .++|++.+.||+|+||.||++....               ...||+|.+... .......+.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4689999999999999999987642               234899988765 334455788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHhccccc--------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCce
Q 017503          109 GCCVQGTRRILVYEYVENNSLDRVLLGATK--------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI  180 (370)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Ni  180 (370)
                      +++......++||||+.+++|.+++.....        ....+++..++.++.|++.||.|||+.   +++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            999999999999999999999998843211        112468899999999999999999999   999999999999


Q ss_pred             EeCCCCCeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhC--CCCCCcccccc
Q 017503          181 LLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG--RNSGKAMWGQM  257 (370)
Q Consensus       181 ll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg--~~p~~~~~~~~  257 (370)
                      +++.++.+||+|||++........ .......++..|+|||.+.++.++.++||||||+++|+|+++  ..||.....  
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence            999999999999999976543221 111223346789999999888999999999999999999984  455543321  


Q ss_pred             hhhHHHHHHHHHhcC-CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          258 NKFLLEWAWQLHQEE-KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       258 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                       .............. ....      ...++..+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus       239 -~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 -EQVIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             -HHHHHHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             11111111111111 1100      0111223346899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.6e-40  Score=299.96  Aligned_cols=263  Identities=24%  Similarity=0.432  Sum_probs=204.5

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQG  114 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  114 (370)
                      ..+.++|++.+.||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            346789999999999999999999754      24579999876543 23344677899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhccccc------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCe
Q 017503          115 TRRILVYEYVENNSLDRVLLGATK------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP  188 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~  188 (370)
                      ...++||||+.+|+|.+++.....      ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence            999999999999999999854221      123456778899999999999999999   99999999999999999999


Q ss_pred             EEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 017503          189 KIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAW  266 (370)
Q Consensus       189 kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  266 (370)
                      +|+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||.....   ......  
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~~--  233 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLKF--  233 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH--
Confidence            9999999875533221 11122234678999999998899999999999999999998 6777754321   111111  


Q ss_pred             HHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                       .. ...        ....+......+.+++.+||+.+|.+|||+.++++.|....
T Consensus       234 -~~-~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         234 -VM-DGG--------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             -HH-cCC--------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence             11 110        11112223356889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.1e-40  Score=305.19  Aligned_cols=242  Identities=26%  Similarity=0.346  Sum_probs=192.5

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||+|+++ +++.||+|++...   .......+..|.+++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999976 5789999988654   223345567788888866 899999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....... ..
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~  152 (321)
T cd05591          81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT  152 (321)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence            99998883    345688999999999999999999999   99999999999999999999999999987543221 12


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.....   .....   .......          ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~---~i~~~~~----------~~p  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFE---SILHDDV----------LYP  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHH---HHHcCCC----------CCC
Confidence            2335689999999999999999999999999999999999999864421   11111   1111110          111


Q ss_pred             hHHHHHHHHHHHHchhhccCCCC-------CHHHHHHH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRP-------QMNQVIKM  317 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RP-------t~~evl~~  317 (370)
                      ......+.+++.+||+.+|.+||       ++.++++.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            12234578899999999999999       77777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.5e-40  Score=294.10  Aligned_cols=252  Identities=30%  Similarity=0.454  Sum_probs=200.0

Q ss_pred             CcccceeeecCCeEEEEEEECC-CCEEEEEECcCcChhcHH--HHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           48 FHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVR--EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      |++.+.||+|+||+||+++... ++.||+|.+.........  ...+|+.++++++||||+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            7789999999999999999874 568999998877543322  3456999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      .+++|.+++.    ....+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||.+..... ..
T Consensus        81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN  152 (260)
T ss_dssp             TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred             cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence            9999999984    455689999999999999999999999   999999999999999999999999999986422 22


Q ss_pred             ceeecccCCCCCCCccccc-CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .......++..|+|||.+. +...+.++||||+|+++|+|++|..||...............   .........      
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~------  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKI---LKRPLPSSS------  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHH---HHTHHHHHT------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc---ccccccccc------
Confidence            2334456788999999998 788999999999999999999999998765211111111111   100000000      


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .........+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000011256889999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.2e-40  Score=292.48  Aligned_cols=245  Identities=28%  Similarity=0.431  Sum_probs=194.2

Q ss_pred             eeeecCCeEEEEEEEC---CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 017503           53 KIGRGGFGTVYKGTLT---NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        53 ~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      .||+|+||.||+|.++   ++..+|+|++....  ......+.+|+.+++.+.||||+++++++. ....++||||+.++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999753   57789999886542  334567889999999999999999999875 45678999999999


Q ss_pred             CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce-
Q 017503          128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-  206 (370)
Q Consensus       128 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~-  206 (370)
                      +|.+++.    ....+++..++.++.|++.||.|||++   +++||||||+||+++.++.++|+|||++.......... 
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9999983    334689999999999999999999999   99999999999999999999999999998664432211 


Q ss_pred             -eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          207 -TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       207 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                       .....++..|+|||.+....++.++||||||+++|||++ |..||.....   .....    .......        ..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~----~i~~~~~--------~~  218 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQ----MIESGER--------ME  218 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHCCCC--------CC
Confidence             112234578999999988889999999999999999998 8989865422   11111    1111111        11


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                      .+......+.+++.+||+.+|.+||++.+|.+.|+.
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            222334558899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=305.22  Aligned_cols=294  Identities=27%  Similarity=0.435  Sum_probs=230.3

Q ss_pred             cccccCCCCCCccccccccccCHH------HHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChh-cHHH
Q 017503           16 SAEREAPQGVDGELLRNVNHFSYT------ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQ-GVRE   88 (370)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~-~~~~   88 (370)
                      .++-...+++.....+.+..+++.      ..+-......+.++||+|-||.|.......+.+||+|.++..... ..++
T Consensus       502 ~a~iv~~Q~vs~~Nss~v~y~~~~~~k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~  581 (807)
T KOG1094|consen  502 EADIVTLQGVSGGNSSAVPYLPPGVGKGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARND  581 (807)
T ss_pred             ccccccccCCCCCccccccccCcccccCcchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHH
Confidence            344555566666666666666555      223335667889999999999999999887899999999887544 4588


Q ss_pred             HHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 017503           89 FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP  168 (370)
Q Consensus        89 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~  168 (370)
                      |.+|+++|.+++||||++++|+|..++.+++|+||+++|+|.+|+..+....  +.-....+|+.||+.|++||.+.   
T Consensus       582 F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---  656 (807)
T KOG1094|consen  582 FLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---  656 (807)
T ss_pred             HHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---
Confidence            9999999999999999999999999999999999999999999996543332  34555677999999999999999   


Q ss_pred             CeEeecCCCCceEeCCCCCeEEeeecCccccCCC-CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh--
Q 017503          169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS--  245 (370)
Q Consensus       169 ~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt--  245 (370)
                      +++||||.+.|+|++.++++||+|||+++.+... ..+...+..-..+|||||.+..++++.++|+|+||+++||+++  
T Consensus       657 nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C  736 (807)
T KOG1094|consen  657 NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLC  736 (807)
T ss_pred             chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHH
Confidence            9999999999999999999999999999955443 3344444556789999999999999999999999999999865  


Q ss_pred             CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          246 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       246 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      ...||....+   ...++...........     ......|+-++.++.+++.+||..+-++||+++++...|++..
T Consensus       737 ~e~Py~~lt~---e~vven~~~~~~~~~~-----~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  737 REQPYSQLTD---EQVVENAGEFFRDQGR-----QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             hhCchhhhhH---HHHHHhhhhhcCCCCc-----ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            4556654432   1122222222221111     1123456667777889999999999999999999999998753

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.2e-40  Score=296.29  Aligned_cols=247  Identities=26%  Similarity=0.327  Sum_probs=192.5

Q ss_pred             eeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCH
Q 017503           54 IGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL  129 (370)
Q Consensus        54 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  129 (370)
                      ||+|+||.||++..+ +|+.||+|.+....   ......+..|++++++++||||+++++++......++||||+.+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999975 58999999886432   12233456699999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeec
Q 017503          130 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR  209 (370)
Q Consensus       130 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~  209 (370)
                      ..++..  .....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~  153 (277)
T cd05607          81 KYHIYN--VGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ  153 (277)
T ss_pred             HHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence            888743  2234588999999999999999999999   99999999999999999999999999988654332  2233


Q ss_pred             ccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHH
Q 017503          210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE  289 (370)
Q Consensus       210 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (370)
                      ..++..|+|||++.+..++.++|||||||++|+|++|+.||..........  ..........         ........
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~---------~~~~~~~~  222 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLEDE---------VKFEHQNF  222 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHhhccc---------cccccccC
Confidence            468899999999998889999999999999999999999986543221111  1111111100         00001122


Q ss_pred             HHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          290 IIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       290 ~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      ...+.+++.+||+.+|.+||+++|+++.+
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            34478899999999999999998776433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.7e-40  Score=298.86  Aligned_cols=259  Identities=25%  Similarity=0.434  Sum_probs=203.7

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR  116 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  116 (370)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++|||++++++++.+...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            3578999999999999999999864      46789999887553 3445678889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhccccc------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCC
Q 017503          117 RILVYEYVENNSLDRVLLGATK------------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS  178 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~  178 (370)
                      .++||||+.+++|.+++.....                  ....+++..++.++.|++.||.|||+.   +++||||+|+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence            9999999999999999853221                  123478889999999999999999999   9999999999


Q ss_pred             ceEeCCCCCeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCccccc
Q 017503          179 NILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQ  256 (370)
Q Consensus       179 Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~  256 (370)
                      ||+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|+|++ |..||..... 
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-  238 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-  238 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence            99999999999999999875433211 11122234567999999988899999999999999999998 7777643321 


Q ss_pred             chhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          257 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                        ....    ........        ...+......+.+++.+||+.+|.+|||+.|+++.|++
T Consensus       239 --~~~~----~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 --EEVI----YYVRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --HHHH----HHHhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence              1111    11111111        11222344568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.1e-40  Score=304.33  Aligned_cols=241  Identities=26%  Similarity=0.327  Sum_probs=192.4

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      +|++.+.||+|+||.||+|++. ++..||+|++....   ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5889999999999999999976 57789999887542   22334566678888777 6899999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++|+|..++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999998883    344688999999999999999999999   999999999999999999999999999875332


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..+...    .....        
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~----i~~~~--------  217 (323)
T cd05616         154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQS----IMEHN--------  217 (323)
T ss_pred             CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHH----HHhCC--------
Confidence            11 112335689999999999999999999999999999999999999865422   111111    11111        


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQM  311 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  311 (370)
                       ..++.....++.+++.+||+.+|.+|++.
T Consensus       218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             01122334457889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.1e-40  Score=302.94  Aligned_cols=264  Identities=25%  Similarity=0.419  Sum_probs=206.8

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC--------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT--------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ  113 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  113 (370)
                      ...+|++.+.||+|+||.||++.+.        .+..||+|.+... .......+.+|+++++++ +||||+++++++..
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            3467999999999999999999752        1236899988754 234456788999999999 89999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceE
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL  181 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nil  181 (370)
                      ....+++|||+.+++|.+++.....            ....+++..++.++.|++.||.|||++   +++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence            9999999999999999999854321            223578899999999999999999999   9999999999999


Q ss_pred             eCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchh
Q 017503          182 LDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNK  259 (370)
Q Consensus       182 l~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~  259 (370)
                      ++.++.++|+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.....   .
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~  243 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---E  243 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---H
Confidence            999999999999998765432211 1122234567999999999999999999999999999998 7777754321   1


Q ss_pred             hHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          260 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      ...    ........        ...+......+.+++.+||+.+|.+||++.++++.|..+....
T Consensus       244 ~~~----~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         244 ELF----KLLKEGHR--------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHH----HHHHcCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            111    11111111        1112233456889999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.1e-40  Score=298.81  Aligned_cols=260  Identities=27%  Similarity=0.394  Sum_probs=203.1

Q ss_pred             cCCcccceeeecCCeEEEEEEECC-C--CEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLTN-G--RRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~~-~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ++|++.+.||+|+||.||+|..++ +  ..+++|.++.. .....+.+.+|+.+++++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            689999999999999999998753 3  34788877743 334456788899999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCe
Q 017503          121 YEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP  188 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~  188 (370)
                      |||+++++|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999854321            123588999999999999999999999   99999999999999999999


Q ss_pred             EEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHH
Q 017503          189 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       189 kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      ||+|||++........  ......+..|+|||.+....++.++|||||||++|+|++ |..||......   ...    .
T Consensus       159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~----~  229 (297)
T cd05089         159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELY----E  229 (297)
T ss_pred             EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----H
Confidence            9999999864322111  111223457999999988889999999999999999997 98888544221   111    1


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      ......     .   ...+......+.+++.+||+.+|.+||++.++++.|..+....
T Consensus       230 ~~~~~~-----~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         230 KLPQGY-----R---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHhcCC-----C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            111110     0   1112223345889999999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-40  Score=306.40  Aligned_cols=239  Identities=26%  Similarity=0.284  Sum_probs=191.3

Q ss_pred             cceeeecCCeEEEEEEE----CCCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           51 SNKIGRGGFGTVYKGTL----TNGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .+.||+|+||.||+++.    .++..||+|++.....  .....+..|++++++++||||+++++++.+....++||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999885    2578999998875421  22345678999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      .+++|.+++.    ....+++..+..++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-  152 (318)
T cd05582          81 RGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-  152 (318)
T ss_pred             CCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence            9999999883    345689999999999999999999999   99999999999999999999999999987654321 


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                      .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.....   .....   .... ..         ..
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~---~i~~-~~---------~~  216 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMT---MILK-AK---------LG  216 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHH---HHHc-CC---------CC
Confidence            122345689999999999988899999999999999999999999864321   11111   1111 10         01


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCHHH
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQ  313 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~~e  313 (370)
                      .+......+.+++.+||+.||.+||++.+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            12223345788999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7e-40  Score=292.62  Aligned_cols=255  Identities=27%  Similarity=0.451  Sum_probs=204.1

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..++|++.+.||+|+||.||++...++..+++|.+.... .....+.+|+.+++.++|+|++++++++.+ ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            467899999999999999999998778889999876543 234678889999999999999999999887 778999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++...  .+..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            9999999998432  344678899999999999999999999   99999999999999999999999999998664432


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      ........++..|+|||++....++.++|+||||+++|++++ |+.||.....   .....    ........       
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~----~~~~~~~~-------  222 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIR----ALERGYRM-------  222 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHhCCCCC-------
Confidence            222222335567999999988889999999999999999999 8888764321   11111    11111110       


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                       ..+......+.+++.+||+.+|.+||++.++++.|+.
T Consensus       223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             1112334458899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-39  Score=293.68  Aligned_cols=259  Identities=27%  Similarity=0.448  Sum_probs=203.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCC----EEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGR----RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .++|++.+.||+|+||.||+|.+. ++.    .||+|.+... .......+.+|+.+++.++|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            468999999999999999999864 343    4899988754 334456788899999999999999999998754 567


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      ++++|+++|+|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||++..
T Consensus        85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence            89999999999999842   234689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcce-eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          199 FPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       199 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....   ..+..    ........ 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~----~~~~~~~~-  230 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPD----LLEKGERL-  230 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHCCCcC-
Confidence            64332211 112234578999999988899999999999999999998 8888764322   11111    11111110 


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                             ..+......+.+++.+||+.+|.+||++.++++.|....+..
T Consensus       231 -------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         231 -------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             -------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                   111223445788999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.4e-39  Score=298.87  Aligned_cols=262  Identities=26%  Similarity=0.423  Sum_probs=205.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC--------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT--------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQG  114 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  114 (370)
                      .++|.+.+.||+|+||.||++...        ....+|+|.+... .......+.+|+.+++++ +||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            468899999999999999999752        2456899988754 234456788899999999 699999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe
Q 017503          115 TRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL  182 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill  182 (370)
                      ...+++|||+.+++|.+++.....            ....+++..+..++.|++.||.|||+.   +++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence            999999999999999999854321            224588999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhh
Q 017503          183 DQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKF  260 (370)
Q Consensus       183 ~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~  260 (370)
                      +.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EE  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence            99999999999999865432111 1111223467999999998899999999999999999999 7888754321   11


Q ss_pred             HHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          261 LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      +..    .......        ...+......+.+++.+||..+|.+||++.++++.|.++...
T Consensus       245 ~~~----~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         245 LFK----LLREGHR--------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             HHH----HHHcCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            111    1111111        112233344688899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.8e-40  Score=303.95  Aligned_cols=241  Identities=27%  Similarity=0.345  Sum_probs=192.5

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||+|.++ ++..||+|++...   .......+..|..+++.+ +||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 5788999988754   223345667788888887 799999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....... ..
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  152 (318)
T cd05570          81 GDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT  152 (318)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence            99998883    344689999999999999999999999   99999999999999999999999999986432211 11


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....|+..|+|||++.+..++.++|||||||++|+|++|..||.....   ....    ........         ..+
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~----~~i~~~~~---------~~~  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELF----QSILEDEV---------RYP  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHH----HHHHcCCC---------CCC
Confidence            2234588999999999999999999999999999999999999864321   1111    11111110         112


Q ss_pred             hHHHHHHHHHHHHchhhccCCCCCH-----HHHHH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRPQM-----NQVIK  316 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  316 (370)
                      ......+.+++.+||+.||.+||++     .+++.
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            2233457889999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.9e-40  Score=296.41  Aligned_cols=258  Identities=28%  Similarity=0.405  Sum_probs=202.0

Q ss_pred             hccCCcccceeeecCCeEEEEEEECC------CCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR  116 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  116 (370)
                      ..++|++.+.||+|++|.||+|.+.+      +..|++|.+.... ......+.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35779999999999999999999753      5678999886543 3334568889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhccccc---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC---CeEE
Q 017503          117 RILVYEYVENNSLDRVLLGATK---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKI  190 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kL  190 (370)
                      .++||||+.+++|.+++.....   ....+++..++.++.||+.||.|||+.   +++|+||+|+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999854321   123589999999999999999999999   999999999999998654   5899


Q ss_pred             eeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHH
Q 017503          191 GDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       191 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      +|||++......... .......+..|+|||++.+..++.++|||||||++|+|++ |..||.....   ..+...    
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~----  233 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEF----  233 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----
Confidence            999999865322111 1112223567999999998999999999999999999997 8888764322   111111    


Q ss_pred             HhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ......        ...+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       234 ~~~~~~--------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VTGGGR--------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHcCCc--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111111        1112233456888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.9e-39  Score=295.31  Aligned_cols=264  Identities=25%  Similarity=0.418  Sum_probs=204.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC-----------------CCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcce
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN-----------------GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVE  106 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~  106 (370)
                      .++|++.+.||+|+||.||++.+..                 +..||+|.+.... ......+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            5689999999999999999988642                 2458999887653 344567889999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCCHHHHhccccc-------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCc
Q 017503          107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN  179 (370)
Q Consensus       107 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~N  179 (370)
                      +++++......+++||++.+++|.+++.....       ....+++..++.++.|++.||.|||+.   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999999999999999999999999854331       123689999999999999999999999   99999999999


Q ss_pred             eEeCCCCCeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh--CCCCCCccccc
Q 017503          180 ILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS--GRNSGKAMWGQ  256 (370)
Q Consensus       180 ill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt--g~~p~~~~~~~  256 (370)
                      |+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++  +..||..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999876533221 12223445678999999988889999999999999999998  5566643321 


Q ss_pred             chhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          257 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                        ..................     ....+...+.++.+++.+||+.+|.+|||+.+|++.|+
T Consensus       240 --~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 --QQVIENAGHFFRDDGRQI-----YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             --HHHHHHHHhccccccccc-----cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence              112222211111111100     01112233456899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.2e-40  Score=293.41  Aligned_cols=257  Identities=26%  Similarity=0.450  Sum_probs=203.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC-C---CEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN-G---RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~-~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|+..+.||+|++|.||+|..+. +   ..+++|.+... .......+.+|++++++++|+|++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            4578889999999999999999752 3   36899988755 33445678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+.+++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999999999999842   234689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCccee--ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          200 PDNITHIT--TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       200 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ........  .....+..|+|||++.+..++.++||||||+++|+|++ |+.||.....   .....    ......   
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~----~i~~~~---  227 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMK----AINDGF---  227 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHH----HHhcCC---
Confidence            43222111  11223457999999988889999999999999999997 9999754321   11111    111111   


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                       ..+.    +......+.+++.+||+.+|.+||++.+|++.|.+++
T Consensus       228 -~~~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         228 -RLPA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             -CCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence             0111    1223455889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-40  Score=291.35  Aligned_cols=250  Identities=30%  Similarity=0.486  Sum_probs=204.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.+.||.|++|.||+|... ++.||+|.+..... ....+.+|+.+++.++|+|++++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            568999999999999999999986 78899999876644 4567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          83 AKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            999999998432  223689999999999999999999999   999999999999999999999999999986633221


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                          ....+..|+|||.+....++.++||||||+++|+|++ |..||.....   ..+.    .........        
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~----~~~~~~~~~--------  218 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVV----PHVEKGYRM--------  218 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHhcCCCC--------
Confidence                2234567999999988899999999999999999997 8888754421   1111    111111111        


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                      ..+...+..+.+++.+||..+|.+||++.++++.|+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            1112233558889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=289.63  Aligned_cols=254  Identities=25%  Similarity=0.414  Sum_probs=205.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++.+.||.|++|.||+|.+. ++..+++|.+..........+.+|+.++++++|||++++++++.+....+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            468999999999999999999975 5788999998876655677889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          82 CGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            999999998842   225689999999999999999999999   99999999999999999999999999987654321


Q ss_pred             cceeecccCCCCCCCcccccCC---CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          204 THITTRIAGTTGYLAPEYVLGG---QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      . ......++..|+|||.+.+.   .++.++|+||||+++|+|++|..||........  .    .......     ..+
T Consensus       156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~----~~~~~~~-----~~~  223 (262)
T cd06613         156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--L----FLISKSN-----FPP  223 (262)
T ss_pred             h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHHHhcc-----CCC
Confidence            1 12234577889999998776   789999999999999999999999865432111  1    0111110     011


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ............+.+++.+||..+|.+|||+.+|+.
T Consensus       224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111123344566889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-39  Score=290.55  Aligned_cols=250  Identities=22%  Similarity=0.325  Sum_probs=201.2

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      +|++.+.||.|+||.||++.+. ++..||+|.+... .......+.+|+.+++.++|+|++++++++.+....+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5889999999999999999975 6888999987543 3344567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++++|.+++..  ..+..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            99999988742  2334578999999999999999999999   999999999999999999999999999876543221


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                       ......++..|+|||++.+..++.++|+||||+++|+|++|..||.....   .   ........ ..        ...
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~---~~~~~~~~-~~--------~~~  219 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---K---NLILKVCQ-GS--------YKP  219 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---H---HHHHHHhc-CC--------CCC
Confidence             12234578899999999988899999999999999999999999864321   1   11111111 11        111


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .+......+.+++.+||+.+|.+||++.+|+..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            122233457889999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.3e-39  Score=296.54  Aligned_cols=252  Identities=24%  Similarity=0.433  Sum_probs=203.9

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ...+|++.+.||+|++|.||+|... +++.|++|.+..........+.+|+.+++.++|+|++++++.+......++|||
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            3468999999999999999999964 688999998876655556778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+++|.+++.     ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        98 ~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          98 YLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             ccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            999999999883     23578899999999999999999999   9999999999999999999999999998765432


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      ... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........  .    ......... .      
T Consensus       170 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~----~~~~~~~~~-~------  235 (296)
T cd06654         170 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L----YLIATNGTP-E------  235 (296)
T ss_pred             ccc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--H----HHHhcCCCC-C------
Confidence            211 1223578899999999888899999999999999999999999864432111  1    011111110 0      


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...+......+.+++.+||..+|.+||++.+|+..
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            01122334558889999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.3e-40  Score=313.20  Aligned_cols=261  Identities=21%  Similarity=0.315  Sum_probs=194.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--------
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG--------  114 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------  114 (370)
                      ..++|++.+.||+|+||.||+|... +++.||||.+....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            4578999999999999999999975 57899999875442    2234699999999999999999887432        


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-CeEEeee
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDF  193 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kL~Df  193 (370)
                      ..+++||||+.+ +|.+++......+..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            246789999975 67776654445566789999999999999999999999   999999999999998665 6999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      |++..+.....  .....+++.|+|||++.+. .++.++|||||||++|+|++|.+||.......  .+.. ........
T Consensus       216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~-i~~~~~~p  290 (440)
T PTZ00036        216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVR-IIQVLGTP  290 (440)
T ss_pred             ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHHhCCC
Confidence            99986543221  2234678999999988664 68999999999999999999999986542211  1111 11111000


Q ss_pred             CC----------ccc----cc-CCC-CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          273 KP----------LEL----VD-PEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       273 ~~----------~~~----~~-~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..          ..+    .. ..+ ..++.....++.+++.+||+.+|.+|||+.+++..
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            00          000    00 000 11122234568899999999999999999999854

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.7e-40  Score=302.10  Aligned_cols=240  Identities=25%  Similarity=0.350  Sum_probs=189.9

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||+|+++ ++..||+|.+....   ......+..|..++... +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999986 57899999886531   22344566677787754 899999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++.    .+..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++....... ..
T Consensus        81 g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  152 (316)
T cd05620          81 GDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR  152 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence            99998883    345688999999999999999999999   99999999999999999999999999987432211 12


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||.....   ..+..    ......      +..   +
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~----~~~~~~------~~~---~  216 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFE----SIRVDT------PHY---P  216 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH----HHHhCC------CCC---C
Confidence            2345689999999999999999999999999999999999999864321   11111    111111      111   1


Q ss_pred             hHHHHHHHHHHHHchhhccCCCCCHH-HHH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRPQMN-QVI  315 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl  315 (370)
                      .....++.+++.+||+.||.+||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            22234577899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-39  Score=293.02  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=203.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC----CCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|++.+.||+|+||.||+|.+.+    ...|++|...... ....+.+.+|+.+++.++|||++++++++.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            4678999999999999999998643    2468999887654 4556678899999999999999999998875 45689


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence            9999999999999843   233589999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      ............++..|+|||.+....++.++||||||+++|+|++ |..||......   ....   . .......   
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~---~-~~~~~~~---  227 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIG---R-IENGERL---  227 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHH---H-HHcCCcC---
Confidence            5432222222334567999999988889999999999999999986 99998644321   1111   1 1111111   


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                           ..+......+.+++.+||..+|.+|||+.++++.|..+..
T Consensus       228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 1122334468889999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.1e-40  Score=299.25  Aligned_cols=261  Identities=27%  Similarity=0.399  Sum_probs=202.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCC--EEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGR--RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|++.+.||+|+||.||+|.++ ++.  .+++|.+... .......+.+|+.++.++ +|+||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            468899999999999999999975 343  4577776543 334456788899999999 89999999999999999999


Q ss_pred             EEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          120 VYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                      ||||+++++|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence            9999999999999854321            223578999999999999999999999   9999999999999999999


Q ss_pred             eEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 017503          188 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAW  266 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  266 (370)
                      ++|+|||++.......  ......++..|+|||.+.+..++.++||||||+++|+|+| |..||......   ....   
T Consensus       163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~---  234 (303)
T cd05088         163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE---  234 (303)
T ss_pred             EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH---
Confidence            9999999986322111  1111223567999999988889999999999999999998 99888543221   1111   


Q ss_pred             HHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                       .......        ...+......+.+++.+||+.+|.+||++.+++..|.++....
T Consensus       235 -~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         235 -KLPQGYR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             -HHhcCCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence             1111100        0111122345788999999999999999999999998876644

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=304.11  Aligned_cols=261  Identities=28%  Similarity=0.436  Sum_probs=218.7

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEECC---C--CEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLTN---G--RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG  114 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  114 (370)
                      ++-..+..++.+.||.|-||.||+|...+   |  -.||||..+.+ ..+..+.|+.|.-+|++++||||++++|+|.+.
T Consensus       384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~  463 (974)
T KOG4257|consen  384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ  463 (974)
T ss_pred             ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence            33344555667789999999999998542   3  34899988775 455578899999999999999999999999875


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                       ..++|||.+..|.|..|+.   .....++......+++||+.||.|||+.   .++||||...|||+....-+||+|||
T Consensus       464 -P~WivmEL~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  464 -PMWIVMELAPLGELREYLQ---QNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             -ceeEEEecccchhHHHHHH---hccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence             5699999999999999994   4555788899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      +++.+.+..........-..-|||||.++-..++.++|||-||+.+||++. |..||......               ..
T Consensus       537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------------DV  601 (974)
T KOG4257|consen  537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------------DV  601 (974)
T ss_pred             hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---------------ce
Confidence            999988765554444445678999999999999999999999999999876 88888654332               22


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      ...+.+......|++++..|..|+.+||..+|.+||++.+|...|.++..
T Consensus       602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            33444455567788888889999999999999999999999998887765

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.5e-39  Score=302.57  Aligned_cols=264  Identities=23%  Similarity=0.288  Sum_probs=196.5

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT----  115 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----  115 (370)
                      ...++|++.+.||+|+||.||++.+. .+..||+|.+...  .......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            34689999999999999999999975 5889999988643  3334566788999999999999999999986543    


Q ss_pred             --eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          116 --RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       116 --~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                        ..++||||+++ +|...+.      ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence              46899999976 4555542      2478889999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchh------------hH
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK------------FL  261 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~------------~~  261 (370)
                      |++.......  ......+|..|+|||++.+..++.++|||||||++|+|++|+.||........-            ..
T Consensus       168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            9997543221  123346789999999999999999999999999999999999998754221100            00


Q ss_pred             H----HHHHHHHhcCCCccc----------ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          262 L----EWAWQLHQEEKPLEL----------VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       262 ~----~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      .    ...............          ..+............+.+++.+||+.||++|||+.|++..-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            0    000000000000000          00000001111234578999999999999999999998743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.1e-40  Score=301.27  Aligned_cols=240  Identities=28%  Similarity=0.365  Sum_probs=189.6

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHh-cCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSN-VRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||+|.+. ++..||+|++....   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 57889999886541   2233455667778876 4999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      |+|..++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++........ .
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  152 (316)
T cd05619          81 GDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K  152 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence            99999883    345688999999999999999999999   999999999999999999999999999875322111 1


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....||..|+|||++.+..++.++|||||||++|+|++|..||.....   ..+...    .....      +..   +
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~----i~~~~------~~~---~  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQS----IRMDN------PCY---P  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHhCC------CCC---C
Confidence            2334689999999999998999999999999999999999999864321   111111    11111      111   1


Q ss_pred             hHHHHHHHHHHHHchhhccCCCCCHH-HHH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRPQMN-QVI  315 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl  315 (370)
                      ......+.+++.+||+.+|.+||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            12234577889999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=318.34  Aligned_cols=258  Identities=28%  Similarity=0.453  Sum_probs=216.6

Q ss_pred             CcccceeeecCCeEEEEEEEC----CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           48 FHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ..|.++||.|.||.|++|+++    ....||||.++.. ......+|+.|+.||-+++||||+++.|+.......+||+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            478899999999999999976    2456999999876 45667899999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      ||++|+|+.|++.   ....+++.+...++++|+.|++||.+.   +++||||...|||++.+..+|++|||+++.+.++
T Consensus       711 yMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  711 YMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            9999999999954   334589999999999999999999999   9999999999999999999999999999988665


Q ss_pred             Ccceeecc--cCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          203 ITHITTRI--AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       203 ~~~~~~~~--~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      .....+..  .-..+|.|||.+...+++.++||||+|+++||.++ |..|+-..   .++.++..+.+            
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm---SNQdVIkaIe~------------  849 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SNQDVIKAIEQ------------  849 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc---chHHHHHHHHh------------
Confidence            53322222  23468999999999999999999999999999876 77775433   33333332211            


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCc
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  326 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  326 (370)
                      .-...-|.+++..|..|+..||++|-.+||.|.+|+..|.++++.+.
T Consensus       850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence            11224456788889999999999999999999999999999998653

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.5e-40  Score=293.22  Aligned_cols=255  Identities=27%  Similarity=0.467  Sum_probs=201.6

Q ss_pred             cCCcccceeeecCCeEEEEEEECC-C---CEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLTN-G---RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~~-~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .+|++.+.||+|+||.||+|.++. +   ..|++|.+... .......+..|+.++++++||||+++++++.+....++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            468899999999999999999753 2   36999998765 344566889999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+.+++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999999843   234588999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCccee--eccc--CCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          201 DNITHIT--TRIA--GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       201 ~~~~~~~--~~~~--~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      .......  ....  .+..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+    ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i----~~~~~~  230 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAI----EQDYRL  230 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHH----HcCCcC
Confidence            3221111  1111  1347999999998999999999999999999886 8888754321   1111111    111100


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                              ..+.+.+..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         231 --------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    11122334578899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-39  Score=290.02  Aligned_cols=247  Identities=25%  Similarity=0.400  Sum_probs=194.2

Q ss_pred             eeeecCCeEEEEEEEC---CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCC
Q 017503           53 KIGRGGFGTVYKGTLT---NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS  128 (370)
Q Consensus        53 ~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  128 (370)
                      .||+|+||.||+|.+.   .+..||+|++.... ......+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999864   34569999887653 333456889999999999999999999875 457799999999999


Q ss_pred             HHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCccee-
Q 017503          129 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-  207 (370)
Q Consensus       129 L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~-  207 (370)
                      |.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........... 
T Consensus        81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9998842   234689999999999999999999999   999999999999999999999999999986543322111 


Q ss_pred             -ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCC
Q 017503          208 -TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY  285 (370)
Q Consensus       208 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (370)
                       ....++..|+|||.+....++.++||||||+++|+|++ |..||......   ...    ........        ...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~~--------~~~  219 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVM----SFIEQGKR--------LDC  219 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHH----HHHHCCCC--------CCC
Confidence             11223568999999988889999999999999999996 99888654221   111    11111111        112


Q ss_pred             ChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          286 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       286 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      +.....++.+++.+||..+|++||++.+|++.|+..
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            233445688899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.9e-39  Score=323.67  Aligned_cols=263  Identities=22%  Similarity=0.328  Sum_probs=204.5

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++...   .......+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            68999999999999999999976 5889999988654   2233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccccc-------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          122 EYVENNSLDRVLLGATK-------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      ||+++++|.+++.....       ....+++..++.++.||+.||+|||+.   +++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998853211       123456778899999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCc-----------------ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccc
Q 017503          195 LAKLFPDNIT-----------------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM  257 (370)
Q Consensus       195 ~~~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~  257 (370)
                      ++........                 .......||+.|+|||.+.+..++.++|||||||++|+|+||..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521100                 01122468999999999999999999999999999999999999986532110


Q ss_pred             hhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCC-CHHHHHHHHHhhhcc
Q 017503          258 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-QMNQVIKMLTKNIRL  324 (370)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~~~  324 (370)
                         ...   .    ..   ..++.........+..+.+++.+||+.+|++|| +++++++.|+..+..
T Consensus       239 ---i~~---~----~~---i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 ---ISY---R----DV---ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             ---hhh---h----hh---ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence               000   0    00   000000000112234478899999999999995 677788888777653

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.4e-39  Score=296.37  Aligned_cols=263  Identities=23%  Similarity=0.351  Sum_probs=200.2

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            47999999999999999999975 5778999987655 233345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      +++++|.+++.    ....+++..+..++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          81 MDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            99999999984    33568899999999999999999997 5   8999999999999999999999999998754332


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC--------
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP--------  274 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  274 (370)
                      .   .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........................        
T Consensus       154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 M---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             c---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence            1   22346788999999998888999999999999999999999997543211100000000000000000        


Q ss_pred             -------------cccccCCCCCCC-hHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          275 -------------LELVDPELGEYP-PNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       275 -------------~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                                   ...........+ ......+.+++.+||..+|++||++.+|+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                         000000000000 11334588999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.7e-39  Score=297.51  Aligned_cols=255  Identities=21%  Similarity=0.232  Sum_probs=195.5

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||+++++ +++.||+|++...   .......+.+|+.++..++|++|+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            57999999999999999999976 4778999988642   2223345778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+|+|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999842   234688999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCcceeecccCCCCCCCccccc-----CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          202 NITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ..........||+.|+|||++.     ...++.++|||||||++|+|++|+.||.....      .............. 
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~-  227 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERF-  227 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccc-
Confidence            3222233356899999999886     34678999999999999999999999864321      11111111111100 


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccC--CCCCHHHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAAS--RRPQMNQVIKM  317 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~--~RPt~~evl~~  317 (370)
                          ............+.+++.+|+..++.  .|+++.++++.
T Consensus       228 ----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 ----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                01111122334577788887755444  47899998765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.1e-40  Score=301.80  Aligned_cols=239  Identities=25%  Similarity=0.302  Sum_probs=187.3

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHH-HHHhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIM-TLSNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||+++.. +|+.||+|++...   .......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999975 6889999988653   1222344455554 46778999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++    .....+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~  152 (325)
T cd05604          81 GELFFHL----QRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT  152 (325)
T ss_pred             CCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence            9998887    3445789999999999999999999999   99999999999999999999999999987432211 12


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||.....   ....   ........          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~---~~~~~~~~----------~~~  216 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV---AEMY---DNILHKPL----------VLR  216 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH---HHHH---HHHHcCCc----------cCC
Confidence            2345689999999999999999999999999999999999999864321   1111   11111110          111


Q ss_pred             hHHHHHHHHHHHHchhhccCCCCCHHHH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRPQMNQV  314 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RPt~~ev  314 (370)
                      +.....+.+++.+|++.+|.+||++.+.
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence            2233457789999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2e-39  Score=288.74  Aligned_cols=250  Identities=27%  Similarity=0.450  Sum_probs=203.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC-CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++.+.||.|++|.||+|.+.+ +..|++|.+.....  ...+.+|++++++++|+|++++++++......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            4689999999999999999999864 78899998875533  57888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+++|.+++.   ..+..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~L~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          80 CGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             CCCCcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            99999999983   2345689999999999999999999999   99999999999999999999999999998665432


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.........      .. .....      ....
T Consensus       154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~------~~~~  219 (256)
T cd06612         154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FM-IPNKP------PPTL  219 (256)
T ss_pred             c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hh-hccCC------CCCC
Confidence            1 122344788999999998889999999999999999999999998654221110      00 00000      0001


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..+......+.+++.+||+.+|.+||++.+|+.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            112233456888999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-39  Score=297.68  Aligned_cols=261  Identities=22%  Similarity=0.343  Sum_probs=196.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||.||+|+.+ ++..||+|.+.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            367999999999999999999975 57889999886542 2233456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++ +|.+++.   ..+..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          85 YLDK-DLKQYMD---DCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             CCCC-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            9986 7777763   2334578999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc----------
Q 017503          203 ITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE----------  271 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  271 (370)
                      ... .....++..|+|||.+.+ ..++.++||||||+++|+|++|++||.........   .........          
T Consensus       158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         158 TKT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL---HLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             ccc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCHHHHhhhc
Confidence            211 222356889999998765 46889999999999999999999998654321111   111110000          


Q ss_pred             -CCCccccc-CC-----CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          272 -EKPLELVD-PE-----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       272 -~~~~~~~~-~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       .......+ +.     .....+.....+.+++.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             00000000 00     00011123345789999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-39  Score=291.87  Aligned_cols=253  Identities=22%  Similarity=0.389  Sum_probs=200.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+..........+.+|+.+++.++||||+++++++......++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            468999999999999999999975 6888999988766555556678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++.    ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          88 CGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            99999999883    344689999999999999999999999   99999999999999999999999999987554322


Q ss_pred             cceeecccCCCCCCCccccc---CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          204 THITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      . ......|+..|+|||.+.   ...++.++|+|||||++|+|++|..||........  .    .........    .+
T Consensus       161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~----~~~~~~~~~----~~  229 (267)
T cd06645         161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FLMTKSNFQ----PP  229 (267)
T ss_pred             c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H----HhhhccCCC----CC
Confidence            1 122345889999999874   45688999999999999999999998754322110  0    000000000    01


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .... .......+.+++.+||+.+|.+||++.+|+.
T Consensus       230 ~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KLKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            1100 0112234788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1e-39  Score=290.71  Aligned_cols=252  Identities=26%  Similarity=0.470  Sum_probs=201.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      ..+|++.+.||+|++|.||++.+.++..+++|.+..... ....+.+|++++++++|||++++++++......++||||+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            457889999999999999999987788999998865432 2356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      .+++|.+++..   ....+++..++.++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            99999998842   233578999999999999999999999   999999999999999999999999999876543322


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .......++..|+|||.+.++.++.++||||||+++|+|++ |..||.....   ..+..   . .....  ....+.  
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~---~-~~~~~--~~~~~~--  224 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVE---T-INAGF--RLYKPR--  224 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHH---H-HhCCC--CCCCCC--
Confidence            21222234568999999988899999999999999999998 8888754321   11111   1 11110  111111  


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                          .....+.+++.+||+.+|++||++.++++.|
T Consensus       225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                1234588899999999999999999999877

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-39  Score=286.71  Aligned_cols=250  Identities=30%  Similarity=0.485  Sum_probs=202.3

Q ss_pred             ceeeecCCeEEEEEEECC----CCEEEEEECcCcChh-cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLTN----GRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||++....    +..|++|.+...... ....+.+|++.++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            478999999999999764    788999998766433 367888999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccC-----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          127 NSLDRVLLGATKA-----NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       127 ~~L~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ++|.+++......     ...+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998543221     46789999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          202 NIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       202 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ... .......++..|+|||.+....++.++||||||+++|+|++ |..||.....   ..+..    ......      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~----~~~~~~------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLE----YLRKGY------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHHcCC------
Confidence            321 12233456788999999988899999999999999999999 5888865521   11111    111111      


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                        ....+......+.+++.+||+.+|.+||++.++++.|+
T Consensus       225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              11222333456889999999999999999999998773

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.1e-39  Score=292.46  Aligned_cols=251  Identities=26%  Similarity=0.341  Sum_probs=198.6

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .|++.+.||+|+||.||++.+. +++.||+|.+....   ......+.+|+.++++++|++++++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            4778899999999999999975 68899999876432   2223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+++|.+++..  .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          81 LMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             ecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999988843  2234588999999999999999999999   9999999999999999999999999998755432


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      ..  .....|+..|+|||++.+..++.++||||||+++|+|++|..||.............   ..... ..     .  
T Consensus       156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~-~~-----~--  222 (285)
T cd05630         156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE-VQ-----E--  222 (285)
T ss_pred             cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhh-hh-----h--
Confidence            21  123468899999999999999999999999999999999999987543322111111   11000 00     0  


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCC-----HHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  316 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  316 (370)
                       ..+......+.+++..||+.+|.+|||     +.++++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 -EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             111222334788899999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.9e-39  Score=290.61  Aligned_cols=250  Identities=24%  Similarity=0.390  Sum_probs=200.0

Q ss_pred             CCcccceeeecCCeEEEEEEECCCCEEEEEECcCcC------hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      +|++.+.||+|+||.||+|...+++.+|+|.+....      ......+.+|+++++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            588999999999999999998888999999876432      22345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      +||+.+++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            99999999999983    334678999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCC-----cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          201 DNI-----THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       201 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      ...     ........++..|+|||.+.+..++.++||||||+++|+|++|..||........     . ......... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~-~~~~~~~~~-  226 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----M-FYIGAHRGL-  226 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----H-HHhhhccCC-
Confidence            211     1112234578899999999988899999999999999999999999864321110     0 000000000 


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                            ....+......+.+++.+||+.+|.+||++.+++.
T Consensus       227 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 ------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  11122233455788999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.9e-39  Score=295.04  Aligned_cols=259  Identities=27%  Similarity=0.437  Sum_probs=204.4

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCC
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGT  115 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  115 (370)
                      ..++|.+.+.||+|+||.||++...      .+..||+|.+.... ......+.+|+.+++++ +|+||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3468999999999999999999742      24579999887543 34456788999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      ..+++|||+.+++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999998432  223389999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          196 AKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       196 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      +......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  ...    .......
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~----~~~~~~~  261 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFY----KLIKEGY  261 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHH----HHHHcCC
Confidence            9865433221 1122345678999999999999999999999999999998 888876433211  111    1111111


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      ..        ..+......+.+++.+||..+|.+||++.++++.|.++
T Consensus       262 ~~--------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 RM--------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cC--------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            10        11112234588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-39  Score=295.15  Aligned_cols=265  Identities=24%  Similarity=0.372  Sum_probs=205.4

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEE-
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCV-  112 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-  112 (370)
                      +.++.+..+.++|++.+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.+++.+ +|||++++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            556777888999999999999999999999975 578899998764322 235677899999999 7999999999885 


Q ss_pred             ----eCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCe
Q 017503          113 ----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP  188 (370)
Q Consensus       113 ----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~  188 (370)
                          .....++||||+++++|.+++......+..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence                34568999999999999998754444455788999999999999999999999   99999999999999999999


Q ss_pred             EEeeecCccccCCCCcceeecccCCCCCCCcccccC-----CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHH
Q 017503          189 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE  263 (370)
Q Consensus       189 kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~  263 (370)
                      +|+|||++......... .....|+..|+|||.+..     ..++.++|||||||++|+|++|..|+.......  .+  
T Consensus       164 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~--  238 (286)
T cd06638         164 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--AL--  238 (286)
T ss_pred             EEccCCceeecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HH--
Confidence            99999998765432211 223458899999998753     457889999999999999999999976432110  00  


Q ss_pred             HHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          264 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                        .... ........      .+......+.+++.+||+.+|.+||++.+|++.+
T Consensus       239 --~~~~-~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         239 --FKIP-RNPPPTLH------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             --hhcc-ccCCCccc------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence              0000 00000110      1112234588899999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-39  Score=290.60  Aligned_cols=248  Identities=28%  Similarity=0.423  Sum_probs=199.1

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh---------hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK---------QGVREFITEIMTLSNVRHPNLVELIGCCVQGTR  116 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  116 (370)
                      +|.+...||.|++|.||+|... ++..||+|.+.....         .....+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            5788999999999999999875 578899998764322         123567789999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .+++|||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            999999999999999983    334688899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc-----eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc
Q 017503          197 KLFPDNITH-----ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       197 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      .........     ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......  ..    ...... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~----~~~~~~-  226 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QA----IFKIGE-  226 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HH----HHHHhc-
Confidence            866532111     111234778999999999888999999999999999999999998653211  10    111111 


Q ss_pred             CCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                              ......+......+.+++.+||+.+|.+||++.+|++
T Consensus       227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 --------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                    0111222334456888999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1e-39  Score=300.73  Aligned_cols=241  Identities=26%  Similarity=0.338  Sum_probs=192.2

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      +|++.+.||+|+||.||+|..+ ++..||+|++...   .......+..|..+++.+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788999999999999999975 6889999988753   2233456677888888875 577888999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|.+++    .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        81 Ey~~~g~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            999999999988    3445689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ......   ... ...       
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~---i~~-~~~-------  218 (323)
T cd05615         154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQS---IME-HNV-------  218 (323)
T ss_pred             CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH---HHh-CCC-------
Confidence            21 112334689999999999999999999999999999999999999865422   111111   111 110       


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQM  311 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  311 (370)
                        ..+......+.+++.+||+.+|.+|++.
T Consensus       219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              1122233457889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.2e-39  Score=293.32  Aligned_cols=252  Identities=24%  Similarity=0.444  Sum_probs=201.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .+.|++.+.||.|+||.||+|.+. ++..|++|.+..........+.+|+.+++.++|+|++++++++......++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            367999999999999999999976 4788999998877666677888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+++|..++..   ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        91 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          91 CPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            999999888732   234589999999999999999999999   99999999999999999999999999987543221


Q ss_pred             cceeecccCCCCCCCccccc-----CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          204 THITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      . ......++..|+|||++.     ...++.++|||||||++|+|++|..||.....      ............+    
T Consensus       165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~----  233 (292)
T cd06644         165 Q-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEPP----  233 (292)
T ss_pred             c-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCCCc----
Confidence            1 122345788999999874     34578899999999999999999999754321      1111111111111    


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                        .. ..+......+.+++.+||..+|.+||++.++++
T Consensus       234 --~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 --TL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             --cC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              00 112223345788999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.5e-40  Score=302.88  Aligned_cols=241  Identities=25%  Similarity=0.302  Sum_probs=187.5

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHH-HHHhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIM-TLSNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||++++. +++.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999976 56789999886432   122233444443 46778999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|.+++.    ....+++..+..++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~  152 (325)
T cd05602          81 GELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT  152 (325)
T ss_pred             CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence            99999883    345678888999999999999999999   99999999999999999999999999987532221 12


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||.....   .....   ..... . .        ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~---~i~~~-~-~--------~~~  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYD---NILNK-P-L--------QLK  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHH---HHHhC-C-c--------CCC
Confidence            2345689999999999999999999999999999999999999864321   11111   11111 0 0        111


Q ss_pred             hHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      +.....+.+++.+||+.+|.+||++.+.+.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            223345788999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5e-39  Score=291.11  Aligned_cols=251  Identities=25%  Similarity=0.318  Sum_probs=197.5

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .|+..+.||+|+||+||++.+. +++.||+|.+....   ......+.+|+++++.++|+|++++.+++...+..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            4778899999999999999975 68899999886542   2223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+++|..++..  .....+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          81 IMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             eccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            9999999988742  2234689999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      ..  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||........   ............         
T Consensus       156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~---------  221 (285)
T cd05632         156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE---------  221 (285)
T ss_pred             Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc---------
Confidence            21  2234688999999999888999999999999999999999999865422111   111111111100         


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCC-----HHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  316 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  316 (370)
                      ...+......+.+++.+||+.+|.+||+     +.+++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            0111222334778889999999999999     666655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-39  Score=291.66  Aligned_cols=257  Identities=25%  Similarity=0.382  Sum_probs=204.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|++|.||++.+. ++..||+|++.... ......+.+|+++++.++||||+++++++......++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            468899999999999999999975 58889999876543 3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      |+++++|..++.    ....+++..+..++.+++.||.|||+ .   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          84 FMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             cCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            999999999883    33468999999999999999999997 5   899999999999999999999999999865432


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccc-----hhhHHHHHHHHHhcCCCcc
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-----NKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  276 (370)
                      ..   .....++..|+|||++.+..++.++|||||||++|+|++|..||.......     ...............    
T Consensus       157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  229 (284)
T cd06620         157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----  229 (284)
T ss_pred             hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence            21   123468899999999988899999999999999999999999987543321     111111111111111    


Q ss_pred             cccCCCCCCC-hHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          277 LVDPELGEYP-PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       277 ~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                           ....+ ......+.+++.+||+.+|.+||++.|+++...-
T Consensus       230 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         230 -----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             -----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence                 11111 1234568899999999999999999999886533

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-39  Score=300.22  Aligned_cols=262  Identities=26%  Similarity=0.420  Sum_probs=201.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEE------CCCCEEEEEECcCcC-hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeC-C
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL------TNGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQG-T  115 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~  115 (370)
                      .++|++.+.||+|+||.||+|.+      .+++.||||++.... ......+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            56899999999999999999974      246789999987543 33456788899999999 789999999988654 4


Q ss_pred             eeEEEEEecCCCCHHHHhccccc---------------------------------------------------------
Q 017503          116 RRILVYEYVENNSLDRVLLGATK---------------------------------------------------------  138 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~---------------------------------------------------------  138 (370)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999999853211                                                         


Q ss_pred             ------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc-eeeccc
Q 017503          139 ------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIA  211 (370)
Q Consensus       139 ------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~  211 (370)
                            ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......... ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  012467888999999999999999999   9999999999999999999999999998765332211 111233


Q ss_pred             CCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHH
Q 017503          212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI  290 (370)
Q Consensus       212 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (370)
                      ++..|+|||.+.+..++.++||||||+++|+|++ |..||......  ...    .....+.....     ....   ..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~~~~~-----~~~~---~~  308 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF----CRRLKEGTRMR-----APDY---TT  308 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHH----HHHHhccCCCC-----CCCC---CC
Confidence            4567999999988899999999999999999997 88887543221  111    11111111111     1111   12


Q ss_pred             HHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          291 IRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       291 ~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      ..+.+++.+||+.+|.+||++.+|++.|+.+.+
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            347888999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-39  Score=285.24  Aligned_cols=265  Identities=25%  Similarity=0.316  Sum_probs=200.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCC-cceeeeEEEeCC-----
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPN-LVELIGCCVQGT-----  115 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~-----  115 (370)
                      ...|+..++||+|+||+||+|+.+ +|+.||+|.+.-+..  ..-....+|+-+|+.++|+| |+.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            455777788999999999999975 688999998876533  23345678999999999999 999999999877     


Q ss_pred             -eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          116 -RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       116 -~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                       .+++|+||++. +|..++.........++...+..+++||+.||+|||++   +|+||||||+||||+.+|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             78999999966 89998855443324577788999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC-
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE-  272 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  272 (370)
                      +++.+.-.... .+...+|.+|.|||++.+. .|+...||||+||++.||+++++-|......   .....+.+..... 
T Consensus       166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~---~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI---DQLFRIFRLLGTPN  241 (323)
T ss_pred             hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH---HHHHHHHHHcCCCC
Confidence            99966533222 3345678999999998876 7999999999999999999988766544331   1111122211111 


Q ss_pred             ---CCc----ccccCCCCCC------C---hHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          273 ---KPL----ELVDPELGEY------P---PNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       273 ---~~~----~~~~~~~~~~------~---~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         ++.    ...+......      .   +.......+++.+|++.+|.+|.|++..+..
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               110    0111111111      1   1111357889999999999999999998775

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3e-39  Score=292.01  Aligned_cols=250  Identities=25%  Similarity=0.436  Sum_probs=198.9

Q ss_pred             CcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           48 FHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      |++.+.||.|+||.||+|.+. ++..+++|.+..........+.+|+++++.++|||++++++++......++|+||+.+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            688899999999999999976 4677899988766656667788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++..   ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++........ .
T Consensus        87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~  159 (282)
T cd06643          87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R  159 (282)
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence            999988742   234689999999999999999999999   999999999999999999999999999875433221 1


Q ss_pred             eecccCCCCCCCccccc-----CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          207 TTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .....++..|+|||++.     +..++.++|||||||++|+|++|.+||......  .    ........... ..    
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~----~~~~~~~~~~~-~~----  228 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--R----VLLKIAKSEPP-TL----  228 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--H----HHHHHhhcCCC-CC----
Confidence            22345788999999874     345788999999999999999999998653211  1    11111111111 11    


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                        ..+......+.+++.+||+.+|.+||++.++++.
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              1112233458899999999999999999998654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.5e-39  Score=291.82  Aligned_cols=262  Identities=25%  Similarity=0.327  Sum_probs=196.0

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||+|++|.||+|+.. ++..||+|.+...  .......+.+|+.+++.++|||++++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5889999999999999999975 6889999987644  223346678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +. ++|.+++.... .+..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 57888774322 235689999999999999999999999   99999999999999999999999999987654322


Q ss_pred             cceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH-------HhcC---
Q 017503          204 THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL-------HQEE---  272 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~---  272 (370)
                      . ......+++.|+|||.+.+. .++.++||||||+++|+|++|++||........  ........       +...   
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhh
Confidence            1 12223467899999987654 578999999999999999999998864322110  00000000       0000   


Q ss_pred             -----CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          273 -----KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       273 -----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                           ...................++.+++.+||+.||.+|||+.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                 00000000000111122345778999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-39  Score=294.70  Aligned_cols=263  Identities=25%  Similarity=0.421  Sum_probs=205.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-----CCCEEEEEECcCcChh-cHHHHHHHHHHHHhcCCCCcceeeeEEEe--CCe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-----NGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQ--GTR  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~  116 (370)
                      .++|++.+.||+|+||.||++.+.     .+..||+|.+...... ....+.+|+.+++.+.|+||+++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            357888999999999999999854     3678999988766443 45678999999999999999999999887  567


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .+++|||+++++|.+++..   ....+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        83 ~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             eEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            8999999999999999843   223589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcce--eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchh--------hHHHHHH
Q 017503          197 KLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--------FLLEWAW  266 (370)
Q Consensus       197 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~--------~~~~~~~  266 (370)
                      ..........  .....++..|++||.+.+..++.++||||||+++|+|++|..|+.........        .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            8765332211  11223456799999998889999999999999999999999887654322110        0011111


Q ss_pred             HHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      ........        ...+..+...+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       237 ~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGER--------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCc--------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111111        111223335688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3e-39  Score=294.30  Aligned_cols=251  Identities=24%  Similarity=0.428  Sum_probs=202.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..+|++.+.||+|++|.||++... +++.||+|.+..........+.+|+.+++.++|+|++++++++......++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            478999999999999999999974 6899999988765544556788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++.     ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          98 LAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             cCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            99999999983     23578899999999999999999999   99999999999999999999999999987654332


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .. .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.........      .......      .+. .
T Consensus       170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------~~~~~~~------~~~-~  235 (297)
T cd06656         170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG------TPE-L  235 (297)
T ss_pred             cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------eeeccCC------CCC-C
Confidence            11 12245788999999999888999999999999999999999998643221100      0000000      000 1


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..+......+.+++.+||+.+|.+||++.+|++.
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122333457789999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-38  Score=298.09  Aligned_cols=193  Identities=26%  Similarity=0.359  Sum_probs=163.8

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ....+|++.+.||+|+||.||+|... ++..||+|+.....      ...|+.++++++|+||+++++++......++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34568999999999999999999976 56789999754332      245899999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      |++.+ +|.+++.   .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus       137 e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        137 PHYSS-DLYTYLT---KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             EccCC-cHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            99964 7777763   2345689999999999999999999999   999999999999999999999999999874322


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  250 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~  250 (370)
                      .  .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       210 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 A--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             C--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            1  1123356899999999999999999999999999999999865543

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-40  Score=289.76  Aligned_cols=257  Identities=25%  Similarity=0.346  Sum_probs=198.6

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----eeEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----RRILV  120 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv  120 (370)
                      .|.-.+++|.|.||.||+|... ++..||||....+...    -.+|+.+|+.+.|||||++..+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4677899999999999999965 5789999988766432    125899999999999999998887432     33589


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC-CCeEEeeecCcccc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLF  199 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kL~Dfg~~~~~  199 (370)
                      |||++. +|.+++......+..++...+.-+..||.+||.|||+.   +|+||||||+|+|+|.+ |.+||||||.|..+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 89998876666678888888999999999999999999   99999999999999965 89999999999988


Q ss_pred             CCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc-------
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE-------  271 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------  271 (370)
                      ..+..+  .....|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|......++-  ...+ +.+.-       
T Consensus       177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL--~eIi-k~lG~Pt~e~I~  251 (364)
T KOG0658|consen  177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL--VEII-KVLGTPTREDIK  251 (364)
T ss_pred             ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH--HHHH-HHhCCCCHHHHh
Confidence            766554  33467889999998877 47999999999999999999999877664332221  1111 11110       


Q ss_pred             ---CCCcccccCCCC-----C-CChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          272 ---EKPLELVDPELG-----E-YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       272 ---~~~~~~~~~~~~-----~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                         ....+...+.+.     . +......++++++.++++.+|.+|.++.+++.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence               010111112221     1 23345556889999999999999999999875

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3e-39  Score=302.17  Aligned_cols=201  Identities=25%  Similarity=0.346  Sum_probs=173.9

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||++..+ ++..||+|++...   .......+..|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999976 5889999988643   2334556788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            9999999999983    345689999999999999999999999   999999999999999999999999999874421


Q ss_pred             CCc----------------------------------ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCC
Q 017503          202 NIT----------------------------------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR  247 (370)
Q Consensus       202 ~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~  247 (370)
                      ...                                  .......||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            100                                  0012346899999999999999999999999999999999999


Q ss_pred             CCCCcc
Q 017503          248 NSGKAM  253 (370)
Q Consensus       248 ~p~~~~  253 (370)
                      .||...
T Consensus       234 ~Pf~~~  239 (360)
T cd05627         234 PPFCSE  239 (360)
T ss_pred             CCCCCC
Confidence            998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.1e-39  Score=292.59  Aligned_cols=251  Identities=23%  Similarity=0.433  Sum_probs=203.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..+|++.+.||.|++|.||+|... +++.|++|.+..........+.+|+.+++.++|||++++++++......++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            346999999999999999999864 6889999988765544566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+++|..++.     ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          98 LAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             cCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            99999999883     23589999999999999999999999   99999999999999999999999999987654332


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.........      ......... .      .
T Consensus       170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~~~~-~------~  235 (296)
T cd06655         170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGTP-E------L  235 (296)
T ss_pred             cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcCCc-c------c
Confidence            21 12245788999999998888999999999999999999999998654321111      111111110 0      0


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..+......+.+++.+||..+|.+||++.+|+..
T Consensus       236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            1122233457889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.5e-39  Score=288.33  Aligned_cols=250  Identities=27%  Similarity=0.402  Sum_probs=198.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEE-eCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV-QGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~  123 (370)
                      .++|++.+.||+|++|.||++... +..|++|......  ....+.+|+.++++++|+|++++++++. .....+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            358999999999999999999876 7889999886543  2457888999999999999999999765 45678999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++...  ....+++..++.++.|++.||+|||+.   +++||||+|+||++++++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9999999998432  223578999999999999999999999   99999999999999999999999999987543321


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                          ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.....   ..+..   . ......     +  
T Consensus       157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~---~-~~~~~~-----~--  218 (256)
T cd05082         157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP---R-VEKGYK-----M--  218 (256)
T ss_pred             ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---H-HhcCCC-----C--
Confidence                12234567999999998899999999999999999998 8888753211   11111   1 111111     1  


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                       ..++..+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence             11223345588899999999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=281.97  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=203.7

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ..+.|++.+.||+|.|+.|++..+. +|+.+|+|+++-.  .....+++.+|+++.+.|+||||+++.+...+....|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4688999999999999999998764 6899999987643  233567889999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC---CCeEEeeecCcc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAK  197 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kL~Dfg~~~  197 (370)
                      +|+++|+.|-.-+.    ....+++..+...++||++||.|+|.+   +|+|||+||.|+++-+.   .-+||+|||++.
T Consensus        89 Fe~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   89 FDLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999865552    225678999999999999999999999   99999999999999543   348999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ....  ...-....||+.|||||++...+|+..+|||+.|++||-|+.|++||...   ....+.+.+..    ... . 
T Consensus       162 ~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~---~~~rlye~I~~----g~y-d-  230 (355)
T KOG0033|consen  162 EVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYEQIKA----GAY-D-  230 (355)
T ss_pred             EeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhc----ccc-C-
Confidence            7762  33344567999999999999999999999999999999999999998542   22223222221    111 0 


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .+   +...+....+..+|+++||..||.+|.|+.|.++
T Consensus       231 ~~---~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  231 YP---SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CC---CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            11   1123344455889999999999999999998874

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.5e-40  Score=327.85  Aligned_cols=260  Identities=22%  Similarity=0.320  Sum_probs=200.4

Q ss_pred             HHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--C
Q 017503           40 ELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--G  114 (370)
Q Consensus        40 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~  114 (370)
                      ......++|++.+.||+|+||.||++.+. .+..||+|.+...  .......+..|+.++++++||||++++++|.+  .
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            34455789999999999999999999976 5678899987653  23345678889999999999999999998865  4


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCC----CCeEeecCCCCceEeCC------
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV----PHIVHRDIKASNILLDQ------  184 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~----~~iiH~dlkp~Nill~~------  184 (370)
                      ..+|+||||+.+++|.+++.........+++..++.|+.||+.||.|||+...    .+|+||||||+||||+.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            56899999999999999986544445579999999999999999999998521    15999999999999964      


Q ss_pred             -----------CCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccC--CCcCccccchhhhHHHHHHHhCCCCCC
Q 017503          185 -----------EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGK  251 (370)
Q Consensus       185 -----------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~  251 (370)
                                 .+.+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||+||+|++|..||.
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                       2348999999998654321  1233468999999998854  458899999999999999999999986


Q ss_pred             cccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          252 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ....     ..... ........     ..+.    .....+.+||..||+.+|.+||++.+++.
T Consensus       245 ~~~~-----~~qli-~~lk~~p~-----lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        245 KANN-----FSQLI-SELKRGPD-----LPIK----GKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cCCc-----HHHHH-HHHhcCCC-----CCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            4321     11111 11111110     0111    12345888999999999999999999984

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4e-39  Score=286.91  Aligned_cols=251  Identities=21%  Similarity=0.346  Sum_probs=203.2

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||.|+||.||.++.. ++..+++|.+...  .......+.+|++++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5889999999999999999864 5888999987644  344456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999985322  45689999999999999999999999   99999999999999999999999999998664433


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....   .   ........ .        ...
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~---~~~~~~~~-~--------~~~  219 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---L---NLVVKIVQ-G--------NYT  219 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH---H---HHHHHHHc-C--------CCC
Confidence            2 22334578999999999888889999999999999999999998864321   1   11111111 1        111


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      ..+......+.+++.+||+.+|.+||++.++++.+
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11233345588899999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.8e-39  Score=291.49  Aligned_cols=259  Identities=25%  Similarity=0.359  Sum_probs=191.8

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhc---CCCCcceeeeEEEe-----CC
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNV---RHPNLVELIGCCVQ-----GT  115 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~  115 (370)
                      +|++.+.||+|+||.||+|.++ +++.||+|.+....  ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5889999999999999999976 68889999876532  12223455677766655   79999999998864     34


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      ..+++|||+.+ +|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            57899999975 788877422  233589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc----
Q 017503          196 AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE----  271 (370)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----  271 (370)
                      +.......  ......++..|+|||++.+..++.++|||||||++|+|++|++||.......  .+ .........    
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~-~~~~~~~~~~~~~  229 (288)
T cd07863         155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QL-GKIFDLIGLPPED  229 (288)
T ss_pred             cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HH-HHHHHHhCCCChh
Confidence            98654321  1223457889999999998899999999999999999999999885432211  11 111111100    


Q ss_pred             CCC------cccccCC----CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          272 EKP------LELVDPE----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       272 ~~~------~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...      .....+.    .....+.....+.+++.+||+.||.+|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000      0000000    01112233455789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=297.34  Aligned_cols=253  Identities=24%  Similarity=0.317  Sum_probs=210.7

Q ss_pred             HhccCCcccceeeecCCeEEEEEEECC-CCEEEEEECcCcCh---hcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCee
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESK---QGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRR  117 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  117 (370)
                      ...+.|++.+.||.|.||.||+++.+. |+.+|+|.+.....   .....+.+|+.+|+++. ||||+.+++++++....
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            346789999999999999999999874 99999999876533   23467889999999998 99999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC----CCeEEeee
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE----FNPKIGDF  193 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~----~~~kL~Df  193 (370)
                      ++|||++.||.|.+.+...     .+++..+..++.|++.|++|||+.   |++||||||+|+|+...    +.+|++||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            9999999999999988543     399999999999999999999999   99999999999999633    47999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      |++.....  .......+||+.|+|||++....|+...||||+|+++|.|++|.+||..........      .......
T Consensus       184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~  255 (382)
T KOG0032|consen  184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF  255 (382)
T ss_pred             CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC
Confidence            99998766  445566789999999999999999999999999999999999999987654322111      1111111


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                        ..    .....+.....+.+++..|+..||.+|+|+.++++.
T Consensus       256 --~f----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 --DF----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             --CC----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence              11    123334456668899999999999999999999884

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-39  Score=287.04  Aligned_cols=247  Identities=28%  Similarity=0.458  Sum_probs=195.4

Q ss_pred             ceeeecCCeEEEEEEECC----CCEEEEEECcCcCh-hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLTN----GRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||+|.+..    +..||+|.+..... .....+.+|+.+++.++|+|++++++++. ....++||||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999998532    26799998876543 34567888999999999999999999876 4567999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|.+++.    ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..........
T Consensus        80 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLK----KRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999984    333689999999999999999999999   99999999999999999999999999998664332211


Q ss_pred             e--ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          207 T--TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       207 ~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ..+....    ......        
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~----~~~~~~--------  217 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAML----ESGERL--------  217 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----HcCCcC--------
Confidence            1  11223467999999998999999999999999999998 8999865422   1122211    111111        


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      ..+......+.+++.+||..+|.+||++.+|++.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            11223334688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.9e-39  Score=287.08  Aligned_cols=239  Identities=23%  Similarity=0.343  Sum_probs=187.3

Q ss_pred             ceeeecCCeEEEEEEECC-------------CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           52 NKIGRGGFGTVYKGTLTN-------------GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~-------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      +.||+|+||.||+|+...             ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998531             2358999877665555567888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC-------eEEe
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN-------PKIG  191 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~-------~kL~  191 (370)
                      +||||+++++|..++.   .....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            9999999999998873   2334689999999999999999999999   9999999999999986654       8999


Q ss_pred             eecCccccCCCCcceeecccCCCCCCCccccc-CCCcCccccchhhhHHHHHHH-hCCCCCCcccccchhhHHHHHHHHH
Q 017503          192 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEII-SGRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       192 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      |||++......     ....++..|+|||.+. +..++.++||||||+++|+|+ +|..|+........       ....
T Consensus       155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~  222 (262)
T cd05077         155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY  222 (262)
T ss_pred             CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH
Confidence            99998754322     2234678899999886 467899999999999999998 57777653321110       0111


Q ss_pred             hcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          270 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      ....  .        ........+.+++.+||+.+|.+||++.+|++.+
T Consensus       223 ~~~~--~--------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         223 EGQC--M--------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hcCc--c--------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            1000  0        0111234578899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4e-39  Score=289.51  Aligned_cols=254  Identities=25%  Similarity=0.424  Sum_probs=198.9

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeC-----
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQG-----  114 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----  114 (370)
                      +.+.+.|++.+.||+|+||.||+|.+. .++.||+|.+.... .....+..|+.+++++ +|+|++++++++...     
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            456788999999999999999999975 57889999886543 3345778899999998 799999999998753     


Q ss_pred             -CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          115 -TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       115 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                       ...+++|||+.+++|.+++...  .+..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence             4578999999999999998432  234688999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCccccc-----CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      |++........ ......|+..|+|||++.     ...++.++|||||||++|+|++|..||.........      ...
T Consensus       156 g~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------~~~  228 (272)
T cd06637         156 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLI  228 (272)
T ss_pred             CCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH------HHH
Confidence            99876543221 223356788999999885     345788999999999999999999998643221111      011


Q ss_pred             HhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .. ...     ..  .........+.+++.+||..+|.+|||+.++++
T Consensus       229 ~~-~~~-----~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 PR-NPA-----PR--LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             hc-CCC-----CC--CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            11 100     00  011122345788999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.1e-39  Score=289.75  Aligned_cols=253  Identities=26%  Similarity=0.439  Sum_probs=201.1

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ++|++.+.||+|+||.||++.+. ++..||+|.+... .......+.+|+.++++++|+||+++++++......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            47899999999999999999986 6889999987654 334456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      +++++|..++.... ....+++..+..++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999884321 13468999999999999999999996 5   8999999999999999999999999998765332


Q ss_pred             CcceeecccCCCCCCCcccccCC------CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGG------QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      .   .....++..|+|||.+.+.      .++.++|||||||++|+|++|..||.....   ..........        
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~--------  222 (286)
T cd06622         157 L---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLSAI--------  222 (286)
T ss_pred             c---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHHHH--------
Confidence            2   2223577889999988554      358899999999999999999999864321   1111111111        


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                       .+......++.....+.+++.+||+.+|.+||++.+++..
T Consensus       223 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         223 -VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence             1111122334455668899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-39  Score=289.50  Aligned_cols=248  Identities=27%  Similarity=0.455  Sum_probs=201.8

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ++|++.+.||.|++|.||+|.+. ++..|++|.+.... ......+.+|+.+++.++|+|++++++++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            47899999999999999999975 68899999887553 34456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+++|.+++..     ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            999999999842     2789999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|..||......      ........ ...     +.+.
T Consensus       153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~~~~-~~~-----~~~~  219 (274)
T cd06609         153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFLIPK-NNP-----PSLE  219 (274)
T ss_pred             c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHHhhh-cCC-----CCCc
Confidence            1 122345778899999999888999999999999999999999998643211      11111111 111     1111


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..  .....+.+++.+||..+|++||++.++++
T Consensus       220 ~~--~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 GN--KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cc--ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11  13445888999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-39  Score=285.31  Aligned_cols=247  Identities=29%  Similarity=0.420  Sum_probs=197.0

Q ss_pred             ceeeecCCeEEEEEEECCCCEEEEEECcCcChh-cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCHH
Q 017503           52 NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD  130 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  130 (370)
                      ++||+|++|.||++.+.+++.|++|.+...... ....+.+|++++++++|+||+++++++.+....++||||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            478999999999999877899999988765333 4567889999999999999999999999999999999999999999


Q ss_pred             HHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCccee-ec
Q 017503          131 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TR  209 (370)
Q Consensus       131 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~-~~  209 (370)
                      +++..   ....+++..++.++.+++.||.|||++   +++||||+|+||+++.++.++|+|||++........... ..
T Consensus        81 ~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            99842   233578999999999999999999999   999999999999999999999999999876543221111 11


Q ss_pred             ccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChH
Q 017503          210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN  288 (370)
Q Consensus       210 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (370)
                      ...+..|+|||.+.++.++.++|+||||+++|+|++ |..||......   ....    .......        ...+..
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~----~~~~~~~--------~~~~~~  219 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRE----RIESGYR--------MPAPQL  219 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHH----HHhcCCC--------CCCCcc
Confidence            223567999999988899999999999999999999 77776543221   1111    1111100        011223


Q ss_pred             HHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          289 EIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       289 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      .+..+.+++.+||..+|.+||++.+|++.|+
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-39  Score=290.00  Aligned_cols=258  Identities=29%  Similarity=0.449  Sum_probs=204.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC-CC----EEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN-GR----RIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~-~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .++|++.+.||+|+||.||+|.+++ +.    .||+|...... ......+.+|+.+++.++|||++++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            3678999999999999999998642 32    58999876553 3445678899999999999999999999987 7889


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+.+++|.+++..   ....+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        85 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          85 LITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            99999999999999842   234589999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCccee-ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          199 FPDNITHIT-TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       199 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ......... ....++..|+|||.+....++.++|+||||+++|+|++ |..||......   .+..    .......  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~--  229 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPD----LLEKGER--  229 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHhCCCC--
Confidence            653322111 11223567999999988899999999999999999998 99998654221   1111    1111111  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                            ...+..+...+.+++.+||..+|.+||++.++++.|.++.+.
T Consensus       230 ------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         230 ------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence                  111222334578899999999999999999999999988663

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.5e-39  Score=285.31  Aligned_cols=248  Identities=27%  Similarity=0.436  Sum_probs=197.7

Q ss_pred             ceeeecCCeEEEEEEECC--C--CEEEEEECcCcCh-hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLTN--G--RRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~--~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998743  3  3589999887755 556788999999999999999999999988 888999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc-
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-  205 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-  205 (370)
                      ++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++......... 
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999854322  4689999999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             -eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          206 -ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       206 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                       ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .......   ......        .
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~---~~~~~~--------~  220 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKI---DKEGER--------L  220 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---HhcCCc--------C
Confidence             1112346778999999998899999999999999999998 9999753321   1111111   111100        0


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ..+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            111223455888999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.9e-39  Score=288.20  Aligned_cols=248  Identities=26%  Similarity=0.420  Sum_probs=203.3

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..|+..+.||.|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.+.|+||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            56888999999999999999975 57889999877543 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++.     ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999999883     23578899999999999999999999   99999999999999999999999999997654322


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      . ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........   .   .. ..        .....
T Consensus       156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~---~~-~~--------~~~~~  219 (277)
T cd06640         156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---L---FL-IP--------KNNPP  219 (277)
T ss_pred             c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---h---hh-hh--------cCCCC
Confidence            1 12223577889999999888899999999999999999999999864422110   0   00 00        00112


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .........+.+++.+||+.+|.+||++.+++..
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            3344566678899999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-39  Score=300.19  Aligned_cols=261  Identities=21%  Similarity=0.299  Sum_probs=196.2

Q ss_pred             HHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--
Q 017503           40 ELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--  114 (370)
Q Consensus        40 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--  114 (370)
                      .+....++|++.+.||.|+||.||+|.+. ++..||+|.+....  ......+.+|+.++++++||||+++++++...  
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878           9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            44556789999999999999999999975 67889999886542  23345677899999999999999999987543  


Q ss_pred             ----CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEE
Q 017503          115 ----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI  190 (370)
Q Consensus       115 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL  190 (370)
                          ...+++++++ +++|.+++.     ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl  159 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRI  159 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEE
Confidence                3468999988 678988772     34689999999999999999999999   9999999999999999999999


Q ss_pred             eeecCccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH
Q 017503          191 GDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       191 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      +|||++......    .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.......   .........
T Consensus       160 ~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~  232 (343)
T cd07878         160 LDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVV  232 (343)
T ss_pred             cCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHh
Confidence            999999865432    223457899999998876 568999999999999999999999985432110   000000000


Q ss_pred             hcCCCcccc-----------cCCCCCCC--------hHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          270 QEEKPLELV-----------DPELGEYP--------PNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       270 ~~~~~~~~~-----------~~~~~~~~--------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .. ......           ...+...+        ......+.+++.+||+.||.+|||+.+++..
T Consensus       233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         233 GT-PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CC-CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00 000000           00000000        1112346789999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-39  Score=288.62  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=194.7

Q ss_pred             ceeeecCCeEEEEEEECC-CC--EEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLTN-GR--RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||+|..++ +.  .+++|.+... .......+.+|+++++++ +||||+++++++......+++|||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999753 33  4688887743 344456788999999999 899999999999999999999999999


Q ss_pred             CCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          127 NSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       127 ~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      ++|.+++.....            ....+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999854321            123578999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      ++........  ......+..|+|||++....++.++||||||+++|+|++ |..||.....   ....    .......
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~----~~~~~~~  228 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELY----EKLPQGY  228 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHH----HHHhCCC
Confidence            9863221111  111223567999999988889999999999999999997 8888754321   1111    1111111


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      ..        ..+......+.+++.+||..+|.+|||+.+++..|.+++
T Consensus       229 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 RL--------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CC--------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            00        111223345789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-39  Score=303.02  Aligned_cols=261  Identities=19%  Similarity=0.210  Sum_probs=197.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC---CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT---NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ..+|++.+.||.|+||.||++...   .+..|++|.+...     ....+|++++++++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999753   3577999987643     23457999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      |++. ++|.+++    .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus       166 e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        166 PKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             hhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            9996 5777777    3445789999999999999999999999   999999999999999999999999999976544


Q ss_pred             CCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc-----
Q 017503          202 NIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL-----  275 (370)
Q Consensus       202 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  275 (370)
                      ... .......||+.|+|||++....++.++|||||||++|+|++|+.||...........+..+..........     
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            322 12234568999999999999999999999999999999999999986543222111111111111100000     


Q ss_pred             ------------ccccCC--CCCC--ChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          276 ------------ELVDPE--LGEY--PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       276 ------------~~~~~~--~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                                  ....+.  ....  .......+.+++.+||..+|++||++.+++..-
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p  376 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP  376 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                        000000  0000  001234577889999999999999999998753

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-39  Score=297.89  Aligned_cols=250  Identities=22%  Similarity=0.349  Sum_probs=198.3

Q ss_pred             HhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .....|++.++||+||.+.||++...+.+.||+|.+...  +.+...-|.+|+..|.+| .|.+|+++++|-..++.+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            345689999999999999999999887788888866543  667788899999999999 58999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||- ..+|..++.+   ....++.-.+..+..|++.|+.++|+.   ||||.||||.|+|+- .|.+||+|||.+..+
T Consensus       438 vmE~G-d~DL~kiL~k---~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKK---KKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAI  509 (677)
T ss_pred             Eeecc-cccHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence            99975 4599999843   222233227788999999999999999   999999999999884 679999999999988


Q ss_pred             CCCCcce-eecccCCCCCCCcccccCC-----------CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 017503          200 PDNITHI-TTRIAGTTGYLAPEYVLGG-----------QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       200 ~~~~~~~-~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      ..+.+.. ....+||+.||+||.+...           ..++++|||||||+||+|+.|+.||.......+        +
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a--------K  581 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA--------K  581 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH--------H
Confidence            7765553 3456899999999987432           256899999999999999999999875532111        1


Q ss_pred             HHhcCCCcccccCC----CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          268 LHQEEKPLELVDPE----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       268 ~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .      ..+.+|.    .+..++..  ++.+++..||+.||++||++.++|.
T Consensus       582 l------~aI~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  582 L------HAITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             H------HhhcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhc
Confidence            1      1222331    12222221  2788888899999999999999975

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.4e-39  Score=286.14  Aligned_cols=250  Identities=23%  Similarity=0.379  Sum_probs=199.8

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe-CCeeEEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ-GTRRILVYE  122 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  122 (370)
                      +|++.+.||.|++|.||++.++ +++.||+|.+...  .......+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5899999999999999999975 5788999988644  23445668889999999999999999988764 446789999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|.+++...  .+..+++.+++.++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999988532  234589999999999999999999999   9999999999999999999999999999866432


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      .. ......+++.|+|||++.+..++.++||||||+++++|++|..||.....   ...   ...... ..        +
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~---~~~~~~-~~--------~  219 (257)
T cd08223         156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSL---VYRIIE-GK--------L  219 (257)
T ss_pred             CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHH---HHHHHh-cC--------C
Confidence            21 22334578899999999999999999999999999999999998764321   111   111111 11        1


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...+......+.+++.+||+.+|.+||++.++++.
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            12233444568899999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-39  Score=292.02  Aligned_cols=253  Identities=26%  Similarity=0.454  Sum_probs=202.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++.+.||.|++|.||++.+. ++..||+|.+..........+..|+.++++++|+|++++++++......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467999999999999999999975 5888999998777666667888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            999999999842   234689999999999999999999999   99999999999999999999999999887543322


Q ss_pred             cceeecccCCCCCCCccccc-----CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          204 THITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      . ......++..|+|||.+.     ...++.++||||||+++|+|++|..||......      ...........+    
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~----  226 (280)
T cd06611         158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKSEPP----  226 (280)
T ss_pred             c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcCCCC----
Confidence            1 122345788999999874     345788999999999999999999998654211      111111111110    


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                        .+ ..+......+.+++.+||+.+|.+||++.++++.
T Consensus       227 --~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 --TL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --Cc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence              00 1122233457889999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.3e-39  Score=290.25  Aligned_cols=263  Identities=24%  Similarity=0.353  Sum_probs=199.2

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++|++.+.||+|++|.||+|+++ +++.||+|.+....  ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            57999999999999999999986 58899999876432  2233567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|..++    .....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELE----KNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            99999998876    2344689999999999999999999999   9999999999999999999999999999876443


Q ss_pred             CcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHH--------HHHhcCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW--------QLHQEEK  273 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  273 (370)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||................        .......
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            21 1122346788999998866 457899999999999999999999986543221111000000        0000000


Q ss_pred             C-cccccCCCC------CCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 P-LELVDPELG------EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 ~-~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      . .....+...      ...+.....+.+++.+||+.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0 000000000      001122455889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.5e-39  Score=287.59  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=201.3

Q ss_pred             cCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcChh-cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      ++|++.+.||.|+||.||+|+.+      +...|++|........ ....+.+|++++++++|+|++++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            67899999999999999999964      2457899987655433 4567889999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHHhcccccC-----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          119 LVYEYVENNSLDRVLLGATKA-----NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      +||||+++++|.+++......     ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998543311     12589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      |++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||.....   .....   . ....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~---~-~~~~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLN---R-LQAG  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHH---H-HHcC
Confidence            9987543222222222345677999999988889999999999999999999 7777753321   11111   1 1111


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      .. ..      ..+...+..+.+++.+||+.+|.+||++.+++..|.
T Consensus       235 ~~-~~------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KL-EL------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             Cc-CC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            10 00      011223345888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.2e-39  Score=286.96  Aligned_cols=257  Identities=25%  Similarity=0.331  Sum_probs=201.4

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ++.+++.+.....||+|+||.||+|.+. ++..|++|.+..........+.+|+.+++.++|+||+++++++......++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            4456677777789999999999999965 577899998877666666788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-CCCeEEeeecCc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKL--NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLA  196 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kL~Dfg~~  196 (370)
                      |+||+.+++|.+++...   ...+  ++..+..++.|++.||.|||+.   +++||||+|+||+++. ++.++|+|||++
T Consensus        83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          83 FMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            99999999999998432   1234  7888889999999999999999   9999999999999976 678999999998


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccCCC--cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      ........ ......++..|+|||.+....  ++.++||||||+++|+|++|..||.........   .+  ...     
T Consensus       157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~--~~~-----  225 (268)
T cd06624         157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MF--KVG-----  225 (268)
T ss_pred             eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hh--hhh-----
Confidence            76543221 122235788999999886644  789999999999999999999997543211100   00  000     


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         ........+......+.+++.+||+.+|.+|||+.+++..
T Consensus       226 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         226 ---MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ---hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence               0001112233344568899999999999999999999763

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.4e-39  Score=290.77  Aligned_cols=266  Identities=27%  Similarity=0.390  Sum_probs=207.2

Q ss_pred             cccCHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEE
Q 017503           34 NHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCC  111 (370)
Q Consensus        34 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~  111 (370)
                      ..+.+.++..+.++|++.+.||+|+||.||++..+ +++.+|+|.+..... ....+.+|+.+++++ +|||++++++++
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             hhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            34677888889999999999999999999999975 688899998865422 234567899999998 899999999998


Q ss_pred             EeC-----CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC
Q 017503          112 VQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF  186 (370)
Q Consensus       112 ~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~  186 (370)
                      ...     ...++||||+++++|.+++......+..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~  165 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence            754     357999999999999998854444556789999999999999999999999   999999999999999999


Q ss_pred             CeEEeeecCccccCCCCcceeecccCCCCCCCcccccCC-----CcCccccchhhhHHHHHHHhCCCCCCcccccchhhH
Q 017503          187 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL  261 (370)
Q Consensus       187 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~  261 (370)
                      .++|+|||++......... .....++..|+|||.+...     .++.++|||||||++|+|++|+.||......  .. 
T Consensus       166 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~-  241 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KT-  241 (291)
T ss_pred             CEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HH-
Confidence            9999999998865432211 1223578899999987543     3689999999999999999999998643211  11 


Q ss_pred             HHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          262 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         ..... ........      .+......+.+++.+||+.+|.+||++.+++..
T Consensus       242 ---~~~~~-~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 ---LFKIP-RNPPPTLL------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ---HHHHh-cCCCCCCC------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence               11111 11111111      112233458899999999999999999999763

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.4e-39  Score=289.79  Aligned_cols=238  Identities=25%  Similarity=0.386  Sum_probs=185.9

Q ss_pred             eeeecCCeEEEEEEECC-------------------------CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCccee
Q 017503           53 KIGRGGFGTVYKGTLTN-------------------------GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL  107 (370)
Q Consensus        53 ~lg~G~~g~v~~~~~~~-------------------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~  107 (370)
                      .||+|+||.||+|.+..                         ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            68999999999987421                         23588998876555555678889999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-
Q 017503          108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-  186 (370)
Q Consensus       108 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-  186 (370)
                      ++++.+....++||||+++++|..++..   ....+++..+..++.|++.||+|||+.   +++||||||+||+++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            9999999999999999999999998842   344688999999999999999999999   999999999999997543 


Q ss_pred             ------CeEEeeecCccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHH-hCCCCCCcccccch
Q 017503          187 ------NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEII-SGRNSGKAMWGQMN  258 (370)
Q Consensus       187 ------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell-tg~~p~~~~~~~~~  258 (370)
                            .++++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||........
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                  3899999987643221     12346788999998865 56899999999999999995 68888764422111


Q ss_pred             hhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                         ..    ......       ..   +......+.+++.+||+.+|.+||++.+|++.|
T Consensus       231 ---~~----~~~~~~-------~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         231 ---ER----FYEKKH-------RL---PEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             ---HH----HHHhcc-------CC---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence               11    111100       00   111123578899999999999999999999877

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-39  Score=286.34  Aligned_cols=253  Identities=24%  Similarity=0.298  Sum_probs=204.0

Q ss_pred             hccCCcccceeeecCCeEEEEEEECC-CCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..+.|++++.||.|..|+||+++.++ +..+|+|++....   .....+...|-+||+.++||.++.+|..+......++
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            34678999999999999999999874 5789999997653   3344566779999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      +||||.||+|..+..  ++.+..+++..+.-++.+++.||+|||-.   |||+|||||+||||.++|++.|+||.|+...
T Consensus       155 ~meyCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEecCCCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            999999999999884  45666799999999999999999999999   9999999999999999999999999988543


Q ss_pred             CCC---------------------------------Cc----------------------ceeecccCCCCCCCcccccC
Q 017503          200 PDN---------------------------------IT----------------------HITTRIAGTTGYLAPEYVLG  224 (370)
Q Consensus       200 ~~~---------------------------------~~----------------------~~~~~~~~~~~y~aPE~~~~  224 (370)
                      ...                                 ..                      ......+||-.|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            110                                 00                      00112458889999999999


Q ss_pred             CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhc
Q 017503          225 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA  304 (370)
Q Consensus       225 ~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  304 (370)
                      ...+.++|+|+|||+||||+.|.-||.......  .+    .++..+       +..+.+.+ .....+.+||++.|.+|
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl----~NIv~~-------~l~Fp~~~-~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TL----RNIVGQ-------PLKFPEEP-EVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh--hH----HHHhcC-------CCcCCCCC-cchhHHHHHHHHHhccC
Confidence            999999999999999999999999998653321  11    111111       11122222 55567899999999999


Q ss_pred             cCCCCC----HHHHH
Q 017503          305 ASRRPQ----MNQVI  315 (370)
Q Consensus       305 p~~RPt----~~evl  315 (370)
                      |.+|..    +.||-
T Consensus       376 P~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIK  390 (459)
T ss_pred             hhhhhccccchHHhh
Confidence            999988    66664

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-38  Score=301.97  Aligned_cols=260  Identities=22%  Similarity=0.277  Sum_probs=193.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..+|.+.+.||+|+||.||++.+. .++.||||....      ..+.+|+++|++++|+||+++++++......++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999986 478899996432      2346799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +. ++|..++..   ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++.......
T Consensus       242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            95 578777732   234689999999999999999999999   99999999999999999999999999998654322


Q ss_pred             c-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCccccc-----chhhHHHHHHHHHhc--CCCc
Q 017503          204 T-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ-----MNKFLLEWAWQLHQE--EKPL  275 (370)
Q Consensus       204 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~--~~~~  275 (370)
                      . .......||..|+|||++.+..++.++|||||||+||||++|..|+......     ....+...+......  +...
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            1 1223456899999999999999999999999999999999987654222111     011111111110000  0000


Q ss_pred             c---------------cccCCC--CCCC--hHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          276 E---------------LVDPEL--GEYP--PNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       276 ~---------------~~~~~~--~~~~--~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .               ...+..  ..+.  ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0               000000  0000  0112357789999999999999999999874

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.3e-39  Score=292.70  Aligned_cols=261  Identities=22%  Similarity=0.345  Sum_probs=197.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||.|+||.||+|+.+ ++..||+|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            468999999999999999999975 57889999886442 2333467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+ +|.+++..   .+..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          85 YLDK-DLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             cccc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            9974 88887732   344678999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc----------
Q 017503          203 ITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE----------  271 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  271 (370)
                      ... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|++||......   .....+......          
T Consensus       158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         158 TKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             CCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchhhh
Confidence            211 122346789999998765 45788999999999999999999998654321   111111111000          


Q ss_pred             -CCCccccc-CC-----CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          272 -EKPLELVD-PE-----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       272 -~~~~~~~~-~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       .......+ +.     +....+.....+.+++.+||+.||.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             00000000 00     00111123345788999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.9e-39  Score=298.45  Aligned_cols=261  Identities=22%  Similarity=0.280  Sum_probs=196.5

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----  114 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  114 (370)
                      ...++|++.+.||+|+||.||++.+. .++.||+|.+...  .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45689999999999999999999875 5888999988653  333456777899999999999999999988643     


Q ss_pred             -CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          115 -TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       115 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                       ...++||||+++ +|.+.+.      ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence             356899999976 5655552      2478899999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHH--------
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA--------  265 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~--------  265 (370)
                      |++......  .......++..|+|||++.+..++.++|||||||++|+|++|+.||........  .....        
T Consensus       164 g~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  239 (355)
T cd07874         164 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCP  239 (355)
T ss_pred             cccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence            999865332  122334688999999999998999999999999999999999999864321110  00000        


Q ss_pred             ----------HHHHhcCCCc-ccc------cCCC---CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          266 ----------WQLHQEEKPL-ELV------DPEL---GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       266 ----------~~~~~~~~~~-~~~------~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                                .......... ...      +...   ..........+.+++.+||+.||.+|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                      0000000000 000      0000   01111223457899999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-38  Score=286.87  Aligned_cols=262  Identities=24%  Similarity=0.356  Sum_probs=202.6

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--CeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~  121 (370)
                      ++|+..+.||.|++|.||++.+. +++.+|+|.+.... ......+.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            47889999999999999999985 57889999887543 23456788999999999999999999988653  4689999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988754444556689999999999999999999999   999999999999999999999999999875433


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      ..   .....++..|+|||.+.+..++.++||||||+++|+|++|..||......... ..... ............+. 
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~-  231 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELL-SYIVNMPNPELKDE-  231 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHH-HHHhcCCchhhccC-
Confidence            22   12334678899999999899999999999999999999999998755321111 11111 11111111111100 


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      . .........+.+++.+||+.+|.+|||+.||++.
T Consensus       232 ~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         232 P-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             C-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            0 0001234568899999999999999999999873

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-38  Score=297.69  Aligned_cols=193  Identities=26%  Similarity=0.376  Sum_probs=167.4

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-C-----CCcceeeeEEEeCCeeEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-H-----PNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~l  119 (370)
                      +|++.+.||+|.||.|.++.+. +++.||||++++... -.+....|+.+|..|+ |     -|+|+++++|...+++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            8999999999999999999975 699999999987643 3456677999999986 3     379999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC--CeEEeeecCcc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF--NPKIGDFGLAK  197 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~--~~kL~Dfg~~~  197 (370)
                      |+|.+.. +|.+++..+.-.  .++...+..++.||+.||..||+.   +|||+||||+||||.+.+  .+||+|||.+.
T Consensus       266 VfELL~~-NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence            9999965 999999654444  488999999999999999999999   999999999999997543  59999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCC
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  250 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~  250 (370)
                      ......    .....+..|.|||++.+.+|+.+.||||||||+.||++|.+-|
T Consensus       340 ~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf  388 (586)
T KOG0667|consen  340 FESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF  388 (586)
T ss_pred             ccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence            655432    2455678999999999999999999999999999999997644

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.3e-39  Score=285.17  Aligned_cols=251  Identities=31%  Similarity=0.517  Sum_probs=199.9

Q ss_pred             CcccceeeecCCeEEEEEEECC-----CCEEEEEECcCcChh-cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           48 FHLSNKIGRGGFGTVYKGTLTN-----GRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      +++.+.||.|+||.||++.+.+     +..||+|.+...... ....+..|+..++.++|+|++++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4678999999999999999763     378999998765433 5678889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+++|.+++....  ...+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            9999999999984322  11289999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ..........++..|+|||.+.+..++.++||||||+++|+|++ |.+||....   ...+..   . ......      
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~~~~~---~-~~~~~~------  222 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NEEVLE---Y-LKKGYR------  222 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH---H-HhcCCC------
Confidence            42222212336789999999988889999999999999999998 777765421   111111   1 111111      


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                        ...+......+.+++.+||..+|.+|||+.++++.|
T Consensus       223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              111222445588899999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.4e-38  Score=298.12  Aligned_cols=261  Identities=23%  Similarity=0.282  Sum_probs=196.3

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----  114 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  114 (370)
                      ...++|++.+.||+|+||.||++.+. .++.||||.+...  .......+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            34689999999999999999999975 5788999988653  233456678899999999999999999987543     


Q ss_pred             -CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          115 -TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       115 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                       ...++||||+++ +|..++.      ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence             357999999976 6666652      2478889999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHH--------
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA--------  265 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~--------  265 (370)
                      |++.......  ......++..|+|||++.+..++.++|||||||++|+|++|+.||........  .....        
T Consensus       171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~  246 (364)
T cd07875         171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCP  246 (364)
T ss_pred             CCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence            9998654321  12334688999999999999999999999999999999999999864422110  00000        


Q ss_pred             ----------HHHHhcCCCccc------cc----CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          266 ----------WQLHQEEKPLEL------VD----PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       266 ----------~~~~~~~~~~~~------~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                                .....+......      ..    +............+.+++.+||+.||.+|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                      000000000000      00    00001111123457899999999999999999999774

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.6e-39  Score=290.71  Aligned_cols=248  Identities=26%  Similarity=0.421  Sum_probs=200.6

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +.|+..+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45778889999999999999875 57789999887543 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++.     ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            99999999883     24688999999999999999999999   99999999999999999999999999987654322


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|..|+........      ... ....        ...
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~-~~~~--------~~~  219 (277)
T cd06642         156 I-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFL-IPKN--------SPP  219 (277)
T ss_pred             h-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hhh-hhcC--------CCC
Confidence            1 12224578889999999988899999999999999999999999764322110      000 0000        011


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .........+.+++.+||+.+|.+||++.+++..
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            1222344568899999999999999999999874

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.2e-38  Score=282.57  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=190.4

Q ss_pred             ceeeecCCeEEEEEEECC---CCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 017503           52 NKIGRGGFGTVYKGTLTN---GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      +.||+|+||.||+|...+   +..+++|.+.... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            468999999999998643   4578999887653 233457888999999999999999999999999999999999999


Q ss_pred             CHHHHhccccc-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          128 SLDRVLLGATK-ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       128 ~L~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      +|.+++..... .....++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999854322 223457778889999999999999999   99999999999999999999999999987543322211


Q ss_pred             -eecccCCCCCCCcccccCC-------CcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          207 -TTRIAGTTGYLAPEYVLGG-------QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       207 -~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                       .....++..|+|||++.+.       .++.++||||||+++|+|++ |..||.......   .....    ........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT----VREQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----hhcccCCC
Confidence             1224467789999987542       35789999999999999996 999986543211   11111    11111122


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      .++.+..   .....+.+++.+|| .+|.+|||+.+|++.|+
T Consensus       231 ~~~~~~~---~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKL---PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCC---CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            2222211   12234667778899 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7.8e-39  Score=285.98  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=204.1

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--CCeeEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVY  121 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~  121 (370)
                      +|++.+.||.|++|.||++.+. ++..||+|.+...  .......+.+|+.+++.++|+|++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5889999999999999999864 6788999987643  33445668889999999999999999998764  45678999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH-----EELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      ||+++++|.+++.........+++..++.++.|++.||.|||     +.   +++|+||+|+||+++.++.++|+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999998655445667899999999999999999999     77   9999999999999999999999999999


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ......... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....   ...+..    ....     
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~----~~~~-----  224 (265)
T cd08217         158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLAS----KIKE-----  224 (265)
T ss_pred             ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHH----HHhc-----
Confidence            876543321 223457889999999998889999999999999999999999986543   111111    1111     


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         ......+......+.+++.+||+.+|.+||++.+|++.
T Consensus       225 ---~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         225 ---GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence               11122334445668899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-38  Score=292.71  Aligned_cols=197  Identities=27%  Similarity=0.460  Sum_probs=159.8

Q ss_pred             cceeeecCCeEEEEEEEC---CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--CCeeEEEEEecC
Q 017503           51 SNKIGRGGFGTVYKGTLT---NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVE  125 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~  125 (370)
                      .++||+|+||.||+|+.+   +++.||+|.+.....  ...+.+|+.++++++||||+++++++..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999865   467899998865432  3456789999999999999999998864  456789999986


Q ss_pred             CCCHHHHhcccc-----cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe----CCCCCeEEeeecCc
Q 017503          126 NNSLDRVLLGAT-----KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLA  196 (370)
Q Consensus       126 ~~~L~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kL~Dfg~~  196 (370)
                      + +|.+++....     .....+++..+..++.|++.||.|||+.   +++||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 7777763221     1223588999999999999999999999   99999999999999    45678999999999


Q ss_pred             cccCCCCcc--eeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcc
Q 017503          197 KLFPDNITH--ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  253 (370)
Q Consensus       197 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~  253 (370)
                      .........  ......+|+.|+|||++.+. .++.++||||+||++|+|++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876543221  12345688999999988764 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.1e-39  Score=287.11  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=200.8

Q ss_pred             CCcccceeeecCCeEEEEEEECC--CCEEEEEECcCc----------ChhcHHHHHHHHHHHHh-cCCCCcceeeeEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLTN--GRRIAVKPLSAE----------SKQGVREFITEIMTLSN-VRHPNLVELIGCCVQ  113 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~~--~~~vaiK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~  113 (370)
                      +|++.+.||+|+||.||+|.++.  +..+|+|.+...          .......+..|+.++.+ ++|||++++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999764  678999977532          12234556778888875 799999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGD  192 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~D  192 (370)
                      ....+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999998875444455678999999999999999999996 5   899999999999999999999999


Q ss_pred             ecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          193 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       193 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      ||++.......  ......++..|++||.+.+..++.++||||||+++|+|++|+.||.....   ...   ..... ..
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~---~~~~~-~~  228 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSL---ATKIV-EA  228 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHH---HHHHh-hc
Confidence            99998654432  22345578899999999988899999999999999999999999754321   111   11111 11


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ..    .+...   ......+.+++.+||+.+|.+||++.|+..++.
T Consensus       229 ~~----~~~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VY----EPLPE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cC----CcCCc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            10    01111   112345788999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.9e-39  Score=285.36  Aligned_cols=250  Identities=26%  Similarity=0.415  Sum_probs=191.1

Q ss_pred             ceeeecCCeEEEEEEEC----CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEE-eCCeeEEEEEecC
Q 017503           52 NKIGRGGFGTVYKGTLT----NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCV-QGTRRILVYEYVE  125 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~  125 (370)
                      +.||+|+||.||+|.+.    ....||+|.+... .......+.+|+.+++.++|||++++++++. .....+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863    2457999987543 3344567888999999999999999999776 4556789999999


Q ss_pred             CCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc
Q 017503          126 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH  205 (370)
Q Consensus       126 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  205 (370)
                      +++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++.........
T Consensus        81 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            9999999842   233467788899999999999999999   9999999999999999999999999999755332111


Q ss_pred             ---eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhC-CCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          206 ---ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       206 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                         ......++..|+|||.+.+..++.++||||||+++|||++| .+||....   ......   .......      + 
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~---~~~~~~~------~-  221 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITV---YLLQGRR------L-  221 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH---HHhcCCC------C-
Confidence               11123456789999999888999999999999999999995 45554321   111111   1111110      0 


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                        ..+...+..+.+++..||+.+|.+||++.+|++.|+++.
T Consensus       222 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         222 --LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             --CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence              111122345788999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-38  Score=282.05  Aligned_cols=247  Identities=28%  Similarity=0.435  Sum_probs=200.4

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-----hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      +|+..+.||+|++|.||+|... ++..|++|.+....     ....+.+.+|+.+++.++|+|++++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5788899999999999999986 78899999875432     33456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      +||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999999983    334588999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcceeecccCCCCCCCcccccCCC-cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ...  ......++..|++||.+.... ++.++|+||||+++|+|++|..||.....  .    ..........       
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~----~~~~~~~~~~-------  218 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--V----AAVFKIGRSK-------  218 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--H----HHHHHHHhcc-------
Confidence            332  123345788999999987766 89999999999999999999999865431  1    1111111100       


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       .....+......+.+++.+||+.+|.+||++.+++.
T Consensus       219 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 -ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             011222333455788999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-38  Score=283.93  Aligned_cols=249  Identities=23%  Similarity=0.375  Sum_probs=201.0

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||+|+||.+|.+... +++.|++|.+...  .......+.+|+.++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5889999999999999999975 6889999987643  233456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+++|.+++..  .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            999999998842  2233578999999999999999999999   99999999999999999999999999998654322


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .. .....++..|+|||.+.+..++.++|+||||+++++|++|..|+.....   .   ..........         ..
T Consensus       156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~---~~~~~~~~~~---------~~  219 (256)
T cd08218         156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---K---NLVLKIIRGS---------YP  219 (256)
T ss_pred             hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---H---HHHHHHhcCC---------CC
Confidence            11 1223478889999999888899999999999999999999998754311   1   1111111111         11


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..+......+.+++.+||+.+|.+||++.+|++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            122333455889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.2e-38  Score=282.24  Aligned_cols=251  Identities=29%  Similarity=0.496  Sum_probs=201.2

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||+|++|.||+|... +++.|++|.+.....  .....+..|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5889999999999999999975 688999998876543  3567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++.    .+..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            99999999983    344578899999999999999999999   99999999999999999999999999998765433


Q ss_pred             cceee---cccCCCCCCCcccccCCC---cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          204 THITT---RIAGTTGYLAPEYVLGGQ---LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       204 ~~~~~---~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      .....   ...++..|+|||.+.+..   ++.++||||||+++|+|++|..||........  .   ...... .     
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~---~~~~~~-~-----  222 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--I---MFHVGA-G-----  222 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--H---HHHHhc-C-----
Confidence            22211   345778999999988766   88999999999999999999999864421111  0   111111 0     


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..+.+... ......+.+++.+||+.+|.+||++.+++.
T Consensus       223 ~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 HKPPIPDS-LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCCcc-cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            01111111 112445778999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=288.55  Aligned_cols=261  Identities=22%  Similarity=0.346  Sum_probs=201.9

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++|++.+.||+|++|.||+|.+. +++.|++|.+...  .......+.+|++++++++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47999999999999999999976 5788999987653  23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |++++.+..+.    .....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            99988777665    3344589999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH-----------h
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH-----------Q  270 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~  270 (370)
                      .........++..|+|||++.+. .++.++||||||+++|+|++|.+||........  + .......           .
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ--L-YLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHhCCCCHHHhhhcc
Confidence            33223334577889999999887 789999999999999999999998864322111  0 0000000           0


Q ss_pred             cCCCc---ccccCCC-----CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          271 EEKPL---ELVDPEL-----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       271 ~~~~~---~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .....   ...+...     ...+......+.+++.+||..+|.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00000   0000000     0111223566889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-41  Score=284.90  Aligned_cols=274  Identities=24%  Similarity=0.394  Sum_probs=220.4

Q ss_pred             cccccccccCCCCC-CccccccccccCHHHHHHhc-cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHH
Q 017503           12 HSKKSAEREAPQGV-DGELLRNVNHFSYTELRSAT-DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVRE   88 (370)
Q Consensus        12 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~   88 (370)
                      +++.++++..+.+. +.+      +++-+.+.+-. +-|.+..+||+|.||.||++.++ .|+.+|||.+..+..  .++
T Consensus         3 ps~ds~~~~~~~~ss~~~------KLd~~sL~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD--LQE   74 (502)
T KOG0574|consen    3 PSTDSSRRNSEEGSSDGF------KLDSSALNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD--LQE   74 (502)
T ss_pred             CCcchhhcCCCCCccccc------ccChhhhcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch--HHH
Confidence            45556666665554 333      23333333332 44788999999999999999986 699999998876643  578


Q ss_pred             HHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 017503           89 FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP  168 (370)
Q Consensus        89 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~  168 (370)
                      +.+|+.++++.+.|++|++||.+.....+++|||||..|++.+.++   ..+..+++.++..+++..+.||+|||..   
T Consensus        75 IIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---  148 (502)
T KOG0574|consen   75 IIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---  148 (502)
T ss_pred             HHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---
Confidence            8999999999999999999999999999999999999999999983   5667899999999999999999999999   


Q ss_pred             CeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCC
Q 017503          169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  248 (370)
Q Consensus       169 ~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~  248 (370)
                      .-||||||..|||++.+|.+||+|||.+-.+.+.-. ....+.||+.|||||++..-.|..++||||||++..||..|++
T Consensus       149 ~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~P  227 (502)
T KOG0574|consen  149 KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRP  227 (502)
T ss_pred             HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCC
Confidence            889999999999999999999999999976644322 2344689999999999999899999999999999999999999


Q ss_pred             CCCcccccchhhHHHHHHHHHhcCCCcccccCCC---CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          249 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL---GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      |+....+-...                .++....   -..|..-..++-++++.||-.+|++|-|+.++++
T Consensus       228 PYsDIHPMRAI----------------FMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  228 PYSDIHPMRAI----------------FMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             Cccccccccee----------------EeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            98765432111                1111111   1223444556889999999999999999988864

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5e-38  Score=282.05  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=187.9

Q ss_pred             ceeeecCCeEEEEEEECC---CCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 017503           52 NKIGRGGFGTVYKGTLTN---GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|+..++.++|+||+++++.+......++||||+.++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997543   3568888776543 333456788999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccC-CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc-
Q 017503          128 SLDRVLLGATKA-NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-  205 (370)
Q Consensus       128 ~L~~~~~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-  205 (370)
                      +|.+++...... ....++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999998544322 23356788899999999999999999   9999999999999999999999999998754322111 


Q ss_pred             eeecccCCCCCCCcccccC-------CCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          206 ITTRIAGTTGYLAPEYVLG-------GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       206 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ......++..|+|||++..       ..++.++|||||||++|+|++ |..||......   ...   ..... ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~---~~~~~-~~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVL---KQVVR-EQDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH---HHHhh-ccCccC
Confidence            1222345677999998643       356889999999999999999 67777543221   111   11111 111122


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ..+..   +......+.+++..|| .+|++|||+.+|++.|.
T Consensus       231 ~~~~~---~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQL---DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcc---cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            22222   1223334566777788 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.7e-38  Score=286.10  Aligned_cols=244  Identities=28%  Similarity=0.361  Sum_probs=199.4

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|++|.||++.+. +++.||+|.+....   ......+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999975 58899999876432   233466888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            9999999999983    335789999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .    .....+++.|+|||.+.+...+.++||||||+++|+|++|..||.....   ....    .......      . 
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~----~~~~~~~------~-  215 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIY----EKILEGK------V-  215 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHH----HHHhcCC------c-
Confidence            3    2334578899999999888899999999999999999999999864331   1111    1111111      0 


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  316 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  316 (370)
                        ..+......+.+++.+||..+|.+||     ++++++.
T Consensus       216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              11122234578899999999999998     6777754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.7e-38  Score=286.15  Aligned_cols=261  Identities=24%  Similarity=0.371  Sum_probs=200.8

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||+|++|.||+|.+. ++..|++|.+....  ......+.+|+.++++++|||++++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5889999999999999999975 68899999887553  33356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      + +++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 9999998842   235689999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC--------
Q 017503          204 THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP--------  274 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  274 (370)
                      ........++..|+|||.+.+. .++.++||||+|+++|+|++|.++|.....   ................        
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence            2223334678899999988654 468999999999999999999777643321   1111111111100000        


Q ss_pred             ----cccccCC-----CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          275 ----LELVDPE-----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       275 ----~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                          ..+..+.     +....++....+.+++.+||+.+|.+||++++++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                0000000     011112334678899999999999999999999763

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.3e-38  Score=282.03  Aligned_cols=249  Identities=27%  Similarity=0.421  Sum_probs=193.6

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-----ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--CCee
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-----SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRR  117 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~  117 (370)
                      .+|++.+.||+|+||.||+|... .+..|++|.+...     .......+.+|+.++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47899999999999999999975 5889999987543     12334567889999999999999999998875  3577


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++++||+.+++|.+++.    ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            89999999999999983    334588999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCc--ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          198 LFPDNIT--HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       198 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      .......  .......++..|+|||.+.+..++.++|||||||++|+|++|..||......      ..........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~---  225 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP---  225 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC---
Confidence            5532211  1112245788999999999888999999999999999999999998644211      0011111000   


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                        ..+   ..+......+..++ +||..+|++||++++|++
T Consensus       226 --~~~---~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 --TNP---QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             --CCC---CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence              011   22223333455555 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=302.09  Aligned_cols=244  Identities=27%  Similarity=0.391  Sum_probs=201.4

Q ss_pred             eeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCHHH
Q 017503           53 KIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR  131 (370)
Q Consensus        53 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  131 (370)
                      +||+|.||+||.|++. +...+|||.+...+....+-+..|+...+.|+|+|||+++|.+.+++.+-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            7999999999999976 456689999988877777889999999999999999999999999999999999999999999


Q ss_pred             HhcccccCCccC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC-CCCCeEEeeecCccccCCCCcceee
Q 017503          132 VLLGATKANIKL--NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITT  208 (370)
Q Consensus       132 ~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~  208 (370)
                      ++..   .=.++  ++..+..+.+||++||.|||++   .|+|||||-+||||+ -.|.+||+|||.+..+..-. .-+.
T Consensus       662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TE  734 (1226)
T KOG4279|consen  662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTE  734 (1226)
T ss_pred             HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-cccc
Confidence            9943   22244  7888888999999999999999   999999999999997 57889999999998765433 2344


Q ss_pred             cccCCCCCCCcccccCCC--cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          209 RIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       209 ~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      ...||.-|||||++-.++  |+.++|||||||++.||.||++||-..-.- +.   . ..++   +.     -..-+..|
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-qA---A-MFkV---Gm-----yKvHP~iP  801 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-QA---A-MFKV---GM-----YKVHPPIP  801 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-hH---h-hhhh---cc-----eecCCCCc
Confidence            567999999999997664  789999999999999999999998543211 00   0 0000   00     01114557


Q ss_pred             hHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .+...+...+|.+|+..+|.+||++++++.
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            777888999999999999999999999986

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.1e-38  Score=280.33  Aligned_cols=255  Identities=29%  Similarity=0.445  Sum_probs=203.2

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ++|++.+.||.|++|.||+|... ++..+++|++.... ......+.+|+..++.++|+|++++++.+......+++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            57999999999999999999965 67889999886542 23567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++..... ...+++..+..++.|++.||.+||+.   +++|+||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999843221 24588999999999999999999999   99999999999999999999999999998665432


Q ss_pred             cc---eeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          204 TH---ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       204 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ..   ......++..|+|||.+... .++.++|+||||+++|+|++|+.||......  ..+    ........      
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~----~~~~~~~~------  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVL----MLTLQNDP------  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhH----HHHhcCCC------
Confidence            22   22334578899999988776 7899999999999999999999998644221  111    11111111      


Q ss_pred             CCCCCC--ChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          280 PELGEY--PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       280 ~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      +.....  .......+.+++.+||+.+|.+||++.+|++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111111  1233455889999999999999999999976

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.6e-39  Score=309.59  Aligned_cols=262  Identities=19%  Similarity=0.212  Sum_probs=189.9

Q ss_pred             HHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCC------CCcceeeeEEE
Q 017503           40 ELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRH------PNLVELIGCCV  112 (370)
Q Consensus        40 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~  112 (370)
                      ++....++|++.+.||+|+||+||+|.+. .++.||||++..... .......|+.+++.+.|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34455789999999999999999999975 578899999864322 23445567777776644      45888888887


Q ss_pred             eC-CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCC----
Q 017503          113 QG-TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEF----  186 (370)
Q Consensus       113 ~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~----  186 (370)
                      .. ...++||+++ +++|.+++.    ....+++..+..++.||+.||.|||+ .   +|+||||||+|||++.++    
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence            54 5678999988 567777773    33468999999999999999999997 6   999999999999998765    


Q ss_pred             ------------CeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCccc
Q 017503          187 ------------NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW  254 (370)
Q Consensus       187 ------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~  254 (370)
                                  .+||+|||.+.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                        499999998753221    2334578999999999999999999999999999999999999986543


Q ss_pred             ccchhhHHHHHHHHHh--------------------cC-CCcccccCC-----CCCC---ChHHHHHHHHHHHHchhhcc
Q 017503          255 GQMNKFLLEWAWQLHQ--------------------EE-KPLELVDPE-----LGEY---PPNEIIRYMKVAFFCTQAAA  305 (370)
Q Consensus       255 ~~~~~~~~~~~~~~~~--------------------~~-~~~~~~~~~-----~~~~---~~~~~~~l~~li~~cl~~~p  305 (370)
                      ....   ...+.....                    .. ......++.     ....   .......+.+|+.+||+.||
T Consensus       350 ~~~~---~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  426 (467)
T PTZ00284        350 NLEH---LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR  426 (467)
T ss_pred             hHHH---HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence            2111   111100000                    00 000000000     0000   00112347799999999999


Q ss_pred             CCCCCHHHHHHH
Q 017503          306 SRRPQMNQVIKM  317 (370)
Q Consensus       306 ~~RPt~~evl~~  317 (370)
                      ++|||+.|+++.
T Consensus       427 ~~R~ta~e~L~H  438 (467)
T PTZ00284        427 QKRLNARQMTTH  438 (467)
T ss_pred             hhCCCHHHHhcC
Confidence            999999999873

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.8e-39  Score=286.42  Aligned_cols=239  Identities=26%  Similarity=0.401  Sum_probs=187.7

Q ss_pred             ceeeecCCeEEEEEEECC--------CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           52 NKIGRGGFGTVYKGTLTN--------GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +.||+|+||.||+|..+.        ...|++|..........+.+.+|+.+++.++|||++++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999998642        234888887665555566788899999999999999999999998999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC--------eEEeeecC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN--------PKIGDFGL  195 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~--------~kL~Dfg~  195 (370)
                      +.+|+|..++..   .+..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            999999999843   233688999999999999999999999   9999999999999987765        69999998


Q ss_pred             ccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCC-CCCCcccccchhhHHHHHHHHHhcCC
Q 017503          196 AKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGR-NSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      +......     ....++..|+|||++.+ ..++.++||||||+++|+|++|. .|+.......   ..    ...... 
T Consensus       155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~----~~~~~~-  221 (258)
T cd05078         155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KL----QFYEDR-  221 (258)
T ss_pred             ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HH----HHHHcc-
Confidence            8654321     22356788999999876 45789999999999999999995 4443321111   00    011110 


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                               ...+.....++.+++.+||+.+|.+|||+.+|++.|
T Consensus       222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         222 ---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                     011222234588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-39  Score=295.87  Aligned_cols=240  Identities=27%  Similarity=0.275  Sum_probs=184.4

Q ss_pred             eeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhc---CCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           54 IGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNV---RHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        54 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      ||+|+||.||+|+++ ++..||+|++....   .........|..++...   +||||+++++++......++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999975 58899999886432   12233445566666654   799999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|..++.    ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.++|+|||++....... ..
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~  152 (330)
T cd05586          81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT  152 (330)
T ss_pred             ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence            99998883    445689999999999999999999999   99999999999999999999999999987533221 11


Q ss_pred             eecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY  285 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (370)
                      .....||..|+|||++.+. .++.++|||||||++|+|++|..||.....   ....    ........      .+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~----~~i~~~~~------~~~~-  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMY----RNIAFGKV------RFPK-  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHH----HHHHcCCC------CCCC-
Confidence            2345689999999988764 479999999999999999999999864321   1111    11111110      0100 


Q ss_pred             ChHHHHHHHHHHHHchhhccCCCC----CHHHHHH
Q 017503          286 PPNEIIRYMKVAFFCTQAAASRRP----QMNQVIK  316 (370)
Q Consensus       286 ~~~~~~~l~~li~~cl~~~p~~RP----t~~evl~  316 (370)
                       ......+.+++.+||+.+|.+||    ++.++++
T Consensus       219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             11233477899999999999998    5666655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-38  Score=283.44  Aligned_cols=252  Identities=22%  Similarity=0.405  Sum_probs=200.6

Q ss_pred             CCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCcC------hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAES------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      +|+..+.||+|++|.||++.. .++..||+|.+....      ......+.+|+.+++.++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            588899999999999999996 468899999886432      1234678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-CeEEeeecCccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKL  198 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kL~Dfg~~~~  198 (370)
                      |+||+.+++|.+++.    ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++ .++|+|||.+..
T Consensus        81 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            999999999999983    334688999999999999999999999   999999999999998776 599999999876


Q ss_pred             cCCCCcc---eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          199 FPDNITH---ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       199 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      .......   ......++..|+|||.+.+..++.++||||+|+++|+|++|..||.........   .........    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~----  226 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASA----  226 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhcc----
Confidence            6543211   122345788999999998888999999999999999999999998643221111   111111100    


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                          ......+......+.+++.+||+.+|.+||++.++++
T Consensus       227 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 ----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                0012233444566888999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.4e-38  Score=281.20  Aligned_cols=249  Identities=26%  Similarity=0.392  Sum_probs=196.3

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-----hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--Cee
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-----KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRR  117 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~  117 (370)
                      .+|++.+.||+|+||.||.|.+. ++..|++|.+....     ......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57999999999999999999975 58899999875321     23345788899999999999999999988763  467


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      +++|||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            89999999999999883    334578899999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCc--ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          198 LFPDNIT--HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       198 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      .......  .......++..|+|||.+.+..++.++||||||+++|+|++|+.||......     .. ......     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~-----  223 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIAT-----  223 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH-HHHHhc-----
Confidence            5532111  1122345788999999998888999999999999999999999998643211     01 111110     


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                         .+.....+......+.+++.+|+. +|.+||++.+|++
T Consensus       224 ---~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         224 ---QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ---CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence               011122344445567888888984 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=286.42  Aligned_cols=257  Identities=27%  Similarity=0.454  Sum_probs=201.8

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCC----
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGT----  115 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~----  115 (370)
                      ....++|++.+.||.|++|.||+|.++ +++.+++|.+..... ....+.+|+.+++++ +|+||+++++++....    
T Consensus         2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            346789999999999999999999985 578899998876543 346788999999998 7999999999997654    


Q ss_pred             --eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          116 --RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       116 --~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                        ..++||||+++++|.+++......+..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence              47999999999999998854443456789999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccC-----CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      |++........ ......++..|+|||.+..     ..++.++||||||+++|+|++|+.||......  ..+    ...
T Consensus       158 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~----~~~  230 (275)
T cd06608         158 GVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RAL----FKI  230 (275)
T ss_pred             ccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHH----HHh
Confidence            99876543221 1223457889999998753     34678999999999999999999998643211  111    111


Q ss_pred             HhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .. ...     +.+ ..+......+.+++.+||..||.+|||+.++++
T Consensus       231 ~~-~~~-----~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PR-NPP-----PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hc-cCC-----CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11 111     111 111223456889999999999999999999976

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-38  Score=284.10  Aligned_cols=248  Identities=26%  Similarity=0.434  Sum_probs=197.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.+.||+|+||.||++.. ++..||+|.+....  ....+.+|+.+++.++|||++++++++... ..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            36799999999999999999975 57789999886543  235788899999999999999999998764 478999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      .+++|.+++...  ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            999999998432  234578999999999999999999999   99999999999999999999999999987543221 


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                         .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||......   ....    ........        
T Consensus       155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~--------  216 (254)
T cd05083         155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKE----CVEKGYRM--------  216 (254)
T ss_pred             ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHH----HHhCCCCC--------
Confidence               12234567999999988899999999999999999998 88887543221   1111    11111110        


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                      ..+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1122334557899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.8e-39  Score=289.39  Aligned_cols=260  Identities=26%  Similarity=0.362  Sum_probs=198.1

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++|++.+.||+|++|.||+|.++ +++.||+|.+....  ......+.+|+++++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            57899999999999999999986 58899999876432  2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|..+..    ....+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            999999988763    334589999999999999999999999   9999999999999999999999999998865433


Q ss_pred             CcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc----------
Q 017503          203 ITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE----------  271 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  271 (370)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||.......   ...........          
T Consensus       154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhc
Confidence            21 1222446789999998865 457889999999999999999998875432111   00000000000          


Q ss_pred             -CCC-cccccCCC------CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          272 -EKP-LELVDPEL------GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       272 -~~~-~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       ... .....+..      ....+.....+.+++.+||+.+|.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             000 00000000      0111233456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.9e-38  Score=281.14  Aligned_cols=254  Identities=25%  Similarity=0.371  Sum_probs=197.8

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh----------hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK----------QGVREFITEIMTLSNVRHPNLVELIGCCVQGT  115 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  115 (370)
                      +|.+.+.||.|++|.||+|... +++.||+|.+.....          ...+.+.+|+.+++.++|+|++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5788999999999999999865 688999998753211          12345778999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      ..++||||+.+++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            99999999999999999842    34688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc-eeecccCCCCCCCcccccCCC--cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          196 AKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       196 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      +......... ......++..|+|||.+....  ++.++|+||||+++|+|++|..||......      ..........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~  228 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKR  228 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccc
Confidence            9765432211 122345788999999887654  789999999999999999999998532111      1011111111


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..... .   ..........+.+++.+||..+|.+||++.+|+..
T Consensus       229 ~~~~~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 SAPPI-P---PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCcC-C---ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11111 1   11222334568889999999999999999998763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.4e-38  Score=292.23  Aligned_cols=256  Identities=20%  Similarity=0.251  Sum_probs=192.4

Q ss_pred             ccceeeec--CCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           50 LSNKIGRG--GFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        50 ~~~~lg~G--~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      +.++||+|  +|++||++..+ +|+.||+|.+....  ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            57889999  67899999875 68899999987542  334456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++++|.+++....  ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++++||+..........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999984322  23588999999999999999999999   999999999999999999999999986543321110


Q ss_pred             ------ceeecccCCCCCCCcccccC--CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          205 ------HITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       205 ------~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                            .......++..|+|||++.+  ..++.++|||||||++|+|++|+.||.......  ....    .... ....
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~----~~~~-~~~~  229 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLE----KLNG-TVPC  229 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHH----HhcC-Cccc
Confidence                  00112345678999999876  458899999999999999999999986432111  0000    0000 0000


Q ss_pred             cc-------------------cC------------------CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          277 LV-------------------DP------------------ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       277 ~~-------------------~~------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..                   +.                  ............+.+++.+||+.||.+|||+.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            00                   00                  0001111233468899999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7e-38  Score=279.90  Aligned_cols=252  Identities=26%  Similarity=0.419  Sum_probs=205.8

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh-hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ++|++.+.||.|++|.||++.+. ++..|++|.+..... .....+.+|+..+.+++|+|++++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            47889999999999999999986 489999998876643 4457788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      +++++|.+++.    ....+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            99999999984    23578999999999999999999999 8   9999999999999999999999999999866443


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      ... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..........+..   ... ..        ..
T Consensus       154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~-~~--------~~  220 (264)
T cd06623         154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---AIC-DG--------PP  220 (264)
T ss_pred             CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH---HHh-cC--------CC
Confidence            222 123457789999999998899999999999999999999999986553211111111   111 11        11


Q ss_pred             CCCChH-HHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          283 GEYPPN-EIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       283 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...+.. ....+.+++.+||..+|.+||++.++++.
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111222 44568899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.9e-38  Score=286.74  Aligned_cols=260  Identities=24%  Similarity=0.412  Sum_probs=202.7

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ  113 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  113 (370)
                      .+..++....+.|++.+.||.|+||.||+|.+. +++.||+|++..... ....+..|+.+++++ +|+|++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            466777788899999999999999999999975 578899998765432 345677899999998 79999999999863


Q ss_pred             ------CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          114 ------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       114 ------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                            ....+++|||+.+++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence                  45789999999999999988432  234578888999999999999999999   9999999999999999999


Q ss_pred             eEEeeecCccccCCCCcceeecccCCCCCCCccccc-----CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHH
Q 017503          188 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL  262 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~  262 (370)
                      ++|+|||++........ ......++..|+|||.+.     ...++.++||||||+++|+|++|..||........    
T Consensus       160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~----  234 (282)
T cd06636         160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA----  234 (282)
T ss_pred             EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh----
Confidence            99999999875432211 122345788999999875     34678899999999999999999999864322110    


Q ss_pred             HHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          263 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                        ...... ..     .+.  .........+.+++.+||..+|.+||++.+|++
T Consensus       235 --~~~~~~-~~-----~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 --LFLIPR-NP-----PPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --hhhHhh-CC-----CCC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence              000000 00     000  111223345889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.6e-38  Score=288.90  Aligned_cols=257  Identities=27%  Similarity=0.460  Sum_probs=200.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCC----EEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGR----RIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .++|+..+.||+|+||.||+|.+. ++.    .||+|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            467888999999999999999864 343    57999877553 23344678899999999999999999998754 467


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +++||+.+|+|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence            89999999999998842   234578999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          199 FPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       199 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .....    ........ 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~----~~~~~~~~-  230 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPD----LLEKGERL-  230 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHCCCCC-
Confidence            6433221 1222335678999999988899999999999999999997 8888754321   11111    11111110 


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                             ..++.....+.+++..||..+|.+||++.++++.|..+..
T Consensus       231 -------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         231 -------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                   1112233457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.6e-38  Score=283.27  Aligned_cols=237  Identities=25%  Similarity=0.433  Sum_probs=186.8

Q ss_pred             ceeeecCCeEEEEEEECCCC-----------EEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           52 NKIGRGGFGTVYKGTLTNGR-----------RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~~~-----------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999986432           5788877655433 5778899999999999999999999988 778999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-------CeEEeee
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-------NPKIGDF  193 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-------~~kL~Df  193 (370)
                      |||+.+++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++       .++|+||
T Consensus        79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence            9999999999998432   22688999999999999999999999   999999999999999887       7999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCC--CcCccccchhhhHHHHHHHhC-CCCCCcccccchhhHHHHHHHHHh
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGG--QLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQ  270 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~  270 (370)
                      |++.....     .....++..|+|||++...  .++.++||||||+++|+|++| ..|+........   ..    ...
T Consensus       153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~----~~~  220 (259)
T cd05037         153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ER----FYQ  220 (259)
T ss_pred             Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HH----HHh
Confidence            99886543     1223456789999998776  789999999999999999995 666644321110   00    000


Q ss_pred             cCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      ....       .   +......+.+++.+||..+|.+||++.+|++.|
T Consensus       221 ~~~~-------~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 DQHR-------L---PMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             cCCC-------C---CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            0000       0   001115688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.1e-38  Score=282.55  Aligned_cols=253  Identities=25%  Similarity=0.441  Sum_probs=202.7

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ++|++.+.||.|++|.||++.++ +++.|++|.+.... ......+.+|+.++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            47889999999999999999986 68889999887653 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      +.+++|.+++....   ..+++..+..++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999999984322   568899999999999999999999 8   9999999999999999999999999998755322


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      ...   ...++..|+|||.+.+..++.++||||||+++|+|++|..||........ ..............         
T Consensus       155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~---------  221 (265)
T cd06605         155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNEPP---------  221 (265)
T ss_pred             Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcCCC---------
Confidence            111   15578899999999988999999999999999999999999865422111 11111111111111         


Q ss_pred             CCCChH-HHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          283 GEYPPN-EIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       283 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...+.. ....+.++|.+||..+|++|||+.+++..
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            111111 34458899999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.3e-37  Score=279.37  Aligned_cols=254  Identities=24%  Similarity=0.408  Sum_probs=188.1

Q ss_pred             ceeeecCCeEEEEEEECCC---CEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 017503           52 NKIGRGGFGTVYKGTLTNG---RRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      +.||+|+||.||++...++   ..+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+.++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3689999999999975433   345677665442 344567889999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC-Ccce
Q 017503          128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN-ITHI  206 (370)
Q Consensus       128 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~  206 (370)
                      +|.+++..........++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++...... ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999865433344567778889999999999999999   9999999999999999999999999997643221 1111


Q ss_pred             eecccCCCCCCCcccccC-------CCcCccccchhhhHHHHHHHhC-CCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          207 TTRIAGTTGYLAPEYVLG-------GQLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..||.....   .....   .... .......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~---~~~~-~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLN---HVIK-DQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---HHHh-hcccccC
Confidence            223457789999998743       2457899999999999999975 556643221   11111   1111 1222223


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ++.+..   .....+.+++..|| .+|++||++.+|++.|.
T Consensus       231 ~~~~~~---~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLEL---PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCC---CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            333321   12234667888899 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-38  Score=286.01  Aligned_cols=251  Identities=32%  Similarity=0.509  Sum_probs=195.7

Q ss_pred             ceeeecCCeEEEEEEECC-------CCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           52 NKIGRGGFGTVYKGTLTN-------GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +.||+|+||.||+|+.++       +..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999998652       2578999776542 23456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhccccc---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-----CeEEeeecC
Q 017503          124 VENNSLDRVLLGATK---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-----NPKIGDFGL  195 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-----~~kL~Dfg~  195 (370)
                      +++++|.+++.....   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999854322   234578999999999999999999999   999999999999999877     899999999


Q ss_pred             ccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          196 AKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       196 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      +........ .......++..|+|||.+.++.++.++||||||+++|+|++ |..||.....   ......    .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~----~~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQH----VTAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHH----HhcCC
Confidence            875533211 11122345678999999999999999999999999999998 8888753321   111111    11111


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                              ....+...+..+.+++.+||..+|.+||++.+|++.|++
T Consensus       231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                    011122334568899999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-38  Score=288.38  Aligned_cols=260  Identities=21%  Similarity=0.293  Sum_probs=195.1

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||+|++|.||+|++. +|..|++|.+....  ......+.+|+.++++++|||++++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            5889999999999999999985 68899999886532  22234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+ +|.+++.   ..+..+++..++.++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CDQ-DLKKYFD---SCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CCC-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            975 6777663   2234689999999999999999999999   99999999999999999999999999998654322


Q ss_pred             cceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH-----------hc
Q 017503          204 THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH-----------QE  271 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~  271 (370)
                      .. .....++..|+|||.+.+. .++.++|||||||++|+|++|..|+.......  ..........           ..
T Consensus       154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhh
Confidence            11 1223567899999988764 46899999999999999999988864332211  1111111110           00


Q ss_pred             CCCcccc---cCCC--CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          272 EKPLELV---DPEL--GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       272 ~~~~~~~---~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .......   ....  ....+.....+.+++.+||+.+|.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000000   0000  1111233456789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.3e-38  Score=286.12  Aligned_cols=251  Identities=25%  Similarity=0.452  Sum_probs=202.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++.+.||+|+||.||++... ++..|++|.+..........+.+|+.+++.++|||++++++++......++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            478999999999999999999864 6788999988765544556788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++.     ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          98 LAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            99999999983     23578899999999999999999999   99999999999999999999999999887554332


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .. .....+++.|++||.+....++.++|+||||+++|+|++|..||........  +    ........      +.. 
T Consensus       170 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~----~~~~~~~~------~~~-  235 (293)
T cd06647         170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L----YLIATNGT------PEL-  235 (293)
T ss_pred             cc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--e----eehhcCCC------CCC-
Confidence            21 1223577889999999888899999999999999999999999864322110  0    00000000      000 


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..+......+.+++.+||..+|.+||++.+++..
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122234458889999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.7e-38  Score=280.52  Aligned_cols=248  Identities=24%  Similarity=0.385  Sum_probs=199.3

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||+|++|.||++... ++..+|+|.+...  .......+.+|+.++++++|||++++++.+......++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5889999999999999999975 6788999987654  234456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-CeEEeeecCccccCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDN  202 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~  202 (370)
                      +++++|.+++...  .+..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++ .++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999998432  234588999999999999999999999   999999999999998554 5799999999866443


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      ..  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....   ....   ......         ..
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~---~~~~~~---------~~  218 (256)
T cd08220         156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALV---LKIMSG---------TF  218 (256)
T ss_pred             cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHH---HHHHhc---------CC
Confidence            21  2224578899999999888899999999999999999999998754321   1111   111111         01


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...+......+.+++.+||+.+|.+|||+.+++.
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1122233445889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1e-38  Score=289.99  Aligned_cols=249  Identities=22%  Similarity=0.392  Sum_probs=198.1

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecC
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE  125 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  125 (370)
                      .|.....||+|+||.||++... ++..||||.+..........+.+|+..++.++|+|++++++.+...+..++||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3444577999999999999975 588999998876555556678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc
Q 017503          126 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH  205 (370)
Q Consensus       126 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  205 (370)
                      +++|.+++.     ...+++..++.++.||+.||.|||+.   +++||||+|+||+++.++.++|+|||++.........
T Consensus       103 ~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658         103 GGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            999999873     23578999999999999999999999   9999999999999999999999999998765433221


Q ss_pred             eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCC
Q 017503          206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY  285 (370)
Q Consensus       206 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (370)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......   ....    .....     ..+... .
T Consensus       175 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~----~~~~~-----~~~~~~-~  240 (292)
T cd06658         175 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMR----RIRDN-----LPPRVK-D  240 (292)
T ss_pred             -CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhc-----CCCccc-c
Confidence             22345788999999998888999999999999999999999998643211   1111    11111     111111 1


Q ss_pred             ChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          286 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       286 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .......+..++.+||..+|.+|||+.++++.
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11223347788888999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5e-38  Score=288.77  Aligned_cols=196  Identities=27%  Similarity=0.452  Sum_probs=158.5

Q ss_pred             ceeeecCCeEEEEEEEC---CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--CCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT---NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~  126 (370)
                      .+||+|+||.||+|+.+   .+..||+|.+....  ....+.+|+.++++++||||+++++++..  ....++||||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            58999999999999965   35689999886543  23457789999999999999999999854  5577899999876


Q ss_pred             CCHHHHhcccc-----cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe----CCCCCeEEeeecCcc
Q 017503          127 NSLDRVLLGAT-----KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLAK  197 (370)
Q Consensus       127 ~~L~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kL~Dfg~~~  197 (370)
                       +|.+++....     .....+++..+..++.|++.||.|||+.   +++||||||+||++    +.++.+||+|||++.
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             6666653211     1233578999999999999999999999   99999999999999    456789999999998


Q ss_pred             ccCCCCcc--eeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcc
Q 017503          198 LFPDNITH--ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM  253 (370)
Q Consensus       198 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~  253 (370)
                      ........  ......+|..|+|||++.+ ..++.++|||||||++|+|+||.+||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            76443221  1233467889999998876 45789999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.5e-38  Score=282.16  Aligned_cols=247  Identities=26%  Similarity=0.345  Sum_probs=201.5

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      +|++.+.||.|+||.||++.+. ++..||+|.+....   ......+.+|++++++++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5889999999999999999986 58899999887542   2446788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+++|..++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999999983    235788999999999999999999999   9999999999999999999999999998865443


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      .  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..........+.    .....         ..
T Consensus       154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~---------~~  218 (258)
T cd05578         154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET---------AD  218 (258)
T ss_pred             c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc---------cc
Confidence            2  123345788999999998888999999999999999999999998755432111111    11110         01


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCH--HHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQM--NQVI  315 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~evl  315 (370)
                      ...+......+.+++.+||+.+|.+||++  ++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11222334568899999999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.7e-38  Score=286.37  Aligned_cols=250  Identities=21%  Similarity=0.365  Sum_probs=199.6

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      ..|.....||+|+||.||++... ++..||+|.+..........+.+|+.+++.++|||++++++++......++||||+
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            34555678999999999999975 68899999886654445567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++++|..++.     ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus       101 ~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         101 QGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            9999998772     24588999999999999999999999   999999999999999999999999999875543322


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                      . .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......   ...    ..........      ..
T Consensus       173 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~----~~~~~~~~~~------~~  238 (297)
T cd06659         173 K-RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAM----KRLRDSPPPK------LK  238 (297)
T ss_pred             c-ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHhccCCCC------cc
Confidence            1 22345788999999999888999999999999999999999998643211   111    1111111100      01


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ........+.+++.+||+.+|.+||++.++++.
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            111223447888999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.2e-38  Score=282.30  Aligned_cols=248  Identities=27%  Similarity=0.413  Sum_probs=199.7

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +-|++.+.||.|+||.||+|.+. ++..||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34778899999999999999875 67889999876442 33456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+++|..++.     ...+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          84 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999999883     23588999999999999999999999   99999999999999999999999999987654322


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      . ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......   ..   ... .....        ..
T Consensus       156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~---~~~-~~~~~--------~~  219 (277)
T cd06641         156 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KV---LFL-IPKNN--------PP  219 (277)
T ss_pred             h-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HH---HHH-HhcCC--------CC
Confidence            1 122245788899999998888899999999999999999999998643211   01   111 11110        11


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .........+.+++.+||+.+|.+||++.+++..
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1222334457888999999999999999999884

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.9e-38  Score=288.06  Aligned_cols=256  Identities=21%  Similarity=0.284  Sum_probs=200.2

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||++.+. .++.|++|.+....   ......+.+|+++++.++||||+++++.+......++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47899999999999999999976 57889999886543   233456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            9999999999983    334689999999999999999999999   999999999999999999999999998864211


Q ss_pred             CCc--------------ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 017503          202 NIT--------------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       202 ~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      ...              .......++..|+|||.+.+..++.++|+||||+++|+|++|..||....   ...+..   .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~~---~  227 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFG---Q  227 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---H
Confidence            100              01112346778999999988889999999999999999999999985321   111111   1


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      ......    ..+..   .......+.+++.+||+.+|.+||+..++.+.|...
T Consensus       228 ~~~~~~----~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         228 VISDDI----EWPEG---DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHhccc----CCCCc---cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            111110    01111   112334478999999999999999987777767653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-39  Score=271.78  Aligned_cols=255  Identities=23%  Similarity=0.326  Sum_probs=204.4

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--------ChhcHHHHHHHHHHHHhc-CCCCcceeeeEE
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--------SKQGVREFITEIMTLSNV-RHPNLVELIGCC  111 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~  111 (370)
                      ...-..|.-.+.||.|..+.|-+..++ ++..+|+|++...        .....+.-.+|+.+|+++ .||+|+.+.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            344567888899999999999887764 6788888877432        122234556799999997 799999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEe
Q 017503          112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG  191 (370)
Q Consensus       112 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~  191 (370)
                      +.....++|+|.++.|.|.+++    .....++++...+|++|+.+|++|||..   +|+||||||+|||++++.+++|+
T Consensus        93 es~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEe
Confidence            9999999999999999999999    5777899999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCcceeecccCCCCCCCccccc------CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHH
Q 017503          192 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVL------GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA  265 (370)
Q Consensus       192 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~  265 (370)
                      |||++..+..+  ..-...+||++|+|||.+.      ...|+...|+|++|+++|.|+.|.+||....   +...+.. 
T Consensus       166 DFGFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlMLR~-  239 (411)
T KOG0599|consen  166 DFGFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLMLRM-  239 (411)
T ss_pred             ccceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHHHH-
Confidence            99999977654  2345578999999999874      2458889999999999999999999974321   1111111 


Q ss_pred             HHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          266 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         ..+++. ..    ......+......+||.+||+.||.+|.|++|.+..
T Consensus       240 ---ImeGky-qF----~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  240 ---IMEGKY-QF----RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             ---HHhccc-cc----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence               111111 11    122334555668899999999999999999999864

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4e-38  Score=283.12  Aligned_cols=256  Identities=24%  Similarity=0.429  Sum_probs=198.0

Q ss_pred             CcccceeeecCCeEEEEEEEC----CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC------
Q 017503           48 FHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------  115 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------  115 (370)
                      |++.+.||+|+||.||+|.+.    ++..||+|.+..+  .....+.+.+|+.+++.++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999854    3678999988754  3344567888999999999999999999886532      


Q ss_pred             eeEEEEEecCCCCHHHHhcccc--cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          116 RRILVYEYVENNSLDRVLLGAT--KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      ..+++++|+.+++|..++....  .....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999988874322  1223578999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhc
Q 017503          194 GLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       194 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      |++......... ......++..|++||.+.+..++.++||||||+++|+|++ |.+||.....   ..+..+    ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~----~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY----LIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH----HHc
Confidence            998865432211 1112234567999999998889999999999999999999 7888754321   111111    111


Q ss_pred             CCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      ....        ..++.....+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       231 ~~~~--------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNRL--------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCcC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1110        11123345688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=286.62  Aligned_cols=252  Identities=24%  Similarity=0.299  Sum_probs=199.6

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh---hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK---QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|++|.||++... ++..||+|.+.....   .....+.+|+++++.++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47899999999999999999976 488999998875532   24556888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+++|.+++..  ..+..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999999842  2335689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCcc----------------------------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcc
Q 017503          202 NITH----------------------------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  253 (370)
Q Consensus       202 ~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~  253 (370)
                      ....                            ......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            2110                            011235788899999999888999999999999999999999998644


Q ss_pred             cccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCC----HHHHHH
Q 017503          254 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ----MNQVIK  316 (370)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~  316 (370)
                      ...  ..+    ........       .... .......+.+++.+||+.+|.+||+    +.+++.
T Consensus       236 ~~~--~~~----~~~~~~~~-------~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NRD--ETF----SNILKKEV-------TFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             chH--HHH----HHHhcCCc-------cCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            221  111    11111110       0000 1113456889999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.3e-38  Score=285.61  Aligned_cols=259  Identities=22%  Similarity=0.321  Sum_probs=196.9

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChh-----cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQ-----GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      +|++.+.||.|++|.||+|.+. +++.|++|.+......     ....+..|+.++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            5888999999999999999975 6889999988755322     334567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+ +++|.+++...   ...+++..++.++.||+.||.|||++   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 88999998421   23689999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC-------
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE-------  272 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  272 (370)
                      ..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|.++|.......   ............       
T Consensus       154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhh
Confidence            43211 122345778999998754 467899999999999999999977765432211   111111100000       


Q ss_pred             --CC-cccc-----cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          273 --KP-LELV-----DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       273 --~~-~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                        .. ....     ..............+.+++.+||+.+|++|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence              00 0000     00001112233456889999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=289.39  Aligned_cols=249  Identities=21%  Similarity=0.340  Sum_probs=209.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .+-|.+.+.||+|.|..|-++++- .|.+||||++...  +....-++.+|++.|+-..|||||++|.+...+..+|+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            456889999999999999999864 7999999999765  3444567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC-CCCCeEEeeecCccccC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~  200 (370)
                      |.-++|+|.+||.+   ....+++..+.+++.||+.||.|+|+.   .++||||||+||.+. .-|-+||.|||++..+.
T Consensus        97 ELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            99999999999953   445689999999999999999999999   999999999999775 56789999999998776


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcC-ccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      .+.  .-...+|++.|.|||++.+..|+ ++.||||||++||-|++|++||+..-+.+               ...-+.|
T Consensus       171 PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImD  233 (864)
T KOG4717|consen  171 PGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMD  233 (864)
T ss_pred             Ccc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhc
Confidence            543  34456899999999999999986 78999999999999999999987543211               1111222


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      -. -..|.....++.+||..||..||++|.+.++|...
T Consensus       234 CK-YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  234 CK-YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             cc-ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            21 14466777789999999999999999999998643

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-39  Score=295.61  Aligned_cols=264  Identities=22%  Similarity=0.400  Sum_probs=215.0

Q ss_pred             HHHHHhccCCcccceeeecCCeEEEEEEECC-CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           39 TELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        39 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      +.++-...+..+.++||-|-||.||.|.|+. .-.||||.++.+.- ...+|++|+.+|+.++|||+|+++|+|.....+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            5555556677788999999999999999974 56799998876643 468899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      |||+|||..|+|-+|+...  +...++....+.++.||+.|+.||..+   ++|||||...|+|+.++..+|++|||+++
T Consensus       339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence            9999999999999999543  334567788899999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhC-CCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ++..+.........-.+-|.|||-+..+.++.++|||+||++|||+.|- -.|+...    +.   ..+...+.+.-.. 
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi----dl---SqVY~LLEkgyRM-  485 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI----DL---SQVYGLLEKGYRM-  485 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc----cH---HHHHHHHhccccc-
Confidence            9987655554444456789999999999999999999999999999884 4454322    11   1122222222211 


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                             +.+..|+.++.+|++.||++.|.+||++.|+.+.++....
T Consensus       486 -------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  486 -------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             -------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence                   2344555668888888999999999999999988877654

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1e-37  Score=281.93  Aligned_cols=253  Identities=25%  Similarity=0.428  Sum_probs=193.7

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHH-HHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMT-LSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++|++.+.||+|+||.||++.++ +|..||+|.+.... ......+..|+.. ++.++|||++++++++......+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47999999999999999999976 68999999886542 2223445556665 556799999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |++ ++|.+++......+..+++..++.++.|++.||.|||++.  +++||||+|+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 5888777544444567899999999999999999999842  7999999999999999999999999998865432


Q ss_pred             CcceeecccCCCCCCCcccccC----CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          203 ITHITTRIAGTTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      .  ......++..|+|||.+.+    ..++.++|+||||+++|+|++|..||........     ........ ..    
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~-~~----  225 (283)
T cd06617         158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-----QLKQVVEE-PS----  225 (283)
T ss_pred             c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-----HHHHHHhc-CC----
Confidence            1  1122457888999998754    4568899999999999999999999864322111     11111111 10    


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       +...  .......+.+++.+||..+|.+||++.+|+.
T Consensus       226 -~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 -PQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -CCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             1110  0112345888999999999999999999976

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-38  Score=281.42  Aligned_cols=248  Identities=27%  Similarity=0.439  Sum_probs=198.0

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcC---CCCcceeeeEEEeCCeeEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVR---HPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .|++.+.||+|+||.||+|.+. ++..|++|.+... .......+.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5788999999999999999974 6889999988654 3344567788999999986   999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+++|.+++..     ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            99999999998832     2688999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      .... .....++..|+|||.+.++ .++.++|+||||+++|+|++|..||.......      ... .....     ..+
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~~-----~~~  220 (277)
T cd06917         154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPKS-----KPP  220 (277)
T ss_pred             Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-ccccC-----CCC
Confidence            3322 2234578899999988654 56899999999999999999999986432110      000 00000     011


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .+..  ......+.+++.+||+.+|.+||++.++++.
T Consensus       221 ~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         221 RLED--NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            1111  0134458889999999999999999999763

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-38  Score=287.94  Aligned_cols=266  Identities=24%  Similarity=0.371  Sum_probs=196.8

Q ss_pred             CCcccceeeecCCeEEEEEEEC---CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--CeeE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT---NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRI  118 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~  118 (370)
                      +|++.+.||+|++|.||+|...   ++..||+|.+....   ......+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            5889999999999999999975   37899999887632   34456678899999999999999999999988  8899


Q ss_pred             EEEEecCCCCHHHHhcccccC-CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC----CCCeEEeee
Q 017503          119 LVYEYVENNSLDRVLLGATKA-NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ----EFNPKIGDF  193 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~----~~~~kL~Df  193 (370)
                      +||||+++ +|.+++...... ...+++..++.++.|++.||.|||+.   +++||||+|+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999976 566655433332 23789999999999999999999999   9999999999999999    899999999


Q ss_pred             cCccccCCCCc--ceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchh------hHHHH
Q 017503          194 GLAKLFPDNIT--HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK------FLLEW  264 (370)
Q Consensus       194 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~------~~~~~  264 (370)
                      |++........  .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||.........      .....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986644322  112234578899999987664 5789999999999999999999998754433200      00000


Q ss_pred             HHHHHhcCC------------Ccccc-cCCCCCCC----h-------HHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          265 AWQLHQEEK------------PLELV-DPELGEYP----P-------NEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       265 ~~~~~~~~~------------~~~~~-~~~~~~~~----~-------~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .........            ..... .......+    .       .....+.+++.+||+.+|++|||+.+++.
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000000            00000 00000011    0       22345788999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=281.15  Aligned_cols=262  Identities=23%  Similarity=0.352  Sum_probs=195.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh-hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            478999999999999999999976 678999998865422 223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+ +|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        84 ~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          84 YLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            9985 89888742   233678999999999999999999999   9999999999999999999999999998754321


Q ss_pred             CcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc-----
Q 017503          203 ITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE-----  276 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  276 (370)
                      ... .....++..|+|||++.+ ..++.++||||+|+++|+|++|..||........  ................     
T Consensus       157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhh
Confidence            111 112235788999998865 4588999999999999999999999864432111  1111111110000000     


Q ss_pred             -----------cccCC-CCCCCh--HHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          277 -----------LVDPE-LGEYPP--NEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       277 -----------~~~~~-~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                                 ...+. +....+  .....+.+++.+||+.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                       00000 000000  11245778999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.8e-38  Score=283.41  Aligned_cols=263  Identities=23%  Similarity=0.321  Sum_probs=194.6

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh-hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++++|++.+.||+|+||.||+|... ++..|++|.+..... .....+.+|+.+++.++|+||+++.+++......++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4688999999999999999999875 688999998865432 22345678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+. ++|.+++.   .....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMI---QHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9996 56666653   2234578888999999999999999999   999999999999999999999999999875432


Q ss_pred             CCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC--------
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE--------  272 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  272 (370)
                      .... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||........  .....+......        
T Consensus       156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhh
Confidence            2111 1223468899999988754 578899999999999999999999875432111  111111100000        


Q ss_pred             ----CC-ccccc---C-CCCCC--ChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          273 ----KP-LELVD---P-ELGEY--PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       273 ----~~-~~~~~---~-~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                          .. .....   + .+...  .......+.+++.+|+..+|.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                00 00000   0 00000  0011345778899999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-38  Score=303.60  Aligned_cols=269  Identities=19%  Similarity=0.291  Sum_probs=188.6

Q ss_pred             hccCCcccceeeecCCeEEEEEEECC--CCEEEEE------------------ECcCcChhcHHHHHHHHHHHHhcCCCC
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTN--GRRIAVK------------------PLSAESKQGVREFITEIMTLSNVRHPN  103 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~--~~~vaiK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~~  103 (370)
                      ..++|++.+.||+|+||+||++..+.  +...++|                  .+. ........+.+|+.+|++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            45789999999999999999987532  2222222                  111 11223456788999999999999


Q ss_pred             cceeeeEEEeCCeeEEEEEecCCCCHHHHhcccc-cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe
Q 017503          104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT-KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL  182 (370)
Q Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill  182 (370)
                      |+++++++...+..++|++++.+ +|..++.... ..........+..++.||+.||.|||++   +|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            99999999999999999999965 5655553221 1122344667788999999999999999   99999999999999


Q ss_pred             CCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCC-CCCcccccchhhH
Q 017503          183 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN-SGKAMWGQMNKFL  261 (370)
Q Consensus       183 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~-p~~~~~~~~~~~~  261 (370)
                      +.++.+||+|||++..+............|+..|+|||++.+..++.++|||||||++|||++|.. |+..........+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            999999999999998765543333444678999999999999999999999999999999999875 3332222211222


Q ss_pred             HHHHHHHH--hcCCCc------ccccC-CC---CCCCh------HHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          262 LEWAWQLH--QEEKPL------ELVDP-EL---GEYPP------NEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       262 ~~~~~~~~--~~~~~~------~~~~~-~~---~~~~~------~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ........  ..+.+.      ..++. ..   ....+      .....+.+++.+||+.||.+|||+.|++..
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            21111000  000000      00000 00   00000      112246677889999999999999999864

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4e-38  Score=280.43  Aligned_cols=250  Identities=23%  Similarity=0.407  Sum_probs=199.9

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||.|+||.||+|..+ ++..||+|.+....  ......+.+|+.+++.++|+|++++++.+.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5888999999999999999976 57889999886542  23345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC-eEEeeecCccccCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN-PKIGDFGLAKLFPDN  202 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~-~kL~Dfg~~~~~~~~  202 (370)
                      +.+++|.+++..  ..+..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++. ++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            999999998843  2234578999999999999999999999   9999999999999998764 699999998866433


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      .. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      ......... .        ..
T Consensus       156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~--------~~  219 (257)
T cd08225         156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-G--------YF  219 (257)
T ss_pred             cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-c--------cC
Confidence            21 12224578899999999888899999999999999999999999754321      111111111 1        11


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ....+.....+.+++.+||..+|.+|||+.++++.
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11222334468899999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.8e-38  Score=277.63  Aligned_cols=251  Identities=23%  Similarity=0.417  Sum_probs=205.7

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||.|++|.||++.+. ++..|++|.+....  ......+.+|+++++.++|+|++++.+.+......++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5889999999999999999976 68899999887653  24556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++......+..+++..+..++.+++.||.+||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999865443456799999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                       .......+++.|+|||.+.+..++.++|+||+|+++++|++|..||.....   .   ........ .        ...
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~---~~~~~~~~-~--------~~~  221 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---L---ELALKILK-G--------QYP  221 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH---H---HHHHHHhc-C--------CCC
Confidence             122334578899999999888899999999999999999999999754421   1   11111111 1        111


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..+......+.+++.+||..+|.+||++.++++
T Consensus       222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            222234455888999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.9e-37  Score=323.26  Aligned_cols=268  Identities=31%  Similarity=0.562  Sum_probs=210.1

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG  114 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  114 (370)
                      ++++++.   ..|.....||+|+||.||+|... ++..||+|.+......    ...|++.+++++||||+++++++.+.
T Consensus       683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~  755 (968)
T PLN00113        683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE  755 (968)
T ss_pred             hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence            4444443   45777889999999999999974 7889999988644321    12468889999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      ...++||||+++|+|.+++.       .++|..+..++.|++.||+|||....++++||||||+||+++.++..++. |+
T Consensus       756 ~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~  827 (968)
T PLN00113        756 KGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS  827 (968)
T ss_pred             CCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence            99999999999999999983       37899999999999999999995433399999999999999998888775 56


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      ........     ....++..|+|||++.+..++.++|||||||++|||+||+.||+..... ......|..........
T Consensus       828 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~  901 (968)
T PLN00113        828 LPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHL  901 (968)
T ss_pred             cccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccch
Confidence            54432211     1235788999999999999999999999999999999999998644332 22334444333323233


Q ss_pred             cccccCCCC---CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          275 LELVDPELG---EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       275 ~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      ...+++.+.   .....+..++++++.+||+.+|.+||++.+|++.|+.+.+.
T Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            334454442   33456777889999999999999999999999999987663

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.3e-37  Score=281.91  Aligned_cols=248  Identities=25%  Similarity=0.430  Sum_probs=199.1

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecC
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE  125 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  125 (370)
                      .|...+.||+|++|.||++... ++..+++|.+..........+.+|+.+++.++|||++++++++...+..++++||+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            4555689999999999999964 688899998866555555678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc
Q 017503          126 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH  205 (370)
Q Consensus       126 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  205 (370)
                      +++|.+++..     ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||.+.........
T Consensus       100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648         100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            9999999832     4588999999999999999999999   9999999999999999999999999988755433221


Q ss_pred             eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCC
Q 017503          206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY  285 (370)
Q Consensus       206 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (370)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|..||.....      ....... .....     +.. ..
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~-~~~~~-----~~~-~~  237 (285)
T cd06648         172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRI-RDNLP-----PKL-KN  237 (285)
T ss_pred             -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHH-HhcCC-----CCC-cc
Confidence             2224578899999999888899999999999999999999999754211      1111111 11111     111 11


Q ss_pred             ChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          286 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       286 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      +......+.+++.+||+.+|.+||++.++++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            1123345889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.2e-37  Score=274.27  Aligned_cols=249  Identities=32%  Similarity=0.540  Sum_probs=202.8

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecC
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE  125 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  125 (370)
                      +|++.+.||+|++|.||++.+. ++..+++|.+..........+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            5888999999999999999986 688899999877655556788899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc
Q 017503          126 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH  205 (370)
Q Consensus       126 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  205 (370)
                      +++|.+++...   ...+++..+..++.|++.||.+||+.   +++||||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999998432   25689999999999999999999998   999999999999999999999999999886654332 


Q ss_pred             eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCC
Q 017503          206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY  285 (370)
Q Consensus       206 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (370)
                       .....++..|++||.+.+..++.++|+||||+++|+|++|..||........  .    ..... .......      .
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~-~~~~~~~------~  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--L----FKIAT-NGPPGLR------N  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHHh-cCCCCcC------c
Confidence             2334578899999999888899999999999999999999999764421111  0    01111 1110110      0


Q ss_pred             ChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          286 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       286 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .......+.+++.+||+.+|.+|||+.++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111345888999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.2e-37  Score=281.78  Aligned_cols=260  Identities=23%  Similarity=0.339  Sum_probs=194.9

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||.|++|.||+|+++ ++..|+||.+....  ......+.+|++++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4889999999999999999975 68899999886542  22345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +. ++|..++..  ..+..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 578888743  2245689999999999999999999999   99999999999999999999999999987654322


Q ss_pred             cceeecccCCCCCCCcccccCCC-cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC---------
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK---------  273 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  273 (370)
                      .. .....++..|+|||.+.+.. ++.++||||||+++|+|+||+.||.....  ........ .......         
T Consensus       155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~  230 (284)
T cd07860         155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIF-RTLGTPDEVVWPGVTS  230 (284)
T ss_pred             cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHH-HHhCCCChhhhhhhhH
Confidence            11 12234678899999886644 68899999999999999999998854321  11111110 0000000         


Q ss_pred             -------CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 -------PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 -------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                             ........+....+.....+.+++.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                   0000000000111122344778999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.2e-38  Score=278.52  Aligned_cols=250  Identities=27%  Similarity=0.415  Sum_probs=205.3

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||.|++|.||++... ++..+++|.+...  .......+.+|+.+++.++|+||+++.+++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5889999999999999999865 6788999987653  233455677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++......+..+++..++.++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            999999999865444456789999999999999999999999   99999999999999999999999999998765541


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                         .....++..|++||.+.+..++.++|+||||+++|+|++|+.||......   .+..   ...         .....
T Consensus       158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~~---------~~~~~  219 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY---KVQ---------RGKYP  219 (256)
T ss_pred             ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHh---------cCCCC
Confidence               22245788999999999888999999999999999999999998654221   1111   111         11112


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..+......+.+++.+||..+|.+||++.+++..
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            2334555668999999999999999999999753

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.7e-37  Score=281.17  Aligned_cols=254  Identities=24%  Similarity=0.458  Sum_probs=203.8

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ...+.|++...||+|++|.||+|.+. ++..|++|.+..... ....+.+|++.++.++|+|++++++++......++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34677999999999999999999986 688899998876544 4567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|.+++....   ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            9999999999984322   3789999999999999999999999   999999999999999999999999999875543


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      ... ......++..|++||.+.+..++.++|+||||+++|+|++|..||........  .    ....... ...     
T Consensus       169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~----~~~~~~~-~~~-----  235 (286)
T cd06614         169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--L----FLITTKG-IPP-----  235 (286)
T ss_pred             chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHHHhcC-CCC-----
Confidence            221 11223467889999999888899999999999999999999999764322110  0    0111111 100     


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      . .........+.+++.+||+.+|.+||++.+|++.
T Consensus       236 ~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         236 L-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             C-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            0 1111234458889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4e-37  Score=281.59  Aligned_cols=248  Identities=31%  Similarity=0.462  Sum_probs=195.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|++|.||+|... +++.||+|.+...   .......+.+|+.+++.++|||++++.+++.+....++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356999999999999999999975 6889999987643   223345688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+.+ ++.+++.   .....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        94 ~e~~~g-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          94 MEYCLG-SASDILE---VHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HHhhCC-CHHHHHH---HcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            999975 6666653   2234689999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCcceeecccCCCCCCCccccc---CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ..     ....++..|+|||++.   ...++.++||||||+++|+|++|..||.......      ..........    
T Consensus       167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~~~~~~----  231 (307)
T cd06607         167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNDS----  231 (307)
T ss_pred             CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHHhcCCC----
Confidence            32     2235778999999874   4568899999999999999999999975432111      1111111111    


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                        +.+  ........+.+++.+||..+|.+||++.+|+...
T Consensus       232 --~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         232 --PTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             --CCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence              011  1122345688999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6e-37  Score=272.59  Aligned_cols=250  Identities=29%  Similarity=0.429  Sum_probs=204.7

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--CeeEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVY  121 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~  121 (370)
                      +|++.+.||+|++|.||+|... ++..|++|.+.....  .....+.+|+..+++++|+||+++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5788899999999999999986 688999998876542  4567888999999999999999999999988  8899999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+++|.+++.    ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLK----KFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            9999999999984    233789999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          202 NITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       202 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      .... ......++..|+|||.+.....+.++||||||+++++|++|..||......     .........        ..
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~--------~~  220 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGS--------SG  220 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccc--------cC
Confidence            4321 123345788999999998888999999999999999999999998755411     111111111        01


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .....+......+.+++.+|++.+|.+||++.+++.
T Consensus       221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            112223333566889999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=292.76  Aligned_cols=244  Identities=31%  Similarity=0.473  Sum_probs=198.4

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh---hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK---QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .|.-.+.||.|.||.||.+++. +...||||......+   .-++++.+|+..|++++|||++.+.|+|......|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3566789999999999999975 678899998876533   447789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      ||-| +-.+++.   -...++-+.++..|..+.+.||+|||+.   +.||||||..|||+++.|.|||+|||.+......
T Consensus       107 YClG-SAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  107 YCLG-SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HHhc-cHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            9965 6666663   2345688899999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeecccCCCCCCCccccc---CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          203 ITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                           ..++||+.|||||++.   .+.|+-++||||||++..||...++|....    +.  +........++.+     
T Consensus       180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM----NA--MSALYHIAQNesP-----  243 (948)
T KOG0577|consen  180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NA--MSALYHIAQNESP-----  243 (948)
T ss_pred             -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc----hH--HHHHHHHHhcCCC-----
Confidence                 3467999999999885   478999999999999999999999986543    11  1112222223322     


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       .+.  .++-...+..++..||+.-|.+|||..++++
T Consensus       244 -tLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  244 -TLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -CCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             221  2344455778888899999999999988864

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-38  Score=290.69  Aligned_cols=262  Identities=23%  Similarity=0.336  Sum_probs=195.2

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----Ce
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TR  116 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~  116 (370)
                      ..++|++.+.||+|++|.||+|.+. +++.||+|.+... .......+.+|+.++++++|+||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            3578999999999999999999975 6889999988643 233445677899999999999999999987644     35


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .++++||+.+ +|..++.     ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        83 ~~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          83 VYIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             EEEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence            7899999975 7777762     34689999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcc--eeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          197 KLFPDNITH--ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       197 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      .........  ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......   ..............
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~  230 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPS  230 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCC
Confidence            765432211  1123457889999998654 56889999999999999999999998543210   00000000000000


Q ss_pred             C-----------cccc-----cCCC--CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          274 P-----------LELV-----DPEL--GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       274 ~-----------~~~~-----~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .           ....     .+..  ....+.....+.+++.+||+.+|.+|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0           0000     0000  00112234558899999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.6e-37  Score=279.44  Aligned_cols=261  Identities=24%  Similarity=0.383  Sum_probs=197.0

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh-hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      +|++.+.||.|++|.||+|++. ++..||+|.+..... .....+.+|+.++++++|+|++++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5889999999999999999986 688899998876532 23456678999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      .+ +|.+++.... ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            86 7887774322 134689999999999999999999999   999999999999999999999999999975543221


Q ss_pred             ceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC--------CCc
Q 017503          205 HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE--------KPL  275 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~  275 (370)
                      . .....++..|++||.+.+. .++.++||||||+++|+|++|..||........   ...........        ...
T Consensus       156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhHHHHhcC
Confidence            1 1223467889999987654 578999999999999999999999865432111   11010000000        000


Q ss_pred             ccccCCC--------CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 ELVDPEL--------GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 ~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .......        ....+.....+.+++.+||+.+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000        1111223455789999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=279.64  Aligned_cols=260  Identities=25%  Similarity=0.349  Sum_probs=195.2

Q ss_pred             CcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           48 FHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      |++.+.||.|++|.||+|.++ +|..||+|++....  ......+.+|+.+++.++|||++++++++.+....+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            678899999999999999975 68999999886543  223456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      . ++|.+++....  ...+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 58988874322  23689999999999999999999999   999999999999999999999999999975543221


Q ss_pred             ceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH----------hcCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH----------QEEK  273 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~  273 (370)
                      . .....++..|+|||++.+. .++.++||||||+++|+|++|++||......  ..+........          ....
T Consensus       155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhch
Confidence            1 1222457889999987664 5789999999999999999999998643221  11111000000          0000


Q ss_pred             -----CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 -----PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 -----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                           .............+.....+.+++.+||+.+|.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                 0000000111112233356889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3e-37  Score=280.49  Aligned_cols=264  Identities=24%  Similarity=0.336  Sum_probs=196.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--CeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l  119 (370)
                      .++|++.+.||.|++|.||+|.++ +++.+++|.+.....  .....+.+|+.++++++||||+++++++...  ...++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            368999999999999999999986 578899998865432  2233567899999999999999999999877  88999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+.+ +|.+++..   ....+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        84 v~e~~~~-~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          84 VMEYVEH-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             EehhcCc-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            9999975 88888742   223689999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHH-H-------HHHHHHh
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL-E-------WAWQLHQ  270 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-~-------~~~~~~~  270 (370)
                      ...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||..........-. .       ..+....
T Consensus       157 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         157 GSPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             cCCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            543211 2223467889999988664 4689999999999999999999998654321110000 0       0000000


Q ss_pred             cCC------CcccccCCC-CCCChH-HHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          271 EEK------PLELVDPEL-GEYPPN-EIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       271 ~~~------~~~~~~~~~-~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .-.      ........+ ..++.. ....+.+++.+||+.+|++|||+.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            000      000000000 111111 2455788999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-37  Score=279.96  Aligned_cols=259  Identities=25%  Similarity=0.350  Sum_probs=197.0

Q ss_pred             CcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--CeeEEEEE
Q 017503           48 FHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYE  122 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e  122 (370)
                      |++.+.||.|++|.||+|.+. ++..+|+|.+....  ......+.+|+.++++++|+|++++++++.+.  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999986 47889999887652  33446688899999999999999999999988  88999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++ +|..++..   ....+++..++.++.|++.||++||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 78887732   224689999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc------
Q 017503          203 ITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL------  275 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  275 (370)
                      .........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......   ...............      
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence            3222333456788999997765 457899999999999999999999986543211   111111110000000      


Q ss_pred             -----------ccccCCCCCCChH-HHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 -----------ELVDPELGEYPPN-EIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 -----------~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                                 ......+...... +...+.+++.+||..+|.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                       0000000000011 2456889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.2e-37  Score=278.60  Aligned_cols=258  Identities=21%  Similarity=0.244  Sum_probs=183.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC----CCEEEEEECcCcChhcHH-----------HHHHHHHHHHhcCCCCcceeee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAESKQGVR-----------EFITEIMTLSNVRHPNLVELIG  109 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~~iv~~~~  109 (370)
                      .++|++.+.||+|+||.||+|.+.+    +..+++|+..........           ....++..+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4789999999999999999999764    345677764433221111           1122334455678999999999


Q ss_pred             EEEeCC----eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC
Q 017503          110 CCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE  185 (370)
Q Consensus       110 ~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~  185 (370)
                      ++....    ..+++++++.. ++.+.+.    .....++..+..++.|++.||.|||+.   +++||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK----RIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHH----hhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            876543    34677887644 5665552    222356788899999999999999999   99999999999999999


Q ss_pred             CCeEEeeecCccccCCCCcc------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchh
Q 017503          186 FNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK  259 (370)
Q Consensus       186 ~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~  259 (370)
                      +.++|+|||++..+......      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999866432111      112245899999999999999999999999999999999999999765322211


Q ss_pred             hHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          260 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      .. ...........     ....  ..+.....+.+++..||..+|++||++.+|++.|
T Consensus       243 ~~-~~~~~~~~~~~-----~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        243 IH-AAKCDFIKRLH-----EGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HH-HhHHHHHHHhh-----hhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            10 00000000000     0000  0112234577888889999999999999999876

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.4e-37  Score=284.88  Aligned_cols=263  Identities=23%  Similarity=0.286  Sum_probs=196.8

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----  114 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  114 (370)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|.+...  .......+.+|+.+++.++|+||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            45689999999999999999999975 6889999988643  233445677899999999999999999988643     


Q ss_pred             -CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          115 -TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       115 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                       ...++||||+.+ +|.+.+.    .  .++...+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~----~--~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQ----M--DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHh----h--cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence             356999999965 7777762    1  278899999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccch------------hhH
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN------------KFL  261 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~------------~~~  261 (370)
                      |++........  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........            ..+
T Consensus       163 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         163 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             ccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99986543221  2234578899999999999999999999999999999999999864321100            000


Q ss_pred             HH----HHHHHHhcCCCc------ccccCCC-----CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          262 LE----WAWQLHQEEKPL------ELVDPEL-----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       262 ~~----~~~~~~~~~~~~------~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..    ............      .......     ..........+.+++.+||+.||.+|||+.+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00    000000000000      0000000     00112334567899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=273.96  Aligned_cols=241  Identities=29%  Similarity=0.351  Sum_probs=198.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      -++|...++||+|.||+|.+++.+ .++.||||+++.+   .++...+-..|-++|+..+||.+..+...|...+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            478899999999999999999965 7899999998876   344556667899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||..||.|.-.+    .....+++....-+...|+.||.|||+.   +|++||||.+|+|++.+|++||+|||++..--
T Consensus       247 MeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence            9999999987766    3455789999999999999999999999   99999999999999999999999999997421


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      . ........+||+.|+|||++....|+.+.|.|.+|+++|||++|+.||....   ...+...+.   ..       + 
T Consensus       320 ~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d---h~kLFeLIl---~e-------d-  384 (516)
T KOG0690|consen  320 K-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD---HEKLFELIL---ME-------D-  384 (516)
T ss_pred             c-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc---hhHHHHHHH---hh-------h-
Confidence            1 2234566899999999999999999999999999999999999999986442   222221111   00       0 


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCC
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRP  309 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP  309 (370)
                        ..+|.....+...|+...|..||++|.
T Consensus       385 --~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  385 --LKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             --ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence              123333444577788889999999995

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=273.16  Aligned_cols=247  Identities=29%  Similarity=0.478  Sum_probs=202.1

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|++.+.||+|++|.||++.+. ++..|++|.+.....  .....+.+|++++++++|+|++++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5889999999999999999876 578899998876643  4556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++.    ....+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999999983    335789999999999999999999999   99999999999999999999999999998765433


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .. .....++..|+|||...+..++.++|||++|+++|+|++|..||......      ...+..... .        ..
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~-~--------~~  217 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIVQD-D--------HP  217 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhcc-C--------CC
Confidence            22 22345788999999988888899999999999999999999998643211      001111111 0        11


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..+......+.+++.+||..+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            122233455788999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.4e-36  Score=279.29  Aligned_cols=252  Identities=29%  Similarity=0.423  Sum_probs=197.7

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .|+..+.||+|+||.||+|++. ++..||+|.+...   .......+.+|+++++.++|+|++++++++.+....++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3777899999999999999975 6889999987643   22334578889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+ +|.+++.   .....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus       106 ~~~g-~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCLG-SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCCC-CHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            9975 6766653   2344689999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CcceeecccCCCCCCCccccc---CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          203 ITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                           ....++..|+|||.+.   .+.++.++||||||+++|+|++|..||......  . .   ..........     
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~-~---~~~~~~~~~~-----  242 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--S-A---LYHIAQNESP-----  242 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--H-H---HHHHHhccCC-----
Confidence                 2245788999999873   456889999999999999999999997543211  1 0   1111111110     


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                         ..........+.+++.+||+.+|.+||++.+|++.+......
T Consensus       243 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         243 ---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             ---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence               011122334588899999999999999999999876554443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.9e-37  Score=277.82  Aligned_cols=256  Identities=27%  Similarity=0.416  Sum_probs=194.5

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++|+..+.||+|+||.||++.+. +++.||+|.+.... ......+.+|+.++.++. |+||+++++++......+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            45667889999999999999975 58899999886542 334557788999999995 9999999999999999999999


Q ss_pred             ecCCCCHHHHhcc-cccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          123 YVENNSLDRVLLG-ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       123 ~~~~~~L~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      |+.. ++.++... .......+++..+..++.|++.||+|||+..  +++||||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9865 55443311 1123356899999999999999999999732  899999999999999999999999999875543


Q ss_pred             CCcceeecccCCCCCCCcccccCC---CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGG---QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      ...  .....++..|+|||.+.+.   .++.++||||||+++|+|++|+.||.....     .............     
T Consensus       161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~-----  228 (288)
T cd06616         161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKGDP-----  228 (288)
T ss_pred             CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCCCC-----
Confidence            221  1223578899999998766   688999999999999999999999864321     1111111111111     


Q ss_pred             cCCC-CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          279 DPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       279 ~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                       +.+ ..........+.+++.+||+.+|.+|||+.+|++.
T Consensus       229 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 -PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             111 11122345568899999999999999999999764

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.8e-37  Score=273.14  Aligned_cols=242  Identities=22%  Similarity=0.274  Sum_probs=194.7

Q ss_pred             eeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCH
Q 017503           54 IGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL  129 (370)
Q Consensus        54 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  129 (370)
                      ||.|++|.||+++.. +++.|++|.+....   ......+.+|+.+++.++||||+++++.+.+....++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999986 48899999886532   23446788999999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeec
Q 017503          130 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR  209 (370)
Q Consensus       130 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~  209 (370)
                      .+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILR----DRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            99983    334588999999999999999999999   99999999999999999999999999998665432  2223


Q ss_pred             ccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHH
Q 017503          210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE  289 (370)
Q Consensus       210 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (370)
                      ..++..|++||.+.+..++.++|+||||+++|+|++|..||.....+.. ..   .......        ......+...
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~---~~~~~~~--------~~~~~~~~~~  219 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EI---YNDILKG--------NGKLEFPNYI  219 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HH---HHHHhcc--------CCCCCCCccc
Confidence            4578899999999888899999999999999999999999875542111 11   1111100        0111222233


Q ss_pred             HHHHHHHHHHchhhccCCCCC-----HHHHHH
Q 017503          290 IIRYMKVAFFCTQAAASRRPQ-----MNQVIK  316 (370)
Q Consensus       290 ~~~l~~li~~cl~~~p~~RPt-----~~evl~  316 (370)
                      ...+.+++.+||+.+|.+||+     ++|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            456889999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.1e-37  Score=280.53  Aligned_cols=262  Identities=23%  Similarity=0.310  Sum_probs=194.3

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCe-----
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTR-----  116 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-----  116 (370)
                      ++|++.+.||+|+||.||+|.+. ++..||+|......  ......+.+|+.+++.+ +|+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47999999999999999999975 68899999876542  22345678899999999 56999999999987665     


Q ss_pred             eEEEEEecCCCCHHHHhcccccC-CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-CCCeEEeeec
Q 017503          117 RILVYEYVENNSLDRVLLGATKA-NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFG  194 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kL~Dfg  194 (370)
                      .++||||+++ +|.+++...... +..+++..++.++.||+.||.|||+.   +++||||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 788777543322 45689999999999999999999999   9999999999999998 8899999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      ++..+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......  ..+... ...... .
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~-~~~~~~-~  231 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--QQLLHI-FKLLGT-P  231 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH-HHHhCC-C
Confidence            98765432211 122345788999998765 45789999999999999999999988643211  111110 010000 0


Q ss_pred             Ccccc-----------cC-----CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 PLELV-----------DP-----ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 ~~~~~-----------~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .....           .+     .+....+.....+.++|.+||..+|.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000           00     000111223455889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-37  Score=287.04  Aligned_cols=262  Identities=21%  Similarity=0.311  Sum_probs=197.9

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----C
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----T  115 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~  115 (370)
                      ..++|.+.+.||+|+||.||++.+. ++..||||.+...  .......+.+|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            3568999999999999999999975 6889999987643  233345677899999999999999999987644     3


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      ..++|+||+. ++|.+++.    .+..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        83 ~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence            4799999996 58888873    445689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC--
Q 017503          196 AKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE--  272 (370)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  272 (370)
                      +....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|++||.......   ............  
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~  230 (337)
T cd07858         155 ARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSE  230 (337)
T ss_pred             ccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCh
Confidence            98654332 12233457889999998765 468899999999999999999999986432110   011111100000  


Q ss_pred             ---------C-------CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          273 ---------K-------PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       273 ---------~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                               .       .....++......+.....+.+++.+||+.+|.+|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                     0       00000111111122345568899999999999999999999876

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.6e-38  Score=309.15  Aligned_cols=252  Identities=27%  Similarity=0.438  Sum_probs=190.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-------
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-------  115 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------  115 (370)
                      ..+|+.+..||+||||.||+++++ +|+.||||.+... .......+.+|+..|.+|+|||||+++..+.+..       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            467889999999999999999998 8999999988766 4455677899999999999999999875542110       


Q ss_pred             --------------------------------------------------------------------------------
Q 017503          116 --------------------------------------------------------------------------------  115 (370)
Q Consensus       116 --------------------------------------------------------------------------------  115 (370)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             --------------------------------eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHh
Q 017503          116 --------------------------------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH  163 (370)
Q Consensus       116 --------------------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH  163 (370)
                                                      .+||-||||+..+|.+++..+....   .....|+++++|++||.|+|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHH
Confidence                                            1467799999988888884322211   46778999999999999999


Q ss_pred             hcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC------C-----------CCcceeecccCCCCCCCcccccCC-
Q 017503          164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP------D-----------NITHITTRIAGTTGYLAPEYVLGG-  225 (370)
Q Consensus       164 ~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~------~-----------~~~~~~~~~~~~~~y~aPE~~~~~-  225 (370)
                      +.   |+|||||||.||++++++.|||+|||++....      .           ......+...||.-|+|||++.+. 
T Consensus       715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            99   99999999999999999999999999998621      0           011123456799999999988664 


Q ss_pred             --CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhh
Q 017503          226 --QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA  303 (370)
Q Consensus       226 --~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  303 (370)
                        .|+.|.|+||||++++||+.-   |...   +.  -+.    .+.+-+...+..+  .++..+....-.++|+++++.
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~yP---F~Ts---ME--Ra~----iL~~LR~g~iP~~--~~f~~~~~~~e~slI~~Ll~h  857 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLYP---FGTS---ME--RAS----ILTNLRKGSIPEP--ADFFDPEHPEEASLIRWLLSH  857 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhcc---CCch---HH--HHH----HHHhcccCCCCCC--cccccccchHHHHHHHHHhcC
Confidence              599999999999999999863   3221   11  111    1111111111111  233445555567899999999


Q ss_pred             ccCCCCCHHHHHH
Q 017503          304 AASRRPQMNQVIK  316 (370)
Q Consensus       304 ~p~~RPt~~evl~  316 (370)
                      ||.+|||+.|+|.
T Consensus       858 dP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  858 DPSKRPTATELLN  870 (1351)
T ss_pred             CCccCCCHHHHhh
Confidence            9999999999974

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=292.75  Aligned_cols=272  Identities=27%  Similarity=0.382  Sum_probs=206.9

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC------ee
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------RR  117 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~  117 (370)
                      .-|...+.||+|+||.||+|+++ .|+.||||.++.. .....+...+|+++|++++|+|||+++++-+...      ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            45677889999999999999975 7999999998765 3444567788999999999999999998866543      56


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC--CCCC--eEEeee
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD--QEFN--PKIGDF  193 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~--~~~~--~kL~Df  193 (370)
                      .+|||||.+|+|...+.... +...|++.+.+.++..++.||.|||++   +|+||||||.||++-  .+|+  -||+||
T Consensus        93 vlvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence            89999999999999996433 445799999999999999999999999   999999999999984  3344  599999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCccccc-CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      |.++..+++.  ......||..|++||+.. .+.|+...|.|||||++|++.||..||.++...-+..-..|........
T Consensus       169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~  246 (732)
T KOG4250|consen  169 GAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS  246 (732)
T ss_pred             cccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence            9999887654  567788999999999888 5889999999999999999999999998877654322222221111111


Q ss_pred             CCccccc-------------CCCCCCChHHHHHHHHHHHHchhhccCCCC--CHHHHHHHHHhhhc
Q 017503          273 KPLELVD-------------PELGEYPPNEIIRYMKVAFFCTQAAASRRP--QMNQVIKMLTKNIR  323 (370)
Q Consensus       273 ~~~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP--t~~evl~~L~~~~~  323 (370)
                      ......+             |......+.....+-+.+..+|..+|.+|-  .+.+....+..++.
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            0000000             001122334444455666668889999998  65555555555553

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=271.71  Aligned_cols=249  Identities=27%  Similarity=0.399  Sum_probs=196.7

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-----ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--Cee
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-----SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRR  117 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~  117 (370)
                      .+|++.+.||+|++|.||+|.+. ++..|++|.+...     .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57999999999999999999975 5889999986432     223456788899999999999999999998764  467


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++++||+.+++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            89999999999999883    334578999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCc--ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          198 LFPDNIT--HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       198 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      .......  .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......     .. ......     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~-~~~~~~-----  223 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AA-IFKIAT-----  223 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HH-HHHHHc-----
Confidence            6532111  1112345788999999998888999999999999999999999998643211     11 111110     


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                         .+.....+......+.+++.+||. +|.+||+..+++.
T Consensus       224 ---~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         224 ---QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence               011122344445668889999998 5799999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.9e-37  Score=280.85  Aligned_cols=265  Identities=26%  Similarity=0.350  Sum_probs=197.4

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC---
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT---  115 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---  115 (370)
                      ....++|++.+.||+|++|.||+|.++ +++.||+|.+....  ......+.+|+.+++.++|||++++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            345789999999999999999999986 57889999886542  223346678999999999999999999987654   


Q ss_pred             -------eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCe
Q 017503          116 -------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP  188 (370)
Q Consensus       116 -------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~  188 (370)
                             ..++|+||+++ ++..++..   ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence                   78999999987 66666532   234689999999999999999999999   99999999999999999999


Q ss_pred             EEeeecCccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 017503          189 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       189 kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      ||+|||++...............++..|+|||.+.+ ..++.++|||||||++|+|++|++||......   ........
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~  232 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISR  232 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHH
Confidence            999999998765433222222345778999998765 45789999999999999999999998643221   11111111


Q ss_pred             HHhcCCCcc-----------cccC------CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          268 LHQEEKPLE-----------LVDP------ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       268 ~~~~~~~~~-----------~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .........           ..+.      .........+..+.+++.+||+.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111100000           0000      000011122455889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.9e-37  Score=275.89  Aligned_cols=244  Identities=26%  Similarity=0.340  Sum_probs=190.6

Q ss_pred             eeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCH
Q 017503           54 IGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL  129 (370)
Q Consensus        54 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  129 (370)
                      ||+|+||+||++... ++..|++|.+....   ......+..|+.+++.++|||++++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 68899999876432   22344567899999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeec
Q 017503          130 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR  209 (370)
Q Consensus       130 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~  209 (370)
                      .+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.......  ....
T Consensus        81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~  153 (277)
T cd05577          81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG  153 (277)
T ss_pred             HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence            9988432  223689999999999999999999999   99999999999999999999999999987654321  1223


Q ss_pred             ccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHH
Q 017503          210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE  289 (370)
Q Consensus       210 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (370)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||............   ..    .. .    ......+...
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~----~~-~----~~~~~~~~~~  221 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KR----RT-L----EMAVEYPDKF  221 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hh----cc-c----cccccCCccC
Confidence            45678899999998888999999999999999999999998654331111110   00    00 0    0011122233


Q ss_pred             HHHHHHHHHHchhhccCCCC-----CHHHHHH
Q 017503          290 IIRYMKVAFFCTQAAASRRP-----QMNQVIK  316 (370)
Q Consensus       290 ~~~l~~li~~cl~~~p~~RP-----t~~evl~  316 (370)
                      ...+.+++.+||+.+|.+||     ++.+++.
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            44588999999999999999     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.1e-37  Score=280.22  Aligned_cols=262  Identities=27%  Similarity=0.368  Sum_probs=194.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--CeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l  119 (370)
                      .++|++.+.||.|+||.||+|.++ ++..||+|.+.....  .....+.+|+.++++++|+|++++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            578999999999999999999975 588999998764422  2223456799999999999999999998765  56899


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+.+ +|.+++..   ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++...
T Consensus        86 v~e~~~~-~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCEQ-DLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            9999975 78877742   235689999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC-----
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK-----  273 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  273 (370)
                      ...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|.+||.......   .............     
T Consensus       159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhch
Confidence            543211 122235678999998865 457899999999999999999999986442211   1111111100000     


Q ss_pred             ---------CcccccCCC---CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          274 ---------PLELVDPEL---GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       274 ---------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                               .........   ..........+.+++.+||+.||.+|||+.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                     000000000   00001124457789999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-36  Score=272.81  Aligned_cols=250  Identities=22%  Similarity=0.279  Sum_probs=192.8

Q ss_pred             HHHHHHhccCCccccee--eecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 017503           38 YTELRSATDDFHLSNKI--GRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ  113 (370)
Q Consensus        38 ~~~~~~~~~~y~~~~~l--g~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  113 (370)
                      ..+.....++|++.+.+  |+|+||.||++..+ ++..+|+|.+........     |+.....+ +|||++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence            44555566788888877  99999999999975 678899998765422111     22222222 79999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-CeEEee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGD  192 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kL~D  192 (370)
                      .+..++||||+++++|.+++.    .+..+++..++.++.|++.||.|||+.   +++||||+|+||+++.++ .++|+|
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLK----KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence            999999999999999999983    333789999999999999999999999   999999999999999888 999999


Q ss_pred             ecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          193 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       193 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      ||++.......     ...++..|+|||++.+..++.++||||||+++|+|++|..||....... .....+....   .
T Consensus       154 fg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---~  224 (267)
T PHA03390        154 YGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ---Q  224 (267)
T ss_pred             CccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh---c
Confidence            99987654321     2357889999999998899999999999999999999999987443221 0111111111   0


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCC-HHHHHH
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-MNQVIK  316 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~  316 (370)
                      .        ....+......+.+++.+||+.+|.+||+ ++++++
T Consensus       225 ~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 K--------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             c--------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            0        00112234445888999999999999996 688874

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.8e-37  Score=275.63  Aligned_cols=256  Identities=24%  Similarity=0.308  Sum_probs=191.1

Q ss_pred             CcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeC--CeeEEEEE
Q 017503           48 FHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVR-HPNLVELIGCCVQG--TRRILVYE  122 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e  122 (370)
                      |++.+.||+|+||.||+|... ++..||+|.+.... ........+|+.++.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            678899999999999999975 68889999886542 222234457888898884 99999999999987  88999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.+ +|.+++..   ....+++..++.++.|++.||.|||+.   +++||||+|+||+++. +.++|+|||++......
T Consensus        81 ~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMDM-NLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCCc-cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            9975 67666632   234689999999999999999999999   9999999999999999 99999999999865433


Q ss_pred             CcceeecccCCCCCCCccccc-CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH-----------h
Q 017503          203 ITHITTRIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH-----------Q  270 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~  270 (370)
                      ...  ....++..|+|||.+. ++.++.++|||||||++|+|++|..||.......   .........           .
T Consensus       153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence            221  2235788999999764 4567899999999999999999999986432211   111111100           0


Q ss_pred             cCCCcccccCC-----CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          271 EEKPLELVDPE-----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       271 ~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .........+.     +....+.....+.+++.+||+.+|.+||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000000000     01112234567899999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.5e-36  Score=275.85  Aligned_cols=245  Identities=23%  Similarity=0.404  Sum_probs=195.5

Q ss_pred             ccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCC
Q 017503           50 LSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS  128 (370)
Q Consensus        50 ~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  128 (370)
                      ...+||+|+||.||++..+ ++..||+|.+..........+.+|+.+++.++|+|++++++++...+..++||||+++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            3478999999999999875 688999998865555556678899999999999999999999999999999999999999


Q ss_pred             HHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceee
Q 017503          129 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT  208 (370)
Q Consensus       129 L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  208 (370)
                      |.+++.     ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++......... ..
T Consensus       104 L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-~~  174 (292)
T cd06657         104 LTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RK  174 (292)
T ss_pred             HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc-cc
Confidence            998873     23578999999999999999999999   9999999999999999999999999998765433211 22


Q ss_pred             cccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChH
Q 017503          209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN  288 (370)
Q Consensus       209 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (370)
                      ...++..|++||.+.+..++.++|+||+|+++|+|++|..||......   ....    .......     ..+. ....
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~----~~~~~~~-----~~~~-~~~~  241 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMK----MIRDNLP-----PKLK-NLHK  241 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhhCC-----cccC-Cccc
Confidence            345788999999998888899999999999999999999997643211   1111    1111111     1110 0112


Q ss_pred             HHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          289 EIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       289 ~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ....+.+++.+||+.+|.+||++.+++.
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            2334778889999999999999999977

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-38  Score=292.65  Aligned_cols=251  Identities=25%  Similarity=0.366  Sum_probs=202.6

Q ss_pred             cCCcccceeeecCCeEEEEEEEC--CC--CEEEEEECcCcChh-cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT--NG--RRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~--~~--~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ++..+.++||+|.||.|++|.|+  +|  ..||||.+..+... ....|.+|+.+|.+|+|+|++++||+..+ ....+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            45567789999999999999986  33  35899999876443 67789999999999999999999999988 677899


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      ||.+..|+|.+.+++  .....|.......++.|||.|+.||..+   ++|||||...|+++-....+||+|||+.+.+.
T Consensus       189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence            999999999999965  3455678889999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCcce--eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhC-CCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          201 DNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       201 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      .+....  .....-.+.|+|||.++...++.++|||+|||+||||+|+ ..||.....    ..   +.+.+.       
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~q---IL~~iD-------  329 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQ---ILKNID-------  329 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----HH---HHHhcc-------
Confidence            543322  1122345679999999999999999999999999999995 456543321    11   111111       


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                       +.....-+..+...+.+++..||..+|.+||||..|.+.
T Consensus       330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence             111234456677778888899999999999999999743

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9.9e-37  Score=275.19  Aligned_cols=242  Identities=25%  Similarity=0.322  Sum_probs=185.5

Q ss_pred             eeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHH---hcCCCCcceeeeEEEeCCeeEEEEEecC
Q 017503           53 KIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLS---NVRHPNLVELIGCCVQGTRRILVYEYVE  125 (370)
Q Consensus        53 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~---~l~h~~iv~~~~~~~~~~~~~lv~e~~~  125 (370)
                      .||+|+||.||++... +++.||+|.+....   ......+.++..+++   ..+|||++.+++++...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 58899999875432   111222334443333   3479999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc
Q 017503          126 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH  205 (370)
Q Consensus       126 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  205 (370)
                      +++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            999998883    344689999999999999999999999   99999999999999999999999999987543321  


Q ss_pred             eeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          206 ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       206 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                       .....++..|+|||.+.. ..++.++||||+||++|+|++|..||..........+..    ...      ....   .
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~------~~~~---~  217 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTL------TVNV---E  217 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hhh------cCCc---C
Confidence             123458899999998864 568899999999999999999999986543322211111    100      0011   1


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCC-----CHHHHHHH
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  317 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  317 (370)
                      .+......+.+++.+||+.+|.+||     +++++++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2233445688899999999999999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=294.75  Aligned_cols=251  Identities=24%  Similarity=0.441  Sum_probs=204.8

Q ss_pred             cCCcccceeeecCCeEEEEEEECCC-CEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLTNG-RRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      +-|.|+..||-|+||+||++.+++. -.-|-|++..........|.-|++||..+.||+|+++++.|...+.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            4578889999999999999998743 334778888777788899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      .||-.+..+.   .-+..|.+.++..+++|++.||.|||++   .|||||||..|||++.+|.++|+|||.+...... .
T Consensus       112 ~GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~  184 (1187)
T KOG0579|consen  112 GGGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-R  184 (1187)
T ss_pred             CCchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-H
Confidence            9999999884   4567899999999999999999999999   9999999999999999999999999998643221 1


Q ss_pred             ceeecccCCCCCCCcccc-----cCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          205 HITTRIAGTTGYLAPEYV-----LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      .......||+.|||||+.     ...+|+.++||||||++|.||..+.+|-....      .+.........+.+ .++ 
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMRVllKiaKSePP-TLl-  256 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSEPP-TLL-  256 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHHHHHHHhhcCCC-ccc-
Confidence            234457899999999976     45789999999999999999999998854321      12222233322222 222 


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                           .|..-...+.+++.+||..+|..||++.++++
T Consensus       257 -----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 -----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                 23344445788888999999999999999975

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-37  Score=277.08  Aligned_cols=258  Identities=25%  Similarity=0.362  Sum_probs=198.1

Q ss_pred             CcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           48 FHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      |++.+.||.|++|.||++... ++..+++|.+.....  .....+.+|+.++++++|+|++++++++......++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            678899999999999999975 688899998765432  23467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      .+ +|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            76 77777632   235789999999999999999999999   99999999999999999999999999998765433 


Q ss_pred             ceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC---------
Q 017503          205 HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP---------  274 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------  274 (370)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........   .............         
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhh
Confidence            112224567889999988776 789999999999999999999988754322111   0000000000000         


Q ss_pred             -----ccc---ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          275 -----LEL---VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       275 -----~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                           ...   .........+....++.+++.+||+.+|.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                 000   000111122345567889999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.8e-37  Score=282.69  Aligned_cols=265  Identities=25%  Similarity=0.374  Sum_probs=196.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeC--Cee
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQG--TRR  117 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~  117 (370)
                      ..++|++.+.||+|+||.||+|.+. ++..+|+|.+...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4688999999999999999999976 5788999977542  233345677899999999 999999999998653  468


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+.+ +|..++.    .+ .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        85 ~lv~e~~~~-~L~~~~~----~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYMET-DLHAVIR----AN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEeccccc-CHHHHHh----cC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            999999974 8888873    22 678899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcc----eeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhH-HHH-------
Q 017503          198 LFPDNITH----ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL-LEW-------  264 (370)
Q Consensus       198 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~-~~~-------  264 (370)
                      ........    ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... ...       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            66433211    2223457889999998755 5678999999999999999999999854322111000 000       


Q ss_pred             HHHHHhcCCCccccc-------CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          265 AWQLHQEEKPLELVD-------PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       265 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .............++       .......+.....+.+++.+||+.+|.+|||+.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000000000000       00111112234568899999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.3e-37  Score=279.57  Aligned_cols=263  Identities=26%  Similarity=0.358  Sum_probs=192.8

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----  115 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  115 (370)
                      ..++|++.+.||+|++|.||+|... +++.||+|.+....  ......+.+|+.++++++||||+++++++....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3568999999999999999999975 68899999876442  222345567999999999999999999987654     


Q ss_pred             ---eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEee
Q 017503          116 ---RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD  192 (370)
Q Consensus       116 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~D  192 (370)
                         ..++||||+.+ +|.+++.   .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLS---NKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence               34999999975 7777763   2334689999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCcc---eeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH
Q 017503          193 FGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       193 fg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      ||++.........   ......++..|+|||.+.+. .++.++||||||+++|+|++|.+||........   .......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~---~~~~~~~  239 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ---LTLISQL  239 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH
Confidence            9999866432211   11233467889999987664 478899999999999999999998865432111   1111111


Q ss_pred             HhcCCC--------cccccC-CCCCC----------ChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          269 HQEEKP--------LELVDP-ELGEY----------PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       269 ~~~~~~--------~~~~~~-~~~~~----------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ......        ....+. .....          .......+.+++.+||..+|.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            100000        000000 00000          0011234678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.9e-37  Score=283.80  Aligned_cols=263  Identities=20%  Similarity=0.329  Sum_probs=198.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEe----CCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~  117 (370)
                      .++|++.+.||.|++|.||+|..+ ++..||+|.+....  ......+.+|+.+++.++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999975 58899999886542  2345567789999999999999999988753    3567


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+. ++|.+++.    .+..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999996 58888873    344589999999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCcc---eeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHh---
Q 017503          198 LFPDNITH---ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ---  270 (370)
Q Consensus       198 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  270 (370)
                      ........   ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........   .........   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~  232 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPS  232 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCCh
Confidence            65432211   1223467889999998765 4688999999999999999999999865422111   000000000   


Q ss_pred             --------cCCCccc---cc----CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          271 --------EEKPLEL---VD----PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       271 --------~~~~~~~---~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                              .......   ..    .......+.....+.+++.+||+.+|.+||++.+++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence                    0000000   00    000111123456688999999999999999999988743

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.7e-36  Score=274.88  Aligned_cols=256  Identities=26%  Similarity=0.328  Sum_probs=198.8

Q ss_pred             CCcccceeeecCCeEEEEEEEC----CCCEEEEEECcCcC----hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCee
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAES----KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  117 (370)
                      +|++.+.||+|++|.||++...    ++..||+|.+....    ......+.+|+.++.++ +|||++++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4888999999999999998853    56789999876431    22345677899999999 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+.+++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999999883    334688999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCCC--cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      ..............++..|++||.+.+..  .+.++||||||+++|+|++|..||........  ............   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~---  228 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSK---  228 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccC---
Confidence            65443222223345788999999887655  78899999999999999999999853221110  111111111110   


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                          +   ..+......+.+++.+||+.+|++|||+.++.+.|...
T Consensus       229 ----~---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         229 ----P---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ----C---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                1   11222334578899999999999999999887777553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.8e-36  Score=275.45  Aligned_cols=260  Identities=25%  Similarity=0.345  Sum_probs=193.6

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++|++.+.||.|++|.||+|.++ +++.||+|.+....  ......+.+|++++++++|||++++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57999999999999999999976 68899999876542  2334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-CCCeEEeeecCccccCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kL~Dfg~~~~~~~  201 (370)
                      |+.+ +|.+++..  .....+++..+..++.||+.||.|||+.   +++|+||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLDL-DLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             cccc-cHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            9965 77766632  2233467888889999999999999999   9999999999999985 55799999999976543


Q ss_pred             CCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc---
Q 017503          202 NITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL---  277 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  277 (370)
                      ... ......++..|+|||.+.+ ..++.++||||||+++|+|+||.+||......  ..+.. ........ ....   
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~-~~~~~~~~-~~~~~~~  230 (294)
T PLN00009        156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFK-IFRILGTP-NEETWPG  230 (294)
T ss_pred             Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HHHHhCCC-Chhhccc
Confidence            211 1122346789999998866 45789999999999999999999998653221  11111 10100000 0000   


Q ss_pred             --------------ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          278 --------------VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       278 --------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                                    .........+.....+.+++.+|++.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                          000000111223345788999999999999999999986

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-37  Score=282.62  Aligned_cols=260  Identities=24%  Similarity=0.336  Sum_probs=199.9

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----eeE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----RRI  118 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~  118 (370)
                      +|++.+.||.|++|.||+|+.. ++..|++|.+....  ......+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5899999999999999999976 48899999887543  344567888999999999999999999988765     789


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      ++|||+.+ +|.+++.    .+..+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        81 lv~e~~~~-~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELMET-DLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchhh-hHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999984 7888873    334789999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCc--ceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc----
Q 017503          199 FPDNIT--HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE----  271 (370)
Q Consensus       199 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----  271 (370)
                      ......  .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.......   ...........    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~  229 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEE  229 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChh
Confidence            654321  112234578889999999887 78999999999999999999999986543211   00100000000    


Q ss_pred             -------CCCccccc-------CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          272 -------EKPLELVD-------PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       272 -------~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                             ......+.       ..+....+.....+.+++.+||+.+|.+||++.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                   00000000       00011122234568899999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.2e-36  Score=274.41  Aligned_cols=251  Identities=25%  Similarity=0.339  Sum_probs=195.2

Q ss_pred             CCcccceeeecCCeEEEEEEEC----CCCEEEEEECcCcC----hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCee
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAES----KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  117 (370)
                      .|++.+.||.|+||.||.+...    +|..||+|.+....    ......+.+|+.+++++ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4888999999999999999863    67889999886532    22345677899999999 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999983    344688999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCC--CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGG--QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      ..............++..|+|||.+...  .++.++||||||+++|+|++|..||......  ..............   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~---  228 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE---  228 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC---
Confidence            6544322222334578899999988653  4678999999999999999999998632111  11111111111111   


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  316 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  316 (370)
                             ...+......+.+++.+||+.+|.+||     ++.+++.
T Consensus       229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                   111222334578899999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.6e-37  Score=274.52  Aligned_cols=245  Identities=24%  Similarity=0.322  Sum_probs=193.7

Q ss_pred             eeecCCeEEEEEEEC-CCCEEEEEECcCcCh---hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCH
Q 017503           54 IGRGGFGTVYKGTLT-NGRRIAVKPLSAESK---QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL  129 (370)
Q Consensus        54 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  129 (370)
                      ||.|++|.||++.+. ++..|++|.+.....   .....+.+|++++++++|||++++++.+......+++|||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999986 489999998865532   4456788899999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc-----
Q 017503          130 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-----  204 (370)
Q Consensus       130 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-----  204 (370)
                      .+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........     
T Consensus        81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            999842    23689999999999999999999999   999999999999999999999999999875433211     


Q ss_pred             --ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          205 --HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       205 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                        .......++..|++||.+.....+.++||||||+++|+|++|..||......   ....   ... ....      ..
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~~-~~~~------~~  220 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQ---NIL-NGKI------EW  220 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHh-cCCc------CC
Confidence              1122345778899999998888999999999999999999999998644311   1111   111 1000      00


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ... ......+.+++.+||+.+|.+|||+.++.+.|.
T Consensus       221 ~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         221 PED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             Ccc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            000 001455789999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-36  Score=281.82  Aligned_cols=269  Identities=20%  Similarity=0.340  Sum_probs=197.6

Q ss_pred             cCHHHHHHh----ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceee
Q 017503           36 FSYTELRSA----TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELI  108 (370)
Q Consensus        36 ~~~~~~~~~----~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~  108 (370)
                      |+.+++..+    .++|.+.+.||+|++|.||+|.+. ++..||+|.+...  .......+.+|+.+++.++||||++++
T Consensus         1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~   80 (342)
T cd07879           1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL   80 (342)
T ss_pred             CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence            344455544    489999999999999999999975 6889999987643  222345678899999999999999999


Q ss_pred             eEEEeCC------eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe
Q 017503          109 GCCVQGT------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL  182 (370)
Q Consensus       109 ~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill  182 (370)
                      +++....      ..++|+||+.. +|..+.      +..+++..+..++.|++.||+|||+.   +++||||+|+||++
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll  150 (342)
T cd07879          81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAV  150 (342)
T ss_pred             heecccccCCCCceEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEE
Confidence            9987543      45899999864 777664      23588999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhH
Q 017503          183 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL  261 (370)
Q Consensus       183 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~  261 (370)
                      +.++.++|+|||++......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......  . .
T Consensus       151 ~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--~-~  223 (342)
T cd07879         151 NEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--D-Q  223 (342)
T ss_pred             CCCCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--H-H
Confidence            99999999999998754322    122356788999998876 46889999999999999999999998643211  0 0


Q ss_pred             HHHHHHHH-----------hcCCCc-------ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH--HHhh
Q 017503          262 LEWAWQLH-----------QEEKPL-------ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM--LTKN  321 (370)
Q Consensus       262 ~~~~~~~~-----------~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~  321 (370)
                      ........           ......       ......+....+.....+.+++.+||+.+|.+||++.+++..  ++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         224 LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            11011000           000000       000000011111233457899999999999999999999853  4444

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.8e-37  Score=276.91  Aligned_cols=248  Identities=23%  Similarity=0.343  Sum_probs=200.1

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ++|++.+.||+|++|.||++... ++..|++|++...   .......+.+|+.+++++. |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999975 6889999988653   2233456788999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      ||++.+++|.+++.    ....+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999983    334799999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCc-------------------ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhH
Q 017503          201 DNIT-------------------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL  261 (370)
Q Consensus       201 ~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~  261 (370)
                      ....                   .......++..|+|||.+....++.++||||||+++++|++|..||.....  ... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~-  230 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--YLT-  230 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--HHH-
Confidence            4321                   112234567889999999888899999999999999999999999875431  111 


Q ss_pred             HHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCH----HHHHH
Q 017503          262 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM----NQVIK  316 (370)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~evl~  316 (370)
                      .   ......          ....+......+.+++.+||+.+|.+||++    .+++.
T Consensus       231 ~---~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 F---QKILKL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             H---HHHHhc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1   111100          011122224458899999999999999999    77654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-36  Score=279.66  Aligned_cols=268  Identities=22%  Similarity=0.289  Sum_probs=201.7

Q ss_pred             ccccCHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeee
Q 017503           33 VNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIG  109 (370)
Q Consensus        33 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~  109 (370)
                      +++....++..+.++|++.+.||+|+||.||+|... ++..||+|.+...  .......+.+|+.++++++||||+++++
T Consensus         4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~   83 (345)
T cd07877           4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD   83 (345)
T ss_pred             chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence            566677888899999999999999999999999864 6889999988653  2233456778999999999999999999


Q ss_pred             EEEeC------CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC
Q 017503          110 CCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD  183 (370)
Q Consensus       110 ~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~  183 (370)
                      ++...      ...+++++++ +++|.+++.     ...+++..+..++.|++.||.|||+.   +++||||+|+||+++
T Consensus        84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~  154 (345)
T cd07877          84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVN  154 (345)
T ss_pred             eeeecccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEc
Confidence            88643      3467888876 678988772     23589999999999999999999999   999999999999999


Q ss_pred             CCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHH
Q 017503          184 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL  262 (370)
Q Consensus       184 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~  262 (370)
                      .++.++|+|||++......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......  ..+.
T Consensus       155 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~--~~~~  228 (345)
T cd07877         155 EDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLK  228 (345)
T ss_pred             CCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence            9999999999998754322    223457889999998766 56889999999999999999999998543211  1010


Q ss_pred             HHHHHHHhcCCCc-------------------ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          263 EWAWQLHQEEKPL-------------------ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       263 ~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      . ...... ....                   .................+.+++.+|++.+|.+||++.+++..
T Consensus       229 ~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         229 L-ILRLVG-TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             H-HHHHhC-CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0 000000 0000                   000000001111123457899999999999999999999765

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.7e-37  Score=283.89  Aligned_cols=250  Identities=23%  Similarity=0.333  Sum_probs=205.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ...|.+.+.||+|.|++|.+|++. ++..||||++...  +....+.+.+|+++|+.++|||||+++.+.+....+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            567999999999999999999975 6899999998765  3444566889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+.+|.+.+++.    ....+.+..+..++.|+..|++|+|++   .|+|||||++|+||+.+.++||+|||++..+..
T Consensus       135 eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  135 EYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence            9999999999993    444566688999999999999999999   999999999999999999999999999998763


Q ss_pred             CCcceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                        .......+|++.|.|||++.+..| ++..|+||+|++||-|+.|..||+...-..           .+..   . +..
T Consensus       208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------Lr~r---v-l~g  270 (596)
T KOG0586|consen  208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------LRPR---V-LRG  270 (596)
T ss_pred             --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------ccch---h-eee
Confidence              344566789999999999999876 589999999999999999999997542110           0000   0 000


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      . -..+.-...++.+++++++-.+|.+|+++.++.+.-.
T Consensus       271 k-~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  271 K-YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             e-ecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence            0 0112222334667888899999999999999976443

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7e-37  Score=280.19  Aligned_cols=262  Identities=26%  Similarity=0.375  Sum_probs=191.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC------
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQGT------  115 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------  115 (370)
                      .++|++.+.||.|++|.||+|.++ +++.|++|.+.....  .....+.+|+++++.++|+||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            689999999999999999999975 688999998754322  22345678999999999999999999876433      


Q ss_pred             --eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          116 --RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       116 --~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                        ..++|+||+.+ +|...+.   .....+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.++|+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~---~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLE---NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              46899999976 5665553   2345689999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcc----------eeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHH
Q 017503          194 GLAKLFPDNITH----------ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL  262 (370)
Q Consensus       194 g~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~  262 (370)
                      |++.........          ......++..|+|||.+.+. .++.++||||||+++|+|++|++||........   .
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~  236 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---L  236 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---H
Confidence            999865432211          11223467889999987654 578999999999999999999999864332111   1


Q ss_pred             HHHHHHHhcCCCc---------c----cc----cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          263 EWAWQLHQEEKPL---------E----LV----DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       263 ~~~~~~~~~~~~~---------~----~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .............         .    ..    .+.+..........+.+++.+||+.+|.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1111110000000         0    00    00000000112245789999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.8e-36  Score=273.13  Aligned_cols=244  Identities=30%  Similarity=0.467  Sum_probs=191.3

Q ss_pred             CcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           48 FHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      |...+.||+|++|.||+|+.. ++..|++|.+...   .......+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999975 6888999987643   223345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.+ ++.+++.   .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....  
T Consensus       103 ~~~-~l~~~l~---~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CLG-SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CCC-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            965 6666663   2344689999999999999999999999   999999999999999999999999998864322  


Q ss_pred             cceeecccCCCCCCCccccc---CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          204 THITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                         .....++..|+|||.+.   ...++.++||||||+++|+|++|..|+.......      ..........+      
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~~------  238 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNDSP------  238 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCCC------
Confidence               12345788999999874   4568899999999999999999999875442211      11111111111      


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..  ........+.+++.+||+.+|.+||++.+++..
T Consensus       239 ~~--~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 TL--QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00  111222347889999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-37  Score=289.59  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=194.0

Q ss_pred             ccCC-cccceeeecCCeEEEEEEEC-CCCEEEEEECcC----cChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe--
Q 017503           45 TDDF-HLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSA----ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR--  116 (370)
Q Consensus        45 ~~~y-~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--  116 (370)
                      +++| +....||+|+|-+||+|.+. .|..||--.++.    ..+...+++..|+.+|+.|+||||+++++++.+...  
T Consensus        38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence            3444 45578999999999999975 577776543332    234556889999999999999999999999997665  


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-CCCeEEeeecC
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGL  195 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kL~Dfg~  195 (370)
                      ..+|+|.+..|+|..|+    +....++.+.+..|++||++||.|||++.+ +|||||||.+||+|+. -|.|||+|+||
T Consensus       118 in~iTEL~TSGtLr~Y~----kk~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  118 INFITELFTSGTLREYR----KKHRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             eeeeeecccCCcHHHHH----HHhccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhH
Confidence            77899999999999998    455567888999999999999999999854 8999999999999984 58899999999


Q ss_pred             ccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          196 AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      |.......   .....|||.|||||+.. ..|++..||||||+.+.||.|+.-|+..-  .....    +++....+...
T Consensus       193 Atl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC--~n~AQ----IYKKV~SGiKP  262 (632)
T KOG0584|consen  193 ATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC--TNPAQ----IYKKVTSGIKP  262 (632)
T ss_pred             HHHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh--CCHHH----HHHHHHcCCCH
Confidence            99775432   22368999999999776 78999999999999999999998886432  22222    22222222211


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..+..    .   ...++.++|.+|+.. ..+|||+.|+|+
T Consensus       263 ~sl~k----V---~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  263 AALSK----V---KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHhhc----c---CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            11111    1   122378999999999 999999999986

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-36  Score=269.41  Aligned_cols=258  Identities=26%  Similarity=0.365  Sum_probs=193.2

Q ss_pred             CcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhc---CCCCcceeeeEEEeCCe-----
Q 017503           48 FHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNV---RHPNLVELIGCCVQGTR-----  116 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~-----  116 (370)
                      |++.+.||+|++|.||+|+++ ++..||+|.+....  ......+.+|+.+++++   +|+|++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999986 48899999886432  22234556677777665   69999999999988776     


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .+++|||+.+ +|.+++....  ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            8999999975 7888774322  23589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC---
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK---  273 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---  273 (370)
                      ........  .....++..|+|||.+.+..++.++|+||||+++|+|++|.+||.......  .+.. .........   
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~  229 (287)
T cd07838         155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDK-IFDVIGLPSEEE  229 (287)
T ss_pred             eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHH-HHHHcCCCChHh
Confidence            87643321  122346788999999999899999999999999999999998876433211  1111 111000000   


Q ss_pred             -C------ccccc----CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 -P------LELVD----PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 -~------~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       .      .....    .......+.....+.+++.+||+.+|.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence             0      00000    0011112234466789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.6e-36  Score=274.72  Aligned_cols=250  Identities=29%  Similarity=0.433  Sum_probs=195.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .+.|+..+.||+|++|.||+|+.. ++..+++|.+...   .......+.+|+++++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            455888899999999999999975 5778999987532   233445678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+. ++|.+++.   ..+..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++....
T Consensus        94 ~e~~~-~~l~~~~~---~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          94 MEYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             EEccC-CCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            99997 57776663   2234588999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcceeecccCCCCCCCccccc---CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ..     ....++..|+|||.+.   ...++.++|||||||++|+|++|..|+.......      ..........+   
T Consensus       167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~---  232 (308)
T cd06634         167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNESP---  232 (308)
T ss_pred             Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHhhcCCC---
Confidence            32     2235788999999874   3567889999999999999999999875432110      01111111110   


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                         .  .........+.+++.+||+.+|.+||++.+++.....
T Consensus       233 ---~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         233 ---A--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             ---C--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence               0  1122334557889999999999999999999876443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3e-36  Score=271.91  Aligned_cols=241  Identities=24%  Similarity=0.313  Sum_probs=185.3

Q ss_pred             eeeecCCeEEEEEEEC-CCCEEEEEECcCcCh---hcHHHHHHHH---HHHHhcCCCCcceeeeEEEeCCeeEEEEEecC
Q 017503           53 KIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK---QGVREFITEI---MTLSNVRHPNLVELIGCCVQGTRRILVYEYVE  125 (370)
Q Consensus        53 ~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  125 (370)
                      .||+|+||.||++... +++.||+|.+.....   .....+..|.   ..++...||+++++++++.+.+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999975 578999998765321   1112233343   33444689999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc
Q 017503          126 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH  205 (370)
Q Consensus       126 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  205 (370)
                      +++|..++.    ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......  
T Consensus        81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            999998883    344689999999999999999999999   99999999999999999999999999987553322  


Q ss_pred             eeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          206 ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       206 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                       .....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||............    .....      ...   .
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~------~~~---~  217 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLT------MAV---E  217 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhhc------cCC---C
Confidence             1234588999999998754 6899999999999999999999998755332211111    10000      011   1


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCC-----CHHHHHH
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  316 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  316 (370)
                      .+......+.+++.+|+..+|.+||     ++.++++
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1222345688899999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-36  Score=267.36  Aligned_cols=243  Identities=23%  Similarity=0.274  Sum_probs=186.5

Q ss_pred             ceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh---hcHHHHHHHHHHH-HhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK---QGVREFITEIMTL-SNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||.|++|.||+|... +++.||+|.+.....   .....+..|..++ ...+|+|++++++++...+..++|+||+.+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57899999999999975 588999998865421   2223334454444 445899999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....     
T Consensus        82 ~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            99999983    334688999999999999999999999   999999999999999999999999999875432     


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                      .....++..|++||.+.+..++.++||||||+++|+|++|..||.....   .....   . ...... . ...   ...
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~---~-~~~~~~-~-~~~---~~~  217 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFD---N-ILSRRI-N-WPE---EVK  217 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHH---H-HHhccc-C-CCC---ccc
Confidence            2223577899999999888899999999999999999999999864322   11111   1 111110 0 001   111


Q ss_pred             hHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       287 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      ......+.+++.+||+.+|.+||++.++.+.|
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            12344588999999999999999776555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.1e-36  Score=271.95  Aligned_cols=250  Identities=23%  Similarity=0.353  Sum_probs=195.3

Q ss_pred             CCcccceeeecCCeEEEEEEECC-CCEEEEEECcC---c--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSA---E--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~---~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      +|.+.+.||+|+||.||++.+.. +..+++|+.+.   .  .......+..|+.+++.++|||++++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            68899999999999999998753 34455554432   1  122234566789999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+.+++|.+++......+..+++..++.++.|++.||.|||+.   +++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998865445566799999999999999999999999   9999999999999975 569999999987654


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      .... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....      .........         .
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~---------~  220 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVE---------G  220 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHc---------C
Confidence            3221 22234578899999999888889999999999999999999998753211      111111111         1


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .....+......+.+++.+||..+|.+||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            111223444556889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-36  Score=280.20  Aligned_cols=263  Identities=24%  Similarity=0.334  Sum_probs=197.4

Q ss_pred             HHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 017503           39 TELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT  115 (370)
Q Consensus        39 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  115 (370)
                      .++....++|++.+.||+|++|.||++... ++..||+|.+...  .......+.+|+.++++++||||+++++++....
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880           8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            355667889999999999999999999865 6889999987543  2333456788999999999999999999987543


Q ss_pred             ------eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeE
Q 017503          116 ------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK  189 (370)
Q Consensus       116 ------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  189 (370)
                            ..++||||+ +++|..++.     ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence                  358999998 668988873     24689999999999999999999999   999999999999999999999


Q ss_pred             EeeecCccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHH--
Q 017503          190 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW--  266 (370)
Q Consensus       190 L~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~--  266 (370)
                      |+|||++......    .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......  ........  
T Consensus       159 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~  232 (343)
T cd07880         159 ILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVT  232 (343)
T ss_pred             EeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhc
Confidence            9999998765432    122356789999998876 45889999999999999999999998643211  00000000  


Q ss_pred             --------HHHhcCCCcc-------cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          267 --------QLHQEEKPLE-------LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       267 --------~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                              ..........       .....+....+.....+.+++.+|++.+|.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                    0000000000       0000011111223345789999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.6e-36  Score=272.62  Aligned_cols=254  Identities=26%  Similarity=0.422  Sum_probs=194.2

Q ss_pred             hccCCcccceeeecCCeEEEEEEECC-CCEEEEEECcCcC-hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ..++|++.+.||+|++|.||+|.+.. ++.||+|.+.... ......+..|+.++.+. .|+||+++++++.+....+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            45788999999999999999999864 8899999886542 23344566677767666 599999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      |||+.+ +|.+++..   ....+++..+..++.|++.||.|||+ .   +++||||+|+||++++++.++|+|||++..+
T Consensus        93 ~e~~~~-~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          93 MELMST-CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             eeccCc-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            999854 67776632   23478999999999999999999997 5   8999999999999999999999999998765


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCC----cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQ----LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      .....  .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.......     +........... 
T Consensus       166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~-  237 (296)
T cd06618         166 VDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQEEPP-  237 (296)
T ss_pred             cCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcCCCC-
Confidence            43221  12234678899999886553    7899999999999999999999986432110     111111111111 


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                           ... .......++.+++.+||+.+|.+||++.+++...
T Consensus       238 -----~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         238 -----SLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             -----CCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence                 010 0112334588999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.9e-36  Score=275.95  Aligned_cols=260  Identities=20%  Similarity=0.290  Sum_probs=190.9

Q ss_pred             ceeeec--CCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRG--GFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G--~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      ..||.|  +||+||.+.+. .++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  89999999975 6899999988653  233456788899999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      ++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||+.+..........
T Consensus        84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            99999885432  23588999999999999999999999   99999999999999999999999998654332111100


Q ss_pred             ------eecccCCCCCCCcccccCC--CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH-----------
Q 017503          207 ------TTRIAGTTGYLAPEYVLGG--QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ-----------  267 (370)
Q Consensus       207 ------~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----------  267 (370)
                            .....++..|+|||++.+.  .++.++|||||||++|+|++|..||........  .......           
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCcccccc
Confidence                  0112245679999998764  478999999999999999999999865432110  0000000           


Q ss_pred             -----H----------------HhcCCCcccccCCC-CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          268 -----L----------------HQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       268 -----~----------------~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                           .                .............+ ..........+.+++.+||+.||.+|||+.++++.-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                 0                00000000000001 111234556789999999999999999999998643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.8e-36  Score=279.42  Aligned_cols=263  Identities=22%  Similarity=0.298  Sum_probs=195.6

Q ss_pred             hccCCcc-cceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhc--------------HHHHHHHHHHHHhcCCCCccee
Q 017503           44 ATDDFHL-SNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQG--------------VREFITEIMTLSNVRHPNLVEL  107 (370)
Q Consensus        44 ~~~~y~~-~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~  107 (370)
                      ..++|.. .+.||.|+||.||+|.++ +++.||+|.+.......              ...+.+|+.+++.++|+||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            3567764 577999999999999975 68899999876432211              1246789999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       108 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                      ++++......++||||+. ++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~  157 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI  157 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence            999999999999999997 58888873    345689999999999999999999999   9999999999999999999


Q ss_pred             eEEeeecCccccCCCC-------------cceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcc
Q 017503          188 PKIGDFGLAKLFPDNI-------------THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  253 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~  253 (370)
                      ++|+|||++.......             ........++..|+|||.+.+. .++.++||||||+++|+|++|.+||...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999997654110             0111123457789999988764 4689999999999999999999998654


Q ss_pred             cccchhhHHHHHHHHHhcCCCc---------------ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          254 WGQMNKFLLEWAWQLHQEEKPL---------------ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ....   ....+..........               .................+.+++.+||+.+|.+||++.+++..
T Consensus       238 ~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        238 NEID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CHHH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            3211   111111111100000               000000111112234557899999999999999999999863

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.7e-36  Score=273.93  Aligned_cols=261  Identities=19%  Similarity=0.239  Sum_probs=189.9

Q ss_pred             ccceeeecCCeEEEEEEECCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 017503           50 LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        50 ~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      +.+.+|.|+++.|+++.. +++.||+|++...  .......+.+|+.+++.++|+||+++++++......+++|||+.++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344445555555555444 5889999988654  3445677899999999999999999999999999999999999999


Q ss_pred             CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc---
Q 017503          128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---  204 (370)
Q Consensus       128 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---  204 (370)
                      +|.+++...  ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+||+.+........   
T Consensus        85 ~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          85 SCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            999998532  234588899999999999999999999   999999999999999999999999998875432111   


Q ss_pred             ---ceeecccCCCCCCCcccccC--CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHh---------
Q 017503          205 ---HITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ---------  270 (370)
Q Consensus       205 ---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------  270 (370)
                         .......++..|+|||.+..  ..++.++|||||||++|+|++|..||......  ............         
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchh
Confidence               11122346678999998865  35789999999999999999999998753221  111111000000         


Q ss_pred             --cCCCcc----cccCC-----CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          271 --EEKPLE----LVDPE-----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       271 --~~~~~~----~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                        ......    ..++.     ...........+.+++.+||+.+|.+|||+.++++.-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence              000000    00000     0112233445688899999999999999999998743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.3e-36  Score=280.73  Aligned_cols=261  Identities=21%  Similarity=0.299  Sum_probs=193.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC---------
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG---------  114 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---------  114 (370)
                      ..+|++.+.||.|+||.||+|..+ ++..||+|.+........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            478999999999999999999975 5889999988776656667788999999999999999999776543         


Q ss_pred             -----CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC-CCCCe
Q 017503          115 -----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEFNP  188 (370)
Q Consensus       115 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~-~~~~~  188 (370)
                           ...++||||+. ++|.+++.     ...+++..+..++.|++.||.|||+.   +++||||||+||+++ .++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 35789999997 48888773     23588999999999999999999999   999999999999997 45678


Q ss_pred             EEeeecCccccCCCCcce--eecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHH
Q 017503          189 KIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA  265 (370)
Q Consensus       189 kL~Dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~  265 (370)
                      +|+|||++..........  .....++..|+|||.+.. ..++.++|||||||++|+|++|..||........  .....
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~  232 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLIL  232 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence            999999997654321111  122346788999997654 5678899999999999999999999864422111  00000


Q ss_pred             HHH----------HhcCCCccc------ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          266 WQL----------HQEEKPLEL------VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       266 ~~~----------~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...          .........      .........+....++.+++.+||+.+|.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            000          000000000      000000111123345788999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-36  Score=270.62  Aligned_cols=261  Identities=22%  Similarity=0.328  Sum_probs=193.1

Q ss_pred             CcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh-hcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEEEEEec
Q 017503           48 FHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK-QGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      |++.+.||.|++|.||+|... +++.|+||.+..... .......+|+..+++++ |+|++++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            678899999999999999986 478899998765422 22234456899999998 999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                       +++|.+++....  +..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             778888774322  34689999999999999999999999   999999999999999999999999999976543221


Q ss_pred             ceeecccCCCCCCCccccc-CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhh-HH---------HHHHHHHhcCC
Q 017503          205 HITTRIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF-LL---------EWAWQLHQEEK  273 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~-~~---------~~~~~~~~~~~  273 (370)
                        .....++..|+|||++. ...++.++|+||||+++++|++|++||.......... ..         .+.........
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              12345778899999875 4567899999999999999999998885442211100 00         00000000000


Q ss_pred             Cccccc----CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 PLELVD----PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 ~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ....+.    ..+....+.....+.+++.+||+.+|.+|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000    0001111122456889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=268.58  Aligned_cols=273  Identities=27%  Similarity=0.347  Sum_probs=213.7

Q ss_pred             CHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHh--cCCCCcceeeeEEEeC
Q 017503           37 SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSN--VRHPNLVELIGCCVQG  114 (370)
Q Consensus        37 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~  114 (370)
                      ..=..+....+.++++.||+|.||.||+|.+. |..||||++...++   +...+|.++.+.  |+|+||+.+++.-...
T Consensus       202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            34445666788999999999999999999997 89999999987755   345668888775  5999999998875432


Q ss_pred             ----CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEeecCCCCceEeCCC
Q 017503          115 ----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE-----LVPHIVHRDIKASNILLDQE  185 (370)
Q Consensus       115 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-----~~~~iiH~dlkp~Nill~~~  185 (370)
                          ..++||++|.+.|+|.+|+.     ...++....++++..+|.||++||..     ..|.|.|||||+.|||+..+
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn  352 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  352 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence                36799999999999999993     35789999999999999999999954     46689999999999999999


Q ss_pred             CCeEEeeecCccccCCCCcc---eeecccCCCCCCCcccccCC------CcCccccchhhhHHHHHHHhC----------
Q 017503          186 FNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGG------QLTMKADVYSFGVLVLEIISG----------  246 (370)
Q Consensus       186 ~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~elltg----------  246 (370)
                      ++..|+|+||+.....+...   ......||.+|||||++...      .--..+||||||+++||+.-.          
T Consensus       353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence            99999999999877655332   23446799999999988542      122568999999999999764          


Q ss_pred             CCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC--CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          247 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL--GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       247 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      ++||....+.+..+      +...+......+.|..  ......++..+.++++.||..+|.-|-|+--|-+.|.++...
T Consensus       433 ~~Pyyd~Vp~DPs~------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  433 QLPYYDVVPSDPSF------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             cCCcccCCCCCCCH------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            24665544433221      1222223333344443  345568888899999999999999999999999999888753

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.1e-36  Score=279.29  Aligned_cols=261  Identities=23%  Similarity=0.301  Sum_probs=196.4

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe-CCe
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ-GTR  116 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~  116 (370)
                      +..++++|++.+.||.|+||.||++... ++..||+|.+...  .......+.+|+.+++.++|||++++.+++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            4457889999999999999999999975 6889999987542  22334667789999999999999999999876 567


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .++++||+ +++|..++.     ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        85 ~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          85 IYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             EEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            88999998 458888873     23578888889999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHh-----
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ-----  270 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  270 (370)
                      ......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........   .........     
T Consensus       156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~  228 (328)
T cd07856         156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ---FSIITDLLGTPPDD  228 (328)
T ss_pred             cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence            754322    122356788999998766 5689999999999999999999999864432110   000000000     


Q ss_pred             ------cCCCcccccCC-C------CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          271 ------EEKPLELVDPE-L------GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       271 ------~~~~~~~~~~~-~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                            .......+... .      ....+.....+.+++.+||+.+|.+||++.+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  00000000000 0      01111233568899999999999999999998664

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-37  Score=273.36  Aligned_cols=256  Identities=29%  Similarity=0.380  Sum_probs=199.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCcC-------hhcHHHHHHHHHHHHhcCCCCcceeeeEEE-eCC
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAES-------KQGVREFITEIMTLSNVRHPNLVELIGCCV-QGT  115 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~  115 (370)
                      .++|-++.+||+|||+.||++.+ ..++.||+|+-..+.       ........+|.++.+.|.||.||++|+++. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            45799999999999999999995 467889999754321       122445678999999999999999999986 567


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC---CCCeEEee
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGD  192 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kL~D  192 (370)
                      .++-|+|||+|.+|+-|+    +....++++++..|+.||+.||.||.+..+ +|||.||||.|||+-.   -|.+||.|
T Consensus       542 sFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             cceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccEEEecCcccceeEeee
Confidence            788999999999999999    566789999999999999999999999855 7999999999999953   46799999


Q ss_pred             ecCccccCCCCcc------eeecccCCCCCCCcccccCC----CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHH
Q 017503          193 FGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGG----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL  262 (370)
Q Consensus       193 fg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~  262 (370)
                      ||++.++.++...      .+....||.+|++||++.-+    ..+.+.||||+||++|+.+.|+.||.....+  +.++
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdIL  694 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDIL  694 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHH
Confidence            9999998765433      24456799999999987543    4689999999999999999999999765332  2222


Q ss_pred             HHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHH
Q 017503          263 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  315 (370)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  315 (370)
                      +       .......-.-.+ ...+....+...+|++||+..-++|....++.
T Consensus       695 q-------eNTIlkAtEVqF-P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  695 Q-------ENTILKATEVQF-PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             h-------hhchhcceeccC-CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            2       111111111111 11123344578899999999999998777664

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-38  Score=309.47  Aligned_cols=253  Identities=28%  Similarity=0.389  Sum_probs=204.4

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .+-+|+-...||.|.||.||.+.+. +|...|+|-+...+  ......+.+|..+|..++|||+|+++|+-.+.+..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            3457888889999999999999964 67888999776553  34456678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      ||||++|+|.+.+    ..+...++.....+..|++.|+.|||+.   ||+||||||.||+++.+|.+|++|||.+..+.
T Consensus      1313 MEyC~~GsLa~ll----~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHhccCcHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999998    4555566777777889999999999999   99999999999999999999999999998776


Q ss_pred             CCCcc---eeecccCCCCCCCcccccCC---CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          201 DNITH---ITTRIAGTTGYLAPEYVLGG---QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       201 ~~~~~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      .....   .-....||+-|||||++.+.   .-..++||||+||++.||.||+.||.....+-+.     ...+....  
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI-----My~V~~gh-- 1458 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI-----MYHVAAGH-- 1458 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH-----HhHHhccC--
Confidence            54322   12345799999999999764   3568999999999999999999998766442221     11111111  


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                             .+..|.....+-.+++.+||+.||++|.++.++++.
T Consensus      1459 -------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                   124455556667899999999999999888877653

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-36  Score=277.69  Aligned_cols=258  Identities=24%  Similarity=0.329  Sum_probs=195.6

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe---
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR---  116 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---  116 (370)
                      ...++|++.+.||+|++|.||+|++. ++..||+|.+...  .......+.+|+.++++++|+|++++.+++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            45788999999999999999999986 5788999987643  23334567789999999999999999988766554   


Q ss_pred             ---eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          117 ---RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       117 ---~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                         .++|+||+ +++|.+++.     ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence               89999998 568988883     24689999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      |++......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......   ........... .
T Consensus       163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~-~  234 (343)
T cd07851         163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVG-T  234 (343)
T ss_pred             ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcC-C
Confidence            999865432    223356788999998765 36789999999999999999999998643221   11111111000 0


Q ss_pred             CCccc------------c-------cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          273 KPLEL------------V-------DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       273 ~~~~~------------~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .....            .       .+............+.+++.+||..+|.+|||+.+|+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00000            0       000000011224568899999999999999999999753

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=254.97  Aligned_cols=253  Identities=26%  Similarity=0.465  Sum_probs=197.0

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ..++.+.+..||+|.-|.||+.+.+ .|...|||..... +....++++..+.++..- .+|+||+.+|+|..+...++-
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic  169 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC  169 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence            3456677788999999999999986 5788999988765 566677888888888776 489999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      ||.+.. -++.++.   ....++++..+-++...++.||.||.++-  +|+|||+||+|||+|+.|++||||||.+-.+-
T Consensus       170 MelMs~-C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  170 MELMST-CAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             HHHHHH-HHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence            998754 4555552   34456888888899999999999999864  89999999999999999999999999997664


Q ss_pred             CCCcceeecccCCCCCCCcccccC---CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      +.  ...+...|-+.|||||.+.-   ..|+.++||||||+.|+||.||..||..-..+.     +....+..++.+  .
T Consensus       244 dS--kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln~ePP--~  314 (391)
T KOG0983|consen  244 DS--KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLNEEPP--L  314 (391)
T ss_pred             cc--cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHhcCCC--C
Confidence            43  23445568899999998853   468999999999999999999999986532221     112233333332  2


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      +++..+ +.+    .+.+++..||+.|+.+||.+.++++
T Consensus       315 L~~~~g-FSp----~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  315 LPGHMG-FSP----DFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCcccC-cCH----HHHHHHHHHhhcCcccCcchHHHhc
Confidence            222211 333    4788888899999999999999876

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-37  Score=260.74  Aligned_cols=256  Identities=20%  Similarity=0.224  Sum_probs=198.0

Q ss_pred             HhccCCccc-ceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEe----CC
Q 017503           43 SATDDFHLS-NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ----GT  115 (370)
Q Consensus        43 ~~~~~y~~~-~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~  115 (370)
                      ..+++|++. ++||-|-.|+|....++ +++++|+|++...     ...++|++..-.. .|||||.+++++..    ..
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            457888887 58999999999988876 6899999988654     3445688877665 69999999999863    45


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC---CCCeEEee
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGD  192 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kL~D  192 (370)
                      .+.+|||.++||.|.+.+..  .....+++.++..|+.||..|+.|||+.   +|.||||||+|+|...   |..+||+|
T Consensus       133 cLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             eeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence            77899999999999988832  3344689999999999999999999999   9999999999999964   45699999


Q ss_pred             ecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          193 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       193 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      ||++..-..  .......+.|+.|.|||++....|+...|+||+||++|-|++|++||....+..-..-.   ...+...
T Consensus       208 fGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM---k~rI~~g  282 (400)
T KOG0604|consen  208 FGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KRRIRTG  282 (400)
T ss_pred             cccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH---HhHhhcc
Confidence            999986443  23344567799999999999999999999999999999999999998765442110000   0000000


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      . .+.    .............++|+.+|..+|.+|.|+.+++..-
T Consensus       283 q-y~F----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  283 Q-YEF----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             C-ccC----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            0 000    0122234556678899999999999999999998654

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.1e-35  Score=273.22  Aligned_cols=260  Identities=22%  Similarity=0.306  Sum_probs=190.9

Q ss_pred             CCcccceeeecCCeEEEEEEEC-C--CCEEEEEECcCc--ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeC----Ce
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-N--GRRIAVKPLSAE--SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQG----TR  116 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~--~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~  116 (370)
                      +|++.+.||+|+||.||++... .  +..||+|.+...  .......+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            5888999999999999999975 3  678999987643  222345678899999999 699999999876432    45


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .+++++++. ++|.+++.    .+..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            678889886 58888873    445689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc---eeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH---
Q 017503          197 KLFPDNITH---ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH---  269 (370)
Q Consensus       197 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---  269 (370)
                      .........   ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||.......   .........   
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~  229 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTP  229 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCC
Confidence            865432211   1223467889999998765 468999999999999999999999886432110   000000000   


Q ss_pred             --------hcCCC------c-ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          270 --------QEEKP------L-ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       270 --------~~~~~------~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                              .....      . ......+....+.....+.+++.+||+.+|.+|||+.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                    00000      0 000000111111223458899999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-37  Score=274.00  Aligned_cols=247  Identities=25%  Similarity=0.347  Sum_probs=199.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .+.|..-++||+||||.||-...+ +|.-||.|.+...   ......-.++|-.+|.+++.+.||.+-..|+..+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            467888999999999999998865 6888999866543   223345567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      +..|+||+|.-+|..  -.+..++++.+.-++.+|+.||++||..   +|++|||||.|||+|+.|+++|+|+|++..+.
T Consensus       264 LtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            999999999877732  2335799999999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      .....  ....||.+|||||++.+..|+...|.|||||+||||+.|+.||..........-++.   ..       +  .
T Consensus       339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr---r~-------~--~  404 (591)
T KOG0986|consen  339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR---RT-------L--E  404 (591)
T ss_pred             CCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH---HH-------h--c
Confidence            65433  334799999999999999999999999999999999999999976543322211110   00       0  0


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCC
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQ  310 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  310 (370)
                      .-..++.....+...+.+..|+.||.+|..
T Consensus       405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             chhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            112344555556777777799999999964

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=267.72  Aligned_cols=258  Identities=26%  Similarity=0.360  Sum_probs=196.4

Q ss_pred             CcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           48 FHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      |++.+.||+|++|.||+|+.. +++.|++|.+....  ......+..|+.+++.++|+|++++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            667889999999999999976 58999999887652  333466778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      .+ +|.+++...   ...+++..+..++.|++.||.+||+.   +++||||+|+||++++++.++|+|||++........
T Consensus        81 ~~-~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 DM-DLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             Cc-CHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            84 899988432   24689999999999999999999999   999999999999999999999999999986644322


Q ss_pred             ceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH-----------hcC
Q 017503          205 HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH-----------QEE  272 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~  272 (370)
                      . .....++..|+|||.+.+. .++.++||||||+++|+|++|.+||......   ..........           ...
T Consensus       154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhhccc
Confidence            1 1223456789999988776 7899999999999999999999887543211   0111110000           000


Q ss_pred             CCcccccCC-----CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          273 KPLELVDPE-----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       273 ~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ......-+.     .....+.....+.+++.+||+.+|.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000000     00111122456899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=266.73  Aligned_cols=270  Identities=30%  Similarity=0.415  Sum_probs=203.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHh--cCCCCcceeeeEEEeCC----eeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSN--VRHPNLVELIGCCVQGT----RRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~  118 (370)
                      ....++.+.+|+|.||.||+|... ++.||||++...+.   +.+.+|-++.+.  +.|+||+++++.-....    ..+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            556677889999999999999986 59999999986644   456667777765  58999999999877655    789


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEeecCCCCceEeCCCCCeEEee
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL------VPHIVHRDIKASNILLDQEFNPKIGD  192 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------~~~iiH~dlkp~Nill~~~~~~kL~D  192 (370)
                      ||++|.+.|+|.+|+     ....++|....+++.-++.||+|||+..      .|+|+|||||++||||..|++..|+|
T Consensus       285 LVt~fh~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             EEeeeccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            999999999999999     4457899999999999999999999763      34799999999999999999999999


Q ss_pred             ecCccccCCCCcc-eeecccCCCCCCCcccccCCC-c-----CccccchhhhHHHHHHHhCCCCC--------Cccccc-
Q 017503          193 FGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQ-L-----TMKADVYSFGVLVLEIISGRNSG--------KAMWGQ-  256 (370)
Q Consensus       193 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~-----~~~~Di~slG~il~elltg~~p~--------~~~~~~-  256 (370)
                      ||++..+...... ......||.+|||||++.+.. +     -.+.||||+|.+||||+++..-.        ..++.. 
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            9999987654332 223367999999999986642 1     24689999999999999975322        222211 


Q ss_pred             --chhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCc
Q 017503          257 --MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  326 (370)
Q Consensus       257 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  326 (370)
                        ....+.+....+..+...-.+.+.   ...-..+..+.+.+..||..||+.|.|+.=+.+.+.++....+
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~---W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDA---WRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhh---hhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence              111111111122222221111111   1112455668889999999999999999999999999887653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=289.78  Aligned_cols=266  Identities=28%  Similarity=0.437  Sum_probs=207.8

Q ss_pred             HHHHhccCCcccceeeecCCeEEEEEEEC----C----CCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeee
Q 017503           40 ELRSATDDFHLSNKIGRGGFGTVYKGTLT----N----GRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIG  109 (370)
Q Consensus        40 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~----~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~  109 (370)
                      .++...++..+.+.||+|.||.|++|...    .    ...||+|..+.. .....+.+..|+.+|+.+ .|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            45555666677889999999999999843    1    356899988765 335567889999999998 7999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHhcccc---c-------CC--ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCC
Q 017503          110 CCVQGTRRILVYEYVENNSLDRVLLGAT---K-------AN--IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA  177 (370)
Q Consensus       110 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~-------~~--~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp  177 (370)
                      +|......++|+||+..|+|..++...+   .       ..  ..++....+.++.||+.|++||++.   +++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999996554   0       01  2388999999999999999999999   999999999


Q ss_pred             CceEeCCCCCeEEeeecCccccCCCCcceeecccC--CCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCccc
Q 017503          178 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG--TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMW  254 (370)
Q Consensus       178 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~  254 (370)
                      +|||+..+..+||+|||+++...+..........+  ...|||||.+....++.++||||||++|||++| |..|+....
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999999655443333222222  345999999999999999999999999999999 555654311


Q ss_pred             ccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          255 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                        ....+.    +...++..        ...|..+..++.++++.||+.+|++||++.++.+.+...+
T Consensus       527 --~~~~l~----~~l~~G~r--------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  527 --PTEELL----EFLKEGNR--------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             --cHHHHH----HHHhcCCC--------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence              011122    22222222        1223344455667777799999999999999999999854

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=259.26  Aligned_cols=256  Identities=24%  Similarity=0.299  Sum_probs=197.7

Q ss_pred             cceeeecCCeEEEEEE-ECCCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCCCC
Q 017503           51 SNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNS  128 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  128 (370)
                      .+.||+|+|+.|-.+. ..++..||||++..........+.+|++++.+. .|+||+.++++|+++..+|+|||.+.||.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            3579999999998877 468999999999988777788899999999998 69999999999999999999999999999


Q ss_pred             HHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC---eEEeeecCccccCC--CC
Q 017503          129 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKLFPD--NI  203 (370)
Q Consensus       129 L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kL~Dfg~~~~~~~--~~  203 (370)
                      |-..|    .+..-+++.++.++...|+.||.+||.+   ||.||||||+|||..+-..   +|||||.+..-+..  +.
T Consensus       163 lLshI----~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  163 LLSHI----QKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             HHHHH----HHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            98888    4556789999999999999999999999   9999999999999976554   79999998864321  11


Q ss_pred             c----ceeecccCCCCCCCccccc-----CCCcCccccchhhhHHHHHHHhCCCCCCcccccc------h--hhHHHHHH
Q 017503          204 T----HITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM------N--KFLLEWAW  266 (370)
Q Consensus       204 ~----~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~------~--~~~~~~~~  266 (370)
                      .    ..-...+|+..|||||+..     .-.|+.+.|.||||++||-||+|++||...-+.+      .  ....+...
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence            1    1122356788899999763     2358899999999999999999999986553211      1  11111112


Q ss_pred             HHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      +-++++.. +..|.    .......+..+++...+..++.+|.++..++..-
T Consensus       316 esIQEGkY-eFPdk----dWahIS~eakdlisnLlvrda~~rlsa~~vlnhP  362 (463)
T KOG0607|consen  316 ESIQEGKY-EFPDK----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP  362 (463)
T ss_pred             HHHhccCC-cCChh----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence            22222211 11111    1123445567888889999999999999887643

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=260.14  Aligned_cols=236  Identities=29%  Similarity=0.357  Sum_probs=190.1

Q ss_pred             eeecCCeEEEEEEEC-CCCEEEEEECcCcCh---hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCH
Q 017503           54 IGRGGFGTVYKGTLT-NGRRIAVKPLSAESK---QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL  129 (370)
Q Consensus        54 lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  129 (370)
                      ||.|++|.||++... +++.|++|.+.....   .....+..|+.++++++|+|++++++.+......++||||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999976 588999998765432   2455788899999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeec
Q 017503          130 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR  209 (370)
Q Consensus       130 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~  209 (370)
                      .+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        81 ~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~  152 (250)
T cd05123          81 FSHLS----KEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT  152 (250)
T ss_pred             HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence            99983    334689999999999999999999998   99999999999999999999999999998654332 11233


Q ss_pred             ccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHH
Q 017503          210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE  289 (370)
Q Consensus       210 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (370)
                      ..++..|++||.+.+...+.++|+||||+++|+|++|..||.....   .....   .... .      ..   ..+...
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~~~-~------~~---~~~~~~  216 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE---KILK-D------PL---RFPEFL  216 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHhc-C------CC---CCCCCC
Confidence            4578899999999888889999999999999999999999854322   11111   1111 0      01   112222


Q ss_pred             HHHHHHHHHHchhhccCCCCCHHH
Q 017503          290 IIRYMKVAFFCTQAAASRRPQMNQ  313 (370)
Q Consensus       290 ~~~l~~li~~cl~~~p~~RPt~~e  313 (370)
                      ...+.+++.+||..+|.+||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            445788999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=277.38  Aligned_cols=262  Identities=25%  Similarity=0.434  Sum_probs=211.2

Q ss_pred             ccCHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEE
Q 017503           35 HFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCV  112 (370)
Q Consensus        35 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  112 (370)
                      .+.++.+..-++.|++...+|.|.+|+||+++.. +++..|+|+...... ...++..|.++|+.+ +|||++.++|++.
T Consensus         8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen    8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            3455666667889999999999999999999964 688899998765533 346677799999987 7999999999986


Q ss_pred             e-----CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          113 Q-----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       113 ~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                      -     ++.+|||||||.+|+..+++....  +..+.|..+..|++.++.|+.+||.+   .++|||||-.|||++.++.
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence            3     568899999999999999986544  77899999999999999999999999   9999999999999999999


Q ss_pred             eEEeeecCccccCCCCcceeecccCCCCCCCcccccC-----CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHH
Q 017503          188 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL  262 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~  262 (370)
                      +||+|||.+..+...... .....||+.|||||++.-     ..|+..+|+||||++..||--|.+|+.++.+.-.-   
T Consensus       162 VKLvDFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL---  237 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL---  237 (953)
T ss_pred             EEEeeeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh---
Confidence            999999999876544333 334679999999999854     34778999999999999999999998766542110   


Q ss_pred             HHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          263 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                         ..... ..+     |. ...+..-..++.++|..||..|..+||++.++++
T Consensus       238 ---F~IpR-NPP-----Pk-Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 ---FLIPR-NPP-----PK-LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ---ccCCC-CCC-----cc-ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence               00000 011     11 1224456667899999999999999999998874

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.2e-34  Score=285.18  Aligned_cols=146  Identities=30%  Similarity=0.435  Sum_probs=131.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.++||+|+||.||+|.+. .++.||||++...   .......+..|+.+++.++|+||+++++++......++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            578999999999999999999986 6889999988653   233346678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      |||+.+++|.+++.    ....+++..++.++.||+.||.|||..   +|+||||||+|||++.++.++|+|||+++
T Consensus        83 mEy~~g~~L~~li~----~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999983    234578899999999999999999999   99999999999999999999999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=273.04  Aligned_cols=267  Identities=22%  Similarity=0.257  Sum_probs=207.0

Q ss_pred             cCCCCCCccccccccccCHHHHHH-----hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHH
Q 017503           20 EAPQGVDGELLRNVNHFSYTELRS-----ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEI   93 (370)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~   93 (370)
                      ....+.+..+.++++.-....+..     +++.|++...+|.|+|+.|-.+.+. +++..++|++.....+    -.+|+
T Consensus       291 ~~~~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~  366 (612)
T KOG0603|consen  291 LSASGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEI  366 (612)
T ss_pred             CCCCccccchhcCCCccChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccccc----ccccc
Confidence            334444546666777666666665     4788999999999999999888764 6888999998766222    23466


Q ss_pred             HHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 017503           94 MTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH  172 (370)
Q Consensus        94 ~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH  172 (370)
                      .++... +|||++++.+++.+....|+|||.+.++-+.+.+.    ...... ..+..|+.+|+.|+.|||++   |++|
T Consensus       367 ~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~----~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvh  438 (612)
T KOG0603|consen  367 PISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIR----SKPEFC-SEASQWAAELVSAVDYLHEQ---GVVH  438 (612)
T ss_pred             chhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHH----hcchhH-HHHHHHHHHHHHHHHHHHhc---Ceee
Confidence            565554 89999999999999999999999999998777662    222333 77788999999999999999   9999


Q ss_pred             ecCCCCceEe-CCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCC
Q 017503          173 RDIKASNILL-DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  251 (370)
Q Consensus       173 ~dlkp~Nill-~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~  251 (370)
                      |||||+|||+ ++.++++|+|||.+......    ....+-|..|.|||+.....|++++||||||++||+||+|+.||.
T Consensus       439 RDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~  514 (612)
T KOG0603|consen  439 RDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFA  514 (612)
T ss_pred             cCCChhheeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccc
Confidence            9999999999 69999999999999876554    222345778999999999999999999999999999999999987


Q ss_pred             cccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          252 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ....+.  .+.    .....           +.+.........+|+.+||+.+|.+||++.++...-.
T Consensus       515 ~~P~~~--ei~----~~i~~-----------~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w  565 (612)
T KOG0603|consen  515 AHPAGI--EIH----TRIQM-----------PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW  565 (612)
T ss_pred             cCCchH--HHH----HhhcC-----------CccccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence            665441  111    11111           1111334445788999999999999999999976443

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.6e-34  Score=254.58  Aligned_cols=219  Identities=21%  Similarity=0.169  Sum_probs=173.8

Q ss_pred             cCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcc
Q 017503           57 GGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG  135 (370)
Q Consensus        57 G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  135 (370)
                      |.+|.||+++++ +++.||+|.+.....     ...|...+....|||++++++++.+....++||||+.+++|.+++. 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS-   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH-
Confidence            889999999975 688999999875432     2234455555679999999999999999999999999999999883 


Q ss_pred             cccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCC
Q 017503          136 ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG  215 (370)
Q Consensus       136 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~  215 (370)
                         ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||.+......    .....++..
T Consensus        78 ---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~  147 (237)
T cd05576          78 ---KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM  147 (237)
T ss_pred             ---HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence               233589999999999999999999999   9999999999999999999999999987654432    122335677


Q ss_pred             CCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHH
Q 017503          216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK  295 (370)
Q Consensus       216 y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  295 (370)
                      |+|||.+....++.++||||+|+++|+|++|..|+.......            .....        ...+......+.+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~~--------~~~~~~~~~~~~~  207 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHTT--------LNIPEWVSEEARS  207 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccccc--------cCCcccCCHHHHH
Confidence            999999988889999999999999999999987754221100            00000        0122223345888


Q ss_pred             HHHHchhhccCCCCCH
Q 017503          296 VAFFCTQAAASRRPQM  311 (370)
Q Consensus       296 li~~cl~~~p~~RPt~  311 (370)
                      ++.+||+.||.+||++
T Consensus       208 li~~~l~~dp~~R~~~  223 (237)
T cd05576         208 LLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHccCCHHHhcCC
Confidence            9999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=287.16  Aligned_cols=259  Identities=24%  Similarity=0.248  Sum_probs=202.3

Q ss_pred             HHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 017503           38 YTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQ  113 (370)
Q Consensus        38 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  113 (370)
                      +..++-..++|+++++||+|+||.|..++++ .++.||+|+++...   ......|..|-.+|..-+.+=|+.+...|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4456666789999999999999999999986 57789999887631   2334567778888888888999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      ..++|+||||+.||+|-.++.    +...+++..+..++..|+.||.-||+.   |+|||||||+||||+..|++||+||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlS----k~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLS----KFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHh----hcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            999999999999999999993    333799999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccC-----CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      |.+-.+..+..-.....+|||.|.+||++..     +.|+...|.||+||++|||+.|.-||...      .++..-.+.
T Consensus       220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KI  293 (1317)
T KOG0612|consen  220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKI  293 (1317)
T ss_pred             hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHH
Confidence            9999887665555566789999999998853     57899999999999999999999998532      122111111


Q ss_pred             HhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCC---HHHHHH
Q 017503          269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ---MNQVIK  316 (370)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~  316 (370)
                      ......+..     + ...+......+||.+.+ .+|+.|..   +.++-.
T Consensus       294 m~hk~~l~F-----P-~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  294 MNHKESLSF-----P-DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hchhhhcCC-----C-cccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence            111111111     1 01223444666666654 46777776   777644

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.6e-35  Score=253.66  Aligned_cols=207  Identities=28%  Similarity=0.435  Sum_probs=170.6

Q ss_pred             HhccCCcccceeeecCCeEEEEEEECC-----CCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEe-C
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLTN-----GRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQ-G  114 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~  114 (370)
                      .....|++++.||+|.||.||+|.-++     ...+|||.++.+.  ........+|+..++.++|||++.+..++.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            345689999999999999999996432     2368999887652  2233456789999999999999999999887 7


Q ss_pred             CeeEEEEEecCCCCHHHHhccccc-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC----CCeE
Q 017503          115 TRRILVYEYVENNSLDRVLLGATK-ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE----FNPK  189 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~----~~~k  189 (370)
                      ...++++||.+. +|.+.++.++. ....++...+..|+.||+.|+.|||++   =|+||||||.|||+..+    |.+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence            788999999987 77777754433 334688889999999999999999999   79999999999999877    8899


Q ss_pred             EeeecCccccCCCCcc--eeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcc
Q 017503          190 IGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM  253 (370)
Q Consensus       190 L~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~  253 (370)
                      |+|||+++.+.+....  ....+..|.+|.|||.+.+. -|+.+.|||+.||++.||+|-.+-|...
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            9999999988664332  23446678999999988875 5899999999999999999987766543

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-35  Score=277.96  Aligned_cols=256  Identities=28%  Similarity=0.415  Sum_probs=209.3

Q ss_pred             cccceeeecCCeEEEEEEEC-C----CCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           49 HLSNKIGRGGFGTVYKGTLT-N----GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        49 ~~~~~lg~G~~g~v~~~~~~-~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      +..++||+|+||+||+|.+- .    .-+||||++... ..+...++..|+-+|.+++|||++++++++.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            34689999999999999863 3    346899987655 4455678999999999999999999999998766 778999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |++.|+|.+++..   ....+..+..+.|..||++|+.|||++   +++||||-.+|||+..-..+|+.|||+++....+
T Consensus       778 ~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999953   445688899999999999999999999   9999999999999999999999999999988765


Q ss_pred             Ccceeec-ccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          203 ITHITTR-IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       203 ~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ....... ..-.+.|+|-|.+....++.++|||||||++||++| |..|++.....+-.       ..+.        .+
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-------dlle--------~g  916 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-------DLLE--------KG  916 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-------HHHh--------cc
Confidence            4433222 223467999999999999999999999999999988 67776544322211       1111        12


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCc
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  326 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  326 (370)
                      .....|+.+..++..++.+||..|++.||+++++...+.+..+.+.
T Consensus       917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence            2245677888888999999999999999999999999988876543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-35  Score=255.52  Aligned_cols=262  Identities=20%  Similarity=0.266  Sum_probs=197.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC--CCC----cceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR--HPN----LVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~----iv~~~~~~~~~~~~  117 (370)
                      .++|++...+|+|.||.|....+. .+..||||+++.-... .++.+-|+++|++++  .|+    ++.+.++|...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            889999999999999999998864 4688999998765433 355667999999993  233    67777889999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-------------
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-------------  184 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-------------  184 (370)
                      ++|+|.+ |.++.+++..  ++..+++...+..++.|+++++++||+.   +++|-||||+|||+.+             
T Consensus       167 Civfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence            9999988 5588888843  3445688899999999999999999999   9999999999999832             


Q ss_pred             -------CCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccc
Q 017503          185 -------EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM  257 (370)
Q Consensus       185 -------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~  257 (370)
                             +..++|+|||.+.......    .....|..|.|||++.+-.++..+||||+||+|+||.||..-|......+
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                   2348999999998654332    44567899999999999999999999999999999999987766554332


Q ss_pred             hhhHHHHHH--------------HHHhcCCCc-----------cccc-CCC----CCCChHHHHHHHHHHHHchhhccCC
Q 017503          258 NKFLLEWAW--------------QLHQEEKPL-----------ELVD-PEL----GEYPPNEIIRYMKVAFFCTQAAASR  307 (370)
Q Consensus       258 ~~~~~~~~~--------------~~~~~~~~~-----------~~~~-~~~----~~~~~~~~~~l~~li~~cl~~~p~~  307 (370)
                      .-.+++.+.              +.+......           ...+ +..    -...+.+-..|.+|+++||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            222222111              001111000           0000 000    1122356667999999999999999


Q ss_pred             CCCHHHHHHH
Q 017503          308 RPQMNQVIKM  317 (370)
Q Consensus       308 RPt~~evl~~  317 (370)
                      |+|+.|++..
T Consensus       397 RiTl~EAL~H  406 (415)
T KOG0671|consen  397 RITLREALSH  406 (415)
T ss_pred             cccHHHHhcC
Confidence            9999999763

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=251.58  Aligned_cols=257  Identities=28%  Similarity=0.412  Sum_probs=196.5

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh-hcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK-QGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++.+-...||.|+||+|++-.++ .|+..|||.+..... ....+++.|.+...+- +.||||++||.+..++..|+-||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            34455678999999999998875 689999999987643 4556777788776654 78999999999999999999999


Q ss_pred             ecCCCCHHHHhc-ccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          123 YVENNSLDRVLL-GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       123 ~~~~~~L~~~~~-~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      .++- +|+.+.. -...++..+++..+-.|....+.||.||.+..  .|||||+||+|||++..|.+||||||.+-.+.+
T Consensus       144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            9965 6665442 22344567888888889999999999999865  899999999999999999999999999976544


Q ss_pred             CCcceeecccCCCCCCCcccccC--CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          202 NITHITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ...  .+.-.|-..|||||.+..  ..|+.++||||||++|||+.||+.|+.....     +.+....+.....+.-..+
T Consensus       221 SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdpp~l~~~  293 (361)
T KOG1006|consen  221 SIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDPPILLFD  293 (361)
T ss_pred             HHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCCCeecCc
Confidence            322  223357789999998854  3489999999999999999999999765432     2333334444443332222


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...    -+....+..+|--|+.+|-..||.+.++.+
T Consensus       294 ~~~----~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  294 KEC----VHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ccc----cccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            221    223445777888899999999999999865

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=264.02  Aligned_cols=243  Identities=25%  Similarity=0.346  Sum_probs=196.4

Q ss_pred             cceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 017503           51 SNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      .+.||+|-||+||-|+++ +|+.||||++...  .......+.+|+++|++++||.||.+.-.|+..+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            368999999999999975 7999999998764  3444578899999999999999999999999999999999999988


Q ss_pred             CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC---CCeEEeeecCccccCCCCc
Q 017503          128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       128 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kL~Dfg~~~~~~~~~~  204 (370)
                      -|+..+.   ....++++.....+..||+.||.|||.+   +|+|.||||+|||+.+.   .++||||||+++++.... 
T Consensus       649 MLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-  721 (888)
T KOG4236|consen  649 MLEMILS---SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-  721 (888)
T ss_pred             HHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence            8888773   4556788888888999999999999999   99999999999999754   359999999999987653 


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                       ....+.||+.|+|||++.++.|...-|+||.|+++|--++|..||....+-.+     .+    ++-  ..++.+..  
T Consensus       722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-----QI----QNA--aFMyPp~P--  787 (888)
T KOG4236|consen  722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-----QI----QNA--AFMYPPNP--  787 (888)
T ss_pred             -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-----Hh----hcc--ccccCCCc--
Confidence             34557899999999999999999999999999999999999999865433111     11    110  01111111  


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCHHHHH
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  315 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  315 (370)
                       ..+.....+++|...|+..-.+|-+...-+
T Consensus       788 -W~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  788 -WSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             -hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence             122333467888888999999998877654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.7e-33  Score=273.75  Aligned_cols=266  Identities=21%  Similarity=0.230  Sum_probs=168.6

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-C----CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeE------EE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-N----GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGC------CV  112 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~  112 (370)
                      ..++|++.+.||+|+||.||+|.+. +    +..||+|.+......  .....+  .++...+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5789999999999999999999976 4    688999987643221  111111  1222222222222211      23


Q ss_pred             eCCeeEEEEEecCCCCHHHHhccccc----------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCC
Q 017503          113 QGTRRILVYEYVENNSLDRVLLGATK----------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK  176 (370)
Q Consensus       113 ~~~~~~lv~e~~~~~~L~~~~~~~~~----------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlk  176 (370)
                      .....++|+||+.+++|.+++.....                .+.......+..++.|++.||.|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            55678999999999999998843211                001112344667999999999999999   99999999


Q ss_pred             CCceEeCC-CCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCC----------------------CcCccccc
Q 017503          177 ASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG----------------------QLTMKADV  233 (370)
Q Consensus       177 p~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di  233 (370)
                      |+|||++. ++.+||+|||++..+............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999985 57899999999986544333334456788999999965322                      23456799


Q ss_pred             hhhhHHHHHHHhCCCCCCcccccchhhHHHHH--HHHHhcCCCcccccCCC---CCCChHHHHHHHHHHHHchhhccCCC
Q 017503          234 YSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA--WQLHQEEKPLELVDPEL---GEYPPNEIIRYMKVAFFCTQAAASRR  308 (370)
Q Consensus       234 ~slG~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~R  308 (370)
                      |||||+||||+++..+++.........+....  ...+...... ...+.+   .+..........+|+.+||+.||.+|
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-RASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-ccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            99999999999976654322111100000000  0000000000 000000   00001111234579999999999999


Q ss_pred             CCHHHHHHH
Q 017503          309 PQMNQVIKM  317 (370)
Q Consensus       309 Pt~~evl~~  317 (370)
                      ||+.++++.
T Consensus       442 ~ta~e~L~H  450 (566)
T PLN03225        442 ISAKAALAH  450 (566)
T ss_pred             CCHHHHhCC
Confidence            999999874

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=226.90  Aligned_cols=260  Identities=22%  Similarity=0.323  Sum_probs=192.7

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +|.-.++||+|.||+||+|++. .++-||+|.+.-+  +...-....+|+-+|+.++|+|||+++++...+..+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566789999999999999976 5777999987655  334455678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      |+. .|..+..   .-+..++.+.+..++.|++.||.+.|++   ++.||||||+|++|+.+|.+||+|||+++.+.-..
T Consensus        83 cdq-dlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            976 7777762   4566789999999999999999999999   99999999999999999999999999999876544


Q ss_pred             cceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC----CC--cc
Q 017503          204 THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE----KP--LE  276 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~--~~  276 (370)
                      .-... ...|.+|.+|.++.+. -|+..-|+||.||++.|+..-..|..+..+- ...+ ..+.......    .+  ..
T Consensus       156 rcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddql-krif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  156 RCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQL-KRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             Eeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHH-HHHHHHhCCCccccCCcccc
Confidence            32222 3468999999998875 4789999999999999998754443222111 1111 2222221111    11  11


Q ss_pred             cccCCC-C---------CCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          277 LVDPEL-G---------EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       277 ~~~~~~-~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      +.|-.. +         ...+.....-.+++++.+.-+|.+|.++++.++
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            111111 1         111222333456777788889999999987754

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.9e-33  Score=246.12  Aligned_cols=238  Identities=26%  Similarity=0.370  Sum_probs=191.2

Q ss_pred             CCeEEEEEEEC-CCCEEEEEECcCcChhc-HHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcc
Q 017503           58 GFGTVYKGTLT-NGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG  135 (370)
Q Consensus        58 ~~g~v~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  135 (370)
                      +||.||+|.+. ++..+++|++....... ...+.+|++.+++++|+|++++++.+......++++|++.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 48899999987765444 67889999999999999999999999999999999999999999999842


Q ss_pred             cccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCC
Q 017503          136 ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG  215 (370)
Q Consensus       136 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~  215 (370)
                          ...+++..++.++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.......  ......++..
T Consensus        81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 ----RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             ----ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence                22388999999999999999999999   99999999999999999999999999998765432  2233457789


Q ss_pred             CCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHH
Q 017503          216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK  295 (370)
Q Consensus       216 y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  295 (370)
                      |++||.+....++.++|||+||+++++|++|..||.....  ....    ...........      ..........+.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~----~~~~~~~~~~~------~~~~~~~~~~~~~  219 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLEL----FKKIGKPKPPF------PPPEWKISPEAKD  219 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHH----HHHHhccCCCC------ccccccCCHHHHH
Confidence            9999999888899999999999999999999998865311  1111    11111111100      0000003345888


Q ss_pred             HHHHchhhccCCCCCHHHHHH
Q 017503          296 VAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       296 li~~cl~~~p~~RPt~~evl~  316 (370)
                      ++.+||..+|.+||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-35  Score=263.33  Aligned_cols=251  Identities=21%  Similarity=0.271  Sum_probs=205.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCC-EEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGR-RIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~-~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ..+++++..||-|+||.|=++..++.. .+|+|+++..   +....+++..|-++|...+.|.||++|-.|.+....|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            567788889999999999988876433 3788877654   556677889999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      ||-|-||.|+..+    +....+....+..++..+++|+.|||.+   +||+|||||+|++++.+|.+||.|||++..+.
T Consensus       499 mEaClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  499 MEACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             HHhhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            9999999999998    5666788888899999999999999999   99999999999999999999999999999876


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      .+..  +-+.+||+.|.|||++.+...+.++|.||||+++|||++|.+||....+-.   ....+.+.         +|.
T Consensus       572 ~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---tYn~ILkG---------id~  637 (732)
T KOG0614|consen  572 SGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---TYNLILKG---------IDK  637 (732)
T ss_pred             cCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHhh---------hhh
Confidence            5433  445689999999999999999999999999999999999999998664321   11111111         111


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCC-----HHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIKML  318 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~L  318 (370)
                        -.+|........+++++.+..+|.+|..     +.+|-+.-
T Consensus       638 --i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  638 --IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             --hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence              1334455556778888889999999975     55665443

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=254.21  Aligned_cols=241  Identities=27%  Similarity=0.331  Sum_probs=192.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..+|.++.+||+|+||+|-++.-+ ....||||+++.+-   .+..+--+.|-++|... +-|.++.+..+|..-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            457888999999999999999865 46779999887652   22233345577777665 56788888888888999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+.||+|-..+    ++-.++-+..+.-++.+|+.||-+||++   |||+||||.+|||++.+|++||+|||++..-
T Consensus       428 VMEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             EEEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999998777    5556788888999999999999999999   9999999999999999999999999999742


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      --+ ...+...+||+.|+|||++..++|+.+.|.||+|++||||+.|++||+....   ..+.+.+..    .       
T Consensus       501 i~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~elF~aI~e----h-------  565 (683)
T KOG0696|consen  501 IFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQAIME----H-------  565 (683)
T ss_pred             ccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHH----c-------
Confidence            111 1234567899999999999999999999999999999999999999875432   222222211    1       


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCC
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRP  309 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  309 (370)
                        -..+|.....+.+.++...+...|.+|.
T Consensus       566 --nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  566 --NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             --cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence              1134455556678888888999999985

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.4e-32  Score=257.62  Aligned_cols=266  Identities=22%  Similarity=0.263  Sum_probs=178.1

Q ss_pred             hccCCcccceeeecCCeEEEEEEE-----------------CCCCEEEEEECcCcChhcHHHH--------------HHH
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTL-----------------TNGRRIAVKPLSAESKQGVREF--------------ITE   92 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~-----------------~~~~~vaiK~~~~~~~~~~~~~--------------~~e   92 (370)
                      ..++|++.++||+|+||.||+|..                 ..++.||||.+........+++              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999964                 2356799999875533222233              236


Q ss_pred             HHHHHhcCCCCc-----ceeeeEEEe--------CCeeEEEEEecCCCCHHHHhccccc--------------------C
Q 017503           93 IMTLSNVRHPNL-----VELIGCCVQ--------GTRRILVYEYVENNSLDRVLLGATK--------------------A  139 (370)
Q Consensus        93 ~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~  139 (370)
                      +..+.+++|.++     ++++++|..        ....++||||+.+++|.+++.....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666667765543     667777653        3567999999999999998853211                    1


Q ss_pred             CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCc
Q 017503          140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP  219 (370)
Q Consensus       140 ~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP  219 (370)
                      ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            12346778899999999999999999   999999999999999999999999999975543322222223347899999


Q ss_pred             ccccCCC--------------------c--CccccchhhhHHHHHHHhCCC-CCCcccccchhhHHH--HHHHHHhcCCC
Q 017503          220 EYVLGGQ--------------------L--TMKADVYSFGVLVLEIISGRN-SGKAMWGQMNKFLLE--WAWQLHQEEKP  274 (370)
Q Consensus       220 E~~~~~~--------------------~--~~~~Di~slG~il~elltg~~-p~~~~~~~~~~~~~~--~~~~~~~~~~~  274 (370)
                      |.+....                    +  ..+.||||+||++++|++|.. |+..... .+..+..  .....+.....
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~-f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRL-FNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhh-hhhHHhhccchHHHHHhhcc
Confidence            9875432                    1  134699999999999999875 5432110 1111100  00000110000


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhcc---CCCCCHHHHHHH
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAA---SRRPQMNQVIKM  317 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~evl~~  317 (370)
                      . ..+..   ..+.......+++.+|+..+|   .+|+|+.|+++.
T Consensus       459 ~-~~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        459 Q-KYDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             c-CCCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0 00111   112233446788888898765   689999999763

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=247.60  Aligned_cols=266  Identities=21%  Similarity=0.318  Sum_probs=209.4

Q ss_pred             HHHHHHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeE
Q 017503           38 YTELRSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGC  110 (370)
Q Consensus        38 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  110 (370)
                      .+++..-.++++...++-+|.||.||.|.+.      +.+.|.+|.++.. +.-+...+..|...+..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4566666788999999999999999999764      2345677776655 34456678889999999999999999999


Q ss_pred             EEe-CCeeEEEEEecCCCCHHHHhccc----ccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC
Q 017503          111 CVQ-GTRRILVYEYVENNSLDRVLLGA----TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE  185 (370)
Q Consensus       111 ~~~-~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~  185 (370)
                      +.+ ...+++++.+..-|+|..++..-    ....+.++..+...++.|++.|++|||..   ++||.||...|++|++.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            875 56778899999999999998522    22334567888889999999999999999   99999999999999999


Q ss_pred             CCeEEeeecCcccc-CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHH
Q 017503          186 FNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE  263 (370)
Q Consensus       186 ~~~kL~Dfg~~~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~  263 (370)
                      .++||+|=.+++-+ +.+..-..........||+||.+.+..|+.++|+||||++||||+| |+.|+....+.+   +..
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---m~~  509 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---MEH  509 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---HHH
Confidence            99999999998843 3333333333345678999999999999999999999999999998 666754332211   111


Q ss_pred             HHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          264 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                                  .+.|......|.+++.++..++..||...|++||+++++...|.+-
T Consensus       510 ------------ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  510 ------------YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ------------HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                        1223333345667888899999999999999999999999988764

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-34  Score=240.37  Aligned_cols=262  Identities=25%  Similarity=0.379  Sum_probs=189.0

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCCcceeeeEEEe--------C
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQ--------G  114 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~  114 (370)
                      ..|+-..++|+|.||.||+|+.+ .+++||+|++-.++.  .--....+|+.+|..++|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45667789999999999999976 477789886544322  223345679999999999999999887753        3


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      ..+|+||.+|+. +|.-++.   ....+++..++.+++.++..||.|+|..   .|+|||+|+.|+||+.+|.+||+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            457999999986 6666662   3446789999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCC---cceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHh
Q 017503          195 LAKLFPDNI---THITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ  270 (370)
Q Consensus       195 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  270 (370)
                      +++.+....   ....+....|.+|.+||.+.+ ..|+...|||..||++.||+|+.+-+.....+   ..+..+.....
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq---qql~~Is~LcG  246 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ---QQLHLISQLCG  246 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH---HHHHHHHHHhc
Confidence            998664321   112233456899999998876 57999999999999999999998765443221   11111111111


Q ss_pred             --------cCCCcccccCC----CCC----CChHHHH------HHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          271 --------EEKPLELVDPE----LGE----YPPNEII------RYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       271 --------~~~~~~~~~~~----~~~----~~~~~~~------~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                              +.....+....    ++.    ...+...      ...+|+..++..||.+|+++.+++..
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                    00000000000    100    0111111      46678888999999999999988753

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=4.7e-33  Score=225.67  Aligned_cols=208  Identities=27%  Similarity=0.430  Sum_probs=175.0

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCee
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  117 (370)
                      +....++...+..||+|++|.|-+-++. +|+..|+|.+... +.+...+.+.|+.+..+. .+|.+|++||........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            4555667777889999999999887764 7889999988765 444556677788887765 799999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++.||.++. +|+.+..+....+..+++..+-+|+..+..||.|||++.  .+||||+||+||||+.+|++|+||||.+-
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999965 888887777778889999999999999999999999986  89999999999999999999999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccC----CCcCccccchhhhHHHHHHHhCCCCCCcc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISGRNSGKAM  253 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~elltg~~p~~~~  253 (370)
                      .+.+.....  -..|-..|+|||.+..    ..|+.++||||||+++.||.+++.|++..
T Consensus       198 ~L~dSiAkt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVDSIAKT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehhhhHHH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            765543222  1246678999998743    46899999999999999999999997654

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.1e-32  Score=235.81  Aligned_cols=250  Identities=27%  Similarity=0.364  Sum_probs=193.8

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCee
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  117 (370)
                      ....+|.+.++||+|.|++|..++++ ..+-||+|+++.+   +...+.-.+.|-.+..+- +||.+|.+..+|.....+
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            34678999999999999999999975 5778999988754   223333344566666554 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++|.||++||+|--.+    +.+.+++++.+..+...|+.||.|||+.   |||+||||.+|||++.+|++||.|+|++.
T Consensus       327 ffvieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             EEEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence            9999999999986655    5667899999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCccc-ccchhhHHHHHHHHHhcCCCcc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW-GQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      .--. ....+...+||+.|.|||.+.+..|....|.|+||++++||+.|+.||+..- .+.+....++..++.-+...  
T Consensus       400 e~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--  476 (593)
T KOG0695|consen  400 EGLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--  476 (593)
T ss_pred             cCCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--
Confidence            4322 2233556789999999999999999999999999999999999999997432 12222233333333322211  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCC
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  309 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  309 (370)
                             ..|.....+...++..-|.+||++|.
T Consensus       477 -------riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 -------RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -------cccceeehhhHHHHHHhhcCCcHHhc
Confidence                   11222223344556667999999985

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=262.74  Aligned_cols=242  Identities=26%  Similarity=0.358  Sum_probs=187.4

Q ss_pred             cceeeecCCeE-EEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCCCC
Q 017503           51 SNKIGRGGFGT-VYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNS  128 (370)
Q Consensus        51 ~~~lg~G~~g~-v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  128 (370)
                      .+.+|.|..|+ ||+|... ++.||||.+-.+.   .....+|+..|+.- +||||+++++.-.+....||..|.|.. +
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s  588 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S  588 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence            35688999986 7999985 7899999876543   23556799999987 799999999999999999999999965 9


Q ss_pred             HHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC---C--CCeEEeeecCccccCCCC
Q 017503          129 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---E--FNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       129 L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~---~--~~~kL~Dfg~~~~~~~~~  203 (370)
                      |++++...........-...+.++.|+++||++||+.   +|+||||||+||||+.   +  ..++|+|||++..++.+.
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            9999954311111122245677899999999999998   9999999999999975   3  458999999999887654


Q ss_pred             cce--eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhC-CCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          204 THI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       204 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ...  .....||-+|+|||++.....+.++||||+||++|+.++| ..||........+        ..........+.+
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--------Il~~~~~L~~L~~  737 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--------ILTGNYTLVHLEP  737 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--------hhcCccceeeecc
Confidence            332  3446799999999999998888999999999999999987 7898766443221        1222222222221


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  315 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  315 (370)
                      .     .++  ...+||.+|+..+|..||++.+|+
T Consensus       738 ~-----~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  738 L-----PDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             C-----chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            1     122  678999999999999999999997

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1e-31  Score=249.14  Aligned_cols=205  Identities=24%  Similarity=0.301  Sum_probs=171.8

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .-|..++.||-|+||+|.+++.. ....||+|.+...+   .....+...|-.||..-+++-||++|..|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            45888899999999999999854 46678999887653   344556778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC-
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-  200 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~-  200 (370)
                      +|+.||++-.++.    .-.-+.+..+..++.++..|+++.|..   |+|||||||+|||||.+|++||.||||+.-+. 
T Consensus       709 dYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             eccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence            9999999988873    334578888888999999999999999   99999999999999999999999999996431 


Q ss_pred             --------CCCcce--------------------------------eecccCCCCCCCcccccCCCcCccccchhhhHHH
Q 017503          201 --------DNITHI--------------------------------TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV  240 (370)
Q Consensus       201 --------~~~~~~--------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  240 (370)
                              .+....                                .....||..|+|||++....++..+|.||.||+|
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence                    000000                                0013589999999999999999999999999999


Q ss_pred             HHHHhCCCCCCcccccc
Q 017503          241 LEIISGRNSGKAMWGQM  257 (370)
Q Consensus       241 ~elltg~~p~~~~~~~~  257 (370)
                      |||+.|++||.......
T Consensus       862 ~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHHhhCCCCccCCCCCc
Confidence            99999999997665543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=6.2e-30  Score=219.60  Aligned_cols=210  Identities=35%  Similarity=0.594  Sum_probs=181.4

Q ss_pred             eeecCCeEEEEEEECC-CCEEEEEECcCcChh-cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCHHH
Q 017503           54 IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR  131 (370)
Q Consensus        54 lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  131 (370)
                      ||+|.+|.||++...+ +..+++|.+...... ....+.+|++.++.+.|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 889999998766432 34678899999999999999999999999999999999999999999


Q ss_pred             HhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-CCCeEEeeecCccccCCCCcceeecc
Q 017503          132 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRI  210 (370)
Q Consensus       132 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~  210 (370)
                      ++....   ..+++..++.++.+++.++.+||+.   +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            984221   4688999999999999999999999   9999999999999998 89999999999986654321 12234


Q ss_pred             cCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHH
Q 017503          211 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE  289 (370)
Q Consensus       211 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (370)
                      .+...|++||.+... ..+.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            467889999998877 888999999999999998                                              


Q ss_pred             HHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          290 IIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       290 ~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                       ..+.+++..|+..+|.+||++.++++.
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             347789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.6e-31  Score=218.76  Aligned_cols=257  Identities=19%  Similarity=0.339  Sum_probs=193.2

Q ss_pred             HhccCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeC--CeeE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQG--TRRI  118 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~  118 (370)
                      ...++|++.+++|+|-++.||.|.+ .++.+++||+++.-.   ...+.+|+.+|+.|. ||||+++++...+.  ....
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            4578999999999999999999995 578899999987543   356788999999996 99999999998764  4567


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC-CCeEEeeecCcc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAK  197 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kL~Dfg~~~  197 (370)
                      +|+||+++.+...+.       ..++...+..++.+++.||.|+|+.   ||.|||+||.|++|+.. ..++|+|+|++.
T Consensus       112 LiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence            999999998777665       3578888999999999999999999   99999999999999954 569999999999


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhH-----------HHHH
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL-----------LEWA  265 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~-----------~~~~  265 (370)
                      .+........  ..-+..|--||.+.. ..|+..-|+|||||+|..|+..+.||....++.++.+           ..+.
T Consensus       182 FYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  182 FYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            8765432211  123455678998766 4578899999999999999999999876655544321           1111


Q ss_pred             HHHHhcCCC--ccc------------ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          266 WQLHQEEKP--LEL------------VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       266 ~~~~~~~~~--~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .+....-.+  ..+            +.+.-..+   ...+.++++.+.|..|-.+|||++|.+..
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl---~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHL---VSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCcccccc---CChHHHHHHHHHHhhccccccchHHHhcC
Confidence            111111000  000            00110111   12346788888999999999999998653

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-32  Score=229.63  Aligned_cols=264  Identities=23%  Similarity=0.330  Sum_probs=192.2

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----eeE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----RRI  118 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~  118 (370)
                      +.+-.+.||.|+||.||.+.+. +|+.|++|.+.+-  +-.....+.+|+.+|..++|.|++..++...-..     ..|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4456789999999999999974 7999999977643  2334567888999999999999998887764332     346


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +++|.+. .+|+..+    -....++...+.-+++||+.||+|||+.   +|.||||||.|+|++.|..+||||||+++.
T Consensus       134 V~TELmQ-SDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHH-hhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence            6777764 3677766    4566788888899999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHH--------HHHHH
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW--------AWQLH  269 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~  269 (370)
                      ...+....++....|..|.|||.+.+. .|+.+.||||.||++.||+..+.-|....+-.+-.+..-        ..+..
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            776666656666678899999998875 589999999999999999988766544322111111100        00000


Q ss_pred             hcCCCcccc-----cCCC-----CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          270 QEEKPLELV-----DPEL-----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       270 ~~~~~~~~~-----~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      -++....++     .|.+     ..-+.....+...+...++..+|++|.+..+.+..+
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            111111111     1111     011223344456667778999999999998887654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=1.3e-31  Score=243.42  Aligned_cols=269  Identities=20%  Similarity=0.237  Sum_probs=205.0

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCC------CCcceee
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRH------PNLVELI  108 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~  108 (370)
                      |.+.--+....+|.+....|+|-|++|..|.+. .|+.||||++.++. .....=+.|+++|++|+.      -|+++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            555555666899999999999999999999975 57899999998653 233455679999999952      4789999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-C
Q 017503          109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-N  187 (370)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-~  187 (370)
                      -.|...+++|||+|-+.. +|.+++.+. ..+..|....+..++.|+..||..|...   +|+|.||||+|||+++.. .
T Consensus       501 r~F~hknHLClVFE~Lsl-NLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLSL-NLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHhhhcceeEEEehhhhc-hHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence            999999999999998854 888888543 3455688999999999999999999999   999999999999999654 5


Q ss_pred             eEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 017503          188 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      +||||||.+.....+.   .+....+..|.|||++.+.+|+..-|+||.||+||||.||+..|.....   ..++.+...
T Consensus       576 LKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN---N~MLrl~me  649 (752)
T KOG0670|consen  576 LKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN---NQMLRLFME  649 (752)
T ss_pred             eeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc---HHHHHHHHH
Confidence            8999999998655432   2223345679999999999999999999999999999999976544322   111111110


Q ss_pred             ------------------HHhcC-----------------CCcccc------------cCCCCCCChHHHHHHHHHHHHc
Q 017503          268 ------------------LHQEE-----------------KPLELV------------DPELGEYPPNEIIRYMKVAFFC  300 (370)
Q Consensus       268 ------------------~~~~~-----------------~~~~~~------------~~~~~~~~~~~~~~l~~li~~c  300 (370)
                                        .+...                 .+...+            .+.+.+..+..+..+++|+..|
T Consensus       650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm  729 (752)
T KOG0670|consen  650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM  729 (752)
T ss_pred             hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence                              00000                 000001            1123344456677799999999


Q ss_pred             hhhccCCCCCHHHHHH
Q 017503          301 TQAAASRRPQMNQVIK  316 (370)
Q Consensus       301 l~~~p~~RPt~~evl~  316 (370)
                      +..||.+|.|..+.|+
T Consensus       730 l~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  730 LILDPEKRITVNQALK  745 (752)
T ss_pred             hccChhhcCCHHHHhc
Confidence            9999999999998875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=218.69  Aligned_cols=253  Identities=17%  Similarity=0.289  Sum_probs=186.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEE-EeCCeeEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCC-VQGTRRILVY  121 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~~~lv~  121 (370)
                      .+.|.|.+.||+|.||.+-+++++ .++.+++|.+..... ...+|.+|...--.| .|.||+.-|++. ...+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            478999999999999999999987 577899998765533 356788888776666 589999888764 4556677899


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC--CCCCeEEeeecCcccc
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD--QEFNPKIGDFGLAKLF  199 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~--~~~~~kL~Dfg~~~~~  199 (370)
                      ||++.|+|..-+.     ...+.+....+++.|+++||.|+|++   +++|||||.+||||-  +...+||||||+.+..
T Consensus       102 E~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  102 EFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence            9999999988772     23577788889999999999999999   999999999999994  3346999999998854


Q ss_pred             CCCCcceeecccCCCCCCCcccccC---C--CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLG---G--QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~---~--~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      +...    ....-+..|.+||....   +  ...+.+|+|.||+++|.++||++||+..+..+.....   +..+.....
T Consensus       174 g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~---~~~w~~rk~  246 (378)
T KOG1345|consen  174 GTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE---WEQWLKRKN  246 (378)
T ss_pred             Ccee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH---HHHHhcccC
Confidence            4322    22234567999997633   2  3468899999999999999999999866554444332   222222222


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      .     .++.........++++.++-+..+|++|=-..++-+..
T Consensus       247 ~-----~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  247 P-----ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             c-----cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            2     22222223334477788888999999995444444433

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-29  Score=229.22  Aligned_cols=132  Identities=29%  Similarity=0.463  Sum_probs=109.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-----C---CCcceeeeEEEe--
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-----H---PNLVELIGCCVQ--  113 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~--  113 (370)
                      .++|.++++||+|.|++||++.+. +.+.||+|+.+.. ....+....||.+|++++     |   .+||++++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            379999999999999999999975 5778999988754 233456678999999872     3   469999999974  


Q ss_pred             --CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe
Q 017503          114 --GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL  182 (370)
Q Consensus       114 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill  182 (370)
                        +.+.++|+|++ |.+|-.+|..  .....++...+..|++||+.||.|||..+  +|||.||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence              56889999999 4477777743  34456888999999999999999999987  99999999999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.6e-29  Score=218.70  Aligned_cols=198  Identities=34%  Similarity=0.517  Sum_probs=171.8

Q ss_pred             CcccceeeecCCeEEEEEEECC-CCEEEEEECcCcChh-cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecC
Q 017503           48 FHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE  125 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  125 (370)
                      |.+.+.||.|++|.||++...+ +..+++|.+...... ....+.+|++.++.++|+|++++++++......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5678999999999999999874 889999998876544 56788899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCcc-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          126 NNSLDRVLLGATKANIK-LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       126 ~~~L~~~~~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      +++|.+++..    ... +++..+..++.+++.++.+||+.   +++|+||+|.||+++.++.++|+|||.+........
T Consensus        81 ~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       81 GGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             CCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            9999999843    223 78999999999999999999999   999999999999999999999999999987655421


Q ss_pred             ceeecccCCCCCCCcccc-cCCCcCccccchhhhHHHHHHHhCCCCCCc
Q 017503          205 HITTRIAGTTGYLAPEYV-LGGQLTMKADVYSFGVLVLEIISGRNSGKA  252 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~elltg~~p~~~  252 (370)
                      .......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            122334567889999988 667788899999999999999999999844

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=249.03  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=202.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++...+|.|.||.||+++++ .+...|+|+++.+......-+.+|+-+++..+||||+.+++.+...+.+++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            578999999999999999999975 6888999999988777778888899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      |.+|+|++..    .-...+++-++..+.++.+.|++|||+.   +-+|||||-.||++++.|.+||+|||.+-.+....
T Consensus        94 cgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   94 CGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             cCCCccccee----eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh
Confidence            9999999876    3456789999999999999999999999   88999999999999999999999999987654332


Q ss_pred             cceeecccCCCCCCCcccc---cCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          204 THITTRIAGTTGYLAPEYV---LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      . ......||+.|||||+.   ..+.|...+|||++|+...|+-.-++|-....+.-+-.+.       .    ...+++
T Consensus       167 ~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-------T----kS~~qp  234 (829)
T KOG0576|consen  167 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-------T----KSGFQP  234 (829)
T ss_pred             h-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-------h----ccCCCC
Confidence            2 23446799999999976   4567899999999999999998877774333221111111       1    111222


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI  315 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  315 (370)
                      .-......-...+-++++.|+..+|++||+++.++
T Consensus       235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             CcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            11111122223366777779999999999988765

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=240.27  Aligned_cols=197  Identities=25%  Similarity=0.353  Sum_probs=167.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh---hcHH-----HHHHHHHHHHhcC---CCCcceeeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK---QGVR-----EFITEIMTLSNVR---HPNLVELIGCCV  112 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~---~~~~-----~~~~e~~~l~~l~---h~~iv~~~~~~~  112 (370)
                      ..+|+..+.||.|+||.|+.+.++ +...|+||.+..+.-   .+.+     .+-.|+.+|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            457999999999999999999987 456689998765421   1111     1346999999996   999999999999


Q ss_pred             eCCeeEEEEEecC-CCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEe
Q 017503          113 QGTRRILVYEYVE-NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG  191 (370)
Q Consensus       113 ~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~  191 (370)
                      +++..|++||.-. +.+|.+++    ..+..+++.++..|+.|++.|+++||+.   +|+|||||-+||.++.+|-+||+
T Consensus       640 ddd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence            9999999999764 44888888    5667899999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCcceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCC
Q 017503          192 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGK  251 (370)
Q Consensus       192 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~  251 (370)
                      |||.+.....+   ......||..|.|||++.+.+| +..-|||++|++||.++...+||.
T Consensus       713 dfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99998765443   2445679999999999998877 577899999999999998888864

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=6e-30  Score=220.34  Aligned_cols=261  Identities=25%  Similarity=0.298  Sum_probs=192.1

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC------
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------  114 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------  114 (370)
                      ...+|.-.+.+|.|.- .|..+.+. .++.||+|.....  +....+...+|+..+..++|+||++++.++.-.      
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3567888889999988 66666653 6888999976543  344566777899999999999999999998643      


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      ...|+|||++.. +|.+.+.      ..++-+.+..++.|++.|++|||+.   +|+||||||+||++..++.+||.|||
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence            356899999965 8888773      4577888999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcc--cccchh----------h--
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM--WGQMNK----------F--  260 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~--~~~~~~----------~--  260 (370)
                      +++.-...  ...+....+..|.|||++.+-.+.+.+||||+||++.||++|+.-|...  .++..+          .  
T Consensus       164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  164 LARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            99854433  3455567788999999998888999999999999999999998644321  111100          0  


Q ss_pred             --HHHHHHHHHhcCC------Cccc-ccCCC---CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          261 --LLEWAWQLHQEEK------PLEL-VDPEL---GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       261 --~~~~~~~~~~~~~------~~~~-~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                        +...+........      ..++ .|...   .+.++-....+.+++.+||-.+|++|.++.++|..
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence              1111111111000      0000 01111   12223344457789999999999999999999874

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-27  Score=216.77  Aligned_cols=270  Identities=21%  Similarity=0.275  Sum_probs=201.3

Q ss_pred             CCcccceeeecCCeEEEEEEECCC--CEEEEEECcCcChhcHHHHHHHHHHHHhcCC----CCcceeeeEE-EeCCeeEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLTNG--RRIAVKPLSAESKQGVREFITEIMTLSNVRH----PNLVELIGCC-VQGTRRIL  119 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h----~~iv~~~~~~-~~~~~~~l  119 (370)
                      +|.+.+.||+|+||.||.+.....  ..+|+|............+..|+.++..+..    +++..+++.+ ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999997653  4789998776533322366778888888862    6899999998 47778899


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC-----CCeEEeeec
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-----FNPKIGDFG  194 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~-----~~~kL~Dfg  194 (370)
                      ||+.+ |.+|.++.....  ...++..++++++.|++.+|++||+.   |++||||||.|+++...     ..++|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99987 669999874333  56799999999999999999999999   99999999999999755     359999999


Q ss_pred             Ccc--ccCCCCcc------e-eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHH
Q 017503          195 LAK--LFPDNITH------I-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA  265 (370)
Q Consensus       195 ~~~--~~~~~~~~------~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~  265 (370)
                      +++  .+......      . .....||..|.++..+.+...+.+.|+||+++++.+|+.|..||..........-..  
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~--  250 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE--  250 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH--
Confidence            998  43222211      1 123459999999999999999999999999999999999999986654332211111  


Q ss_pred             HHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCccccCCCC
Q 017503          266 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG  333 (370)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~p~  333 (370)
                       .....    ..... .....+.+...+...   +-..+...+|.+..+...|+............|.
T Consensus       251 -~~~~~----~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~  309 (322)
T KOG1164|consen  251 -KDPRK----LLTDR-FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPF  309 (322)
T ss_pred             -HHhhh----hcccc-ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCC
Confidence             10100    01110 233344544444444   5558999999999999999888775533333343

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.2e-27  Score=213.27  Aligned_cols=264  Identities=25%  Similarity=0.354  Sum_probs=195.8

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC----CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCC
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGT  115 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  115 (370)
                      +....+.|.++.+||.|.|+.||++.+.    .+..||+|.+.....  -..+.+|++.|..+ .+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            4445678999999999999999999853    467899998876532  35678899999998 6899999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-CCCeEEeeec
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFG  194 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kL~Dfg  194 (370)
                      ...+|+||++.....++..       .++...+..+++.++.||+++|.+   ||+||||||+|+|.+. -+.-.|+|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            9999999999999988872       467888999999999999999999   9999999999999984 4568999999


Q ss_pred             CccccCCC--------------C-----------------------------cceeecccCCCCCCCcccccC-CCcCcc
Q 017503          195 LAKLFPDN--------------I-----------------------------THITTRIAGTTGYLAPEYVLG-GQLTMK  230 (370)
Q Consensus       195 ~~~~~~~~--------------~-----------------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~  230 (370)
                      ++......              .                             ........||++|.|||++.. ...+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            99721000              0                             000112459999999998866 457899


Q ss_pred             ccchhhhHHHHHHHhCCCCCCcccccchhhHH-----------HHHH---H--HHhcC-------------CC-cccccC
Q 017503          231 ADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL-----------EWAW---Q--LHQEE-------------KP-LELVDP  280 (370)
Q Consensus       231 ~Di~slG~il~elltg~~p~~~~~~~~~~~~~-----------~~~~---~--~~~~~-------------~~-~~~~~~  280 (370)
                      .||||.|+++..+++++.||.....+......           ..+.   .  .+...             .. .+.+.+
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            99999999999999999998655443322110           0000   0  00000             00 000000


Q ss_pred             ------CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          281 ------ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       281 ------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                            .........+..+.+++.+|++.||.+|.|+++.|+
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                  011111223336789999999999999999999976

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=4e-28  Score=248.36  Aligned_cols=195  Identities=16%  Similarity=0.205  Sum_probs=135.7

Q ss_pred             hcCC-CCcceeeeEE-------EeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 017503           98 NVRH-PNLVELIGCC-------VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH  169 (370)
Q Consensus        98 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~  169 (370)
                      .++| +||++++++|       .+...+++++|++ +++|.+++..   ....+++..++.++.||+.||.|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            4455 5777777776       2334567788877 5599999842   234589999999999999999999999   9


Q ss_pred             eEeecCCCCceEeCCCCC-------------------eEEeeecCccccCCCC---------------cceeecccCCCC
Q 017503          170 IVHRDIKASNILLDQEFN-------------------PKIGDFGLAKLFPDNI---------------THITTRIAGTTG  215 (370)
Q Consensus       170 iiH~dlkp~Nill~~~~~-------------------~kL~Dfg~~~~~~~~~---------------~~~~~~~~~~~~  215 (370)
                      |+||||||+||||+..+.                   +|++|||+++......               ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999965444                   5555555554321100               000111357888


Q ss_pred             CCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHH
Q 017503          216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK  295 (370)
Q Consensus       216 y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  295 (370)
                      |+|||++.+..++.++|||||||+||||++|.+|+.....    ....    ....     ...+..    .........
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~----~~~~-----~~~~~~----~~~~~~~~~  243 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSS----LRHR-----VLPPQI----LLNWPKEAS  243 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHH----HHHh-----hcChhh----hhcCHHHHH
Confidence            9999999999999999999999999999998877542111    0100    0000     011110    111233567


Q ss_pred             HHHHchhhccCCCCCHHHHHH
Q 017503          296 VAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       296 li~~cl~~~p~~RPt~~evl~  316 (370)
                      ++.+||+.+|.+||++.+|++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            788899999999999999975

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1e-25  Score=195.17  Aligned_cols=264  Identities=20%  Similarity=0.296  Sum_probs=206.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .-.|.+.++||+|.||.++.|++ -+++.||||.....+.  ...+..|.+..+.| ..++|..++.+..++.+-.+|+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            34699999999999999999995 4789999997654432  35666788888888 57999999988888888899999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-----CeEEeeecCcc
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-----NPKIGDFGLAK  197 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-----~~kL~Dfg~~~  197 (370)
                      .+ |.+|++++.   .-+..++.++++.+|.|++.-++|+|++   .+|+|||||+|+||..-+     .+.++|||++.
T Consensus       105 LL-GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  105 LL-GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hh-CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            88 668988873   4567899999999999999999999999   999999999999996433     48999999999


Q ss_pred             ccCCCCcce------eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc
Q 017503          198 LFPDNITHI------TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       198 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      .+.+..+..      .....||.+||+-..+.+.+.+.+.|+-|||-++++.|-|..||.......++.-.+.+....+.
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~  257 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS  257 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence            876654332      23456999999999999999999999999999999999999999887665555444433322222


Q ss_pred             CCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      ..+.++     ....|++....+..   .-..+-.+-|.+.-+...+..++...
T Consensus       258 T~i~~L-----c~g~P~efa~Yl~y---vR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  258 TPIEVL-----CEGFPEEFATYLRY---VRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             CCHHHH-----HhcCHHHHHHHHHH---HHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            222111     22234555555555   44557788899998888888777644

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=1.6e-26  Score=193.93  Aligned_cols=169  Identities=22%  Similarity=0.206  Sum_probs=126.3

Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      |+|.+++.   ..+..+++..++.++.|++.||.|||+.   +      ||+||+++.++.+++  ||++.......   
T Consensus         1 GsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILE---VRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            68888884   2245699999999999999999999998   6      999999999999999  99988654322   


Q ss_pred             eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCC
Q 017503          207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP  286 (370)
Q Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (370)
                         ..|++.|+|||++.+..++.++|||||||++|||++|..||....... ..+..    ........   ++.....+
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~----~~~~~~~~---~~~~~~~~  132 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEI----LLNGMPAD---DPRDRSNL  132 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHH----HHHHhccC---CccccccH
Confidence               257899999999999999999999999999999999999986432211 11111    11111110   00001111


Q ss_pred             hHHHH--HHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          287 PNEII--RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       287 ~~~~~--~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      .....  .+.+++.+||..+|.+||++.++++.+.....
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            22222  58899999999999999999999998876643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=6.7e-26  Score=188.28  Aligned_cols=262  Identities=19%  Similarity=0.297  Sum_probs=200.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCC-CCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .+.|.++++||+|+||.+|.|.. .+|..||||+-......  ..+..|..+.+.|.+ ..|..+..++.+...-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            57899999999999999999995 68999999987665433  456668888888864 678888888889999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC---CCeEEeeecCcccc
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAKLF  199 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kL~Dfg~~~~~  199 (370)
                      .+ |.+|++++.   --...++.++++-++-|++.-++|+|..   +++||||||+|+|..-+   ..+.|+|||++..+
T Consensus        92 LL-GPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence            88 669998873   2345688999999999999999999999   99999999999999643   45899999999977


Q ss_pred             CCCCcc------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          200 PDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       200 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      .+..+.      ......||.+|.+-..+.+...+.+.|+-|+|++|.++.-|..||+.........-.+.+.+...   
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~---  241 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM---  241 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc---
Confidence            554322      23346699999999988888899999999999999999999999987765444333332222111   


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                       ...+......+|    .++.-.+.-|-...-++-|...-+.+...-+.+
T Consensus       242 -s~~ie~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  242 -STPIEVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             -CCCHHHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence             111111112333    335555555888888999998877766655544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=7e-25  Score=201.39  Aligned_cols=168  Identities=21%  Similarity=0.225  Sum_probs=130.3

Q ss_pred             HHHHhccCCcccceeeecCCeEEEEEEEC--CCCEEEEEECcCc-----ChhcHHHHHHHHHHHHhcCCCCcceeeeEEE
Q 017503           40 ELRSATDDFHLSNKIGRGGFGTVYKGTLT--NGRRIAVKPLSAE-----SKQGVREFITEIMTLSNVRHPNLVELIGCCV  112 (370)
Q Consensus        40 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~--~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  112 (370)
                      ......++|++.+.||+|+||+||+|.++  +++.||||.+...     .......+.+|+++|++++|+|+++.+..  
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--   89 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--   89 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence            34556789999999999999999999875  5777899976432     22234568899999999999999853322  


Q ss_pred             eCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecC-CCCceEeCCCCCeEEe
Q 017503          113 QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI-KASNILLDQEFNPKIG  191 (370)
Q Consensus       113 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dl-kp~Nill~~~~~~kL~  191 (370)
                       ....++||||+++++|....    ..+       ...++.|++.||.|||+.   +|+|||| ||+|||++.++.++|+
T Consensus        90 -~~~~~LVmE~~~G~~L~~~~----~~~-------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHLAR----PHG-------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             -cCCcEEEEEccCCCCHHHhC----ccc-------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEE
Confidence             24579999999999996321    111       146788999999999999   9999999 9999999999999999


Q ss_pred             eecCccccCCCCcce-------eecccCCCCCCCcccccC
Q 017503          192 DFGLAKLFPDNITHI-------TTRIAGTTGYLAPEYVLG  224 (370)
Q Consensus       192 Dfg~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~  224 (370)
                      |||++..+.......       -....+++.|++||.+..
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999999765432111       124567788999998754

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.9e-25  Score=186.87  Aligned_cols=248  Identities=22%  Similarity=0.386  Sum_probs=184.1

Q ss_pred             cccceeeecCCeEEEEEEECCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           49 HLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        49 ~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      .+..+|.+...|..|+|+++ |..++.|++...  .....+.|..|.-.|+.+.||||+++++.|.....+.++..|++.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            45567888999999999997 456666766544  333456788899999999999999999999999999999999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEe--eecCccccCCCCc
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG--DFGLAKLFPDNIT  204 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~--Dfg~~~~~~~~~~  204 (370)
                      |+|...++.  ..+...+..++.+++..++.|++|||+..+ -|..-.|++..|+|+++.+++|.  |-.++.       
T Consensus       272 gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsf-------  341 (448)
T KOG0195|consen  272 GSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSF-------  341 (448)
T ss_pred             hHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeee-------
Confidence            999999954  445567788899999999999999999752 34445789999999999887765  322211       


Q ss_pred             ceeecccCCCCCCCcccccCCCcC---ccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLT---MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~---~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                       ......-.+.|++||.++..+-+   .++|+|||+++||||.|...||....+-      +...+..     .+-+.. 
T Consensus       342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm------ecgmkia-----leglrv-  408 (448)
T KOG0195|consen  342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM------ECGMKIA-----LEGLRV-  408 (448)
T ss_pred             -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch------hhhhhhh-----hccccc-
Confidence             11112345789999999876543   6799999999999999999998754331      1111111     122222 


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                        ..|+.....+.+|+.-|+..||.+||.+..|+-.|++..
T Consensus       409 --~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  409 --HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence              223333334555555599999999999999999888753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=4.4e-22  Score=182.42  Aligned_cols=260  Identities=29%  Similarity=0.410  Sum_probs=196.6

Q ss_pred             CcccceeeecCCeEEEEEEECCCCEEEEEECcCcChh---cHHHHHHHHHHHHhcCCC-CcceeeeEEEeCCeeEEEEEe
Q 017503           48 FHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQ---GVREFITEIMTLSNVRHP-NLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      |.+.+.||.|+|+.||.+...  ..+++|.+......   ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            778899999999999999987  78899988765332   367788999999999888 799999999777778999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-CeEEeeecCccccCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDN  202 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~  202 (370)
                      +.++++.+++...... ..+.......++.|++.++.++|..   +++|||+||+||+++..+ .++++|||.+......
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999776322111 3688899999999999999999999   999999999999999988 6999999999865543


Q ss_pred             Ccc-----eeecccCCCCCCCcccccC---CCcCccccchhhhHHHHHHHhCCCCCCccccc-chhhHHHHHHHHHhcCC
Q 017503          203 ITH-----ITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ-MNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       203 ~~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~  273 (370)
                      ...     ......++..|++||.+.+   .......|+|++|++++++++|..|+...... .........    ....
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~  231 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII----LELP  231 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH----HhcC
Confidence            322     2345678999999999887   57889999999999999999999996544321 011111111    1111


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...................+.+++..|+..+|..|.+..+....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            10000000000012223457788888999999999998887764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1e-23  Score=180.54  Aligned_cols=170  Identities=16%  Similarity=0.180  Sum_probs=133.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHH---H------HHHHHHHHHhcCCCCcceeeeEEEeC-
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVR---E------FITEIMTLSNVRHPNLVELIGCCVQG-  114 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~---~------~~~e~~~l~~l~h~~iv~~~~~~~~~-  114 (370)
                      .++|++.++||.|+||.||.+.. ++..+|+|++.........   .      +.+|+..+.++.|++|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            68999999999999999999766 5778999998755322222   2      57899999999999999999886643 


Q ss_pred             -------CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          115 -------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       115 -------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                             ...+++|||++|.+|.++.        .++.    ....+++.+|..+|..   |++|||++|+||+++.++ 
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence                   3578999999999998774        1222    2456999999999999   999999999999999888 


Q ss_pred             eEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHH
Q 017503          188 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII  244 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  244 (370)
                      ++|+|||...........             ..+.....+..++|+|+||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999988755322111             00234445667999999999987664

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=3e-24  Score=209.76  Aligned_cols=254  Identities=22%  Similarity=0.293  Sum_probs=185.1

Q ss_pred             cccceeeecCCeEEEEEEEC-CCCEEEEEECc-----CcCh-hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           49 HLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLS-----AESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        49 ~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~-----~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .....+|.|.+|.|+..... ....++.|.+.     .... +....+..|+.+-..++|+|++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999977766543 22223333221     1111 11122556777777889999988877776666666669


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      |||++ +|..++    .....++..++..++.|++.|++|+|+.   |+.|||+|++|+++..+|.+||+|||.+..+..
T Consensus       401 E~~~~-Dlf~~~----~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLV----MSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHH----hcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 998888    3345688899999999999999999999   999999999999999999999999999987654


Q ss_pred             CCc---ceeecccCCCCCCCcccccCCCcC-ccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          202 NIT---HITTRIAGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       202 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ...   .......|+-.|+|||++.+..|+ ...||||.|++++.|.+|+.||......++...      ..........
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------~~~~~~~~~~  546 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------TNNYSDQRNI  546 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------hhcccccccc
Confidence            322   344567789999999999999987 567999999999999999999988766655430      0000000011


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      . ..........+..-..++.+||+.+|.+|.|+++|++.
T Consensus       547 ~-~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  547 F-EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             c-cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            0 01111222333446778888999999999999999763

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=3.3e-24  Score=210.52  Aligned_cols=262  Identities=21%  Similarity=0.245  Sum_probs=186.8

Q ss_pred             cccCHHHHHHhcc-CCcccceeeecCCeEEEEEEECCCCEEEEEECcCcC-hhcHHHHHHHHHHHH--hcCCCCcceeee
Q 017503           34 NHFSYTELRSATD-DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES-KQGVREFITEIMTLS--NVRHPNLVELIG  109 (370)
Q Consensus        34 ~~~~~~~~~~~~~-~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~--~l~h~~iv~~~~  109 (370)
                      +...++.+..... +|...+.||.+.|=+|.++++.+|. |+||++-..+ ....+.+.++++-.+  .+++||.+++..
T Consensus        10 Qi~~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk   88 (1431)
T KOG1240|consen   10 QISPVEVYFSDLSVECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQK   88 (1431)
T ss_pred             ccchHHHHhhcCccceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHH
Confidence            3344555555444 7888999999999999999998776 8899876554 444555555544444  458999999988


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeE
Q 017503          110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK  189 (370)
Q Consensus       110 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  189 (370)
                      +.......|+|-+|... +|.+.+    ....-+...+...|+.|++.||..+|..   ||+|||||.+||||+.-+.+.
T Consensus        89 ~~~t~kAAylvRqyvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~  160 (1431)
T KOG1240|consen   89 VLVTDKAAYLVRQYVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLY  160 (1431)
T ss_pred             HHHhhHHHHHHHHHHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhh
Confidence            87777778888898866 787777    2333467778888999999999999999   999999999999999999999


Q ss_pred             EeeecCcccc--CCCCcce----eecccCCCCCCCcccccC----------CC-cCccccchhhhHHHHHHHh-CCCCCC
Q 017503          190 IGDFGLAKLF--PDNITHI----TTRIAGTTGYLAPEYVLG----------GQ-LTMKADVYSFGVLVLEIIS-GRNSGK  251 (370)
Q Consensus       190 L~Dfg~~~~~--~~~~~~~----~~~~~~~~~y~aPE~~~~----------~~-~~~~~Di~slG~il~ellt-g~~p~~  251 (370)
                      |+||..-+..  +.+++..    ..+...-.+|.|||.+..          .. ++++.||||+||++.||++ |.++|.
T Consensus       161 LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  161 LTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             hhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            9999887632  3333222    222333458999998743          12 6789999999999999987 577764


Q ss_pred             cccccchhhHHHHHHH-HHhcCCCc-ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          252 AMWGQMNKFLLEWAWQ-LHQEEKPL-ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       252 ~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      ..     + +..+-.. ....+..+ .+.|.           .+.+++..|++.||.+|.++++.|+....+
T Consensus       241 LS-----Q-L~aYr~~~~~~~e~~Le~Ied~-----------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  241 LS-----Q-LLAYRSGNADDPEQLLEKIEDV-----------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             HH-----H-HHhHhccCccCHHHHHHhCcCc-----------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            22     1 1111000 00000000 11111           377889999999999999999998875443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.8e-22  Score=170.67  Aligned_cols=141  Identities=18%  Similarity=0.203  Sum_probs=109.0

Q ss_pred             ccceeeecCCeEEEEEEECCCCEEEEEECcCcChh--c------------------------HHHHHHHHHHHHhcCCCC
Q 017503           50 LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQ--G------------------------VREFITEIMTLSNVRHPN  103 (370)
Q Consensus        50 ~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~  103 (370)
                      +...||+|++|.||+|...+|+.||+|+++.....  .                        ......|+..+.++.+++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            35789999999999999888999999988654210  0                        012235899999998777


Q ss_pred             cceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEeecCCCCceEe
Q 017503          104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL-HEELVPHIVHRDIKASNILL  182 (370)
Q Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~iiH~dlkp~Nill  182 (370)
                      +.....+..  ...++||||++++++.....    ....++...+..++.|++.+|.++ |+.   +|+||||||+||++
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli  151 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLY  151 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence            644333222  23389999999987765431    234688999999999999999999 688   99999999999999


Q ss_pred             CCCCCeEEeeecCccccC
Q 017503          183 DQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       183 ~~~~~~kL~Dfg~~~~~~  200 (370)
                      + ++.++|+|||++....
T Consensus       152 ~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         152 H-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             E-CCcEEEEEccccccCC
Confidence            8 4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2.3e-21  Score=164.46  Aligned_cols=142  Identities=19%  Similarity=0.251  Sum_probs=110.9

Q ss_pred             ccceeeecCCeEEEEEEECCCCEEEEEECcCcChh---------------------c-----HHHHHHHHHHHHhcCCCC
Q 017503           50 LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQ---------------------G-----VREFITEIMTLSNVRHPN  103 (370)
Q Consensus        50 ~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~~  103 (370)
                      +...||+|++|.||+|.+.+|+.||||++......                     .     ......|...+.++.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            46789999999999999878999999987754211                     0     112356889999999888


Q ss_pred             cceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEe
Q 017503          104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILL  182 (370)
Q Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill  182 (370)
                      +.....+...  ..++||||++++++.....    ....++...+..++.|++.++.++|+ .   |++||||||+||++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            7544433332  2489999999885543321    22357788899999999999999999 8   99999999999999


Q ss_pred             CCCCCeEEeeecCccccCC
Q 017503          183 DQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       183 ~~~~~~kL~Dfg~~~~~~~  201 (370)
                      + ++.++|+|||++.....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            8 88999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=2.8e-21  Score=170.44  Aligned_cols=234  Identities=19%  Similarity=0.217  Sum_probs=149.6

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCC----------CCcceeeeEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRH----------PNLVELIGCCV  112 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~~iv~~~~~~~  112 (370)
                      .+.....||.|+++.||.+.+. +++.+|+|++....   ....+.+.+|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4456789999999999999986 58999999875442   2345566666544444322          12333333332


Q ss_pred             e---------C---C-----eeEEEEEecCCCCHHHHhc---ccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 017503          113 Q---------G---T-----RRILVYEYVENNSLDRVLL---GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH  172 (370)
Q Consensus       113 ~---------~---~-----~~~lv~e~~~~~~L~~~~~---~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH  172 (370)
                      -         .   .     ..+++|+.+ .++|..++.   ........+....++.+..|++..+++||..   |++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence            1         1   1     235677777 447877652   1122233455666777889999999999999   9999


Q ss_pred             ecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccC--------CCcCccccchhhhHHHHHHH
Q 017503          173 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--------GQLTMKADVYSFGVLVLEII  244 (370)
Q Consensus       173 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell  244 (370)
                      +||+|+|++++.+|.++|+||+........    ......+..|.+||....        -.++.+.|.|+||++||.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999887754332    111234577999996633        25788999999999999999


Q ss_pred             hCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCC
Q 017503          245 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR  308 (370)
Q Consensus       245 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  308 (370)
                      ++..||...........                   .+..+. +.+..+..||..+|+.+|.+|
T Consensus       245 C~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999876543322111                   223333 777779999999999999987

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=5.6e-21  Score=178.89  Aligned_cols=217  Identities=27%  Similarity=0.387  Sum_probs=164.4

Q ss_pred             HHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe-Eeec
Q 017503           96 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI-VHRD  174 (370)
Q Consensus        96 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i-iH~d  174 (370)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.   .....+++.....+.+.++.||.|||..   .+ .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~---~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILS---NEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHh---ccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            356899999999999999999999999999999999984   3566789999999999999999999998   44 9999


Q ss_pred             CCCCceEeCCCCCeEEeeecCccccCCC-CcceeecccCCCCCCCcccccCC-------CcCccccchhhhHHHHHHHhC
Q 017503          175 IKASNILLDQEFNPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVLGG-------QLTMKADVYSFGVLVLEIISG  246 (370)
Q Consensus       175 lkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~elltg  246 (370)
                      +++.|++++....+||.|||+....... .........-..-|.|||.+...       ..+.+.||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999999876431 01111111234579999988663       146789999999999999999


Q ss_pred             CCCCCcccccchh-hHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          247 RNSGKAMWGQMNK-FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       247 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      ..||......... .+...+   ..  .....+.|.+.... +....+..++..||..+|.+||++..|...+..+...
T Consensus       155 ~~~~~~~~~~~~~~eii~~~---~~--~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRV---KK--GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cCccccccccCChHHHHHHH---Hh--cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9999865444332 222221   11  11112222221111 3333588899999999999999999998888776653

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.7e-20  Score=157.44  Aligned_cols=183  Identities=17%  Similarity=0.139  Sum_probs=138.1

Q ss_pred             cccceeeecCCeEEEEEEECCCCEEEEEECcCcChh----cHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEEEEEe
Q 017503           49 HLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQ----GVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        49 ~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .+...|+.|+||+||.+.. .+.+++.+.+......    ....+.+|+++|+++. |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4568899999999997765 5788887777655321    1225788999999995 5889999886    346899999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecC-CCCceEeCCCCCeEEeeecCccccCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI-KASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dl-kp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      +.|.+|.....    .       ....++.|++.+|.++|+.   ||+|||| ||.|||++.++.++|+|||++......
T Consensus        80 I~G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPP----R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhh----h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            99999875431    1       1134788999999999999   9999999 799999999999999999999865443


Q ss_pred             Ccc----e--------eecccCCCCCCCcccccCC-CcC-ccccchhhhHHHHHHHhCCCCC
Q 017503          203 ITH----I--------TTRIAGTTGYLAPEYVLGG-QLT-MKADVYSFGVLVLEIISGRNSG  250 (370)
Q Consensus       203 ~~~----~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~Di~slG~il~elltg~~p~  250 (370)
                      ...    .        ......++.|++|+...-. ..+ .+.+.++.|+.+|.++|+..+.
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            211    0        0112256778888755432 333 5678889999999999998763

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.2e-20  Score=188.34  Aligned_cols=253  Identities=19%  Similarity=0.224  Sum_probs=183.5

Q ss_pred             HHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcC---CCCcceeeeEEEeCCe
Q 017503           40 ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR---HPNLVELIGCCVQGTR  116 (370)
Q Consensus        40 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~  116 (370)
                      +++...+.|.|.+.||+|+||+||+|...+|+.||+|+-+..+....--   -.+++.+|+   -+.|.++.....-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI---~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI---CLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee---hHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            4455578899999999999999999998889999999877654421110   122333333   3456677777777778


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-------CCCeE
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-------EFNPK  189 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-------~~~~k  189 (370)
                      -++|+||.+.|+|.+++.    ....++|..++.+..|++..++.||..   +||||||||+|+||..       +..++
T Consensus       769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence            899999999999999994    666789999999999999999999999   9999999999999932       34489


Q ss_pred             EeeecCccccCC-CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH
Q 017503          190 IGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       190 L~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      |+|||.+--+.- .........++|-.+-.+|+..+.+++...|.|.|+-+++-||.|+..                .  
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------------q--  903 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------------E--  903 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------------H--
Confidence            999999864421 122344556788899999999999999999999999999999998531                1  


Q ss_pred             HhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      ..++... .++..++.+...  .-+-+++..+|..+-..=|...++...|++.+.
T Consensus       904 ~~~g~~~-~~~~~~~Ry~~~--~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  904 VKNGSSW-MVKTNFPRYWKR--DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             hcCCcce-eccccchhhhhH--HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence            1111111 111111111111  113455555776454455888888888877764

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=8.2e-21  Score=168.63  Aligned_cols=197  Identities=22%  Similarity=0.301  Sum_probs=140.0

Q ss_pred             CCCCcceeeeEEEe---------------------------CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHH
Q 017503          100 RHPNLVELIGCCVQ---------------------------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC  152 (370)
Q Consensus       100 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~  152 (370)
                      .|||||++.+.|.+                           ...+|+||..++. +|..++.     ....+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHH
Confidence            59999999887753                           2246899988755 8999882     3345667777789


Q ss_pred             HHHHHHHHHHhhcCCCCeEeecCCCCceEeC--CCC--CeEEeeecCccccCCC-----CcceeecccCCCCCCCccccc
Q 017503          153 VGIAKGLAFLHEELVPHIVHRDIKASNILLD--QEF--NPKIGDFGLAKLFPDN-----ITHITTRIAGTTGYLAPEYVL  223 (370)
Q Consensus       153 ~qi~~al~~LH~~~~~~iiH~dlkp~Nill~--~~~--~~kL~Dfg~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~  223 (370)
                      .|+++|+.|||.+   ||.|||+|++|||+.  +++  .+.|+|||++-.....     .........|+-..||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   999999999999994  332  4799999998643321     111122345777889999875


Q ss_pred             CCC------cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHH
Q 017503          224 GGQ------LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA  297 (370)
Q Consensus       224 ~~~------~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  297 (370)
                      ..+      --.++|.|+.|.+.||+++..+||... +.+.  + +.          ....+..++..+..++..+.+++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~--L-~~----------r~Yqe~qLPalp~~vpp~~rqlV  490 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEML--L-DT----------RTYQESQLPALPSRVPPVARQLV  490 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc-chhe--e-ch----------hhhhhhhCCCCcccCChHHHHHH
Confidence            432      236899999999999999999998641 1000  0 00          00112234455555666688899


Q ss_pred             HHchhhccCCCCCHHHHHHHHH
Q 017503          298 FFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       298 ~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ...++.||.+|++..=....|.
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            9999999999998765555554

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=1e-19  Score=155.40  Aligned_cols=136  Identities=15%  Similarity=0.195  Sum_probs=104.7

Q ss_pred             cccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhc-----CCCCcceeeeEEEeCC---e-eEE
Q 017503           49 HLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-----RHPNLVELIGCCVQGT---R-RIL  119 (370)
Q Consensus        49 ~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-~~l  119 (370)
                      .-..+||+|+++.||.  +......+||++........+.+.+|+.+++.+     .||||+++++++....   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999996  443333478988765444556789999999999     5799999999998864   3 337


Q ss_pred             EEEe--cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEeecCCCCceEeCC----CCCeEEee
Q 017503          120 VYEY--VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL-AFLHEELVPHIVHRDIKASNILLDQ----EFNPKIGD  192 (370)
Q Consensus       120 v~e~--~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~~~iiH~dlkp~Nill~~----~~~~kL~D  192 (370)
                      |+||  +.+++|.+++..    + .+++.  ..++.+++.++ +|||++   +|+||||||+|||++.    +..++|+|
T Consensus        83 I~e~~G~~~~tL~~~l~~----~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ----C-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EecCCCCcchhHHHHHHc----c-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            8999  557899999932    2 35444  35677888777 899999   9999999999999974    34799999


Q ss_pred             ecCc
Q 017503          193 FGLA  196 (370)
Q Consensus       193 fg~~  196 (370)
                      |+-+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            4433

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2.1e-19  Score=157.16  Aligned_cols=152  Identities=20%  Similarity=0.188  Sum_probs=115.5

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEE--ECCCCEEEEEECcCcChh------------------------cHHHH
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGT--LTNGRRIAVKPLSAESKQ------------------------GVREF   89 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~--~~~~~~vaiK~~~~~~~~------------------------~~~~~   89 (370)
                      .....+..-...|.+.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+
T Consensus        18 ~~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   97 (237)
T smart00090       18 LALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWA   97 (237)
T ss_pred             HHHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHH
Confidence            3344444445569999999999999999998  458999999987643210                        01235


Q ss_pred             HHHHHHHHhcCCC--CcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCC
Q 017503           90 ITEIMTLSNVRHP--NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV  167 (370)
Q Consensus        90 ~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~  167 (370)
                      ..|+..+.++.+.  .+.++++.    ...++||||+++.+|.....    ....+....+..++.|++.++.+||+.  
T Consensus        98 ~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~--  167 (237)
T smart00090       98 EKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE--  167 (237)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc--
Confidence            6799999999653  33444432    23489999999988866541    233455666789999999999999999  


Q ss_pred             CC-eEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          168 PH-IVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       168 ~~-iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                       + ++|+||||+||+++ ++.++|+|||.+...
T Consensus       168 -g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      168 -GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence             9 99999999999999 889999999988743

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=6.6e-21  Score=178.69  Aligned_cols=225  Identities=24%  Similarity=0.259  Sum_probs=174.2

Q ss_pred             eeeecCCeEEEEEEE----CCCCEEEEEECcCcChh--cHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEEEEEecC
Q 017503           53 KIGRGGFGTVYKGTL----TNGRRIAVKPLSAESKQ--GVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVE  125 (370)
Q Consensus        53 ~lg~G~~g~v~~~~~----~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~  125 (370)
                      .+|+|.||.|+.++.    ..+..||+|+.+.....  .......|-.++...+ ||.++++...+......++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999998652    34777888877654211  1114455777788875 9999999999999999999999999


Q ss_pred             CCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc
Q 017503          126 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH  205 (370)
Q Consensus       126 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  205 (370)
                      +|.|...+    .....+.+.....+...++-|+.++|+.   +++|||+|++||+++.+|++++.|||+++..-.... 
T Consensus        81 gg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   81 GGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             cchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            99887766    4555677777888888999999999999   999999999999999999999999999986533221 


Q ss_pred             eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCC
Q 017503          206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY  285 (370)
Q Consensus       206 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (370)
                          .+||..|||||+++  ....+.|.||||++.+||+||..||...       ...   ....          .-...
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-------~~~---~Il~----------~~~~~  206 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-------TMK---RILK----------AELEM  206 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-------HHH---HHhh----------hccCC
Confidence                27899999999888  5678999999999999999999998751       111   1111          01133


Q ss_pred             ChHHHHHHHHHHHHchhhccCCCCCH
Q 017503          286 PPNEIIRYMKVAFFCTQAAASRRPQM  311 (370)
Q Consensus       286 ~~~~~~~l~~li~~cl~~~p~~RPt~  311 (370)
                      +......+..++..++..+|..|.-.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            44555556777778888899988654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=3.5e-20  Score=170.65  Aligned_cols=123  Identities=28%  Similarity=0.450  Sum_probs=107.7

Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      .+|+.|++|+..+|.+|+... ......++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            578999999999999999532 334457888899999999999999   6   889999999999999999999999999


Q ss_pred             ccccCCCC-----cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh
Q 017503          196 AKLFPDNI-----THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS  245 (370)
Q Consensus       196 ~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  245 (370)
                      ........     ....+...||.+||+||.+.+..|+.++|||+||++|+||+.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            98766544     233455679999999999999999999999999999999997

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2.5e-18  Score=148.48  Aligned_cols=134  Identities=24%  Similarity=0.310  Sum_probs=111.9

Q ss_pred             ceeeecCCeEEEEEEECCCCEEEEEECcCcCh--------hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           52 NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESK--------QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      +.||+|++|.||+|.+ .+..+++|+......        .....+.+|+.++..+.|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6789999999999998 577899997654321        1123567899999999999988777777777888999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      ++|++|.+++..    .   .+ .+..++.+++.+|.++|+.   +++|+|++|.||+++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999998832    1   12 7788999999999999999   999999999999999 78999999998763

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=4.3e-18  Score=145.53  Aligned_cols=147  Identities=22%  Similarity=0.205  Sum_probs=114.0

Q ss_pred             HHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcCh----------------------hcHHHHHHHHHH
Q 017503           38 YTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESK----------------------QGVREFITEIMT   95 (370)
Q Consensus        38 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~e~~~   95 (370)
                      ..++......|.+.+.||+|+||.||++...+|+.||||++.....                      ........|+.+
T Consensus         7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            3455555556889999999999999999988899999998654320                      011235678888


Q ss_pred             HHhcCCCC--cceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEee
Q 017503           96 LSNVRHPN--LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR  173 (370)
Q Consensus        96 l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~  173 (370)
                      +..+.|++  +...++    ....++||||+++++|.....          ......++.+++.++.++|+.   +++||
T Consensus        87 l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~  149 (198)
T cd05144          87 LKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHG  149 (198)
T ss_pred             HHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcC
Confidence            88887764  444443    245589999999999876541          023567889999999999999   99999


Q ss_pred             cCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          174 DIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       174 dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+|+||+++.++.++|+|||++.....
T Consensus       150 Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         150 DLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999999875443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1e-17  Score=164.29  Aligned_cols=146  Identities=21%  Similarity=0.299  Sum_probs=116.7

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEE-CcCc-------ChhcHHHHHHHHHHHHhcCCCCccee
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKP-LSAE-------SKQGVREFITEIMTLSNVRHPNLVEL  107 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~-~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~  107 (370)
                      .++.........|...+.||+|+||.||+|.+.... +++|. ....       .......+.+|+++++.++|++++..
T Consensus       323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p  401 (535)
T PRK09605        323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP  401 (535)
T ss_pred             eeeccccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence            444555555666777899999999999999876443 33332 2111       11223467889999999999999888


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       108 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                      ..++.+....++||||+++++|.+++.            ....++.+++.+|.+||+.   +++||||||+||++ .++.
T Consensus       402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~  465 (535)
T PRK09605        402 VIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDR  465 (535)
T ss_pred             EEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCc
Confidence            877777778899999999999998872            3567899999999999999   99999999999999 6789


Q ss_pred             eEEeeecCccc
Q 017503          188 PKIGDFGLAKL  198 (370)
Q Consensus       188 ~kL~Dfg~~~~  198 (370)
                      ++|+|||++..
T Consensus       466 ~~liDFGla~~  476 (535)
T PRK09605        466 LYLIDFGLGKY  476 (535)
T ss_pred             EEEEeCccccc
Confidence            99999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=1.4e-17  Score=142.47  Aligned_cols=130  Identities=25%  Similarity=0.355  Sum_probs=105.0

Q ss_pred             eeeecCCeEEEEEEECCCCEEEEEECcCcC--------hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           53 KIGRGGFGTVYKGTLTNGRRIAVKPLSAES--------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        53 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .||+|++|.||+|.+ ++..+++|......        ......+.+|+++++.+.|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            479999999999996 46789999754321        111345678999999998887665555566677779999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +|++|.+++..    ...       .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEE----GND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988732    110       7899999999999999   999999999999999 88999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.70  E-value=1.3e-17  Score=164.40  Aligned_cols=209  Identities=23%  Similarity=0.322  Sum_probs=139.4

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ...+|..++.+..|+||.||.++++ ..+.+|+| ++.++-     +.+-  ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee-----------------
Confidence            3578999999999999999999987 45677885 332211     1110  22222333332                 


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                          |+-...+    +.-..++..        ++.+++|||+.   +|+|||+||+|++|+.-|++|+.|||+.......
T Consensus       136 ----gDc~tll----k~~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 ----GDCATLL----KNIGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             ----chhhhhc----ccCCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                2222222    121223322        27899999999   9999999999999999999999999999753211


Q ss_pred             Cc--------------ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH
Q 017503          203 IT--------------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       203 ~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      ..              .....++||+.|.|||++....|+..+|+|++|+++|+.+-|..||.....+   .+   ...+
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---el---fg~v  270 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---EL---FGQV  270 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---HH---Hhhh
Confidence            00              1123468999999999999999999999999999999999999998655321   11   1122


Q ss_pred             HhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCC
Q 017503          269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP  309 (370)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  309 (370)
                      ..+.....--|   ...++    +..+++.+.|+.+|..|-
T Consensus       271 isd~i~wpE~d---ea~p~----Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  271 ISDDIEWPEED---EALPP----EAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhccccccC---cCCCH----HHHHHHHHHHHhChHhhc
Confidence            22211111001   12233    367788889999999994

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=6.4e-16  Score=125.63  Aligned_cols=135  Identities=22%  Similarity=0.225  Sum_probs=112.6

Q ss_pred             ccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCC--CCcceeeeEEEeCCeeEEEEEecCCC
Q 017503           50 LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH--PNLVELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        50 ~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      +.+.||.|.++.||++...+ ..+++|.......  ...+.+|+..++.+.|  .++++++.+....+..+++|||+.++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            46789999999999999864 7899998865543  4567889999999966  58889988888778899999999887


Q ss_pred             CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       128 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      .+..+           +......++.+++.+++++|.....+++|+|++|.||+++..+.++++||+.+..
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            66532           4556677899999999999996333799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=3.4e-16  Score=132.53  Aligned_cols=133  Identities=24%  Similarity=0.274  Sum_probs=97.5

Q ss_pred             ccceeeecCCeEEEEEEECCCCEEEEEECcCcChh--cHHH----------------------HHHHHHHHHhcCCC--C
Q 017503           50 LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQ--GVRE----------------------FITEIMTLSNVRHP--N  103 (370)
Q Consensus        50 ~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--~  103 (370)
                      +.+.||+|+||.||+|...+++.||||++......  ....                      ...|...+..+.+.  .
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            35789999999999999888999999987653211  1111                      13455566665433  2


Q ss_pred             cceeeeEEEeCCeeEEEEEecCCCC-----HHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCC
Q 017503          104 LVELIGCCVQGTRRILVYEYVENNS-----LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKA  177 (370)
Q Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp  177 (370)
                      +.+++++    ...++||||++++.     |.+..         .. ..+..++.+++.++.++|. .   +++|+||+|
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p  143 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---------LL-EDPEELYDQILELMRKLYREA---GLVHGDLSE  143 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh---------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCCh
Confidence            4444433    24589999999854     33221         11 5677899999999999999 8   999999999


Q ss_pred             CceEeCCCCCeEEeeecCccccC
Q 017503          178 SNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       178 ~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      +||+++ ++.++|+|||.+....
T Consensus       144 ~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         144 YNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             hhEEEE-CCcEEEEECccccccc
Confidence            999999 8899999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=2.9e-15  Score=131.26  Aligned_cols=134  Identities=23%  Similarity=0.249  Sum_probs=102.9

Q ss_pred             ceee-ecCCeEEEEEEECCCCEEEEEECcCcC-------------hhcHHHHHHHHHHHHhcCCCCc--ceeeeEEEeCC
Q 017503           52 NKIG-RGGFGTVYKGTLTNGRRIAVKPLSAES-------------KQGVREFITEIMTLSNVRHPNL--VELIGCCVQGT  115 (370)
Q Consensus        52 ~~lg-~G~~g~v~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~  115 (370)
                      ..|| .||.|+||.+... +..++||.+....             ......+.+|++++..+.|+++  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 8889999998875 6788888774311             1223457789999999988774  66676654322


Q ss_pred             ----eeEEEEEecCC-CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEE
Q 017503          116 ----RRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI  190 (370)
Q Consensus       116 ----~~~lv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL  190 (370)
                          ..++|||++++ .+|.+++..     ..++..    .+.+++.+|.+||+.   ||+|+||||.|||++.++.++|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence                23599999997 689888732     234443    367899999999999   9999999999999998889999


Q ss_pred             eeecCccc
Q 017503          191 GDFGLAKL  198 (370)
Q Consensus       191 ~Dfg~~~~  198 (370)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=1.1e-17  Score=163.73  Aligned_cols=256  Identities=22%  Similarity=0.270  Sum_probs=186.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC--CCEEEEEECcCcC--hhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN--GRRIAVKPLSAES--KQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l  119 (370)
                      ...|.+.+.||+|.|+.|-......  ...+|.|.+....  ......+..|..+-+.+. |.|++++++...+....++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3456777789999999998777643  3446666655443  233344455777777776 9999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEeecCCCCceEeCCCC-CeEEeeecCcc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH-EELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAK  197 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~iiH~dlkp~Nill~~~~-~~kL~Dfg~~~  197 (370)
                      ++++..++++..-+.  .......+...+-.++.|+..++.|+| ..   ++.|+|++|+|.+++..+ .++++|||++.
T Consensus        99 ~~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            999999998877662  122224556667789999999999999 77   999999999999999999 99999999999


Q ss_pred             ccCC--CCcceeecccC-CCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          198 LFPD--NITHITTRIAG-TTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       198 ~~~~--~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      .+..  +.........| ++.|+|||...+. ......|+||.|+++.-+++|..||............      +....
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~------~~~~~  247 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS------WKSNK  247 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee------ecccc
Confidence            7765  33333445567 9999999988774 5578899999999999999999998876554422110      00000


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                           ...-...........+++..+++..+|..|.+.+++-.
T Consensus       248 -----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 -----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -----cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence                 00000011122223667777788899999999887743

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=2.7e-14  Score=135.80  Aligned_cols=164  Identities=18%  Similarity=0.291  Sum_probs=112.0

Q ss_pred             cccccccccCHHHHHHhccC------------CcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcH---------
Q 017503           28 ELLRNVNHFSYTELRSATDD------------FHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGV---------   86 (370)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~~~------------y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~---------   86 (370)
                      .|..++..+++++++...++            |. .+.||.|++|.||+|+.++|+.||||+.+.......         
T Consensus        88 ~Lqd~v~p~~~~~~~~~l~~elg~~~~~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~  166 (437)
T TIGR01982        88 LLQDRVPPFDFKVARKVIEAALGGPLEELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYR  166 (437)
T ss_pred             HHhcCCCCCCHHHHHHHHHHHhCcCHHHHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHH
Confidence            45667777888777766432            22 368999999999999999999999998764321100         


Q ss_pred             -------------------------------HHHHHHHHHHHhc----CCCCcceeeeEEE-eCCeeEEEEEecCCCCHH
Q 017503           87 -------------------------------REFITEIMTLSNV----RHPNLVELIGCCV-QGTRRILVYEYVENNSLD  130 (370)
Q Consensus        87 -------------------------------~~~~~e~~~l~~l----~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~  130 (370)
                                                     -++.+|++.+.++    .|.+-+.+-.++. ..+..++||||++|++|.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~  246 (437)
T TIGR01982       167 LARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLS  246 (437)
T ss_pred             HHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccc
Confidence                                           0133444444444    2322233333332 244578999999999998


Q ss_pred             HHhcccccCCccCCHHHHHHHHHHHHH-HHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          131 RVLLGATKANIKLNWEKRSDICVGIAK-GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       131 ~~~~~~~~~~~~l~~~~~~~i~~qi~~-al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ++.....   ...   ....++..++. .+.++|..   |++|+|++|.||+++.++.++|+|||++..+..
T Consensus       247 ~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       247 DIAALDE---AGL---DRKALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             cHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            7753111   111   23346666665 47889998   999999999999999999999999999976543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.51  E-value=5e-13  Score=127.24  Aligned_cols=166  Identities=19%  Similarity=0.273  Sum_probs=126.1

Q ss_pred             ECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHH
Q 017503           67 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE  146 (370)
Q Consensus        67 ~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~  146 (370)
                      ..++.+|.+...+..+........+-+..|+.++||||+++++.++..+..|+|+|.+.  .|..++.       .++..
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk-------~l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK-------ELGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH-------HhHHH
Confidence            34677888877766655555667778899999999999999999999999999999875  4666652       23356


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCC
Q 017503          147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ  226 (370)
Q Consensus       147 ~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  226 (370)
                      .+...+.||+.||.+||+.+  +++|++|.-+.|+++..|..||++|.++........ .......-..|..|+.+....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence            66778899999999998664  899999999999999999999999998865433221 011111123466666443222


Q ss_pred             cCccccchhhhHHHHHHHhC
Q 017503          227 LTMKADVYSFGVLVLEIISG  246 (370)
Q Consensus       227 ~~~~~Di~slG~il~elltg  246 (370)
                        ...|.|.|||++++++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              456999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.47  E-value=3.9e-13  Score=129.49  Aligned_cols=162  Identities=17%  Similarity=0.210  Sum_probs=106.1

Q ss_pred             cccccccccCHHHHHHhcc------------CCcccceeeecCCeEEEEEEECC-CCEEEEEECcCcChh----------
Q 017503           28 ELLRNVNHFSYTELRSATD------------DFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQ----------   84 (370)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~~------------~y~~~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~----------   84 (370)
                      .|...+..|++++++...+            .|+. +.||.|++|.||+|+.++ |+.||||+....-..          
T Consensus        90 ~Lqd~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~  168 (537)
T PRK04750         90 LLQDRVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMY  168 (537)
T ss_pred             HHHcCCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHH
Confidence            4566777788776665543            4665 799999999999999987 999999988643110          


Q ss_pred             --------------------c----HHH------HHHHHHHHHhc----CCCCcceeeeEEEe-CCeeEEEEEecCCCCH
Q 017503           85 --------------------G----VRE------FITEIMTLSNV----RHPNLVELIGCCVQ-GTRRILVYEYVENNSL  129 (370)
Q Consensus        85 --------------------~----~~~------~~~e~~~l~~l----~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L  129 (370)
                                          .    .+.      +.+|+.-+.++    .+.+.+.+-.++.+ ....++||||++|+.+
T Consensus       169 ~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l  248 (537)
T PRK04750        169 RLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPV  248 (537)
T ss_pred             HHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccH
Confidence                                0    111      23344333333    23333444444433 4567899999999999


Q ss_pred             HHHhcccccCCc---cCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC----CeEEeeecCccccCC
Q 017503          130 DRVLLGATKANI---KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----NPKIGDFGLAKLFPD  201 (370)
Q Consensus       130 ~~~~~~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kL~Dfg~~~~~~~  201 (370)
                      .++..- ...+.   .+....+..++.|       +...   |++|+|++|.||+++.++    .++++|||+...+..
T Consensus       249 ~d~~~l-~~~g~d~~~la~~~v~~~~~Q-------if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        249 SDVAAL-RAAGTDMKLLAERGVEVFFTQ-------VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HhHHHH-HhcCCCHHHHHHHHHHHHHHH-------HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            875210 11111   2333333333334       4456   999999999999999888    899999999987654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=1.2e-13  Score=120.61  Aligned_cols=203  Identities=21%  Similarity=0.268  Sum_probs=139.1

Q ss_pred             HHHhcCCCCcceeeeEEEeC-----CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 017503           95 TLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH  169 (370)
Q Consensus        95 ~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~  169 (370)
                      -|-++-|.|++++..|+.+.     ....+++||+..|++.+++.+..+.+..+..+.-.+|+-||+.||.|||+.. |.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence            34456799999998887653     3467899999999999999888888888888888999999999999999974 47


Q ss_pred             eEeecCCCCceEeCCCCCeEEeeecCccccCCCCc---ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhC
Q 017503          170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG  246 (370)
Q Consensus       170 iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg  246 (370)
                      ++|+++..+.|++..+|-+|+.--.-.........   .......+.++|.+||.=..-..+-++|||+||....+|.-+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            99999999999999998888864222111111000   011123356789999976666778899999999999999776


Q ss_pred             CCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          247 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       247 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ............  ....+.     ....-..++.           -..++..|++..|..||++++++.
T Consensus       279 Eiq~tnseS~~~--~ee~ia-----~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  279 EIQSTNSESKVE--VEENIA-----NVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eeccCCCcceee--hhhhhh-----hheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence            532111111000  000000     0000011111           134566799999999999998863

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=1.5e-13  Score=129.35  Aligned_cols=249  Identities=21%  Similarity=0.249  Sum_probs=174.8

Q ss_pred             ccCCcccceeee--cCCeEEEEEEE--C-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCe
Q 017503           45 TDDFHLSNKIGR--GGFGTVYKGTL--T-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTR  116 (370)
Q Consensus        45 ~~~y~~~~~lg~--G~~g~v~~~~~--~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  116 (370)
                      ...|.+.+.+|.  |.+|.+|.+..  . ++..+|+|.-+..  .......-.+|+....++ .|++.++....+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345677899999  99999999987  3 5778898863332  222222233466666666 58999998899999999


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEeecCCCCceEeCCC-CCeEEe
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK----GLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIG  191 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kL~  191 (370)
                      .++-+|++. .+|..+.+   .....++...++.++.+...    |+.++|..   +++|-|++|.||+...+ ...+++
T Consensus       193 lfiqtE~~~-~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             ceeeecccc-chhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence            999999996 57777663   23334667777778888888    99999999   99999999999999999 889999


Q ss_pred             eecCccccCCCCcc----eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 017503          192 DFGLAKLFPDNITH----ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       192 Dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      |||+...+.+..-.    ......+...|++||. ..+-++...|+|++|.++.+-.++.........   .     .|.
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~---~-----~W~  336 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKN---S-----SWS  336 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCC---C-----Ccc
Confidence            99999987654321    1223357788999994 456788999999999999998887543211100   0     000


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..   ....+.    .++...-..++...+..+++.+|..|++.+.+..
T Consensus       337 ~~---r~~~ip----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  337 QL---RQGYIP----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc---ccccCc----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            00   000010    1112222223444777799999999999887753

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=7.1e-13  Score=110.22  Aligned_cols=130  Identities=18%  Similarity=0.131  Sum_probs=95.2

Q ss_pred             cceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcc-eeeeEEEeCCeeEEEEEecCCCCH
Q 017503           51 SNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV-ELIGCCVQGTRRILVYEYVENNSL  129 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L  129 (370)
                      .+.|+.|..+.||++... +..|++|....... ....+..|+.+++.+.+.+++ +++..  .....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence            467889999999999876 77899998765432 123456789999988655544 44443  23345899999999877


Q ss_pred             HHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          130 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL--VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       130 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ....         .   ....++.+++.+|+.||...  ..+++|+|++|.||+++ ++.++++||+.+.
T Consensus        79 ~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            5320         1   11235678999999999982  11259999999999998 6789999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.38  E-value=8.6e-12  Score=104.81  Aligned_cols=137  Identities=17%  Similarity=0.177  Sum_probs=98.2

Q ss_pred             cceeeecCCeEEEEEEECC-------CCEEEEEECcCc-------------C---------hhcHHHHH----HHHHHHH
Q 017503           51 SNKIGRGGFGTVYKGTLTN-------GRRIAVKPLSAE-------------S---------KQGVREFI----TEIMTLS   97 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~-------~~~vaiK~~~~~-------------~---------~~~~~~~~----~e~~~l~   97 (370)
                      ...||.|--+.||.|...+       +..+|||+.+..             +         ......+.    +|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998543       478999976421             0         01122233    7999999


Q ss_pred             hcCC--CCcceeeeEEEeCCeeEEEEEecCCCCHHH-HhcccccCCccCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEee
Q 017503           98 NVRH--PNLVELIGCCVQGTRRILVYEYVENNSLDR-VLLGATKANIKLNWEKRSDICVGIAKGLAFL-HEELVPHIVHR  173 (370)
Q Consensus        98 ~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~iiH~  173 (370)
                      ++..  -++..++++    ...++||||+.+..+.. .+     ....++......++.+++.+|..| |..   +++||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-----kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG  149 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-----KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA  149 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-----hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            8843  455666654    45689999998753321 12     112344556677889999999999 888   99999


Q ss_pred             cCCCCceEeCCCCCeEEeeecCccccC
Q 017503          174 DIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       174 dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      ||++.||++. ++.++|+|||.+....
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999996 4689999999887554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.34  E-value=2e-11  Score=98.82  Aligned_cols=143  Identities=21%  Similarity=0.303  Sum_probs=106.3

Q ss_pred             ccceeeecCCeEEEEEEECCCCEEEEEECcCc--------ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           50 LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--------SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        50 ~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ...++.+|+-+.|+++.+. |+..+||..-..        ..-......+|++.|.++.--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5688999999999999986 777777743221        1223345678999999886556655556677777888999


Q ss_pred             EecCC-CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC---eEEeeecCcc
Q 017503          122 EYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAK  197 (370)
Q Consensus       122 e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kL~Dfg~~~  197 (370)
                      ||+++ .++.+++......  .........++..|-+.+.-||.+   +++||||..+||++..++.   +.|+|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99987 4777777422211  222333367889999999999999   9999999999999975543   5899999987


Q ss_pred             c
Q 017503          198 L  198 (370)
Q Consensus       198 ~  198 (370)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=2.3e-11  Score=98.97  Aligned_cols=131  Identities=27%  Similarity=0.324  Sum_probs=100.1

Q ss_pred             ceeeecCCeEEEEEEECCCCEEEEEECcCc---C-----hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           52 NKIGRGGFGTVYKGTLTNGRRIAVKPLSAE---S-----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~---~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..+++|+-+.+|.+.+. |..+++|.-...   .     .-......+|++++.++.--.|.-.+-+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999775 445777743322   1     12233456799999988655665555566778888899999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      ++|..|.+++...           ...++..+-.-+.-||..   +|+|+||.++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888322           245777888888999999   999999999999997654 99999999874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.27  E-value=5.1e-12  Score=119.16  Aligned_cols=262  Identities=21%  Similarity=0.224  Sum_probs=177.8

Q ss_pred             cccccccCHHH-HHHhccCCcccceeeecCCeEEEEEEEC--CCCEEEEEECcCcChhcHH--HHHHHHHHHHhc-CCCC
Q 017503           30 LRNVNHFSYTE-LRSATDDFHLSNKIGRGGFGTVYKGTLT--NGRRIAVKPLSAESKQGVR--EFITEIMTLSNV-RHPN  103 (370)
Q Consensus        30 ~~~~~~~~~~~-~~~~~~~y~~~~~lg~G~~g~v~~~~~~--~~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l-~h~~  103 (370)
                      ++..+.|.-.+ --.-..+|..+..||.|.|+.|+.....  ++..|++|.....-.....  .-..|+.+...+ .|.+
T Consensus       248 ~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~  327 (524)
T KOG0601|consen  248 LKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLP  327 (524)
T ss_pred             cchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccc
Confidence            33444455555 3333578999999999999999887643  5778899877654222222  223456555555 5888


Q ss_pred             cceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC
Q 017503          104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD  183 (370)
Q Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~  183 (370)
                      ++..+..+......|+-.|||+++++...+    .-...+.+..++++..|++.++.++|+.   .++|+|++|+||++.
T Consensus       328 ~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~  400 (524)
T KOG0601|consen  328 SVGKNSSWSQLRQGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILIS  400 (524)
T ss_pred             cCCCCCCccccccccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeec
Confidence            888888888888888999999999887665    2233467778899999999999999999   999999999999998


Q ss_pred             CC-CCeEEeeecCccccCCCCcceeecccCCCCCC--CcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhh
Q 017503          184 QE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYL--APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF  260 (370)
Q Consensus       184 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~  260 (370)
                      .+ +..++.||+++..+.-.    .......-++.  ++.......+..+.|++|||..+.+..++..--....      
T Consensus       401 ~~~~~~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------  470 (524)
T KOG0601|consen  401 NDGFFSKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------  470 (524)
T ss_pred             cchhhhhcccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc------
Confidence            76 77899999998642111    11112223344  5555566778899999999999999999864211100      


Q ss_pred             HHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          261 LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                                  ....+..... ...+.....+..+...+...++..||.+.++.......
T Consensus       471 ------------~~~~i~~~~~-p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  471 ------------QSLTIRSGDT-PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ------------cceeeecccc-cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                        0001111111 11122224455566668999999999998876655443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=7.4e-11  Score=102.40  Aligned_cols=142  Identities=23%  Similarity=0.312  Sum_probs=107.5

Q ss_pred             ceeeecCCeEEEEEEECCCCEEEEEECcCcCh-hcHHHHHHHHHHHHhcCC--CCcceeeeEEEeCC---eeEEEEEecC
Q 017503           52 NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESK-QGVREFITEIMTLSNVRH--PNLVELIGCCVQGT---RRILVYEYVE  125 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~---~~~lv~e~~~  125 (370)
                      +.|+.|..+.+|++...+|..+++|....... .....+..|+.+++.+.+  ..+.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            67899999999999987678899998765432 134567889999999865  34566777665532   5689999999


Q ss_pred             CCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 017503          126 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL---------------------------------------  166 (370)
Q Consensus       126 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------------  166 (370)
                      |.++...+.     ...++......++.+++.+|..||+..                                       
T Consensus        84 G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            988876541     134667777778888888888888531                                       


Q ss_pred             --------------CCCeEeecCCCCceEeCC--CCCeEEeeecCccc
Q 017503          167 --------------VPHIVHRDIKASNILLDQ--EFNPKIGDFGLAKL  198 (370)
Q Consensus       167 --------------~~~iiH~dlkp~Nill~~--~~~~kL~Dfg~~~~  198 (370)
                                    ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          235799999999999998  56689999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.15  E-value=1.3e-09  Score=101.37  Aligned_cols=168  Identities=19%  Similarity=0.315  Sum_probs=127.4

Q ss_pred             eEEEEEEE-CCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEE----eCCeeEEEEEecCCC-CHHHHh
Q 017503           60 GTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV----QGTRRILVYEYVENN-SLDRVL  133 (370)
Q Consensus        60 g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~~-~L~~~~  133 (370)
                      .+.|++.. .+|..|++|++..+..........-+++++++.|.|+|++.+++.    ....+++|++|.++. +|-++.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            46799885 489999999995443333333344678899999999999998876    355778999999864 665544


Q ss_pred             cccc-----------cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          134 LGAT-----------KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       134 ~~~~-----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      ....           ..+...++..+|.++.|+..||.++|+.   |+..+-|.+.+|+++.+..++|...|.......+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            2221           2345578899999999999999999999   9999999999999999999999988887655443


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN  248 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~  248 (370)
                      ..               +.+..   -.+-|.=.||.++..|.||..
T Consensus       447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            20               11111   135688899999999999953

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.14  E-value=1.8e-11  Score=121.67  Aligned_cols=250  Identities=20%  Similarity=0.235  Sum_probs=166.8

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhc---HHHHHHHHHHHHhcCCCCcceeeeEEEeCCe
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQG---VREFITEIMTLSNVRHPNLVELIGCCVQGTR  116 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  116 (370)
                      .+...+.+.+.+.+-+|.++.++.+.-. .+...++|.....+...   .+....+-.++-.-.+|-++.....+.....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            6677889999999999999999987643 34333444332221111   1111112222222234656655555566778


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .+++++|..+++|...++.    -...+..-.......+..++++||..   .+.|+|++|.|.++..++..++.||+..
T Consensus       879 ~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTL  951 (1205)
T ss_pred             cchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccc
Confidence            8999999999999888742    22345555555667788999999998   7899999999999999999999999843


Q ss_pred             cccCCC-----C-------------------------cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhC
Q 017503          197 KLFPDN-----I-------------------------THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG  246 (370)
Q Consensus       197 ~~~~~~-----~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg  246 (370)
                      ......     .                         ........+|+.|.+||...+......+|+|++|+++++.++|
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence            321100     0                         0011234588999999999999999999999999999999999


Q ss_pred             CCCCCcccccchhhHHHHHHHHHhcCCCcccccCC--CCCCChHHHHHHHHHHHHchhhccCCCCCHH
Q 017503          247 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE--LGEYPPNEIIRYMKVAFFCTQAAASRRPQMN  312 (370)
Q Consensus       247 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  312 (370)
                      .+||.....+.          .+.     .+....  ....+.........++...+..+|.+|-.+.
T Consensus      1032 ~pp~na~tpq~----------~f~-----ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQ----------IFE-----NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCcchhh----------hhh-----ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99987664421          111     111111  1222333334456666678889999997665

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=1.1e-09  Score=91.81  Aligned_cols=126  Identities=25%  Similarity=0.265  Sum_probs=81.9

Q ss_pred             EEEEEEECCCCEEEEEECcCcC--------------------------hhcHHHHHHHHHHHHhcCCC--CcceeeeEEE
Q 017503           61 TVYKGTLTNGRRIAVKPLSAES--------------------------KQGVREFITEIMTLSNVRHP--NLVELIGCCV  112 (370)
Q Consensus        61 ~v~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~  112 (370)
                      .||.|...+|..+|+|+.....                          ........+|++.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999889999999764210                          01122356799999999765  455665442 


Q ss_pred             eCCeeEEEEEecC--CCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHH-HhhcCCCCeEeecCCCCceEeCCCCCeE
Q 017503          113 QGTRRILVYEYVE--NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF-LHEELVPHIVHRDIKASNILLDQEFNPK  189 (370)
Q Consensus       113 ~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~~~iiH~dlkp~Nill~~~~~~k  189 (370)
                         ..++||||++  |..+..+...      .++......++.+++..+.. +|..   |++||||++.||+++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3479999999  6555443311      11234456677888885555 5788   99999999999999887 999


Q ss_pred             EeeecCccccC
Q 017503          190 IGDFGLAKLFP  200 (370)
Q Consensus       190 L~Dfg~~~~~~  200 (370)
                      ++|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999887443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.07  E-value=6.7e-09  Score=92.22  Aligned_cols=135  Identities=13%  Similarity=0.047  Sum_probs=95.7

Q ss_pred             CCeEEEEEEECCCCEEEEEECcCcChh-cH----------HHHHHHHHHHHhcCCCC--cceeeeEEEe-----CCeeEE
Q 017503           58 GFGTVYKGTLTNGRRIAVKPLSAESKQ-GV----------REFITEIMTLSNVRHPN--LVELIGCCVQ-----GTRRIL  119 (370)
Q Consensus        58 ~~g~v~~~~~~~~~~vaiK~~~~~~~~-~~----------~~~~~e~~~l~~l~h~~--iv~~~~~~~~-----~~~~~l  119 (370)
                      ....|+++.. +|+.|.||........ ..          ..+.+|++.+.++...+  ++.++++.+.     ....++
T Consensus        34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         34 EGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             CCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence            3344666655 4778999976443211 01          13667888888874333  3445555543     234689


Q ss_pred             EEEecCCC-CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-------CCCeEEe
Q 017503          120 VYEYVENN-SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-------EFNPKIG  191 (370)
Q Consensus       120 v~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-------~~~~kL~  191 (370)
                      |||++++. +|.+++....  ....+...+..++.+++..+..||..   |++|+|++++|||++.       +..+.|+
T Consensus       113 Vte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI  187 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVI  187 (268)
T ss_pred             EEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEE
Confidence            99999986 8998874221  22345667778999999999999999   9999999999999975       4679999


Q ss_pred             eecCccc
Q 017503          192 DFGLAKL  198 (370)
Q Consensus       192 Dfg~~~~  198 (370)
                      ||+.+..
T Consensus       188 Dl~r~~~  194 (268)
T PRK15123        188 DLHRAQI  194 (268)
T ss_pred             ECCcccc
Confidence            9998753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.07  E-value=1.1e-08  Score=92.96  Aligned_cols=265  Identities=15%  Similarity=0.135  Sum_probs=159.6

Q ss_pred             cccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeE------EE-eCCeeEEE
Q 017503           49 HLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGC------CV-QGTRRILV  120 (370)
Q Consensus        49 ~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~------~~-~~~~~~lv  120 (370)
                      ...+.||+|+-+.+|..-.-  ...+-|++.........+   .+..|... .||-+-.-+.+      .- .....-+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            45678999999999965432  122447666554432222   33334443 45533221111      01 12225678


Q ss_pred             EEecCCC-CHHHHhc--ccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          121 YEYVENN-SLDRVLL--GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       121 ~e~~~~~-~L~~~~~--~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      |+.+.+. ....++.  ..++......|.-.+++++.++.+.+.||..   |.+-||++++|+|+++++.+.|.|-....
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            8887764 3344432  1123445578999999999999999999999   99999999999999999999999865544


Q ss_pred             ccCCCCcceeecccCCCCCCCccccc-----CCCcCccccchhhhHHHHHHHhC-CCCCCcccccch-hhHHH-HHHHHH
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMN-KFLLE-WAWQLH  269 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg-~~p~~~~~~~~~-~~~~~-~~~~~~  269 (370)
                      ...  +........|...|.+||.-.     +..-+...|.|.||++|++|+.| +.||........ ....+ .+....
T Consensus       166 i~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         166 INA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             ecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            332  233344556888999999654     33456789999999999999887 788765432211 11111 110000


Q ss_pred             h--cCCCcccccCCCCCCCh-HHHHHHHHHHHHchhh--ccCCCCCHHHHHHHHHhhhc
Q 017503          270 Q--EEKPLELVDPELGEYPP-NEIIRYMKVAFFCTQA--AASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       270 ~--~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~--~p~~RPt~~evl~~L~~~~~  323 (370)
                      .  ......-..+.....+- --...+..+..+|+..  .+.-|||++.++..|..+..
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            0  00000001111111111 1222366677778765  36689999998877766543

>PRK09902 hypothetical protein; Provisional

Probab=98.97  E-value=3.3e-08  Score=83.43  Aligned_cols=161  Identities=14%  Similarity=0.121  Sum_probs=117.5

Q ss_pred             cccccCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcC------hhcHHHHHHHHHHHHhcCCC--C
Q 017503           32 NVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES------KQGVREFITEIMTLSNVRHP--N  103 (370)
Q Consensus        32 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~--~  103 (370)
                      +...-+++.+.....++.-.-.-|.||-+.|+..... |..+-+|.-.+.-      +.....|.+|+..|++|...  .
T Consensus         4 ~~~~~~f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP   82 (216)
T PRK09902          4 SAKYDEFNHWWATEGDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI   82 (216)
T ss_pred             cchhhhHHHHHhCCCceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC
Confidence            3445567788888888877777788999999998765 4478888654221      33456788999999988432  2


Q ss_pred             cceeeeEEEe----CCeeEEEEEecCC-CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCC
Q 017503          104 LVELIGCCVQ----GTRRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS  178 (370)
Q Consensus       104 iv~~~~~~~~----~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~  178 (370)
                      +.+++.....    ....+||+|-+++ .+|.+++.....  ...+...+..++.+++.++..||+.   |+.|+|+.+.
T Consensus        83 VP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~k  157 (216)
T PRK09902         83 VPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVR  157 (216)
T ss_pred             CCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHh
Confidence            4444422222    1235799997764 488888733221  2456777789999999999999999   9999999999


Q ss_pred             ceEeCCCCC--eEEeeecCccc
Q 017503          179 NILLDQEFN--PKIGDFGLAKL  198 (370)
Q Consensus       179 Nill~~~~~--~kL~Dfg~~~~  198 (370)
                      ||+++.++.  +.++||.-++.
T Consensus       158 hIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        158 HIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             heeecCCCCeeEEEEEhhccch
Confidence            999986667  99999987763

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.97  E-value=6.7e-09  Score=89.73  Aligned_cols=139  Identities=24%  Similarity=0.222  Sum_probs=101.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCc------------------C----hhcHHHHHHHHHHHHhcCCC
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE------------------S----KQGVREFITEIMTLSNVRHP  102 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~------------------~----~~~~~~~~~e~~~l~~l~h~  102 (370)
                      ..-+.+..+||-|--+.||.|...+|.++|||.-...                  .    ........+|.++|.+|...
T Consensus        90 ~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~  169 (304)
T COG0478          90 GIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE  169 (304)
T ss_pred             ChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence            3345677899999999999999999999999953211                  0    01123456799999998654


Q ss_pred             --CcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCce
Q 017503          103 --NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI  180 (370)
Q Consensus       103 --~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Ni  180 (370)
                        .+.+.++    .+...+|||+++|-.|...-         +..+..-.++..|+.-+..+-..   |++|+|+++-||
T Consensus       170 G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNI  233 (304)
T COG0478         170 GVKVPKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNI  233 (304)
T ss_pred             CCCCCCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheE
Confidence              5666654    35567999999986654321         12344445566666666666676   999999999999


Q ss_pred             EeCCCCCeEEeeecCcccc
Q 017503          181 LLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       181 ll~~~~~~kL~Dfg~~~~~  199 (370)
                      +++++|.+.++||--+...
T Consensus       234 lV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         234 LVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EEecCCCEEEEeCcccccC
Confidence            9999999999999876643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.84  E-value=3.7e-08  Score=84.51  Aligned_cols=106  Identities=23%  Similarity=0.240  Sum_probs=81.6

Q ss_pred             HHHHHHHHHHHhcCC--CCcceeeeEEEeCC----eeEEEEEecCCC-CHHHHhcccccCCccCCHHHHHHHHHHHHHHH
Q 017503           87 REFITEIMTLSNVRH--PNLVELIGCCVQGT----RRILVYEYVENN-SLDRVLLGATKANIKLNWEKRSDICVGIAKGL  159 (370)
Q Consensus        87 ~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~----~~~lv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al  159 (370)
                      ....+|...+..|..  -.+.+.+++.....    ..++|+|++++. +|.+++..    ...++......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHHHHH
Confidence            456678877777632  33455666665532    347999999885 79998832    12256667788999999999


Q ss_pred             HHHhhcCCCCeEeecCCCCceEeCCCC---CeEEeeecCcccc
Q 017503          160 AFLHEELVPHIVHRDIKASNILLDQEF---NPKIGDFGLAKLF  199 (370)
Q Consensus       160 ~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kL~Dfg~~~~~  199 (370)
                      ..||+.   |++|+|+++.|||++.++   .+.|+||+.+...
T Consensus       132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999   999999999999999887   7999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.80  E-value=1.1e-07  Score=80.55  Aligned_cols=136  Identities=17%  Similarity=0.250  Sum_probs=91.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHH---------HHHHHHHhcC---CCCcceeeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFI---------TEIMTLSNVR---HPNLVELIGCCV  112 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~---------~e~~~l~~l~---h~~iv~~~~~~~  112 (370)
                      .++|.+.+.+.......|.+... +|..+++|..........+.+.         +.+..+.++.   -..+..++.+.+
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            57888888888877777776665 4789999988766543333322         2333333332   223333333322


Q ss_pred             -----eCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          113 -----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       113 -----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                           -....+++|||++|..|.++.        .++.    .++..+.+++..||+.   |++|+|..|+|+++..+ .
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-c
Confidence                 223456899999998776543        1222    2456678899999999   99999999999999855 5


Q ss_pred             eEEeeecCcc
Q 017503          188 PKIGDFGLAK  197 (370)
Q Consensus       188 ~kL~Dfg~~~  197 (370)
                      ++++||+.-.
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.76  E-value=4.4e-08  Score=94.23  Aligned_cols=165  Identities=19%  Similarity=0.274  Sum_probs=102.3

Q ss_pred             cccccccccCHHHHHHhcc------------CCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChh-----------
Q 017503           28 ELLRNVNHFSYTELRSATD------------DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQ-----------   84 (370)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~~------------~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~-----------   84 (370)
                      .|...+..|+++......+            .|. ...|+.++.|.||+|+.++|+.||||+.+..-..           
T Consensus        96 ~LQD~vpp~~~~~~~~iie~eLG~~iee~F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~  174 (517)
T COG0661          96 KLQDRVPPFPFEEAERIIEEELGRPIEELFSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRR  174 (517)
T ss_pred             HhhcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHH
Confidence            3455566666665554432            222 2689999999999999999999999987532110           


Q ss_pred             -------------------cHH----------HHHHHHHHHHhc----CCCCcceeeeEEE-eCCeeEEEEEecCCCCHH
Q 017503           85 -------------------GVR----------EFITEIMTLSNV----RHPNLVELIGCCV-QGTRRILVYEYVENNSLD  130 (370)
Q Consensus        85 -------------------~~~----------~~~~e~~~l~~l----~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~  130 (370)
                                         ..+          ++.+|+.-+.++    ++..-+++-.++. -....+++|||++|-.+.
T Consensus       175 ~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~  254 (517)
T COG0661         175 LARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKIS  254 (517)
T ss_pred             HHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecc
Confidence                               011          123344444443    2222223333333 355678999999998887


Q ss_pred             HHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          131 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       131 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      +...-   .....+.+.+...+.++  .+..+-..   |++|.|..|.||+++.+|.+.+.|||+...++.
T Consensus       255 d~~~l---~~~g~d~k~ia~~~~~~--f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         255 DIAAL---KSAGIDRKELAELLVRA--FLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cHHHH---HhcCCCHHHHHHHHHHH--HHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            77421   11233433333222221  22333334   899999999999999999999999999987654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.74  E-value=2.4e-09  Score=102.85  Aligned_cols=152  Identities=25%  Similarity=0.345  Sum_probs=100.7

Q ss_pred             HHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce--------eecccCCCCCCCccccc
Q 017503          152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--------TTRIAGTTGYLAPEYVL  223 (370)
Q Consensus       152 ~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~  223 (370)
                      +.+++.|+.++|...  +++|++|.|++|.++.++..||+.|+.+..........        .-...-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            344559999999875  89999999999999999999999999987654421111        11122345799999999


Q ss_pred             CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhh
Q 017503          224 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA  303 (370)
Q Consensus       224 ~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  303 (370)
                      +...+.++|+||+|+++|.+..|..+-.....    ....+......       .+........+.+.++.+-+.+++..
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~----~~~~~~~~~~~-------~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANG----GLLSYSFSRNL-------LNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccC----Ccchhhhhhcc-------cccccccccccCcHHHHHHHHHHhcC
Confidence            98889999999999999999855433111111    01111111111       11111222234444566666678999


Q ss_pred             ccCCCCCHHHHHH
Q 017503          304 AASRRPQMNQVIK  316 (370)
Q Consensus       304 ~p~~RPt~~evl~  316 (370)
                      ++.-||++.++..
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999997776643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.71  E-value=4.7e-07  Score=78.72  Aligned_cols=138  Identities=17%  Similarity=0.194  Sum_probs=84.4

Q ss_pred             ceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCC--cceeeeEEEeCCeeEEEEEecCCCC-
Q 017503           52 NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN--LVELIGCCVQGTRRILVYEYVENNS-  128 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~-  128 (370)
                      .+||+|..+.||+.   .+..+++|......  ......+|.++++.+..-+  +.+++++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            67899999999984   24567889876533  2345678999999885433  4677888777777889999999963 


Q ss_pred             HHHHh---------------------cccccCCccCCHHHHHH-HHH----------HHHH-HHHHHhhc-CCCCeEeec
Q 017503          129 LDRVL---------------------LGATKANIKLNWEKRSD-ICV----------GIAK-GLAFLHEE-LVPHIVHRD  174 (370)
Q Consensus       129 L~~~~---------------------~~~~~~~~~l~~~~~~~-i~~----------qi~~-al~~LH~~-~~~~iiH~d  174 (370)
                      +...+                     +........+  ..... +..          .+.. ...+|... ..+.++|+|
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l--~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTF--QSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcH--HHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            22111                     1000001011  00000 000          0001 11222211 123578999


Q ss_pred             CCCCceEeCCCCCeEEeeecCcc
Q 017503          175 IKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       175 lkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      +.|.||++++++ +.++||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.62  E-value=7.7e-07  Score=76.37  Aligned_cols=156  Identities=21%  Similarity=0.280  Sum_probs=106.5

Q ss_pred             ccccCHHHHHHhccCCcccceeee---cCCeEEEEEEECCCCEEEEEECcCcChh-------------------cHHH--
Q 017503           33 VNHFSYTELRSATDDFHLSNKIGR---GGFGTVYKGTLTNGRRIAVKPLSAESKQ-------------------GVRE--   88 (370)
Q Consensus        33 ~~~~~~~~~~~~~~~y~~~~~lg~---G~~g~v~~~~~~~~~~vaiK~~~~~~~~-------------------~~~~--   88 (370)
                      .-..+...+.....+..+....|.   |--+.||+|...++..+|+|++......                   ..+.  
T Consensus        32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            345678888888888888877665   4556799999888999999987643210                   0011  


Q ss_pred             ---HHHHHHHHHhcC--CCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHh
Q 017503           89 ---FITEIMTLSNVR--HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH  163 (370)
Q Consensus        89 ---~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH  163 (370)
                         ..+|+.-|+++.  +-.+.+.+++.    ...+||||+....+    --.......+...+...+..+++..+.-|-
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL----PAPRLKDVPLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC----CCCCcccCCcCchhHHHHHHHHHHHHHHHH
Confidence               235777777663  33344444433    34689999865411    000112222334467778888999998888


Q ss_pred             h-cCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          164 E-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       164 ~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      . .   +++|+||+.-|||+. ++.+.++||+-+....
T Consensus       184 ~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         184 KEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             Hhc---CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            7 6   999999999999999 8899999999887554

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.57  E-value=1.6e-06  Score=75.67  Aligned_cols=144  Identities=19%  Similarity=0.177  Sum_probs=83.6

Q ss_pred             cceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCC--CcceeeeEEE---eCCeeEEEEEecC
Q 017503           51 SNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHP--NLVELIGCCV---QGTRRILVYEYVE  125 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~---~~~~~~lv~e~~~  125 (370)
                      ++.|+.|..+.||.+...+ ..+++|.....  .....+.+|..+++.+...  .+.+++....   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4688999999999999876 68999986544  3456677888888887433  3556666443   2345689999999


Q ss_pred             CCCHHH----------------Hh---cccccCCccCCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 017503          126 NNSLDR----------------VL---LGATKANIKLNWEK---------RSDI------------CVGIAK-GLAFLHE  164 (370)
Q Consensus       126 ~~~L~~----------------~~---~~~~~~~~~l~~~~---------~~~i------------~~qi~~-al~~LH~  164 (370)
                      +..+..                .+   +........+....         ....            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987776                11   11100111111000         0000            111222 2333332


Q ss_pred             c----CCCCeEeecCCCCceEeC-CCCCeEEeeecCcc
Q 017503          165 E----LVPHIVHRDIKASNILLD-QEFNPKIGDFGLAK  197 (370)
Q Consensus       165 ~----~~~~iiH~dlkp~Nill~-~~~~~kL~Dfg~~~  197 (370)
                      .    ....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            1    223799999999999999 56666899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.43  E-value=4.6e-06  Score=73.55  Aligned_cols=142  Identities=17%  Similarity=0.112  Sum_probs=85.7

Q ss_pred             ceeeecCC-eEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEEEEEecCCCCH
Q 017503           52 NKIGRGGF-GTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSL  129 (370)
Q Consensus        52 ~~lg~G~~-g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  129 (370)
                      ..|..|.. +.||+.... +..+++|+.....   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++
T Consensus         4 ~~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             eecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            34555666 678998765 4788889876543   235667888888873 44466777777766678999999999877


Q ss_pred             HHHh-------------------cccccCCccCC--HHHHHHHHH--------------------HHHHHHHHHhhc---
Q 017503          130 DRVL-------------------LGATKANIKLN--WEKRSDICV--------------------GIAKGLAFLHEE---  165 (370)
Q Consensus       130 ~~~~-------------------~~~~~~~~~l~--~~~~~~i~~--------------------qi~~al~~LH~~---  165 (370)
                      ....                   +........+.  .........                    .+...+..|-..   
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6432                   10000000111  000000000                    011112222111   


Q ss_pred             -CCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          166 -LVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       166 -~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                       ..+.++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence             12368999999999999987778899999765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.37  E-value=2.9e-06  Score=81.55  Aligned_cols=167  Identities=19%  Similarity=0.228  Sum_probs=102.2

Q ss_pred             cccccccccCHHHHHHhccC---------C--cccceeeecCCeEEEEEEECCCCEEEEEECcCcChh------------
Q 017503           28 ELLRNVNHFSYTELRSATDD---------F--HLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQ------------   84 (370)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~~~---------y--~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~------------   84 (370)
                      .|......|+++++....++         |  --.+.||.-..|.||+|+.++|+.||||+-+..-..            
T Consensus       132 ~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~  211 (538)
T KOG1235|consen  132 ELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLL  211 (538)
T ss_pred             HHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHH
Confidence            56677788888888776432         2  123689999999999999999999999976532110            


Q ss_pred             -------------------cHHH------HHHHHHHHH----hcCCCC---cceeeeEEE-eCCeeEEEEEecCCCCHHH
Q 017503           85 -------------------GVRE------FITEIMTLS----NVRHPN---LVELIGCCV-QGTRRILVYEYVENNSLDR  131 (370)
Q Consensus        85 -------------------~~~~------~~~e~~~l~----~l~h~~---iv~~~~~~~-~~~~~~lv~e~~~~~~L~~  131 (370)
                                         ....      |.+|++-..    .+.|-+   -|.+-.++. .....+|+|||++|..+.+
T Consensus       212 ~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~D  291 (538)
T KOG1235|consen  212 AKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKIND  291 (538)
T ss_pred             HHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCC
Confidence                               0011      122322221    233433   122222222 2456789999999986654


Q ss_pred             HhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC----CCCeEEeeecCccccCCC
Q 017503          132 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ----EFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       132 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~----~~~~kL~Dfg~~~~~~~~  202 (370)
                      .-.   -....++...+..-+.++..  ..|=..   |++|+|=.|.||++..    ++.+.+.|||+.......
T Consensus       292 l~~---i~~~gi~~~~i~~~l~~~~~--~qIf~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  292 LDA---IDKRGISPHDILNKLVEAYL--EQIFKT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHH---HHHcCCCHHHHHHHHHHHHH--HHHHhc---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            421   12234555544443333221  122233   8999999999999984    667999999999866543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.31  E-value=4.7e-06  Score=67.81  Aligned_cols=130  Identities=19%  Similarity=0.312  Sum_probs=91.2

Q ss_pred             CCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCeeEEEEEecC
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYVE  125 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~  125 (370)
                      ...+.+.|++|+.|.||++.+. |..+|+|+-..+++  ...+..|+++|..+.--++ .+++.+..+    ++.|||++
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~   95 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID   95 (201)
T ss_pred             hhhhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence            3456788999999999999997 55889997766544  4678889999999876554 344544333    35599999


Q ss_pred             CCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCC--CceEeCCCCCeEEeeecCccc
Q 017503          126 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA--SNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       126 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp--~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      |-.|..+....       ..+.    ...++++-.-|...   ||-|+.|+-  .||++ .++.+.|+||..+..
T Consensus        96 G~~L~~~~~~~-------~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv-~~~~~~iIDFd~At~  155 (201)
T COG2112          96 GRPLGKLEIGG-------DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLV-NDRDVYIIDFDSATF  155 (201)
T ss_pred             Ccchhhhhhcc-------cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEe-cCCcEEEEEccchhh
Confidence            98887765211       2222    33455665556666   999999875  45555 445999999998873

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.28  E-value=4.8e-06  Score=70.05  Aligned_cols=105  Identities=21%  Similarity=0.276  Sum_probs=81.3

Q ss_pred             HHHHHHHHhcCC-CCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 017503           90 ITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP  168 (370)
Q Consensus        90 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~  168 (370)
                      ..|..+++.+.+ +++++++|+|    ..+++.||...+++.... ....+-...+|..+.+|+.++++.+.+++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            358888888865 6999999998    346799999866443110 0001222568999999999999999999996543


Q ss_pred             CeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       169 ~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      .+.-.|++++|+-+++++.+|++|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            6888999999999999999999999877643

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.26  E-value=3.3e-05  Score=65.33  Aligned_cols=128  Identities=20%  Similarity=0.273  Sum_probs=91.1

Q ss_pred             cceeeecCCeEEEEEEECCCCEEEEEECcCcC----------------hhcHHHHHHHHHHHHhcC------CCCcceee
Q 017503           51 SNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES----------------KQGVREFITEIMTLSNVR------HPNLVELI  108 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~iv~~~  108 (370)
                      ...||+|+.=.||.  +.++...+||+.....                ....+...+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46899999988885  4556677888877655                123455566666666555      78899999


Q ss_pred             eEEEeCCeeEEEEEecCC------CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe
Q 017503          109 GCCVQGTRRILVYEYVEN------NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL  182 (370)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill  182 (370)
                      |+....-..-+|+|.+.+      .+|.+++.     ...++. .   +...+-+-..+|-+.   +|+.+|++|.||++
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVV  151 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence            999999889999998753      27888872     223444 2   333444556677777   99999999999999


Q ss_pred             CCCC----CeEEee
Q 017503          183 DQEF----NPKIGD  192 (370)
Q Consensus       183 ~~~~----~~kL~D  192 (370)
                      ....    .+.|+|
T Consensus       152 ~~~~~~~~~lvlID  165 (199)
T PF10707_consen  152 QRRDSGEFRLVLID  165 (199)
T ss_pred             EecCCCceEEEEEe
Confidence            5332    477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.22  E-value=2.8e-05  Score=80.54  Aligned_cols=149  Identities=19%  Similarity=0.276  Sum_probs=90.8

Q ss_pred             cceeeecCCeEEEEEEECCC---CEEEEEECcCcC-hhcHHHHHHHHHHHHhcC-CCCc--ceeeeEEEeC---CeeEEE
Q 017503           51 SNKIGRGGFGTVYKGTLTNG---RRIAVKPLSAES-KQGVREFITEIMTLSNVR-HPNL--VELIGCCVQG---TRRILV  120 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv  120 (370)
                      .+.++.|.++.+|+....++   ..+++|+..... ......+.+|+++++.+. |.++  .+++.++.+.   ...|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56788899999999887643   467778654332 122346778999999985 6654  7777777654   357899


Q ss_pred             EEecCCCCHHH--------------------H---hcccccC-------CccCC--HHHHHHHHH---------------
Q 017503          121 YEYVENNSLDR--------------------V---LLGATKA-------NIKLN--WEKRSDICV---------------  153 (370)
Q Consensus       121 ~e~~~~~~L~~--------------------~---~~~~~~~-------~~~l~--~~~~~~i~~---------------  153 (370)
                      |||++|..+.+                    .   ++.....       +....  ..++..|..               
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99998864321                    0   1110000       00101  111211111               


Q ss_pred             HHHHHHHHHhhcCC--------CCeEeecCCCCceEeCC-CCC-eEEeeecCcccc
Q 017503          154 GIAKGLAFLHEELV--------PHIVHRDIKASNILLDQ-EFN-PKIGDFGLAKLF  199 (370)
Q Consensus       154 qi~~al~~LH~~~~--------~~iiH~dlkp~Nill~~-~~~-~kL~Dfg~~~~~  199 (370)
                      .+...+.+|..+.+        +.++|+|+++.||+++. ++. +-|.||+++..-
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            12334566655432        25999999999999985 333 579999988653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.20  E-value=2.3e-07  Score=88.80  Aligned_cols=192  Identities=21%  Similarity=0.160  Sum_probs=135.4

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCC-cceeeeEEEeCCeeEE
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN-LVELIGCCVQGTRRIL  119 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~l  119 (370)
                      ++.-+.-+...+.+++|+++++++.+-...+....+.+...     ....-++++|.+.+||| .+..++-+..+...++
T Consensus       237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            33334455666778899999999887543333344544433     23345789999999999 6666666777778899


Q ss_pred             EEEecCCC-CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          120 VYEYVENN-SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       120 v~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +++++.++ +-...+   ......+...+...+.+.-+++++++|+.   .=+|+|    ||+..+ +..++.||+....
T Consensus       312 ~~~i~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  312 PMRICSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQ  380 (829)
T ss_pred             hhhhhcCCccccccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcc
Confidence            99999876 221111   01112234445556777788899999997   557887    666544 6889999999886


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCC
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG  250 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~  250 (370)
                      +....  ......+++.++|||+...+.+..+.|+|++|.-..++--|.+|-
T Consensus       381 L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  381 LTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            65443  234456899999999999999999999999998777887776653

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.13  E-value=3.5e-05  Score=67.51  Aligned_cols=74  Identities=14%  Similarity=0.171  Sum_probs=48.5

Q ss_pred             cceeeecCCeEEEEEEECC--CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCeeEEEEEecCCC
Q 017503           51 SNKIGRGGFGTVYKGTLTN--GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      .+.|..|-.+.+|+....+  +..|++|+....... .....+|+.+++.+...++ .++++.+.    ..++|||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            3567778888999998764  678999977644222 1233468888888854333 44443322    24799999987


Q ss_pred             CH
Q 017503          128 SL  129 (370)
Q Consensus       128 ~L  129 (370)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.12  E-value=0.00021  Score=67.02  Aligned_cols=76  Identities=16%  Similarity=0.178  Sum_probs=53.3

Q ss_pred             cceeeecCCeEEEEEEECCC-CEEEEEECcCc-----C--hhcHHHHHHHHHHHHhcC---CCCcceeeeEEEeCCeeEE
Q 017503           51 SNKIGRGGFGTVYKGTLTNG-RRIAVKPLSAE-----S--KQGVREFITEIMTLSNVR---HPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~~-~~vaiK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l  119 (370)
                      .+.||.|.++.||++...+| +.|+||.-...     .  +........|.+.|+.+.   ..++.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            36789999999999998876 48999975321     1  223456667888888762   2456666665  4456789


Q ss_pred             EEEecCCCC
Q 017503          120 VYEYVENNS  128 (370)
Q Consensus       120 v~e~~~~~~  128 (370)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.10  E-value=1.8e-05  Score=70.31  Aligned_cols=139  Identities=17%  Similarity=0.147  Sum_probs=78.3

Q ss_pred             eeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCeeEEEEEecCCCCHHH
Q 017503           53 KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYVENNSLDR  131 (370)
Q Consensus        53 ~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~  131 (370)
                      .+..|-.+.+|+... ++..+++|..............+|..+++.+...++ .+++...  .  .++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence            345577788998874 467888997654432211234678888888854333 3344332  2  368999999866532


Q ss_pred             H-----------------hcccccCCccCCHHHH-HHHHHHH---------HHHHHHHhhc-----CCCCeEeecCCCCc
Q 017503          132 V-----------------LLGATKANIKLNWEKR-SDICVGI---------AKGLAFLHEE-----LVPHIVHRDIKASN  179 (370)
Q Consensus       132 ~-----------------~~~~~~~~~~l~~~~~-~~i~~qi---------~~al~~LH~~-----~~~~iiH~dlkp~N  179 (370)
                      .                 ++.....+..++.... ..+..++         ...+..+-..     ..+.++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 1111111222222211 1111111         1112222111     12258999999999


Q ss_pred             eEeCCCCCeEEeeecCcc
Q 017503          180 ILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       180 ill~~~~~~kL~Dfg~~~  197 (370)
                      |+++.++ +.|+||+.+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999876 7899999876

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=98.08  E-value=8.6e-05  Score=68.25  Aligned_cols=161  Identities=17%  Similarity=0.172  Sum_probs=86.7

Q ss_pred             ccccCHHHHHHhccCCcc-----cceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCC--cc
Q 017503           33 VNHFSYTELRSATDDFHL-----SNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN--LV  105 (370)
Q Consensus        33 ~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv  105 (370)
                      +-.++.+++......|.+     .+.++.|....+|.....+| .+++|++.....   ..+..++..+..|...+  +.
T Consensus         4 yt~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP   79 (319)
T PRK05231          4 YTDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVP   79 (319)
T ss_pred             cccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCC
Confidence            344566667666666755     34566677778999887655 688898752222   23334555555552211  33


Q ss_pred             eeee------EEEeCCeeEEEEEecCCCCHH-----HH------h---cccccC-------CccC-CHHHHHH-------
Q 017503          106 ELIG------CCVQGTRRILVYEYVENNSLD-----RV------L---LGATKA-------NIKL-NWEKRSD-------  150 (370)
Q Consensus       106 ~~~~------~~~~~~~~~lv~e~~~~~~L~-----~~------~---~~~~~~-------~~~l-~~~~~~~-------  150 (370)
                      +++.      +....+..+++++|++|..+.     ++      +   +.....       ...+ .|.....       
T Consensus        80 ~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  159 (319)
T PRK05231         80 APVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLA  159 (319)
T ss_pred             cceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccC
Confidence            3332      122345678999999886331     11      1   110000       0011 1111111       


Q ss_pred             -----HHHH-HHHHHHHHhh----cCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          151 -----ICVG-IAKGLAFLHE----ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       151 -----i~~q-i~~al~~LH~----~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                           .+.+ +...+..+..    ..+.+++|+|+.|.||+++.+...-|+||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        160 DEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             hhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                 1111 1112233321    134489999999999999866556899999875

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.03  E-value=4.1e-05  Score=67.10  Aligned_cols=74  Identities=19%  Similarity=0.242  Sum_probs=45.6

Q ss_pred             cceeeecCCe-EEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCC---CcceeeeEEEeC---CeeEEEEEe
Q 017503           51 SNKIGRGGFG-TVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHP---NLVELIGCCVQG---TRRILVYEY  123 (370)
Q Consensus        51 ~~~lg~G~~g-~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~  123 (370)
                      +..++.|+.. .||+.    +..+++|......  ....+.+|++.++.+...   .+.++++.....   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567777766 58875    2357788755422  234678899999887532   234444433322   234789999


Q ss_pred             cCCCCHH
Q 017503          124 VENNSLD  130 (370)
Q Consensus       124 ~~~~~L~  130 (370)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.03  E-value=9e-05  Score=67.29  Aligned_cols=80  Identities=13%  Similarity=0.063  Sum_probs=57.3

Q ss_pred             CCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCC---CCcceeeeEEEe---CCeeEEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH---PNLVELIGCCVQ---GTRRILV  120 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv  120 (370)
                      ...-.+.||.|..+.||.....++ .+++|..+...  ....+..|.+.|+.+..   ..+.++++++..   .+..++|
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            334456899999999999886655 46777744311  22467789999988842   467888887754   3568999


Q ss_pred             EEecCCCCH
Q 017503          121 YEYVENNSL  129 (370)
Q Consensus       121 ~e~~~~~~L  129 (370)
                      ||++++.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998754

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.89  E-value=0.00018  Score=65.38  Aligned_cols=143  Identities=20%  Similarity=0.159  Sum_probs=82.6

Q ss_pred             cceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCC--cceeeeE------EEeCCeeEEEEE
Q 017503           51 SNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN--LVELIGC------CVQGTRRILVYE  122 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~e  122 (370)
                      .+.+..|....+|+....+ ..+++|+.....   ...+..|++++..+.+.+  +.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567777778999987654 578889876422   345566777777774322  3444331      123445689999


Q ss_pred             ecCCCCHHH----Hh----------ccc----ccC---CccCCHHHHH----------HHHHHHHHHHHHHhh----cCC
Q 017503          123 YVENNSLDR----VL----------LGA----TKA---NIKLNWEKRS----------DICVGIAKGLAFLHE----ELV  167 (370)
Q Consensus       123 ~~~~~~L~~----~~----------~~~----~~~---~~~l~~~~~~----------~i~~qi~~al~~LH~----~~~  167 (370)
                      +++|..+..    ..          +..    ...   .....|....          .....+..++.++..    ..+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998865421    00          100    000   0001111110          011123344445443    123


Q ss_pred             CCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          168 PHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       168 ~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      .+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            379999999999999987777899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.87  E-value=0.00028  Score=59.41  Aligned_cols=132  Identities=25%  Similarity=0.351  Sum_probs=91.0

Q ss_pred             cccCHHHHHHhccCCcccceeeecCC-eEEEEEEECCCCEEEEEECcC---cCh------------------hcHHHHHH
Q 017503           34 NHFSYTELRSATDDFHLSNKIGRGGF-GTVYKGTLTNGRRIAVKPLSA---ESK------------------QGVREFIT   91 (370)
Q Consensus        34 ~~~~~~~~~~~~~~y~~~~~lg~G~~-g~v~~~~~~~~~~vaiK~~~~---~~~------------------~~~~~~~~   91 (370)
                      ++|+.     ...+++.++.||.|.- |.||+++.. |+.||+|++..   ...                  .....|..
T Consensus        30 ~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~  103 (207)
T PF13095_consen   30 EPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNC  103 (207)
T ss_pred             CCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHH
Confidence            45555     2388999999999999 999999986 77999998321   110                  11223566


Q ss_pred             HHHHHHhc---CCCCc--ceeeeEEEeCC------------------eeEEEEEecCCCCHHHHhcccccCCccCCHHHH
Q 017503           92 EIMTLSNV---RHPNL--VELIGCCVQGT------------------RRILVYEYVENNSLDRVLLGATKANIKLNWEKR  148 (370)
Q Consensus        92 e~~~l~~l---~h~~i--v~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~  148 (370)
                      |.+...+|   .+.++  ++++|+..-..                  ..-||.||+....             .+.    
T Consensus       104 ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----  166 (207)
T PF13095_consen  104 ECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----  166 (207)
T ss_pred             HHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----
Confidence            77666665   45566  89998874220                  1236777665432             122    


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       149 ~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      ..-+.++.+-+..+|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       167 ~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  167 IRDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             hhHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            22355677788889999   9999999999986     4589999854

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.86  E-value=0.00052  Score=62.73  Aligned_cols=160  Identities=19%  Similarity=0.245  Sum_probs=88.8

Q ss_pred             ccCHHHHHHhccCCcc-----cceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCC--ccee
Q 017503           35 HFSYTELRSATDDFHL-----SNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN--LVEL  107 (370)
Q Consensus        35 ~~~~~~~~~~~~~y~~-----~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~  107 (370)
                      ..+.+.+....+.|.+     ++.++.|....+|+....++ .+++|+......  ...+..+++++..|...+  +.++
T Consensus         6 ~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~   82 (307)
T TIGR00938         6 SVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKP   82 (307)
T ss_pred             cCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCcc
Confidence            3455666666666655     45667777788998876544 678887654321  233445667676663222  3343


Q ss_pred             eeE------EEeCCeeEEEEEecCCCCHH-----H------H---hcccccC---C----c-cCCHHHHH----------
Q 017503          108 IGC------CVQGTRRILVYEYVENNSLD-----R------V---LLGATKA---N----I-KLNWEKRS----------  149 (370)
Q Consensus       108 ~~~------~~~~~~~~lv~e~~~~~~L~-----~------~---~~~~~~~---~----~-~l~~~~~~----------  149 (370)
                      +..      ....+..+++++|++|..+.     .      .   ++.....   .    . .-.|....          
T Consensus        83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l  162 (307)
T TIGR00938        83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQL  162 (307)
T ss_pred             ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccccc
Confidence            332      11244568999999885321     1      0   1110000   0    0 01111110          


Q ss_pred             --HHHHHHHHHHHHHhh----cCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          150 --DICVGIAKGLAFLHE----ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       150 --~i~~qi~~al~~LH~----~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                        .....+...+.++..    ..+.+++|+|+.+.||+++.++...|+||+.+.
T Consensus       163 ~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       163 EAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence              011123334544532    223489999999999999988777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.72  E-value=0.00032  Score=63.91  Aligned_cols=141  Identities=22%  Similarity=0.242  Sum_probs=81.9

Q ss_pred             ceeeecCCeEEEEEEECC-------CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCeeEEEEEe
Q 017503           52 NKIGRGGFGTVYKGTLTN-------GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~  123 (370)
                      +.|..|-...+|+....+       +..|++|+...... ......+|++++..+...++ .++++++. +   .+|++|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            456667777899988654       57899998665432 22345678888888753333 34455443 2   358999


Q ss_pred             cCCCCHHHHh-----------------cccccC--Cc---cCC--HHHHHH--------------------------HHH
Q 017503          124 VENNSLDRVL-----------------LGATKA--NI---KLN--WEKRSD--------------------------ICV  153 (370)
Q Consensus       124 ~~~~~L~~~~-----------------~~~~~~--~~---~l~--~~~~~~--------------------------i~~  153 (370)
                      ++|..+....                 +.....  ..   ..+  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            8887654311                 111111  00   000  111101                          111


Q ss_pred             HHHHHHHHHhh------cCCCCeEeecCCCCceEeCCC----CCeEEeeecCcc
Q 017503          154 GIAKGLAFLHE------ELVPHIVHRDIKASNILLDQE----FNPKIGDFGLAK  197 (370)
Q Consensus       154 qi~~al~~LH~------~~~~~iiH~dlkp~Nill~~~----~~~kL~Dfg~~~  197 (370)
                      .+...+..+..      .....++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22223334432      123478999999999999875    889999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.71  E-value=0.00016  Score=74.31  Aligned_cols=199  Identities=20%  Similarity=0.227  Sum_probs=132.9

Q ss_pred             HHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE----EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHH
Q 017503           86 VREFITEIMTLSNVRHPNLVELIGCCVQGTRRI----LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF  161 (370)
Q Consensus        86 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~  161 (370)
                      ......|+..+.++.|+|++.++.|..+....-    +..+++..-++...+    ..-...+....+.+..++.+|+.+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~  301 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAY  301 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHH
Confidence            344456778888889999999998876544332    344777777776666    444567888888999999999999


Q ss_pred             HhhcCCCCeEeecCCCC---ceEeCCCCCeEEe--eecCccccCCCCcceeecccCCCCCCCcccccCCCcC--ccccch
Q 017503          162 LHEELVPHIVHRDIKAS---NILLDQEFNPKIG--DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT--MKADVY  234 (370)
Q Consensus       162 LH~~~~~~iiH~dlkp~---Nill~~~~~~kL~--Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~Di~  234 (370)
                      +|+.   ...|.-+..+   +...+.++.+.+.  ||+....+++......  ...+..+.+||........  ...|+|
T Consensus       302 ~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  302 LHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHH
Confidence            9998   6666655555   4445566666666  8888876655432221  2234557778866655544  457999


Q ss_pred             hhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHH
Q 017503          235 SFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV  314 (370)
Q Consensus       235 slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev  314 (370)
                      .+|..+..+..|..+.....                  .+...    +......   .+......|+..++++|++..++
T Consensus       377 ~lgll~~~~~~~~~i~~~~~------------------~~~~~----l~~~~~~---~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSA------------------VPVSL----LDVLSTS---ELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHHhhhhhcCccccccc------------------chhhh----hccccch---hhhhhhhhhcchhhhhccchhhh
Confidence            99999999988765422110                  00000    1111111   35566677999999999999999


Q ss_pred             HHHH
Q 017503          315 IKML  318 (370)
Q Consensus       315 l~~L  318 (370)
                      +...
T Consensus       432 l~~~  435 (1351)
T KOG1035|consen  432 LTHP  435 (1351)
T ss_pred             hhch
Confidence            7754

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.64  E-value=4e-05  Score=68.42  Aligned_cols=149  Identities=17%  Similarity=0.177  Sum_probs=101.7

Q ss_pred             ccCHHHHHHhccC---CcccceeeecCCeEEEEEEECCCCEEEEEECcCc------------------Chhc----HHHH
Q 017503           35 HFSYTELRSATDD---FHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE------------------SKQG----VREF   89 (370)
Q Consensus        35 ~~~~~~~~~~~~~---y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~------------------~~~~----~~~~   89 (370)
                      -++|-.|+....+   +.+...||-|--+.||.+-+.+|+..++|.-.-.                  ...+    .-..
T Consensus        78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            3556666665543   6778899999999999999999999999943210                  0000    1123


Q ss_pred             HHHHHHHHhcC-CC-CcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCC
Q 017503           90 ITEIMTLSNVR-HP-NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV  167 (370)
Q Consensus        90 ~~e~~~l~~l~-h~-~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~  167 (370)
                      .+|+..|+.|. |. -+.+.+    +.+..++|||++.+..|.+.-       ...+..   .+...+...|.-|...  
T Consensus       158 ~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~-------~v~d~~---~ly~~lm~~Iv~la~~--  221 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVR-------HVEDPP---TLYDDLMGLIVRLANH--  221 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeee-------ecCChH---HHHHHHHHHHHHHHHc--
Confidence            56888888874 32 233444    344568899999887775432       112222   3444555566677777  


Q ss_pred             CCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       168 ~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                       |+||+|.+--||++++++.++++||--.....
T Consensus       222 -GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  222 -GLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             -CceecccchheeEEecCCCEEEeechHhhccC
Confidence             99999999999999999999999997655433

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.59  E-value=0.00061  Score=61.26  Aligned_cols=75  Identities=19%  Similarity=0.201  Sum_probs=47.2

Q ss_pred             cccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhc---CCCCcceeeeEEEeCCeeEEEEEecC
Q 017503           49 HLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV---RHPNLVELIGCCVQGTRRILVYEYVE  125 (370)
Q Consensus        49 ~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~  125 (370)
                      +-.+.++.|....+|+.. .+++.+.+|.-....   ...+..|++-|+.|   ..-.+.+++++....+..++||||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            344678889999999988 567889999765222   24566688878777   34557788998888778899999998


Q ss_pred             CC
Q 017503          126 NN  127 (370)
Q Consensus       126 ~~  127 (370)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            66

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.57  E-value=0.00097  Score=60.49  Aligned_cols=141  Identities=20%  Similarity=0.269  Sum_probs=86.2

Q ss_pred             CcccceeeecCCeEEEEEEECCCCEEEEEECc--CcChhcHHHHHHHHHHHHhcCC--CCcceeeeEEEeCC--eeEEEE
Q 017503           48 FHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLS--AESKQGVREFITEIMTLSNVRH--PNLVELIGCCVQGT--RRILVY  121 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~  121 (370)
                      ..+.+....|....+|..... ++++++. ..  ...........+|+.+++.+.-  .-+...+++|.++.  ..|.||
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             CceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            344455544555556666655 7788888 33  2233445666778888888743  23445567776665  679999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHH-HHHHHHHHHHh-------------------------------------
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDIC-VGIAKGLAFLH-------------------------------------  163 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~-~qi~~al~~LH-------------------------------------  163 (370)
                      +|++|..+.+...       ..+..  .+.+ ..++..|..||                                     
T Consensus       105 ~~veGe~~~~~~~-------~~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~  175 (321)
T COG3173         105 EWVEGEVVWSALP-------PESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGG  175 (321)
T ss_pred             EEecceeccCcCC-------cccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccC
Confidence            9998843322110       00000  0111 23344444444                                     


Q ss_pred             -------------hcC-----CCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          164 -------------EEL-----VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       164 -------------~~~-----~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                                   .+.     .+.++|||+.+.|++++.++-+=+.||+++..-
T Consensus       176 ~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         176 RIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                         332     235899999999999998888999999998753

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.47  E-value=0.0013  Score=60.04  Aligned_cols=142  Identities=17%  Similarity=0.213  Sum_probs=94.6

Q ss_pred             ccceeeecCCeEEEEEEECCCCEEEEEECcCc-------------------------ChhcHHH-HHHHHHHHHhcCCCC
Q 017503           50 LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE-------------------------SKQGVRE-FITEIMTLSNVRHPN  103 (370)
Q Consensus        50 ~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~-------------------------~~~~~~~-~~~e~~~l~~l~h~~  103 (370)
                      +...|..|--+.||.+...+|..+|||+++-.                         ......- ..+|++-|.+|+...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            44567778888999999999999999976421                         0111111 235777777776544


Q ss_pred             cceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC
Q 017503          104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD  183 (370)
Q Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~  183 (370)
                      |.-. .-.. -...+|||+++.....-.    .......++...+..+-.+++.-+.-|.+.+  +++|.||+--|+|+ 
T Consensus       228 IP~P-ePIl-Lk~hVLVM~FlGrdgw~a----PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-  298 (520)
T KOG2270|consen  228 IPCP-EPIL-LKNHVLVMEFLGRDGWAA----PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-  298 (520)
T ss_pred             CCCC-Ccee-eecceEeeeeccCCCCcC----cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-
Confidence            3211 0000 123468999996432211    1123445677778888889999999888876  89999999999988 


Q ss_pred             CCCCeEEeeecCccccC
Q 017503          184 QEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       184 ~~~~~kL~Dfg~~~~~~  200 (370)
                      .+|.+.++|.+-+....
T Consensus       299 hdG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  299 HDGKLYIIDVSQSVEHD  315 (520)
T ss_pred             ECCEEEEEEccccccCC
Confidence            56799999988776443

>PLN02236 choline kinase

Probab=97.44  E-value=0.0017  Score=60.24  Aligned_cols=141  Identities=17%  Similarity=0.226  Sum_probs=80.8

Q ss_pred             ceeeecCCeEEEEEEECC-----CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCeeEEEEEecC
Q 017503           52 NKIGRGGFGTVYKGTLTN-----GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYVE  125 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~  125 (370)
                      ..|..|-...+|++...+     +..|++|+......... ...+|..+++.+...++ .++++.+..+    .|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            355557778899987542     36799998766543322 23568888888854443 3455554322    5789998


Q ss_pred             CCCHHHH-----------------hcccccCCc--cCCHHHHHHHHHHH-----------------HHHHHHH----hh-
Q 017503          126 NNSLDRV-----------------LLGATKANI--KLNWEKRSDICVGI-----------------AKGLAFL----HE-  164 (370)
Q Consensus       126 ~~~L~~~-----------------~~~~~~~~~--~l~~~~~~~i~~qi-----------------~~al~~L----H~-  164 (370)
                      +.+|...                 ++.......  ...+.++..++.++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7666421                 111111111  11233333333221                 1112222    11 


Q ss_pred             cCCCCeEeecCCCCceEeCC-CCCeEEeeecCcc
Q 017503          165 ELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAK  197 (370)
Q Consensus       165 ~~~~~iiH~dlkp~Nill~~-~~~~kL~Dfg~~~  197 (370)
                      .....++|+|+++.||++++ ++.+.|+||..+.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            11226899999999999986 4679999999876

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.30  E-value=0.0076  Score=56.61  Aligned_cols=73  Identities=15%  Similarity=0.140  Sum_probs=49.0

Q ss_pred             cceeeecCCeEEEEEEECCCCEEEEEECcCc-----C--hhcHHHHHHHHHHHHhcC---CCCcceeeeEEEeCCeeEEE
Q 017503           51 SNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE-----S--KQGVREFITEIMTLSNVR---HPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .+.||.|....||+.... +..|+||.-...     .  +....+...|++.|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            567898999999998875 456889965411     1  112334444677776653   246777887776  456788


Q ss_pred             EEecCC
Q 017503          121 YEYVEN  126 (370)
Q Consensus       121 ~e~~~~  126 (370)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.28  E-value=0.0043  Score=55.72  Aligned_cols=30  Identities=30%  Similarity=0.514  Sum_probs=25.2

Q ss_pred             CeEeecCCCCceEeCCCCC-eEEeeecCccc
Q 017503          169 HIVHRDIKASNILLDQEFN-PKIGDFGLAKL  198 (370)
Q Consensus       169 ~iiH~dlkp~Nill~~~~~-~kL~Dfg~~~~  198 (370)
                      .++|+|+.|.||+++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            5899999999999987555 46999998763

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.11  E-value=8.2e-05  Score=78.29  Aligned_cols=158  Identities=13%  Similarity=-0.006  Sum_probs=115.0

Q ss_pred             HHHHHHhcCCCCcceeeeEEEe--CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCC-
Q 017503           92 EIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP-  168 (370)
Q Consensus        92 e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~-  168 (370)
                      |...++...|+++...+.-...  ....+.+++++.+|.+.+.+.++......+...-+.....+...+..-+|...+. 
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence            4444555678888766554432  3355789999999999999977766666665555544444446666666654321 


Q ss_pred             -CeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCC
Q 017503          169 -HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR  247 (370)
Q Consensus       169 -~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~  247 (370)
                       -.+|++|++-|.+|..+..++++++|+.+...+. ........+++.|++|+..+.-.++.++|+|..|+.+|.+..|.
T Consensus      1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred             ccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence             3689999999999999999999999999843332 22233345777889999888888898899999999999998887


Q ss_pred             CCC
Q 017503          248 NSG  250 (370)
Q Consensus       248 ~p~  250 (370)
                      .+|
T Consensus      1438 ~~f 1440 (2724)
T KOG1826|consen 1438 AYF 1440 (2724)
T ss_pred             HHH
Confidence            654

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=97.06  E-value=0.0038  Score=53.01  Aligned_cols=117  Identities=17%  Similarity=0.127  Sum_probs=69.5

Q ss_pred             cCCeEEEEEEECCCCEEEEEECcCcChh-cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcc
Q 017503           57 GGFGTVYKGTLTNGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG  135 (370)
Q Consensus        57 G~~g~v~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  135 (370)
                      ++.++.-.++.+-|.. .+|.+..-+.. ....|.++.+++.+++  .|+++..-  ..-..-+|.|+|.....      
T Consensus        73 ~gNsTl~~~kt~iG~L-~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIGPL-FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccchh-hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            3444444444333333 34444433322 4456778899998876  45665521  22344588898854211      


Q ss_pred             cccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          136 ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       136 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                             . .  .-.|.. =+.+|.-.|+.. .+.+|||..|+|||.+..|.+||.|=+..
T Consensus       142 -------~-~--~N~i~a-gi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 -------N-F--SNFITA-GIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             -------c-h--hHHHHH-hHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence                   0 0  001111 146677888542 28999999999999999999999996543

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.94  E-value=0.0075  Score=55.70  Aligned_cols=142  Identities=13%  Similarity=0.181  Sum_probs=78.4

Q ss_pred             ceeeecCCeEEEEEEECC----CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLTN----GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.|..|-...+|+....+    +..|++|+....... .-.-.+|..+++.+..-++ .++++++. ..   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            445447777899887543    247999987654332 2233568888888855444 34555542 22   48888877


Q ss_pred             CCHHHH-------h----------cccccC-CccC-CHHHHHHHHHHH-------------------------HHHHHHH
Q 017503          127 NSLDRV-------L----------LGATKA-NIKL-NWEKRSDICVGI-------------------------AKGLAFL  162 (370)
Q Consensus       127 ~~L~~~-------~----------~~~~~~-~~~l-~~~~~~~i~~qi-------------------------~~al~~L  162 (370)
                      .+|..-       +          +..... .... .+..+..+..++                         +..+..+
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            655221       0          111101 0111 123222222221                         1111112


Q ss_pred             h-hc-CCCCeEeecCCCCceEeCC-CCCeEEeeecCccc
Q 017503          163 H-EE-LVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKL  198 (370)
Q Consensus       163 H-~~-~~~~iiH~dlkp~Nill~~-~~~~kL~Dfg~~~~  198 (370)
                      . .. .+.-++|+|+.+.||++++ ++.++++||..+..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1 11 1124789999999999974 57899999998763

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.90  E-value=0.015  Score=53.61  Aligned_cols=73  Identities=16%  Similarity=0.187  Sum_probs=47.3

Q ss_pred             eeeecCCeEEEEEEECCC-CEEEEEECcC-------cChhcHHHHHHHHHHHHhcC--CCC-cceeeeEEEeCCeeEEEE
Q 017503           53 KIGRGGFGTVYKGTLTNG-RRIAVKPLSA-------ESKQGVREFITEIMTLSNVR--HPN-LVELIGCCVQGTRRILVY  121 (370)
Q Consensus        53 ~lg~G~~g~v~~~~~~~~-~~vaiK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv~  121 (370)
                      .+|-|....||++...++ +.|+||.-..       .-+....+..-|.+.|+...  .|. +.+++  +.+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence            468899999999998654 5799995431       22333445556778887653  343 44443  33555667899


Q ss_pred             EecCCC
Q 017503          122 EYVENN  127 (370)
Q Consensus       122 e~~~~~  127 (370)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.85  E-value=0.078  Score=48.86  Aligned_cols=96  Identities=14%  Similarity=0.106  Sum_probs=59.1

Q ss_pred             cccccCHHHHHHhccCCccc--c--eeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCC--cc
Q 017503           32 NVNHFSYTELRSATDDFHLS--N--KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN--LV  105 (370)
Q Consensus        32 ~~~~~~~~~~~~~~~~y~~~--~--~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv  105 (370)
                      .+..++.+.+..+.+.+-+.  .  ..-.+.-..||+....++..+++|+..... .....+..|++.+..|....  ++
T Consensus         7 ~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~   85 (325)
T PRK11768          7 PFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVV   85 (325)
T ss_pred             CCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCC
Confidence            46678888888888777443  1  112345568999988778889999875332 23455667777777663211  22


Q ss_pred             eee---e--EEEeCCeeEEEEEecCCCC
Q 017503          106 ELI---G--CCVQGTRRILVYEYVENNS  128 (370)
Q Consensus       106 ~~~---~--~~~~~~~~~lv~e~~~~~~  128 (370)
                      ...   |  ....++..+.++++++|..
T Consensus        86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         86 APLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            211   1  1223456778999988753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.83  E-value=0.0041  Score=53.43  Aligned_cols=29  Identities=31%  Similarity=0.494  Sum_probs=21.0

Q ss_pred             CeEeecCCCCceEe-CCCCCeEEeeecCcc
Q 017503          169 HIVHRDIKASNILL-DQEFNPKIGDFGLAK  197 (370)
Q Consensus       169 ~iiH~dlkp~Nill-~~~~~~kL~Dfg~~~  197 (370)
                      .++|+|+.|.||++ +.++.++|+||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            57899999999999 888999999999876

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.73  E-value=0.029  Score=51.26  Aligned_cols=32  Identities=22%  Similarity=0.262  Sum_probs=28.3

Q ss_pred             CCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       167 ~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +.+++|+|+.++|++++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            33799999999999999999999999998763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.73  E-value=0.009  Score=54.60  Aligned_cols=109  Identities=18%  Similarity=0.196  Sum_probs=74.2

Q ss_pred             eCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEee
Q 017503          113 QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD  192 (370)
Q Consensus       113 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~D  192 (370)
                      +....|++|++- |+.+...        ..-.++++..++.+.+..+.-+..+.  ..-|||+.-.||+|+ +|++.|+|
T Consensus       297 e~~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLID  364 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLID  364 (488)
T ss_pred             CceEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEE
Confidence            344566777764 3344321        12457889999999999888888875  789999999999999 99999999


Q ss_pred             ecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHH
Q 017503          193 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV  240 (370)
Q Consensus       193 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  240 (370)
                      |.+++.-... ....     ...+-.|-.+. +.-+..-+||-+.-.+
T Consensus       365 fklsRl~~~q-~~is-----y~rldhp~lF~-G~dd~QFeIYrlMr~l  405 (488)
T COG5072         365 FKLSRLSYSQ-GIIS-----YNRLDHPDLFN-GVDDYQFEIYRLMRRL  405 (488)
T ss_pred             eeeeecccCC-ceee-----ccccCchhhhc-CccceeeeHHHHHHHH
Confidence            9999943221 1111     12334565555 3336677777765443

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.53  E-value=0.036  Score=50.87  Aligned_cols=159  Identities=23%  Similarity=0.338  Sum_probs=88.8

Q ss_pred             ccCHHHHHHhccCCcccc-----eeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCC---CCcce
Q 017503           35 HFSYTELRSATDDFHLSN-----KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH---PNLVE  106 (370)
Q Consensus        35 ~~~~~~~~~~~~~y~~~~-----~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~  106 (370)
                      .++-.++..+...|.+.-     .|.+ .-..+|+....+|+. ++|+....  ....++..|+..|+.|.-   +-.++
T Consensus        10 ~~~~~~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~P   85 (331)
T COG2334          10 PLTSDEAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAP   85 (331)
T ss_pred             CcChHHHHHHHHhcCcCcccccccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCC
Confidence            344455555555554432     3333 445788888876666 88987765  334566678888887732   21122


Q ss_pred             ---eeeE----EEeCCeeEEEEEecCCCCHHH-H-----------h-------cccc----cCCccCCHH----------
Q 017503          107 ---LIGC----CVQGTRRILVYEYVENNSLDR-V-----------L-------LGAT----KANIKLNWE----------  146 (370)
Q Consensus       107 ---~~~~----~~~~~~~~lv~e~~~~~~L~~-~-----------~-------~~~~----~~~~~l~~~----------  146 (370)
                         .-|-    .......+.+++|++|..+.. .           +       .+..    .......|.          
T Consensus        86 l~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~  165 (331)
T COG2334          86 LPSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRL  165 (331)
T ss_pred             ccCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhh
Confidence               1111    111236678899999877662 0           0       0000    000012222          


Q ss_pred             ---HHHHHHHHHHHHHHHHhhc----CCCC---eEeecCCCCceEeCCCCC-eEEeeecCcc
Q 017503          147 ---KRSDICVGIAKGLAFLHEE----LVPH---IVHRDIKASNILLDQEFN-PKIGDFGLAK  197 (370)
Q Consensus       147 ---~~~~i~~qi~~al~~LH~~----~~~~---iiH~dlkp~Nill~~~~~-~kL~Dfg~~~  197 (370)
                         .-.....++...+..+.+.    .+..   +||+|+.|.||+++.+.. +-+.||+.+.
T Consensus       166 ~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         166 DLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               0011223344444444433    2224   899999999999998885 8999999876

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.46  E-value=0.13  Score=46.81  Aligned_cols=29  Identities=28%  Similarity=0.340  Sum_probs=25.5

Q ss_pred             CCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          168 PHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       168 ~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            38999999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.28  E-value=0.029  Score=52.49  Aligned_cols=74  Identities=18%  Similarity=0.169  Sum_probs=49.4

Q ss_pred             cceeeecCCeEEEEEEECC-CCEEEEEECcC------cChhcHHHHHHHHHHHHhcC--CCC-cceeeeEEEeCCeeEEE
Q 017503           51 SNKIGRGGFGTVYKGTLTN-GRRIAVKPLSA------ESKQGVREFITEIMTLSNVR--HPN-LVELIGCCVQGTRRILV  120 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~------~~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv  120 (370)
                      .+.||-|....||++.+.+ +..|+||.-..      +-+-...+..-|.+.|+...  .|. +.+++.  .+.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            5688999999999999753 56799995421      22344556667888888763  343 444443  355566789


Q ss_pred             EEecCC
Q 017503          121 YEYVEN  126 (370)
Q Consensus       121 ~e~~~~  126 (370)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999854

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.28  E-value=0.067  Score=45.97  Aligned_cols=76  Identities=17%  Similarity=0.225  Sum_probs=53.1

Q ss_pred             cceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhc---CCCCcceeeeEEEeCCeeEEEEEecCCC
Q 017503           51 SNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV---RHPNLVELIGCCVQGTRRILVYEYVENN  127 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~  127 (370)
                      .+.+.-|..-.-|...+. ...+.+|.-.   ......|..|+.-|..|   +.-.+.+++.+..+..+.|+||||++.+
T Consensus        21 r~~v~gG~inea~~v~dg-~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          21 REEVSGGDINEAWRLRDG-TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             ccccCCccccceeEeecC-CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            345666666666766653 5678888532   23345666777777666   4466888898989999999999999876


Q ss_pred             CHH
Q 017503          128 SLD  130 (370)
Q Consensus       128 ~L~  130 (370)
                      .++
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            554

>PRK06148 hypothetical protein; Provisional

Probab=96.24  E-value=0.16  Score=54.07  Aligned_cols=164  Identities=18%  Similarity=0.262  Sum_probs=87.5

Q ss_pred             cccccCHHHHHHhc-cCCccc---ceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhc-------C
Q 017503           32 NVNHFSYTELRSAT-DDFHLS---NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-------R  100 (370)
Q Consensus        32 ~~~~~~~~~~~~~~-~~y~~~---~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-------~  100 (370)
                      ..+.++.+++.... +.|-+.   +.|+ |..-.+|+....++..+++|+.+.....  .....|.+.|..|       .
T Consensus         7 ~~p~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glp   83 (1013)
T PRK06148          7 PAPEFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLP   83 (1013)
T ss_pred             CCCCCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCC
Confidence            34456666665543 344432   4554 4567789988877889999998755322  2333345555544       2


Q ss_pred             CCCcceee-e----EEEe-CC--eeEEEEEecCCCCHHHHh---------------------ccc--ccCCccCCHHH--
Q 017503          101 HPNLVELI-G----CCVQ-GT--RRILVYEYVENNSLDRVL---------------------LGA--TKANIKLNWEK--  147 (370)
Q Consensus       101 h~~iv~~~-~----~~~~-~~--~~~lv~e~~~~~~L~~~~---------------------~~~--~~~~~~l~~~~--  147 (370)
                      -|.+++-. |    .... ..  ..+.+++|++|..+.+..                     ...  ......+.|..  
T Consensus        84 vP~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~  163 (1013)
T PRK06148         84 VPRLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRH  163 (1013)
T ss_pred             cCeeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCccccccccccc
Confidence            23333221 1    1111 11  456789999987765411                     000  00011112211  


Q ss_pred             ---------------HHHHHHHHHHHHHH----HhhcCCCCeEeecCCCCceEeCCCC--CeE-EeeecCccc
Q 017503          148 ---------------RSDICVGIAKGLAF----LHEELVPHIVHRDIKASNILLDQEF--NPK-IGDFGLAKL  198 (370)
Q Consensus       148 ---------------~~~i~~qi~~al~~----LH~~~~~~iiH~dlkp~Nill~~~~--~~k-L~Dfg~~~~  198 (370)
                                     ...++.+++..+..    .-...+.++||+|+.+.||+++.++  .+. |+|||.+..
T Consensus       164 ~~~l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        164 AGRARDRLHFIDDPEDRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             chhhhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence                           11222223322221    1112244799999999999998775  555 999998763

>PTZ00384 choline kinase; Provisional

Probab=96.13  E-value=0.058  Score=50.76  Aligned_cols=75  Identities=23%  Similarity=0.286  Sum_probs=44.7

Q ss_pred             cceeeecCCeEEEEEEECCC--C-----EEEEEECcCcChhcHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCeeEEEEE
Q 017503           51 SNKIGRGGFGTVYKGTLTNG--R-----RIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYE  122 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~~--~-----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e  122 (370)
                      .+.|..|-.+.+|++...++  .     .|+++..... ....-.-.+|+++++.+...++ .++++.+.    .+++.|
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e  129 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE  129 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence            34555577789999875432  1     2455543222 2222233568899999865554 44555543    258999


Q ss_pred             ecCCCCHH
Q 017503          123 YVENNSLD  130 (370)
Q Consensus       123 ~~~~~~L~  130 (370)
                      |++|.+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99987664

>PTZ00296 choline kinase; Provisional

Probab=95.64  E-value=0.15  Score=48.87  Aligned_cols=74  Identities=15%  Similarity=0.206  Sum_probs=46.5

Q ss_pred             cceeeecCCeEEEEEEECC---------CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcc-eeeeEEEeCCeeEEE
Q 017503           51 SNKIGRGGFGTVYKGTLTN---------GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV-ELIGCCVQGTRRILV  120 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv  120 (370)
                      .+.|..|-...+|++...+         +..|++++......... .-..|..+++.+...++- ++++.+.    .+.|
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I  184 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRI  184 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence            4556667777889887542         45789998766543332 345578888777544443 4454432    3457


Q ss_pred             EEecCCCCH
Q 017503          121 YEYVENNSL  129 (370)
Q Consensus       121 ~e~~~~~~L  129 (370)
                      .+|++|.+|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            899987644

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.29  E-value=0.017  Score=55.20  Aligned_cols=46  Identities=24%  Similarity=0.340  Sum_probs=35.7

Q ss_pred             HHHHHHHHHHHhcCCCCcceeeeEEEe-CCeeEEEEEecCCCCHHHHh
Q 017503           87 REFITEIMTLSNVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVL  133 (370)
Q Consensus        87 ~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~  133 (370)
                      ..+.-...+++.+.|+|...++++... .....+|+|++.. +|++.+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~   73 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDIL   73 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHH
Confidence            456667888999999999998887754 3346789999854 888887

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	370
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-61
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-61
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-54
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-54
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-38
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-29
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-28
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-27
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-27
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-25
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-24
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-24
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-24
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-24
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-24
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-24
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-24
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-24
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-24
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-24
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-24
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-24
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-23
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-23
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-23
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-23
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-22
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-22
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-22
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-22
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-22
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-22
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-22
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-22
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-22
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-22
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-22
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-22
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-22
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-22
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-22
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-22
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-22
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-22
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-22
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-22
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-22
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-22
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-22
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-21
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-21
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-21
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-21
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-21
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-21
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-21
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-20
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		8e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-19
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-19
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-18
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-18
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-18
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-18
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-18
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-17
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-17
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-17
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-17
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-17
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-17
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-17
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-17
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-17
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-17
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-17
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-17
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-17
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-17
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-17
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-17
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-16
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-16
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-16
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-16
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-16
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-16
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-16
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-16
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-16
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-16
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-16
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-15
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-15
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-15
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-15
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-15
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-15
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-14
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-14
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-14
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-14
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-14
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-14
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-14
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-13
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-08
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		4e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-08
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		4e-08
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-07
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-07
3soa_A	444	Full-Length Human Camkii Length = 444		6e-07
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		9e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-06
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-06
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		4e-06
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-06
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-06
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-06
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-06
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-06
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-06
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-06
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  232 bits (591), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 126/304 (41%), Positives = 187/304 (61%), Gaps = 5/304 (1%)
Query: 20  EAPQGVDGEL-LRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPL 78
           + P   D E+ L  +  FS  EL+ A+D+F   N +GRGGFG VYKG L +G  +AVK L
Sbjct: 11  DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 70
Query: 79  SAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT 137
             E  QG   +F TE+  +S   H NL+ L G C+  T R+LVY Y+ N S+   L    
Sbjct: 71  KEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 130
Query: 138 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK 197
           ++   L+W KR  I +G A+GLA+LH+   P I+HRD+KA+NILLD+EF   +GDFGLAK
Sbjct: 131 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 190
Query: 198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK--AMWG 255
           L      H+   + GT G++APEY+  G+ + K DV+ +GV++LE+I+G+ +     +  
Sbjct: 191 LMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 250
Query: 256 QMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV 314
             +  LL+W   L +E+K   LVD +L G Y   E+ + ++VA  CTQ++   RP+M++V
Sbjct: 251 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 310
Query: 315 IKML 318
           ++ML
Sbjct: 311 VRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  230 bits (587), Expect = 9e-61,   Method: Compositional matrix adjust.
 Identities = 125/304 (41%), Positives = 186/304 (61%), Gaps = 5/304 (1%)
Query: 20  EAPQGVDGEL-LRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPL 78
           + P   D E+ L  +  FS  EL+ A+D+F   N +GRGGFG VYKG L +G  +AVK L
Sbjct: 3   DVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRL 62
Query: 79  SAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT 137
             E  QG   +F TE+  +S   H NL+ L G C+  T R+LVY Y+ N S+   L    
Sbjct: 63  KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 138 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK 197
           ++   L+W KR  I +G A+GLA+LH+   P I+HRD+KA+NILLD+EF   +GDFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK--AMWG 255
           L      H+   + G  G++APEY+  G+ + K DV+ +GV++LE+I+G+ +     +  
Sbjct: 183 LMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 256 QMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV 314
             +  LL+W   L +E+K   LVD +L G Y   E+ + ++VA  CTQ++   RP+M++V
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
Query: 315 IKML 318
           ++ML
Sbjct: 303 VRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  209 bits (533), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 119/290 (41%), Positives = 176/290 (60%), Gaps = 5/290 (1%)
Query: 39  TELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSN 98
            +L  AT++F     IG G FG VYKG L +G ++A+K  + ES QG+ EF TEI TLS 
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            RHP+LV LIG C +    IL+Y+Y+EN +L R L G+    + ++WE+R +IC+G A+G
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYL 217
           L +LH      I+HRD+K+ NILLD+ F PKI DFG++K   + + TH+   + GT GY+
Sbjct: 152 LHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
            PEY + G+LT K+DVYSFGV++ E++  R++      +    L EWA + H   +  ++
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 278 VDPELGE-YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 326
           VDP L +   P  + ++   A  C   ++  RP M  V+  L   +RL E
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  208 bits (530), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 119/290 (41%), Positives = 175/290 (60%), Gaps = 5/290 (1%)
Query: 39  TELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSN 98
            +L  AT++F     IG G FG VYKG L +G ++A+K  + ES QG+ EF TEI TLS 
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            RHP+LV LIG C +    IL+Y+Y+EN +L R L G+    + ++WE+R +IC+G A+G
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYL 217
           L +LH      I+HRD+K+ NILLD+ F PKI DFG++K   +   TH+   + GT GY+
Sbjct: 152 LHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
            PEY + G+LT K+DVYSFGV++ E++  R++      +    L EWA + H   +  ++
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 278 VDPELGE-YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 326
           VDP L +   P  + ++   A  C   ++  RP M  V+  L   +RL E
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 109/297 (36%), Positives = 162/297 (54%), Gaps = 24/297 (8%)
Query: 36  FSYTELRSATDDFHL------SNKIGRGGFGTVYKGTLTNGRRIAVKPLSA----ESKQG 85
           FS+ EL++ T++F         NK+G GGFG VYKG + N   +AVK L+A     +++ 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 86  VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLN 144
            ++F  EI  ++  +H NLVEL+G    G    LVY Y+ N SL DR  L        L+
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLS 131
Query: 145 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPD 201
           W  R  I  G A G+ FLHE    H +HRDIK++NILLD+ F  KI DFGLA+    F  
Sbjct: 132 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 261
            +  + +RI GTT Y+APE  L G++T K+D+YSFGV++LEII+G  +      +    L
Sbjct: 189 TV--MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLL 244
Query: 262 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
                   +E+   + +D ++ +     +     VA  C     ++RP + +V ++L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 109/297 (36%), Positives = 161/297 (54%), Gaps = 24/297 (8%)
Query: 36  FSYTELRSATDDFHL------SNKIGRGGFGTVYKGTLTNGRRIAVKPLSA----ESKQG 85
           FS+ EL++ T++F         NK+G GGFG VYKG + N   +AVK L+A     +++ 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 86  VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLN 144
            ++F  EI  ++  +H NLVEL+G    G    LVY Y+ N SL DR  L        L+
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLS 131
Query: 145 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPD 201
           W  R  I  G A G+ FLHE    H +HRDIK++NILLD+ F  KI DFGLA+    F  
Sbjct: 132 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 261
            +  +  RI GTT Y+APE  L G++T K+D+YSFGV++LEII+G  +      +    L
Sbjct: 189 TV--MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLL 244
Query: 262 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
                   +E+   + +D ++ +     +     VA  C     ++RP + +V ++L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 109/297 (36%), Positives = 161/297 (54%), Gaps = 24/297 (8%)
Query: 36  FSYTELRSATDDFHL------SNKIGRGGFGTVYKGTLTNGRRIAVKPLSA----ESKQG 85
           FS+ EL++ T++F         NK+G GGFG VYKG + N   +AVK L+A     +++ 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 86  VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLN 144
            ++F  EI  ++  +H NLVEL+G    G    LVY Y+ N SL DR  L        L+
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLS 125
Query: 145 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPD 201
           W  R  I  G A G+ FLHE    H +HRDIK++NILLD+ F  KI DFGLA+    F  
Sbjct: 126 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 261
            +  +  RI GTT Y+APE  L G++T K+D+YSFGV++LEII+G  +      +    L
Sbjct: 183 XV--MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLL 238
Query: 262 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
                   +E+   + +D ++ +     +     VA  C     ++RP + +V ++L
Sbjct: 239 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 109/297 (36%), Positives = 156/297 (52%), Gaps = 24/297 (8%)
Query: 36  FSYTELRSATDDFHL------SNKIGRGGFGTVYKGTLTNGRRIAVKPLSA----ESKQG 85
           FS+ EL++ T++F         NK G GGFG VYKG + N   +AVK L+A     +++ 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 86  VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLN 144
            ++F  EI   +  +H NLVEL+G    G    LVY Y  N SL DR  L        L+
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDR--LSCLDGTPPLS 122
Query: 145 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPD 201
           W  R  I  G A G+ FLHE    H +HRDIK++NILLD+ F  KI DFGLA+    F  
Sbjct: 123 WHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 261
            +    +RI GTT Y APE  L G++T K+D+YSFGV++LEII+G  +      +    L
Sbjct: 180 XVX--XSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLL 235
Query: 262 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
                   +E+   + +D +  +     +     VA  C     ++RP + +V ++L
Sbjct: 236 DIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 75/214 (35%), Positives = 120/214 (56%), Gaps = 10/214 (4%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNL 104
           D ++  KIG G FGTV++    +G  +AVK L  +    + V EF+ E+  +  +RHPN+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           V  +G   Q     +V EY+   SL R LL  + A  +L+  +R  +   +AKG+ +LH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
              P IVHRD+K+ N+L+D+++  K+ DFGL++L        +   AGT  ++APE +  
Sbjct: 156 R-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL-XSKXAAGTPEWMAPEVLRD 213
Query: 225 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
                K+DVYSFGV++ E+ + +      WG +N
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP----WGNLN 243

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 124/215 (57%), Gaps = 12/215 (5%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNL 104
           D ++  KIG G FGTV++    +G  +AVK L  +    + V EF+ E+  +  +RHPN+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           V  +G   Q     +V EY+   SL R LL  + A  +L+  +R  +   +AKG+ +LH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEYVL 223
              P IVHR++K+ N+L+D+++  K+ DFGL++L     T ++++  AGT  ++APE + 
Sbjct: 156 R-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLR 212
Query: 224 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
                 K+DVYSFGV++ E+ + +      WG +N
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP----WGNLN 243

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 88/276 (31%), Positives = 137/276 (49%), Gaps = 34/276 (12%)
Query: 54  IGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ 113
           +GRG FG V K      + +A+K + +ES++  + FI E+  LS V HPN+V+L G C+ 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 114 GTRRILVYEYVENNSLDRVLLGATK-----ANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
                LV EY E  SL  VL GA       A   ++W      C+  ++G+A+LH     
Sbjct: 73  PV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPK 124
Query: 169 HIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
            ++HRD+K  N+LL       KI DFG A    D  TH+T    G+  ++APE   G   
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNN-KGSAAWMAPEVFEGSNY 180
Query: 228 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP 287
           + K DV+S+G+++ E+I+ R     + G   + +    W +H   +      P L +  P
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----WAVHNGTR------PPLIKNLP 230
Query: 288 NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
             I   M     C     S+RP M +++K++T  +R
Sbjct: 231 KPIESLMTR---CWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 88/276 (31%), Positives = 137/276 (49%), Gaps = 34/276 (12%)
Query: 54  IGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ 113
           +GRG FG V K      + +A+K + +ES++  + FI E+  LS V HPN+V+L G C+ 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 114 GTRRILVYEYVENNSLDRVLLGATK-----ANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
                LV EY E  SL  VL GA       A   ++W      C+  ++G+A+LH     
Sbjct: 74  PV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPK 125
Query: 169 HIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
            ++HRD+K  N+LL       KI DFG A    D  TH+T    G+  ++APE   G   
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNN-KGSAAWMAPEVFEGSNY 181
Query: 228 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP 287
           + K DV+S+G+++ E+I+ R     + G   + +    W +H   +      P L +  P
Sbjct: 182 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----WAVHNGTR------PPLIKNLP 231
Query: 288 NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
             I   M     C     S+RP M +++K++T  +R
Sbjct: 232 KPIESLMTR---CWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 27/215 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFI----TEIMTLSNVRHP 102
           +  L   IG GGFG VY+     G  +AVK    +  + + + I     E    + ++HP
Sbjct: 8   ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA-TKANIKLNWEKRSDICVGIAKGLAF 161
           N++ L G C++     LV E+     L+RVL G     +I +NW       V IA+G+ +
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNY 120
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP--------KIGDFGLAKLFPDNITHITTRI--A 211
           LH+E +  I+HRD+K+SNIL+ Q+           KI DFGLA+ +     H TT++  A
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRTTKMSAA 175
Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           G   ++APE +     +  +DV+S+GVL+ E+++G
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV 99
           E     +   L  ++G G FG V+ G      ++AVK L  +       F+ E   +  +
Sbjct: 15  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 73
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA+G+
Sbjct: 74  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGM 130
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             + AP
Sbjct: 131 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 187
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E +  G  T+K+DV+SFG+L+ EI++
Sbjct: 188 EAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV 99
           E     +   L  ++G G FG V+ G      ++AVK L  +       F+ E   +  +
Sbjct: 13  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 71
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA+G+
Sbjct: 72  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGM 128
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             + AP
Sbjct: 129 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 185
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E +  G  T+K+DV+SFG+L+ EI++
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV 99
           E     +   L  ++G G FG V+ G      ++AVK L  +       F+ E   +  +
Sbjct: 16  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 74
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA+G+
Sbjct: 75  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGM 131
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             + AP
Sbjct: 132 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 188
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E +  G  T+K+DV+SFG+L+ EI++
Sbjct: 189 EAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV 99
           E     +   L  ++G G FG V+ G      ++AVK L  +       F+ E   +  +
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA+G+
Sbjct: 66  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGM 122
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             + AP
Sbjct: 123 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 179
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E +  G  T+K+DV+SFG+L+ EI++
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 107/209 (51%), Gaps = 13/209 (6%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVRE---FITEIMTL 96
           E     +   L  ++G G FG V+ G      ++AVK L    KQG      F+ E   +
Sbjct: 13  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLM 68
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
             ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA
Sbjct: 69  KQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIA 125
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
           +G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             +
Sbjct: 126 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 182
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
            APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 107/209 (51%), Gaps = 13/209 (6%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVRE---FITEIMTL 96
           E     +   L  ++G G FG V+ G      ++AVK L    KQG      F+ E   +
Sbjct: 17  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLM 72
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
             ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA
Sbjct: 73  KQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIA 129
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
           +G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             +
Sbjct: 130 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 186
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
            APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 187 TAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 107/209 (51%), Gaps = 13/209 (6%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVRE---FITEIMTL 96
           E     +   L  ++G G FG V+ G      ++AVK L    KQG      F+ E   +
Sbjct: 12  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLM 67
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
             ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA
Sbjct: 68  KQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIA 124
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
           +G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             +
Sbjct: 125 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 181
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
            APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 182 TAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 107/209 (51%), Gaps = 13/209 (6%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVRE---FITEIMTL 96
           E     +   L  ++G G FG V+ G      ++AVK L    KQG      F+ E   +
Sbjct: 8   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLM 63
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
             ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA
Sbjct: 64  KQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIA 120
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
           +G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             +
Sbjct: 121 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 177
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
            APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 178 TAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV 99
           E     +   L  ++G G FG V+ G      ++AVK L  +       F+ E   +  +
Sbjct: 9   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 67
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA+G+
Sbjct: 68  QHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGM 124
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             + AP
Sbjct: 125 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 181
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E +  G  T+K+DV+SFG+L+ EI++
Sbjct: 182 EAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 107/209 (51%), Gaps = 13/209 (6%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVRE---FITEIMTL 96
           E     +   L  ++G G FG V+ G      ++AVK L    KQG      F+ E   +
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLM 62
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
             ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA
Sbjct: 63  KQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIA 119
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
           +G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             +
Sbjct: 120 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
            APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 107/209 (51%), Gaps = 13/209 (6%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVRE---FITEIMTL 96
           E     +   L  ++G G FG V+ G      ++AVK L    KQG      F+ E   +
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLM 62
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
             ++H  LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA
Sbjct: 63  KQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIA 119
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
           +G+AF+ E    + +HRD++A+NIL+    + KI DFGLA+L  DN             +
Sbjct: 120 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
            APE +  G  T+K+DV+SFG+L+ EI++
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVRE---FITEIMTLSNVRHP 102
           +   L  ++G G FG V+ G      ++AVK L    KQG      F+ E   +  ++H 
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQ 63
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
            LV L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA+G+AF+
Sbjct: 64  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFI 120
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
            E    + +HRD++A+NIL+    + KI DFGLA+L  DN             + APE +
Sbjct: 121 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 177
Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
             G  T+K+DV+SFG+L+ EI++
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVT 200

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  ++G G FG V+ G      ++AVK L  +       F+ E   +  ++H  LV
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 67
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA+G+AF+ E 
Sbjct: 68  RLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER 124
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HR+++A+NIL+    + KI DFGLA+L  DN             + APE +  G
Sbjct: 125 ---NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 181
Query: 226 QLTMKADVYSFGVLVLEIIS 245
             T+K+DV+SFG+L+ EI++
Sbjct: 182 TFTIKSDVWSFGILLTEIVT 201

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 66
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L     +    I V EY+   SL   L G T   ++L   +  D+   IA G+A++   
Sbjct: 67  QLYAVVSEEPIXI-VTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAYVERM 123
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 124 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 180
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 181 RFTIKSDVWSFGILLTELTT 200

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 69
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G T   ++L   +  D+   IA G+A++   
Sbjct: 70  QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAYVERM 126
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 127 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 183
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 184 RFTIKSDVWSFGILLTELTT 203

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G T   ++L   +  D+   IA G+A++   
Sbjct: 74  QLYAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVDMSAQIASGMAYVERM 130
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 131 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYG 187
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 188 RFTIKSDVWSFGILLTELTT 207

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G T   ++L   +  D+   IA G+A++   
Sbjct: 74  QLYAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVDMSAQIASGMAYVERM 130
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 131 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 187
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 188 RFTIKSDVWSFGILLTELTT 207

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  ++G G  G V+ G      ++AVK L  +       F+ E   +  ++H  LV
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            L     Q    I+  EY+EN SL   L   T + IKL   K  D+   IA+G+AF+ E 
Sbjct: 72  RLYAVVTQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD++A+NIL+    + KI DFGLA+L  D              + APE +  G
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYG 185
Query: 226 QLTMKADVYSFGVLVLEIIS 245
             T+K+DV+SFG+L+ EI++
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G T   ++L   +  D+   IA G+A++   
Sbjct: 243 QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVERM 299
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 300 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G T   ++L   +  D+   IA G+A++   
Sbjct: 243 QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVERM 299
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 300 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 142/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 206
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHITTRIAGTTGYL 217
           FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  T       ++
Sbjct: 207 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  +   L
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRR---L 315
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
           + P   EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 316 LQP---EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 351

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 148
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHITTRIAGTTGYL 217
           FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  T       ++
Sbjct: 149 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  + L+ 
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRRLLQ- 259
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                 EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 260 -----PEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 293

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L     +    I++ EY+   SL   L G     ++L   +  D+   IA G+A++   
Sbjct: 77  QLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM 133
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 190
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKIRHEKLV 76
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G     ++L   +  D+   IA G+A++   
Sbjct: 77  QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM 133
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 152
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHITTRIAGTTGYL 217
           FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  T       ++
Sbjct: 153 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  + L+ 
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRRLLQ- 263
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                 EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 264 -----PEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 297

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 148
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHITTRIAGTTGYL 217
           FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  T       ++
Sbjct: 149 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  + L+ 
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRRLLQ- 259
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                 EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 260 -----PEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 293

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L   +      F+ E   +  +RH  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 325
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G T   ++L   +  D+   IA G+A++   
Sbjct: 326 QLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVERM 382
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 383 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 147
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHITTRIAGTTGYL 217
           FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  T       ++
Sbjct: 148 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  + L+ 
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRRLLQ- 258
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                 EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 259 -----PEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 292

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 145
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHITTRIAGTTGYL 217
           FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  T       ++
Sbjct: 146 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  + L+ 
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRRLLQ- 256
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                 EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 257 -----PEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 290

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G T   ++L   +  D+   IA G+A++   
Sbjct: 243 QLYAV-VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVERM 299
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 300 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L     +    I++ EY+   SL   L G     ++L   +  D+   IA G+A++   
Sbjct: 77  QLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM 133
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 147
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---NITHITTRIAGTTGYL 217
           FL  +     VHRD+ A N +LD++F  K+ DFGLA+   D   +  H  T       ++
Sbjct: 148 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  + L+ 
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRRLLQ- 258
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                 EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 259 -----PEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 292

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 65
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G     ++L   +  D+   IA G+A++   
Sbjct: 66  QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM 122
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 123 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 179
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 180 RFTIKSDVWSFGILLTELTT 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 67
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G     ++L   +  D+   IA G+A++   
Sbjct: 68  QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM 124
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 125 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 181
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 182 RFTIKSDVWSFGILLTELTT 201

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G     ++L   +  D+   IA G+A++   
Sbjct: 77  QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM 133
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G     ++L   +  D+   IA G+A++   
Sbjct: 77  QLYAV-VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM 133
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 165
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYL 217
           +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  T       ++
Sbjct: 166 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  + L+ 
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRRLLQ- 276
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                 EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 277 -----PEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 310

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 166
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYL 217
           +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  T       ++
Sbjct: 167 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 223
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  + L+ 
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRRLLQ- 277
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                 EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 278 -----PEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 311

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G     ++L   +  D+   IA G+A++   
Sbjct: 77  QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM 133
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD+ A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 134 ---NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 146
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYL 217
           +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  T       ++
Sbjct: 147 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 203
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  + L+ 
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRRLLQ- 257
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                 EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 258 -----PEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 291

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 144
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYL 217
           +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  T       ++
Sbjct: 145 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 201
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  + L+ 
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRRLLQ- 255
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                 EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 256 -----PEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 142/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 139
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYL 217
           +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  T       ++
Sbjct: 140 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 196
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  +   L
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRR---L 248
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
           + P   EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 249 LQP---EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 284

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 146
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYL 217
           +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  T       ++
Sbjct: 147 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  +   L
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRR---L 255
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
           + P   EY P+ +   M     C    A  RP  ++++  ++
Sbjct: 256 LQP---EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 291

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 147
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYL 217
           +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  T       ++
Sbjct: 148 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  + L+ 
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRRLLQ- 258
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                 EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 259 -----PEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 141/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 147
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYL 217
           +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  T       ++
Sbjct: 148 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  + L+ 
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRRLLQ- 258
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
                 EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 259 -----PEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 142/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 142
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYL 217
           +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  T       ++
Sbjct: 143 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  +   L
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRR---L 251
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
           + P   EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 252 LQP---EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 287

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 142/282 (50%), Gaps = 33/282 (11%)
Query: 49  HLSNKIGRGGFGTVYKGTL--TNGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPN 103
           H +  IGRG FG VY GTL   +G++I  AVK L+  +  G V +F+TE + + +  HPN
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 104 LVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLA 160
           ++ L+G C++     ++V  Y+++  L   +   T      N   +  I  G  +AKG+ 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMK 145
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYL 217
           +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D      H  T       ++
Sbjct: 146 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 202
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           A E +   + T K+DV+SFGVL+ E+++    G   +  +N F  +    L Q  +   L
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT---RGAPPYPDVNTF--DITVYLLQGRR---L 254
Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
           + P   EY P+ +    +V   C    A  RP  ++++  ++
Sbjct: 255 LQP---EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 290

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+    L   L G     ++L   +  D+   IA G+A++   
Sbjct: 77  QLYAV-VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM 133
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+    L   L G     ++L   +  D+   IA G+A++   
Sbjct: 77  QLYAV-VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM 133
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLV 243
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L    V      +V EY+   SL   L G     ++L   +  D+   IA G+A++   
Sbjct: 244 QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVERM 300
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGL +L  DN             + APE  L G
Sbjct: 301 ---NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYG 357
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 358 RFTIKSDVWSFGILLTELTT 377

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 139/279 (49%), Gaps = 29/279 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRR---IAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G FG V  G L   G+R   +A+K L S  +++  R+F++E   +    HPN++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   + T  +++ E++EN SLD  L    + + +    +   +  GIA G+ +L +    
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLADM--- 154
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTG--YLAPEYVLG 224
           + VHRD+ A NIL++     K+ DFGL++   D+ +    T+ + G     + APE +  
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 225 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 284
            + T  +DV+S+G+++ E++S     +  W   N+ ++    Q ++   P++        
Sbjct: 215 RKFTSASDVWSYGIVMWEVMS--YGERPYWDMTNQDVINAIEQDYRLPPPMDC------- 265
Query: 285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
             P+ + + M     C Q   + RP+  Q++  L K IR
Sbjct: 266 --PSALHQLM---LDCWQKDRNHRPKFGQIVNTLDKMIR 299

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 143/307 (46%), Gaps = 36/307 (11%)
Query: 33  VNHFSYTELRSATDDF---------HLSNKIGRGGFGTVYKGTL-TNGRR---IAVKPLS 79
           V+ F++ +   A  +F          +   IG G FG V  G L   G+R   +A+K L 
Sbjct: 7   VDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLK 66
Query: 80  A-ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK 138
           A  + +  R+F++E   +    HPN++ L G   +    +++ EY+EN SLD  L    K
Sbjct: 67  AGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL---RK 123
Query: 139 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 198
            + +    +   +  GI  G+ +L +      VHRD+ A NIL++     K+ DFG++++
Sbjct: 124 NDGRFTVIQLVGMLRGIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRV 180
Query: 199 FPDNITHITTRIAGTTG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 256
             D+     T   G     + APE +   + T  +DV+S+G+++ E++S     +  W  
Sbjct: 181 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS--YGERPYWDM 238
Query: 257 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
            N+ +++   + ++   P++              I   ++   C Q   S RP+  Q++ 
Sbjct: 239 SNQDVIKAIEEGYRLPPPMDCP------------IALHQLMLDCWQKERSDRPKFGQIVN 286
Query: 317 MLTKNIR 323
           ML K IR
Sbjct: 287 MLDKLIR 293

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 119/217 (54%), Gaps = 18/217 (8%)
Query: 42  RSATDDFHLSN-------KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIM 94
           R ++DD+ + +       +IG G FGTVYKG       + +  ++A + Q ++ F  E+ 
Sbjct: 1   RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVG 60
Query: 95  TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
            L   RH N++  +G   +  +  +V ++ E +SL   L     +  K   +K  DI   
Sbjct: 61  VLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQ 116
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGT 213
            A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+
Sbjct: 117 TARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGS 173
Query: 214 TGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 247
             ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 174 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTL-TNGRR---IAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G FG V  G L   G+R   +A+K L A  + +  R+F++E   +    HPN++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    +++ EY+EN SLD  L    K + +    +   +  GI  G+ +L +    
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMKYLSDM--- 135
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFG++++  D+     T   G     + APE +   +
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 196 FTSASDVWSYGIVMWEVMS--YGERPYWDMSNQDVIKAIEEGYRLPPPMDCP-------- 245
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
               I   ++   C Q   S RP+  Q++ ML K IR
Sbjct: 246 ----IALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 278

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 116/217 (53%), Gaps = 18/217 (8%)
Query: 42  RSATDDFHLSN-------KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIM 94
           R A DD+ + +       +IG G FGTVYKG       + +  ++A + Q ++ F  E+ 
Sbjct: 13  RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 95  TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
            L   RH N++  +G      +  +V ++ E +SL   L     +  K   +K  DI   
Sbjct: 73  VLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQ 128
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGT 213
            A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA      + +H   +++G+
Sbjct: 129 TARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 214 TGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 247
             ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 13/215 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  ++G G FG V+ G   N  ++AVK L   +   V+ F+ E   +  ++H  LV
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 71
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            L     +     ++ EY+   SL   L       + L   K  D    IA+G+A++  +
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK 129
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD++A+N+L+ +    KI DFGLA++  DN             + APE +  G
Sbjct: 130 ---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 186
Query: 226 QLTMKADVYSFGVLVLEIIS-------GRNSGKAM 253
             T+K+DV+SFG+L+ EI++       GR +   M
Sbjct: 187 CFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVM 221

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 115/211 (54%), Gaps = 12/211 (5%)
Query: 43  SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGV-REFITEIMTLSNVR 100
           S++  F    K+G G + TVYKG   T G  +A+K +  +S++G     I EI  +  ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           H N+V L        +  LV+E+++N+    +D   +G T   ++LN  K       + +
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY--FQWQLLQ 119
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 217
           GLAF HE     I+HRD+K  N+L+++    K+GDFGLA+ F   +   ++ +  T  Y 
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYR 175
Query: 218 APEYVLGGQ-LTMKADVYSFGVLVLEIISGR 247
           AP+ ++G +  +   D++S G ++ E+I+G+
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 135/277 (48%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLT-NGRR---IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G FG V  G L   G+R   +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V EY+EN SLD  L    K + +    +   +  GI+ G+ +L +    
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFL---KKNDGQFTVIQLVGMLRGISAGMKYLSDM--- 143
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + APE +   +
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 204 FTSASDVWSYGIVMWEVVS--YGERPYWEMTNQDVIKAVEEGYRLPSPMDC--------- 252
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+ ++++ ML K IR
Sbjct: 253 PAALYQLM---LDCWQKERNSRPKFDEIVNMLDKLIR 286

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 146/300 (48%), Gaps = 30/300 (10%)
Query: 31  RNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRR---IAVKPLS-AESKQG 85
           R V+ F+  EL ++     +   IG G FG V  G L   G+R   +A+K L    +++ 
Sbjct: 31  RAVHQFA-KELDASC--IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ 87
Query: 86  VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 145
            R+F+ E   +    HPN+V L G   +G   ++V E++EN +LD  L    K + +   
Sbjct: 88  RRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL---RKHDGQFTV 144
Query: 146 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 205
            +   +  GIA G+ +L +      VHRD+ A NIL++     K+ DFGL+++  D+   
Sbjct: 145 IQLVGMLRGIAAGMRYLADM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEA 201
Query: 206 ITTRIAGT--TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE 263
           + T   G     + APE +   + T  +DV+S+G+++ E++S     +  W   N+ +++
Sbjct: 202 VYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS--YGERPYWDMSNQDVIK 259
Query: 264 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
              + ++   P++          P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 260 AIEEGYRLPAPMDC---------PAGLHQLM---LDCWQKERAERPKFEQIVGILDKMIR 307

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTL-TNGRR---IAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G FG V  G L   G+R   +A+K L A  + +  R+F++E   +    HPN++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    +++ EY+EN SLD  L    K + +    +   +  GI  G+ +L +    
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMKYLSDM--- 129
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFG++++  D+     T   G     + APE +   +
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 190 FTSASDVWSYGIVMWEVMS--YGERPYWDMSNQDVIKAIEEGYRLPPPMDCP-------- 239
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
               I   ++   C Q   S RP+  Q++ ML K IR
Sbjct: 240 ----IALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 272

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 118/217 (54%), Gaps = 18/217 (8%)
Query: 42  RSATDDFHLSN-------KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIM 94
           R ++DD+ + +       +IG G FGTVYKG       + +  ++A + Q ++ F  E+ 
Sbjct: 13  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 95  TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
            L   RH N++  +G   +  +  +V ++ E +SL   L     +  K   +K  DI   
Sbjct: 73  VLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQ 128
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGT 213
            A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA      + +H   +++G+
Sbjct: 129 TARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 214 TGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 247
             ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 52  NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
            +IG G FG V+ G   N  ++A+K +  E      +FI E   +  + HP LV+L G C
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 112 VQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           ++     LV+E++E+  L    R   G   A   L       +C+ + +G+A+L E  V 
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEACV- 127
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 228
             +HRD+ A N L+ +    K+ DFG+ +   D+    +T       + +PE     + +
Sbjct: 128 --IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 229 MKADVYSFGVLVLEIIS 245
            K+DV+SFGVL+ E+ S
Sbjct: 186 SKSDVWSFGVLMWEVFS 202

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 52  NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
            +IG G FG V+ G   N  ++A+K +  E      +FI E   +  + HP LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 112 VQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           ++     LV+E++E+  L    R   G   A   L       +C+ + +G+A+L E  V 
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEACV- 122
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 228
             +HRD+ A N L+ +    K+ DFG+ +   D+    +T       + +PE     + +
Sbjct: 123 --IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 229 MKADVYSFGVLVLEIIS 245
            K+DV+SFGVL+ E+ S
Sbjct: 181 SKSDVWSFGVLMWEVFS 197

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 52  NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
            +IG G FG V+ G   N  ++A+K +  E      +FI E   +  + HP LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 112 VQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           ++     LV+E++E+  L    R   G   A   L       +C+ + +G+A+L E  V 
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEACV- 124
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 228
             +HRD+ A N L+ +    K+ DFG+ +   D+    +T       + +PE     + +
Sbjct: 125 --IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 229 MKADVYSFGVLVLEIIS 245
            K+DV+SFGVL+ E+ S
Sbjct: 183 SKSDVWSFGVLMWEVFS 199

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  LSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
           L  ++G G FG V+     N         +AVK L   S    ++F  E   L+N++H +
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 104 LVELIGCCVQGTRRILVYEYVENNSL---------DRVLLGATKANIKLNWEKRSDICVG 154
           +V+  G CV+G   I+V+EY+++  L         D VL+       +L   +   I   
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
           IA G+ +L  +   H VHRD+   N L+ +    KIGDFG+++   D  +    R+ G T
Sbjct: 137 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTDYYRVGGHT 190
Query: 215 ----GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
                ++ PE ++  + T ++DV+S GV++ EI +    GK  W Q++
Sbjct: 191 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT---YGKQPWYQLS 235

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 52  NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
            +IG G FG V+ G   N  ++A+K +  E      +FI E   +  + HP LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 112 VQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           ++     LV+E++E+  L    R   G   A   L       +C+ + +G+A+L E    
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEE---A 122
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 228
            ++HRD+ A N L+ +    K+ DFG+ +   D+    +T       + +PE     + +
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 229 MKADVYSFGVLVLEIIS 245
            K+DV+SFGVL+ E+ S
Sbjct: 183 SKSDVWSFGVLMWEVFS 199

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 52  NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
            +IG G FG V+ G   N  ++A+K +  E      +FI E   +  + HP LV+L G C
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 112 VQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           ++     LV+E++E+  L    R   G   A   L       +C+ + +G+A+L E  V 
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEACV- 144
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 228
             +HRD+ A N L+ +    K+ DFG+ +   D+    +T       + +PE     + +
Sbjct: 145 --IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 229 MKADVYSFGVLVLEIIS 245
            K+DV+SFGVL+ E+ S
Sbjct: 203 SKSDVWSFGVLMWEVFS 219

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G G FG V+  T     ++AVK +   S   V  F+ E   +  ++H  LV
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 73
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L     +    I+  E++   SL   L     +   L   K  D    IA+G+AF+ + 
Sbjct: 74  KLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR 130
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD++A+NIL+      KI DFGLA++  DN             + APE +  G
Sbjct: 131 ---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 187
Query: 226 QLTMKADVYSFGVLVLEIIS 245
             T+K+DV+SFG+L++EI++
Sbjct: 188 SFTIKSDVWSFGILLMEIVT 207

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 138/279 (49%), Gaps = 29/279 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRR---IAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G FG V  G L   G+R   +A+K L S  +++  R+F++E   +    HPN++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   + T  +++ E++EN SLD  L    + + +    +   +  GIA G+ +L +    
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLADM--- 128
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTG--YLAPEYVLG 224
           + VHR + A NIL++     K+ DFGL++   D+ +    T+ + G     + APE +  
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 225 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 284
            + T  +DV+S+G+++ E++S     +  W   N+ ++    Q ++   P++        
Sbjct: 189 RKFTSASDVWSYGIVMWEVMS--YGERPYWDMTNQDVINAIEQDYRLPPPMDC------- 239
Query: 285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
             P+ + + M     C Q   + RP+  Q++  L K IR
Sbjct: 240 --PSALHQLM---LDCWQKDRNHRPKFGQIVNTLDKMIR 273

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 117/217 (53%), Gaps = 18/217 (8%)
Query: 42  RSATDDFHLSN-------KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIM 94
           R ++DD+ + +       +IG G FGTVYKG       + +  ++A + Q ++ F  E+ 
Sbjct: 25  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 95  TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
            L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI   
Sbjct: 85  VLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQ 140
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGT 213
            A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+
Sbjct: 141 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 214 TGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 247
             ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 117/217 (53%), Gaps = 18/217 (8%)
Query: 42  RSATDDFHLSN-------KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIM 94
           R ++DD+ + +       +IG G FGTVYKG       + +  ++A + Q ++ F  E+ 
Sbjct: 24  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVG 83
Query: 95  TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
            L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI   
Sbjct: 84  VLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQ 139
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGT 213
            A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+
Sbjct: 140 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 214 TGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 247
             ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 52  NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
            +IG G FG V+ G   N  ++A+K +  E      +FI E   +  + HP LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 112 VQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           ++     LV E++E+  L    R   G   A   L       +C+ + +G+A+L E  V 
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEACV- 125
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 228
             +HRD+ A N L+ +    K+ DFG+ +   D+    +T       + +PE     + +
Sbjct: 126 --IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 229 MKADVYSFGVLVLEIIS 245
            K+DV+SFGVL+ E+ S
Sbjct: 184 SKSDVWSFGVLMWEVFS 200

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 135/286 (47%), Gaps = 27/286 (9%)
Query: 48  FHLSNKIGRGGFGTVYKGTL-TNGRR---IAVKPLSA-ESKQGVREFITEIMTLSNVRHP 102
            H+   IG G  G V  G L   G+R   +A+K L A  +++  R+F++E   +    HP
Sbjct: 51  IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N++ L G   +G   ++V EY+EN SLD  L      + +    +   +  G+  G+ +L
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPE 220
            +      VHRD+ A N+L+D     K+ DFGL+++  D+     T   G     + APE
Sbjct: 168 SDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPE 224
Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP 280
            +     +  +DV+SFGV++ E+++     +  W   N+ ++    + ++   P+     
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA--YGERPYWNMTNRDVISSVEEGYRLPAPMGC--- 279
Query: 281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 326
                 P+ + + M     C     ++RP+ +Q++ +L   IR  E
Sbjct: 280 ------PHALHQLM---LDCWHKDRAQRPRFSQIVSVLDALIRSPE 316

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 6/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G G FG V+ G   N  ++AVK L   +   V+ F+ E   +  ++H  LV
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 70
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            L     +     ++ E++   SL   L       + L   K  D    IA+G+A++  +
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK 128
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD++A+N+L+ +    KI DFGLA++  DN             + APE +  G
Sbjct: 129 ---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 185
Query: 226 QLTMKADVYSFGVLVLEIIS 245
             T+K++V+SFG+L+ EI++
Sbjct: 186 CFTIKSNVWSFGILLYEIVT 205

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 140/293 (47%), Gaps = 39/293 (13%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQG-------VREFITEIMT 95
           A ++     +IG+GGFG V+KG L   + + A+K L     +G        +EF  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +SN+ HPN+V+L G      R  +V E+V    L   LL        + W  +  + + I
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDI 131
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLD--QEFNP---KIGDFGLAKLFPDNITHITTRI 210
           A G+ ++  +  P IVHRD+++ NI L    E  P   K+ DFGL++       H  + +
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGL 186
Query: 211 AGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNS-GKAMWGQMNKFLLEWAWQ 267
            G   ++APE +   +   T KAD YSF +++  I++G     +  +G++ KF+      
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFI-----N 240
Query: 268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           + +EE  L    PE  + PP    R   V   C      +RP  + ++K L++
Sbjct: 241 MIREEG-LRPTIPE--DCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 7/200 (3%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G G FG V+  T     ++AVK +   S   V  F+ E   +  ++H  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 246
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L     +    I+  E++   SL   L     +   L   K  D    IA+G+AF+ + 
Sbjct: 247 KLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR 303
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD++A+NIL+      KI DFGLA++  DN             + APE +  G
Sbjct: 304 ---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 226 QLTMKADVYSFGVLVLEIIS 245
             T+K+DV+SFG+L++EI++
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 135/285 (47%), Gaps = 27/285 (9%)
Query: 49  HLSNKIGRGGFGTVYKGTL-TNGRR---IAVKPLSA-ESKQGVREFITEIMTLSNVRHPN 103
           H+   IG G  G V  G L   G+R   +A+K L A  +++  R+F++E   +    HPN
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           ++ L G   +G   ++V EY+EN SLD  L      + +    +   +  G+  G+ +L 
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEY 221
           +      VHRD+ A N+L+D     K+ DFGL+++  D+     T   G     + APE 
Sbjct: 169 DL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 222 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE 281
           +     +  +DV+SFGV++ E+++     +  W   N+ ++    + ++   P+      
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA--YGERPYWNMTNRDVISSVEEGYRLPAPMGC---- 279
Query: 282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 326
                P+ + + M     C     ++RP+ +Q++ +L   IR  E
Sbjct: 280 -----PHALHQLM---LDCWHKDRAQRPRFSQIVSVLDALIRSPE 316

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 132/277 (47%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 166
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGLA++  D+     T   G     + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 227 FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC--------- 275
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 119/254 (46%), Gaps = 25/254 (9%)
Query: 24  GVDGELLRNVNHFSYTELRS-ATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVK 76
           G+ G ++ N  +FS   +      D  L  ++G G FG V+     N         +AVK
Sbjct: 18  GLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK 77
Query: 77  PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL-- 134
            L   S+   ++F  E   L+ ++H ++V   G C +G   ++V+EY+ +  L+R L   
Sbjct: 78  ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137
Query: 135 ---------GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 185
                    G   A   L   +   +   +A G+ +L      H VHRD+   N L+ Q 
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194
Query: 186 FNPKIGDFGLAK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
              KIGDFG+++ ++  +   +  R      ++ PE +L  + T ++DV+SFGV++ EI 
Sbjct: 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
Query: 245 SGRNSGKAMWGQMN 258
           +    GK  W Q++
Sbjct: 255 T---YGKQPWYQLS 265

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 132/277 (47%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 166
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +PE +   +
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 227 FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC--------- 275
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 116/217 (53%), Gaps = 18/217 (8%)
Query: 42  RSATDDFHLSN-------KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIM 94
           R ++DD+ + +       +IG G FGTVYKG       + +  ++A + Q ++ F  E+ 
Sbjct: 17  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVG 76
Query: 95  TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
            L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI   
Sbjct: 77  VLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQ 132
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGT 213
            A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA      + +H   +++G+
Sbjct: 133 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 214 TGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 247
             ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 116/217 (53%), Gaps = 18/217 (8%)
Query: 42  RSATDDFHLSN-------KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIM 94
           R ++DD+ + +       +IG G FGTVYKG       + +  ++A + Q ++ F  E+ 
Sbjct: 25  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 95  TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
            L   RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI   
Sbjct: 85  VLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQ 140
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGT 213
            A+G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA      + +H   +++G+
Sbjct: 141 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 214 TGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 247
             ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 10/213 (4%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  ++G G FG V+ GT     ++A+K L   +      F+ E   +  ++H  LV
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLV 67
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L     +    I V EY+   SL   L       +KL      D+   +A G+A++   
Sbjct: 68  QLYAVVSEEPIYI-VTEYMNKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIERM 124
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD++++NIL+      KI DFGLA+L  DN             + APE  L G
Sbjct: 125 ---NYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 181
Query: 226 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
           + T+K+DV+SFG+L+ E+++    G+  +  MN
Sbjct: 182 RFTIKSDVWSFGILLTELVT---KGRVPYPGMN 211

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 116/215 (53%), Gaps = 18/215 (8%)
Query: 44  ATDDFHLSN-------KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTL 96
           ++DD+ + +       +IG G FGTVYKG       + +  ++A + Q ++ F  E+  L
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
              RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI    A
Sbjct: 64  RKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTA 119
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTG 215
           +G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+  
Sbjct: 120 QGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 216 YLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 247
           ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 116/215 (53%), Gaps = 18/215 (8%)
Query: 44  ATDDFHLSN-------KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTL 96
           ++DD+ + +       +IG G FGTVYKG       + +  ++A + Q ++ F  E+  L
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
              RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI    A
Sbjct: 64  RKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTA 119
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTG 215
           +G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+  
Sbjct: 120 QGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 216 YLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 247
           ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 116/215 (53%), Gaps = 18/215 (8%)
Query: 44  ATDDFHLSN-------KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTL 96
           ++DD+ + +       +IG G FGTVYKG       + +  ++A + Q ++ F  E+  L
Sbjct: 1   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
              RH N++  +G   +  +  +V ++ E +SL   L        K    K  DI    A
Sbjct: 61  RKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTA 116
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTG 215
           +G+ +LH +    I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+  
Sbjct: 117 QGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 216 YLAPEYVL---GGQLTMKADVYSFGVLVLEIISGR 247
           ++APE +        + ++DVY+FG+++ E+++G+
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 132/277 (47%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 166
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 227 FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC--------- 275
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 132/277 (47%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 166
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 227 FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC--------- 275
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 132/277 (47%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 166
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 227 FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC--------- 275
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 11/202 (5%)
Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           +  +IG G FGTVYKG       + +  ++A + Q ++ F  E+  L   RH N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
              +    I V ++ E +SL   L        K    K  DI    A+G+ +LH +    
Sbjct: 72  YSTKPQLAI-VTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAK---S 124
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVL---GG 225
           I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+  ++APE +      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 226 QLTMKADVYSFGVLVLEIISGR 247
             + ++DVY+FG+++ E+++G+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 132/277 (47%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 164
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +PE +   +
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 224
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 225 FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC--------- 273
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 274 PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 307

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 132/277 (47%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 166
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 227 FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC--------- 275
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 101/198 (51%), Gaps = 19/198 (9%)
Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQG---VREFITEIMTLSNVRHPNLVELI 108
           +IG G FG VY    + N   +A+K +S   KQ     ++ I E+  L  +RHPN ++  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           GC ++     LV EY   ++ D  LL   K    L   + + +  G  +GLA+LH     
Sbjct: 121 GCYLREHTAWLVMEYCLGSASD--LLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH--- 173
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---G 225
           +++HRD+KA NILL +    K+GDFG A     +I        GT  ++APE +L    G
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPYWMAPEVILAMDEG 228
Query: 226 QLTMKADVYSFGVLVLEI 243
           Q   K DV+S G+  +E+
Sbjct: 229 QYDGKVDVWSLGITCIEL 246

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 101/198 (51%), Gaps = 19/198 (9%)
Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQG---VREFITEIMTLSNVRHPNLVELI 108
           +IG G FG VY    + N   +A+K +S   KQ     ++ I E+  L  +RHPN ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           GC ++     LV EY   ++ D  LL   K    L   + + +  G  +GLA+LH     
Sbjct: 82  GCYLREHTAWLVMEYCLGSASD--LLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH--- 134
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---G 225
           +++HRD+KA NILL +    K+GDFG A     +I        GT  ++APE +L    G
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 226 QLTMKADVYSFGVLVLEI 243
           Q   K DV+S G+  +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 133/295 (45%), Gaps = 44/295 (14%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           D  L  ++G G FG V+     N         +AVK L   +    ++F  E   L+N++
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 75
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG------------ATKANIKLNWEKR 148
           H ++V+  G C  G   I+V+EY+++  L++ L                +A  +L   + 
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
             I   IA G+ +L  +   H VHRD+   N L+      KIGDFG+++   D  +    
Sbjct: 136 LHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYY 189
Query: 209 RIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLLE 263
           R+ G T     ++ PE ++  + T ++DV+SFGV++ EI +    GK  W Q+ N  ++E
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---YGKQPWFQLSNTEVIE 246
Query: 264 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
              Q    E+P            P E+     V   C Q    +R  + ++ K+L
Sbjct: 247 CITQGRVLERP---------RVCPKEV---YDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 109/202 (53%), Gaps = 11/202 (5%)
Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           +  +IG G FGTVYKG       + +  ++A + Q ++ F  E+  L   RH N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
                 +  +V ++ E +SL   L        K    K  DI    A+G+ +LH +    
Sbjct: 72  YST-APQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAK---S 124
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVL---GG 225
           I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+  ++APE +      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 226 QLTMKADVYSFGVLVLEIISGR 247
             + ++DVY+FG+++ E+++G+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 131/277 (47%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 166
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL ++  D+     T   G     + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 227 FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC--------- 275
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 134/284 (47%), Gaps = 27/284 (9%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRH 101
           +  +   +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ +
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAP 219
           L +      VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +P
Sbjct: 151 LSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD 279
           E +   + T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++   
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC-- 263
Query: 280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
                  P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 264 -------PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 297

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 136/278 (48%), Gaps = 28/278 (10%)
Query: 54  IGRGGFGTVYKGTL--TNGRR---IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVEL 107
           IG G FG VYKG L  ++G++   +A+K L A   +  R +F+ E   +    H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
            G   +    +++ EY+EN +LD+ L    + + + +  +   +  GIA G+ +L     
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANM-- 166
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGG 225
            + VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + APE +   
Sbjct: 167 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 226 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY 285
           + T  +DV+SFG+++ E+++     +  W   N  +++      +   P++         
Sbjct: 226 KFTSASDVWSFGIVMWEVMT--YGERPYWELSNHEVMKAINDGFRLPTPMDC-------- 275
Query: 286 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
            P+ I + M     C Q   +RRP+   ++ +L K IR
Sbjct: 276 -PSAIYQLM---MQCWQQERARRPKFADIVSILDKLIR 309

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 139/293 (47%), Gaps = 39/293 (13%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQG-------VREFITEIMT 95
           A ++     +IG+GGFG V+KG L   + + A+K L     +G        +EF  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +SN+ HPN+V+L G      R  +V E+V    L   LL        + W  +  + + I
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDI 131
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLD--QEFNP---KIGDFGLAKLFPDNITHITTRI 210
           A G+ ++  +  P IVHRD+++ NI L    E  P   K+ DF L++       H  + +
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGL 186
Query: 211 AGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNS-GKAMWGQMNKFLLEWAWQ 267
            G   ++APE +   +   T KAD YSF +++  I++G     +  +G++ KF+      
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFI-----N 240
Query: 268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           + +EE  L    PE  + PP    R   V   C      +RP  + ++K L++
Sbjct: 241 MIREEG-LRPTIPE--DCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 139/293 (47%), Gaps = 39/293 (13%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQG-------VREFITEIMT 95
           A ++     +IG+GGFG V+KG L   + + A+K L     +G        +EF  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +SN+ HPN+V+L G      R  +V E+V    L   LL        + W  +  + + I
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDI 131
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLD--QEFNP---KIGDFGLAKLFPDNITHITTRI 210
           A G+ ++  +  P IVHRD+++ NI L    E  P   K+ DFG ++       H  + +
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGL 186
Query: 211 AGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNS-GKAMWGQMNKFLLEWAWQ 267
            G   ++APE +   +   T KAD YSF +++  I++G     +  +G++ KF+      
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFI-----N 240
Query: 268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           + +EE  L    PE  + PP    R   V   C      +RP  + ++K L++
Sbjct: 241 MIREEG-LRPTIPE--DCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 132/277 (47%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 137
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +PE +   +
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 198 FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC--------- 246
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 247 PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 116/273 (42%), Gaps = 35/273 (12%)
Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV 112
           +G+G FG   K T    G  + +K L    ++  R F+ E+  +  + HPN+++ IG   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 113 QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH 172
           +  R   + EY++  +L  ++      + +  W +R      IA G+A+LH     +I+H
Sbjct: 78  KDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 173 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-------------TRIAGTTGYLAP 219
           RD+ + N L+ +  N  + DFGLA+L  D  T                  + G   ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD 279
           E + G     K DV+SFG+++ EII   N+      +   F L               V 
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--------------VR 237
Query: 280 PELGEY-PPNEIIRYMKVAFFCTQAAASRRPQM 311
             L  Y PPN    +  +   C      +RP  
Sbjct: 238 GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSF 270

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 19/204 (9%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATK--ANIKLNWEKRSDICVGIAKGLAFLH 163
            G C    RR   L+ EY+   SL   L    +   +IKL  +  S IC    KG+ +L 
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL-LQYTSQIC----KGMEYLG 134
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEY 221
                  +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE 
Sbjct: 135 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 222 VLGGQLTMKADVYSFGVLVLEIIS 245
           +   + ++ +DV+SFGV++ E+ +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 131
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 118/235 (50%), Gaps = 16/235 (6%)
Query: 15  KSAEREAPQGVDGELLRNVNHFSYT--ELRSATDDFHLSNKIGRGGFGTVYKGTL-TNGR 71
           +S +RE PQ V  E  R          + RS  D+F    KIG G  G V   T+ ++G+
Sbjct: 45  RSPQRE-PQRVSHEQFRAALQLVVDPGDPRSYLDNF---IKIGEGSTGIVCIATVRSSGK 100
Query: 72  RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 131
            +AVK +    +Q       E++ + + +H N+VE+    + G    +V E++E  +L  
Sbjct: 101 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 160
Query: 132 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 191
           ++      + ++N E+ + +C+ + + L+ LH +    ++HRDIK+ +ILL  +   K+ 
Sbjct: 161 IV-----THTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 212
Query: 192 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           DFG        +      + GT  ++APE +       + D++S G++V+E++ G
Sbjct: 213 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 118/235 (50%), Gaps = 16/235 (6%)
Query: 15  KSAEREAPQGVDGELLRNVNHFSYT--ELRSATDDFHLSNKIGRGGFGTVYKGTL-TNGR 71
           +S +RE PQ V  E  R          + RS  D+F    KIG G  G V   T+ ++G+
Sbjct: 122 RSPQRE-PQRVSHEQFRAALQLVVDPGDPRSYLDNF---IKIGEGSTGIVCIATVRSSGK 177
Query: 72  RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 131
            +AVK +    +Q       E++ + + +H N+VE+    + G    +V E++E  +L  
Sbjct: 178 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 237
Query: 132 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 191
           ++      + ++N E+ + +C+ + + L+ LH +    ++HRDIK+ +ILL  +   K+ 
Sbjct: 238 IV-----THTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 289
Query: 192 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           DFG        +      + GT  ++APE +       + D++S G++V+E++ G
Sbjct: 290 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYK-GTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLS 97
           + +  DF +   +G G FG V+   +  NGR  A+K L  E     + V     E + LS
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            V HP ++ + G      +  ++ +Y+E   L  +L  + +    +     +++C+    
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA--- 118
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 217
            L +LH +    I++RD+K  NILLD+  + KI DFG AK  PD    +T  + GT  Y+
Sbjct: 119 -LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYI 170
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISG 246
           APE V         D +SFG+L+ E+++G
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 131
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 130
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 131 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 117/234 (50%), Gaps = 16/234 (6%)
Query: 16  SAEREAPQGVDGELLRNVNHFSYT--ELRSATDDFHLSNKIGRGGFGTVYKGTL-TNGRR 72
           S +RE PQ V  E  R          + RS  D+F    KIG G  G V   T+ ++G+ 
Sbjct: 3   SPQRE-PQRVSHEQFRAALQLVVDPGDPRSYLDNF---IKIGEGSTGIVCIATVRSSGKL 58
Query: 73  IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 132
           +AVK +    +Q       E++ + + +H N+VE+    + G    +V E++E  +L  +
Sbjct: 59  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 118
Query: 133 LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD 192
           +      + ++N E+ + +C+ + + L+ LH +    ++HRDIK+ +ILL  +   K+ D
Sbjct: 119 V-----THTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSD 170
Query: 193 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           FG        +      + GT  ++APE +       + D++S G++V+E++ G
Sbjct: 171 FGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 129
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 130 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 134
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 135 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 117/234 (50%), Gaps = 16/234 (6%)
Query: 16  SAEREAPQGVDGELLRNVNHFSYT--ELRSATDDFHLSNKIGRGGFGTVYKGTL-TNGRR 72
           S +RE PQ V  E  R          + RS  D+F    KIG G  G V   T+ ++G+ 
Sbjct: 1   SPQRE-PQRVSHEQFRAALQLVVDPGDPRSYLDNF---IKIGEGSTGIVCIATVRSSGKL 56
Query: 73  IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 132
           +AVK +    +Q       E++ + + +H N+VE+    + G    +V E++E  +L  +
Sbjct: 57  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 116
Query: 133 LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD 192
           +      + ++N E+ + +C+ + + L+ LH +    ++HRDIK+ +ILL  +   K+ D
Sbjct: 117 V-----THTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSD 168
Query: 193 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           FG        +      + GT  ++APE +       + D++S G++V+E++ G
Sbjct: 169 FGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 109/202 (53%), Gaps = 11/202 (5%)
Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           +  +IG G FGTVYKG       + +  ++A + Q ++ F  E+  L   RH N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
              +  +  +V ++ E +SL   L        K    K  DI    A+G+ +LH +    
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAK---S 124
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVL---GG 225
           I+HRD+K++NI L ++   KIGDFGLA      + +H   +++G+  ++APE +      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 226 QLTMKADVYSFGVLVLEIISGR 247
             + ++DVY+FG+++ E+++G+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 131
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 136
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 137 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 162
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 137
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 138 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 138
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 139 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 135
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 136 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 149
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 150 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 149
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 150 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 137/284 (48%), Gaps = 39/284 (13%)
Query: 54  IGRGGFGTVYKGTL-TNGRR---IAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G FG V +G L   G++   +A+K L    +++  REF++E   +    HPN++ L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV-----GIAKGLAFLH 163
           G        +++ E++EN +LD  L        +LN  + + I +     GIA G+ +L 
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFL--------RLNDGQFTVIQLVGMLRGIASGMRYLA 133
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTG--YLAP 219
           E      VHRD+ A NIL++     K+ DFGL++   +N +    T+ + G     + AP
Sbjct: 134 EM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD 279
           E +   + T  +D +S+G+++ E++S     +  W   N+ ++     + Q+ +    + 
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMS--FGERPYWDMSNQDVIN---AIEQDYR----LP 241
Query: 280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P     PP+      ++   C Q   + RP+  QV+  L K IR
Sbjct: 242 P-----PPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 280

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 24/230 (10%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           D  L  ++G G FG V+     N         +AVK L   S+   ++F  E   L+ ++
Sbjct: 19  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 78
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL-----------GATKANIKLNWEKRS 149
           H ++V   G C +G   ++V+EY+ +  L+R L            G   A   L   +  
Sbjct: 79  HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 138
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITT 208
            +   +A G+ +L      H VHRD+   N L+ Q    KIGDFG+++ ++  +   +  
Sbjct: 139 AVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 195
Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
           R      ++ PE +L  + T ++DV+SFGV++ EI +    GK  W Q++
Sbjct: 196 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT---YGKQPWYQLS 242

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ EY+   SL   L    K   +++  K       I KG+ +L   
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 132
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HR++   NIL++ E   KIGDFGL K+ P +  +   +  G +   + APE + 
Sbjct: 133 -TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           L  ++G G FG V  G       +AVK +  E      EF  E  T+  + HP LV+  G
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
            C +     +V EY+ N  L   L    K    L   +  ++C  + +G+AFL       
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESH---Q 124
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN--ITHITTRIAGTTGYLAPEYVLGGQL 227
            +HRD+ A N L+D++   K+ DFG+ +   D+  ++ + T+      + APE     + 
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP--VKWSAPEVFHYFKY 182
Query: 228 TMKADVYSFGVLVLEIIS 245
           + K+DV++FG+L+ E+ S
Sbjct: 183 SSKSDVWAFGILMWEVFS 200

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 24/230 (10%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           D  L  ++G G FG V+     N         +AVK L   S+   ++F  E   L+ ++
Sbjct: 13  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 72
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL-----------GATKANIKLNWEKRS 149
           H ++V   G C +G   ++V+EY+ +  L+R L            G   A   L   +  
Sbjct: 73  HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 132
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITT 208
            +   +A G+ +L      H VHRD+   N L+ Q    KIGDFG+++ ++  +   +  
Sbjct: 133 AVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 189
Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
           R      ++ PE +L  + T ++DV+SFGV++ EI +    GK  W Q++
Sbjct: 190 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT---YGKQPWYQLS 236

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 53  KIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G+G FG+V    Y     N G  +AVK L   +++ +R+F  EI  L +++H N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 108 IGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C    RR   L+ E++   SL   L    K   +++  K       I KG+ +L   
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL---QKHKERIDHIKLLQYTSQICKGMEYLG-- 134
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                +HRD+   NIL++ E   KIGDFGL K+ P +      +  G +   + APE + 
Sbjct: 135 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 224 GGQLTMKADVYSFGVLVLEIIS 245
             + ++ +DV+SFGV++ E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TELCGTLDYLPP 175
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 147
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 148 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 201
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 136/284 (47%), Gaps = 39/284 (13%)
Query: 54  IGRGGFGTVYKGTL-TNGRR---IAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G FG V +G L   G++   +A+K L    +++  REF++E   +    HPN++ L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV-----GIAKGLAFLH 163
           G        +++ E++EN +LD  L        +LN  + + I +     GIA G+ +L 
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFL--------RLNDGQFTVIQLVGMLRGIASGMRYLA 135
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTG--YLAP 219
           E      VHRD+ A NIL++     K+ DFGL++   +N +    T+ + G     + AP
Sbjct: 136 EM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD 279
           E +   + T  +D +S+G+++ E++S     +  W   N+ ++    Q ++       + 
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSF--GERPYWDMSNQDVINAIEQDYR-------LP 243
Query: 280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P     PP+      ++   C Q   + RP+  QV+  L K IR
Sbjct: 244 P-----PPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 282

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 138
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 139 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 192
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 122
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T ++GT  YL P
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR---TTLSGTLDYLPP 176
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 131/277 (47%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V E +EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 166
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +PE +   +
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 227 FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC--------- 275
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 131/277 (47%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V E +EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 166
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 227 FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC--------- 275
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 276 PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 175
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 124
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 178
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPP 175
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           RS  D+F    KIG G  G V   T+ ++G+ +AVK +    +Q       E++ + + +
Sbjct: 19  RSYLDNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ 75
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           H N+VE+    + G    +V E++E  +L  ++      + ++N E+ + +C+ + + L+
Sbjct: 76  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALS 130
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            LH +    ++HRDIK+ +ILL  +   K+ DFG        +      + GT  ++APE
Sbjct: 131 VLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPE 186
Query: 221 YVLGGQLTMKADVYSFGVLVLEIISG 246
            +       + D++S G++V+E++ G
Sbjct: 187 LISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           RS  D+F    KIG G  G V   T+ ++G+ +AVK +    +Q       E++ + + +
Sbjct: 23  RSYLDNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ 79
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           H N+VE+    + G    +V E++E  +L  ++      + ++N E+ + +C+ + + L+
Sbjct: 80  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALS 134
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            LH +    ++HRDIK+ +ILL  +   K+ DFG        +      + GT  ++APE
Sbjct: 135 VLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPE 190
Query: 221 YVLGGQLTMKADVYSFGVLVLEIISG 246
            +       + D++S G++V+E++ G
Sbjct: 191 LISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           KIG+G  GTVY    +  G+ +A++ ++ + +      I EI+ +   ++PN+V  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           + G    +V EY+   SL  V+         ++  + + +C    + L FLH      ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 172 HRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 230
           HRDIK+ NILL  + + K+ DFG  A++ P+     T  + GT  ++APE V       K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 196
Query: 231 ADVYSFGVLVLEIISG 246
            D++S G++ +E+I G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 126
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H + V   +HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 127 SYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 180
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 126
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPP 180
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 120
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 121 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 174
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
           E + G     K D++S GVL  E + G+   +A
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TXLCGTLDYLPP 175
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
           E + G     K D++S GVL  E + G+   +A
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 126
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 180
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPP 175
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 122
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPP 176
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY     N + I A+K L  +   K GV  +   E+   S++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  YL P
Sbjct: 122 SYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLPP 175
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           KIG+G  GTVY    +  G+ +A++ ++ + +      I EI+ +   ++PN+V  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           + G    +V EY+   SL  V+         ++  + + +C    + L FLH      ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 172 HRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 230
           HRDIK+ NILL  + + K+ DFG  A++ P+      + + GT  ++APE V       K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVTRKAYGPK 196
Query: 231 ADVYSFGVLVLEIISG 246
            D++S G++ +E+I G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 124
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 178
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 131/277 (47%), Gaps = 27/277 (9%)
Query: 54  IGRGGFGTVYKGTLTNGRR----IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    HPN++ L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G   +    ++V E +EN SLD  L    K + +    +   +  GIA G+ +L +    
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 137
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQ 226
             VHRD+ A NIL++     K+ DFGL+++  D+     T   G     + +PE +   +
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 227 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
            T  +DV+S+G+++ E++S     +  W   N+ +++   + ++   P++          
Sbjct: 198 FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVDEGYRLPPPMDC--------- 246
Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
           P  + + M     C Q   + RP+  Q++ +L K IR
Sbjct: 247 PAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 125
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 126 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 179
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY     + + L   +K     + ++ +     +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELANAL 126
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 180
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           F +  K+G G +G+VYK      G+ +A+K +  ES   ++E I EI  +     P++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G   + T   +V EY    S+  ++    K    L  ++ + I     KGL +LH   
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYLH--- 142
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
               +HRDIKA NILL+ E + K+ DFG+A    D +      + GT  ++APE +    
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK-RNXVIGTPFWMAPEVIQEIG 201
Query: 227 LTMKADVYSFGVLVLEIISGR 247
               AD++S G+  +E+  G+
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           KIG+G  GTVY    +  G+ +A++ ++ + +      I EI+ +   ++PN+V  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           + G    +V EY+   SL  V+         ++  + + +C    + L FLH      ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 172 HRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 230
           HRDIK+ NILL  + + K+ DFG  A++ P+      + + GT  ++APE V       K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYGPK 196
Query: 231 ADVYSFGVLVLEIISG 246
            D++S G++ +E+I G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           KIG+G  GTVY    +  G+ +A++ ++ + +      I EI+ +   ++PN+V  +   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           + G    +V EY+   SL  V+         ++  + + +C    + L FLH      ++
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 172 HRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 230
           HRDIK+ NILL  + + K+ DFG  A++ P+      + + GT  ++APE V       K
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYGPK 197
Query: 231 ADVYSFGVLVLEIISG 246
            D++S G++ +E+I G
Sbjct: 198 VDIWSLGIMAIEMIEG 213

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 106/209 (50%), Gaps = 26/209 (12%)
Query: 55  GRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQ 113
            RG FG V+K  L N   +AVK    + KQ  + E+  E+ +L  ++H N+++ IG   +
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKR 89
Query: 114 GTR----RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL--- 166
           GT       L+  + E  SL   L    KAN+ ++W +   I   +A+GLA+LHE++   
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFL----KANV-VSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 167 ----VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEY 221
                P I HRDIK+ N+LL       I DFGLA  F    +   T    GT  Y+APE 
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204
Query: 222 VLGG-----QLTMKADVYSFGVLVLEIIS 245
           + G         ++ D+Y+ G+++ E+ S
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G G FG V+  T     ++AVK +   S   V  F+ E   +  ++H  LV
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 240
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L     +    I+  E++   SL   L     +   L   K  D    IA+G+AF+ + 
Sbjct: 241 KLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR 297
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPDNITHITTRIAGTTGYLAPEYV 222
              + +HRD++A+NIL+      KI DFGLA++   FP               + APE +
Sbjct: 298 ---NYIHRDLRAANILVSASLVCKIADFGLARVGAKFP-------------IKWTAPEAI 341
Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
             G  T+K+DV+SFG+L++EI++
Sbjct: 342 NFGSFTIKSDVWSFGILLMEIVT 364

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 108/208 (51%), Gaps = 25/208 (12%)
Query: 48  FHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           + +  ++G G FG VYK      G   A K +  +S++ + ++I EI  L+   HP +V+
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLL----GATKANIKLNWEKRSDICVGIAKGLAFL 162
           L+G      +  ++ E+    ++D ++L    G T+  I++       +C  + + L FL
Sbjct: 73  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQMLEALNFL 125
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLAPE 220
           H +    I+HRD+KA N+L+  E + ++ DFG++     N+  +  R    GT  ++APE
Sbjct: 126 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYWMAPE 179
Query: 221 YVLGGQL-----TMKADVYSFGVLVLEI 243
            V+   +       KAD++S G+ ++E+
Sbjct: 180 VVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 118
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL P
Sbjct: 119 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 172
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
           E + G     K D++S GVL  E + G+   +A
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 205

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 108/208 (51%), Gaps = 25/208 (12%)
Query: 48  FHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           + +  ++G G FG VYK      G   A K +  +S++ + ++I EI  L+   HP +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLL----GATKANIKLNWEKRSDICVGIAKGLAFL 162
           L+G      +  ++ E+    ++D ++L    G T+  I++       +C  + + L FL
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQMLEALNFL 133
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLAPE 220
           H +    I+HRD+KA N+L+  E + ++ DFG++     N+  +  R    GT  ++APE
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYWMAPE 187
Query: 221 YVLGGQL-----TMKADVYSFGVLVLEI 243
            V+   +       KAD++S G+ ++E+
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 53  KIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           KIG G  G V       +GR++AVK +    +Q       E++ + + +H N+VE+    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           + G    ++ E+++  +L  ++     + ++LN E+ + +C  + + LA+LH +    ++
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQ---GVI 163
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKA 231
           HRDIK+ +ILL  +   K+ DFG       ++      + GT  ++APE +       + 
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKXLVGTPYWMAPEVISRSLYATEV 222
Query: 232 DVYSFGVLVLEIISG 246
           D++S G++V+E++ G
Sbjct: 223 DIWSLGIMVIEMVDG 237

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 63
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 121
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 122 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK 178
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 63
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 121
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 122 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 178
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 67
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 125
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 126 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 182
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 67
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 125
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 126 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 53  KIGRGGFGTVYKGTLTNGRRIAVKP--LSAESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           K+G G +G VYK   + GR +A+K   L AE +      I EI  L  + HPN+V LI  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 111 CVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                   LV+E++E +    LD    G   + IK+           + +G+A  H+   
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI-------YLYQLLRGVAHCHQH-- 138
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-Q 226
             I+HRD+K  N+L++ +   K+ DFGLA+ F   +   T  +  T  Y AP+ ++G  +
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKK 196
Query: 227 LTMKADVYSFGVLVLEIISGR 247
            +   D++S G +  E+I+G+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 53  KIGRGGFGTVYKGTLTNGRRIAVKP--LSAESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           K+G G +G VYK   + GR +A+K   L AE +      I EI  L  + HPN+V LI  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 111 CVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                   LV+E++E +    LD    G   + IK+           + +G+A  H+   
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI-------YLYQLLRGVAHCHQH-- 138
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-Q 226
             I+HRD+K  N+L++ +   K+ DFGLA+ F   +   T  +  T  Y AP+ ++G  +
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKK 196
Query: 227 LTMKADVYSFGVLVLEIISGR 247
            +   D++S G +  E+I+G+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           LS +IG G FGTVYKG       + +  +   + +  + F  E+  L   RH N++  +G
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
              +    I V ++ E +SL + L        K    +  DI    A+G+ +LH +   +
Sbjct: 100 YMTKDNLAI-VTQWCEGSSLYKHL---HVQETKFQMFQLIDIARQTAQGMDYLHAK---N 152
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVL---GG 225
           I+HRD+K++NI L +    KIGDFGLA +    + +    +  G+  ++APE +      
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 226 QLTMKADVYSFGVLVLEIISG 246
             + ++DVYS+G+++ E+++G
Sbjct: 213 PFSFQSDVYSYGIVLYELMTG 233

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 64
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 122
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 123 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK 179
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 105/201 (52%), Gaps = 12/201 (5%)
Query: 49  HLSN--KIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +L+N  KIG G  G V   T  + G+++AVK +    +Q       E++ + +  H N+V
Sbjct: 46  YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVV 105
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           ++    + G    +V E++E  +L  ++      + ++N E+ + +C+ + + L++LH +
Sbjct: 106 DMYSSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ 160
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
               ++HRDIK+ +ILL  +   K+ DFG        +      + GT  ++APE +   
Sbjct: 161 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKXLVGTPYWMAPEVISRL 216
Query: 226 QLTMKADVYSFGVLVLEIISG 246
               + D++S G++V+E+I G
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDG 237

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 147
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  YL P
Sbjct: 148 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLCGTLDYLPP 201
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 67
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 125
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 126 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 124
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 125 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 123
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  YL P
Sbjct: 124 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPP 177
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 75
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 133
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 134 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 190
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           D  + +K+G G FG VY+G        +AVK L  ++ + V EF+ E   +  ++HPNLV
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L+G C +     ++ E++   +L   L    +  +         +   I+  + +L ++
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQISSAMEYLEKK 128
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD+ A N L+ +    K+ DFGL++L   +             + APE +   
Sbjct: 129 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYN 185
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + ++K+DV++FGVL+ EI +
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 124
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  YL P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLPP 178
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 120
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 67
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 125
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 126 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 64
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 122
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 123 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 64
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 122
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 123 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 123
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI +FG +   P +     T + GT  YL P
Sbjct: 124 SYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLCGTLDYLPP 177
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 124
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  YL P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPP 178
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  YL P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLPP 175
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
           E + G     K D++S GVL  E + G+   +A
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 122
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  YL P
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT---LCGTLDYLPP 176
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 120
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 121
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  YL P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLPP 175
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
           E + G     K D++S GVL  E + G+   +A
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 124
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI +FG +   P +     T + GT  YL P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLCGTLDYLPP 178
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           KIG+G  GTVY    +  G+ +A++ ++ + +      I EI+ +   ++PN+V  +   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
           + G    +V EY+   SL  V+         ++  + + +C    + L FLH      ++
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 172 HRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 230
           HR+IK+ NILL  + + K+ DFG  A++ P+     T  + GT  ++APE V       K
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 197
Query: 231 ADVYSFGVLVLEIISG 246
            D++S G++ +E+I G
Sbjct: 198 VDIWSLGIMAIEMIEG 213

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY     + + L   +K     + ++ +     +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELANAL 126
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  YL P
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLXGTLDYLPP 180
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E + G     K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNV 99
           A +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           RHPN++ L G     TR  L+ EY    ++ R L   +K     + ++ +     +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANAL 124
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++ H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  YL P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLCGTLDYLPP 178
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
           E + G     K D++S GVL  E + G+   +A
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 88/290 (30%), Positives = 133/290 (45%), Gaps = 48/290 (16%)
Query: 54  IGRGGFGTV--YKGTLTN---GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVEL 107
           +G G FG V  Y    TN   G  +AVK L A+     R  +  EI  L  + H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 108 IGCCV-QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            GCC  QG + + LV EYV   SL   L   +    +L    +      I +G+A+LH +
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ-----ICEGMAYLHSQ 136
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
              H +HR++ A N+LLD +   KIGDFGLAK  P+   +   R  G +   + APE + 
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 224 GGQLTMKADVYSFGVLVLEIISGRNSGKA-----------MWGQMNKF----LLEWAWQL 268
             +    +DV+SFGV + E+++  +S ++             GQM       LLE   +L
Sbjct: 194 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 253
Query: 269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
            + +K             P E+   MK    C +  AS RP    +I +L
Sbjct: 254 PRPDK------------CPCEVYHLMKN---CWETEASFRPTFENLIPIL 288

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   +  ++HPNLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L+G C +     ++ E++   +L   L    +  +         +   I+  + +L ++
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQISSAMEYLEKK 128
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD+ A N L+ +    K+ DFGL++L   +             + APE +   
Sbjct: 129 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYN 185
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + ++K+DV++FGVL+ EI +
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +         +   I
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 120
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 67
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +         +   I
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 125
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 126 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +         +   I
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 120
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +         +   I
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 120
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 88/290 (30%), Positives = 133/290 (45%), Gaps = 48/290 (16%)
Query: 54  IGRGGFGTV--YKGTLTN---GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVEL 107
           +G G FG V  Y    TN   G  +AVK L A+     R  +  EI  L  + H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 108 IGCCV-QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            GCC  QG + + LV EYV   SL   L   +    +L    +      I +G+A+LH +
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ-----ICEGMAYLHAQ 136
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
              H +HR++ A N+LLD +   KIGDFGLAK  P+   +   R  G +   + APE + 
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 224 GGQLTMKADVYSFGVLVLEIISGRNSGKA-----------MWGQMNKF----LLEWAWQL 268
             +    +DV+SFGV + E+++  +S ++             GQM       LLE   +L
Sbjct: 194 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 253
Query: 269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
            + +K             P E+   MK    C +  AS RP    +I +L
Sbjct: 254 PRPDK------------CPCEVYHLMKN---CWETEASFRPTFENLIPIL 288

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +         +   I
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 120
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   +  ++HPNLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L+G C +     ++ E++   +L   L    +  +         +   I+  + +L ++
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQISSAMEYLEKK 128
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD+ A N L+ +    K+ DFGL++L   +             + APE +   
Sbjct: 129 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYN 185
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + ++K+DV++FGVL+ EI +
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNVRH 101
           +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN++ L G     TR  L+ EY    ++ R L   ++     + ++ +     +A  L++
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR----FDEQRTATYITELANALSY 127
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
            H +    ++HRDIK  N+LL      KI DFG +   P +     T + GT  YL PE 
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEM 181
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           + G     K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 30/207 (14%)
Query: 54  IGRGGFGTVYKGTL-----TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVEL 107
           +G G FGTVYKG       T    +A+K L+  +  +   EF+ E + ++++ HP+LV L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 108 IGCCVQGTRRIL--------VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +G C+  T +++        + EYV  +  D +      + + LNW      CV IAKG+
Sbjct: 83  LGVCLSPTIQLVTQLMPHGCLLEYVHEHK-DNI-----GSQLLLNW------CVQIAKGM 130
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 218
            +L E     +VHRD+ A N+L+    + KI DFGLA+L   D   +          ++A
Sbjct: 131 MYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 187
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIIS 245
            E +   + T ++DV+S+GV + E+++
Sbjct: 188 LECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 48  FHLSNKIGRGGFGTVY--KGTLTNGRRIAVKPL---SAESKQGVREFITEIMTLSNVRHP 102
           + + +K+G GG  TVY  + T+ N  ++A+K +     E ++ ++ F  E+   S + H 
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLA 160
           N+V +I    +     LV EY+E  +L   +   G    +  +N+  +      I  G+ 
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQ------ILDGIK 125
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
             H+     IVHRDIK  NIL+D     KI DFG+AK   +     T  + GT  Y +PE
Sbjct: 126 HAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGR 247
              G       D+YS G+++ E++ G 
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 30/207 (14%)
Query: 54  IGRGGFGTVYKGTL-----TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVEL 107
           +G G FGTVYKG       T    +A+K L+  +  +   EF+ E + ++++ HP+LV L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 108 IGCCVQGTRRIL--------VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +G C+  T +++        + EYV  +  D +      + + LNW      CV IAKG+
Sbjct: 106 LGVCLSPTIQLVTQLMPHGCLLEYVHEHK-DNI-----GSQLLLNW------CVQIAKGM 153
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLA 218
            +L E     +VHRD+ A N+L+    + KI DFGLA+L   D   +          ++A
Sbjct: 154 MYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 210
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIIS 245
            E +   + T ++DV+S+GV + E+++
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 134/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T ++++        LD V     K NI     LNW      CV IA
Sbjct: 77  NPHVCRLLGICLTSTVQLIMQLMPFGXLLDYV--REHKDNIGSQYLLNW------CVQIA 128
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 241
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 242 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 289

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 129/290 (44%), Gaps = 48/290 (16%)
Query: 54  IGRGGFGTV--YKGTLTN---GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVEL 107
           +G G FG V  Y    TN   G  +AVK L A++    R  +  EI  L  + H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 108 IGCC--VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            GCC         LV EYV   SL   L   +    +L    +      I +G+A+LH +
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ-----ICEGMAYLHAQ 153
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
              H +HRD+ A N+LLD +   KIGDFGLAK  P+       R  G +   + APE + 
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 224 GGQLTMKADVYSFGVLVLEIISGRNSGKA-----------MWGQMNKF----LLEWAWQL 268
             +    +DV+SFGV + E+++  +S ++             GQM       LLE   +L
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 270
Query: 269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
            + +K             P E+   MK    C +  AS RP    +I +L
Sbjct: 271 PRPDK------------CPAEVYHLMKN---CWETEASFRPTFENLIPIL 305

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 134/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T ++++        LD V     K NI     LNW      CV IA
Sbjct: 76  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 127
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 240
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 241 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 134/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T ++++        LD V     K NI     LNW      CV IA
Sbjct: 80  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 131
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 244
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 245 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 292

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 134/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T ++++        LD V     K NI     LNW      CV IA
Sbjct: 77  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 128
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 241
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 242 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 289

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 134/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T ++++        LD V     K NI     LNW      CV IA
Sbjct: 79  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 130
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 243
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 244 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 291

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGXLLDYV--REHKDNIGSQYLLNW------CVQIA 127
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 240
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 241 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 308
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +  N      +   I
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--NAVVLLYMATQI 366
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HR++ A N L+ +    K+ DFGL++L   +             
Sbjct: 367 SSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 423
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 134/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T ++++        LD V     K NI     LNW      CV IA
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 129
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 242
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 243 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 290

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYK-GTLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF   +++G G  G V K     +G  +A K +  E K  +R + I E+  L     P 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL    K   ++  E    + + + +GLA+L 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  Y+APE + 
Sbjct: 132 EKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMAPERLQ 186
Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   ++++D++S G+ ++E+  GR
Sbjct: 187 GTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           D  + +K+G G +G VY G        +AVK L  ++ + V EF+ E   +  ++HPNLV
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 91
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L+G C       +V EY+   +L   L    +  +         +   I+  + +L ++
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAV--VLLYMATQISSAMEYLEKK 149
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD+ A N L+ +    K+ DFGL++L   +             + APE +   
Sbjct: 150 ---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 206
Query: 226 QLTMKADVYSFGVLVLEIIS 245
             ++K+DV++FGVL+ EI +
Sbjct: 207 TFSIKSDVWAFGVLLWEIAT 226

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 82  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 133
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 134 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 246
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 247 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 294

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 121
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 122 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 234
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 235 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 118/244 (48%), Gaps = 26/244 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF   +++G G  G V+K +   +G  +A K +  E K  +R + I E+  L     P 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL    K   ++  +    + + + KGL +L 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 140
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  Y++PE + 
Sbjct: 141 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 195
Query: 224 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG 283
           G   ++++D++S G+ ++E+  GR    +  G M  F               EL+D  + 
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIF---------------ELLDYIVN 240
Query: 284 EYPP 287
           E PP
Sbjct: 241 EPPP 244

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 127
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 240
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 241 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 79  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 130
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 243
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 244 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 291

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 79  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 130
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 243
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 244 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 291

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 134
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 247
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 248 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 295

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 78  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 129
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 242
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 243 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 290

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 101 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 152
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 153 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 265
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 266 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 313

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNVRH 101
           +DF +   +G+G FG VY       + I A+K L  +   K GV  +   E+   S++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN++ L G     TR  L+ EY    ++ R L   ++     + ++ +     +A  L++
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR----FDEQRTATYITELANALSY 127
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
            H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  YL PE 
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT---LCGTLDYLPPEM 181
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           + G     K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF   +++G G  G V+K +   +G  +A K +  E K  +R + I E+  L     P 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL  A +    +  +    + + + KGL +L 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLR 183
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  Y++PE + 
Sbjct: 184 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 238
Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   ++++D++S G+ ++E+  GR
Sbjct: 239 GTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHPN 103
           + +H   KIG G +G VYK     G   A+K +  E + +G+    I EI  L  ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L        R +LV+E+++ +   + LL   +  ++    K     + +  G+A+ H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAK--SFLLQLLNGIAYCH 117
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           +     ++HRD+K  N+L+++E   KI DFGLA+ F   +   T  I  T  Y AP+ ++
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 224 GG-QLTMKADVYSFGVLVLEIISG 246
           G  + +   D++S G +  E+++G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 130/291 (44%), Gaps = 50/291 (17%)
Query: 54  IGRGGFGTV--YKGTLTN---GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVEL 107
           +G G FG V  Y    TN   G  +AVK L       +R  +  EI  L  + H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 108 IGCCV-QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK-------- 157
            GCC  QG + + LV EYV   SL   L                  CVG+A+        
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---------------PRHCVGLAQLLLFAQQI 120
Query: 158 --GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
             G+A+LH +   H +HR + A N+LLD +   KIGDFGLAK  P+   +   R  G + 
Sbjct: 121 CEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 177
Query: 216 --YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL----- 268
             + APE +   +    +DV+SFGV + E+++  +S ++   +  + +     Q+     
Sbjct: 178 VFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRL 237
Query: 269 -HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
               E+   L  P+     P EI   MK    C +  AS RP    ++ +L
Sbjct: 238 TELLERGERLPRPDRC---PCEIYHLMKN---CWETEASFRPTFQNLVPIL 282

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 130/291 (44%), Gaps = 50/291 (17%)
Query: 54  IGRGGFGTV--YKGTLTN---GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVEL 107
           +G G FG V  Y    TN   G  +AVK L       +R  +  EI  L  + H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 108 IGCCV-QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK-------- 157
            GCC  QG + + LV EYV   SL   L                  CVG+A+        
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---------------PRHCVGLAQLLLFAQQI 121
Query: 158 --GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
             G+A+LH +   H +HR + A N+LLD +   KIGDFGLAK  P+   +   R  G + 
Sbjct: 122 CEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 178
Query: 216 --YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL----- 268
             + APE +   +    +DV+SFGV + E+++  +S ++   +  + +     Q+     
Sbjct: 179 VFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRL 238
Query: 269 -HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
               E+   L  P+     P EI   MK    C +  AS RP    ++ +L
Sbjct: 239 TELLERGERLPRPDRC---PCEIYHLMKN---CWETEASFRPTFQNLVPIL 283

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF   +++G G  G V+K +   +G  +A K +  E K  +R + I E+  L     P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL  A +    +  +    + + + KGL +L 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLR 148
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  Y++PE + 
Sbjct: 149 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 203
Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   ++++D++S G+ ++E+  GR
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 174
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 79  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 130
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 243
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 244 -----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 291

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 104/210 (49%), Gaps = 7/210 (3%)
Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 269
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +  +         +   I
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQI 327
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L ++   + +HR++ A N L+ +    K+ DFGL++L   +             
Sbjct: 328 SSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           + APE +   + ++K+DV++FGVL+ EI +
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 182
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF   +++G G  G V+K +   +G  +A K +  E K  +R + I E+  L     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL    K   ++  +    + + + KGL +L 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  Y++PE + 
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 176
Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   ++++D++S G+ ++E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 86  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 137
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 138 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 250
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 251 -----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 298

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 40/300 (13%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS------AESKQGVREFITEIMTLSNV 99
           +F     +G G FGTVYKG  +  G ++ + P++      A S +  +E + E   +++V
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKI-PVAIMELREATSPKANKEILDEAYVMASV 108
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGI 155
            +P++  L+G C+  T +++         LD V     K NI     LNW      CV I
Sbjct: 109 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQI 160
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTT 214
           AKG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +         
Sbjct: 161 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK 273
            ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q   
Sbjct: 218 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ--- 274
Query: 274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                       PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 275 ------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 322

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF   +++G G  G V+K +   +G  +A K +  E K  +R + I E+  L     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL    K   ++  +    + + + KGL +L 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  Y++PE + 
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 176
Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   ++++D++S G+ ++E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 123
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 124 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 179
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHPN 103
           + +H   KIG G +G VYK     G   A+K +  E + +G+    I EI  L  ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L        R +LV+E+++ +   + LL   +  ++    K     + +  G+A+ H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAK--SFLLQLLNGIAYCH 117
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           +     ++HRD+K  N+L+++E   KI DFGLA+ F   +   T  +  T  Y AP+ ++
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 224 GG-QLTMKADVYSFGVLVLEIISG 246
           G  + +   D++S G +  E+++G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 127
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 240
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 241 -----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 182
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHPN 103
           + +H   KIG G +G VYK     G   A+K +  E + +G+    I EI  L  ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L        R +LV+E+++ +   + LL   +  ++    K     + +  G+A+ H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAK--SFLLQLLNGIAYCH 117
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           +     ++HRD+K  N+L+++E   KI DFGLA+ F   +   T  +  T  Y AP+ ++
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 224 GG-QLTMKADVYSFGVLVLEIISG 246
           G  + +   D++S G +  E+++G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF   +++G G  G V+K +   +G  +A K +  E K  +R + I E+  L     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL  A +    +  +    + + + KGL +L 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLR 121
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  Y++PE + 
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 176
Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   ++++D++S G+ ++E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF   +++G G  G V+K +   +G  +A K +  E K  +R + I E+  L     P 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL    K   ++  +    + + + KGL +L 
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++      I  +     GT  Y++PE + 
Sbjct: 125 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDEMANEFVGTRSYMSPERLQ 179
Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   ++++D++S G+ ++E+  GR
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF   +++G G  G V+K +   +G  +A K +  E K  +R + I E+  L     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL    K   ++  +    + + + KGL +L 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  Y++PE + 
Sbjct: 122 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 176
Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   ++++D++S G+ ++E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           DDF   +++G G  G V+K +   +G  +A K +  E K  +R + I E+  L     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL    K   ++  +    + + + KGL +L 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +      GT  Y++PE + 
Sbjct: 122 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 176
Query: 224 GGQLTMKADVYSFGVLVLEIISGR 247
           G   ++++D++S G+ ++E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 18/215 (8%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-GR-----RIAVKPLSAESKQGVRE-FITEIMTLSN 98
           ++      +G G FG V + T    G+     ++AVK L + +    +E  ++E+  +S+
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK------LNWEKRSDI 151
           + +H N+V L+G C  G   +++ EY     L   L    +A++       L        
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
              +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+   ++  +I    A
Sbjct: 158 SSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 212 G-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                ++APE +     T+++DV+S+G+L+ EI S
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 16/209 (7%)
Query: 54  IGRGGFGTV----YKGTLTN-GRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVEL 107
           +G G FG V    Y     N G ++AVK L  ES    + +   EI  L N+ H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 108 IGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C +  G    L+ E++ + SL   L    K   K+N +++    V I KG+ +L   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                VHRD+ A N+L++ E   KIGDFGL K    +    T +    +   + APE ++
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 224 GGQLTMKADVYSFGVLVLEIISGRNSGKA 252
             +  + +DV+SFGV + E+++  +S  +
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSS 231

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 16/209 (7%)
Query: 54  IGRGGFGTV----YKGTLTN-GRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVEL 107
           +G G FG V    Y     N G ++AVK L  ES    + +   EI  L N+ H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 108 IGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            G C +  G    L+ E++ + SL   L    K   K+N +++    V I KG+ +L   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVL 223
                VHRD+ A N+L++ E   KIGDFGL K    +    T +    +   + APE ++
Sbjct: 134 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 224 GGQLTMKADVYSFGVLVLEIISGRNSGKA 252
             +  + +DV+SFGV + E+++  +S  +
Sbjct: 191 QSKFYIASDVWSFGVTLHELLTYCDSDSS 219

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 18/215 (8%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-GR-----RIAVKPLSAESKQGVRE-FITEIMTLSN 98
           ++      +G G FG V + T    G+     ++AVK L + +    +E  ++E+  +S+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK------LNWEKRSDI 151
           + +H N+V L+G C  G   +++ EY     L   L    +A++       L        
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
              +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+   ++  +I    A
Sbjct: 166 SSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 212 G-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                ++APE +     T+++DV+S+G+L+ EI S
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 139/313 (44%), Gaps = 50/313 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K       ++AVK L ++ +++ + + I+E+  +
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD----- 150
             + +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +     
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 151 -------ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
                      +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 200
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            HI      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 201 HHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPV 258
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 259 EELFKLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 306
Query: 319 TKNIRL--NEEEL 329
            + + L  N+E L
Sbjct: 307 DRIVALTSNQEXL 319

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 73  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 124
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           +G+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 125 EGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 237
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 238 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 285

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 28/226 (12%)
Query: 55  GRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG 114
            RG FG V+K  L N   +AVK    + KQ  +    EI +   ++H NL++ I    +G
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQSE-REIFSTPGMKHENLLQFIAAEKRG 81
Query: 115 T----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL---- 166
           +       L+  + +  SL   L    K NI + W +   +   +++GL++LHE++    
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYL----KGNI-ITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 167 ----VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEY 221
                P I HRD K+ N+LL  +    + DFGLA  F P      T    GT  Y+APE 
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV 196
Query: 222 VLGG-----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 262
           + G         ++ D+Y+ G+++ E++S     KA  G +++++L
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVS---RCKAADGPVDEYML 239

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKP-LSAESKQGVREF-ITEIMTLSNVRHPNLVELIGC 110
           +G G +G V K      GR +A+K  L ++  + V++  + EI  L  +RH NLV L+  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI 170
           C +  R  LV+E+V++  LD + L        L+++        I  G+ F H     +I
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NI 145
Query: 171 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 230
           +HRDIK  NIL+ Q    K+ DFG A+            +A T  Y APE ++G     K
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKYGK 204
Query: 231 A-DVYSFGVLVLEIISG 246
           A DV++ G LV E+  G
Sbjct: 205 AVDVWAIGCLVTEMFMG 221

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 52  NKIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIG 109
           ++IG+G FG VYKG   + + + A+K +  E  +   E I  EI  LS    P +    G
Sbjct: 25  DRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 110 CCVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
             ++ T+  ++ EY+   S LD +  G  +          + I   I KGL +LH E   
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYI------ATILREILKGLDYLHSE--- 135
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLGGQL 227
             +HRDIKA+N+LL ++ + K+ DFG+A    D  T I      GT  ++APE +     
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 228 TMKADVYSFGVLVLEIISG 246
             KAD++S G+  +E+  G
Sbjct: 194 DFKADIWSLGITAIELAKG 212

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E+V+ + L + +  +    I L   K       + +GLA
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-GR-----RIAVKPLSAESKQGVRE-FITEIMTLSN 98
           ++      +G G FG V + T    G+     ++AVK L + +    +E  ++E+  +S+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----------ANIKLNWEK 147
           + +H N+V L+G C  G   +++ EY     L   L   ++          AN  L+   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 148 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 207
                  +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+   ++  +I 
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 208 TRIAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              A     ++APE +     T+++DV+S+G+L+ EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E+V  + L   +  +    I L   K       + +GLAF 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQD-LKTFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +  G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T ++++        LD V     K NI     LNW      CV IA
Sbjct: 83  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 134
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 247
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 248 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 295

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T ++++        LD V     K NI     LNW      CV IA
Sbjct: 80  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 131
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFG AKL   +   +          
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 244
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 245 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 292

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 114/221 (51%), Gaps = 29/221 (13%)
Query: 36  FSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSA---ESKQGVREF-- 89
           F  TELR           +G G FGTV+KG  +  G  I + P+     E K G + F  
Sbjct: 28  FKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKI-PVCIKVIEDKSGRQSFQA 79
Query: 90  ITE-IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLL--GATKANIKLNW 145
           +T+ ++ + ++ H ++V L+G C  G+   LV +Y+   SL D V    GA    + LNW
Sbjct: 80  VTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 138
Query: 146 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 205
                  V IAKG+ +L E     +VHR++ A N+LL      ++ DFG+A L P +   
Sbjct: 139 ------GVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189
Query: 206 ITTRIAGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           +    A T   ++A E +  G+ T ++DV+S+GV V E+++
Sbjct: 190 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T ++++        LD V     K NI     LNW      CV IA
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 129
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFG AKL   +   +          
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 242
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 243 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 290

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +  G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 127
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 240
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 241 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GL+F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLSFC 119
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 127
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFG AKL   +   +          
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 240
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 241 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 113/221 (51%), Gaps = 29/221 (13%)
Query: 36  FSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSA---ESKQGVREF-- 89
           F  TELR           +G G FGTV+KG  +  G  I + P+     E K G + F  
Sbjct: 10  FKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKI-PVCIKVIEDKSGRQSFQA 61
Query: 90  ITE-IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL---DRVLLGATKANIKLNW 145
           +T+ ++ + ++ H ++V L+G C  G+   LV +Y+   SL    R   GA    + LNW
Sbjct: 62  VTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 146 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 205
                  V IAKG+ +L E     +VHR++ A N+LL      ++ DFG+A L P +   
Sbjct: 121 ------GVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 206 ITTRIAGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           +    A T   ++A E +  G+ T ++DV+S+GV V E+++
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +  G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 134
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 247
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 248 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 295

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 134
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFG AKL   +   +          
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 247
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 248 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 295

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 136/310 (43%), Gaps = 48/310 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K       ++AVK L ++ +++ + + I+E+  +
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD----- 150
             + +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +     
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 151 -------ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
                      +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I
Sbjct: 137 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 189
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            HI      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 190 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL--GGSPYPGVPV 247
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 248 EELFKLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 295
Query: 319 TKNIRLNEEE 328
            + + L   +
Sbjct: 296 DRIVALTSNQ 305

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREFI-TEIMTLSNVRHPN 103
           D F    K+G G FG V+     ++G    +K ++ +  Q   E I  EI  L ++ HPN
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           ++++           +V E  E   L   ++ A      L+    +++   +   LA+ H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
            +   H+VH+D+K  NIL  Q+ +P    KI DFGLA+LF  +    +T  AGT  Y+AP
Sbjct: 142 SQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAP 195
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISG 246
           E V    +T K D++S GV++  +++G
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 19/217 (8%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAE---SKQGVREFITEIMT 95
           +++   +DF L   +G+G FG V+        +  A+K L  +       V   + E   
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 96  LSNV-RHPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
           LS    HP L  +  C  Q    +  V EY+    L    +   ++  K +  + +    
Sbjct: 72  LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFDLSRATFYAA 126
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIA 211
            I  GL FLH +    IV+RD+K  NILLD++ + KI DFG+ K   +N+     T    
Sbjct: 127 EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNEFC 180
Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           GT  Y+APE +LG +     D +SFGVL+ E++ G++
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 217

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 136/310 (43%), Gaps = 48/310 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K       ++AVK L ++ +++ + + I+E+  +
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD----- 150
             + +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +     
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 151 -------ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
                      +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 200
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            HI      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 201 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPV 258
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 259 EELFKLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 306
Query: 319 TKNIRLNEEE 328
            + + L   +
Sbjct: 307 DRIVALTSNQ 316

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 136/310 (43%), Gaps = 48/310 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K       ++AVK L ++ +++ + + I+E+  +
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD----- 150
             + +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +     
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 151 -------ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
                      +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I
Sbjct: 189 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 241
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            HI      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPV 299
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 300 EELFKLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 347
Query: 319 TKNIRLNEEE 328
            + + L   +
Sbjct: 348 DRIVALTSNQ 357

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 136/310 (43%), Gaps = 48/310 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K       ++AVK L ++ +++ + + I+E+  +
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD----- 150
             + +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +     
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 151 -------ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
                      +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I
Sbjct: 141 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 193
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            HI      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 194 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPV 251
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 252 EELFKLLKEGHRMDKPSNCT---------NELYMMMR---DCWHAVPSQRPTFKQLVEDL 299
Query: 319 TKNIRLNEEE 328
            + + L   +
Sbjct: 300 DRIVALTSNQ 309

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 136/310 (43%), Gaps = 48/310 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K       ++AVK L ++ +++ + + I+E+  +
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD----- 150
             + +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +     
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 151 -------ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
                      +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I
Sbjct: 140 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 192
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            HI      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 193 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPV 250
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 251 EELFKLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 298
Query: 319 TKNIRLNEEE 328
            + + L   +
Sbjct: 299 DRIVALTSNQ 308

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 136/310 (43%), Gaps = 48/310 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K       ++AVK L ++ +++ + + I+E+  +
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD----- 150
             + +H N++ L+G C Q     ++ EY    +L   L       ++ ++    +     
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 151 -------ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
                      +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 200
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            HI      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 201 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPV 258
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 259 EELFKLLKEGHRMDKPSNCT---------NELYMMMR---DCWHAVPSQRPTFKQLVEDL 306
Query: 319 TKNIRLNEEE 328
            + + L   +
Sbjct: 307 DRIVALTSNQ 316

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T ++++        LD V     K NI     LNW      CV IA
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 129
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFG AKL   +   +          
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 242
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 243 -----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 290

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 174
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 7/199 (3%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           D     ++G G FG V  G       +A+K +  E      EFI E   + N+ H  LV+
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           L G C +     ++ EY+ N  L   L    +   +   ++  ++C  + + + +L  + 
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK- 139
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
               +HRD+ A N L++ +   K+ DFGL++   D+    +        +  PE ++  +
Sbjct: 140 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSK 197
Query: 227 LTMKADVYSFGVLVLEIIS 245
            + K+D+++FGVL+ EI S
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 174
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 121
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 177
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 139/313 (44%), Gaps = 50/313 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K       ++AVK L ++ +++ + + I+E+  +
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI------------KL 143
             + +H N++ L+G C Q     ++ EY    +L   L       +            +L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 144 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
           + +        +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 200
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            HI      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 201 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPV 258
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 259 EELFKLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 306
Query: 319 TKNIRL--NEEEL 329
            + + L  N+E L
Sbjct: 307 DRIVALTSNQEYL 319

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+  +  +++ +GV    I EI  L  + HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+  +  +++ +GV    I EI  L  + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 53  KIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGC 110
           KIG+G FG V+KG     +++ A+K +  E  +   E I  EI  LS    P + +  G 
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 111 CVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
            ++ T+  ++ EY+   S LD +  G       L+  + + I   I KGL +LH E    
Sbjct: 74  YLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHSE---K 124
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
            +HRDIKA+N+LL +    K+ DFG+A    D      T + GT  ++APE +       
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 183
Query: 230 KADVYSFGVLVLEIISG 246
           KAD++S G+  +E+  G
Sbjct: 184 KADIWSLGITAIELARG 200

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 7/199 (3%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           D     ++G G FG V  G       +A+K +  E      EFI E   + N+ H  LV+
Sbjct: 9   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 67
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           L G C +     ++ EY+ N  L   L    +   +   ++  ++C  + + + +L  + 
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK- 123
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
               +HRD+ A N L++ +   K+ DFGL++   D+    +        +  PE ++  +
Sbjct: 124 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 181
Query: 227 LTMKADVYSFGVLVLEIIS 245
            + K+D+++FGVL+ EI S
Sbjct: 182 FSSKSDIWAFGVLMWEIYS 200

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 7/199 (3%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           D     ++G G FG V  G       +A+K +  E      EFI E   + N+ H  LV+
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           L G C +     ++ EY+ N  L   L    +   +   ++  ++C  + + + +L  + 
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
               +HRD+ A N L++ +   K+ DFGL++   D+    +        +  PE ++  +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 227 LTMKADVYSFGVLVLEIIS 245
            + K+D+++FGVL+ EI S
Sbjct: 178 FSSKSDIWAFGVLMWEIYS 196

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 7/199 (3%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           D     ++G G FG V  G       +A+K +  E      EFI E   + N+ H  LV+
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           L G C +     ++ EY+ N  L   L    +   +   ++  ++C  + + + +L  + 
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK- 139
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
               +HRD+ A N L++ +   K+ DFGL++   D+    +        +  PE ++  +
Sbjct: 140 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 197
Query: 227 LTMKADVYSFGVLVLEIIS 245
            + K+D+++FGVL+ EI S
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLAF 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 120
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE +
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 176
Query: 223 LGGQLTMKA-DVYSFGVLVLEIISGR 247
           LG +    A D++S G +  E+++ R
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRI----AVKPL-SAESKQGVREFITEIMTLSNVR 100
           +F     +G G FGTVYKG  +  G ++    A+K L  A S +  +E + E   +++V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK----LNWEKRSDICVGIA 156
           +P++  L+G C+  T +++         LD V     K NI     LNW      CV IA
Sbjct: 78  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIA 129
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTG 215
           KG+ +L +     +VHRD+ A N+L+    + KI DFG AKL   +   +          
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           ++A E +L    T ++DV+S+GV V E+++ G      +       +LE   +L Q    
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 242
Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
                      PP   I    +   C    A  RP+  ++I   +K  R  +  L   G
Sbjct: 243 -----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 290

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 7/199 (3%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           D     ++G G FG V  G       +A+K +  E      EFI E   + N+ H  LV+
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           L G C +     ++ EY+ N  L   L    +   +   ++  ++C  + + + +L  + 
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK- 124
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
               +HRD+ A N L++ +   K+ DFGL++   D+    +        +  PE ++  +
Sbjct: 125 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 182
Query: 227 LTMKADVYSFGVLVLEIIS 245
            + K+D+++FGVL+ EI S
Sbjct: 183 FSSKSDIWAFGVLMWEIYS 201

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 22/203 (10%)
Query: 54  IGRGGFGTVYKGT-LTNGRRI----AVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVEL 107
           +G G FGTVYKG  + +G  +    A+K L    S +  +E + E   ++ V  P +  L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +G C+  T +++         LD V    G   +   LNW      C+ IAKG+++L + 
Sbjct: 85  LGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYLEDV 138
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG---TTGYLAPEYV 222
               +VHRD+ A N+L+    + KI DFGLA+L   +I        G      ++A E +
Sbjct: 139 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKWMALESI 193
Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
           L  + T ++DV+S+GV V E+++
Sbjct: 194 LRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 7/199 (3%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           D     ++G G FG V  G       +A+K +  E      EFI E   + N+ H  LV+
Sbjct: 16  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 74
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           L G C +     ++ EY+ N  L   L    +   +   ++  ++C  + + + +L  + 
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK- 130
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
               +HRD+ A N L++ +   K+ DFGL++   D+    +        +  PE ++  +
Sbjct: 131 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 188
Query: 227 LTMKADVYSFGVLVLEIIS 245
            + K+D+++FGVL+ EI S
Sbjct: 189 FSSKSDIWAFGVLMWEIYS 207

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 136/310 (43%), Gaps = 48/310 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K       ++AVK L ++ +++ + + I+E+  +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI------------KL 143
             + +H N++ L+G C Q     ++ EY    +L   L       +            +L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 144 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
           + +        +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 185
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            HI      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL--GGSPYPGVPV 243
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 244 EELFKLLKEGHRMDKPSNCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 291
Query: 319 TKNIRLNEEE 328
            + + L   +
Sbjct: 292 DRIVALTSNQ 301

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAES--KQG-VREFITEIMTLSNVRH 101
           +DF + N +G+G F  VY+  ++  G  +A+K +  ++  K G V+    E+     ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P+++EL           LV E   N  ++R L    K     +  +       I  G+ +
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLY 127
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPE 220
           LH      I+HRD+  SN+LL +  N KI DFGLA +L   +  H T  + GT  Y++PE
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPE 182
Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGR 247
                   +++DV+S G +   ++ GR
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAV-KPLSAESKQGVREFITEIMTLSNVRHPNL 104
           D + +  ++G G FG VYK        +A  K +  +S++ + +++ EI  L++  HPN+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLG----ATKANIKLNWEKRSDICVGIAKGLA 160
           V+L+          ++ E+    ++D V+L      T++ I++       +C      L 
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-------VCKQTLDALN 149
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLA 218
           +LH+     I+HRD+KA NIL   + + K+ DFG++     N   I  R    GT  ++A
Sbjct: 150 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRXIQRRDXFIGTPYWMA 203
Query: 219 PEYVL-----GGQLTMKADVYSFGVLVLEI 243
           PE V+           KADV+S G+ ++E+
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L + +  +    I L   K       + +GLA
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 7/199 (3%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           D     ++G G FG V  G       +A+K +  E      EFI E   + N+ H  LV+
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           L G C +     ++ EY+ N  L   L    +   +   ++  ++C  + + + +L  + 
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK- 124
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
               +HRD+ A N L++ +   K+ DFGL++   D+    +        +  PE ++  +
Sbjct: 125 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSK 182
Query: 227 LTMKADVYSFGVLVLEIIS 245
            + K+D+++FGVL+ EI S
Sbjct: 183 FSSKSDIWAFGVLMWEIYS 201

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAV-KPLSAESKQGVREFITEIMTLSNVRHPNL 104
           D + +  ++G G FG VYK        +A  K +  +S++ + +++ EI  L++  HPN+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLG----ATKANIKLNWEKRSDICVGIAKGLA 160
           V+L+          ++ E+    ++D V+L      T++ I++       +C      L 
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-------VCKQTLDALN 149
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLA 218
           +LH+     I+HRD+KA NIL   + + K+ DFG++     N   I  R    GT  ++A
Sbjct: 150 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRXIQRRDSFIGTPYWMA 203
Query: 219 PEYVL-----GGQLTMKADVYSFGVLVLEI 243
           PE V+           KADV+S G+ ++E+
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAV-KPLSAESKQGVREFITEIMTLSNVRHPNL 104
           D + +  ++G G FG VYK        +A  K +  +S++ + +++ EI  L++  HPN+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLG----ATKANIKLNWEKRSDICVGIAKGLA 160
           V+L+          ++ E+    ++D V+L      T++ I++       +C      L 
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-------VCKQTLDALN 149
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           +LH+     I+HRD+KA NIL   + + K+ DFG++      I    + I GT  ++APE
Sbjct: 150 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPE 205
Query: 221 YVL-----GGQLTMKADVYSFGVLVLEI 243
            V+           KADV+S G+ ++E+
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 53  KIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGC 110
           KIG+G FG V+KG     +++ A+K +  E  +   E I  EI  LS    P + +  G 
Sbjct: 34  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 93
Query: 111 CVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
            ++ T+  ++ EY+   S LD +  G       L+  + + I   I KGL +LH E    
Sbjct: 94  YLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHSE---K 144
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
            +HRDIKA+N+LL +    K+ DFG+A    D      T + GT  ++APE +       
Sbjct: 145 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 203
Query: 230 KADVYSFGVLVLEIISGR 247
           KAD++S G+  +E+  G 
Sbjct: 204 KADIWSLGITAIELARGE 221

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 53  KIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGC 110
           KIG+G FG V+KG     +++ A+K +  E  +   E I  EI  LS    P + +  G 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 111 CVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
            ++ T+  ++ EY+   S LD +  G       L+  + + I   I KGL +LH E    
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHSE---K 139
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLGGQLT 228
            +HRDIKA+N+LL +    K+ DFG+A    D  T I      GT  ++APE +      
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSAYD 197
Query: 229 MKADVYSFGVLVLEIISG 246
            KAD++S G+  +E+  G
Sbjct: 198 SKADIWSLGITAIELARG 215

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-GR-----RIAVKPLSAESKQGVRE-FITEIMTLSN 98
           ++      +G G FG V + T    G+     ++AVK L + +    +E  ++E+  +S+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----------ANIKLNWEK 147
           + +H N+V L+G C  G   +++ EY     L   L   ++          AN   +   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 148 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 207
                  +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+   ++  +I 
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 208 TRIAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              A     ++APE +     T+++DV+S+G+L+ EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 135/305 (44%), Gaps = 38/305 (12%)
Query: 23  QGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPL 78
           + +D  LL  V        R  T   H    IG+G FG VY G       N  + A+K L
Sbjct: 1   RDLDSALLAEVKDVLIPHERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL 57
Query: 79  SAESK-QGVREFITEIMTLSNVRHPNLVELIGCCV--QGTRRILVYEYVENNSLDRVLLG 135
           S  ++ Q V  F+ E + +  + HPN++ LIG  +  +G   +L+      + L  +   
Sbjct: 58  SRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP 117
Query: 136 ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL 195
                +K          + +A+G+ +L E+     VHRD+ A N +LD+ F  K+ DFGL
Sbjct: 118 QRNPTVK----DLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGL 170
Query: 196 AKLFPDN-----ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSG 250
           A+   D        H   R+     + A E +   + T K+DV+SFGVL+ E+++    G
Sbjct: 171 ARDILDREYYSVQQHRHARLP--VKWTALESLQTYRFTTKSDVWSFGVLLWELLT---RG 225
Query: 251 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ 310
              +  ++ F L      H   +   L  P   EY P+ + + M+    C +A  + RP 
Sbjct: 226 APPYRHIDPFDLT-----HFLAQGRRLPQP---EYCPDSLYQVMQQ---CWEADPAVRPT 274
Query: 311 MNQVI 315
              ++
Sbjct: 275 FRVLV 279

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 127/295 (43%), Gaps = 45/295 (15%)
Query: 54  IGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVRE-FITEIMTLSNV-RHPNLV 105
           +G G FG V + T            +AVK L   +    RE  ++E+  LS +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 106 ELIGCCVQGTRRILVYEYVENNSL--------DRVLLGATKANI------KLNWEKRSDI 151
            L+G C  G   +++ EY     L        D  +   T   I       L+ E     
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
              +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+   ++  ++    A
Sbjct: 174 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 212 G-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLLEWAWQ 267
                ++APE +     T ++DV+S+G+ + E+ S  +S   G  +  +  K + E    
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 290
Query: 268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
           L  E  P E+ D              MK    C  A   +RP   Q+++++ K I
Sbjct: 291 LSPEHAPAEMYD-------------IMKT---CWDADPLKRPTFKQIVQLIEKQI 329

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 53  KIGRGGFGTVYKGTLTNGRR---IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELI 108
           ++G G FG+V +G     ++   +A+K L     K    E + E   +  + +P +V LI
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--------IAKGLA 160
           G C Q    +LV E      L + L+G           KR +I V         ++ G+ 
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVG-----------KREEIPVSNVAELLHQVSMGMK 124
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLA 218
           +L E+   + VHRD+ A N+LL      KI DFGL+K    + ++ T R AG     + A
Sbjct: 125 YLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 181
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWG 255
           PE +   + + ++DV+S+GV + E +S G+   K M G
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 53  KIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGC 110
           KIG+G FG V+KG     +++ A+K +  E  +   E I  EI  LS    P + +  G 
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 111 CVQGTRRILVYEYVENNS-LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
            ++ T+  ++ EY+   S LD +  G       L+  + + I   I KGL +LH E    
Sbjct: 74  YLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHSE---K 124
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLGGQLT 228
            +HRDIKA+N+LL +    K+ DFG+A    D  T I      GT  ++APE +      
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSAYD 182
Query: 229 MKADVYSFGVLVLEIISG 246
            KAD++S G+  +E+  G
Sbjct: 183 SKADIWSLGITAIELARG 200

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 127/295 (43%), Gaps = 45/295 (15%)
Query: 54  IGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVRE-FITEIMTLSNV-RHPNLV 105
           +G G FG V + T            +AVK L   +    RE  ++E+  LS +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 106 ELIGCCVQGTRRILVYEYVENNSL--------DRVLLGATKANI------KLNWEKRSDI 151
            L+G C  G   +++ EY     L        D  +   T   I       L+ E     
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
              +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+   ++  ++    A
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 212 G-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLLEWAWQ 267
                ++APE +     T ++DV+S+G+ + E+ S  +S   G  +  +  K + E    
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 267
Query: 268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
           L  E  P E+ D              MK    C  A   +RP   Q+++++ K I
Sbjct: 268 LSPEHAPAEMYD-------------IMKT---CWDADPLKRPTFKQIVQLIEKQI 306

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 107/226 (47%), Gaps = 37/226 (16%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPL-SAESKQGVREFITEIMTLSNVR 100
           R+      +  +IG+G +G V+ G    G ++AVK   + E     RE  TEI     +R
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMR 89
Query: 101 HPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGAT---KANIKLNWEKRSDICV 153
           H N++  I   ++GT    +  L+ +Y EN SL   L   T   K+ +KL +   S    
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVS---- 145
Query: 154 GIAKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-- 206
               GL  LH E+      P I HRD+K+ NIL+ +     I D GLA  F  +   +  
Sbjct: 146 ----GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 207 --TTRIAGTTGYLAPEYVLGGQLT-------MKADVYSFGVLVLEI 243
              TR+ GT  Y+ PE VL   L        + AD+YSFG+++ E+
Sbjct: 202 PPNTRV-GTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 127/295 (43%), Gaps = 45/295 (15%)
Query: 54  IGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVRE-FITEIMTLSNV-RHPNLV 105
           +G G FG V + T            +AVK L   +    RE  ++E+  LS +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 106 ELIGCCVQGTRRILVYEYVENNSL--------DRVLLGATKANI------KLNWEKRSDI 151
            L+G C  G   +++ EY     L        D  +   T   I       L+ E     
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
              +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+   ++  ++    A
Sbjct: 174 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 212 G-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLLEWAWQ 267
                ++APE +     T ++DV+S+G+ + E+ S  +S   G  +  +  K + E    
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 290
Query: 268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
           L  E  P E+ D              MK    C  A   +RP   Q+++++ K I
Sbjct: 291 LSPEHAPAEMYD-------------IMKT---CWDADPLKRPTFKQIVQLIEKQI 329

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 127/295 (43%), Gaps = 45/295 (15%)
Query: 54  IGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVRE-FITEIMTLSNV-RHPNLV 105
           +G G FG V + T            +AVK L   +    RE  ++E+  LS +  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 106 ELIGCCVQGTRRILVYEYVENNSL--------DRVLLGATKANI------KLNWEKRSDI 151
            L+G C  G   +++ EY     L        D  +   T   I       L+ E     
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
              +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+   ++  ++    A
Sbjct: 167 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 212 G-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLLEWAWQ 267
                ++APE +     T ++DV+S+G+ + E+ S  +S   G  +  +  K + E    
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 283
Query: 268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
           L  E  P E+ D              MK    C  A   +RP   Q+++++ K I
Sbjct: 284 LSPEHAPAEMYD-------------IMKT---CWDADPLKRPTFKQIVQLIEKQI 322

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 19/217 (8%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAE---SKQGVREFITEIMT 95
           +++   +DF L   +G+G FG V+        +  A+K L  +       V   + E   
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 96  LSNV-RHPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
           LS    HP L  +  C  Q    +  V EY+    L    +   ++  K +  + +    
Sbjct: 71  LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFDLSRATFYAA 125
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIA 211
            I  GL FLH +    IV+RD+K  NILLD++ + KI DFG+ K   +N+     T    
Sbjct: 126 EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNXFC 179
Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           GT  Y+APE +LG +     D +SFGVL+ E++ G++
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L   +  +    I L   K       + +GLA
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKTFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 127/295 (43%), Gaps = 45/295 (15%)
Query: 54  IGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVRE-FITEIMTLSNV-RHPNLV 105
           +G G FG V + T            +AVK L   +    RE  ++E+  LS +  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 106 ELIGCCVQGTRRILVYEYVENNSL--------DRVLLGATKANI------KLNWEKRSDI 151
            L+G C  G   +++ EY     L        D  +   T   I       L+ E     
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
              +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+   ++  ++    A
Sbjct: 169 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 212 G-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLLEWAWQ 267
                ++APE +     T ++DV+S+G+ + E+ S  +S   G  +  +  K + E    
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 285
Query: 268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
           L  E  P E+ D              MK    C  A   +RP   Q+++++ K I
Sbjct: 286 LSPEHAPAEMYD-------------IMKT---CWDADPLKRPTFKQIVQLIEKQI 324

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L   +  +    I L   K       + +GLA
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKDFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 118 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-----RH 101
           DF L   IGRG +  V    L    RI    +  +      E I  + T  +V      H
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV L  C    +R   V EYV    L    +   +   KL  E        I+  L +
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLAP 219
           LHE     I++RD+K  N+LLD E + K+ D+G+ K  L P + T   +   GT  Y+AP
Sbjct: 137 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAP 190
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           E + G       D ++ GVL+ E+++GR+
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGRS 219

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           +D  L  +IGRG FG V+ G L  +   +AVK         ++ +F+ E   L    HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V LIG C Q     +V E V+       L        +L  +    +    A G+ +L 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-TGYLAPEYV 222
            +     +HRD+ A N L+ ++   KI DFG+++   D +   +  +      + APE +
Sbjct: 231 SKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
             G+ + ++DV+SFG+L+ E  S
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-----RH 101
           DF L   IGRG +  V    L    RI    +  +      E I  + T  +V      H
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV L  C    +R   V EYV    L    +   +   KL  E        I+  L +
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLAP 219
           LHE     I++RD+K  N+LLD E + K+ D+G+ K  L P + T   +   GT  Y+AP
Sbjct: 122 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAP 175
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           E + G       D ++ GVL+ E+++GR+
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGRS 204

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 110/239 (46%), Gaps = 25/239 (10%)
Query: 25  VDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPL 78
           V+ E     + +   E   A +   +S ++G+G FG VY+G            R+A+K +
Sbjct: 4   VNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 63
Query: 79  SAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLL 134
           +  +    R EF+ E   +      ++V L+G   QG   +++ E +    L    R L 
Sbjct: 64  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 123
Query: 135 GATKANIKL---NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 191
            A   N  L   +  K   +   IA G+A+L+       VHRD+ A N ++ ++F  KIG
Sbjct: 124 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 180
Query: 192 DFGLAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           DFG+ +    +I        G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 181 DFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-GR-----RIAVKPLSAESKQGVRE-FITEIMTLSN 98
           ++      +G G FG V + T    G+     ++AVK L + +    +E  ++E+  +S+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD------- 150
           + +H N+V L+G C  G   +++ EY     L   L       ++ ++    +       
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 151 -----ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 205
                    +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+   ++  +
Sbjct: 166 RDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 206 ITTRIAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           I    A     ++APE +     T+++DV+S+G+L+ EI S
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-----RH 101
           DF L   IGRG +  V    L    RI    +  +      E I  + T  +V      H
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV L  C    +R   V EYV    L    +   +   KL  E        I+  L +
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLAP 219
           LHE     I++RD+K  N+LLD E + K+ D+G+ K  L P + T   +   GT  Y+AP
Sbjct: 126 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAP 179
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           E + G       D ++ GVL+ E+++GR+
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRS 208

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPN 103
           +D  L  +IGRG FG V+ G L  +   +AVK         ++ +F+ E   L    HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V LIG C Q     +V E V+       L        +L  +    +    A G+ +L 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-TGYLAPEYV 222
            +     +HRD+ A N L+ ++   KI DFG+++   D +   +  +      + APE +
Sbjct: 231 SKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
             G+ + ++DV+SFG+L+ E  S
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 134/307 (43%), Gaps = 43/307 (14%)
Query: 36  FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-E 88
           F   E   + +   L  ++G+G FG VY+G   +        R+AVK ++  +    R E
Sbjct: 4   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 63
Query: 89  FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN---- 144
           F+ E   +      ++V L+G   +G   ++V E + +  L +  L + +   + N    
Sbjct: 64  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRP 122
Query: 145 ---WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 201
               ++   +   IA G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    
Sbjct: 123 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR---- 175
Query: 202 NITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 256
           +I        G  G     ++APE +  G  T  +D++SFGV++ EI S           
Sbjct: 176 DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------- 224
Query: 257 MNKFLLEWAWQLHQEEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 315
               L E  +Q    E+ L+ V D    + P N   R   +   C Q     RP   +++
Sbjct: 225 ----LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 280
Query: 316 KMLTKNI 322
            +L  ++
Sbjct: 281 NLLKDDL 287

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L   +  +    I L   K       + +GLA
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKDFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 134/307 (43%), Gaps = 43/307 (14%)
Query: 36  FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-E 88
           F   E   + +   L  ++G+G FG VY+G   +        R+AVK ++  +    R E
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 89  FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN---- 144
           F+ E   +      ++V L+G   +G   ++V E + +  L +  L + +   + N    
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRP 125
Query: 145 ---WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 201
               ++   +   IA G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR---- 178
Query: 202 NITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 256
           +I        G  G     ++APE +  G  T  +D++SFGV++ EI S           
Sbjct: 179 DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------- 227
Query: 257 MNKFLLEWAWQLHQEEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 315
               L E  +Q    E+ L+ V D    + P N   R   +   C Q     RP   +++
Sbjct: 228 ----LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 316 KMLTKNI 322
            +L  ++
Sbjct: 284 NLLKDDL 290

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 103/227 (45%), Gaps = 38/227 (16%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITE--IMTLSNVRHPN 103
           D+  L   IGRG +G VYKG+L + R +AVK  S  ++Q    FI E  I  +  + H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDN 68
Query: 104 LVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           +   I    + T       +LV EY  N SL + L   T      +W     +   + +G
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRG 123
Query: 159 LAFLHEEL------VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-------PDNITH 205
           LA+LH EL       P I HRD+ + N+L+  +    I DFGL+          P    +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 206 ITTRIAGTTGYLAPEYVLGGQLTMK--------ADVYSFGVLVLEII 244
                 GT  Y+APE VL G + ++         D+Y+ G++  EI 
Sbjct: 184 AAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVR 100
           + ++F    KIG G +G VYK      G  +A+K +  +++ +GV    I EI  L  + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN+V+L+       +  LV+E++  + L   +  +    I L   K       + +GLA
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKDFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           F H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +      +  T  Y APE
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 221 YVLGGQLTMKA-DVYSFGVLVLEIISGR 247
            +LG +    A D++S G +  E+++ R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 50  LSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHP 102
           L  ++G+G FG VY+G   +        R+AVK ++  +    R EF+ E   +      
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------WEKRSDICVGI 155
           ++V L+G   +G   ++V E + +  L +  L + +   + N        ++   +   I
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           A G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    +I        G  G
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKG 192
Query: 216 -----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 270
                ++APE +  G  T  +D++SFGV++ EI S               L E  +Q   
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 237
Query: 271 EEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
            E+ L+ V D    + P N   R   +   C Q   + RP   +++ +L  ++
Sbjct: 238 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDL 290

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRR-IAVKPLSAESKQ------GVREFITEIMT 95
           A   +    +IG G +G V+K   L NG R +A+K +  ++ +       +RE +  +  
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRH 67
Query: 96  LSNVRHPNLVELIGCCV-----QGTRRILVYEYVENN---SLDRVL-LGATKANIKLNWE 146
           L    HPN+V L   C      + T+  LV+E+V+ +    LD+V   G     IK    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---- 123
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
              D+   + +GL FLH      +VHRD+K  NIL+      K+ DFGLA+++  +    
Sbjct: 124 ---DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMA 175
Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
            T +  T  Y APE +L        D++S G +  E+   +    G +   Q+ K L
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 138/313 (44%), Gaps = 50/313 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE--------- 146
             + +H N++ L+G C Q     ++ EY    +L   L       ++ +++         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 147 --KRSDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
             K    C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            +I      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 208 NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL--GGSPYPGIPV 265
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 266 EELFKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 313
Query: 319 TKNIRL--NEEEL 329
            + + L  NEE L
Sbjct: 314 DRILTLTTNEEYL 326

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-----RH 101
           DF L   IGRG +  V    L    RI    +  +      E I  + T  +V      H
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV L  C    +R   V EYV    L    +   +   KL  E        I+  L +
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLAP 219
           LHE     I++RD+K  N+LLD E + K+ D+G+ K  L P + T   +   GT  Y+AP
Sbjct: 169 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAP 222
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           E + G       D ++ GVL+ E+++GR+
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRS 251

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 50  LSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLV 105
           L + +G G FG V  G     G ++AVK L+ +   S   V +   EI  L   RHP+++
Sbjct: 20  LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L       +   +V EYV    L          N +L+ ++   +   I  G+ + H  
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
           +V   VHRD+K  N+LLD   N KI DFGL+ +  D          G+  Y APE V+ G
Sbjct: 136 MV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRXSCGSPNYAAPE-VISG 189
Query: 226 QLTM--KADVYSFGVLVLEIISG 246
           +L    + D++S GV++  ++ G
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCG 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNG-RRIAVKPLSAESKQ------GVREFITEIMT 95
           A   +    +IG G +G V+K   L NG R +A+K +  ++ +       +RE +  +  
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRH 67
Query: 96  LSNVRHPNLVELIGCCV-----QGTRRILVYEYVENN---SLDRVL-LGATKANIKLNWE 146
           L    HPN+V L   C      + T+  LV+E+V+ +    LD+V   G     IK    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---- 123
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
              D+   + +GL FLH      +VHRD+K  NIL+      K+ DFGLA+++  +    
Sbjct: 124 ---DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMA 175
Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
            T +  T  Y APE +L        D++S G +  E+   +    G +   Q+ K L
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 138/313 (44%), Gaps = 50/313 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE--------- 146
             + +H N++ L+G C Q     ++ EY    +L   L       ++ +++         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 147 --KRSDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
             K    C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            +I      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 208 NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL--GGSPYPGIPV 265
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 266 EELFKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 313
Query: 319 TKNIRL--NEEEL 329
            + + L  NEE L
Sbjct: 314 DRILTLTTNEEYL 326

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 36/292 (12%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRI--AVKPLSA-ESKQGVREFITEIMTLSNV-R 100
           +D    + IG G FG V K  +  +G R+  A+K +    SK   R+F  E+  L  +  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSL------------DRVLLGATKANIKLNWEKR 148
           HPN++ L+G C       L  EY  + +L            D     A      L+ ++ 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
                 +A+G+ +L ++     +HRD+ A NIL+ + +  KI DFGL++     +     
Sbjct: 135 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 191
Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 268
           R+     ++A E +     T  +DV+S+GVL+ EI+S    G    G     L E   Q 
Sbjct: 192 RLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL--GGTPYCGMTCAELYEKLPQG 247
Query: 269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           ++ EKPL   D         E+   M+    C +     RP   Q++  L +
Sbjct: 248 YRLEKPLNCDD---------EVYDLMRQ---CWREKPYERPSFAQILVSLNR 287

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 36/292 (12%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRI--AVKPLSA-ESKQGVREFITEIMTLSNV-R 100
           +D    + IG G FG V K  +  +G R+  A+K +    SK   R+F  E+  L  +  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSL------------DRVLLGATKANIKLNWEKR 148
           HPN++ L+G C       L  EY  + +L            D     A      L+ ++ 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
                 +A+G+ +L ++     +HRD+ A NIL+ + +  KI DFGL++     +     
Sbjct: 145 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 201
Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 268
           R+     ++A E +     T  +DV+S+GVL+ EI+S    G    G     L E   Q 
Sbjct: 202 RLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGTPYCGMTCAELYEKLPQG 257
Query: 269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           ++ EKPL   D         E+   M+    C +     RP   Q++  L +
Sbjct: 258 YRLEKPLNCDD---------EVYDLMRQ---CWREKPYERPSFAQILVSLNR 297

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNG-RRIAVKPLSAESKQ------GVREFITEIMT 95
           A   +    +IG G +G V+K   L NG R +A+K +  ++ +       +RE +  +  
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRH 67
Query: 96  LSNVRHPNLVELIGCCV-----QGTRRILVYEYVENN---SLDRVL-LGATKANIKLNWE 146
           L    HPN+V L   C      + T+  LV+E+V+ +    LD+V   G     IK    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---- 123
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
              D+   + +GL FLH      +VHRD+K  NIL+      K+ DFGLA+++  +    
Sbjct: 124 ---DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMA 175
Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
            T +  T  Y APE +L        D++S G +  E+   +    G +   Q+ K L
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 23/213 (10%)
Query: 53  KIGRGGFGTVYKGTL------TNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLV 105
           ++G   FG VYKG L         + +A+K L  +++  +RE F  E M  + ++HPN+V
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLL--------GATKAN--IKLNWEKRS--DICV 153
            L+G   +     +++ Y  +  L   L+        G+T  +  +K   E      +  
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 212
            IA G+ +L      H+VH+D+   N+L+  + N KI D GL + ++  +   +      
Sbjct: 153 QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209
Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              ++APE ++ G+ ++ +D++S+GV++ E+ S
Sbjct: 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 45  TDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVR---EFITEIMTLSNVR 100
           +D + L   +G GG   V+    L + R +AVK L A+  +       F  E    + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 101 HPNLVELIGC----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           HP +V +          G    +V EYV+  +L  ++        K   E  +D C    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC---- 126
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD--NITHITTRIAGTT 214
           + L F H+     I+HRD+K +NIL+      K+ DFG+A+   D  N    T  + GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            YL+PE   G  +  ++DVYS G ++ E+++G
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 138/315 (43%), Gaps = 43/315 (13%)
Query: 36  FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-E 88
           F   E   + +   L  ++G+G FG VY+G   +        R+AVK ++  +    R E
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 89  FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN---- 144
           F+ E   +      ++V L+G   +G   ++V E + +  L +  L + +   + N    
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRP 125
Query: 145 ---WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 201
               ++   +   IA G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR---- 178
Query: 202 NITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 256
           +I        G  G     ++APE +  G  T  +D++SFGV++ EI S           
Sbjct: 179 DIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------- 227
Query: 257 MNKFLLEWAWQLHQEEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 315
               L E  +Q    E+ L+ V D    + P N   R   +   C Q     RP   +++
Sbjct: 228 ----LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 316 KMLTKNIRLNEEELT 330
            +L  ++  +  E++
Sbjct: 284 NLLKDDLHPSFPEVS 298

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 23/213 (10%)
Query: 53  KIGRGGFGTVYKGTL------TNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLV 105
           ++G   FG VYKG L         + +A+K L  +++  +RE F  E M  + ++HPN+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLL--------GATKAN--IKLNWEKRS--DICV 153
            L+G   +     +++ Y  +  L   L+        G+T  +  +K   E      +  
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAG 212
            IA G+ +L      H+VH+D+   N+L+  + N KI D GL + ++  +   +      
Sbjct: 136 QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              ++APE ++ G+ ++ +D++S+GV++ E+ S
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 110/239 (46%), Gaps = 25/239 (10%)
Query: 25  VDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPL 78
           V+ E     + +   E   A +   +S ++G+G FG VY+G            R+A+K +
Sbjct: 4   VNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 63
Query: 79  SAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLL 134
           +  +    R EF+ E   +      ++V L+G   QG   +++ E +    L    R L 
Sbjct: 64  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 123
Query: 135 GATKANIKL---NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 191
              + N  L   +  K   +   IA G+A+L+       VHRD+ A N ++ ++F  KIG
Sbjct: 124 PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 180
Query: 192 DFGLAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           DFG+ +    +I        G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 181 DFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 9/198 (4%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV 112
           +G+G +G VY G  L+N  RIA+K +     +  +    EI    +++H N+V+ +G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 113 QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH 172
           +     +  E V   SL   LL +    +K N +        I +GL +LH+     IVH
Sbjct: 90  ENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 173 RDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ--LTM 229
           RDIK  N+L++      KI DFG +K     I   T    GT  Y+APE +  G      
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 230 KADVYSFGVLVLEIISGR 247
            AD++S G  ++E+ +G+
Sbjct: 205 AADIWSLGCTIIEMATGK 222

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITE 92
           E   A +   +S ++G+G FG VY+G            R+A+K ++  +    R EF+ E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWE 146
              +      ++V L+G   QG   +++ E +    L    R L  A   N  L   +  
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 128
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
           K   +   IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I   
Sbjct: 129 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 181
Query: 207 TTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 182 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 116/257 (45%), Gaps = 29/257 (11%)
Query: 11  FHSKKSAEREAP----QGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT 66
           FH K++  R         V+ E     + +   E   A +   +S ++G+G FG VY+G 
Sbjct: 8   FHRKRNNSRLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGV 67
Query: 67  LTN------GRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRIL 119
                      R+A+K ++  +    R EF+ E   +      ++V L+G   QG   ++
Sbjct: 68  AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 127
Query: 120 VYEYVENNSLD---RVLLGATKANIKL---NWEKRSDICVGIAKGLAFLHEELVPHIVHR 173
           + E +    L    R L    + N  L   +  K   +   IA G+A+L+       VHR
Sbjct: 128 IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHR 184
Query: 174 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLT 228
           D+ A N ++ ++F  KIGDFG+ +    +I        G  G     +++PE +  G  T
Sbjct: 185 DLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 240
Query: 229 MKADVYSFGVLVLEIIS 245
             +DV+SFGV++ EI +
Sbjct: 241 TYSDVWSFGVVLWEIAT 257

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 45  TDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVR---EFITEIMTLSNVR 100
           +D + L   +G GG   V+    L + R +AVK L A+  +       F  E    + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 101 HPNLVELIGC----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           HP +V +          G    +V EYV+  +L  ++        K   E  +D C    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC---- 126
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA--GTT 214
           + L F H+     I+HRD+K +NI++      K+ DFG+A+   D+   +T   A  GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            YL+PE   G  +  ++DVYS G ++ E+++G
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 45  TDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVR---EFITEIMTLSNVR 100
           +D + L   +G GG   V+    L + R +AVK L A+  +       F  E    + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 101 HPNLVELIGC----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           HP +V +          G    +V EYV+  +L  ++        K   E  +D C    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC---- 126
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA--GTT 214
           + L F H+     I+HRD+K +NI++      K+ DFG+A+   D+   +T   A  GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            YL+PE   G  +  ++DVYS G ++ E+++G
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 138/315 (43%), Gaps = 43/315 (13%)
Query: 36  FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-E 88
           F   E   + +   L  ++G+G FG VY+G   +        R+AVK ++  +    R E
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 89  FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN---- 144
           F+ E   +      ++V L+G   +G   ++V E + +  L +  L + +   + N    
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRP 125
Query: 145 ---WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 201
               ++   +   IA G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR---- 178
Query: 202 NITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 256
           +I        G  G     ++APE +  G  T  +D++SFGV++ EI S           
Sbjct: 179 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------- 227
Query: 257 MNKFLLEWAWQLHQEEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 315
               L E  +Q    E+ L+ V D    + P N   R   +   C Q     RP   +++
Sbjct: 228 ----LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 316 KMLTKNIRLNEEELT 330
            +L  ++  +  E++
Sbjct: 284 NLLKDDLHPSFPEVS 298

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 14/210 (6%)
Query: 53  KIGRGGFGTVYKGTLTNGRR---IAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVELI 108
           ++G G FG+V +G     ++   +A+K L     K    E + E   +  + +P +V LI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G C Q    +LV E      L + L+G  +   ++     +++   ++ G+ +L E+   
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK--- 455
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGGQ 226
           + VHR++ A N+LL      KI DFGL+K    + ++ T R AG     + APE +   +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 227 LTMKADVYSFGVLVLEIIS-GRNSGKAMWG 255
            + ++DV+S+GV + E +S G+   K M G
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 9/198 (4%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV 112
           +G+G +G VY G  L+N  RIA+K +     +  +    EI    +++H N+V+ +G   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 113 QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH 172
           +     +  E V   SL   LL +    +K N +        I +GL +LH+     IVH
Sbjct: 76  ENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 131
Query: 173 RDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ--LTM 229
           RDIK  N+L++      KI DFG +K     I   T    GT  Y+APE +  G      
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPRGYGK 190
Query: 230 KADVYSFGVLVLEIISGR 247
            AD++S G  ++E+ +G+
Sbjct: 191 AADIWSLGCTIIEMATGK 208

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 11/203 (5%)
Query: 53  KIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGC 110
           +IG+G FG V+KG     +++ A+K +  E  +   E I  EI  LS      + +  G 
Sbjct: 30  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGS 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI 170
            ++G++  ++ EY+   S   +L        ++     + +   I KGL +LH E     
Sbjct: 90  YLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEILKGLDYLHSE---KK 141
Query: 171 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 230
           +HRDIKA+N+LL ++ + K+ DFG+A    D      T + GT  ++APE +       K
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSK 200
Query: 231 ADVYSFGVLVLEIISGRNSGKAM 253
           AD++S G+  +E+  G      M
Sbjct: 201 ADIWSLGITAIELAKGEPPNSDM 223

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITE 92
           E   A +   +S ++G+G FG VY+G            R+A+K ++  +    R EF+ E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWE 146
              +      ++V L+G   QG   +++ E +    L    R L    + N  L   +  
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
           K   +   IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I   
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXET 176
Query: 207 TTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 177 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 137/311 (44%), Gaps = 50/311 (16%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE--------- 146
             + +H N++ L+G C Q     ++ EY    +L   L       ++ +++         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 147 --KRSDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
             K    C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            +I      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL--GGSPYPGIPV 265
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 266 EELFKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 313
Query: 319 TKNIRL--NEE 327
            + + L  NEE
Sbjct: 314 DRILTLTTNEE 324

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 53  KIGRGGFGTVYKG-TLTNGRRIAVKP-LSAESKQGVREF-ITEIMTLSNVRHPNLVELIG 109
           KIG G +G V+K      G+ +A+K  L +E    +++  + EI  L  ++HPNLV L+ 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 110 CCVQGTRRILVYEYVEN---NSLDRVLLGATKANIK-LNWEKRSDICVGIAKGLAFLHEE 165
              +  R  LV+EY ++   + LDR   G  +  +K + W+          + + F H+ 
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNFCHKH 121
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD+K  NIL+ +    K+ DFG A+L      +    +A T  Y +PE ++G 
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGD 177
Query: 226 -QLTMKADVYSFGVLVLEIISG 246
            Q     DV++ G +  E++SG
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSG 199

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 136/308 (44%), Gaps = 44/308 (14%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE--------- 146
             + +H N++ L+G C Q     ++ EY    +L   L       ++ +++         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 147 --KRSDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
             K    C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+   +NI
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNI 210
Query: 204 THITTRIAG--TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 261
            +      G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L
Sbjct: 211 DYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL--GGSPYPGIPVEEL 268
Query: 262 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 321
            +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + 
Sbjct: 269 FKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRI 316
Query: 322 IRL--NEE 327
           + L  NEE
Sbjct: 317 LTLTTNEE 324

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITE 92
           E   A +   +S ++G+G FG VY+G            R+A+K ++  +    R EF+ E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWE 146
              +      ++V L+G   QG   +++ E +    L    R L    + N  L   +  
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
           K   +   IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I   
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXET 185
Query: 207 TTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 186 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 137/311 (44%), Gaps = 50/311 (16%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE--------- 146
             + +H N++ L+G C Q     ++ EY    +L   L       ++ +++         
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 147 --KRSDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
             K    C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            +I      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPV 265
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 266 EELFKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 313
Query: 319 TKNIRL--NEE 327
            + + L  NEE
Sbjct: 314 DRILTLTTNEE 324

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 130/293 (44%), Gaps = 43/293 (14%)
Query: 50  LSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHP 102
           L  ++G+G FG VY+G   +        R+AVK ++  +    R EF+ E   +      
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------WEKRSDICVGI 155
           ++V L+G   +G   ++V E + +  L +  L + +   + N        ++   +   I
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           A G+A+L+ +     VHRD+ A N ++  +F  KIGDFG+ +    +I        G  G
Sbjct: 139 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKG 191
Query: 216 -----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 270
                ++APE +  G  T  +D++SFGV++ EI S               L E  +Q   
Sbjct: 192 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 236
Query: 271 EEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
            E+ L+ V D    + P N   R   +   C Q     RP   +++ +L  ++
Sbjct: 237 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 289

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVR---EFITEIMTLSNVRHP 102
           +F +  KIGRG F  VY+   L +G  +A+K +        +   + I EI  L  + HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+++     ++     +V E  +   L R++    K    +         V +   L  +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRDIK +N+ +      K+GD GL + F    T   + + GT  Y++PE +
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 208
Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
                  K+D++S G L+ E+ +
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAA 231

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 52  NKIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           +++G+G FG+V    Y     N G  +AVK L        R+F  EI  L  +    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 107 LIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
             G      R+ L  V EY+ +  L   L    +   +L+  +       I KG+ +L  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYV 222
                 VHRD+ A NIL++ E + KI DFGLAKL P +  +   R  G +   + APE +
Sbjct: 146 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
                + ++DV+SFGV++ E+ +
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 137/311 (44%), Gaps = 50/311 (16%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE--------- 146
             + +H N++ L+G C Q     ++ EY    +L   L       ++ +++         
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 147 --KRSDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
             K    C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            +I      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPV 265
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 266 EELFKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 313
Query: 319 TKNIRL--NEE 327
            + + L  NEE
Sbjct: 314 DRILTLTTNEE 324

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNVRH 101
           DDF +   +G+G FG VY       + I A+K L  S   K+GV  +   EI   S++RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN++ +        R  L+ E+     L + L    + + + + ++ +     +A  L +
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHY 130
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
            HE  V   +HRDIK  N+L+  +   KI DFG +   P   +     + GT  YL PE 
Sbjct: 131 CHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRXMCGTLDYLPPEM 184
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           + G     K D++  GVL  E + G
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 32/225 (14%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D  +L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD------ 150
           +  H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   D      
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKTPEDLYKDFL 145
Query: 151 -----ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---P 200
                IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     P
Sbjct: 146 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           D +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 203 DXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 134/307 (43%), Gaps = 42/307 (13%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE--------- 146
             + +H N++ L+G C Q     ++ EY    +L   L       ++ +++         
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 147 --KRSDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
             K    C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+   +NI
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNI 256
Query: 204 THITTRIAG--TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL 261
            +      G     ++APE +     T ++DV+SFGVL+ EI +    G    G   + L
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL--GGSPYPGIPVEEL 314
Query: 262 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 321
            +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L + 
Sbjct: 315 FKLLKEGHRMDKPANCT---------NELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 362
Query: 322 IRLNEEE 328
           + L   E
Sbjct: 363 LTLTTNE 369

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 25/228 (10%)
Query: 36  FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-E 88
           F   E   A +   +S ++G+G FG VY+G            R+A+K ++  +    R E
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 89  FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL-- 143
           F+ E   +      ++V L+G   QG   +++ E +    L    R L    + N  L  
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 144 -NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN 202
            +  K   +   IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +
Sbjct: 126 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----D 178
Query: 203 ITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           I        G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 52  NKIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           +++G+G FG+V    Y     N G  +AVK L        R+F  EI  L  +    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 107 LIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
             G      R+ L  V EY+ +  L   L    +   +L+  +       I KG+ +L  
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYV 222
                 VHRD+ A NIL++ E + KI DFGLAKL P +  +   R  G +   + APE +
Sbjct: 133 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 189
Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
                + ++DV+SFGV++ E+ +
Sbjct: 190 SDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 52  NKIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           +++G+G FG+V    Y     N G  +AVK L        R+F  EI  L  +    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 107 LIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
             G      R+ L  V EY+ +  L   L    +   +L+  +       I KG+ +L  
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGS 133
Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYV 222
                 VHRD+ A NIL++ E + KI DFGLAKL P +  +   R  G +   + APE +
Sbjct: 134 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 190
Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
                + ++DV+SFGV++ E+ +
Sbjct: 191 SDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 108/228 (47%), Gaps = 31/228 (13%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-GR-----RIAVKPLSAESKQGVRE-FITEIMTLSN 98
           ++      +G G FG V + T    G+     ++AVK L + +    +E  ++E+  +S+
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD------- 150
           + +H N+V L+G C  G   +++ EY     L   L    +A +  +     D       
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 151 ------------ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 198
                           +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+ 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 199 FPDNITHITTRIAG-TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
             ++  +I    A     ++APE +     T+++DV+S+G+L+ EI S
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNVRH 101
           DDF +   +G+G FG VY       + I A+K L  S   K+GV  +   EI   S++RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN++ +        R  L+ E+     L + L    + + + + ++ +     +A  L +
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHY 129
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
            HE  V   +HRDIK  N+L+  +   KI DFG +   P   +     + GT  YL PE 
Sbjct: 130 CHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRXMCGTLDYLPPEM 183
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           + G     K D++  GVL  E + G
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 82/336 (24%), Positives = 145/336 (43%), Gaps = 53/336 (15%)
Query: 24  GVDGELLRNVNHFSYTE---LRSATDDFHLSNKIGRGGFGTVY--------KGTLTNGRR 72
            +D  +L  V+ +   E        D   L   +G G FG V         K        
Sbjct: 2   AMDTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVT 61
Query: 73  IAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLD 130
           +AVK L  + +++ + + ++E+  +  + +H N++ L+G C Q     ++ EY    +L 
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 121
Query: 131 RVLLGATKANIKLNWE-----------KRSDICV-GIAKGLAFLHEELVPHIVHRDIKAS 178
             L       ++ +++           K    C   +A+G+ +L  +     +HRD+ A 
Sbjct: 122 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 178
Query: 179 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLTMKADV 233
           N+L+ +    KI DFGLA+    +I +I      T G     ++APE +     T ++DV
Sbjct: 179 NVLVTENNVMKIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 234
Query: 234 YSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 293
           +SFGVL+ EI +    G    G   + L +   + H+ +KP             NE+   
Sbjct: 235 WSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------NELYMM 283
Query: 294 MKVAFFCTQAAASRRPQMNQVIKMLTKNIRL--NEE 327
           M+    C  A  S+RP   Q+++ L + + L  NEE
Sbjct: 284 MRD---CWHAVPSQRPTFKQLVEDLDRILTLTTNEE 316

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITE 92
           E   A +   +S ++G+G FG VY+G            R+A+K ++  +    R EF+ E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWE 146
              +      ++V L+G   QG   +++ E +    L    R L    + N  L   +  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
           K   +   IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I   
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 178
Query: 207 TTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITE 92
           E   A +   +S ++G+G FG VY+G            R+A+K ++  +    R EF+ E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWE 146
              +      ++V L+G   QG   +++ E +    L    R L    + N  L   +  
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
           K   +   IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I   
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 184
Query: 207 TTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           L   IG+G FG V++G    G  +AVK  S+ E +   RE   EI     +RH N++  I
Sbjct: 8   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 64
Query: 109 GCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
               +     T+  LV +Y E+ SL   L   T     +  E    + +  A GLA LH 
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 119
Query: 165 ELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLA---KLFPDNITHITTRIAGTTGY 216
           E+V     P I HRD+K+ NIL+ +     I D GLA       D I        GT  Y
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 217 LAPEYVLGGQLTMK-------ADVYSFGVLVLEI 243
           +APE VL   + MK       AD+Y+ G++  EI
Sbjct: 180 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           L   IG+G FG V++G    G  +AVK  S+ E +   RE   EI     +RH N++  I
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 63
Query: 109 GCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
               +     T+  LV +Y E+ SL   L   T     +  E    + +  A GLA LH 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 118
Query: 165 ELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLA---KLFPDNITHITTRIAGTTGY 216
           E+V     P I HRD+K+ NIL+ +     I D GLA       D I        GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 217 LAPEYVLGGQLTMK-------ADVYSFGVLVLEI 243
           +APE VL   + MK       AD+Y+ G++  EI
Sbjct: 179 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 36/292 (12%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRI--AVKPLSA-ESKQGVREFITEIMTLSNV-R 100
           +D    + IG G FG V K  +  +G R+  A+K +    SK   R+F  E+  L  +  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSL------------DRVLLGATKANIKLNWEKR 148
           HPN++ L+G C       L  EY  + +L            D     A      L+ ++ 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
                 +A+G+ +L ++     +HR++ A NIL+ + +  KI DFGL++     +     
Sbjct: 142 LHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 198
Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 268
           R+     ++A E +     T  +DV+S+GVL+ EI+S    G    G     L E   Q 
Sbjct: 199 RLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL--GGTPYCGMTCAELYEKLPQG 254
Query: 269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           ++ EKPL   D         E+   M+    C +     RP   Q++  L +
Sbjct: 255 YRLEKPLNCDD---------EVYDLMRQ---CWREKPYERPSFAQILVSLNR 294

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 41  LRSATDD------FHLSNKIGRGGFGTV--YKGTLTNGRRIAVKPLSAE--SKQGVREFI 90
           + SATD+      + L   IG+G F  V   +  LT GR +AVK +     +   +++  
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLF 62
Query: 91  TEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 150
            E+  +  + HPN+V+L           LV EY     +   L+   +   K   E R+ 
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAK 119
Query: 151 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 210
               I   + + H++   +IVHRD+KA N+LLD + N KI DFG +  F   + +     
Sbjct: 120 FR-QIVSAVQYCHQK---YIVHRDLKAENLLLDGDMNIKIADFGFSNEF--TVGNKLDTF 173
Query: 211 AGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEIISG 246
            G+  Y APE   G +    + DV+S GV++  ++SG
Sbjct: 174 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITE 92
           E   A +   +S ++G+G FG VY+G            R+A+K ++  +    R EF+ E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWE 146
              +      ++V L+G   QG   +++ E +    L    R L    + N  L   +  
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
           K   +   IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I   
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 184
Query: 207 TTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITE 92
           E   A +   +S ++G+G FG VY+G            R+A+K ++  +    R EF+ E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWE 146
              +      ++V L+G   QG   +++ E +    L    R L    + N  L   +  
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
           K   +   IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I   
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 185
Query: 207 TTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 186 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 107/214 (50%), Gaps = 11/214 (5%)
Query: 53  KIGRGGFG-TVYKGTLTNGRRIAVKPL--SAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           KIG G FG  +   +  +GR+  +K +  S  S +   E   E+  L+N++HPN+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
              +     +V +Y E   L + +    +  +    ++  D  V I   L  +H+     
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHDR---K 145
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
           I+HRDIK+ NI L ++   ++GDFG+A++  ++   +     GT  YL+PE         
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 230 KADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE 263
           K+D+++ G ++ E+ + +++ +A  G M   +L+
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEA--GSMKNLVLK 236

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 45  TDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVR---EFITEIMTLSNVR 100
           +D + L   +G GG   V+    L   R +AVK L A+  +       F  E    + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 101 HPNLVELIGC----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           HP +V +          G    +V EYV+  +L  ++        K   E  +D C    
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC---- 126
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA--GTT 214
           + L F H+     I+HRD+K +NI++      K+ DFG+A+   D+   +T   A  GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            YL+PE   G  +  ++DVYS G ++ E+++G
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 137/311 (44%), Gaps = 50/311 (16%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE--------- 146
             + +H N++ L+G C Q     ++ EY    +L   L       ++ +++         
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 147 --KRSDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
             K    C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DI 196
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            +I      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 197 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPV 254
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 255 EELFKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 302
Query: 319 TKNIRL--NEE 327
            + + L  NEE
Sbjct: 303 DRILTLTTNEE 313

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S + H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 159 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRASYYRKGGCAMLPVK 211
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 137/311 (44%), Gaps = 50/311 (16%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE--------- 146
             + +H N++ L+G C Q     ++ EY    +L   L       ++ +++         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 147 --KRSDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
             K    C   +A+G+ +L  +     +HRD+ A N+L+ +    +I DFGLA+    +I
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLAR----DI 207
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            +I      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL--GGSPYPGIPV 265
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 266 EELFKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 313
Query: 319 TKNIRL--NEE 327
            + + L  NEE
Sbjct: 314 DRILTLTTNEE 324

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           L   IG+G FG V++G    G  +AVK  S+ E +   RE   EI     +RH N++  I
Sbjct: 13  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 69
Query: 109 GCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
               +     T+  LV +Y E+ SL   L   T     +  E    + +  A GLA LH 
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 124
Query: 165 ELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLA---KLFPDNITHITTRIAGTTGY 216
           E+V     P I HRD+K+ NIL+ +     I D GLA       D I        GT  Y
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 217 LAPEYVLGGQLTMK-------ADVYSFGVLVLEI 243
           +APE VL   + MK       AD+Y+ G++  EI
Sbjct: 185 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S + H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRASYYRKGGCAMLPVK 225
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           L   IG+G FG V++G    G  +AVK  S+ E +   RE   EI     +RH N++  I
Sbjct: 10  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 66
Query: 109 GCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
               +     T+  LV +Y E+ SL   L   T     +  E    + +  A GLA LH 
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 121
Query: 165 ELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLA---KLFPDNITHITTRIAGTTGY 216
           E+V     P I HRD+K+ NIL+ +     I D GLA       D I        GT  Y
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 217 LAPEYVLGGQLTMK-------ADVYSFGVLVLEI 243
           +APE VL   + MK       AD+Y+ G++  EI
Sbjct: 182 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S   H N+V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 185 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRASYYRKGGCAMLPVK 237
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S   H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRASYYRKGGCAMLPVK 225
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           L   IG+G FG V++G    G  +AVK  S+ E +   RE   EI     +RH N++  I
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 102
Query: 109 GCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
               +     T+  LV +Y E+ SL   L   T     +  E    + +  A GLA LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 157
Query: 165 ELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLA---KLFPDNITHITTRIAGTTGY 216
           E+V     P I HRD+K+ NIL+ +     I D GLA       D I        GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 217 LAPEYVLGGQLTMK-------ADVYSFGVLVLEI 243
           +APE VL   + MK       AD+Y+ G++  EI
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELI 108
           L   IG+G FG V++G    G  +AVK  S+ E +   RE   EI     +RH N++  I
Sbjct: 33  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 89
Query: 109 GCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
               +     T+  LV +Y E+ SL   L   T     +  E    + +  A GLA LH 
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 144
Query: 165 ELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLA---KLFPDNITHITTRIAGTTGY 216
           E+V     P I HRD+K+ NIL+ +     I D GLA       D I        GT  Y
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 217 LAPEYVLGGQLTMK-------ADVYSFGVLVLEI 243
           +APE VL   + MK       AD+Y+ G++  EI
Sbjct: 205 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S   H N+V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 175 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRASYYRKGGCAMLPVK 227
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 228 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 133/297 (44%), Gaps = 42/297 (14%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGR----RIAVKPLSAESKQGVRE-FITEIMTLSN 98
           A +D  L+  +G G FG VY+G  TN +     +AVK    +     +E F++E + + N
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 99  VRHPNLVELIGCCVQGTRRILVY--------EYVENNSLDRVLLGATKANIKLNWEKRSD 150
           + HP++V+LIG   +    I++          Y+E N     +L     +++        
Sbjct: 82  LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ-------- 133
Query: 151 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 210
               I K +A+L      + VHRDI   NIL+      K+GDFGL++   D   +  +  
Sbjct: 134 ----ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 186
Query: 211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 270
                +++PE +   + T  +DV+ F V + EI+S        +G+   F LE    +  
Sbjct: 187 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS--------FGKQPFFWLENKDVIGV 238
Query: 271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE 327
            EK   L  P+L   PP   + Y  +   C     S RP+  +++  L+   ++ ++
Sbjct: 239 LEKGDRLPKPDLC--PP---VLYTLMT-RCWDYDPSDRPRFTELVCSLSDVYQMEKD 289

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 8/210 (3%)
Query: 43  SATDDFHLSNKIGRGGFGTVYK-GTLTNGRRIAVKPLSAESKQGVRE--FITEIMTLSNV 99
           S  +D+ +   IG G +G   K    ++G+ +  K L   S     +   ++E+  L  +
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 100 RHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           +HPN+V      +  T   L  V EY E   L  V+   TK    L+ E    +   +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 158 GLAFLHEELV--PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
            L   H        ++HRD+K +N+ LD + N K+GDFGLA++   + +   T   GT  
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPY 181
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           Y++PE +       K+D++S G L+ E+ +
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 33/225 (14%)
Query: 50  LSNKIGRGGFGTVYKGTLTN--GR----RIAVKPLSAE-SKQGVREFITEIMTLSNVRHP 102
           L   +G G FG V K T  +  GR     +AVK L    S   +R+ ++E   L  V HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN------------IKLNWEKRSD 150
           ++++L G C Q    +L+ EY +  SL   L  + K                L+      
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 151 ICVG--------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN 202
           + +G        I++G+ +L E     +VHRD+ A NIL+ +    KI DFGL++   + 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 203 ITHITTRIAG--TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
            +++  R  G     ++A E +     T ++DV+SFGVL+ EI++
Sbjct: 204 DSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 133/297 (44%), Gaps = 42/297 (14%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGR----RIAVKPLSAESKQGVRE-FITEIMTLSN 98
           A +D  L+  +G G FG VY+G  TN +     +AVK    +     +E F++E + + N
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 99  VRHPNLVELIGCCVQGTRRILVY--------EYVENNSLDRVLLGATKANIKLNWEKRSD 150
           + HP++V+LIG   +    I++          Y+E N     +L     +++        
Sbjct: 66  LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ-------- 117
Query: 151 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 210
               I K +A+L      + VHRDI   NIL+      K+GDFGL++   D   +  +  
Sbjct: 118 ----ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 170
Query: 211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 270
                +++PE +   + T  +DV+ F V + EI+S        +G+   F LE    +  
Sbjct: 171 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS--------FGKQPFFWLENKDVIGV 222
Query: 271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE 327
            EK   L  P+L   PP   + Y  +   C     S RP+  +++  L+   ++ ++
Sbjct: 223 LEKGDRLPKPDLC--PP---VLYTLMT-RCWDYDPSDRPRFTELVCSLSDVYQMEKD 273

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S   H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRASYYRKGGCAMLPVK 225
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S   H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 158 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRASYYRKGGCAMLPVK 210
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S   H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 158 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRASYYRKGGCAMLPVK 210
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 133/297 (44%), Gaps = 42/297 (14%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGR----RIAVKPLSAESKQGVRE-FITEIMTLSN 98
           A +D  L+  +G G FG VY+G  TN +     +AVK    +     +E F++E + + N
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 99  VRHPNLVELIGCCVQGTRRILVY--------EYVENNSLDRVLLGATKANIKLNWEKRSD 150
           + HP++V+LIG   +    I++          Y+E N     +L     +++        
Sbjct: 70  LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ-------- 121
Query: 151 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 210
               I K +A+L      + VHRDI   NIL+      K+GDFGL++   D   +  +  
Sbjct: 122 ----ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 174
Query: 211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 270
                +++PE +   + T  +DV+ F V + EI+S        +G+   F LE    +  
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS--------FGKQPFFWLENKDVIGV 226
Query: 271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE 327
            EK   L  P+L   PP   + Y  +   C     S RP+  +++  L+   ++ ++
Sbjct: 227 LEKGDRLPKPDLC--PP---VLYTLMT-RCWDYDPSDRPRFTELVCSLSDVYQMEKD 277

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 48  FHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLV 105
           + +  ++G GGFG V +    + G ++A+K    E     RE +  EI  +  + HPN+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 106 EL------IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
                   +         +L  EY E   L R  L   +    L       +   I+  L
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDL-RKYLNQFENCCGLKEGPIRTLLSDISSAL 135
Query: 160 AFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
            +LHE     I+HRD+K  NI+L    Q    KI D G AK    +   + T   GT  Y
Sbjct: 136 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQY 190
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           LAPE +   + T+  D +SFG L  E I+G
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 43  SATDDFHLSNK-------IGRGGFGTVYKGTLTNGRR----IAVKPLSAESKQGVRE-FI 90
           S+T D+ +  +       IG G FG V++G   +       +A+K     +   VRE F+
Sbjct: 28  SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 87
Query: 91  TEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 150
            E +T+    HP++V+LIG   +    I++ E      L R  L   K ++ L     S 
Sbjct: 88  QEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SL 141
Query: 151 ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
           I     ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  +
Sbjct: 142 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 198
Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
           +      ++APE +   + T  +DV+ FGV + EI+
Sbjct: 199 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 48  FHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLV 105
           + +  ++G GGFG V +    + G ++A+K    E     RE +  EI  +  + HPN+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 106 EL------IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
                   +         +L  EY E   L R  L   +    L       +   I+  L
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDL-RKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 160 AFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
            +LHE     I+HRD+K  NI+L    Q    KI D G AK    +   + T   GT  Y
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQY 189
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           LAPE +   + T+  D +SFG L  E I+G
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S   H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 159 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRASYYRKGGCAMLPVK 211
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 45  TDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVR---EFITEIMTLSNVR 100
           +D + L   +G GG   V+    L   R +AVK L A+  +       F  E    + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 101 HPNLVELIGC----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           HP +V +          G    +V EYV+  +L  ++        K   E  +D C    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC---- 126
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA--GTT 214
           + L F H+     I+HRD+K +NI++      K+ DFG+A+   D+   +T   A  GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            YL+PE   G  +  ++DVYS G ++ E+++G
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S   H N+V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 150 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRASYYRKGGCAMLPVK 202
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 43  SATDDFHLSNK-------IGRGGFGTVYKGTLTNGRR----IAVKPLSAESKQGVRE-FI 90
           S+T D+ +  +       IG G FG V++G   +       +A+K     +   VRE F+
Sbjct: 5   SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 91  TEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 150
            E +T+    HP++V+LIG   +    I++ E      L R  L   K ++ L     S 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SL 118
Query: 151 ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
           I     ++  LA+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  +
Sbjct: 119 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 175
Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
           +      ++APE +   + T  +DV+ FGV + EI+
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/311 (24%), Positives = 138/311 (44%), Gaps = 43/311 (13%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITE 92
           E   + +   L  ++G+G FG VY+G   +        R+AVK ++  +    R EF+ E
Sbjct: 12  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 71
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------W 145
              +      ++V L+G   +G   ++V E + +  L +  L + +   + N        
Sbjct: 72  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTL 130
Query: 146 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 205
           ++   +   IA G+A+L+ +     VHR++ A N ++  +F  KIGDFG+ +    +I  
Sbjct: 131 QEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYE 183
Query: 206 ITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF 260
                 G  G     ++APE +  G  T  +D++SFGV++ EI S               
Sbjct: 184 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------------- 228
Query: 261 LLEWAWQLHQEEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
           L E  +Q    E+ L+ V D    + P N   R   +   C Q   + RP   +++ +L 
Sbjct: 229 LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288
Query: 320 KNIRLNEEELT 330
            ++  +  E++
Sbjct: 289 DDLHPSFPEVS 299

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/311 (24%), Positives = 138/311 (44%), Gaps = 43/311 (13%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITE 92
           E   + +   L  ++G+G FG VY+G   +        R+AVK ++  +    R EF+ E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-------W 145
              +      ++V L+G   +G   ++V E + +  L +  L + +   + N        
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL-KSYLRSLRPEAENNPGRPPPTL 129
Query: 146 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 205
           ++   +   IA G+A+L+ +     VHR++ A N ++  +F  KIGDFG+ +    +I  
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYE 182
Query: 206 ITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF 260
                 G  G     ++APE +  G  T  +D++SFGV++ EI S               
Sbjct: 183 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------------- 227
Query: 261 LLEWAWQLHQEEKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
           L E  +Q    E+ L+ V D    + P N   R   +   C Q   + RP   +++ +L 
Sbjct: 228 LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287
Query: 320 KNIRLNEEELT 330
            ++  +  E++
Sbjct: 288 DDLHPSFPEVS 298

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S   H N+V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 165 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRASYYRKGGCAMLPVK 217
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 25/220 (11%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D  +L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIK--------LNWEKR 148
           +  H N+V L+G C + G   +++ E+ +  +L   L       +         L  E  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITH 205
                 +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +  
Sbjct: 147 IXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 204 GDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 8/210 (3%)
Query: 43  SATDDFHLSNKIGRGGFGTVYK-GTLTNGRRIAVKPLSAESKQGVRE--FITEIMTLSNV 99
           S  +D+ +   IG G +G   K    ++G+ +  K L   S     +   ++E+  L  +
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 100 RHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           +HPN+V      +  T   L  V EY E   L  V+   TK    L+ E    +   +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 158 GLAFLHEELV--PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
            L   H        ++HRD+K +N+ LD + N K+GDFGLA++  ++ T       GT  
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFVGTPY 181
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           Y++PE +       K+D++S G L+ E+ +
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S   H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 159 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAQ---DIYRASYYRKGGCAMLPVK 211
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           +  L   IG+G FG V  G    G ++AVK +  ++    + F+ E   ++ +RH NLV+
Sbjct: 22  ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQ 78
Query: 107 LIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           L+G  V+    + +V EY+   SL   L   ++    L  +      + + + + +L   
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD+ A N+L+ ++   K+ DFGL K    + T  T ++     + APE +   
Sbjct: 137 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREK 189
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + + K+DV+SFG+L+ EI S
Sbjct: 190 KFSTKSDVWSFGILLWEIYS 209

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 50  LSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNL 104
           L   IG G FG V++G   +       +A+K     +   VRE F+ E +T+    HP++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLAFL 162
           V+LIG   +    I++ E      L R  L   K ++ L     S I     ++  LA+L
Sbjct: 74  VKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SLILYAYQLSTALAYL 127
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
             +     VHRDI A N+L+      K+GDFGL++   D+  +  ++      ++APE +
Sbjct: 128 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 184
Query: 223 LGGQLTMKADVYSFGVLVLEII 244
              + T  +DV+ FGV + EI+
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           +  L   IG+G FG V  G    G ++AVK +  ++    + F+ E   ++ +RH NLV+
Sbjct: 13  ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQ 69
Query: 107 LIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           L+G  V+    + +V EY+   SL   L   ++    L  +      + + + + +L   
Sbjct: 70  LLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 127
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD+ A N+L+ ++   K+ DFGL K    + T  T ++     + APE +   
Sbjct: 128 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREA 180
Query: 226 QLTMKADVYSFGVLVLEIIS 245
             + K+DV+SFG+L+ EI S
Sbjct: 181 AFSTKSDVWSFGILLWEIYS 200

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 134/306 (43%), Gaps = 48/306 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE--------- 146
             + +H N++ L+G C Q     ++ EY    +L   L       ++ +++         
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 147 --KRSDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
             K    C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLAR----DI 194
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            +I      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 195 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL--GGSPYPGIPV 252
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 253 EELFKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 300
Query: 319 TKNIRL 324
            + + L
Sbjct: 301 DRILTL 306

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 49  HLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSAESKQGVRE-FITEIMTLSNVRHPN 103
            L   IG G FG V++G   +       +A+K     +   VRE F+ E +T+    HP+
Sbjct: 10  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLAF 161
           +V+LIG   +    I++ E      L R  L   K ++ L     S I     ++  LA+
Sbjct: 70  IVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SLILYAYQLSTALAY 123
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++      ++APE 
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 222 VLGGQLTMKADVYSFGVLVLEII 244
           +   + T  +DV+ FGV + EI+
Sbjct: 181 INFRRFTSASDVWMFGVCMWEIL 203

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           +  L   IG+G FG V  G    G ++AVK +  ++    + F+ E   ++ +RH NLV+
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQ 63
Query: 107 LIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           L+G  V+    + +V EY+   SL   L   ++    L  +      + + + + +L   
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 121
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD+ A N+L+ ++   K+ DFGL K    + T  T ++     + APE +   
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREK 174
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + + K+DV+SFG+L+ EI S
Sbjct: 175 KFSTKSDVWSFGILLWEIYS 194

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 45  TDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVR---EFITEIMTLSNVR 100
           +D + L   +G GG   V+    L   R +AVK L A+  +       F  E    + + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 101 HPNLVELIGC----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           HP +V +          G    +V EYV+  +L  ++        K   E  +D C    
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC---- 143
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA--GTT 214
           + L F H+     I+HRD+K +NI++      K+ DFG+A+   D+   +T   A  GT 
Sbjct: 144 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            YL+PE   G  +  ++DVYS G ++ E+++G
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 25/224 (11%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITE 92
           E   A +   +S ++G+G FG VY+G            R+A+K ++  +    R EF+ E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKL---NWE 146
              +      ++V L+G   QG   +++ E +    L    R L    + N  L   +  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
           K   +   IA G+A+L+       VHRD+ A N  + ++F  KIGDFG+ +    +I   
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYET 178
Query: 207 TTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                G  G     +++PE +  G  T  +DV+SFGV++ EI +
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 49  HLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSAESKQGVRE-FITEIMTLSNVRHPN 103
            L   IG G FG V++G   +       +A+K     +   VRE F+ E +T+    HP+
Sbjct: 15  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 74
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLAF 161
           +V+LIG   +    I++ E      L R  L   K ++ L     S I     ++  LA+
Sbjct: 75  IVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SLILYAYQLSTALAY 128
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++      ++APE 
Sbjct: 129 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 185
Query: 222 VLGGQLTMKADVYSFGVLVLEII 244
           +   + T  +DV+ FGV + EI+
Sbjct: 186 INFRRFTSASDVWMFGVCMWEIL 208

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 39/228 (17%)
Query: 50  LSNKIGRGGFGTVYKGTLTN--GR----RIAVKPLSAE-SKQGVREFITEIMTLSNVRHP 102
           L   +G G FG V K T  +  GR     +AVK L    S   +R+ ++E   L  V HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN------------IKLNWEKRSD 150
           ++++L G C Q    +L+ EY +  SL   L  + K                L+      
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 151 ICVG--------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN 202
           + +G        I++G+ +L E     +VHRD+ A NIL+ +    KI DFGL++    +
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSR----D 199
Query: 203 ITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           +    + +  + G     ++A E +     T ++DV+SFGVL+ EI++
Sbjct: 200 VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 39/228 (17%)
Query: 50  LSNKIGRGGFGTVYKGTLTN--GR----RIAVKPLSAE-SKQGVREFITEIMTLSNVRHP 102
           L   +G G FG V K T  +  GR     +AVK L    S   +R+ ++E   L  V HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN------------IKLNWEKRSD 150
           ++++L G C Q    +L+ EY +  SL   L  + K                L+      
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 151 ICVG--------IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN 202
           + +G        I++G+ +L E     +VHRD+ A NIL+ +    KI DFGL++    +
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFGLSR----D 199
Query: 203 ITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           +    + +  + G     ++A E +     T ++DV+SFGVL+ EI++
Sbjct: 200 VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           +  L   IG+G FG V  G    G ++AVK +  ++    + F+ E   ++ +RH NLV+
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQ 250
Query: 107 LIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           L+G  V+    + +V EY+   SL   L   ++    L  +      + + + + +L   
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD+ A N+L+ ++   K+ DFGL K    + T  T ++     + APE +   
Sbjct: 309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREK 361
Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + + K+DV+SFG+L+ EI S
Sbjct: 362 KFSTKSDVWSFGILLWEIYS 381

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S   H N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 199 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAGYYRKGGCAMLPVK 251
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 50  LSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSAESKQGVRE-FITEIMTLSNVRHPNL 104
           L   IG G FG V++G   +       +A+K     +   VRE F+ E +T+    HP++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLAFL 162
           V+LIG   +    I++ E      L R  L   K ++ L     S I     ++  LA+L
Sbjct: 74  VKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SLILYAYQLSTALAYL 127
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
             +     VHRDI A N+L+      K+GDFGL++   D+  +  ++      ++APE +
Sbjct: 128 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 184
Query: 223 LGGQLTMKADVYSFGVLVLEII 244
              + T  +DV+ FGV + EI+
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 54  IGRGGFGTVYKGTLT------NGRRIAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVE 106
           +G G FG VY+G ++      +  ++AVK L    S+Q   +F+ E + +S   H N+V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD---ICVGIAKGLAFLH 163
            IG  +Q   R ++ E +    L   L        + +     D   +   IA G  +L 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 164 EELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT----G 215
           E    H +HRDI A N LL     P    KIGDFG+A+   D       R  G       
Sbjct: 176 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR---DIYRAGYYRKGGCAMLPVK 228
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           ++ PE  + G  T K D +SFGVL+ EI S
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 49  HLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSAESKQGVRE-FITEIMTLSNVRHPN 103
            L   IG G FG V++G   +       +A+K     +   VRE F+ E +T+    HP+
Sbjct: 16  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 75
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLAF 161
           +V+LIG   +    I++ E      L R  L   K ++ L     S I     ++  LA+
Sbjct: 76  IVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKYSLDLA----SLILYAYQLSTALAY 129
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++      ++APE 
Sbjct: 130 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 186
Query: 222 VLGGQLTMKADVYSFGVLVLEII 244
           +   + T  +DV+ FGV + EI+
Sbjct: 187 INFRRFTSASDVWMFGVCMWEIL 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 136/311 (43%), Gaps = 50/311 (16%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE--------- 146
             + +H N++ L+G C Q     ++  Y    +L   L       ++ +++         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 147 --KRSDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
             K    C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            +I      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPV 265
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 266 EELFKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 313
Query: 319 TKNIRL--NEE 327
            + + L  NEE
Sbjct: 314 DRILTLTTNEE 324

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 49  HLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPN 103
            L   IG G FG V++G   +       +A+K     +   VRE F+ E +T+    HP+
Sbjct: 13  ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLAF 161
           +V+LIG   +    I++ E      L R  L   K ++ L     S I     ++  LA+
Sbjct: 73  IVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKFSLDLA----SLILYAYQLSTALAY 126
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++      ++APE 
Sbjct: 127 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 222 VLGGQLTMKADVYSFGVLVLEII 244
           +   + T  +DV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 27/222 (12%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D   L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIK----------LNWE 146
           +  H N+V L+G C + G   +++ E+ +  +L   L       +           L  E
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLE 148
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNI 203
                   +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +
Sbjct: 149 HLIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 206 RKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 22/201 (10%)
Query: 54  IGRGGFGTVYKGTLTN----GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELI 108
           IG G FG V++G   +       +A+K     +   VRE F+ E +T+    HP++V+LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANI---KLNWEKRSDICVG--IAKGLAFLH 163
           G   +    I+         ++   LG  ++ +   K + +  S I     ++  LA+L 
Sbjct: 458 GVITENPVWII---------MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
            +     VHRDI A N+L+      K+GDFGL++   D+  +  ++      ++APE + 
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 224 GGQLTMKADVYSFGVLVLEII 244
             + T  +DV+ FGV + EI+
Sbjct: 566 FRRFTSASDVWMFGVCMWEIL 586

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 33/226 (14%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D   L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD------ 150
           +  H N+V L+G C + G   +++ E+ +  +L   L   +K N  + +++  +      
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKEAPEDLYKDF 146
Query: 151 ------ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--- 199
                 IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 203
Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           PD +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 204 PDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 25/220 (11%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D  +L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIK--------LNWEKR 148
           +  H N+V L+G C + G   +++ E+ +  +L   L       +         L  E  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITH 205
                 +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +  
Sbjct: 147 ICYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 204 GDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 49  HLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPN 103
            L   IG G FG V++G   +       +A+K     +   VRE F+ E +T+    HP+
Sbjct: 13  ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLAF 161
           +V+LIG   +    I++ E      L R  L   K ++ L     S I     ++  LA+
Sbjct: 73  IVKLIGVITENPVWIIM-ELCTLGEL-RSFLQVRKFSLDLA----SLILYAYQLSTALAY 126
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           L  +     VHRDI A N+L+      K+GDFGL++   D+     ++      ++APE 
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPES 183
Query: 222 VLGGQLTMKADVYSFGVLVLEII 244
           +   + T  +DV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 54  IGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVE 106
           IG G FG V++              +AVK L  E+   ++ +F  E   ++   +PN+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLG--------------ATKANIK------LNWE 146
           L+G C  G    L++EY+    L+  L                +T+A +       L+  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITH 205
           ++  I   +A G+A+L E      VHRD+   N L+ +    KI DFGL++ ++  +   
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                A    ++ PE +   + T ++DV+++GV++ EI S
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 134/310 (43%), Gaps = 48/310 (15%)
Query: 46  DDFHLSNKIGRGGFGTVY--------KGTLTNGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V         K        +AVK L  + +++ + + ++E+  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE--------- 146
             + +H N++ L+G C Q     ++  Y    +L   L       ++ +++         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 147 --KRSDICV-GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
             K    C   +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 204 THITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
            +I      T G     ++APE +     T ++DV+SFGVL+ EI +    G    G   
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPV 265
Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ L
Sbjct: 266 EELFKLLKEGHRMDKPANCT---------NELYMMMRD---CWHAVPSQRPTFKQLVEDL 313
Query: 319 TKNIRLNEEE 328
            + + L   E
Sbjct: 314 DRILTLTTNE 323

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 52  NKIGRGGFGTV----YKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           +++G+G FG+V    Y     N G  +AVK L        R+F  EI  L  +    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 107 LIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
             G      R    LV EY+ +  L   L    +   +L+  +       I KG+ +L  
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYV 222
                 VHRD+ A NIL++ E + KI DFGLAKL P +      R  G +   + APE +
Sbjct: 130 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESL 186
Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
                + ++DV+SFGV++ E+ +
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 50  LSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNL 104
           L   IG G FG V++G   +       +A+K     +   VRE F+ E +T+    HP++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI---KLNWEKRSDICVG--IAKGL 159
           V+LIG   +    I+         ++   LG  ++ +   K + +  S I     ++  L
Sbjct: 454 VKLIGVITENPVWII---------MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           A+L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++      ++AP
Sbjct: 505 AYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 220 EYVLGGQLTMKADVYSFGVLVLEII 244
           E +   + T  +DV+ FGV + EI+
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 8/210 (3%)
Query: 43  SATDDFHLSNKIGRGGFGTVYK-GTLTNGRRIAVKPLSAESKQGVRE--FITEIMTLSNV 99
           S  +D+ +   IG G +G   K    ++G+ +  K L   S     +   ++E+  L  +
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 100 RHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           +HPN+V      +  T   L  V EY E   L  V+   TK    L+ E    +   +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 158 GLAFLHEELV--PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
            L   H        ++HRD+K +N+ LD + N K+GDFGLA++  ++         GT  
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDEDFAKEFVGTPY 181
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           Y++PE +       K+D++S G L+ E+ +
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR-RIAVKPLSAESKQ-GVREFITEIMTLSNVRHPN 103
           DD+ L   IG G    V        + ++A+K ++ E  Q  + E + EI  +S   HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLL-----GATKANIKLNWEKRSDICVGIAKG 158
           +V      V      LV + +   S+  ++      G  K+ + L+    + I   + +G
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEG 133
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD--NITHITTR--IAGTT 214
           L +LH+      +HRD+KA NILL ++ + +I DFG++       +IT    R    GT 
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 215 GYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISG 246
            ++APE +   +    KAD++SFG+  +E+ +G
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D   L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD------ 150
           +  H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +      
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDF 135
Query: 151 ------ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--- 199
                 IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192
Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           PD +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 193 PDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D   L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD------ 150
           +  H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +      
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDF 135
Query: 151 ------ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--- 199
                 IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192
Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           PD +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 193 PDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR-RIAVKPLSAESKQ-GVREFITEIMTLSNVRHPN 103
           DD+ L   IG G    V        + ++A+K ++ E  Q  + E + EI  +S   HPN
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLL-----GATKANIKLNWEKRSDICVGIAKG 158
           +V      V      LV + +   S+  ++      G  K+ + L+    + I   + +G
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEG 128
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD--NITHITTR--IAGTT 214
           L +LH+      +HRD+KA NILL ++ + +I DFG++       +IT    R    GT 
Sbjct: 129 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 215 GYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISG 246
            ++APE +   +    KAD++SFG+  +E+ +G
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSN 98
           +DF     +G+G FG V     K T   GR  A+K L  E   +K  V   +TE   L N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            RHP L  L        R   V EY     L       ++  +    E+       I   
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEIVSA 117
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGYL 217
           L +LH      +V+RDIK  N++LD++ + KI DFGL K    D  T  T    GT  YL
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 172
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           APE +         D +  GV++ E++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSN 98
           +DF     +G+G FG V     K T   GR  A+K L  E   +K  V   +TE   L N
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            RHP L  L        R   V EY     L       ++  +    E+       I   
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEIVSA 120
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGYL 217
           L +LH      +V+RDIK  N++LD++ + KI DFGL K    D  T  T    GT  YL
Sbjct: 121 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 175
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           APE +         D +  GV++ E++ GR
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNVR 100
           ++ +   +G G FG V      T G+++A+K      L+    QG  E   EI  L  +R
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HP++++L          I+V EY  N   D ++        K++ ++       I   + 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV-----QRDKMSEQEARRFFQQIISAVE 117
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           + H      IVHRD+K  N+LLD+  N KI DFGL+ +  D     T+   G+  Y APE
Sbjct: 118 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 172
Query: 221 YVLGGQLTM--KADVYSFGVLVLEIISGR 247
            V+ G+L    + DV+S GV++  ++  R
Sbjct: 173 -VISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D   L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD------ 150
           +  H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +      
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDF 144
Query: 151 ------ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--- 199
                 IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           PD +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 202 PDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D   L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD------ 150
           +  H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +      
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDF 144
Query: 151 ------ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--- 199
                 IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           PD +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 202 PDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNVR 100
           ++ +   +G G FG V      T G+++A+K      L+    QG  E   EI  L  +R
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HP++++L          I+V EY  N   D ++        K++ ++       I   + 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV-----QRDKMSEQEARRFFQQIISAVE 127
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           + H      IVHRD+K  N+LLD+  N KI DFGL+ +  D     T+   G+  Y APE
Sbjct: 128 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 182
Query: 221 YVLGGQLTM--KADVYSFGVLVLEIISGR 247
            V+ G+L    + DV+S GV++  ++  R
Sbjct: 183 -VISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D   L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD------ 150
           +  H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +      
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDF 144
Query: 151 ------ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--- 199
                 IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           PD +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 202 PDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNVR 100
           ++ +   +G G FG V      T G+++A+K      L+    QG  E   EI  L  +R
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HP++++L          I+V EY  N   D ++        K++ ++       I   + 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV-----QRDKMSEQEARRFFQQIISAVE 126
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           + H      IVHRD+K  N+LLD+  N KI DFGL+ +  D     T+   G+  Y APE
Sbjct: 127 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 181
Query: 221 YVLGGQLTM--KADVYSFGVLVLEIISGR 247
            V+ G+L    + DV+S GV++  ++  R
Sbjct: 182 -VISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNVR 100
           ++ +   +G G FG V      T G+++A+K      L+    QG  E   EI  L  +R
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HP++++L          I+V EY  N   D ++        K++ ++       I   + 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV-----QRDKMSEQEARRFFQQIISAVE 121
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           + H      IVHRD+K  N+LLD+  N KI DFGL+ +  D     T+   G+  Y APE
Sbjct: 122 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 176
Query: 221 YVLGGQLTM--KADVYSFGVLVLEIISGR 247
            V+ G+L    + DV+S GV++  ++  R
Sbjct: 177 -VISGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSN 98
           +DF     +G+G FG V     K T   GR  A+K L  E   +K  V   +TE   L N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            RHP L  L        R   V EY     L       ++  +    E+       I   
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEIVSA 117
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGYL 217
           L +LH      +V+RDIK  N++LD++ + KI DFGL K    D  T  T    GT  YL
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 172
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           APE +         D +  GV++ E++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 135/303 (44%), Gaps = 52/303 (17%)
Query: 34  NHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPL--SAESKQGVREFI 90
            H+ +T      +D     +IGRG +G+V K     +G+ +AVK +  + + K+  +  +
Sbjct: 15  QHWDFT-----AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM 69
Query: 91  TEIMTLSNVRHPNLVELIGC---------CVQ--GTRRILVYEYVENNSLDRVLLGATKA 139
              + + +   P +V+  G          C++   T     Y+YV  + LD V+      
Sbjct: 70  DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYV-YSVLDDVIPEEILG 128
Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 199
            I L             K L  L E L   I+HRDIK SNILLD+  N K+ DFG++   
Sbjct: 129 KITL----------ATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQ----LTMKADVYSFGVLVLEIISGRNSGKAMWG 255
            D+I    TR AG   Y+APE +          +++DV+S G+ + E+ +GR      W 
Sbjct: 177 VDSIAK--TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP-YPKWN 233
Query: 256 QMNKFLLEWAWQLHQEEK--PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQ 313
            +         QL Q  K  P +L + E  E+ P+    ++     C     S+RP+  +
Sbjct: 234 SVFD-------QLTQVVKGDPPQLSNSEEREFSPS----FINFVNLCLTKDESKRPKYKE 282
Query: 314 VIK 316
           ++K
Sbjct: 283 LLK 285

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 13/211 (6%)
Query: 42  RSATDDFHLSNKIGRGGFGTV-YKGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLS 97
           R   ++F     +G+G FG V        GR  A+K L  E   +K  V   +TE   L 
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           N RHP L  L        R   V EY     L       ++  +  + ++       I  
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERV-FSEDRARFYGAEIVS 259
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGY 216
            L +LH E   ++V+RD+K  N++LD++ + KI DFGL K    D  T  T    GT  Y
Sbjct: 260 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           LAPE +         D +  GV++ E++ GR
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 13/211 (6%)
Query: 42  RSATDDFHLSNKIGRGGFGTV-YKGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLS 97
           R   ++F     +G+G FG V        GR  A+K L  E   +K  V   +TE   L 
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           N RHP L  L        R   V EY     L       ++  +  + ++       I  
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERV-FSEDRARFYGAEIVS 262
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGY 216
            L +LH E   ++V+RD+K  N++LD++ + KI DFGL K    D  T  T    GT  Y
Sbjct: 263 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 318
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           LAPE +         D +  GV++ E++ GR
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSN 98
           +DF     +G+G FG V     K T   GR  A+K L  E   +K  V   +TE   L N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            RHP L  L        R   V EY     L       ++  +    E+       I   
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEIVSA 117
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGTTGY 216
           L +LH      +V+RDIK  N++LD++ + KI DFGL K   + I+   T     GT  Y
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEY 171
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           LAPE +         D +  GV++ E++ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 112/216 (51%), Gaps = 23/216 (10%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLS----AESKQGV-REFITEI 93
           +++S    +   + +G G F TVYK    N  +I A+K +     +E+K G+ R  + EI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 94  MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL----LGATKANIKLNWEKRS 149
             L  + HPN++ L+      +   LV++++E + L+ ++    L  T ++IK       
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKA------ 116
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 209
              +   +GL +LH+     I+HRD+K +N+LLD+    K+ DFGLAK F         +
Sbjct: 117 -YMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQ 172
Query: 210 IAGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEII 244
           +  T  Y APE + G ++  +  D+++ G ++ E++
Sbjct: 173 VV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D   L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD------ 150
           +  H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +      
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDF 135
Query: 151 ------ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--- 199
                 IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192
Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           PD +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 193 PDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D   L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 123
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD------ 150
           +  H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +      
Sbjct: 124 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDF 181
Query: 151 ------ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--- 199
                 IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     
Sbjct: 182 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 238
Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           PD +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 239 PDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGV-REFITEIMTLSN 98
           D   L   +GRG FG V +            R +AVK L   +     R  ++E+  L +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 99  V-RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD------ 150
           +  H N+V L+G C + G   +++ E+ +  +L   L   +K N  + ++   +      
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDF 135
Query: 151 ------ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--- 199
                 IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192
Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
           PD +     R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 193 PDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSN 98
           +DF     +G+G FG V     K T   GR  A+K L  E   +K  V   +TE   L N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            RHP L  L        R   V EY     L       ++  +    E+       I   
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEIVSA 117
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGTTGY 216
           L +LH      +V+RDIK  N++LD++ + KI DFGL K   + I+   T     GT  Y
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEY 171
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           LAPE +         D +  GV++ E++ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 108/230 (46%), Gaps = 22/230 (9%)
Query: 31  RNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVR 87
           R+++    + LR     F L   +G G +G VYKG  +  G+  A+K   ++ + ++ ++
Sbjct: 9   RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK 68
Query: 88  EFITEIMTLSNVRHPNLVELIGCCVQ------GTRRILVYEYVENNSLDRVLLGATKANI 141
           + I  +   S+  H N+    G  ++        +  LV E+    S+  ++       +
Sbjct: 69  QEINMLKKYSH--HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 142 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 201
           K  W   + IC  I +GL+ LH+  V   +HRDIK  N+LL +    K+ DFG++     
Sbjct: 127 KEEW--IAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 202 NITHITTRIAGTTGYLAPEYVLGGQ-----LTMKADVYSFGVLVLEIISG 246
            +    T I GT  ++APE +   +        K+D++S G+  +E+  G
Sbjct: 182 TVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL 104
           D + +  ++G G FG V++ T    G   A K +    +        EI T+S +RHP L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           V L          +++YE++    L          + K++ ++  +    + KGL  +HE
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 167
Query: 165 ELVPHIVHRDIKASNILLDQEFNP--KIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEY 221
               + VH D+K  NI+   + +   K+ DFGL A L P     +TT   GT  + APE 
Sbjct: 168 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 221
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
             G  +    D++S GVL   ++SG
Sbjct: 222 AEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSN 98
           +DF     +G+G FG V     K T   GR  A+K L  E   +K  V   +TE   L N
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            RHP L  L        R   V EY     L       ++  +    E+       I   
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEIVSA 122
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGTTGY 216
           L +LH      +V+RDIK  N++LD++ + KI DFGL K   + I+   T     GT  Y
Sbjct: 123 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEY 176
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           LAPE +         D +  GV++ E++ GR
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 114/239 (47%), Gaps = 38/239 (15%)
Query: 41  LRSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV 99
           LR A+D F     +G+G FG V K     + R  A+K +   +++ +   ++E+M L+++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASL 59
Query: 100 RHP-------------NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 146
            H              N V+ +    + +   +  EY EN +L  ++      N+    +
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI---HSENLNQQRD 116
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--------- 197
           +   +   I + L+++H +    I+HRD+K  NI +D+  N KIGDFGLAK         
Sbjct: 117 EYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 198 -----LFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSG 250
                  P +  ++T+ I GT  Y+A E + G G    K D+YS G++  E+I   ++G
Sbjct: 174 KLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 38/228 (16%)
Query: 48  FHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPL--SAESKQGVREFITEIMTLSNVR-HPN 103
           + L  K+G+G +G V+K      G  +AVK +  + ++    +    EIM L+ +  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 104 LVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           +V L+        R   LV++Y+E +     L    +ANI L    +  +   + K + +
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETD-----LHAVIRANI-LEPVHKQYVVYQLIKVIKY 124
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI----------- 210
           LH      ++HRD+K SNILL+ E + K+ DFGL++ F  NI  +T  I           
Sbjct: 125 LHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFV-NIRRVTNNIPLSINENTENF 180
Query: 211 ----------AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 247
                       T  Y APE +LG  + T   D++S G ++ EI+ G+
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSN 98
           +DF     +G+G FG V     K T   GR  A+K L  E   +K  V   +TE   L N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            RHP L  L        R   V EY     L       ++  +    E+       I   
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEIVSA 117
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGTTGY 216
           L +LH      +V+RDIK  N++LD++ + KI DFGL K   + I+   T     GT  Y
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEY 171
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           LAPE +         D +  GV++ E++ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 114/239 (47%), Gaps = 38/239 (15%)
Query: 41  LRSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV 99
           LR A+D F     +G+G FG V K     + R  A+K +   +++ +   ++E+M L+++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASL 59
Query: 100 RHP-------------NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 146
            H              N V+ +    + +   +  EY EN +L  ++      N+    +
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRD 116
Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--------- 197
           +   +   I + L+++H +    I+HRD+K  NI +D+  N KIGDFGLAK         
Sbjct: 117 EYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 198 -----LFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSG 250
                  P +  ++T+ I GT  Y+A E + G G    K D+YS G++  E+I   ++G
Sbjct: 174 KLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     + +G +IAVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
               T      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 119 FTPATS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 173
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 174 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 226
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
               M  D++S G ++ E+++GR
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL 104
           D + +  ++G G FG V++ T    G   A K +    +        EI T+S +RHP L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           V L          +++YE++    L          + K++ ++  +    + KGL  +HE
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 165 ELVPHIVHRDIKASNILLDQEFNP--KIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEY 221
               + VH D+K  NI+   + +   K+ DFGL A L P     +TT   GT  + APE 
Sbjct: 274 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 327
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
             G  +    D++S GVL   ++SG
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLT--NGRRIAV-----KPLSAESKQGVREFITEIMTLSNV 99
           D  L  K+G G FG V +G     +G+ ++V     KP      + + +FI E+  + ++
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            H NL+ L G  +    +++       + LDR  L   + +  L     S   V +A+G+
Sbjct: 69  DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLG--TLSRYAVQVAEGM 124
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT--GYL 217
            +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +        + 
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
           APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 219

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLT--NGRRIAV-----KPLSAESKQGVREFITEIMTLSNV 99
           D  L  K+G G FG V +G     +G+ ++V     KP      + + +FI E+  + ++
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            H NL+ L G  +    +++       + LDR  L   + +  L     S   V +A+G+
Sbjct: 69  DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLG--TLSRYAVQVAEGM 124
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT--GYL 217
            +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +        + 
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
           APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 219

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLT--NGRRIAV-----KPLSAESKQGVREFITEIMTLSNV 99
           D  L  K+G G FG V +G     +G+ ++V     KP      + + +FI E+  + ++
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 72
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            H NL+ L G  +    +++       + LDR  L   + +  L     S   V +A+G+
Sbjct: 73  DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLG--TLSRYAVQVAEGM 128
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT--GYL 217
            +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +        + 
Sbjct: 129 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
           APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 223

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLT--NGRRIAV-----KPLSAESKQGVREFITEIMTLSNV 99
           D  L  K+G G FG V +G     +G+ ++V     KP      + + +FI E+  + ++
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            H NL+ L G  +    +++       + LDR  L   + +  L     S   V +A+G+
Sbjct: 69  DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLG--TLSRYAVQVAEGM 124
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT--GYL 217
            +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +        + 
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
           APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 219

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLS 97
           R     + L + +G G FG V  G     G ++AVK L+ +   S   V +   EI  L 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
             RHP++++L       T   +V EYV    L   +    +       E R  +   I  
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE---EMEARR-LFQQILS 122
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 217
            + + H  +V   VHRD+K  N+LLD   N KI DFGL+ +  D     T+   G+  Y 
Sbjct: 123 AVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYA 177
Query: 218 APEYVLGGQLTM--KADVYSFGVLVLEIISG 246
           APE V+ G+L    + D++S GV++  ++ G
Sbjct: 178 APE-VISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLT--NGRRIAV-----KPLSAESKQGVREFITEIMTLSNV 99
           D  L  K+G G FG V +G     +G+ ++V     KP      + + +FI E+  + ++
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            H NL+ L G  +    +++       + LDR  L   + +  L     S   V +A+G+
Sbjct: 79  DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLG--TLSRYAVQVAEGM 134
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT--GYL 217
            +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +        + 
Sbjct: 135 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
           APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 229

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
           ++ L   IG+G F  V     +  G+ +AVK +     +   +++   E+  +  + HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L           LV EY     +   L+   +   K   E R+     I   + + H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKFR-QIVSAVQYCH 130
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           ++    IVHRD+KA N+LLD + N KI DFG +  F     +      G+  Y APE   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPELFQ 185
Query: 224 GGQLT-MKADVYSFGVLVLEIISG 246
           G +    + DV+S GV++  ++SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLT--NGRRIAV-----KPLSAESKQGVREFITEIMTLSNV 99
           D  L  K+G G FG V +G     +G+ ++V     KP      + + +FI E+  + ++
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 72
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            H NL+ L G  +    +++       + LDR  L   + +  L     S   V +A+G+
Sbjct: 73  DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLG--TLSRYAVQVAEGM 128
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT--GYL 217
            +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +        + 
Sbjct: 129 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
           APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 223

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLT--NGRRIAV-----KPLSAESKQGVREFITEIMTLSNV 99
           D  L  K+G G FG V +G     +G+ ++V     KP      + + +FI E+  + ++
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            H NL+ L G  +    +++       + LDR  L   + +  L     S   V +A+G+
Sbjct: 79  DHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLG--TLSRYAVQVAEGM 134
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT--GYL 217
            +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +        + 
Sbjct: 135 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
           APE +     +  +D + FGV + E+ +    G+  W  +N
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFT---YGQEPWIGLN 229

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
           ++ L   IG+G F  V     +  GR +A+K +     +   +++   E+  +  + HPN
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L           L+ EY     +   L+   +   K   E RS     I   + + H
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK---EARSKFR-QIVSAVQYCH 128
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           ++    IVHRD+KA N+LLD + N KI DFG +  F   +        G+  Y APE   
Sbjct: 129 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDTFCGSPPYAAPELFQ 183
Query: 224 GGQLT-MKADVYSFGVLVLEIISG 246
           G +    + DV+S GV++  ++SG
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
           ++ L   IG+G F  V     +  G+ +AVK +     +   +++   E+  +  + HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L           LV EY     +   L+   +   K   E R+     I   + + H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKFR-QIVSAVQYCH 130
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           ++    IVHRD+KA N+LLD + N KI DFG +  F     +      G+  Y APE   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPELFQ 185
Query: 224 GGQLT-MKADVYSFGVLVLEIISG 246
           G +    + DV+S GV++  ++SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLS 97
           R   D+F     +G+G FG V    +   G   AVK L  +       V   +TE   LS
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 98  NVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
             R HP L +L  C     R   V E+V    L    +   + + + +  +       I 
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAEII 134
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTT 214
             L FLH++    I++RD+K  N+LLD E + K+ DFG+ K   + I +   T    GT 
Sbjct: 135 SALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTP 188
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
            Y+APE +         D ++ GVL+ E++ G    +A
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK---------QGVREFITEI 93
           AT  +    +IG G +GTVYK     +G  +A+K +   +            VRE +  +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE-VALL 65
Query: 94  MTLSNVRHPNLVELIGCCV--QGTRRI---LVYEYVENNSLDRVLLGATKANIKLNWEKR 148
             L    HPN+V L+  C   +  R I   LV+E+V+ + L   L  A      L  E  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPG--LPAETI 122
Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
            D+     +GL FLH      IVHRD+K  NIL+      K+ DFGLA+++  +     T
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALT 177
Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
            +  T  Y APE +L        D++S G +  E+ 
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 31/223 (13%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVR 100
           R+   D  L   +G+G +G V++G+   G  +AVK  S+ + K   RE  TE+     +R
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLR 60
Query: 101 HPNLVELIGCCV----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           H N++  I   +      T+  L+  Y E  SL   L   T   +         I + IA
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIA 115
Query: 157 KGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--- 208
            GLA LH E+      P I HRD+K+ NIL+ +     I D GLA +   +   +     
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 209 -RIAGTTGYLAPEYVLGGQLTM-------KADVYSFGVLVLEI 243
            R+ GT  Y+APE VL   + +       + D+++FG+++ E+
Sbjct: 176 PRV-GTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 50  LSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLV 105
           L + +G G FG V  G     G ++AVK L+ +   S   V +   EI  L   RHP+++
Sbjct: 15  LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L       T   +V EYV    L   +    +       E R  +   I   + + H  
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE---EMEARR-LFQQILSAVDYCHRH 130
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
           +V   VHRD+K  N+LLD   N KI DFGL+ +  D          G+  Y APE V+ G
Sbjct: 131 MV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRDSCGSPNYAAPE-VISG 184
Query: 226 QLTM--KADVYSFGVLVLEIISG 246
           +L    + D++S GV++  ++ G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCG 207

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
           ++ L   IG+G F  V     +  G+ +AV+ +     +   +++   E+  +  + HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L           LV EY     +   L+   +   K   E R+     I   + + H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKFR-QIVSAVQYCH 130
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           ++    IVHRD+KA N+LLD + N KI DFG +  F     +      G+  Y APE   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDEFCGSPPYAAPELFQ 185
Query: 224 GGQLT-MKADVYSFGVLVLEIISG 246
           G +    + DV+S GV++  ++SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 36/220 (16%)
Query: 43  SATDDFHLSNKIGRGGFGTVYKG--TLTNGRRIAVKPLSAE-SKQGVR-EFITEIMTLSN 98
           ++ D +    K+G G +G VYK   T+TN   +A+K +  E  ++GV    I E+  L  
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTN-ETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK- 157
           ++H N++EL        R  L++EY EN             ++K   +K  D+ + + K 
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEN-------------DLKKYMDKNPDVSMRVIKS 136
Query: 158 -------GLAFLHEELVPHIVHRDIKASNILL---DQEFNP--KIGDFGLAKLFPDNITH 205
                  G+ F H       +HRD+K  N+LL   D    P  KIGDFGLA+ F   I  
Sbjct: 137 FLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193
Query: 206 ITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII 244
            T  I  T  Y  PE +LG +  +   D++S   +  E++
Sbjct: 194 FTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
           ++ L   IG+G F  V     +  G+ +AVK +     +   +++   E+  +  + HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L           LV EY     +   L+   +   K   E R+     I   + + H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKFR-QIVSAVQYCH 130
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           ++    IVHRD+KA N+LLD + N KI DFG +  F     +      G   Y APE   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPELFQ 185
Query: 224 GGQLT-MKADVYSFGVLVLEIISG 246
           G +    + DV+S GV++  ++SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 104/219 (47%), Gaps = 19/219 (8%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++      
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII-----G 105
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANI-KLNWEKRSDICV---GIAKGLAFLHEELV 167
           +    R    E +++  L   L+GA    + K        IC     I +GL ++H    
Sbjct: 106 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-- 163
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGG 225
            +++HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  
Sbjct: 164 -NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 226 Q-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
           +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 107/249 (42%), Gaps = 40/249 (16%)
Query: 34  NHFSYTELRSATDDF---------HLSNKIGRGGFGTVYKGTLTN------GRRIAVKPL 78
           N + Y + R    D               +G G FG V   T           ++AVK L
Sbjct: 24  NEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML 83
Query: 79  SAESKQGVRE-FITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA 136
             ++    RE  ++E+  ++ +  H N+V L+G C       L++EY     L   L   
Sbjct: 84  KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK 143
Query: 137 ----TKANIKLNWEKRSD-------------ICVG--IAKGLAFLHEELVPHIVHRDIKA 177
               ++  I+   +KR +             +C    +AKG+ FL        VHRD+ A
Sbjct: 144 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 200
Query: 178 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-TGYLAPEYVLGGQLTMKADVYSF 236
            N+L+      KI DFGLA+    +  ++    A     ++APE +  G  T+K+DV+S+
Sbjct: 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260
Query: 237 GVLVLEIIS 245
           G+L+ EI S
Sbjct: 261 GILLWEIFS 269

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQ------GVREFITEIMTL 96
           AT  +    +IG G +GTVYK     +G  +A+K +   + +       VRE +  +  L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVRE-VALLRRL 60
Query: 97  SNVRHPNLVELIGCCV--QGTRRI---LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
               HPN+V L+  C   +  R I   LV+E+V+ + L   L  A      L  E   D+
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPG--LPAETIKDL 117
Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
                +GL FLH      IVHRD+K  NIL+      K+ DFGLA+++  +       + 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALAPVV 172
Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
            T  Y APE +L        D++S G +  E+ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQ------GVREFITEIMTL 96
           AT  +    +IG G +GTVYK     +G  +A+K +   + +       VRE +  +  L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVRE-VALLRRL 60
Query: 97  SNVRHPNLVELIGCCV--QGTRRI---LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
               HPN+V L+  C   +  R I   LV+E+V+ + L   L  A      L  E   D+
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPG--LPAETIKDL 117
Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
                +GL FLH      IVHRD+K  NIL+      K+ DFGLA+++   +      + 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV- 173
Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
            T  Y APE +L        D++S G +  E+ 
Sbjct: 174 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
           ++ L   IG+G F  V     +  GR +A+K +     +   +++   E+  +  + HPN
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L           L+ EY     +   L+   +   K   E RS     I   + + H
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK---EARSKF-RQIVSAVQYCH 131
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           ++    IVHRD+KA N+LLD + N KI DFG +  F   +        G   Y APE   
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAFCGAPPYAAPELFQ 186
Query: 224 GGQLT-MKADVYSFGVLVLEIISG 246
           G +    + DV+S GV++  ++SG
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 47  DFHLSN-----KIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSN 98
           D H+ N      IG+G F  V     +  G+ +AVK +     +   +++   E+  +  
Sbjct: 3   DLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 62
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG---I 155
           + HPN+V+L           LV EY     +   L+          W K  +       I
Sbjct: 63  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-------GWMKEKEARAKFRQI 115
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
              + + H++    IVHRD+KA N+LLD + N KI DFG +  F     +      G+  
Sbjct: 116 VSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPP 170
Query: 216 YLAPEYVLGGQLT-MKADVYSFGVLVLEIISG 246
           Y APE   G +    + DV+S GV++  ++SG
Sbjct: 171 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 9/233 (3%)
Query: 25  VDGELLRNVNHFSYTELRSATDDFHLSNKI-GRGGFGTVYKGTL-TNGRRIAVKPLSAES 82
           +D +       + + E +   +D+ L  ++ GRGGFG V+   +   G+  A K L+ + 
Sbjct: 163 LDSKYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR 222
Query: 83  KQ---GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA 139
            +   G +  + E   L+ V    +V L       T   LV   +    +   +    + 
Sbjct: 223 LKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDED 282
Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 199
           N      +       I  GL  LH+    +I++RD+K  N+LLD + N +I D GLA   
Sbjct: 283 NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339
Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
               T  T   AGT G++APE +LG +     D ++ GV + E+I+ R   +A
Sbjct: 340 KAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
           ++ L   IG+G F  V     +  G+ +AV+ +     +   +++   E+  +  + HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L           LV EY     +   L+   +   K   E R+     I   + + H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK---EARAKFR-QIVSAVQYCH 130
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           ++    IVHRD+KA N+LLD + N KI DFG +  F     +      G+  Y APE   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPELFQ 185
Query: 224 GGQLT-MKADVYSFGVLVLEIISG 246
           G +    + DV+S GV++  ++SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 44  ATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQ------GVREFITEIMTL 96
           AT  +    +IG G +GTVYK     +G  +A+K +   + +       VRE +  +  L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVRE-VALLRRL 60
Query: 97  SNVRHPNLVELIGCCV--QGTRRI---LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
               HPN+V L+  C   +  R I   LV+E+V+ + L   L  A      L  E   D+
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPG--LPAETIKDL 117
Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
                +GL FLH      IVHRD+K  NIL+      K+ DFGLA+++  +       + 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALDPVV 172
Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
            T  Y APE +L        D++S G +  E+ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 13/211 (6%)
Query: 42  RSATDDFHLSNKIGRGGFGTV-YKGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLS 97
           R   ++F     +G+G FG V        GR  A+K L  E   +K  V   +TE   L 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           N RHP L  L        R   V EY     L       ++  +  + ++       I  
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERV-FSEDRARFYGAEIVS 120
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGY 216
            L +LH E   ++V+RD+K  N++LD++ + KI DFGL K    D  T       GT  Y
Sbjct: 121 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEY 176
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           LAPE +         D +  GV++ E++ GR
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 13/211 (6%)
Query: 42  RSATDDFHLSNKIGRGGFGTV-YKGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLS 97
           R   ++F     +G+G FG V        GR  A+K L  E   +K  V   +TE   L 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           N RHP L  L        R   V EY     L       ++  +  + ++       I  
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERV-FSEDRARFYGAEIVS 121
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGY 216
            L +LH E   ++V+RD+K  N++LD++ + KI DFGL K    D  T       GT  Y
Sbjct: 122 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEY 177
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           LAPE +         D +  GV++ E++ GR
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 13/211 (6%)
Query: 42  RSATDDFHLSNKIGRGGFGTV-YKGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLS 97
           R   ++F     +G+G FG V        GR  A+K L  E   +K  V   +TE   L 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           N RHP L  L        R   V EY     L       ++  +  + ++       I  
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERV-FSEDRARFYGAEIVS 119
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGY 216
            L +LH E   ++V+RD+K  N++LD++ + KI DFGL K    D  T       GT  Y
Sbjct: 120 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEY 175
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           LAPE +         D +  GV++ E++ GR
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 146
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 9/223 (4%)
Query: 35  HFSYTELRSATDDFHLSNKI-GRGGFGTVYKGTL-TNGRRIAVKPLSAESKQ---GVREF 89
            + + E +   +D+ L  ++ GRGGFG V+   +   G+  A K L+ +  +   G +  
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 90  ITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 149
           + E   L+ V    +V L       T   LV   +    +   +    + N      +  
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 209
                I  GL  LH+    +I++RD+K  N+LLD + N +I D GLA       T  T  
Sbjct: 293 FYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKG 348
Query: 210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
            AGT G++APE +LG +     D ++ GV + E+I+ R   +A
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 146
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 146
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 147 HRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 9/223 (4%)
Query: 35  HFSYTELRSATDDFHLSNKI-GRGGFGTVYKGTL-TNGRRIAVKPLSAESKQ---GVREF 89
            + + E +   +D+ L  ++ GRGGFG V+   +   G+  A K L+ +  +   G +  
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 90  ITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 149
           + E   L+ V    +V L       T   LV   +    +   +    + N      +  
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 209
                I  GL  LH+    +I++RD+K  N+LLD + N +I D GLA       T  T  
Sbjct: 293 FYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKG 348
Query: 210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
            AGT G++APE +LG +     D ++ GV + E+I+ R   +A
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 116/244 (47%), Gaps = 19/244 (7%)
Query: 50  LSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
           L   +G G FG+V +G L        ++AVK +  +  S++ + EF++E   + +  HPN
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 104 LVELIGCCVQGTRR-----ILVYEYVENNSLDRVLLGA--TKANIKLNWEKRSDICVGIA 156
           ++ L+G C++ + +     +++  +++   L   LL +        +  +      V IA
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-TG 215
            G+ +L      + +HRD+ A N +L  +    + DFGL+K       +   RIA     
Sbjct: 158 LGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 275
           ++A E +     T K+DV++FGV + EI +   +     G  N  + ++    H+ ++P 
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP--GVQNHEMYDYLLHGHRLKQPE 272
Query: 276 ELVD 279
           + +D
Sbjct: 273 DCLD 276

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 9/223 (4%)
Query: 35  HFSYTELRSATDDFHLSNKI-GRGGFGTVYKGTL-TNGRRIAVKPLSAESKQ---GVREF 89
            + + E +   +D+ L  ++ GRGGFG V+   +   G+  A K L+ +  +   G +  
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 90  ITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 149
           + E   L+ V    +V L       T   LV   +    +   +    + N      +  
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 209
                I  GL  LH+    +I++RD+K  N+LLD + N +I D GLA       T  T  
Sbjct: 293 FYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKG 348
Query: 210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 252
            AGT G++APE +LG +     D ++ GV + E+I+ R   +A
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAE---SKQGVREFITEIMTLSNVRH 101
           D F +   IG+G FG V      + +++ A+K ++ +    +  VR    E+  +  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV L           +V + +    L   L    + N+    E        +   L +
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMALDY 130
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           L  +    I+HRD+K  NILLD+  +  I DF +A + P   T ITT +AGT  Y+APE 
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT-MAGTKPYMAPEM 185
Query: 222 V---LGGQLTMKADVYSFGVLVLEIISGR 247
                G   +   D +S GV   E++ GR
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 88/203 (43%), Gaps = 27/203 (13%)
Query: 53  KIGRGGFGTVYKGTLTNGR------RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           +IGRG F TVYKG  T          +  + L+   +Q  +E   E   L  ++HPN+V 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE---EAEXLKGLQHPNIVR 89
Query: 107 LIG---CCVQGTRRI-LVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLA 160
                   V+G + I LV E   + +L   L      K  +  +W      C  I KGL 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILKGLQ 143
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           FLH    P I+HRD+K  NI +       KIGD GLA L           + GT  + AP
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAP 199
Query: 220 EYVLGGQLTMKADVYSFGVLVLE 242
           E     +     DVY+FG   LE
Sbjct: 200 E-XYEEKYDESVDVYAFGXCXLE 221

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 146
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 150
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 148
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 150
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 54  IGRGGFGTVYK-GTLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G+G FG V K       +  AVK ++  S   +     + E+  L  + HPN+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 111 CVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
               +   +V E Y      D ++        + +    + I   +  G+ ++H+    +
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 170 IVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
           IVHRD+K  NILL   +++ + KI DFGL+  F  N T +  RI GT  Y+APE VL G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGT 198
Query: 227 LTMKADVYSFGVLVLEIISG 246
              K DV+S GV++  ++SG
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 151
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 211
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 212 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 144
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 204
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 205 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVE----L 107
           IG G +G V          R+A+K +S  E +   +  + EI  L   RH N++     L
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
               ++  R + + + +    L ++L     +N  + +         I +GL ++H    
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-----FLYQILRGLKYIHSA-- 163
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGG 225
            +++HRD+K SN+L++   + KI DFGLA++      H    T    T  Y APE +L  
Sbjct: 164 -NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNS 222
Query: 226 Q-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
           +  T   D++S G ++ E++S R    GK    Q+N  L
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 152
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 153 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 212
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 213 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 247

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 143
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 144 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 203
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 204 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 238

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 150
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 144
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 204
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 205 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 154
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 155 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 214
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 215 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 249

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 146
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPL--SAESKQGV-REFITEIMTLSNVRH 101
           DDF +   +G+G FG VY         I A+K L  S   K+GV  +   EI   +++ H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN++ L        R  L+ EY     L + L    + +   + ++ + I   +A  L +
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL----QKSCTFDEQRTATIMEELADALMY 138
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
            H + V   +HRDIK  N+LL  +   KI DFG +   P ++   T  + GT  YL PE 
Sbjct: 139 CHGKKV---IHRDIKPENLLLGLKGELKIADFGWSVHAP-SLRRKT--MCGTLDYLPPEM 192
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           + G     K D++  GVL  E++ G
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 166
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 167 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 226
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 227 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 150
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQG-VREFITEIMTLSNVR 100
           R+      L   +G+G +G V++G L +G  +AVK  S+  +Q   RE  TEI     +R
Sbjct: 4   RTVARQVALVECVGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRE--TEIYNTVLLR 60
Query: 101 HPNLVELIGCCV----QGTRRILVYEYVENNSLDRVLLGAT-KANIKLNWEKRSDICVGI 155
           H N++  I   +      T+  L+  Y E+ SL   L   T + ++ L       + V  
Sbjct: 61  HDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALR------LAVSA 114
Query: 156 AKGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI---- 206
           A GLA LH E+      P I HRD K+ N+L+       I D GLA +      ++    
Sbjct: 115 ACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGN 174
Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKA-------DVYSFGVLVLEI 243
             R+ GT  Y+APE VL  Q+           D+++FG+++ EI
Sbjct: 175 NPRV-GTKRYMAPE-VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 148
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 43/230 (18%)
Query: 47  DFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNL 104
           DF     +GRGGFG V++     +    A+K +   +++  RE  + E+  L+ + HP +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 105 VELIGCCVQG--TRRIL-----VYEYVENNSLDRVLLGATKANIKLNW--------EKRS 149
           V      ++   T ++      VY Y++       +    K N+K +W        E+  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQ-------MQLCRKENLK-DWMNGRCTIEERER 117
Query: 150 DICV----GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 205
            +C+     IA+ + FLH +    ++HRD+K SNI    +   K+GDFGL      +   
Sbjct: 118 SVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 206 IT-----------TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
            T           T   GT  Y++PE + G   + K D++S G+++ E++
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 54  IGRGGFGTVYK-GTLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G+G FG V K       +  AVK ++  S   +     + E+  L  + HPN+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 111 CVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
               +   +V E Y      D ++        + +    + I   +  G+ ++H+    +
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 170 IVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
           IVHRD+K  NILL   +++ + KI DFGL+  F  N T +  RI GT  Y+APE VL G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGT 198
Query: 227 LTMKADVYSFGVLVLEIISG 246
              K DV+S GV++  ++SG
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 54  IGRGGFGTVYK-GTLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G+G FG V K       +  AVK ++  S   +     + E+  L  + HPN+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 111 CVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
               +   +V E Y      D ++        + +    + I   +  G+ ++H+    +
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 170 IVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
           IVHRD+K  NILL   +++ + KI DFGL+  F  N T +  RI GT  Y+APE VL G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGT 198
Query: 227 LTMKADVYSFGVLVLEIISG 246
              K DV+S GV++  ++SG
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 53  KIGRGGFGTVYKGTLTNGR-RIAVKPLS---------AESKQGVREF----ITEIMTLSN 98
           K+G G +G V      NG    A+K +          ++  + + +F      EI  L +
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           + HPN+++L           LV E+ E   L   ++   K     +    ++I   I  G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQILSG 158
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           + +LH+    +IVHRDIK  NILL+ +    N KI DFGL+  F  +   +  R+ GT  
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRL-GTAY 213
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           Y+APE VL  +   K DV+S GV++  ++ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 148
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 149 HRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 53  KIGRGGFGTVYKGTL-----TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G G FGTV KG            + +    A       E + E   +  + +P +V +
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
           IG C +    +LV E  E   L++ L    + N  +  +   ++   ++ G+ +L E   
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES-- 146
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGG 225
            + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G     + APE +   
Sbjct: 147 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 226 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 263
           + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 53  KIGRGGFGTVYKGTL-----TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G G FGTV KG            + +    A       E + E   +  + +P +V +
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
           IG C +    +LV E  E   L++ L    + N  +  +   ++   ++ G+ +L E   
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES-- 146
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGG 225
            + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G     + APE +   
Sbjct: 147 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 226 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 263
           + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 13/204 (6%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
           ++ L   IG+G F  V     +  G+ +AVK +     +   +++   E+     + HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L           LV EY     +   L+   +   K   E R+     I   + + H
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK---EARAKFR-QIVSAVQYCH 130
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           ++    IVHRD+KA N+LLD + N KI DFG +  F     +      G   Y APE   
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPELFQ 185
Query: 224 GGQLT-MKADVYSFGVLVLEIISG 246
           G +    + DV+S GV++  ++SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVR 100
           R+      L   +G+G +G V++G+   G  +AVK  S+ + K   RE  TE+     +R
Sbjct: 4   RTVAHQITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLR 60
Query: 101 HPNLVELIGCCV----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           H N++  I   +      T+  L+  Y E  SL   L   T   +         I + IA
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIA 115
Query: 157 KGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--- 208
            GLA LH E+      P I HRD+K+ NIL+ +     I D GLA +   +   +     
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 209 -RIAGTTGYLAPEYVLGGQLTM-------KADVYSFGVLVLEI 243
            R+ GT  Y+APE VL   + +       + D+++FG+++ E+
Sbjct: 176 PRV-GTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 53  KIGRGGFGTVYKG-----TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G G FGTV KG      +     + +    A       E + E   +  + +P +V +
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
           IG C +    +LV E  E   L++ L    + N  +  +   ++   ++ G+ +L E   
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES-- 489
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGG 225
            + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G     + APE +   
Sbjct: 490 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 226 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 263
           + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 549 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 587

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 53  KIGRGGFGTVYKG-----TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G G FGTV KG      +     + +    A       E + E   +  + +P +V +
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
           IG C +    +LV E  E   L++ L    + N  +  +   ++   ++ G+ +L E   
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES-- 144
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGG 225
            + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G     + APE +   
Sbjct: 145 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 226 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 263
           + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 242

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 53  KIGRGGFGTVYKG-----TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G G FGTV KG      +     + +    A       E + E   +  + +P +V +
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
           IG C +    +LV E  E   L++ L    + N  +  +   ++   ++ G+ +L E   
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES-- 488
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGG 225
            + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G     + APE +   
Sbjct: 489 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 226 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 263
           + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 548 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 118/246 (47%), Gaps = 17/246 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRH 101
            DD     ++GRG +G V K   + +G+ +AVK + A   S++  R  +   +++  V  
Sbjct: 50  ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 109
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P  V   G   +     +  E + + SLD+           +  +    I V I K L  
Sbjct: 110 PFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 168
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH +L   ++HRD+K SN+L++     K+ DFG++    D++    T  AG   Y+APE 
Sbjct: 169 LHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK--TIDAGCKPYMAPER 224
Query: 222 V---LGGQ-LTMKADVYSFGVLVLEIISGRNSGKAMWG----QMNKFLLEWAWQLHQEEK 273
           +   L  +  ++K+D++S G+ ++E+   R    + WG    Q+ + + E + QL  ++ 
Sbjct: 225 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-WGTPFQQLKQVVEEPSPQLPADKF 283
Query: 274 PLELVD 279
             E VD
Sbjct: 284 SAEFVD 289

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A++ +S  E +   +  + EI  L   RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 150
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T   T    T  Y APE +L  +  T
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 53  KIGRGGFGTVYKG-----TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G G FGTV KG      +     + +    A       E + E   +  + +P +V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
           IG C +    +LV E  E   L++ L    + N  +  +   ++   ++ G+ +L E   
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES-- 136
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGG 225
            + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G     + APE +   
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 226 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 263
           + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 53  KIGRGGFGTVYKG-----TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G G FGTV KG      +     + +    A       E + E   +  + +P +V +
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
           IG C +    +LV E  E   L++ L    + N  +  +   ++   ++ G+ +L E   
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES-- 130
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGG 225
            + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G     + APE +   
Sbjct: 131 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 226 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 263
           + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 53  KIGRGGFGTVYKG-----TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G G FGTV KG      +     + +    A       E + E   +  + +P +V +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
           IG C +    +LV E  E   L++ L    + N  +  +   ++   ++ G+ +L E   
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES-- 126
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGG 225
            + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G     + APE +   
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 226 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 263
           + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 53  KIGRGGFGTVYKG-----TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G G FGTV KG      +     + +    A       E + E   +  + +P +V +
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
           IG C +    +LV E  E   L++ L    + N  +  +   ++   ++ G+ +L E   
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES-- 124
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGG 225
            + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G     + APE +   
Sbjct: 125 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 226 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 263
           + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 222

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 48  FHLSNKIGRGGFGTVY---KGTLTNGRRIAVKPLSAESKQGVREFITEIM---TLSNVRH 101
           F L   +G+G FG V+   K + ++ R++    +  ++   VR+ +   M    L  V H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P +V+L        +  L+ +++    L           +    E        +A  L  
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAP 219
           LH      I++RD+K  NILLD+E + K+ DFGL+K   ++I H        GT  Y+AP
Sbjct: 142 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAP 195
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISG 246
           E V     T  AD +SFGVL+ E+++G
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 100 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 154
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 155 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 207
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGTLTNGRR-IAVKPLSAE-SKQGVREFITEIMTLSNVRHP 102
           +D F + +++GRG    VY+      ++  A+K L     K+ VR   TEI  L  + HP
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVLLRLSHP 108
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+++L       T   LV E V    L DR++     +         +D    I + +A+
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE-----RDAADAVKQILEAVAY 163
Query: 162 LHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
           LHE     IVHRD+K  N+L      +   KI DFGL+K+    +   T  + GT GY A
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCA 218
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE + G     + D++S G++   ++ G
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 53  KIGRGGFGTVYKG-----TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL 107
           ++G G FGTV KG      +     + +    A       E + E   +  + +P +V +
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
           IG C +    +LV E  E   L++ L    + N  +  +   ++   ++ G+ +L E   
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES-- 130
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--PDNITHITTRIAGTTGYLAPEYVLGG 225
            + VHRD+ A N+LL  +   KI DFGL+K     +N     T       + APE +   
Sbjct: 131 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 226 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE 263
           + + K+DV+SFGVL+ E  S G+   + M G     +LE
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 94
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L  C     +      Y +N  L + +  +G+        +         I  
Sbjct: 95  DHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 148
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 149 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 96  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 150 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNA 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           IG G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 95  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 42  RSATDDFHLSNKIGRGGFGTVY---KGTLTNGRRIAVKPLSAESKQGVREFITEIM---T 95
           ++    F L   +G+G FG V+   K + ++ R++    +  ++   VR+ +   M    
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           L  V HP +V+L        +  L+ +++    L           +    E        +
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAEL 135
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGT 213
           A  L  LH      I++RD+K  NILLD+E + K+ DFGL+K   ++I H        GT
Sbjct: 136 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGT 189
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             Y+APE V     T  AD +SFGVL+ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 42  RSATDDFHLSNKIGRGGFGTVY---KGTLTNGRRIAVKPLSAESKQGVREFITEIM---T 95
           ++    F L   +G+G FG V+   K + ++ R++    +  ++   VR+ +   M    
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           L  V HP +V+L        +  L+ +++    L           +    E        +
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAEL 136
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGT 213
           A  L  LH      I++RD+K  NILLD+E + K+ DFGL+K   ++I H        GT
Sbjct: 137 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGT 190
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             Y+APE V     T  AD +SFGVL+ E+++G
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 86  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 193
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 109 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 163
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 216
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 86  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 193
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSA-ESKQGVREFITEIMTLSNVR 100
           R+      L   +G+G +G V++G+   G  +AVK  S+ + K   RE  TE+     +R
Sbjct: 33  RTVARQITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLR 89
Query: 101 HPNLVELIGCCV----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           H N++  I   +      T+  L+  Y E  SL   L   T   +         I + IA
Sbjct: 90  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIA 144
Query: 157 KGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--- 208
            GLA LH E+      P I HRD+K+ NIL+ +     I D GLA +   +   +     
Sbjct: 145 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 204
Query: 209 -RIAGTTGYLAPEYVLGGQLTM-------KADVYSFGVLVLEI 243
            R+ GT  Y+APE VL   + +       + D+++FG+++ E+
Sbjct: 205 PRV-GTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 110 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 217
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 150
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T        T  Y APE +L  +  T
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 210
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 11/215 (5%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           IG G +G V       N  R+A+K +S  E +   +  + EI  L   RH N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
              T   +   Y+  + ++  L    K    L+ +        I +GL ++H     +++
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVL 151
Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLF-PD-NITHITTRIAGTTGYLAPEYVLGGQ-LT 228
           HRD+K SN+LL+   + KI DFGLA++  PD + T        T  Y APE +L  +  T
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 211
Query: 229 MKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
              D++S G ++ E++S R    GK    Q+N  L
Sbjct: 212 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 102 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 209
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 101 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 154
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 155 -ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 208
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 95  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 97  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNW 204
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 96  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 150 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 97  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNW 204
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 97  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNW 204
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 96  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 150 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 96  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 150 -ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 117/246 (47%), Gaps = 17/246 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRH 101
            DD     ++GRG +G V K   + +G+ +AVK + A   S++  R  +   +++  V  
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P  V   G   +     +  E + + SLD+           +  +    I V I K L  
Sbjct: 66  PFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH +L   ++HRD+K SN+L++     K+ DFG++    D++       AG   Y+APE 
Sbjct: 125 LHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--AGCKPYMAPER 180
Query: 222 V---LGGQ-LTMKADVYSFGVLVLEIISGRNSGKAMWG----QMNKFLLEWAWQLHQEEK 273
           +   L  +  ++K+D++S G+ ++E+   R    + WG    Q+ + + E + QL  ++ 
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-WGTPFQQLKQVVEEPSPQLPADKF 239
Query: 274 PLELVD 279
             E VD
Sbjct: 240 SAEFVD 245

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 95  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 95  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 89  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 143
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 144 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 196
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 97  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 204
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 92  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 92  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 147 --DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 87  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 141
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 194
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 86  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 193
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 92  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 102 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 209
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 102 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 209
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 92  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 101 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 155
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 156 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 208
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 110 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 217
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 15/212 (7%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAE---SKQGVREFITEIMTLS 97
           R    DF+    +G+G FG V          + A+K L  +       V   + E   L+
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLA 74
Query: 98  NVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
            +  P  +  +  C Q   R+  V EYV    L    +   +   K    +       I+
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL----MYHIQQVGKFKEPQAVFYAAEIS 130
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTG 215
            GL FLH+     I++RD+K  N++LD E + KI DFG+ K     +  +TTR   GT  
Sbjct: 131 IGLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPD 185
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           Y+APE +         D +++GVL+ E+++G+
Sbjct: 186 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 113 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 167
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 168 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 220
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 87  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 141
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 194
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG---TTGYLAPEYVL 223
              I+HRD+K SN+ ++++   KI DFGLA+       H    +AG   T  Y APE +L
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEIML 195
Query: 224 GG-QLTMKADVYSFGVLVLEIISGR 247
                    D++S G ++ E+++GR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG---TTGYLAPEYVL 223
              I+HRD+K SN+ ++++   KI DFGLA+       H    +AG   T  Y APE +L
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEIML 195
Query: 224 GG-QLTMKADVYSFGVLVLEIISGR 247
                    D++S G ++ E+++GR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 88  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 142
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 143 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 195
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 109 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 163
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR      Y APE +L  
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 216
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 102/235 (43%), Gaps = 37/235 (15%)
Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAES---KQGVREFITEI-MTLSNVRH 101
           DFH    IG+G FG V            AVK L  ++   K+  +  ++E  + L NV+H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRSDICVG- 154
           P LV L        +   V +Y+    L      +R  L           E R+      
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL-----------EPRARFYAAE 147
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAG 212
           IA  L +LH     +IV+RD+K  NILLD + +  + DFGL K   +NI H   T+   G
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCG 201
Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG------RNSGKAMWGQMNKFL 261
           T  YLAPE +         D +  G ++ E++ G      RN+ +     +NK L
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 256

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 52  NKIGRGGFGTVYKGT--LTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELI 108
           +K+G G + TVYKG   LT+   +A+K +  E ++G     I E+  L +++H N+V L 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 109 GCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
                     LV+EY++ +    LD         N+KL           + +GLA+ H +
Sbjct: 67  DIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL-------FLFQLLRGLAYCHRQ 119
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRIAGTTGYLAPEYVL 223
               ++HRD+K  N+L+++    K+ DFGL  AK  P   T        T  Y  P+ +L
Sbjct: 120 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYDNEVVTLWYRPPDILL 173
Query: 224 GG-QLTMKADVYSFGVLVLEIISGR 247
           G    + + D++  G +  E+ +GR
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG- 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +    T    T  Y APE +L   
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGXVATRWYRAPEIMLNWM 198
Query: 226 QLTMKADVYSFGVLVLEIISGR 247
                 D++S G ++ E+++GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 86  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG---TTGYLAPEYVL 223
              I+HRD+K SN+ ++++   KI DFGLA+       H    +AG   T  Y APE +L
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEIML 191
Query: 224 GG-QLTMKADVYSFGVLVLEIISGR 247
                    D++S G ++ E+++GR
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI   + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 48  FHLSNKIGRGGFGTVYKGTLTNGR----RIAVKPLSAE--SKQGVREFITEIMTLSNVRH 101
           F L   +G+G FG+V +  L        ++AVK L A+  +   + EF+ E   +    H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 102 PNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI--CV 153
           P++ +L+G  ++   +      +++  ++++  L   LL +       N   ++ +   V
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAG 212
            IA G+ +L      + +HRD+ A N +L ++    + DFGL+ K++  +          
Sbjct: 145 DIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              +LA E +     T+ +DV++FGV + EI++
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFIT-EIMTLSNVRHPNLVELIG 109
           +G G FG V   T     +++A+K +S +   K  +   +  EI  L  +RHP++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
                T  ++V EY      D ++        ++  ++       I   + + H      
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIV-----EKKRMTEDEGRRFFQQIICAIEYCHRH---K 128
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
           IVHRD+K  N+LLD   N KI DFGL+ +  D     T+   G+  Y APE V+ G+L  
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VINGKLYA 185
Query: 230 --KADVYSFGVLVLEIISGR 247
             + DV+S G+++  ++ GR
Sbjct: 186 GPEVDVWSCGIVLYVMLVGR 205

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI D+GLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSAES---KQGVREFITEIMTLSN 98
           D +   + +G G F  V    L   +R    +A+K ++ E+   K+G  E   EI  L  
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEIAVLHK 72
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 157
           ++HPN+V L      G    L+ + V    L DR++               S +   +  
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-----RDASRLIFQVLD 127
Query: 158 GLAFLHEELVPHIVHRDIKASNIL---LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
            + +LH+     IVHRD+K  N+L   LD++    I DFGL+K+  ++   + +   GT 
Sbjct: 128 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTP 182
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           GY+APE +     +   D +S GV+   ++ G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSAES---KQGVREFITEIMTLSN 98
           D +   + +G G F  V    L   +R    +A+K ++ E+   K+G  E   EI  L  
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEIAVLHK 72
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 157
           ++HPN+V L      G    L+ + V    L DR++               S +   +  
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-----RDASRLIFQVLD 127
Query: 158 GLAFLHEELVPHIVHRDIKASNIL---LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
            + +LH+     IVHRD+K  N+L   LD++    I DFGL+K+  ++   + +   GT 
Sbjct: 128 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTP 182
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           GY+APE +     +   D +S GV+   ++ G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 119 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 48  FHLSNKIGRGGFGTVY---KGTLTNGRRIAVKPLSAESKQGVREFITEIM---TLSNVRH 101
           F L   +G+G FG V+   K T  +   +    +  ++   VR+ +   M    L++V H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P +V+L        +  L+ +++    L           +    E        +A GL  
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALGLDH 145
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      I++RD+K  NILLD+E + K+ DFGL+K   D+     +   GT  Y+APE 
Sbjct: 146 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS-FCGTVEYMAPEV 201
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           V     +  AD +S+GVL+ E+++G
Sbjct: 202 VNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 120 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSAES---KQGVREFITEIMTLSN 98
           D +   + +G G F  V    L   +R    +A+K ++ E+   K+G  E   EI  L  
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEIAVLHK 72
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 157
           ++HPN+V L      G    L+ + V    L DR++               S +   +  
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-----RDASRLIFQVLD 127
Query: 158 GLAFLHEELVPHIVHRDIKASNIL---LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
            + +LH+     IVHRD+K  N+L   LD++    I DFGL+K+  ++   + +   GT 
Sbjct: 128 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTP 182
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           GY+APE +     +   D +S GV+   ++ G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G +G V           +AVK +  +      E I  EI     + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 108/226 (47%), Gaps = 24/226 (10%)
Query: 28  ELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYK-GTLTNGRRIAVKPLSAESKQGV 86
           E L+ V++    E+  AT       ++GRG FG V++      G + AVK +  E  +  
Sbjct: 60  EKLKPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA- 114
Query: 87  REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 146
                E+M  + +  P +V L G   +G    +  E +E  SL +++    K    L  E
Sbjct: 115 ----EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLP-E 165
Query: 147 KRSDICVGIA-KGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLA-KLFPDNI 203
            R+   +G A +GL +LH      I+H D+KA N+LL  +  +  + DFG A  L PD +
Sbjct: 166 DRALYYLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGL 222
Query: 204 TH---ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
                    I GT  ++APE VLG     K DV+S   ++L +++G
Sbjct: 223 GKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGL +   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 108/226 (47%), Gaps = 24/226 (10%)
Query: 28  ELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYK-GTLTNGRRIAVKPLSAESKQGV 86
           E L+ V++    E+  AT       ++GRG FG V++      G + AVK +  E  +  
Sbjct: 79  EKLKPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA- 133
Query: 87  REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 146
                E+M  + +  P +V L G   +G    +  E +E  SL +++    K    L  E
Sbjct: 134 ----EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLP-E 184
Query: 147 KRSDICVGIA-KGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLA-KLFPDNI 203
            R+   +G A +GL +LH      I+H D+KA N+LL  +  +  + DFG A  L PD +
Sbjct: 185 DRALYYLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGL 241
Query: 204 TH---ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
                    I GT  ++APE VLG     K DV+S   ++L +++G
Sbjct: 242 GKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 48  FHLSNKIGRGGFGTVYKGTLTNGR--------RIAVKPLSAESKQGVREFITEIMTLSNV 99
           F L   +G+GG+G V++     G         ++  K +   + +       E   L  V
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +HP +V+LI     G +  L+ EY+    L    +   +  I +  +        I+  L
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFME-DTACFYLAEISMAL 134
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
             LH++    I++RD+K  NI+L+ + + K+ DFGL K    + T +T    GT  Y+AP
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEYMAP 190
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISG 246
           E ++        D +S G L+ ++++G
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 111/241 (46%), Gaps = 42/241 (17%)
Query: 41  LRSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV 99
           LR A+D F     +G+G FG V K     + R  A+K +   +++ +   ++E+  L+++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASL 59
Query: 100 RHPNLVELIGCCVQGTRRILV---------------YEYVENNSLDRVLLGATKANIKLN 144
            H  +V      ++  RR  V                EY EN +L  ++      N+   
Sbjct: 60  NHQYVVRYYAAWLE--RRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLI---HSENLNQQ 114
Query: 145 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK------- 197
            ++   +   I + L+++H +    I+HR++K  NI +D+  N KIGDFGLAK       
Sbjct: 115 RDEYWRLFRQILEALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 198 -------LFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNS 249
                    P +  ++T+ I GT  Y+A E + G G    K D YS G++  E I   ++
Sbjct: 172 ILKLDSQNLPGSSDNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFST 230
Query: 250 G 250
           G
Sbjct: 231 G 231

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 110 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG- 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +         T  Y APE +L   
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----XGXVATRWYRAPEIMLNWM 218
Query: 226 QLTMKADVYSFGVLVLEIISGR 247
                 D++S G ++ E+++GR
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                 R L  E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DF LA+   D +T ++ TR      Y APE +L  
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 48  FHLSNKIGRGGFGTVYKGTLTNGR--------RIAVKPLSAESKQGVREFITEIMTLSNV 99
           F L   +G+GG+G V++     G         ++  K +   + +       E   L  V
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +HP +V+LI     G +  L+ EY+    L    +   +  I +  +        I+  L
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFME-DTACFYLAEISMAL 134
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
             LH++    I++RD+K  NI+L+ + + K+ DFGL K    + T +T    GT  Y+AP
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAP 190
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISG 246
           E ++        D +S G L+ ++++G
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 113 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 166
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI DFGLA+   D +  ++ TR      Y APE +L  
Sbjct: 167 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WYRAPEIMLNW 220
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFY------TAEIVS 143
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +     +  +D+++ G ++ ++++G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSA---ESKQGVREFITEIMTLSN 98
           D +   + +G G F  V    L   +R    +A+K ++    E K+G  E   EI  L  
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSME--NEIAVLHK 72
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 157
           ++HPN+V L      G    L+ + V    L DR++               S +   +  
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-----RDASRLIFQVLD 127
Query: 158 GLAFLHEELVPHIVHRDIKASNIL---LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
            + +LH+     IVHRD+K  N+L   LD++    I DFGL+K+  ++   + +   GT 
Sbjct: 128 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTP 182
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           GY+APE +     +   D +S GV+   ++ G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 66
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 67  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 120
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 121 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 67
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 68  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 121
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 122 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K  ++    EI  L N+R  PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR---EIKILENLRGGPN 93
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 146
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 147 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 201
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 65
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 66  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 119
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 120 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 64
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 65  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 118
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 119 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 43  SATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH 101
           S  D + +  ++G G FG V++      GR    K ++            EI  ++ + H
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           P L+ L          +L+ E++    L DR+       + K++  +  +      +GL 
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLK 163
Query: 161 FLHEELVPHIVHRDIKASNILLD--QEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYL 217
            +HE     IVH DIK  NI+ +  +  + KI DFGLA KL PD I  +TT    T  + 
Sbjct: 164 HMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFA 217
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISG 246
           APE V    +    D+++ GVL   ++SG
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 86
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 140
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 141 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 90
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 144
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 145 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V       +G ++A+K LS   +S+   +    E++ L +++H N++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 111 CVQGTRRILVYEY-----VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
               +     Y++          L +++       +K + EK   +   + KGL ++H  
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS- 144
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG---TTGYLAPEYV 222
               +VHRD+K  N+ ++++   KI DFGLA+       H    + G   T  Y APE +
Sbjct: 145 --AGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVI 195
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
           L         D++S G ++ E+++G+    GK    Q+ + L
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 141
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 141
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 143
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 86
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 140
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 141 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 90
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 144
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 145 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 141
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 143
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 53  KIGRGGFGTVYKGTLTNGRRI-AVKPLS-AESKQGV-REFITEIMTLSNVRHPNLVELIG 109
           KIG G +GTV+K        I A+K +   +  +GV    + EI  L  ++H N+V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
                 +  LV+E+ + + L +        N  L+ E        + KGL F H     +
Sbjct: 69  VLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-T 228
           ++HRD+K  N+L+++    K+ DFGLA+ F   +   +  +  T  Y  P+ + G +L +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 229 MKADVYSFGVLVLEIISG 246
              D++S G +  E+ + 
Sbjct: 181 TSIDMWSAGCIFAELANA 198

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 143
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 71
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 72  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 125
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 126 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 53  KIGRGGFGTVY--KGTLTNGRR-IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           K+G G +G V   +  +T+  R I +   ++ S     + + E+  L  + HPN+++L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 110 CCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
                    LV E  +   L D ++       +K N    + I   +  G+ +LH+    
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEII-----HRMKFNEVDAAVIIKQVLSGVTYLHKH--- 155
Query: 169 HIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
           +IVHRD+K  N+LL+ +      KI DFGL+ +F +N   +  R+ GT  Y+APE VL  
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERL-GTAYYIAPE-VLRK 212
Query: 226 QLTMKADVYSFGVLVLEIISG 246
           +   K DV+S GV++  +++G
Sbjct: 213 KYDEKCDVWSIGVILFILLAG 233

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI  FGLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/94 (42%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
           I  GL  LH E    IV+RD+K  NILLD   + +I D GLA   P+  T I  R+ GT 
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTV 349
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           GY+APE V   + T   D ++ G L+ E+I+G++
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGT-VYKGTLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F T V    L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 141
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 143
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI D GLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 109/244 (44%), Gaps = 25/244 (10%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPL--SAESKQGVREFITEIMTLSN 98
           ++  +D     ++G G  G V+K      G  IAVK +  S   ++  R  +   + L +
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS 80
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVEN--NSLDRVLLGATKANIKLNWEKRSDICVGIA 156
              P +V+  G  +  T   +  E +      L + + G     I         + V I 
Sbjct: 81  HDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI------LGKMTVAIV 134
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
           K L +L E+    ++HRD+K SNILLD+    K+ DFG++    D+      R AG   Y
Sbjct: 135 KALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--KAKDRSAGCAAY 190
Query: 217 LAPEYVLGGQLT-----MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 271
           +APE +     T     ++ADV+S G+ ++E+ +G+   K       K   E   ++ QE
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC-----KTDFEVLTKVLQE 245
Query: 272 EKPL 275
           E PL
Sbjct: 246 EPPL 249

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/94 (42%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
           I  GL  LH E    IV+RD+K  NILLD   + +I D GLA   P+  T I  R+ GT 
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTV 349
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           GY+APE V   + T   D ++ G L+ E+I+G++
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 92
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 93  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 146
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 147 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE----FIT-EIMTLSNV 99
           +DF     +G G F TV     L   R  A+K L  E +  ++E    ++T E   +S +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAK 157
            HP  V+L        +      Y +N  L + +  +G+        +         I  
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY------TAEIVS 143
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGY 216
            L +LH +    I+HRD+K  NILL+++ + +I DFG AK L P++         GT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++PE +        +D+++ G ++ ++++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
            +D+ L   +G G  G V           +AVK +  +      E I  EI     + H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+V+  G   +G  + L  EY     L DR+     + +I +           +  G+ +
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPE 220
           LH      I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE
Sbjct: 120 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 221 YVLGGQLTMK-ADVYSFGVLVLEIISG 246
            +   +   +  DV+S G+++  +++G
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKGT-----LTNGRRIAVKPLSAESKQGV--REFITEIMTLSN 98
           D + +  ++G G F  V K       L    +   K  S  S++GV   E   E+  L  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V HPN++ L       T  +L+ E V    L   L  A K +  L+ E+ +     I  G
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKES--LSEEEATSFIKQILDG 127
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT 214
           + +LH      I H D+K  NI+L  +  P    K+ DFGLA    D +      I GT 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTP 182
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            ++APE V    L ++AD++S GV+   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI D GLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 45  TDDFHLSNKIGRGGFGTVY--KGTLTNGRRIAVKPLS---AESKQGVREFITEIMTLSNV 99
           +D +     +G+G FG V   K  +T G+  AVK +S    + K      + E+  L  +
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 100 RHPNLVELIGCCVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            HPN+++L           LV E Y      D ++     +  + +    + I   +  G
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAARIIRQVLSG 144
Query: 159 LAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           + ++H+     IVHRD+K  N+LL+   ++ N +I DFGL+  F  +   +  +I GT  
Sbjct: 145 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKI-GTAY 199
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           Y+APE VL G    K DV+S GV++  ++SG
Sbjct: 200 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 53  KIGRGGFGTVYKGTLTNGRRI-AVKPLS-AESKQGV-REFITEIMTLSNVRHPNLVELIG 109
           KIG G +GTV+K        I A+K +   +  +GV    + EI  L  ++H N+V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
                 +  LV+E+ + + L +        N  L+ E        + KGL F H     +
Sbjct: 69  VLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-T 228
           ++HRD+K  N+L+++    K+ +FGLA+ F   +   +  +  T  Y  P+ + G +L +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 229 MKADVYSFGVLVLEIISGRNSGKAMW 254
              D++S G +  E+    N+G+ ++
Sbjct: 181 TSIDMWSAGCIFAELA---NAGRPLF 203

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLT-NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V     T  G R+AVK LS   +S    +    E+  L +++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
                      E   +  L   L+GA   NI    KL  +    +   I +GL ++H   
Sbjct: 90  FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   KI D GLA+   D +T ++ TR      Y APE +L  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E+++GR
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 51  SNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELI 108
           S  +G G +  V    +L NG+  AVK +  ++         E+ TL   + + N++ELI
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
                 TR  LV+E ++  S+    L   +     N  + S +   +A  L FLH     
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSI----LAHIQKQKHFNEREASRVVRDVAAALDFLH---TK 130
Query: 169 HIVHRDIKASNILLD--QEFNP-KIGDFGLAK--LFPDNITHIT----TRIAGTTGYLAP 219
            I HRD+K  NIL +  ++ +P KI DF L       ++ T IT    T   G+  Y+AP
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 220 EY--VLGGQLTM---KADVYSFGVLVLEIISG 246
           E   V   Q T    + D++S GV++  ++SG
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 42  RSATDDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIM 94
           R    DF+    +G+G FG V     KGT       AVK L  +       V   + E  
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 95  TLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVL--LGATKANIKLNWEKRSDI 151
            L+    P  +  +  C Q   R+  V EYV    L   +  +G  K    + +      
Sbjct: 73  VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY------ 126
Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTR- 209
              IA GL FL  +    I++RD+K  N++LD E + KI DFG+ K   +NI   +TT+ 
Sbjct: 127 AAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKX 180
Query: 210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
             GT  Y+APE +         D ++FGVL+ E+++G+
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 54  IGRGGFGTVY--KGTLTNGRRIAVKPLS---AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G+G FG V   K  +T G+  AVK +S    + K      + E+  L  + HPN+++L 
Sbjct: 34  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 109 GCCVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                     LV E Y      D ++     +  + +    + I   +  G+ ++H+   
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAARIIRQVLSGITYMHKN-- 145
Query: 168 PHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
             IVHRD+K  N+LL+   ++ N +I DFGL+  F  +   +  +I GT  Y+APE VL 
Sbjct: 146 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKI-GTAYYIAPE-VLH 201
Query: 225 GQLTMKADVYSFGVLVLEIISG 246
           G    K DV+S GV++  ++SG
Sbjct: 202 GTYDEKCDVWSTGVILYILLSG 223

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 45  TDDFHLSNKIGRGGFGTVY--KGTLTNGRRIAVKPLS---AESKQGVREFITEIMTLSNV 99
           +D +     +G+G FG V   K  +T G+  AVK +S    + K      + E+  L  +
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 100 RHPNLVELIGCCVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            HPN+++L           LV E Y      D ++     +  + +    + I   +  G
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAARIIRQVLSG 161
Query: 159 LAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           + ++H+     IVHRD+K  N+LL+   ++ N +I DFGL+  F  +   +  +I GT  
Sbjct: 162 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKI-GTAY 216
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           Y+APE VL G    K DV+S GV++  ++SG
Sbjct: 217 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 42  RSATDDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIM 94
           R    DF+    +G+G FG V     KGT       AVK L  +       V   + E  
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 95  TLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVL--LGATKANIKLNWEKRSDI 151
            L+    P  +  +  C Q   R+  V EYV    L   +  +G  K    + +      
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY------ 447
Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTR- 209
              IA GL FL  +    I++RD+K  N++LD E + KI DFG+ K   +NI   +TT+ 
Sbjct: 448 AAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKX 501
Query: 210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
             GT  Y+APE +         D ++FGVL+ E+++G+
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 124/297 (41%), Gaps = 39/297 (13%)
Query: 54  IGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ 113
           IG+G FG VY G       I +  +  +++  ++ F  E+M     RH N+V  +G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR 173
                ++    +  +L  V+     A I L+  K   I   I KG+ +LH +    I+H+
Sbjct: 101 PPHLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHK 154
Query: 174 DIKASNILLDQEFNPK--IGDFGL---AKLFPDNITHITTRIA-GTTGYLAPEYVLGGQ- 226
           D+K+ N+  D   N K  I DFGL   + +          RI  G   +LAPE +     
Sbjct: 155 DLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 227 --------LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 278
                    +  +DV++ G +  E+ +     K    Q  + ++   WQ+    KP  L 
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT---QPAEAII---WQMGTGMKP-NLS 264
Query: 279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLF 335
              +G+   +       +  FC       RP   +++ ML K  + N   L+ PG F
Sbjct: 265 QIGMGKEISD-------ILLFCWAFEQEERPTFTKLMDMLEKLPKRN-RRLSHPGHF 313

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 45  TDDFHLSNKIGRGGFGTVY--KGTLTNGRRIAVKPLS---AESKQGVREFITEIMTLSNV 99
           +D +     +G+G FG V   K  +T G+  AVK +S    + K      + E+  L  +
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 100 RHPNLVELIGCCVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            HPN+++L           LV E Y      D ++     +  + +    + I   +  G
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAARIIRQVLSG 162
Query: 159 LAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           + ++H+     IVHRD+K  N+LL+   ++ N +I DFGL+  F  +   +  +I GT  
Sbjct: 163 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKI-GTAY 217
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           Y+APE VL G    K DV+S GV++  ++SG
Sbjct: 218 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAES---KQGVREFITEIMTLSNVRH 101
           +DF +   IGRGGFG VY     + G+  A+K L  +    KQG    + E + LS V  
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR-----SDI---CV 153
            +    I C        + Y +   + L  +L      ++  +  +      +D+     
Sbjct: 248 GD-CPFIVC--------MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA 298
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
            I  GL  +H   V   V+RD+K +NILLD+  + +I D GLA  F     H +    GT
Sbjct: 299 EIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 352
Query: 214 TGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN 248
            GY+APE +  G      AD +S G ++ +++ G +
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 388

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAES---KQGVREFITEIMTLSNVRH 101
           +DF +   IGRGGFG VY     + G+  A+K L  +    KQG    + E + LS V  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR-----SDI---CV 153
            +    I C        + Y +   + L  +L      ++  +  +      +D+     
Sbjct: 249 GD-CPFIVC--------MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA 299
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
            I  GL  +H   V   V+RD+K +NILLD+  + +I D GLA  F     H +    GT
Sbjct: 300 EIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 214 TGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN 248
            GY+APE +  G      AD +S G ++ +++ G +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAES---KQGVREFITEIMTLSNVRH 101
           +DF +   IGRGGFG VY     + G+  A+K L  +    KQG    + E + LS V  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR-----SDI---CV 153
            +    I C        + Y +   + L  +L      ++  +  +      +D+     
Sbjct: 249 GD-CPFIVC--------MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA 299
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
            I  GL  +H   V   V+RD+K +NILLD+  + +I D GLA  F     H +    GT
Sbjct: 300 EIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 214 TGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN 248
            GY+APE +  G      AD +S G ++ +++ G +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAES---KQGVREFITEIMTLSNVRH 101
           +DF +   IGRGGFG VY     + G+  A+K L  +    KQG    + E + LS V  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR-----SDI---CV 153
            +    I C        + Y +   + L  +L      ++  +  +      +D+     
Sbjct: 249 GD-CPFIVC--------MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA 299
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
            I  GL  +H   V   V+RD+K +NILLD+  + +I D GLA  F     H +    GT
Sbjct: 300 EIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 214 TGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN 248
            GY+APE +  G      AD +S G ++ +++ G +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 111/245 (45%), Gaps = 15/245 (6%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRH 101
            DD     ++GRG +G V K   + +G+  AVK + A   S++  R      ++   V  
Sbjct: 33  ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDC 92
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P  V   G   +     +  E + + SLD+           +  +    I V I K L  
Sbjct: 93  PFTVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 151
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH +L   ++HRD+K SN+L++     K  DFG++    D++       AG   Y APE 
Sbjct: 152 LHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID--AGCKPYXAPER 207
Query: 222 V---LGGQ-LTMKADVYSFGVLVLEIISGR---NSGKAMWGQMNKFLLEWAWQLHQEEKP 274
           +   L  +  ++K+D++S G+  +E+   R   +S    + Q+ + + E + QL  ++  
Sbjct: 208 INPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 267
Query: 275 LELVD 279
            E VD
Sbjct: 268 AEFVD 272

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 54  IGRGGFGTVYKG-TLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V       +G ++A+K LS   +S+   +    E++ L +++H N++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 111 CVQGTRRILVYEY-----VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
               +     Y++          L +++       ++ + EK   +   + KGL ++H  
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA 163
Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG---TTGYLAPEYV 222
               +VHRD+K  N+ ++++   KI DFGLA+       H    + G   T  Y APE +
Sbjct: 164 ---GVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVI 213
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
           L         D++S G ++ E+++G+    GK    Q+ + L
Sbjct: 214 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 255

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 53  KIGRGGFGTVYK-GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           ++GRG FG V++      G + AVK +  E  +     + E++  + +  P +V L G  
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 135
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA-KGLAFLHEELVPHI 170
            +G    +  E +E  SL +++       +    E R+   +G A +GL +LH      I
Sbjct: 136 REGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 187
Query: 171 VHRDIKASNILLDQEFN-PKIGDFGLA-KLFPDNITH---ITTRIAGTTGYLAPEYVLGG 225
           +H D+KA N+LL  + +   + DFG A  L PD +         I GT  ++APE V+G 
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 226 QLTMKADVYSFGVLVLEIISG 246
               K D++S   ++L +++G
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNG 268

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHP 102
           D++ +   IG G +G V        G+++A+K  P + +     +  + E+  L + +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 103 NLVELIGCCVQGTRRILVYE-----YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           N++ +        R  + Y      YV  + ++  L     ++  L  E        + +
Sbjct: 115 NIIAIKDIL----RPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLR 170
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIAGTT 214
           GL ++H      ++HRD+K SN+L+++    KIGDFG+A+     P    +  T    T 
Sbjct: 171 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 215 GYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRN 248
            Y APE +L   + T   D++S G +  E+++ R 
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 53  KIGRGGFGTVYK-GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           ++GRG FG V++      G + AVK +  E  +     + E++  + +  P +V L G  
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 119
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA-KGLAFLHEELVPHI 170
            +G    +  E +E  SL +++       +    E R+   +G A +GL +LH      I
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 171 VHRDIKASNILLDQEFN-PKIGDFGLA-KLFPDNITH---ITTRIAGTTGYLAPEYVLGG 225
           +H D+KA N+LL  + +   + DFG A  L PD +         I GT  ++APE V+G 
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 226 QLTMKADVYSFGVLVLEIISG 246
               K D++S   ++L +++G
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 53  KIGRGGFGTVYK-GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           ++GRG FG V++      G + AVK +  E  +     + E++  + +  P +V L G  
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 133
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA-KGLAFLHEELVPHI 170
            +G    +  E +E  SL +++       +    E R+   +G A +GL +LH      I
Sbjct: 134 REGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 185
Query: 171 VHRDIKASNILLDQEFN-PKIGDFGLA-KLFPDNITH---ITTRIAGTTGYLAPEYVLGG 225
           +H D+KA N+LL  + +   + DFG A  L PD +         I GT  ++APE V+G 
Sbjct: 186 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 226 QLTMKADVYSFGVLVLEIISG 246
               K D++S   ++L +++G
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNG 266

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 54  IGRGGFGTVY--KGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           +G G F  V+  K  LT G+  A+K +             EI  L  ++H N+V L    
Sbjct: 17  LGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 112 VQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPH 169
              T   LV + V    L DR+L            EK + + +  +   + +LHE     
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYT------EKDASLVIQQVLSAVKYLHEN---G 126
Query: 170 IVHRDIKASNIL-LDQEFNPKI--GDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
           IVHRD+K  N+L L  E N KI   DFGL+K+  + I    +   GT GY+APE +    
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVLAQKP 183
Query: 227 LTMKADVYSFGVLVLEIISG 246
            +   D +S GV+   ++ G
Sbjct: 184 YSKAVDCWSIGVITYILLCG 203

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 21/231 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHP 102
           D++ +   IG G +G V        G+++A+K  P + +     +  + E+  L + +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 103 NLVELIGCCVQGTRRILVYE-----YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           N++ +        R  + Y      YV  + ++  L     ++  L  E        + +
Sbjct: 114 NIIAIKDIL----RPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLR 169
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIAGTT 214
           GL ++H      ++HRD+K SN+L+++    KIGDFG+A+     P    +  T    T 
Sbjct: 170 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 215 GYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLL 262
            Y APE +L   + T   D++S G +  E+++ R    GK    Q+   ++
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 117/251 (46%), Gaps = 25/251 (9%)
Query: 34  NHFSYTELRSATDDFHLSNK---IGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREF 89
           +H   T  + A + F+  +K   +G G FG V+K   T  G ++A K +     +   E 
Sbjct: 74  DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV 133
Query: 90  ITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKR 148
             EI  ++ + H NL++L          +LV EYV+   L DR++      +   N  + 
Sbjct: 134 KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII------DESYNLTEL 187
Query: 149 SDICV--GIAKGLAFLHEELVPHIVHRDIKASNIL-LDQEFNP-KIGDFGLAKLF-PDNI 203
             I     I +G+  +H+    +I+H D+K  NIL ++++    KI DFGLA+ + P   
Sbjct: 188 DTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244
Query: 204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS--GKAMWGQMNKFL 261
             +     GT  +LAPE V    ++   D++S GV+   ++SG +   G      +N  +
Sbjct: 245 LKVNF---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN-I 300
Query: 262 LEWAWQLHQEE 272
           L   W L  EE
Sbjct: 301 LACRWDLEDEE 311

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLS----AESKQGV--REFITEIMT 95
           D + +  ++G G F  V     KGT   G+  A K +     + S++GV   E   E+  
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           L  +RHPN++ L       T  +L+ E V    L   L  A K +  L  ++ +     I
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKES--LTEDEATQFLKQI 124
Query: 156 AKGLAFLHEELVPHIVHRDIKASNI-LLDQEF-NPKIG--DFGLA-KLFPDNITHITTRI 210
             G+ +LH +    I H D+K  NI LLD+   NP+I   DFG+A K+   N       I
Sbjct: 125 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNI 178
Query: 211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 110/252 (43%), Gaps = 42/252 (16%)
Query: 21  APQGVDGELLRNVNHFSYTELRSAT----------DDFHLSNKIGRGGFGTVY-----KG 65
           A  G  GE L  V H    ELR+A           ++F L   +G G +G V+      G
Sbjct: 23  ADGGDGGEQLLTVKH----ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISG 78
Query: 66  TLTNGRRIAVKPLS-------AESKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRR 117
             T G+  A+K L        A++ +  R   TE   L ++R  P LV L       T+ 
Sbjct: 79  HDT-GKLYAMKVLKKATIVQKAKTTEHTR---TERQVLEHIRQSPFLVTLHYAFQTETKL 134
Query: 118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIK 176
            L+ +Y+    L   L    +       E    I VG I   L  LH+     I++RDIK
Sbjct: 135 HLILDYINGGELFTHLSQRERFT-----EHEVQIYVGEIVLALEHLHK---LGIIYRDIK 186
Query: 177 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL--TMKADVY 234
             NILLD   +  + DFGL+K F  + T       GT  Y+AP+ V GG        D +
Sbjct: 187 LENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWW 246
Query: 235 SFGVLVLEIISG 246
           S GVL+ E+++G
Sbjct: 247 SLGVLMYELLTG 258

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 15/221 (6%)
Query: 34  NHFSYTELRSAT----DDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSA--ESKQGV 86
           N F   E+  +T      +     IG G  G V     T  G  +AVK LS   +++   
Sbjct: 8   NQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 67
Query: 87  REFITEIMTLSNVRHPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNW 145
           +    E++ L  V H N++ L+     Q T       Y+    +D  L      +++L+ 
Sbjct: 68  KRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--HMELDH 125
Query: 146 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 205
           E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+    N   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-- 180
Query: 206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           + T    T  Y APE +LG       D++S G ++ E++ G
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLTNGR-RIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V        R ++AVK LS   +S    R    E+  L +++H N++ L+  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
               T      E      L   L+GA   NI     L+ E    +   + +GL ++H   
Sbjct: 88  FTPATS----IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS-- 141
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   +I DFGLA+   + +T ++ TR      Y APE +L  
Sbjct: 142 -AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLNW 195
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E++ G+
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 46  DDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTLS 97
           DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQILN 125
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAGT 213
           G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I GT
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGT 180
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE V    L ++AD++S GV+   ++SG
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 54  IGRGGFGTVYKGTLTNGR-RIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           +G G +G+V        R ++AVK LS   +S    R    E+  L +++H N++ L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 111 CVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEEL 166
               T      E      L   L+GA   NI     L+ E    +   + +GL ++H   
Sbjct: 96  FTPATS----IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS-- 149
Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 225
              I+HRD+K SN+ ++++   +I DFGLA+   + +T ++ TR      Y APE +L  
Sbjct: 150 -AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLNW 203
Query: 226 -QLTMKADVYSFGVLVLEIISGR 247
                  D++S G ++ E++ G+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLS----AESKQGV--REFITEIMT 95
           D + +  ++G G F  V     KGT   G+  A K +     + S++GV   E   E+  
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           L  +RHPN++ L       T  +L+ E V    L   L  A K +  L  ++ +     I
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKES--LTEDEATQFLKQI 117
Query: 156 AKGLAFLHEELVPHIVHRDIKASNI-LLDQEF-NPKIG--DFGLA-KLFPDNITHITTRI 210
             G+ +LH +    I H D+K  NI LLD+   NP+I   DFG+A K+   N       I
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNI 171
Query: 211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G G +G+V   Y   L   +++AVK LS   +S    R    E+  L +++H N++ L+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHE 164
                 T      E      L   L+GA   NI     L+ E    +   + +GL ++H 
Sbjct: 94  DVFTPATS----IEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVL 223
                I+HRD+K SN+ ++++   +I DFGLA+   + +T ++ TR      Y APE +L
Sbjct: 150 ---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 201
Query: 224 GG-QLTMKADVYSFGVLVLEIISGR 247
                    D++S G ++ E++ G+
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           DF     IG GGFG V+K     +G+   +K +   +++  RE    +  L+ + H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIV 67
Query: 106 ELIGC----------CVQGTRR------ILVYEYVENNSLDRVLLGATKANIKLNWEKRS 149
              GC            + + R       +  E+ +  +L++ +    +   KL+     
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLAL 125
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 209
           ++   I KG+ ++H +    +++RD+K SNI L      KIGDFGL     ++      R
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--XR 180
Query: 210 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
             GT  Y++PE +       + D+Y+ G+++ E++
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 53  KIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCC 111
           K+GRG +G VYK    +G+      L      G+      EI  L  ++HPN++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 112 VQGTRR--ILVYEYVENNSLDRVLLG-ATKAN---IKLNWEKRSDICVGIAKGLAFLHEE 165
           +    R   L+++Y E++    +    A+KAN   ++L       +   I  G+ +LH  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 166 LVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFPDNITHIT--TRIAGTTGYLA 218
            V   +HRD+K +NIL+  E  P     KI D G A+LF   +  +     +  T  Y A
Sbjct: 148 WV---LHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 219 PEYVLGGQLTMKA-DVYSFGVLVLEIISG 246
           PE +LG +   KA D+++ G +  E+++ 
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGC 110
           IG G  G V     T  G  +AVK LS   +++   +    E++ L  V H N++ L+  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 111 CV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
              Q T       Y+    +D  L      +++L+ E+ S +   +  G+  LH      
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDANLCQVI--HMELDHERMSYLLYQMLCGIKHLHSA---G 144
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
           I+HRD+K SNI++  +   KI DFGLA+    N   + T    T  Y APE +LG     
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNF--MMTPYVVTRYYRAPEVILGMGYKE 202
Query: 230 KADVYSFGVLVLEIISG 246
             D++S G ++ E++ G
Sbjct: 203 NVDIWSVGCIMGELVKG 219

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 111/241 (46%), Gaps = 31/241 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL----- 107
           +G GG G V+     +  +R+A+K +     Q V+  + EI  +  + H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 108 ---------IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
                    +G   +     +V EY+E +      L        L  E        + +G
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETD------LANVLEQGPLLEEHARLFMYQLLRG 132
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAG--TTG 215
           L ++H     +++HRD+K +N+ ++ E    KIGDFGLA++   + +H      G  T  
Sbjct: 133 LKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 216 YLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQLHQEE 272
           Y +P  +L      KA D+++ G +  E+++G+   +G     QM + +LE    +H+E+
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM-QLILESIPVVHEED 248
Query: 273 K 273
           +
Sbjct: 249 R 249

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 46  DDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTLS 97
           DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L 
Sbjct: 10  DDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQILN 125
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAGT 213
           G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I GT
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGT 180
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE V    L ++AD++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 46  DDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTLS 97
           DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L 
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I  
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQILN 124
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAGT 213
           G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I GT
Sbjct: 125 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGT 179
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE V    L ++AD++S GV+   ++SG
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 46  DDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTLS 97
           DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQILN 125
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAGT 213
           G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I GT
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGT 180
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE V    L ++AD++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLS----AESKQGV--REFITEIMT 95
           D + +  ++G G F  V     KGT   G+  A K +       S++GV   E   E+  
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLXSSRRGVSREEIEREVNI 82
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           L  +RHPN++ L       T  +L+ E V    L   L  A K +  L  ++ +     I
Sbjct: 83  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKES--LTEDEATQFLKQI 138
Query: 156 AKGLAFLHEELVPHIVHRDIKASNI-LLDQEF-NPKIG--DFGLA-KLFPDNITHITTRI 210
             G+ +LH +    I H D+K  NI LLD+   NP+I   DFG+A K+   N       I
Sbjct: 139 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNI 192
Query: 211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 193 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 45  TDDFHLSNKIGRGGFGTVY--KGTLTNGRRIA--VKPLSAESKQGVREFITEIMTLSNVR 100
           +D +    K+G G +G V   K  LT   R    +K  S  +       + E+  L  + 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           HPN+++L           LV E      L D ++L    + +       + I   +  G 
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVD-----AAVIMKQVLSGT 134
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGY 216
            +LH+    +IVHRD+K  N+LL+ +      KI DFGL+  F   +        GT  Y
Sbjct: 135 TYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERLGTAYY 189
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           +APE VL  +   K DV+S GV++  ++ G
Sbjct: 190 IAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 46  DDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTLS 97
           DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L 
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I  
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQILN 124
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAGT 213
           G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I GT
Sbjct: 125 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGT 179
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE V    L ++AD++S GV+   ++SG
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 46  DDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTLS 97
           DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQILN 125
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAGT 213
           G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I GT
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGT 180
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE V    L ++AD++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 46  DDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTLS 97
           DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQILN 125
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAGT 213
           G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I GT
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGT 180
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE V    L ++AD++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 46  DDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTLS 97
           DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQILN 125
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAGT 213
           G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I GT
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGT 180
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE V    L ++AD++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 46  DDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTLS 97
           DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQILN 125
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAGT 213
           G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I GT
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGT 180
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE V    L ++AD++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 109 GC-----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
                   ++  + + +   + + +L +V+       ++L+ E+ S +   +  G+  LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVI------QMELDHERMSYLLYQMLVGIKHLH 143
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
                 I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +L
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 224 GGQLTMKADVYSFGVLVLEIISG 246
           G       D++S GV++ E+I G
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 46  DDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTLS 97
           DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L 
Sbjct: 10  DDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQILN 125
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAGT 213
           G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I GT
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGT 180
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE V    L ++AD++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 45  TDDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTL 96
            DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
             ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQIL 124
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAG 212
            G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I G
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFG 179
Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           T  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 109 GC-----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
                   ++  + + +   + + +L +V+       ++L+ E+ S +   +  G+  LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVI------QMELDHERMSYLLYQMLVGIKHLH 143
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
                 I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +L
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 224 GGQLTMKADVYSFGVLVLEIISG 246
           G       D++S GV++ E+I G
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 45  TDDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTL 96
            DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
             ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQIL 124
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAG 212
            G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I G
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFG 179
Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           T  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 45  TDDFHLSNKIGRGGFGTVY--KGTLTNGRRIA--VKPLSAESKQGVREFITEIMTLSNVR 100
           +D +    K+G G +G V   K  LT   R    +K  S  +       + E+  L  + 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           HPN+++L           LV E      L D ++L    + +       + I   +  G 
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVD-----AAVIMKQVLSGT 117
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGY 216
            +LH+    +IVHRD+K  N+LL+ +      KI DFGL+  F   +        GT  Y
Sbjct: 118 TYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERLGTAYY 172
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           +APE VL  +   K DV+S GV++  ++ G
Sbjct: 173 IAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSA-- 145
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 146 -GIIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 45  TDDFHLSNKIGRGGFGT--VYKGTLTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRH 101
           +D + L   IG G FG   + +    N   +AVK +  E  + + E +  EI+   ++RH
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQAN-ELVAVKYI--ERGEKIDENVKREIINHRSLRH 74
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN+V      +  T   +V EY     L   +  A     + + ++       +  G+++
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSY 130
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIA-GTTGYLA 218
            H      + HRD+K  N LLD    P  KI DFG +K    ++ H   + A GT  Y+A
Sbjct: 131 AH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA---SVLHSQPKSAVGTPAYIA 184
Query: 219 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 246
           PE +L  +   K ADV+S GV +  ++ G
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT--------LTNGRRIAVKPLSAESKQGVREFITEIMTL 96
            +D   +  +G+G F  ++KG           +   + +K L    +     F      +
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           S + H +LV   G CV G   ILV E+V+  SLD   L   K  I + W  + ++   +A
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD-TYLKKNKNCINILW--KLEVAKQLA 123
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR----IAG 212
             + FL E     ++H ++ A NILL +E + K G+    KL    I+ IT      +  
Sbjct: 124 AAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQE 179
Query: 213 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISG 246
              ++ PE +   + L +  D +SFG  + EI SG
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 37/226 (16%)
Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           DF     IG GGFG V+K     +G+   ++ +   +++  RE    +  L+ + H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIV 68
Query: 106 ELIGCC-------VQGTRRILVYEYVENNSLDRVLLGATKANIKLNW----------EKR 148
              GC              +   +Y   NS +          I++ +          EKR
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 149 S----------DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 198
                      ++   I KG+ ++H +    ++HRD+K SNI L      KIGDFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
             ++     TR  GT  Y++PE +       + D+Y+ G+++ E++
Sbjct: 186 LKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 46  DDFH-LSNKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTLS 97
           DD++    ++G G F  V K       L    +   K  +  S++GV RE I  E+  L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKES--LTEEEATEFLKQILN 125
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAGT 213
           G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I GT
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGT 180
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE V    L ++AD++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 54  IGRGGFGTVY--KGTLTNGRRIAVKPLS---AESKQGVREFITEIMTLSNVRHPNLVELI 108
           +G+G FG V   K  +T G+  AVK +S    + K      + E+  L  + HPN+ +L 
Sbjct: 34  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 109 GCCVQGTRRILVYE-YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                     LV E Y      D ++     +  + +    + I   +  G+ + H+   
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAARIIRQVLSGITYXHKN-- 145
Query: 168 PHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
             IVHRD+K  N+LL+   ++ N +I DFGL+  F    +       GT  Y+APE VL 
Sbjct: 146 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXKDKIGTAYYIAPE-VLH 201
Query: 225 GQLTMKADVYSFGVLVLEIISG 246
           G    K DV+S GV++  ++SG
Sbjct: 202 GTYDEKCDVWSTGVILYILLSG 223

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 46  DDFHLS-NKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV-REFIT-EIMTLS 97
           DD++ +  ++G G F  V K       L    +   K  +  S++GV RE I  E+  L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++HPN++ L       T  IL+ E V    L   L  A K +  L  E+ ++    I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL--AEKES--LTEEEATEFLKQILN 125
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK----IGDFGLAKLFPDNITHITTRIAGT 213
           G+ +LH      I H D+K  NI+L     PK    I DFGLA     +  +    I GT
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGT 180
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE V    L ++AD++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 13/210 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNV 99
           D + L   IG+G F  V +      G++ AVK       ++       +   E      +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +HP++VEL+          +V+E+++   L   ++    A    +    S     I + L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGY 216
            + H+    +I+HRD+K  N+LL  + N    K+GDFG+A    ++      R+ GT  +
Sbjct: 144 RYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV-GTPHF 199
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           +APE V         DV+  GV++  ++SG
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV--REFITEIMTLSN 98
           D + +  ++G G F  V K       L    +   K  S  S++GV   E   E+  L  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V H N++ L       T  +L+ E V    L   L  A K +  L+ E+ +     I  G
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKES--LSEEEATSFIKQILDG 127
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT 214
           + +LH      I H D+K  NI+L  +  P    K+ DFGLA    D +      I GT 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTP 182
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            ++APE V    L ++AD++S GV+   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 94/190 (49%), Gaps = 29/190 (15%)
Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVKPLSAES-KQGVR-EFITEIMTLSNVRHPNLVELIG 109
           KIG+G FG V+K      G+++A+K +  E+ K+G     + EI  L  ++H N+V LI 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 110 CC---------VQGTRRILVYEYVENNS---LDRVLLGATKANIKLNWEKRSDICVGIAK 157
            C          +G+   LV+++ E++    L  VL+  T + IK        +   +  
Sbjct: 85  ICRTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVLVKFTLSEIK-------RVMQMLLN 136
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG---TT 214
           GL ++H      I+HRD+KA+N+L+ ++   K+ DFGLA+ F         R      T 
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 215 GYLAPEYVLG 224
            Y  PE +LG
Sbjct: 194 WYRPPELLLG 203

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV--REFITEIMTLSN 98
           D + +  ++G G F  V K       L    +   K  S  S++GV   E   E+  L  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V H N++ L       T  +L+ E V    L   L  A K +  L+ E+ +     I  G
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKES--LSEEEATSFIKQILDG 127
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT 214
           + +LH      I H D+K  NI+L  +  P    K+ DFGLA    D +      I GT 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTP 182
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            ++APE V    L ++AD++S GV+   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 94/190 (49%), Gaps = 29/190 (15%)
Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVKPLSAES-KQGVR-EFITEIMTLSNVRHPNLVELIG 109
           KIG+G FG V+K      G+++A+K +  E+ K+G     + EI  L  ++H N+V LI 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 110 CC---------VQGTRRILVYEYVENNS---LDRVLLGATKANIKLNWEKRSDICVGIAK 157
            C          +G+   LV+++ E++    L  VL+  T + IK        +   +  
Sbjct: 84  ICRTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVLVKFTLSEIK-------RVMQMLLN 135
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG---TT 214
           GL ++H      I+HRD+KA+N+L+ ++   K+ DFGLA+ F         R      T 
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 192
Query: 215 GYLAPEYVLG 224
            Y  PE +LG
Sbjct: 193 WYRPPELLLG 202

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSA-- 145
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 146 -GIIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSA-- 138
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 139 -GIIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     IG G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   K+ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV--REFITEIMTLSN 98
           D + +  ++G G F  V K       L    +   K  S  S++GV   E   E+  L  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V H N++ L       T  +L+ E V    L   L  A K +  L+ E+ +     I  G
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKES--LSEEEATSFIKQILDG 127
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT 214
           + +LH      I H D+K  NI+L  +  P    K+ DFGLA    D +      I GT 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTP 182
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            ++APE V    L ++AD++S GV+   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV--REFITEIM 94
           +   D + +  ++G G F  V K       L    +   K  S  S++GV   E   E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 95  TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
            L  V H N++ L       T  +L+ E V    L   L  A K +  L+ E+ +     
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKES--LSEEEATSFIKQ 123
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRI 210
           I  G+ +LH      I H D+K  NI+L  +  P    K+ DFGLA    D +      I
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNI 178
Query: 211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            GT  ++APE V    L ++AD++S GV+   ++SG
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 46  DDFHLSNKIGRGGFGTVYK-----GTLTNGRRIAVKPLSAESKQGV--REFITEIMTLSN 98
           D + +  ++G G F  V K       L    +   K  S  S++GV   E   E+  L  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V H N++ L       T  +L+ E V    L   L  A K +  L+ E+ +     I  G
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKES--LSEEEATSFIKQILDG 127
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT 214
           + +LH      I H D+K  NI+L  +  P    K+ DFGLA    D +      I GT 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTP 182
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            ++APE V    L ++AD++S GV+   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 94/190 (49%), Gaps = 29/190 (15%)
Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVKPLSAES-KQGVR-EFITEIMTLSNVRHPNLVELIG 109
           KIG+G FG V+K      G+++A+K +  E+ K+G     + EI  L  ++H N+V LI 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 110 CC---------VQGTRRILVYEYVENNS---LDRVLLGATKANIKLNWEKRSDICVGIAK 157
            C          +G+   LV+++ E++    L  VL+  T + IK        +   +  
Sbjct: 85  ICRTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVLVKFTLSEIK-------RVMQMLLN 136
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG---TT 214
           GL ++H      I+HRD+KA+N+L+ ++   K+ DFGLA+ F         R      T 
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 215 GYLAPEYVLG 224
            Y  PE +LG
Sbjct: 194 WYRPPELLLG 203

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 27/189 (14%)
Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVKPLSAES-KQGVR-EFITEIMTLSNVRHPNLVELIG 109
           KIG+G FG V+K      G+++A+K +  E+ K+G     + EI  L  ++H N+V LI 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 110 CCVQGTRRI--------LVYEYVENNS---LDRVLLGATKANIKLNWEKRSDICVGIAKG 158
            C               LV+++ E++    L  VL+  T + IK        +   +  G
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-------RVMQMLLNG 137
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG---TTG 215
           L ++H      I+HRD+KA+N+L+ ++   K+ DFGLA+ F         R      T  
Sbjct: 138 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 216 YLAPEYVLG 224
           Y  PE +LG
Sbjct: 195 YRPPELLLG 203

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 54  IGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ 113
           IG G FG V++  L     +A+K +  + +   RE   +IM +  V+HPN+V+L      
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL--QIMRI--VKHPNVVDLKAFFYS 103
Query: 114 -GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC----VGIAKGLAFLHEELVP 168
            G ++  V+  +    +   +  A++   KL       +       + + LA++H     
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI--- 160
Query: 169 HIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVLG 224
            I HRDIK  N+LLD      K+ DFG AK+      N++ I +R      Y APE + G
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-----YRAPELIFG 215
Query: 225 G-QLTMKADVYSFGVLVLEIISGR 247
               T   D++S G ++ E++ G+
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 145
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 146 -GIIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 145
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 146 -GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 144
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 145 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 201
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 202 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 237

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 146
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 147 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 239

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 48  FHLSNKIGRGGFG-TVYKGTLTNGRRIAVKPLSAESKQGVREFI-TEIMTLSNVRHPNLV 105
           F     +G G F   V       G+  AVK +  ++ +G    I  EI  L  ++H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 106 ELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
            L           LV + V    L DR++            +  S +   +   + +LH 
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTE-----KDASTLIRQVLDAVYYLHR 138
Query: 165 ELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
                IVHRD+K  N+L    D+E    I DFGL+K+  +    + +   GT GY+APE 
Sbjct: 139 ---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAPEV 193
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +     +   D +S GV+   ++ G
Sbjct: 194 LAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 145
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 146 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 138
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 139 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 139
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 140 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 232

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 145
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 146 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 139
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 140 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 232

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 45  TDDFHLSNKIGRGGFGT--VYKGTLTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRH 101
           +D + L   IG G FG   + +   +N   +AVK +  E  + + E +  EI+   ++RH
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYI--ERGEKIDENVKREIINHRSLRH 73
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN+V      +  T   +V EY     L   +  A     + + ++       +  G+++
Sbjct: 74  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSY 129
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTR-IAGTTGYLA 218
            H      + HRD+K  N LLD    P  KI DFG +K    ++ H   +   GT  Y+A
Sbjct: 130 CH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIA 183
Query: 219 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 246
           PE +L  +   K ADV+S GV +  ++ G
Sbjct: 184 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 146
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 147 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 239

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 183
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 184 -GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q +       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 145
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 146 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 228 TMKADVYSFGVLVLEIISG 246
               D++S G ++ E+I G
Sbjct: 203 KENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 109 GC-----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
                   ++  + + +   + + +L +V+       ++L+ E+ S +   +  G+  LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVI------QMELDHERMSYLLYQMLCGIKHLH 143
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
                 I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +L
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 224 GGQLTMKADVYSFGVLVLEIISG 246
           G       D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q +       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 145
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 146 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 228 TMKADVYSFGVLVLEIISG 246
               D++S G ++ E+I G
Sbjct: 203 KENVDIWSVGCIMGEMIKG 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q T       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 183
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 184 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     IG G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EY+    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   K+ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 109 GC-----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
                   ++  + + +   + + +L +V+       ++L+ E+ S +   +  G+  LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVI------QMELDHERMSYLLYQMLVGIKHLH 143
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
                 I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +L
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 224 GGQLTMKADVYSFGVLVLEIISG 246
           G       D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 45  TDDFHLSNKIGRGGFGT--VYKGTLTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRH 101
           +D +     IG G FG   + +  LT    +AVK +  E    + E +  EI+   ++RH
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTK-ELVAVKYI--ERGAAIDENVQREIINHRSLRH 75
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN+V      +  T   ++ EY     L   +  A     + + ++       +  G+++
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSY 131
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTR-IAGTTGYLA 218
            H      I HRD+K  N LLD    P  KI DFG +K    ++ H   +   GT  Y+A
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIA 185
Query: 219 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 246
           PE +L  +   K ADV+S GV +  ++ G
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 109 GC-----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
                   ++  + + +   + + +L +V+       ++L+ E+ S +   +  G+  LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVI------QMELDHERMSYLLYQMLCGIKHLH 143
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
                 I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +L
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 224 GGQLTMKADVYSFGVLVLEIISG 246
           G       D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 151 ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITH 205
           IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +  
Sbjct: 201 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 257
Query: 206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 258 GDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     IG G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EY+    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   K+ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 33  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q +       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 146
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 147 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 228 TMKADVYSFGVLVLEIISG 246
               D++S G ++ E+I G
Sbjct: 204 KENVDIWSVGCIMGEMIKG 222

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 151 ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITH 205
           IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +  
Sbjct: 196 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 253 GDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 151 ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITH 205
           IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +  
Sbjct: 203 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 259
Query: 206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 260 GDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 151 ICVG--IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITH 205
           IC    +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+     PD +  
Sbjct: 194 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 250
Query: 206 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              R+     ++APE +     T+++DV+SFGVL+ EI S
Sbjct: 251 GDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRH 101
           +D++ +  ++G+G F  V +    T G   A K ++ +  S +  ++   E      ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLA 160
           PN+V L     + +   LV++ V    L   ++       +   E  +  C+  I + +A
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIA 142
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGYL 217
           + H      IVHR++K  N+LL  +      K+ DFGLA     N +      AGT GYL
Sbjct: 143 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 197
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISG 246
           +PE +     +   D+++ GV++  ++ G
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRH 101
           +D++ +  ++G+G F  V +    T G   A K ++ +  S +  ++   E      ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLA 160
           PN+V L     + +   LV++ V    L   ++       +   E  +  C+  I + +A
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIA 119
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKLFPDNITHITTRIAGTTGYL 217
           + H      IVHR++K  N+LL  +      K+ DFGLA     N +      AGT GYL
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 174
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISG 246
           +PE +     +   D+++ GV++  ++ G
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRH 101
           +D++ +  ++G+G F  V +    T G   A K ++ +  S +  ++   E      ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLA 160
           PN+V L     + +   LV++ V    L   ++       +   E  +  C+  I + +A
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIA 119
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKLFPDNITHITTRIAGTTGYL 217
           + H      IVHR++K  N+LL  +      K+ DFGLA     N +      AGT GYL
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 174
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISG 246
           +PE +     +   D+++ GV++  ++ G
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 109 GC-----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
                   ++  + + +   + + +L +V+       ++L+ E+ S +   +  G+  LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVI------QMELDHERMSYLLYQMLCGIKHLH 143
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
                 I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +L
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVIL 198
Query: 224 GGQLTMKADVYSFGVLVLEIISG 246
           G       D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRH 101
           +D++ +  ++G+G F  V +    T G   A K ++ +  S +  ++   E      ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLA 160
           PN+V L     + +   LV++ V    L   ++       +   E  +  C+  I + +A
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIA 118
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKLFPDNITHITTRIAGTTGYL 217
           + H      IVHR++K  N+LL  +      K+ DFGLA     N +      AGT GYL
Sbjct: 119 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 173
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISG 246
           +PE +     +   D+++ GV++  ++ G
Sbjct: 174 SPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 54  IGRGGFGTVYKGTLTNGRRI---AVKPLSAESKQGVREFI-TEIMTLSNVRHPNLVELIG 109
           +G+GGF   Y+ T  + + +    V P S   K   +E + TEI    ++ +P++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV---------GIAKGLA 160
                        + E++    V+L   +    L   KR                 +G+ 
Sbjct: 110 -------------FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           +LH      ++HRD+K  N+ L+ + + KIGDFGLA     +     T + GT  Y+APE
Sbjct: 157 YLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAPE 212
Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGR 247
            +     + + D++S G ++  ++ G+
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT--------LTNGRRIAVKPLSAESKQGVREFITEIMTL 96
            +D   +  +G+G F  ++KG           +   + +K L    +     F      +
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           S + H +LV   G C  G   ILV E+V+  SLD   L   K  I + W  + ++   +A
Sbjct: 67  SKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLD-TYLKKNKNCINILW--KLEVAKQLA 123
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR----IAG 212
             + FL E     ++H ++ A NILL +E + K G+    KL    I+ IT      +  
Sbjct: 124 WAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQE 179
Query: 213 TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISG 246
              ++ PE +   + L +  D +SFG  + EI SG
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 211
           +A+G+ FL        +HRD+ A NILL +    KI DFGLA+     PD +    TR+ 
Sbjct: 208 VARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
               ++APE +     + K+DV+S+GVL+ EI S
Sbjct: 265 --LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    ++E    + E   L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EY     +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+++DQ+   K+ DFGLAK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q +       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 145
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 146 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPEVVTRYYRAPEVILGMGY 202
Query: 228 TMKADVYSFGVLVLEIISG 246
               D++S G ++ E+I G
Sbjct: 203 KENVDIWSVGCIMGEMIKG 221

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 45  TDDFHLSNKIGRGGFGT--VYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHP 102
           +D + L   IG G FG   + +   +N   +AVK +    K        EI+   ++RHP
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIAAN-VKREIINHRSLRHP 75
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V      +  T   +V EY     L   +  A     + + ++       +  G+++ 
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYC 131
Query: 163 HEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTR-IAGTTGYLAP 219
           H      + HRD+K  N LLD    P  KI DFG +K    ++ H   +   GT  Y+AP
Sbjct: 132 HAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAP 185
Query: 220 EYVLGGQLTMK-ADVYSFGVLVLEIISG 246
           E +L  +   K ADV+S GV +  ++ G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPL--SAESKQGVREFITEIMTL 96
           E+R+   D      +G G +G V        G ++A+K L    +S+   +    E+  L
Sbjct: 22  EVRAVYRDLQ---PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 78
Query: 97  SNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 150
            ++RH N++ L+            T   LV  ++  +      LG    + KL  ++   
Sbjct: 79  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD------LGKLMKHEKLGEDRIQF 132
Query: 151 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 210
           +   + KGL ++H      I+HRD+K  N+ ++++   KI DFGLA+     +       
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV-- 187
Query: 211 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN 248
             T  Y APE +L   + T   D++S G ++ E+I+G+ 
Sbjct: 188 --TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIM-TLSNV 99
           R   D F +    G+G FGTV  G   + G  +A+K +  + +   RE   +IM  L+ +
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL--QIMQDLAVL 76
Query: 100 RHPNLVELIGCCV---QGTRRIL----VYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 152
            HPN+V+L        +  RR +    V EYV + +L R      +  +           
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLA-KLFPD--NITHITT 208
             + + +  LH   V ++ HRDIK  N+L+++ +   K+ DFG A KL P   N+ +I +
Sbjct: 136 FQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194
Query: 209 RIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 261
           R      Y APE + G Q  T   D++S G +  E++ G     G    GQ+++ +
Sbjct: 195 RY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 34  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q +       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 92  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 147
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + +      T  Y APE +LG   
Sbjct: 148 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMVPFVVTRYYRAPEVILGMGY 204
Query: 228 TMKADVYSFGVLVLEIISG 246
               D++S G ++ E+I G
Sbjct: 205 KENVDIWSVGCIMGEMIKG 223

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 29/211 (13%)
Query: 54  IGRGGFGTVYKGT-LTNGRRIAVK-------PLSAESKQGVREFIT-EIMTLSNVR-HPN 103
           IGRG    V +      G   AVK        LS E  + VRE    E   L  V  HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           ++ LI      +   LV++ +    L   L       + L+ ++   I   + + ++FLH
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYV 222
                +IVHRD+K  NILLD     ++ DFG +  L P         + GT GYLAPE +
Sbjct: 218 AN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPE-I 270
Query: 223 LGGQLT-------MKADVYSFGVLVLEIISG 246
           L   +         + D+++ GV++  +++G
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 48  FHLSNKIGRGGFGTVYKGTLTNGRRI--AVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           + L N IGRG +G V K  +  G RI  A K +     + V  F  EI  + ++ HPN++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 106 ELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            L       T   LV E      L       RV   +  A I  +          +   +
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD----------VLSAV 119
Query: 160 AFLHEELVPHIVHRDIKASNILL--DQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGY 216
           A+ H+    ++ HRD+K  N L   D   +P K+ DFGLA  F      + T++ GT  Y
Sbjct: 120 AYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-GTPYY 174
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++P+ VL G    + D +S GV++  ++ G
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 48  FHLSNKIGRGGFGTVYKGTLTNGRRI--AVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           + L N IGRG +G V K  +  G RI  A K +     + V  F  EI  + ++ HPN++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 106 ELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            L       T   LV E      L       RV   +  A I  +          +   +
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD----------VLSAV 136
Query: 160 AFLHEELVPHIVHRDIKASNILL--DQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGY 216
           A+ H+    ++ HRD+K  N L   D   +P K+ DFGLA  F      + T++ GT  Y
Sbjct: 137 AYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-GTPYY 191
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++P+ VL G    + D +S GV++  ++ G
Sbjct: 192 VSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 54  IGRGGFGTVYKGTLTNGRRI---AVKPLSAESKQGVREFI-TEIMTLSNVRHPNLVELIG 109
           +G+GGF   Y+ T  + + +    V P S   K   +E + TEI    ++ +P++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV---------GIAKGLA 160
                        + E++    V+L   +    L   KR                 +G+ 
Sbjct: 110 -------------FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAP 219
           +LH      ++HRD+K  N+ L+ + + KIGDFGLA K+  D        + GT  Y+AP
Sbjct: 157 YLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKXLCGTPNYIAP 211
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E +     + + D++S G ++  ++ G+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 78  LSAESKQGVREF-ITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG 135
            SAE  Q +RE  + E+  L  V  HPN+++L       T   LV++ ++   L   L  
Sbjct: 45  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 102
Query: 136 ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL 195
                + L+ ++   I   + + +  LH+    +IVHRD+K  NILLD + N K+ DFG 
Sbjct: 103 --TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 157
Query: 196 A-KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM---------KADVYSFGVLVLEIIS 245
           + +L P         + GT  YLAPE +   + +M         + D++S GV++  +++
Sbjct: 158 SCQLDPGEKLR---EVCGTPSYLAPEII---ECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211
Query: 246 G 246
           G
Sbjct: 212 G 212

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 54  IGRGGFGTVYKGTLTNGRRI---AVKPLSAESKQGVREFI-TEIMTLSNVRHPNLVELIG 109
           +G+GGF   Y+ T  + + +    V P S   K   +E + TEI    ++ +P++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV---------GIAKGLA 160
                        + E++    V+L   +    L   KR                 +G+ 
Sbjct: 94  -------------FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 140
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAP 219
           +LH      ++HRD+K  N+ L+ + + KIGDFGLA K+  D        + GT  Y+AP
Sbjct: 141 YLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKDLCGTPNYIAP 195
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E +     + + D++S G ++  ++ G+
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 78  LSAESKQGVREF-ITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG 135
            SAE  Q +RE  + E+  L  V  HPN+++L       T   LV++ ++   L   L  
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 115
Query: 136 ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL 195
                + L+ ++   I   + + +  LH+    +IVHRD+K  NILLD + N K+ DFG 
Sbjct: 116 --TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 196 A-KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM---------KADVYSFGVLVLEIIS 245
           + +L P         + GT  YLAPE +   + +M         + D++S GV++  +++
Sbjct: 171 SCQLDPGEKLR---EVCGTPSYLAPEII---ECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
Query: 246 G 246
           G
Sbjct: 225 G 225

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 54  IGRGGFGTVYKGTLTNGRRI---AVKPLSAESKQGVREFI-TEIMTLSNVRHPNLVELIG 109
           +G+GGF   Y+ T  + + +    V P S   K   +E + TEI    ++ +P++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV---------GIAKGLA 160
                        + E++    V+L   +    L   KR                 +G+ 
Sbjct: 110 -------------FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAP 219
           +LH      ++HRD+K  N+ L+ + + KIGDFGLA K+  D        + GT  Y+AP
Sbjct: 157 YLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKDLCGTPNYIAP 211
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E +     + + D++S G ++  ++ G+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 45  TDDFHLSNKIGRGGFGTV---YKGTLTN---GRRIAVKPLSAESKQGVREFITEIMTLSN 98
           TDD+ L  ++G+G F  V    K T T     + I  K LSA   Q +     E      
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER---EARICRL 86
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAK 157
           ++HPN+V L     +     LV++ V    L   ++     +     E  +  C+  I +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS-----EADASHCIHQILE 141
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKLFPDNITHITTRIAGTT 214
            +  +H+     IVHRD+K  N+LL  +      K+ DFGLA +            AGT 
Sbjct: 142 SVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTP 197
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           GYL+PE +         D+++ GV++  ++ G
Sbjct: 198 GYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  +AGT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLAGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    ++E    + E   L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EY     +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+++DQ+   ++ DFGLAK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 158 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 210
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 142
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 143 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAPEI 195
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 78  LSAESKQGVREF-ITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG 135
            SAE  Q +RE  + E+  L  V  HPN+++L       T   LV++ ++   L   L  
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 115
Query: 136 ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL 195
                + L+ ++   I   + + +  LH+    +IVHRD+K  NILLD + N K+ DFG 
Sbjct: 116 --TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 196 A-KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM---------KADVYSFGVLVLEIIS 245
           + +L P         + GT  YLAPE +   + +M         + D++S GV++  +++
Sbjct: 171 SCQLDPGEKLR---SVCGTPSYLAPEII---ECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
Query: 246 G 246
           G
Sbjct: 225 G 225

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 26  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q +       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 84  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 139
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 140 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 197 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 232

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 158 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAPEI 210
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 37  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q +       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 95  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 150
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + + T    T  Y APE +LG   
Sbjct: 151 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGY 207
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 208 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 243

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 105/270 (38%), Gaps = 78/270 (28%)
Query: 47  DFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNL 104
           DF     +GRGGFG V++     +    A+K +   +++  RE  + E+  L+ + HP +
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 105 VELIGCCVQGTRRILVYE----YVENNSLDRVLLGAT----------------------- 137
           V      ++        E    ++++ S D  L   +                       
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 138 ------------------KANIKLNW--------EKRSDIC----VGIAKGLAFLHEELV 167
                             K N+K +W        ++   +C    + IA+ + FLH +  
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLK-DWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKL-------------FPDNITHITTRIAGTT 214
             ++HRD+K SNI    +   K+GDFGL                 P   TH      GT 
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQ--VGTK 240
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
            Y++PE + G   + K D++S G+++ E++
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSN 98
           D F     +G G FG V    +K T   G   A+K L  +    +++    + E   L  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V  P LV+L       +   +V EYV    +        +   + +          I   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
             +LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +L        D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSN 98
           D F     +G G FG V    +K T   G   A+K L  +    +++    + E   L  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V  P LV+L       +   +V EYV    +        +   + +          I   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
             +LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +L        D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSN 98
           D F     +G G FG V    +K T   G   A+K L  +    +++    + E   L  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V  P LV+L       +   +V EYV    +        +   + +          I   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
             +LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +L        D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   +            I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   +            I     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 158 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 210
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 41  LRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAES--KQGVREFITE---IM 94
           L+   +D+ +   IGRG FG V        +++ A+K LS     K+    F  E   IM
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 95  TLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
             +N   P +V+L  C  Q  + + +V EY+    L  ++   +  ++   W K     V
Sbjct: 130 AFAN--SPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEV 183
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAG 212
            +A  L  +H      ++HRD+K  N+LLD+  + K+ DFG   K+    + H  T + G
Sbjct: 184 VLA--LDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-G 237
Query: 213 TTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISG 246
           T  Y++PE +      G    + D +S GV + E++ G
Sbjct: 238 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   +            I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSN 98
           D F     +G G FG V    +K T   G   A+K L  +    +++    + E   L  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V  P LV+L       +   +V EYV    +        +   + +          I   
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 146
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
             +LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLA
Sbjct: 147 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 199
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +L        D ++ GVL+ E+ +G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 45  TDDFHLSNKIGRGGFGT--VYKGTLTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRH 101
           +D + L   IG G FG   + +   +N   +AVK +  E  + + E +  EI+   ++RH
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYI--ERGEKIDENVKREIINHRSLRH 74
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN+V      +  T   +V EY     L   +  A     + + ++       +  G+++
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSY 130
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTR-IAGTTGYLA 218
            H      + HRD+K  N LLD    P  KI  FG +K    ++ H   +   GT  Y+A
Sbjct: 131 CH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYIA 184
Query: 219 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 246
           PE +L  +   K ADV+S GV +  ++ G
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSN 98
           D F     +G G FG V    +K T   G   A+K L  +    +++    + E   L  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V  P LV+L       +   +V EYV    +        +   + +          I   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
             +LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLA
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 207
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +L        D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSN 98
           D F     +G G FG V    +K T   G   A+K L  +    +++    + E   L  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V  P LV+L       +   +V EYV    +        +   + +          I   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
             +LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLA
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 207
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +L        D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EY     +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+++DQ+   K+ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSN 98
           D F     +G G FG V    +K T   G   A+K L  +    +++    + E   L  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V  P LV+L       +   +V EYV    +        +   + +          I   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
             +LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLA
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 207
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +L        D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 45  TDDFHLSNKIGRGGFGT--VYKGTLTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRH 101
           +D + L   IG G FG   + +   +N   +AVK +  E  + + E +  EI+   ++RH
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYI--ERGEKIDENVKREIINHRSLRH 74
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN+V      +  T   +V EY     L   +  A     + + ++       +  G+++
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSY 130
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTR-IAGTTGYLA 218
            H      + HRD+K  N LLD    P  KI  FG +K    ++ H   +   GT  Y+A
Sbjct: 131 CH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYIA 184
Query: 219 PEYVLGGQLTMK-ADVYSFGVLVLEIISG 246
           PE +L  +   K ADV+S GV +  ++ G
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSN 98
           D F     +G G FG V    +K T   G   A+K L  +    +++    + E   L  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V  P LV+L       +   +V EYV    +        +   + +          I   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 174
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
             +LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLA
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 227
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +L        D ++ GVL+ E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 177
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 178 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGATWTLCGTPEYLAPEI 230
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 43  SATDDFHLSNKIGRGGFGTVYK------GTLTNGRRIAVKPLSAESKQGVREFITEIMTL 96
           S TD++ L  ++G+G F  V +      G     + I  K LSA   Q +     E    
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARIC 57
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
             ++HPN+V L     +     LV++ V    L   ++          +   +D    I 
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-------EYYSEADASHCIQ 110
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGT 213
           + L  ++   +  IVHRD+K  N+LL  +      K+ DFGLA +            AGT
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGT 169
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            GYL+PE +         D+++ GV++  ++ G
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSN 98
           D F     +G G FG V    +K T   G   A+K L  +    +++    + E   L  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V  P LV+L       +   +V EYV    +        +   +            I   
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLT 146
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
             +LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLA
Sbjct: 147 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 199
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +L        D ++ GVL+ E+ +G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 43  SATDDFHLSNKIGRGGFGTVYK------GTLTNGRRIAVKPLSAESKQGVREFITEIMTL 96
           S TD++ L  ++G+G F  V +      G     + I  K LSA   Q +     E    
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARIC 57
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
             ++HPN+V L     +     LV++ V    L   ++          +   +D    I 
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-------EYYSEADASHCIQ 110
Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGT 213
           + L  ++   +  IVHRD+K  N+LL  +      K+ DFGLA +            AGT
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGT 169
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            GYL+PE +         D+++ GV++  ++ G
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EY     +        +   +            I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+++DQ+   K+ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 32/258 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 117
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 175
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N+++I +R      Y APE +
Sbjct: 176 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELI 228
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKP-- 274
            G    T   DV+S G ++ E++ G+     +SG     ++ K L     +  +E  P  
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288
Query: 275 LELVDPELGEYPPNEIIR 292
            E   P++  +P  ++ R
Sbjct: 289 TEFKFPQIKAHPWTKVFR 306

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 31/232 (13%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR-IAVKPLSA--ESKQGVREFITEIMTLSNVRHP 102
           D++ + + IGRG +G VY     N  + +A+K ++   E     +  + EI  L+ ++  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
            ++ L    +          Y+     D  L    K  I L  +    I   +  G  F+
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFI 147
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAG--------- 212
           HE     I+HRD+K +N LL+Q+ + KI DFGLA+    D   HI   +           
Sbjct: 148 HES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 213 --------------TTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNS 249
                         T  Y APE +L  +  T   D++S G +  E+++   S
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 32/258 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 111
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 112 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 169
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N+++I +R      Y APE +
Sbjct: 170 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELI 222
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKP-- 274
            G    T   DV+S G ++ E++ G+     +SG     ++ K L     +  +E  P  
Sbjct: 223 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 282
Query: 275 LELVDPELGEYPPNEIIR 292
            E   P++  +P  ++ R
Sbjct: 283 TEFKFPQIKAHPWTKVFR 300

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 158 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 210
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++ +VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 84  SSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N++ I +R      Y APE +
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELI 194
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR 247
            G    T   DV+S G ++ E++ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 84  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N+++I +R      Y APE +
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELI 194
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR 247
            G    T   DV+S G ++ E++ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 32/258 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 88
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 89  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 146
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N+++I +R      Y APE +
Sbjct: 147 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELI 199
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKP-- 274
            G    T   DV+S G ++ E++ G+     +SG     ++ K L     +  +E  P  
Sbjct: 200 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 259
Query: 275 LELVDPELGEYPPNEIIR 292
            E   P++  +P  ++ R
Sbjct: 260 TEFKFPQIKAHPWTKVFR 277

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 32/258 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 119
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 120 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 177
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N+++I +R      Y APE +
Sbjct: 178 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELI 230
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKP-- 274
            G    T   DV+S G ++ E++ G+     +SG     ++ K L     +  +E  P  
Sbjct: 231 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 290
Query: 275 LELVDPELGEYPPNEIIR 292
            E   P++  +P  ++ R
Sbjct: 291 TEFKFPQIKAHPWTKVFR 308

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQ--GVREFITEIMTLSNVRH 101
           + DF L + +G G +G V   T    G  +A+K +    K    +R  + EI  L + +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 102 PNLVELIGC----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            N++ +         +    + + + +    L RV+     ++  + +           +
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLR 123
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT---------T 208
            +  LH     +++HRD+K SN+L++   + K+ DFGLA++  ++    +         T
Sbjct: 124 AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 209 RIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIISGR 247
               T  Y APE +L   + +   DV+S G ++ E+   R
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSN 98
           D F     +G G FG V    +K T   G   A+K L  +    +++    + E   L  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           V  P LV+L       +   +V EY     +        +   + +          I   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
             +LH      +++RD+K  N+++DQ+   K+ DFG AK     +   T  + GT  YLA
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLA 207
Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PE +L        D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 96
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 97  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 154
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N+++I +R      Y APE +
Sbjct: 155 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELI 207
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR 247
            G    T   DV+S G ++ E++ G+
Sbjct: 208 FGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQ--GVREFITEIMTLSNVRH 101
           + DF L + +G G +G V   T    G  +A+K +    K    +R  + EI  L + +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 102 PNLVELIGC----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            N++ +         +    + + + +    L RV+     ++  + +           +
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLR 123
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT---------T 208
            +  LH     +++HRD+K SN+L++   + K+ DFGLA++  ++    +         T
Sbjct: 124 AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 209 RIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIISGR 247
               T  Y APE +L   + +   DV+S G ++ E+   R
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 32/258 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 121
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 122 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 179
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N+++I +R      Y APE +
Sbjct: 180 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELI 232
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKP-- 274
            G    T   DV+S G ++ E++ G+     +SG     ++ K L     +  +E  P  
Sbjct: 233 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 292
Query: 275 LELVDPELGEYPPNEIIR 292
            E   P++  +P  ++ R
Sbjct: 293 TEFKFPQIKAHPWTKVFR 310

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLXGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 32/258 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 162
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 163 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 220
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N+++I +R      Y APE +
Sbjct: 221 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELI 273
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKP-- 274
            G    T   DV+S G ++ E++ G+     +SG     ++ K L     +  +E  P  
Sbjct: 274 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 333
Query: 275 LELVDPELGEYPPNEIIR 292
            E   P++  +P  ++ R
Sbjct: 334 TEFKFPQIKAHPWTKVFR 351

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 30/207 (14%)
Query: 54  IGRGGFGTVYKGTLTNGRRI---AVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIG 109
           +G+GGF   ++ +  + + +    + P S   K   RE ++ EI    ++ H ++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV---------GIAKGLA 160
                        + E+N    V+L   +    L   KR               I  G  
Sbjct: 85  -------------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           +LH      ++HRD+K  N+ L+++   KIGDFGLA     +     T + GT  Y+APE
Sbjct: 132 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPE 187
Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGR 247
            +     + + DV+S G ++  ++ G+
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 45  TDDFHLSNKIGRGGFGT----VYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           TD + +   IG G +      ++K T       AVK +    +    E   EI+ L   +
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKAT---NMEFAVKIIDKSKRDPTEEI--EIL-LRYGQ 74
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           HPN++ L      G    +V E ++   L D++L          +  + S +   I K +
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-----FSEREASAVLFTITKTV 129
Query: 160 AFLHEELVPHIVHRDIKASNIL-LDQEFNP---KIGDFGLAK-LFPDNITHITTRIAGTT 214
            +LH +    +VHRD+K SNIL +D+  NP   +I DFG AK L  +N   +T     T 
Sbjct: 130 EYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP--CYTA 184
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            ++APE +         D++S GVL+  +++G
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 38/230 (16%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR-IAVKPLSA--ESKQGVREFITEIMTLSNVRHP 102
           D++ + + IGRG +G VY     N  + +A+K ++   E     +  + EI  L+ ++  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
            ++ L    +          Y+     D  L    K  I L  E    I   +  G  F+
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-------------------PDN- 202
           HE     I+HRD+K +N LL+Q+ + K+ DFGLA+                     P N 
Sbjct: 146 HES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 203 ------ITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIIS 245
                  +H+ TR      Y APE +L  +  T   D++S G +  E+++
Sbjct: 203 NLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 30/207 (14%)
Query: 54  IGRGGFGTVYKGTLTNGRRI---AVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIG 109
           +G+GGF   ++ +  + + +    + P S   K   RE ++ EI    ++ H ++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV---------GIAKGLA 160
                        + E+N    V+L   +    L   KR               I  G  
Sbjct: 85  -------------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           +LH      ++HRD+K  N+ L+++   KIGDFGLA     +     T + GT  Y+APE
Sbjct: 132 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPE 187
Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGR 247
            +     + + DV+S G ++  ++ G+
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 30/207 (14%)
Query: 54  IGRGGFGTVYKGTLTNGRRI---AVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIG 109
           +G+GGF   ++ +  + + +    + P S   K   RE ++ EI    ++ H ++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV---------GIAKGLA 160
                        + E+N    V+L   +    L   KR               I  G  
Sbjct: 89  -------------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 135
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           +LH      ++HRD+K  N+ L+++   KIGDFGLA     +     T + GT  Y+APE
Sbjct: 136 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPE 191
Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGR 247
            +     + + DV+S G ++  ++ G+
Sbjct: 192 VLSKKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   +            I     +
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 151
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 152 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 204
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
           +++RD+K  N+L+DQ+   K+ DFG AK     +   T  + GT  YLAPE +L      
Sbjct: 163 LIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 230 KADVYSFGVLVLEIISG 246
             D ++ GVL+ E+ +G
Sbjct: 219 AVDWWALGVLIYEMAAG 235

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EY     +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+++DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   +            I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   +            I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   +            I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   +            I     +
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 177
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 178 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 230
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAES--KQGVREFITE---I 93
           +LR   +D+ +   IGRG FG V      + R++ A+K LS     K+    F  E   I
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 94  MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
           M  +N   P +V+L           +V EY+    L  ++   +  ++   W +     V
Sbjct: 128 MAFAN--SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEV 182
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAG 212
            +A  L  +H       +HRD+K  N+LLD+  + K+ DFG   K+  + +    T + G
Sbjct: 183 VLA--LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 236
Query: 213 TTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISG 246
           T  Y++PE +      G    + D +S GV + E++ G
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 115/258 (44%), Gaps = 32/258 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K    +  QG      E+  +  + H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 84  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N+++I +R      Y APE +
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELI 194
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKP-- 274
            G    T   DV+S G ++ E++ G+     +SG     ++ K L     +  +E  P  
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 275 LELVDPELGEYPPNEIIR 292
            E   P++  +P  ++ R
Sbjct: 255 TEFAFPQIKAHPWTKVFR 272

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   +            I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFAEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 83/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P L +L       +   +V EY     +        +   + +          I     +
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+++DQ+   K+ DFG AK     +   T  + GT  YLAPE 
Sbjct: 158 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 210
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 36/210 (17%)
Query: 54  IGRGGFGTVYKGTLTNGRRI---AVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIG 109
           +G+GGF   ++ +  + + +    + P S   K   RE ++ EI    ++ H ++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV---------GIAKGLA 160
                        + E+N    V+L   +    L   KR               I  G  
Sbjct: 83  -------------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR---IAGTTGYL 217
           +LH      ++HRD+K  N+ L+++   KIGDFGLA      + +   R   + GT  Y+
Sbjct: 130 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLAT----KVEYDGERKKVLCGTPNYI 182
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           APE +     + + DV+S G ++  ++ G+
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 83/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P L +L       +   +V EY     +        +   + +          I     +
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+++DQ+   K+ DFG AK     +   T  + GT  YLAPE 
Sbjct: 158 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 210
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAES--KQGVREFITE---I 93
           +LR   +D+ +   IGRG FG V      + R++ A+K LS     K+    F  E   I
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 94  MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
           M  +N   P +V+L           +V EY+    L  ++   +  ++   W +     V
Sbjct: 123 MAFAN--SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEV 177
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAG 212
            +A  L  +H       +HRD+K  N+LLD+  + K+ DFG   K+  + +    T + G
Sbjct: 178 VLA--LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 231
Query: 213 TTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISG 246
           T  Y++PE +      G    + D +S GV + E++ G
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAES--KQGVREFITE---I 93
           +LR   +D+ +   IGRG FG V      + R++ A+K LS     K+    F  E   I
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 94  MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
           M  +N   P +V+L           +V EY+    L  ++   +  ++   W +     V
Sbjct: 128 MAFAN--SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEV 182
Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAG 212
            +A  L  +H       +HRD+K  N+LLD+  + K+ DFG   K+  + +    T + G
Sbjct: 183 VLA--LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 236
Query: 213 TTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISG 246
           T  Y++PE +      G    + D +S GV + E++ G
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ ++ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 36/210 (17%)
Query: 54  IGRGGFGTVYKGTLTNGRRI---AVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIG 109
           +G+GGF   ++ +  + + +    + P S   K   RE ++ EI    ++ H ++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV---------GIAKGLA 160
                        + E+N    V+L   +    L   KR               I  G  
Sbjct: 107 -------------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 153
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR---IAGTTGYL 217
           +LH      ++HRD+K  N+ L+++   KIGDFGLA      + +   R   + GT  Y+
Sbjct: 154 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLAT----KVEYDGERKKVLCGTPNYI 206
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           APE +     + + DV+S G ++  ++ G+
Sbjct: 207 APEVLSKKGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q +       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 145
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + +      T  Y APE +LG   
Sbjct: 146 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMEPEVVTRYYRAPEVILGMGY 202
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 203 KENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 238

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 36/210 (17%)
Query: 54  IGRGGFGTVYKGTLTNGRRI---AVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIG 109
           +G+GGF   ++ +  + + +    + P S   K   RE ++ EI    ++ H ++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV---------GIAKGLA 160
                        + E+N    V+L   +    L   KR               I  G  
Sbjct: 109 -------------FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR---IAGTTGYL 217
           +LH      ++HRD+K  N+ L+++   KIGDFGLA      + +   R   + GT  Y+
Sbjct: 156 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLAT----KVEYDGERKKVLCGTPNYI 208
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           APE +     + + DV+S G ++  ++ G+
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 115/258 (44%), Gaps = 32/258 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 117
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 175
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N++ I +R      Y APE +
Sbjct: 176 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELI 228
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKP-- 274
            G    T   DV+S G ++ E++ G+     +SG     ++ K L     +  +E  P  
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288
Query: 275 LELVDPELGEYPPNEIIR 292
            E   P++  +P  ++ R
Sbjct: 289 TEFKFPQIKAHPWTKVFR 306

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 84
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 85  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 142
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N++ I +R      Y APE +
Sbjct: 143 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELI 195
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR 247
            G    T   DV+S G ++ E++ G+
Sbjct: 196 FGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 84  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N++ I +R      Y APE +
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELI 194
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR 247
            G    T   DV+S G ++ E++ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 83
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 84  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N++ I +R      Y APE +
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELI 194
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR 247
            G    T   DV+S G ++ E++ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/220 (21%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQ--GVREFITEIMTLSNVRH 101
           + DF L + +G G +G V   T    G  +A+K +    K    +R  + EI  L + +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 102 PNLVELIGC----CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            N++ +         +    + + + +    L RV+     ++  + +           +
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLR 123
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT---------T 208
            +  LH     +++HRD+K SN+L++   + K+ DFGLA++  ++    +          
Sbjct: 124 AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 209 RIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIISGR 247
               T  Y APE +L   + +   DV+S G ++ E+   R
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 95
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 96  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 153
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N++ I +R      Y APE +
Sbjct: 154 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELI 206
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR 247
            G    T   DV+S G ++ E++ G+
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 143
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+D++   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 144 LHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 196
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 87
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 88  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 145
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N++ I +R      Y APE +
Sbjct: 146 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELI 198
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR 247
            G    T   DV+S G ++ E++ G+
Sbjct: 199 FGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 91
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 92  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 149
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N++ I +R      Y APE +
Sbjct: 150 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELI 202
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR 247
            G    T   DV+S G ++ E++ G+
Sbjct: 203 FGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 95
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 96  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 153
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N++ I +R      Y APE +
Sbjct: 154 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELI 206
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR 247
            G    T   DV+S G ++ E++ G+
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K +  + +   RE    +  +  + H N+V L     
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 102
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 103 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 160
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N++ I +R      Y APE +
Sbjct: 161 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELI 213
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR 247
            G    T   DV+S G ++ E++ G+
Sbjct: 214 FGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V     +  G   A+K L  +    +++    + E   L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P L +L       +   +V EY     +        +   +            I     +
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+++DQ+   K+ DFG AK     +   T  + GT  YLAPE 
Sbjct: 158 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 210
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 17/216 (7%)
Query: 54  IGRGGFGTV---YKGTLTNGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELI 108
           IG G  G V   Y   L   R +A+K LS   +++   +    E++ +  V H N++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 109 GCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
                Q +       Y+    +D  L    +  ++L+ E+ S +   +  G+  LH    
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA-- 145
Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             I+HRD+K SNI++  +   KI DFGLA+      + +      T  Y APE +LG   
Sbjct: 146 -GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMEPEVVTRYYRAPEVILGMGY 202
Query: 228 TMKADVYSFGVLVLEIISGR--NSGKAMWGQMNKFL 261
               D++S G ++ E++  +    G+    Q NK +
Sbjct: 203 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 238

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 130/297 (43%), Gaps = 35/297 (11%)
Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNL 104
           + +  +IG G FG +++GT L N +++A+K  P  +++ Q   E+ T  +       PN+
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
                   +G   +LV + +  +  D + L   K ++K        + +   + LA +  
Sbjct: 72  YYF---GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKT-------VAMAAKQMLARVQS 121
Query: 165 ELVPHIVHRDIKASNILLDQEFNPK------IGDFGLAKLFPDNIT--HITTR----IAG 212
                +V+RDIK  N L+ +  N K      + DFG+ K + D +T  HI  R    ++G
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRP-NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE 272
           T  Y++    LG + + + D+ + G + +  + G    + +    NK   E   +  ++ 
Sbjct: 181 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE-KKQS 239
Query: 273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI-RLNEEE 328
            PL     EL    P E  +YM    +    A    P  + +  + +K + RLN  E
Sbjct: 240 TPLR----ELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTE 289

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K    +  QG      E+  +  + H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 84  SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N+++I +R      Y APE +
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELI 194
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR 247
            G    T   DV+S G ++ E++ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 130/297 (43%), Gaps = 35/297 (11%)
Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNL 104
           + +  +IG G FG +++GT L N +++A+K  P  +++ Q   E+ T  +       PN+
Sbjct: 11  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 70
Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
                   +G   +LV + +  +  D + L   K ++K        + +   + LA +  
Sbjct: 71  YYF---GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKT-------VAMAAKQMLARVQS 120
Query: 165 ELVPHIVHRDIKASNILLDQEFNPK------IGDFGLAKLFPDNIT--HITTR----IAG 212
                +V+RDIK  N L+ +  N K      + DFG+ K + D +T  HI  R    ++G
Sbjct: 121 IHEKSLVYRDIKPDNFLIGRP-NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 179
Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE 272
           T  Y++    LG + + + D+ + G + +  + G    + +    NK   E   +  ++ 
Sbjct: 180 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE-KKQS 238
Query: 273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI-RLNEEE 328
            PL     EL    P E  +YM    +    A    P  + +  + +K + RLN  E
Sbjct: 239 TPLR----ELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTE 288

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++AVK L    K+ +     EI  L N+R  PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKI---KREIKILENLRGGPN 93
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 146
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+L+D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 147 CHSM---GIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 201
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 13/210 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNV 99
           D + L   IG+G F  V +      G++ AVK       ++       +   E      +
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +HP++VEL+          +V+E+++   L   ++    A    +    S     I + L
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 145
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGY 216
            + H+    +I+HRD+K   +LL  + N    K+G FG+A    ++      R+ GT  +
Sbjct: 146 RYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHF 201
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           +APE V         DV+  GV++  ++SG
Sbjct: 202 MAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+++DQ+   ++ DFG AK     +   T  + GT  YLAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           ++        D ++ GVL+ E+ +G
Sbjct: 210 IISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 13/210 (6%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNV 99
           D + L   IG+G F  V +      G++ AVK       ++       +   E      +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           +HP++VEL+          +V+E+++   L   ++    A    +    S     I + L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGY 216
            + H+    +I+HRD+K   +LL  + N    K+G FG+A    ++      R+ GT  +
Sbjct: 144 RYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHF 199
Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           +APE V         DV+  GV++  ++SG
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT  YLAP  
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPAI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 45  TDDFHLSNKIGRGGFGT----VYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           TD + +   IG G +      ++K T       AVK +    +    E   EI+ L   +
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKAT---NXEFAVKIIDKSKRDPTEEI--EIL-LRYGQ 74
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           HPN++ L      G    +V E  +   L D++L          +  + S +   I K +
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-----FSEREASAVLFTITKTV 129
Query: 160 AFLHEELVPHIVHRDIKASNIL-LDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTG 215
            +LH + V   VHRD+K SNIL +D+  NP   +I DFG AK        + T    T  
Sbjct: 130 EYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TAN 185
Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           ++APE +         D++S GVL+   ++G
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 32/258 (12%)
Query: 54  IGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVEL-IGCC 111
           IG G FG VY+  L + G  +A+K    +  QG      E+  +  + H N+V L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 112 VQGTRRILVY-----EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             G ++  VY     +YV   ++ RV    ++A   L           + + LA++H   
Sbjct: 84  SSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 167 VPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYV 222
              I HRDIK  N+LLD +    K+ DFG AK       N++ I +R      Y APE +
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELI 194
Query: 223 LGG-QLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKP-- 274
            G    T   DV+S G ++ E++ G+     +SG     ++ K L     +  +E  P  
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 275 LELVDPELGEYPPNEIIR 292
            E   P++  +P  ++ R
Sbjct: 255 TEFAFPQIKAHPWTKVFR 272

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 22/214 (10%)
Query: 43  SATDDFHLSNKIGRGGFGTVYK------GTLTNGRRIAVKPLSAESKQGVREFITEIMTL 96
           S TD++ L   IG+G F  V +      G     + I  K LSA   Q +     E    
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLER---EARIC 57
Query: 97  SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-I 155
             ++H N+V L     +     LV++ V    L   ++     +     E  +  C+  I
Sbjct: 58  RLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS-----EADASHCIQQI 112
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAG 212
            + +   H+  V   VHRD+K  N+LL  +      K+ DFGLA +            AG
Sbjct: 113 LEAVLHCHQMGV---VHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAG 168
Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           T GYL+PE +         D+++ GV++  ++ G
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 51  SNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK-QGVR-EFITEIMTLSNVRH-PNLVE 106
           S ++GRG F  V +  + + G+  A K L    + Q  R E + EI  L   +  P ++ 
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           L       +  IL+ EY     +  + L      +  N   R  +   I +G+ +LH+  
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR--LIKQILEGVYYLHQN- 150
Query: 167 VPHIVHRDIKASNILLDQEF---NPKIGDFGLAKLFPDNITHITT--RIAGTTGYLAPEY 221
             +IVH D+K  NILL   +   + KI DFG+++     I H      I GT  YLAPE 
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR----KIGHACELREIMGTPEYLAPEI 204
Query: 222 VLGGQLTMKADVYSFGVLVLEIIS 245
           +    +T   D+++ G++   +++
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLT 228

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 45  TDDFHLSNKIGRGGFG----TVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           +D + +   IG G +      V+K T       AVK +    +    E   EI+ L   +
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEI--EIL-LRYGQ 79
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICV-GIAKG 158
           HPN++ L      G    LV E +    L D++L        K   E+ +   +  I K 
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL------RQKFFSEREASFVLHTIGKT 133
Query: 159 LAFLHEELVPHIVHRDIKASNIL-LDQEFNP---KIGDFGLAK-LFPDNITHITTRIAGT 213
           + +LH +    +VHRD+K SNIL +D+  NP   +I DFG AK L  +N   +T     T
Sbjct: 134 VEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CYT 188
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE +         D++S G+L+  +++G
Sbjct: 189 ANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLS--------AESKQGVREFITE 92
           ++  D++ +S  +G G  G V         +++A+K +S        A          TE
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKLNWEKRS 149
           I  L  + HP +++ I          +V E +E   L   ++G  +   A  KL + +  
Sbjct: 66  IEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ-- 122
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHI 206
                +   + +LHE     I+HRD+K  N+LL   +++   KI DFG +K+  +  T +
Sbjct: 123 -----MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 172
Query: 207 TTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 246
              + GT  YLAPE ++           D +S GV++   +SG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 46  DDFHLSNKIGRGGFGTVY-KGTLTNGRRIAVKPLSAESKQGVREF---ITEIMTLSNVRH 101
           D F     +G G FG V       +G   A+K L  +    +++    + E   L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P LV+L       +   +V EYV    +        +   + +          I     +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +++RD+K  N+L+DQ+   ++ DFG AK     +   T  + GT   LAPE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEALAPEI 209
Query: 222 VLGGQLTMKADVYSFGVLVLEIISG 246
           +L        D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLS--------AESKQGVREFITE 92
           ++  D++ +S  +G G  G V         +++A+K +S        A          TE
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKLNWEKRS 149
           I  L  + HP +++ I          +V E +E   L   ++G  +   A  KL + +  
Sbjct: 66  IEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ-- 122
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHI 206
                +   + +LHE     I+HRD+K  N+LL   +++   KI DFG +K+  +  T +
Sbjct: 123 -----MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 172
Query: 207 TTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 246
              + GT  YLAPE ++           D +S GV++   +SG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLS--------AESKQGVREFITE 92
           ++  D++ +S  +G G  G V         +++A+K +S        A          TE
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKLNWEKRS 149
           I  L  + HP +++ I          +V E +E   L   ++G  +   A  KL + +  
Sbjct: 65  IEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ-- 121
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHI 206
                +   + +LHE     I+HRD+K  N+LL   +++   KI DFG +K+  +  T +
Sbjct: 122 -----MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 171
Query: 207 TTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 246
              + GT  YLAPE ++           D +S GV++   +SG
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 17/217 (7%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQGVRE---FITEIMT 95
           E++   +DF +   IGRG FG V    + N  RI A+K L+        E   F  E   
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 127
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG- 154
           L N     +  L           LV +Y     L  +L   +K   KL  E  +   +G 
Sbjct: 128 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDKLP-EDMARFYIGE 183
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
           +   +  +H+    H VHRDIK  N+LLD   + ++ DFG      D+ T  ++   GT 
Sbjct: 184 MVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTP 240
Query: 215 GYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISG 246
            Y++PE +       G+   + D +S GV + E++ G
Sbjct: 241 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLS--------AESKQGVREFITE 92
           ++  D++ +S  +G G  G V         +++A+K +S        A          TE
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKLNWEKRS 149
           I  L  + HP +++ I          +V E +E   L   ++G  +   A  KL + +  
Sbjct: 66  IEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ-- 122
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHI 206
                +   + +LHE     I+HRD+K  N+LL   +++   KI DFG +K+  +  T +
Sbjct: 123 -----MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 172
Query: 207 TTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 246
              + GT  YLAPE ++           D +S GV++   +SG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 45  TDDFHLSNKIGRGGFG----TVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           +D + +   IG G +      V+K T       AVK +    +    E   EI+ L   +
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEI--EIL-LRYGQ 79
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICV-GIAKG 158
           HPN++ L      G    LV E +    L D++L        K   E+ +   +  I K 
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL------RQKFFSEREASFVLHTIGKT 133
Query: 159 LAFLHEELVPHIVHRDIKASNIL-LDQEFNP---KIGDFGLAK-LFPDNITHITTRIAGT 213
           + +LH +    +VHRD+K SNIL +D+  NP   +I DFG AK L  +N   +T     T
Sbjct: 134 VEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CYT 188
Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
             ++APE +         D++S G+L+  +++G
Sbjct: 189 ANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 17/217 (7%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQGVRE---FITEIMT 95
           E++   +DF +   IGRG FG V    + N  RI A+K L+        E   F  E   
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 143
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG- 154
           L N     +  L           LV +Y     L  +L   +K   KL  E  +   +G 
Sbjct: 144 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDKLP-EDMARFYIGE 199
Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
           +   +  +H+    H VHRDIK  N+LLD   + ++ DFG      D+ T  ++   GT 
Sbjct: 200 MVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTP 256
Query: 215 GYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISG 246
            Y++PE +       G+   + D +S GV + E++ G
Sbjct: 257 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLS--------AESKQGVREFITE 92
           ++  D++ +S  +G G  G V         +++A+K +S        A          TE
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 71
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKLNWEKRS 149
           I  L  + HP +++ I          +V E +E   L   ++G  +   A  KL + +  
Sbjct: 72  IEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ-- 128
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHI 206
                +   + +LHE     I+HRD+K  N+LL   +++   KI DFG +K+  +  T +
Sbjct: 129 -----MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 178
Query: 207 TTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 246
              + GT  YLAPE ++           D +S GV++   +SG
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/280 (22%), Positives = 113/280 (40%), Gaps = 41/280 (14%)
Query: 53  KIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGC 110
           K+     G ++KG    G  I VK L     S +  R+F  E   L    HPN++ ++G 
Sbjct: 17  KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 111 CVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           C         L+  ++   SL  VL   T  N  ++  +     + +A+G+AFLH  L P
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHT-LEP 132
Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 228
            I    + + ++++D++   +I           ++  +           AP +V    L 
Sbjct: 133 LIPRHALNSRSVMIDEDMTARI-----------SMADVKFSFQSPGRMYAPAWVAPEALQ 181
Query: 229 MK--------ADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP 280
            K        AD++SF VL+ E+++ R    A    M   +          +  LE + P
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVT-REVPFADLSNMEIGM----------KVALEGLRP 230
Query: 281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
            +   PP       K+   C     ++RP+ + ++ +L K
Sbjct: 231 TI---PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 17/217 (7%)
Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRI-AVKPLSAESKQGVRE---FITEIMT 95
           ++R   +DF +   IGRG FG V    L N  ++ A+K L+        E   F  E   
Sbjct: 68  QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV 127
Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           L N     +  L           LV +Y     L  +L   +K   +L  E        +
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEM 184
Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG-LAKLFPDNITHITTRIAGTT 214
              +  +H+    H VHRDIK  NIL+D   + ++ DFG   KL  D     +  + GT 
Sbjct: 185 VIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTP 240
Query: 215 GYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISG 246
            Y++PE +       G+   + D +S GV + E++ G
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 84/169 (49%), Gaps = 18/169 (10%)
Query: 86  VREFITEIMTLSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRV--LLGATKANI 141
           + +   EI  L  + HPN+V+L+            +V+E V    +  V  L   ++   
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 142 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 201
           +  ++        + KG+ +LH +    I+HRDIK SN+L+ ++ + KI DFG++  F  
Sbjct: 140 RFYFQD-------LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 202 NITHITTRIAGTTGYLAPEYVLGGQ--LTMKA-DVYSFGVLVLEIISGR 247
           +   ++  + GT  ++APE +   +   + KA DV++ GV +   + G+
Sbjct: 190 SDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLS--------AESKQGVREFITE 92
           ++  D++ +S  +G G  G V         +++A++ +S        A          TE
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKLNWEKRS 149
           I  L  + HP +++ I          +V E +E   L   ++G  +   A  KL + +  
Sbjct: 191 IEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ-- 247
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHI 206
                +   + +LHE     I+HRD+K  N+LL   +++   KI DFG +K+  +  T +
Sbjct: 248 -----MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 297
Query: 207 TTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 246
              + GT  YLAPE ++           D +S GV++   +SG
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 42  RSATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLS--------AESKQGVREFITE 92
           ++  D++ +S  +G G  G V         +++A++ +S        A          TE
Sbjct: 145 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 204
Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKLNWEKRS 149
           I  L  + HP +++ I          +V E +E   L   ++G  +   A  KL + +  
Sbjct: 205 IEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ-- 261
Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHI 206
                +   + +LHE     I+HRD+K  N+LL   +++   KI DFG +K+  +  T +
Sbjct: 262 -----MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSL 311
Query: 207 TTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISG 246
              + GT  YLAPE ++           D +S GV++   +SG
Sbjct: 312 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 48  FHLSNKIGRGGFGTVYK------GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH 101
           + L  ++G+G F  V +      G     + I  K LSA   Q +     E      ++H
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLER---EARICRLLKH 80
Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLA 160
           PN+V L     +     L+++ V    L   ++     +     E  +  C+  I + + 
Sbjct: 81  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS-----EADASHCIQQILEAVL 135
Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGYL 217
             H+  V   VHRD+K  N+LL  +      K+ DFGLA +  +         AGT GYL
Sbjct: 136 HCHQMGV---VHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYL 191
Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIISG 246
           +PE +         D+++ GV++  ++ G
Sbjct: 192 SPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/256 (21%), Positives = 108/256 (42%), Gaps = 50/256 (19%)
Query: 21  APQGVDGELLRNVNHFSY-----TELRSATDDFHLSNKIGRGGFGTV------------- 62
            P G   ++L N ++  Y      E     +D+ +   + +G F  +             
Sbjct: 1   GPLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALK 60
Query: 63  -YKGTLTNGRRIAVKP----LSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR 117
            Y+ +L   +R   K     +S +SK    +F  E+  ++++++   +   G        
Sbjct: 61  KYEKSLLEKKRDFTKSNNDKISIKSKYD--DFKNELQIITDIKNEYCLTCEGIITNYDEV 118
Query: 118 ILVYEYVENNSLDR------VLLGATKANIKLNWEKRSDICV--GIAKGLAFLHEELVPH 169
            ++YEY+EN+S+ +      VL       I +   K    C+   +    +++H E   +
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK----CIIKSVLNSFSYIHNE--KN 172
Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG---YLAPEYVLGGQ 226
           I HRD+K SNIL+D+    K+ DFG ++   D       +I G+ G   ++ PE+     
Sbjct: 173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD------KKIKGSRGTYEFMPPEFFSNES 226
Query: 227 LT--MKADVYSFGVLV 240
                K D++S G+ +
Sbjct: 227 SYNGAKVDIWSLGICL 242

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  R+ VK L    K+ +     E+  L N+R   N
Sbjct: 38  DDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKI---KREVKILENLRGGTN 94
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           +++LI        +   LV+EY+ N    ++    T  +I+            + K L +
Sbjct: 95  IIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRF-------YMYELLKALDY 147
Query: 162 LHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H +    I+HRD+K  N+++D Q+   ++ D+GLA+ +         R+A +  +  PE
Sbjct: 148 CHSK---GIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFY-HPAQEYNVRVA-SRYFKGPE 202
Query: 221 YVLGGQL-TMKADVYSFGVLVLEIISGR 247
            ++  Q+     D++S G ++  +I  R
Sbjct: 203 LLVDYQMYDYSLDMWSLGCMLASMIFRR 230

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 47  DFHLSNK-IGRGGFGTVYKGTLTNGRR-IAVKPLSAESKQGVREFITEIMTLSNVRHPNL 104
           D  L +K +G G F    K       +  AVK +S   +   ++ IT +       HPN+
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNI 68
Query: 105 VELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           V+L           LV E +    L +R+     K     +  + S I   +   ++ +H
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGELFERI-----KKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 164 EELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           +     +VHRD+K  N+L   E      KI DFG A+L P +   + T    T  Y APE
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPE 179
Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGR 247
            +         D++S GV++  ++SG+
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 45  TDDFHLSNKIGRGGFGTVYK------GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSN 98
           T+++ L  ++G+G F  V +      G       I  K LSA   Q +     E      
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRL 66
Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAK 157
           ++HPN+V L     +     L+++ V    L   ++     +     E  +  C+  I +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS-----EADASHCIQQILE 121
Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 214
            +   H+  V   VHR++K  N+LL  +      K+ DFGLA +  +         AGT 
Sbjct: 122 AVLHCHQMGV---VHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTP 177
Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           GYL+PE +         D+++ GV++  ++ G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  R+ VK L    K+ +     E+  L N+R   N
Sbjct: 43  DDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKI---KREVKILENLRGGTN 99
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           +++LI        +   LV+EY+ N    ++    T  +I+            + K L +
Sbjct: 100 IIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRF-------YMYELLKALDY 152
Query: 162 LHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H +    I+HRD+K  N+++D Q+   ++ D+GLA+ +         R+A +  +  PE
Sbjct: 153 CHSK---GIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFY-HPAQEYNVRVA-SRYFKGPE 207
Query: 221 YVLGGQL-TMKADVYSFGVLVLEIISGR 247
            ++  Q+     D++S G ++  +I  R
Sbjct: 208 LLVDYQMYDYSLDMWSLGCMLASMIFRR 235

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 106/255 (41%), Gaps = 45/255 (17%)
Query: 54  IGRGGFGT-VYKGTLTNGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCC 111
           +G G  GT VY+G   N R +AVK +  E      RE   +++  S+  HPN++     C
Sbjct: 32  LGHGAEGTIVYRGMFDN-RDVAVKRILPECFSFADRE--VQLLRESD-EHPNVIRYF--C 85
Query: 112 VQGTRRI----------LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
            +  R+            + EYVE      + L      I L  +  S        GLA 
Sbjct: 86  TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP----ITLLQQTTS--------GLAH 133
Query: 162 LHEELVPHIVHRDIKASNILLDQ-----EFNPKIGDFGLAKLFPDNITHITTR--IAGTT 214
           LH     +IVHRD+K  NIL+       +    I DFGL K         + R  + GT 
Sbjct: 134 LHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 215 GYLAPEYV---LGGQLTMKADVYSFGVLVLEIIS--GRNSGKAMWGQMNKFLLEWAWQLH 269
           G++APE +        T   D++S G +   +IS      GK++  Q N  L   +    
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250
Query: 270 QEEKPLELVDPELGE 284
             EK  +++  EL E
Sbjct: 251 HPEKHEDVIARELIE 265

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 105/233 (45%), Gaps = 43/233 (18%)
Query: 54  IGRGGFGTV-YKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCC 111
           +G G  GTV ++G+   GR +AVK +  +        + EI  L+    HPN++     C
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVIRYY--C 76
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATK----ANIKLNWEKRS-DICVGIAKGLAFLHEEL 166
            + T R L Y  +E  +L+   L  +K     N+KL  E     +   IA G+A LH   
Sbjct: 77  SETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL- 134
Query: 167 VPHIVHRDIKASNILL--------DQEFNPK-----IGDFGLAKLFPDNITHITTRI--- 210
              I+HRD+K  NIL+        DQ+   +     I DFGL K      +   T +   
Sbjct: 135 --KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 211 AGTTGYLAPEYV-------LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 256
           +GT+G+ APE +          +LT   D++S G +   I+S    GK  +G 
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS---KGKHPFGD 242

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 26/241 (10%)
Query: 39  TELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQG-----------VR 87
            EL +    + +   I  G +G V  G  + G  +A+K +      G            +
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 88  EFITEIMTLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKL 143
             + EI  L++  HPN++ L    V        ++ +   +    L +V+       I +
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI---HDQRIVI 131
Query: 144 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
           + +        I  GL  LHE  V   VHRD+   NILL    +  I DF LA+   D  
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAR--EDTA 186
Query: 204 THITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKF 260
               T       Y APE V+  +  T   D++S G ++ E+ + +    G   + Q+NK 
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246
Query: 261 L 261
           +
Sbjct: 247 V 247

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 26/241 (10%)
Query: 39  TELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQG-----------VR 87
            EL +    + +   I  G +G V  G  + G  +A+K +      G            +
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 88  EFITEIMTLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKL 143
             + EI  L++  HPN++ L    V        ++ +   +    L +V+       I +
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI---HDQRIVI 131
Query: 144 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
           + +        I  GL  LHE  V   VHRD+   NILL    +  I DF LA+   D  
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAR--EDTA 186
Query: 204 THITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKF 260
               T       Y APE V+  +  T   D++S G ++ E+ + +    G   + Q+NK 
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246
Query: 261 L 261
           +
Sbjct: 247 V 247

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 93
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 146
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 147 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 201
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 93
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 146
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 147 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 201
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 93
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 146
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 147 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 201
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 93
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 146
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 147 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 201
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 92
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 145
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 146 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 200
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMI 225

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 93
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 146
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 147 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 201
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 93
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 146
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 147 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 201
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 92
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 145
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 146 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 200
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMI 225

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 91
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 144
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 145 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 199
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMI 224

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 93
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 146
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 147 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 201
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 93
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 146
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 147 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 201
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 42  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 98
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 99  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDY 151
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 152 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 206
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 207 LLVDYQMYDYSLDMWSLGCMLASMI 231

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 34/231 (14%)
Query: 47  DFHLSNKIGRGGFGTVYK-GTLTNGRRIAVK----PLSAESKQGVREFITEIMTLSNV-R 100
            F   +++G G +G V+K  +  +GR  AVK    P      +  +  + E+ +   V +
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARK--LAEVGSHEKVGQ 115
Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDR--VLLGATKANIKLNWEKRSDICVGIAKG 158
           HP  V L     +G    L  E     SL +     GA+    ++ W    D  +     
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV-WGYLRDTLLA---- 169
Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--- 215
           LA LH +    +VH D+K +NI L      K+GDFGL       +  + T  AG      
Sbjct: 170 LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL-------LVELGTAGAGEVQEGD 219
Query: 216 --YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLL 262
             Y+APE +L G     ADV+S G+ +LE+        G   W Q+ +  L
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL 269

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 54  IGRGGFGTV-YKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCC 111
           +G G  GTV ++G+   GR +AVK +  +        + EI  L+    HPN++     C
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVIRYY--C 94
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATK----ANIKLNWEKRS-DICVGIAKGLAFLHEEL 166
            + T R L Y  +E  +L+   L  +K     N+KL  E     +   IA G+A LH   
Sbjct: 95  SETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL- 152
Query: 167 VPHIVHRDIKASNILL--------DQEFNPK-----IGDFGLAKLFPDNITHITTRI--- 210
              I+HRD+K  NIL+        DQ+   +     I DFGL K            +   
Sbjct: 153 --KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 211 AGTTGYLAPEYV---LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 256
           +GT+G+ APE +      +LT   D++S G +   I+S    GK  +G 
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS---KGKHPFGD 256

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 54  IGRGGFGTV-YKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCC 111
           +G G  GTV ++G+   GR +AVK +  +        + EI  L+    HPN++     C
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVIRYY--C 94
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATK----ANIKLNWEKRS-DICVGIAKGLAFLHEEL 166
            + T R L Y  +E  +L+   L  +K     N+KL  E     +   IA G+A LH   
Sbjct: 95  SETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL- 152
Query: 167 VPHIVHRDIKASNILL--------DQEFNPK-----IGDFGLAKLFPDNITHITTRI--- 210
              I+HRD+K  NIL+        DQ+   +     I DFGL K            +   
Sbjct: 153 --KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 211 AGTTGYLAPEYV---LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 256
           +GT+G+ APE +      +LT   D++S G +   I+S    GK  +G 
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS---KGKHPFGD 256

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+ +     EI  L N+R  PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPN 93
Query: 104 LVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++    T  +I+            I K L +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLRQTLTDYDIRF-------YMYEILKALDY 146
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +   R+A +  +  PE
Sbjct: 147 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPE 201
Query: 221 YVLGGQL-TMKADVYSFGVLVLEII 244
            ++  Q+     D++S G ++  +I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 56/263 (21%)
Query: 35  HFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVRE------ 88
           +F    L      +HL   IG+G +G V +  + N  R A++ +   +K  +R+      
Sbjct: 15  YFQGGSLLELQKKYHLKGAIGQGSYGVV-RVAIENQTR-AIRAIKIMNKNKIRQINPKDV 72
Query: 89  --FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE------------NNSLDRVLL 134
               TE+  +  + HPN+  L           LV E               ++S  +  +
Sbjct: 73  ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 135 GATKANI--------------------KLNWEKR----SDICVGIAKGLAFLHEELVPHI 170
              K  I                     L++ +R    S+I   I   L +LH +    I
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GI 189
Query: 171 VHRDIKASNILL--DQEFNPKIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVLGG 225
            HRDIK  N L   ++ F  K+ DFGL+K F    +   +  T  AGT  ++APE +   
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249
Query: 226 QLTM--KADVYSFGVLVLEIISG 246
             +   K D +S GVL+  ++ G
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMG 272

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 22/227 (9%)
Query: 26  DGELLRNVNHFSYTELR---SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE 81
           D  +LR   ++ Y  L       DD+ +  K+GRG +  V++G  + N  +  +K L   
Sbjct: 9   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 68
Query: 82  SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKA 139
            K+ ++  I  +  L     PN+V+L+        +   L++EYV N     +    T  
Sbjct: 69  KKKKIKREIKILQNLCG--GPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDY 126
Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKL 198
           +I+            + K L + H +    I+HRD+K  N+++D E    ++ D+GLA+ 
Sbjct: 127 DIRY-------YIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 176
Query: 199 FPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII 244
           +     +   R+A +  +  PE ++  Q      D++S G +   +I
Sbjct: 177 YHPGKEY-NVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 221

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 22/227 (9%)
Query: 26  DGELLRNVNHFSYTELR---SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE 81
           D  +LR   ++ Y  L       DD+ +  K+GRG +  V++G  + N  +  +K L   
Sbjct: 29  DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 88
Query: 82  SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKA 139
            K+ ++  I  +  L     PN+V+L+        +   L++EYV N     +    T  
Sbjct: 89  KKKKIKREIKILQNLXG--GPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDY 146
Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKL 198
           +I+            + K L + H +    I+HRD+K  N+++D E    ++ D+GLA+ 
Sbjct: 147 DIRY-------YIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 196
Query: 199 FPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII 244
           +     +   R+A +  +  PE ++  Q      D++S G +   +I
Sbjct: 197 YHPGKEY-NVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 241

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 22/227 (9%)
Query: 26  DGELLRNVNHFSYTELR---SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE 81
           D  +LR   ++ Y  L       DD+ +  K+GRG +  V++G  + N  +  +K L   
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 82  SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKA 139
            K+ ++  I  +  L     PN+V+L+        +   L++EYV N     +    T  
Sbjct: 68  KKKKIKREIKILQNLCG--GPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDY 125
Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKL 198
           +I+            + K L + H +    I+HRD+K  N+++D E    ++ D+GLA+ 
Sbjct: 126 DIRY-------YIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 175
Query: 199 FPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII 244
           +     +   R+A +  +  PE ++  Q      D++S G +   +I
Sbjct: 176 YHPGKEY-NVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 104/244 (42%), Gaps = 46/244 (18%)
Query: 38  YTELRSATDDFHLSNKIGRGGFGTVYKGT--LTNG--RRIAVKPLSAESKQGVREFITEI 93
           Y  +   ++ F + +KIG G F +VY  T  L  G   +IA+K L   S   +R    E+
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIR-IAAEL 70
Query: 94  MTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 152
             L+      N++ +  C  +    ++   Y+E+ S   +L         L++++  +  
Sbjct: 71  QCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-------LSFQEVREYM 123
Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRI- 210
           + + K L  +H+     IVHRD+K SN L ++      + DFGLA+   D    +   + 
Sbjct: 124 LNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQ 180
Query: 211 --------------------------AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEI 243
                                     AGT G+ APE +      T   D++S GV+ L +
Sbjct: 181 SEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240
Query: 244 ISGR 247
           +SGR
Sbjct: 241 LSGR 244

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 22/227 (9%)
Query: 26  DGELLRNVNHFSYTELR---SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE 81
           D  +LR   ++ Y  L       DD+ +  K+GRG +  V++G  + N  +  +K L   
Sbjct: 10  DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 69
Query: 82  SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKA 139
            K+ ++  I  +  L     PN+V+L+        +   L++EYV N     +    T  
Sbjct: 70  KKKKIKREIKILQNLCG--GPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDY 127
Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKL 198
           +I+            + K L + H +    I+HRD+K  N+++D E    ++ D+GLA+ 
Sbjct: 128 DIRY-------YIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 177
Query: 199 FPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII 244
           +     +   R+A +  +  PE ++  Q      D++S G +   +I
Sbjct: 178 YHPGKEY-NVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 222

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 22/227 (9%)
Query: 26  DGELLRNVNHFSYTELR---SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE 81
           D  +LR   ++ Y  L       DD+ +  K+GRG +  V++G  + N  +  +K L   
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 82  SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKA 139
            K+ ++  I  +  L     PN+V+L+        +   L++EYV N     +    T  
Sbjct: 68  KKKKIKREIKILQNLCG--GPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDY 125
Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKL 198
           +I+            + K L + H +    I+HRD+K  N+++D E    ++ D+GLA+ 
Sbjct: 126 DIRY-------YIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 175
Query: 199 FPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII 244
           +     +   R+A +  +  PE ++  Q      D++S G +   +I
Sbjct: 176 YHPGKEY-NVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 22/227 (9%)
Query: 26  DGELLRNVNHFSYTELR---SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE 81
           D  +LR   ++ Y  L       DD+ +  K+GRG +  V++G  + N  +  +K L   
Sbjct: 9   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 68
Query: 82  SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKA 139
            K+ ++  I  +  L     PN+V+L+        +   L++EYV N     +    T  
Sbjct: 69  KKKKIKREIKILQNLXG--GPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDY 126
Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKL 198
           +I+            + K L + H +    I+HRD+K  N+++D E    ++ D+GLA+ 
Sbjct: 127 DIRY-------YIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 176
Query: 199 FPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII 244
           +     +   R+A +  +  PE ++  Q      D++S G +   +I
Sbjct: 177 YHPGKEY-NVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 221

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 22/227 (9%)
Query: 26  DGELLRNVNHFSYTELR---SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE 81
           D  +LR   ++ Y  L       DD+ +  K+GRG +  V++G  + N  +  +K L   
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 82  SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKA 139
            K+ ++  I  +  L     PN+V+L+        +   L++EYV N     +    T  
Sbjct: 68  KKKKIKREIKILQNLXG--GPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDY 125
Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKL 198
           +I+            + K L + H +    I+HRD+K  N+++D E    ++ D+GLA+ 
Sbjct: 126 DIRY-------YIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 175
Query: 199 FPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII 244
           +     +   R+A +  +  PE ++  Q      D++S G +   +I
Sbjct: 176 YHPGKEY-NVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 22/227 (9%)
Query: 26  DGELLRNVNHFSYTELR---SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE 81
           D  +LR   ++ Y  L       DD+ +  K+GRG +  V++G  + N  +  +K L   
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 82  SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKA 139
            K+ ++  I  +  L     PN+V+L+        +   L++EYV N     +    T  
Sbjct: 68  KKKKIKREIKILQNLXG--GPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDY 125
Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKL 198
           +I+            + K L + H +    I+HRD+K  N+++D E    ++ D+GLA+ 
Sbjct: 126 DIRY-------YIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 175
Query: 199 FPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII 244
           +     +   R+A +  +  PE ++  Q      D++S G +   +I
Sbjct: 176 YHPGKEY-NVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 22/227 (9%)
Query: 26  DGELLRNVNHFSYTELR---SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE 81
           D  +LR   ++ Y  L       DD+ +  K+GRG +  V++G  + N  +  +K L   
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 82  SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKA 139
            K+ ++  I  +  L     PN+V+L+        +   L++EYV N     +    T  
Sbjct: 68  KKKKIKREIKILQNLXG--GPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDY 125
Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKL 198
           +I+            + K L + H +    I+HRD+K  N+++D E    ++ D+GLA+ 
Sbjct: 126 DIRY-------YIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 175
Query: 199 FPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII 244
           +     +   R+A +  +  PE ++  Q      D++S G +   +I
Sbjct: 176 YHPGKEY-NVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFIT--EIMTLSNVRHPN 103
           + + ++  +GRG FG V++   T+ ++  +        +G  + +   EI  L+  RH N
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRN 62
Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           ++ L          ++++E++  + LD +      +  +LN  +       + + L FLH
Sbjct: 63  ILHLHESFESMEELVMIFEFI--SGLD-IFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 164 EELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAK-LFP-DNITHITTRIAGTTGYLAP 219
              + H    DI+  NI+     +   KI +FG A+ L P DN   + T       Y AP
Sbjct: 120 SHNIGHF---DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT----APEYYAP 172
Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           E      ++   D++S G LV  ++SG N
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGIN 201

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 103/227 (45%), Gaps = 22/227 (9%)
Query: 26  DGELLRNVNHFSYTELR---SATDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE 81
           D  +LR   ++ Y  L       DD+ +  K+GRG +  V++G  + N  +  +K L   
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 82  SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI--LVYEYVENNSLDRVLLGATKA 139
            K+ ++  I  +  L  +  PN+V+L+        +   L++EYV N     +    T  
Sbjct: 68  KKKKIKREIKILQNL--MGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDY 125
Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKL 198
           +I+            + K L + H +    I+HRD+K  N+++D E    ++ D+GLA+ 
Sbjct: 126 DIRY-------YIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 175
Query: 199 FPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEII 244
           +     +   R+A +  +  PE ++  Q      D++S G +   +I
Sbjct: 176 YHPGKEY-NVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 47  DFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESKQG---VREFIT---EIMTLSNV 99
           ++ L   +G+GGFGTV+ G  LT+  ++A+K +      G   + + +T   E+  L  V
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 100 R----HPNLVELIGC--CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
                HP ++ L+      +G   +L       +  D +     K  +    E  S    
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLG---EGPSRCFF 145
Query: 154 G-IAKGLAFLHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIA 211
           G +   +   H      +VHRDIK  NIL+D +    K+ DFG   L  D      T   
Sbjct: 146 GQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFD 199
Query: 212 GTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISG 246
           GT  Y  PE++   Q   + A V+S G+L+ +++ G
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 43/233 (18%)
Query: 54  IGRGGFGTV-YKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCC 111
           +G G  GTV ++G+   GR +AVK +  +        + EI  L+    HPN++     C
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVIRYY--C 76
Query: 112 VQGTRRILVYEYVENNSLDRVLLGATK----ANIKLNWEKRS-DICVGIAKGLAFLHEEL 166
            + T R L Y  +E  +L+   L  +K     N+KL  E     +   IA G+A LH   
Sbjct: 77  SETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL- 134
Query: 167 VPHIVHRDIKASNILL--------DQEFNPK-----IGDFGLAKLFPDNITHITTRI--- 210
              I+HRD+K  NIL+        DQ+   +     I DFGL K            +   
Sbjct: 135 --KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 192
Query: 211 AGTTGYLAPEYV-------LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ 256
           +GT+G+ APE +          +LT   D++S G +   I+S    GK  +G 
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS---KGKHPFGD 242

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 52  NKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--------SKQGVREFITEIMTLSNVRHP 102
           + +G G FG V+        + + VK +  E            + +   EI  LS V H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 103 NLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+++++     QG  ++++ ++   + LD  L      + +L+    S I   +   + +
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKH--GSGLD--LFAFIDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           L    +  I+HRDIK  NI++ ++F  K+ DFG A          T    GT  Y APE 
Sbjct: 146 LR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTIEYCAPEV 200
Query: 222 VLGGQLT-MKADVYSFGVLVLEIISGRN 248
           ++G      + +++S GV +  ++   N
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEEN 228

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 16/161 (9%)
Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCC 111
           +  GGF  VY+   + +GR  A+K L +  ++  R  I E+  +  +  HPN+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 112 VQGTRR--------ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
             G           +L+ E  +   ++   L   ++   L+ +    I     + +  +H
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVE--FLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPD 201
            +  P I+HRD+K  N+LL  +   K+ DFG A     +PD
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	370
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-173
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-152
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-152
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-90
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-75
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-66
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-63
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-59
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-59
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-58
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-57
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-57
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-55
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-54
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-44
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-43
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-43
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-43
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-42
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-41
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-41
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-41
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-40
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-40
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-40
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-40
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-39
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-38
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-38
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-38
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-38
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-38
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-38
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-37
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-37
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-37
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-37
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-37
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-37
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-37
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-37
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-37
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-36
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-36
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-35
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-35
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-35
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-35
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-35
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-34
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-34
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-33
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-33
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-33
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-33
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-32
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-32
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-32
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-32
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-32
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-32
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-31
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-31
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-31
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-30
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-30
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-30
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-30
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-30
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-30
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-30
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-30
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-30
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-30
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-30
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-30
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-29
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-29
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-29
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-29
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-29
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-29
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-29
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-29
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-29
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-29
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-29
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-28
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-28
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-28
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-28
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-28
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-28
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-27
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-27
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-27
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-27
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-27
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-27
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-27
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-26
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-24
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-24
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-24
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-23
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-23
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-23
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-22
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-22
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-22
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-21
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-21
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-21
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-20
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-20
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-20
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-19
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-18
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  484 bits (1248), Expect = e-173
 Identities = 129/305 (42%), Positives = 190/305 (62%), Gaps = 5/305 (1%)

Query: 20  EAPQGVDGEL-LRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPL 78
           + P   D E+ L  +  FS  EL+ A+D+F   N +GRGGFG VYKG L +G  +AVK L
Sbjct: 3   DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62

Query: 79  SAESKQGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT 137
             E  QG   +F TE+  +S   H NL+ L G C+  T R+LVY Y+ N S+   L    
Sbjct: 63  KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122

Query: 138 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK 197
           ++   L+W KR  I +G A+GLA+LH+   P I+HRD+KA+NILLD+EF   +GDFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182

Query: 198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS--GKAMWG 255
           L     TH+TT + GT G++APEY+  G+ + K DV+ +GV++LE+I+G+ +     +  
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242

Query: 256 QMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV 314
             +  LL+W   L +E+K   LVD +L G Y   E+ + ++VA  CTQ++   RP+M++V
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

Query: 315 IKMLT 319
           ++ML 
Sbjct: 303 VRMLE 307

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  430 bits (1109), Expect = e-152
 Identities = 114/313 (36%), Positives = 169/313 (53%), Gaps = 24/313 (7%)

Query: 18  EREAPQGVDGELLRNVNHFSYTELRSATDDFH------LSNKIGRGGFGTVYKGTLTNGR 71
           E ++ +  D         FS+ EL++ T++F         NK+G GGFG VYKG + N  
Sbjct: 1   ENKSLEVSDTRFHS----FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNT 55

Query: 72  RIAVKPLSA----ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 127
            +AVK L+A     +++  ++F  EI  ++  +H NLVEL+G    G    LVY Y+ N 
Sbjct: 56  TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115

Query: 128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 187
           SL   L         L+W  R  I  G A G+ FLHE    H +HRDIK++NILLD+ F 
Sbjct: 116 SLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFT 171

Query: 188 PKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
            KI DFGLA+       T +T+RI GTT Y+APE  L G++T K+D+YSFGV++LEII+G
Sbjct: 172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITG 230

Query: 247 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLE-LVDPELGEYPPNEIIRYMKVAFFCTQAAA 305
             +           LL+   ++  EEK +E  +D ++ +     +     VA  C     
Sbjct: 231 LPAVDEHREPQL--LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKK 288

Query: 306 SRRPQMNQVIKML 318
           ++RP + +V ++L
Sbjct: 289 NKRPDIKKVQQLL 301

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  429 bits (1106), Expect = e-152
 Identities = 124/321 (38%), Positives = 186/321 (57%), Gaps = 6/321 (1%)

Query: 8   GSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTL 67
           GS+ +SK +            +          +L  AT++F     IG G FG VYKG L
Sbjct: 2   GSK-YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60

Query: 68  TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 127
            +G ++A+K  + ES QG+ EF TEI TLS  RHP+LV LIG C +    IL+Y+Y+EN 
Sbjct: 61  RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120

Query: 128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 187
           +L R L G+    + ++WE+R +IC+G A+GL +LH      I+HRD+K+ NILLD+ F 
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFV 177

Query: 188 PKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 246
           PKI DFG++K   + + TH++T + GT GY+ PEY + G+LT K+DVYSFGV++ E++  
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237

Query: 247 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAA 305
           R++      +    L EWA + H   +  ++VDP L  +  P  + ++   A  C   ++
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297

Query: 306 SRRPQMNQVIKMLTKNIRLNE 326
             RP M  V+  L   +RL E
Sbjct: 298 EDRPSMGDVLWKLEYALRLQE 318

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  274 bits (702), Expect = 1e-90
 Identities = 77/310 (24%), Positives = 124/310 (40%), Gaps = 31/310 (10%)

Query: 35  HFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIM 94
                 L   +    L     RG FG V+K  L     +AVK    + KQ   +   E+ 
Sbjct: 13  DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVY 70

Query: 95  TLSNVRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 150
           +L  ++H N+++ IG   +G        L+  + E  SL   L         ++W +   
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCH 125

Query: 151 ICVGIAKGLAFLHEELV-------PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
           I   +A+GLA+LHE++        P I HRDIK+ N+LL       I DFGLA  F    
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 204 THI-TTRIAGTTGYLAPEYVLGG-----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQM 257
           +   T    GT  Y+APE + G         ++ D+Y+ G+++ E+ S   +      + 
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 258 NKFLLEWAWQLHQEEKPLELV-----DPEL-GEYPPNEIIRYM-KVAFFCTQAAASRRPQ 310
                E   Q    E   E+V      P L   +  +  +  + +    C    A  R  
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 311 MNQVIKMLTK 320
              V + +T+
Sbjct: 306 AGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  235 bits (601), Expect = 3e-75
 Identities = 74/329 (22%), Positives = 126/329 (38%), Gaps = 44/329 (13%)

Query: 36  FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMT 95
            + +E     D+  L   IGRG +G VYKG+L + R +AVK  S  ++Q        I  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINE-KNIYR 60

Query: 96  LSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 150
           +  + H N+   I    + T        LV EY  N SL + L   T      +W     
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCR 115

Query: 151 ICVGIAKGLAFLHEELV------PHIVHRDIKASNILLDQEFNPKIGDFGLAKLF----- 199
           +   + +GLA+LH EL       P I HRD+ + N+L+  +    I DFGL+        
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 200 --PDNITHITTRIAGTTGYLAPEYVLG-------GQLTMKADVYSFGVLVLEIISGRNSG 250
             P    +      GT  Y+APE + G            + D+Y+ G++  EI   R + 
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTD 234

Query: 251 KAMWGQMNKFLLEWAWQLHQEEKPLELVD--------PELGE-YPPNEII--RYMKVAFF 299
                 + ++ + +  ++       ++          P+  E +  N +      +    
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 300 CTQAAASRRPQMNQVIKMLTKNIRLNEEE 328
           C    A  R       + + + + + E  
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERN 323

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  211 bits (539), Expect = 3e-66
 Identities = 82/276 (29%), Positives = 131/276 (47%), Gaps = 24/276 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
            +  +   +GRG FG V K      + +A+K + +ES++  + FI E+  LS V HPN+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L G C+      LV EY E  SL  VL GA +             C+  ++G+A+LH  
Sbjct: 65  KLYGACLNPV--CLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 166 LVPHIVHRDIKASNILLDQEFN-PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
               ++HRD+K  N+LL       KI DFG A     +I    T   G+  ++APE   G
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 225 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 284
              + K DV+S+G+++ E+I+ R      + ++        W +H   +      P L +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTR------PPLIK 227

Query: 285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
             P  I   M     C     S+RP M +++K++T 
Sbjct: 228 NLPKPIESLMTR---CWSKDPSQRPSMEEIVKIMTH 260

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  203 bits (519), Expect = 3e-63
 Identities = 77/281 (27%), Positives = 134/281 (47%), Gaps = 32/281 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
            D ++  KIG G FGTV++    +G  +AVK L  +    + V EF+ E+  +  +RHPN
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V  +G   Q     +V EY+   SL R+L   + A  +L+  +R  +   +AKG+ +LH
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
               P IVHR++K+ N+L+D+++  K+ DFGL++L        +   AGT  ++APE + 
Sbjct: 155 NR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLR 212

Query: 224 GGQLTMKADVYSFGVLVLEIISGR------NSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
                 K+DVYSFGV++ E+ + +      N  + +     K                  
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR--------------- 257

Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
              E+      ++   ++    C      +RP    ++ +L
Sbjct: 258 --LEIPRNLNPQVAAIIEG---CWTNEPWKRPSFATIMDLL 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  201 bits (514), Expect = 6e-63
 Identities = 73/291 (25%), Positives = 136/291 (46%), Gaps = 39/291 (13%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQG-------VREFITEIMTLS 97
           ++     +IG+GGFG V+KG  + +   +A+K L     +G        +EF  E+  +S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           N+ HPN+V+L G      R  +V E+V    L   LL        + W  +  + + IA 
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIAL 133

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQ-----EFNPKIGDFGLAKLFPDNITHITTRIAG 212
           G+ ++  +  P IVHRD+++ NI L           K+ DFGL++       H  + + G
Sbjct: 134 GIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLG 188

Query: 213 TTGYLAPEYVLGGQL---TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH 269
              ++APE  +G +    T KAD YSF +++  I+    +G+  + + +   +++   + 
Sbjct: 189 NFQWMAPE-TIGAEEESYTEKADTYSFAMILYTIL----TGEGPFDEYSYGKIKFINMIR 243

Query: 270 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           +E        P + E  P  +   +++   C      +RP  + ++K L++
Sbjct: 244 EEGL-----RPTIPEDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKELSE 286

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  198 bits (505), Expect = 1e-61
 Identities = 74/287 (25%), Positives = 128/287 (44%), Gaps = 35/287 (12%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPL----SAESKQGVREFITEIMTLSNVRH 101
            +  L   IG GGFG VY+     G  +AVK        +  Q +     E    + ++H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN++ L G C++     LV E+     L+RVL     +  ++  +   +  V IA+G+ +
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNY 120

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP--------KIGDFGLAKLFPDNITHITTRIAGT 213
           LH+E +  I+HRD+K+SNIL+ Q+           KI DFGLA+ +           AG 
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMSAAGA 177

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 273
             ++APE +     +  +DV+S+GVL+ E++    +G+  +  ++   L  A+ +   + 
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELL----TGEVPFRGID--GLAVAYGVAMNKL 231

Query: 274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
                   +    P    + M+    C       RP    ++  LT 
Sbjct: 232 A-----LPIPSTCPEPFAKLMED---CWNPDPHSRPSFTNILDQLTT 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  198 bits (506), Expect = 2e-61
 Identities = 70/320 (21%), Positives = 128/320 (40%), Gaps = 34/320 (10%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL 104
            D      +G+G FG   K T    G  + +K L    ++  R F+ E+  +  + HPN+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           ++ IG   +  R   + EY++  +L  ++      + +  W +R      IA G+A+LH 
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-------------IA 211
               +I+HRD+ + N L+ +  N  + DFGLA+L  D  T                  + 
Sbjct: 127 M---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 271
           G   ++APE + G     K DV+SFG+++ EII   N             +++       
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN----ADPDYLPRTMDFG---LNV 236

Query: 272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTA 331
              L+   P     PP     +  +   C      +RP   ++   L + +R++      
Sbjct: 237 RGFLDRYCPP--NCPP----SFFPITVRCCDLDPEKRPSFVKLEHWL-ETLRMHLAGHLP 289

Query: 332 PGLFQDSESSSVGTSDKKSS 351
            G   +        + ++  
Sbjct: 290 LGPQLEQLDRGFWETYRRGE 309

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  192 bits (491), Expect = 1e-59
 Identities = 58/283 (20%), Positives = 116/283 (40%), Gaps = 33/283 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
              +   K+     G ++KG    G  I VK L     S +  R+F  E   L    HPN
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 104 LVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ ++G C         L+  ++   SL  VL      N  ++  +     + +A+G+AF
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAF 126

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH  L P I    + + ++++D++   +I    +   F       +        ++APE 
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPE- 178

Query: 222 VLGGQ----LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
            L  +        AD++SF VL+ E+++     +  +  ++   +E   ++  E      
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTR----EVPFADLS--NMEIGMKVALEGL---- 228

Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
             P +       + + MK+   C     ++RP+ + ++ +L K
Sbjct: 229 -RPTIPPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILEK 267

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  194 bits (495), Expect = 2e-59
 Identities = 77/302 (25%), Positives = 117/302 (38%), Gaps = 37/302 (12%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNL 104
               +  +IG+G +G V+ G    G ++AVK      +    RE  TEI     +RH N+
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENI 93

Query: 105 VELIGCCVQGTRRI----LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           +  I   ++GT       L+ +Y EN SL   L      +  L+ +    +      GL 
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLC 148

Query: 161 FLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI---TTRIAG 212
            LH E+      P I HRD+K+ NIL+ +     I D GLA  F  +   +        G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208

Query: 213 TTGYLAPEYVLGGQLTM-------KADVYSFGVLVL-EIISGRNSGKAMWGQMNKFLLEW 264
           T  Y+ PE VL   L          AD+YSFG L+L E+     SG  +      +    
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFG-LILWEVARRCVSGGIVEEYQLPYHDLV 266

Query: 265 AWQLHQEEKPLELVD----PELGEYPPNEII--RYMKVAFFCTQAAASRRPQMNQVIKML 318
                 E+    +      P       ++    +  K+   C     + R    +V K L
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

Query: 319 TK 320
            K
Sbjct: 327 AK 328

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  187 bits (478), Expect = 2e-57
 Identities = 75/280 (26%), Positives = 135/280 (48%), Gaps = 27/280 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
               +  +IG G FGTVYKG   +G  +AVK L+    + Q ++ F  E+  L   RH N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           ++  +G        I V ++ E +SL   L     +  K   +K  DI    A+G+ +LH
Sbjct: 82  ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH 137

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYV 222
                 I+HRD+K++NI L ++   KIGDFGLA      + +H   +++G+  ++APE V
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-V 193

Query: 223 LGGQL----TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 278
           +  Q     + ++DVY+FG+++ E+++G+      +  +N    +    + +     +L 
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSNIN-NRDQIIEMVGRGSLSPDL- 247

Query: 279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
             ++    P  + R M     C +     RP   +++  +
Sbjct: 248 -SKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  187 bits (477), Expect = 6e-57
 Identities = 66/290 (22%), Positives = 114/290 (39%), Gaps = 38/290 (13%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPN 103
           +   +   IG+G FG VY G   +G  +A++ +  E  ++  ++ F  E+M     RH N
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V  +G C+      ++    +  +L  V+     A I L+  K   I   I KG+ +LH
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEIVKGMGYLH 147

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL----FPDNITHITTRIAGTTGYLAP 219
                 I+H+D+K+ N+  D      I DFGL  +                 G   +LAP
Sbjct: 148 A---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 220 EYVLGGQL---------TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 270
           E +              +  +DV++ G +  E+ +        +       +   WQ+  
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----FKTQPAEAI--IWQMGT 257

Query: 271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
             KP      ++G     EI   +    FC       RP   +++ ML K
Sbjct: 258 GMKPN---LSQIGM--GKEISDILL---FCWAFEQEERPTFTKLMDMLEK 299

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  186 bits (475), Expect = 6e-57
 Identities = 76/309 (24%), Positives = 125/309 (40%), Gaps = 43/309 (13%)

Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQG-VREFITEIMTLSNVR 100
           R+   D  L   +G+G +G V++G+   G  +AVK  S+  ++   RE  TE+     +R
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLR 60

Query: 101 HPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           H N++  I   +      T+  L+  Y E  SL   L         L+      I + IA
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIA 115

Query: 157 KGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI---TT 208
            GLA LH E+      P I HRD+K+ NIL+ +     I D GLA +   +   +     
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 209 RIAGTTGYLAPEYVLGGQL-------TMKADVYSFGVLVLEIISGRNSGKA--------- 252
              GT  Y+APE VL   +         + D+++FG+++ E+     S            
Sbjct: 176 PRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234

Query: 253 -MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM 311
            +      F          +++P  + +    +     + + MK    C     S R   
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRP-NIPNRWFSDPTLTSLAKLMKE---CWYQNPSARLTA 290

Query: 312 NQVIKMLTK 320
            ++ K LTK
Sbjct: 291 LRIKKTLTK 299

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  180 bits (458), Expect = 6e-54
 Identities = 78/309 (25%), Positives = 121/309 (39%), Gaps = 43/309 (13%)

Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQG-VREFITEIMTLSNVR 100
           R+      L   IG+G FG V++G    G  +AVK  S+  ++   RE   EI     +R
Sbjct: 38  RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLR 94

Query: 101 HPNLVELIGCCVQGTRRI----LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           H N++  I    +         LV +Y E+ SL   L   T     +  E    + +  A
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTA 149

Query: 157 KGLAFLHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT---T 208
            GLA LH E+V     P I HRD+K+ NIL+ +     I D GLA         I     
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 209 RIAGTTGYLAPEYVLGGQLTM-------KADVYSFGVLVLEIISGRNSG----------K 251
              GT  Y+APE VL   + M       +AD+Y+ G++  EI    + G           
Sbjct: 210 HRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268

Query: 252 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM 311
            +                Q+ +P  + +          + + M+    C  A  + R   
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRP-NIPNRWQSCEALRVMAKIMRE---CWYANGAARLTA 324

Query: 312 NQVIKMLTK 320
            ++ K L++
Sbjct: 325 LRIKKTLSQ 333

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  154 bits (392), Expect = 7e-44
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 15/206 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPL-SAESKQGVREFITEIMTLSNVRHPN 103
           +D  L  +IGRG FG V+ G L  +   +AVK            +F+ E   L    HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V LIG C Q     +V E V+       L        +L  +    +    A G+ +L 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE 230

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY----LAP 219
            +     +HRD+ A N L+ ++   KI DFG+++   D    +     G         AP
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAP 284

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E +  G+ + ++DV+SFG+L+ E  S
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS 310

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  151 bits (383), Expect = 2e-43
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-----NGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
                  ++G+G FG+V            G  +AVK L   +++ +R+F  EI  L +++
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 101 HPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           H N+V+  G C    RR   L+ EY+   SL   L    +   +++  K       I KG
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKG 126

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------ 212
           + +L  +     +HRD+   NIL++ E   KIGDFGL K+ P +      +  G      
Sbjct: 127 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 184 Y----APESLTESKFSVASDVWSFGVVLYELFT 212

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  150 bits (382), Expect = 3e-43
 Identities = 61/203 (30%), Positives = 88/203 (43%), Gaps = 17/203 (8%)

Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIG 109
           +IGRG F TVYKG        +A         +K   + F  E   L  ++HPN+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 110 CCVQGTRR----ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
                 +     +LV E + + +L   L    K    +  +     C  I KGL FLH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 166 LVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
             P I+HRD+K  NI +     + KIGD GLA L   +       + GT  ++APE    
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204

Query: 225 GQLTMKADVYSFGVLVLEIISGR 247
                  DVY+FG+ +LE+ +  
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  150 bits (382), Expect = 4e-43
 Identities = 71/298 (23%), Positives = 123/298 (41%), Gaps = 36/298 (12%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-----NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV 99
                   +G G FG V            G ++AVK L  E     + +   EI  L N+
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 100 RHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            H N+V+  G C +       L+ E++ + SL   L        K+N +++    V I K
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICK 137

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG----- 212
           G+ +L        VHRD+ A N+L++ E   KIGDFGL K    +  + T +        
Sbjct: 138 GMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194

Query: 213 -TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 271
                 APE ++  +  + +DV+SFGV + E+++  +S  +      K +     Q+   
Sbjct: 195 WY----APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250

Query: 272 EKPLELVDPELG---EYP---PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
              +  +  + G     P   P+E+ + M+    C +   S R     +I+     ++
Sbjct: 251 RL-VNTL--KEGKRLPCPPNCPDEVYQLMRK---CWEFQPSNRTSFQNLIEGFEALLK 302

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  150 bits (382), Expect = 7e-43
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 23/213 (10%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-----NGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
                  ++G+G FG+V            G  +AVK L   +++ +R+F  EI  L +++
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 101 HPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           H N+V+  G C    RR   L+ EY+   SL   L    +   +++  K       I KG
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKG 157

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------ 212
           + +L  +     +HRD+   NIL++ E   KIGDFGL K+ P +  +   +  G      
Sbjct: 158 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                APE +   + ++ +DV+SFGV++ E+ +
Sbjct: 215 Y----APESLTESKFSVASDVWSFGVVLYELFT 243

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  147 bits (374), Expect = 8e-42
 Identities = 81/295 (27%), Positives = 120/295 (40%), Gaps = 38/295 (12%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-----GRRIAVKPLSAE-SKQGVREFITEIMTLSNV 99
                   +G G FG V            G  +AVK L A+   Q    +  EI  L  +
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 100 RHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            H ++++  GCC         LV EYV   SL   L      +  +   +       I +
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRH-SIGLAQLLLFAQQICE 145

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 217
           G+A+LH +   H +HRD+ A N+LLD +   KIGDFGLAK  P+   +   R     G  
Sbjct: 146 GMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR---EDGDS 199

Query: 218 -----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQE 271
                APE +   +    +DV+SFGV + E+++   +S       +    +    Q+   
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQMTVL 258

Query: 272 EKPLELVDPELGEY---PPN---EIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
               EL+  E GE    P     E+   MK    C +  AS RP    +I +L  
Sbjct: 259 RL-TELL--ERGERLPRPDKCPAEVYHLMKN---CWETEASFRPTFENLIPILKT 307

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  145 bits (368), Expect = 3e-41
 Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 9/198 (4%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV 112
           +G+G +G VY G  L+N  RIA+K +     +  +    EI    +++H N+V+ +G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 113 QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH 172
           +     +  E V   SL   LL +    +K N +        I +GL +LH+     IVH
Sbjct: 90  ENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 173 RDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL--TM 229
           RDIK  N+L++      KI DFG +K          T   GT  Y+APE +  G      
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGK 204

Query: 230 KADVYSFGVLVLEIISGR 247
            AD++S G  ++E+ +G+
Sbjct: 205 AADIWSLGCTIIEMATGK 222

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  146 bits (371), Expect = 3e-41
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR-----IAVKPLSAESKQGVR-EFITEIMTLSNV 99
            +F     +G G FGTVYKG            +A+K L   +      E + E   +++V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            +P++  L+G C+  T ++ + + +    L   +    +    +  +   + CV IAKG+
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGM 130

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-----IAGTT 214
            +L +     +VHRD+ A N+L+    + KI DFGLAKL                I    
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM- 186

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              A E +L    T ++DV+S+GV V E+++
Sbjct: 187 ---ALESILHRIYTHQSDVWSYGVTVWELMT 214

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  146 bits (370), Expect = 3e-41
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 23/213 (10%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-----NGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
                 +++G+G FG+V            G  +AVK L        R+F  EI  L  + 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 101 HPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
              +V+  G      R+   LV EY+ +  L   L    +   +L+  +       I KG
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKG 139

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------ 212
           + +L        VHRD+ A NIL++ E + KI DFGLAKL P +  +   R  G      
Sbjct: 140 MEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                APE +     + ++DV+SFGV++ E+ +
Sbjct: 197 Y----APESLSDNIFSRQSDVWSFGVVLYELFT 225

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  145 bits (367), Expect = 4e-41
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 19/206 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
            D     ++G G FG V  G       +A+K +   S     EFI E   + N+ H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 82

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L G C +     ++ EY+ N  L   L        +   ++  ++C  + + + +L  +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK 139

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLAP 219
                +HRD+ A N L++ +   K+ DFGL++   D+     T   G+      +    P
Sbjct: 140 ---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWS---PP 190

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E ++  + + K+D+++FGVL+ EI S
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYS 216

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  146 bits (370), Expect = 4e-41
 Identities = 84/347 (24%), Positives = 138/347 (39%), Gaps = 50/347 (14%)

Query: 13  SKKSAEREAPQGVDGELLRNVNHFSYTELRS-ATDDFHLSNKIGRGGFGTVYKGTLTNGR 71
           S  S       G+ G ++ N  +FS   +      D  L  ++G G FG V+     N  
Sbjct: 7   SSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLL 66

Query: 72  ------RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 125
                  +AVK L   S+   ++F  E   L+ ++H ++V   G C +G   ++V+EY+ 
Sbjct: 67  PEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMR 126

Query: 126 NNSLDRVL-----------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD 174
           +  L+R L            G   A   L   +   +   +A G+ +L      H VHRD
Sbjct: 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRD 183

Query: 175 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTM 229
           +   N L+ Q    KIGDFG+++    +I        G    L      PE +L  + T 
Sbjct: 184 LATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT 239

Query: 230 KADVYSFGVLVLEIIS-GRNSGKAM--WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 286
           ++DV+SFGV++ EI + G+        +   N   ++   Q  + E+P            
Sbjct: 240 ESDVWSFGVVLWEIFTYGK-----QPWYQLSNTEAIDCITQGRELERP---------RAC 285

Query: 287 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
           P E+   M+    C Q    +R  +  V   L    +     L   G
Sbjct: 286 PPEVYAIMRG---CWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 329

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  143 bits (364), Expect = 8e-41
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 19/206 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
            +     +IG G FG V+ G   N  ++A+K +   +     +FI E   +  + HP LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLV 66

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L G C++     LV E++E+  L   L            E    +C+ + +G+A+L E 
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEA 123

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLAP 219
               ++HRD+ A N L+ +    K+ DFG+ +   D+     T   GT          +P
Sbjct: 124 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWA---SP 174

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E     + + K+DV+SFGVL+ E+ S
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFS 200

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  143 bits (364), Expect = 8e-41
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 19/206 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           ++  L  ++G G FG V  G       +AVK +   S     EF  E  T+  + HP LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLV 66

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +  G C +     +V EY+ N  L   L    K    L   +  ++C  + +G+AFL   
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH 123

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLAP 219
                +HRD+ A N L+D++   K+ DFG+ +   D+         GT      +   AP
Sbjct: 124 ---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKWS---AP 174

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E     + + K+DV++FG+L+ E+ S
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFS 200

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  148 bits (376), Expect = 1e-40
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 7/201 (3%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL 104
            D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   +  ++HPNL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           V+L+G C +     ++ E++   +L   L    +  +         +   I+  + +L +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYLEK 336

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
           +   + +HR++ A N L+ +    K+ DFGL++L   +             + APE +  
Sbjct: 337 K---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393

Query: 225 GQLTMKADVYSFGVLVLEIIS 245
            + ++K+DV++FGVL+ EI +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  144 bits (366), Expect = 1e-40
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 22/212 (10%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR-----RIAVKPLSAE-SKQGVREFITEIMTLSNV 99
                   IG G FG VYKG L          +A+K L A  +++   +F+ E   +   
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            H N++ L G   +    +++ EY+EN +LD+ L    + + + +  +   +  GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGM 160

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------T 213
            +L      + VHRD+ A NIL++     K+ DFGL+++  D+     T   G      T
Sbjct: 161 KYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
               APE +   + T  +DV+SFG+++ E+++
Sbjct: 218 ----APEAISYRKFTSASDVWSFGIVMWEVMT 245

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  144 bits (364), Expect = 2e-40
 Identities = 56/240 (23%), Positives = 88/240 (36%), Gaps = 14/240 (5%)

Query: 12  HSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNG 70
             +    R + +G   E L++  +            F   +++G G +G V+K     +G
Sbjct: 23  MHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDG 82

Query: 71  RRIAVK--PLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENN 127
           R  AVK         +     + E+ +   V +HP  V L     +G    L  E    +
Sbjct: 83  RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPS 142

Query: 128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 187
                          L   +           LA LH +    +VH D+K +NI L     
Sbjct: 143 LQQHCE----AWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGR 195

Query: 188 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
            K+GDFGL             +  G   Y+APE +L G     ADV+S G+ +LE+    
Sbjct: 196 CKLGDFGLLVEL-GTAGAGEVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  143 bits (362), Expect = 2e-40
 Identities = 73/206 (35%), Positives = 106/206 (51%), Gaps = 19/206 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  ++G G FG V+ G      ++AVK L   S      F+ E   +  ++H  LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            L     Q    I + EY+EN SL   L   T + IKL   K  D+   IA+G+AF+ E 
Sbjct: 72  RLYAVVTQEPIYI-ITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLAP 219
              + +HRD++A+NIL+    + KI DFGLA+L  DN     T   G       T   AP
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWT---AP 179

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E +  G  T+K+DV+SFG+L+ EI++
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT 205

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  143 bits (363), Expect = 2e-40
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 46/311 (14%)

Query: 40  ELRSATDDF---------HLSNKIGRGGFGTVYKGTLTNGR----RIAVKPLSAE-SKQG 85
           EL  A             H +  IGRG FG VY GTL +        AVK L+       
Sbjct: 10  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69

Query: 86  VREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLN 144
           V +F+TE + + +  HPN++ L+G C++     L V  Y+++  L   +           
Sbjct: 70  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPT 126

Query: 145 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 204
            +      + +AKG+ +L  +     VHRD+ A N +LD++F  K+ DFGLA+   D   
Sbjct: 127 VKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYD 180

Query: 205 HITTRIAGTTGYL------APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQM 257
                +   TG        A E +   + T K+DV+SFGVL+ E+++ G           
Sbjct: 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA---PPYPDVN 237

Query: 258 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 317
              +  +  Q  +  +P         EY P+ +   M     C    A  RP  ++++  
Sbjct: 238 TFDITVYLLQGRRLLQP---------EYCPDPLYEVMLK---CWHPKAEMRPSFSELVSR 285

Query: 318 LTKNIRLNEEE 328
           ++        E
Sbjct: 286 ISAIFSTFIGE 296

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  146 bits (371), Expect = 3e-40
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 19/206 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G G FG V+  T     ++AVK +   S   V  F+ E   +  ++H  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 246

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L     +    I + E++   SL   L     +   L   K  D    IA+G+AF+ + 
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR 303

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLAP 219
              + +HRD++A+NIL+      KI DFGLA++  DN     T   G       T   AP
Sbjct: 304 ---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWT---AP 354

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E +  G  T+K+DV+SFG+L++EI++
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVT 380

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  143 bits (363), Expect = 3e-40
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 8/206 (3%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPL---SAESKQGVREFITEIMTLSNVRH 101
            +F +  KIGRG F  VY+   L +G  +A+K +        +   + I EI  L  + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN+++     ++     +V E  +   L R++    K    +         V +   L  
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           +H      ++HRDIK +N+ +      K+GD GL + F    T   + + GT  Y++PE 
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207

Query: 222 VLGGQLTMKADVYSFGVLVLEIISGR 247
           +       K+D++S G L+ E+ + +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQ 233

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  143 bits (362), Expect = 3e-40
 Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 39/239 (16%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
             DF     +G+G FG V K     + R  A+K +    ++ +   ++E+M L+++ H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 104 LVELIGCCVQGTRRI-------------LVYEYVENNSL-DRVLLGATKANIKLNWEKRS 149
           +V      ++    +             +  EY EN +L D +       N+    ++  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYW 119

Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---------- 199
            +   I + L+++H +    I+HRD+K  NI +D+  N KIGDFGLAK            
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 200 ----PDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM 253
               P +  ++T+ I GT  Y+A E + G G    K D+YS G++  E+I   ++G   
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMER 234

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  146 bits (371), Expect = 3e-40
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 25/207 (12%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
            +  L   IG+G FG V  G    G ++AVK +  ++    + F+ E   ++ +RH NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249

Query: 106 ELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           +L+G  V+    + +V EY+   SL   L    ++ +    +      + + + + +L  
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYLEG 307

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLA 218
               + VHRD+ A N+L+ ++   K+ DFGL K         ++           T   A
Sbjct: 308 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWT---A 354

Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIIS 245
           PE +   + + K+DV+SFG+L+ EI S
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYS 381

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  142 bits (360), Expect = 5e-40
 Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 40/223 (17%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR--------RIAVKPLSAESKQGVREFITEIMTLS 97
           +D   +  +G+G F  ++KG               + +K L    +     F      +S
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            + H +LV   G CV G   ILV E+V+  SLD  L    K  I + W+   ++   +A 
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKL--EVAKQLAA 124

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNP--------KIGDFGLAKLFPDNITHITTR 209
            + FL E     ++H ++ A NILL +E +         K+ D G++             
Sbjct: 125 AMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT----------- 170

Query: 210 IAGTTGY------LAPEYVL-GGQLTMKADVYSFGVLVLEIIS 245
           +            + PE +     L +  D +SFG  + EI S
Sbjct: 171 VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  143 bits (362), Expect = 5e-40
 Identities = 58/249 (23%), Positives = 104/249 (41%), Gaps = 26/249 (10%)

Query: 7   GGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT 66
           G ++         +    +  E L+ V++    E R          ++GRG FG V++  
Sbjct: 23  GSAKLQRLGPETEDNEGVLLTEKLKPVDY----EYREEVHWMTHQPRVGRGSFGEVHRMK 78

Query: 67  -LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 123
               G + AVK   L     +       E++  + +  P +V L G   +G    +  E 
Sbjct: 79  DKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131

Query: 124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 183
           +E  SL +++    K    L  ++         +GL +LH      I+H D+KA N+LL 
Sbjct: 132 LEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLS 184

Query: 184 QEFNP-KIGDFGLAKLFPDNITHITTR----IAGTTGYLAPEYVLGGQLTMKADVYSFGV 238
            + +   + DFG A     +    +      I GT  ++APE V+G     K D++S   
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 244

Query: 239 LVLEIISGR 247
           ++L +++G 
Sbjct: 245 MMLHMLNGC 253

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  143 bits (363), Expect = 6e-40
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 11/206 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHP 102
           + +    KIG G FG         +GR+  +K   +S  S +   E   E+  L+N++HP
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR-SDICVGIAKGLAF 161
           N+V+      +     +V +Y E   L + +        +   E +  D  V I   L  
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ---EDQILDWFVQICLALKH 140

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           +H+     I+HRDIK+ NI L ++   ++GDFG+A++    +      I GT  YL+PE 
Sbjct: 141 VHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEI 196

Query: 222 VLGGQLTMKADVYSFGVLVLEIISGR 247
                   K+D+++ G ++ E+ + +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLK 222

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  146 bits (369), Expect = 6e-40
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 7/200 (3%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L   +      F+ E   +  +RH  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 242

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L     +    I V EY+   SL   L    +    L   +  D+   IA G+A++   
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM 299

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 300 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356

Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  142 bits (361), Expect = 8e-40
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSAE-SKQGVREFITEIMTLSNVR 100
              H+   IG G  G V  G L    +    +A+K L A  +++  R+F++E   +    
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN++ L G   +G   ++V EY+EN SLD  L      + +    +   +  G+  G+ 
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMR 165

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------TT 214
           +L +      VHRD+ A N+L+D     K+ DFGL+++  D+     T   G      T 
Sbjct: 166 YLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT- 221

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              APE +     +  +DV+SFGV++ E+++
Sbjct: 222 ---APEAIAFRTFSSASDVWSFGVVMWEVLA 249

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  146 bits (369), Expect = 2e-39
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 7/200 (3%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L   +      F+ E   +  +RH  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 325

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L     +    I V EY+   SL   L    +    L   +  D+   IA G+A++   
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM 382

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 383 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439

Query: 226 QLTMKADVYSFGVLVLEIIS 245
           + T+K+DV+SFG+L+ E+ +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  142 bits (361), Expect = 2e-39
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 21/211 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSAE-SKQGVREFITEIMTLSNVR 100
            +  +   +G G FG V  G L    +    +A+K L    +++  R+F+ E   +    
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN++ L G   +    ++V EY+EN SLD  L    K + +    +   +  GIA G+ 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMK 161

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------TT 214
           +L +      VHRD+ A NIL++     K+ DFGL ++  D+     T   G      T 
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT- 217

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              +PE +   + T  +DV+S+G+++ E++S
Sbjct: 218 ---SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  140 bits (355), Expect = 2e-39
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 24/212 (11%)

Query: 46  DDFHLSNK-IGRGGFGTVYKGTLTNGRR---IAVKPLSAE--SKQGVREFITEIMTLSNV 99
               L +K +G G FGTV KG     +    +AVK L  E        E + E   +  +
Sbjct: 16  KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            +P +V +IG C   +  + V E  E   L++ L    + N  +  +   ++   ++ G+
Sbjct: 76  DNPYIVRMIGICEAESWML-VMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGM 130

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------T 213
            +L EE   + VHRD+ A N+LL  +   KI DFGL+K    +  +   +  G       
Sbjct: 131 KYL-EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 187

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
               APE +   + + K+DV+SFGVL+ E  S
Sbjct: 188 ----APECINYYKFSSKSDVWSFGVLMWEAFS 215

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  140 bits (356), Expect = 4e-39
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR-----IAVKPLSAES-KQGVREFITEIMTLSNV 99
            +F     +G G FGTVYKG            +A+K L   +  +  +E + E   +++V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            +P++  L+G C+  T ++ + + +    L   +    +    +  +   + CV IAKG+
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGM 130

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-----IAGTT 214
            +L +     +VHRD+ A N+L+    + KI DFGLAKL                I    
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM- 186

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
              A E +L    T ++DV+S+GV V E+++
Sbjct: 187 ---ALESILHRIYTHQSDVWSYGVTVWELMT 214

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  140 bits (354), Expect = 4e-39
 Identities = 77/299 (25%), Positives = 129/299 (43%), Gaps = 46/299 (15%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR------RIAVKPLSAESKQGVREFITEIMTLSNV 99
            D  L  ++G G FG V+     N         +AVK L   +    ++F  E   L+N+
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL------------LGATKANIKLNWEK 147
           +H ++V+  G C  G   I+V+EY+++  L++ L                +A  +L   +
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 148 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 207
              I   IA G+ +L  +   H VHRD+   N L+      KIGDFG+++    ++    
Sbjct: 135 MLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTD 187

Query: 208 TRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFL 261
               G    L      PE ++  + T ++DV+SFGV++ EI +    GK  W Q+ N  +
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---YGKQPWFQLSNTEV 244

Query: 262 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           +E   Q    E+P            P E+   M     C Q    +R  + ++ K+L  
Sbjct: 245 IECITQGRVLERP---------RVCPKEVYDVMLG---CWQREPQQRLNIKEIYKILHA 291

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  139 bits (352), Expect = 5e-39
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 8/212 (3%)

Query: 43  SATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNV 99
           S  +D+ +   IG G +G   K    ++G+ +  K     + ++   +  ++E+  L  +
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62

Query: 100 RHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           +HPN+V      +  T   L  V EY E   L  V+   TK    L+ E    +   +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 158 GLAFLHE--ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
            L   H   +    ++HRD+K +N+ LD + N K+GDFGLA++   + +   T + GT  
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPY 181

Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           Y++PE +       K+D++S G L+ E+ +  
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  139 bits (352), Expect = 7e-39
 Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 17/206 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR-RIAVKPLSAESKQGVREFITEIMTLSNVRHPNL 104
            D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   +  ++HPNL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           V+L+G C +     ++ E++   +L   L    +  +         +   I+  + +L +
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYLEK 129

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----AP 219
           +   + +HRD+ A N L+ +    K+ DFGL++L   +     T  A           AP
Sbjct: 130 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWTAP 181

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIIS 245
           E +   + ++K+DV++FGVL+ EI +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  138 bits (351), Expect = 1e-38
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 21/203 (10%)

Query: 53  KIGRGGFGTVYKGTLTNGRR---IAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELI 108
           ++G G FG+V +G     ++   +A+K L     K    E + E   +  + +P +V LI
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G C Q    +LV E      L + L+G  +   ++     +++   ++ G+ +L EE   
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYL-EEK-- 129

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------TTGYLAPEYV 222
           + VHRD+ A N+LL      KI DFGL+K    + ++ T R AG           APE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 185

Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
              + + ++DV+S+GV + E +S
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  138 bits (351), Expect = 1e-38
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 11/202 (5%)

Query: 50  LSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS---AESKQGVREFITEIMTLSNVRHPNLV 105
           + +K+G GG  TVY         ++A+K +     E ++ ++ F  E+   S + H N+V
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            +I    +     LV EY+E  +L   +    +++  L+ +   +    I  G+   H+ 
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
               IVHRDIK  NIL+D     KI DFG+AK   +     T  + GT  Y +PE   G 
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187

Query: 226 QLTMKADVYSFGVLVLEIISGR 247
                 D+YS G+++ E++ G 
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGE 209

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  139 bits (353), Expect = 1e-38
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 25/218 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR------RIAVKPLSAE-SKQGVREFITEIMTLSN 98
           +   +S ++G+G FG VY+G            R+A+K ++   S +   EF+ E   +  
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLD------RVLLGATKANIKLNWEKRSDIC 152
               ++V L+G   QG   +++ E +    L       R  +         +  K   + 
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 212
             IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +    +I        G
Sbjct: 145 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKG 197

Query: 213 TTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 245
             G L     +PE +  G  T  +DV+SFGV++ EI +
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  138 bits (349), Expect = 1e-38
 Identities = 72/292 (24%), Positives = 130/292 (44%), Gaps = 42/292 (14%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
            +  L   IG+G FG V  G    G ++AVK +  ++    + F+ E   ++ +RH NLV
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77

Query: 106 ELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           +L+G  V+    + +V EY+   SL   L    ++ +    +      + + + + +L  
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYLEG 135

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLA 218
               + VHRD+ A N+L+ ++   K+ DFGL K         ++           T   A
Sbjct: 136 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWT---A 182

Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
           PE +   + + K+DV+SFG+L+ EI S GR           K ++    + ++ + P   
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGR---VPYPRIPLKDVVPRVEKGYKMDAP--- 236

Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 329
                 +  P  +   MK    C    A+ RP   Q+ + L ++I+ +E  L
Sbjct: 237 ------DGCPPAVYEVMKN---CWHLDAAMRPSFLQLREQL-EHIKTHELHL 278

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  139 bits (352), Expect = 1e-38
 Identities = 78/316 (24%), Positives = 122/316 (38%), Gaps = 42/316 (13%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR------RIAVKPLSAE-SKQGVREFITEIMTLSN 98
            +  L   +G G FG VY+G ++         ++AVK L    S+Q   +F+ E + +S 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL---GATKANIKLNWEKRSDICVGI 155
             H N+V  IG  +Q   R ++ E +    L   L            L       +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAG 212
           A G  +L E    H +HRDI A N LL         KIGDFG+A+    +I   +    G
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 202

Query: 213 TTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAW 266
               L      PE  + G  T K D +SFGVL+ EI S G         + N+ +LE+  
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY---MPYPSKSNQEVLEFVT 259

Query: 267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 326
              + + P         +  P  + R M     C Q     RP    +++ + +    + 
Sbjct: 260 SGGRMDPP---------KNCPGPVYRIMTQ---CWQHQPEDRPNFAIILERI-EYCTQDP 306

Query: 327 EELTAPGLFQDSESSS 342
           + +      +      
Sbjct: 307 DVINTALPIEYGPLVE 322

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  138 bits (350), Expect = 2e-38
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
              +    KIG+G  GTVY    +  G+ +A++ ++ + +      I EI+ +   ++PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V  +   + G    +V EY+   SL  V+         ++  + + +C    + L FLH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
                 ++HRDIK+ NILL  + + K+ DFG         +  +T + GT  ++APE V 
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189

Query: 224 GGQLTMKADVYSFGVLVLEIISG 246
                 K D++S G++ +E+I G
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG 212

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  138 bits (351), Expect = 2e-38
 Identities = 65/323 (20%), Positives = 129/323 (39%), Gaps = 40/323 (12%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR-----IAVKPLSAES-KQGVREFITEIMTLSNV 99
            +      +G G FGTV+KG            + +K +  +S +Q  +     ++ + ++
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            H ++V L+G C   + ++ V +Y+   SL   +    +    L  +   +  V IAKG+
Sbjct: 73  DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGM 128

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-----IAGTT 214
            +L E     +VHR++ A N+LL      ++ DFG+A L P +   +        I    
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM- 184

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK 273
              A E +  G+ T ++DV+S+GV V E+++ G    +   G     + +   +  +  +
Sbjct: 185 ---ALESIHFGKYTHQSDVWSYGVTVWELMTFGA---EPYAGLRLAEVPDLLEKGERLAQ 238

Query: 274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 333
           P         +    ++   M     C     + RP   ++    T+  R     L    
Sbjct: 239 P---------QICTIDVYMVMVK---CWMIDENIRPTFKELANEFTRMARDPPRYLVIKR 286

Query: 334 LFQDSESSSVGTSDKKSSDSTLQ 356
             +     + G      ++  L+
Sbjct: 287 --ESGPGIAPGPEPHGLTNKKLE 307

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  138 bits (350), Expect = 3e-38
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 17/208 (8%)

Query: 50  LSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS---AESKQGVREFITEIMTLSNVRHPNLV 105
           L   +G GG   V+    L + R +AVK L    A        F  E    + + HP +V
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 106 EL--IGCCVQGTRRI--LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
            +   G        +  +V EYV+  +L  ++         +  ++  ++     + L F
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNF 131

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGTTGYLAP 219
            H+     I+HRD+K +NI++      K+ DFG+A+   D+   +T    + GT  YL+P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E   G  +  ++DVYS G ++ E+++G 
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGE 216

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  139 bits (352), Expect = 3e-38
 Identities = 63/255 (24%), Positives = 116/255 (45%), Gaps = 11/255 (4%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPN 103
           DDF   +++G G  G V+K +   +G  +A K +  E K  +R  I  E+  L     P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V   G         +  E+++  SLD+VL    K   ++  +    + + + KGL +L 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 148

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           E+    I+HRD+K SNIL++     K+ DFG++    D++ +  + + GT  Y++PE + 
Sbjct: 149 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYMSPERLQ 203

Query: 224 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG 283
           G   ++++D++S G+ ++E+  GR        +  + +     +    E P     P   
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

Query: 284 EYPPNEIIRYMKVAF 298
                   R     F
Sbjct: 264 LNKFGMDSRPPMAIF 278

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  136 bits (346), Expect = 6e-38
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 24/213 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT--NGRRIAV-----KPLSAESKQGVREFITEIMTLSN 98
            D  L  K+G G FG V +G     +G+ ++V     KP      + + +FI E+  + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           + H NL+ L G  +    ++ V E     SL   L    + +  L     S   V +A+G
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK-HQGHFLL--GTLSRYAVQVAEG 133

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------ 212
           + +L  +     +HRD+ A N+LL      KIGDFGL +  P N  H   +         
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
                APE +     +  +D + FGV + E+ +
Sbjct: 191 C----APESLKTRTFSHASDTWMFGVTLWEMFT 219

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  136 bits (345), Expect = 6e-38
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 22/210 (10%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR----RIAVKPLSAE-SKQGVREFITEIMTLSNVR 100
           +D  L+  +G G FG VY+G  TN +     +AVK    + +     +F++E + + N+ 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HP++V+LIG   +    I + E      L   L         L         + I K +A
Sbjct: 72  HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMA 127

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL--- 217
           +L      + VHRDI   NIL+      K+GDFGL++   D           +   L   
Sbjct: 128 YLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-----YKASVTRLPIK 179

Query: 218 --APEYVLGGQLTMKADVYSFGVLVLEIIS 245
             +PE +   + T  +DV+ F V + EI+S
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILS 209

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  137 bits (347), Expect = 6e-38
 Identities = 51/203 (25%), Positives = 102/203 (50%), Gaps = 10/203 (4%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
                   KIG G  G V       +GR++AVK +    +Q       E++ + + +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +VE+    + G    ++ E+++  +L  ++       ++LN E+ + +C  + + LA+LH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLH 158

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
            +    ++HRDIK+ +ILL  +   K+ DFG       ++    + + GT  ++APE + 
Sbjct: 159 AQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVIS 214

Query: 224 GGQLTMKADVYSFGVLVLEIISG 246
                 + D++S G++V+E++ G
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDG 237

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  136 bits (344), Expect = 1e-37
 Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 31/224 (13%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR------RIAVKPLSAE-SKQGVREFITEIMTLSN 98
                  ++G   FG VYKG L           +A+K L  +       EF  E M  + 
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL------------LGATKANIKLNWE 146
           ++HPN+V L+G   +     +++ Y  +  L   L                     L   
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 147 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
               +   IA G+ +L      H+VH+D+   N+L+  + N KI D GL +     +   
Sbjct: 129 DFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAA 181

Query: 207 TTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 245
                     L     APE ++ G+ ++ +D++S+GV++ E+ S
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  136 bits (344), Expect = 1e-37
 Identities = 70/292 (23%), Positives = 123/292 (42%), Gaps = 35/292 (11%)

Query: 49  HLSNKIGRGGFGTVYKGTLTNGR----RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPN 103
           H    IG+G FG VY G   +      + A+K LS     Q V  F+ E + +  + HPN
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 104 LVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           ++ LIG  +        +  Y+ +  L + +    +       +      + +A+G+ +L
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYL 140

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL----- 217
            E+     VHRD+ A N +LD+ F  K+ DFGLA+   D      +        L     
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR--EYYSVQQHRHARLPVKWT 195

Query: 218 APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE 276
           A E +   + T K+DV+SFGVL+ E+++ G              L  +  Q  +  +P  
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGA---PPYRHIDPFDLTHFLAQGRRLPQP-- 250

Query: 277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 328
                  EY P+ + + M+    C +A  + RP    ++  + + +     +
Sbjct: 251 -------EYCPDSLYQVMQQ---CWEADPAVRPTFRVLVGEVEQIVSALLGD 292

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  137 bits (348), Expect = 1e-37
 Identities = 81/332 (24%), Positives = 136/332 (40%), Gaps = 38/332 (11%)

Query: 9   SRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT 68
           + +    +        ++ EL++ V H             H +  IGRG FG VY GTL 
Sbjct: 55  NLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSL---IVHFNEVIGRGHFGCVYHGTLL 111

Query: 69  NGR----RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL-VYE 122
           +        AVK L+       V +F+TE + + +  HPN++ L+G C++     L V  
Sbjct: 112 DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171

Query: 123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 182
           Y+++  L   +            +      + +AKG+ FL  +     VHRD+ A N +L
Sbjct: 172 YMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCML 225

Query: 183 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFG 237
           D++F  K+ DFGLA+   D           T   L     A E +   + T K+DV+SFG
Sbjct: 226 DEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 283

Query: 238 VLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 296
           VL+ E+++ G              +  +  Q  +  +P         EY P+ +   M  
Sbjct: 284 VLLWELMTRGA---PPYPDVNTFDITVYLLQGRRLLQP---------EYCPDPLYEVMLK 331

Query: 297 AFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 328
              C    A  RP  ++++  ++        E
Sbjct: 332 ---CWHPKAEMRPSFSELVSRISAIFSTFIGE 360

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  137 bits (348), Expect = 1e-37
 Identities = 78/316 (24%), Positives = 121/316 (38%), Gaps = 42/316 (13%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR------RIAVKPLSAE-SKQGVREFITEIMTLSN 98
            +  L   +G G FG VY+G ++         ++AVK L    S+Q   +F+ E + +S 
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLD---RVLLGATKANIKLNWEKRSDICVGI 155
             H N+V  IG  +Q   R ++ E +    L    R           L       +   I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAG 212
           A G  +L E    H +HRDI A N LL         KIGDFG+A+    +I        G
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKG 243

Query: 213 TTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAW 266
               L      PE  + G  T K D +SFGVL+ EI S G         + N+ +LE+  
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY---MPYPSKSNQEVLEFVT 300

Query: 267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 326
              + + P         +  P  + R M     C Q     RP    +++ + +    + 
Sbjct: 301 SGGRMDPP---------KNCPGPVYRIMTQ---CWQHQPEDRPNFAIILERI-EYCTQDP 347

Query: 327 EELTAPGLFQDSESSS 342
           + +      +      
Sbjct: 348 DVINTALPIEYGPLVE 363

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  135 bits (343), Expect = 1e-37
 Identities = 49/228 (21%), Positives = 84/228 (36%), Gaps = 34/228 (14%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNV-R 100
           T +FH   KIG G FG+V+K     +G   A+K            +  + E+   + + +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           H ++V       +    ++  EY    SL   +    +        +  D+ + + +GL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNP-------------------KIGDFGLAKLFPD 201
           ++H      +VH DIK SNI + +   P                   KIGD G       
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 202 NITHITTRIAGTTGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGR 247
                     G + +LA E VL        KAD+++  + V+      
Sbjct: 187 PQVEE-----GDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  141 bits (357), Expect = 2e-37
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 21/203 (10%)

Query: 53  KIGRGGFGTVYKGTLTNGRR---IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELI 108
           ++G G FG+V +G     ++   +A+K L   +++    E + E   +  + +P +V LI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 168
           G C Q    +LV E      L + L+       ++     +++   ++ G+ +L EE   
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYL-EEK-- 455

Query: 169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------TTGYLAPEYV 222
           + VHR++ A N+LL      KI DFGL+K    + ++ T R AG           APE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 511

Query: 223 LGGQLTMKADVYSFGVLVLEIIS 245
              + + ++DV+S+GV + E +S
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  135 bits (343), Expect = 2e-37
 Identities = 56/258 (21%), Positives = 96/258 (37%), Gaps = 33/258 (12%)

Query: 7   GGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT 66
           G S  H   S+ RE        +   +++  Y  ++          K+G GGF  V    
Sbjct: 2   GSSHHHHHHSSGRENLYFQGHMV--IIDNKHYLFIQ----------KLGEGGFSYVDLVE 49

Query: 67  -LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR----ILVY 121
            L +G   A+K +    +Q   E   E        HPN++ L+  C++         L+ 
Sbjct: 50  GLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109

Query: 122 EYVENNSLDRVLLGATKANIKLNWEKRS-DICVGIAKGLAFLHEELVPHIVHRDIKASNI 180
            + +  +L   +         L  E +   + +GI +GL  +H        HRD+K +NI
Sbjct: 110 PFFKRGTLWNEIERLKDKGNFLT-EDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNI 165

Query: 181 LLDQEFNPKIGDFGLAKLFPDNITHITTRIA--------GTTGYLAPEYV---LGGQLTM 229
           LL  E  P + D G       ++      +          T  Y APE         +  
Sbjct: 166 LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE 225

Query: 230 KADVYSFGVLVLEIISGR 247
           + DV+S G ++  ++ G 
Sbjct: 226 RTDVWSLGCVLYAMMFGE 243

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  135 bits (341), Expect = 3e-37
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 22/210 (10%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSAE-SKQGVREFITEIMTLSNVR 100
           +   L   IG G FG V++G   +       +A+K      S     +F+ E +T+    
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HP++V+LIG   +    I + E      L   L         L+          ++  LA
Sbjct: 75  HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALA 130

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL--- 217
           +L  +     VHRDI A N+L+      K+GDFGL++   D+          + G L   
Sbjct: 131 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLPIK 182

Query: 218 --APEYVLGGQLTMKADVYSFGVLVLEIIS 245
             APE +   + T  +DV+ FGV + EI+ 
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILM 212

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  135 bits (343), Expect = 3e-37
 Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 26/219 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNG----RRIAVKPL--SAESKQGVREFITEIMTLSNV 99
             F L   +G+G FG+V +  L        ++AVK L     +   + EF+ E   +   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 100 RHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKAN--IKLNWEKRSDI 151
            HP++ +L+G  ++   +       ++  ++++  L   LL +        L  +     
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
            V IA G+ +L      + +HRD+ A N +L ++    + DFGL++     I        
Sbjct: 143 MVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQ 195

Query: 212 GTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 245
           G    L     A E +     T+ +DV++FGV + EI++
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  135 bits (341), Expect = 4e-37
 Identities = 45/217 (20%), Positives = 88/217 (40%), Gaps = 25/217 (11%)

Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNL 104
            + +  +IG GG   V++      +  A+K   L     Q +  +  EI  L+ ++  + 
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 105 --VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
             + L    +      +V E   N  L+  L    K    ++  +R      + + +  +
Sbjct: 89  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTI 143

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEY 221
           H+     IVH D+K +N L+      K+ DFG+A     + T +      GT  Y+ PE 
Sbjct: 144 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 222 VLG-----------GQLTMKADVYSFGVLVLEIISGR 247
           +              +++ K+DV+S G ++  +  G+
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  134 bits (339), Expect = 5e-37
 Identities = 54/240 (22%), Positives = 104/240 (43%), Gaps = 28/240 (11%)

Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMT 95
           ++T  +    DF     IG GGFG V+K     +G+   +K +   +++  RE    +  
Sbjct: 2   AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKA 57

Query: 96  LSNVRHPNLVELIGC----------------CVQGTRRILVYEYVENNSLDRVLLGATKA 139
           L+ + H N+V   GC                  +     +  E+ +  +L++ +    + 
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRR 115

Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 199
             KL+     ++   I KG+ ++H +    +++RD+K SNI L      KIGDFGL    
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172

Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK 259
            ++     TR  GT  Y++PE +       + D+Y+ G+++ E++   ++          
Sbjct: 173 KNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  134 bits (340), Expect = 5e-37
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 10/203 (4%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
            + F +  K+G G +G+VYK      G+ +A+K +  ES   ++E I EI  +     P+
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+  G   + T   +V EY    S+  ++      N  L  ++ + I     KGL +LH
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
                  +HRDIKA NILL+ E + K+ DFG+A    D +    T I GT  ++APE + 
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQ 198

Query: 224 GGQLTMKADVYSFGVLVLEIISG 246
                  AD++S G+  +E+  G
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEG 221

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  135 bits (341), Expect = 7e-37
 Identities = 74/310 (23%), Positives = 127/310 (40%), Gaps = 49/310 (15%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAE-SKQGVREFITEIMTLSN 98
           ++      +G G FG V + T           ++AVK L +          ++E+  +S+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSL----------DRVLLGATKANIKLNWEK 147
           + +H N+V L+G C  G   +++ EY     L                   AN   +   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 148 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 207
                  +A+G+AFL  +   + +HRD+ A N+LL      KIGDFGLA+    +I + +
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDS 218

Query: 208 TRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRN--SGKAMWGQMNK 259
             I      L     APE +     T+++DV+S+G+L+ EI S G N   G  +  +  K
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278

Query: 260 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 319
            + +     +Q  +P          + P  I   M+    C     + RP   Q+   L 
Sbjct: 279 LVKDG----YQMAQP---------AFAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQ 322

Query: 320 KNIRLNEEEL 329
           +  + +  E 
Sbjct: 323 EQAQEDRRER 332

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  134 bits (339), Expect = 7e-37
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 11/204 (5%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHP 102
            + F    KIG+G FG V+KG      + +A+K +  E  +  + +   EI  LS    P
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
            + +  G  ++ T+  ++ EY+   S   +L    +    L+  + + I   I KGL +L
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPG-PLDETQIATILREILKGLDYL 135

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H E     +HRDIKA+N+LL +    K+ DFG+A    D      T + GT  ++APE +
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 191

Query: 223 LGGQLTMKADVYSFGVLVLEIISG 246
                  KAD++S G+  +E+  G
Sbjct: 192 KQSAYDSKADIWSLGITAIELARG 215

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  134 bits (339), Expect = 8e-37
 Identities = 56/218 (25%), Positives = 108/218 (49%), Gaps = 16/218 (7%)

Query: 38  YTELRSATD---DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEI 93
           Y  +R   D    + +  ++G G FG VYK      G   A K +  +S++ + ++I EI
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67

Query: 94  MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
             L+   HP +V+L+G      +  ++ E+    ++D ++    + +  L   +   +C 
Sbjct: 68  EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCR 124

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
            + + L FLH +    I+HRD+KA N+L+  E + ++ DFG++      +    + I GT
Sbjct: 125 QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GT 180

Query: 214 TGYLAPEYVLGGQLT-----MKADVYSFGVLVLEIISG 246
             ++APE V+   +       KAD++S G+ ++E+   
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  134 bits (339), Expect = 8e-37
 Identities = 75/314 (23%), Positives = 126/314 (40%), Gaps = 53/314 (16%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR------RIAVKPLSAE-SKQGVREFITEIMTLSN 98
           +       +G G FG V + T            +AVK L            ++E+  LS 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRS-- 149
           +  H N+V L+G C  G   +++ EY     L       R     +K +  +  +     
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 150 ------DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
                      +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+    +I
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR----DI 195

Query: 204 THITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRN--SGKAMWG 255
            + +  +      L     APE +     T ++DV+S+G+ + E+ S G +   G  +  
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255

Query: 256 QMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 315
           +  K + E      +   P         E+ P E+   MK    C  A   +RP   Q++
Sbjct: 256 KFYKMIKEG----FRMLSP---------EHAPAEMYDIMKT---CWDADPLKRPTFKQIV 299

Query: 316 KMLTKNIRLNEEEL 329
           +++ K I  +   +
Sbjct: 300 QLIEKQISESTNHI 313

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  134 bits (339), Expect = 1e-36
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 25/218 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR----RIAVKPLSAE--SKQGVREFITEIMTLSNV 99
           +   L   +G G FG+V +G L        ++AVK +  +  S++ + EF++E   + + 
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 100 RHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS--DIC 152
            HPN++ L+G C++       + +++  +++   L   LL +       +   ++     
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 212
           V IA G+ +L      + +HRD+ A N +L  +    + DFGL+K     I        G
Sbjct: 154 VDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQG 206

Query: 213 TTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 245
               +     A E +     T K+DV++FGV + EI +
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  134 bits (339), Expect = 1e-36
 Identities = 45/217 (20%), Positives = 88/217 (40%), Gaps = 25/217 (11%)

Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNL 104
            + +  +IG GG   V++      +  A+K   L     Q +  +  EI  L+ ++  + 
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 105 --VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
             + L    +      +V E   N  L+  L    K    ++  +R      + + +  +
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTI 124

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEY 221
           H+     IVH D+K +N L+      K+ DFG+A     + T +      GT  Y+ PE 
Sbjct: 125 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 222 VLG-----------GQLTMKADVYSFGVLVLEIISGR 247
           +              +++ K+DV+S G ++  +  G+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  133 bits (337), Expect = 2e-36
 Identities = 76/312 (24%), Positives = 127/312 (40%), Gaps = 52/312 (16%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAE-SKQGVREFITEIMTLSN 98
           D   L   +GRG FG V +            R +AVK L    +    R  ++E+  L +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 99  V-RHPNLVELIGCCVQGTRRILV-YEYVENNSLDRVLLGATKANIKLNWEKRS------- 149
           +  H N+V L+G C +    ++V  E+ +  +L   L       +               
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 150 -----DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 204
                     +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+    +I 
Sbjct: 147 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR----DIY 199

Query: 205 HITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRN--SGKAMWGQ 256
                +      L     APE +     T+++DV+SFGVL+ EI S G +   G  +  +
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259

Query: 257 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
             + L E      +   P         +Y   E+ + M     C     S+RP  +++++
Sbjct: 260 FCRRLKEG----TRMRAP---------DYTTPEMYQTMLD---CWHGEPSQRPTFSELVE 303

Query: 317 MLTKNIRLNEEE 328
            L   ++ N ++
Sbjct: 304 HLGNLLQANAQQ 315

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  133 bits (337), Expect = 2e-36
 Identities = 76/329 (23%), Positives = 132/329 (40%), Gaps = 49/329 (14%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNG---RRIAVKPLSAE-SKQGVREFITEIMTLSNV-R 100
           +D    + IG G FG V K  +         A+K +    SK   R+F  E+  L  +  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS----------- 149
           HPN++ L+G C       L  EY  + +L   L  +        +   +           
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 150 -DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
                 +A+G+ +L ++     +HRD+ A NIL+ + +  KI DFGL++   +       
Sbjct: 145 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYV---- 196

Query: 209 RIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLL 262
               T G L     A E +     T  +DV+S+GVL+ EI+S G   G    G     L 
Sbjct: 197 --KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG---GTPYCGMTCAELY 251

Query: 263 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
           E   Q ++ EKP             +E+   M+    C +     RP   Q++  L + +
Sbjct: 252 EKLPQGYRLEKP---------LNCDDEVYDLMRQ---CWREKPYERPSFAQILVSLNRML 299

Query: 323 RLNEEELTAPGLFQDSESSSVGTSDKKSS 351
              +  +    L++    + +  S ++++
Sbjct: 300 EERKTYVNT-TLYEKFTYAGIDCSAEEAA 327

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  133 bits (337), Expect = 3e-36
 Identities = 73/311 (23%), Positives = 133/311 (42%), Gaps = 50/311 (16%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR--------RIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V                  +AVK L  + +++ + + ++E+  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS------ 149
             + +H N++ L+G C Q     ++ EY    +L   L       ++ +++         
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 150 ------DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
                      +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207

Query: 204 THITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM- 257
            +I      T G L     APE +     T ++DV+SFGVL+ EI +    G + +  + 
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL---GGSPYPGIP 264

Query: 258 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 317
            + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ 
Sbjct: 265 VEELFKLLKEGHRMDKP---------ANCTNELYMMMRD---CWHAVPSQRPTFKQLVED 312

Query: 318 LTKNIRLNEEE 328
           L + + L   E
Sbjct: 313 LDRILTLTTNE 323

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  131 bits (332), Expect = 4e-36
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 14/206 (6%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFIT-EIMTLSNVRH 101
           +DF +   +G+G FG VY      +   +A+K L      K GV   +  E+   S++RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN++ L G     TR  L+ EY    ++ R L    +   K + ++ +     +A  L++
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 124

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
            H +    ++HRDIK  N+LL      KI DFG +   P +         GT  YL PE 
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDL--CGTLDYLPPEM 178

Query: 222 VLGGQLTMKADVYSFGVLVLEIISGR 247
           + G     K D++S GVL  E + G+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGK 204

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  134 bits (338), Expect = 4e-36
 Identities = 73/311 (23%), Positives = 133/311 (42%), Gaps = 50/311 (16%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR--------RIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V                  +AVK L  + +++ + + ++E+  +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS------ 149
             + +H N++ L+G C Q     ++ EY    +L   L       ++ +++         
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 150 ------DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
                      +A+G+ +L  +     +HRD+ A N+L+ +    KI DFGLA+    +I
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253

Query: 204 THITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM- 257
            +I      T G L     APE +     T ++DV+SFGVL+ EI +    G + +  + 
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL---GGSPYPGIP 310

Query: 258 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 317
            + L +   + H+ +KP             NE+   M+    C  A  S+RP   Q+++ 
Sbjct: 311 VEELFKLLKEGHRMDKP---------ANCTNELYMMMRD---CWHAVPSQRPTFKQLVED 358

Query: 318 LTKNIRLNEEE 328
           L + + L   E
Sbjct: 359 LDRILTLTTNE 369

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  132 bits (333), Expect = 4e-36
 Identities = 61/299 (20%), Positives = 110/299 (36%), Gaps = 52/299 (17%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHP 102
            DF     +GRGGFG V++     +    A+K   L         + + E+  L+ + HP
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-REKVMREVKALAKLEHP 63

Query: 103 NLVELIGC---------CVQGTRRILVY---EYVENNSLDRVLLGATKANIKLNWEKRSD 150
            +V                  + ++ +Y   +     +L    +       +        
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-WMNGRCTIEERERSVCLH 122

Query: 151 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF----------- 199
           I + IA+ + FLH +    ++HRD+K SNI    +   K+GDFGL               
Sbjct: 123 IFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK 259
           P       T   GT  Y++PE + G   + K D++S G+++ E++           QM +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFSTQMER 233

Query: 260 FLLEWAWQLHQEEKPLELVDPELGEYPPNE--IIRYMKVAFFCTQAAASRRPQMNQVIK 316
                     +  K      P   +  P E  +++ M         +   RP+   +I+
Sbjct: 234 VRT---LTDVRNLKF----PPLFTQKYPCEYVMVQDM------LSPSPMERPEAINIIE 279

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  133 bits (336), Expect = 9e-36
 Identities = 44/217 (20%), Positives = 87/217 (40%), Gaps = 25/217 (11%)

Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNL 104
            + +  +IG GG   V++      +  A+K   L     Q +  +  EI  L+ ++  + 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 105 --VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
             + L    +      +V E   N  L+  L    K    ++  +R      + + +  +
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTI 171

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEY 221
           H+     IVH D+K +N L+      K+ DFG+A     + T +      G   Y+ PE 
Sbjct: 172 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227

Query: 222 VLG-----------GQLTMKADVYSFGVLVLEIISGR 247
           +              +++ K+DV+S G ++  +  G+
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  136 bits (344), Expect = 1e-35
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSAE-SKQGVREFITEIMTLSNVR 100
           +   L   IG G FG V++G   +       +A+K      S     +F+ E +T+    
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HP++V+LIG   +    I + E      L   L         L+          ++  LA
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALA 505

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR----IAGTTGY 216
           +L  +     VHRDI A N+L+      K+GDFGL++   D+  +  ++    I      
Sbjct: 506 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM--- 559

Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIIS 245
            APE +   + T  +DV+ FGV + EI+ 
Sbjct: 560 -APESINFRRFTSASDVWMFGVCMWEILM 587

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  131 bits (331), Expect = 1e-35
 Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 39/232 (16%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR------RIAVKPLSAE-SKQGVREFITEIMTLSN 98
            +  L   +G G FG V K T  + +       +AVK L    S   +R+ ++E   L  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSL------------DRVLLGATKANIKLNWE 146
           V HP++++L G C Q    +L+ EY +  SL              +  G ++ +  L+  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 147 KRS--------DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 198
                           I++G+ +L E     +VHRD+ A NIL+ +    KI DFGL++ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSR- 198

Query: 199 FPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 245
              ++    + +  + G +     A E +     T ++DV+SFGVL+ EI++
Sbjct: 199 ---DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  131 bits (332), Expect = 2e-35
 Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 39/232 (16%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR------RIAVKPLSAE-SKQGVREFITEIMTLSN 98
           ++      IG G FG V++              +AVK L  E S     +F  E   ++ 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL------------LGATKANIKLNWE 146
             +PN+V+L+G C  G    L++EY+    L+  L                    +++  
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 147 KRS--------DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 198
                       I   +A G+A+L E      VHRD+   N L+ +    KI DFGL++ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR- 222

Query: 199 FPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 245
              NI       A     +      PE +   + T ++DV+++GV++ EI S
Sbjct: 223 ---NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  130 bits (328), Expect = 2e-35
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 12/209 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFI-TEI-MTLSNVRHP 102
           DD     ++GRG +G V K     +G+ +AVK + A      ++ +  ++ +++  V  P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
             V   G   +     +  E + + SLD+           +  +    I V I K L  L
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H +L   ++HRD+K SN+L++     K+ DFG++    D++       AG   Y+APE +
Sbjct: 126 HSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--AGCKPYMAPERI 181

Query: 223 LGGQL----TMKADVYSFGVLVLEIISGR 247
                    ++K+D++S G+ ++E+   R
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILR 210

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  130 bits (330), Expect = 2e-35
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 13/210 (6%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFI-TEI-MTLSNVRHP 102
           +D     +IGRG +G+V K     +G+ +AVK + +   +  ++ +  ++ + + +   P
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR-SDICVGIAKGLAF 161
            +V+  G   +     +  E + + S D+           +  E+    I +   K L  
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           L E L   I+HRDIK SNILLD+  N K+ DFG++    D+I    TR AG   Y+APE 
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPER 196

Query: 222 VLGGQL----TMKADVYSFGVLVLEIISGR 247
           +          +++DV+S G+ + E+ +GR
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  130 bits (328), Expect = 3e-35
 Identities = 50/205 (24%), Positives = 81/205 (39%), Gaps = 13/205 (6%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVRE-FITEIMTLSNVRHPN 103
           + L   +GRGG G VY+       R +A+K +S    S    R     E  T   ++ P+
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V +        +  +    +    L  +L    +    L   +   I   I   L   H
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH 151

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYV 222
                   HRD+K  NIL+  +    + DFG+A    D  +T       GT  Y+APE  
Sbjct: 152 AA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERF 207

Query: 223 LGGQLTMKADVYSFGVLVLEIISGR 247
                T +AD+Y+   ++ E ++G 
Sbjct: 208 SESHATYRADIYALTCVLYECLTGS 232

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  130 bits (329), Expect = 4e-35
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQ-GVREFITEIMTLSNVR 100
              F    +IG G FG VY    + N   +A+K    S +      ++ I E+  L  +R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN ++  GC ++     LV EY   ++ D + +        L   + + +  G  +GLA
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLA 168

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLA 218
           +LH     +++HRD+KA NILL +    K+GDFG A       + +       GT  ++A
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFVGTPYWMA 218

Query: 219 PEYVLGGQLT---MKADVYSFGVLVLEIISG 246
           PE +L         K DV+S G+  +E+   
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  132 bits (333), Expect = 5e-35
 Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 21/211 (9%)

Query: 47  DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGV-REFITEIMTLSNVRHPNLV 105
            F   + +G G  GT+    + + R +AVK +  E      RE   +++  S+  HPN++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE--VQLLRESD-EHPNVI 81

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
                      + +  E       + V     + +      +   +      GLA LH  
Sbjct: 82  RYFCTEKDRQFQYIAIELCAATLQEYVE----QKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 166 LVPHIVHRDIKASNILL-----DQEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLA 218
              +IVHRD+K  NIL+       +    I DFGL K         + R  + GT G++A
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 219 PEYVLG---GQLTMKADVYSFGVLVLEIISG 246
           PE +        T   D++S G +   +IS 
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  128 bits (325), Expect = 5e-35
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 14/206 (6%)

Query: 46  DDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAE--SKQGVREFI-TEIMTLSNVRH 101
           DDF +   +G+G FG VY      N   +A+K L      K+GV   +  EI   S++RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN++ +        R  L+ E+     L + L    + + + + ++ +     +A  L +
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHY 129

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
            HE     ++HRDIK  N+L+  +   KI DFG +   P      T    GT  YL PE 
Sbjct: 130 CHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPPEM 183

Query: 222 VLGGQLTMKADVYSFGVLVLEIISGR 247
           + G     K D++  GVL  E + G 
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  130 bits (328), Expect = 7e-35
 Identities = 50/313 (15%), Positives = 99/313 (31%), Gaps = 30/313 (9%)

Query: 39  TELRSATDDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGVREFITE 92
           TE +  +   ++ + +G G F  VY+ T        N ++  +K     +          
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDI 151
           +  L        ++     +     +LV E     +L + + L        +        
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-----------KIGDFGLA---K 197
            + +   +  +H+     I+H DIK  N +L   F              + D G +   K
Sbjct: 178 AMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR----NSGKAM 253
           LFP      T +   T+G+   E +       + D +     V  ++ G      +    
Sbjct: 235 LFPKGTI-FTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292

Query: 254 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQ 313
                 F       +  E   + L  P+    P  +++R      F        R   N+
Sbjct: 293 CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNR 352

Query: 314 VIKMLTKNIRLNE 326
           +I +L +  R  +
Sbjct: 353 LIVLLLECKRSRK 365

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  129 bits (327), Expect = 7e-35
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 18/209 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAES--KQGVRE-FITEIMTLSNVRH 101
             +     +G+GGF   ++ +        A K +      K   RE    EI    ++ H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN-WEKRSDICVGIAKGLA 160
            ++V   G         +V E     SL  +     K    L   E R      I  G  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARY-YLRQIVLGCQ 155

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAP 219
           +LH      ++HRD+K  N+ L+++   KIGDFGLA K+  D        + GT  Y+AP
Sbjct: 156 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAP 210

Query: 220 EYVLGGQL-TMKADVYSFGVLVLEIISGR 247
           E VL  +  + + DV+S G ++  ++ G+
Sbjct: 211 E-VLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  128 bits (324), Expect = 8e-35
 Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 16/208 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAES--KQGVRE-FITEIMTLSNVRH 101
             +     +G+GGF   ++ +        A K +      K   RE    EI    ++ H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
            ++V   G         +V E     SL  +     K    L   +       I  G  +
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQY 130

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPE 220
           LH      ++HRD+K  N+ L+++   KIGDFGLA K+  D        + GT  Y+APE
Sbjct: 131 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPE 185

Query: 221 YVLGGQL-TMKADVYSFGVLVLEIISGR 247
            VL  +  + + DV+S G ++  ++ G+
Sbjct: 186 -VLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  129 bits (326), Expect = 1e-34
 Identities = 45/254 (17%), Positives = 94/254 (37%), Gaps = 34/254 (13%)

Query: 22  PQGVDGELLRNVNHFSYTELRSAT-----DDFHLSNKIGRGGFGTVY------------- 63
           P G   ++L N ++  Y            +D+ +   + +G F  +              
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKK 61

Query: 64  --KGTLTNGRRIAVKPLSAESKQGVREFI-TEIMTLSNVRHPNLVELIGCCVQGTRRILV 120
             K  L   R          S +   +    E+  ++++++   +   G         ++
Sbjct: 62  YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYII 121

Query: 121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICV----GIAKGLAFLHEELVPHIVHRDIK 176
           YEY+EN+S+ +        +          +       +    +++H E   +I HRD+K
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVK 179

Query: 177 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM---KADV 233
            SNIL+D+    K+ DFG ++   D      +   GT  ++ PE     + +    K D+
Sbjct: 180 PSNILMDKNGRVKLSDFGESEYMVDKKIK-GS--RGTYEFMPPE-FFSNESSYNGAKVDI 235

Query: 234 YSFGVLVLEIISGR 247
           +S G+ +  +    
Sbjct: 236 WSLGICLYVMFYNV 249

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  129 bits (327), Expect = 2e-34
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 34/227 (14%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN--------GRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V                 ++AVK L ++ +++ + + I+E+  +
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSL------------DRVLLGATKANIKL 143
             + +H N++ L+G C Q     ++ EY    +L            +     +     +L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 144 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
           + +        +A+G+ +L  +     +HRD+ A N+L+ ++   KI DFGLA+    +I
Sbjct: 189 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 241

Query: 204 THITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 245
            HI      T G L     APE +     T ++DV+SFGVL+ EI +
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  132 bits (334), Expect = 2e-34
 Identities = 75/332 (22%), Positives = 118/332 (35%), Gaps = 28/332 (8%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHP 102
              + +  ++G GGFG V +      G ++A+K    E     RE    EI  +  + HP
Sbjct: 13  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72

Query: 103 NLVELI------GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           N+V                  +L  EY E   L R  L   +    L       +   I+
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDL-RKYLNQFENCCGLKEGPIRTLLSDIS 131

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGT 213
             L +LHE     I+HRD+K  NI+L         KI D G AK         T  + GT
Sbjct: 132 SALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GT 186

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK 273
             YLAPE +   + T+  D +SFG L  E I+G       W  +         Q H + +
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV---------QWHGKVR 237

Query: 274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI--RLNEEELTA 331
                   + +     +     +      +          +  ML  +   R  + +   
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297

Query: 332 PGLFQDSESSSVGTSDKKSSDSTLQMSSVPVT 363
            G FQ  +S          +  + ++ + PVT
Sbjct: 298 VGCFQALDSILSLKLLSVMNMVSGRVHTYPVT 329

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  126 bits (320), Expect = 3e-34
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 15/208 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAES--KQGVREFIT-EIMTLSNVRH 101
           +DF + N +G+G F  VY+   +  G  +A+K +  ++  K G+ + +  E+     ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P+++EL           LV E   N  ++R L    K     +  +       I  G+ +
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLY 127

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPE 220
           LH      I+HRD+  SN+LL +  N KI DFGLA +L   +  H T  + GT  Y++PE
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPE 182

Query: 221 YVLGGQL-TMKADVYSFGVLVLEIISGR 247
            +       +++DV+S G +   ++ GR
Sbjct: 183 -IATRSAHGLESDVWSLGCMFYTLLIGR 209

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  127 bits (321), Expect = 3e-34
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 14/213 (6%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPN 103
           DD+ L   IG G    V          ++A+K ++ E  Q  + E + EI  +S   HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----ANIKLNWEKRSDICVGIAKGL 159
           +V      V      LV + +   S+  ++          +  L+    + I   + +GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHITTR---IAGTTG 215
            +LH+      +HRD+KA NILL ++ + +I DFG+ A L                GT  
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 216 YLAPEYVL-GGQLTMKADVYSFGVLVLEIISGR 247
           ++APE +        KAD++SFG+  +E+ +G 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  128 bits (323), Expect = 3e-34
 Identities = 74/319 (23%), Positives = 122/319 (38%), Gaps = 58/319 (18%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGR------RIAVKPLSAE-SKQGVREFITEIMTLSN 98
           ++      +G G FG V   T           ++AVK L  +         ++E+  ++ 
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSL-------------------DRVLLGATK 138
           +  H N+V L+G C       L++EY     L                   ++  L   +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 139 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 198
               L +E        +AKG+ FL  +     VHRD+ A N+L+      KI DFGLA+ 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLAR- 220

Query: 199 FPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRN--SG 250
              +I   +  +      L     APE +  G  T+K+DV+S+G+L+ EI S G N   G
Sbjct: 221 ---DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

Query: 251 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ 310
             +     K +        + ++P          Y   EI   M+    C    + +RP 
Sbjct: 278 IPVDANFYKLIQNG----FKMDQP---------FYATEEIYIIMQS---CWAFDSRKRPS 321

Query: 311 MNQVIKMLTKNIRLNEEEL 329
              +   L   +   EE +
Sbjct: 322 FPNLTSFLGCQLADAEEAM 340

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  128 bits (323), Expect = 7e-34
 Identities = 47/217 (21%), Positives = 79/217 (36%), Gaps = 20/217 (9%)

Query: 45  TDDFHLSNKIGRG--GFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNV 99
              + L   IG+G     TV        G  + V+   L A S + V     E+      
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            HPN+V      +      +V  ++   S  + L+     +  +N    + I  G+ K L
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMD-GMNELAIAYILQGVLKAL 141

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI------AGT 213
            ++H       VHR +KAS+IL+  +    +           +                 
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 214 TGYLAPEYVLGGQL---TMKADVYSFGVLVLEIISGR 247
             +L+PE VL   L     K+D+YS G+   E+ +G 
Sbjct: 199 LPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGH 234

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  130 bits (329), Expect = 1e-33
 Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 24/208 (11%)

Query: 48  FHLSNKIGRGGFGTVYKG--TLTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNL 104
           + +   I  GG G +Y       NGR + +K L        +   + E   L+ V HP++
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141

Query: 105 VEL--IGCCVQGTRRILVY---EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           V++             + Y   EYV   SL R          KL   +     + I   L
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPAL 195

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           ++LH      +V+ D+K  NI+L +E   K+ D G        I      + GT G+ AP
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS----RINS-FGYLYGTPGFQAP 246

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGR 247
           E V  G  T+  D+Y+ G  +  +    
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDL 273

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  125 bits (317), Expect = 1e-33
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 20/229 (8%)

Query: 31  RNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREF 89
           R+++    + LR     F L   +G G +G VYKG  +  G+  A+K +         E 
Sbjct: 9   RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEI 67

Query: 90  ITEIMTLSNV-RHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIK 142
             EI  L     H N+    G  ++           LV E+    S+   L+  TK N  
Sbjct: 68  KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGN-T 125

Query: 143 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN 202
           L  E  + IC  I +GL+ LH+     ++HRDIK  N+LL +    K+ DFG++      
Sbjct: 126 LKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182

Query: 203 ITHITTRIAGTTGYLAPEYVLGGQLT-----MKADVYSFGVLVLEIISG 246
           +    T I GT  ++APE +   +        K+D++S G+  +E+  G
Sbjct: 183 VGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  125 bits (315), Expect = 1e-33
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHP 102
            D F    K+G G FG V+     ++G    +K ++   S+  + +   EI  L ++ HP
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N++++           +V E  E   L +R++    +    L+    +++   +   LA+
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMNALAY 139

Query: 162 LHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
            H +   H+VH+D+K  NIL          KI DFGLA+LF  +    +T  AGT  Y+A
Sbjct: 140 FHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMA 194

Query: 219 PEYVLGGQLTMKADVYSFGV 238
           PE V    +T K D++S GV
Sbjct: 195 PE-VFKRDVTFKCDIWSAGV 213

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (316), Expect = 2e-33
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 22/221 (9%)

Query: 43  SATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVR 100
           ++   + LS+ +G+G    V++G     G   A+K  +  S     +    E   L  + 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 101 HPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           H N+V+L     + T R  +L+ E+    SL  VL         L   +   +   +  G
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGG 124

Query: 159 LAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
           +  L E     IVHR+IK  NI+     D +   K+ DFG A+   D+     +   GT 
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTE 179

Query: 215 GYLAPEYVLGGQLTM--------KADVYSFGVLVLEIISGR 247
            YL P+      L            D++S GV      +G 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  128 bits (323), Expect = 3e-33
 Identities = 60/243 (24%), Positives = 105/243 (43%), Gaps = 18/243 (7%)

Query: 12  HSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNG 70
           H    +         G+L      F  ++    ++ +    K+G G +G V         
Sbjct: 3   HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62

Query: 71  RRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 128
              A+K    ++ S     + + E+  L  + HPN+++L           LV E  +   
Sbjct: 63  VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122

Query: 129 L-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQ 184
           L D ++       +K N    + I   +  G+ +LH+    +IVHRD+K  N+LL   ++
Sbjct: 123 LFDEII-----HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEK 174

Query: 185 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 244
           +   KI DFGL+ +F +          GT  Y+APE VL  +   K DV+S GV++  ++
Sbjct: 175 DALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILL 231

Query: 245 SGR 247
           +G 
Sbjct: 232 AGY 234

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  124 bits (312), Expect = 1e-32
 Identities = 25/244 (10%), Positives = 53/244 (21%), Gaps = 43/244 (17%)

Query: 39  TELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK---PLSAESKQGVREFITEIM 94
           + L        L   +  G    V+    +      A+K     +  S+  +        
Sbjct: 55  SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATF 114

Query: 95  TLSNVRHPNLVELIGCC----------VQGTRRI----------------LVYEYVENN- 127
             + +   +  E               VQ                     L+      + 
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174

Query: 128 -SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 186
             L   L                 +   + +  A L  +    +VH      N+ +  + 
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDG 231

Query: 187 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ---LTMKADVYSFGVLVLEI 243
              +GD                  +      AP   L       T   + +  G+ +  +
Sbjct: 232 RLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286

Query: 244 ISGR 247
               
Sbjct: 287 WCLF 290

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  121 bits (307), Expect = 2e-32
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRH 101
            + +++   +G+G FG V K       +  AVK    ++   +     + E+  L  + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           PN+++L       +   +V E      L D ++        + +    + I   +  G+ 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGIT 135

Query: 161 FLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 217
           ++H+    +IVHRD+K  NILL   +++ + KI DFGL+  F  N         GT  Y+
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYI 190

Query: 218 APEYVLGGQLTMKADVYSFGV 238
           APE VL G    K DV+S GV
Sbjct: 191 APE-VLRGTYDEKCDVWSAGV 210

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  124 bits (312), Expect = 2e-32
 Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 24/222 (10%)

Query: 43  SATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVR 100
           ++   + LS+ +G+G    V++G     G   A+K  +  S     +    E   L  + 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 101 HPNLVELIGCCVQGTRR--ILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 157
           H N+V+L     + T R  +L+ E+    SL     L        L   +   +   +  
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTV--LEEPSNAYGLPESEFLIVLRDVVG 123

Query: 158 GLAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
           G+  L E     IVHR+IK  NI+     D +   K+ DFG A+   D+     +   GT
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GT 178

Query: 214 TGYLAPEYVLGGQLTM--------KADVYSFGVLVLEIISGR 247
             YL P+      L            D++S GV      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  121 bits (306), Expect = 3e-32
 Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 16/199 (8%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
              + L N IGRG +G V          R A K +     + V  F  EI  + ++ HPN
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 104 LVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           ++ L       T   LV E      L +RV+               + I   +   +A+ 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVV-----HKRVFRESDAARIMKDVLSAVAYC 122

Query: 163 HEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           H+    ++ HRD+K  N L      +   K+ DFGLA  F      +     GT  Y++P
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSP 177

Query: 220 EYVLGGQLTMKADVYSFGV 238
           + VL G    + D +S GV
Sbjct: 178 Q-VLEGLYGPECDEWSAGV 195

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  125 bits (315), Expect = 4e-32
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 19/211 (9%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS---AESKQGVREFITEIMTLSNVR 100
           +D +     +G+G FG V        G+  AVK +S    + K      + E+  L  + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           HPN+++L           LV E      L D ++     +  + +    + I   +  G+
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAARIIRQVLSGI 139

Query: 160 AFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
            ++H+     IVHRD+K  N+LL    ++ N +I DFGL+  F  +         GT  Y
Sbjct: 140 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYY 194

Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           +APE VL G    K DV+S GV++  ++SG 
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  122 bits (307), Expect = 4e-32
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 16/210 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFIT-EIMTL-SNVRHP 102
           +D     ++G G  G V+K      G  IAVK +     +   + I  ++  +  +   P
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
            +V+  G  +  T   +  E +     +++     +    +       + V I K L +L
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYL 140

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE-- 220
            E+    ++HRD+K SNILLD+    K+ DFG++    D+      R AG   Y+APE  
Sbjct: 141 KEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERI 196

Query: 221 ---YVLGGQLTMKADVYSFGVLVLEIISGR 247
                      ++ADV+S G+ ++E+ +G+
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  124 bits (312), Expect = 9e-32
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 20/221 (9%)

Query: 34  NHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFI 90
            +  +    +  + +++   +G+G FG V K       +  AVK    ++   +     +
Sbjct: 12  ENLYFQG--TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69

Query: 91  TEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRS 149
            E+  L  + HPN+++L       +   +V E      L D ++        + +    +
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAA 124

Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHI 206
            I   +  G+ ++H+    +IVHRD+K  NILL   +++ + KI DFGL+  F  N    
Sbjct: 125 RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TK 179

Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
                GT  Y+APE VL G    K DV+S GV++  ++SG 
Sbjct: 180 MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  119 bits (301), Expect = 2e-31
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 30/213 (14%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--------PLSAESKQGVREFI-TEIM 94
            +++     +GRG    V +       +  AVK          SAE  Q +RE    E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 95  TLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDIC 152
            L  V  HPN+++L       T   LV++ ++   L D +        + L+ ++   I 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIM 130

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 212
             + + +  LH+    +IVHRD+K  NILLD + N K+ DFG +             + G
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCG 185

Query: 213 TTGYLAPEYVLGGQLTM-------KADVYSFGV 238
           T  YLAPE ++   +         + D++S GV
Sbjct: 186 TPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGV 217

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  123 bits (310), Expect = 2e-31
 Identities = 62/254 (24%), Positives = 101/254 (39%), Gaps = 29/254 (11%)

Query: 12  HSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNG 70
           H                +  N   +   +     + +    K+G G +G V         
Sbjct: 2   HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61

Query: 71  RRIAVK-------------PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR 117
              A+K               +   ++   E   EI  L ++ HPN+++L          
Sbjct: 62  SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121

Query: 118 ILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 176
            LV E+ E   L ++++        K +    ++I   I  G+ +LH+    +IVHRDIK
Sbjct: 122 YLVTEFYEGGELFEQII-----NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIK 173

Query: 177 ASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADV 233
             NILL   +   N KI DFGL+  F  +  +      GT  Y+APE VL  +   K DV
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPE-VLKKKYNEKCDV 230

Query: 234 YSFGVLVLEIISGR 247
           +S GV++  ++ G 
Sbjct: 231 WSCGVIMYILLCGY 244

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  119 bits (300), Expect = 2e-31
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 25/205 (12%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK-----PLSAESKQGVREFITEIMTLSN 98
           +D++ +  ++G+G F  V +    T G   A K      LSA   Q +     E      
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 61

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 157
           ++HPN+V L     + +   LV++ V    L + ++     A    +    S     I +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-----AREFYSEADASHCIQQILE 116

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 214
            +A+ H      IVHR++K  N+LL  +      K+ DFGLA    D+        AGT 
Sbjct: 117 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTP 171

Query: 215 GYLAPEYVLGGQL-TMKADVYSFGV 238
           GYL+PE VL     +   D+++ GV
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGV 195

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  121 bits (304), Expect = 6e-31
 Identities = 58/227 (25%), Positives = 87/227 (38%), Gaps = 32/227 (14%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGV-REFITEIMTLSNVRHPNL 104
           +       +G G  GTV       GR +AVK +  +       E   +++T S   HPN+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME--IKLLTES-DDHPNV 71

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLL-GATKANIKLNWEKR-SDICVGIAKGLAFL 162
           +             +  E    N  D V     +  N+KL  E     +   IA G+A L
Sbjct: 72  IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 163 HEELVPHIVHRDIKASNILLD-------------QEFNPKIGDFGLAKLFPDNITHITTR 209
           H      I+HRD+K  NIL+              +     I DFGL K      +   T 
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 210 ---IAGTTGYLAPEYVLGG-------QLTMKADVYSFGVLVLEIISG 246
               +GT+G+ APE +          +LT   D++S G +   I+S 
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  118 bits (298), Expect = 2e-30
 Identities = 62/254 (24%), Positives = 102/254 (40%), Gaps = 33/254 (12%)

Query: 7   GGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFH----LSNKIGRGGFGTV 62
             +     K      P+G +    +++         +A  +F+      + IGRG    V
Sbjct: 51  SANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVV 110

Query: 63  YKGT-LTNGRRIAVK-------PLSAESKQGVREFI-TEIMTLSNVR-HPNLVELIGCCV 112
            +      G   AVK        LS E  + VRE    E   L  V  HP+++ LI    
Sbjct: 111 RRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170

Query: 113 QGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 171
             +   LV++ +    L D +        + L+ ++   I   + + ++FLH     +IV
Sbjct: 171 SSSFMFLVFDLMRKGELFDYLT-----EKVALSEKETRSIMRSLLEAVSFLHAN---NIV 222

Query: 172 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM-- 229
           HRD+K  NILLD     ++ DFG +             + GT GYLAPE +L   +    
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPE-ILKCSMDETH 279

Query: 230 -----KADVYSFGV 238
                + D+++ GV
Sbjct: 280 PGYGKEVDLWACGV 293

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  118 bits (298), Expect = 2e-30
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 15/205 (7%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK-----PLSAESKQGVREFITEIMTLSN 98
            D + L   IG+G F  V +      G++ AVK       ++       +   E      
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 157
           ++HP++VEL+          +V+E+++   L   ++     A    +    S     I +
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASHYMRQILE 141

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 214
            L + H+    +I+HRD+K   +LL  + N    K+G FG+A    ++      R+ GT 
Sbjct: 142 ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTP 197

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVL 239
            ++APE V         DV+  GV+
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVI 222

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  117 bits (295), Expect = 2e-30
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 17/212 (8%)

Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES-KQGV-REFITEIMTLSNV 99
           +   + +    K+G G +G VYK   + GR +A+K +  ++  +G+    I EI  L  +
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDICVGIA 156
            HPN+V LI          LV+E++E      LD    G   + IK+           + 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI-------YLYQLL 129

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
           +G+A  H+     I+HRD+K  N+L++ +   K+ DFGLA+ F   +   T  +  T  Y
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWY 185

Query: 217 LAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
            AP+ ++G +  +   D++S G +  E+I+G+
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  119 bits (299), Expect = 2e-30
 Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 13/199 (6%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
            D + +  ++G G FG V++      GR    K ++            EI  ++ + HP 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 104 LVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           L+ L          +L+ E++    L DR+       + K++  +  +      +GL  +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 163 HEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           HE     IVH DIK  NI+ + +     KI DFGLA     +   I      T  + APE
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPE 220

Query: 221 YVLGGQLTMKADVYSFGVL 239
            V    +    D+++ GVL
Sbjct: 221 IVDREPVGFYTDMWAIGVL 239

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  116 bits (294), Expect = 3e-30
 Identities = 42/201 (20%), Positives = 84/201 (41%), Gaps = 18/201 (8%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRH 101
            + + ++  +GRG FG V++    ++ +    K   +    +  V+    EI  L+  RH
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARH 60

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
            N++ L          ++++E++    + +R+      +  +LN  +       + + L 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERIN----TSAFELNEREIVSYVHQVCEALQ 116

Query: 161 FLHEELVPHIVHRDIKASNILL-DQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
           FLH     +I H DI+  NI+   +  +  KI +FG A+            +     Y A
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYA 171

Query: 219 PEYVLGGQLTMKADVYSFGVL 239
           PE      ++   D++S G L
Sbjct: 172 PEVHQHDVVSTATDMWSLGTL 192

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  117 bits (294), Expect = 4e-30
 Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 20/202 (9%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
           TD + +   IG G +    +          AVK +    +    E   EI+ L   +HPN
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEIL-LRYGQHPN 77

Query: 104 LVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           ++ L      G    +V E ++   L D++L          +  + S +   I K + +L
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKIL-----RQKFFSEREASAVLFTITKTVEYL 132

Query: 163 HEELVPHIVHRDIKASNILL-DQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
           H +    +VHRD+K SNIL  D+  NP   +I DFG AK        + T    T  ++A
Sbjct: 133 HAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVA 188

Query: 219 PEYVLGGQL-TMKADVYSFGVL 239
           PE VL  Q      D++S GVL
Sbjct: 189 PE-VLERQGYDAACDIWSLGVL 209

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  117 bits (294), Expect = 4e-30
 Identities = 63/267 (23%), Positives = 94/267 (35%), Gaps = 54/267 (20%)

Query: 31  RNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK-----PLSAESKQ 84
           R   +F    L      +HL   IG+G +G V            A+K      +   + +
Sbjct: 11  RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70

Query: 85  GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKL 143
            V    TE+  +  + HPN+  L           LV E      L D++ +    +  K 
Sbjct: 71  DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKC 130

Query: 144 NWEKR-----------------------------------SDICVGIAKGLAFLHEELVP 168
             +                                     S+I   I   L +LH +   
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--- 187

Query: 169 HIVHRDIKASNILL--DQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYLAPEYVL 223
            I HRDIK  N L   ++ F  K+ DFGL+K F        +  T  AGT  ++APE VL
Sbjct: 188 GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VL 246

Query: 224 GGQL---TMKADVYSFGVLVLEIISGR 247
                    K D +S GVL+  ++ G 
Sbjct: 247 NTTNESYGPKCDAWSAGVLLHLLLMGA 273

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  116 bits (292), Expect = 5e-30
 Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 16/199 (8%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
              F     +G G F  V+       G+  A+K +             EI  L  ++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 104 LVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           +V L       T   LV + V    L DR+L            +  S +   +   + +L
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRIL-----ERGVYTEKDASLVIQQVLSAVKYL 122

Query: 163 HEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           HE     IVHRD+K  N+L    ++     I DFGL+K+  + I    +   GT GY+AP
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAP 176

Query: 220 EYVLGGQLTMKADVYSFGV 238
           E +     +   D +S GV
Sbjct: 177 EVLAQKPYSKAVDCWSIGV 195

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  116 bits (292), Expect = 6e-30
 Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 22/207 (10%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK-----PLSAESKQGVREFI-TEIMTLS 97
            D + +  ++G G F  V K    + G   A K        A  +   RE I  E+  L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIA 156
            V H N++ L       T  +L+ E V    L D +          L+ E+ +     I 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA-----QKESLSEEEATSFIKQIL 125

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAG 212
            G+ +LH +    I H D+K  NI+L  +  P    K+ DFGLA    D        I G
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFG 180

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVL 239
           T  ++APE V    L ++AD++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  119 bits (300), Expect = 6e-30
 Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 13/200 (6%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
            D + +  ++G G FG V++ T    G   A K +    +        EI T+S +RHP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 104 LVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           LV L          +++YE++    L ++V       + K++ ++  +    + KGL  +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVA----DEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 163 HEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           HE    + VH D+K  NI+   + +   K+ DFGL                GT  + APE
Sbjct: 272 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPE 326

Query: 221 YVLGGQLTMKADVYSFGVLV 240
              G  +    D++S GVL 
Sbjct: 327 VAEGKPVGYYTDMWSVGVLS 346

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  114 bits (289), Expect = 7e-30
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 22/207 (10%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK------PLSAESKQGVREFITEIMTLS 97
            D + +  ++G G F  V K      G+  A K        S+       E   E+  L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIA 156
            +RHPN++ L       T  +L+ E V    L D +          L  ++ +     I 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA-----EKESLTEDEATQFLKQIL 118

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAG 212
            G+ +LH +    I H D+K  NI+L  +  P    K+ DFG+A        +    I G
Sbjct: 119 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFG 173

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVL 239
           T  ++APE V    L ++AD++S GV+
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVI 200

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  115 bits (291), Expect = 8e-30
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 17/208 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGV-REFITEIMTLSNVRHPN 103
           + +   +K+G G + TVYKG        +A+K +  E ++G     I E+  L +++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 104 LVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           +V L           LV+EY++      LD         N+KL           + +GLA
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL-------FLFQLLRGLA 114

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           + H      ++HRD+K  N+L+++    K+ DFGLA+            +  T  Y  P+
Sbjct: 115 YCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPD 170

Query: 221 YVLGGQL-TMKADVYSFGVLVLEIISGR 247
            +LG    + + D++  G +  E+ +GR
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  116 bits (292), Expect = 1e-29
 Identities = 53/197 (26%), Positives = 84/197 (42%), Gaps = 13/197 (6%)

Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
               +  +G G FG V+K      G ++A K +     +   E   EI  ++ + H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 106 ELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           +L          +LV EYV+   L DR+       +  L           I +G+  +H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRI----IDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 165 ELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
               +I+H D+K  NIL         KI DFGLA+ +            GT  +LAPE V
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVV 260

Query: 223 LGGQLTMKADVYSFGVL 239
               ++   D++S GV+
Sbjct: 261 NYDFVSFPTDMWSVGVI 277

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  116 bits (293), Expect = 2e-29
 Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 29/213 (13%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--------PLSAESKQGVREFITEIMT 95
            D++ +S  +G G  G V         +++A++          SA          TEI  
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVG 154
           L  + HP ++++           +V E +E   L D+V+      N +L           
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQ 247

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIA 211
           +   + +LHE     I+HRD+K  N+LL   +++   KI DFG +K+  +    +   + 
Sbjct: 248 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLC 302

Query: 212 GTTGYLAPEYVLGGQL----TMKADVYSFGVLV 240
           GT  YLAPE VL            D +S GV++
Sbjct: 303 GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVIL 334

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  115 bits (290), Expect = 2e-29
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 23/204 (11%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK-----PLSAESKQGVREFITEIMTLSN 98
           +D++ +  ++G+G F  V +    T G   A K      LSA   Q +     E      
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 84

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 157
           ++HPN+V L     + +   LV++ V    L + ++     A    +    S     I +
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-----AREFYSEADASHCIQQILE 139

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTT 214
            +A+ H      IVHR++K  N+LL  +      K+ DFGLA    D+        AGT 
Sbjct: 140 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTP 194

Query: 215 GYLAPEYVLGGQLTMKADVYSFGV 238
           GYL+PE +     +   D+++ GV
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGV 218

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  113 bits (286), Expect = 2e-29
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 17/208 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES-KQGV-REFITEIMTLSNVRHPN 103
           + +H   KIG G +G VYK     G   A+K +  E   +G+    I EI  L  ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 104 LVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           +V+L        R +LV+E+++      LD    G      K          + +  G+A
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS-------FLLQLLNGIA 114

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           + H+     ++HRD+K  N+L+++E   KI DFGLA+ F   +   T  I  T  Y AP+
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170

Query: 221 YVLGGQL-TMKADVYSFGVLVLEIISGR 247
            ++G +  +   D++S G +  E+++G 
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  114 bits (288), Expect = 2e-29
 Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 31/212 (14%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--------PLSAESKQGVREFITEIMT 95
            D++ +S  +G G  G V         +++A+K          SA          TEI  
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 96  LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICV 153
           L  + HP ++++            +V E +E   L D+V       N +L          
Sbjct: 69  LKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKV-----VGNKRLKEATCKLYFY 121

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRI 210
            +   + +LHE     I+HRD+K  N+LL   +++   KI DFG +K+  +    +   +
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTL 176

Query: 211 AGTTGYLAPEYVLGGQL----TMKADVYSFGV 238
            GT  YLAPE VL            D +S GV
Sbjct: 177 CGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGV 207

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  114 bits (287), Expect = 3e-29
 Identities = 65/213 (30%), Positives = 114/213 (53%), Gaps = 16/213 (7%)

Query: 43  SATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT---EIMTLSN 98
           S++  F    K+G G + TVYKG   T G  +A+K +  +S++G     T   EI  +  
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKE 59

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDICVGI 155
           ++H N+V L        +  LV+E+++N     +D   +G T   ++LN  K       +
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY--FQWQL 117

Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
            +GLAF HE     I+HRD+K  N+L+++    K+GDFGLA+ F   +   ++ +  T  
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLW 173

Query: 216 YLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
           Y AP+ ++G +  +   D++S G ++ E+I+G+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  114 bits (288), Expect = 3e-29
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 24/212 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFIT---EIMTLSNV 99
           + +     +G G +G V K      GR +A+K    S +  + V+       EI  L  +
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVK--KIAMREIKLLKQL 81

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIA 156
           RH NLV L+  C +  R  LV+E+V++     L+    G     ++            I 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQK-------YLFQII 134

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
            G+ F H     +I+HRDIK  NIL+ Q    K+ DFG A+            +A T  Y
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWY 190

Query: 217 LAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 247
            APE ++G  +     DV++ G LV E+  G 
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (290), Expect = 3e-29
 Identities = 31/232 (13%), Positives = 71/232 (30%), Gaps = 41/232 (17%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVK------PLSAESKQGVREFITEIMTLSNVRHPN--- 103
           +G+       + T    G    V          + + + ++E +  +  L  +++     
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 104 -----LVELIGCCVQGTRRI----------------LVYEYVENNSLDRV--LLGATKAN 140
                +           +++                 +Y  +++N       LL  +  +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 141 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 200
             L    R  + + + + LA LH      +VH  ++  +I+LDQ     +  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 201 DNITHITTRIAGTTGYLAPEYVLGGQ-----LTMKADVYSFGVLVLEIISGR 247
            +      R        A   +  GQ     +T   D ++ G+ +  I    
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  115 bits (289), Expect = 3e-29
 Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 22/207 (10%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK-----PLSAESKQGVREFI-TEIMTLS 97
            D + +  ++G G F  V K    + G   A K        A  +   RE I  E+  L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIA 156
            V HPN++ L       T  +L+ E V    L D +          L+ E+ +     I 
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA-----QKESLSEEEATSFIKQIL 125

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAG 212
            G+ +LH +    I H D+K  NI+L  +  P    K+ DFGLA    D        I G
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFG 180

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVL 239
           T  ++APE V    L ++AD++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  113 bits (285), Expect = 4e-29
 Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 18/209 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAES-KQGV-REFITEIMTLSNVRHP 102
             +    KIG G +GTV+K         +A+K +  +   +GV    + EI  L  ++H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 103 NLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
           N+V L        +  LV+E+ +       D          +K            + KGL
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS-------FLFQLLKGL 114

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
            F H     +++HRD+K  N+L+++    K+ +FGLA+ F   +   +  +  T  Y  P
Sbjct: 115 GFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPP 170

Query: 220 EYVLGGQL-TMKADVYSFGVLVLEIISGR 247
           + + G +L +   D++S G +  E+ +  
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAG 199

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  113 bits (285), Expect = 6e-29
 Identities = 57/207 (27%), Positives = 86/207 (41%), Gaps = 22/207 (10%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK------PLSAESKQGVREFITEIMTLS 97
            D +    ++G G F  V K    + G + A K        S+       +   E+  L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 98  NVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIA 156
            ++HPN++ L       T  IL+ E V    L D +          L  E+ ++    I 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA-----EKESLTEEEATEFLKQIL 124

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAG 212
            G+ +LH      I H D+K  NI+L     P    KI DFGLA        +    I G
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFG 179

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVL 239
           T  ++APE V    L ++AD++S GV+
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVI 206

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  113 bits (285), Expect = 7e-29
 Identities = 49/251 (19%), Positives = 95/251 (37%), Gaps = 27/251 (10%)

Query: 21  APQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS 79
            P  + G   R+ + F    +        +   +  GGF  VY+   + +GR  A+K L 
Sbjct: 3   GPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL 62

Query: 80  AESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRR--------ILVYEYVENNSLD 130
           +  ++  R  I E+  +  +  HPN+V+       G           +L+ E  +   ++
Sbjct: 63  SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE 122

Query: 131 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI 190
              L   ++   L+ +    I     + +  +H    P I+HRD+K  N+LL  +   K+
Sbjct: 123 --FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKL 179

Query: 191 GDFGLAKLFPDNITHITTRIA-----------GTTGYLAPEYV---LGGQLTMKADVYSF 236
            DFG A        +  +               T  Y  PE +       +  K D+++ 
Sbjct: 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL 239

Query: 237 GVLVLEIISGR 247
           G ++  +   +
Sbjct: 240 GCILYLLCFRQ 250

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  113 bits (286), Expect = 7e-29
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 30/210 (14%)

Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK----PLSAESKQGVREFIT--- 91
           +++S    +   + +G G F TVYK       + +A+K       +E+K G+    T   
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALR 61

Query: 92  EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKR 148
           EI  L  + HPN++ L+      +   LV++++E      +    L  T ++IK      
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA----- 116

Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
               +   +GL +LH+     I+HRD+K +N+LLD+    K+ DFGLAK F       T 
Sbjct: 117 --YMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171

Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGV 238
           ++  T  Y APE + G      A +Y  GV
Sbjct: 172 QVV-TRWYRAPELLFG------ARMYGVGV 194

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  113 bits (285), Expect = 9e-29
 Identities = 37/238 (15%), Positives = 74/238 (31%), Gaps = 52/238 (21%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVK-------PLSAESKQGVRE----------------- 88
           +G+       + T    G    V        P S   KQ   E                 
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 89  ----FITEIMTLSNVRHPNLVELIGCC--VQGTRRILVYEYVENNSLDRV--LLGATKAN 140
               FI     + + +   ++ +      +    R  +Y  +++N       LL  +  +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 141 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 200
             L    R  + + + + LA LH      +VH  ++  +I+LDQ     +  F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 255

Query: 201 DNITHITTRIAGTTGYLAPEYVL-----------GGQLTMKADVYSFGVLVLEIISGR 247
           D    +++    + G+  PE                 +T   D ++ G+++  I    
Sbjct: 256 DGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  112 bits (282), Expect = 1e-28
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFIT---EIMTLSNV 99
           + +    KIG G +G V+K      G+ +A+K    S +    ++       EI  L  +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIK--KIALREIRMLKQL 59

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIA 156
           +HPNLV L+    +  R  LV+EY ++     LDR   G  +  +K        I     
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK-------SITWQTL 112

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
           + + F H+    + +HRD+K  NIL+ +    K+ DFG A+L      +    +A T  Y
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWY 168

Query: 217 LAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
            +PE ++G        DV++ G +  E++SG 
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  113 bits (284), Expect = 4e-28
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 24/205 (11%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK-----PLSAESKQGVREFITEIMTLSN 98
           T+++ L  ++G+G F  V +   +  G+  A        LSA   Q +     E      
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRL 66

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 157
           ++HPN+V L     +     L+++ V    L + ++     A    +    S     I +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV-----AREYYSEADASHCIQQILE 121

Query: 158 GLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
            +   H+     +VHR++K  N+LL    +    K+ DFGLA              AGT 
Sbjct: 122 AVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTP 177

Query: 215 GYLAPEYVLGGQL-TMKADVYSFGV 238
           GYL+PE VL         D+++ GV
Sbjct: 178 GYLSPE-VLRKDPYGKPVDLWACGV 201

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  111 bits (280), Expect = 5e-28
 Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 19/200 (9%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHP 102
           +D F + +++GRG    VY+       +  A+K L     K+ VR   TEI  L  + HP
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVLLRLSHP 108

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           N+++L       T   LV E V    L DR++          +    +D    I + +A+
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIV-----EKGYYSERDAADAVKQILEAVAY 163

Query: 162 LHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
           LHE     IVHRD+K  N+L      +   KI DFGL+K+       +   + GT GY A
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCA 218

Query: 219 PEYVLGGQLTMKADVYSFGV 238
           PE + G     + D++S G+
Sbjct: 219 PEILRGCAYGPEVDMWSVGI 238

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  114 bits (286), Expect = 5e-28
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 17/221 (7%)

Query: 36  FSYTELRSAT-DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVR 87
           + + E +    D F     +GRGGFG V+    K T   G+  A K L+ +    ++G +
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQ 230

Query: 88  EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 147
             + E   L+ V    +V L       T   LV   +    +   +    + N     E 
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EP 289

Query: 148 RSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
           R+      I  GL  LH+    +I++RD+K  N+LLD + N +I D GLA       T  
Sbjct: 290 RAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346

Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
               AGT G++APE +LG +     D ++ GV + E+I+ R
Sbjct: 347 KGY-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  113 bits (284), Expect = 9e-28
 Identities = 64/221 (28%), Positives = 94/221 (42%), Gaps = 20/221 (9%)

Query: 36  FSYTELRSAT-DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVR 87
           + + E +  T + F     +G+GGFG V     + T   G+  A K L  +    ++G  
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEA 229

Query: 88  EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 147
             + E   L  V    +V L           LV   +    L   +    +A      E 
Sbjct: 230 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EA 286

Query: 148 RSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 206
           R+      I  GL  LH E    IV+RD+K  NILLD   + +I D GLA   P+  T  
Sbjct: 287 RAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 341

Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
                GT GY+APE V   + T   D ++ G L+ E+I+G+
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  111 bits (280), Expect = 1e-27
 Identities = 64/256 (25%), Positives = 106/256 (41%), Gaps = 35/256 (13%)

Query: 9   SRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT 68
            +  S   + + +      ++   V        R     +  +  IG G FG VY+  L 
Sbjct: 17  VQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLC 76

Query: 69  -NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI------LVY 121
            +G  +A+K +  + +   RE    +  +  + H N+V L         +       LV 
Sbjct: 77  DSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132

Query: 122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVG-----IAKGLAFLHEELVPHIVHRDIK 176
           +YV    + RV    ++A   L       I V      + + LA++H      I HRDIK
Sbjct: 133 DYVPET-VYRVARHYSRAKQTL-----PVIYVKLYMYQLFRSLAYIHSF---GICHRDIK 183

Query: 177 ASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVLGGQL-TMKA 231
             N+LLD +    K+ DFG AK       N+++I +R      Y APE + G    T   
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSSI 238

Query: 232 DVYSFGVLVLEIISGR 247
           DV+S G ++ E++ G+
Sbjct: 239 DVWSAGCVLAELLLGQ 254

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  110 bits (278), Expect = 1e-27
 Identities = 59/252 (23%), Positives = 105/252 (41%), Gaps = 35/252 (13%)

Query: 12  HSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGR 71
           ++  +  +  P     ++++ +     T        +     IG G FG V++  L    
Sbjct: 7   NAPLNGVKLNPLDDPNKVIKVLASDGKT-GEQREIAYTNCKVIGNGSFGVVFQAKLVESD 65

Query: 72  RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI------LVYEYVE 125
            +A+K +  + +   R    E+  +  V+HPN+V+L         +       LV EYV 
Sbjct: 66  EVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121

Query: 126 NNSLDRVLLGATKANIKLNWEKRSDICVG-----IAKGLAFLHEELVPHIVHRDIKASNI 180
              + R      K    +       + +      + + LA++H      I HRDIK  N+
Sbjct: 122 ET-VYRASRHYAKLKQTM-----PMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNL 172

Query: 181 LLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYS 235
           LLD      K+ DFG AK+      N+++I +R      Y APE + G    T   D++S
Sbjct: 173 LLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNYTTNIDIWS 227

Query: 236 FGVLVLEIISGR 247
            G ++ E++ G+
Sbjct: 228 TGCVMAELMQGQ 239

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  110 bits (276), Expect = 2e-27
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 31/224 (13%)

Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           R   D F +    G+G FGTV  G     G  +A+K +  + +   RE +  +  L+ + 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77

Query: 101 HPNLVELIGCCVQGTRR-------ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
           HPN+V+L         R        +V EYV +  L R      +  +         I +
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAP-----PPILI 131

Query: 154 G-----IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNIT 204
                 + + +  LH     ++ HRDIK  N+L+++     K+ DFG AK       N+ 
Sbjct: 132 KVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190

Query: 205 HITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
           +I +R      Y APE + G Q  T   D++S G +  E++ G 
Sbjct: 191 YICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  108 bits (273), Expect = 3e-27
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 24/214 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAES-KQGV-REFITEIMTLSNVRHP 102
           D +    K+G G +G VYK         +A+K +  E  ++GV    I E+  L  ++H 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVL---LGATKANIKLNWEKRSDICVGIAKGL 159
           N++EL        R  L++EY EN+ L + +      +   IK            +  G+
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKS-------FLYQLINGV 145

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFPDNITHITTRIAGTT 214
            F H       +HRD+K  N+LL           KIGDFGLA+ F   I   T  I  T 
Sbjct: 146 NFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TL 201

Query: 215 GYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
            Y  PE +LG +  +   D++S   +  E++   
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  108 bits (272), Expect = 4e-27
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 32/223 (14%)

Query: 43  SATDDFHLSNKIGRGGFGTVYKG--TLTNGRRIAVKPLSAES-KQGV-----REFITEIM 94
            A   +    +IG G +G V+K       GR +A+K +  ++ ++G+     RE +  + 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLR 66

Query: 95  TLSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVL-----LGATKANIKLN 144
            L    HPN+V L   C            LV+E+V+ + L   L      G     IK  
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIK-- 123

Query: 145 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 204
                D+   + +GL FLH      +VHRD+K  NIL+      K+ DFGLA+++   + 
Sbjct: 124 -----DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175

Query: 205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
            +T+ +  T  Y APE +L        D++S G +  E+   +
Sbjct: 176 -LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  108 bits (272), Expect = 4e-27
 Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 17/204 (8%)

Query: 45  TDDFHLSNK-IGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVR 100
            + + L++K +GRG F  V +    + G+  A K        +    E + EI  L   +
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 101 H-PNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKG 158
             P ++ L       +  IL+ EY     +    L    +    ++      +   I +G
Sbjct: 87  SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL---PELAEMVSENDVIRLIKQILEG 143

Query: 159 LAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           + +LH+    +IVH D+K  NILL       + KI DFG+++            I GT  
Sbjct: 144 VYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPE 198

Query: 216 YLAPEYVLGGQLTMKADVYSFGVL 239
           YLAPE +    +T   D+++ G++
Sbjct: 199 YLAPEILNYDPITTATDMWNIGII 222

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  108 bits (273), Expect = 5e-27
 Identities = 63/240 (26%), Positives = 108/240 (45%), Gaps = 35/240 (14%)

Query: 29  LLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAES-KQGV 86
           + +  +             +    KIG+G FG V+K      G+++A+K +  E+ K+G 
Sbjct: 1   MAKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59

Query: 87  REFIT---EIMTLSNVRHPNLVELIGCCVQGTRRI--------LVYEYVENN---SLDRV 132
              IT   EI  L  ++H N+V LI  C               LV+++ E++    L  V
Sbjct: 60  P--ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 117

Query: 133 LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD 192
           L+  T + IK        +   +  GL ++H      I+HRD+KA+N+L+ ++   K+ D
Sbjct: 118 LVKFTLSEIK-------RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167

Query: 193 FGLAKLF----PDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
           FGLA+ F           T R+  T  Y  PE +LG +      D++  G ++ E+ +  
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  107 bits (270), Expect = 6e-27
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 32/224 (14%)

Query: 43  SATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAES-KQGVREF-IT---EI--- 93
            AT  +    +IG G +GTVYK     +G  +A+K +   +   G     I+   E+   
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 94  MTLSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVL-----LGATKANIKL 143
             L    HPN+V L+  C            LV+E+V+ + L   L      G     IK 
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIK- 123

Query: 144 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
                 D+     +GL FLH      IVHRD+K  NIL+      K+ DFGLA+++   +
Sbjct: 124 ------DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174

Query: 204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
             +T  +  T  Y APE +L        D++S G +  E+   +
Sbjct: 175 A-LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  106 bits (268), Expect = 1e-26
 Identities = 50/197 (25%), Positives = 80/197 (40%), Gaps = 20/197 (10%)

Query: 50  LSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVEL 107
               +G G F    K     + +  AVK +S   +   ++   EI  L     HPN+V+L
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKL 71

Query: 108 IGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
                      LV E +    L +R+           +  + S I   +   ++ +H+  
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIK-----KKKHFSETEASYIMRKLVSAVSHMHDV- 125

Query: 167 VPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
              +VHRD+K  N+L    +     KI DFG A+L P +   + T    T  Y APE +L
Sbjct: 126 --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPE-LL 181

Query: 224 GGQL-TMKADVYSFGVL 239
                    D++S GV+
Sbjct: 182 NQNGYDESCDLWSLGVI 198

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  106 bits (267), Expect = 2e-26
 Identities = 50/215 (23%), Positives = 85/215 (39%), Gaps = 28/215 (13%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAES----KQGVREFITEIMTLSNVR 100
           +DF     +G G F TV         R  A+K L         + V     E   +S + 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLD 88

Query: 101 HPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG----- 154
           HP  V+L     Q   ++     Y +N  L + +                D         
Sbjct: 89  HPFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYI----------RKIGSFDETCTRFYTA 137

Query: 155 -IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAG 212
            I   L +LH +    I+HRD+K  NILL+++ + +I DFG AK+              G
Sbjct: 138 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           T  Y++PE +        +D+++ G ++ ++++G 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (267), Expect = 2e-26
 Identities = 61/340 (17%), Positives = 115/340 (33%), Gaps = 87/340 (25%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFI-TEIMTLSNVRHPN 103
            DF     +GRGGFG V++     +    A+K +   +++  RE +  E+  L+ + HP 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVL---LGATKANIKLNWEKRS----------- 149
           +V      ++        E  E    D      L +       + + R            
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 150 ---------------DICVG------IAKGLAFLHEEL-------------VPHI----- 170
                           +C        + +  +    E              V  +     
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 171 VHRDIKASNILLDQEFNPKIGDFGLAK-----------LFPDNITHITTRIAGTTGYLAP 219
           +HRD+K SNI    +   K+GDFGL             L P       T   GT  Y++P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD 279
           E + G   + K D++S G+++ E++   ++       M +  +     +   + P     
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQ------MERVRI--ITDVRNLKFP----- 292

Query: 280 PELGEYPPNE--IIRYMKVAFFCTQAAASRRPQMNQVIKM 317
               +  P E  +++ M         + + RP+   +I+ 
Sbjct: 293 LLFTQKYPQEHMMVQDM------LSPSPTERPEATDIIEN 326

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  105 bits (263), Expect = 5e-26
 Identities = 53/214 (24%), Positives = 79/214 (36%), Gaps = 28/214 (13%)

Query: 45  TDDFHLSNK-IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-H 101
            D + L    +G G    V     L   +  AVK +  +          E+  L   + H
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
            N++ELI    +  R  LV+E +   S+   +           N  + S +   +A  L 
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH-----KRRHFNELEASVVVQDVASALD 125

Query: 161 FLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTR------IA 211
           FLH      I HRD+K  NIL    +Q    KI DF L      N               
Sbjct: 126 FLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 212 GTTGYLAPEYVLGGQLTM------KADVYSFGVL 239
           G+  Y+APE V+            + D++S GV+
Sbjct: 183 GSAEYMAPE-VVEAFSEEASIYDKRCDLWSLGVI 215

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  104 bits (262), Expect = 1e-25
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 25/206 (12%)

Query: 45  TDDFHLSNK-IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHP 102
           TDD+ LS + +G G  G V +      G++ A+K L  +S +  +E   +         P
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV--DHH-WQASGGP 82

Query: 103 NLVELIGCC---VQGTRRI-LVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 157
           ++V ++        G R + ++ E +E   L  R+     + +      + ++I   I  
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ---ERGDQAFTEREAAEIMRDIGT 139

Query: 158 GLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
            + FLH     +I HRD+K  N+L    +++   K+ DFG AK    N   + T    T 
Sbjct: 140 AIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTP 193

Query: 215 GYLAPEYVLGGQL-TMKADVYSFGVL 239
            Y+APE VLG +      D++S GV+
Sbjct: 194 YYVAPE-VLGPEKYDKSCDMWSLGVI 218

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  105 bits (263), Expect = 2e-25
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 30/230 (13%)

Query: 39  TELRSATDDFH-LSNKIGRGGFGTVYKG---TLTNGRRIAVKPLSAE--SKQGVREFITE 92
           +E     D F     K+GRG +G VYK       + +  A+K +     S    RE    
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE---- 68

Query: 93  IMTLSNVRHPNLVELIGCCVQGT-RRI-LVYEYVENNSLDRVL-----LGATKANIKLNW 145
           I  L  ++HPN++ L    +    R++ L+++Y E++ L  ++       A K  ++L  
Sbjct: 69  IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPR 127

Query: 146 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLF-- 199
                +   I  G+ +LH      ++HRD+K +NIL+  E       KI D G A+LF  
Sbjct: 128 GMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184

Query: 200 PDN-ITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
           P   +  +   +  T  Y APE +LG +  T   D+++ G +  E+++  
Sbjct: 185 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  103 bits (258), Expect = 3e-25
 Identities = 51/253 (20%), Positives = 90/253 (35%), Gaps = 30/253 (11%)

Query: 12  HSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNG 70
           H                 L         E       + +   +G GGFG+VY G  +++ 
Sbjct: 9   HHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDN 68

Query: 71  RRIAVKPLSAESKQGVREFIT---------EIMTLSNVRH--PNLVELIGCCVQGTRRIL 119
             +A+K +    K  + ++           E++ L  V      ++ L+    +    +L
Sbjct: 69  LPVAIKHVE---KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125

Query: 120 VYEYVENNS--LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 177
           + E  E      D +          L  E        + + +   H      ++HRDIK 
Sbjct: 126 ILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKD 177

Query: 178 SNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT-MKADVYS 235
            NIL+D      K+ DFG   L  D +        GT  Y  PE++   +     A V+S
Sbjct: 178 ENILIDLNRGELKLIDFGSGALLKDTVYT-DF--DGTRVYSPPEWIRYHRYHGRSAAVWS 234

Query: 236 FGVLVLEIISGRN 248
            G+L+ +++ G  
Sbjct: 235 LGILLYDMVCGDI 247

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  101 bits (253), Expect = 8e-25
 Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 15/200 (7%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGCC 111
           +G G +G V           +AVK +  +      E I  EI     + H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 112 VQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI 170
            +G  + L  EY     L DR+       +I +           +  G+ +LH      I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GI 126

Query: 171 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-GTTGYLAPEYVLGGQL-- 227
            HRDIK  N+LLD+  N KI DFGLA +F  N          GT  Y+APE +L  +   
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFH 185

Query: 228 TMKADVYSFGVLVLEIISGR 247
               DV+S G+++  +++G 
Sbjct: 186 AEPVDVWSCGIVLTAMLAGE 205

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  102 bits (255), Expect = 2e-24
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 26/214 (12%)

Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSN 98
           D F +   IG+G FG V       T    +  A+K ++ +    +  VR    E+  +  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71

Query: 99  VRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IA 156
           + HP LV L     Q    + +V + +    L R  L   + N+    E+   + +  + 
Sbjct: 72  LEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL-RYHL---QQNVHFK-EETVKLFICELV 125

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
             L +L  +    I+HRD+K  NILLD+  +  I DF +A + P      T  +AGT  Y
Sbjct: 126 MALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPY 180

Query: 217 LAPEYVLGGQL---TMKADVYSFGVLVLEIISGR 247
           +APE     +    +   D +S GV   E++ GR
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  100 bits (251), Expect = 3e-24
 Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 15/200 (7%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGCC 111
           +G G +G V           +AVK +  +      E I  EI     + H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 112 VQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI 170
            +G  + L  EY     L DR+       +I +           +  G+ +LH      I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GI 126

Query: 171 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-GTTGYLAPEYVLGGQL-- 227
            HRDIK  N+LLD+  N KI DFGLA +F  N          GT  Y+APE +L  +   
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFH 185

Query: 228 TMKADVYSFGVLVLEIISGR 247
               DV+S G+++  +++G 
Sbjct: 186 AEPVDVWSCGIVLTAMLAGE 205

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  100 bits (252), Expect = 4e-24
 Identities = 62/251 (24%), Positives = 102/251 (40%), Gaps = 27/251 (10%)

Query: 8   GSRFHSKKSAEREAPQGVDGELLRNV-NHFSYTELRSAT-DDFHLSNKIGRGGFGTVY-- 63
           G+   +KK +E+E+ +    +   +    +      +A  D F     +G G FG V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60

Query: 64  --KGTLTNGRRIAVKPLS----AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR 117
             K +   G   A+K L      + KQ +   + E   L  V  P LV+L       +  
Sbjct: 61  KHKES---GNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116

Query: 118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIK 176
            +V EYV    +   L    + +     E  +      I     +LH      +++RD+K
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFS-----EPHARFYAAQIVLTFEYLHSL---DLIYRDLK 168

Query: 177 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 236
             N+L+DQ+   ++ DFG AK         T  + GT   LAPE +L        D ++ 
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWAL 224

Query: 237 GVLVLEIISGR 247
           GVL+ E+ +G 
Sbjct: 225 GVLIYEMAAGY 235

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  101 bits (253), Expect = 4e-24
 Identities = 54/242 (22%), Positives = 98/242 (40%), Gaps = 27/242 (11%)

Query: 9   SRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNK-IGRGGFGTVYKGT- 66
           +  H         PQ      +++        +    DD+ ++++ +G G  G V +   
Sbjct: 27  ALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAI---IDDYKVTSQVLGLGINGKVLQIFN 83

Query: 67  LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC---VQGTRRI-LVYE 122
                + A+K L    K   RE   E+      + P++V ++        G + + +V E
Sbjct: 84  KRTQEKFALKMLQDCPKAR-RE--VELH-WRASQCPHIVRIVDVYENLYAGRKCLLIVME 139

Query: 123 YVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 181
            ++   L  R+     + +      + S+I   I + + +LH     +I HRD+K  N+L
Sbjct: 140 CLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLL 193

Query: 182 L---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFG 237
                     K+ DFG AK    + +  T     T  Y+APE VLG +      D++S G
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPE-VLGPEKYDKSCDMWSLG 250

Query: 238 VL 239
           V+
Sbjct: 251 VI 252

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 99.6 bits (249), Expect = 5e-24
 Identities = 52/211 (24%), Positives = 83/211 (39%), Gaps = 30/211 (14%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT----EIMTLSNVRHPNLVELI 108
           +G G +G V +        R AVK L  +  + +         EI  L  +RH N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 109 GCCVQGTRR--ILVYEYVENNS---LDRVLLGATKANIKLN-WEKRSDICVGIAKGLAFL 162
                  ++   +V EY        LD V         +    +        +  GL +L
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK------RFPVCQAH-GYFCQLIDGLEYL 125

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF----PDNITHITTRIAGTTGYLA 218
           H +    IVH+DIK  N+LL      KI   G+A+       D+    T+   G+  +  
Sbjct: 126 HSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR-TS--QGSPAFQP 179

Query: 219 PEYVLGGQL--TMKADVYSFGVLVLEIISGR 247
           PE   G       K D++S GV +  I +G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  101 bits (254), Expect = 5e-24
 Identities = 68/219 (31%), Positives = 95/219 (43%), Gaps = 37/219 (16%)

Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSN 98
           ++F     +G+G FG V     K T   GR  A+K L  E   +K  V   +TE   L N
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204

Query: 99  VRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEKRSDI 151
            RHP L  L     Q   R+  V EY     L      +RV             E R+  
Sbjct: 205 SRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFS-----------EDRARF 252

Query: 152 CVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITT 208
               I   L +LH E   ++V+RD+K  N++LD++ + KI DFGL K   + I       
Sbjct: 253 YGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMK 307

Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
              GT  YLAPE +         D +  GV++ E++ GR
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 99.0 bits (247), Expect = 5e-24
 Identities = 23/244 (9%), Positives = 59/244 (24%), Gaps = 57/244 (23%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVK---PLSAESKQGVREFITEIMTLSNVRHPN 103
           + L    G       ++       R++A+    P        ++E ++  + LS +  P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +  ++         ++V E++   SL  V   +       +          +A      H
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAH 146

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
                 +       S + +  + +  +                          +      
Sbjct: 147 RA---GVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA--- 179

Query: 224 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG 283
                 + D+   G  +  ++  R                W          L   + +  
Sbjct: 180 ----NPQDDIRGIGASLYALLVNR----------------WPLPEAGVRSGLAPAERDTA 219

Query: 284 EYPP 287
             P 
Sbjct: 220 GQPI 223

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 99.7 bits (249), Expect = 6e-24
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 15/199 (7%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGC 110
           IG+G F  V     +  GR +A+K +     +   +++   E+  +  + HPN+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 111 CVQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 169
                   L+ EY     + D +      A+ ++  ++       I   + + H++    
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL-----VAHGRMKEKEARSKFRQIVSAVQYCHQK---R 134

Query: 170 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT- 228
           IVHRD+KA N+LLD + N KI DFG +  F      +     G   Y APE   G +   
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAF-CGAPPYAAPELFQGKKYDG 192

Query: 229 MKADVYSFGVLVLEIISGR 247
            + DV+S GV++  ++SG 
Sbjct: 193 PEVDVWSLGVILYTLVSGS 211

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  101 bits (254), Expect = 9e-24
 Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 26/214 (12%)

Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITE---IMT 95
           +DF +   IGRGGFG VY      T   G+  A+K L  +    KQG    + E   +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245

Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG- 154
           +S    P +V +        +   + + +    L   L     +   +  E         
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYAAE 300

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
           I  GL  +H      +V+RD+K +NILLD+  + +I D GLA  F     H      GT 
Sbjct: 301 IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--AS-VGTH 354

Query: 215 GYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
           GY+APE +  G      AD +S G ++ +++ G 
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 59/249 (23%), Positives = 96/249 (38%), Gaps = 28/249 (11%)

Query: 16  SAEREAPQGVDGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIA 74
           S   +  QG               +  +   ++ L   +G+GGFGTV+ G  LT+  ++A
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA 60

Query: 75  VKPLSAE---SKQGVREFIT---EIMTLSNVR----HPNLVELIGCCVQGTRRILVYEYV 124
           +K +          + + +T   E+  L  V     HP ++ L+         +LV E  
Sbjct: 61  IKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERP 120

Query: 125 ENNS--LDRVLLGATKANIKLNWEKRS-DICVGIAKGLAFLHEELVPHIVHRDIKASNIL 181
                  D +     K  +    E  S      +   +   H      +VHRDIK  NIL
Sbjct: 121 LPAQDLFDYI---TEKGPLG---EGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENIL 171

Query: 182 LDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT-MKADVYSFGVL 239
           +D      K+ DFG   L  D          GT  Y  PE++   Q   + A V+S G+L
Sbjct: 172 IDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYSPPEWISRHQYHALPATVWSLGIL 228

Query: 240 VLEIISGRN 248
           + +++ G  
Sbjct: 229 LYDMVCGDI 237

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 98.0 bits (245), Expect = 1e-23
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAES--KQGVREFIT-EIMTLSNVRHPNLVELIG 109
           +G G FG V  G     G ++AVK L+ +      V   I  EI  L   RHP++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 110 CCVQGTRR--ILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             V  T     +V EYV    L D +       + ++   +   +   I   + + H   
Sbjct: 79  --VISTPTDFFMVMEYVSGGELFDYIC-----KHGRVEEMEARRLFQQILSAVDYCHRH- 130

Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
              +VHRD+K  N+LLD   N KI DFGL+ +  D     T+   G+  Y APE V+ G+
Sbjct: 131 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISGR 185

Query: 227 L--TMKADVYSFGVLVLEIISGR 247
           L    + D++S GV++  ++ G 
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGT 208

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 25/211 (11%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HP 102
            DD+ L  K+GRG +  V++   +TN  ++ VK L    K+   +   EI  L N+R  P
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91

Query: 103 NLVELIGCCV---QGTRRILVYEYVENNSLDRVLLGATKANIK-LNWEKRSDICVGIAKG 158
           N++ L    V         LV+E+V N    ++    T  +I+   +E        I K 
Sbjct: 92  NIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKA 142

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYL 217
           L + H      I+HRD+K  N+++D E    ++ D+GLA+ F         R+A +  + 
Sbjct: 143 LDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVA-SRYFK 197

Query: 218 APEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
            PE ++  Q+     D++S G ++  +I  +
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 99.1 bits (247), Expect = 3e-23
 Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 25/223 (11%)

Query: 39  TELRSATDDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFIT 91
            ++R   +DF +   IGRG FG V     K      +  A+K L+      +     F  
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFRE 123

Query: 92  EIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 150
           E   L N     +  L     Q    + LV +Y     L  +L   +K   +L  E+ + 
Sbjct: 124 ERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLP-EEMAR 178

Query: 151 ICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 209
             +  +   +  +H+    H VHRDIK  NIL+D   + ++ DFG      ++ T  ++ 
Sbjct: 179 FYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235

Query: 210 IAGTTGYLAPEYVLGGQL-----TMKADVYSFGVLVLEIISGR 247
             GT  Y++PE +   +        + D +S GV + E++ G 
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 97.0 bits (242), Expect = 4e-23
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 43/222 (19%)

Query: 50  LSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS-------------------------AESK 83
           L ++IG+G +G V       +    A+K LS                             
Sbjct: 17  LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76

Query: 84  QGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSL-DRVLLGATKA 139
           +G  E +  EI  L  + HPN+V+L+            +V+E V    + +   L     
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---- 132

Query: 140 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 199
              L+ ++       + KG+ +LH +    I+HRDIK SN+L+ ++ + KI DFG++  F
Sbjct: 133 --PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 200 PDNITHITTRIAGTTGYLAPEYVLGGQLT---MKADVYSFGV 238
             +   ++    GT  ++APE +   +        DV++ GV
Sbjct: 188 KGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 69/219 (31%), Positives = 95/219 (43%), Gaps = 38/219 (17%)

Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAE---SKQGVREFITEIMTLSN 98
           +DF     +G+G FG V     K T   GR  A+K L  E   +K  V   +TE   L N
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 99  VRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEKRSDI 151
            RHP L  L     Q   R+  V EY     L      +RV             E+R+  
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT-----------EERARF 109

Query: 152 CVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITT 208
               I   L +LH      +V+RDIK  N++LD++ + KI DFGL K   + I+      
Sbjct: 110 YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMK 163

Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
              GT  YLAPE +         D +  GV++ E++ GR
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 96.8 bits (242), Expect = 5e-23
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 27/212 (12%)

Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLS----AESKQGVREFITEIMTLS 97
            DF +   +G G FG V+    +     GR  A+K L        KQ V     E + LS
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLS 61

Query: 98  NVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-I 155
            V HP ++ + G   Q  ++I ++ +Y+E   L  +L  + +          +      +
Sbjct: 62  IVTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFP-----NPVAKFYAAEV 115

Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
              L +LH +    I++RD+K  NILLD+  + KI DFG AK  PD    +T  + GT  
Sbjct: 116 CLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPD 168

Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           Y+APE V         D +SFG+L+ E+++G 
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 97.9 bits (244), Expect = 9e-23
 Identities = 58/224 (25%), Positives = 88/224 (39%), Gaps = 27/224 (12%)

Query: 40  ELRSATDDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITE 92
           E+R   DDF +   IGRG F  V     K T   G+  A+K ++      +  V  F  E
Sbjct: 55  EVRLQRDDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREE 111

Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
              L N     + +L     Q    + LV EY     L  +L   +K   ++   + +  
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL---SKFGERIP-AEMARF 166

Query: 152 CVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 210
            +  I   +  +H       VHRDIK  NILLD+  + ++ DFG       + T  +   
Sbjct: 167 YLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223

Query: 211 AGTTGYLAPEYVLGGQLTMKADVY-------SFGVLVLEIISGR 247
            GT  YL+PE +           Y       + GV   E+  G+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 96.3 bits (240), Expect = 1e-22
 Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 24/215 (11%)

Query: 47  DFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFIT------EIMTLS 97
            +   + +G G FG V+        + + VK +  E   +    E         EI  LS
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 98  NVRHPNLVELIGCCVQGTRRILVYE-YVENNSL-DRVLLGATKANIKLNWEKRSDICVGI 155
            V H N+++++          LV E +     L   +       + +L+    S I   +
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID-----RHPRLDEPLASYIFRQL 139

Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
              + +L  +    I+HRDIK  NI++ ++F  K+ DFG A          T    GT  
Sbjct: 140 VSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIE 194

Query: 216 YLAPEYVLGGQL--TMKADVYSFGVLVLEIISGRN 248
           Y APE VL G      + +++S GV +  ++   N
Sbjct: 195 YCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEEN 228

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 95.3 bits (238), Expect = 2e-22
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 36/219 (16%)

Query: 46  DDFHLSNKIGRGGFGTVY---KGTLTNGRRI-AVKPLSAES---KQGVREFITEIMTLSN 98
             F L   +G+G FG V+   K + ++ R++ A+K L   +   +  V     E   L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDILVE 82

Query: 99  VRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEKRSDI 151
           V HP +V+L     Q   ++ L+ +++    L      + +             E+    
Sbjct: 83  VNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-----------EEDVKF 130

Query: 152 CVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITT 208
            +  +A  L  LH      I++RD+K  NILLD+E + K+ DFGL+K    +I H     
Sbjct: 131 YLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE---SIDHEKKAY 184

Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
              GT  Y+APE V     T  AD +SFGVL+ E+++G 
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 94.5 bits (236), Expect = 5e-22
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 36/220 (16%)

Query: 46  DDFHLSNKIGRGGFGTVY---KGTLTNGRRI-AVKPLS----AESKQGVREFITEIMTLS 97
           + F L   +G+GG+G V+   K T  N  +I A+K L       + +       E   L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 98  NVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEKRSD 150
            V+HP +V+LI    Q   ++ L+ EY+    L      + + +           E  + 
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFM-----------EDTAC 124

Query: 151 ICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--IT 207
             +  I+  L  LH++    I++RD+K  NI+L+ + + K+ DFGL K    +I    +T
Sbjct: 125 FYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE---SIHDGTVT 178

Query: 208 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
               GT  Y+APE ++        D +S G L+ ++++G 
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 56/192 (29%), Positives = 83/192 (43%), Gaps = 20/192 (10%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGCC 111
           IG G FG             +AVK +  E    + E +  EI+   ++RHPN+V      
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 112 VQGTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI 170
           +  T   ++ EY     L +R+         + + ++       +  G+++ H      I
Sbjct: 86  LTPTHLAIIMEYASGGELYERIC-----NAGRFSEDEARFFFQQLLSGVSYCHSM---QI 137

Query: 171 VHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL- 227
            HRD+K  N LLD    P  KI DFG +K    +    +T   GT  Y+APE VL  Q  
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE-VLLRQEY 194

Query: 228 -TMKADVYSFGV 238
               ADV+S GV
Sbjct: 195 DGKIADVWSCGV 206

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 95.2 bits (237), Expect = 6e-22
 Identities = 56/229 (24%), Positives = 88/229 (38%), Gaps = 40/229 (17%)

Query: 39  TELRSATDDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFIT 91
            +LR   +D+ +   IGRG FG V     K T    +  A+K LS      +     F  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWE 118

Query: 92  EIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 150
           E   ++    P +V+L     Q  R + +V EY+    L             +N     D
Sbjct: 119 ERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYD 164

Query: 151 ICVGIAK--------GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN 202
           +    A+         L  +H       +HRD+K  N+LLD+  + K+ DFG        
Sbjct: 165 VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221

Query: 203 ITHITTRIAGTTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISGR 247
                    GT  Y++PE +      G    + D +S GV + E++ G 
Sbjct: 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 70/223 (31%), Positives = 97/223 (43%), Gaps = 45/223 (20%)

Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAESKQGV--REFITEIMT---- 95
            DF L   IGRG +  V     K T    R  A+K +    K+ V   E I  + T    
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKVVK---KELVNDDEDIDWVQTEKHV 62

Query: 96  -LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEK 147
                 HP LV L   C Q   R+  V EYV    L       R L            E+
Sbjct: 63  FEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-----------EE 110

Query: 148 RSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNIT 204
            +      I+  L +LHE     I++RD+K  N+LLD E + K+ D+G+ K  L P + T
Sbjct: 111 HARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167

Query: 205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
             T    GT  Y+APE + G       D ++ GVL+ E+++GR
Sbjct: 168 S-T--FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 21/202 (10%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAE--SKQGVREFIT-EIMTLSNVRHPNLVELIG 109
           +G G FG V   T     +++A+K +S +   K  +   +  EI  L  +RHP++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 110 CCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 167
             V  T    ++V EY      D ++        ++  ++       I   + + H    
Sbjct: 77  --VITTPTDIVMVIEYAGGELFDYIV-----EKKRMTEDEGRRFFQQIICAIEYCHRH-- 127

Query: 168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 227
             IVHRD+K  N+LLD   N KI DFGL+ +  D     T+   G+  Y APE V+ G+L
Sbjct: 128 -KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VINGKL 183

Query: 228 --TMKADVYSFGVLVLEIISGR 247
               + DV+S G+++  ++ GR
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR 205

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 73/258 (28%), Positives = 104/258 (40%), Gaps = 46/258 (17%)

Query: 12  HSKKSAEREAPQGVDGELLRNVNHFSYTELRSAT-DDFHLSNKIGRGGFGTVY----KGT 66
                 +     G++ E        S     S    DF L   IGRG +  V     K T
Sbjct: 17  TENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKT 76

Query: 67  LTNGRRIAVKPLSAESKQGV--REFITEIMT-----LSNVRHPNLVELIGCCVQGTRRI- 118
               R  A++ +    K+ V   E I  + T          HP LV L   C Q   R+ 
Sbjct: 77  ---DRIYAMRVVK---KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLF 129

Query: 119 LVYEYVENNSL------DRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIV 171
            V EYV    L       R L            E+ +      I+  L +LHE     I+
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLP-----------EEHARFYSAEISLALNYLHER---GII 175

Query: 172 HRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 229
           +RD+K  N+LLD E + K+ D+G+ K  L P + T  T    GT  Y+APE + G     
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-T--FCGTPNYIAPEILRGEDYGF 232

Query: 230 KADVYSFGVLVLEIISGR 247
             D ++ GVL+ E+++GR
Sbjct: 233 SVDWWALGVLMFEMMAGR 250

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 22/203 (10%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAES--KQGVREFIT-EIMTLSNVRHPNLVELIG 109
           +G G FG V  G     G ++AVK L+ +      V   I  EI  L   RHP++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 110 CCVQGTRR--ILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
             V  T     +V EYV    L D +       N +L+ ++   +   I  G+ + H   
Sbjct: 84  --VISTPSDIFMVMEYVSGGELFDYIC-----KNGRLDEKESRRLFQQILSGVDYCHRH- 135

Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 226
              +VHRD+K  N+LLD   N KI DFGL+ +  D     T+   G+  Y APE V+ G+
Sbjct: 136 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISGR 190

Query: 227 L--TMKADVYSFGVLVLEIISGR 247
           L    + D++S GV++  ++ G 
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGT 213

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 93.3 bits (232), Expect = 3e-21
 Identities = 53/252 (21%), Positives = 97/252 (38%), Gaps = 67/252 (26%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
           +  + L   +G G FG V +     +G+R A+K +  + +   RE    +  +  + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61

Query: 104 LVELIGCCVQGTRRI--------------------------------------LVYEYVE 125
           +++L+                                                ++ EYV 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 126 NNSLDRVLLGATKANIKLNWEKRSDICVG-----IAKGLAFLHEELVPHIVHRDIKASNI 180
           +  L +VL    ++   +         +      + + + F+H      I HRDIK  N+
Sbjct: 122 DT-LHKVLKSFIRSGRSI-----PMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172

Query: 181 LLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYS 235
           L++ + N  K+ DFG AK       ++ +I +R      Y APE +LG    T   D++S
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWS 227

Query: 236 FGVLVLEIISGR 247
            G +  E+I G+
Sbjct: 228 IGCVFGELILGK 239

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 45/223 (20%)

Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAESKQGV--REFITEIMT---- 95
            DFH    IG+G FG V     K         AVK L    K+ +  ++    IM+    
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAE---EVFYAVKVLQ---KKAILKKKEEKHIMSERNV 91

Query: 96  -LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEK 147
            L NV+HP LV L     Q   ++  V +Y+    L      +R  L           E 
Sbjct: 92  LLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFL-----------EP 139

Query: 148 RSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH- 205
           R+      IA  L +LH     +IV+RD+K  NILLD + +  + DFGL K   +NI H 
Sbjct: 140 RARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHN 193

Query: 206 -ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
             T+   GT  YLAPE +         D +  G ++ E++ G 
Sbjct: 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 93.9 bits (233), Expect = 4e-21
 Identities = 65/221 (29%), Positives = 94/221 (42%), Gaps = 41/221 (18%)

Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAE---SKQGVREFITE--IMTL 96
            DF+    +G+G FG V     KGT       AVK L  +       V   + E  ++ L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397

Query: 97  SNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEKRS 149
              + P L +L   C Q   R+  V EYV    L                      E  +
Sbjct: 398 PG-KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-----------EPHA 444

Query: 150 DICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--I 206
                 IA GL FL  +    I++RD+K  N++LD E + KI DFG+ K   +NI     
Sbjct: 445 VFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVT 498

Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           T    GT  Y+APE +         D ++FGVL+ E+++G+
Sbjct: 499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 91.1 bits (227), Expect = 9e-21
 Identities = 64/221 (28%), Positives = 94/221 (42%), Gaps = 41/221 (18%)

Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAE---SKQGVREFITE--IMTL 96
            DF+    +G+G FG V     KGT       AVK L  +       V   + E  ++ L
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76

Query: 97  SNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEKRS 149
              + P L +L   C Q   R+  V EYV    L                      E  +
Sbjct: 77  PG-KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-----------EPHA 123

Query: 150 DICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHI 206
                 IA GL FL  +    I++RD+K  N++LD E + KI DFG+ K  ++    T  
Sbjct: 124 VFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK- 179

Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           T    GT  Y+APE +         D ++FGVL+ E+++G+
Sbjct: 180 T--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 57/228 (25%), Positives = 88/228 (38%), Gaps = 42/228 (18%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVK--PLSAESKQGVREFIT---------EI 93
              + +   I  G +G V  G  + G  +A+K    +    + V              EI
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 94  MTLSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKR 148
             L++  HPN++ L    V           LV E +  + L +V        I       
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQV--------IHDQRIVI 131

Query: 149 SDICVG-----IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--PD 201
           S   +      I  GL  LHE     +VHRD+   NILL    +  I DF LA+      
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 202 NIT-HITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 247
           N T ++T R      Y APE V+  +   K  D++S G ++ E+ + +
Sbjct: 189 NKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 66/223 (29%), Positives = 95/223 (42%), Gaps = 45/223 (20%)

Query: 46  DDFHLSNKIGRGGFGTV----YKGTLTNGRRIAVKPLSAESKQGV--REFITEIMT---- 95
           +DF L   +G+G FG V    +K T    +  A+K L    K  V   + +   M     
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALK---KDVVLMDDDVECTMVEKRV 70

Query: 96  -LSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEK 147
                 HP L  +  C  Q    +  V EY+    L                        
Sbjct: 71  LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD-----------LS 118

Query: 148 RSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH- 205
           R+      I  GL FLH +    IV+RD+K  NILLD++ + KI DFG+ K   +N+   
Sbjct: 119 RATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGD 172

Query: 206 -ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
             T    GT  Y+APE +LG +     D +SFGVL+ E++ G+
Sbjct: 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 52/218 (23%), Positives = 103/218 (47%), Gaps = 34/218 (15%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS------AESKQGVREFITEIMTLS 97
              +     +G G +G+V       +G ++A+K LS        +K+  RE    ++ L 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRE----LLLLK 78

Query: 98  NVRHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
           +++H N++ L+      +         LV  +++ + L +++       +K + EK   +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIM------GLKFSEEKIQYL 131

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRI 210
              + KGL ++H      +VHRD+K  N+ ++++   KI DFGLA+     +T  + TR 
Sbjct: 132 VYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW 188

Query: 211 AGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
                Y APE +L         D++S G ++ E+++G+
Sbjct: 189 -----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 29/216 (13%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLS------AESKQGVREFITEIMTLS 97
              +     IG G  G V         R +A+K LS        +K+  RE    ++ + 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE----LVLMK 79

Query: 98  NVRHPNLVELIGC-CVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
            V H N++ L+     Q +        +V E ++ N L +V+       ++L+ E+ S +
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI------QMELDHERMSYL 132

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
              +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+    +   + T   
Sbjct: 133 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYV 187

Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
            T  Y APE +LG       D++S G ++ E+I G 
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 90.3 bits (224), Expect = 4e-20
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 29/216 (13%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS------AESKQGVREFITEIMTLS 97
              +     IG G  G V         R +A+K LS        +K+  RE    ++ + 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE----LVLMK 116

Query: 98  NVRHPNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
            V H N++ L+                LV E ++ N L +V+       ++L+ E+ S +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYL 169

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 211
              +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+    +   + T   
Sbjct: 170 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYV 224

Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
            T  Y APE +LG       D++S G ++ E++  +
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 89.2 bits (222), Expect = 4e-20
 Identities = 67/221 (30%), Positives = 96/221 (43%), Gaps = 41/221 (18%)

Query: 46  DDFHLSNKIGRGGFGTVY----KGTLTNGRRIAVKPLSAE---SKQGVREFITE--IMTL 96
           D+F     +G+G FG V     K T   G   AVK L  +       V   +TE  I++L
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79

Query: 97  SNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEKRS 149
           +   HP L +L  CC Q   R+  V E+V    L       R              E R+
Sbjct: 80  AR-NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-----------EARA 126

Query: 150 DICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHI 206
                 I   L FLH++    I++RD+K  N+LLD E + K+ DFG+ K  +     T  
Sbjct: 127 RFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA- 182

Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
           T    GT  Y+APE +         D ++ GVL+ E++ G 
Sbjct: 183 T--FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 34/221 (15%)

Query: 46  DDFHLSNKIGRGGFGTVY---KGTLTNGRRI-AVKPLSAESKQGVREFITEIMT----LS 97
           ++F L   +G G +G V+   K +  +  ++ A+K L   +     +      T    L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 98  NVRH-PNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEKRS 149
           ++R  P LV L     Q   ++ L+ +Y+    L                      E   
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFT-----------EHEV 161

Query: 150 DICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
            I VG I   L  LH+     I++RDIK  NILLD   +  + DFGL+K F  + T    
Sbjct: 162 QIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218

Query: 209 RIAGTTGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGR 247
              GT  Y+AP+ V GG        D +S GVL+ E+++G 
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 88.5 bits (220), Expect = 8e-20
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 33/218 (15%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLS------AESKQGVREFITEIMTLS 97
              +     +G G +G V        G ++A+K L         +K+  RE    +  L 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE----LRLLK 79

Query: 98  NVRHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
           ++RH N++ L+                LV  ++  + L +++    K   KL  ++   +
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLM----KHE-KLGEDRIQFL 133

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRI 210
              + KGL ++H      I+HRD+K  N+ ++++   KI DFGLA+     +T ++ TR 
Sbjct: 134 VYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW 190

Query: 211 AGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
                Y APE +L     T   D++S G ++ E+I+G+
Sbjct: 191 -----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 29/218 (13%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSA-----ESKQGVREFITEIMTLSN 98
              +   + IG G +G V       N  R+A+K +S        ++ +RE    I  L  
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE----IKILLR 81

Query: 99  VRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
            RH N++ +       T        +V + +E + L ++L    K    L+ +       
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLL----KTQH-LSNDHICYFLY 135

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRI 210
            I +GL ++H     +++HRD+K SN+LL+   + KI DFGLA++     D+   +T  +
Sbjct: 136 QILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 211 AGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 247
           A T  Y APE +L  +   K+ D++S G ++ E++S R
Sbjct: 193 A-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 33/218 (15%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLS------AESKQGVREFITEIMTLS 97
            + +   + +G G +G+V     T  G R+AVK LS        +K+  RE    +  L 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE----LRLLK 83

Query: 98  NVRHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 151
           +++H N++ L+                LV   +  + L+ ++    K   KL  +    +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIV----KCQ-KLTDDHVQFL 137

Query: 152 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRI 210
              I +GL ++H      I+HRD+K SN+ ++++   KI DFGLA+   D +T ++ TR 
Sbjct: 138 IYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW 194

Query: 211 AGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
                Y APE +L         D++S G ++ E+++GR
Sbjct: 195 -----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 47/224 (20%), Positives = 96/224 (42%), Gaps = 34/224 (15%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSA-----ESKQGVREFITEIMTLSN 98
           + DF L + +G G +G V   T    G  +A+K +        + + +RE    I  L +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKILKH 65

Query: 99  VRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 153
            +H N++ +       +        ++ E ++ + L RV+       + L+ +       
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVI----STQM-LSDDHIQYFIY 119

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
              + +  LH     +++HRD+K SN+L++   + K+ DFGLA++  ++    +      
Sbjct: 120 QTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 214 ---TGYL------APEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
                ++      APE +L     +   DV+S G ++ E+   R
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 30/223 (13%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
              +     +G GG G V+        +R+A+K +     Q V+  + EI  +  + H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 104 LVELIGCCVQGTRRI--------------LVYEYVENNSLDRVLLGATKANIKLNWEKRS 149
           +V++         ++              +V EY+E + L  VL    +    L  E   
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVL----EQG-PLLEEHAR 123

Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLF---PDNITH 205
                + +GL ++H     +++HRD+K +N+ ++ E    KIGDFGLA++      +  H
Sbjct: 124 LFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180

Query: 206 ITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
           ++  +  T  Y +P  +L     T   D+++ G +  E+++G+
Sbjct: 181 LSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 83.4 bits (206), Expect = 5e-18
 Identities = 76/354 (21%), Positives = 121/354 (34%), Gaps = 102/354 (28%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPL-----SAESKQGVREF----- 89
           D   L   +GRG FG V +            R +AVK L      +E +  + E      
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 90  -----------------------ITEIMTLSNVRHP---NLVELIGCCVQGTRRILVYEY 123
                                  I E     N+         E +    +G R     +Y
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141

Query: 124 VENNSLD-----RVLLGATKANIKLNWEKRSDICVG------------------------ 154
           V    +D       +  +  +      E++S   V                         
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
           +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+    +I      +    
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGD 254

Query: 215 GYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRN--SGKAMWGQMNKFLLEWAW 266
             L     APE +     T+++DV+SFGVL+ EI S G +   G  +  +  + L E   
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-- 312

Query: 267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
              +   P         +Y   E+ + M     C     S+RP  +++++ L  
Sbjct: 313 --TRMRAP---------DYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGN 352

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 82.0 bits (203), Expect = 7e-18
 Identities = 42/205 (20%), Positives = 80/205 (39%), Gaps = 43/205 (20%)

Query: 45  TDDFHLSNK-IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHP 102
            DD+ ++++ +G G  G V +        + A+K L  +  +  RE   E+      + P
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE--VELH-WRASQCP 71

Query: 103 NLVELIGCC---VQGTRRI-LVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAK 157
           ++V ++        G + + +V E ++   L  R+     + +      + S+I   I +
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGE 128

Query: 158 GLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
            + +LH     +I HRD+K  N+L          K+ DFG                    
Sbjct: 129 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG-------------------- 165

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVL 239
              A E   G +     D++S GV+
Sbjct: 166 --FAKE-TTGEKYDKSCDMWSLGVI 187

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 49/197 (24%), Positives = 87/197 (44%), Gaps = 25/197 (12%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLS------AESKQGVREFITEIMTLS 97
            D++ + + IGRG +G VY        + +A+K ++       + K+ +RE    I  L+
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE----ITILN 80

Query: 98  NVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 152
            ++   ++ L    +           +V E  +++ L ++     K  I L  E    I 
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLF----KTPIFLTEEHIKTIL 135

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIA 211
             +  G  F+HE     I+HRD+K +N LL+Q+ + K+ DFGLA  +  +  T+I   + 
Sbjct: 136 YNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192

Query: 212 GTTGYLAPEYVLGGQLT 228
                      L  QLT
Sbjct: 193 ENEEPGPHNKNLKKQLT 209

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 77.2 bits (189), Expect = 5e-16
 Identities = 38/248 (15%), Positives = 71/248 (28%), Gaps = 58/248 (23%)

Query: 44  ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVK--PLSA------ESKQGVREFITEIMT 95
            T+      KIG G FG V++    +   +A+K   +          ++   E + EI+ 
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 96  LSNV---------RHPNLVELIGC-CVQGTRR---ILVYEY--VENNSLDRVLLGATKAN 140
              +         R    + L    CVQG+     +  +++      S +          
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 141 I-------------------KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 181
           +                     +      I   +   LA     L     HRD+   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVL 194

Query: 182 LDQEFNPKIGDFGLAKLF--------PDNITHITTRIAGTTGYL-----APEYVLGGQLT 228
           L +    K+      K             I +  +R+      +       E +  G   
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGD 254

Query: 229 MKADVYSF 236
            + D+Y  
Sbjct: 255 YQFDIYRL 262

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.6 bits (191), Expect = 7e-16
 Identities = 35/164 (21%), Positives = 75/164 (45%), Gaps = 24/164 (14%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS------AESKQGVREFITEIMTLS 97
            D + + + IG G +G V +       R +A+K +        + K+ +RE    I  L+
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE----IAILN 107

Query: 98  NVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 152
            + H ++V+++   +           +V E  +++   ++     +  + L       + 
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLF----RTPVYLTELHIKTLL 162

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA 196
             +  G+ ++H      I+HRD+K +N L++Q+ + K+ DFGLA
Sbjct: 163 YNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 32/217 (14%)

Query: 53  KIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC 111
           K+G G F TV+    + N   +A+K +  + K        EI  L  V   +  +     
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 112 VQGTRRILVYEYVENNS----------LDRVLLGATKAN----IKLNWEKRSDICVGIAK 157
                ++L +   +  +          L   LL   K      I L + K+  I   +  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQLLL 142

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNP------KIGDFGLAKLFPDNIT-HITTRI 210
           GL ++H      I+H DIK  N+L++   +P      KI D G A  + ++ T  I TR 
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200

Query: 211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
                Y +PE +LG      AD++S   L+ E+I+G 
Sbjct: 201 -----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 44/234 (18%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS------AESKQGVREFITEIMTLS 97
              + L  K+G+G +G V+K      G  +AVK +        ++++  RE    IM L+
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE----IMILT 63

Query: 98  NVR-HPNLVELIGCCV-QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
            +  H N+V L+        R + LV++Y+E + L  V+    +ANI L    +  +   
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVI----RANI-LEPVHKQYVVYQ 117

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT- 213
           + K + +LH      ++HRD+K SNILL+ E + K+ DFGL++ F +             
Sbjct: 118 LIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 214 -------------TGYL------APEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
                        T Y+      APE +LG    T   D++S G ++ EI+ G+
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 32/189 (16%), Positives = 61/189 (32%), Gaps = 44/189 (23%)

Query: 48  FHLSNKIGRGGFGTVYKGT---------LTNGRRIAVK------PLSAESKQGVREF--- 89
           + L +   R   G +Y+               ++ ++K       L  E     R     
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 90  -ITEIMTLSNVRHPNLVELIGCCVQGTR-RILVYEYVENNSLDRVLLGATKANIKLNWEK 147
            + +   L +     +   +G  V   + R LV             LG +  +  L+   
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSLQSA-LDVSP 152

Query: 148 RSD--------ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI--GDFGLAK 197
           +          +   +   L FLHE      VH ++ A NI +D E   ++    +G A 
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

Query: 198 LFPDNITHI 206
            +  +  H+
Sbjct: 210 RYCPSGKHV 218

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 46/191 (24%), Positives = 83/191 (43%), Gaps = 40/191 (20%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRH-PN 103
           + +  +IG G FG +++GT L N +++A+K  P  +++ Q   E       L+     PN
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDE-YRTYKLLAGCTGIPN 70

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS-------DICVGIA 156
              +     +G   +LV +          LLG +  ++ L+   R             + 
Sbjct: 71  ---VYYFGQEGLHNVLVID----------LLGPSLEDL-LDLCGRKFSVKTVAMAAKQML 116

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPK-----IGDFGLAKLFPDNIT--HITTR 209
             +  +HE+    +V+RDIK  N L+ +  +       + DFG+ K + D +T  HI  R
Sbjct: 117 ARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173

Query: 210 ----IAGTTGY 216
               ++GT  Y
Sbjct: 174 EKKNLSGTARY 184

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 68.0 bits (166), Expect = 9e-13
 Identities = 52/277 (18%), Positives = 90/277 (32%), Gaps = 96/277 (34%)

Query: 45  TDDFHLSNKIGRGGFGTVYKG-TLTNGRRIAVKPLSAESK---QGVREF-ITEIMTLSNV 99
              +H+  K+G G F TV+    +   + +A+K + +        + E  + + +  S+ 
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDP 95

Query: 100 RHPNLVELIGCCVQ-----------GTRRILVYE--------YVENNSLDRVLLGATKAN 140
             PN        VQ           GT   +V+E        ++  ++   + L   K  
Sbjct: 96  NDPNR----EMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK- 150

Query: 141 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL------------------ 182
                     I   + +GL +LH +    I+H DIK  NILL                  
Sbjct: 151 ----------IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198

Query: 183 -------------------------------DQEFNPKIGDFGLAKLFPDNITH-ITTRI 210
                                           ++   KI D G A     + T  I TR 
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ 258

Query: 211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
                Y + E ++G      AD++S   +  E+ +G 
Sbjct: 259 -----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 43/190 (22%), Positives = 72/190 (37%), Gaps = 38/190 (20%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREF-ITEIMTLSNVRH-PNL 104
           F +  KIG G FG +  G  L     +A+K    +S+             L +    P +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS-------DICVGIAK 157
                    G    +V E          LLG +  ++  +   R+        I + +  
Sbjct: 71  ---YYFGPCGKYNAMVLE----------LLGPSLEDL-FDLCDRTFSLKTVLMIAIQLIS 116

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK-----IGDFGLAKLFPDNIT--HITTR- 209
            + ++H +   ++++RD+K  N L+ +  N       I DF LAK + D  T  HI  R 
Sbjct: 117 RMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173

Query: 210 ---IAGTTGY 216
              + GT  Y
Sbjct: 174 HKSLTGTARY 183

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 58/289 (20%), Positives = 96/289 (33%), Gaps = 65/289 (22%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVK----------PLSAESK-----QGVREFIT 91
           + L  KIG GGFG +Y         + A            PL +E K        ++ I 
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDCIK 97

Query: 92  EIMTLSNVRHPNLVELIGCCVQGTR----RILVYEYVENNSLDRVLLGATKANIKLNWEK 147
           + +    + +  +    G  +   +    R +V E           LG     I      
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME----------RLGIDLQKI-SGQNG 146

Query: 148 R-SDICV-GIA----KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI--GDFGLAKLF 199
                 V  +       L ++HE      VH DIKA+N+LL  +   ++   D+GL+  +
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

Query: 200 PDNITHI------TTRIAGTTGYLAPEYV-----LGGQLTMKADVYSFGVLVLEIISGRN 248
             N  H            GT      E+       G  L+ ++DV   G  +L  + G  
Sbjct: 204 CPNGNHKQYQENPRKGHNGTI-----EFTSLDAHKGVALSRRSDVEILGYCMLRWLCG-- 256

Query: 249 SGKAMWGQMNKFLLEWAWQLHQ--EEKPLELVDPELGEYPPNEIIRYMK 295
             K  W Q  K  +          +E P  ++          EI +++ 
Sbjct: 257 --KLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLV 303

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 40/213 (18%)

Query: 54  IGRGGFGTVYKGT-LTNGRRIAVKPLSAESK---QGVREFITEIMTLSNVRHP----NLV 105
           IG+G FG V K       + +A+K +  E +   Q   E    I+     +      N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE--IRILEHLRKQDKDNTMNVI 162

Query: 106 ELIG--------CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
            ++         C       + +YE ++ N      L   +                I +
Sbjct: 163 HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK-----------FAHSILQ 211

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNI-THITTRIAGTT 214
            L  LH+     I+H D+K  NILL Q+     K+ DFG +      + T+I +R     
Sbjct: 212 CLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF---- 264

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
            Y APE +LG +  M  D++S G ++ E+++G 
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.7 bits (158), Expect = 6e-12
 Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 36/188 (19%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNL 104
           + L  KIG G FG +Y GT +  G  +A+K   +  +  Q   E       +       +
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGG--VGI 67

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS-------DICVGIAK 157
             +  C  +G   ++V E          LLG +  ++  N+  R         +   +  
Sbjct: 68  PTIRWCGAEGDYNVMVME----------LLGPSLEDL-FNFCSRKFSLKTVLLLADQMIS 116

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK---IGDFGLAKLFPDNIT--HITTR--- 209
            + ++H +   + +HRD+K  N L+          I DFGLAK + D  T  HI  R   
Sbjct: 117 RIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173

Query: 210 -IAGTTGY 216
            + GT  Y
Sbjct: 174 NLTGTARY 181

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 37/189 (19%), Positives = 68/189 (35%), Gaps = 44/189 (23%)

Query: 48  FHLSNKIGRGGFGTVYKGTLTNGRRIAVK-------------PLSAESKQ----GVREFI 90
           + +   IG+GGFG +Y   + +   +                PL  E K        E I
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 91  TEIMTLSNVRHPNLVELIGCCVQGTR----RILVYEYVENNSLDRVLLGATKANIKLNWE 146
            + +    +++  + +  G  +        R ++ +            G+    I     
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMD----------RFGSDLQKI-YEAN 145

Query: 147 KR--SDICV-GIA----KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI--GDFGLAK 197
            +  S   V  ++      L ++HE      VH DIKASN+LL+ +   ++   D+GLA 
Sbjct: 146 AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

Query: 198 LFPDNITHI 206
            +     H 
Sbjct: 203 RYCPEGVHK 211

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 49/188 (26%), Positives = 74/188 (39%), Gaps = 36/188 (19%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNL 104
           F L  KIG G FG +Y GT +     +A+K   +  +  Q + E       L       +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI-YRILQGG--TGI 65

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS-------DICVGIAK 157
             +    V+G   +LV +          LLG +  ++  N+  R         +   +  
Sbjct: 66  PNVRWFGVEGDYNVLVMD----------LLGPSLEDL-FNFCSRKLSLKTVLMLADQMIN 114

Query: 158 GLAFLHEELVPHIVHRDIKASNILLDQEFNPK---IGDFGLAKLFPDNIT--HITTR--- 209
            + F+H +     +HRDIK  N L+          I DFGLAK + D  T  HI  R   
Sbjct: 115 RVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171

Query: 210 -IAGTTGY 216
            + GT  Y
Sbjct: 172 NLTGTARY 179

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 50/221 (22%), Positives = 83/221 (37%), Gaps = 42/221 (19%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESK---QGVREFITEIMTLSNVRHP- 102
           + + + IG+G FG V K         +A+K +  +     Q       E+  L  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHD 111

Query: 103 -----NLVELIG--------CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 149
                 +V L          C V       +Y+ + N +   V L  T+           
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK---------- 161

Query: 150 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNI-THI 206
                +   L FL    +  I+H D+K  NILL        KI DFG +      I  +I
Sbjct: 162 -FAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219

Query: 207 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
            +R      Y +PE +LG    +  D++S G +++E+ +G 
Sbjct: 220 QSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.1 bits (142), Expect = 1e-09
 Identities = 63/388 (16%), Positives = 115/388 (29%), Gaps = 113/388 (29%)

Query: 4   RCFGGSRFHSKKSAEREAPQGVDGELLRNVNHFSYTELRSATDDF-HLSNKIGRGGFGTV 62
           R +  ++  +K +  R  P       LR     +  ELR A +         G  G G  
Sbjct: 118 RLYNDNQVFAKYNVSRLQPY----LKLRQ----ALLELRPAKNVLID-----GVLGSG-- 162

Query: 63  YKGTLTNGRRIAVKPLSAESKQGVREFITEI--MTLSNVRHPNLVELIGCCVQGTRRILV 120
            K  +      A+    +   Q   +F  +I  + L N   P  V               
Sbjct: 163 -KTWV------ALDVCLSYKVQCKMDF--KIFWLNLKNCNSPETV--------------- 198

Query: 121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 180
            E ++       LL      I  NW  RSD    I   +  +  EL   +  +  +   +
Sbjct: 199 LEMLQK------LL----YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248

Query: 181 LLDQEFNPKIGDFGLAKLFPDNI---THITTRIAGTTGYLAPEY---------------- 221
           +L    N K         F  N+     +TTR    T +L+                   
Sbjct: 249 VLLNVQNAKA-----WNAF--NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301

Query: 222 ----VLGGQLTMKAD-----VYSFGVLVLEIISGR-NSGKAMWGQMNKFLLEWAWQLHQE 271
               +L   L  +       V +     L II+     G A W           W+    
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN---------WKHVNC 352

Query: 272 EKPLELVDPELGEYPPNEI-IRYMKVAFFCTQAAASRRPQMN---QVIKMLTKNIRLNEE 327
           +K   +++  L    P E    + +++ F         P  +    ++ ++  ++  ++ 
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKMFDRLSVF--------PPSAHIPTILLSLIWFDVIKSDV 404

Query: 328 ELTAPGLFQDSESSSVGTSDKKSSDSTL 355
            +            S+     K S  ++
Sbjct: 405 MVVV----NKLHKYSLVEKQPKESTISI 428

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 46/246 (18%), Positives = 77/246 (31%), Gaps = 78/246 (31%)

Query: 48  FHLSNKIGRGGFGTVYKG--TLTNGRRIAVKPLSAESK---QGVREFITEIMTLSNVR-- 100
           + +   +G G FG V +         ++A+K +    K           EI  L  ++  
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEK 76

Query: 101 -------------------HPNLV-ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN 140
                              H  +  EL+G           +E+++ N+     L   +  
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELLGKNT--------FEFLKENNFQPYPLPHVRH- 127

Query: 141 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP------------ 188
                     +   +   L FLHE     + H D+K  NIL                   
Sbjct: 128 ----------MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174

Query: 189 -------KIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 240
                  ++ DFG A    ++  T + TR      Y  PE +L        DV+S G ++
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCIL 229

Query: 241 LEIISG 246
            E   G
Sbjct: 230 FEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 49.2 bits (118), Expect = 8e-07
 Identities = 52/246 (21%), Positives = 85/246 (34%), Gaps = 78/246 (31%)

Query: 48  FHLSNKIGRGGFGTVYKG--TLTNGRRIAVKPLSAESK---QGVREFITEIMTLSNVR-- 100
           + + + +G G FG V +       GR +AVK +    +          +EI  L ++   
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTT 71

Query: 101 -------------------HPNLV-ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN 140
                              H  +V EL+G           Y++++ N      L   +  
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELLGLST--------YDFIKENGFLPFRLDHIRK- 122

Query: 141 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP------------ 188
                     +   I K + FLH      + H D+K  NIL  Q                
Sbjct: 123 ----------MAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169

Query: 189 -------KIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 240
                  K+ DFG A    ++  T ++TR      Y APE +L    +   DV+S G ++
Sbjct: 170 TLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQPCDVWSIGCIL 224

Query: 241 LEIISG 246
           +E   G
Sbjct: 225 IEYYLG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 55/250 (22%), Positives = 86/250 (34%), Gaps = 82/250 (32%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESK---QGVREFITEIMTLSNVR--- 100
           F +  K+G G FG V     + N +  AVK +    K           E   L  ++   
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDD 92

Query: 101 -----------------HPNLV-ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 142
                            H  L+ E +G  +        YE +  N+ +   +   K    
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPLGPSL--------YEIITRNNYNGFHIEDIKL--- 141

Query: 143 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-------------- 188
                    C+ I K L +L +     + H D+K  NILLD  +                
Sbjct: 142 --------YCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190

Query: 189 -----------KIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 236
                      K+ DFG A    D   + I TR      Y APE +L     + +D++SF
Sbjct: 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPEVILNLGWDVSSDMWSF 245

Query: 237 GVLVLEIISG 246
           G ++ E+ +G
Sbjct: 246 GCVLAELYTG 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	370
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.48
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.13
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.83
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.68
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.66
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.61
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.38
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.23
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.22
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.16
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.95
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.85
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.76
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.69
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.67
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.54
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.5
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.44
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.38
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.34
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.27
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.08
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.84
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.19
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.62
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	93.89
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.62
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.11

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.3e-58  Score=420.98  Aligned_cols=262  Identities=25%  Similarity=0.404  Sum_probs=210.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .++|.+.++||+|+||+||+|+++      +++.||||+++..+....+.|.+|+++|++++|||||+++++|.+....+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            367888999999999999999864      47789999998777777788999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhccccc-----------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          119 LVYEYVENNSLDRVLLGATK-----------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                      +|||||++|+|.+++.....           ....++|.+++.|+.||+.||.|||+.   +|+||||||+||||+.++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence            99999999999999965432           234689999999999999999999999   9999999999999999999


Q ss_pred             eEEeeecCccccCCCC-cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHH
Q 017503          188 PKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWA  265 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~  265 (370)
                      +||+|||+++...... ........||+.|+|||++.+..++.++|||||||+||||+| |+.||.....   ..+...+
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i  273 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCI  273 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence            9999999998664432 223344678999999999999999999999999999999999 8999865422   1222211


Q ss_pred             HHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          266 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                          .....        ...+..++.++.+++.+||+.||.+|||+.||++.|+.+...
T Consensus       274 ----~~g~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          274 ----TQGRE--------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ----HHTCC--------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----HcCCC--------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                11111        122333445688899999999999999999999999988764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5e-58  Score=414.23  Aligned_cols=261  Identities=24%  Similarity=0.432  Sum_probs=215.0

Q ss_pred             cCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++.......+.|.+|+++|++++|||||+++++|.+.+..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57889999999999999999864      367899999987777777889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccc---------cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEE
Q 017503          120 VYEYVENNSLDRVLLGAT---------KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI  190 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL  190 (370)
                      |||||++|+|.+++....         .....++|..++.++.||+.||.|||++   +|+||||||+||||+.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence            999999999999995432         2345699999999999999999999999   9999999999999999999999


Q ss_pred             eeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHH
Q 017503          191 GDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       191 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      +|||+++........ ......||+.|+|||++.+..++.++|||||||+||||+| |+.||.....   ..+...   .
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~---i  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIEC---I  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHH---H
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH---H
Confidence            999999866443222 2233468999999999999999999999999999999999 8999865422   222221   1


Q ss_pred             HhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      . ....        ...+..++.++.+++.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       244 ~-~~~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          244 T-QGRV--------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             H-HTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H-cCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            1 1111        122334445688999999999999999999999999987653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-55  Score=399.16  Aligned_cols=261  Identities=26%  Similarity=0.444  Sum_probs=207.2

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ..+++++.++||+|+||+||+|+++  ..||||+++..  +....+.|.+|+.+|++++|||||++++++.+ +..++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            3578889999999999999999975  36999988643  34556789999999999999999999998764 5689999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      |||++|+|.+++.   .....+++..++.|+.||+.||.|||++   +|+||||||+||||++++.+||+|||+++....
T Consensus       111 Ey~~gGsL~~~l~---~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          111 QWCEGSSLYKHLH---VQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             ECCSSCBHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EcCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            9999999999984   2345699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CC-cceeecccCCCCCCCcccccC---CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          202 NI-THITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       202 ~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      .. ........||+.|+|||++.+   +.|+.++|||||||+||||+||+.||.......  .    ........    .
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~----~~~~~~~~----~  254 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--Q----IIFMVGRG----Y  254 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--H----HHHHHHTT----C
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--H----HHHHHhcC----C
Confidence            32 223445679999999999864   468999999999999999999999986543211  1    11111111    1


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      ..+.+...+.+++..+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       255 ~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          255 ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            1223334445556678899999999999999999999999987653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.5e-57  Score=407.89  Aligned_cols=259  Identities=23%  Similarity=0.397  Sum_probs=211.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      ..++++.+.||+|+||+||+|.+.      +++.||||.++.. .....+.|.+|+.++++++|||||+++|+|.+.+..
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            355778899999999999999863      4678999998755 334567899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC
Q 017503          118 ILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE  185 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~  185 (370)
                      ++|||||++|+|.+++.....            ....++|..++.|+.||+.||.|||++   +|+||||||+||||+++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK  181 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC
Confidence            999999999999999954321            134689999999999999999999999   99999999999999999


Q ss_pred             CCeEEeeecCccccCCCC-cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHH
Q 017503          186 FNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLE  263 (370)
Q Consensus       186 ~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~  263 (370)
                      +.+||+|||+++...... ........||+.|+|||++.++.++.++|||||||+||||+| |..||.....   ..+..
T Consensus       182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~  258 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVE  258 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHH
T ss_pred             CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHH
Confidence            999999999998654322 223344678999999999999999999999999999999998 8889865432   22222


Q ss_pred             HHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          264 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                          .......        ...+.+++..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       259 ----~i~~~~~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          259 ----MIRNRQV--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ----HHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----HHHcCCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                1222211        123344556688999999999999999999999999764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.3e-57  Score=414.85  Aligned_cols=251  Identities=23%  Similarity=0.373  Sum_probs=203.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .++|++++.||+|+||+||+|+++ +|+.||||++...  .......+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            378999999999999999999985 6899999998654  3445677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      |||++|+|.+++..  ..+..+++..++.|+.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++....
T Consensus       103 Ey~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          103 DYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             ECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             eCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            99999999999842  2344678999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .. ......+||+.|+|||++.+..|+.++|||||||+||||+||+.||.....   ..+   .........        
T Consensus       178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~---~~~i~~~~~--------  242 (350)
T 4b9d_A          178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNL---VLKIISGSF--------  242 (350)
T ss_dssp             HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH---HHHHHHTCC--------
T ss_pred             Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHH---HHHHHcCCC--------
Confidence            21 123346799999999999999999999999999999999999999965321   111   122222211        


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       ...+......+.+|+.+||+.||.+|||+.|+++
T Consensus       243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1122233445889999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-55  Score=403.01  Aligned_cols=250  Identities=22%  Similarity=0.384  Sum_probs=208.3

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      +.|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999986 68999999987655445566889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++|+|.+++..     ..+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||++..+.....
T Consensus       154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            99999999832     3589999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                       .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.....   .....   .... ...     +.+ .
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~---~i~~-~~~-----~~~-~  291 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMK---MIRD-NLP-----PRL-K  291 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH---HHHH-SSC-----CCC-S
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHH---HHHc-CCC-----CCC-C
Confidence             23456899999999999999999999999999999999999999864321   11111   1111 111     111 1


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ........+.+|+.+||+.||.+|||+.|+++.
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            122334558899999999999999999998763

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-55  Score=402.39  Aligned_cols=256  Identities=23%  Similarity=0.314  Sum_probs=208.8

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ..+.|++.++||+|+||.||+|+++ +|+.||||+++.+..     ..+|+.+|+.++|||||++++++.+.+..|||||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            3467889999999999999999986 689999999875432     2369999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-CeEEeeecCccccCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPD  201 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~  201 (370)
                      ||++|+|.+++.    ....+++..+..++.||+.||.|||++   +|+||||||+||||+.++ .+||+|||+++.+..
T Consensus       131 y~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          131 LLEGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             ccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            999999999993    345699999999999999999999999   999999999999999887 599999999987654


Q ss_pred             CCcc----eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          202 NITH----ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       202 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ....    .....+||+.|+|||++.+..|+.++|||||||++|||+||++||.......   +..   .........  
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~---~i~~~~~~~--  275 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCL---KIASEPPPI--  275 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHH---HHHHSCCGG--
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHH---HHHcCCCCc--
Confidence            3211    1233579999999999999999999999999999999999999996543221   111   111221111  


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                           ...++.....+.+++.+||+.||.+|||+.||++.|...+..
T Consensus       276 -----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          276 -----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             -----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence                 122334445688999999999999999999999999887753

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.2e-55  Score=396.45  Aligned_cols=249  Identities=21%  Similarity=0.332  Sum_probs=208.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||+||+|+++ +++.||||++...   .....+.+.+|+++|++++|||||++++++.+.+..|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            367999999999999999999985 6899999998643   234467789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      ||||++|+|.+++.    ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++..+.
T Consensus       111 mEy~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          111 LSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             ECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            99999999999993    345799999999999999999999999   99999999999999999999999999999775


Q ss_pred             CCC-cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          201 DNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       201 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ... .......+||+.|+|||++.+..|+.++||||+||++|+|++|+.||....   ...+..   .......      
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~---~i~~~~~------  251 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFA---KIIKLEY------  251 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHTCC------
T ss_pred             CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HHHcCCC------
Confidence            432 233455789999999999999999999999999999999999999996432   112221   1111111      


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                          .++.....++.+|+.+||+.||.+|||+.|++.
T Consensus       252 ----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          252 ----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             ----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             ----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence                112223345889999999999999999998743

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.3e-54  Score=404.79  Aligned_cols=250  Identities=22%  Similarity=0.387  Sum_probs=208.0

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      +.|++.+.||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999986 68999999987665555567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++|+|.+++.     ...+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||+|||++..+.....
T Consensus       231 ~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          231 EGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             TTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            9999999983     23589999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|.+||.....   .....   .... ...     +.+ .
T Consensus       303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~---~i~~-~~~-----~~~-~  368 (423)
T 4fie_A          303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMK---MIRD-NLP-----PRL-K  368 (423)
T ss_dssp             -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH---HHHH-SCC-----CCC-S
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHH---HHHc-CCC-----CCC-c
Confidence             23456799999999999999999999999999999999999999864321   11111   1111 111     111 1


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ........+.+|+.+||+.||.+|||+.|+++.
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            112233458899999999999999999998763

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-53  Score=383.09  Aligned_cols=247  Identities=26%  Similarity=0.385  Sum_probs=197.8

Q ss_pred             cCC-cccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe----CCee
Q 017503           46 DDF-HLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRR  117 (370)
Q Consensus        46 ~~y-~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~  117 (370)
                      ++| ++.+.||+|+||+||+|.++ ++..||+|.+...  .....+.+.+|+.+|++++|||||++++++.+    ....
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            344 67788999999999999986 5889999988643  34445678999999999999999999999875    3467


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeecCCCCceEeC-CCCCeEEeeec
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLD-QEFNPKIGDFG  194 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~dlkp~Nill~-~~~~~kL~Dfg  194 (370)
                      |+|||||++|+|.+++.    ....+++..+..++.||+.||.|||++   +  |+||||||+||||+ .++.+||+|||
T Consensus       105 ~lvmEy~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCc
Confidence            99999999999999994    345789999999999999999999998   6  99999999999998 47899999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      ++......   ......||+.|+|||++.+ .|+.++|||||||+||||+||+.||......  ..    ..........
T Consensus       178 la~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~----~~~~i~~~~~  247 (290)
T 3fpq_A          178 LATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQ----IYRRVTSGVK  247 (290)
T ss_dssp             GGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HH----HHHHHTTTCC
T ss_pred             CCEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HH----HHHHHHcCCC
Confidence            99864432   2345679999999998865 6999999999999999999999998643221  11    1111222111


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ....       +.....++.+++.+||+.||.+|||+.|+++
T Consensus       248 ~~~~-------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          248 PASF-------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CGGG-------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCC-------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111       1112234788999999999999999999975

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-54  Score=400.76  Aligned_cols=272  Identities=25%  Similarity=0.394  Sum_probs=219.2

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEECC------CCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCC-CCccee
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAES-KQGVREFITEIMTLSNVRH-PNLVEL  107 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~iv~~  107 (370)
                      ++.+.++...++|++.+.||+|+||+||+|.+..      ++.||||.+.... ....+.+.+|+.+|.++.| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4556677778899999999999999999998642      3579999987653 3445678999999999965 999999


Q ss_pred             eeEEEeC-CeeEEEEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeec
Q 017503          108 IGCCVQG-TRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD  174 (370)
Q Consensus       108 ~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~d  174 (370)
                      +++|.+. ...++|||||++|+|.+++.....            ....+++..++.++.||+.||.|||++   +|+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            9999764 568999999999999999964322            134589999999999999999999999   999999


Q ss_pred             CCCCceEeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCc
Q 017503          175 IKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKA  252 (370)
Q Consensus       175 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~  252 (370)
                      |||+|||+++++.+||+|||+++........ ......||+.|+|||++.+..|+.++|||||||+||||+| |..||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876544332 3344678999999999999999999999999999999998 8999865


Q ss_pred             ccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          253 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      ....  ..+.    .........        ..+..+..++.+++.+||+.||.+|||+.+|++.|+.+++.
T Consensus       291 ~~~~--~~~~----~~i~~g~~~--------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          291 VKID--EEFC----RRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCCS--HHHH----HHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHH--HHHH----HHHHcCCCC--------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            4321  1111    122222111        12233344588889999999999999999999999988764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5e-54  Score=382.31  Aligned_cols=247  Identities=23%  Similarity=0.366  Sum_probs=190.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++...   .......+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999975 6899999998654   234456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+ +|+|.+++.    ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        92 mEy~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           92 IEYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             EECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             EeCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            9999 568888883    345799999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ...  ......||+.|+|||++.+..+ +.++||||+||++|+|+||+.||....   ...+..   .... ...     
T Consensus       164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~~---~i~~-~~~-----  229 (275)
T 3hyh_A          164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLFK---NISN-GVY-----  229 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHH-TCC-----
T ss_pred             CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHH---HHHc-CCC-----
Confidence            322  2334679999999999998876 579999999999999999999986432   111111   1111 111     


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                          .++......+.+++.+||+.||.+|||+.|+++.
T Consensus       230 ----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          230 ----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                1122233457889999999999999999999874

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.7e-53  Score=385.39  Aligned_cols=267  Identities=26%  Similarity=0.337  Sum_probs=201.6

Q ss_pred             cCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----eeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT----RRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~  121 (370)
                      ++|.+.+.||+|+||+||+|+++ |+.||||++...... ......|+..+.+++||||+++++++.+.+    ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            56889999999999999999985 889999998755332 122334666667889999999999998654    579999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-----VPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      ||+++|+|.+++.     ...+++..+++++.|++.||+|||++.     .++|+||||||+||||+.++.+||+|||++
T Consensus        81 Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           81 DYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999994     235899999999999999999999752     338999999999999999999999999999


Q ss_pred             cccCCCCcc---eeecccCCCCCCCcccccCC------CcCccccchhhhHHHHHHHhCCCCCCcccccchh--------
Q 017503          197 KLFPDNITH---ITTRIAGTTGYLAPEYVLGG------QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--------  259 (370)
Q Consensus       197 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~--------  259 (370)
                      +........   ......||+.|+|||++.+.      .++.++|||||||+||||+||.+|+.........        
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            876543322   12345799999999998764      4678999999999999999998776432211100        


Q ss_pred             hHHHHHHHHHhcCCCcccccCCCCC--CChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          260 FLLEWAWQLHQEEKPLELVDPELGE--YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      ............    ...++.++.  ...+.+..+.+++.+||+.||.+|||+.+|++.|+++..
T Consensus       236 ~~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          236 PSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            001111111111    112222221  123566778899999999999999999999999998765

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.1e-54  Score=386.45  Aligned_cols=247  Identities=25%  Similarity=0.293  Sum_probs=195.6

Q ss_pred             cCCcccceeeecCCeEEEEEEEC----CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ++|++.+.||+|+||+||+|+..    .++.||||++....  ......+.+|+++|++++|||||++++++.+.+..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            67999999999999999999863    46789999886542  2223457789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      |||||++|+|.+++.    ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       104 vmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999983    345799999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      .... .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.....   ..+..   .......      
T Consensus       177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~---~i~~~~~------  243 (304)
T 3ubd_A          177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMT---MILKAKL------  243 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHCCC------
T ss_pred             cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHH---HHHcCCC------
Confidence            4322 223446799999999999999999999999999999999999999865321   11221   1111111      


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCH-----HHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQM-----NQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  316 (370)
                          ..+.....++.+++.+||+.||.+|||+     +|+++
T Consensus       244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                1122233458899999999999999984     56654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.7e-52  Score=378.63  Aligned_cols=251  Identities=21%  Similarity=0.344  Sum_probs=188.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-------
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-------  115 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------  115 (370)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            356999999999999999999986 68999999886543 344567889999999999999999999987644       


Q ss_pred             -----eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEE
Q 017503          116 -----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI  190 (370)
Q Consensus       116 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL  190 (370)
                           .+|+|||||++|+|.+++.... ......+..++.++.||+.||+|||++   +|+||||||+|||++.++.+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence                 3689999999999999995322 122345677889999999999999999   9999999999999999999999


Q ss_pred             eeecCccccCCCCcc-----------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchh
Q 017503          191 GDFGLAKLFPDNITH-----------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK  259 (370)
Q Consensus       191 ~Dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~  259 (370)
                      +|||+++.+......           .....+||+.|+|||++.+..|+.++|||||||++|||++   ||....     
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----  231 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----  231 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----
Confidence            999999876543211           1233579999999999999999999999999999999996   554221     


Q ss_pred             hHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          260 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .......... ..        ..+.........+.+++.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~-~~--------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 ERVRTLTDVR-NL--------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHHHH-TT--------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHh-cC--------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111111111 11        111112333445678999999999999999999876

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.8e-51  Score=373.65  Aligned_cols=292  Identities=41%  Similarity=0.720  Sum_probs=245.0

Q ss_pred             cccccCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEE
Q 017503           32 NVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC  111 (370)
Q Consensus        32 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  111 (370)
                      ....+++.++..++++|++.+.||+|+||.||+|.+++++.||+|.+..........+.+|+.+++.++||||+++++++
T Consensus        25 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  104 (321)
T 2qkw_B           25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC  104 (321)
T ss_dssp             -----CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred             cceeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34567777888899999999999999999999999888999999998877666677889999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEe
Q 017503          112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG  191 (370)
Q Consensus       112 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~  191 (370)
                      .+.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEEC
T ss_pred             cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEe
Confidence            999999999999999999999865544455689999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCC-cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHh
Q 017503          192 DFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ  270 (370)
Q Consensus       192 Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  270 (370)
                      |||++....... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.............+......
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN  261 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence            999998654322 1223334588999999999989999999999999999999999999876555444444444444444


Q ss_pred             cCCCcccccCCC-CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCc
Q 017503          271 EEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  326 (370)
Q Consensus       271 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  326 (370)
                      ........++.+ ....+.....+.+++.+||+.||.+|||+.+|++.|+.+++..+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            455555555554 45678888999999999999999999999999999999887653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=372.97  Aligned_cols=262  Identities=21%  Similarity=0.338  Sum_probs=201.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe------CC
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ------GT  115 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~  115 (370)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++...  .......+.+|+.+|+.++|||||++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            468999999999999999999985 6899999998654  33445678899999999999999999999764      35


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      ..|+|||||+ |+|.+++    ..+..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~ivmE~~~-g~L~~~i----~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CEEEEEECCS-EEHHHHH----TSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEeCCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence            7899999996 5788888    3456799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCC---cceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc
Q 017503          196 AKLFPDNI---THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       196 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      ++.+....   .......+||+.|+|||++.+. .++.++||||+||++|||++|++||.....   ......+......
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~  281 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGT  281 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCC
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCC
Confidence            98664321   2233456899999999998775 569999999999999999999999864322   1122222221111


Q ss_pred             CCCccc-----------cc--CCCCC-----CChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          272 EKPLEL-----------VD--PELGE-----YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       272 ~~~~~~-----------~~--~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ......           +.  +....     ..+.....+.+|+.+||+.||.+|||+.|+++.
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            100000           00  00000     011223457899999999999999999998763

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-49  Score=366.21  Aligned_cols=294  Identities=43%  Similarity=0.735  Sum_probs=245.1

Q ss_pred             ccccccccCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcCh-hcHHHHHHHHHHHHhcCCCCccee
Q 017503           29 LLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVEL  107 (370)
Q Consensus        29 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~  107 (370)
                      .....+.|++.++..+.++|++.+.||+|+||.||+|.+.+++.||+|++..... .....+.+|+.+++.++||||+++
T Consensus        13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   92 (326)
T 3uim_A           13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL   92 (326)
T ss_dssp             --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred             ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence            3455788999999999999999999999999999999988899999999876532 223367889999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       108 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                      ++++......++||||+.+++|.+++.........+++..++.++.|++.||.|||+...++++||||||+||+++.++.
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence            99999999999999999999999999766666667999999999999999999999986568999999999999999999


Q ss_pred             eEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCccc--ccchhhHHHHH
Q 017503          188 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW--GQMNKFLLEWA  265 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~--~~~~~~~~~~~  265 (370)
                      +||+|||++...............||+.|+|||++.+..++.++||||||+++|+|++|..||....  .........+.
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            9999999998776555555555669999999999988899999999999999999999999986322  11222233333


Q ss_pred             HHHHhcCCCcccccCCC-CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          266 WQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       266 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      .............+..+ ...+......+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            33333444444445444 4567888899999999999999999999999999998743

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.8e-49  Score=364.26  Aligned_cols=204  Identities=28%  Similarity=0.411  Sum_probs=173.3

Q ss_pred             HHHHHhccCCcccceeeecCCeEEEEEEEC----CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 017503           39 TELRSATDDFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ  113 (370)
Q Consensus        39 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  113 (370)
                      +.+....++|++.+.||+|+||+||+|+++    .++.||+|.+....  ....+.+|+++|+.+ +||||+++++++.+
T Consensus        14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            344456789999999999999999999863    46789999876543  235678899999998 79999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC-CCeEEee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGD  192 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kL~D  192 (370)
                      .+..|+||||+++++|.+++.       .+++.++..++.||+.||+|||++   +|+||||||+|||++.+ +.+||+|
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred             CCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECc
Confidence            999999999999999999982       489999999999999999999999   99999999999999876 7999999


Q ss_pred             ecCccccCCCCc---------------------------ceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHH
Q 017503          193 FGLAKLFPDNIT---------------------------HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEII  244 (370)
Q Consensus       193 fg~~~~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell  244 (370)
                      ||+++.......                           ......+||+.|+|||++.+. .++.++||||+||++|||+
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence            999986543211                           112235699999999998775 4899999999999999999


Q ss_pred             hCCCCCCccc
Q 017503          245 SGRNSGKAMW  254 (370)
Q Consensus       245 tg~~p~~~~~  254 (370)
                      +|+.||....
T Consensus       242 ~G~~Pf~~~~  251 (361)
T 4f9c_A          242 SGRYPFYKAS  251 (361)
T ss_dssp             HTCSSSSCCS
T ss_pred             HCCCCCCCCC
Confidence            9999986543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.1e-48  Score=380.45  Aligned_cols=253  Identities=23%  Similarity=0.330  Sum_probs=209.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++.+.||+|+||.||+|+++ +|+.||+|++..........+.+|+.+|+.++||||+++++++.+....|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            478999999999999999999986 6899999998776666667888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC--CCeEEeeecCccccCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE--FNPKIGDFGLAKLFPD  201 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~--~~~kL~Dfg~~~~~~~  201 (370)
                      |++|+|.+++.   .....+++..+..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||++..+..
T Consensus       236 ~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          236 MSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             cCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            99999999883   2345699999999999999999999999   99999999999999854  8899999999997754


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      ..  .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.....   .....   .......  ...++.
T Consensus       310 ~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~~---~i~~~~~--~~~~~~  379 (573)
T 3uto_A          310 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLR---NVKSCDW--NMDDSA  379 (573)
T ss_dssp             TS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH---HHHTTCC--CCCSGG
T ss_pred             CC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHH---HHHhCCC--CCCccc
Confidence            32  23445799999999999999999999999999999999999999865422   11111   1111111  011111


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...    ....+.+|+.+||+.||.+|||+.|+++.
T Consensus       380 ~~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          380 FSG----ISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             GTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            112    23447899999999999999999999863

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-48  Score=381.49  Aligned_cols=249  Identities=24%  Similarity=0.295  Sum_probs=200.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHH---HHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREF---ITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++....   ......+   ..++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            478999999999999999999986 68999999986431   1222233   3346667778999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      |+||||+.||+|.+++.    ....+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||+|||++.
T Consensus       268 ylVmEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence            99999999999999993    345799999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      .+....   ....+||+.|+|||++.. ..|+.++|||||||+||||++|.+||..........+..   .......   
T Consensus       341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~~~~---  411 (689)
T 3v5w_A          341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTMAV---  411 (689)
T ss_dssp             ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHHCCC---
T ss_pred             ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcCCCC---
Confidence            765432   344689999999999975 579999999999999999999999997543332221111   1111111   


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCC-----HHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  316 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  316 (370)
                             .++.....++.+|+.+||+.||.+|++     +.||++
T Consensus       412 -------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          412 -------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                   122233445889999999999999998     677764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.3e-47  Score=344.71  Aligned_cols=261  Identities=26%  Similarity=0.473  Sum_probs=213.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+...+......+.+|+.++++++||||+++++++.+....++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            578999999999999999999985 6889999988777777778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999843   345689999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cce-------------eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHh
Q 017503          204 THI-------------TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ  270 (370)
Q Consensus       204 ~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  270 (370)
                      ...             .....||+.|+|||++.+..++.++||||||+++|+|++|..|+.............. .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~  241 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLD  241 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hcccc
Confidence            211             1145689999999999999999999999999999999999988765433221110000 00000


Q ss_pred             cCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      .            ..++.....+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       242 ~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          242 R------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             H------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            0            01122223478899999999999999999999999988653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-46  Score=343.35  Aligned_cols=270  Identities=29%  Similarity=0.465  Sum_probs=206.5

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQ  113 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  113 (370)
                      ++-.++....++|++.+.||+|+||.||+|++. +..||+|++....  ......+.+|+.++++++||||+++++++.+
T Consensus        27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             -----CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCcccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            444455555789999999999999999999884 7889999886553  3445678899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeecCCCCceEeCCCCCeEEe
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLDQEFNPKIG  191 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~dlkp~Nill~~~~~~kL~  191 (370)
                      ....++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.   +  ++||||||+||+++.++.+||+
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             CCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEEC
Confidence            999999999999999999984321 112489999999999999999999999   8  9999999999999999999999


Q ss_pred             eecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc
Q 017503          192 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       192 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      |||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......   .   .......
T Consensus       182 Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~---~~~~~~~  254 (309)
T 3p86_A          182 DFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---V---VAAVGFK  254 (309)
T ss_dssp             CCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---H---HHHHHHS
T ss_pred             CCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhc
Confidence            999997544322 12234568999999999999999999999999999999999999986543211   1   1111111


Q ss_pred             CCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      ...        ...+......+.+++.+||+.+|.+|||+.+|++.|+.++...
T Consensus       255 ~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          255 CKR--------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CCC--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            111        1222333445889999999999999999999999999988754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.7e-46  Score=337.24  Aligned_cols=252  Identities=23%  Similarity=0.413  Sum_probs=208.9

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            3578999999999999999999974 689999999876655556778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        98 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            9999999999842     2589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      .. ......||+.|+|||++.+..++.++||||||+++|+|++|..||........      ...........       
T Consensus       170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~~-------  235 (297)
T 3fxz_A          170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPE-------  235 (297)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSCC-------
T ss_pred             cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCC-------
Confidence            32 23345689999999999999999999999999999999999999865422111      11111111110       


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...+......+.+++.+||+.||.+|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11123344558899999999999999999999763

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-45  Score=333.85  Aligned_cols=263  Identities=25%  Similarity=0.386  Sum_probs=208.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||++++. ++..||+|.+...   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            578999999999999999999975 6889999987543   334456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999983    334689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ...........||+.|+|||.+.+..++.++||||||+++|+|++|..||......      ...........+ ...  
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~-~~~--  233 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSVP-NVT--  233 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCCC-CHH--
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccCC-Ccc--
Confidence            44333344456899999999999999999999999999999999999998654321      111122221111 110  


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCC-CHHHHHHHHHhhhccC
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRP-QMNQVIKMLTKNIRLN  325 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~~~~  325 (370)
                        .......+..+.+++.+||+.||.+|| ++.++.+.|..+....
T Consensus       234 --~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          234 --TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             --HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             --hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence              011222334588999999999999998 8999999998876543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=344.83  Aligned_cols=260  Identities=27%  Similarity=0.435  Sum_probs=210.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC----CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|++.+.||+|+||.||+|.+.    .+..||||.+... .......+.+|+.++++++||||+++++++.+....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467899999999999999999985    3456999998765 44455678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++++|.+++.   .....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus       128 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          128 VTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeeCCCCCcHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            999999999999984   2335689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcc--eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          200 PDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       200 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ......  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......   ....    .......  
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~----~~~~~~~--  272 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVIS----SVEEGYR--  272 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH----HHHTTCC--
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHH----HHHcCCC--
Confidence            543222  2222345778999999998999999999999999999999 99998654321   1111    1111111  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                            ...+......+.+++.+||+.+|.+|||+.+|++.|+.+....
T Consensus       273 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          273 ------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             ------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                  1122233455889999999999999999999999999988754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.8e-46  Score=335.26  Aligned_cols=259  Identities=24%  Similarity=0.400  Sum_probs=213.4

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..++|++.+.||+|+||.||+|.++++..||+|++..... ....+.+|+.++++++||||+++++++.+....++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            3578999999999999999999998888999999875532 346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++++|.+++..   .+..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           85 ISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             CTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             cCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            999999999842   234689999999999999999999999   99999999999999999999999999998776554


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   .   ..... ....        
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~~-~~~~--------  223 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---V---VLKVS-QGHR--------  223 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H---HHHHH-TTCC--------
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---H---HHHHH-cCCC--------
Confidence            444444556778999999998899999999999999999999 999986543211   1   11111 1111        


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      ...+......+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            011112234588899999999999999999999999887654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.5e-46  Score=349.84  Aligned_cols=262  Identities=26%  Similarity=0.429  Sum_probs=213.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC--------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT--------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQG  114 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  114 (370)
                      .++|++.+.||+|+||.||+|++.        ++..||+|++... .......+.+|+.+++.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            578999999999999999999862        3457999998765 334566789999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe
Q 017503          115 TRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL  182 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill  182 (370)
                      +..++||||+++|+|.+++.....            ....+++..++.++.||+.||.|||++   +|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            999999999999999999864332            123588999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhh
Q 017503          183 DQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKF  260 (370)
Q Consensus       183 ~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~  260 (370)
                      +.++.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||......   .
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence            9999999999999986654322 12233456788999999999999999999999999999999 99998654321   1


Q ss_pred             HHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          261 LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      +..    ......        ....+......+.+++.+||+.+|.+||++.++++.|+.++..
T Consensus       314 ~~~----~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          314 LFK----LLKEGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             HHH----HHHTTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH----HHhcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            111    111111        1122333445688999999999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.8e-45  Score=331.93  Aligned_cols=284  Identities=38%  Similarity=0.625  Sum_probs=231.3

Q ss_pred             cccccCHHHHHHhccCCccc------ceeeecCCeEEEEEEECCCCEEEEEECcCc----ChhcHHHHHHHHHHHHhcCC
Q 017503           32 NVNHFSYTELRSATDDFHLS------NKIGRGGFGTVYKGTLTNGRRIAVKPLSAE----SKQGVREFITEIMTLSNVRH  101 (370)
Q Consensus        32 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h  101 (370)
                      ....|++.++..++++|...      +.||+|+||.||+|.+ +++.||+|.+...    .......+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45779999999999998777      8999999999999997 4789999987643    23345678899999999999


Q ss_pred             CCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceE
Q 017503          102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL  181 (370)
Q Consensus       102 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nil  181 (370)
                      |||+++++++.+....++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.   +++||||||+||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence            999999999999999999999999999999985322 234689999999999999999999999   9999999999999


Q ss_pred             eCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhh
Q 017503          182 LDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF  260 (370)
Q Consensus       182 l~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~  260 (370)
                      ++.++.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||........  
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--  242 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--  242 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence            999999999999999876543222 2334568999999998764 588999999999999999999999875433211  


Q ss_pred             HHHHHHHHHhcC-CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          261 LLEWAWQLHQEE-KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       261 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      +..+........ .....+++.+...+......+.+++.+||+.+|.+|||+.+|++.|+++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            111111111111 122344555666778888899999999999999999999999999988753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-46  Score=335.86  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=212.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            578999999999999999999998889999999876532 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++++|.+++.   .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           88 EHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             TTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             CCCcHHHHHH---hcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            9999999984   2344689999999999999999999999   999999999999999999999999999987654333


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   ....   . ......        .
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~---~-~~~~~~--------~  226 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE---D-ISTGFR--------L  226 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---H-HHTTCC--------C
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHH---H-HhcCcc--------C
Confidence            33334456778999999998999999999999999999999 89998654221   1111   1 111111        1


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      ..+......+.+++.+||+.+|.+||++.++++.|+++..
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            1112223458889999999999999999999999998765

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.1e-46  Score=341.43  Aligned_cols=253  Identities=24%  Similarity=0.363  Sum_probs=207.5

Q ss_pred             HHHHhccCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe
Q 017503           40 ELRSATDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR  116 (370)
Q Consensus        40 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  116 (370)
                      +.....++|++.+.||+|+||.||+|.+ .+|+.||||++...  +......+.+|+.+++.++||||+++++++...+.
T Consensus         9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A            9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence            3344578999999999999999999998 47899999988654  34456678899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .++||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        89 ~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  161 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFS  161 (328)
T ss_dssp             EEEEECCCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred             EEEEEECCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence            999999999999999983    334689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccCCCcC-ccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      .......  ......||+.|+|||++.+..+. .++|||||||++|+|++|..||.....   ..+.   ........  
T Consensus       162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~---~~i~~~~~--  231 (328)
T 3fe3_A          162 NEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---KELR---ERVLRGKY--  231 (328)
T ss_dssp             GGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHCCC--
T ss_pred             eecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhCCC--
Confidence            8665432  23445799999999999888765 899999999999999999999865421   1111   11111111  


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                              ..+......+.+++.+||..||.+|||+.++++.
T Consensus       232 --------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 --------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             --------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             --------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                    1122233457889999999999999999999764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.4e-45  Score=334.43  Aligned_cols=265  Identities=22%  Similarity=0.376  Sum_probs=216.7

Q ss_pred             cccccCHHHHHHhccC----------CcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC
Q 017503           32 NVNHFSYTELRSATDD----------FHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR  100 (370)
Q Consensus        32 ~~~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~  100 (370)
                      ....|++++++.+++.          |+..+.||+|+||.||+|++. +|+.||||++..........+.+|+.++++++
T Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ  100 (321)
T ss_dssp             ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred             cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence            4467999999998875          778889999999999999986 78999999987766666778899999999999


Q ss_pred             CCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCce
Q 017503          101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI  180 (370)
Q Consensus       101 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Ni  180 (370)
                      ||||+++++++...+..++||||+++++|.+++.     ...+++..+..++.|++.||.|||+.   +++||||||+||
T Consensus       101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  172 (321)
T 2c30_A          101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI  172 (321)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            9999999999999999999999999999999983     34689999999999999999999999   999999999999


Q ss_pred             EeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhh
Q 017503          181 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF  260 (370)
Q Consensus       181 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~  260 (370)
                      +++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......   .
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~  248 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---Q  248 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---H
T ss_pred             EECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H
Confidence            9999999999999999876543222 23456899999999999999999999999999999999999998643221   1


Q ss_pred             HHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          261 LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      .   ...... ...     +.+ .........+.+++.+||+.||.+|||+.++++..
T Consensus       249 ~---~~~~~~-~~~-----~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          249 A---MKRLRD-SPP-----PKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             H---HHHHHH-SSC-----CCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             H---HHHHhc-CCC-----CCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            1   111111 111     111 11122334588899999999999999999998743

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.2e-45  Score=331.21  Aligned_cols=274  Identities=19%  Similarity=0.274  Sum_probs=217.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++.....  ...+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            57899999999999999999997 4688999998865432  24567899999999 89999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC-----eEEeeecCcc
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN-----PKIGDFGLAK  197 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~-----~kL~Dfg~~~  197 (370)
                      |+ +++|.+++..   .+..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.     +||+|||++.
T Consensus        87 ~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           87 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99 8999999842   244689999999999999999999999   9999999999999987776     9999999998


Q ss_pred             ccCCCCcc------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc
Q 017503          198 LFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       198 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      ........      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            76543221      223456899999999999999999999999999999999999999875443333332222221111


Q ss_pred             CCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCccccCCCCcc
Q 017503          272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLF  335 (370)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~p~~~  335 (370)
                      ......        ....+..+.+++.+||+.+|.+||++.+|++.|+++..........+..|
T Consensus       240 ~~~~~~--------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  295 (298)
T 1csn_A          240 TPLREL--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  295 (298)
T ss_dssp             SCHHHH--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             ccHHHH--------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence            111111        11223458889999999999999999999999999987654444444433

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.1e-45  Score=337.31  Aligned_cols=268  Identities=18%  Similarity=0.243  Sum_probs=214.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||.||+|++. +++.||||++.....  ...+.+|+.+++++ +||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            578999999999999999999974 688999998865432  23577899999999 99999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC-----eEEeeecCcc
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN-----PKIGDFGLAK  197 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~-----~kL~Dfg~~~  197 (370)
                      |+ +++|.+++..   ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.     +||+|||++.
T Consensus        86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           86 LL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             eC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99 8999999843   245799999999999999999999999   9999999999999998887     9999999998


Q ss_pred             ccCCCCcc------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc
Q 017503          198 LFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       198 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      .+......      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....................
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            76443221      123467899999999999999999999999999999999999999765433322222222111111


Q ss_pred             CCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCccccC
Q 017503          272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELT  330 (370)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~  330 (370)
                      ... ..    +..   ..+ .+.+++..||+.+|.+||++.+|++.|+++.........
T Consensus       239 ~~~-~~----~~~---~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~  288 (330)
T 2izr_A          239 TPI-EV----LCE---NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFD  288 (330)
T ss_dssp             SCH-HH----HTT---TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCH-HH----Hhc---cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence            111 00    001   112 688899999999999999999999999988765544333

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.3e-47  Score=342.24  Aligned_cols=265  Identities=24%  Similarity=0.397  Sum_probs=208.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEE-----CCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--CCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL-----TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~  117 (370)
                      .++|++.+.||+|+||.||++++     .+++.||+|++........+.+.+|+.++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            57899999999999999999984     2578999999987777777889999999999999999999999865  3558


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            999999999999999843   234589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCc--ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccch---------hhHHHHHH
Q 017503          198 LFPDNIT--HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN---------KFLLEWAW  266 (370)
Q Consensus       198 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~---------~~~~~~~~  266 (370)
                      .......  .......++..|+|||.+.+..++.++||||||+++|+|++|..|+........         ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            7654322  122234467789999999999999999999999999999999988765422110         00111111


Q ss_pred             HHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      .......        ....+......+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       243 ~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          243 ELLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhccC--------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            1111111        112233444568899999999999999999999999998865

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.1e-45  Score=336.28  Aligned_cols=254  Identities=23%  Similarity=0.320  Sum_probs=203.7

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            4579999999999999999999986 78899999886543 233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|.+++    .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..+..
T Consensus        85 e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           85 EYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             ECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            999999999888    3455699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCc-ceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          202 NIT-HITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       202 ~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......... ...    .......     
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~----~~~~~~~-----  227 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD----WKEKKTY-----  227 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHH----HHTTCTT-----
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHH----Hhccccc-----
Confidence            221 22334578999999999988775 78999999999999999999999755432221 111    1111000     


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         ..........+.+++.+||+.||.+|||+.|+++.
T Consensus       228 ---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence               01112333457889999999999999999999764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5e-46  Score=344.14  Aligned_cols=269  Identities=24%  Similarity=0.394  Sum_probs=214.8

Q ss_pred             HHHHHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEE
Q 017503           39 TELRSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCC  111 (370)
Q Consensus        39 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  111 (370)
                      ..+....++|++.+.||+|+||.||+|++.      +++.||+|++... .......+.+|+.++++++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            334455789999999999999999999975      2478999998765 344456789999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHhcccccC--------------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 017503          112 VQGTRRILVYEYVENNSLDRVLLGATKA--------------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIV  171 (370)
Q Consensus       112 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ii  171 (370)
                      .+....++||||+++++|.+++......                    ...+++..++.++.||+.||.|||+.   +++
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            9999999999999999999998543221                    25689999999999999999999999   999


Q ss_pred             eecCCCCceEeCCCCCeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCC
Q 017503          172 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNS  249 (370)
Q Consensus       172 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p  249 (370)
                      ||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999986543221 12233457889999999998899999999999999999999 9989


Q ss_pred             CCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          250 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      |.....   ....    ........        ...+......+.+++.+||+.+|.+||++.+|++.|+++....
T Consensus       277 ~~~~~~---~~~~----~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          277 YYGMAH---EEVI----YYVRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             TTTSCH---HHHH----HHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CCCCCh---HHHH----HHHhCCCc--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            865422   1111    11111111        1222333446888999999999999999999999999987644

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.2e-46  Score=347.69  Aligned_cols=261  Identities=25%  Similarity=0.374  Sum_probs=210.8

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ....++|++.+.||+|+||.||+|.++ +++.||+|.+... .......+.+|+.++++++||||+++++++.+....++
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            344678999999999999999999986 7899999998755 23344567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++++|.+++.   ..+..+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||++...
T Consensus       190 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          190 VMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             EEECCTTCBHHHHHH---HHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEcCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            999999999999984   2334689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCccee-ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          200 PDNITHIT-TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       200 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ........ ....+++.|+|||.+.++.++.++||||||+++|||++ |..||......   ...    ........   
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~----~~~~~~~~---  333 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTR----EFVEKGGR---  333 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHH----HHHHTTCC---
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCC---
Confidence            43321111 11234668999999998999999999999999999998 88888654321   111    11111111   


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                           ...+...+..+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       334 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          334 -----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                 11122334457889999999999999999999999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.2e-46  Score=337.40  Aligned_cols=259  Identities=22%  Similarity=0.384  Sum_probs=210.2

Q ss_pred             HhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ...++|++.+.||+|+||.||++.+.++..||+|++..... ....+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            34678999999999999999999999888999999876532 24678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus       100 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A          100 YMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             ccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999999843   244689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ..    ........     . 
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~-----~-  240 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TA----EHIAQGLR-----L-  240 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH----HHHHTTCC-----C-
T ss_pred             ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HH----HHHhcccC-----C-
Confidence            3233333456778999999998899999999999999999998 999986543211   11    11111110     1 


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                        ..+......+.+++.+||+.+|.+|||+.++++.|.++..
T Consensus       241 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          241 --YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             --CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence              1112223458889999999999999999999999998764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=328.58  Aligned_cols=274  Identities=22%  Similarity=0.253  Sum_probs=215.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC--eeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT--RRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv  120 (370)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            578999999999999999999986 58899999987543 344567789999999999999999999998765  77999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe----CCCCCeEEeeecCc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLA  196 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kL~Dfg~~  196 (370)
                      |||+++++|.+++..... ...+++..++.++.|++.||.|||+.   +++||||||+||++    +.++.+||+|||++
T Consensus        88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999854322 23389999999999999999999999   99999999999999    77788999999999


Q ss_pred             cccCCCCcceeecccCCCCCCCccccc--------CCCcCccccchhhhHHHHHHHhCCCCCCcccccch-hhHHHHHHH
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVL--------GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN-KFLLEWAWQ  267 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~  267 (370)
                      ........  .....||+.|+|||++.        +..++.++|||||||++|+|++|..||........ .........
T Consensus       164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            87654322  23356899999999886        57889999999999999999999999875443222 222221111


Q ss_pred             HHhcCCCccc---------cc---CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          268 LHQEEKPLEL---------VD---PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       268 ~~~~~~~~~~---------~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      ..........         ..   +............+.+++.+||+.||.+|||+.|+++...+....
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            1111100000         00   111345567778889999999999999999999999999877653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-45  Score=337.86  Aligned_cols=269  Identities=28%  Similarity=0.407  Sum_probs=208.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----eeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT----RRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv  120 (370)
                      .++|++.+.||+|+||.||+|++. ++.||||++...... ......|+.++++++||||+++++++.+..    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            578999999999999999999986 789999998765433 344556889999999999999999998744    46999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC-------CCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-------VPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      |||+++|+|.+++..     ..+++..++.++.|++.||.|||+..       .++++||||||+|||++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            999999999999832     34899999999999999999999851       227999999999999999999999999


Q ss_pred             cCccccCCCCcc-eeecccCCCCCCCcccccC-----CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHH----
Q 017503          194 GLAKLFPDNITH-ITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE----  263 (370)
Q Consensus       194 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~----  263 (370)
                      |++......... ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.............    
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            999876543322 2333568999999999876     356678999999999999999999987543322111110    


Q ss_pred             -----HHHHHHhcCCCcccccCCCCC--CChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          264 -----WAWQLHQEEKPLELVDPELGE--YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       264 -----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                           ..........    ..+.+..  ........+.+++.+||+.||.+|||+.+|++.|+++.+.
T Consensus       256 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          256 HPSLEDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                 0111111111    1111111  1234566799999999999999999999999999988754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-44  Score=328.48  Aligned_cols=260  Identities=25%  Similarity=0.382  Sum_probs=202.9

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHh--cCCCCcceeeeEEEeC----Cee
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSN--VRHPNLVELIGCCVQG----TRR  117 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~  117 (370)
                      ..++|++.+.||+|+||.||+|++ +++.||+|++....   ...+..|.+++..  ++||||+++++++...    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            467999999999999999999998 58899999986543   3445556666666  7999999999987653    457


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEeecCCCCceEeCCCCCeE
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH--------EELVPHIVHRDIKASNILLDQEFNPK  189 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~iiH~dlkp~Nill~~~~~~k  189 (370)
                      ++||||+++++|.+++.     ...+++..++.++.|++.||.|||        +.   +++||||||+|||++.++.+|
T Consensus        82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred             EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence            89999999999999992     346899999999999999999999        88   999999999999999999999


Q ss_pred             EeeecCccccCCCCcce---eecccCCCCCCCcccccCC------CcCccccchhhhHHHHHHHhC----------CCCC
Q 017503          190 IGDFGLAKLFPDNITHI---TTRIAGTTGYLAPEYVLGG------QLTMKADVYSFGVLVLEIISG----------RNSG  250 (370)
Q Consensus       190 L~Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~elltg----------~~p~  250 (370)
                      |+|||++..........   .....||+.|+|||++.+.      .++.++||||||+++|+|++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999997654433222   2234689999999999876      556799999999999999999          7777


Q ss_pred             CcccccchhhHHHHHHHHHhcCCCcccccCCC--CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          251 KAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL--GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      .......... .. .........    ..+.+  ..........+.+++.+||+.||.+|||+.+|++.|+++
T Consensus       234 ~~~~~~~~~~-~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPSF-ED-MRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCCH-HH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcch-hh-hhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            5443322211 11 111111111    11111  112345677899999999999999999999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.1e-44  Score=335.15  Aligned_cols=252  Identities=25%  Similarity=0.322  Sum_probs=205.2

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh------hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK------QGVREFITEIMTLSNVRHPNLVELIGCCVQGTR  116 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  116 (370)
                      ..++|++.+.||+|+||.||+++++ +|+.||+|++.....      .....+.+|+.++++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3578999999999999999999986 688999998865422      135678899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC----CeEEee
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----NPKIGD  192 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kL~D  192 (370)
                      .++||||+.+++|.+++    .....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++    .+||+|
T Consensus        90 ~~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           90 VVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEEECCCSCBHHHHH----TTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            99999999999999998    3445799999999999999999999999   999999999999998777    799999


Q ss_pred             ecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          193 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       193 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      ||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....   .....   .... .
T Consensus       163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~~~~---~i~~-~  233 (361)
T 2yab_A          163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLA---NITA-V  233 (361)
T ss_dssp             CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH---HHHT-T
T ss_pred             cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHh-c
Confidence            99998765432  22345699999999999999999999999999999999999999865321   11111   1111 1


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .. . .++   .........+.+++.+||..||.+|||+.++++
T Consensus       234 ~~-~-~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          234 SY-D-FDE---EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CC-C-CCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CC-C-CCc---hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00 0 000   000122345788999999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-45  Score=331.21  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=198.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEECC----CCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|..... .......+.+|+.++++++||||+++++++ ..+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence            45789999999999999999999753    456999988764 344456788999999999999999999997 456789


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence            99999999999999842   334689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      .............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....    ......   
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~----i~~~~~---  235 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGER---  235 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCC---
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHH----HHcCCC---
Confidence            65443333333456788999999998899999999999999999997 888986543221   1111    111111   


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                           ...++.....+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       236 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          236 -----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                 11223344558889999999999999999999999998865

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.4e-45  Score=344.99  Aligned_cols=260  Identities=27%  Similarity=0.446  Sum_probs=200.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC----CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|++.+.||+|+||.||+|+++    ++..||||.+... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            458999999999999999999865    5678999998765 34455678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++++|.+++.   ..+..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus       124 v~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          124 VTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEeCCCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999999999994   2344689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcce--eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          200 PDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       200 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      .......  .....+++.|+|||++.+..++.++||||||+++|||++ |..||.....   ..+...    ......  
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~----i~~~~~--  268 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKA----VDEGYR--  268 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHH----HHTTEE--
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcCCC--
Confidence            5432211  122235678999999999999999999999999999998 9999864422   111111    111100  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                            ...+......+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus       269 ------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          269 ------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                  1112233455889999999999999999999999999987643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.9e-45  Score=333.94  Aligned_cols=266  Identities=28%  Similarity=0.415  Sum_probs=214.9

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ  113 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  113 (370)
                      +....++|++.+.||+|+||.||+|.+.      ++..||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            3344688999999999999999999862      3578999998765 34556778899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhccccc--------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATK--------------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR  173 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~  173 (370)
                      ....++||||+++++|.+++.....                    ....+++..++.++.|++.||.|||++   +++||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~  174 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR  174 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence            9999999999999999999964332                    123489999999999999999999999   99999


Q ss_pred             cCCCCceEeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCC
Q 017503          174 DIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  251 (370)
Q Consensus       174 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~  251 (370)
                      ||||+||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999876543322 2233456788999999999999999999999999999999 999986


Q ss_pred             cccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          252 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      ......   +..    .......        ...+......+.+++.+||+.||.+||++.+|++.|++++..
T Consensus       255 ~~~~~~---~~~----~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          255 GIPPER---LFN----LLKTGHR--------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             TCCGGG---HHH----HHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCHHH---HHH----HhhcCCc--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            543221   111    1111111        112233345588999999999999999999999999988653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-44  Score=333.19  Aligned_cols=249  Identities=28%  Similarity=0.335  Sum_probs=205.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||+++.+ +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            578999999999999999999986 6899999998654   234456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++|+|..++.    ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        84 ~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999999999883    344689999999999999999999999   99999999999999999999999999998543


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|..||.....   ..+..   .......       
T Consensus       157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~---~i~~~~~-------  222 (337)
T 1o6l_A          157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFE---LILMEEI-------  222 (337)
T ss_dssp             CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHCCC-------
T ss_pred             cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHHHH---HHHcCCC-------
Confidence            222 223345789999999999999999999999999999999999999864321   11111   1111111       


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  317 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  317 (370)
                         .++......+.+++.+||+.||.+||     ++.+|++.
T Consensus       223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence               11223334588899999999999999     89999764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.3e-45  Score=340.30  Aligned_cols=282  Identities=16%  Similarity=0.208  Sum_probs=210.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC------CCEEEEEECcCcChhcH-----------HHHHHHHHHHHhcCCCCccee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGV-----------REFITEIMTLSNVRHPNLVEL  107 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~------~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~  107 (370)
                      .++|++.+.||+|+||.||+|.+..      ++.||||++........           ..+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            6799999999999999999999864      47899998876542211           123345566777889999999


Q ss_pred             eeEEEeC----CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC
Q 017503          108 IGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD  183 (370)
Q Consensus       108 ~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~  183 (370)
                      ++++...    ...++||||+ +++|.+++..   .+..+++..++.++.||+.||.|||+.   +|+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            9998764    4579999999 9999999843   345799999999999999999999999   999999999999998


Q ss_pred             --CCCCeEEeeecCccccCCCCcc------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccc
Q 017503          184 --QEFNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWG  255 (370)
Q Consensus       184 --~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~  255 (370)
                        .++.+||+|||++..+......      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999866432211      11334589999999999999999999999999999999999999975433


Q ss_pred             cchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCccccCCCCcc
Q 017503          256 QMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLF  335 (370)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~p~~~  335 (370)
                      ...  ........... .....+++.+.  ....+..+.+++..||+.+|.+||++.+|++.|+.++.........+..|
T Consensus       267 ~~~--~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  341 (364)
T 3op5_A          267 DPK--YVRDSKIRYRE-NIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL  341 (364)
T ss_dssp             CHH--HHHHHHHHHHH-CHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred             CHH--HHHHHHHHhhh-hHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence            211  11111111111 11112221110  01223457888889999999999999999999999987665555555445


Q ss_pred             ccC
Q 017503          336 QDS  338 (370)
Q Consensus       336 ~~~  338 (370)
                      ...
T Consensus       342 ~~~  344 (364)
T 3op5_A          342 SVV  344 (364)
T ss_dssp             ---
T ss_pred             Eec
Confidence            433

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.3e-46  Score=355.15  Aligned_cols=266  Identities=26%  Similarity=0.409  Sum_probs=215.3

Q ss_pred             HHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           38 YTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        38 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      ...+....++|++.+.||+|+||.||+|.++++..||||.+.... ...+.+.+|+.+|++++||||+++++++. ....
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            344555678899999999999999999999888999999987654 34678999999999999999999999986 6678


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+.+|+|.+++...  .+..+++..++.++.||+.||.|||++   +++||||||+|||++.++.+||+|||++.
T Consensus       258 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence            9999999999999999432  223578899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ..............++..|+|||++....++.++||||||+++|||++ |..||.....   ..+....    .....  
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i----~~~~~--  403 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRAL----ERGYR--  403 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHH----HHTCC--
T ss_pred             EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCC--
Confidence            765432222233346778999999998999999999999999999999 9999865422   1121111    11111  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                            ...+...+..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       404 ------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          404 ------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence                  1112334456888999999999999999999999999887644

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=343.47  Aligned_cols=265  Identities=26%  Similarity=0.419  Sum_probs=214.5

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC--------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT--------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCV  112 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  112 (370)
                      ...++|++.+.||+|+||.||+|++.        .+..||+|++... .......+.+|+++++++ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            34578999999999999999999863        2357999998765 344557788999999999 9999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCce
Q 017503          113 QGTRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI  180 (370)
Q Consensus       113 ~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Ni  180 (370)
                      +.+..++||||+++++|.+++.....            ....+++..++.++.|++.||.|||+.   +++||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence            99999999999999999999964332            124589999999999999999999999   999999999999


Q ss_pred             EeCCCCCeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccch
Q 017503          181 LLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMN  258 (370)
Q Consensus       181 ll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~  258 (370)
                      |++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....   
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---  299 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  299 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence            999999999999999986654322 22333456788999999999999999999999999999999 9988864421   


Q ss_pred             hhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      ..+.    ........        ...+......+.+++.+||+.+|.+|||+.+|++.|+++....
T Consensus       300 ~~~~----~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          300 EELF----KLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             HHHH----HHHHTTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHH----HHHHcCCC--------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            1111    11221111        1112233445888999999999999999999999999998654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.4e-44  Score=330.23  Aligned_cols=262  Identities=24%  Similarity=0.377  Sum_probs=202.4

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ..++|++.+.||+|+||.||+|++.+++.||+|++....  ......+.+|+.++++++||||+++++++.+....++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            358899999999999999999999889999999886542  223467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++ +|.+++.   .....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        99 e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           99 EFMEK-DLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             ECCSE-EHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             cCCCC-CHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99986 7777663   3344689999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc----
Q 017503          202 NITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE----  276 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  276 (370)
                      .... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||........   ...............    
T Consensus       172 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          172 PVRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGG
T ss_pred             Cccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhh
Confidence            3222 233467999999998876 5689999999999999999999999875443222   111222111111100    


Q ss_pred             ------------cccCC-CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          277 ------------LVDPE-LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       277 ------------~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                                  ..... .....+....++.+++.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                        00000 00011122345789999999999999999999976

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.7e-46  Score=337.22  Aligned_cols=264  Identities=26%  Similarity=0.402  Sum_probs=208.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEE-----CCCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--Ce
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL-----TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TR  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~  116 (370)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++... .......+.+|+.+++.++||||+++++++.+.  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            45689999999999999999983     36889999998754 334557788999999999999999999999876  66


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence            8999999999999999842   334589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc--eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccc--------hhhHHHHHH
Q 017503          197 KLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM--------NKFLLEWAW  266 (370)
Q Consensus       197 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~--------~~~~~~~~~  266 (370)
                      .........  ......+|..|+|||.+.+..++.++||||||+++|+|++|..|+.......        .........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            877554322  2234557888999999999999999999999999999999998864332110        000111111


Q ss_pred             HHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      .......        ....+......+.+++.+||+.||.+|||+.++++.|+.++
T Consensus       254 ~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          254 NTLKEGK--------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhccC--------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1111111        11223334456889999999999999999999999998875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.9e-45  Score=336.16  Aligned_cols=250  Identities=23%  Similarity=0.333  Sum_probs=204.1

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++...   .......+.+|+.+++.++||||+++++++......++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3579999999999999999999974 6889999988643   12234578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+ +|+|.+++.    ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        87 v~E~~-~g~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~  158 (336)
T 3h4j_B           87 VIEYA-GGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM  158 (336)
T ss_dssp             EECCC-CEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred             EEECC-CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence            99999 678888773    334689999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      ....  ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......                ....+
T Consensus       159 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------------~~~~i  220 (336)
T 3h4j_B          159 TDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------------LFKKV  220 (336)
T ss_dssp             TTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------------CBCCC
T ss_pred             cCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------------HHHHH
Confidence            5432  2234568999999999988776 689999999999999999999986532110                01111


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      .......+......+.+++.+||+.||.+|||+.++++.-.
T Consensus       221 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          221 NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence            11112223334455889999999999999999999987544

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.8e-45  Score=352.82  Aligned_cols=266  Identities=29%  Similarity=0.454  Sum_probs=209.4

Q ss_pred             HHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           39 TELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        39 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      ..+....++|++.+.||+|+||.||+|.++++..||||.+..... ..+.+.+|+.+|++++||||+++++++.+ ...+
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            334445678999999999999999999998888899999876542 35678999999999999999999999876 6789


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+++|+|.+++...  .+..+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||++..
T Consensus       255 iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             EEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             EEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence            999999999999999421  234589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      .............++..|+|||.+....++.++||||||+++|||++ |..||.....   .....   . ......   
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~---~-i~~~~~---  399 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD---Q-VERGYR---  399 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH---H-HHTTCC---
T ss_pred             cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHH---H-HHcCCC---
Confidence            65433233333456788999999999999999999999999999999 8988865422   11111   1 111111   


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCc
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  326 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  326 (370)
                           ...+...+..+.+++.+||+.+|.+|||+.+|++.|+.+....+
T Consensus       400 -----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          400 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence                 11223444568889999999999999999999999998876543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.1e-45  Score=342.18  Aligned_cols=274  Identities=25%  Similarity=0.387  Sum_probs=218.2

Q ss_pred             ccccCHHHHHHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCc
Q 017503           33 VNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNL  104 (370)
Q Consensus        33 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i  104 (370)
                      ...++...+....++|++.+.||+|+||.||+|++.      +++.||||++... .......+.+|+.+++++ +||||
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A            9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence            345667777888899999999999999999999842      4578999998765 334456789999999999 89999


Q ss_pred             ceeeeEEEeCCe-eEEEEEecCCCCHHHHhcccccC--------------------------------------------
Q 017503          105 VELIGCCVQGTR-RILVYEYVENNSLDRVLLGATKA--------------------------------------------  139 (370)
Q Consensus       105 v~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~--------------------------------------------  139 (370)
                      +++++++.+... .++||||+++|+|.+++......                                            
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            999999987554 89999999999999999644321                                            


Q ss_pred             ------------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          140 ------------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       140 ------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                                        ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                              12289999999999999999999999   999999999999999999999999999986644


Q ss_pred             CCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          202 NIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       202 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......  .+.    .........    
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~----~~~~~~~~~----  315 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRM----  315 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHH----HHHHHTCCC----
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHH----HHHHcCCCC----
Confidence            322 22334567889999999999999999999999999999998 999986543221  111    111111111    


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                          ..+......+.+++.+||+.+|.+|||+.+|++.|+.++.
T Consensus       316 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          316 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence                1122233458889999999999999999999999998875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.1e-44  Score=336.39  Aligned_cols=255  Identities=21%  Similarity=0.308  Sum_probs=205.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-----ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-----SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .++|++.+.||+|+||.||++.++ +++.||+|++...     .......+.+|+.+++.++||||+++++++.+....+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            467999999999999999999975 6899999988532     1224577889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC---eEEeeecC
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGL  195 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kL~Dfg~  195 (370)
                      +||||+++++|.+++......+..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            99999999999888865444555689999999999999999999999   9999999999999986655   99999999


Q ss_pred             ccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          196 AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      +........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||....    ..+..   .........
T Consensus       180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~---~i~~~~~~~  251 (351)
T 3c0i_A          180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFE---GIIKGKYKM  251 (351)
T ss_dssp             CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHH---HHHHTCCCC
T ss_pred             eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHH---HHHcCCCCC
Confidence            987654322 2334568999999999999999999999999999999999999986531    11111   111111100


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .   +.   ........+.+++.+||+.||.+|||+.++++
T Consensus       252 ~---~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          252 N---PR---QWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             C---HH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C---cc---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0   00   00112345889999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1e-45  Score=340.08  Aligned_cols=267  Identities=25%  Similarity=0.348  Sum_probs=212.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEE-----CCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEE--eCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL-----TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV--QGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~  117 (370)
                      .++|++.+.||+|+||.||++++     .++..||+|++........+.+.+|+.++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            57899999999999999999984     367889999998777776778999999999999999999999987  45678


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence            999999999999999843   234589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcc--eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhh--------HHHHHHH
Q 017503          198 LFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF--------LLEWAWQ  267 (370)
Q Consensus       198 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~  267 (370)
                      ........  ......++..|+|||++.+..++.++||||||+++|+|++|..||..........        .......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76544322  2233457788999999999999999999999999999999999875432211000        0011111


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      ......        ....+......+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       256 ~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          256 LLEEGQ--------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             Hhhccc--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            111111        11223344456889999999999999999999999999887644

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-44  Score=339.61  Aligned_cols=251  Identities=27%  Similarity=0.369  Sum_probs=199.1

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  118 (370)
                      ..++|++.+.||+|+||+||+|+++ +++.||+|++...   .......+..|..++.++ +||||+++++++.+....+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            4678999999999999999999986 5788999988754   223334577899999887 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+.+|+|..++.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       130 lV~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            9999999999999883    345689999999999999999999999   999999999999999999999999999985


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchh--hHHHHHHHHHhcCCCcc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--FLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~  276 (370)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ...............  
T Consensus       203 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--  279 (396)
T 4dc2_A          203 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--  279 (396)
T ss_dssp             CCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred             cccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence            32221 2234467999999999999999999999999999999999999999643221111  011111111111111  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  311 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  311 (370)
                             .++......+.+++.+||+.||.+||++
T Consensus       280 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 -------RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                   1222334458899999999999999995

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=338.14  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=205.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||++.+. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            578999999999999999999976 5788999988643   234457788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+.+|+|..++.    .+..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        94 ~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             ECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999999983    455799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccCCCCCCCcccccC---CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ...  ......||+.|+|||++..   ..++.++|||||||++|+|++|..||...............   .. .     
T Consensus       167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~-~-----  235 (384)
T 4fr4_A          167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF---ET-T-----  235 (384)
T ss_dssp             TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH---HH-C-----
T ss_pred             CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hh-c-----
Confidence            432  2344679999999999864   45899999999999999999999999754433322222211   11 1     


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCC-HHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-MNQVIK  316 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~  316 (370)
                          ....+......+.+++.+||+.+|.+||+ +.+|+.
T Consensus       236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                11222333455889999999999999998 777654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=330.26  Aligned_cols=254  Identities=20%  Similarity=0.269  Sum_probs=206.8

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ..++|++.+.||+|+||.||++.+. ++..||+|.+..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            4589999999999999999999986 578899998875533 34568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC--CCCeEEeeecCccccC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ--EFNPKIGDFGLAKLFP  200 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~--~~~~kL~Dfg~~~~~~  200 (370)
                      |+++++|.+++.   .....+++..++.++.|++.||.|||+.   +++||||||+||+++.  ++.+||+|||++....
T Consensus        82 ~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           82 FISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             eCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            999999999983   2334689999999999999999999999   9999999999999987  7899999999998765


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ...  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....   .....   ..........  . 
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~---~i~~~~~~~~--~-  224 (321)
T 1tki_A          156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIE---NIMNAEYTFD--E-  224 (321)
T ss_dssp             TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH---HHHHTCCCCC--H-
T ss_pred             CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHH---HHHcCCCCCC--h-
Confidence            432  23345689999999999998899999999999999999999999865322   11111   1111111100  0 


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                         ...+.....+.+++.+||..||.+|||+.++++.-
T Consensus       225 ---~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          225 ---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             ---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ---hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence               00012234588999999999999999999998844

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.3e-44  Score=323.64  Aligned_cols=251  Identities=29%  Similarity=0.497  Sum_probs=195.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcC----hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||+|.+. +..||+|++....    ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            578999999999999999999986 7899999887542    23356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC---eEeecCCCCceEeCC--------CCCeE
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH---IVHRDIKASNILLDQ--------EFNPK  189 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~---iiH~dlkp~Nill~~--------~~~~k  189 (370)
                      |||+++++|.+++.     +..+++..++.++.|++.||.|||+.   +   ++||||||+||+++.        ++.+|
T Consensus        85 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           85 MEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             EECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             EEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceE
Confidence            99999999999982     34689999999999999999999999   7   999999999999986        67899


Q ss_pred             EeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH
Q 017503          190 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       190 L~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      |+|||++.......   .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......      ......
T Consensus       157 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~  227 (271)
T 3dtc_A          157 ITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVA  227 (271)
T ss_dssp             ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHH
T ss_pred             EccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhh
Confidence            99999998654332   223468999999999999999999999999999999999999986543211      111111


Q ss_pred             hcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          270 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      .....        ...+......+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       228 ~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          228 MNKLA--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             TSCCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             cCCCC--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            11111        112233344588999999999999999999999999753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.4e-45  Score=336.91  Aligned_cols=267  Identities=22%  Similarity=0.407  Sum_probs=198.4

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEECCC----CEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLTNG----RRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG  114 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~----~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  114 (370)
                      +....++|++.+.||+|+||.||+|.+...    ..||+|++...  .....+.+.+|+.++++++||||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            344567899999999999999999997533    27999998765  334567889999999999999999999999877


Q ss_pred             Cee------EEEEEecCCCCHHHHhcccc--cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC
Q 017503          115 TRR------ILVYEYVENNSLDRVLLGAT--KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF  186 (370)
Q Consensus       115 ~~~------~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~  186 (370)
                      ...      ++||||+.+++|.+++....  .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence            655      89999999999999985332  2223589999999999999999999999   999999999999999999


Q ss_pred             CeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHH
Q 017503          187 NPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEW  264 (370)
Q Consensus       187 ~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~  264 (370)
                      .+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~  251 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYNY  251 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHHH
Confidence            999999999986644322 12223446778999999999999999999999999999999 899986543321   1111


Q ss_pred             HHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          265 AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                          .....        ....++.....+.+++.+||+.||.+|||+.++++.|++++...
T Consensus       252 ----~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          252 ----LIGGN--------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             ----HHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ----HhcCC--------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                11111        11222333456889999999999999999999999999988643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.5e-44  Score=332.30  Aligned_cols=259  Identities=27%  Similarity=0.430  Sum_probs=203.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCC----EEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGR----RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .++|++.+.||+|+||.||+|++. ++.    +||+|.+... .......+.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            578999999999999999999974 333    4688887644 3355678899999999999999999999998765 77


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +|++|+.+|+|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            89999999999999843   345689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          199 FPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       199 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......   +..    .......  
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~--  237 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGER--  237 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCC--
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH----HHHcCCC--
Confidence            6543322 2233456789999999999999999999999999999999 999987543321   111    1111111  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                            ...+......+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus       238 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          238 ------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             ------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             ------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence                  1122334456889999999999999999999999999887643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-44  Score=334.34  Aligned_cols=253  Identities=21%  Similarity=0.275  Sum_probs=207.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++.+.||+|+||.||+|.++ +++.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            578999999999999999999986 6889999998776555566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC--CCCeEEeeecCccccCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ--EFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~--~~~~kL~Dfg~~~~~~~  201 (370)
                      +.+++|.+++.   .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.  ++.+||+|||++.....
T Consensus       130 ~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999984   2344689999999999999999999999   9999999999999974  46799999999987654


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      ...  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   .....   ........   .++ 
T Consensus       204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~---~i~~~~~~---~~~-  271 (387)
T 1kob_A          204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQ---NVKRCDWE---FDE-  271 (387)
T ss_dssp             TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH---HHHHCCCC---CCS-
T ss_pred             Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCCCC---CCc-
Confidence            322  2334689999999999999999999999999999999999999865321   11111   11111111   111 


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                        .........+.+++.+||+.||.+|||+.++++.
T Consensus       272 --~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          272 --DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             --STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence              1112233458899999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-45  Score=338.60  Aligned_cols=278  Identities=23%  Similarity=0.396  Sum_probs=221.8

Q ss_pred             cccccccCHHHHHHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCC
Q 017503           30 LRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHP  102 (370)
Q Consensus        30 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~  102 (370)
                      .+....+..+++....++|++.+.||+|+||.||+|.+.      .+..||+|.+.... ......+.+|+.+++.++||
T Consensus         9 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~   88 (322)
T 1p4o_A            9 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH   88 (322)
T ss_dssp             SBCCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCT
T ss_pred             cccccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCC
Confidence            445566777777888899999999999999999999864      36789999987553 34455788999999999999


Q ss_pred             CcceeeeEEEeCCeeEEEEEecCCCCHHHHhccccc------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCC
Q 017503          103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK  176 (370)
Q Consensus       103 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlk  176 (370)
                      ||+++++++.+....++||||+++++|.+++.....      ....+++..++.++.|++.||.|||++   +++|||||
T Consensus        89 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dik  165 (322)
T 1p4o_A           89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLA  165 (322)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCS
T ss_pred             CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCc
Confidence            999999999999999999999999999999853221      124568999999999999999999999   99999999


Q ss_pred             CCceEeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCccc
Q 017503          177 ASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMW  254 (370)
Q Consensus       177 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~  254 (370)
                      |+||+++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus       166 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  245 (322)
T 1p4o_A          166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  245 (322)
T ss_dssp             GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             cceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence            99999999999999999999865432211 1223346788999999999999999999999999999999 888876542


Q ss_pred             ccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          255 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      .   ....    .......        ....+......+.+++.+||+.+|.+|||+.++++.|++.....
T Consensus       246 ~---~~~~----~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          246 N---EQVL----RFVMEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             H---HHHH----HHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             H---HHHH----HHHHcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence            2   1111    1111111        11222333455888999999999999999999999999887644

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.1e-44  Score=324.88  Aligned_cols=261  Identities=20%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            68999999999999999999986 6889999988654  23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |++++.+..+.    ..+..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~~l~~~~~----~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCCCHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            99875444443    3345799999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CcceeecccCCCCCCCcccccCCC-cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc-----
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE-----  276 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  276 (370)
                      .. ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..|+.....  ...................     
T Consensus       155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhc
Confidence            22 223356899999999987765 79999999999999999999888643322  1122222222111111000     


Q ss_pred             ---------c--ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          277 ---------L--VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       277 ---------~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                               .  ....+....+.....+.+++.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                     0  001111222334456889999999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.9e-45  Score=328.48  Aligned_cols=263  Identities=29%  Similarity=0.452  Sum_probs=212.8

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      +....++|++.+.||+|+||.||+|.+.++..||+|.+.... .....+.+|+.++++++||||+++++++. .+..++|
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   85 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII   85 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence            344568899999999999999999999888899999887543 23567889999999999999999999876 4568999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++++|.+++...  .+..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             EECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            9999999999998421  123689999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ...........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .....   . ......     
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~---~-~~~~~~-----  228 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQ---N-LERGYR-----  228 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH---H-HHTTCC-----
T ss_pred             CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHH---H-HhcccC-----
Confidence            543333334456788999999998899999999999999999999 8888864322   11111   1 111111     


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                         ...+......+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus       229 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          229 ---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence               1112233345888999999999999999999999999987644

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.5e-45  Score=335.25  Aligned_cols=265  Identities=27%  Similarity=0.385  Sum_probs=209.6

Q ss_pred             ccCC-cccceeeecCCeEEEEEEEC-----CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--CC
Q 017503           45 TDDF-HLSNKIGRGGFGTVYKGTLT-----NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GT  115 (370)
Q Consensus        45 ~~~y-~~~~~lg~G~~g~v~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~  115 (370)
                      .++| ++.+.||+|+||.||++.+.     +++.||+|++.... ......+.+|+.++++++||||+++++++.+  ..
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            3455 99999999999999988643     57889999987653 3446678999999999999999999999988  46


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      ..++||||+++++|.+++..     ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             eEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccc
Confidence            78999999999999999832     2489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc--eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccch--------hhHHHHH
Q 017503          196 AKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN--------KFLLEWA  265 (370)
Q Consensus       196 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~--------~~~~~~~  265 (370)
                      +.........  ......++..|+|||.+.+..++.++||||||+++|+|++|..||........        .......
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            9877554322  22334577889999999999999999999999999999999998765422110        0000001


Q ss_pred             HHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          266 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      ........        ....+......+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus       261 ~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          261 TELLERGE--------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhccc--------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            11111111        11223334456889999999999999999999999999887543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-45  Score=327.37  Aligned_cols=257  Identities=25%  Similarity=0.413  Sum_probs=211.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.+.||+|+||.||++.+.++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            578999999999999999999998888999999876533 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++........
T Consensus        86 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           86 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             TTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             CCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            99999999842   334689999999999999999999999   999999999999999999999999999986644322


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .......++..|+|||++.+..++.++||||||+++|+|++ |..||.....   .....   . ......        .
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~---~-i~~~~~--------~  224 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVE---D-ISTGFR--------L  224 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH---H-HHTTCC--------C
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHH---H-HhcCCc--------C
Confidence            22233456778999999998899999999999999999999 8988865322   11111   1 111111        0


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      ..+......+.+++.+||+.+|.+||++.++++.|+++..
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1122233458889999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.7e-44  Score=323.29  Aligned_cols=260  Identities=27%  Similarity=0.493  Sum_probs=198.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||.||+|++.  ..||+|++...  .....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            678999999999999999999875  35999988654  345567789999999999999999999965 5566899999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|.+++.   .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus       100 ~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A          100 WCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             CCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             ecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence            999999999984   3345689999999999999999999999   9999999999999999999999999999765432


Q ss_pred             C-cceeecccCCCCCCCccccc---CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          203 I-THITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       203 ~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      . ........||+.|+|||.+.   +..++.++||||||+++|+|++|..||.......  .+.    ........    
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~----~~~~~~~~----  243 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QII----EMVGRGSL----  243 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHH----HHHHHTSC----
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHH----HHhccccc----
Confidence            1 12233456899999999886   5678899999999999999999999987543321  111    11111111    


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      .+.+..........+.+++.+||+.+|.+|||+.++++.|+++.+
T Consensus       244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            111222233444568899999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-45  Score=336.58  Aligned_cols=278  Identities=24%  Similarity=0.372  Sum_probs=214.1

Q ss_pred             ccccccCHH-HHHHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CC
Q 017503           31 RNVNHFSYT-ELRSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RH  101 (370)
Q Consensus        31 ~~~~~~~~~-~~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h  101 (370)
                      .+.+.+.+. ++....++|++.+.||+|+||.||+|.+.      ++..||+|++... .......+.+|+.+++++ +|
T Consensus        29 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h  108 (344)
T 1rjb_A           29 VDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH  108 (344)
T ss_dssp             CCGGGSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCC
T ss_pred             ccchhcccCcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCC
Confidence            344444332 23445689999999999999999999962      4567999998754 233456788999999999 99


Q ss_pred             CCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccC-------------------CccCCHHHHHHHHHHHHHHHHHH
Q 017503          102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-------------------NIKLNWEKRSDICVGIAKGLAFL  162 (370)
Q Consensus       102 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------------------~~~l~~~~~~~i~~qi~~al~~L  162 (370)
                      |||+++++++...+..++||||+++++|.+++......                   ...+++..++.++.|++.||.||
T Consensus       109 p~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  188 (344)
T 1rjb_A          109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL  188 (344)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH
T ss_pred             CCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999543221                   13479999999999999999999


Q ss_pred             hhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHH
Q 017503          163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL  241 (370)
Q Consensus       163 H~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  241 (370)
                      |+.   +++||||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|
T Consensus       189 H~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~  265 (344)
T 1rjb_A          189 EFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW  265 (344)
T ss_dssp             HHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             HhC---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHH
Confidence            999   9999999999999999999999999999866433222 233345678899999999999999999999999999


Q ss_pred             HHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          242 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       242 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                      +|+| |..||.......  ...    ........        ...+......+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       266 el~t~g~~p~~~~~~~~--~~~----~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  331 (344)
T 1rjb_A          266 EIFSLGVNPYPGIPVDA--NFY----KLIQNGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  331 (344)
T ss_dssp             HHTTTSCCSSTTCCCSH--HHH----HHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHcCCCCCcccCCcHH--HHH----HHHhcCCC--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            9998 999986543221  111    11111111        11122334458889999999999999999999999998


Q ss_pred             hhccC
Q 017503          321 NIRLN  325 (370)
Q Consensus       321 ~~~~~  325 (370)
                      +....
T Consensus       332 ~~~~~  336 (344)
T 1rjb_A          332 QLADA  336 (344)
T ss_dssp             HC---
T ss_pred             HHHHH
Confidence            87644

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.4e-44  Score=335.37  Aligned_cols=254  Identities=22%  Similarity=0.297  Sum_probs=205.8

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ...++|++.+.||+|+||.||++.++ ++..||+|++...  .......+.+|+.+++.++||||+++++++.+....++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            44678999999999999999999986 6889999998654  33445678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC---CeEEeeecCc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKIGDFGLA  196 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kL~Dfg~~  196 (370)
                      ||||+.+++|.+++.    ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++   .+||+|||++
T Consensus       106 v~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          106 VFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            999999999999883    345689999999999999999999999   999999999999998654   5999999999


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      .......  ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.....   ..+...   .......  
T Consensus       179 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~---i~~~~~~--  248 (362)
T 2bdw_A          179 IEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQ---IKAGAYD--  248 (362)
T ss_dssp             BCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH---HHHTCCC--
T ss_pred             eEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHH---HHhCCCC--
Confidence            8665332  22345689999999999999999999999999999999999999864321   111111   1111110  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...    .........+.+++.+||+.||.+||++.++++.
T Consensus       249 ~~~----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 YPS----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CCT----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCc----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000    1112233458899999999999999999999764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=330.54  Aligned_cols=252  Identities=25%  Similarity=0.302  Sum_probs=204.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh------hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK------QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|++.+.||+|+||.||++.++ ++..||+|++.....      .....+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            467999999999999999999986 688999998865421      2357788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC----CeEEeee
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----NPKIGDF  193 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kL~Df  193 (370)
                      ++||||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999983    445789999999999999999999999   999999999999999887    7999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      |++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....   .....   .......
T Consensus       163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~---~~~~~~~  234 (326)
T 2y0a_A          163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLA---NVSAVNY  234 (326)
T ss_dssp             TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH---HHHHTCC
T ss_pred             CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHH---HHHhcCC
Confidence            9998765332  22345689999999999999999999999999999999999999864322   11111   1111110


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..  ..    .........+.+++.+||+.||.+|||+.++++.
T Consensus       235 ~~--~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          235 EF--ED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CC--CH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             Cc--Cc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00  00    0011223457889999999999999999999863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.4e-45  Score=333.13  Aligned_cols=265  Identities=20%  Similarity=0.260  Sum_probs=209.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe----CCeeE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRRI  118 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~  118 (370)
                      ..++|++.+.||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            357899999999999999999997 4789999998877666667788999999999999999999999873    34778


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+.+++|.+++......+..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999999865545567799999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCcc--------eeecccCCCCCCCcccccCCC---cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 017503          199 FPDNITH--------ITTRIAGTTGYLAPEYVLGGQ---LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       199 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      .......        ......|++.|+|||.+.+..   ++.++||||||+++|+|++|..||...........     .
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----~  258 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-----L  258 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-----H
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-----H
Confidence            4321110        011234689999999887654   68999999999999999999999854322111110     0


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      .......        ..........+.+++.+||+.||.+||++.++++.|+.+...
T Consensus       259 ~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          259 AVQNQLS--------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHHCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             HhhccCC--------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            1111000        011122334588999999999999999999999999887643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.3e-44  Score=322.77  Aligned_cols=276  Identities=20%  Similarity=0.286  Sum_probs=214.8

Q ss_pred             hccCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEE-EeCCeeEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC-VQGTRRILVY  121 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~  121 (370)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++......  ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            468999999999999999999997 47889999987655332  4577899999999888766665554 6778889999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC---CCCCeEEeeecCccc
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKL  198 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kL~Dfg~~~~  198 (370)
                      ||+ +++|.+++..   ....+++..++.++.|++.||.|||++   +++||||||+||+++   .++.+||+|||++..
T Consensus        85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            999 8899999842   344689999999999999999999999   999999999999994   888999999999987


Q ss_pred             cCCCCcc------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          199 FPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       199 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      .......      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            6543321      1234568999999999999999999999999999999999999997654332222222221111111


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCccccCCCCccc
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQ  336 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~p~~~~  336 (370)
                      .. ..       ........+.+++.+||+.+|.+||++.+|++.|+.+..........+..|.
T Consensus       238 ~~-~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 3uzp_A          238 PI-EV-------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             CH-HH-------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred             ch-HH-------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence            10 00       0112224488899999999999999999999999999877655555554443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-44  Score=332.82  Aligned_cols=251  Identities=20%  Similarity=0.354  Sum_probs=198.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-------
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-------  115 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------  115 (370)
                      .++|++.+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            568999999999999999999986 78999999986543 334567899999999999999999999987643       


Q ss_pred             --------------------------------------------------eeEEEEEecCCCCHHHHhcccccCCccCCH
Q 017503          116 --------------------------------------------------RRILVYEYVENNSLDRVLLGATKANIKLNW  145 (370)
Q Consensus       116 --------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~  145 (370)
                                                                        ..++||||+++++|.+++.... .....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence                                                              3789999999999999985433 2234567


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc-----------ceeecccCCC
Q 017503          146 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-----------HITTRIAGTT  214 (370)
Q Consensus       146 ~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~~  214 (370)
                      ..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            77899999999999999999   999999999999999999999999999987654321           1123346899


Q ss_pred             CCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHH
Q 017503          215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM  294 (370)
Q Consensus       215 ~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  294 (370)
                      .|+|||++.+..++.++||||||+++|+|++|..|+...        ...... ....        ............+.
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~-~~~~--------~~~~~~~~~~~~~~  303 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITD-VRNL--------KFPLLFTQKYPQEH  303 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHH-HHTT--------CCCHHHHHHCHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHH-hhcc--------CCCcccccCChhHH
Confidence            999999999999999999999999999999987653211        111111 1111        11112234445678


Q ss_pred             HHHHHchhhccCCCCCHHHHHH
Q 017503          295 KVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       295 ~li~~cl~~~p~~RPt~~evl~  316 (370)
                      +++.+||+.||.+|||+.++++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCCCcCCCHHHHhh
Confidence            9999999999999999999976

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=331.66  Aligned_cols=264  Identities=27%  Similarity=0.422  Sum_probs=204.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCC----EEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGR----RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .++|++.+.||+|+||.||+|.+. +++    +|++|.+... .......+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            578999999999999999999975 344    3577776543 3445678899999999999999999999998765 78


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +|++++.+++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            89999999999999843   345689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          199 FPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       199 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   +..    .......  
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~~~~~~~--  237 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGER--  237 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCC--
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCC--
Confidence            6443222 2223446778999999999999999999999999999999 999987543322   111    1111111  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCccccC
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELT  330 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~  330 (370)
                            ...+......+.+++.+||+.+|.+||++.++++.|+.+.........
T Consensus       238 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  285 (327)
T 3lzb_A          238 ------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLV  285 (327)
T ss_dssp             ------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHHBC
T ss_pred             ------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCceEE
Confidence                  112233344588899999999999999999999999998875544433

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=341.23  Aligned_cols=255  Identities=20%  Similarity=0.286  Sum_probs=204.8

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ...++|++.+.||+|+||.||++.+. +++.||+|++....  ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            34678999999999999999999975 68899999886543  3345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC---CCCCeEEeeecCc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLA  196 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kL~Dfg~~  196 (370)
                      ||||+.+|+|.+++.    ....+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+||+|||++
T Consensus        88 v~E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           88 IFDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EECCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            999999999998884    345689999999999999999999999   999999999999998   4678999999999


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ........ ......||+.|+|||++.+..++.++|||||||++|+|++|.+||....   ...+...   ... ... .
T Consensus       161 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~---i~~-~~~-~  231 (444)
T 3soa_A          161 IEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQ---IKA-GAY-D  231 (444)
T ss_dssp             BCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHH---HHH-TCC-C
T ss_pred             EEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHH---HHh-CCC-C
Confidence            86654322 2234579999999999999999999999999999999999999985432   1112111   111 111 1


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...+...    .....+.+++.+||+.||.+|||+.++++.
T Consensus       232 ~~~~~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          232 FPSPEWD----TVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CCTTTTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCccccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1111112    223458899999999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.5e-44  Score=322.31  Aligned_cols=253  Identities=28%  Similarity=0.491  Sum_probs=202.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChh-------cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQ-------GVREFITEIMTLSNVRHPNLVELIGCCVQGTR  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  116 (370)
                      .++|++.+.||+|+||.||+|++. +++.||+|++......       ..+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            578999999999999999999985 7889999998654321       1267889999999999999999999986554 


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeecCCCCceEeCCCCC-----eE
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLDQEFN-----PK  189 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~dlkp~Nill~~~~~-----~k  189 (370)
                       ++||||+++++|.+++.   .....+++..++.++.|++.||.|||+.   +  ++||||||+||+++.++.     +|
T Consensus        97 -~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             -EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             -eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence             69999999999988874   3445789999999999999999999999   8  999999999999988776     99


Q ss_pred             EeeecCccccCCCCcceeecccCCCCCCCcccc--cCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 017503          190 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV--LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       190 L~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      |+|||++.....    ......||+.|+|||++  ....++.++||||||+++|+|++|..||...........    ..
T Consensus       170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~  241 (287)
T 4f0f_A          170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI----NM  241 (287)
T ss_dssp             ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH----HH
T ss_pred             eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH----HH
Confidence            999999974433    23345689999999998  445678999999999999999999999875443222111    11


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      .......        ...+......+.+++.+||+.||.+|||+.++++.|+++
T Consensus       242 ~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          242 IREEGLR--------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHSCCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HhccCCC--------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1111111        112233345588999999999999999999999999763

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.3e-44  Score=324.14  Aligned_cols=277  Identities=20%  Similarity=0.300  Sum_probs=210.1

Q ss_pred             HhccCCcccceeeecCCeEEEEEEE-CCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEE-EeCCeeEEE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTL-TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC-VQGTRRILV  120 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv  120 (370)
                      ...++|++.+.||+|+||.||+|++ .+++.||+|++......  ..+.+|+.+++.++|++++..+..+ ......++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3468999999999999999999997 46889999986544322  3467799999999887776666555 677888999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe---CCCCCeEEeeecCcc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAK  197 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kL~Dfg~~~  197 (370)
                      |||+ +++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||++   +.++.+||+|||++.
T Consensus        84 ~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           84 MELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            9999 8899999842   344689999999999999999999999   99999999999999   788999999999998


Q ss_pred             ccCCCCcc------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc
Q 017503          198 LFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       198 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      ........      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....................
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            76543221      223456899999999999999999999999999999999999999765433322222222111111


Q ss_pred             CCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCccccCCCCccc
Q 017503          272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQ  336 (370)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~p~~~~  336 (370)
                      ... ...   ....    ...+.+++.+||+.+|.+|||+.+|++.|+.+..........+..|.
T Consensus       237 ~~~-~~~---~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 4hgt_A          237 TPI-EVL---CKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             SCH-HHH---TTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred             chh-hhh---hccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence            110 000   0112    24588999999999999999999999999999876655555544443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=343.31  Aligned_cols=263  Identities=27%  Similarity=0.388  Sum_probs=210.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|++.+.||+|+||.||+|.+.      ++..||||.+... .......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            478999999999999999999953      4668999998654 344456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccc---cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC---CeEEe
Q 017503          118 ILVYEYVENNSLDRVLLGAT---KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKIG  191 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~---~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kL~  191 (370)
                      ++||||+++++|.+++....   .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999985433   2234589999999999999999999999   999999999999999555   49999


Q ss_pred             eecCccccCCC-CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHH
Q 017503          192 DFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       192 Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      |||++...... .........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....   ..+..    ..
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~----~i  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLE----FV  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHH----HH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HH
Confidence            99999754221 1122233457889999999999999999999999999999998 9999865422   11111    11


Q ss_pred             hcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          270 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      .....        ...+......+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus       300 ~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          300 TSGGR--------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HcCCC--------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            11111        1112233345888999999999999999999999999887644

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-44  Score=350.80  Aligned_cols=262  Identities=24%  Similarity=0.414  Sum_probs=215.0

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEECC-CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      +....++|++.+.||+|+||.||+|.++. +..||||.+..... ....+.+|+.+|++++||||+++++++.+....++
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            33446789999999999999999999874 78899999876543 45788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+.+|+|.+++...  ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus       294 v~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          294 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence            99999999999998532  234589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      ............++..|+|||++....++.++||||||+++|||++ |..||......   .+..    .......    
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~----  437 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE----LLEKDYR----  437 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----HHHTTCC----
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCC----
Confidence            5443333333456778999999999999999999999999999999 88888654321   1111    1111111    


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                          ...+......+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       438 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          438 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                11223344558889999999999999999999999988764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.4e-45  Score=328.11  Aligned_cols=262  Identities=24%  Similarity=0.409  Sum_probs=216.5

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ....++|++.+.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.++++++||||+++++++.+....++|
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence            345788999999999999999999986 478899999875543 356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++++|.+++..  .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999999999843  2334689999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ...........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...    .......     
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~----~~~~~~~-----  230 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDYR-----  230 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCC-----
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhccCC-----
Confidence            554444444567788999999998999999999999999999999 888886543221   111    1111111     


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                         ...+......+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       231 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          231 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence               111223334588999999999999999999999999988753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.7e-44  Score=344.55  Aligned_cols=254  Identities=26%  Similarity=0.388  Sum_probs=207.3

Q ss_pred             HhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-eeEEEE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-RRILVY  121 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~  121 (370)
                      ...++|++.+.||+|+||.||+|.++ ++.||||.++...  ..+.+.+|+.++++++||||+++++++.+.. ..++||
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            34678999999999999999999986 7799999987654  3467889999999999999999999988765 789999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++|+|.+++...  ....+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus       267 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             ECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999999999999532  223478999999999999999999999   999999999999999999999999999985433


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      .    .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......   ....    ......      
T Consensus       342 ~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~~~~------  404 (450)
T 1k9a_A          342 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYK------  404 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HHTTCC------
T ss_pred             c----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCC------
Confidence            2    122356789999999999999999999999999999998 999986543221   1111    111111      


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                        ...+..++..+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       405 --~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          405 --MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence              12233344568889999999999999999999999998764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-44  Score=328.44  Aligned_cols=262  Identities=20%  Similarity=0.217  Sum_probs=200.9

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..++|++.+.||+|+||.||++.+. +++.||+|++....   ......+.+|+.++++++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3689999999999999999999986 68889999987542   3335678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++...
T Consensus       112 v~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          112 DMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEECCCCEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            999999999999984    334689999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ............+++.|+|||.+.+..++.++||||||+++|+|++|..||......       ............    
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~----  253 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR----  253 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC----
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC----
Confidence            544333334456899999999999999999999999999999999999998653211       111111111111    


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCC-CHHHHHHHHHhhhccC
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRP-QMNQVIKMLTKNIRLN  325 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~~~~  325 (370)
                        ....++.....+.+++.+||+.+|.+|| ++.++++.|+..+...
T Consensus       254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence              0111222333488899999999999999 9999999999887644

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7e-44  Score=326.28  Aligned_cols=245  Identities=28%  Similarity=0.373  Sum_probs=204.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||+++.+ +++.||+|++....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            578999999999999999999986 68999999986542   23456788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++++|.+++.    ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        85 ~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999984    345689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ..    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ...   .........       
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~---~~~i~~~~~-------  220 (318)
T 1fot_A          158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKT---YEKILNAEL-------  220 (318)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHH---HHHHHHCCC-------
T ss_pred             Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHH---HHHHHhCCC-------
Confidence            32    2345789999999999999999999999999999999999999865321   111   111111111       


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  316 (370)
                         .++......+.+++.+||+.||.+||     ++.+|++
T Consensus       221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence               11222334588899999999999999     8888875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-44  Score=333.85  Aligned_cols=264  Identities=25%  Similarity=0.428  Sum_probs=212.5

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC--------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT--------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ  113 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  113 (370)
                      ..++|++.+.||+|+||.||+|.+.        ++..||+|++... .......+.+|+.+++++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3689999999999999999999863        4678999998765 334566788999999999 89999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccC------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceE
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKA------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL  181 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nil  181 (370)
                      .+..++||||+++++|.+++......            ...+++..++.++.|++.||.|||+.   +++||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence            99999999999999999999643321            23489999999999999999999999   9999999999999


Q ss_pred             eCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchh
Q 017503          182 LDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNK  259 (370)
Q Consensus       182 l~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~  259 (370)
                      ++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.....   .
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~  266 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---E  266 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---H
Confidence            999999999999999876543221 2233456788999999988899999999999999999999 9998864421   1


Q ss_pred             hHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          260 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      .+..    .......        ...+......+.+++.+||+.+|.+||++.++++.|+++....
T Consensus       267 ~~~~----~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          267 ELFK----LLKEGHR--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             HHHH----HHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHH----HHhcCCC--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            1111    1111111        1112233445888999999999999999999999999988643

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-44  Score=343.18  Aligned_cols=265  Identities=22%  Similarity=0.213  Sum_probs=211.0

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEE
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCC  111 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  111 (370)
                      +.+.+++...++|++.+.||+|+||+||+|+++ +++.||+|++....   ......+.+|+.++..++||||+++++++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345666677899999999999999999999987 47889999886431   12223477899999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEe
Q 017503          112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG  191 (370)
Q Consensus       112 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~  191 (370)
                      .+....++||||+.+|+|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEc
Confidence            999999999999999999999842   245699999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCcceeecccCCCCCCCccccc-----CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHH
Q 017503          192 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW  266 (370)
Q Consensus       192 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~  266 (370)
                      |||++...............||+.|+|||++.     ...++.++|||||||++|||++|+.||.....   ......+.
T Consensus       218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~  294 (437)
T 4aw2_A          218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIM  294 (437)
T ss_dssp             CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH
T ss_pred             chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhh
Confidence            99999876554444444567999999999987     56789999999999999999999999865321   11111111


Q ss_pred             HHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCC--CCCHHHHHHH
Q 017503          267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR--RPQMNQVIKM  317 (370)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  317 (370)
                      .....        ...+.........+.+++.+||..+|++  ||++.++++.
T Consensus       295 ~~~~~--------~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          295 NHKER--------FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             THHHH--------CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hcccc--------ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            11000        0111111122344788999999888888  9999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=334.73  Aligned_cols=249  Identities=27%  Similarity=0.363  Sum_probs=199.8

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  118 (370)
                      ..++|++.+.||+|+||.||+|+++ +++.||+|++...   .......+..|..+++.+ +||||+++++++.+....+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3689999999999999999999986 5889999998754   234456678899999988 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+.+|+|..++.    ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       101 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999983    345689999999999999999999999   999999999999999999999999999985


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ..+..   .......     
T Consensus       174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~---~i~~~~~-----  241 (353)
T 3txo_A          174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DDLFE---AILNDEV-----  241 (353)
T ss_dssp             SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHCCC-----
T ss_pred             cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HHHHH---HHHcCCC-----
Confidence            43221 223445799999999999988999999999999999999999999865422   11111   1111111     


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCH------HHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM------NQVIK  316 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~  316 (370)
                           .++......+.+++.+||+.+|.+||++      .++++
T Consensus       242 -----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 -----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                 1122233457889999999999999998      67765

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.6e-44  Score=330.14  Aligned_cols=250  Identities=28%  Similarity=0.370  Sum_probs=200.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++...   .......+.+|+.++.++ +||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            478999999999999999999986 5888999998754   334456678899999987 89999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++++|.+++.    ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus        88 v~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            999999999999983    334689999999999999999999999   9999999999999999999999999999854


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchh--hHHHHHHHHHhcCCCccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--FLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  277 (370)
                      .... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........  ...............   
T Consensus       161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---  236 (345)
T 3a8x_A          161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---  236 (345)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred             cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence            3221 2234457999999999999999999999999999999999999999643221110  011111111111111   


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  311 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  311 (370)
                            .++......+.+++.+||+.||.+||++
T Consensus       237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 ------RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                  1222334458889999999999999995

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-44  Score=340.75  Aligned_cols=261  Identities=21%  Similarity=0.243  Sum_probs=208.3

Q ss_pred             HHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 017503           38 YTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQ  113 (370)
Q Consensus        38 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  113 (370)
                      ..+++...++|++.+.||+|+||.||+|+++ +++.||+|++....   ......+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3455566789999999999999999999986 58899999886421   1223447789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      ....++||||+++|+|.+++..     ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence            9999999999999999998832     3589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCC----cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ----LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      |++...............||+.|+|||++.+..    ++.++|||||||++|||++|+.||.....   ......+....
T Consensus       213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~  289 (410)
T 3v8s_A          213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHK  289 (410)
T ss_dssp             TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTHH
T ss_pred             ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---hhHHHHHHhcc
Confidence            999876654433344567999999999997765    88999999999999999999999864321   11111111110


Q ss_pred             hcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCC--CCCHHHHHHHH
Q 017503          270 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR--RPQMNQVIKML  318 (370)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~L  318 (370)
                      ..     ..-+.....    ...+.+++.+||..+|.+  ||++.+|++.-
T Consensus       290 ~~-----~~~p~~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          290 NS-----LTFPDDNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             HH-----CCCCTTCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             cc-----ccCCCcccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence            00     000111122    234788999999999998  99999998753

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.4e-44  Score=328.55  Aligned_cols=266  Identities=26%  Similarity=0.425  Sum_probs=213.8

Q ss_pred             HhccCCcccceeeecCCeEEEEEEE------CCCCEEEEEECcCcC-hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTL------TNGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQG  114 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  114 (370)
                      ...++|++.+.||+|+||.||+|.+      .++..||+|++.... ......+.+|+.+++++ +||||+++++++.+.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3467899999999999999999985      246789999987553 34456788999999999 999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhccccc--------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCce
Q 017503          115 TRRILVYEYVENNSLDRVLLGATK--------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI  180 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Ni  180 (370)
                      +..++||||+++++|.+++.....              ....+++..++.++.|++.||.|||+.   +++||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence            999999999999999999854322              123589999999999999999999999   999999999999


Q ss_pred             EeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccch
Q 017503          181 LLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMN  258 (370)
Q Consensus       181 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~  258 (370)
                      +++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            9999999999999999876544322 2233456788999999999999999999999999999999 9999865433211


Q ss_pred             hhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                        ...    .......     .   ..+......+.+++.+||+.||.+|||+.++++.|++++...
T Consensus       257 --~~~----~~~~~~~-----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          257 --FYK----MIKEGFR-----M---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             --HHH----HHHHTCC-----C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             --HHH----HhccCCC-----C---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence              111    1111111     1   111223345888999999999999999999999999987643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.5e-44  Score=325.09  Aligned_cols=266  Identities=21%  Similarity=0.362  Sum_probs=203.8

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..++|++.+.||+|+||.||+|... ++..||+|++...   .......+.+|+.++++++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            4578999999999999999999974 6899999988653   34456678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++++|.+++.........+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999865444566789999999999999999999999   9999999999999999999999999998865


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........    ..... .......    
T Consensus       187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~-~~~~~~~----  256 (310)
T 2wqm_A          187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCKK-IEQCDYP----  256 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH----HHHHH-HHTTCSC----
T ss_pred             cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH----HHHHH-hhcccCC----
Confidence            43321 12234688999999999999999999999999999999999999864322211    11111 1111110    


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      +..   .......+.+++.+||+.||.+||++.+|++.|+++....
T Consensus       257 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          257 PLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            000   1222345888999999999999999999999999987643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=332.41  Aligned_cols=275  Identities=17%  Similarity=0.183  Sum_probs=212.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC---------CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcce---------
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN---------GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE---------  106 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~---------  106 (370)
                      .++|++.+.||+|+||.||+|++..         ++.||+|.+...     ..+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4789999999999999999999863         788999988654     35678999999999999887         


Q ss_pred             ------eeeEEEe-CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCc
Q 017503          107 ------LIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN  179 (370)
Q Consensus       107 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~N  179 (370)
                            +++++.. ....++||||+ +++|.+++...  .+..+++..++.++.||+.||.|||++   +++||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  6777776 77889999999 99999999532  235799999999999999999999999   99999999999


Q ss_pred             eEeCCCC--CeEEeeecCccccCCCCcc------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCC
Q 017503          180 ILLDQEF--NPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  251 (370)
Q Consensus       180 ill~~~~--~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~  251 (370)
                      |+++.++  .+||+|||++..+......      ......||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999988  8999999999866432211      1133468999999999999999999999999999999999999987


Q ss_pred             cccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCccccCC
Q 017503          252 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTA  331 (370)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~  331 (370)
                      ........ +...........  ....+...  ........+.+++.+||+.||.+||++.+|++.|+.+..........
T Consensus       270 ~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~  344 (352)
T 2jii_A          270 NCLPNTED-IMKQKQKFVDKP--GPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYD  344 (352)
T ss_dssp             GGTTCHHH-HHHHHHHHHHSC--CCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred             cCCcCHHH-HHHHHHhccCCh--hhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCc
Confidence            65432221 222211111111  11111111  00112345888999999999999999999999999998766555455


Q ss_pred             CCcc
Q 017503          332 PGLF  335 (370)
Q Consensus       332 p~~~  335 (370)
                      |..|
T Consensus       345 ~~dw  348 (352)
T 2jii_A          345 PIGL  348 (352)
T ss_dssp             CCCC
T ss_pred             cccC
Confidence            5444

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.8e-44  Score=322.41  Aligned_cols=253  Identities=24%  Similarity=0.401  Sum_probs=203.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC-C-------CEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN-G-------RRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~-~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  116 (370)
                      .++|++.+.||+|+||.||+|.+.. +       ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            5789999999999999999998653 3       4699999877766667889999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC--------e
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN--------P  188 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~--------~  188 (370)
                      .++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999843   333489999999999999999999999   9999999999999998887        9


Q ss_pred             EEeeecCccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 017503          189 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       189 kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      ||+|||++......     ....+++.|+|||++.+ ..++.++||||||+++|+|++|..|+........  .    ..
T Consensus       161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~----~~  229 (289)
T 4fvq_A          161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--K----LQ  229 (289)
T ss_dssp             EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--H----HH
T ss_pred             eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--H----HH
Confidence            99999998754321     22457889999999987 6789999999999999999996554332222111  1    11


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      .......       +   +......+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       230 ~~~~~~~-------~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          230 FYEDRHQ-------L---PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHTTCC-------C---CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             HhhccCC-------C---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            1111110       0   111122377899999999999999999999999988763

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.7e-44  Score=328.63  Aligned_cols=273  Identities=25%  Similarity=0.396  Sum_probs=217.5

Q ss_pred             ccCHHHHHHhccCCcccceeeecCCeEEEEEEE------CCCCEEEEEECcCcC-hhcHHHHHHHHHHHHhc-CCCCcce
Q 017503           35 HFSYTELRSATDDFHLSNKIGRGGFGTVYKGTL------TNGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVE  106 (370)
Q Consensus        35 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~  106 (370)
                      .++...+....++|++.+.||+|+||.||+|.+      .+++.||+|++.... ......+.+|+.+++++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            456677777789999999999999999999984      246789999987653 34456788999999999 7999999


Q ss_pred             eeeEEEeCC-eeEEEEEecCCCCHHHHhcccccC------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEee
Q 017503          107 LIGCCVQGT-RRILVYEYVENNSLDRVLLGATKA------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR  173 (370)
Q Consensus       107 ~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~  173 (370)
                      +++++...+ ..++||||+++++|.+++......            ...+++..++.++.|++.||.|||+.   +++||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            999988754 589999999999999999543321            12388999999999999999999999   99999


Q ss_pred             cCCCCceEeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCC
Q 017503          174 DIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGK  251 (370)
Q Consensus       174 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~  251 (370)
                      ||||+||+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999999999999999866543222 2333457889999999999999999999999999999998 999986


Q ss_pred             cccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          252 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      ......  .+.    .........        ..+......+.+++.+||+.+|.+|||+.+|++.|+.++..
T Consensus       253 ~~~~~~--~~~----~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          253 GVKIDE--EFC----RRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             TCCCSH--HHH----HHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccchhH--HHH----HHhccCccC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            543221  111    111111111        11222334588899999999999999999999999988753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.7e-44  Score=330.22  Aligned_cols=246  Identities=24%  Similarity=0.299  Sum_probs=204.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||+++++ +++.||+|++....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            478999999999999999999986 68999999986542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++++|.+++.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       120 ~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          120 MEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999984    334689999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ..    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   .....   ..... ..      
T Consensus       193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~---~i~~~-~~------  255 (350)
T 1rdq_E          193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYE---KIVSG-KV------  255 (350)
T ss_dssp             SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHC-CC------
T ss_pred             CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHHH---HHHcC-CC------
Confidence            33    2345689999999999999999999999999999999999999864321   11111   11111 11      


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCC-----HHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIKM  317 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  317 (370)
                         .++......+.+++.+||+.||.+||+     +.+|++.
T Consensus       256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence               112233445889999999999999998     8888753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.5e-44  Score=323.99  Aligned_cols=260  Identities=24%  Similarity=0.364  Sum_probs=200.0

Q ss_pred             cCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ++|++.+.||+|+||.||+|++.+++.||+|.+....  ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            6899999999999999999999889999999886543  23346778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++ +|.+++.   .....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            986 8888874   2335689999999999999999999999   99999999999999999999999999998664322


Q ss_pred             cceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc-------
Q 017503          204 THITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL-------  275 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------  275 (370)
                      . ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......   ................       
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhc
Confidence            1 1233467999999999876 45899999999999999999999998654221   1111121211111000       


Q ss_pred             -ccccCCC--------CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 -ELVDPEL--------GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 -~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       ...++..        ..........+.+++.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             0011111        0111223445789999999999999999999976

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-43  Score=320.71  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=210.9

Q ss_pred             ccCCcccc-eeeecCCeEEEEEEEC---CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSN-KIGRGGFGTVYKGTLT---NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~-~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|.+.. .||+|+||.||+|.+.   ++..||+|++... .......+.+|+.++++++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            46777776 9999999999999864   5778999998765 344567788999999999999999999999 5567899


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++++|.+++.   .....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++...
T Consensus        87 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           87 VMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            999999999999984   2345689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcce--eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          200 PDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       200 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      .......  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   ....    .......  
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~----~i~~~~~--  231 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKR--  231 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH----HHHTTCC--
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHH----HHhcCCc--
Confidence            5433221  222346788999999988899999999999999999998 99998654321   1111    1111111  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                            ...+......+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus       232 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          232 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                  1223334456889999999999999999999999999988654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.1e-44  Score=322.77  Aligned_cols=249  Identities=22%  Similarity=0.333  Sum_probs=195.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--------------------------hcHHHHHHHHHHHH
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--------------------------QGVREFITEIMTLS   97 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--------------------------~~~~~~~~e~~~l~   97 (370)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.....                          .....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            578999999999999999999975 688899998865421                          12356788999999


Q ss_pred             hcCCCCcceeeeEEEe--CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecC
Q 017503           98 NVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI  175 (370)
Q Consensus        98 ~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dl  175 (370)
                      +++||||+++++++.+  ....++||||+++++|.+++     ....+++..++.++.|++.||.|||+.   +++||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            9999999999999987  56889999999999987754     334689999999999999999999999   9999999


Q ss_pred             CCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCC---cCccccchhhhHHHHHHHhCCCCCCc
Q 017503          176 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ---LTMKADVYSFGVLVLEIISGRNSGKA  252 (370)
Q Consensus       176 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~elltg~~p~~~  252 (370)
                      ||+||+++.++.+||+|||++........ ......||+.|+|||.+.+..   ++.++||||||+++|+|++|..||..
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999987654322 233456899999999987765   47889999999999999999999864


Q ss_pred             ccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          253 MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...   ..+   ...........    +....    ....+.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~---~~~---~~~~~~~~~~~----~~~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERI---MCL---HSKIKSQALEF----PDQPD----IAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSH---HHH---HHHHHHCCCCC----CSSSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccH---HHH---HHHHhcccCCC----CCccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            321   111   11111111110    11112    2345889999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.7e-44  Score=320.85  Aligned_cols=259  Identities=25%  Similarity=0.357  Sum_probs=205.2

Q ss_pred             hccCCcccceeeecCCeEEEEEEECC----CCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      ..++|++.+.||+|+||.||+|.+.+    +..||+|.+... .......+.+|+.++++++||||+++++++.+ ...+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            46789999999999999999998642    235999998765 34456778899999999999999999999765 4568


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+.+++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        89 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            99999999999999842   334589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      .............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.......   .....    ......  
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~~~~--  233 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKGDRL--  233 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHTCCC--
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcCCCC--
Confidence            65443333334456788999999998899999999999999999998 999986443221   11111    111110  


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                            ..+......+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus       234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          234 ------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                  11122334588899999999999999999999999987653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=327.28  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=190.7

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ...++|++.+.||+|+||.||+|++. +++.||+|++....  ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            34678999999999999999999986 57889999987543  2356778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC---CCCeEEeeecCccc
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKL  198 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kL~Dfg~~~~  198 (370)
                      ||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||||+||+++.   ++.+||+|||++..
T Consensus       128 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          128 ELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             CCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            9999999999983    345689999999999999999999999   9999999999999975   88999999999986


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ...    ........ ...
T Consensus       201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~----~~i~~~~~-~~~  271 (349)
T 2w4o_A          201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMF----RRILNCEY-YFI  271 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHH----HHHHTTCC-CCC
T ss_pred             cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHH----HHHHhCCC-ccC
Confidence            54321  2234568999999999999999999999999999999999999986543211  111    11111111 111


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .    .........+.+++.+||+.||.+|||+.++++
T Consensus       272 ~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 S----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             T----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1    112233445889999999999999999999976

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=321.30  Aligned_cols=258  Identities=31%  Similarity=0.500  Sum_probs=199.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.+.||+|+||.||++++. ++.||+|.+....  ....+.+|+.++++++||||+++++++.  +..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            468999999999999999999986 7889999986543  3467889999999999999999999876  3478999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC-eEEeeecCccccCCCC
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN-PKIGDFGLAKLFPDNI  203 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~-~kL~Dfg~~~~~~~~~  203 (370)
                      ++++|.+++.... ....+++..++.++.|++.||.|||+....+++||||||+||+++.++. +||+|||++...... 
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            9999999985322 1224788999999999999999999921118999999999999998887 799999999755332 


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                         .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........    ...+.... ...        .
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~-~~~--------~  223 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVHN-GTR--------P  223 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHHT-TCC--------C
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHhc-CCC--------C
Confidence               2234589999999999999999999999999999999999999865432211    11111111 111        1


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      ..+......+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus       224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            112223345888999999999999999999999999987654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-43  Score=329.41  Aligned_cols=211  Identities=27%  Similarity=0.379  Sum_probs=183.3

Q ss_pred             cccccCHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-----CCCcc
Q 017503           32 NVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-----HPNLV  105 (370)
Q Consensus        32 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv  105 (370)
                      ....|++.+.....++|++.+.||+|+||.||+|++. +++.||||++... ......+..|+.+++.+.     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            3456777777788899999999999999999999985 6889999998743 333456778999999986     99999


Q ss_pred             eeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-
Q 017503          106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-  184 (370)
Q Consensus       106 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-  184 (370)
                      ++++++...+..++||||+ +++|.+++...  ....+++..+..++.||+.||.|||+.   +|+||||||+|||++. 
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP  173 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence            9999999999999999999 88999998532  233589999999999999999999999   9999999999999975 


Q ss_pred             ------------------------CCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHH
Q 017503          185 ------------------------EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV  240 (370)
Q Consensus       185 ------------------------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  240 (370)
                                              ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                    788999999999865432    2345689999999999999999999999999999


Q ss_pred             HHHHhCCCCCCcc
Q 017503          241 LEIISGRNSGKAM  253 (370)
Q Consensus       241 ~elltg~~p~~~~  253 (370)
                      |+|++|+.||...
T Consensus       250 ~ell~g~~pf~~~  262 (360)
T 3llt_A          250 AELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHHSSCSCCCS
T ss_pred             HHHHHCCCCCCCC
Confidence            9999999998654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.3e-44  Score=319.30  Aligned_cols=253  Identities=21%  Similarity=0.368  Sum_probs=205.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC--CeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv  120 (370)
                      .++|++.+.||+|+||.||+|+++ +..||+|++...  .....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            578999999999999999999986 888999988765  344456789999999999999999999999877  778999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      |||+++++|.+++..  ..+..+++..++.++.|++.||.|||+.   +  ++||||||+||+++.++.++|+|||+...
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           88 THWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             ecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence            999999999999953  2233589999999999999999999998   7  99999999999999999999999988764


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCc---cccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTM---KADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      ...      ....+|+.|+|||.+.+..++.   ++||||||+++|+|++|..||.......      ........... 
T Consensus       163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~-  229 (271)
T 3kmu_A          163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEGLR-  229 (271)
T ss_dssp             TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSCCC-
T ss_pred             ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcCCC-
Confidence            332      2245789999999998766554   7999999999999999999986543211      11111111111 


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                             ...+......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       230 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          230 -------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                   11223334458889999999999999999999999988753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.1e-45  Score=335.57  Aligned_cols=250  Identities=27%  Similarity=0.389  Sum_probs=202.9

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCe
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTR  116 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  116 (370)
                      ....++|++.+.||+|+||.||+|+++ +++.||+|++....   ......+..|..++..+ +||||+++++++.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            445789999999999999999999986 58889999987542   23456677899999876 99999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .++||||+++|+|.+++.    ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        93 ~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            999999999999999983    334689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ..+..   .... ..   
T Consensus       166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~---~i~~-~~---  234 (345)
T 1xjd_A          166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFH---SIRM-DN---  234 (345)
T ss_dssp             BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHH-CC---
T ss_pred             hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHH---HHHh-CC---
Confidence            8543222 123446799999999999999999999999999999999999999864321   11111   1111 11   


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHH-HHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN-QVI  315 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl  315 (370)
                         +   .++......+.+++.+||+.||.+||++. +|+
T Consensus       235 ---~---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 ---P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ---C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---C---CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence               1   11222334588899999999999999997 664

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-44  Score=329.55  Aligned_cols=260  Identities=26%  Similarity=0.418  Sum_probs=203.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC-----CCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN-----GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .++|++.+.||+|+||.||+|.+..     +..||+|.+... .......+.+|+.++++++||||+++++++.+....+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4678889999999999999998652     235999998765 3344567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus       123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999999842   345689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc--eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          199 FPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       199 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      .......  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....   ..+.    ........ 
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~----~~~~~~~~-  268 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVM----KAINDGFR-  268 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH----HHHHTTCC-
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHH----HHHHCCCc-
Confidence            6543221  1222345778999999999999999999999999999999 9999864322   1111    11111111 


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                             ...+......+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus       269 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          269 -------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             -------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                   1112233445888999999999999999999999999988644

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=339.17  Aligned_cols=264  Identities=22%  Similarity=0.195  Sum_probs=209.1

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEE
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCC  111 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  111 (370)
                      +...++....++|++.+.||+|+||.||+++++ +++.||+|++....   ......+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            455666777899999999999999999999986 68999999986432   22234577899999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEe
Q 017503          112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG  191 (370)
Q Consensus       112 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~  191 (370)
                      .+....|+||||+.+|+|.+++..   .+..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence            999999999999999999999842   234689999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCcceeecccCCCCCCCccccc-------CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHH
Q 017503          192 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-------GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW  264 (370)
Q Consensus       192 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~  264 (370)
                      |||++...............||+.|+|||++.       ...++.++|||||||++|||++|+.||.....   ......
T Consensus       205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~  281 (412)
T 2vd5_A          205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---AETYGK  281 (412)
T ss_dssp             CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHH
T ss_pred             echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence            99999876554433344467999999999987       45789999999999999999999999865322   111111


Q ss_pred             HHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCC---CCHHHHHHH
Q 017503          265 AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR---PQMNQVIKM  317 (370)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~evl~~  317 (370)
                      +.......        .+..........+.+++.+||. +|.+|   |++.+|++.
T Consensus       282 i~~~~~~~--------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          282 IVHYKEHL--------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHTHHHHC--------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHhcccCc--------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            11110000        0111112233458899999999 99998   689998764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-43  Score=333.06  Aligned_cols=268  Identities=20%  Similarity=0.234  Sum_probs=204.6

Q ss_pred             HhccCCcccceeeec--CCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           43 SATDDFHLSNKIGRG--GFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G--~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      ...++|++.+.||+|  +||.||+|+++ +++.||||++...  .......+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            457889999999999  99999999986 6899999998754  244456788899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+++++|.+++...  ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||.+.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            9999999999999998532  234589999999999999999999999   99999999999999999999999999886


Q ss_pred             ccCCCC------cceeecccCCCCCCCcccccC--CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH
Q 017503          198 LFPDNI------THITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       198 ~~~~~~------~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      ......      ........||+.|+|||++.+  ..++.++|||||||++|+|++|..||........  +........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~  254 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV  254 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-----
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCC
Confidence            542211      111222468889999999987  5789999999999999999999999865432211  000000000


Q ss_pred             h---c--CCCc-----------------c----------cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          270 Q---E--EKPL-----------------E----------LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       270 ~---~--~~~~-----------------~----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .   .  ....                 .          ..+......+......+.+++.+||+.||.+|||+.++++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0   0  0000                 0          00000011222334558899999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.7e-45  Score=357.55  Aligned_cols=265  Identities=28%  Similarity=0.446  Sum_probs=213.8

Q ss_pred             HHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           39 TELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        39 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      ..+....++|++.+.||+|+||.||+|.++++..||||++.... ...+.+.+|+.+|++++||||+++++++.+ ...+
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            34445567899999999999999999999888889999987654 235678999999999999999999999876 6789


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+.+|+|.+++...  .+..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence            999999999999999421  223588999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      .............++..|+|||++....++.++||||||++||||++ |..||.....   ..+..    .......   
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~----~i~~~~~---  482 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD----QVERGYR---  482 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHH----HHHTTCC---
T ss_pred             cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHcCCC---
Confidence            65432222233446788999999999999999999999999999999 8888865422   11111    1111111   


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                           ...+..+...+.+++.+||+.+|.+|||+.+|++.|+.+....
T Consensus       483 -----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          483 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                 1122334455888999999999999999999999999887644

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.1e-44  Score=325.52  Aligned_cols=259  Identities=24%  Similarity=0.337  Sum_probs=196.6

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe---
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR---  116 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---  116 (370)
                      ..++|++.+.||+|+||.||++++. +++.||+|++...   .......+.+|+.++++++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            3578999999999999999999974 6889999998764   33445678899999999999999999999876543   


Q ss_pred             -eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          117 -RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       117 -~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                       .++||||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        90 ~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             ccEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence             499999999999999984    334689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcc--eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          196 AKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       196 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      +.........  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......      ...........
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~  236 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDP  236 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCC
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCC
Confidence            9866443221  223356899999999999999999999999999999999999998654221      11112222211


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHH-HHHHhh
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI-KMLTKN  321 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl-~~L~~~  321 (370)
                      ....      .........+.+++.+||+.||.+||+..+++ ..+...
T Consensus       237 ~~~~------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          237 IPPS------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCHH------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCcc------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            1100      00111234588899999999999999766655 444444

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-44  Score=331.09  Aligned_cols=255  Identities=20%  Similarity=0.314  Sum_probs=199.0

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCC--CCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRH--PNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~l  119 (370)
                      ..++|++.+.||+|+||.||++.+.+++.||+|++...  .......+.+|+.+++++.|  +||+++++++......++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            35789999999999999999999988999999988654  34455778899999999976  999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||| +.+++|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|||++...
T Consensus        87 v~e-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           87 VME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEC-CCSEEHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEe-CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            999 56779999984    345789999999999999999999999   999999999999996 678999999999876


Q ss_pred             CCCCcc-eeecccCCCCCCCcccccC-----------CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 017503          200 PDNITH-ITTRIAGTTGYLAPEYVLG-----------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       200 ~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      ...... ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||.........     ...
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~~  232 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHA  232 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHH
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-----HHH
Confidence            543222 2334579999999999864           67889999999999999999999998754332111     111


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                      .......        ...+......+.+++.+||+.||.+|||+.++++...-
T Consensus       233 ~~~~~~~--------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~  277 (343)
T 3dbq_A          233 IIDPNHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  277 (343)
T ss_dssp             HHCTTSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HhcCCcc--------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence            1111110        11122223457889999999999999999999876543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.4e-44  Score=329.92  Aligned_cols=262  Identities=23%  Similarity=0.248  Sum_probs=202.7

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-----ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-----SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG  114 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  114 (370)
                      +....++|++.+.||+|+||.||+|.+. ++..||+|++...     .......+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3456789999999999999999999975 6788999987643     234456788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccC------------------------------------CccCCHHHHHHHHHHHHHH
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKA------------------------------------NIKLNWEKRSDICVGIAKG  158 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~a  158 (370)
                      ...++||||+++++|.+++......                                    ...+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999998421111                                    2234678888999999999


Q ss_pred             HHHHhhcCCCCeEeecCCCCceEeCCCC--CeEEeeecCccccCCCCc---ceeecccCCCCCCCcccccC--CCcCccc
Q 017503          159 LAFLHEELVPHIVHRDIKASNILLDQEF--NPKIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLG--GQLTMKA  231 (370)
Q Consensus       159 l~~LH~~~~~~iiH~dlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~  231 (370)
                      |.|||+.   +++||||||+||+++.++  .+||+|||++..+.....   .......||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999   999999999999998776  899999999986533211   12334568999999999865  6789999


Q ss_pred             cchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCH
Q 017503          232 DVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM  311 (370)
Q Consensus       232 Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  311 (370)
                      ||||||+++|+|++|..||......      ..............  .+.    .......+.+++.+||+.+|.+||++
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~--~~~----~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFE--NPN----YNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTT--SGG----GGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccC--Ccc----cccCCHHHHHHHHHHcCCChhHCCCH
Confidence            9999999999999999998654321      11112222111110  111    11233458899999999999999999


Q ss_pred             HHHHHH
Q 017503          312 NQVIKM  317 (370)
Q Consensus       312 ~evl~~  317 (370)
                      .++++.
T Consensus       326 ~~~l~h  331 (345)
T 3hko_A          326 MRALQH  331 (345)
T ss_dssp             HHHHHS
T ss_pred             HHHhcC
Confidence            999873

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.7e-44  Score=328.72  Aligned_cols=259  Identities=25%  Similarity=0.406  Sum_probs=203.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCC----EEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGR----RIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .++|++.+.||+|+||.||+|.+. ++.    +||+|.+.... ......+.+|+.++++++||||+++++++. ....+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            468999999999999999999975 344    37888765432 233345677999999999999999999886 45688


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+.+++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        91 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence            99999999999999842   345789999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          199 FPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       199 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ...    ........ 
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~-  236 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPD----LLEKGERL-  236 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHH----HHHTTCBC-
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHH----HHHcCCCC-
Confidence            7544322 2334557789999999999999999999999999999999 999987543221   111    11111111 


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                             ..+......+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus       237 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          237 -------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             -------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             -------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                   111112223778899999999999999999999999987643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.1e-43  Score=315.41  Aligned_cols=253  Identities=23%  Similarity=0.339  Sum_probs=204.8

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ..++|++.+.||+|+||.||+|.++ ++..||+|++...  .......+.+|+.++++++||||+++++++.+....++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            4689999999999999999999976 5889999988654  334456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC---eEEeeecCcc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAK  197 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kL~Dfg~~~  197 (370)
                      |||+.+++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.   +||+|||++.
T Consensus        84 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           84 FDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             ECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            99999999988873    334689999999999999999999999   9999999999999986655   9999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      .......  .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.....   .....   .......  ..
T Consensus       157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~---~~~~~~~--~~  226 (284)
T 3kk8_A          157 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYA---QIKAGAY--DY  226 (284)
T ss_dssp             ECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHTCC--CC
T ss_pred             EcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHHH---HHHhccc--cC
Confidence            6654322  2335689999999999999999999999999999999999999864322   11111   1111111  11


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..+.....    ...+.+++.+||+.+|.+|||+.++++.
T Consensus       227 ~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          227 PSPEWDTV----TPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CTTTTTTS----CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             Cchhhccc----CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            11111222    3448889999999999999999999874

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.5e-43  Score=329.94  Aligned_cols=255  Identities=22%  Similarity=0.263  Sum_probs=194.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ..++|++.+.||+|+||.||++++. +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            3678999999999999999999986 788999998875433 23567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC--eEEeeecCccccC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN--PKIGDFGLAKLFP  200 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~  200 (370)
                      |+.+++|.+++.    ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.  +||+|||++....
T Consensus        97 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           97 YASGGELYERIC----NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             eCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            999999999883    334689999999999999999999999   9999999999999987765  9999999987432


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCcc-ccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMK-ADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ..  .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........  ..............  .  
T Consensus       170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~~~--~--  241 (361)
T 3uc3_A          170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVKYS--I--  241 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTCCC--C--
T ss_pred             cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCCCC--C--
Confidence            22  12233568999999999988887655 8999999999999999999875433211  11111111111100  0  


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      +....    ....+.+++.+||+.+|.+|||+.++++.-
T Consensus       242 ~~~~~----~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          242 PDDIR----ISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             CTTSC----CCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             CCcCC----CCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence            00011    224478999999999999999999998753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.4e-44  Score=329.75  Aligned_cols=265  Identities=20%  Similarity=0.258  Sum_probs=199.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC----CCCEEEEEECcCcChh-----------cHHHHHHHHHHHHhcCCCCcceeee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAESKQ-----------GVREFITEIMTLSNVRHPNLVELIG  109 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~  109 (370)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|........           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            478999999999999999999986    5778999988755321           1223567888899999999999999


Q ss_pred             EEEe----CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC
Q 017503          110 CCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE  185 (370)
Q Consensus       110 ~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~  185 (370)
                      ++..    ....++||||+ +++|.+++.    ....+++..++.++.||+.||.|||+.   +++||||||+||+++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISG----QNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCB----GGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence            9988    78899999999 999999984    333789999999999999999999999   99999999999999887


Q ss_pred             C--CeEEeeecCccccCCCCcc------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccc
Q 017503          186 F--NPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM  257 (370)
Q Consensus       186 ~--~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~  257 (370)
                      +  .+||+|||++..+......      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999866432111      1134568999999999999999999999999999999999999986433222


Q ss_pred             hhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          258 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      .. . ...........+...... ..  .......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       268 ~~-~-~~~~~~~~~~~~~~~~~~-~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          268 VA-V-QTAKTNLLDELPQSVLKW-AP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HH-H-HHHHHHHHHTTTHHHHHH-SC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HH-H-HHHHHhhcccccHHHHhh-cc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            11 1 111111111111111000 00  0022335888999999999999999999999997754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=333.10  Aligned_cols=272  Identities=22%  Similarity=0.270  Sum_probs=215.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC--eeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT--RRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv  120 (370)
                      .++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            578999999999999999999986 58999999987543 344567789999999999999999999998765  77999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe----CCCCCeEEeeecCc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLA  196 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kL~Dfg~~  196 (370)
                      |||+++++|.+++..... ...+++..++.++.|++.||.|||+.   +|+||||||+||++    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999853222 22389999999999999999999999   99999999999999    77778999999999


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccC--------CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLG--------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      .......  ......||+.|+|||++.+        ..++.++|||||||++|+|++|..||.........  .......
T Consensus       164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~  239 (396)
T 4eut_A          164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI  239 (396)
T ss_dssp             EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred             eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence            8765432  2233568999999998865        56788999999999999999999998754432211  1112222


Q ss_pred             HhcCCCccc---------------ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          269 HQEEKPLEL---------------VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       269 ~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      .........               .-+............+.+++.+||+.||.+||++.++++.+..++..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            222111000               00111344567778889999999999999999999999999988764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.2e-43  Score=319.07  Aligned_cols=262  Identities=23%  Similarity=0.339  Sum_probs=199.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....  ......+.+|+.++++++||||+++++++.+....++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            478999999999999999999986 58999999876542  333566788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|..++    .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        82 e~~~~~~l~~~~----~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           82 EYCDHTVLHELD----RYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             ECCSEEHHHHHH----HTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EeCCCchHHHHH----hhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            999999999887    3445689999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc---------
Q 017503          202 NITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE---------  271 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------  271 (370)
                      ... ......+|..|+|||.+.+ ..++.++||||||+++|+|++|..||..........   ........         
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          155 PSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY---LIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCHHHHHHH
T ss_pred             ccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhccccccccccc
Confidence            322 1233468899999998876 678999999999999999999999986543322111   11111100         


Q ss_pred             --CCC---cccccCCC-C---CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          272 --EKP---LELVDPEL-G---EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       272 --~~~---~~~~~~~~-~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                        ...   ....++.. .   ...+.....+.+++.+||+.||.+|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence              000   00000000 0   0001233458889999999999999999999763

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.8e-44  Score=327.51  Aligned_cols=267  Identities=22%  Similarity=0.406  Sum_probs=202.6

Q ss_pred             HHHHhccCCcccceeeecCCeEEEEEEEC----CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 017503           40 ELRSATDDFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ  113 (370)
Q Consensus        40 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  113 (370)
                      ++....++|++.+.||+|+||.||+|.+.    .+..||+|.+...  .......+.+|+.++++++||||+++++++.+
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            33345788999999999999999999864    2457999998754  34445678899999999999999999999986


Q ss_pred             CC-----eeEEEEEecCCCCHHHHhcccc--cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC
Q 017503          114 GT-----RRILVYEYVENNSLDRVLLGAT--KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF  186 (370)
Q Consensus       114 ~~-----~~~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~  186 (370)
                      ..     ..++||||+.+++|.+++....  .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence            55     3489999999999999984332  3345689999999999999999999999   999999999999999999


Q ss_pred             CeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHH
Q 017503          187 NPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEW  264 (370)
Q Consensus       187 ~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~  264 (370)
                      .+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~  261 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDY  261 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHH
Confidence            999999999986643321 12233456788999999999999999999999999999999 888876543221   1111


Q ss_pred             HHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          265 AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                          ......        ...+......+.+++.+||..+|.+||++.++++.|+.+...
T Consensus       262 ----~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          262 ----LLHGHR--------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             ----HHTTCC--------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHcCCC--------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                111111        112223344588999999999999999999999999988764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-43  Score=338.34  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=205.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++....   ......+.+|+.+++.++||||+++++++......++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            578999999999999999999986 78999999986542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++++|.+++.    .+..+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        95 ~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           95 MEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999983    455799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ...  ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....   ..+..   .. .....     
T Consensus       168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~---~i-~~~~~-----  233 (476)
T 2y94_A          168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFK---KI-CDGIF-----  233 (476)
T ss_dssp             TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHH---HH-HTTCC-----
T ss_pred             ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHH---HH-hcCCc-----
Confidence            432  2334578999999999988765 6899999999999999999999875422   11111   11 11110     


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                          ..+......+.+++.+||+.||.+|||+.++++.
T Consensus       234 ----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                1112223457889999999999999999999873

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-43  Score=319.62  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=199.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||.||++... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            578999999999999999999975 68899999886553 3346788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe---CCCCCeEEeeecCcccc
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kL~Dfg~~~~~  199 (370)
                      |+++++|.+++......+..+++..++.++.|++.||.|||+.   +++||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999998865544556799999999999999999999999   99999999999999   45678999999999865


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ....  ......+++.|+|||.+. +.++.++||||||+++|+|++|..||......   ..   ............   
T Consensus       178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~---~~~~~~~~~~~~---  245 (285)
T 3is5_A          178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EV---QQKATYKEPNYA---  245 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHCCCCCC---
T ss_pred             CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HH---HhhhccCCcccc---
Confidence            4432  223456899999999875 56899999999999999999999998654321   11   111111111111   


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ......    ...+.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 VECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             C--CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            011112    234788999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.5e-43  Score=339.11  Aligned_cols=264  Identities=22%  Similarity=0.332  Sum_probs=210.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCC-CCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||.||+|.+. +++.||||++......  ..+..|+.+++.+.| +++..+..++......++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            578999999999999999999974 6899999987654332  346789999999976 566666677788889999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe---CCCCCeEEeeecCcccc
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kL~Dfg~~~~~  199 (370)
                      |+ +++|.+++..   ....+++..++.++.||+.||.|||++   +|+||||||+||||   +.++.+||+|||++..+
T Consensus        84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99 8899999842   345699999999999999999999999   99999999999999   58889999999999876


Q ss_pred             CCCCcc------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          200 PDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       200 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      ......      ......||..|+|||++.+..++.++|||||||+||+|++|..||..............+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            543321      12246789999999999999999999999999999999999999987654433333332222211111


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      ...+.    ..+    ..++.+++..||+.+|.+||++.+|++.|+.++...
T Consensus       237 ~~~l~----~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          237 IEALC----RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHH----TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHh----cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            11110    122    345888999999999999999999999999987644

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-43  Score=325.41  Aligned_cols=249  Identities=24%  Similarity=0.338  Sum_probs=194.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEE----CCCCEEEEEECcCcC----hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL----TNGRRIAVKPLSAES----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  116 (370)
                      .++|++.+.||+|+||.||+++.    .+++.||+|++....    ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            57899999999999999999997    368899999887542    2334567789999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .++||||+++++|.+++.    ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999999983    334688999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....   .....   .......   
T Consensus       169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~---~i~~~~~---  238 (327)
T 3a62_A          169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTID---KILKCKL---  238 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHH---HHHHTCC---
T ss_pred             cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHhCCC---
Confidence            7543221 123345689999999999999999999999999999999999999865422   11111   1111110   


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  317 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  317 (370)
                             ..++.....+.+++.+||+.+|.+||     ++.++++.
T Consensus       239 -------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          239 -------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             -------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             -------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                   11223334588899999999999999     77788763

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=324.45  Aligned_cols=245  Identities=24%  Similarity=0.311  Sum_probs=191.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.++||+|+||+||+|++. +++.||||++...  ..........|+..+.++ +||||+++++++.+....++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            368999999999999999999986 7899999987653  223334455566666555 999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+ +++|.+++..   .+..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       136 ~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          136 TELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             Eecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            9999 5688887742   345699999999999999999999999   99999999999999999999999999988664


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ...  ......||+.|+|||++.+ .++.++||||||+++|+|++|..|+.....          +..........    
T Consensus       209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~----  271 (311)
T 3p1a_A          209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPP----  271 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCCH----
T ss_pred             cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCCc----
Confidence            332  2233468999999998875 789999999999999999999765432210          11111111100    


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                         ..+......+.+++.+||+.||.+|||+.++++
T Consensus       272 ---~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 ---EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence               011122345889999999999999999999976

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.9e-44  Score=323.88  Aligned_cols=258  Identities=24%  Similarity=0.354  Sum_probs=207.1

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--CCeeE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRI  118 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~  118 (370)
                      ..++|++.+.||+|+||.||++.+. +++.||+|.+...  .....+.+.+|+.++++++||||+++++++.+  ....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            4678999999999999999999986 6889999988654  34455678899999999999999999998865  56889


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEeecCCCCceEeCCCCCeEEeee
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH-----IVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~-----iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      +||||+++++|.+++.........+++..++.++.|++.||.|||+.   +     ++||||+|+||+++.++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            99999999999999965555555699999999999999999999999   7     999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      |++........ ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....   ..+..    ......
T Consensus       161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~----~i~~~~  232 (279)
T 2w5a_A          161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAG----KIREGK  232 (279)
T ss_dssp             CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHTC
T ss_pred             chheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHH----HHhhcc
Confidence            99986654321 12234689999999999999999999999999999999999999875422   11111    111111


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                      .        ...+......+.+++.+||+.+|.+||++.+|++.+..
T Consensus       233 ~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          233 F--------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             c--------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            1        11222334458889999999999999999999886643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-43  Score=321.35  Aligned_cols=262  Identities=27%  Similarity=0.388  Sum_probs=208.1

Q ss_pred             HHHHhccCCcccc-eeeecCCeEEEEEEEC---CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 017503           40 ELRSATDDFHLSN-KIGRGGFGTVYKGTLT---NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQ  113 (370)
Q Consensus        40 ~~~~~~~~y~~~~-~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  113 (370)
                      ++....++|++.+ .||+|+||.||+|.+.   .+..||+|++....  ......+.+|+.+++.++||||+++++++ .
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            3334467899988 9999999999999642   46789999987553  33356788999999999999999999999 6


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      .+..++||||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             CCCcEEEEEeCCCCCHHHHHH----hCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccC
Confidence            677899999999999999984    344689999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcce--eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHh
Q 017503          194 GLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQ  270 (370)
Q Consensus       194 g~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  270 (370)
                      |++..........  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   ...    ....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~  234 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT----AMLE  234 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHH
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHH
Confidence            9998765443322  222345688999999998889999999999999999999 99998654321   111    1111


Q ss_pred             cCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      ....        ...+......+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus       235 ~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          235 KGER--------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             TTCC--------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             cCCC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            1111        112233445588999999999999999999999999988754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.3e-43  Score=317.04  Aligned_cols=249  Identities=28%  Similarity=0.408  Sum_probs=201.5

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      +.++|++.+.||+|+||.||+|.+. ++..||+|++...   .......+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            4678999999999999999999976 5778999988543   22335678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++...
T Consensus        87 v~e~~~~~~l~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            999999999999883    334689999999999999999999999   9999999999999999999999999988654


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ....   .....+++.|+|||.+.+..++.++||||||+++|+|++|..||......   ....   ......       
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~~~~~~-------  223 (279)
T 3fdn_A          160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYK---RISRVE-------  223 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHHTC-------
T ss_pred             Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---HHHH---HHHhCC-------
Confidence            3321   23356899999999999999999999999999999999999998643221   1111   111110       


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      .   ..+......+.+++.+||+.+|.+|||+.++++.-
T Consensus       224 ~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          224 F---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             C---CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             C---CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            1   11222334578899999999999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=316.44  Aligned_cols=250  Identities=24%  Similarity=0.391  Sum_probs=184.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..++|++.+.||+|+||.||+|++. +++.||+|.+....   ......+.+|+.++++++||||+++++++.+....++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            4578999999999999999999974 68999999886442   2335678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++...
T Consensus        89 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             EEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            9999999999999842   335689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ..... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........          .....   ..+
T Consensus       163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~~~~---~~~  228 (278)
T 3cok_A          163 KMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------LNKVV---LAD  228 (278)
T ss_dssp             C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CC---SSC
T ss_pred             cCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------HHHHh---hcc
Confidence            43222 12235688999999999988999999999999999999999999865432110          00000   001


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .   ..+......+.+++.+||+.||.+|||+.++++
T Consensus       229 ~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 Y---EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             C---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c---CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1   112223345888999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-43  Score=321.90  Aligned_cols=261  Identities=27%  Similarity=0.412  Sum_probs=204.4

Q ss_pred             hccCCcccceeeecCCeEEEEEEECC----CCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEE-eCCee
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCV-QGTRR  117 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~  117 (370)
                      ...+|++.+.||+|+||.||+|.+.+    ...||+|.+... .......+.+|+.++++++||||+++++++. .....
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            35679999999999999999998642    235899987754 3445677889999999999999999999865 45678


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+++++|.+++.   .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus       103 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             EEEEECCTTCBHHHHHH---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             EEEEeCCCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence            99999999999999984   2345689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCc---ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhC-CCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          198 LFPDNIT---HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       198 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      .......   .......+|+.|+|||.+.+..++.++||||||+++|+|++| .+||.......   ...   .... ..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~---~~~~-~~  249 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV---YLLQ-GR  249 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH---HHHT-TC
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH---HHhc-CC
Confidence            6644321   112334567889999999999999999999999999999995 55554332211   111   1111 11


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      .        ...+......+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus       250 ~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          250 R--------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             C--------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1        1111222345888999999999999999999999999987643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-42  Score=319.94  Aligned_cols=275  Identities=24%  Similarity=0.364  Sum_probs=207.5

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHh--cCCCCcceeeeEEEe
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSN--VRHPNLVELIGCCVQ  113 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~  113 (370)
                      +.........++|++.+.||+|+||.||+|++. ++.||+|++.....   .....|.+++..  ++||||+++++++..
T Consensus        27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            344455556789999999999999999999986 89999998864432   334445566555  499999999999998


Q ss_pred             C----CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEeecCCCCceEeCC
Q 017503          114 G----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-----VPHIVHRDIKASNILLDQ  184 (370)
Q Consensus       114 ~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~iiH~dlkp~Nill~~  184 (370)
                      .    ...++||||+++++|.+++..     ..+++..++.++.|++.||.|||+..     .++++||||||+||+++.
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~  177 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK  177 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence            7    788999999999999999832     35899999999999999999999761     227999999999999999


Q ss_pred             CCCeEEeeecCccccCCCCcce---eecccCCCCCCCcccccCCCcCcc------ccchhhhHHHHHHHhC---------
Q 017503          185 EFNPKIGDFGLAKLFPDNITHI---TTRIAGTTGYLAPEYVLGGQLTMK------ADVYSFGVLVLEIISG---------  246 (370)
Q Consensus       185 ~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------~Di~slG~il~elltg---------  246 (370)
                      ++.+||+|||++..........   .....||+.|+|||++.+......      +|||||||++|||++|         
T Consensus       178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            9999999999997664432221   123568999999999987766655      9999999999999999         


Q ss_pred             -CCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC--CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          247 -RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG--EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       247 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                       ..||..........  .........    ....+...  .....+...+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       258 ~~~p~~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          258 YQLPYHDLVPSDPSY--EDMREIVCI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             CCCTTTTTSCSSCCH--HHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccHhhhcCCCCch--hhhHHHHhh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence             55554433222111  111111111    11111111  1123677889999999999999999999999999999876


Q ss_pred             cC
Q 017503          324 LN  325 (370)
Q Consensus       324 ~~  325 (370)
                      ..
T Consensus       332 ~~  333 (337)
T 3mdy_A          332 SQ  333 (337)
T ss_dssp             TT
T ss_pred             hc
Confidence            54

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.9e-43  Score=321.48  Aligned_cols=265  Identities=25%  Similarity=0.364  Sum_probs=189.0

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ..++|++.+.||+|+||.||+|.++ +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3578999999999999999999975 68899999886543 233467788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhccccc--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          122 EYVENNSLDRVLLGATK--ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||++ ++|.+++.....  ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 589888743321  223589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc---
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL---  275 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  275 (370)
                      ..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......   .....+..........   
T Consensus       159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCG
T ss_pred             CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhh
Confidence            43322 1233468999999999876 46899999999999999999999998654321   1122222211110000   


Q ss_pred             -----ccccCCCC-------------CCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 -----ELVDPELG-------------EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 -----~~~~~~~~-------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                           ....+...             .........+.+++.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                 00000000             000112345889999999999999999999876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-43  Score=326.79  Aligned_cols=261  Identities=27%  Similarity=0.402  Sum_probs=206.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCE--EEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRR--IAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~--vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|++.+.||+|+||.||+|++. ++..  +++|.+... .......+.+|+.+++++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            478999999999999999999975 4554  488987653 334456788999999999 99999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccc------------cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          120 VYEYVENNSLDRVLLGAT------------KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                      ||||+++++|.+++....            .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence            999999999999985432            2234689999999999999999999999   9999999999999999999


Q ss_pred             eEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHH
Q 017503          188 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAW  266 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  266 (370)
                      +||+|||++......  .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   .+    .
T Consensus       181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~----~  251 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---EL----Y  251 (327)
T ss_dssp             EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----H
T ss_pred             EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HH----H
Confidence            999999998743221  11222346788999999998889999999999999999998 99998654221   11    1


Q ss_pred             HHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      .......        ....+......+.+++.+||+.+|.+|||+.++++.|..+....
T Consensus       252 ~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          252 EKLPQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HHGGGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHhhcCC--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            1111111        11122233455889999999999999999999999999988754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=325.06  Aligned_cols=265  Identities=24%  Similarity=0.391  Sum_probs=210.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEE-----CCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC--ee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL-----TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT--RR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~  117 (370)
                      .++|++.+.||+|+||.||++++     .+++.||+|++........+.+.+|+.++++++||||+++++++....  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46799999999999999999984     368899999988776666778999999999999999999999987543  67


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            999999999999999843   234689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcce--eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccch---------hhHHHHHH
Q 017503          198 LFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN---------KFLLEWAW  266 (370)
Q Consensus       198 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~---------~~~~~~~~  266 (370)
                      .........  .....++..|+|||.+.+..++.++||||||+++|+|++|..|+........         ........
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            775443221  2223467789999999988899999999999999999999988754311100         01111111


Q ss_pred             HHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      ........        ...+......+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       274 ~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          274 ELLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHTTCC--------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhhcCCC--------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11111111        11223344568899999999999999999999999998764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.4e-43  Score=333.34  Aligned_cols=252  Identities=19%  Similarity=0.313  Sum_probs=197.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcC--CCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVR--HPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||++.+.+++.||||++...  .......+.+|+.+++++.  ||||+++++++......++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            3569999999999999999999888999999988654  3445677899999999996  59999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      || +.+++|.+++.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||++..+.
T Consensus       135 ~E-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            99 56789999984    334688999999999999999999999   999999999999995 5899999999998765


Q ss_pred             CCCcc-eeecccCCCCCCCcccccC-----------CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH
Q 017503          201 DNITH-ITTRIAGTTGYLAPEYVLG-----------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       201 ~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      ..... ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||........     .....
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~~~~~  280 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHAI  280 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHHH
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-----HHHHH
Confidence            43222 2334579999999999865           4688999999999999999999999865432211     11111


Q ss_pred             HhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      ......     .   ..+......+.+++.+||+.||.+||++.++++..
T Consensus       281 ~~~~~~-----~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          281 IDPNHE-----I---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             HCTTSC-----C---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             hCcccc-----C---CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence            111110     1   11111234578899999999999999999998754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.8e-43  Score=326.64  Aligned_cols=249  Identities=25%  Similarity=0.321  Sum_probs=203.0

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  118 (370)
                      ..++|++.+.||+|+||.||+|+++ +++.||+|++...   .......+..|..++..+ +||||+++++++.+....+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4689999999999999999999986 4788999998754   223456778899999987 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+++|+|.+++.    ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus        98 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999999983    334689999999999999999999999   999999999999999999999999999985


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|..||.....   ..+..   .......     
T Consensus       171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~---~i~~~~~-----  238 (353)
T 2i0e_A          171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ---SIMEHNV-----  238 (353)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHCCC-----
T ss_pred             cccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHHH---HHHhCCC-----
Confidence            43221 223446799999999999999999999999999999999999999864321   11211   1111111     


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCC-----HHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  316 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  316 (370)
                           .++......+.+++.+||+.+|.+||+     +.+|++
T Consensus       239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 122233445889999999999999995     577764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.4e-43  Score=315.49  Aligned_cols=251  Identities=22%  Similarity=0.284  Sum_probs=203.9

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|.+........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            4578999999999999999999986 477899998876655567788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe---CCCCCeEEeeecCcccc
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kL~Dfg~~~~~  199 (370)
                      |+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||||+||++   +.++.++|+|||++...
T Consensus        87 ~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           87 LCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             CCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            999999999883    344689999999999999999999999   99999999999999   78889999999999876


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ....  ......+|+.|+|||.+.+. ++.++||||||+++|+|++|..||......   ...   ...........  .
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~~~~~~~~~~~--~  228 (277)
T 3f3z_A          160 KPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVM---LKIREGTFTFP--E  228 (277)
T ss_dssp             CTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCCCCCC--H
T ss_pred             cCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHhCCCCCC--c
Confidence            5432  22335689999999987654 899999999999999999999998654321   111   11111111100  0


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ....    .....+.+++.+||+.+|.+|||+.++++
T Consensus       229 ~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          229 KDWL----NVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000    12345889999999999999999999976

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=350.55  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=204.8

Q ss_pred             ccCCcccc-eeeecCCeEEEEEEEC---CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSN-KIGRGGFGTVYKGTLT---NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~-~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .+++.+.. .||+|+||.||+|.++   ++..||||+++.. .......+.+|+.+|++++||||+++++++.. +..++
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  412 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML  412 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence            34455555 7999999999999864   4567999999765 33456789999999999999999999999976 56899


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+.+|+|.+++..   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus       413 v~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             EEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            9999999999999842   345689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcce--eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          200 PDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       200 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      .......  .....+++.|+|||++.+..++.++|||||||++|||++ |..||......   .+..    .......  
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~----~i~~~~~--  557 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKR--  557 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHH----HHHTTCC--
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHH----HHHcCCC--
Confidence            5432211  122335678999999999999999999999999999998 99998754332   1111    1111111  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                            ...+..+...+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus       558 ------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          558 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             ------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                  1223344456888999999999999999999999999887544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.5e-43  Score=320.57  Aligned_cols=252  Identities=24%  Similarity=0.314  Sum_probs=204.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh------hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK------QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|++.+.||+|+||.||++.++ ++..||+|.+.....      .....+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            567999999999999999999986 688999998865422      1356788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC----CeEEeee
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----NPKIGDF  193 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kL~Df  193 (370)
                      ++||||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999983    345689999999999999999999999   999999999999999887    7999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      |++........  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.....   .....   .... ..
T Consensus       164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~---~i~~-~~  234 (321)
T 2a2a_A          164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLA---NITS-VS  234 (321)
T ss_dssp             TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH---HHHT-TC
T ss_pred             ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHh-cc
Confidence            99987654322  2334689999999999999999999999999999999999999864322   11111   1111 10


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      . . .++.   ........+.+++.+||+.||.+|||+.++++.
T Consensus       235 ~-~-~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          235 Y-D-FDEE---FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             C-C-CCHH---HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             c-c-cChh---hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0 0 0000   001223458899999999999999999999863

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5e-44  Score=329.52  Aligned_cols=267  Identities=25%  Similarity=0.443  Sum_probs=212.5

Q ss_pred             HHHHhccCCcccceeeecCCeEEEEEEECC-C-----CEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEE
Q 017503           40 ELRSATDDFHLSNKIGRGGFGTVYKGTLTN-G-----RRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCC  111 (370)
Q Consensus        40 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~  111 (370)
                      .+....++|++.+.||+|+||.||+|.+.. +     ..||+|.+... .......+.+|+.+++.+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            445557899999999999999999999752 2     47999988765 334456788999999999 899999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHhccccc----------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceE
Q 017503          112 VQGTRRILVYEYVENNSLDRVLLGATK----------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL  181 (370)
Q Consensus       112 ~~~~~~~lv~e~~~~~~L~~~~~~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nil  181 (370)
                      .+....++||||+++++|.+++.....          ....+++..++.++.|++.||.|||+.   +++||||||+||+
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence            999999999999999999999853321          134579999999999999999999999   9999999999999


Q ss_pred             eCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchh
Q 017503          182 LDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNK  259 (370)
Q Consensus       182 l~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~  259 (370)
                      ++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ 
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence            999999999999999865433222 2233456788999999999999999999999999999998 8888865433211 


Q ss_pred             hHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          260 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                       ..    ........     .   ..+......+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       276 -~~----~~~~~~~~-----~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          276 -FY----KLVKDGYQ-----M---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             -HH----HHHHHTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HH----HHHhcCCC-----C---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence             11    11111111     0   1112223458889999999999999999999999998765

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-43  Score=317.51  Aligned_cols=259  Identities=25%  Similarity=0.360  Sum_probs=204.0

Q ss_pred             CCcccceeeecCCeEEEEEEECC----CCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee-EEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR-ILV  120 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv  120 (370)
                      .|.+.+.||+|+||.||+|.+.+    +..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46667999999999999998632    236999988754 334567788999999999999999999999876655 899


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+.+++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus       102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999999842   345689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCc---ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          201 DNIT---HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       201 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ....   .......++..|+|||.+.+..++.++||||||+++|+|++|..|+.......  .....    ......   
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~----~~~~~~---  246 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHF----LAQGRR---  246 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHH----HHTTCC---
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHH----hhcCCC---
Confidence            3221   12233457889999999999999999999999999999999655543222211  11111    111111   


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                           ...+......+.+++.+||+.+|.+|||+.++++.|+++....
T Consensus       247 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          247 -----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                 1112223345888999999999999999999999999987644

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5e-43  Score=323.26  Aligned_cols=249  Identities=20%  Similarity=0.305  Sum_probs=205.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||++.+. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            578999999999999999999986 5788999987654   334556788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++++|.+++.    ....+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus       120 ~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            99999999999883    335689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      .... ......|+..|+|||++.+..++.++||||||+++|+|++|..||.......   .   .........       
T Consensus       193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~~~~~~~-------  258 (335)
T 2owb_A          193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---T---YLRIKKNEY-------  258 (335)
T ss_dssp             STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHHTCC-------
T ss_pred             cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---H---HHHHhcCCC-------
Confidence            3322 2233568999999999999999999999999999999999999986542211   1   111111111       


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         ..+......+.+++.+||+.||.+||++.++++.
T Consensus       259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               1112223457889999999999999999999874

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.2e-43  Score=328.16  Aligned_cols=246  Identities=24%  Similarity=0.284  Sum_probs=196.2

Q ss_pred             cceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCH
Q 017503           51 SNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL  129 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  129 (370)
                      .+.||+|+||.||+|.+. ++..||+|++..........+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            568999999999999975 6899999999877666667889999999999999999999999999999999999999999


Q ss_pred             HHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe--CCCCCeEEeeecCccccCCCCccee
Q 017503          130 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL--DQEFNPKIGDFGLAKLFPDNITHIT  207 (370)
Q Consensus       130 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill--~~~~~~kL~Dfg~~~~~~~~~~~~~  207 (370)
                      .+++.   .....+++..++.++.||+.||.|||+.   +|+||||||+|||+  +.++.+||+|||++........  .
T Consensus       174 ~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~  245 (373)
T 2x4f_A          174 FDRII---DESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L  245 (373)
T ss_dssp             HHHHH---HTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred             HHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence            88874   2345689999999999999999999999   99999999999999  5678899999999987654322  2


Q ss_pred             ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCCh
Q 017503          208 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP  287 (370)
Q Consensus       208 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (370)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ...   ..........  ........   
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~---~~~i~~~~~~--~~~~~~~~---  314 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AET---LNNILACRWD--LEDEEFQD---  314 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHH---HHHHHHTCCC--SCSGGGTT---
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHH---HHHHHhccCC--CChhhhcc---
Confidence            234689999999999999999999999999999999999999865422   111   1111111111  00111112   


Q ss_pred             HHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          288 NEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       288 ~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       ....+.+++.+||+.||.+|||+.++++
T Consensus       315 -~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          315 -ISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             2345889999999999999999999987

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.3e-44  Score=328.04  Aligned_cols=242  Identities=22%  Similarity=0.316  Sum_probs=200.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--------hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--------QGVREFITEIMTLSNVRHPNLVELIGCCVQGT  115 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  115 (370)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++.....        .....+.+|+.++++++||||+++++++.+..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            578999999999999999999975 688899998865421        12335667999999999999999999999999


Q ss_pred             eeEEEEEecCCC-CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          116 RRILVYEYVENN-SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       116 ~~~lv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      ..++||||+.+| +|.+++    .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHH----HTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999999776 999998    3445699999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      ++........  .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......                
T Consensus       176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------  237 (335)
T 3dls_A          176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV----------------  237 (335)
T ss_dssp             TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------------
T ss_pred             cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------------
Confidence            9987654322  233568999999999988877 789999999999999999999986532110                


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                           ... ...+......+.+++.+||+.+|.+|||+.++++.
T Consensus       238 -----~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 -----EAA-IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----TTC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----hhc-cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000 01111123458889999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.5e-43  Score=319.15  Aligned_cols=247  Identities=21%  Similarity=0.320  Sum_probs=200.1

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+...  .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3578999999999999999999986 7899999988754  233456788899999998 99999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC--------------
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE--------------  185 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~--------------  185 (370)
                      ||||+++++|.+++.........+++..++.++.|++.||.|||++   +++||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999965444446689999999999999999999999   99999999999999844              


Q ss_pred             -----CCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchh
Q 017503          186 -----FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK  259 (370)
Q Consensus       186 -----~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~  259 (370)
                           ..++|+|||++.......     ...||+.|+|||.+.+. .++.++||||||+++|+|++|.+++....     
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence                 479999999998765432     23489999999998776 56789999999999999999987653221     


Q ss_pred             hHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          260 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..     .......        ....+......+.+++.+||+.||.+|||+.++++
T Consensus       236 ~~-----~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 QW-----HEIRQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HH-----HHHHTTC--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH-----HHHHcCC--------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            01     1111111        11222233445889999999999999999999976

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.8e-44  Score=340.48  Aligned_cols=250  Identities=26%  Similarity=0.324  Sum_probs=195.7

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            3578999999999999999999975 6889999988653   23344567789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      ||||+++++|.+++.    ....+++..+..++.||+.||.|||+ .   +|+||||||+|||++.++.+||+|||++..
T Consensus       226 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          226 VMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EECCCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEeeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999883    34468999999999999999999998 8   999999999999999999999999999985


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ..+..   .......     
T Consensus       299 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~---~i~~~~~-----  366 (446)
T 4ejn_A          299 GIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE---LILMEEI-----  366 (446)
T ss_dssp             TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHCCC-----
T ss_pred             ccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHH---HHHhCCC-----
Confidence            43322 223346799999999999999999999999999999999999999865422   11111   1111111     


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  317 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  317 (370)
                           .++......+.+++.+||+.||.+||     ++.++++.
T Consensus       367 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          367 -----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                 11222334588999999999999999     99999763

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-44  Score=332.98  Aligned_cols=259  Identities=27%  Similarity=0.420  Sum_probs=196.5

Q ss_pred             cCCcccceeeecCCeEEEEEEEC--CC--CEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe-CCeeEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT--NG--RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ-GTRRIL  119 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~--~~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l  119 (370)
                      ..|++.+.||+|+||.||+|.+.  ++  ..||+|.+... .......+.+|+.++++++||||+++++++.+ .+..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            35778899999999999999864  22  35899988654 34556788999999999999999999998764 457899


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++++|.+++.   .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus       169 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence            999999999999984   3345688999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCcc---eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          200 PDNITH---ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       200 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      ......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||........   ...    ...... 
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~----~~~~~~-  314 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY----LLQGRR-  314 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHH----HHTTCC-
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHH----HHcCCC-
Confidence            432211   1223456788999999999999999999999999999999 6667654432211   111    111111 


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                             ...+......+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus       315 -------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          315 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                   1112223345888999999999999999999999999988643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-43  Score=326.29  Aligned_cols=255  Identities=22%  Similarity=0.245  Sum_probs=180.6

Q ss_pred             cCCccc---ceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEEE
Q 017503           46 DDFHLS---NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        46 ~~y~~~---~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ++|++.   +.||+|+||.||++.++ +++.||+|++...   ....+.+|+.+++.+. ||||+++++++.+....++|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            345554   78999999999999986 6889999998644   3356778999999996 99999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC---CeEEeeecCcc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKIGDFGLAK  197 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kL~Dfg~~~  197 (370)
                      |||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++   .+||+|||++.
T Consensus        85 ~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           85 MELLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             ECCCCSCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999999999984    345789999999999999999999999   999999999999997665   79999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||......................... .
T Consensus       158 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-~  235 (325)
T 3kn6_A          158 LKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-F  235 (325)
T ss_dssp             ECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-C
T ss_pred             ecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-C
Confidence            6654322 2234567999999999999999999999999999999999999987543321111111111111111100 0


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                          ...........+.+++.+||+.||.+|||+.++++
T Consensus       236 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          236 ----EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ----CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ----CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence                00001123445889999999999999999998864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.7e-43  Score=340.56  Aligned_cols=255  Identities=26%  Similarity=0.368  Sum_probs=208.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||+++++ +|+.||+|++....   ......+.+|+.++++++||||+++++++.+....++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            478999999999999999999986 68999999986542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++|+|.+++.........+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999865544456799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccch-hhHHHHHHHHHhcCCCccccc
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN-KFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ..... .....||+.|+|||++.+..++.++|||||||++|||++|..||........ ..+..   ......       
T Consensus       341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---~i~~~~-------  409 (543)
T 3c4z_A          341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RVLEQA-------  409 (543)
T ss_dssp             TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---HHHHCC-------
T ss_pred             CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---HHhhcc-------
Confidence            43221 2335799999999999999999999999999999999999999975432211 11111   111111       


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCH-----HHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQM-----NQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  316 (370)
                         ..++......+.+++.+||+.||.+||++     .+|+.
T Consensus       410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ---cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence               11223334458889999999999999975     55653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.7e-43  Score=323.01  Aligned_cols=272  Identities=25%  Similarity=0.342  Sum_probs=212.9

Q ss_pred             ccCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHh--cCCCCcceeeeEEE
Q 017503           35 HFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSN--VRHPNLVELIGCCV  112 (370)
Q Consensus        35 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~  112 (370)
                      ...........++|++.+.||+|+||.||+|++. ++.||+|++....   ...+.+|++++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            3445555666789999999999999999999985 8899999986443   3566778888887  79999999999998


Q ss_pred             eCC----eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEeecCCCCce
Q 017503          113 QGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH--------EELVPHIVHRDIKASNI  180 (370)
Q Consensus       113 ~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~iiH~dlkp~Ni  180 (370)
                      ...    ..++||||+++++|.+++..     ..+++..++.++.|++.||.|||        +.   +++||||||+||
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI  178 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI  178 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence            876    78999999999999999842     35899999999999999999999        77   999999999999


Q ss_pred             EeCCCCCeEEeeecCccccCCCCcc---eeecccCCCCCCCcccccCC------CcCccccchhhhHHHHHHHhC-----
Q 017503          181 LLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGG------QLTMKADVYSFGVLVLEIISG-----  246 (370)
Q Consensus       181 ll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~elltg-----  246 (370)
                      +++.++.+||+|||++.........   ......||+.|+|||++.+.      .++.++||||||+++|+|++|     
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~  258 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  258 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence            9999999999999999866543322   12345689999999998775      344789999999999999999     


Q ss_pred             -----CCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC--CChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          247 -----RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE--YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       247 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                           ..||......... ... ........    ...+.+..  ........+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       259 ~~~~~~~p~~~~~~~~~~-~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          259 IHEDYQLPYYDLVPSDPS-VEE-MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             BCCCCCCTTTTTSCSSCC-HHH-HHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cccccccCccccCcCccc-HHH-HHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence                 6676544322111 111 11111111    11111111  23466778999999999999999999999999999


Q ss_pred             hhhcc
Q 017503          320 KNIRL  324 (370)
Q Consensus       320 ~~~~~  324 (370)
                      .+...
T Consensus       333 ~i~~~  337 (342)
T 1b6c_B          333 QLSQQ  337 (342)
T ss_dssp             HHHHT
T ss_pred             HHHHH
Confidence            98754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.1e-43  Score=326.36  Aligned_cols=253  Identities=23%  Similarity=0.292  Sum_probs=201.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ..++|++.+.||+|+||.||++.++ +++.||+|++......    ..+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4678999999999999999999986 6889999998755332    34588888887 7999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC----CCeEEeeecCcc
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE----FNPKIGDFGLAK  197 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~----~~~kL~Dfg~~~  197 (370)
                      ||+++|+|.+++.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||+.++    +.+||+|||++.
T Consensus        96 E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           96 ELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             CCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            9999999999883    345689999999999999999999999   99999999999998543    249999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........+...+   .. ... ..
T Consensus       169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~~-~~~-~~  242 (342)
T 2qr7_A          169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI---GS-GKF-SL  242 (342)
T ss_dssp             ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH---HH-CCC-CC
T ss_pred             cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH---cc-CCc-cc
Confidence            6644322 223456899999999998888999999999999999999999998754332222222211   11 111 00


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .    ..........+.+++.+||..||.+||++.++++.
T Consensus       243 ~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          243 S----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             C----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             C----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0    11122334458899999999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3e-43  Score=321.91  Aligned_cols=261  Identities=24%  Similarity=0.272  Sum_probs=198.8

Q ss_pred             ccCCccc-ceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEE
Q 017503           45 TDDFHLS-NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        45 ~~~y~~~-~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .++|++. +.||+|+||.||+|.+. +++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4678885 78999999999999965 6899999998776656677889999999985 7999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC---eEEeeecCccc
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKL  198 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kL~Dfg~~~~  198 (370)
                      ||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.   +||+|||++..
T Consensus        91 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           91 EKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             ECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            9999999999984    234689999999999999999999999   9999999999999998776   99999999876


Q ss_pred             cCCCCc------ceeecccCCCCCCCcccccC-----CCcCccccchhhhHHHHHHHhCCCCCCcccccchh--------
Q 017503          199 FPDNIT------HITTRIAGTTGYLAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--------  259 (370)
Q Consensus       199 ~~~~~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~--------  259 (370)
                      ......      .......||+.|+|||++.+     ..++.++|||||||++|+|++|..||.........        
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            532211      11223458999999999875     56889999999999999999999998754322100        


Q ss_pred             hHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          260 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ............... ........    .....+.+++.+||+.||.+|||+.++++.
T Consensus       244 ~~~~~~~~~i~~~~~-~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          244 ACQNMLFESIQEGKY-EFPDKDWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHHCCC-CCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hHHHHHHHHHhccCc-ccCchhcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            000111111111111 00000001    123458899999999999999999999773

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.8e-43  Score=323.84  Aligned_cols=262  Identities=21%  Similarity=0.284  Sum_probs=205.4

Q ss_pred             CHHHHHHhccCCccc-ceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhc-CCCCcceeeeEE
Q 017503           37 SYTELRSATDDFHLS-NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNV-RHPNLVELIGCC  111 (370)
Q Consensus        37 ~~~~~~~~~~~y~~~-~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~  111 (370)
                      .+.......++|.+. +.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.+++.+ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344455667888888 89999999999999986 6899999988754  233467788999999998 569999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC---CCCe
Q 017503          112 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNP  188 (370)
Q Consensus       112 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~---~~~~  188 (370)
                      .+....++||||+.+++|.+++..  .....+++..++.++.|++.||.|||+.   +++||||||+||+++.   ++.+
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence            999999999999999999988732  2335689999999999999999999999   9999999999999987   7899


Q ss_pred             EEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH
Q 017503          189 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       189 kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      ||+|||++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......   ...   ..
T Consensus       174 kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~---~i  245 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYL---NI  245 (327)
T ss_dssp             EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HH
T ss_pred             EEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHH---HH
Confidence            9999999987643321  233568999999999999999999999999999999999999986543211   111   11


Q ss_pred             HhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .....  ...    ..........+.+++.+||+.||.+|||+.++++.
T Consensus       246 ~~~~~--~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          246 SQVNV--DYS----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHTCC--CCC----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             Hhccc--ccC----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            11110  111    11122333458889999999999999999999764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=326.42  Aligned_cols=261  Identities=19%  Similarity=0.263  Sum_probs=191.9

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEe-------
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQ-------  113 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-------  113 (370)
                      ....+|++.+.||+|+||.||+|++. +++.||+|++..........+.+|+.+++++. ||||+++++++..       
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            33568999999999999999999975 68899999887666666778899999999995 9999999999953       


Q ss_pred             -CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeecCCCCceEeCCCCCeEE
Q 017503          114 -GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLDQEFNPKI  190 (370)
Q Consensus       114 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~dlkp~Nill~~~~~~kL  190 (370)
                       ....++||||+. |+|.+++.... ....+++..++.++.||+.||.|||+.   +  ++||||||+|||++.++.+||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence             345789999996 58888774322 334689999999999999999999999   8  999999999999999999999


Q ss_pred             eeecCccccCCCCcce-----------eecccCCCCCCCcccc---cCCCcCccccchhhhHHHHHHHhCCCCCCccccc
Q 017503          191 GDFGLAKLFPDNITHI-----------TTRIAGTTGYLAPEYV---LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ  256 (370)
Q Consensus       191 ~Dfg~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~  256 (370)
                      +|||++..........           .....+|+.|+|||++   .+..++.++||||||+++|+|++|..||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998765432111           1134588999999988   5667899999999999999999999998543210


Q ss_pred             chhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCc
Q 017503          257 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE  326 (370)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  326 (370)
                                ........    .+.....+    ..+.+++.+||+.+|.+||++.++++.|+.+.....
T Consensus       260 ----------~~~~~~~~----~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          260 ----------RIVNGKYS----IPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ----------------CC----CCTTCCSS----GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ----------HhhcCccc----CCcccccc----hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                      00000000    00011112    237788999999999999999999999999876543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8e-43  Score=312.75  Aligned_cols=253  Identities=24%  Similarity=0.335  Sum_probs=205.0

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4678999999999999999999986 68899999886542 334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|.+++    .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        85 e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           85 EYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             ECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            999999999887    3445689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCc-ceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          202 NIT-HITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       202 ~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ... .......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||......... ...     .......    
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~-----~~~~~~~----  227 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD-----WKEKKTY----  227 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHH-----HHTTCTT----
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHH-----hhhcccc----
Confidence            221 12234568999999999987765 78999999999999999999999765432211 111     1111100    


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                         ..........+.+++.+||+.||.+|||+.++++
T Consensus       228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               0111223345788999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.2e-43  Score=328.25  Aligned_cols=263  Identities=25%  Similarity=0.362  Sum_probs=191.5

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCC--e
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGT--R  116 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~  116 (370)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34689999999999999999999975 6899999987543  3445567888999999996 999999999998644  6


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .++||||+++ +|..++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~lv~e~~~~-~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYMET-DLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCSE-EHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccCc-CHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            8999999984 89888832     3688999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC--------------------cceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccc
Q 017503          197 KLFPDNI--------------------THITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWG  255 (370)
Q Consensus       197 ~~~~~~~--------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~  255 (370)
                      +.+....                    ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            8653210                    111233578999999999876 6789999999999999999999999865422


Q ss_pred             cchhhHHHHHHHHHhcCCCccc---------------------ccCCCCCCC-------------hHHHHHHHHHHHHch
Q 017503          256 QMNKFLLEWAWQLHQEEKPLEL---------------------VDPELGEYP-------------PNEIIRYMKVAFFCT  301 (370)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~-------------~~~~~~l~~li~~cl  301 (370)
                      ..   ....+...........+                     .........             ......+.+++.+||
T Consensus       237 ~~---~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L  313 (388)
T 3oz6_A          237 MN---QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL  313 (388)
T ss_dssp             HH---HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred             HH---HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence            11   11111111110000000                     000000000             022345889999999


Q ss_pred             hhccCCCCCHHHHHHH
Q 017503          302 QAAASRRPQMNQVIKM  317 (370)
Q Consensus       302 ~~~p~~RPt~~evl~~  317 (370)
                      +.||.+|||+.++++.
T Consensus       314 ~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          314 QFNPNKRISANDALKH  329 (388)
T ss_dssp             CSSGGGSCCHHHHTTS
T ss_pred             ccCcccCCCHHHHhCC
Confidence            9999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.9e-43  Score=341.37  Aligned_cols=255  Identities=25%  Similarity=0.323  Sum_probs=207.5

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..++|++.+.||+|+||.||+|+++ +|+.||+|++...   .......+.+|+.+|+.++||||+++++++.+....++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            4578999999999999999999986 6899999988653   22345667889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++|+|.+++...  ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus       262 VmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999999988432  233589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      .....  .....||+.|+|||++.+..++.++|||||||++|+|++|..||............   ........      
T Consensus       337 ~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i---~~~i~~~~------  405 (576)
T 2acx_A          337 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVP------  405 (576)
T ss_dssp             CTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH---HHHHHHCC------
T ss_pred             ccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH---HHHhhccc------
Confidence            54322  23457999999999999999999999999999999999999999765432221111   11111111      


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  317 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  317 (370)
                         ..++......+.+++.+||+.||.+||     ++.+|++.
T Consensus       406 ---~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          406 ---EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ---ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence               111223334588999999999999999     78888753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-42  Score=327.49  Aligned_cols=254  Identities=19%  Similarity=0.241  Sum_probs=192.2

Q ss_pred             ccCCccc-ceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHh-cCCCCcceeeeEEEe----CCee
Q 017503           45 TDDFHLS-NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSN-VRHPNLVELIGCCVQ----GTRR  117 (370)
Q Consensus        45 ~~~y~~~-~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~  117 (370)
                      .++|.+. +.||+|+||+||++.++ +++.||||++...     ..+.+|+.++.+ .+||||+++++++..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            5677776 68999999999999986 6889999998633     345678888754 589999999999876    5678


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC---CCCeEEeeec
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFG  194 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kL~Dfg  194 (370)
                      ++||||+++|+|.+++..  .....+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||
T Consensus       135 ~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence            999999999999999843  2234689999999999999999999999   9999999999999987   7889999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccch-hhHHHHHHHHHhcCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN-KFLLEWAWQLHQEEK  273 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~  273 (370)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ......+   .....
T Consensus       210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i---~~~~~  284 (400)
T 1nxk_A          210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---RMGQY  284 (400)
T ss_dssp             TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH---HHTCC
T ss_pred             cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH---HcCcc
Confidence            998654322  22345689999999999999999999999999999999999999865432211 0011111   11110


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                        ....+..    ......+.+++.+||+.||.+|||+.++++...
T Consensus       285 --~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          285 --EFPNPEW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             --CCCTTTT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             --cCCCccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence              0111111    223345889999999999999999999988543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.7e-43  Score=318.22  Aligned_cols=250  Identities=28%  Similarity=0.444  Sum_probs=206.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .+.|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            467999999999999999999975 68899999886543 3456788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|.+++.     ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus       101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999999983     34689999999999999999999999   9999999999999999999999999999866443


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      .. ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......   ...   ..... ...     +  
T Consensus       173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~-~~~-----~--  237 (303)
T 3a7i_A          173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVL---FLIPK-NNP-----P--  237 (303)
T ss_dssp             BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHHHH-SCC-----C--
T ss_pred             cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHH---HHhhc-CCC-----C--
Confidence            21 223356889999999999999999999999999999999999998654221   111   11111 111     1  


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                       ..+......+.+++.+||+.+|.+|||+.++++..
T Consensus       238 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          238 -TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             -CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             -CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence             11222334588899999999999999999998754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=319.18  Aligned_cols=262  Identities=26%  Similarity=0.337  Sum_probs=196.9

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-----hhcHHHHHHHHHHHHhc---CCCCcceeeeEEEeC
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-----KQGVREFITEIMTLSNV---RHPNLVELIGCCVQG  114 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~  114 (370)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....     ......+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4689999999999999999999974 68899999886432     11223555677777665   599999999999876


Q ss_pred             C-----eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeE
Q 017503          115 T-----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK  189 (370)
Q Consensus       115 ~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  189 (370)
                      .     ..++||||+. ++|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence            5     5789999997 4999988432  223489999999999999999999999   999999999999999999999


Q ss_pred             EeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH
Q 017503          190 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       190 L~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      |+|||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|.+||......   ..........
T Consensus       161 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~  235 (308)
T 3g33_A          161 LADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLI  235 (308)
T ss_dssp             ECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHHH
T ss_pred             EeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh
Confidence            99999998664332  223456899999999999999999999999999999999999998654321   1122222221


Q ss_pred             hcCCCccc----------ccCCC----CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          270 QEEKPLEL----------VDPEL----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       270 ~~~~~~~~----------~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ........          +.+..    ....+.....+.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            11110000          00000    0011223355889999999999999999999976

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.6e-44  Score=320.38  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=199.4

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-CeeEEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-TRRILVYE  122 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e  122 (370)
                      ..++|++.+.||+|+||.||++.++ ++.||+|.+....  ..+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            3678999999999999999999986 7899999987553  346788999999999999999999997654 47899999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        96 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             cCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            99999999998432  122378999999999999999999999   9999999999999999999999999998754432


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                          .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...    .......       
T Consensus       171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~----~~~~~~~-------  232 (278)
T 1byg_A          171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGYK-------  232 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH----HHTTTCC-------
T ss_pred             ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhcCCC-------
Confidence                122356789999999998999999999999999999998 999986543211   111    1111111       


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                       ...+......+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus       233 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          233 -MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence             11223334558889999999999999999999999998754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-43  Score=327.88  Aligned_cols=257  Identities=25%  Similarity=0.322  Sum_probs=204.4

Q ss_pred             hccCCcccceeeecCCeEEEEEEE----CCCCEEEEEECcCcC----hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTL----TNGRRIAVKPLSAES----KQGVREFITEIMTLSNV-RHPNLVELIGCCVQG  114 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  114 (370)
                      ..++|++.+.||+|+||.||+++.    .+++.||||++....    ......+.+|+.+++.+ +||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            357899999999999999999997    368999999886432    22334566799999999 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      ...++||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             ceEEEEeecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence            99999999999999999984    334689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccC--CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      ++..+............||+.|+|||++.+  ..++.++|||||||++|+|++|..||.........  ...........
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~  282 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE  282 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC
Confidence            998765443333445679999999999886  34789999999999999999999998654322211  11111111111


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHHHHH
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKMLT  319 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~L~  319 (370)
                                ...+......+.+++.+||..||.+||     ++.++++...
T Consensus       283 ----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          283 ----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             ----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence                      112233344578899999999999999     9999987553

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.5e-43  Score=318.04  Aligned_cols=252  Identities=22%  Similarity=0.307  Sum_probs=202.6

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ..++|++.+.||+|+||.||++++. +++.||+|.+..........+.+|+.++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            4578999999999999999999986 689999999876654445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe---CCCCCeEEeeecCcccc
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kL~Dfg~~~~~  199 (370)
                      |+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||+|+||++   +.++.++|+|||++...
T Consensus        87 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           87 LVSGGELFDRIL----ERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             cCCCccHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            999999999883    334689999999999999999999999   99999999999999   77889999999998754


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ...   ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.....   ..+..   .... ... ... 
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~---~i~~-~~~-~~~-  227 (304)
T 2jam_A          160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFE---KIKE-GYY-EFE-  227 (304)
T ss_dssp             CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH---HHHH-CCC-CCC-
T ss_pred             CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHc-CCC-CCC-
Confidence            332   12234589999999999999999999999999999999999999865322   11111   1111 111 011 


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         ..........+.+++.+||+.||.+||++.++++.
T Consensus       228 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          228 ---SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             ---TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence               11122333458899999999999999999999874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.5e-43  Score=323.91  Aligned_cols=248  Identities=30%  Similarity=0.449  Sum_probs=199.7

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||.||+|++. +++.||||++...   .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            55999999999999999999974 6889999988654   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+. |+|.+++.   .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 47777663   2345689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCcceeecccCCCCCCCccccc---CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          202 NITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      .     ....||+.|+|||++.   ...++.++|||||||++|+|++|..||......      ...........+.   
T Consensus       207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~~~~---  272 (348)
T 1u5q_A          207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESPA---  272 (348)
T ss_dssp             B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCCC---
T ss_pred             C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCCCC---
Confidence            2     2346899999999884   567899999999999999999999998644221      1111222221111   


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                         .  ........+.+++.+||+.+|.+|||+.++++...
T Consensus       273 ---~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          273 ---L--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             ---C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             ---C--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence               1  11122344788999999999999999999986543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.5e-43  Score=314.98  Aligned_cols=251  Identities=22%  Similarity=0.373  Sum_probs=204.0

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe---------
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ---------  113 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------  113 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+.....    .+.+|+.++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3578999999999999999999986 789999998876542    45679999999999999999998864         


Q ss_pred             -------CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC
Q 017503          114 -------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF  186 (370)
Q Consensus       114 -------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~  186 (370)
                             ....++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence                   44578999999999999998532  234689999999999999999999999   999999999999999999


Q ss_pred             CeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHH
Q 017503          187 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW  266 (370)
Q Consensus       187 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~  266 (370)
                      .+||+|||++........  .....+++.|+|||.+.+..++.++||||||+++|+|++|..|+...    .    . ..
T Consensus       160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~----~-~~  228 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----S----K-FF  228 (284)
T ss_dssp             EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----H----H-HH
T ss_pred             CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----H----H-HH
Confidence            999999999987654322  23346899999999999999999999999999999999998875321    0    0 11


Q ss_pred             HHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          267 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      .......        +.   ......+.+++.+||+.||.+|||+.++++.|..+....
T Consensus       229 ~~~~~~~--------~~---~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          229 TDLRDGI--------IS---DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             HHHHTTC--------CC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             HHhhccc--------cc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            1111111        11   112234788999999999999999999999999887644

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.3e-42  Score=314.48  Aligned_cols=249  Identities=20%  Similarity=0.302  Sum_probs=205.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||++.+. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            578999999999999999999986 5788999987654   234456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999999883    334689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      .... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......      ..........       
T Consensus       167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~-------  232 (294)
T 2rku_A          167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNEY-------  232 (294)
T ss_dssp             STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTCC-------
T ss_pred             cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhhccC-------
Confidence            3222 2233568999999999999899999999999999999999999986543211      1111111110       


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         ..+......+.+++.+||+.+|.+|||+.++++.
T Consensus       233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence               1122223457889999999999999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-42  Score=313.14  Aligned_cols=247  Identities=25%  Similarity=0.364  Sum_probs=203.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            578999999999999999999986 57789999886432   23356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++....
T Consensus        93 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           93 LEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             ECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999999984    234689999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ...   .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......   .   ...... .      +.
T Consensus       166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~~~~-~------~~  229 (284)
T 2vgo_A          166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---T---HRRIVN-V------DL  229 (284)
T ss_dssp             SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHT-T------CC
T ss_pred             ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---H---HHHHhc-c------cc
Confidence            322   233568999999999999999999999999999999999999986543211   1   111111 1      01


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         ..+......+.+++.+||+.+|.+||++.++++.
T Consensus       230 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          230 ---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence               1122233457889999999999999999999873

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.9e-43  Score=328.74  Aligned_cols=247  Identities=26%  Similarity=0.309  Sum_probs=192.0

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHH-HHhcCCCCcceeeeEEEeCCeeE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMT-LSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      ..++|++.+.||+|+||.||+++++ +++.||+|++....   ......+..|..+ ++.++||||+++++++.+.+..|
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            3578999999999999999999986 57889999886542   2233455667666 46689999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+.+|+|.+++.    ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       116 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            9999999999999883    344688999999999999999999999   999999999999999999999999999985


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|..||.....   .....   .......     
T Consensus       189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~---~i~~~~~-----  256 (373)
T 2r5t_A          189 NIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYD---NILNKPL-----  256 (373)
T ss_dssp             GBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHH---HHHHSCC-----
T ss_pred             cccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHH---HHHhccc-----
Confidence            43221 223446799999999999999999999999999999999999999864321   11111   1111110     


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV  314 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev  314 (370)
                           .+++.....+.+++.+||+.||.+||++.+.
T Consensus       257 -----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          257 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             -----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence                 1122233458889999999999999998543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.6e-42  Score=330.58  Aligned_cols=198  Identities=27%  Similarity=0.437  Sum_probs=167.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----Ce
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TR  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~  116 (370)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.+|+.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            579999999999999999999986 5788999998653  344556788999999999999999999999766     57


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .|+||||+++ +|.+++    ..+..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~-~L~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIADS-DLKKLF----KTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCSE-EHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCCc-CHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            8999999875 999988    3455699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc---------------------eeecccCCCCCCCcccc-cCCCcCccccchhhhHHHHHHHhCCCCC
Q 017503          197 KLFPDNITH---------------------ITTRIAGTTGYLAPEYV-LGGQLTMKADVYSFGVLVLEIISGRNSG  250 (370)
Q Consensus       197 ~~~~~~~~~---------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~elltg~~p~  250 (370)
                      .........                     ......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            876543211                     12456789999999986 5567999999999999999999865544

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=324.59  Aligned_cols=261  Identities=22%  Similarity=0.341  Sum_probs=194.2

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhc-HHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+|+.+++.++||||+++++++.+....++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            68999999999999999999986 68899999886543221 12345699999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++ +|.+++.   ..+..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LDK-DLKQYLD---DCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CSE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             ccc-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            985 8888774   2344689999999999999999999999   99999999999999999999999999998654322


Q ss_pred             cceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc---ccc
Q 017503          204 THITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE---LVD  279 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  279 (370)
                      . ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......   .................   ...
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhc
Confidence            1 2233467999999998876 56899999999999999999999998654322   12222222111111000   000


Q ss_pred             ---------CCC-----CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          280 ---------PEL-----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       280 ---------~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                               +..     ....+.....+.+++.+||+.||.+|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                     000     00011223457899999999999999999999873

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=323.79  Aligned_cols=258  Identities=14%  Similarity=0.172  Sum_probs=207.2

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEE------ECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcC---CCCcceeeeEE
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR---HPNLVELIGCC  111 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~  111 (370)
                      +....++|++.+.||+|+||.||+|.      ...++.||+|++.....   ..+..|+++++.++   |+||+++++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            33456789999999999999999994      34688999999876543   45667788888776   89999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHhccccc-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC------
Q 017503          112 VQGTRRILVYEYVENNSLDRVLLGATK-ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ------  184 (370)
Q Consensus       112 ~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~------  184 (370)
                      ...+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence            999999999999999999999854322 345699999999999999999999999   9999999999999998      


Q ss_pred             -----CCCeEEeeecCccccCC-CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccch
Q 017503          185 -----EFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN  258 (370)
Q Consensus       185 -----~~~~kL~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~  258 (370)
                           ++.+||+|||++..+.. ..........||+.|+|||++.+..++.++|||||||++|||+||+.||....... 
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-  292 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-  292 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence                 89999999999975432 22233445679999999999999999999999999999999999999985432211 


Q ss_pred             hhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCC-CCHHHHHHHHHhhhcc
Q 017503          259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR-PQMNQVIKMLTKNIRL  324 (370)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~evl~~L~~~~~~  324 (370)
                                       ..+...+...+  ....+.+++..|++.+|.+| |++.++.+.|++.+..
T Consensus       293 -----------------~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 -----------------CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             -----------------EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -----------------eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                             01111121211  13456778888999999999 7889998888887653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=320.18  Aligned_cols=272  Identities=26%  Similarity=0.353  Sum_probs=199.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHH--HHhcCCCCcceeeeEEEe-----CCe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMT--LSNVRHPNLVELIGCCVQ-----GTR  116 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~-----~~~  116 (370)
                      ..++|++.+.||+|+||.||+|+. +++.||||++.....   ..+..|.++  +..++||||+++++.+..     ...
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            368999999999999999999987 478999999865432   333334444  445899999999986653     235


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEeecCCCCceEeCCCCCeEE
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL------VPHIVHRDIKASNILLDQEFNPKI  190 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------~~~iiH~dlkp~Nill~~~~~~kL  190 (370)
                      .++||||+++|+|.+++..     ...++..++.++.|++.||.|||+..      .++|+||||||+|||++.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            6899999999999999832     23588999999999999999999862      227999999999999999999999


Q ss_pred             eeecCccccCCCC-------cceeecccCCCCCCCcccccC-------CCcCccccchhhhHHHHHHHhCCCCCCccccc
Q 017503          191 GDFGLAKLFPDNI-------THITTRIAGTTGYLAPEYVLG-------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ  256 (370)
Q Consensus       191 ~Dfg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~elltg~~p~~~~~~~  256 (370)
                      +|||++..+....       ........||+.|+|||++.+       ..++.++|||||||++|||++|..|+......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            9999998764321       111223468999999999877       45678999999999999999997765432221


Q ss_pred             ch--hh---------HHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          257 MN--KF---------LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       257 ~~--~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      ..  ..         .................+.. ...........+.+++.+||+.||.+|||+.++++.|++++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE-AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT-TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc-ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence            10  00         00001111111111111111 11223346677999999999999999999999999999998654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.1e-42  Score=308.32  Aligned_cols=248  Identities=26%  Similarity=0.380  Sum_probs=198.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe----CCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~  117 (370)
                      .+.|++.+.||+|+||.||+|.+. ++..||+|.+...  .......+.+|+.++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            345888999999999999999975 6788999987654  34456778899999999999999999999875    4568


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeecCCCCceEeC-CCCCeEEeeec
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLD-QEFNPKIGDFG  194 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~dlkp~Nill~-~~~~~kL~Dfg  194 (370)
                      ++||||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +  ++||||||+||+++ .++.+||+|||
T Consensus       105 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEEEEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            99999999999999983    335689999999999999999999999   7  99999999999997 78999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      ++.......   .....|++.|+|||.+. +.++.++||||||+++|+|++|..||........      ..........
T Consensus       178 ~~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~  247 (290)
T 1t4h_A          178 LATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVK  247 (290)
T ss_dssp             GGGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCC
T ss_pred             Ccccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCC
Confidence            997654332   23356899999999876 4589999999999999999999999865432111      1111111111


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...       .+......+.+++.+||+.+|.+|||+.++++
T Consensus       248 ~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 PAS-------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CGG-------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccc-------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            111       11112235889999999999999999999976

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-42  Score=334.00  Aligned_cols=259  Identities=22%  Similarity=0.282  Sum_probs=195.4

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC------
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------  114 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------  114 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3689999999999999999999975 6889999998654  344566788999999999999999999999654      


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      ...++||||++++ |.+.+.      ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CeEEEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence            3579999999875 555552      2388999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....+.........
T Consensus       210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          210 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCP  284 (464)
T ss_dssp             CC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCH
T ss_pred             eeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence            99865432  22344578999999999999999999999999999999999999986542211   11111111100000


Q ss_pred             c----------ccc--cCCCCC-----------------CChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          275 L----------ELV--DPELGE-----------------YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       275 ~----------~~~--~~~~~~-----------------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .          ..+  .+....                 ........+.+|+.+||+.||.+|||+.|+++.
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0          000  000000                 001124568899999999999999999999874

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.6e-43  Score=336.40  Aligned_cols=194  Identities=24%  Similarity=0.410  Sum_probs=155.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----Ce
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TR  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~  116 (370)
                      .++|++.+.||+|+||.||+|++. +++.||||++...  .......+.+|+.+|+.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999976 6889999988653  344556788999999999999999999998543     56


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .|+||||+. ++|.+++    .....+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||++
T Consensus       132 ~~lv~e~~~-~~L~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLF----RTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCCS-EEHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccc-cchhhhc----ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            899999985 5888888    3455799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCc--------------------------ceeecccCCCCCCCcccc-cCCCcCccccchhhhHHHHHHHhC
Q 017503          197 KLFPDNIT--------------------------HITTRIAGTTGYLAPEYV-LGGQLTMKADVYSFGVLVLEIISG  246 (370)
Q Consensus       197 ~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~elltg  246 (370)
                      +.......                          .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            87643211                          112345689999999976 456799999999999999999994

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-42  Score=312.85  Aligned_cols=251  Identities=25%  Similarity=0.325  Sum_probs=200.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC------hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|++.+.||+|+||.||++.+. +++.||+|.+....      ......+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999986 68999999876542      12367788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC----CeEEeee
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----NPKIGDF  193 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kL~Df  193 (370)
                      ++||||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++    .+||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           84 VLILELVSGGELFDFLA----EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence            99999999999999983    344689999999999999999999999   999999999999998877    7999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      |++........  .....+++.|+|||.+.+..++.++||||||+++|+|++|..||......   ....   . .....
T Consensus       157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~-~~~~~  227 (283)
T 3bhy_A          157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETLT---N-ISAVN  227 (283)
T ss_dssp             TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---H-HHTTC
T ss_pred             ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHHH---H-hHhcc
Confidence            99986644321  23345889999999999999999999999999999999999998654221   1111   1 11111


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..  ...   .........+.+++.+||..+|.+||++.++++
T Consensus       228 ~~--~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          228 YD--FDE---EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CC--CCH---HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cC--Ccc---hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            00  000   001122345888999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-42  Score=324.17  Aligned_cols=264  Identities=22%  Similarity=0.359  Sum_probs=203.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||.||++.+. ++..||+|++... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            468999999999999999999986 6889999988765 34445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|.+++.    ....+++..+..++.|++.||.|||+..  +++||||||+||+++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999984    3346899999999999999999999831  7999999999999999999999999998754221


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHh------------
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ------------  270 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------  270 (370)
                         ......||+.|+|||++.+..++.++||||||+++|+|++|..||....................            
T Consensus       186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence               12334689999999999999999999999999999999999999875432211110000000000            


Q ss_pred             -----------cCCCc----ccccCCCCC-CChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          271 -----------EEKPL----ELVDPELGE-YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       271 -----------~~~~~----~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                                 .....    .+....... ........+.+++.+||+.||.+|||+.++++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                       00000    000000000 011123458899999999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3e-43  Score=323.57  Aligned_cols=263  Identities=27%  Similarity=0.386  Sum_probs=206.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEE------CCCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL------TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|++.+.||+|+||.||+|++      .++..||+|.+... .......+.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            57899999999999999999984      24678999998754 344556788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhccccc---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC---CCCeEEe
Q 017503          118 ILVYEYVENNSLDRVLLGATK---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIG  191 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kL~  191 (370)
                      ++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999964332   124589999999999999999999999   9999999999999984   4469999


Q ss_pred             eecCccccCCCC-cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHH
Q 017503          192 DFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       192 Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      |||++....... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....   .....    ..
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~----~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLE----FV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHH----HH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHH----HH
Confidence            999997543322 122233457889999999998999999999999999999998 8888864322   11111    11


Q ss_pred             hcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          270 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      .....        ...+......+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus       259 ~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          259 TSGGR--------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             hcCCC--------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            11111        1112233345888999999999999999999999999877643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=324.19  Aligned_cols=258  Identities=22%  Similarity=0.307  Sum_probs=196.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----  115 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  115 (370)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||.+...  .......+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            3578999999999999999999985 6899999998543  3344567889999999999999999999998653     


Q ss_pred             -eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          116 -RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       116 -~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                       ..++||||+ +++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence             459999999 7799999842     4689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      ++......    .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.......   ....+........
T Consensus       174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~~  246 (367)
T 1cm8_A          174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPP  246 (367)
T ss_dssp             TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCC
T ss_pred             cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCC
Confidence            99875432    234568999999999877 679999999999999999999999986543211   1111111100000


Q ss_pred             ------------------CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          274 ------------------PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       274 ------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                                        ........+....+.....+.+++.+||+.||.+|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                              00000011112223334568899999999999999999999874

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.8e-42  Score=320.23  Aligned_cols=263  Identities=24%  Similarity=0.324  Sum_probs=199.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--------
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQ--------  113 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------  113 (370)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....  ......+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            578999999999999999999984 78999999886542  2334567789999999999999999999987        


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      ....++||||+++ +|...+.   .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCC-CHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence            3468999999986 6666553   3334689999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCc---ceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH
Q 017503          194 GLAKLFPDNIT---HITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       194 g~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      |++..+.....   .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......   ..........
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~  245 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLC  245 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHH
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence            99987653221   22234568999999998876 46899999999999999999999998754322   1122222211


Q ss_pred             hcCCCcc--------cccC---C--CCCCChHH------HHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          270 QEEKPLE--------LVDP---E--LGEYPPNE------IIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       270 ~~~~~~~--------~~~~---~--~~~~~~~~------~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .......        ..+.   .  ........      ...+.+++.+||+.||.+|||+.++++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            1111000        0000   0  00000111      2347899999999999999999999774

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2e-43  Score=331.13  Aligned_cols=243  Identities=14%  Similarity=0.112  Sum_probs=188.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHH---HHHhcCCCCcceee-------eE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIM---TLSNVRHPNLVELI-------GC  110 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~iv~~~-------~~  110 (370)
                      .++|++.+.||+|+||.||+|++. +++.||||++...   .....+.+.+|+.   .+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            477999999999999999999974 6899999998632   3344577889994   45556899999998       66


Q ss_pred             EEeCC-----------------eeEEEEEecCCCCHHHHhccccc---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 017503          111 CVQGT-----------------RRILVYEYVENNSLDRVLLGATK---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHI  170 (370)
Q Consensus       111 ~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i  170 (370)
                      +.+.+                 ..++||||+ +|+|.+++.....   ....+++..++.++.||+.||.|||+.   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            66553                 278999999 5799999853211   122345688889999999999999999   99


Q ss_pred             EeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCC-----------CcCccccchhhhHH
Q 017503          171 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-----------QLTMKADVYSFGVL  239 (370)
Q Consensus       171 iH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~i  239 (370)
                      +||||||+|||++.++.+||+|||++.....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999985332    2334567 999999999877           89999999999999


Q ss_pred             HHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          240 VLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       240 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      +|+|++|+.||.......                ....+.......+    ..+.+++.+||+.||.+|||+.++++
T Consensus       303 l~elltg~~Pf~~~~~~~----------------~~~~~~~~~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALG----------------GSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------C----------------CSGGGGSSCCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCccccccc----------------chhhhhhhccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999985432111                1111111112233    44888999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-42  Score=318.84  Aligned_cols=267  Identities=23%  Similarity=0.314  Sum_probs=197.6

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh-----hcHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK-----QGVREFITEIMTLSNVRHPNLVELIGCCVQG  114 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  114 (370)
                      +....++|++.+.||+|+||.||+|.+. +++.||+|++.....     .....+.+|+.+++.++||||+++++++.+.
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            3455789999999999999999999975 589999999875321     1124677899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      ...++||||+++ +|.+++.   .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             CceEEEEEcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecc
Confidence            999999999987 7888873   2345688999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      ++........ ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.....   ......+........
T Consensus       158 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~  233 (346)
T 1ua2_A          158 LAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPT  233 (346)
T ss_dssp             GGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred             cceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCC
Confidence            9987643322 22345689999999998664 589999999999999999999988764422   111122222111111


Q ss_pred             Ccccc------c----CCCCCCC-----hHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          274 PLELV------D----PELGEYP-----PNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       274 ~~~~~------~----~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      .....      +    ......+     ......+.+++.+||+.||.+|||+.|+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            00000      0    0001111     22335688999999999999999999998754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.4e-43  Score=322.50  Aligned_cols=263  Identities=26%  Similarity=0.387  Sum_probs=199.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .++|++.+.||+|+||.||+|++. +++.||+|++...  .......+.+|+.++++++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            578999999999999999999986 5889999987544  2334556788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++++|..++    .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus       104 e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLE----LFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHH----HSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            999999999886    3345689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHH----------HHHh
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW----------QLHQ  270 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~  270 (370)
                      ... ......++..|+|||++.+. .++.++||||||+++|+|++|..||........  +.....          ....
T Consensus       177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHH
T ss_pred             Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhh
Confidence            221 22334689999999998775 789999999999999999999999865432211  111100          0000


Q ss_pred             cCCC-cccccCCCC------CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          271 EEKP-LELVDPELG------EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       271 ~~~~-~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .... .....+...      ...+.....+.+++.+||+.||.+|||+.++++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000 000001110      0111234568899999999999999999999763

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7e-43  Score=321.47  Aligned_cols=264  Identities=23%  Similarity=0.287  Sum_probs=193.2

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh--hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      -....++|++.+.||+|+||.||+|.+. +++.||+|++.....  .....+.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            3455789999999999999999999975 688999999875532  2345677899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC-----CCCCeEEee
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-----QEFNPKIGD  192 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~-----~~~~~kL~D  192 (370)
                      ++||||+++ +|.+++.    ....+++..++.++.||+.||.|||+.   +|+||||||+|||++     .++.+||+|
T Consensus       109 ~lv~e~~~~-~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             EEEEECCSE-EHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             EEEEecCCC-CHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECc
Confidence            999999985 8988883    344689999999999999999999999   999999999999994     455599999


Q ss_pred             ecCccccCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc
Q 017503          193 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       193 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      ||++........ ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......   ............
T Consensus       181 fg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~  256 (329)
T 3gbz_A          181 FGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGL  256 (329)
T ss_dssp             TTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCC
T ss_pred             CCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCC
Confidence            999986643322 22334579999999998774 5899999999999999999999998654221   111111111110


Q ss_pred             CCCcc-----------cccCCCCCC------ChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          272 EKPLE-----------LVDPELGEY------PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       272 ~~~~~-----------~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .....           ...+.....      .......+.+++.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00000           000000000      0012345789999999999999999999976

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-42  Score=329.03  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=191.7

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--------hhcHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--------KQGVREFITEIMTLSNVRHPNLVELIGCCVQ  113 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  113 (370)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++....        ......+.+|+.+|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            44689999999999999999999975 57899999876431        122234778999999999999999999975 


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC---CeEE
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKI  190 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kL  190 (370)
                      ....++||||+++++|.+++    .....+++..+..++.|++.||.|||+.   +++||||||+|||++.++   .+||
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             cCceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence            55689999999999998887    3455789999999999999999999999   999999999999997544   5999


Q ss_pred             eeecCccccCCCCcceeecccCCCCCCCcccccC---CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 017503          191 GDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       191 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      +|||++......  .......||+.|+|||++.+   ..++.++|||||||++|+|++|..||........  +..    
T Consensus       284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~----  355 (419)
T 3i6u_A          284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----  355 (419)
T ss_dssp             CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH----
T ss_pred             eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH----
Confidence            999999876432  22334568999999998853   6788999999999999999999999875432211  111    


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ........ .    ...........+.+++.+||+.||.+|||+.++++.
T Consensus       356 ~i~~~~~~-~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          356 QITSGKYN-F----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHHTTCCC-C----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhcCCCC-C----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            11111100 0    000001223458899999999999999999999863

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.1e-42  Score=324.22  Aligned_cols=271  Identities=22%  Similarity=0.251  Sum_probs=201.1

Q ss_pred             ccCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcC-----------hhcHHHHHHHHHHHHhcCCCC
Q 017503           35 HFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES-----------KQGVREFITEIMTLSNVRHPN  103 (370)
Q Consensus        35 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~  103 (370)
                      +..++++....++|++.+.||+|+||.||+|.+.++..||||++....           ....+.+.+|+.++++++|||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            345778899999999999999999999999998889999999875431           222467889999999999999


Q ss_pred             cceeeeEEEeC-----CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCC
Q 017503          104 LVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS  178 (370)
Q Consensus       104 iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~  178 (370)
                      |+++++++...     ...++||||+.+ +|.+++.   .....+++..+..++.|++.||.|||+.   +++||||||+
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  163 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG  163 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCCC-CHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence            99999998653     367999999985 7777763   3445689999999999999999999999   9999999999


Q ss_pred             ceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccc
Q 017503          179 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM  257 (370)
Q Consensus       179 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~  257 (370)
                      ||+++.++.+||+|||++.......  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  241 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN  241 (362)
T ss_dssp             GEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             HEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999997543322  2233568899999998877 678999999999999999999999986543211


Q ss_pred             hhhHHHHHHHHHhcCC-------------------CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          258 NKFLLEWAWQLHQEEK-------------------PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       258 ~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         .............                   .............+.....+.+++.+||+.||.+|||+.++++.
T Consensus       242 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          242 ---QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             ---HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence               1111111110000                   00000000001112233458899999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.6e-43  Score=312.99  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=196.8

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++...   .......+.+|+.+++.++||||+++++++......++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            4579999999999999999999986 7899999988654   22345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+.+++|.+++.    ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        89 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           89 VMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            999999999999984    334689999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      ....  ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.....   ....    ........    
T Consensus       162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~----~~~~~~~~----  228 (276)
T 2h6d_A          162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLF----KKIRGGVF----  228 (276)
T ss_dssp             CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHCCC----
T ss_pred             CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHH----HHhhcCcc----
Confidence            4432  1233468899999999987765 6899999999999999999999865321   1111    11111110    


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                           ..+......+.+++.+||+.||.+|||+.++++.
T Consensus       229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 1122223457889999999999999999999874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=309.61  Aligned_cols=254  Identities=26%  Similarity=0.356  Sum_probs=199.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|.....||+|+||.||+|.+. ++..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            345566679999999999999975 6889999998776666667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-CCCeEEeeecCccccCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kL~Dfg~~~~~~~~  202 (370)
                      +++++|.+++.... ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++. ++.+||+|||++......
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          101 VPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             CCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            99999999985321 233567889999999999999999999   9999999999999987 899999999999876442


Q ss_pred             CcceeecccCCCCCCCcccccCCC--cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      .. ......|++.|+|||++.+..  ++.++||||||+++|+|++|..||......... ..   ..... .     .. 
T Consensus       177 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~---~~~~~-~-----~~-  244 (295)
T 2clq_A          177 NP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MF---KVGMF-K-----VH-  244 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HH---HHHHH-C-----CC-
T ss_pred             CC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HH---hhccc-c-----cc-
Confidence            21 123346889999999987654  789999999999999999999998643221111 10   00010 0     01 


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                        ...+......+.+++.+||+.||.+||++.++++
T Consensus       245 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          245 --PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             --CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             --ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              1222333445888999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.4e-42  Score=320.55  Aligned_cols=258  Identities=22%  Similarity=0.360  Sum_probs=204.8

Q ss_pred             HHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--------hhcHHHHHHHHHHHHhc-CCCCccee
Q 017503           38 YTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--------KQGVREFITEIMTLSNV-RHPNLVEL  107 (370)
Q Consensus        38 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~iv~~  107 (370)
                      ........++|++.+.||+|+||.||+|.+. +|+.||||++....        ......+.+|+.+++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3444555678999999999999999999986 68999999876542        12245677899999999 89999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC
Q 017503          108 IGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN  187 (370)
Q Consensus       108 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~  187 (370)
                      ++++......++||||+++++|.+++.    ....+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence            999999999999999999999999984    344689999999999999999999999   9999999999999999999


Q ss_pred             eEEeeecCccccCCCCcceeecccCCCCCCCcccccC------CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhH
Q 017503          188 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL  261 (370)
Q Consensus       188 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~  261 (370)
                      ++|+|||++.......  ......||+.|+|||++.+      ..++.++|||||||++|+|++|..||.....   ...
T Consensus       239 ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~  313 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILM  313 (365)
T ss_dssp             EEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH
T ss_pred             EEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHH
Confidence            9999999998765432  2234568999999998853      3688999999999999999999999864321   111


Q ss_pred             HHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          262 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...   .........  .+...    .....+.+++.+||+.||.+|||+.++++
T Consensus       314 ~~~---i~~~~~~~~--~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          314 LRM---IMEGQYQFS--SPEWD----DRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHH---HHHTCCCCC--HHHHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHH---HHhCCCCCC--Ccccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111   111110000  00001    12234888999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=318.77  Aligned_cols=265  Identities=25%  Similarity=0.426  Sum_probs=200.8

Q ss_pred             cccccCHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeee
Q 017503           32 NVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIG  109 (370)
Q Consensus        32 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~  109 (370)
                      .+..+++.++....++|++.+.||+|+||.||+|++. +++.||+|++..... ....+.+|+.+++++ +||||+++++
T Consensus        10 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~   88 (326)
T 2x7f_A           10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYG   88 (326)
T ss_dssp             ------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred             cchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeee
Confidence            3455666777778899999999999999999999985 688999998865433 246788899999998 8999999999


Q ss_pred             EEEe------CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC
Q 017503          110 CCVQ------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD  183 (370)
Q Consensus       110 ~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~  183 (370)
                      ++..      ....++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++
T Consensus        89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~  163 (326)
T 2x7f_A           89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLT  163 (326)
T ss_dssp             EEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC
T ss_pred             EEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEc
Confidence            9987      46789999999999999998532  234689999999999999999999999   999999999999999


Q ss_pred             CCCCeEEeeecCccccCCCCcceeecccCCCCCCCccccc-----CCCcCccccchhhhHHHHHHHhCCCCCCcccccch
Q 017503          184 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN  258 (370)
Q Consensus       184 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~  258 (370)
                      .++.+||+|||++........ ......|++.|+|||++.     +..++.++||||||+++|+|++|..||....... 
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-  241 (326)
T 2x7f_A          164 ENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-  241 (326)
T ss_dssp             TTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-
T ss_pred             CCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-
Confidence            999999999999986543221 123346899999999986     5678999999999999999999999986443211 


Q ss_pred             hhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                           ...........      ..  ........+.+++.+||..||.+||++.++++.
T Consensus       242 -----~~~~~~~~~~~------~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          242 -----ALFLIPRNPAP------RL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             -----HHHHHHHSCCC------CC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -----HHHHhhcCccc------cC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 11111111111      00  111223458889999999999999999999873

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-42  Score=327.01  Aligned_cols=262  Identities=22%  Similarity=0.297  Sum_probs=200.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC--------CCCcceeeeEEE---
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR--------HPNLVELIGCCV---  112 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~---  112 (370)
                      .++|++.+.||+|+||.||+|++. +++.||||++... ......+.+|+.+++.+.        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            589999999999999999999975 5788999998754 334567888999999884        788999999987   


Q ss_pred             -eCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-----
Q 017503          113 -QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-----  186 (370)
Q Consensus       113 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-----  186 (370)
                       .....++||||+.+ +|.+++..  .....+++..++.++.||+.||.|||++.  +|+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVLGH-HLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCCCC-BHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEeccCc-cHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence             45678999999955 55555432  22346899999999999999999999953  799999999999999775     


Q ss_pred             --------------------------------------------CeEEeeecCccccCCCCcceeecccCCCCCCCcccc
Q 017503          187 --------------------------------------------NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV  222 (370)
Q Consensus       187 --------------------------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  222 (370)
                                                                  .+||+|||++......    .....||+.|+|||++
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence                                                        7999999999865432    2334689999999999


Q ss_pred             cCCCcCccccchhhhHHHHHHHhCCCCCCcccccch---hhHHHHHHHHHhcCC---------CcccccC----------
Q 017503          223 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN---KFLLEWAWQLHQEEK---------PLELVDP----------  280 (370)
Q Consensus       223 ~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~---------~~~~~~~----------  280 (370)
                      .+..++.++|||||||++|+|++|..||........   ...............         .......          
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            999999999999999999999999999975443221   111111111111100         0000000          


Q ss_pred             ----------CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          281 ----------ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       281 ----------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                                .....+......+.+++.+||+.||.+|||+.++++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                      001345677778999999999999999999999976

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.4e-42  Score=333.26  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=201.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .++|++.+.||+|+||.||++++. +++.||+|++...  .......+.+|+.++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            578999999999999999999986 6899999988543  2234577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC---CCCCeEEeeecCccc
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKL  198 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kL~Dfg~~~~  198 (370)
                      ||+.+++|.+++.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||++   .++.+||+|||++..
T Consensus       101 e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          101 ELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999988883    334689999999999999999999999   999999999999995   456799999999986


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      .....  ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.....   .....   ........... 
T Consensus       174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~---~i~~~~~~~~~-  243 (486)
T 3mwu_A          174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILK---RVETGKYAFDL-  243 (486)
T ss_dssp             BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHTCCCSCS-
T ss_pred             CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCCCCCCC-
Confidence            65432  2234568999999998875 589999999999999999999999865322   11111   11111111100 


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                           .........+.+++.+||+.+|.+|||+.++++.
T Consensus       244 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          244 -----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 0112233458899999999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.2e-43  Score=318.71  Aligned_cols=266  Identities=24%  Similarity=0.372  Sum_probs=187.4

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ....++|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            345789999999999999999999964 68899999886543 3345677889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccc----cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          120 VYEYVENNSLDRVLLGAT----KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      ||||+++++|.+++....    .....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            999999999999884321    1345689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCc----ceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHh
Q 017503          196 AKLFPDNIT----HITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ  270 (370)
Q Consensus       196 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  270 (370)
                      +........    .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||........  .    .....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~----~~~~~  241 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--L----MLTLQ  241 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--H----HHHHT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--H----HHHhc
Confidence            876543211    11233468999999998865 5689999999999999999999999875432211  1    11111


Q ss_pred             cCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ......................+.+++.+||+.||.+||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1111100000001112223345888999999999999999999976

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=312.55  Aligned_cols=251  Identities=26%  Similarity=0.432  Sum_probs=200.1

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+....  ....+.+|+.+++.++||||+++++++......++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3578999999999999999999986 58999999887543  24678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|.+++.   .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus       105 ~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          105 YCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             CCTTEEHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999984   2345689999999999999999999999   9999999999999999999999999999866443


Q ss_pred             CcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                      .. ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......      ........... .      
T Consensus       179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~-~------  244 (314)
T 3com_A          179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIPTNPPP-T------  244 (314)
T ss_dssp             BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCC-C------
T ss_pred             cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCc-c------
Confidence            22 2233468899999999999999999999999999999999999986543211      11111111111 0      


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...+......+.+++.+||..||.+|||+.++++
T Consensus       245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0112223345889999999999999999999976

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.2e-42  Score=333.23  Aligned_cols=252  Identities=24%  Similarity=0.346  Sum_probs=198.2

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ..++|++.+.||+|+||.||+|+++ ++..||+|++....  ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3567999999999999999999986 68899999886542  23356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC---CCeEEeeecCcc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAK  197 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kL~Dfg~~~  197 (370)
                      |||+.+|+|.+++.    ....+++..++.++.||+.||.|||+.   +|+||||||+|||++..   +.+||+|||++.
T Consensus       115 ~e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          115 MECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999988873    334689999999999999999999999   99999999999999764   459999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ......  ......||+.|+|||++. ..++.++|||||||++|+|++|.+||.....   ..+..   .........  
T Consensus       188 ~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~---~i~~~~~~~--  256 (494)
T 3lij_A          188 VFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILR---KVEKGKYTF--  256 (494)
T ss_dssp             ECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHTCCCC--
T ss_pred             ECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCCCCC--
Confidence            765432  233456899999999876 5699999999999999999999999865432   11111   111111110  


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..+....    ....+.+++.+||+.+|.+|||+.++++.
T Consensus       257 ~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 DSPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CSGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             Cchhccc----CCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            0111112    23458899999999999999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.7e-41  Score=312.14  Aligned_cols=257  Identities=20%  Similarity=0.290  Sum_probs=199.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEe--CCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQ--GTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....   ...+.+|+.+++++. ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            478999999999999999999974 68899999987543   356788999999996 9999999999987  6678999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-CeEEeeecCcccc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLF  199 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kL~Dfg~~~~~  199 (370)
                      |||+.+++|.+++.       .+++..+..++.|++.||.|||+.   +++||||||+|||++.++ .+||+|||++...
T Consensus       112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999999999872       388999999999999999999999   999999999999999776 8999999999876


Q ss_pred             CCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHH--------HHHh
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW--------QLHQ  270 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~  270 (370)
                      .....  .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.......... .....        ....
T Consensus       182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l-~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL-VRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH-HHHHHHHCHHHHHHHHH
T ss_pred             CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH-HHHHHhcCCchhhhHHH
Confidence            54322  233468899999999877 678999999999999999999999985443322111 11000        0000


Q ss_pred             cCC--------------CcccccCCC-CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          271 EEK--------------PLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       271 ~~~--------------~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...              ......... ..........+.+++.+||+.||.+|||+.++++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000              000000000 11112234568899999999999999999999863

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.5e-42  Score=334.21  Aligned_cols=253  Identities=24%  Similarity=0.328  Sum_probs=205.2

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ..++|++.+.||+|+||.||++.++ +++.||||++...   .......+.+|+.++++++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3578999999999999999999986 7899999988543   23456788899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe---CCCCCeEEeeecCc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLA  196 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kL~Dfg~~  196 (370)
                      ||||+.+++|.+++.    ....+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||++
T Consensus       104 v~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          104 VGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            999999999999883    445689999999999999999999999   99999999999999   56788999999999


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ..+.....  .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.....   .....   ..........
T Consensus       177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~---~i~~~~~~~~  247 (484)
T 3nyv_A          177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILK---KVEKGKYTFE  247 (484)
T ss_dssp             HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHCCCCCC
T ss_pred             EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHcCCCCCC
Confidence            87654322  233568999999998866 689999999999999999999999865422   11111   1111111110


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      .      .........+.+++.+||+.+|.+|||+.++++.-
T Consensus       248 ~------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          248 L------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             S------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             C------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence            0      11122344588999999999999999999998743

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.5e-42  Score=313.38  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=197.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC--CCC--EEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT--NGR--RIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~--~~~--~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|++.+.||+|+||.||+|.+.  ++.  .||+|++...   .....+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            578999999999999999999863  233  6899988654   2345677889999999999999999999998765 7


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||+.+++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            899999999999999843   234689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcce--eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          198 LFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       198 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      .........  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ...   ..........
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~---~~~~~~~~~~  243 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQI---LHKIDKEGER  243 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH---HHHHHTSCCC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHH---HHHHHccCCC
Confidence            765443221  223456778999999998889999999999999999999 9999865422   111   1111111111


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                              ...+......+.+++.+||+.+|.+||++.++++.|+++..
T Consensus       244 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          244 --------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             --------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                    11122334458899999999999999999999999988764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-42  Score=323.53  Aligned_cols=263  Identities=22%  Similarity=0.294  Sum_probs=197.5

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----  114 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  114 (370)
                      +....++|++.+.||+|+||.||+|.+. +++.||+|++..+...    ..+|+.+++.++||||+++++++...     
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            3456789999999999999999999974 6899999988655322    23699999999999999999998543     


Q ss_pred             ---------------------------------CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHH
Q 017503          115 ---------------------------------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF  161 (370)
Q Consensus       115 ---------------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~  161 (370)
                                                       ...++||||+++ +|.+.+......+..+++..+..++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             347899999985 8877775544566789999999999999999999


Q ss_pred             HhhcCCCCeEeecCCCCceEeC-CCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHH
Q 017503          162 LHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVL  239 (370)
Q Consensus       162 LH~~~~~~iiH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~i  239 (370)
                      ||+.   +|+||||||+||+++ .++.+||+|||++........  .....+|..|+|||.+.+. .++.++|||||||+
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999   999999999999997 688999999999987644322  2334678999999988765 48999999999999


Q ss_pred             HHHHHhCCCCCCcccccchhhHHHHHHHHHhcC----------CCcccccCCCC------CCChHHHHHHHHHHHHchhh
Q 017503          240 VLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE----------KPLELVDPELG------EYPPNEIIRYMKVAFFCTQA  303 (370)
Q Consensus       240 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~  303 (370)
                      +|+|++|+.||.......  .+.. ........          ......-+...      ..+......+.+++.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~~--~~~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSID--QLVR-IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChHH--HHHH-HHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            999999999987543211  1111 11111000          00000000000      02223345588999999999


Q ss_pred             ccCCCCCHHHHHH
Q 017503          304 AASRRPQMNQVIK  316 (370)
Q Consensus       304 ~p~~RPt~~evl~  316 (370)
                      +|.+|||+.|+++
T Consensus       309 dP~~R~t~~e~l~  321 (383)
T 3eb0_A          309 EPDLRINPYEAMA  321 (383)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.2e-42  Score=343.64  Aligned_cols=249  Identities=27%  Similarity=0.404  Sum_probs=198.3

Q ss_pred             ceeeecCCeEEEEEEEC---CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT---NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      +.||+|+||.||+|.+.   .+..||||+++..  .......+.+|+.++++++||||+++++++.. +..++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   4678999998764  33446789999999999999999999999864 557899999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc--
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--  204 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--  204 (370)
                      |+|.+++.    .+..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++..+.....  
T Consensus       454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999993    345689999999999999999999999   999999999999999999999999999987654322  


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .......+++.|+|||++.+..++.++|||||||++|||++ |..||......   .+.    ........        .
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~----~~i~~~~~--------~  591 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT----AMLEKGER--------M  591 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCC--------C
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCC--------C
Confidence            12223346788999999999999999999999999999998 99998654321   111    11111111        1


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      ..+......+.+++.+||+.||.+||++.+|++.|+....
T Consensus       592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            2223344568889999999999999999999999987653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.1e-42  Score=312.22  Aligned_cols=255  Identities=24%  Similarity=0.368  Sum_probs=189.0

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-h-hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-K-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ..++|++.+.||+|+||.||++.+. +++.||+|++.... . .....+.++...++.++||||+++++++.+....++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            4688999999999999999999985 68899999887552 2 2233344455557778999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++ +|.+++......+..+++..++.++.|++.||.|||++.  +++||||||+||+++.++.+||+|||++....
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            999985 887777544456678999999999999999999999842  89999999999999999999999999998664


Q ss_pred             CCCcceeecccCCCCCCCcccc----cCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          201 DNITHITTRIAGTTGYLAPEYV----LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ....  .....||+.|+|||.+    .+..++.++||||||+++|+|++|..||........     ............ 
T Consensus       162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~-  233 (290)
T 3fme_A          162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----QLKQVVEEPSPQ-  233 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----HHHHHHHSCCCC-
T ss_pred             cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----HHHHHhccCCCC-
Confidence            4322  2234689999999986    556789999999999999999999999865322111     111111111111 


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                             .........+.+++.+||+.+|.+|||+.++++
T Consensus       234 -------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          234 -------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                   011122345889999999999999999999987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.9e-43  Score=317.83  Aligned_cols=253  Identities=23%  Similarity=0.432  Sum_probs=199.5

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++..........+.+|+.+++.++||||+++++++......++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            4578999999999999999999986 588999999887766667889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++......
T Consensus        97 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             eCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999998842   234689999999999999999999999   9999999999999999999999999987532111


Q ss_pred             CcceeecccCCCCCCCcccc-----cCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          203 ITHITTRIAGTTGYLAPEYV-----LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      . .......|++.|+|||.+     ....++.++||||||+++|+|++|..||......      .............  
T Consensus       171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~--  241 (302)
T 2j7t_A          171 L-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSDPPT--  241 (302)
T ss_dssp             H-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCCC--
T ss_pred             c-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccCCcc--
Confidence            0 112234688999999988     4677899999999999999999999998654321      1111111111111  


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                           ...+......+.+++.+||+.+|.+|||+.++++
T Consensus       242 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 -----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 0112233445889999999999999999999865

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.7e-43  Score=347.37  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=207.2

Q ss_pred             HHHHhccCCcccceeeecCCeEEEEEEECC----CCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 017503           40 ELRSATDDFHLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG  114 (370)
Q Consensus        40 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  114 (370)
                      +.....++|++.+.||+|+||.||+|.+..    +..||+|.+... .......+.+|+.++++++||||+++++++. .
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            344456789999999999999999999742    457999988754 3444567889999999999999999999985 4


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      +..++||||+++|+|.+++..   .+..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence            568999999999999999842   344689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      ++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.....   .....   .... ..
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~---~i~~-~~  609 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIG---RIEN-GE  609 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH---HHHH-TC
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHH---HHHc-CC
Confidence            998765443333334456789999999998899999999999999999997 8888865422   11111   1111 11


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      .        ...++.....+.+++.+||+.||.+||++.+|++.|+.++.
T Consensus       610 ~--------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          610 R--------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C--------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            1        11223344568899999999999999999999999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.6e-42  Score=331.53  Aligned_cols=253  Identities=24%  Similarity=0.348  Sum_probs=200.7

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh-------------hcHHHHHHHHHHHHhcCCCCcceee
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK-------------QGVREFITEIMTLSNVRHPNLVELI  108 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~  108 (370)
                      ...++|++.+.||+|+||.||+|.++ ++..||+|++.....             ...+.+.+|+.++++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            45689999999999999999999986 578899998865321             2356788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC--
Q 017503          109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF--  186 (370)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~--  186 (370)
                      +++.+....++||||+++++|.+++.    ....+++..++.++.||+.||.|||+.   +|+||||||+||+++.++  
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCC
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCC
Confidence            99999999999999999999998883    334689999999999999999999999   999999999999998776  


Q ss_pred             -CeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHH
Q 017503          187 -NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA  265 (370)
Q Consensus       187 -~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~  265 (370)
                       .+||+|||++.......  ......||+.|+|||++. +.++.++|||||||++|+|++|.+||.....   ..+..  
T Consensus       186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~--  257 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDIIK--  257 (504)
T ss_dssp             SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH--
T ss_pred             ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHH--
Confidence             69999999998765432  223456899999999876 5689999999999999999999999865422   11111  


Q ss_pred             HHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          266 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                       ...........  +...    .....+.+++.+||+.||.+|||+.++++.
T Consensus       258 -~i~~~~~~~~~--~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          258 -KVEKGKYYFDF--NDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             -HHHHCCCCCCH--HHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHcCCCCCCc--cccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence             11111111000  0001    123458899999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-41  Score=308.19  Aligned_cols=254  Identities=21%  Similarity=0.286  Sum_probs=203.2

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---------hhcHHHHHHHHHHHHhcC-CCCcceeeeE
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---------KQGVREFITEIMTLSNVR-HPNLVELIGC  110 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~  110 (370)
                      ....++|++.+.||+|+||.||+|.++ +++.||+|++....         ......+.+|+.+++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            345689999999999999999999986 68899999886542         123456788999999995 9999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEE
Q 017503          111 CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI  190 (370)
Q Consensus       111 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL  190 (370)
                      +......++||||+++++|.+++.    ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  165 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKL  165 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             eccCCeEEEEEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEE
Confidence            999999999999999999999984    335689999999999999999999999   9999999999999999999999


Q ss_pred             eeecCccccCCCCcceeecccCCCCCCCccccc------CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHH
Q 017503          191 GDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL------GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW  264 (370)
Q Consensus       191 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~  264 (370)
                      +|||++.......  ......+++.|+|||++.      ...++.++||||||+++|+|++|..||.....   ..... 
T Consensus       166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~-  239 (298)
T 1phk_A          166 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLR-  239 (298)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH-
T ss_pred             ecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHH-
Confidence            9999998765432  223356889999999875      45688999999999999999999999864321   11111 


Q ss_pred             HHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          265 AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                        ........  ..    ..........+.+++.+||+.||.+|||+.++++
T Consensus       240 --~~~~~~~~--~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 --MIMSGNYQ--FG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --HHHHTCCC--CC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HHhcCCcc--cC----cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence              11111111  00    0111233455889999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.1e-42  Score=319.14  Aligned_cols=263  Identities=23%  Similarity=0.308  Sum_probs=201.1

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----C
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----T  115 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~  115 (370)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|++... .......+.+|+.++++++||||+++++++...     .
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            34679999999999999999999976 6788999988754 334456788999999999999999999999764     3


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      ..++||||+.+ +|.+++.     ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus       104 ~~~iv~e~~~~-~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          104 DVYIVQDLMET-DLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             CEEEEEECCSE-EHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEcccCc-CHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence            68999999985 8888873     23589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcce--eecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          196 AKLFPDNITHI--TTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       196 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      +..........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........   ...........
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~  251 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSP  251 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSC
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCC
Confidence            98765332211  234578999999998654 5589999999999999999999999865432221   11111111000


Q ss_pred             CCc---------------ccccCC---CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          273 KPL---------------ELVDPE---LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       273 ~~~---------------~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...               ......   .....+.....+.+++.+||+.||.+|||+.++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000               000000   000112233458899999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.6e-42  Score=313.20  Aligned_cols=252  Identities=22%  Similarity=0.320  Sum_probs=195.9

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--------hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--------KQGVREFITEIMTLSNVRHPNLVELIGCCVQG  114 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  114 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++....        ......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4578999999999999999999986 57889999886432        12234577899999999999999999998765


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC---eEEe
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIG  191 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kL~  191 (370)
                      . .++||||+++++|.+++.    .+..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.   +||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             c-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence            5 899999999999999883    455789999999999999999999999   9999999999999987665   9999


Q ss_pred             eecCccccCCCCcceeecccCCCCCCCccccc---CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHH
Q 017503          192 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       192 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      |||++.......  ......|++.|+|||++.   ...++.++||||||+++|+|++|..||........  +....   
T Consensus       160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~---  232 (322)
T 2ycf_A          160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI---  232 (322)
T ss_dssp             CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH---
T ss_pred             cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH---
Confidence            999998764321  123346899999999874   56789999999999999999999999865433211  11111   


Q ss_pred             HhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       ...... .    ...........+.+++.+||+.||.+||++.++++
T Consensus       233 -~~~~~~-~----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 -TSGKYN-F----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -HHTCCC-C----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HhCccc-c----CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             111100 0    00001122345889999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=306.28  Aligned_cols=253  Identities=21%  Similarity=0.260  Sum_probs=197.9

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC----hhcHHHHHHHHHHHHhcCCCCcceeeeEEE--eCCe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES----KQGVREFITEIMTLSNVRHPNLVELIGCCV--QGTR  116 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~  116 (370)
                      ..++|++.+.||+|+||.||++.+. ++..||+|++....    ......+.+|+.++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4589999999999999999999975 68899999987542    234567889999999999999999999985  4557


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .++||||+.++ |.+++..  .....+++..++.++.|++.||.|||++   +++||||||+||+++.++.++|+|||++
T Consensus        83 ~~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEehhccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccc
Confidence            89999999887 6666532  2345689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC-cceeecccCCCCCCCcccccCCC--cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          197 KLFPDNI-THITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       197 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      ....... ........|++.|+|||++.+..  ++.++||||||+++|+|++|..||.....   ....   .. .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---~~-i~~~~  229 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---YKLF---EN-IGKGS  229 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HH-HHHCC
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---HHHH---HH-HhcCC
Confidence            8764322 22233456899999999987644  47899999999999999999999865321   1111   11 11111


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      .         ..+......+.+++.+||+.||.+|||+.++++..
T Consensus       230 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          230 Y---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             C---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             C---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            1         11223334578899999999999999999998753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.8e-42  Score=319.64  Aligned_cols=259  Identities=17%  Similarity=0.247  Sum_probs=203.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhc-----------------HHHHHHHHHHHHhcCCCCccee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQG-----------------VREFITEIMTLSNVRHPNLVEL  107 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~iv~~  107 (370)
                      .++|++.+.||+|+||.||+|.+ +++.||+|.+.......                 ...+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            57999999999999999999999 89999999886542111                 1778899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHhcc----cccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEe
Q 017503          108 IGCCVQGTRRILVYEYVENNSLDRVLLG----ATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILL  182 (370)
Q Consensus       108 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill  182 (370)
                      ++++.+.+..++||||+++++|.+++..    .......+++..++.++.|++.||.|||+ .   +++||||+|+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence            9999999999999999999999988211    11225678999999999999999999999 8   99999999999999


Q ss_pred             CCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCC-CcCc-cccchhhhHHHHHHHhCCCCCCcccccchhh
Q 017503          183 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTM-KADVYSFGVLVLEIISGRNSGKAMWGQMNKF  260 (370)
Q Consensus       183 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Di~slG~il~elltg~~p~~~~~~~~~~~  260 (370)
                      +.++.++|+|||++......   ......++..|+|||.+.+. .++. ++||||||+++|+|++|..||......  ..
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence            99999999999999865433   23445689999999999887 6666 999999999999999999998754331  11


Q ss_pred             HHHHHHHHHhcCCC-cccc-----cC----CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          261 LLEWAWQLHQEEKP-LELV-----DP----ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       261 ~~~~~~~~~~~~~~-~~~~-----~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ..    ........ ....     .+    ............+.+++.+||+.||.+|||+.++++
T Consensus       261 ~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LF----NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HH----HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HH----HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11    11111111 0000     00    000011233455889999999999999999999976

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=316.57  Aligned_cols=266  Identities=24%  Similarity=0.397  Sum_probs=201.6

Q ss_pred             CHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 017503           37 SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQG  114 (370)
Q Consensus        37 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  114 (370)
                      ...++....++|++.+.||+|+||.||+|.+.+  .||+|.+....  ......+.+|+.++++++||||+++++++.+.
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            334444557899999999999999999999863  48999886542  23334567799999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      ...++||||+++++|.+++..   .+..+++..++.++.|++.||.|||+.   +++||||||+||+++ ++.++|+|||
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             CceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence            999999999999999999842   334689999999999999999999999   999999999999998 6799999999


Q ss_pred             CccccCCCC----cceeecccCCCCCCCcccccC---------CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhH
Q 017503          195 LAKLFPDNI----THITTRIAGTTGYLAPEYVLG---------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL  261 (370)
Q Consensus       195 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~  261 (370)
                      ++.......    ........|++.|+|||.+..         ..++.++||||||+++|+|++|..||......   ..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~  251 (319)
T 2y4i_B          175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AI  251 (319)
T ss_dssp             CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HH
T ss_pred             CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH
Confidence            987543211    111223458899999998864         45788999999999999999999998654321   11


Q ss_pred             HHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          262 LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                         ..... .........   ...+    ..+.+++.+||..+|.+|||+.++++.|+.+....
T Consensus       252 ---~~~~~-~~~~~~~~~---~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          252 ---IWQMG-TGMKPNLSQ---IGMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             ---HHHHH-TTCCCCCCC---SSCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             ---HHHhc-cCCCCCCCc---CCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence               11111 111111100   1122    23788999999999999999999999999887654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.9e-42  Score=321.79  Aligned_cols=257  Identities=24%  Similarity=0.324  Sum_probs=184.1

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC------
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------  114 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------  114 (370)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            3589999999999999999999975 6889999998653  334556788999999999999999999998754      


Q ss_pred             CeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          115 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                      ...++|+|++ +++|.+++.     ...+++..+..++.||+.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             CeEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence            5679999999 678888873     24689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      ++......    .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......   .....+....... 
T Consensus       178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p-  249 (367)
T 2fst_X          178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTP-  249 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSC-
T ss_pred             cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC-
Confidence            99865432    234568999999999877 67899999999999999999999998654321   1111111111000 


Q ss_pred             Ccccc------------c--CCCCC-----CChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          274 PLELV------------D--PELGE-----YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       274 ~~~~~------------~--~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..+..            .  +....     ..+.....+.+|+.+||+.||.+|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00000            0  00000     011223457899999999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3e-41  Score=315.69  Aligned_cols=260  Identities=23%  Similarity=0.292  Sum_probs=193.1

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----  115 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  115 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            3589999999999999999999975 6888999988653  3444567889999999999999999999997654     


Q ss_pred             -eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          116 -RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       116 -~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                       ..++||||+++ +|.+++.      ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence             78999999986 6777762      2488999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH-------
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ-------  267 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------  267 (370)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+..       
T Consensus       173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          173 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCP  247 (371)
T ss_dssp             C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCH
T ss_pred             ccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCH
Confidence            998654321  2234568999999999999999999999999999999999999986542211   0000000       


Q ss_pred             ------------HHhcCCCcc------ccc----CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          268 ------------LHQEEKPLE------LVD----PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       268 ------------~~~~~~~~~------~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                                  .........      ...    +............+.+++.+||+.||.+|||+.++++.-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence                        000000000      000    000001122356789999999999999999999998743

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4e-41  Score=320.51  Aligned_cols=199  Identities=23%  Similarity=0.317  Sum_probs=171.2

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc------CCCCcceeeeEEEeCCe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV------RHPNLVELIGCCVQGTR  116 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~  116 (370)
                      ...+|++.+.||+|+||.||+|.+. +++.||||++.... .....+.+|+.+++.+      +|+||+++++++.....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            3568999999999999999999976 58899999987543 3345677788888776      57799999999999999


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC--eEEeeec
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN--PKIGDFG  194 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~--~kL~Dfg  194 (370)
                      .++||||+. ++|.+++...  ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.  +||+|||
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            999999996 5888887432  223589999999999999999999999   9999999999999999887  9999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcc
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  253 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~  253 (370)
                      ++......    .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus       248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            99765432    23356899999999999999999999999999999999999998654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-41  Score=308.94  Aligned_cols=253  Identities=24%  Similarity=0.394  Sum_probs=193.7

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe---------
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ---------  113 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------  113 (370)
                      ..++|++.+.||+|+||.||+|++. +++.||+|.+... ......+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3578999999999999999999975 7899999988643 3445678899999999999999999999865         


Q ss_pred             ----CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeE
Q 017503          114 ----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK  189 (370)
Q Consensus       114 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  189 (370)
                          ....++||||+++++|.+++..   .+..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence                3567899999999999999842   345678899999999999999999999   999999999999999999999


Q ss_pred             EeeecCccccCCCC-------------cceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccc
Q 017503          190 IGDFGLAKLFPDNI-------------THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWG  255 (370)
Q Consensus       190 L~Dfg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~  255 (370)
                      |+|||++.......             ........|++.|+|||++.+. .++.++||||||+++|+|++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            99999998654321             1112335688999999998764 78999999999999999998   3332111


Q ss_pred             cchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          256 QMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                        ..   ... ........  ..   ....+......+.+++.+||+.||.+|||+.++++.
T Consensus       234 --~~---~~~-~~~~~~~~--~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 --RV---NIL-KKLRSVSI--EF---PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             --HH---HHH-HHHHSTTC--CC---CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --HH---HHH-Hhcccccc--cc---CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence              11   111 11111110  01   122334445568899999999999999999999863

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.1e-42  Score=315.99  Aligned_cols=264  Identities=19%  Similarity=0.318  Sum_probs=201.5

Q ss_pred             ccccCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcC--CCCcceee
Q 017503           33 VNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVR--HPNLVELI  108 (370)
Q Consensus        33 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~  108 (370)
                      .+.+.++.+....++|++.+.||+|+||.||++.+.+++.||+|++...  .......+.+|+.+++++.  |+||++++
T Consensus        15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~   94 (313)
T 3cek_A           15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY   94 (313)
T ss_dssp             -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred             CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence            4456666666778899999999999999999999988999999988654  3445677889999999996  59999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCe
Q 017503          109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP  188 (370)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~  188 (370)
                      +++......++||| +.+++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||||+||+++ ++.+
T Consensus        95 ~~~~~~~~~~lv~e-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~  165 (313)
T 3cek_A           95 DYEITDQYIYMVME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML  165 (313)
T ss_dssp             EEEECSSEEEEEEC-CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEE
T ss_pred             EEeecCCEEEEEEe-cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeE
Confidence            99999999999999 56789999984    344689999999999999999999999   999999999999996 4899


Q ss_pred             EEeeecCccccCCCCcc-eeecccCCCCCCCcccccC-----------CCcCccccchhhhHHHHHHHhCCCCCCccccc
Q 017503          189 KIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLG-----------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ  256 (370)
Q Consensus       189 kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~il~elltg~~p~~~~~~~  256 (370)
                      ||+|||++......... ......|++.|+|||.+.+           ..++.++||||||+++|+|++|..||......
T Consensus       166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (313)
T 3cek_A          166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  245 (313)
T ss_dssp             EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence            99999999866443221 1233468999999998865           46888999999999999999999998654332


Q ss_pred             chhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          257 MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      ...     ..........        ...+......+.+++.+||+.||.+||++.++++..
T Consensus       246 ~~~-----~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          246 ISK-----LHAIIDPNHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             HHH-----HHHHHCTTSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHH-----HHHHHhcccc--------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            111     1111111110        111122234578889999999999999999998754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.1e-42  Score=344.68  Aligned_cols=249  Identities=25%  Similarity=0.320  Sum_probs=203.6

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  118 (370)
                      ..++|++.+.||+|+||.||+|+++ +++.||||++...   .......+..|..++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4678999999999999999999986 5788999998743   223456677899999987 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+++|+|..++.    ....+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||++..
T Consensus       419 lV~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEeCcCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            9999999999999984    334689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      ..... .......||+.|+|||++.+..++.++||||||++||||++|..||.....   ..+..   .... ..     
T Consensus       492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~---~i~~-~~-----  558 (674)
T 3pfq_A          492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ---SIME-HN-----  558 (674)
T ss_dssp             CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHS-SC-----
T ss_pred             cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHH---HHHh-CC-----
Confidence            43322 223456799999999999999999999999999999999999999865321   11111   1111 11     


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCH-----HHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQM-----NQVIK  316 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  316 (370)
                          ..++......+.+|+.+||+.||.+||++     .+|++
T Consensus       559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                12223344558899999999999999997     66654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.1e-42  Score=322.35  Aligned_cols=253  Identities=9%  Similarity=0.025  Sum_probs=182.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhc--CCCCcceee-------eEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNV--RHPNLVELI-------GCC  111 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~  111 (370)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            456999999999999999999976 68899999987753   23445667775544444  699977754       555


Q ss_pred             EeC-----------------CeeEEEEEecCCCCHHHHhcccccCCccCCHHHH------HHHHHHHHHHHHHHhhcCCC
Q 017503          112 VQG-----------------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKR------SDICVGIAKGLAFLHEELVP  168 (370)
Q Consensus       112 ~~~-----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~------~~i~~qi~~al~~LH~~~~~  168 (370)
                      ...                 ...++||||++ ++|.+++...   +..+.+..+      +.++.||+.||+|||++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence            443                 33799999999 7999998532   233455556      78889999999999999   


Q ss_pred             CeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccC--CCcCccccchhhhHHHHHHHhC
Q 017503          169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISG  246 (370)
Q Consensus       169 ~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg  246 (370)
                      +|+||||||+|||++.++.+||+|||++......    .....+|+.|+|||++.+  ..++.++|||||||++|+|++|
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999865432    224456799999999987  6799999999999999999999


Q ss_pred             CCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC-CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          247 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       247 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      +.||...........        ............. ....+.....+.+++.+||+.||.+|||+.++++
T Consensus       290 ~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999876643221100        0000000000010 1111233456889999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=308.95  Aligned_cols=261  Identities=21%  Similarity=0.324  Sum_probs=194.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEE-----------
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV-----------  112 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----------  112 (370)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+...+....+.+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            578999999999999999999986 48899999988777677788899999999999999999999873           


Q ss_pred             ---eCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC-CCCCe
Q 017503          113 ---QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEFNP  188 (370)
Q Consensus       113 ---~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~-~~~~~  188 (370)
                         +....++||||++ ++|.+++.     ...+++..++.++.|++.||.|||+.   +++||||||+||+++ .++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence               3467899999998 59999883     34689999999999999999999999   999999999999997 56789


Q ss_pred             EEeeecCccccCCCCc--ceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHH
Q 017503          189 KIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA  265 (370)
Q Consensus       189 kL~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~  265 (370)
                      ||+|||++........  .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......   .....
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~  237 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLI  237 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence            9999999987643221  11233457889999998765 678999999999999999999999987543211   11111


Q ss_pred             HHHH-----------hcCCCcc----cccCC--CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          266 WQLH-----------QEEKPLE----LVDPE--LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       266 ~~~~-----------~~~~~~~----~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ....           .......    ...+.  +....+.....+.+++.+||+.||.+|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            1000           0000000    00000  001112234558899999999999999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.3e-41  Score=318.38  Aligned_cols=260  Identities=24%  Similarity=0.300  Sum_probs=195.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC------Cee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~  117 (370)
                      ..+|++.+.||+|+||.||+|++. +++.||||.+.....    ...+|+++|+.++||||+++++++...      ...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            457999999999999999999986 589999998865432    223699999999999999999998642      236


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC-CCeEEeeecCc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLA  196 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kL~Dfg~~  196 (370)
                      ++||||+.+ +|.+++.........+++..+..++.||+.||.|||+.   +|+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence            789999986 56665543334566799999999999999999999999   99999999999999955 56899999999


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHh-----
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ-----  270 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  270 (370)
                      ........  .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......  ..+.... ....     
T Consensus       205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~-~~lg~p~~~  279 (420)
T 1j1b_A          205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEII-KVLGTPTRE  279 (420)
T ss_dssp             EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-HHHCSCCHH
T ss_pred             hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-HHhCCCCHH
Confidence            87644322  2335689999999998765 7899999999999999999999998654321  1111111 1110     


Q ss_pred             -----cCCCcccccCCCCC------CChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          271 -----EEKPLELVDPELGE------YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       271 -----~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                           ........-+.+..      +.+.....+.+|+.+||+.||.+||++.|+++.
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence                 00000110111111      122334568899999999999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.3e-41  Score=314.57  Aligned_cols=263  Identities=21%  Similarity=0.280  Sum_probs=199.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-----------CCCcceeeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-----------HPNLVELIGCCV  112 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~  112 (370)
                      .++|++.+.||+|+||.||+|++. +++.||||++.... .....+.+|+.+++++.           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            578999999999999999999974 68899999987542 33466788999998875           899999999998


Q ss_pred             eCC----eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC-----
Q 017503          113 QGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-----  183 (370)
Q Consensus       113 ~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~-----  183 (370)
                      ...    ..++|||++ +++|.+++...  ....+++..++.++.||+.||.|||++.  +|+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence            654    788999999 88999988532  2345899999999999999999999942  899999999999994     


Q ss_pred             -CCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccch---h
Q 017503          184 -QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN---K  259 (370)
Q Consensus       184 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~---~  259 (370)
                       ..+.+||+|||++......    .....+|+.|+|||++.+..++.++||||||+++|+|++|..||........   .
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence             4447999999999866432    2334689999999999999999999999999999999999999875432111   1


Q ss_pred             hHHHHHHHHHhcCC------------------Cccccc-----------CCCCCCChHHHHHHHHHHHHchhhccCCCCC
Q 017503          260 FLLEWAWQLHQEEK------------------PLELVD-----------PELGEYPPNEIIRYMKVAFFCTQAAASRRPQ  310 (370)
Q Consensus       260 ~~~~~~~~~~~~~~------------------~~~~~~-----------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  310 (370)
                      ..............                  ....+.           ......+......+.+++.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            11111111110000                  000000           0011345677888999999999999999999


Q ss_pred             HHHHHHH
Q 017503          311 MNQVIKM  317 (370)
Q Consensus       311 ~~evl~~  317 (370)
                      +.++++.
T Consensus       328 ~~ell~h  334 (373)
T 1q8y_A          328 AGGLVNH  334 (373)
T ss_dssp             HHHHHTC
T ss_pred             HHHHhhC
Confidence            9999774

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.8e-41  Score=314.45  Aligned_cols=270  Identities=20%  Similarity=0.261  Sum_probs=192.8

Q ss_pred             HHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe
Q 017503           38 YTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR  116 (370)
Q Consensus        38 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  116 (370)
                      ........++|++.+.||+|+||.||+|++. ++..||||++..... ......+++..+..++||||+++++++.....
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            3456677899999999999999999999985 688999998765432 23455678888889999999999999976433


Q ss_pred             -------eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEeecCCCCceEeCC-CC
Q 017503          117 -------RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH--EELVPHIVHRDIKASNILLDQ-EF  186 (370)
Q Consensus       117 -------~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~~~iiH~dlkp~Nill~~-~~  186 (370)
                             .++||||+.+ +|...+.........+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence                   7899999987 554444333345667899999999999999999999  88   9999999999999996 89


Q ss_pred             CeEEeeecCccccCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHH
Q 017503          187 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA  265 (370)
Q Consensus       187 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~  265 (370)
                      .+||+|||++........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......   ......
T Consensus       170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~  244 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEI  244 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred             cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHH
Confidence            999999999987654322  2345689999999988665 4899999999999999999999998654321   111111


Q ss_pred             HHHHhc------------CCCcccccC-------CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          266 WQLHQE------------EKPLELVDP-------ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       266 ~~~~~~------------~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ......            .......+.       .+..........+.+++.+||+.||.+|||+.++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111100            000000000       0112222345678999999999999999999999763

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.7e-41  Score=311.46  Aligned_cols=258  Identities=21%  Similarity=0.301  Sum_probs=202.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEE-C-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCC------CcceeeeEEEeCCe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTL-T-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHP------NLVELIGCCVQGTR  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~-~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~  116 (370)
                      .++|++.+.||+|+||.||+|.+ . +++.||+|++.... .....+.+|+.+++.++|+      +++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            57999999999999999999997 3 67889999987543 3356778899999888654      59999999999999


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC------------
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ------------  184 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~------------  184 (370)
                      .++||||+ +++|.+++...  ....+++..+..++.|++.||.|||++   +++||||||+||+++.            
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence            99999999 78998888432  223688999999999999999999999   9999999999999987            


Q ss_pred             -------CCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccc
Q 017503          185 -------EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM  257 (370)
Q Consensus       185 -------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~  257 (370)
                             ++.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             cccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                   668999999999865432    233568999999999999999999999999999999999999986543221


Q ss_pred             hhhHHHHHHHHHhcCCCccc---------c---------------------cC--CCCCCChHHHHHHHHHHHHchhhcc
Q 017503          258 NKFLLEWAWQLHQEEKPLEL---------V---------------------DP--ELGEYPPNEIIRYMKVAFFCTQAAA  305 (370)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~---------~---------------------~~--~~~~~~~~~~~~l~~li~~cl~~~p  305 (370)
                      .   ......... ..+...         .                     .+  ............+.+++.+||+.||
T Consensus       242 ~---~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          242 H---LAMMERILG-PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             H---HHHHHHHHC-SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             H---HHHHHHHhC-CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            1   111111110 000000         0                     00  0012234566778999999999999


Q ss_pred             CCCCCHHHHHHH
Q 017503          306 SRRPQMNQVIKM  317 (370)
Q Consensus       306 ~~RPt~~evl~~  317 (370)
                      .+|||+.|+++.
T Consensus       318 ~~Rpt~~ell~h  329 (339)
T 1z57_A          318 AKRITLREALKH  329 (339)
T ss_dssp             TTSCCHHHHTTS
T ss_pred             ccccCHHHHhcC
Confidence            999999999753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=9.1e-42  Score=316.85  Aligned_cols=262  Identities=20%  Similarity=0.290  Sum_probs=199.0

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----Ce
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TR  116 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~  116 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+... .......+.+|+.++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4689999999999999999999986 6889999988654 334456778999999999999999999988754     67


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .++||||+. ++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            899999997 489888832     3689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc---------eeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHH
Q 017503          197 KLFPDNITH---------ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW  266 (370)
Q Consensus       197 ~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~  266 (370)
                      .........         ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......   ......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~  236 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIF  236 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHH
Confidence            876532211         1123468999999998765 678999999999999999999999986543211   111111


Q ss_pred             HHHhcCCCcccc-------------------cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          267 QLHQEEKPLELV-------------------DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       267 ~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ............                   ...+....+.....+.+++.+||+.||.+|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            111100000000                   000000112334457899999999999999999999763

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.8e-41  Score=313.69  Aligned_cols=256  Identities=21%  Similarity=0.343  Sum_probs=196.4

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee---
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR---  117 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---  117 (370)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.+++.++||||+++++++......   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3679999999999999999999976 6889999988754  334456788999999999999999999999877655   


Q ss_pred             ---EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          118 ---ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       118 ---~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                         ++||||+. ++|.+++      +..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus       120 ~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             eeEEEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence               99999998 5888776      22489999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      ++......    .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......   ........... .
T Consensus       190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~-~  261 (371)
T 4exu_A          190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGV-P  261 (371)
T ss_dssp             CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC-C
T ss_pred             cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC-C
Confidence            99855432    234568999999999877 678999999999999999999999986543211   11111110000 0


Q ss_pred             Cccc-------------------ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          274 PLEL-------------------VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       274 ~~~~-------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ....                   .........+.....+.+++.+||+.||.+|||+.++++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            0000                   0000001112234568899999999999999999999764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-41  Score=320.54  Aligned_cols=260  Identities=23%  Similarity=0.301  Sum_probs=194.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe------eE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR------RI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~  118 (370)
                      ..+|++.+.||+|+||.||+|++..+..||+|.+......    ..+|+.+++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            5679999999999999999999987777999877654321    2259999999999999999999965433      78


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC-CCCCeEEeeecCcc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAK  197 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~-~~~~~kL~Dfg~~~  197 (370)
                      +||||+.++.+.. +.........+++..+..++.||+.||.|||+.   +|+||||||+|||++ .++.+||+|||++.
T Consensus       115 lv~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          115 LVLEYVPETVYRA-SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEECCSEEHHHH-HHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeeccCccHHHH-HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            9999998754443 322223456789999999999999999999999   999999999999998 79999999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC--
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP--  274 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  274 (370)
                      .......  .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.......  .+.. +.........  
T Consensus       191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~-i~~~~g~p~~~~  265 (394)
T 4e7w_A          191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVE-IIKVLGTPSREQ  265 (394)
T ss_dssp             ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCHHH
T ss_pred             cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHH
Confidence            7644322  2345689999999988765 58999999999999999999999986543211  1111 1111100000  


Q ss_pred             -----ccccc---CCCC------CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          275 -----LELVD---PELG------EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       275 -----~~~~~---~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                           .....   +...      .+.+.....+.+++.+||+.||.+|||+.++++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                 00000   0000      0112234468899999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.7e-41  Score=309.30  Aligned_cols=263  Identities=24%  Similarity=0.359  Sum_probs=198.8

Q ss_pred             HhccCCcccceeeecCCeEEEEEEEC--CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhc---CCCCcceeeeEEE---
Q 017503           43 SATDDFHLSNKIGRGGFGTVYKGTLT--NGRRIAVKPLSAES--KQGVREFITEIMTLSNV---RHPNLVELIGCCV---  112 (370)
Q Consensus        43 ~~~~~y~~~~~lg~G~~g~v~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~---  112 (370)
                      .+.++|++.+.||+|+||.||+|++.  +++.||+|++....  ......+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            35689999999999999999999983  57889999876432  11223455677776665   8999999999987   


Q ss_pred             --eCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEE
Q 017503          113 --QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI  190 (370)
Q Consensus       113 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL  190 (370)
                        .....++||||+. ++|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence              4567899999998 5999988432  233589999999999999999999999   9999999999999999999999


Q ss_pred             eeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHh
Q 017503          191 GDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ  270 (370)
Q Consensus       191 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  270 (370)
                      +|||++.......  ......++..|+|||++.+..++.++||||||+++|+|++|..||......   ...........
T Consensus       162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~  236 (326)
T 1blx_A          162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIG  236 (326)
T ss_dssp             CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHC
T ss_pred             ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcC
Confidence            9999998654321  223456899999999999999999999999999999999999998654321   11111111111


Q ss_pred             cCCCcc----------ccc----CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          271 EEKPLE----------LVD----PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       271 ~~~~~~----------~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ......          ...    ..+..........+.+++.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000          000    0011122333455889999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.7e-41  Score=303.28  Aligned_cols=254  Identities=24%  Similarity=0.350  Sum_probs=201.9

Q ss_pred             HHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           42 RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        42 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      ....++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.++++++||||+++++++.+....+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            344689999999999999999999986 6889999988644  2345678889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC---CCeEEeeecC
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGL  195 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kL~Dfg~  195 (370)
                      +||||+.+++|.+++.    ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.+   +.+||+|||+
T Consensus        98 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           98 IVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            9999999999988873    234689999999999999999999999   99999999999999754   4699999999


Q ss_pred             ccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          196 AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      +........  .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.....   ....   ..........
T Consensus       171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~---~~~~~~~~~~  241 (287)
T 2wei_A          171 STCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDIL---KRVETGKYAF  241 (287)
T ss_dssp             GGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHCCCCC
T ss_pred             ceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHcCCCCC
Confidence            986644321  122347889999998765 489999999999999999999999865422   1111   1111111110


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ..  +....    ....+.+++.+||+.+|.+|||+.++++.
T Consensus       242 ~~--~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          242 DL--PQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CS--GGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             Cc--hhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            00  01112    23458889999999999999999999873

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.8e-40  Score=311.69  Aligned_cols=207  Identities=23%  Similarity=0.310  Sum_probs=173.6

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-CC-----Ccceee
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HP-----NLVELI  108 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~  108 (370)
                      +.+.......++|++.+.||+|+||.||+|.+. +++.||||++... ......+..|+.+++.++ |+     ++++++
T Consensus        44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            344444556789999999999999999999976 6788999998754 233456777888888874 44     499999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh--cCCCCeEeecCCCCceEeC--C
Q 017503          109 GCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE--ELVPHIVHRDIKASNILLD--Q  184 (370)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~~~~iiH~dlkp~Nill~--~  184 (370)
                      +++......++||||+.+ +|.+++...  ....+++..+..++.|++.||.|||.  .   +|+||||||+|||++  .
T Consensus       123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~---~ivHrDlkp~NIll~~~~  196 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLSY-NLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPEL---SIIHCDLKPENILLCNPK  196 (382)
T ss_dssp             EEEEETTEEEEEEECCCC-BHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTT---CEECCCCSGGGEEESSTT
T ss_pred             eeeccCCceEEEEecCCC-CHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCC---CEEcCCCCcccEEEecCC
Confidence            999999999999999965 898888432  22458999999999999999999994  5   899999999999995  4


Q ss_pred             CCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcc
Q 017503          185 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM  253 (370)
Q Consensus       185 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~  253 (370)
                      ++.+||+|||++......    .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       197 ~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          197 RSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             SCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            778999999999876432    23456899999999999999999999999999999999999998754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=320.59  Aligned_cols=268  Identities=22%  Similarity=0.332  Sum_probs=183.3

Q ss_pred             ccCCcc-cceeeecCCeEEEEEEEC---CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--CCeeE
Q 017503           45 TDDFHL-SNKIGRGGFGTVYKGTLT---NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRI  118 (370)
Q Consensus        45 ~~~y~~-~~~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~  118 (370)
                      .+.|++ .++||+|+||.||+|+++   ++..||+|++.....  ...+.+|+.+|++++||||+++++++..  ....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            455776 458999999999999975   578899999875532  2467789999999999999999999965  67889


Q ss_pred             EEEEecCCCCHHHHhcccc-----cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe----CCCCCeE
Q 017503          119 LVYEYVENNSLDRVLLGAT-----KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL----DQEFNPK  189 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill----~~~~~~k  189 (370)
                      +||||+.+ +|.+++....     .....+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999976 6766663221     1223589999999999999999999999   99999999999999    6778999


Q ss_pred             EeeecCccccCCCCc--ceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccc------hhh
Q 017503          190 IGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQM------NKF  260 (370)
Q Consensus       190 L~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~------~~~  260 (370)
                      |+|||++........  .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.......      ...
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999999987654321  223345789999999998874 58999999999999999999999986443211      001


Q ss_pred             HHHHHHHHHhcCCCc--cccc--------------CCCCCC---------ChHHHHHHHHHHHHchhhccCCCCCHHHHH
Q 017503          261 LLEWAWQLHQEEKPL--ELVD--------------PELGEY---------PPNEIIRYMKVAFFCTQAAASRRPQMNQVI  315 (370)
Q Consensus       261 ~~~~~~~~~~~~~~~--~~~~--------------~~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~evl  315 (370)
                      ....+..........  ..+.              ......         .......+.+|+.+||+.||.+|||+.|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            111111111100000  0000              000000         000123578899999999999999999998


Q ss_pred             HHH
Q 017503          316 KML  318 (370)
Q Consensus       316 ~~L  318 (370)
                      +.-
T Consensus       333 ~hp  335 (405)
T 3rgf_A          333 QDP  335 (405)
T ss_dssp             TSG
T ss_pred             cCh
Confidence            754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=309.87  Aligned_cols=256  Identities=21%  Similarity=0.332  Sum_probs=197.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe-----
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR-----  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----  116 (370)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||.+...  .......+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            578999999999999999999985 6889999988654  33445678899999999999999999999987654     


Q ss_pred             -eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          117 -RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       117 -~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                       .++||||+. ++|.+++.      ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence             499999997 47776651      2489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC--
Q 017503          196 AKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE--  272 (370)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  272 (370)
                      +......    .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.......   ............  
T Consensus       173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~  245 (353)
T 3coi_A          173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGT  245 (353)
T ss_dssp             TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCH
T ss_pred             ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCH
Confidence            9865432    233468999999998877 678999999999999999999999986543211   111111110000  


Q ss_pred             ----------------CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          273 ----------------KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       273 ----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                                      .........+....+.....+.+++.+||+.||.+|||+.++++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                            000000111222333445568899999999999999999999763

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=309.57  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=190.2

Q ss_pred             HHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChh------cHHHHHHHHHHHHhc----CCCCcceee
Q 017503           40 ELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQ------GVREFITEIMTLSNV----RHPNLVELI  108 (370)
Q Consensus        40 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~iv~~~  108 (370)
                      +.....++|++.+.||+|+||.||+|.+. +++.||+|++......      ....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            34455789999999999999999999974 6889999998755321      223355689999888    899999999


Q ss_pred             eEEEeCCeeEEEEEe-cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC-CCC
Q 017503          109 GCCVQGTRRILVYEY-VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEF  186 (370)
Q Consensus       109 ~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~-~~~  186 (370)
                      +++...+..++|||+ +.+++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||||+||+++ .++
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYIT----EKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence            999999999999999 78899999984    234689999999999999999999999   999999999999998 889


Q ss_pred             CeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcC-ccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHH
Q 017503          187 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA  265 (370)
Q Consensus       187 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~  265 (370)
                      .+||+|||++.......   .....++..|+|||++.+..+. .++||||||+++|+|++|+.||....           
T Consensus       178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------  243 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----------  243 (312)
T ss_dssp             EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred             eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------
Confidence            99999999998765432   2334689999999998776664 58999999999999999999986421           


Q ss_pred             HHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          266 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                       .......          ..+......+.+++.+||+.+|.+||++.++++.
T Consensus       244 -~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 -EILEAEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -HHHHTCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -HHhhhcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0111110          1122333458889999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.8e-40  Score=306.19  Aligned_cols=254  Identities=21%  Similarity=0.245  Sum_probs=173.1

Q ss_pred             ccCCcccc-eeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe----CCeeE
Q 017503           45 TDDFHLSN-KIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRRI  118 (370)
Q Consensus        45 ~~~y~~~~-~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~  118 (370)
                      .++|++.+ .||+|+||.||+|.++ +++.||+|++.....    ...+....++.+.||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            67899865 6999999999999986 689999999865421    11222334566799999999999876    45589


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC---CCCeEEeeecC
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGL  195 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kL~Dfg~  195 (370)
                      +||||+++++|.+++..  .....+++..++.++.|++.||.|||+.   +++||||||+||+++.   ++.+||+|||+
T Consensus       103 lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            99999999999999853  2234689999999999999999999999   9999999999999976   44599999999


Q ss_pred             ccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          196 AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      +.......   .....+|+.|+|||++.+..++.++||||||+++|+|++|..||...........   ....... ...
T Consensus       178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~-~~~  250 (336)
T 3fhr_A          178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRL-GQY  250 (336)
T ss_dssp             CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhc-ccc
Confidence            98654322   2334678999999999888999999999999999999999999865432211000   0000000 000


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHH
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML  318 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  318 (370)
                      ....+    ........+.+++.+||+.||.+|||+.++++.-
T Consensus       251 ~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          251 GFPNP----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             CCCTT----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             ccCch----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            00011    1122344588899999999999999999998843

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.4e-40  Score=317.33  Aligned_cols=253  Identities=23%  Similarity=0.287  Sum_probs=187.3

Q ss_pred             cCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEec
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      +.|.+.+.||+|+||+||.+...+|+.||||++..+.   ...+.+|+.+++++ +||||+++++++.+....++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            3445568899999999987766679999999886542   34567899999886 8999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCcc---CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC-------------CCe
Q 017503          125 ENNSLDRVLLGATKANIK---LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-------------FNP  188 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~---l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~-------------~~~  188 (370)
                      . |+|.+++.........   .++..++.++.||+.||.|||+.   +|+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 5999998543322211   13345678999999999999999   99999999999999654             479


Q ss_pred             EEeeecCccccCCCCcc---eeecccCCCCCCCcccccC-------CCcCccccchhhhHHHHHHHh-CCCCCCcccccc
Q 017503          189 KIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLG-------GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQM  257 (370)
Q Consensus       189 kL~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~  257 (370)
                      ||+|||++.........   ......||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999877543222   1233568999999999865       578999999999999999999 899986543321


Q ss_pred             hhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          258 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .        ..........   .............+.+++.+||+.||.+|||+.+|++
T Consensus       248 ~--------~i~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 S--------NIIRGIFSLD---EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H--------HHHHTCCCCC---CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H--------HHhcCCCCcc---cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1        1111111110   0011223456678999999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1e-41  Score=312.44  Aligned_cols=249  Identities=21%  Similarity=0.331  Sum_probs=198.1

Q ss_pred             CHHHHHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh------hcHHHHHHHHHHHHhcC--CCCccee
Q 017503           37 SYTELRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK------QGVREFITEIMTLSNVR--HPNLVEL  107 (370)
Q Consensus        37 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~iv~~  107 (370)
                      ...+.....++|++.+.||+|+||.||+|.+. +++.||+|.+.....      .....+.+|+.++++++  |+||+++
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            34455566789999999999999999999975 688899998865421      11234567999999996  5999999


Q ss_pred             eeEEEeCCeeEEEEEecCC-CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC-CC
Q 017503          108 IGCCVQGTRRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QE  185 (370)
Q Consensus       108 ~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~-~~  185 (370)
                      ++++...+..++|||++.+ ++|.+++.    ....+++..++.++.|++.||.|||+.   +++||||||+||+++ .+
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          114 LDWFERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR  186 (320)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred             EEEEecCCcEEEEEEcCCCCccHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence            9999999999999999986 89999984    345689999999999999999999999   999999999999998 78


Q ss_pred             CCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHH
Q 017503          186 FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW  264 (370)
Q Consensus       186 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~  264 (370)
                      +.+||+|||++.......   .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....         
T Consensus       187 ~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------  254 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------  254 (320)
T ss_dssp             TEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred             CCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------
Confidence            899999999998765432   233468999999999877665 6889999999999999999999864310         


Q ss_pred             HHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          265 AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         ......          ..+......+.+++.+||+.||.+|||+.+|++.
T Consensus       255 ---~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          255 ---IIRGQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ---HHHCCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---hhcccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               111110          0111223457889999999999999999999763

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.8e-40  Score=303.69  Aligned_cols=257  Identities=18%  Similarity=0.255  Sum_probs=197.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CC-CEEEEEECcCcChhcHHHHHHHHHHHHhcCCCC------cceeeeEEEeCCe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NG-RRIAVKPLSAESKQGVREFITEIMTLSNVRHPN------LVELIGCCVQGTR  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~  116 (370)
                      .++|++.+.||+|+||.||+|.+. ++ ..||+|++.... .....+.+|+.++++++|++      ++.+++++.....
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            589999999999999999999975 34 689999987543 33567788999999886655      8999999999999


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe--------------
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL--------------  182 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill--------------  182 (370)
                      .++||||+. ++|.+++..  .....+++..++.++.||+.||.|||+.   +|+||||||+|||+              
T Consensus        97 ~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           97 MCIAFELLG-KNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEECCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEEeccC-CChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence            999999995 556555532  2234689999999999999999999999   99999999999999              


Q ss_pred             -----CCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccc
Q 017503          183 -----DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM  257 (370)
Q Consensus       183 -----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~  257 (370)
                           +.++.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                 56788999999999865432    233568999999999999999999999999999999999999987543221


Q ss_pred             hhhHHHHHHHHHhcCCCccc---------c-c--------------------C--CCCCCChHHHHHHHHHHHHchhhcc
Q 017503          258 NKFLLEWAWQLHQEEKPLEL---------V-D--------------------P--ELGEYPPNEIIRYMKVAFFCTQAAA  305 (370)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~---------~-~--------------------~--~~~~~~~~~~~~l~~li~~cl~~~p  305 (370)
                      .   ......... ..+...         . .                    +  ............+.+++.+||+.||
T Consensus       247 ~---~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          247 H---LVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             H---HHHHHHHHC-CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             H---HHHHHHHcC-CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            1   111111110 000000         0 0                    0  0011223445678899999999999


Q ss_pred             CCCCCHHHHHH
Q 017503          306 SRRPQMNQVIK  316 (370)
Q Consensus       306 ~~RPt~~evl~  316 (370)
                      .+|||+.++++
T Consensus       323 ~~Rpt~~e~l~  333 (355)
T 2eu9_A          323 AQRITLAEALL  333 (355)
T ss_dssp             TTSCCHHHHTT
T ss_pred             hhCcCHHHHhc
Confidence            99999999975

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-40  Score=305.95  Aligned_cols=256  Identities=26%  Similarity=0.416  Sum_probs=178.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHH-HHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIM-TLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .++|++.+.||+|+||.||+|.++ +++.||+|++.... ......+..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            588999999999999999999985 68899999887652 333445555665 666789999999999999999999999


Q ss_pred             EecCCCCHHHHhccc-ccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          122 EYVENNSLDRVLLGA-TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       122 e~~~~~~L~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      ||+.+ +|.+++... ......+++..+..++.|++.||.|||+..  +++||||||+||+++.++.+||+|||++....
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            99986 777766321 123457899999999999999999999953  79999999999999999999999999998654


Q ss_pred             CCCcceeecccCCCCCCCcccc----cCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          201 DNITHITTRIAGTTGYLAPEYV----LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ....  .....|++.|+|||++    .+..++.++||||||+++|+|++|..||........         ...  ....
T Consensus       178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~~--~~~~  244 (327)
T 3aln_A          178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QLT--QVVK  244 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--CCCC
T ss_pred             cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HHH--HHhc
Confidence            3321  2233688999999998    456789999999999999999999999865321100         000  0000


Q ss_pred             cccCCC-CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          277 LVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       277 ~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...+.+ ..........+.+++.+||+.||.+||++.+|++
T Consensus       245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            001111 1111223445889999999999999999999976

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=314.99  Aligned_cols=249  Identities=22%  Similarity=0.289  Sum_probs=186.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ..+|.+.+.||+|+||+||.....+++.||||++......   .+.+|+.+|+++ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            4579999999999999976555567899999988654332   245699999999 899999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-----CCCeEEeeecCccc
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-----EFNPKIGDFGLAKL  198 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-----~~~~kL~Dfg~~~~  198 (370)
                      +.+ +|.+++..   ....+.+..++.++.||+.||.|||+.   +|+||||||+|||++.     ...+||+|||++..
T Consensus       100 ~~g-~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A          100 CAA-TLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CSE-EHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CCC-CHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            974 99998843   223455556788999999999999999   9999999999999953     23578999999987


Q ss_pred             cCCCCc--ceeecccCCCCCCCccccc---CCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          199 FPDNIT--HITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       199 ~~~~~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      ......  .......||+.|+|||++.   ...++.++|||||||++|+|++ |..||........        ......
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--------~~~~~~  244 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--------NILLGA  244 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--------HHHTTC
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--------HHHhcc
Confidence            654321  2233456999999999987   4567889999999999999999 8888854322111        111111


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ....     ...........+.+++.+||+.||.+|||+.+|++
T Consensus       245 ~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          245 CSLD-----CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCT-----TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCcc-----ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1111     11122344556789999999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.3e-40  Score=300.44  Aligned_cols=252  Identities=26%  Similarity=0.395  Sum_probs=180.4

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-h-hcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-K-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... . ...+.+.++..+++.++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3678999999999999999999986 68999999887553 2 2223344455567788999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      |||+ ++.+..+..   .....+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.+||+|||++...
T Consensus       103 ~e~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          103 MELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             ECCC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             Eecc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999 556665552   224568999999999999999999998 6   8999999999999999999999999999765


Q ss_pred             CCCCcceeecccCCCCCCCccccc-----CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      ....  ......+++.|+|||++.     ...++.++||||||+++|+|++|..||.......  ..   ..........
T Consensus       176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~---~~~~~~~~~~  248 (318)
T 2dyl_A          176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EV---LTKVLQEEPP  248 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HH---HHHHHHSCCC
T ss_pred             cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HH---HHHHhccCCC
Confidence            4332  123346899999999984     4568899999999999999999999987533211  11   1112221111


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .      +. ........+.+++.+||+.||.+||++.++++
T Consensus       249 ~------~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 L------LP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C------CC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C------CC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0      10 01112334888999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-39  Score=292.18  Aligned_cols=231  Identities=10%  Similarity=0.083  Sum_probs=184.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|+.++.+++||||+++++++.+.+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            478999999999999999999986 48899999997652   34457788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++++|.+++.    .+  ....++..++.|++.||.|||++   +|+||||||+|||++.++.+||++++      
T Consensus       110 ~e~~~g~~L~~~l~----~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVAD----TS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EECCCEEEHHHHHT----TC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEecCCCCHHHHHh----cC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence            99999999999983    22  35567889999999999999999   99999999999999999999998443      


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                                     |++       .++.++|||||||++|+|++|+.||..........            ........
T Consensus       175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~  220 (286)
T 3uqc_A          175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAG  220 (286)
T ss_dssp             ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTS
T ss_pred             ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhcc
Confidence                           333       36889999999999999999999987543211000            00000000


Q ss_pred             CC---CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          281 EL---GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       281 ~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      ..   ....+.....+.+++.+||+.||.+| |+.++++.|..+....
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            00   01112333458899999999999999 9999999999987644

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.1e-40  Score=326.24  Aligned_cols=270  Identities=25%  Similarity=0.348  Sum_probs=204.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe------CCe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ------GTR  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~  116 (370)
                      .++|++.+.||+|+||.||+|.+. ++..||||++... .......+.+|+.++++++||||+++++++..      ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            578999999999999999999975 6889999988764 44456678899999999999999999998755      667


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCC---eEEeee
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDF  193 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kL~Df  193 (370)
                      .++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            799999999999999985422 233589999999999999999999999   9999999999999987765   899999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH----HH
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ----LH  269 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~----~~  269 (370)
                      |++.......  ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.......     .+...    ..
T Consensus       169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~  241 (676)
T 3qa8_A          169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSN  241 (676)
T ss_dssp             CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC----
T ss_pred             cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccc
Confidence            9998765432  2234568999999999999999999999999999999999999986532110     00000    00


Q ss_pred             hcCCCccc------c---cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHH-----HHHHHHhhhccC
Q 017503          270 QEEKPLEL------V---DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQ-----VIKMLTKNIRLN  325 (370)
Q Consensus       270 ~~~~~~~~------~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e-----vl~~L~~~~~~~  325 (370)
                      ........      .   .+............+.+++.+||..||.+|||+.+     +.+.+..++...
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence            00000000      0   01112345567788999999999999999999987     456666665533

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-39  Score=324.74  Aligned_cols=240  Identities=24%  Similarity=0.334  Sum_probs=193.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC--CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe-----
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT--NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR-----  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----  116 (370)
                      .++|++.+.||+|+||.||+|.+.  +++.||||++... .......+.+|+.++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            489999999999999999999985  5889999988654 34445678899999999999999999999987655     


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .|+||||+++++|.+++.    .  .+++..++.++.||+.||.|||++   +|+||||||+|||++.+ .+||+|||++
T Consensus       159 ~~lv~E~~~g~~L~~~~~----~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG----Q--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEECCCCEECC--------C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eEEEEEeCCCCcHHHHHh----C--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence            699999999999988762    1  689999999999999999999999   99999999999999875 9999999999


Q ss_pred             cccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          197 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      ......     ....||+.|+|||++.+.. +.++|||||||++|+|++|.+|+........               .  
T Consensus       229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------~--  285 (681)
T 2pzi_A          229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------P--  285 (681)
T ss_dssp             EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------C--
T ss_pred             hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------------c--
Confidence            876543     3356899999999887654 8899999999999999999887653221100               0  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCC-HHHHHHHHHhhh
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-MNQVIKMLTKNI  322 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~L~~~~  322 (370)
                         .  ..........+.+++.+||+.||.+||+ ++++...|...+
T Consensus       286 ---~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 ---E--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ---T--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---c--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence               0  0001122356889999999999999995 666666666554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5e-38  Score=285.18  Aligned_cols=228  Identities=19%  Similarity=0.273  Sum_probs=178.5

Q ss_pred             ccCCccc-ceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHH-HhcCCCCcceeeeEEEe----CCee
Q 017503           45 TDDFHLS-NKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTL-SNVRHPNLVELIGCCVQ----GTRR  117 (370)
Q Consensus        45 ~~~y~~~-~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~  117 (370)
                      .++|.+. +.||+|+||.||++.+. +++.||+|++...     ..+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            5678887 78999999999999985 6889999998643     3556788888 55699999999999987    6778


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC---CCCeEEeeec
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFG  194 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kL~Dfg  194 (370)
                      ++||||+++++|.+++..  ..+..+++..++.++.|++.||.|||+.   +++||||||+||+++.   ++.+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            999999999999999853  2234689999999999999999999999   9999999999999998   7889999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      ++....                       +..++.++|||||||++|+|++|..||.......           ..... 
T Consensus       166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----------~~~~~-  210 (299)
T 3m2w_A          166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------ISPGM-  210 (299)
T ss_dssp             TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCS-
T ss_pred             cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-----------hhHHH-
Confidence            886432                       2456789999999999999999999986432210           00000 


Q ss_pred             cccccCCCCCCC----hHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          275 LELVDPELGEYP----PNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       275 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ...+.......+    ......+.+++.+||+.||.+|||+.++++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            011111111111    1234568899999999999999999999874

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2e-38  Score=300.48  Aligned_cols=243  Identities=14%  Similarity=0.112  Sum_probs=179.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCC-CCcc---------eeeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRH-PNLV---------ELIGC  110 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~iv---------~~~~~  110 (370)
                      ...|.+.+.||+|+||.||+|.+. +|+.||||++....   ....+.+.+|+.+++.+.| +|..         ...+.
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            455888899999999999999965 68999999887432   2335678899999999976 3211         11111


Q ss_pred             ------------EEe-----CCeeEEEEEecCCCCHHHHhccc---ccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 017503          111 ------------CVQ-----GTRRILVYEYVENNSLDRVLLGA---TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI  170 (370)
Q Consensus       111 ------------~~~-----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i  170 (370)
                                  +..     ....+++|+++ +++|.+++...   ...+..+++..++.++.|++.||.|||+.   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                        111     12346677765 56898887311   23355688999999999999999999999   99


Q ss_pred             EeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccc----------cCCCcCccccchhhhHHH
Q 017503          171 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV----------LGGQLTMKADVYSFGVLV  240 (370)
Q Consensus       171 iH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Di~slG~il  240 (370)
                      +||||||+|||++.++.+||+|||++......    .....| +.|+|||++          ....++.++|||||||++
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            99999999999999999999999998764432    334567 999999998          555688999999999999


Q ss_pred             HHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          241 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       241 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      |+|++|+.||.......               ....++. .....+    ..+.+++.+||+.||.+||++.++++
T Consensus       308 ~elltg~~Pf~~~~~~~---------------~~~~~~~-~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALG---------------GSEWIFR-SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHSSCCCCTTGGGS---------------CSGGGGS-SCCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHCCCCCCCcchhh---------------hHHHHHh-hcccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999986542211               1111111 111223    45888999999999999999777643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3e-38  Score=291.32  Aligned_cols=242  Identities=14%  Similarity=0.161  Sum_probs=183.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcC--------hhcHHHHHHHHHHHHhcC---------CCCccee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES--------KQGVREFITEIMTLSNVR---------HPNLVEL  107 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~iv~~  107 (370)
                      .++|++.+.||+|+||.||+|++ +++.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            57899999999999999999998 57999999887542        233477888999998885         7777777


Q ss_pred             eeEEE------------------------------eCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHH
Q 017503          108 IGCCV------------------------------QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK  157 (370)
Q Consensus       108 ~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~  157 (370)
                      .+++.                              +....++||||+++|++.+.+.     ...+++..+..++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence            77643                              2678999999999996555542     245899999999999999


Q ss_pred             HHHHHh-hcCCCCeEeecCCCCceEeCCCC--------------------CeEEeeecCccccCCCCcceeecccCCCCC
Q 017503          158 GLAFLH-EELVPHIVHRDIKASNILLDQEF--------------------NPKIGDFGLAKLFPDNITHITTRIAGTTGY  216 (370)
Q Consensus       158 al~~LH-~~~~~~iiH~dlkp~Nill~~~~--------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y  216 (370)
                      ||.||| +.   +|+||||||+|||++.++                    .+||+|||+++.....      ...||+.|
T Consensus       173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y  243 (336)
T 2vuw_A          173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred             HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence            999999 89   999999999999999887                    8999999999866432      23689999


Q ss_pred             CCcccccCCCcCccccchhhhHH-HHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHH
Q 017503          217 LAPEYVLGGQLTMKADVYSFGVL-VLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK  295 (370)
Q Consensus       217 ~aPE~~~~~~~~~~~Di~slG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  295 (370)
                      +|||++.+.. +.++||||+|++ .+++++|..||....      ................  ........+.....+.+
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQMTFK--TKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTCCCS--SCCCSHHHHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhhccC--cccchhhhhhcCHHHHH
Confidence            9999998766 899999998777 777888988863210      0011111111111100  01111223466778999


Q ss_pred             HHHHchhhccCCCCCHHHHH
Q 017503          296 VAFFCTQAAASRRPQMNQVI  315 (370)
Q Consensus       296 li~~cl~~~p~~RPt~~evl  315 (370)
                      ++.+||+.|     |+.+++
T Consensus       315 li~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHGGGSS-----SHHHHH
T ss_pred             HHHHHhccC-----CHHHHH
Confidence            999999865     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=8.1e-32  Score=264.07  Aligned_cols=167  Identities=17%  Similarity=0.168  Sum_probs=124.8

Q ss_pred             CCCEEEEEECcCcC----------hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccc
Q 017503           69 NGRRIAVKPLSAES----------KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT  137 (370)
Q Consensus        69 ~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  137 (370)
                      .|+.|++|++....          ....+++.+|+++|+++ +|+||+++++++++....||||||++|++|.+++.   
T Consensus       258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~---  334 (569)
T 4azs_A          258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA---  334 (569)
T ss_dssp             ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH---
T ss_pred             ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH---
Confidence            47789999886431          23345689999999999 79999999999999999999999999999999993   


Q ss_pred             cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCC
Q 017503          138 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL  217 (370)
Q Consensus       138 ~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~  217 (370)
                       .+..++..   +|+.||+.||+|+|++   ||+||||||+||||+.+|.+||+|||+++....... ......||+.|+
T Consensus       335 -~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~Ym  406 (569)
T 4azs_A          335 -AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFVF  406 (569)
T ss_dssp             -TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHHH
T ss_pred             -hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhhc
Confidence             44456654   4889999999999999   999999999999999999999999999987654332 234467999999


Q ss_pred             CcccccCCCcCccccchhhhHHHHHHHhCC
Q 017503          218 APEYVLGGQLTMKADVYSFGVLVLEIISGR  247 (370)
Q Consensus       218 aPE~~~~~~~~~~~Di~slG~il~elltg~  247 (370)
                      |||++.+ .+..++|+|++|+++++|.++.
T Consensus       407 APE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          407 VNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHHHC------------------CCCCTTH
T ss_pred             cHHHhCC-CCCCcccccccccchhhhcccc
Confidence            9998865 4677899999999988776654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.5e-27  Score=232.54  Aligned_cols=184  Identities=16%  Similarity=0.161  Sum_probs=143.7

Q ss_pred             cccceeeecCCeEEEEEEECCCCEEEEEECcCcC--------hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           49 HLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES--------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        49 ~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ...+.||+|+||.||++.. .+..+++|......        ....+.+.+|++++++++||||+++..++......++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467999999999999955 47788888754321        11234578999999999999999777777788888999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++++|.+++..            +..++.|++.||.|||++   +|+||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999832            567999999999999999   9999999999999998  99999999999775


Q ss_pred             CCCcce------eecccCCCCCCCcccccC--CCcCccccchhhhHHHHHHHhCCCCC
Q 017503          201 DNITHI------TTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSG  250 (370)
Q Consensus       201 ~~~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~elltg~~p~  250 (370)
                      ......      .....||+.|+|||++..  ..|+...|+|+..+-..+-+.++.++
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            532211      234678999999999977  56888899999998888877766554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=6.9e-25  Score=196.62  Aligned_cols=155  Identities=17%  Similarity=0.146  Sum_probs=122.8

Q ss_pred             cCHHHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcCh------------------hcHHHHHHHHHHHH
Q 017503           36 FSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESK------------------QGVREFITEIMTLS   97 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~   97 (370)
                      +....+......|.+.+.||+|+||.||+|.+.+|+.||+|.+.....                  .....+.+|+.+++
T Consensus        80 ~~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~  159 (282)
T 1zar_A           80 YSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ  159 (282)
T ss_dssp             HHHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHH
Confidence            334455555667778899999999999999997789999998864321                  12456889999999


Q ss_pred             hcCCCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCC
Q 017503           98 NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA  177 (370)
Q Consensus        98 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp  177 (370)
                      +++  | +++.+++.. +..++||||+++++|.+ +.        .  .....++.|++.||.|||+.   +++||||||
T Consensus       160 ~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~--~~~~~i~~qi~~~l~~lH~~---giiHrDlkp  221 (282)
T 1zar_A          160 KLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------V--ENPDEVLDMILEEVAKFYHR---GIVHGDLSQ  221 (282)
T ss_dssp             HTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred             hcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc--------h--hhHHHHHHHHHHHHHHHHHC---CCEeCCCCH
Confidence            998  4 666665543 55699999999999987 41        1  22446999999999999999   999999999


Q ss_pred             CceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCccccc
Q 017503          178 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL  223 (370)
Q Consensus       178 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  223 (370)
                      +|||++ ++.+||+|||++..              +..+.|||.+.
T Consensus       222 ~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          222 YNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             TSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             HHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            999999 99999999999873              34568888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=1.4e-20  Score=166.46  Aligned_cols=137  Identities=18%  Similarity=0.198  Sum_probs=107.0

Q ss_pred             CCcccceeeecCCeEEEEEEE-CCCCE--EEEEECcCcChh------------------------cHHHHHHHHHHHHhc
Q 017503           47 DFHLSNKIGRGGFGTVYKGTL-TNGRR--IAVKPLSAESKQ------------------------GVREFITEIMTLSNV   99 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~-~~~~~--vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l   99 (370)
                      -|++.+.||+|+||.||+|.+ .+|+.  ||||++......                        ....+.+|+..|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            467889999999999999998 67888  999986433110                        113577899999999


Q ss_pred             CCCCc--ceeeeEEEeCCeeEEEEEecCC-C----CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHh-hcCCCCeE
Q 017503          100 RHPNL--VELIGCCVQGTRRILVYEYVEN-N----SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH-EELVPHIV  171 (370)
Q Consensus       100 ~h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~ii  171 (370)
                      .|+++  ..+++.    ...++||||+.+ |    +|.++...       .++..+..++.|++.||.||| +.   +++
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv  193 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV  193 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence            87754  334432    356899999942 3    77776521       235567889999999999999 88   999


Q ss_pred             eecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          172 HRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       172 H~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||||.|||++.  .++|+|||++...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=1.2e-18  Score=160.45  Aligned_cols=145  Identities=15%  Similarity=0.193  Sum_probs=103.0

Q ss_pred             HHHHhcc---CCcccceeeecCCeEEEEEEECCCCEEEEEECcCcC--------------hhcHH--------HHHHHHH
Q 017503           40 ELRSATD---DFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES--------------KQGVR--------EFITEIM   94 (370)
Q Consensus        40 ~~~~~~~---~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~--------------~~~~~--------~~~~e~~   94 (370)
                      .+.+..+   -|.+...||.|++|.||+|...+|+.||||+++...              .....        ...+|..
T Consensus        86 AL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~  165 (397)
T 4gyi_A           86 ALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA  165 (397)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence            4444444   499999999999999999999999999999864320              00001        1234667


Q ss_pred             HHHhcCCCCcceeeeEEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeec
Q 017503           95 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD  174 (370)
Q Consensus        95 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~d  174 (370)
                      .|.++.+.++.-..-+...  ..++||||++|++|..+.          .......++.|++.+|.+||+.   |+||||
T Consensus       166 nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~----------~~~~~~~l~~qll~~l~~lH~~---gIVHrD  230 (397)
T 4gyi_A          166 FMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVS----------SVPDPASLYADLIALILRLAKH---GLIHGD  230 (397)
T ss_dssp             HHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCC----------CCSCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhc----------ccHHHHHHHHHHHHHHHHHHHC---CCcCCC
Confidence            7777754443221111112  237999999998876543          1123456889999999999999   999999


Q ss_pred             CCCCceEeCCCCC----------eEEeeecCcccc
Q 017503          175 IKASNILLDQEFN----------PKIGDFGLAKLF  199 (370)
Q Consensus       175 lkp~Nill~~~~~----------~kL~Dfg~~~~~  199 (370)
                      |||.|||+++++.          +.|+||+-+...
T Consensus       231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            9999999987763          899999977643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.48  E-value=1.8e-13  Score=120.95  Aligned_cols=147  Identities=12%  Similarity=0.049  Sum_probs=114.3

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEE
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l  119 (370)
                      +....+.|++...++.|+.+.||++... ++.+++|............+.+|+++++.+. +..+.++++++...+..|+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            4455678999999998999999999865 6889999876532122235778999999884 6778889999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL---------------------------------  166 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------  166 (370)
                      |||+++|.+|.+.+.         +......++.+++.+|..||+..                                 
T Consensus        88 v~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            999999999987631         11223467889999999999810                                 


Q ss_pred             -----------------------CCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          167 -----------------------VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       167 -----------------------~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                                             .+.++|+|++|.||+++++..+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   1268999999999999876556799999765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.32  E-value=2.1e-12  Score=113.69  Aligned_cols=139  Identities=15%  Similarity=0.092  Sum_probs=100.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCC--cceeeeEEEeCCeeEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN--LVELIGCCVQGTRRILVY  121 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~  121 (370)
                      ....|.+....+.|..+.||++...+|..+++|+.....   ...+..|+.+++.+.+.+  +.+++++....+..++||
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            344566544444566689999987777889999865442   234667999998885434  556888888777889999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-----------------------------------  166 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----------------------------------  166 (370)
                      ||++|.+|.  ..   .    ..   ...++.+++.+|..||+..                                   
T Consensus        95 e~i~G~~l~--~~---~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           95 GEVPGQDLL--SS---H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             ECCSSEETT--TS---C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EecCCcccC--cC---c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            999998774  21   0    11   1256777888888888752                                   


Q ss_pred             --------------------CCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          167 --------------------VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       167 --------------------~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                                          +..++|+|++|.||+++.++.+.|+||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                1139999999999999876666799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.13  E-value=1.8e-10  Score=106.37  Aligned_cols=143  Identities=15%  Similarity=0.202  Sum_probs=105.6

Q ss_pred             cccceeeecCCeEEEEEEECCCCEEEEEECc--CcC-hhcHHHHHHHHHHHHhcC--CCCcceeeeEEEeC---CeeEEE
Q 017503           49 HLSNKIGRGGFGTVYKGTLTNGRRIAVKPLS--AES-KQGVREFITEIMTLSNVR--HPNLVELIGCCVQG---TRRILV  120 (370)
Q Consensus        49 ~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv  120 (370)
                      ...+.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+.   +..|+|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            34678899999999998876 4678888765  321 122346778999999986  45578888888766   347899


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL----------------------------------  166 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----------------------------------  166 (370)
                      |||++|..+.+..      -..++......++.+++.+|..||...                                  
T Consensus       120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            9999997764311      124678888899999999999999731                                  


Q ss_pred             ---------------------CCCeEeecCCCCceEeCCCCC--eEEeeecCccc
Q 017503          167 ---------------------VPHIVHRDIKASNILLDQEFN--PKIGDFGLAKL  198 (370)
Q Consensus       167 ---------------------~~~iiH~dlkp~Nill~~~~~--~kL~Dfg~~~~  198 (370)
                                           .+.++|||+++.||+++.++.  +.|+||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 247999999999999987653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=1.5e-10  Score=104.38  Aligned_cols=182  Identities=19%  Similarity=0.224  Sum_probs=118.8

Q ss_pred             cceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCC--cceeeeEEEeCC---eeEEEEEec
Q 017503           51 SNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPN--LVELIGCCVQGT---RRILVYEYV  124 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e~~  124 (370)
                      .+.++.|..+.||++.    ..+++|+....  .....+.+|+++|+.+ .+..  +.+++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    56888875432  3346788899999887 3332  334444433332   358899999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL--------------------------------------  166 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------------------------------------  166 (370)
                      +|.+|.....      ..++..++..++.+++..+..||+..                                      
T Consensus        99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            9988765331      24667777888888888888888611                                      


Q ss_pred             -----------------CCCeEeecCCCCceEeCC--CCCeEEeeecCccccCCCCcceeecccCCCCC---CCcccccC
Q 017503          167 -----------------VPHIVHRDIKASNILLDQ--EFNPKIGDFGLAKLFPDNITHITTRIAGTTGY---LAPEYVLG  224 (370)
Q Consensus       167 -----------------~~~iiH~dlkp~Nill~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y---~aPE~~~~  224 (370)
                                       .+.++|+|++|.||+++.  +..+.|+||+.+........-     .....+   ..|+....
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-----~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-----ISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-----HTTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-----HHHHhhccccCHHHHHH
Confidence                             135899999999999987  456789999988754321000     000111   22222110


Q ss_pred             -----CC---------cCccccchhhhHHHHHHHhCCCC
Q 017503          225 -----GQ---------LTMKADVYSFGVLVLEIISGRNS  249 (370)
Q Consensus       225 -----~~---------~~~~~Di~slG~il~elltg~~p  249 (370)
                           +.         .....+.|+++.++|.+.+|..+
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence                 00         11225789999999999999754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.66  E-value=2.7e-07  Score=81.30  Aligned_cols=140  Identities=16%  Similarity=0.112  Sum_probs=99.0

Q ss_pred             cCCcccceeeecCCe-EEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFG-TVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g-~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ..|+. ..+..|..+ .||+.... ++..+++|+-...   ....+..|...|+.+. +--+.+++.++.+.+..++|||
T Consensus        25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme  100 (272)
T 4gkh_A           25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT  100 (272)
T ss_dssp             TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence            33443 344556555 68988765 4667899975433   3456778999998884 3346788899999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE-------------------------------------  165 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-------------------------------------  165 (370)
                      +++|.++.+....        .......++.+++..|..||..                                     
T Consensus       101 ~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A          101 AIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             CCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             eeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            9999888776521        1223345666777777777753                                     


Q ss_pred             ------------------CCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          166 ------------------LVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       166 ------------------~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                                        ..+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                              01137999999999999887767799999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=3.9e-07  Score=81.98  Aligned_cols=136  Identities=18%  Similarity=0.187  Sum_probs=92.9

Q ss_pred             cceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCC---CcceeeeEEE-eCCeeEEEEEecCC
Q 017503           51 SNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHP---NLVELIGCCV-QGTRRILVYEYVEN  126 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~  126 (370)
                      .+.++.|....||+.    +..+++|+..  .......+..|+++|+.+.+.   .+.+++.++. ..+..++||++++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356888888899988    5678888742  233456788999999998642   3556666664 34557899999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhc-----------------------------------------
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE-----------------------------------------  165 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-----------------------------------------  165 (370)
                      .++.....      ..++......++.++...|..||+.                                         
T Consensus        98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            88865321      0234444455555555555555542                                         


Q ss_pred             ----------------CCCCeEeecCCCCceEeCC---CCC-eEEeeecCccc
Q 017503          166 ----------------LVPHIVHRDIKASNILLDQ---EFN-PKIGDFGLAKL  198 (370)
Q Consensus       166 ----------------~~~~iiH~dlkp~Nill~~---~~~-~kL~Dfg~~~~  198 (370)
                                      ..+.++|+|+.|.||+++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            1225799999999999987   455 48999998763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.38  E-value=5.4e-07  Score=82.79  Aligned_cols=80  Identities=10%  Similarity=0.023  Sum_probs=53.5

Q ss_pred             ccee-eecCCeEEEEEEEC-------CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcC-C--CCcceeeeEEEeC--
Q 017503           51 SNKI-GRGGFGTVYKGTLT-------NGRRIAVKPLSAES---KQGVREFITEIMTLSNVR-H--PNLVELIGCCVQG--  114 (370)
Q Consensus        51 ~~~l-g~G~~g~v~~~~~~-------~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~--  114 (370)
                      .+.| +.|..+.+|+....       ++..+++|+.....   ......+..|+.+++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 77888899988754       26678999765432   001134567888888773 2  3466777776554  


Q ss_pred             -CeeEEEEEecCCCCHH
Q 017503          115 -TRRILVYEYVENNSLD  130 (370)
Q Consensus       115 -~~~~lv~e~~~~~~L~  130 (370)
                       ...++|||+++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3468999999886653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.23  E-value=6.9e-06  Score=76.57  Aligned_cols=75  Identities=17%  Similarity=0.189  Sum_probs=48.4

Q ss_pred             cceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh-------hcHHHHHHHHHHHHhcCC--CCc-ceeeeEEEeCCeeEE
Q 017503           51 SNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK-------QGVREFITEIMTLSNVRH--PNL-VELIGCCVQGTRRIL  119 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~i-v~~~~~~~~~~~~~l  119 (370)
                      .+.||.|..+.||++... +++.+++|.......       .....+..|.++++.+..  +.. .+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            567899999999999754 467899997542211       123345678888887732  333 345433  4556789


Q ss_pred             EEEecCCC
Q 017503          120 VYEYVENN  127 (370)
Q Consensus       120 v~e~~~~~  127 (370)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.22  E-value=9.4e-06  Score=72.13  Aligned_cols=79  Identities=19%  Similarity=0.276  Sum_probs=57.4

Q ss_pred             cCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCC---CCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH---PNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .+..-...+|.|..+.||+....+|+.|++|+...........+..|++.|+.|..   -.+.+++++  +  ..++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEE
Confidence            45666788999999999999999999999998765544333457789999988842   224444443  2  3478999


Q ss_pred             ecCCCC
Q 017503          123 YVENNS  128 (370)
Q Consensus       123 ~~~~~~  128 (370)
                      +++++.
T Consensus        91 ~l~~~~   96 (288)
T 3f7w_A           91 WVDERP   96 (288)
T ss_dssp             CCCCCC
T ss_pred             eecccC
Confidence            998764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.16  E-value=1.7e-05  Score=72.03  Aligned_cols=141  Identities=16%  Similarity=0.249  Sum_probs=77.9

Q ss_pred             ceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-----CCCcceee-e--EEEeCCeeEEEEEe
Q 017503           52 NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-----HPNLVELI-G--CCVQGTRRILVYEY  123 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~-~--~~~~~~~~~lv~e~  123 (370)
                      +.|+.|..+.||+....++ .+++|+.... .   ..+..|+.+++.|.     .|.++... +  +....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4565567889999987654 5889987653 1   23334555555442     23333311 1  12346678999999


Q ss_pred             cCCCCHH-----H---------Hhccccc----C-C-----ccCCHHHH-------------------------------
Q 017503          124 VENNSLD-----R---------VLLGATK----A-N-----IKLNWEKR-------------------------------  148 (370)
Q Consensus       124 ~~~~~L~-----~---------~~~~~~~----~-~-----~~l~~~~~-------------------------------  148 (370)
                      ++|..+.     .         .++....    . .     ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986432     0         0111000    0 0     00122211                               


Q ss_pred             HHHHHHHHHHHHHHhh----------cCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          149 SDICVGIAKGLAFLHE----------ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       149 ~~i~~qi~~al~~LH~----------~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ..+...+..++.+|+.          ..+..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223445666653          123489999999999999888899999999775

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.95  E-value=7.9e-05  Score=66.85  Aligned_cols=76  Identities=14%  Similarity=0.069  Sum_probs=59.2

Q ss_pred             ccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcC---CCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           50 LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR---HPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        50 ~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      -.+.|+.|....+|+... ++..+++|+....   ....+..|++.|+.|.   ...+.+++.++...+..++|||++++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346789999999999886 4678889976533   2456778998888873   35678888888888889999999998


Q ss_pred             CCH
Q 017503          127 NSL  129 (370)
Q Consensus       127 ~~L  129 (370)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.85  E-value=0.00011  Score=68.96  Aligned_cols=78  Identities=9%  Similarity=0.030  Sum_probs=44.8

Q ss_pred             CCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCC---CcCccccchhhhHHHHHHH
Q 017503          168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG---QLTMKADVYSFGVLVLEII  244 (370)
Q Consensus       168 ~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~ell  244 (370)
                      +.++|||+.|.|||++.++ +.|+||+.+..-+....-......-...|++|+.....   .-....++......+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            3899999999999998776 99999998875321100000000001234555544211   1112234557777777776


Q ss_pred             hC
Q 017503          245 SG  246 (370)
Q Consensus       245 tg  246 (370)
                      ++
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            65

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.76  E-value=0.00036  Score=62.73  Aligned_cols=162  Identities=13%  Similarity=0.120  Sum_probs=88.5

Q ss_pred             ccccCHHHHHHhccCCccc-----ceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCC--cc
Q 017503           33 VNHFSYTELRSATDDFHLS-----NKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN--LV  105 (370)
Q Consensus        33 ~~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv  105 (370)
                      +..++.+++.....+|.+.     +.|+.|....+|+....++ .+++|+......  ...+..|+.+++.+...+  +.
T Consensus         4 ~~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            4 YTDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             -CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             cccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCC
Confidence            4457777888887777652     3456677789999987655 688898765211  123445777776653111  23


Q ss_pred             eeeeE------EEeCCeeEEEEEecCCCCHH-----HH---------hccc----ccCC-c--c-CCHHHHHH-------
Q 017503          106 ELIGC------CVQGTRRILVYEYVENNSLD-----RV---------LLGA----TKAN-I--K-LNWEKRSD-------  150 (370)
Q Consensus       106 ~~~~~------~~~~~~~~lv~e~~~~~~L~-----~~---------~~~~----~~~~-~--~-l~~~~~~~-------  150 (370)
                      +++..      ....+..++++++++|..+.     .+         ++..    .... .  . ..|...+.       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            33311      22345678999999875431     00         1100    0000 0  0 01221110       


Q ss_pred             -----HHHHHHHHHHHHhhc----CCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          151 -----ICVGIAKGLAFLHEE----LVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       151 -----i~~qi~~al~~LH~~----~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                           +...+...+..++..    .+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                 001133445555432    13379999999999999877556899999775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.69  E-value=0.00017  Score=64.32  Aligned_cols=74  Identities=8%  Similarity=0.144  Sum_probs=45.2

Q ss_pred             CcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCeeEEEEEec-C
Q 017503           48 FHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYV-E  125 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~  125 (370)
                      +.-.+.|+.|....+|+.     ..+++|+........ .....|+..++.+...++ .++++.  +.+..++++||+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence            333788998999999998     568888776432211 122457777777643223 344443  344457899999 6


Q ss_pred             CCCH
Q 017503          126 NNSL  129 (370)
Q Consensus       126 ~~~L  129 (370)
                      +.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            5444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.67  E-value=0.00087  Score=60.34  Aligned_cols=162  Identities=12%  Similarity=0.081  Sum_probs=90.5

Q ss_pred             ccccCHHHHHHhccCCcc-----cceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCC--Ccc
Q 017503           33 VNHFSYTELRSATDDFHL-----SNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHP--NLV  105 (370)
Q Consensus        33 ~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv  105 (370)
                      +..++.+.+....+.|-+     ...++ |....||+....+|..+++|...... .....+..|..+++.+...  .++
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence            555667777766665543     23566 77889999887677789999876321 1234556677777776321  233


Q ss_pred             eeeeE-----EEeCCeeEEEEEecCCCCHH-----HH-------------hccccc-CCccCCHHHH-------------
Q 017503          106 ELIGC-----CVQGTRRILVYEYVENNSLD-----RV-------------LLGATK-ANIKLNWEKR-------------  148 (370)
Q Consensus       106 ~~~~~-----~~~~~~~~lv~e~~~~~~L~-----~~-------------~~~~~~-~~~~l~~~~~-------------  148 (370)
                      +++..     ....+..+++|++++|..+.     .+             ...... .....++...             
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  165 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL  165 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence            34332     22345668899999875321     11             110000 0011121110             


Q ss_pred             ---------HHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          149 ---------SDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       149 ---------~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                               ...+..++..+..+-. ..+..++|+|+++.||+++ + .+.|+||+.+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                     1111222222222211 1233689999999999998 4 899999987753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.54  E-value=0.00058  Score=61.71  Aligned_cols=143  Identities=19%  Similarity=0.114  Sum_probs=72.0

Q ss_pred             ceeeecCCeE-EEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCC--CCcceeeeEEEeCCeeEEEEEecCCCC
Q 017503           52 NKIGRGGFGT-VYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH--PNLVELIGCCVQGTRRILVYEYVENNS  128 (370)
Q Consensus        52 ~~lg~G~~g~-v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~  128 (370)
                      +.|+.|.... +|+....++..+++|.......   ..+..|+.+++.+..  -.+.+++.+.  ....+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEE--HARGLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTTEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeec--CCCCEEEEeeCCCcc
Confidence            4566665554 6677654467788886543321   123346666666532  2345566553  223378999998766


Q ss_pred             HHHHhccccc---------------------C-CccCCHHHHH-------HH-------------HHHHHHHHHHHhh--
Q 017503          129 LDRVLLGATK---------------------A-NIKLNWEKRS-------DI-------------CVGIAKGLAFLHE--  164 (370)
Q Consensus       129 L~~~~~~~~~---------------------~-~~~l~~~~~~-------~i-------------~~qi~~al~~LH~--  164 (370)
                      +.+++.....                     . ...+......       .+             ...+...+..+..  
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            6544321100                     0 0011111000       00             0011122222211  


Q ss_pred             -cCCCCeEeecCCCCceEeCCC----CCeEEeeecCcccc
Q 017503          165 -ELVPHIVHRDIKASNILLDQE----FNPKIGDFGLAKLF  199 (370)
Q Consensus       165 -~~~~~iiH~dlkp~Nill~~~----~~~kL~Dfg~~~~~  199 (370)
                       ..++.++|||+.+.||+++.+    +.+.|+||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence             123379999999999999874    67899999988753

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.50  E-value=0.00025  Score=59.26  Aligned_cols=102  Identities=18%  Similarity=0.146  Sum_probs=66.8

Q ss_pred             CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCccee
Q 017503          128 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT  207 (370)
Q Consensus       128 ~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  207 (370)
                      +|.+.+.   ..+.+++++++|.++.|.+.+|..+-...  .-..+=+.|..|++..+|+|-+.+ ..+.          
T Consensus        34 SL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           34 SLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             cHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence            7888883   46678999999999999999998873211  112334567999999999987764 1110          


Q ss_pred             ecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCC
Q 017503          208 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS  249 (370)
Q Consensus       208 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p  249 (370)
                         .....+.+||... ...+.+.-|||||++||.-+-...|
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence               1123567888652 3446788899999999999875544

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.44  E-value=0.00046  Score=64.86  Aligned_cols=72  Identities=13%  Similarity=0.193  Sum_probs=47.5

Q ss_pred             cceeeecCCeEEEEEEECC--------CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCeeEEEE
Q 017503           51 SNKIGRGGFGTVYKGTLTN--------GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVY  121 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~  121 (370)
                      .+.|+.|....+|++...+        +..+++|+.....  ....+..|+.+++.+...++ .++++.+.  +  .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            4567778889999998653        5789999874421  11345578888888743333 55665443  2  3899


Q ss_pred             EecCCCC
Q 017503          122 EYVENNS  128 (370)
Q Consensus       122 e~~~~~~  128 (370)
                      ||++|.+
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9998643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.38  E-value=0.0007  Score=62.36  Aligned_cols=142  Identities=18%  Similarity=0.190  Sum_probs=81.1

Q ss_pred             cceeeecCCeEEEEEEEC--------CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCeeEEEE
Q 017503           51 SNKIGRGGFGTVYKGTLT--------NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      .+.|..|-...+|+....        ++..|++|+.... ........+|.++++.+. +.-..++++.+.  +  .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEE
Confidence            356766888889998864        2478999986432 223455668999998874 222355555543  2  2899


Q ss_pred             EecCCCCHHHH-----------------hcccc-cCCccC--CHHHHHHHHHHHHH-------------------HHHHH
Q 017503          122 EYVENNSLDRV-----------------LLGAT-KANIKL--NWEKRSDICVGIAK-------------------GLAFL  162 (370)
Q Consensus       122 e~~~~~~L~~~-----------------~~~~~-~~~~~l--~~~~~~~i~~qi~~-------------------al~~L  162 (370)
                      ||++|.+|..-                 ++... ..+...  -+.++.+++.++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99987654210                 01110 011112  23455555544322                   12222


Q ss_pred             h----hc-CCCCeEeecCCCCceEeCCC----CCeEEeeecCcc
Q 017503          163 H----EE-LVPHIVHRDIKASNILLDQE----FNPKIGDFGLAK  197 (370)
Q Consensus       163 H----~~-~~~~iiH~dlkp~Nill~~~----~~~kL~Dfg~~~  197 (370)
                      .    .. .+..++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2    21 12368999999999999876    689999999876

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.34  E-value=0.0012  Score=62.46  Aligned_cols=74  Identities=9%  Similarity=0.008  Sum_probs=46.5

Q ss_pred             cceeeecCCeEEEEEEECC-CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCeeEEEEEecCCCC
Q 017503           51 SNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYVENNS  128 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~  128 (370)
                      .+.|+.|....+|++...+ +..+++|+........ -....|+.+++.|...++ .++++.+  .+  .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence            3567778888999998764 4788999765432211 112468888988865444 4566655  22  35999998744


Q ss_pred             H
Q 017503          129 L  129 (370)
Q Consensus       129 L  129 (370)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.27  E-value=0.00051  Score=63.13  Aligned_cols=73  Identities=11%  Similarity=0.118  Sum_probs=43.6

Q ss_pred             cceeeecCCeEEEEEEECC---------CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCC-cceeeeEEEeCCeeEEE
Q 017503           51 SNKIGRGGFGTVYKGTLTN---------GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN-LVELIGCCVQGTRRILV  120 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv  120 (370)
                      ...++.|....+|+....+         +..+++|+........ .....|..+++.+...+ ..++++..  .  .++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            4567778888999998754         2688999876542221 12356788887774333 34555443  2  3689


Q ss_pred             EEecCCCC
Q 017503          121 YEYVENNS  128 (370)
Q Consensus       121 ~e~~~~~~  128 (370)
                      |+|++|.+
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.08  E-value=0.002  Score=58.50  Aligned_cols=31  Identities=32%  Similarity=0.356  Sum_probs=27.4

Q ss_pred             CCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          168 PHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       168 ~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3799999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.19  E-value=0.012  Score=55.00  Aligned_cols=74  Identities=14%  Similarity=0.152  Sum_probs=47.1

Q ss_pred             cceeeecCCeEEEEEEECC--------CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCC-cceeeeEEEeCCeeEEEE
Q 017503           51 SNKIGRGGFGTVYKGTLTN--------GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN-LVELIGCCVQGTRRILVY  121 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~  121 (370)
                      .+.+..|-...+|+....+        +..|++++....... .-...+|.++++.+...+ ..++++.+  .  .++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            3566667788999998753        578999986543322 122346888888774222 34555432  2  37899


Q ss_pred             EecCCCCH
Q 017503          122 EYVENNSL  129 (370)
Q Consensus       122 e~~~~~~L  129 (370)
                      +|++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.62  E-value=0.035  Score=51.38  Aligned_cols=30  Identities=27%  Similarity=0.389  Sum_probs=25.1

Q ss_pred             CeEeecCCCCceEe------CCCCCeEEeeecCccc
Q 017503          169 HIVHRDIKASNILL------DQEFNPKIGDFGLAKL  198 (370)
Q Consensus       169 ~iiH~dlkp~Nill------~~~~~~kL~Dfg~~~~  198 (370)
                      .++|+|+.+.||++      +++..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4566799999998863

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=93.89  E-value=0.23  Score=41.50  Aligned_cols=114  Identities=11%  Similarity=0.116  Sum_probs=78.9

Q ss_pred             CCCCcceeeeEEEeCCeeEEEEEecCCC-CHHHHhcccccCCccCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEeecCCC
Q 017503          100 RHPNLVELIGCCVQGTRRILVYEYVENN-SLDRVLLGATKANIKLNWEKRSDICVGIAKGLA-FLHEELVPHIVHRDIKA  177 (370)
Q Consensus       100 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~~~~~iiH~dlkp  177 (370)
                      .||++  -...-.+.+...+.++.-+++ ++..+-        .++...+++++.+|+.... +++..     +|--|.|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P  112 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCP  112 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeC
Confidence            68888  334446677777777765343 444332        5788999999999999888 66665     7888999


Q ss_pred             CceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCC
Q 017503          178 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK  251 (370)
Q Consensus       178 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~  251 (370)
                      +|++++.++.+++.-.|+-..+                  +|..     .+...=+-++=+++..++.++..|.
T Consensus       113 ~NL~f~~~~~p~i~hRGi~~~l------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          113 ENLMFNRALEPFFLHVGVKESL------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GGEEECTTCCEEESCCEETTTB------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             ceEEEeCCCcEEEEEcCCcccC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999999987764322                  2221     1111123367788888888876654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.62  E-value=0.11  Score=43.31  Aligned_cols=116  Identities=11%  Similarity=0.129  Sum_probs=80.1

Q ss_pred             CCCCcceeeeEEEeCCeeEEEEEecCCC-CHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCC
Q 017503          100 RHPNLVELIGCCVQGTRRILVYEYVENN-SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS  178 (370)
Q Consensus       100 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~  178 (370)
                      .||+++.. .+-.+.+...+.++.-+.+ ++..        -..++...+++++.+|+....+++..     +|--|.|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~--------ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~  108 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN--------IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD  108 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG--------GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH--------HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence            68888876 4556666666666554322 3332        23578899999999999998777665     88899999


Q ss_pred             ceEeCCCCCeEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCc
Q 017503          179 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA  252 (370)
Q Consensus       179 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~  252 (370)
                      |++++.++.+++.-.|+-..+                  +|.     .++...=+-.+=+++..+++++..|..
T Consensus       109 NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             GEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             eEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999999887764322                  221     111122234677888999999877643

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.11  E-value=0.22  Score=46.91  Aligned_cols=61  Identities=10%  Similarity=0.179  Sum_probs=18.0

Q ss_pred             cccceeeecCCeEEEEEEECC-CCEEEE------EECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEE
Q 017503           49 HLSNKIGRGGFGTVYKGTLTN-GRRIAV------KPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCV  112 (370)
Q Consensus        49 ~~~~~lg~G~~g~v~~~~~~~-~~~vai------K~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  112 (370)
                      .+.+.||   ||.||+|.+.. ..+||+      |.....  .......+.++..+++.++|||+++..++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4456676   99999999864 467888      655432  2233456778888899999999999887765

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	370
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-74
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-71
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-70
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-69
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-68
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-66
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-65
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-65
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-63
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-63
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-62
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-62
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-62
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-62
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-61
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-60
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-60
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-60
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-60
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-60
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-59
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-59
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-58
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-57
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-57
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-54
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-52
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-49
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-48
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-48
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-48
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-47
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-46
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-46
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-42
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-42
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-40
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-39
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-36
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-22

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (587), Expect = 1e-74
 Identities = 68/279 (24%), Positives = 128/279 (45%), Gaps = 21/279 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
               +  +IG G FGTVYKG       + +  ++A + Q ++ F  E+  L   RH N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
             +G      +  +V ++ E +SL   L        K    K  DI    A+G+ +LH  
Sbjct: 68  LFMGYSTAP-QLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHA- 122

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPEYVLG 224
               I+HRD+K++NI L ++   KIGDFGLA +    + +H   +++G+  ++APE +  
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 225 ---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE 281
                 + ++DVY+FG+++ E+++G+          N+  + +             + P+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ---LPYSNINNRDQIIFMVG-------RGYLSPD 230

Query: 282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           L +   N      ++   C +     RP   Q++  +  
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (568), Expect = 1e-71
 Identities = 80/273 (29%), Positives = 130/273 (47%), Gaps = 21/273 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  ++G G FG V+ G      ++AVK L  +       F+ E   +  ++H  LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            L     Q     ++ EY+EN SL   L   T + IKL   K  D+   IA+G+AF+ E 
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE- 127

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + +HRD++A+NIL+    + KI DFGLA+L  DN             + APE +  G
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 226 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY 285
             T+K+DV+SFG+L+ EI++    G+  +  M          +   E+   +V P   + 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTH---GRIPYPGMT-----NPEVIQNLERGYRMVRP---DN 234

Query: 286 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
            P E+ + M++   C +     RP  + +  +L
Sbjct: 235 CPEELYQLMRL---CWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 8e-70
 Identities = 67/275 (24%), Positives = 121/275 (44%), Gaps = 21/275 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
            +     +IG G FG V+ G   N  ++A+K +  E      +FI E   +  + HP LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L G C++     LV+E++E+  L   L            E    +C+ + +G+A+L E 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE- 119

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
               ++HRD+ A N L+ +    K+ DFG+ +   D+    +T       + +PE     
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 226 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY 285
           + + K+DV+SFGVL+ E+ S    GK  +   +      +  +        L  P L   
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSE---GKIPYENRS-----NSEVVEDISTGFRLYKPRL--- 226

Query: 286 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
               + + M     C +     RP  +++++ L +
Sbjct: 227 ASTHVYQIMN---HCWKERPEDRPAFSRLLRQLAE 258

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (552), Expect = 9e-69
 Identities = 73/318 (22%), Positives = 130/318 (40%), Gaps = 24/318 (7%)

Query: 41  LRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVRE-FITEIMTLSN 98
           +    DDF   +++G G  G V+K +   +G  +A K +  E K  +R   I E+  L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
              P +V   G         +  E+++  SLD+VL    K   ++  +    + + + KG
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKG 116

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
           L +L E+    I+HRD+K SNIL++     K+ DFG++    D    +     GT  Y++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMS 171

Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 278
           PE + G   ++++D++S G+ ++E+  GR        +  + +     +    E P    
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQ-----------VIKMLTKN--IRLN 325
            P           R     F       +  P               V K L KN   R +
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 326 EEELTAPGLFQDSESSSV 343
            ++L      + S++  V
Sbjct: 292 LKQLMVHAFIKRSDAEEV 309

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 3e-68
 Identities = 61/273 (22%), Positives = 113/273 (41%), Gaps = 21/273 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
            D     ++G G FG V  G       +A+K +  E      EFI E   + N+ H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L G C +     ++ EY+ N  L   L        +   ++  ++C  + + + +L   
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES- 118

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
                +HRD+ A N L++ +   K+ DFGL++   D+    +        +  PE ++  
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 226 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY 285
           + + K+D+++FGVL+ EI S    GK  + +        +       + L L  P L   
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSL---GKMPYERFTN-----SETAEHIAQGLRLYRPHL--- 225

Query: 286 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
              ++     + + C    A  RP    ++  +
Sbjct: 226 ASEKVY---TIMYSCWHEKADERPTFKILLSNI 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 1e-66
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 21/283 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
           +   L  K+G+G FG V+ GT     R+A+K L          F+ E   +  +RH  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
           +L     +     +V EY+   SL   L G  +    L   +  D+   IA G+A++   
Sbjct: 76  QLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER- 131

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
              + VHRD++A+NIL+ +    K+ DFGLA+L  DN             + APE  L G
Sbjct: 132 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 226 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY 285
           + T+K+DV+SFG+L+ E+ +    G+  +  M     E   Q+ +  +            
Sbjct: 190 RFTIKSDVWSFGILLTELTTK---GRVPYPGMV--NREVLDQVERGYRM---------PC 235

Query: 286 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 328
           PP        +   C +     RP    +   L       E +
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  207 bits (528), Expect = 2e-65
 Identities = 76/314 (24%), Positives = 139/314 (44%), Gaps = 39/314 (12%)

Query: 36  FSYTELRSATDDFH---------LSNKIGRGGFGTVYKGTLT----NGRRIAVKPL-SAE 81
           F++ +   A  +F          +   IG G FG V  G L         +A+K L S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 82  SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 141
           +++  R+F++E   +    HPN++ L G   + T  +++ E++EN SLD       + + 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---LRQNDG 123

Query: 142 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 201
           +    +   +  GIA G+ +L +    + VHRD+ A NIL++     K+ DFGL++   D
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 202 NITHITTR----IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM 257
           + +  T            + APE +   + T  +DV+S+G+++ E++S    G+  +  M
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY---GERPYWDM 237

Query: 258 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 317
                +    + Q+ +            P +      ++   C Q   + RP+  Q++  
Sbjct: 238 TN--QDVINAIEQDYRL---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 318 LTKNIRLNEEELTA 331
           L K IR N   L A
Sbjct: 287 LDKMIR-NPNSLKA 299

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 4e-65
 Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 34/307 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
               L   IG+G FG V++G    G  +AVK  S+  ++       EI     +RH N++
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60

Query: 106 ELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
             I    +     T+  LV +Y E+ SL   L         +  E    + +  A GLA 
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAH 115

Query: 162 LHEELV-----PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP---DNITHITTRIAGT 213
           LH E+V     P I HRD+K+ NIL+ +     I D GLA       D I        GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 214 TGYLAPEYVLG------GQLTMKADVYSFGVLVLEIISGRNSGKAM----WGQMNKFLLE 263
             Y+APE +         +   +AD+Y+ G++  EI    + G           +    +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 264 WAWQLHQEEKPLELVDPEL-GEYPPNEIIRYM-KVAFFCTQAAASRRPQMNQVIKMLTKN 321
            + +  ++    + + P +   +   E +R M K+   C  A  + R    ++ K L+  
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS-- 293

Query: 322 IRLNEEE 328
            +L+++E
Sbjct: 294 -QLSQQE 299

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (518), Expect = 4e-64
 Identities = 64/285 (22%), Positives = 131/285 (45%), Gaps = 21/285 (7%)

Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQGVREFITEIMT 95
           +Y +      D  + +K+G G +G VY+G        +AVK L  ++ + V EF+ E   
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66

Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 155
           +  ++HPNLV+L+G C +     ++ E++   +L   L    +   +++      +   I
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQI 124

Query: 156 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           +  + +L +    + +HRD+ A N L+ +    K+ DFGL++L   +             
Sbjct: 125 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181

Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 275
           + APE +   + ++K+DV++FGVL+ EI +    G + +  ++   L   ++L +++  +
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATY---GMSPYPGID---LSQVYELLEKDYRM 235

Query: 276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
                   E P     +  ++   C Q   S RP   ++ +    
Sbjct: 236 --------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 2e-63
 Identities = 69/282 (24%), Positives = 127/282 (45%), Gaps = 28/282 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV 105
            +  L   IG+G FG V  G    G ++AVK +  ++    + F+ E   ++ +RH NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 106 ELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           +L+G  V+    + +V EY+   SL   L   ++    L  +      + + + + +L  
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 165 ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 224
               + VHRD+ A N+L+ ++   K+ DFGL K                  + APE +  
Sbjct: 122 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE 174

Query: 225 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 284
            + + K+DV+SFG+L+ EI S    G+  + ++   L +   ++ +  K          +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSF---GRVPYPRIP--LKDVVPRVEKGYKM---------D 220

Query: 285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 326
            P        +V   C    A+ RP   Q+ + L ++I+ +E
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL-EHIKTHE 261

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (511), Expect = 3e-63
 Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 23/281 (8%)

Query: 43  SATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNV 99
           S  +D+ +   IG G +G   K    ++G+ +  K     + ++   +  ++E+  L  +
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 100 RHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           +HPN+V      +  T   L  V EY E   L  V+   TK    L+ E    +   +  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 158 GLAFLHE--ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
            L   H   +    ++HRD+K +N+ LD + N K+GDFGLA++   + T       GT  
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPY 179

Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 275
           Y++PE +       K+D++S G L+ E+ +        +   ++  L    +  +  +  
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP----PFTAFSQKELAGKIREGKFRRIP 235

Query: 276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
                EL     NEII                RP + ++++
Sbjct: 236 YRYSDEL-----NEIITR------MLNLKDYHRPSVEEILE 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  201 bits (512), Expect = 4e-63
 Identities = 66/312 (21%), Positives = 124/312 (39%), Gaps = 45/312 (14%)

Query: 37  SYTELRSATDDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLSAESKQGVR-EF 89
               L    ++      IG G FG V++              +AVK L  E+   ++ +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 90  ITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI-------- 141
             E   ++   +PN+V+L+G C  G    L++EY+    L+  L   +   +        
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 142 ------------KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 189
                        L+  ++  I   +A G+A+L E      VHRD+   N L+ +    K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180

Query: 190 IGDFGLAK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 248
           I DFGL++ ++  +        A    ++ PE +   + T ++DV+++GV++ EI S   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG- 239

Query: 249 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 308
                        L+  + +  EE    + D  +   P N  +    +   C     + R
Sbjct: 240 -------------LQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286

Query: 309 PQMNQVIKMLTK 320
           P    + ++L +
Sbjct: 287 PSFCSIHRILQR 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-62
 Identities = 67/286 (23%), Positives = 125/286 (43%), Gaps = 28/286 (9%)

Query: 40  ELRSATDDFHLSN-KIGRGGFGTVYKGTL---TNGRRIAVKPLSAESKQG-VREFITEIM 94
           +L    D+  +++ ++G G FG+V +G          +A+K L   +++    E + E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 95  TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
            +  + +P +V LIG C Q    +LV E      L + L+G  +   ++     +++   
Sbjct: 62  IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQ 117

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAG 212
           ++ G+ +L E    + VHRD+ A N+LL      KI DFGL+K    + ++ T R     
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 213 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE 272
              + APE +   + + ++DV+S+GV + E +S    G+  + +M     E    + Q +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY---GQKPYKKMK--GPEVMAFIEQGK 229

Query: 273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
           +          E PP        +   C       RP    V + +
Sbjct: 230 RM---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 2e-62
 Identities = 79/322 (24%), Positives = 137/322 (42%), Gaps = 28/322 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN-----GRRIAVKPLS-AESKQGVREFITEIMTLSNV 99
            +F     +G G FGTVYKG            +A+K L  A S +  +E + E   +++V
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
            +P++  L+G C+  T +++         LD V     +    +  +   + CV IAKG+
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 124

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLA 218
            +L +     +VHRD+ A N+L+    + KI DFGLAKL   +   +          ++A
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 219 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 278
            E +L    T ++DV+S+GV V E+++    G   +  +     E +  L + E+     
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTF---GSKPYDGIP--ASEISSILEKGERL---- 232

Query: 279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDS 338
                  PP   I    +   C    A  RP+  ++I   +K  R  +  L   G  +  
Sbjct: 233 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287

Query: 339 ESSSVGTSDKKSSDSTLQMSSV 360
             S   ++  ++      M  V
Sbjct: 288 LPSPTDSNFYRALMDEEDMDDV 309

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 3e-62
 Identities = 74/297 (24%), Positives = 131/297 (44%), Gaps = 30/297 (10%)

Query: 39  TELRSATDDFHLSNKIGRGGFGTVYKGTLTNG-----RRIAVKPLSAESKQGVR-EFITE 92
           TE+            IG G FG VYKG L          +A+K L A   +  R +F+ E
Sbjct: 2   TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59

Query: 93  IMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 152
              +    H N++ L G   +    +++ EY+EN +LD+      + + + +  +   + 
Sbjct: 60  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGML 116

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRI 210
            GIA G+ +L      + VHRD+ A NIL++     K+ DFGL+++  D+   T+ T+  
Sbjct: 117 RGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173

Query: 211 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 270
                + APE +   + T  +DV+SFG+++ E+++                    W+L  
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER--------------PYWELSN 219

Query: 271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE 327
            E    + D      P +      ++   C Q   +RRP+   ++ +L K IR  + 
Sbjct: 220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 3e-62
 Identities = 82/302 (27%), Positives = 138/302 (45%), Gaps = 32/302 (10%)

Query: 28  ELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRR----IAVKPLSAESK 83
           EL++ V H     +  ++   H +  IGRG FG VY GTL +        AVK L+  + 
Sbjct: 12  ELVQAVQHV---VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 68

Query: 84  QG-VREFITEIMTLSNVRHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKANI 141
            G V +F+TE + + +  HPN++ L+G C++     ++V  Y+++  L            
Sbjct: 69  IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETH 125

Query: 142 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 201
               +      + +AKG+ FL        VHRD+ A N +LD++F  K+ DFGLA+   D
Sbjct: 126 NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182

Query: 202 N---ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 258
                 H  T       ++A E +   + T K+DV+SFGVL+ E+++    G   +  +N
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR---GAPPYPDVN 239

Query: 259 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
               +    L Q  + L        EY P+ +   M     C    A  RP  ++++  +
Sbjct: 240 --TFDITVYLLQGRRLL------QPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 288

Query: 319 TK 320
           + 
Sbjct: 289 SA 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 4e-62
 Identities = 70/300 (23%), Positives = 123/300 (41%), Gaps = 39/300 (13%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAESKQGVRE-FITEIMTLSN 98
           +       +G G FG V + T            +AVK L   +    RE  ++E+  LS 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--------------LGATKANIKL 143
           +  H N+V L+G C  G   +++ EY     L   L                     + L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 144 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
           + E        +AKG+AFL  +   + +HRD+ A NILL      KI DFGLA+   ++ 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 204 TH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 262
            + +         ++APE +     T ++DV+S+G+ + E+ S    G + +  M   + 
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL---GSSPYPGMP--VD 254

Query: 263 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
              +++ +E   +          P +       +   C  A   +RP   Q+++++ K I
Sbjct: 255 SKFYKMIKEGFRM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 4e-61
 Identities = 63/282 (22%), Positives = 119/282 (42%), Gaps = 34/282 (12%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN 103
            D + +  ++G G FG VYK          A K +  +S++ + +++ EI  L++  HPN
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L+          ++ E+    ++D V+    +    L   +   +C      L +LH
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLH 127

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           +     I+HRD+KA NIL   + + K+ DFG++      I    + I GT  ++APE V+
Sbjct: 128 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183

Query: 224 GGQL-----TMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLE 276
                      KADV+S G+ ++E+               + K           + +P  
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK---------IAKSEPPT 234

Query: 277 LVDPELGEYPPN--EIIRYMKVAFFCTQAAASRRPQMNQVIK 316
           L  P    +  N  + ++       C +     R   +Q+++
Sbjct: 235 LAQPS--RWSSNFKDFLKK------CLEKNVDARWTTSQLLQ 268

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 6e-61
 Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 29/274 (10%)

Query: 52  NKIGRGGFGTVYKGTLTN---GRRIAVKPLSAESKQG--VREFITEIMTLSNVRHPNLVE 106
            ++G G FGTV KG        + +AVK L  E+       E + E   +  + +P +V 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 107 LIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 166
           +IG C   +  +LV E  E   L++ L    + N  +  +   ++   ++ G+ +L E  
Sbjct: 73  MIGICEAESW-MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES- 126

Query: 167 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLAPEYVLG 224
             + VHRD+ A N+LL  +   KI DFGL+K    +  +   +        + APE +  
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 225 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 284
            + + K+DV+SFGVL+ E  S    G+  +  M     E    L + E+           
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSY---GQKPYRGMK--GSEVTAMLEKGERM---------G 230

Query: 285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
            P         +   C       RP    V   L
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 1e-60
 Identities = 73/318 (22%), Positives = 123/318 (38%), Gaps = 37/318 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNG---RRIAVKPLSAE-SKQGVREFITEIMTLSNV-R 100
           +D    + IG G FG V K  +         A+K +    SK   R+F  E+  L  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG------------ATKANIKLNWEKR 148
           HPN++ L+G C       L  EY  + +L   L              A      L+ ++ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
                 +A+G+ +L +      +HRD+ A NIL+ + +  KI DFGL++     +     
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 268
           R      ++A E +     T  +DV+S+GVL+ EI+S    G   +  M     E   +L
Sbjct: 187 R--LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL---GGTPYCGMT--CAELYEKL 239

Query: 269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 328
            Q  +          E P N       +   C +     RP   Q++  L   +    + 
Sbjct: 240 PQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL-NRMLEERKT 289

Query: 329 LTAPGLFQDSESSSVGTS 346
                L++    + +  S
Sbjct: 290 YVNTTLYEKFTYAGIDCS 307

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 2e-60
 Identities = 67/284 (23%), Positives = 109/284 (38%), Gaps = 29/284 (10%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAE---SKQGVREFITEIMTLSN 98
            D  L  K+G G FG V +G           +AVK L  +     + + +FI E+  + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           + H NL+ L G  +    ++ V E     SL        K          S   V +A+G
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR---LRKHQGHFLLGTLSRYAVQVAEG 123

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGY 216
           + +L        +HRD+ A N+LL      KIGDFGL +  P N  H  +         +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 217 LAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE 276
            APE +     +  +D + FGV + E+ +    G+  W  +N    +   ++ +E + L 
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTY---GQEPWIGLN--GSQILHKIDKEGERLP 235

Query: 277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
                    P +       V   C       RP    +   L +
Sbjct: 236 R--------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 5e-60
 Identities = 68/301 (22%), Positives = 116/301 (38%), Gaps = 44/301 (14%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRR------IAVKPLSAESKQGVRE-FITEIMTLSN 98
           ++      +G G FG V   T     +      +AVK L  ++    RE  ++E+  ++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 99  V-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL-------------------LGATK 138
           +  H N+V L+G C       L++EY     L   L                   L   +
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 139 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 198
               L +E        +AKG+ FL        VHRD+ A N+L+      KI DFGLA+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 199 FPDNITHIT-TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM 257
              +  ++          ++APE +  G  T+K+DV+S+G+L+ EI S    G   +  +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL---GVNPYPGI 270

Query: 258 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 317
              +    ++L Q    +        + P         +   C    + +RP    +   
Sbjct: 271 P--VDANFYKLIQNGFKM--------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

Query: 318 L 318
           L
Sbjct: 321 L 321

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  194 bits (493), Expect = 6e-60
 Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 33/279 (11%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQG---VREFITEIMTLSNVR 100
              F    +IG G FG VY    + N   +A+K +S   KQ     ++ I E+  L  +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HPN ++  GC ++     LV EY   ++ D +          L   + + +  G  +GLA
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLA 129

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           +LH     +++HRD+KA NILL +    K+GDFG A +             GT  ++APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPE 181

Query: 221 YVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 277
            +L    GQ   K DV+S G+  +E+   +         MN   +   + + Q E P   
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK----PPLFNMNA--MSALYHIAQNESP--- 232

Query: 278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
                  +       ++     C Q     RP    ++K
Sbjct: 233 --ALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 9e-60
 Identities = 62/276 (22%), Positives = 107/276 (38%), Gaps = 26/276 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPN 103
           +D+ L   +G G +G V           +AVK +  +      E    EI     + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+  G   +G  + L  EY     L   +    + +I +           +  G+ +LH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH 120

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYV 222
                 I HRDIK  N+LLD+  N KI DFGLA +F  +N   +  ++ GT  Y+APE +
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 223 LGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE-EKPLELVDP 280
              +      DV+S G+++  +++G           +       W+  +    P + +D 
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE---LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234

Query: 281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
                    ++              S R  +  + K
Sbjct: 235 AP-----LALLHK------ILVENPSARITIPDIKK 259

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 2e-59
 Identities = 69/282 (24%), Positives = 117/282 (41%), Gaps = 32/282 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLS---AESKQGVREFITEIMTLSNVRH 101
           +DF +   +G+G FG VY      +   +A+K L     E      +   E+   S++RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           PN++ L G     TR  L+ EY    ++ R L    +   K + ++ +     +A  L++
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 121

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
            H +    ++HRDIK  N+LL      KI DFG +   P +       + GT  YL PE 
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175

Query: 222 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE 281
           + G     K D++S GVL  E + G+           +   +       E    + V   
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQETYKRI--SRVEFTFPDFVTEG 230

Query: 282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM--LTKN 321
                  ++I          +   S+RP + +V++   +T N
Sbjct: 231 A-----RDLISR------LLKHNPSQRPMLREVLEHPWITAN 261

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 3e-59
 Identities = 70/277 (25%), Positives = 107/277 (38%), Gaps = 30/277 (10%)

Query: 48  FHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNL 104
                +IGRG F TVYKG  T     +A   L     +K   + F  E   L  ++HPN+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 105 VELIGCCVQGTRR----ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           V          +     +LV E + + +L   L    K    +  +     C  I KGL 
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQ 126

Query: 161 FLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 219
           FLH    P I+HRD+K  NI +     + KIGD GLA L           + GT  ++AP
Sbjct: 127 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAP 182

Query: 220 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD 279
           E +   +     DVY+FG+ +LE+ +               +        +     ++  
Sbjct: 183 E-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKVAI 239

Query: 280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
           PE+      EII        C +     R  +  ++ 
Sbjct: 240 PEV-----KEIIEG------CIRQNKDERYSIKDLLN 265

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-58
 Identities = 66/280 (23%), Positives = 113/280 (40%), Gaps = 26/280 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAESKQGVRE-FITEIMTLSNVR 100
           +   L   IG G FG V++G   +       +A+K     +   VRE F+ E +T+    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HP++V+LIG   +    I + E      L             L+          ++  LA
Sbjct: 67  HPHIVKLIGVITENPVWI-IMELCTLGELRSF---LQVRKYSLDLASLILYAYQLSTALA 122

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           +L        VHRDI A N+L+      K+GDFGL++   D+  +  ++      ++APE
Sbjct: 123 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP 280
            +   + T  +DV+ FGV + EI+     G   +  +     +   ++   E+       
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMH---GVKPFQGVKNN--DVIGRIENGERL------ 228

Query: 281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
                PPN       +   C     SRRP+  ++   L+ 
Sbjct: 229 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-57
 Identities = 64/294 (21%), Positives = 122/294 (41%), Gaps = 29/294 (9%)

Query: 26  DGELLRNVNHFSYTELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQ 84
           D E+L  +   S   +      +    KIG+G  GTVY    +  G+ +A++ ++ + + 
Sbjct: 2   DEEILEKLR--SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59

Query: 85  GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 144
                I EI+ +   ++PN+V  +   + G    +V EY+   SL  V+         ++
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMD 114

Query: 145 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 204
             + + +C    + L FLH      ++HRDIK+ NILL  + + K+ DFG         +
Sbjct: 115 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLL 262
             +T + GT  ++APE V       K D++S G++ +E+I G      +     +     
Sbjct: 172 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230

Query: 263 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
               +L   EK    +          + +        C      +R    ++++
Sbjct: 231 NGTPELQNPEK----LSAIF-----RDFLNR------CLDMDVEKRGSAKELLQ 269

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 6e-57
 Identities = 68/292 (23%), Positives = 124/292 (42%), Gaps = 33/292 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTN------GRRIAVKPLS-AESKQGVREFITEIMTLSN 98
           +   +S ++G+G FG VY+G            R+A+K ++ A S +   EF+ E   +  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL------LGATKANIKLNWEKRSDIC 152
               ++V L+G   QG   +++ E +    L   L      +         +  K   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 153 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIA 211
             IA G+A+L+       VHRD+ A N ++ ++F  KIGDFG+ +   + +      +  
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 212 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE 271
               +++PE +  G  T  +DV+SFGV++ EI +                 E  +Q    
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA---------------EQPYQGLSN 241

Query: 272 EKPLELV-DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 322
           E+ L  V +  L + P N      ++   C Q     RP   ++I  + + +
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  179 bits (456), Expect = 4e-54
 Identities = 60/276 (21%), Positives = 112/276 (40%), Gaps = 27/276 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL 104
           D + +  ++G G FG V++ T    G   A K +    +        EI T+S +RHP L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           V L          +++YE++    L   +      + K++ ++  +    + KGL  +HE
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 165 ELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
               + VH D+K  NI+   + +   K+ DFGL        +   T   GT  + APE  
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVA 197

Query: 223 LGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP 280
            G  +    D++S GVL   ++SG +   G+     +       +   + ++     +  
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK---SCDWNMDDSAFSGISE 254

Query: 281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
           +       + IR          A  + R  ++Q ++
Sbjct: 255 DG-----KDFIRK------LLLADPNTRMTIHQALE 279

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 5e-54
 Identities = 67/298 (22%), Positives = 127/298 (42%), Gaps = 40/298 (13%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT--------NGRRIAVKPLSAE-SKQGVREFITEIMTL 96
           D   L   +G G FG V                 ++AVK L ++ +++ + + I+E+  +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 97  SNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL------------LGATKANIKL 143
             + +H N++ L+G C Q     ++ EY    +L   L              +     +L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 144 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 203
           + +        +A+G+ +L        +HRD+ A N+L+ ++   KI DFGLA+      
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 204 THITT-RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 262
            +  T        ++APE +     T ++DV+SFGVL+ EI +    G + +  +    +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL---GGSPYPGVP---V 243

Query: 263 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
           E  ++L +E   +        + P N       +   C  A  S+RP   Q+++ L +
Sbjct: 244 EELFKLLKEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 9e-54
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 12/207 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS---AESKQGVREFITEIMTLSNVRH 101
           +DF     +G G F TV     L   R  A+K L       +  V     E   +S + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P  V+L        +      Y +N  L + +    +     +          I   L +
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 123

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPE 220
           LH      I+HRD+K  NILL+++ + +I DFG AK+  P++         GT  Y++PE
Sbjct: 124 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGR 247
            +        +D+++ G ++ ++++G 
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGL 207

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-53
 Identities = 74/302 (24%), Positives = 125/302 (41%), Gaps = 38/302 (12%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT------LTNGRRIAVKPLSAESKQG-VREFITEIMTLS- 97
           D   L   +GRG FG V +            R +AVK L   +     R  ++E+  L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 98  NVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVL------------LGATKANIKLN 144
              H N+V L+G C + G   +++ E+ +  +L   L                     L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 145 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 204
            E        +AKG+ FL        +HRD+ A NILL ++   KI DFGLA+    +  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 205 HI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE 263
           ++          ++APE +     T+++DV+SFGVL+ EI S      + +  +   + E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG---ASPYPGVK--IDE 244

Query: 264 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 323
              +  +E   +   D     Y   E+ + M     C     S+RP  +++++ L   ++
Sbjct: 245 EFCRRLKEGTRMRAPD-----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNLLQ 296

Query: 324 LN 325
            N
Sbjct: 297 AN 298

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  173 bits (440), Expect = 9e-52
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 11/205 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL 104
           D + +  ++G G FG V++      GR    K ++            EI  ++ + HP L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           + L          +L+ E++    L   +      + K++  +  +      +GL  +HE
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 165 ELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
                IVH DIK  NI+ + +     KI DFGLA     +   I      T  + APE V
Sbjct: 146 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIV 200

Query: 223 LGGQLTMKADVYSFGVLVLEIISGR 247
               +    D+++ GVL   ++SG 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 4e-49
 Identities = 61/290 (21%), Positives = 113/290 (38%), Gaps = 29/290 (10%)

Query: 40  ELRSATDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSN 98
           ELR   + + L  KIG G FG +Y GT +  G  +A+K    ++K    +   E      
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58

Query: 99  VRHPNLVELIG-CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK 157
           ++    +  I  C  +G   ++V E +  +  D         + K + +    +   +  
Sbjct: 59  MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN----FCSRKFSLKTVLLLADQMIS 114

Query: 158 GLAFLHEELVPHIVHRDIKASNIL---LDQEFNPKIGDFGLAKLFPDNITHI------TT 208
            + ++H +   + +HRD+K  N L     +     I DFGLAK + D  TH         
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171

Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL 268
            + GT  Y +    LG + + + D+ S G +++    G    + +     +   E     
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-- 229

Query: 269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 318
              EK +      L +  P+E   Y+    FC       +P  + + ++ 
Sbjct: 230 ---EKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLF 273

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  162 bits (412), Expect = 2e-48
 Identities = 61/292 (20%), Positives = 111/292 (38%), Gaps = 46/292 (15%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--------PLSAESKQGVRE-FITEIMT 95
           +++     +GRG    V +       +  AVK          SAE  Q +RE  + E+  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 96  LSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
           L  V  HPN+++L       T   LV++ ++   L   L       + L+ ++   I   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRA 118

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 214
           + + +  LH+    +IVHRD+K  NILLD + N K+ DFG +             + GT 
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTP 173

Query: 215 GYLAPEYVLGGQL------TMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAW 266
            YLAPE +             + D++S GV++  +++G      +     +   +     
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM----- 228

Query: 267 QLHQEEKPLELVDPELGEYPPN--EIIRYMKVAFFCTQAAASRRPQMNQVIK 316
                    +   PE  +Y     +++               +R    + + 
Sbjct: 229 -----SGNYQFGSPEWDDYSDTVKDLVSR------FLVVQPQKRYTAEEALA 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (415), Expect = 2e-48
 Identities = 51/278 (18%), Positives = 99/278 (35%), Gaps = 28/278 (10%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHP 102
            D +   + +G G F  V         + +A+K ++ ++ +G       EI  L  ++HP
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V L      G    L+ + V    L   +               S +   +   + +L
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYL 123

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H+  + H   +        LD++    I DFGL+K+       + +   GT GY+APE +
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVL 181

Query: 223 LGGQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP 280
                +   D +S GV+   ++ G      +       + L          +   E   P
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL----------KAEYEFDSP 231

Query: 281 ELGEYPPN--EIIRYMKVAFFCTQAAASRRPQMNQVIK 316
              +   +  + IR+        +    +R    Q ++
Sbjct: 232 YWDDISDSAKDFIRH------LMEKDPEKRFTCEQALQ 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  164 bits (417), Expect = 3e-48
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 18/211 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLS---AESKQGVREFITEIMT---LSN 98
           +DF +   IGRGGFG VY       G+  A+K L     + KQG    + E +    +S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
              P +V +        +   + + +    L   L      +   +          I  G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 119

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 218
           L  +H      +V+RD+K +NILLD+  + +I D GLA  F     H +    GT GY+A
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 173

Query: 219 PEYVLGGQ-LTMKADVYSFGVLVLEIISGRN 248
           PE +  G      AD +S G ++ +++ G +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 204

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  162 bits (412), Expect = 5e-48
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRH 101
            DF +   +G G FG V+      NGR  A+K L  E     + V     E + LS V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P ++ + G      +  ++ +Y+E   L  +     + + +            +   L +
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL----LRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      I++RD+K  NILLD+  + KI DFG AK  PD    +     GT  Y+APE 
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEV 172

Query: 222 VLGGQLTMKADVYSFGVLVLEIISGR 247
           V         D +SFG+L+ E+++G 
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGY 198

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 1e-47
 Identities = 62/207 (29%), Positives = 91/207 (43%), Gaps = 13/207 (6%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLS---AESKQGVREFITEIMTLS-NVR 100
           +DF L   +G+G FG V+        +  A+K L          V   + E   LS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 101 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 160
           HP L  +            V EY+    L   +    ++  K +  + +     I  GL 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQ 117

Query: 161 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
           FLH      IV+RD+K  NILLD++ + KI DFG+ K          T   GT  Y+APE
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 173

Query: 221 YVLGGQLTMKADVYSFGVLVLEIISGR 247
            +LG +     D +SFGVL+ E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  160 bits (405), Expect = 2e-47
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 17/213 (7%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLS---AESKQGVREFITEIMTLSNVR 100
           +D + L   +G GG   V+    L   R +AVK L    A        F  E    + + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 101 HPNLVELIGCCV----QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           HP +V +          G    +V EYV+  +L  ++         +  ++  ++     
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADAC 121

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTT 214
           + L F H+     I+HRD+K +NI++      K+ DFG+A+   D+   +  T  + GT 
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
            YL+PE   G  +  ++DVYS G ++ E+++G 
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 5e-47
 Identities = 44/206 (21%), Positives = 84/206 (40%), Gaps = 12/206 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL 104
           + + ++  +GRG FG V++    ++ +    K +  +          EI  L+  RH N+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNI 63

Query: 105 VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE 164
           + L          ++++E++    +   +     +  +LN  +       + + L FLH 
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 165 ELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
               +I H DI+  NI+     +   KI +FG A+                  Y APE  
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVH 175

Query: 223 LGGQLTMKADVYSFGVLVLEIISGRN 248
               ++   D++S G LV  ++SG N
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGIN 201

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  159 bits (403), Expect = 7e-47
 Identities = 53/286 (18%), Positives = 113/286 (39%), Gaps = 30/286 (10%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PNLV 105
           + +  +IG G FG +++GT L N +++A+K     S     +   E  T   +     + 
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIP 64

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            +     +G   +LV + +  +  D +         K + +  +     +   +  +HE 
Sbjct: 65  NVYYFGQEGLHNVLVIDLLGPSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIHE- 119

Query: 166 LVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFPDNITHI------TTRIAGTT 214
               +V+RDIK  N L+ +  +       + DFG+ K + D +T           ++GT 
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
            Y++    LG + + + D+ + G + +  + G        G       +   ++ ++++ 
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP---WQGLKAATNKQKYERIGEKKQS 234

Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 320
             L   EL    P E  +YM    +    A    P  + +  + +K
Sbjct: 235 TPL--RELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-46
 Identities = 65/288 (22%), Positives = 116/288 (40%), Gaps = 24/288 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHP 102
           ++F    KIG G +G VYK      G  +A+K   L  E++      I EI  L  + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V+L+       +  LV+E++  +    +   A      +           + +GLAF 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFC 118

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H      ++HRD+K  N+L++ E   K+ DFGLA+ F   +   T  +  T  Y APE +
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEIL 174

Query: 223 LG-GQLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL------LEWAWQLHQEEK 273
           LG    +   D++S G +  E+++ R    G +   Q+ +         E  W       
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 274 PLELVDPELGEYPPNEIIRYMKVAFF-----CTQAAASRRPQMNQVIK 316
             +   P+      ++++  +                ++R      + 
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  156 bits (395), Expect = 6e-46
 Identities = 62/286 (21%), Positives = 112/286 (39%), Gaps = 22/286 (7%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPN 103
           + +H   KIG G +G VYK     G   A+K   L  E +      I EI  L  ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 104 LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH 163
           +V+L        R +LV+E+++ +    +          L         + +  G+A+ H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 164 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 223
           +     ++HRD+K  N+L+++E   KI DFGLA+ F   +   T  I           + 
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 224 GGQLTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 278
             + +   D++S G +  E+++G       S      ++ + L     +       L   
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 279 DPELGEYPPNEIIRYMKVAFF--------CTQAAASRRPQMNQVIK 316
           DP    Y P     ++K              +   ++R    Q ++
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-45
 Identities = 66/292 (22%), Positives = 116/292 (39%), Gaps = 24/292 (8%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHP 102
              +   + IG G +G V       N  R+A+K +S    Q   +  + EI  L   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N++ +       T   +   Y+  + +   L    K    L+ +        I +GL ++
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIAGTTGYLAPE 220
           H     +++HRD+K SN+LL+   + KI DFGLA++   +  H    T    T  Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 221 YVLGGQLTM-KADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL--------LEWAWQLH 269
            +L  +      D++S G ++ E++S R    GK    Q+N  L         +    ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 270 QEEKPLELVDPELGEYPPNEIIRYMKVAFF-----CTQAAASRRPQMNQVIK 316
            + +   L  P   + P N +                     +R ++ Q + 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-44
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 16/214 (7%)

Query: 44  ATDDFHLSNKIGRGGFGTVYKGT--LTNGRRIAVKPLSAES------KQGVREFITEIMT 95
           A   +    +IG G +G V+K       GR +A+K +  ++         +RE +  +  
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRH 63

Query: 96  LSNVRHPNLVELIGCCVQGTRRILVYEYV--ENNSLDRVLLGATKANIKLNWEKRSDICV 153
           L    HPN+V L   C            +  E+   D            +  E   D+  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 154 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 213
            + +GL FLH      +VHRD+K  NIL+      K+ DFGLA+++   +    T +  T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178

Query: 214 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
             Y APE +L        D++S G +  E+   +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-43
 Identities = 78/346 (22%), Positives = 138/346 (39%), Gaps = 34/346 (9%)

Query: 42  RSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR 100
           R     +  +  IG G FG VY+  L  +G  +A+K +  + +   R    E+  +  + 
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLD 71

Query: 101 HPNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
           H N+V L         +       LV +YV      RV    ++A   L           
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGT 213
           + + LA++H      I HRDIK  N+LLD +    K+ DFG AK       +++     +
Sbjct: 131 LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--S 185

Query: 214 TGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQLHQ 270
             Y APE + G    T   DV+S G ++ E++ G+    G +   Q+ + +++      +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE-IIKVLGTPTR 244

Query: 271 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI--RLNEEE 328
           E+      +    ++P  +   + KV    T   A     +    ++L      RL   E
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA-----IALCSRLLEYTPTARLTPLE 299

Query: 329 LTAPGLFQDSESSSVGTSDKKSSD-----STLQMSSVPVTITQVTP 369
             A   F +    +V   + + +      +T ++SS P   T + P
Sbjct: 300 ACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIP 345

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-43
 Identities = 61/279 (21%), Positives = 117/279 (41%), Gaps = 24/279 (8%)

Query: 52  NKIGRGGFGTVYKGTLTN-GRRIAVKPLSAESKQG-----VREFITEIMTLSNVRHPNLV 105
           + +G G F TVYK    N  + +A+K +    +        R  + EI  L  + HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 106 ELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 165
            L+      +   LV++++E +    +       ++ L         +   +GL +LH+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ- 118

Query: 166 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 225
               I+HRD+K +N+LLD+    K+ DFGLAK F       T ++  T  Y APE + G 
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175

Query: 226 QL-TMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL 282
           ++  +  D+++ G ++ E++       G +   Q+ +              P E   P++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI-------FETLGTPTEEQWPDM 228

Query: 283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 321
              P     +           +A+    ++ +  +   N
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 5e-43
 Identities = 60/337 (17%), Positives = 133/337 (39%), Gaps = 37/337 (10%)

Query: 46  DDFHLSNK-IGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHP 102
           DD+ ++++ +G G  G V +        + A+K L     Q   +   E+       + P
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 65

Query: 103 NLVELIGCC----VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           ++V ++             ++V E ++   L   +    + +      + S+I   I + 
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEA 123

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTG 215
           + +LH     +I HRD+K  N+L   +      K+ DFG AK    + +  T     T  
Sbjct: 124 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPY 178

Query: 216 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL 275
           Y+APE +   +     D++S GV++  ++ G       +   +   +    +        
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP----PFYSNHGLAISPGMKTRIRMGQY 234

Query: 276 ELVDPELGEYPPN--EIIRYMKVAFFCTQAAASRRPQMNQVIKM--LTKNIRLNEEEL-T 330
           E  +PE  E       +IR         +   ++R  + + +    + ++ ++ +  L T
Sbjct: 235 EFPNPEWSEVSEEVKMLIRN------LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHT 288

Query: 331 APGLFQDSESSSVGTSDKKSSDSTLQMSSVPVTITQV 367
           +  L +D E       +  S+ +T+++    + I ++
Sbjct: 289 SRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKI 325

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-42
 Identities = 48/213 (22%), Positives = 85/213 (39%), Gaps = 20/213 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVRE------FITEIMTLSN 98
             + +   +G GGFG+VY G  +++   +A+K +  +      E         E++ L  
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 99  VR--HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           V      ++ L+    +    +L+ E  E        +        L  E        + 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVL 120

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTG 215
           + +   H      ++HRDIK  NIL+D      K+ DFG   L  D    + T   GT  
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 174

Query: 216 YLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 247
           Y  PE++   +     A V+S G+L+ +++ G 
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-42
 Identities = 63/206 (30%), Positives = 85/206 (41%), Gaps = 12/206 (5%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRH 101
           +DF     +G+G FG V        GR  A+K L  E   +K  V   +TE   L N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           P L  L        R   V EY     L   L            E+       I   L +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEY 120

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           LH      +V+RDIK  N++LD++ + KI DFGL K    +         GT  YLAPE 
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176

Query: 222 VLGGQLTMKADVYSFGVLVLEIISGR 247
           +         D +  GV++ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-42
 Identities = 62/282 (21%), Positives = 102/282 (36%), Gaps = 32/282 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPL------SAESKQGVREFITEIMTLSN 98
           D +    ++G G F  V K    + G + A K +      S+       +   E+  L  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 99  VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKG 158
           ++HPN++ L       T  IL+ E V    L             L  E+ ++    I  G
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDF----LAEKESLTEEEATEFLKQILNG 125

Query: 159 LAFLHEELVPHIVHRDIKASNILLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTT 214
           + +LH      I H D+K  NI+L     P    KI DFGLA        +    I GT 
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTP 180

Query: 215 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP 274
            ++APE V    L ++AD++S GV+   ++SG +       Q           L      
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---------TLANVSAV 231

Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 316
               + E           +++           +R  +   ++
Sbjct: 232 NYEFEDEYFSNTSALAKDFIRR---LLVKDPKKRMTIQDSLQ 270

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-41
 Identities = 65/297 (21%), Positives = 123/297 (41%), Gaps = 35/297 (11%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHP 102
             +    KIG+G FG V+K      G+++A+K   +  E +      + EI  L  ++H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 103 NLVELIGCCVQGTRRI--------LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 154
           N+V LI  C               LV+++ E++    +        +K    +   +   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQM 125

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 211
           +  GL ++H      I+HRD+KA+N+L+ ++   K+ DFGLA+ F    ++  +  T   
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 212 GTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWA 265
            T  Y  PE +LG +      D++  G ++ E+ +       N+ +     +++      
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 266 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI-KMLTKN 321
            ++       EL       Y   E+++  K        A  R P    +I K+L  +
Sbjct: 243 PEVWPNVDNYEL-------YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-40
 Identities = 55/282 (19%), Positives = 104/282 (36%), Gaps = 19/282 (6%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHP 102
             +    KIG G +GTV+K         +A+K   L  + +      + EI  L  ++H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL 162
           N+V L        +  LV+E+ + +            N  L+ E        + KGL F 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 163 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 222
           H     +++HRD+K  N+L+++    K+ +FGLA+ F   +   +  +            
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 223 LGGQLTMKADVYSFGVLVLEIISGRN---SGKAMWGQMNKFLLEWAWQLHQEEKPLELVD 279
                +   D++S G +  E+ +       G  +  Q+ + +        +E+ P     
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEEQWPSMTKL 233

Query: 280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 321
           P+   YP       +        A        + +  +L  N
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATG-----RDLLQNLLKCN 270

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 2e-39
 Identities = 62/329 (18%), Positives = 120/329 (36%), Gaps = 31/329 (9%)

Query: 36  FSYTELRSAT----DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVRE 88
           F   E+          +     +G G +G V        G ++A+K      +S+   + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 89  FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 148
              E+  L ++RH N++ L+             ++          LG    + KL  ++ 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 149 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 208
             +   + KGL ++H      I+HRD+K  N+ ++++   KI DFGLA+     +T    
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV- 179

Query: 209 RIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGR-----NSGKAMWGQMNKFLL 262
               T  Y APE +L     T   D++S G ++ E+I+G+     +       ++ K   
Sbjct: 180 ---VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236

Query: 263 EWAWQLHQEEKPLELVD-----PELGEYPPNEIIRYMKVAFF-----CTQAAASRRPQMN 312
               +  Q  +  E  +     PEL +     I+                  A +R    
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296

Query: 313 QVIKM-LTKNIRLNEEELTAPGLFQDSES 340
           + +     +++   E+E          + 
Sbjct: 297 EALAHPYFESLHDTEDEPQVQKYDDSFDD 325

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (351), Expect = 8e-39
 Identities = 57/246 (23%), Positives = 99/246 (40%), Gaps = 17/246 (6%)

Query: 8   GSRFHSKKSAEREAPQGVDGELLRN-VNHFSYTELRSAT-DDFHLSNKIGRGGFGTVYKG 65
           G+   +KK +E+E+ +    +   + +  +      +A  D F     +G G FG V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60

Query: 66  T-LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY 121
               +G   A+K L  +     + +   + E   L  V  P LV+L       +   +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120

Query: 122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 181
           EYV    +   L    +   + +          I     +LH      +++RD+K  N+L
Sbjct: 121 EYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLL 173

Query: 182 LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 241
           +DQ+   ++ DFG AK        +     GT   LAPE +L        D ++ GVL+ 
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIY 229

Query: 242 EIISGR 247
           E+ +G 
Sbjct: 230 EMAAGY 235

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  135 bits (341), Expect = 1e-37
 Identities = 60/287 (20%), Positives = 114/287 (39%), Gaps = 26/287 (9%)

Query: 46  DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPN 103
           DD+ L  K+GRG +  V++   +TN  ++ VK L    K+   +   EI  L N+R  PN
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91

Query: 104 LVELIGCCVQGTRR--ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
           ++ L         R   LV+E+V N    ++          L           I K L +
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDY 144

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 220
            H      I+HRD+K  N+++D E    ++ D+GLA+ +     +       +  +  PE
Sbjct: 145 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 199

Query: 221 YVLGGQL-TMKADVYSFGVLVLEIISGRN---SGKAMWGQMNKF--LLEWAWQLHQEEKP 274
            ++  Q+     D++S G ++  +I  +     G   + Q+ +   +L         +K 
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259

Query: 275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 321
              +DP   +       +  +               ++ + K+L  +
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-36
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 18/213 (8%)

Query: 46  DDFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLS----AESKQGVREFITEIMTLS 97
           ++F L   +G G +G V+          G+  A+K L      +  +      TE   L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 98  NVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIA 156
           ++R  P LV L       T+  L+ +Y+    L   L        +    +       I 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIV 139

Query: 157 KGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 216
             L  LH+     I++RDIK  NILLD   +  + DFGL+K F  + T       GT  Y
Sbjct: 140 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196

Query: 217 LAPEYVLGGQ--LTMKADVYSFGVLVLEIISGR 247
           +AP+ V GG        D +S GVL+ E+++G 
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 9e-35
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 25/227 (11%)

Query: 34  NHFSYTELRSAT----DDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGV 86
           N F   E+  +T      +     IG G  G V         R +A+K      +++   
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60

Query: 87  REFITEIMTLSNVRHPNLVELIGCCV------QGTRRILVYEYVENNSLDRVLLGATKAN 140
           +    E++ +  V H N++ L+          +     LV E ++ N    +        
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 113

Query: 141 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 200
           ++L+ E+ S +   +  G+  LH      I+HRD+K SNI++  +   KI DFGLA+   
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170

Query: 201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 247
            +   + T    T  Y APE +LG       D++S G ++ E++  +
Sbjct: 171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 1e-33
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 11/207 (5%)

Query: 45  TDDFHLSNKIGRGGFGTVYKGT-LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRH 101
            + +   + +G G +G+V        G R+AVK      +S    +    E+  L +++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 102 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 161
            N++ L+             +      L    L       KL  +    +   I +GL +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 162 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 221
           +H      I+HRD+K SN+ ++++   KI DFGLA+   D +T        T  Y APE 
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEI 189

Query: 222 VLGGQ-LTMKADVYSFGVLVLEIISGR 247
           +L         D++S G ++ E+++GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (284), Expect = 3e-29
 Identities = 63/321 (19%), Positives = 118/321 (36%), Gaps = 38/321 (11%)

Query: 48  FHLSNKIGRGGFGTVYKGT-LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE 106
           + L  K+G G F TV+    + N   +A+K +  + K        EI  L  V   +  +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTK 73

Query: 107 LIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSD-----------ICVG 154
                     ++L  + +   N +  V++        L   K+ +           I   
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 155 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP------KIGDFGLAKLFPDNITHITT 208
           +  GL ++H      I+H DIK  N+L++   +P      KI D G A  + ++ T+   
Sbjct: 134 LLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI- 190

Query: 209 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR-----------NSGKAMWGQM 257
               T  Y +PE +LG      AD++S   L+ E+I+G                    Q+
Sbjct: 191 ---QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 258 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 317
            + L E    L +  K         G       +++  +    T+     + +  ++   
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 318 LTKNIRLNEEE-LTAPGLFQD 337
           L+  ++L+  +   A GL   
Sbjct: 308 LSPMLQLDPRKRADAGGLVNH 328

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.8 bits (227), Expect = 1e-22
 Identities = 32/205 (15%), Positives = 59/205 (28%), Gaps = 29/205 (14%)

Query: 50  LSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES----------KQGVREFITEIMTLSNV 99
           +   +G G    V+           VK                  G   F    +  +  
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 100 RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 159
               L +L G  V       VY +  N  L  ++       +++       +   I + +
Sbjct: 64  EFRALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEV 116

Query: 160 AFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF--PDNITHITTRIAGTTGYL 217
           A  +      IVH D+   N+L+  E    I DF  +           +   +     Y 
Sbjct: 117 AKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172

Query: 218 APEYVLGGQLTMKADVYSFGVLVLE 242
           +  Y        + D+ S    +L+
Sbjct: 173 SRTY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	370
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.9
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.33
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.88
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.43
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.38
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.14

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-55  Score=386.63  Aligned_cols=258  Identities=24%  Similarity=0.409  Sum_probs=201.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.+.||+|+||.||+|++.++..||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            36899999999999999999999888899999987543 33567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++|+|.+++.   .....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          83 EHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             TTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             CCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            9999999884   3445689999999999999999999999   999999999999999999999999999987765444


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                      .......||+.|+|||++.+..++.++|||||||++|||+|+..|+.....  ...+...+   . ....        ..
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i---~-~~~~--------~~  222 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDI---S-TGFR--------LY  222 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHH---H-HTCC--------CC
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHH---H-hcCC--------CC
Confidence            444456789999999999999999999999999999999996444332211  11122211   1 1111        11


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      .+..+..++.+++.+||+.||.+|||+.+|++.|+++..
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            122333458899999999999999999999999998753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-55  Score=385.96  Aligned_cols=253  Identities=24%  Similarity=0.339  Sum_probs=204.7

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ..++|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            4678999999999999999999985 68999999986543 233456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++|+|.+++    .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        83 Ey~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          83 EYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             ECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             eccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            999999999988    3455799999999999999999999999   999999999999999999999999999987643


Q ss_pred             CC-cceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          202 NI-THITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       202 ~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      .. ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........     . .......    
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-----~-~~~~~~~----  225 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----D-WKEKKTY----  225 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-----H-HHTTCTT----
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-----H-HhcCCCC----
Confidence            32 223445679999999999988876 5789999999999999999999975543222111     1 1111110    


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                         ..........+.+++.+||+.||.+|||+.|+++
T Consensus       226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               0111223345788999999999999999999854

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=382.77  Aligned_cols=260  Identities=27%  Similarity=0.460  Sum_probs=205.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||+||+|+++  ..||||++...  +....+.+.+|+.+|++++||||+++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            578999999999999999999865  36999998654  44556789999999999999999999998754 56799999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+++|+|.+++.   ..+..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        84 y~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          84 WCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CCCEEEHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             cCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            999999999984   2344689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             Cc-ceeecccCCCCCCCcccccC---CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          203 IT-HITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       203 ~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      .. .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||.......  .+    .........    
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~----~~~~~~~~~----  227 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QI----IFMVGRGYL----  227 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HH----HHHHHHTSC----
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HH----HHHHhcCCC----
Confidence            22 23345678999999999864   358999999999999999999999987543221  11    111111111    


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      .+.+...+.+.+..+.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus       228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            111222233444568899999999999999999999999998765

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-54  Score=383.99  Aligned_cols=249  Identities=23%  Similarity=0.419  Sum_probs=208.2

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999975 68999999987665555678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++|+|.+++.     ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++..+.....
T Consensus       100 ~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1         100 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             TTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            9999999873     23589999999999999999999999   999999999999999999999999999987654332


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......      .............       ..
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~-------~~  237 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPE-------LQ  237 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCC-------CS
T ss_pred             -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCCC-------CC
Confidence             234457999999999999999999999999999999999999998643221      1111122221111       11


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .+......+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22333456889999999999999999999865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=384.92  Aligned_cols=258  Identities=29%  Similarity=0.442  Sum_probs=210.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.+.||+|+||.||+|++++++.||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            57899999999999999999999888899999987543 335678999999999999999999998754 5678999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++|+|.+++..  ..+..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++.......
T Consensus        90 ~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          90 ENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             TTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            99999998742  2334589999999999999999999999   999999999999999999999999999998765544


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                      .......||+.|+|||++.++.++.++|||||||++|||+||..|+.....  ...+..    .......        ..
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~----~i~~~~~--------~~  230 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQ----NLERGYR--------MV  230 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHH----HHHTTCC--------CC
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHH----HHHhcCC--------CC
Confidence            444556789999999999999999999999999999999997655433222  111111    1111111        11


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      .+...+..+.+++.+||+.+|++|||+.+|++.|+....
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            223334458889999999999999999999999988654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-54  Score=391.60  Aligned_cols=258  Identities=27%  Similarity=0.451  Sum_probs=201.3

Q ss_pred             cCCcccceeeecCCeEEEEEEECC-C---CEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLTN-G---RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~~-~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ++|++.+.||+|+||+||+|+++. +   ..||||.+... .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            567888999999999999999752 2   35899988654 445567899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++|+|.+++.   .....+++..++.++.||+.||.|||++   +++||||||+||||+.++.+||+|||+++...
T Consensus       106 ~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         106 TEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence            99999999999884   3345689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcce----eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          201 DNITHI----TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       201 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      ......    .....+|+.|+|||.+.++.++.++|||||||++|||+| |..||.....   ..+..   .. ..... 
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~---~i-~~~~~-  251 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVIN---AI-EQDYR-  251 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH---HH-HTTCC-
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHH---HH-HcCCC-
Confidence            432221    122457889999999999999999999999999999998 8999865432   11211   11 11111 


Q ss_pred             ccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          276 ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       276 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                             ...+.+.+..+.+++.+||+.||.+|||+.+|++.|+++++.
T Consensus       252 -------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         252 -------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                   122334455688999999999999999999999999988763

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-55  Score=388.67  Aligned_cols=256  Identities=24%  Similarity=0.369  Sum_probs=197.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--CCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l  119 (370)
                      .++|++.+.||+|+||+||+|+++ +|+.||+|.+...  +....+.+.+|++++++++||||+++++++.+  ....|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            368999999999999999999985 6889999988654  34445678899999999999999999999875  456799


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL--VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ||||+++|+|.+++......+..+++..++.++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|||++.
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998665556678999999999999999999999971  0139999999999999999999999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....   ..+..   ... ....   
T Consensus       163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~---~i~-~~~~---  231 (269)
T d2java1         163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAG---KIR-EGKF---  231 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHH---HHH-HTCC---
T ss_pred             ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHHH---HHH-cCCC---
Confidence            7654322 23446789999999999999999999999999999999999999865322   11111   111 1111   


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                           ...+.....++.+++.+||+.||.+|||+.|+++
T Consensus       232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                 1122233445889999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=382.64  Aligned_cols=246  Identities=27%  Similarity=0.410  Sum_probs=205.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||+||+|+++ +++.||+|++...   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            367999999999999999999986 6889999988643   234456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++|+|.+++.    ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        85 mEy~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          85 LEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             EeecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecC
Confidence            99999999999983    345689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ...   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   .....   .... ..      .
T Consensus       158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~---~i~~-~~------~  221 (263)
T d2j4za1         158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYK---RISR-VE------F  221 (263)
T ss_dssp             CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH---HHHT-TC------C
T ss_pred             CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HHHHH---HHHc-CC------C
Confidence            432   3345799999999999999999999999999999999999999864321   11111   1111 11      1


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                         ..+......+.+++.+||+.||.+|||+.|+++
T Consensus       222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               112223345888999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-54  Score=379.52  Aligned_cols=254  Identities=23%  Similarity=0.398  Sum_probs=213.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.++||+|+||+||+|++++++.||||.++.... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            478999999999999999999998888999999876533 3468999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++|+|.+++.   .....+++..+++++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        82 ~~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          82 ANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TTEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCCcHHHhhh---ccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            9999999873   3445688999999999999999999999   999999999999999999999999999987665544


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                      .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....   ..+..   . ......        .
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~---~-i~~~~~--------~  220 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAE---H-IAQGLR--------L  220 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHH---H-HHTTCC--------C
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHH---H-HHhCCC--------C
Confidence            44445678999999999999999999999999999999998 7888865432   11221   1 111111        1


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHh
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK  320 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  320 (370)
                      ..+......+.+++.+||+.||.+|||+.+|++.|.+
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            1222333568899999999999999999999999865

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-54  Score=387.36  Aligned_cols=263  Identities=24%  Similarity=0.399  Sum_probs=217.2

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ++...++|++.+.||+|+||+||+|+++ +++.||||++..+. ...+.+.+|+.+|++++||||+++++++.+.+..++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3344678999999999999999999986 58889999987553 345678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++|+|.+++..  .....+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++..
T Consensus        91 v~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          91 ITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999999843  2345789999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      ............|++.|+|||++.+..++.++|||||||++|||++|..|+......  ..+    .........     
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~----~~~i~~~~~-----  234 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV----YELLEKDYR-----  234 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH----HHHHHTTCC-----
T ss_pred             CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHH----HHHHhcCCC-----
Confidence            665555455556889999999999999999999999999999999987765433221  111    122222111     


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                         ...+...+..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       235 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         235 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               12223344568899999999999999999999999987754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=380.96  Aligned_cols=251  Identities=25%  Similarity=0.426  Sum_probs=206.1

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      +.|++.+.||+|+||.||+|+++ +++.||+|++........+.+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56999999999999999999985 68899999987766666678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++|+|.+++.   .....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++....... 
T Consensus        92 ~~g~L~~~~~---~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-  164 (288)
T d2jfla1          92 AGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  164 (288)
T ss_dssp             TTEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred             CCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence            9999999874   2345699999999999999999999999   99999999999999999999999999997543211 


Q ss_pred             ceeecccCCCCCCCccccc-----CCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCccccc
Q 017503          205 HITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD  279 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (370)
                      .......||+.|+|||++.     +..++.++|||||||++|+|+||+.||.......   ..   ........+     
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~---~~i~~~~~~-----  233 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VL---LKIAKSEPP-----  233 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHHSCCC-----
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HH---HHHHcCCCC-----
Confidence            1123457999999999884     4568899999999999999999999986543211   11   112222111     


Q ss_pred             CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          280 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       280 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                        ....+......+.+++.+||+.||.+|||+.|+++
T Consensus       234 --~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 --TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             --CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              11222334456889999999999999999999865

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-53  Score=377.34  Aligned_cols=257  Identities=25%  Similarity=0.399  Sum_probs=208.4

Q ss_pred             ccCCcccce-eeecCCeEEEEEEEC---CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNK-IGRGGFGTVYKGTLT---NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~-lg~G~~g~v~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|.+... ||+|+||.||+|.++   ++..||||++... .....+.+.+|+++|++++||||+++++++.+ +..++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            356777774 999999999999864   3557999998754 34456789999999999999999999999865 46799


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+++|+|.+++.   ..+..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        86 vmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          86 VMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence            999999999999873   3345789999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCcce--eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          200 PDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       200 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      .......  .....||+.|+|||++.++.++.++|||||||++|||+| |..||.....   ..+..    .......  
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~----~i~~~~~--  230 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMA----FIEQGKR--  230 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHH----HHHTTCC--
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHH----HHHcCCC--
Confidence            5543222  233468899999999999999999999999999999998 8999875432   11211    1112111  


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                            ...++..+.++.+++.+||+.+|++|||+.+|++.|+....
T Consensus       231 ------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         231 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                  12233444568899999999999999999999999987653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=376.34  Aligned_cols=260  Identities=27%  Similarity=0.432  Sum_probs=205.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEec
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV  124 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  124 (370)
                      .++|++.+.||+|+||+||+|+++++..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            46899999999999999999999888889999987553 335679999999999999999999999854 5678999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++|+|..++...  ....+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++.......
T Consensus        94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            999999888432  234589999999999999999999999   999999999999999999999999999987655444


Q ss_pred             ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCC
Q 017503          205 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE  284 (370)
Q Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (370)
                      .......||+.|+|||++..+.++.++|||||||++|||++|..|+......  ......   .. ....        ..
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~---i~-~~~~--------~~  234 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ---VE-RGYR--------MP  234 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH---HH-TTCC--------CC
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHH---HH-hcCC--------CC
Confidence            4444567899999999999999999999999999999999976665433221  111111   11 1111        12


Q ss_pred             CChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          285 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       285 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      .+.....++.+++.+||+.||++||++.+|++.|+......
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            23334456889999999999999999999999999877644

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=375.26  Aligned_cols=261  Identities=26%  Similarity=0.406  Sum_probs=204.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCC-----CEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNG-----RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (370)
                      .+.|++.++||+|+||.||+|.++..     ..||||.+... .......+.+|+.++++++||||+++++++.+....+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            35788999999999999999987532     36999988654 3344557889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      +||||+.++++.+++.   .....+++..++.++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++.
T Consensus        86 ~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          86 IITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence            9999999999998873   3445799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc--eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          199 FPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       199 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      .......  ......||+.|+|||++.++.++.++|||||||++|||++|..|+.....  ...+..    ......   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~----~i~~~~---  230 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMK----AINDGF---  230 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHH----HHHTTC---
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHH----HHhccC---
Confidence            6543222  22334688999999999999999999999999999999997666543222  111211    112111   


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                           ....+.+.+..+.+++.+||+.+|.+|||+.+|++.|+.+++.+
T Consensus       231 -----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         231 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                 11223344456889999999999999999999999999887643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-53  Score=377.99  Aligned_cols=248  Identities=21%  Similarity=0.327  Sum_probs=203.6

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ++|++.+.||+|+||+||+|+++ +++.||||++...   .......+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            67999999999999999999985 6899999998643   2344567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      ||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||++..+..
T Consensus        88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999999883    445799999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          202 NIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       202 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ..+..   .... ...      
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~---~i~~-~~~------  227 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQ---KIIK-LEY------  227 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHT-TCC------
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHHH---HHHc-CCC------
Confidence            322 233446799999999999999999999999999999999999999864321   11111   1111 111      


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                         .++......+.+++.+||+.||.+|||+.|++.
T Consensus       228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence               112223345889999999999999999999754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=385.43  Aligned_cols=262  Identities=24%  Similarity=0.412  Sum_probs=203.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||+||+|++. +|+.||+|++... .......+.+|+.+|++++||||+++++++.+....++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999999985 6889999998755 33445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      |+++|+|.+++.    ....+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+|||++.....
T Consensus        85 y~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            999999999984    33468999999999999999999997 6   899999999999999999999999999986533


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC---------
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE---------  272 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  272 (370)
                      .   ......||+.|+|||++.+..++.++||||+||++|||++|+.||......................         
T Consensus       158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            2   2234579999999999999999999999999999999999999997643322111000000000000         


Q ss_pred             ----------C-Cc---c----cccCCCCCCC-hHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          273 ----------K-PL---E----LVDPELGEYP-PNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       273 ----------~-~~---~----~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                                . ..   .    .........+ .....++.+++.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                      0 00   0    0000000001 011245788999999999999999999987

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-52  Score=366.53  Aligned_cols=247  Identities=26%  Similarity=0.396  Sum_probs=197.4

Q ss_pred             cCC-cccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe----CCee
Q 017503           46 DDF-HLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRR  117 (370)
Q Consensus        46 ~~y-~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~  117 (370)
                      ++| ++.+.||+|+||+||+|.++ +++.||+|.+...  .....+.+.+|+++|++++||||+++++++.+    ....
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence            445 67788999999999999986 6889999987654  34445678899999999999999999999875    3567


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeecCCCCceEeC-CCCCeEEeeec
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLD-QEFNPKIGDFG  194 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~dlkp~Nill~-~~~~~kL~Dfg  194 (370)
                      ++||||+++|+|.+++.    ....+++..+..++.||+.||.|||++   +  |+||||||+|||++ .++.+||+|||
T Consensus        88 ~ivmE~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFG  160 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  160 (270)
T ss_dssp             EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEEEeCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence            99999999999999983    345789999999999999999999998   6  99999999999996 57899999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      ++.......   .....||+.|+|||++.+ .++.++|||||||++|||++|+.||......  ..+    .........
T Consensus       161 la~~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~----~~~i~~~~~  230 (270)
T d1t4ha_         161 LATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQI----YRRVTSGVK  230 (270)
T ss_dssp             GGGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHH----HHHHTTTCC
T ss_pred             cceeccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHH----HHHHHcCCC
Confidence            998654332   334679999999998865 5999999999999999999999998643221  111    111111111


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...       .+.....++.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~-------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 PAS-------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CGG-------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Ccc-------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            111       11122334788999999999999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.5e-52  Score=381.04  Aligned_cols=253  Identities=21%  Similarity=0.285  Sum_probs=209.2

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++.+.||+|+||.||+|++. +|+.||||++..........+.+|+.+|++++||||+++++++.+....|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            467999999999999999999985 6899999998776655566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC--CCCCeEEeeecCccccCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD--QEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~--~~~~~kL~Dfg~~~~~~~  201 (370)
                      |++|+|.+++.   ..+..+++..++.++.||+.||.|||++   +|+||||||+||||+  .++.+||+|||++..+..
T Consensus       108 ~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         108 LSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence            99999988873   3455799999999999999999999999   999999999999997  678999999999987765


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      ..  ......||+.|+|||++.+..++.++|||||||++|+|+||..||.....   .....   ........  . .  
T Consensus       182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~---~i~~~~~~--~-~--  248 (352)
T d1koba_         182 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQ---NVKRCDWE--F-D--  248 (352)
T ss_dssp             TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH---HHHHCCCC--C-C--
T ss_pred             CC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCCCC--C-C--
Confidence            32  23445789999999999999999999999999999999999999864422   11111   11111111  0 0  


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                       ....+.....+.+|+.+||+.||.+|||+.|+++.
T Consensus       249 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         249 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             11122333458899999999999999999999763

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-52  Score=375.43  Aligned_cols=253  Identities=21%  Similarity=0.299  Sum_probs=191.2

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      ..++|++.+.||+|+||+||+|+++ +++.||||++.... ......+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3577999999999999999999986 68899999987543 223356778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC---CCCCeEEeeecCccc
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKL  198 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kL~Dfg~~~~  198 (370)
                      ||+++|+|.+++.    ....+++..+..++.||+.||+|||++   +|+||||||+||++.   .++.+||+|||++..
T Consensus        87 E~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          87 QLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             CCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             eccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            9999999999983    455799999999999999999999999   999999999999995   578899999999986


Q ss_pred             cCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ....   .........  ..
T Consensus       160 ~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~---~~i~~~~~~--~~  229 (307)
T d1a06a_         160 EDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLF---EQILKAEYE--FD  229 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHHHTTCCC--CC
T ss_pred             ccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHH---HHHhccCCC--CC
Confidence            54332  23345799999999999999999999999999999999999999865322   1111   111111111  11


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .    ...++....+.+++.+||+.||.+|||+.|+++.
T Consensus       230 ~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         230 S----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             T----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             C----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1    1122333458899999999999999999999763

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.5e-51  Score=378.31  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=209.0

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .++|++.+.||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            568999999999999999999985 6899999999877666667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeC--CCCCeEEeeecCccccCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD--QEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~--~~~~~kL~Dfg~~~~~~~  201 (370)
                      +++|+|.+++.   .....+++..+..++.||+.||.|||++   +|+||||||+|||++  .++.+||+|||++.....
T Consensus       105 ~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         105 MSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            99999999883   2345699999999999999999999999   999999999999996  467899999999987654


Q ss_pred             CCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          202 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      ..  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   .....   .........   .  
T Consensus       179 ~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~---~i~~~~~~~---~--  245 (350)
T d1koaa2         179 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLR---NVKSCDWNM---D--  245 (350)
T ss_dssp             TS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHTCCCS---C--
T ss_pred             cc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCCCCC---C--
Confidence            33  23445789999999999999999999999999999999999999864321   11111   111111100   0  


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                       ....+.....+.+++.+||+.||.+|||+.|+++.
T Consensus       246 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 -DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             01112233458899999999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=372.98  Aligned_cols=248  Identities=27%  Similarity=0.404  Sum_probs=199.0

Q ss_pred             ceeeecCCeEEEEEEEC---CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEecCC
Q 017503           52 NKIGRGGFGTVYKGTLT---NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN  126 (370)
Q Consensus        52 ~~lg~G~~g~v~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  126 (370)
                      ++||+|+||+||+|.++   .++.||||++...  +....+.+.+|+.+|++++||||+++++++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            57999999999999864   2467999998654  33445678999999999999999999999865 457899999999


Q ss_pred             CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcce
Q 017503          127 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI  206 (370)
Q Consensus       127 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  206 (370)
                      |+|.+++.    ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999983    445699999999999999999999999   99999999999999999999999999998765443322


Q ss_pred             --eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCCC
Q 017503          207 --TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG  283 (370)
Q Consensus       207 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (370)
                        .....||+.|+|||++.+..++.++|||||||++|||+| |..||.....   ..+.    ........        .
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~----~~i~~~~~--------~  229 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVT----AMLEKGER--------M  229 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHH----HHHHTTCC--------C
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHH----HHHHcCCC--------C
Confidence              233568899999999999999999999999999999998 8999875422   1111    11122111        1


Q ss_pred             CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          284 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       284 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      ..+...+.++.+++.+||+.||.+|||+.+|++.|+...
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            223334456888999999999999999999999887654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=378.92  Aligned_cols=259  Identities=25%  Similarity=0.393  Sum_probs=206.2

Q ss_pred             hccCCcccceeeecCCeEEEEEEECC-C-----CEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCC
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLTN-G-----RRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGT  115 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  115 (370)
                      ..++|++.+.||+|+||+||+|++.. +     ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34789999999999999999999742 2     36899987654 334456788999999998 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhccccc-------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCC
Q 017503          116 RRILVYEYVENNSLDRVLLGATK-------------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK  176 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~-------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlk  176 (370)
                      ..++||||+++|+|.+++.....                   ....+++..++.++.||+.||+|||++   +|+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence            99999999999999999954321                   123589999999999999999999999   99999999


Q ss_pred             CCceEeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCccc
Q 017503          177 ASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMW  254 (370)
Q Consensus       177 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~  254 (370)
                      |+||+++.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |..||....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999866543322 2334568999999999999999999999999999999998 899986543


Q ss_pred             ccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHH
Q 017503          255 GQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT  319 (370)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  319 (370)
                      ..  ..+.    ........        ...+......+.+|+.+||+.+|.+|||+.||++.|.
T Consensus       272 ~~--~~~~----~~~~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VD--ANFY----KLIQNGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CS--HHHH----HHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH--HHHH----HHHhcCCC--------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            22  1111    12222111        1223334456889999999999999999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.7e-52  Score=374.12  Aligned_cols=245  Identities=29%  Similarity=0.459  Sum_probs=201.0

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  121 (370)
                      +.|++++.||+|+||+||+|++. +++.||||++....   ....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35999999999999999999975 68889999886542   344567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCC
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD  201 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  201 (370)
                      |||.+|+|..++    ..+..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        95 E~~~~g~l~~~~----~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            999999998776    3345799999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCcceeecccCCCCCCCcccccC---CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          202 NITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                           .....||+.|+|||++.+   +.++.++|||||||++|||++|..||......      ...........+.   
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~~~~---  233 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESPA---  233 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCCC---
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCC---
Confidence                 233569999999999864   46899999999999999999999998643221      1111222222111   


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                         +  .+......+.+++.+||+.||.+|||+.++++
T Consensus       234 ---~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 ---L--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---C--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---C--CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence               1  11122345888999999999999999999976

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=371.21  Aligned_cols=257  Identities=25%  Similarity=0.374  Sum_probs=199.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC----CCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN----GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      .++|++.+.||+|+||.||+|++..    +..||||.+... .......+.+|+.++++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4789999999999999999998752    346899988654 3444567899999999999999999999985 467899


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      ||||+.+|+|.+++.   .....+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        85 v~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence            999999999998873   3445789999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccc
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV  278 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (370)
                      ............||+.|+|||++.+..++.++|||||||++|||++ |.+||......   .+...   . .....    
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~---i-~~~~~----  227 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR---I-ENGER----  227 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH---H-HTTCC----
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH---H-HcCCC----
Confidence            5544444455668999999999999999999999999999999998 88888654332   12111   1 11111    


Q ss_pred             cCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          279 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       279 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                          ...++..+..+.+++.+||..||.+|||+.+|++.|+.++.
T Consensus       228 ----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         228 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                12233444568899999999999999999999999988764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-51  Score=365.80  Aligned_cols=251  Identities=25%  Similarity=0.305  Sum_probs=204.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc------ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE------SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++...      .....+.+.+|+.+|++++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            478999999999999999999985 6899999987543      123467789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC----CeEEeee
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----NPKIGDF  193 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kL~Df  193 (370)
                      ++|||||++|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+||
T Consensus        89 ~iv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhc----cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            99999999999999983    344799999999999999999999999   999999999999998776    4999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      |++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   .....   .......
T Consensus       162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~---~i~~~~~  233 (293)
T d1jksa_         162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLA---NVSAVNY  233 (293)
T ss_dssp             TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHTTCC
T ss_pred             hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---HHHHH---HHHhcCC
Confidence            9998765432  23345689999999999999999999999999999999999999864321   11111   1111111


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...      ...++.....+.+++.+||+.||.+|||+.++++
T Consensus       234 ~~~------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 EFE------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCC------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCC------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000      0001122345789999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=370.39  Aligned_cols=248  Identities=28%  Similarity=0.324  Sum_probs=206.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||.||+|+++ +|+.||||++...   .......+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            578999999999999999999985 7899999998643   234567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++|+|.+++.    ....+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||++....
T Consensus        84 ~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence            99999999999983    455789999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|++||.....   ..+..   . ......      
T Consensus       157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~---~-i~~~~~------  222 (337)
T d1o6la_         157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFE---L-ILMEEI------  222 (337)
T ss_dssp             CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---H-HHHCCC------
T ss_pred             cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHH---H-HhcCCC------
Confidence            332 223446799999999999999999999999999999999999999865422   11211   1 111111      


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCC-----HHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  316 (370)
                         .++.....++.++|.+||+.||.+||+     +.++++
T Consensus       223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               112233345789999999999999995     888876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-51  Score=373.03  Aligned_cols=264  Identities=24%  Similarity=0.391  Sum_probs=211.3

Q ss_pred             HHHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCcC-hhcHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 017503           41 LRSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQ  113 (370)
Q Consensus        41 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  113 (370)
                      ++...++|++.+.||+|+||+||+|+++      ++..||||++.... ......+.+|+.+|++++||||+++++++..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            4445678999999999999999999864      35689999987653 3445678999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccc--------------------cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGAT--------------------KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR  173 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~  173 (370)
                      ....+++|||+.+|+|.+++....                    .....+++..++.++.|++.||+|||++   +++||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence            999999999999999999984321                    1233488999999999999999999999   99999


Q ss_pred             cCCCCceEeCCCCCeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCC-CCCC
Q 017503          174 DIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR-NSGK  251 (370)
Q Consensus       174 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~-~p~~  251 (370)
                      ||||+|||++.++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            9999999999999999999999986644322 2233456889999999999999999999999999999999996 4554


Q ss_pred             cccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          252 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      ....   ..+..   . ......        ...+...+.++.+++.+||+.+|++|||+.+|++.|+++.
T Consensus       245 ~~~~---~e~~~---~-v~~~~~--------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAH---EEVIY---Y-VRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCH---HHHHH---H-HHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCH---HHHHH---H-HHcCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            4321   11211   1 122211        1223334456889999999999999999999999999864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-50  Score=361.34  Aligned_cols=259  Identities=23%  Similarity=0.331  Sum_probs=202.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----e
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT----R  116 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~  116 (370)
                      .++|++.+.||+|+||.||+|++. +|+.||||++...   +......+.+|+.+++.++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            578999999999999999999975 6889999998654   3344567889999999999999999999998643    4


Q ss_pred             eEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          117 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      .|+||||+++++|.+++    .....+++..++.++.||+.||.|||++   +|+||||||+|||++.++..+|+|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhh----cccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence            78999999999999888    3445789999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCc--ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          197 KLFPDNIT--HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       197 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      ........  .......||+.|+|||++.+..++.++|||||||++|+|+||++||.....      .............
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCC
Confidence            76543322  233446799999999999999999999999999999999999999864321      1112222222221


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCCCC-CHHHHHHHHHhhh
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP-QMNQVIKMLTKNI  322 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~  322 (370)
                      ...      ...++.+..+.+++.+||+.||.+|| |+++++..|.++.
T Consensus       233 ~~~------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 PPS------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CGG------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCc------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            110      11122234588999999999999999 8999998887753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-50  Score=366.41  Aligned_cols=246  Identities=28%  Similarity=0.379  Sum_probs=205.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            467999999999999999999985 6899999998643   234467788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+.+|+|..++    ..+..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        83 mE~~~gg~l~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          83 MDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             ECCCCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eeecCCccccccc----cccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEec
Confidence            9999999999988    4555688899999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ..    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ...   .........       
T Consensus       156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~---~~~i~~~~~-------  218 (316)
T d1fota_         156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKT---YEKILNAEL-------  218 (316)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHH---HHHHHHCCC-------
T ss_pred             cc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---HHH---HHHHHcCCC-------
Confidence            43    3346799999999999999999999999999999999999999865321   111   112222111       


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIKM  317 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  317 (370)
                         ..++.....+.+++.+||+.||.+||     |++++++.
T Consensus       219 ---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence               11222334588899999999999996     89998763

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=363.94  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=198.5

Q ss_pred             ccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe-CCeeEEEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ-GTRRILVYEY  123 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~  123 (370)
                      .++|++.+.||+|+||.||+|+++ |..||||+++.+.  ..+.+.+|+.++++++||||+++++++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            467899999999999999999995 7889999997553  34678899999999999999999999865 4567999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +++|+|.+++...  ....+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||+++..... 
T Consensus        83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            9999999998432  223589999999999999999999999   9999999999999999999999999999865432 


Q ss_pred             cceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCcccccCCC
Q 017503          204 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL  282 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (370)
                         .....++..|+|||++.++.++.++|||||||++|||+| |++||......   .+...    .....        .
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~----i~~~~--------~  218 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----VEKGY--------K  218 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH----HTTTC--------C
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCC--------C
Confidence               223457889999999999999999999999999999998 67776543221   12111    11111        1


Q ss_pred             CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhh
Q 017503          283 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI  322 (370)
Q Consensus       283 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  322 (370)
                      ...+.....++.+++.+||+.||.+|||+.+|++.|+++.
T Consensus       219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1223334456889999999999999999999999998864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=367.37  Aligned_cols=257  Identities=27%  Similarity=0.429  Sum_probs=203.5

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCC----EEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGR----RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL  119 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  119 (370)
                      ++|++.+.||+|+||+||+|.+. +|+    +||+|.+... .....+.+.+|+.++++++||||+++++++.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            57999999999999999999975 333    6899987643 445567899999999999999999999999865 5577


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF  199 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~  199 (370)
                      +++++.+++|.+++.   .....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus        88 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence            889999999988874   3456789999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCCccc
Q 017503          200 PDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL  277 (370)
Q Consensus       200 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (370)
                      ...... ......||+.|+|||++.++.++.++|||||||++|||+| |.+||.......   +....    .....   
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i----~~~~~---  231 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKGER---  231 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHH----HHTCC---
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCCC---
Confidence            543332 2333568999999999999999999999999999999998 788876543221   21111    11111   


Q ss_pred             ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          278 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                           ...++.....+.+++.+||+.||.+|||+.+|++.|..+.+.
T Consensus       232 -----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                 122334445688999999999999999999999999887653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=360.52  Aligned_cols=256  Identities=27%  Similarity=0.424  Sum_probs=197.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC--CC--CEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT--NG--RRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~--~~--~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|++.+.||+|+||.||+|++.  ++  ..||||++...   .....+.+.+|+.+|++++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            467999999999999999999863  22  36899988654   33445788999999999999999999999965 467


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ++||||++++++.+++.   .....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus        86 ~lv~e~~~~~~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHH---HHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             heeeeeecCcchhhhhh---cccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence            89999999999998874   2344699999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCcce--eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          198 LFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       198 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      .........  .....++..|+|||.+.+..++.++||||||+++|||+| |..||......   ..   ..........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~---~~~i~~~~~~  233 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QI---LHKIDKEGER  233 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH---HHHHHTSCCC
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HH---HHHHHhCCCC
Confidence            875543322  233457889999999999999999999999999999998 89998643221   11   1222222111


Q ss_pred             cccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhh
Q 017503          275 LELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN  321 (370)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  321 (370)
                      .        ..++..+..+.+++.+||+.||++|||+.+|++.|.++
T Consensus       234 ~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         234 L--------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             C--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1        11223334588999999999999999999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-49  Score=365.48  Aligned_cols=245  Identities=24%  Similarity=0.301  Sum_probs=204.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      .++|++++.||+|+||.||+|+++ +|+.||||++...   .......+.+|+.+|+.++||||+++++++.+....++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            368999999999999999999985 6899999988643   234456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+.+|+|..++.    ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus       120 ~e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         120 MEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            99999999999883    334689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ..    .....||+.|+|||++.+..++.++|||||||++|+|+||+.||....   ...+..   ...... .      
T Consensus       193 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~---~i~~~~-~------  255 (350)
T d1rdqe_         193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYE---KIVSGK-V------  255 (350)
T ss_dssp             SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHCC-C------
T ss_pred             cc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHHHH---HHhcCC-C------
Confidence            43    234568999999999999999999999999999999999999986432   111111   111111 1      


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCC-----CHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRP-----QMNQVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  316 (370)
                         ..+......+.+++.+||+.||.+|+     |+.++++
T Consensus       256 ---~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               11222334588999999999999994     8999976

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=362.00  Aligned_cols=270  Identities=25%  Similarity=0.381  Sum_probs=203.1

Q ss_pred             CHHHHHHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceee
Q 017503           37 SYTELRSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELI  108 (370)
Q Consensus        37 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~  108 (370)
                      +...++...++|++.+.||+|+||.||+|.+.      +++.||||++... .....+.+.+|...+.++ +|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            34445445688999999999999999999863      2467999998754 334456777888888877 789999999


Q ss_pred             eEEEeC-CeeEEEEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecC
Q 017503          109 GCCVQG-TRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI  175 (370)
Q Consensus       109 ~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dl  175 (370)
                      +++.+. ...++||||+++|+|.+++.....            ....+++..++.++.||+.||.|||++   +|+||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence            988764 468999999999999999854322            134589999999999999999999999   9999999


Q ss_pred             CCCceEeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCC-CCCCcc
Q 017503          176 KASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR-NSGKAM  253 (370)
Q Consensus       176 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~-~p~~~~  253 (370)
                      ||+||||+.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+||. +||...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999866443322 233456899999999999999999999999999999999975 466433


Q ss_pred             cccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          254 WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      ...  ..+.    .........        ..+.....++.+++.+||+.||.+|||+.+|++.|+.+++
T Consensus       241 ~~~--~~~~----~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         241 KID--EEFC----RRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             CCS--HHHH----HHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHH--HHHH----HHHhcCCCC--------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            221  1111    112222111        1222334458899999999999999999999999998865

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-50  Score=363.23  Aligned_cols=259  Identities=26%  Similarity=0.392  Sum_probs=205.7

Q ss_pred             cCCcccceeeecCCeEEEEEEECC-CC--EEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCeeEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLTN-GR--RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ++|++.+.||+|+||.||+|++++ +.  .||||.+... .....+.+.+|+++|+++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            789999999999999999999763 43  4778876543 344556789999999998 799999999999999999999


Q ss_pred             EEecCCCCHHHHhccc------------ccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCe
Q 017503          121 YEYVENNSLDRVLLGA------------TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP  188 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~  188 (370)
                      |||+++|+|.+++...            ......+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999998543            13346789999999999999999999999   99999999999999999999


Q ss_pred             EEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCC-CCCcccccchhhHHHHHHH
Q 017503          189 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN-SGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       189 kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~-p~~~~~~~~~~~~~~~~~~  267 (370)
                      ||+|||++........  .....||..|+|||.+.++.++.++|||||||++|||++|.. ||....   ...+.    .
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~----~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELY----E  237 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHH----H
T ss_pred             EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHH----H
Confidence            9999999975443221  223458899999999999999999999999999999999765 554321   11111    1


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                      ......        ....+.....++.+++.+||+.||++|||+.+|++.|++++..
T Consensus       238 ~i~~~~--------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         238 KLPQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HGGGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHhcC--------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            111111        1122334445688999999999999999999999999998753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-49  Score=367.30  Aligned_cols=249  Identities=24%  Similarity=0.307  Sum_probs=199.1

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---hhcHHHHH---HHHHHHHhcCCCCcceeeeEEEeCCee
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---KQGVREFI---TEIMTLSNVRHPNLVELIGCCVQGTRR  117 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~  117 (370)
                      .++|++.+.||+|+||.||+|+++ +|+.||||++....   ......+.   .++.+++.++||||+++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            478999999999999999999986 68999999885331   12222333   346677778899999999999999999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      |+||||+++|+|.+++.    .+..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        83 ~ivmE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence            99999999999999983    345688999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc
Q 017503          198 LFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE  276 (370)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (370)
                      .+....   .....||+.|+|||++.. ..++.++|||||||++|+|+||+.||..........+.    .... ..   
T Consensus       156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~-~~---  224 (364)
T d1omwa3         156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL-TM---  224 (364)
T ss_dssp             ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSS-SC---
T ss_pred             ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hhcc-cC---
Confidence            765432   334579999999999875 56899999999999999999999999764332221111    1100 00   


Q ss_pred             cccCCCCCCChHHHHHHHHHHHHchhhccCCCCC-----HHHHHH
Q 017503          277 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  316 (370)
Q Consensus       277 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  316 (370)
                           ....+......+.+++.+||+.||.+|||     ++++++
T Consensus       225 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                 01122233345889999999999999999     688875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-49  Score=353.40  Aligned_cols=251  Identities=21%  Similarity=0.290  Sum_probs=203.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC---------hhcHHHHHHHHHHHHhcC-CCCcceeeeEEEe
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES---------KQGVREFITEIMTLSNVR-HPNLVELIGCCVQ  113 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~  113 (370)
                      .++|++.+.||+|+||+||+|++. +++.||||++....         ......+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999985 68899999876542         122345788999999996 9999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      .+..|+||||+++|+|.+++.    ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CcceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence            999999999999999999993    345799999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccC------CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHH
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLG------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ  267 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  267 (370)
                      |++.......  ......||+.|+|||.+.+      ..++.++||||+||++|+|++|+.||.....   .....   .
T Consensus       155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~~---~  226 (277)
T d1phka_         155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLR---M  226 (277)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---H
T ss_pred             hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHHHH---H
Confidence            9998765432  2344678999999998753      4578899999999999999999999875432   11111   1


Q ss_pred             HHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          268 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .......  ..    ....+....++.+++.+||+.+|.+|||+.||++
T Consensus       227 i~~~~~~--~~----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         227 IMSGNYQ--FG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHTCCC--CC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhCCCC--CC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111111  11    1112234456889999999999999999999865

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=359.84  Aligned_cols=253  Identities=21%  Similarity=0.282  Sum_probs=205.8

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ..++|++.+.||+|+||+||+|.++ +++.||+|++...... ...+.+|+.+|+.++||||+++++++.+.+..|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4588999999999999999999986 6888999998766433 3567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCC--CCeEEeeecCccccC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE--FNPKIGDFGLAKLFP  200 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~--~~~kL~Dfg~~~~~~  200 (370)
                      ||++|+|.+++.   ..+..+++.++..++.||+.||.|||++   +|+||||||+|||++.+  ..+||+|||++....
T Consensus        82 ~~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          82 FISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             cCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            999999999983   2344699999999999999999999999   99999999999999854  479999999998764


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ...  ......+++.|+|||.+.+..++.++|||||||++|+|++|..||.....   .....   ..........  ..
T Consensus       156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~---~i~~~~~~~~--~~  225 (321)
T d1tkia_         156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIE---NIMNAEYTFD--EE  225 (321)
T ss_dssp             TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH---HHHHTCCCCC--HH
T ss_pred             cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCCCCCC--hh
Confidence            432  23345689999999999999999999999999999999999999865422   11111   1111111100  00


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ....    ...++.+++.+||..||.+|||+.|+++.
T Consensus       226 ~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         226 AFKE----ISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0011    23347899999999999999999999873

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=358.96  Aligned_cols=254  Identities=27%  Similarity=0.433  Sum_probs=202.7

Q ss_pred             cceeeecCCeEEEEEEECCC----CEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-CeeEEEEEec
Q 017503           51 SNKIGRGGFGTVYKGTLTNG----RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-TRRILVYEYV  124 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~~----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~  124 (370)
                      .++||+|+||+||+|++.++    ..||||.++.. +......+.+|+++|++++||||+++++++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            56899999999999997532    35899988643 555667899999999999999999999998764 5889999999


Q ss_pred             CCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCCc
Q 017503          125 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT  204 (370)
Q Consensus       125 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  204 (370)
                      ++++|.+++.   .....+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||++........
T Consensus       112 ~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            9999999884   3445678899999999999999999999   999999999999999999999999999987654322


Q ss_pred             c---eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccCC
Q 017503          205 H---ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE  281 (370)
Q Consensus       205 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (370)
                      .   ......||+.|+|||.+....++.++||||||+++|||+||..||.......  .+...   .. ....       
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~---i~-~g~~-------  252 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY---LL-QGRR-------  252 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HH-TTCC-------
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH---HH-cCCC-------
Confidence            1   2233568899999999999999999999999999999999887765433211  11111   11 1111       


Q ss_pred             CCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          282 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       282 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                       ...+......+.+++.+||+.||++||++.||++.|+.+...
T Consensus       253 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence             112223344588899999999999999999999999988753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=363.04  Aligned_cols=262  Identities=26%  Similarity=0.429  Sum_probs=207.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEECC--------CCEEEEEECcCcC-hhcHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLTN--------GRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQG  114 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~~--------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  114 (370)
                      .++|++.+.||+|+||.||+|+...        +..||||++..+. ......+.+|...+.++ +||||+++++++.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            5789999999999999999998532        2469999987653 34457788899999888 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhccccc------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEe
Q 017503          115 TRRILVYEYVENNSLDRVLLGATK------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL  182 (370)
Q Consensus       115 ~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill  182 (370)
                      ...++||||+++|+|.+++.....            ....+++..++.++.||+.||+|||+.   +++||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence            999999999999999999954332            234689999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEeeecCccccCCCCc-ceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHh-CCCCCCcccccchhh
Q 017503          183 DQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKF  260 (370)
Q Consensus       183 ~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~p~~~~~~~~~~~  260 (370)
                      +.++.+||+|||++........ .......+++.|+|||.+.++.++.++||||||+++|||++ |.+||.....   ..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~~  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---HH
Confidence            9999999999999987654322 22344568899999999999999999999999999999998 6777754322   11


Q ss_pred             HHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhcc
Q 017503          261 LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL  324 (370)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  324 (370)
                          ...........        ..+......+.+++.+||+.||.+|||+.||++.|++++..
T Consensus       246 ----~~~~i~~~~~~--------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         246 ----LFKLLKEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             ----HHHHHHTTCCC--------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHHcCCCC--------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence                11222222111        22233344588999999999999999999999999998764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=361.37  Aligned_cols=247  Identities=27%  Similarity=0.389  Sum_probs=202.0

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc---ChhcHHHHHHHHHHHH-hcCCCCcceeeeEEEeCCeeEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE---SKQGVREFITEIMTLS-NVRHPNLVELIGCCVQGTRRILV  120 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv  120 (370)
                      ++|++.+.||+|+||+||+|+++ +++.||||++...   .......+..|..++. .++||||+++++++.+.+..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999986 6889999998643   2334556667777765 68999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccC
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP  200 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  200 (370)
                      |||+++|+|.+++.    ....+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||++....
T Consensus        82 mEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999983    445689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccccC
Q 017503          201 DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP  280 (370)
Q Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (370)
                      ... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..+..   . .....      +
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~---~-i~~~~------~  220 (320)
T d1xjda_         155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFH---S-IRMDN------P  220 (320)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---H-HHHCC------C
T ss_pred             ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHHH---H-HHcCC------C
Confidence            432 223445799999999999999999999999999999999999999865321   11111   1 11111      1


Q ss_pred             CCCCCChHHHHHHHHHHHHchhhccCCCCCHH-HHHH
Q 017503          281 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN-QVIK  316 (370)
Q Consensus       281 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~  316 (370)
                         ..+......+.+|+.+||+.||.+||++. ++++
T Consensus       221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               11222334588999999999999999995 6753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=359.45  Aligned_cols=252  Identities=19%  Similarity=0.224  Sum_probs=197.6

Q ss_pred             ccCCcccc-eeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhc-CCCCcceeeeEEEe----CCee
Q 017503           45 TDDFHLSN-KIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ----GTRR  117 (370)
Q Consensus        45 ~~~y~~~~-~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~  117 (370)
                      .++|++.. .||+|+||+||+|++. +++.||||++...     ..+.+|+.++.++ +||||+++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            57899875 5999999999999984 6899999998643     4566799887654 89999999999876    4568


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC---CCCeEEeeec
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFG  194 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kL~Dfg  194 (370)
                      |+|||||++|+|.+++..  .....+++..+..++.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence            999999999999999842  2235699999999999999999999999   9999999999999985   4569999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCC
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP  274 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  274 (370)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.........   ...   .. ...
T Consensus       160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~---~~-~i~  230 (335)
T d2ozaa1         160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGM---KT-RIR  230 (335)
T ss_dssp             TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCC
T ss_pred             eeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHH---HH-HHh
Confidence            998765432  234457999999999999999999999999999999999999998654321110   000   00 000


Q ss_pred             cccccCCCC-CCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          275 LELVDPELG-EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       275 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                        ....... ........++.+|+.+||+.||.+|||+.|+++.
T Consensus       231 --~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         231 --MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             --SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              0000011 1112334568899999999999999999999873

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=360.20  Aligned_cols=262  Identities=25%  Similarity=0.413  Sum_probs=210.6

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCe
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR  116 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  116 (370)
                      ..++|++.+.||+|+||.||+|.++      .++.||||++... .......+.+|+.++++++||||+++++++.....
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            3578999999999999999999864      2578999998754 33445568899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhcccc------cCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEE
Q 017503          117 RILVYEYVENNSLDRVLLGAT------KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI  190 (370)
Q Consensus       117 ~~lv~e~~~~~~L~~~~~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL  190 (370)
                      .++||||+.+|+|.+++....      .....+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEE
Confidence            999999999999999884322      1223468999999999999999999999   9999999999999999999999


Q ss_pred             eeecCccccCCCCcce-eecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCC-CCCCcccccchhhHHHHHHHH
Q 017503          191 GDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR-NSGKAMWGQMNKFLLEWAWQL  268 (370)
Q Consensus       191 ~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~  268 (370)
                      +|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||+||. +||....   ......    .
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~---~~~~~~----~  247 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVLR----F  247 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHHHH----H
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC---HHHHHH----H
Confidence            9999998664432222 23345889999999999999999999999999999999985 5554321   111111    1


Q ss_pred             HhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          269 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      ..+..        ....+......+.+++.+||+.+|.+|||+.+|++.|++.+.
T Consensus       248 i~~~~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         248 VMEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHhCC--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11111        112233344568899999999999999999999999988755

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-49  Score=356.67  Aligned_cols=276  Identities=25%  Similarity=0.401  Sum_probs=216.2

Q ss_pred             cccccCHHH-HHHhccCCcccceeeecCCeEEEEEEEC------CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhc-CCC
Q 017503           32 NVNHFSYTE-LRSATDDFHLSNKIGRGGFGTVYKGTLT------NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHP  102 (370)
Q Consensus        32 ~~~~~~~~~-~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~  102 (370)
                      +..+|+++. ++-..++|++.+.||+|+||.||+|++.      .++.||||++... .......+.+|+.+++++ +||
T Consensus         8 ~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~Hp   87 (311)
T d1t46a_           8 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM   87 (311)
T ss_dssp             CTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred             CcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCC
Confidence            344455433 2233589999999999999999999852      4568999998754 334456788999999999 799


Q ss_pred             CcceeeeEEEeCCeeEEEEEecCCCCHHHHhccccc--------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 017503          103 NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK--------------ANIKLNWEKRSDICVGIAKGLAFLHEELVP  168 (370)
Q Consensus       103 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~  168 (370)
                      ||+++++++.+....++||||+++|+|.+++.....              ....+++..+..++.||+.||+|||++   
T Consensus        88 nIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---  164 (311)
T d1t46a_          88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---  164 (311)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             CEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            999999999999999999999999999999854331              234689999999999999999999999   


Q ss_pred             CeEeecCCCCceEeCCCCCeEEeeecCccccCCCCcc-eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCC
Q 017503          169 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR  247 (370)
Q Consensus       169 ~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~  247 (370)
                      +++||||||+||+++.++.+||+|||++......... ......||+.|+|||.+.++.++.++|||||||++|||+|+.
T Consensus       165 ~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g  244 (311)
T d1t46a_         165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG  244 (311)
T ss_dssp             TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCC
Confidence            9999999999999999999999999999977654332 334467899999999999999999999999999999999954


Q ss_pred             CCCCcccccchhhHHHHHHHHHhcCCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          248 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      .|+........ .+.    ........     +   ..+......+.+|+.+||+.||++|||+.+|++.|++.+.
T Consensus       245 ~p~~~~~~~~~-~~~----~~i~~~~~-----~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         245 SSPYPGMPVDS-KFY----KMIKEGFR-----M---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             CCSSTTCCSSH-HHH----HHHHHTCC-----C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHH-HHH----HHHhcCCC-----C---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            44332222211 111    11111111     1   1122334458899999999999999999999999998765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=357.73  Aligned_cols=267  Identities=26%  Similarity=0.331  Sum_probs=200.1

Q ss_pred             cCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----eeEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT----RRILVY  121 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~  121 (370)
                      ++|.+.+.||+|+||.||+|++. |+.||||++...... ......|+..+.+++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            57888999999999999999974 789999998655322 122233555556789999999999998654    578999


Q ss_pred             EecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEeecCCCCceEeCCCCCeEEeeecCc
Q 017503          122 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-----VPHIVHRDIKASNILLDQEFNPKIGDFGLA  196 (370)
Q Consensus       122 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~  196 (370)
                      ||+++|+|.+++..     ..+++..++.++.|++.||.|||+..     .++|+||||||+||||+.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            99999999999942     35899999999999999999999631     128999999999999999999999999999


Q ss_pred             cccCCCCcc---eeecccCCCCCCCcccccCCC------cCccccchhhhHHHHHHHhCCCCCCcccccchh--------
Q 017503          197 KLFPDNITH---ITTRIAGTTGYLAPEYVLGGQ------LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--------  259 (370)
Q Consensus       197 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~il~elltg~~p~~~~~~~~~~--------  259 (370)
                      .........   ......||+.|+|||++.+..      ++.++|||||||+||||+||..|+.........        
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            876543322   223467999999999887642      678899999999999999998876432211110        


Q ss_pred             hHHHHHHHHHhcCCCcccccCCCCC--CChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhc
Q 017503          260 FLLEWAWQLHQEEKPLELVDPELGE--YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR  323 (370)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  323 (370)
                      .............    ..++.+..  ...+....+.+++.+||+.||.+|||+.||++.|+++..
T Consensus       236 ~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0111111111111    11222211  133566778999999999999999999999999988764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-49  Score=353.61  Aligned_cols=256  Identities=22%  Similarity=0.277  Sum_probs=195.9

Q ss_pred             ccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChh-----cHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           50 LSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQ-----GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        50 ~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      .+++||+|+||+||+|+++ +|+.||||++......     ....+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4678999999999999975 6899999998654221     124578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.++++..+.    ..+..+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            9998777665    4456789999999999999999999999   99999999999999999999999999998665433


Q ss_pred             cceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcccc----
Q 017503          204 THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV----  278 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  278 (370)
                      .. .....||+.|+|||++... .++.++|||||||++|||++|.+||.....   ......+.............    
T Consensus       155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchhc
Confidence            22 2335689999999988654 579999999999999999999999864422   11222222221111000000    


Q ss_pred             ------cCCCCCCC-----hHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          279 ------DPELGEYP-----PNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       279 ------~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                            .......+     +.....+.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                  00001111     122346889999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=351.84  Aligned_cols=262  Identities=24%  Similarity=0.326  Sum_probs=200.0

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcC--hhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++|++++.||+|+||+||+|++. +|+.||||++....  ......+.+|+++|++++||||+++++++.+....|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999985 68999999986542  2345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      |+.++.+....   ......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~~~~~~~~---~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHHHHH---HTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchhhhhh---hhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99876555443   23455699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeecccCCCCCCCcccccCCC-cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC--Ccccc-
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK--PLELV-  278 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-  278 (370)
                      .. ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||.....   ...............  ..... 
T Consensus       156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCCCchhhccccc
Confidence            22 233356899999999877665 57899999999999999999999864322   111111111111100  00000 


Q ss_pred             -----cCCCCC--------CChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          279 -----DPELGE--------YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       279 -----~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                           ......        ..+.....+.+++.+||+.||.+|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                 000000        011223457889999999999999999999764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.6e-48  Score=349.85  Aligned_cols=260  Identities=23%  Similarity=0.355  Sum_probs=201.8

Q ss_pred             cCCcccceeeecCCeEEEEEEECCCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY  123 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  123 (370)
                      ++|++.+.||+|+||+||+|++++|+.||||++...  .......+.+|+.+|++++||||+++++++.+.+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            689999999999999999999999999999998654  233356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCCC
Q 017503          124 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI  203 (370)
Q Consensus       124 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  203 (370)
                      +.++++..+.    .....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            9988777776    4456799999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCcc------
Q 017503          204 THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE------  276 (370)
Q Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  276 (370)
                      . ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......  . ................      
T Consensus       155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~-~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--D-QLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H-HHHHHHHHHCCCCTTTSTTGGG
T ss_pred             c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--H-HHHHHHHhhCCCChhhccchhh
Confidence            2 22334588999999988654 5689999999999999999999998654221  1 1111111111100000      


Q ss_pred             --cccCCC--------CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          277 --LVDPEL--------GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       277 --~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                        ......        ....+.....+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000000        1112223345789999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=352.59  Aligned_cols=240  Identities=22%  Similarity=0.349  Sum_probs=194.7

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcCh------hcHHHHHHHHHHHHhcC--CCCcceeeeEEEeCC
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESK------QGVREFITEIMTLSNVR--HPNLVELIGCCVQGT  115 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~  115 (370)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.....      .....+.+|+.+|++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            578999999999999999999985 689999998764311      11233567999999986  899999999999999


Q ss_pred             eeEEEEEecCC-CCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-CCCeEEeee
Q 017503          116 RRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDF  193 (370)
Q Consensus       116 ~~~lv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kL~Df  193 (370)
                      ..++||||+.+ +++.+++.    .+..+++..+..++.||+.||.|||++   +|+||||||+|||++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence            99999999976 57777773    345789999999999999999999999   9999999999999985 478999999


Q ss_pred             cCccccCCCCcceeecccCCCCCCCcccccCCCc-CccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          194 GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       194 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      |++.......   .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....            ......
T Consensus       156 G~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~  220 (273)
T d1xwsa_         156 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQ  220 (273)
T ss_dssp             TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCC
T ss_pred             ccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcc
Confidence            9998654432   334579999999999987665 577999999999999999999986421            011111


Q ss_pred             CCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          273 KPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      .          ..+.....++.+++.+||+.||.+|||+.|+++
T Consensus       221 ~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 V----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             C----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1          011122345888999999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.7e-47  Score=340.45  Aligned_cols=267  Identities=20%  Similarity=0.317  Sum_probs=209.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCC-CCcceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.....  ...+.+|++.++.+.| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            478999999999999999999976 688999998755432  2346678999999965 899999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC-----CCCeEEeeecCcc
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-----EFNPKIGDFGLAK  197 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~-----~~~~kL~Dfg~~~  197 (370)
                      |+ +++|.+++.   ..+..+++..+..++.|++.||.|||++   +|+||||||+|||++.     ++.+||+|||+++
T Consensus        82 ~~-~~~l~~~~~---~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          82 LL-GPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CC-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHH---hhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99 678888873   3445689999999999999999999999   9999999999999964     5679999999998


Q ss_pred             ccCCCCcc------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc
Q 017503          198 LFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE  271 (370)
Q Consensus       198 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  271 (370)
                      .+......      ......||+.|+|||++.+..++.++|||||||++|||+||..||.....................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            76543221      223457999999999999999999999999999999999999999765444333222222221111


Q ss_pred             CCCcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccCccc
Q 017503          272 EKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE  328 (370)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~  328 (370)
                      ....++    ....+    .++.+++..|+..+|.+||+++.+.+.|++++......
T Consensus       235 ~~~~~l----~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~  283 (293)
T d1csna_         235 TPLREL----CAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  283 (293)
T ss_dssp             SCHHHH----TTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CChHHh----cCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence            111111    11222    34777888899999999999999999998887644333

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=345.16  Aligned_cols=261  Identities=23%  Similarity=0.339  Sum_probs=196.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-C-CCEEEEEECcCcC--hhcHHHHHHHHHHHHhc---CCCCcceeeeEEEe----
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-N-GRRIAVKPLSAES--KQGVREFITEIMTLSNV---RHPNLVELIGCCVQ----  113 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~-~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~----  113 (370)
                      .++|++++.||+|+||+||+|++. + ++.||||++....  ......+.+|+.+|+.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            579999999999999999999974 3 5679999886432  22223455677777665   89999999999863    


Q ss_pred             -CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEee
Q 017503          114 -GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD  192 (370)
Q Consensus       114 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~D  192 (370)
                       ....+++||+++++++.....   .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             346789999999887765542   3455689999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcC
Q 017503          193 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE  272 (370)
Q Consensus       193 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (370)
                      ||++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....   ......+.......
T Consensus       160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~  234 (305)
T d1blxa_         160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLP  234 (305)
T ss_dssp             CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred             hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCC
Confidence            9998754332  233456799999999999999999999999999999999999999865422   11111121111110


Q ss_pred             CCc----------cccc----CCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          273 KPL----------ELVD----PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       273 ~~~----------~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                      ...          ....    .............+.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000          0000    0001122233345788999999999999999999876

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-47  Score=342.12  Aligned_cols=264  Identities=20%  Similarity=0.302  Sum_probs=199.3

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCC-cceeeeEEEeCCeeEEEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN-LVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e  122 (370)
                      .++|++.+.||+|+||.||+|++. +|+.||||++......  ..+..|+++++.++|+| |+.+.+++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            468999999999999999999975 6889999987654322  34678999999997766 4555566678889999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCC---CCCeEEeeecCcccc
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKLF  199 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kL~Dfg~~~~~  199 (370)
                      |+.+ +|...+.   .....+++..+..++.|++.||+|||++   +|+||||||+|||++.   +..++|+|||++..+
T Consensus        84 ~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          84 LLGP-SLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             CCCC-BHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EcCC-chhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            9955 5555542   3455799999999999999999999999   9999999999999864   456999999999976


Q ss_pred             CCCCcc------eeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          200 PDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       200 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||+||..||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            543221      23345799999999999999999999999999999999999999976544332222111111111010


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHHHHhhhccC
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN  325 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  325 (370)
                      . .       ......+.++.+++..||+.+|.+||++.++.+.|+.+....
T Consensus       237 ~-~-------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         237 I-E-------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             H-H-------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             h-h-------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            0 0       011122344788888999999999999999999998876543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=342.56  Aligned_cols=263  Identities=22%  Similarity=0.308  Sum_probs=197.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe--------
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--------  113 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------  113 (370)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++...  .......+.+|+.+|++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999985 7899999988654  33345678899999999999999999999865        


Q ss_pred             CCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeee
Q 017503          114 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF  193 (370)
Q Consensus       114 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Df  193 (370)
                      ....++||||+.++++..+.    .....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence            34578999999988777654    4555788999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCc---ceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHH
Q 017503          194 GLAKLFPDNIT---HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH  269 (370)
Q Consensus       194 g~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  269 (370)
                      |++........   .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....   ...........
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i~~~~  238 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLC  238 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHH
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH---HHHHHHHHHhc
Confidence            99986653221   122335689999999998765 689999999999999999999999865322   12222222222


Q ss_pred             hcCCCccc--c---------cC-CCCCCCh-H------HHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          270 QEEKPLEL--V---------DP-ELGEYPP-N------EIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       270 ~~~~~~~~--~---------~~-~~~~~~~-~------~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      ........  .         .. ....... .      ....+.+|+.+||+.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            11110000  0         00 0000011 1      12346789999999999999999999764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-46  Score=343.03  Aligned_cols=258  Identities=22%  Similarity=0.312  Sum_probs=194.3

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----  115 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  115 (370)
                      ..++|+++++||+|+||+||+|.++ +|+.||||++...  .....+.+.+|+.+|++++||||+++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3579999999999999999999985 6899999998754  3344567889999999999999999999998654     


Q ss_pred             -eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeec
Q 017503          116 -RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG  194 (370)
Q Consensus       116 -~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg  194 (370)
                       ..++||||+ +.+|..++.     ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence             469999999 557877762     34699999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc--
Q 017503          195 LAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE--  271 (370)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  271 (370)
                      ++......    .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||........   ..........  
T Consensus       167 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~  239 (346)
T d1cm8a_         167 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPP  239 (346)
T ss_dssp             TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCC
T ss_pred             ceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH---HHHHHhccCCCc
Confidence            99876543    2345689999999988764 568999999999999999999999865422111   1100000000  


Q ss_pred             ------CC----------CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          272 ------EK----------PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       272 ------~~----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                            ..          ........+..........+.+|+.+||+.||.+|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                  00          00000011111122233457889999999999999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-46  Score=333.03  Aligned_cols=261  Identities=20%  Similarity=0.288  Sum_probs=204.9

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCCeeEEEEE
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE  122 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  122 (370)
                      ++|++++.||+|+||+||+|++. +++.||||+++..  .......+.+|+.+|+.++||||+++++++.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            68999999999999999999985 6889999998644  33446788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccccCCC
Q 017503          123 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN  202 (370)
Q Consensus       123 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  202 (370)
                      ++.+++|..++    .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.+......
T Consensus        82 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ecccccccccc----ccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            99999988887    3456788999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeecccCCCCCCCcccccCCC-cCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc------
Q 017503          203 ITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL------  275 (370)
Q Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  275 (370)
                      ... .....++..|.|||.+.... ++.++|||||||++|||++|+.||.......  .....+..........      
T Consensus       155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGG
T ss_pred             Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhh
Confidence            322 22345678899999887665 6899999999999999999999875432211  1122121111110000      


Q ss_pred             --------cc--ccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          276 --------EL--VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       276 --------~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                              ..  ...............+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    00  001112223333455788999999999999999999865

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=344.19  Aligned_cols=262  Identities=23%  Similarity=0.306  Sum_probs=194.9

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc-ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----eeE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT----RRI  118 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~  118 (370)
                      .++|++++.||+|+||+||+|.++ +|+.||||++... .....+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            568999999999999999999974 7999999998654 3444567889999999999999999999987643    234


Q ss_pred             EEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          119 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       119 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                      ++++++.+++|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus        87 ~l~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          87 YLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence            5556677899999983     23689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcc--eeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCCCc
Q 017503          199 FPDNITH--ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL  275 (370)
Q Consensus       199 ~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (370)
                      .......  ......||+.|+|||++.. ..++.++||||+||++|+|++|+.||.........   .............
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~  235 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQE  235 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChh
Confidence            5433221  2234568999999998854 56789999999999999999999998654321111   1111110000000


Q ss_pred             c-------------cccCCCCC-----CChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          276 E-------------LVDPELGE-----YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       276 ~-------------~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                      .             ...+....     ..+....++.+++.+||+.||.+|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0             00000000     011222357899999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-46  Score=341.66  Aligned_cols=258  Identities=23%  Similarity=0.284  Sum_probs=193.2

Q ss_pred             CCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC------CeeEE
Q 017503           47 DFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TRRIL  119 (370)
Q Consensus        47 ~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~l  119 (370)
                      +|+..++||+|+||+||+|++. +|+.||||++..+...    ..+|+++|++++||||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6888999999999999999986 6899999998765322    23699999999999999999998643      34789


Q ss_pred             EEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-CeEEeeecCccc
Q 017503          120 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKL  198 (370)
Q Consensus       120 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kL~Dfg~~~~  198 (370)
                      ||||++++++..+. ........+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||++..
T Consensus        97 v~Ey~~~~~~~~l~-~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRVAR-HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHHHH-HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCccHHHHH-hhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence            99999876444332 2234566799999999999999999999999   999999999999999775 899999999987


Q ss_pred             cCCCCcceeecccCCCCCCCcccccC-CCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhc------
Q 017503          199 FPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE------  271 (370)
Q Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------  271 (370)
                      ......  .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.......  .+.. .......      
T Consensus       173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~-i~~~~g~~~~~~~  247 (350)
T d1q5ka_         173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVE-IIKVLGTPTREQI  247 (350)
T ss_dssp             CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHH-HHHHHCCCCHHHH
T ss_pred             ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHH-HHHHhCCChHHhh
Confidence            654322  234568999999998765 578999999999999999999999986543211  1111 1110000      


Q ss_pred             ----CCCcccccCCC------CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          272 ----EKPLELVDPEL------GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       272 ----~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                          .......-+..      ....+.....+.+|+.+||+.||.+|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                00000000000      01112234458899999999999999999999863

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=339.98  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=202.6

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC----CCCEEEEEECcCc----ChhcHHHHHHHHHHHHhcCC-CCcceeeeEEEeCC
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT----NGRRIAVKPLSAE----SKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGT  115 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~  115 (370)
                      .++|++.+.||+|+||+||+|+..    +|+.||||++...    +....+.+.+|+.++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            477999999999999999999863    4789999988643    22334567789999999966 89999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      ..+++|||+.+|+|.+++.    ....+++..+..++.||+.||.|||++   +++||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             ceeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence            9999999999999999983    444678899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeecccCCCCCCCcccccCC--CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC
Q 017503          196 AKLFPDNITHITTRIAGTTGYLAPEYVLGG--QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK  273 (370)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  273 (370)
                      +..+............|++.|++||.+.+.  .++.++|||||||+||+|++|..||...........  ......... 
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~~~~~-  252 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILKSE-  252 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHHCC-
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcccCC-
Confidence            987765544445556799999999998764  467899999999999999999999875533222111  111111111 


Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCC-----HHHHHH
Q 017503          274 PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-----MNQVIK  316 (370)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  316 (370)
                               ...+.....++.+++.+||+.||.+|||     ++|+++
T Consensus       253 ---------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                     1122334456888999999999999994     788865

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.1e-45  Score=333.33  Aligned_cols=257  Identities=19%  Similarity=0.276  Sum_probs=196.4

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeC--CeeEEE
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQG--TRRILV  120 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv  120 (370)
                      .++|+++++||+|+||+||+|++. +++.||||+++...   .+.+.+|+.+|++++ ||||+++++++...  ...++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            468999999999999999999985 68899999987543   356788999999995 99999999999853  568999


Q ss_pred             EEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCC-CeEEeeecCcccc
Q 017503          121 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLF  199 (370)
Q Consensus       121 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kL~Dfg~~~~~  199 (370)
                      |||+.+++|..+.       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++ .+||+|||++...
T Consensus       111 ~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         111 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence            9999999987553       3589999999999999999999999   999999999999998655 5999999999876


Q ss_pred             CCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHH-------HHHHHh-
Q 017503          200 PDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW-------AWQLHQ-  270 (370)
Q Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~-  270 (370)
                      .....  .....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||..............       ...... 
T Consensus       181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            54322  3345689999999988765 479999999999999999999999875544322111100       000000 


Q ss_pred             -cCCCccccc------------CCC-CCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          271 -EEKPLELVD------------PEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       271 -~~~~~~~~~------------~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                       .........            ... .........++.+|+.+||+.||.+|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000000000            000 0111223345789999999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-45  Score=337.58  Aligned_cols=261  Identities=21%  Similarity=0.245  Sum_probs=191.8

Q ss_pred             ccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEe------CC
Q 017503           45 TDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ------GT  115 (370)
Q Consensus        45 ~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~  115 (370)
                      .++|+++++||+|+||+||+|+++ +|+.||||++...  +......+.+|+.+|++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            478999999999999999999986 6899999998754  34445678899999999999999999999964      36


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      ..|+||||+.++++..+.       ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++.++++|||+
T Consensus        96 ~~~iv~Ey~~~~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eeEEEEeccchHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence            789999999876665442       3588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchhhHH-------------
Q 017503          196 AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL-------------  262 (370)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~-------------  262 (370)
                      +......  .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||............             
T Consensus       166 ~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            8865432  2234456899999999999999999999999999999999999998644221110000             


Q ss_pred             ---HHHHHHHhcCCCcc----------cccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHHH
Q 017503          263 ---EWAWQLHQEEKPLE----------LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM  317 (370)
Q Consensus       263 ---~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  317 (370)
                         ..............          ...+............+.+|+.+||+.||.+|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               00000111110000          00000011123345668899999999999999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-45  Score=335.33  Aligned_cols=258  Identities=22%  Similarity=0.297  Sum_probs=194.1

Q ss_pred             hccCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCc--ChhcHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----C
Q 017503           44 ATDDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----T  115 (370)
Q Consensus        44 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~  115 (370)
                      ..++|++.++||+|+||+||+|++. +|+.||||++...  +......+.+|+.+|++++|||++++++++...     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            4679999999999999999999975 6899999998754  334456788999999999999999999998643     3


Q ss_pred             eeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeEEeeecC
Q 017503          116 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL  195 (370)
Q Consensus       116 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~  195 (370)
                      ..+++++++.+|+|.+++.     ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+
T Consensus        96 ~~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             ceEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence            4467778888999999983     34699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeecccCCCCCCCcccccCC-CcCccccchhhhHHHHHHHhCCCCCCcccccchhhHHHHHHHHHhcCC-
Q 017503          196 AKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK-  273 (370)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  273 (370)
                      +.....    ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.......   ....+........ 
T Consensus       168 a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         168 ARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGA  240 (348)
T ss_dssp             --CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCH
T ss_pred             hcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCh
Confidence            875432    23345688899999987765 46899999999999999999999986542211   1111111110000 


Q ss_pred             -----------------CcccccCCCCCCChHHHHHHHHHHHHchhhccCCCCCHHHHHH
Q 017503          274 -----------------PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK  316 (370)
Q Consensus       274 -----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  316 (370)
                                       ........+..........+.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                             0000000000001122344788999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-39  Score=301.28  Aligned_cols=260  Identities=21%  Similarity=0.255  Sum_probs=189.7

Q ss_pred             cCCcccceeeecCCeEEEEEEEC-CCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-----------CCCcceeeeEEEe
Q 017503           46 DDFHLSNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-----------HPNLVELIGCCVQ  113 (370)
Q Consensus        46 ~~y~~~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~  113 (370)
                      ++|+++++||+|+||+||+|++. +|+.||||+++.+.. ..+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46999999999999999999985 689999999876532 2456778998888775           5789999988764


Q ss_pred             --CCeeEEEEEecCCCCH-HHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCceEeCCCCC--
Q 017503          114 --GTRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFN--  187 (370)
Q Consensus       114 --~~~~~lv~e~~~~~~L-~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~dlkp~Nill~~~~~--  187 (370)
                        ....+++++++..+.. ....  .......+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++.  
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALI--KKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHH--HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred             ccccceeeeeeeccccccccccc--ccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence              4556677776655432 2222  12445568899999999999999999998 6   8999999999999986553  


Q ss_pred             ----eEEeeecCccccCCCCcceeecccCCCCCCCcccccCCCcCccccchhhhHHHHHHHhCCCCCCcccccchh----
Q 017503          188 ----PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK----  259 (370)
Q Consensus       188 ----~kL~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~p~~~~~~~~~~----  259 (370)
                          ++++|||.+......    .....||+.|+|||++....++.++||||+||++++|++|+.||.........    
T Consensus       167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence                899999998755432    23456899999999999999999999999999999999999998654322111    


Q ss_pred             hHHHHHHHHHhc------------------CCCcccccC-----------CCCCCChHHHHHHHHHHHHchhhccCCCCC
Q 017503          260 FLLEWAWQLHQE------------------EKPLELVDP-----------ELGEYPPNEIIRYMKVAFFCTQAAASRRPQ  310 (370)
Q Consensus       260 ~~~~~~~~~~~~------------------~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  310 (370)
                      .+.... .....                  ......+..           ............+.+|+.+||+.||.+|||
T Consensus       243 ~~~~~~-~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         243 HIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHH-HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            111111 11000                  000000000           012334567778999999999999999999


Q ss_pred             HHHHHH
Q 017503          311 MNQVIK  316 (370)
Q Consensus       311 ~~evl~  316 (370)
                      ++|+++
T Consensus       322 a~e~L~  327 (362)
T d1q8ya_         322 AGGLVN  327 (362)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.1e-24  Score=182.14  Aligned_cols=165  Identities=16%  Similarity=0.132  Sum_probs=121.0

Q ss_pred             CcccceeeecCCeEEEEEEECCCCEEEEEECcCcC------------------hhcHHHHHHHHHHHHhcCCCCcceeee
Q 017503           48 FHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAES------------------KQGVREFITEIMTLSNVRHPNLVELIG  109 (370)
Q Consensus        48 y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~~iv~~~~  109 (370)
                      +.+.++||+|+||.||+|++.+|+.||||++....                  .........|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            35678999999999999999889999999764321                  011223456888899999999988776


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCceEeCCCCCeE
Q 017503          110 CCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK  189 (370)
Q Consensus       110 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  189 (370)
                      +.    ..+++|||+++..+.           .++...+..++.|++.||.|||+.   +|+||||||+|||++++ .++
T Consensus        82 ~~----~~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          82 WE----GNAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             EE----TTEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred             ec----CCEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence            53    237999999875443           244455678999999999999999   99999999999999865 589


Q ss_pred             EeeecCccccCCCCcceeecccCCCCCCCc--c---cccCCCcCccccchhhhHHH
Q 017503          190 IGDFGLAKLFPDNITHITTRIAGTTGYLAP--E---YVLGGQLTMKADVYSFGVLV  240 (370)
Q Consensus       190 L~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP--E---~~~~~~~~~~~Di~slG~il  240 (370)
                      |+|||++.........         .|...  +   .+....|+.++|+||+.--+
T Consensus       143 liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         143 IIDFPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ECCCTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             EEECCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            9999998765433211         01110  0   01235678899999987544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.90  E-value=4.7e-09  Score=90.17  Aligned_cols=149  Identities=13%  Similarity=0.055  Sum_probs=103.8

Q ss_pred             HHHHHhccCCcccceeeecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCee
Q 017503           39 TELRSATDDFHLSNKIGRGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRR  117 (370)
Q Consensus        39 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  117 (370)
                      .+++...+.|++.+..+.+..+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+.+..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            46677778888777765555678998865 46677888776554333345667888887773 33467778888888999


Q ss_pred             EEEEEecCCCCHHHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 017503          118 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-------------------------------  166 (370)
Q Consensus       118 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------  166 (370)
                      ++||++++|.++......         ......++.+++..+..||+..                               
T Consensus        86 ~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            999999999888655411         1112234555666666666430                               


Q ss_pred             -------------------------CCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          167 -------------------------VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       167 -------------------------~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                                               .+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                     1137899999999999877666799999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.33  E-value=7e-07  Score=75.73  Aligned_cols=130  Identities=17%  Similarity=0.110  Sum_probs=85.0

Q ss_pred             eeeecCC-eEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCC--CCcceeeeEEEeCCeeEEEEEecCCCCH
Q 017503           53 KIGRGGF-GTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH--PNLVELIGCCVQGTRRILVYEYVENNSL  129 (370)
Q Consensus        53 ~lg~G~~-g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L  129 (370)
                      .+..|.. +.||+....++..+++|........   .+..|+..++.+..  -.+.+++.+..+.+..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455554 5789998887888899976554332   35567777777632  3356778888888889999999987654


Q ss_pred             HHHhcccccCCccCCHHHHHHHHHHHHHHHHHHhhc--------------------------------------------
Q 017503          130 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE--------------------------------------------  165 (370)
Q Consensus       130 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------------------------------------------  165 (370)
                      ....         ...   ...+.++...|..||+.                                            
T Consensus        94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            3210         111   11222333344444421                                            


Q ss_pred             -------C----CCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          166 -------L----VPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       166 -------~----~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                             .    .+.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                   1    1137999999999999887667899999765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.88  E-value=3e-05  Score=69.92  Aligned_cols=76  Identities=16%  Similarity=0.149  Sum_probs=47.4

Q ss_pred             cceeeecCCeEEEEEEEC-CCCEEEEEECcCc-------ChhcHHHHHHHHHHHHhc-CC-C-CcceeeeEEEeCCeeEE
Q 017503           51 SNKIGRGGFGTVYKGTLT-NGRRIAVKPLSAE-------SKQGVREFITEIMTLSNV-RH-P-NLVELIGCCVQGTRRIL  119 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~-~~~~vaiK~~~~~-------~~~~~~~~~~e~~~l~~l-~h-~-~iv~~~~~~~~~~~~~l  119 (370)
                      .+.||.|....||++... +++.|++|.-...       -.....+...|++.|+.+ .+ | .+.+++.  .+....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence            457899999999999865 4678999954321       111223445688888766 22 3 3444443  35666789


Q ss_pred             EEEecCCCC
Q 017503          120 VYEYVENNS  128 (370)
Q Consensus       120 v~e~~~~~~  128 (370)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.43  E-value=0.00076  Score=58.68  Aligned_cols=163  Identities=14%  Similarity=0.074  Sum_probs=87.9

Q ss_pred             ccccCHHHHHHhccCCc--cc-ceee-ecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCc----
Q 017503           33 VNHFSYTELRSATDDFH--LS-NKIG-RGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL----  104 (370)
Q Consensus        33 ~~~~~~~~~~~~~~~y~--~~-~~lg-~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i----  104 (370)
                      +..++.+.+..+.+.+-  .. +.+- .+.-..||++...+|..|++|+.... ......+..|...+..|...++    
T Consensus         5 f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~   83 (325)
T d1zyla1           5 FQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAA   83 (325)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             ccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCC
Confidence            44566666666654431  11 1111 23346899999999999999987543 2234567778888877632221    


Q ss_pred             -ceee--eEEEeCCeeEEEEEecCCCCH-----HHHh-------------cccc-cCCccCC------------------
Q 017503          105 -VELI--GCCVQGTRRILVYEYVENNSL-----DRVL-------------LGAT-KANIKLN------------------  144 (370)
Q Consensus       105 -v~~~--~~~~~~~~~~lv~e~~~~~~L-----~~~~-------------~~~~-~~~~~l~------------------  144 (370)
                       +..-  ..+......+.+++++.|..+     ..+.             .... ......+                  
T Consensus        84 p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~  163 (325)
T d1zyla1          84 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  163 (325)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             ceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcC
Confidence             1111  123445667889999876321     1111             1000 0001111                  


Q ss_pred             -HH---HHHHHHHHHHHHHHHHh-hcCCCCeEeecCCCCceEeCCCCCeEEeeecCccc
Q 017503          145 -WE---KRSDICVGIAKGLAFLH-EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL  198 (370)
Q Consensus       145 -~~---~~~~i~~qi~~al~~LH-~~~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~~  198 (370)
                       ..   .....+..+...+...- +..+.+++|+|+.+.|||++++  ..++||+.+..
T Consensus       164 ~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         164 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence             11   11222333333333221 2224479999999999999743  45899998763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.38  E-value=0.00045  Score=61.93  Aligned_cols=73  Identities=14%  Similarity=0.209  Sum_probs=48.3

Q ss_pred             cceeeecCCeEEEEEEECC--------CCEEEEEECcCcChhcHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCeeEEEE
Q 017503           51 SNKIGRGGFGTVYKGTLTN--------GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVY  121 (370)
Q Consensus        51 ~~~lg~G~~g~v~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~  121 (370)
                      ++.|+.|-...+|++...+        ...|++++.....  ......+|..+++.+.-.++ .++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3577778888999998653        3567777765322  23455678888888843344 466666532    5789


Q ss_pred             EecCCCCH
Q 017503          122 EYVENNSL  129 (370)
Q Consensus       122 e~~~~~~L  129 (370)
                      ||++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.14  E-value=0.0067  Score=52.01  Aligned_cols=159  Identities=13%  Similarity=0.059  Sum_probs=83.6

Q ss_pred             cCHHHHHHhccCCcccceee-----ecCCeEEEEEEECCCCEEEEEECcCcChhcHHHHHHHHHHHHhcCC-----CCcc
Q 017503           36 FSYTELRSATDDFHLSNKIG-----RGGFGTVYKGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-----PNLV  105 (370)
Q Consensus        36 ~~~~~~~~~~~~y~~~~~lg-----~G~~g~v~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-----~~iv  105 (370)
                      ++.+++.....+|.+.+...     .|--.+.|+....+| .+++|++.....  ...+..++..+..|..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            57788999999998765544     455577899987655 589998754321  1233445666665532     2222


Q ss_pred             eee---eEEEeCCeeEEEEEecCCCCH-----HHHh---------c----ccc--cCC-----------------ccCCH
Q 017503          106 ELI---GCCVQGTRRILVYEYVENNSL-----DRVL---------L----GAT--KAN-----------------IKLNW  145 (370)
Q Consensus       106 ~~~---~~~~~~~~~~lv~e~~~~~~L-----~~~~---------~----~~~--~~~-----------------~~l~~  145 (370)
                      ...   .+..-......++.+..+...     ....         +    ...  ...                 .....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            110   011223445566666554311     1100         0    000  000                 00011


Q ss_pred             HHHHHHHHHHHHHHHHHhhc-CCCCeEeecCCCCceEeCCCCCeEEeeecCcc
Q 017503          146 EKRSDICVGIAKGLAFLHEE-LVPHIVHRDIKASNILLDQEFNPKIGDFGLAK  197 (370)
Q Consensus       146 ~~~~~i~~qi~~al~~LH~~-~~~~iiH~dlkp~Nill~~~~~~kL~Dfg~~~  197 (370)
                      ......+..+...+...+.. .+.++||+|+.++||+++.+...-+.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            11222233333333333332 23389999999999999988777899999875